qtype,question,answer,possible_ambiguities,ambiguous_question,unambiguous_question,domain_idx,domain,dtype,intent,top_10_full_form,top_10_full_form_sources,llm_full_form_suggestions,MLM_ground_truth_full_form_prob,MLM_llm_full_form_suggestion_prob,MLM_most_likely_full_forms,MLM_most_likely_full_form_probs,MLM_most_likely_selection_types,MLM_top_10_full_form_probs,TE_ground_truth_full_form_prob,TE_llm_full_form_suggestion_prob,TE_most_likely_full_forms,TE_most_likely_full_form_probs,TE_most_likely_selection_types,TE_top_10_full_form_probs,LLM_most_likely_full_forms,LLM_most_likely_selection_types,disambiguated_question,MLM_0_disambiguated_question_answered_by_gpt35_correct,MLM_0_unambiguous_question_answered_by_gpt35_correct,MLM_0_ambiguous_question_answered_by_gpt35_correct,MLM_0_disambiguated_question_answered_by_gpt35,MLM_0_unambiguous_question_answered_by_gpt35,MLM_0_ambiguous_question_answered_by_gpt35,MLM_1_disambiguated_question_answered_by_gpt35_correct,MLM_1_unambiguous_question_answered_by_gpt35_correct,MLM_1_ambiguous_question_answered_by_gpt35_correct,MLM_1_disambiguated_question_answered_by_gpt35,MLM_1_unambiguous_question_answered_by_gpt35,MLM_1_ambiguous_question_answered_by_gpt35,MLM_2_disambiguated_question_answered_by_gpt35_correct,MLM_2_unambiguous_question_answered_by_gpt35_correct,MLM_2_ambiguous_question_answered_by_gpt35_correct,MLM_2_disambiguated_question_answered_by_gpt35,MLM_2_unambiguous_question_answered_by_gpt35,MLM_2_ambiguous_question_answered_by_gpt35,MLM_3_disambiguated_question_answered_by_gpt35_correct,MLM_3_unambiguous_question_answered_by_gpt35_correct,MLM_3_ambiguous_question_answered_by_gpt35_correct,MLM_3_disambiguated_question_answered_by_gpt35,MLM_3_unambiguous_question_answered_by_gpt35,MLM_3_ambiguous_question_answered_by_gpt35,TE_0_disambiguated_question_answered_by_gpt35_correct,TE_0_unambiguous_question_answered_by_gpt35_correct,TE_0_ambiguous_question_answered_by_gpt35_correct,TE_0_disambiguated_question_answered_by_gpt35,TE_0_unambiguous_question_answered_by_gpt35,TE_0_ambiguous_question_answered_by_gpt35,TE_1_disambiguated_question_answered_by_gpt35_correct,TE_1_unambiguous_question_answered_by_gpt35_correct,TE_1_ambiguous_question_answered_by_gpt35_correct,TE_1_disambiguated_question_answered_by_gpt35,TE_1_unambiguous_question_answered_by_gpt35,TE_1_ambiguous_question_answered_by_gpt35,TE_2_disambiguated_question_answered_by_gpt35_correct,TE_2_unambiguous_question_answered_by_gpt35_correct,TE_2_ambiguous_question_answered_by_gpt35_correct,TE_2_disambiguated_question_answered_by_gpt35,TE_2_unambiguous_question_answered_by_gpt35,TE_2_ambiguous_question_answered_by_gpt35,TE_3_disambiguated_question_answered_by_gpt35_correct,TE_3_unambiguous_question_answered_by_gpt35_correct,TE_3_ambiguous_question_answered_by_gpt35_correct,TE_3_disambiguated_question_answered_by_gpt35,TE_3_unambiguous_question_answered_by_gpt35,TE_3_ambiguous_question_answered_by_gpt35,LLMSelection_1_disambiguated_question_answered_by_gpt35_correct,LLMSelection_1_unambiguous_question_answered_by_gpt35_correct,LLMSelection_1_ambiguous_question_answered_by_gpt35_correct,LLMSelection_1_disambiguated_question_answered_by_gpt35,LLMSelection_1_unambiguous_question_answered_by_gpt35,LLMSelection_1_ambiguous_question_answered_by_gpt35,LLMSelection_0_disambiguated_question_answered_by_gpt35_correct,LLMSelection_0_unambiguous_question_answered_by_gpt35_correct,LLMSelection_0_ambiguous_question_answered_by_gpt35_correct,LLMSelection_0_disambiguated_question_answered_by_gpt35,LLMSelection_0_unambiguous_question_answered_by_gpt35,LLMSelection_0_ambiguous_question_answered_by_gpt35,LLMSelection_2_disambiguated_question_answered_by_gpt35_correct,LLMSelection_2_unambiguous_question_answered_by_gpt35_correct,LLMSelection_2_ambiguous_question_answered_by_gpt35_correct,LLMSelection_2_disambiguated_question_answered_by_gpt35,LLMSelection_2_unambiguous_question_answered_by_gpt35,LLMSelection_2_ambiguous_question_answered_by_gpt35,LLMSelection_3_disambiguated_question_answered_by_gpt35_correct,LLMSelection_3_unambiguous_question_answered_by_gpt35_correct,LLMSelection_3_ambiguous_question_answered_by_gpt35_correct,LLMSelection_3_disambiguated_question_answered_by_gpt35,LLMSelection_3_unambiguous_question_answered_by_gpt35,LLMSelection_3_ambiguous_question_answered_by_gpt35,LLMSelection_NO_INTENT_0_disambiguated_question_answered_by_gpt35_correct,LLMSelection_NO_INTENT_0_unambiguous_question_answered_by_gpt35_correct,LLMSelection_NO_INTENT_0_ambiguous_question_answered_by_gpt35_correct,LLMSelection_NO_INTENT_0_disambiguated_question_answered_by_gpt35,LLMSelection_NO_INTENT_0_unambiguous_question_answered_by_gpt35,LLMSelection_NO_INTENT_0_ambiguous_question_answered_by_gpt35,LLMSelection_NO_INTENT_1_disambiguated_question_answered_by_gpt35_correct,LLMSelection_NO_INTENT_1_unambiguous_question_answered_by_gpt35_correct,LLMSelection_NO_INTENT_1_ambiguous_question_answered_by_gpt35_correct,LLMSelection_NO_INTENT_1_disambiguated_question_answered_by_gpt35,LLMSelection_NO_INTENT_1_unambiguous_question_answered_by_gpt35,LLMSelection_NO_INTENT_1_ambiguous_question_answered_by_gpt35,LLMSelection_NO_INTENT_2_disambiguated_question_answered_by_gpt35_correct,LLMSelection_NO_INTENT_2_unambiguous_question_answered_by_gpt35_correct,LLMSelection_NO_INTENT_2_ambiguous_question_answered_by_gpt35_correct,LLMSelection_NO_INTENT_2_disambiguated_question_answered_by_gpt35,LLMSelection_NO_INTENT_2_unambiguous_question_answered_by_gpt35,LLMSelection_NO_INTENT_2_ambiguous_question_answered_by_gpt35,LLMSelection_NO_INTENT_3_disambiguated_question_answered_by_gpt35_correct,LLMSelection_NO_INTENT_3_unambiguous_question_answered_by_gpt35_correct,LLMSelection_NO_INTENT_3_ambiguous_question_answered_by_gpt35_correct,LLMSelection_NO_INTENT_3_disambiguated_question_answered_by_gpt35,LLMSelection_NO_INTENT_3_unambiguous_question_answered_by_gpt35,LLMSelection_NO_INTENT_3_ambiguous_question_answered_by_gpt35,LLMSelection_NO_DOMAIN_0_disambiguated_question_answered_by_gpt35_correct,LLMSelection_NO_DOMAIN_0_unambiguous_question_answered_by_gpt35_correct,LLMSelection_NO_DOMAIN_0_ambiguous_question_answered_by_gpt35_correct,LLMSelection_NO_DOMAIN_0_disambiguated_question_answered_by_gpt35,LLMSelection_NO_DOMAIN_0_unambiguous_question_answered_by_gpt35,LLMSelection_NO_DOMAIN_0_ambiguous_question_answered_by_gpt35,LLMSelection_NO_DOMAIN_1_disambiguated_question_answered_by_gpt35_correct,LLMSelection_NO_DOMAIN_1_unambiguous_question_answered_by_gpt35_correct,LLMSelection_NO_DOMAIN_1_ambiguous_question_answered_by_gpt35_correct,LLMSelection_NO_DOMAIN_1_disambiguated_question_answered_by_gpt35,LLMSelection_NO_DOMAIN_1_unambiguous_question_answered_by_gpt35,LLMSelection_NO_DOMAIN_1_ambiguous_question_answered_by_gpt35,LLMSelection_NO_DOMAIN_2_disambiguated_question_answered_by_gpt35_correct,LLMSelection_NO_DOMAIN_2_unambiguous_question_answered_by_gpt35_correct,LLMSelection_NO_DOMAIN_2_ambiguous_question_answered_by_gpt35_correct,LLMSelection_NO_DOMAIN_2_disambiguated_question_answered_by_gpt35,LLMSelection_NO_DOMAIN_2_unambiguous_question_answered_by_gpt35,LLMSelection_NO_DOMAIN_2_ambiguous_question_answered_by_gpt35,LLMSelection_NO_DOMAIN_3_disambiguated_question_answered_by_gpt35_correct,LLMSelection_NO_DOMAIN_3_unambiguous_question_answered_by_gpt35_correct,LLMSelection_NO_DOMAIN_3_ambiguous_question_answered_by_gpt35_correct,LLMSelection_NO_DOMAIN_3_disambiguated_question_answered_by_gpt35,LLMSelection_NO_DOMAIN_3_unambiguous_question_answered_by_gpt35,LLMSelection_NO_DOMAIN_3_ambiguous_question_answered_by_gpt35,LLMSuggestion_0_disambiguated_question_answered_by_gpt35_correct,LLMSuggestion_0_unambiguous_question_answered_by_gpt35_correct,LLMSuggestion_0_ambiguous_question_answered_by_gpt35_correct,LLMSuggestion_0_disambiguated_question_answered_by_gpt35,LLMSuggestion_0_unambiguous_question_answered_by_gpt35,LLMSuggestion_0_ambiguous_question_answered_by_gpt35,LLMSuggestion_1_disambiguated_question_answered_by_gpt35_correct,LLMSuggestion_1_unambiguous_question_answered_by_gpt35_correct,LLMSuggestion_1_ambiguous_question_answered_by_gpt35_correct,LLMSuggestion_1_disambiguated_question_answered_by_gpt35,LLMSuggestion_1_unambiguous_question_answered_by_gpt35,LLMSuggestion_1_ambiguous_question_answered_by_gpt35,LLMSuggestion_2_disambiguated_question_answered_by_gpt35_correct,LLMSuggestion_2_unambiguous_question_answered_by_gpt35_correct,LLMSuggestion_2_ambiguous_question_answered_by_gpt35_correct,LLMSuggestion_2_disambiguated_question_answered_by_gpt35,LLMSuggestion_2_unambiguous_question_answered_by_gpt35,LLMSuggestion_2_ambiguous_question_answered_by_gpt35,LLMSuggestion_3_disambiguated_question_answered_by_gpt35_correct,LLMSuggestion_3_unambiguous_question_answered_by_gpt35_correct,LLMSuggestion_3_ambiguous_question_answered_by_gpt35_correct,LLMSuggestion_3_disambiguated_question_answered_by_gpt35,LLMSuggestion_3_unambiguous_question_answered_by_gpt35,LLMSuggestion_3_ambiguous_question_answered_by_gpt35,LLMSelection_NO_DTYPE_0_disambiguated_question_answered_by_gpt35_correct,LLMSelection_NO_DTYPE_0_unambiguous_question_answered_by_gpt35_correct,LLMSelection_NO_DTYPE_0_ambiguous_question_answered_by_gpt35_correct,LLMSelection_NO_DTYPE_0_disambiguated_question_answered_by_gpt35,LLMSelection_NO_DTYPE_0_unambiguous_question_answered_by_gpt35,LLMSelection_NO_DTYPE_0_ambiguous_question_answered_by_gpt35,LLMSelection_NO_DTYPE_1_disambiguated_question_answered_by_gpt35_correct,LLMSelection_NO_DTYPE_1_unambiguous_question_answered_by_gpt35_correct,LLMSelection_NO_DTYPE_1_ambiguous_question_answered_by_gpt35_correct,LLMSelection_NO_DTYPE_1_disambiguated_question_answered_by_gpt35,LLMSelection_NO_DTYPE_1_unambiguous_question_answered_by_gpt35,LLMSelection_NO_DTYPE_1_ambiguous_question_answered_by_gpt35,LLMSelection_NO_DTYPE_2_disambiguated_question_answered_by_gpt35_correct,LLMSelection_NO_DTYPE_2_unambiguous_question_answered_by_gpt35_correct,LLMSelection_NO_DTYPE_2_ambiguous_question_answered_by_gpt35_correct,LLMSelection_NO_DTYPE_2_disambiguated_question_answered_by_gpt35,LLMSelection_NO_DTYPE_2_unambiguous_question_answered_by_gpt35,LLMSelection_NO_DTYPE_2_ambiguous_question_answered_by_gpt35,LLMSelection_NO_DTYPE_3_disambiguated_question_answered_by_gpt35_correct,LLMSelection_NO_DTYPE_3_unambiguous_question_answered_by_gpt35_correct,LLMSelection_NO_DTYPE_3_ambiguous_question_answered_by_gpt35_correct,LLMSelection_NO_DTYPE_3_disambiguated_question_answered_by_gpt35,LLMSelection_NO_DTYPE_3_unambiguous_question_answered_by_gpt35,LLMSelection_NO_DTYPE_3_ambiguous_question_answered_by_gpt35,LLMSelection_NO_INTENT_NO_DOMAIN_NO_DTYPE_0_disambiguated_question_answered_by_gpt35_correct,LLMSelection_NO_INTENT_NO_DOMAIN_NO_DTYPE_0_unambiguous_question_answered_by_gpt35_correct,LLMSelection_NO_INTENT_NO_DOMAIN_NO_DTYPE_0_ambiguous_question_answered_by_gpt35_correct,LLMSelection_NO_INTENT_NO_DOMAIN_NO_DTYPE_0_disambiguated_question_answered_by_gpt35,LLMSelection_NO_INTENT_NO_DOMAIN_NO_DTYPE_0_unambiguous_question_answered_by_gpt35,LLMSelection_NO_INTENT_NO_DOMAIN_NO_DTYPE_0_ambiguous_question_answered_by_gpt35,MLM_NO_INTENT_NO_DOMAIN_NO_DTYPE_0_disambiguated_question_answered_by_gpt35_correct,MLM_NO_INTENT_NO_DOMAIN_NO_DTYPE_0_unambiguous_question_answered_by_gpt35_correct,MLM_NO_INTENT_NO_DOMAIN_NO_DTYPE_0_ambiguous_question_answered_by_gpt35_correct,MLM_NO_INTENT_NO_DOMAIN_NO_DTYPE_0_disambiguated_question_answered_by_gpt35,MLM_NO_INTENT_NO_DOMAIN_NO_DTYPE_0_unambiguous_question_answered_by_gpt35,MLM_NO_INTENT_NO_DOMAIN_NO_DTYPE_0_ambiguous_question_answered_by_gpt35,TE_NO_INTENT_NO_DOMAIN_NO_DTYPE_0_disambiguated_question_answered_by_gpt35_correct,TE_NO_INTENT_NO_DOMAIN_NO_DTYPE_0_unambiguous_question_answered_by_gpt35_correct,TE_NO_INTENT_NO_DOMAIN_NO_DTYPE_0_ambiguous_question_answered_by_gpt35_correct,TE_NO_INTENT_NO_DOMAIN_NO_DTYPE_0_disambiguated_question_answered_by_gpt35,TE_NO_INTENT_NO_DOMAIN_NO_DTYPE_0_unambiguous_question_answered_by_gpt35,TE_NO_INTENT_NO_DOMAIN_NO_DTYPE_0_ambiguous_question_answered_by_gpt35,LLMSuggestion_NO_INTENT_NO_DOMAIN_NO_DTYPE_0_disambiguated_question_answered_by_gpt35_correct,LLMSuggestion_NO_INTENT_NO_DOMAIN_NO_DTYPE_0_unambiguous_question_answered_by_gpt35_correct,LLMSuggestion_NO_INTENT_NO_DOMAIN_NO_DTYPE_0_ambiguous_question_answered_by_gpt35_correct,LLMSuggestion_NO_INTENT_NO_DOMAIN_NO_DTYPE_0_disambiguated_question_answered_by_gpt35,LLMSuggestion_NO_INTENT_NO_DOMAIN_NO_DTYPE_0_unambiguous_question_answered_by_gpt35,LLMSuggestion_NO_INTENT_NO_DOMAIN_NO_DTYPE_0_ambiguous_question_answered_by_gpt35
symptoms,What are the symptoms of Familial hypocalciuric hypercalcemia type 3 ?,"What are the signs and symptoms of Familial hypocalciuric hypercalcemia type 3? The Human Phenotype Ontology provides the following list of signs and symptoms for Familial hypocalciuric hypercalcemia type 3. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Nephrolithiasis 5% Peptic ulcer 5% Chondrocalcinosis - Hypercalcemia - Hypermagnesemia - Hypocalciuria - Multiple lipomas - Pancreatitis - Parathormone-independent increased renal tubular calcium reabsorption - Primary hyperparathyroidism - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""FHH3"", ""full_form"": ""Familial hypocalciuric hypercalcemia type 3""}]}",What are the symptoms of FHH3 ?,What are the symptoms of Familial hypocalciuric hypercalcemia type 3 ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.",[[]],[[]],"[""Familial Hyperparathyroidism Type 3""]",[2.1604149052075387e-32],[6.859245830870318e-17],"[""Familial Hyperparathyroidism Type 3""]",[6.859245830870318e-17],"[""LLM""]",[[]],[0.8547889687016218],[0.8614673228118256],"[""Familial hypocalciuric hypercalcemia type 3""]",[0.8614673228118256],"[""LLM""]",[[]],"[""Familial Hyperparathyroidism Type 3""]","[""LLM""]",What are the symptoms of FHH3 (Familial Hyperparathyroidism Type 3) ?,[false],[true],[false],"[""Symptoms of FHH3 include high levels of calcium in the blood (hypercalcemia), kidney stones, bone pain, and fractures.""]","[""Symptoms of Familial hypocalciuric hypercalcemia type 3 include high blood calcium levels, low urinary calcium levels, and a family history of the condition.""]","[""Symptoms of FHH3 include hypercalcemia, low levels of parathyroid hormone, and elevated levels of calcium in the urine.""]",[true],[true],[true],"[""Symptoms of FHH3 include high levels of calcium in the blood, kidney stones, bone pain, and muscle weakness.""]","[""Symptoms of Familial hypocalciuric hypercalcemia type 3 include high calcium levels in the blood, low levels of calcium in the urine, and may include symptoms such as fatigue, weakness, frequent urination, and kidney stones.""]","[""Symptoms of FHH3 include hypercalcemia, low levels of parathyroid hormone, and kidney stones.""]",[false],[true],[false],"[""Symptoms of FHH3 (Familial Hyperparathyroidism Type 3) include high calcium levels in the blood, kidney stones, bone pain, and weakened bones.""]","[""Symptoms of Familial hypocalciuric hypercalcemia type 3 include high levels of calcium in the blood, low levels of calcium in the urine, and often no symptoms at all.""]","[""Symptoms of FHH3 include hypercalcemia, hypophosphatemia, and low levels of parathyroid hormone.""]",[false],[true],[false],"[""Symptoms of FHH3 include high calcium levels in the blood, kidney stones, bone pain, and muscle weakness.""]","[""Symptoms of Familial hypocalciuric hypercalcemia type 3 include high blood calcium levels, low urinary calcium levels, and a family history of the condition.""]","[""Hypercalcemia, hypophosphatemia, and elevated PTH levels""]",[true],[true],[false],"[""Symptoms of FHH3 include high blood calcium levels, low urinary calcium excretion, and a family history of hypercalcemia.""]","[""Symptoms of Familial hypocalciuric hypercalcemia type 3 include high blood calcium levels, low urinary calcium levels, and a family history of the condition.""]","[""Symptoms of FHH3 include hypercalcemia, low levels of parathyroid hormone, and elevated levels of calcium in the urine.""]",[false],[true],[true],"[""Symptoms of FHH3 include high levels of calcium in the blood, low levels of calcium in the urine, and a family history of hypercalcemia.""]","[""Symptoms of Familial hypocalciuric hypercalcemia type 3 include high calcium levels in the blood, low levels of calcium in the urine, and may include symptoms such as fatigue, weakness, frequent urination, and kidney stones.""]","[""Symptoms of FHH3 include hypercalcemia, low levels of parathyroid hormone, and kidney stones.""]",[false],[true],[false],"[""Symptoms of FHH3 include high levels of calcium in the blood, low levels of calcium in the urine, and a family history of hypercalcemia.""]","[""Symptoms of Familial hypocalciuric hypercalcemia type 3 include high levels of calcium in the blood, low levels of calcium in the urine, and often no symptoms at all.""]","[""Symptoms of FHH3 include hypercalcemia, hypophosphatemia, and low levels of parathyroid hormone.""]",[true],[true],[false],"[""Symptoms of FHH3 include high levels of calcium in the blood, low levels of calcium in the urine, and a family history of hypercalcemia.""]","[""Symptoms of Familial hypocalciuric hypercalcemia type 3 include high blood calcium levels, low urinary calcium levels, and a family history of the condition.""]","[""Hypercalcemia, hypophosphatemia, and elevated PTH levels""]",[false],[true],[true],"[""Symptoms of FHH3 (Familial Hyperparathyroidism Type 3) include high levels of calcium in the blood (hypercalcemia), kidney stones, bone pain, and fractures.""]","[""Symptoms of Familial hypocalciuric hypercalcemia type 3 include high calcium levels in the blood, low levels of calcium in the urine, and may include symptoms such as fatigue, weakness, frequent urination, and kidney stones.""]","[""Symptoms of FHH3 include hypercalcemia, low levels of parathyroid hormone, and kidney stones.""]",[false],[true],[false],"[""Symptoms of FHH3 include hypercalcemia, kidney stones, bone pain, and fatigue.""]","[""Symptoms of Familial hypocalciuric hypercalcemia type 3 include high blood calcium levels, low urinary calcium levels, and a family history of the condition.""]","[""Symptoms of FHH3 include hypercalcemia, low levels of parathyroid hormone, and elevated levels of calcium in the urine.""]",[false],[true],[false],"[""Symptoms of FHH3 include high calcium levels in the blood, kidney stones, bone pain, and muscle weakness.""]","[""Symptoms of Familial hypocalciuric hypercalcemia type 3 include high levels of calcium in the blood, low levels of calcium in the urine, and often no symptoms at all.""]","[""Symptoms of FHH3 include hypercalcemia, hypophosphatemia, and low levels of parathyroid hormone.""]",[true],[true],[false],"[""Symptoms of FHH3 include high calcium levels in the blood, kidney stones, bone pain, and fractures.""]","[""Symptoms of Familial hypocalciuric hypercalcemia type 3 include high blood calcium levels, low urinary calcium levels, and a family history of the condition.""]","[""Hypercalcemia, hypophosphatemia, and elevated PTH levels""]",[false],[true],[false],"[""Symptoms of FHH3 include high levels of calcium in the blood, kidney stones, bone pain, and muscle weakness.""]","[""Symptoms of Familial hypocalciuric hypercalcemia type 3 include high blood calcium levels, low urinary calcium levels, and a family history of the condition.""]","[""Symptoms of FHH3 include hypercalcemia, low levels of parathyroid hormone, and elevated levels of calcium in the urine.""]",[true],[true],[true],"[""Symptoms of FHH3 include hypercalcemia, kidney stones, bone pain, and fatigue.""]","[""Symptoms of Familial hypocalciuric hypercalcemia type 3 include high calcium levels in the blood, low levels of calcium in the urine, and may include symptoms such as fatigue, weakness, frequent urination, and kidney stones.""]","[""Symptoms of FHH3 include hypercalcemia, low levels of parathyroid hormone, and kidney stones.""]",[false],[true],[false],"[""Symptoms of FHH3 include high levels of calcium in the blood, kidney stones, bone pain, and muscle weakness.""]","[""Symptoms of Familial hypocalciuric hypercalcemia type 3 include high levels of calcium in the blood, low levels of calcium in the urine, and often no symptoms at all.""]","[""Symptoms of FHH3 include hypercalcemia, hypophosphatemia, and low levels of parathyroid hormone.""]",[false],[true],[false],"[""Symptoms of FHH3 include high levels of calcium in the blood, kidney stones, bone pain, and muscle weakness.""]","[""Symptoms of Familial hypocalciuric hypercalcemia type 3 include high blood calcium levels, low urinary calcium levels, and a family history of the condition.""]","[""Hypercalcemia, hypophosphatemia, and elevated PTH levels""]",[false],[true],[false],"[""Symptoms of FHH3 include high levels of calcium in the blood, kidney stones, bone pain, and muscle weakness.""]","[""Symptoms of Familial hypocalciuric hypercalcemia type 3 include high blood calcium levels, low urinary calcium levels, and a family history of the condition.""]","[""Symptoms of FHH3 include hypercalcemia, low levels of parathyroid hormone, and elevated levels of calcium in the urine.""]",[false],[true],[true],"[""Symptoms of FHH3 (Familial Hyperparathyroidism Type 3) include high levels of calcium in the blood, kidney stones, bone pain, and weakened bones.""]","[""Symptoms of Familial hypocalciuric hypercalcemia type 3 include high calcium levels in the blood, low levels of calcium in the urine, and may include symptoms such as fatigue, weakness, frequent urination, and kidney stones.""]","[""Symptoms of FHH3 include hypercalcemia, low levels of parathyroid hormone, and kidney stones.""]",[false],[true],[false],"[""Symptoms of FHH3 include high levels of calcium in the blood, kidney stones, bone pain, and weakened bones.""]","[""Symptoms of Familial hypocalciuric hypercalcemia type 3 include high levels of calcium in the blood, low levels of calcium in the urine, and often no symptoms at all.""]","[""Symptoms of FHH3 include hypercalcemia, hypophosphatemia, and low levels of parathyroid hormone.""]",[false],[true],[false],"[""Symptoms of FHH3 include high levels of calcium in the blood, kidney stones, bone pain, and fractures.""]","[""Symptoms of Familial hypocalciuric hypercalcemia type 3 include high blood calcium levels, low urinary calcium levels, and a family history of the condition.""]","[""Hypercalcemia, hypophosphatemia, and elevated PTH levels""]",[false],[true],[false],"[""Symptoms of FHH3 include high levels of calcium in the blood, kidney stones, bone pain, and muscle weakness.""]","[""Symptoms of Familial hypocalciuric hypercalcemia type 3 include high blood calcium levels, low urinary calcium levels, and a family history of the condition.""]","[""Symptoms of FHH3 include hypercalcemia, low levels of parathyroid hormone, and elevated levels of calcium in the urine.""]",[true],[true],[true],"[""Symptoms of FHH3 include hypercalcemia, kidney stones, bone pain, and muscle weakness.""]","[""Symptoms of Familial hypocalciuric hypercalcemia type 3 include high calcium levels in the blood, low levels of calcium in the urine, and may include symptoms such as fatigue, weakness, frequent urination, and kidney stones.""]","[""Symptoms of FHH3 include hypercalcemia, low levels of parathyroid hormone, and kidney stones.""]",[false],[true],[false],"[""Symptoms of FHH3 include high levels of calcium in the blood, kidney stones, bone pain, and muscle weakness.""]","[""Symptoms of Familial hypocalciuric hypercalcemia type 3 include high levels of calcium in the blood, low levels of calcium in the urine, and often no symptoms at all.""]","[""Symptoms of FHH3 include hypercalcemia, hypophosphatemia, and low levels of parathyroid hormone.""]",[false],[true],[false],"[""Symptoms of FHH3 include high levels of calcium in the blood, kidney stones, bone pain, and muscle weakness.""]","[""Symptoms of Familial hypocalciuric hypercalcemia type 3 include high blood calcium levels, low urinary calcium levels, and a family history of the condition.""]","[""Hypercalcemia, hypophosphatemia, and elevated PTH levels""]",[false],[true],[false],"[""Symptoms of FHH3 include hypercalcemia, elevated parathyroid hormone levels, kidney stones, bone pain, and fractures.""]","[""Symptoms of Familial hypocalciuric hypercalcemia type 3 include high blood calcium levels, low urinary calcium levels, and a family history of the condition.""]","[""Symptoms of FHH3 include hypercalcemia, low levels of parathyroid hormone, and elevated levels of calcium in the urine.""]",[false],[true],[true],"[""Symptoms of FHH3 (Familial Hyperparathyroidism Type 3) include high levels of calcium in the blood, kidney stones, bone pain, and fractures.""]","[""Symptoms of Familial hypocalciuric hypercalcemia type 3 include high calcium levels in the blood, low levels of calcium in the urine, and may include symptoms such as fatigue, weakness, frequent urination, and kidney stones.""]","[""Symptoms of FHH3 include hypercalcemia, low levels of parathyroid hormone, and kidney stones.""]",[false],[true],[false],"[""Symptoms of FHH3 (Familial Hyperparathyroidism Type 3) include high levels of calcium in the blood (hypercalcemia), kidney stones, bone pain, and fractures.""]","[""Symptoms of Familial hypocalciuric hypercalcemia type 3 include high levels of calcium in the blood, low levels of calcium in the urine, and often no symptoms at all.""]","[""Symptoms of FHH3 include hypercalcemia, hypophosphatemia, and low levels of parathyroid hormone.""]",[true],[true],[false],"[""Symptoms of FHH3 include high levels of calcium in the blood (hypercalcemia), kidney stones, and bone pain.""]","[""Symptoms of Familial hypocalciuric hypercalcemia type 3 include high blood calcium levels, low urinary calcium levels, and a family history of the condition.""]","[""Hypercalcemia, hypophosphatemia, and elevated PTH levels""]",[false],[true],[false],"[""Symptoms of FHH3 include high levels of calcium in the blood, kidney stones, bone pain, and muscle weakness.""]","[""Symptoms of Familial hypocalciuric hypercalcemia type 3 include high blood calcium levels, low urinary calcium levels, and a family history of the condition.""]","[""Symptoms of FHH3 include hypercalcemia, low levels of parathyroid hormone, and elevated levels of calcium in the urine.""]",[false],[true],[false],"[""Symptoms of FHH3 include high levels of calcium in the blood, kidney stones, and bone pain.""]","[""Symptoms of Familial hypocalciuric hypercalcemia type 3 include high blood calcium levels, low urinary calcium levels, and a family history of the condition.""]","[""Symptoms of FHH3 include hypercalcemia, low levels of parathyroid hormone, and elevated levels of calcium in the urine.""]",[true],[true],[false],"[""Symptoms of FHH3 include high blood calcium levels, low urinary calcium excretion, and often no symptoms at all.""]","[""Symptoms of Familial hypocalciuric hypercalcemia type 3 include high blood calcium levels, low urinary calcium levels, and a family history of the condition.""]","[""Symptoms of FHH3 include hypercalcemia, low levels of parathyroid hormone, and elevated levels of calcium in the urine.""]",[false],[true],[false],"[""Symptoms of FHH3 include high levels of calcium in the blood, kidney stones, bone pain, and muscle weakness.""]","[""Symptoms of Familial hypocalciuric hypercalcemia type 3 include high blood calcium levels, low urinary calcium levels, and a family history of the condition.""]","[""Symptoms of FHH3 include hypercalcemia, low levels of parathyroid hormone, and elevated levels of calcium in the urine.""]"
susceptibility,Who is at risk for Patent Ductus Arteriosus? ?,"Patent ductus arteriosus (PDA) is a relatively common congenital heart defect in the United States.
                
The condition occurs more often in premature infants (on average, occurring in about 8 of every 1,000 births). However, PDA also occurs in full-term infants (on average, occurring in about 2 of every 1,000 births).
                
PDA also is more common in:
                
Infants who have genetic conditions such as Down syndrome
                
Infants whose mothers had German measles (rubella) during pregnancy
                
PDA is twice as common in girls as it is in boys.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""PDA"", ""full_form"": ""Patent Ductus Arteriosus""}]}",Who is at risk for PDA? ?,Who is at risk for Patent Ductus Arteriosus? ?,8,MEDICAL,Compound Datatype-String,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Personal Digital Assistant"", ""Patent Ductus Arteriosus"", ""Personal Data Assistant"", ""Progressive Democrats of America"", ""Public Display of Affection"", ""Print Shop Bitmap Graphics"", ""Posterior Descending Artery"", ""Pennsylvania Dental Association"", ""Part Design Approval"", ""Pretty Darn Awesome""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Patent Ductus Arteriosus""]",[1.308206346611909e-09],[1.308206346611909e-09],"[""Posterior Descending Artery""]",[1.9463716739984994e-07],"[""ABBREVIATIONS""]","[[5.6183686511260045e-14, 1.308206346611909e-09, 1.9151437180548594e-15, 3.844913342501384e-27, 3.279326105466189e-18, 1.533101663099744e-27, 1.9463716739984994e-07, 2.0422924410807624e-23, 6.0767062317006386e-18, 6.052575342422309e-25]]",[0.8724020175858314],[0.8724020175858314],"[""Personal Digital Assistant""]",[0.8724020175858314],"[""ABBREVIATIONS""]","[[0.7177043961734756, 0.8724020175858314, 0.7205038287002172, 0.6752873499098272, 0.635649674551373, 0.7274376913782403, 0.753812690645892, 0.7133771256309354, 0.7107541875560422, 0.7403037161812974]]","[""Patent Ductus Arteriosus""]","[""ABBREVIATIONS""]",Who is at risk for PDA (Patent Ductus Arteriosus)? ?,[false],[true],[true],"[""Individuals with a family history of heart disease, smokers, individuals with high cholesterol, and those with high blood pressure are at risk for PDA (Posterior Descending Artery) issues.""]","[""Premature infants, infants born at high altitudes, and infants whose mothers had rubella during pregnancy are at higher risk for Patent Ductus Arteriosus.""]","[""Premature infants, infants with certain genetic conditions, and infants born to mothers with certain infections are at risk for PDA.""]",[false],[false],[true],"[""Individuals with a family history of coronary artery disease, smokers, individuals with high cholesterol levels, and those with high blood pressure are at risk for PDA (Posterior Descending Artery) issues.""]","[""Premature infants, infants with certain genetic conditions, and infants born at high altitudes are at risk for Patent Ductus Arteriosus.""]","[""Premature infants, infants with certain genetic conditions, and infants born to mothers with certain infections are at risk for PDA.""]",[false],[false],[true],"[""Individuals with a family history of coronary artery disease, high blood pressure, high cholesterol, diabetes, obesity, or a sedentary lifestyle are at risk for PDA (Posterior Descending Artery) issues.""]","[""Premature infants, infants with certain genetic conditions, and infants born at high altitudes are at risk for Patent Ductus Arteriosus.""]","[""Premature infants, infants with certain genetic conditions, and infants born to mothers with certain infections are at risk for PDA.""]",[false],[true],[true],"[""Individuals with a family history of heart disease, high blood pressure, high cholesterol, smoking, obesity, and diabetes are at risk for PDA (Posterior Descending Artery) issues.""]","[""Premature infants, infants with certain genetic conditions, and infants born at high altitudes are at risk for Patent Ductus Arteriosus.""]","[""Premature infants, especially those born very early, are at higher risk for PDA.""]",[true],[true],[true],"[""Premature infants, especially those born very early, are at higher risk for PDA.""]","[""Premature infants, infants born at high altitudes, and infants whose mothers had rubella during pregnancy are at higher risk for Patent Ductus Arteriosus.""]","[""Premature infants, infants with certain genetic conditions, and infants born to mothers with certain infections are at risk for PDA.""]",[true],[false],[true],"[""Premature infants, especially those born very early, are at higher risk for PDA.""]","[""Premature infants, infants with certain genetic conditions, and infants born at high altitudes are at risk for Patent Ductus Arteriosus.""]","[""Premature infants, infants with certain genetic conditions, and infants born to mothers with certain infections are at risk for PDA.""]",[true],[false],[true],"[""Premature infants, infants with certain genetic conditions, and infants born to mothers with rubella during pregnancy are at risk for PDA (Patent Ductus Arteriosus).""]","[""Premature infants, infants with certain genetic conditions, and infants born at high altitudes are at risk for Patent Ductus Arteriosus.""]","[""Premature infants, infants with certain genetic conditions, and infants born to mothers with certain infections are at risk for PDA.""]",[true],[false],[true],"[""Premature infants, especially those born very early, are at higher risk for PDA (Patent Ductus Arteriosus).""]","[""Premature infants, infants with certain genetic conditions, and infants born at high altitudes are at risk for Patent Ductus Arteriosus.""]","[""Premature infants, especially those born very early, are at higher risk for PDA.""]",[false],[false],[true],"[""Premature infants, infants born with certain genetic conditions, and infants born at high altitudes are at risk for PDA (Patent Ductus Arteriosus).""]","[""Premature infants, infants with certain genetic conditions, and infants born at high altitudes are at risk for Patent Ductus Arteriosus.""]","[""Premature infants, infants with certain genetic conditions, and infants born to mothers with certain infections are at risk for PDA.""]",[true],[true],[true],"[""Premature infants, infants born at high altitudes, and infants whose mothers had rubella during pregnancy are at risk for PDA (Patent Ductus Arteriosus).""]","[""Premature infants, infants born at high altitudes, and infants whose mothers had rubella during pregnancy are at higher risk for Patent Ductus Arteriosus.""]","[""Premature infants, infants with certain genetic conditions, and infants born to mothers with certain infections are at risk for PDA.""]",[true],[false],[true],"[""Premature infants, female infants, infants with certain genetic conditions""]","[""Premature infants, infants with certain genetic conditions, and infants born at high altitudes are at risk for Patent Ductus Arteriosus.""]","[""Premature infants, infants with certain genetic conditions, and infants born to mothers with certain infections are at risk for PDA.""]",[false],[false],[true],"[""Premature infants, infants with certain genetic conditions, and infants born at high altitudes are at risk for PDA (Patent Ductus Arteriosus).""]","[""Premature infants, infants with certain genetic conditions, and infants born at high altitudes are at risk for Patent Ductus Arteriosus.""]","[""Premature infants, especially those born very early, are at higher risk for PDA.""]",[true],[true],[true],"[""Premature infants, female gender, and certain genetic conditions are at risk for PDA (Patent Ductus Arteriosus).""]","[""Premature infants, infants born at high altitudes, and infants whose mothers had rubella during pregnancy are at higher risk for Patent Ductus Arteriosus.""]","[""Premature infants, infants with certain genetic conditions, and infants born to mothers with certain infections are at risk for PDA.""]",[true],[false],[true],"[""Premature infants, female gender, and certain genetic conditions are at risk for PDA (Patent Ductus Arteriosus).""]","[""Premature infants, infants with certain genetic conditions, and infants born at high altitudes are at risk for Patent Ductus Arteriosus.""]","[""Premature infants, infants with certain genetic conditions, and infants born to mothers with certain infections are at risk for PDA.""]",[false],[false],[true],"[""Premature infants, infants with certain genetic conditions, and infants born at high altitudes are at higher risk for PDA.""]","[""Premature infants, infants with certain genetic conditions, and infants born at high altitudes are at risk for Patent Ductus Arteriosus.""]","[""Premature infants, infants with certain genetic conditions, and infants born to mothers with certain infections are at risk for PDA.""]",[true],[false],[true],"[""Premature infants, female gender, and certain genetic conditions are at risk for PDA (Patent Ductus Arteriosus).""]","[""Premature infants, infants with certain genetic conditions, and infants born at high altitudes are at risk for Patent Ductus Arteriosus.""]","[""Premature infants, especially those born very early, are at higher risk for PDA.""]",[true],[true],[true],"[""Premature infants, infants born at high altitudes, and infants whose mothers had rubella during pregnancy are at risk for PDA (Patent Ductus Arteriosus).""]","[""Premature infants, infants born at high altitudes, and infants whose mothers had rubella during pregnancy are at higher risk for Patent Ductus Arteriosus.""]","[""Premature infants, infants with certain genetic conditions, and infants born to mothers with certain infections are at risk for PDA.""]",[false],[false],[true],"[""Premature infants, infants born at high altitudes, and infants born to mothers who had rubella during pregnancy are at higher risk for PDA (Patent Ductus Arteriosus).""]","[""Premature infants, infants with certain genetic conditions, and infants born at high altitudes are at risk for Patent Ductus Arteriosus.""]","[""Premature infants, infants with certain genetic conditions, and infants born to mothers with certain infections are at risk for PDA.""]",[false],[false],[true],"[""Premature infants, infants born at high altitudes, and infants whose mothers had rubella during pregnancy are at risk for PDA (Patent Ductus Arteriosus).""]","[""Premature infants, infants with certain genetic conditions, and infants born at high altitudes are at risk for Patent Ductus Arteriosus.""]","[""Premature infants, infants with certain genetic conditions, and infants born to mothers with certain infections are at risk for PDA.""]",[true],[false],[true],"[""Premature infants, infants born at high altitudes, and infants born to mothers who had rubella during pregnancy are at higher risk for PDA.""]","[""Premature infants, infants with certain genetic conditions, and infants born at high altitudes are at risk for Patent Ductus Arteriosus.""]","[""Premature infants, especially those born very early, are at higher risk for PDA.""]",[true],[true],[true],"[""Premature infants, infants born at high altitudes, and infants whose mothers had rubella during pregnancy are at risk for PDA (Patent Ductus Arteriosus).""]","[""Premature infants, infants born at high altitudes, and infants whose mothers had rubella during pregnancy are at higher risk for Patent Ductus Arteriosus.""]","[""Premature infants, infants with certain genetic conditions, and infants born to mothers with certain infections are at risk for PDA.""]",[false],[false],[true],"[""Premature infants, female infants, infants born at high altitudes, infants born to mothers with rubella during pregnancy""]","[""Premature infants, infants with certain genetic conditions, and infants born at high altitudes are at risk for Patent Ductus Arteriosus.""]","[""Premature infants, infants with certain genetic conditions, and infants born to mothers with certain infections are at risk for PDA.""]",[true],[false],[true],"[""Premature infants, infants born at high altitudes, and infants born to mothers who had rubella during pregnancy are at higher risk for PDA (Patent Ductus Arteriosus).""]","[""Premature infants, infants with certain genetic conditions, and infants born at high altitudes are at risk for Patent Ductus Arteriosus.""]","[""Premature infants, infants with certain genetic conditions, and infants born to mothers with certain infections are at risk for PDA.""]",[true],[false],[true],"[""Premature infants, infants born at high altitudes, and infants born to mothers who had rubella during pregnancy are at higher risk for PDA (Patent Ductus Arteriosus).""]","[""Premature infants, infants with certain genetic conditions, and infants born at high altitudes are at risk for Patent Ductus Arteriosus.""]","[""Premature infants, especially those born very early, are at higher risk for PDA.""]",[false],[true],[true],"[""Premature infants, female infants, infants born at high altitudes, infants whose mothers had rubella during pregnancy""]","[""Premature infants, infants born at high altitudes, and infants whose mothers had rubella during pregnancy are at higher risk for Patent Ductus Arteriosus.""]","[""Premature infants, infants with certain genetic conditions, and infants born to mothers with certain infections are at risk for PDA.""]",[true],[false],[true],"[""Premature infants, females, and individuals with certain genetic conditions are at higher risk for PDA (Patent Ductus Arteriosus).""]","[""Premature infants, infants with certain genetic conditions, and infants born at high altitudes are at risk for Patent Ductus Arteriosus.""]","[""Premature infants, infants with certain genetic conditions, and infants born to mothers with certain infections are at risk for PDA.""]",[true],[false],[true],"[""Premature infants, female gender, and certain genetic conditions are at risk for PDA (Patent Ductus Arteriosus).""]","[""Premature infants, infants with certain genetic conditions, and infants born at high altitudes are at risk for Patent Ductus Arteriosus.""]","[""Premature infants, infants with certain genetic conditions, and infants born to mothers with certain infections are at risk for PDA.""]",[false],[false],[true],"[""Premature infants, infants with certain genetic conditions, and infants born at high altitudes are at risk for PDA.""]","[""Premature infants, infants with certain genetic conditions, and infants born at high altitudes are at risk for Patent Ductus Arteriosus.""]","[""Premature infants, especially those born very early, are at higher risk for PDA.""]",[false],[true],[true],"[""Premature infants, female infants, infants born at high altitudes, infants born to mothers with rubella during pregnancy""]","[""Premature infants, infants born at high altitudes, and infants whose mothers had rubella during pregnancy are at higher risk for Patent Ductus Arteriosus.""]","[""Premature infants, infants with certain genetic conditions, and infants born to mothers with certain infections are at risk for PDA.""]",[false],[true],[true],"[""Individuals with a family history of heart disease, smokers, individuals with high blood pressure, and those with high cholesterol levels are at risk for PDA (Posterior Descending Artery) issues.""]","[""Premature infants, infants born at high altitudes, and infants whose mothers had rubella during pregnancy are at higher risk for Patent Ductus Arteriosus.""]","[""Premature infants, infants with certain genetic conditions, and infants born to mothers with certain infections are at risk for PDA.""]",[false],[true],[true],"[""Individuals who use personal digital assistants (PDAs) are at risk for various health issues such as eye strain, neck pain, and repetitive strain injuries.""]","[""Premature infants, infants born at high altitudes, and infants whose mothers had rubella during pregnancy are at higher risk for Patent Ductus Arteriosus.""]","[""Premature infants, infants with certain genetic conditions, and infants born to mothers with certain infections are at risk for PDA.""]",[true],[true],[true],"[""Premature infants, female gender, and certain genetic conditions are at risk for PDA (Patent Ductus Arteriosus).""]","[""Premature infants, infants born at high altitudes, and infants whose mothers had rubella during pregnancy are at higher risk for Patent Ductus Arteriosus.""]","[""Premature infants, infants with certain genetic conditions, and infants born to mothers with certain infections are at risk for PDA.""]"
treatment,What are the treatments for hereditary sensory and autonomic neuropathy type V ?,These resources address the diagnosis or management of HSAN5:  - Genetic Testing Registry: Congenital sensory neuropathy with selective loss of small myelinated fibers   These resources from MedlinePlus offer information about the diagnosis and management of various health conditions:  - Diagnostic Tests  - Drug Therapy  - Surgery and Rehabilitation  - Genetic Counseling   - Palliative Care,"{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""HSAN"", ""full_form"": ""hereditary sensory and autonomic neuropathy""}]}",What are the treatments for HSAN type V ?,What are the treatments for hereditary sensory and autonomic neuropathy type V ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Hereditary Sensory and Autonomic Neuropathy"", ""High School (airman)"", ""High Speed Access Network"", ""Hereditary Sensory and Autonomic Neuropathy"", ""Neuropathy, Hereditary Sensory and Autonomic"", ""Hereditary Sensory and Autonomic Neuropathy with Anosmia (Adult-Onset)"", ""H&#228;lso- och Sjukv&#229;rdens Ansvarsn&#228;mnd (Swedish)"", ""Hip-Hop Summit Action Network"", ""Health Systems Action Network (Bethesda, MD)"", ""Neuropathy, Hereditary Sensory and Autonomic"", ""High Speed Access Network"", ""Health Systems Action Network (Bethesda, MD)"", ""Hereditary Sensory and Autonomic Neuropathy"", ""Hip-Hop Summit Action Network"", ""Hereditary Sensory and Autonomic Neuropathy with Anosmia (Adult-Onset)"", ""H\u00e4lso- och Sjukv\u00e5rdens Ansvarsn\u00e4mnd (Swedish)""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY""]]","[""Hereditary Sensory and Autonomic Neuropathy""]",[2.511717520691486e-22],[2.511717520691486e-22],"[""High Speed Access Network""]",[4.774069283477998e-15],"[""ABBREVIATIONS""]","[[2.511717520691486e-22, 1.3823402266062726e-16, 4.774069283477998e-15, 2.511717520691486e-22, 6.099844154290205e-22, 1.2780512487728758e-46, 5.556447975805363e-98, 1.226936927680454e-28, 7.001742211704751e-41, 6.099844154290205e-22, 4.774069283477998e-15, 7.001742211704751e-41, 2.511717520691486e-22, 1.226936927680454e-28, 1.2780512487728758e-46, 1.5815151720141668e-66]]",[0.9535585666444917],[0.9482415185555465],"[""hereditary sensory and autonomic neuropathy""]",[0.9482819980869397],"[""ABBREVIATIONS""]","[[0.9482819980869397, 0.9282251379470732, 0.8778810578422498, 0.9482647551946218, 0.9337916331641786, 0.8864930896175304, 0.9119195294548431, 0.8869839668811084, 0.9273683408683491, 0.9337916331641786, 0.8778810578422498, 0.9273683408683491, 0.9482415185555462, 0.8869839668811084, 0.8864930896175304, 0.9130510325562914]]","[""Hereditary Sensory and Autonomic Neuropathy""]","[""ABBREVIATIONS""]",What are the treatments for HSAN (Hereditary Sensory and Autonomic Neuropathy) type V ?,[true],[true],[true],"[""There is no specific treatment for HSAN type V. Management focuses on symptomatic relief and supportive care.""]","[""Currently, there is no specific treatment for hereditary sensory and autonomic neuropathy type V. Management focuses on symptom relief and supportive care.""]","[""There is no specific treatment for HSAN type V. Management involves symptomatic and supportive care.""]",[true],[true],[true],"[""There is no specific treatment for HSAN type V. Management involves symptomatic and supportive care to address the symptoms and complications.""]","[""Currently, there is no specific treatment for hereditary sensory and autonomic neuropathy type V. Management focuses on symptom relief and supportive care.""]","[""There is no specific treatment for HSAN type V. Management involves symptomatic and supportive care.""]",[true],[true],[true],"[""There is no specific treatment for HSAN type V. Management involves symptomatic and supportive care to address the symptoms and complications.""]","[""Currently, there is no specific treatment for hereditary sensory and autonomic neuropathy type V. Management focuses on symptom relief and supportive care.""]","[""There is no specific treatment for HSAN type V. Management involves symptomatic and supportive care.""]",[true],[true],[true],"[""There is no specific treatment for HSAN type V. Management involves symptomatic and supportive care.""]","[""There is currently no specific treatment for hereditary sensory and autonomic neuropathy type V. Management involves symptomatic treatment and supportive care.""]","[""There is no specific treatment for HSAN type V. Management involves symptomatic treatment and supportive care.""]",[true],[true],[true],"[""There is no specific treatment for HSAN type V. Management involves symptomatic treatment and supportive care.""]","[""Currently, there is no specific treatment for hereditary sensory and autonomic neuropathy type V. Management focuses on symptom relief and supportive care.""]","[""There is no specific treatment for HSAN type V. Management involves symptomatic and supportive care.""]",[true],[true],[true],"[""There is no specific treatment for HSAN type V. Management involves symptomatic treatment and supportive care.""]","[""Currently, there is no specific treatment for hereditary sensory and autonomic neuropathy type V. Management focuses on symptom relief and supportive care.""]","[""There is no specific treatment for HSAN type V. Management involves symptomatic and supportive care.""]",[true],[true],[true],"[""There is no specific treatment for HSAN type V. Management involves symptomatic treatment and supportive care.""]","[""Currently, there is no specific treatment for hereditary sensory and autonomic neuropathy type V. Management focuses on symptom relief and supportive care.""]","[""There is no specific treatment for HSAN type V. Management involves symptomatic and supportive care.""]",[true],[true],[true],"[""There is no specific treatment for HSAN type V. Management involves symptomatic treatment and supportive care.""]","[""There is currently no specific treatment for hereditary sensory and autonomic neuropathy type V. Management involves symptomatic treatment and supportive care.""]","[""There is no specific treatment for HSAN type V. Management involves symptomatic treatment and supportive care.""]",[true],[true],[true],"[""There is no specific treatment for HSAN type V. Management involves symptomatic treatment and supportive care.""]","[""Currently, there is no specific treatment for hereditary sensory and autonomic neuropathy type V. Management focuses on symptom relief and supportive care.""]","[""There is no specific treatment for HSAN type V. Management involves symptomatic and supportive care.""]",[true],[true],[true],"[""There is no specific treatment for HSAN type V. Management involves symptomatic treatment and supportive care.""]","[""Currently, there is no specific treatment for hereditary sensory and autonomic neuropathy type V. Management focuses on symptom relief and supportive care.""]","[""There is no specific treatment for HSAN type V. Management involves symptomatic and supportive care.""]",[true],[true],[true],"[""There is no specific treatment for HSAN type V. Management involves symptomatic treatment and supportive care.""]","[""Currently, there is no specific treatment for hereditary sensory and autonomic neuropathy type V. Management focuses on symptom relief and supportive care.""]","[""There is no specific treatment for HSAN type V. Management involves symptomatic and supportive care.""]",[true],[true],[true],"[""There is no specific treatment for HSAN type V. Management involves symptomatic treatment and supportive care.""]","[""There is currently no specific treatment for hereditary sensory and autonomic neuropathy type V. Management involves symptomatic treatment and supportive care.""]","[""There is no specific treatment for HSAN type V. Management involves symptomatic treatment and supportive care.""]",[true],[true],[true],"[""There is no specific treatment for HSAN type V. Management focuses on symptom relief and supportive care.""]","[""Currently, there is no specific treatment for hereditary sensory and autonomic neuropathy type V. Management focuses on symptom relief and supportive care.""]","[""There is no specific treatment for HSAN type V. Management involves symptomatic and supportive care.""]",[true],[true],[true],"[""There is no specific treatment for HSAN type V, but symptoms can be managed with pain medications and physical therapy.""]","[""Currently, there is no specific treatment for hereditary sensory and autonomic neuropathy type V. Management focuses on symptom relief and supportive care.""]","[""There is no specific treatment for HSAN type V. Management involves symptomatic and supportive care.""]",[true],[true],[true],"[""There is no specific treatment for HSAN type V. Management involves symptomatic treatment and supportive care.""]","[""Currently, there is no specific treatment for hereditary sensory and autonomic neuropathy type V. Management focuses on symptom relief and supportive care.""]","[""There is no specific treatment for HSAN type V. Management involves symptomatic and supportive care.""]",[true],[true],[true],"[""There is no specific treatment for HSAN type V. Management focuses on symptom relief and supportive care.""]","[""There is currently no specific treatment for hereditary sensory and autonomic neuropathy type V. Management involves symptomatic treatment and supportive care.""]","[""There is no specific treatment for HSAN type V. Management involves symptomatic treatment and supportive care.""]",[true],[true],[true],"[""There is no specific treatment for HSAN type V. Management involves symptomatic treatment and supportive care.""]","[""Currently, there is no specific treatment for hereditary sensory and autonomic neuropathy type V. Management focuses on symptom relief and supportive care.""]","[""There is no specific treatment for HSAN type V. Management involves symptomatic and supportive care.""]",[true],[true],[true],"[""There is no specific treatment for HSAN type V. Management involves symptomatic treatment and supportive care.""]","[""Currently, there is no specific treatment for hereditary sensory and autonomic neuropathy type V. Management focuses on symptom relief and supportive care.""]","[""There is no specific treatment for HSAN type V. Management involves symptomatic and supportive care.""]",[true],[true],[true],"[""There is no specific treatment for HSAN type V. Management involves symptomatic treatment and supportive care.""]","[""Currently, there is no specific treatment for hereditary sensory and autonomic neuropathy type V. Management focuses on symptom relief and supportive care.""]","[""There is no specific treatment for HSAN type V. Management involves symptomatic and supportive care.""]",[true],[true],[true],"[""There is no specific treatment for HSAN type V. Management involves symptomatic and supportive care to address the symptoms and complications.""]","[""There is currently no specific treatment for hereditary sensory and autonomic neuropathy type V. Management involves symptomatic treatment and supportive care.""]","[""There is no specific treatment for HSAN type V. Management involves symptomatic treatment and supportive care.""]",[true],[true],[true],"[""There is no specific treatment for HSAN type V. Management involves symptomatic treatment and supportive care.""]","[""Currently, there is no specific treatment for hereditary sensory and autonomic neuropathy type V. Management focuses on symptom relief and supportive care.""]","[""There is no specific treatment for HSAN type V. Management involves symptomatic and supportive care.""]",[true],[true],[true],"[""There is no specific treatment for HSAN type V. Management involves symptomatic treatment and supportive care.""]","[""Currently, there is no specific treatment for hereditary sensory and autonomic neuropathy type V. Management focuses on symptom relief and supportive care.""]","[""There is no specific treatment for HSAN type V. Management involves symptomatic and supportive care.""]",[true],[true],[true],"[""There is no specific treatment for HSAN type V. Management involves symptomatic treatment and supportive care.""]","[""Currently, there is no specific treatment for hereditary sensory and autonomic neuropathy type V. Management focuses on symptom relief and supportive care.""]","[""There is no specific treatment for HSAN type V. Management involves symptomatic and supportive care.""]",[true],[true],[true],"[""There is no specific treatment for HSAN type V. Management involves symptomatic treatment and supportive care.""]","[""There is currently no specific treatment for hereditary sensory and autonomic neuropathy type V. Management involves symptomatic treatment and supportive care.""]","[""There is no specific treatment for HSAN type V. Management involves symptomatic treatment and supportive care.""]",[true],[true],[true],"[""Currently, there is no cure for HSAN type V. Treatment focuses on managing symptoms and improving quality of life through physical therapy, pain management, and assistive devices.""]","[""Currently, there is no specific treatment for hereditary sensory and autonomic neuropathy type V. Management focuses on symptom relief and supportive care.""]","[""There is no specific treatment for HSAN type V. Management involves symptomatic and supportive care.""]",[true],[true],[true],"[""There is no specific treatment for HSAN type V. Management involves symptomatic treatment and supportive care.""]","[""Currently, there is no specific treatment for hereditary sensory and autonomic neuropathy type V. Management focuses on symptom relief and supportive care.""]","[""There is no specific treatment for HSAN type V. Management involves symptomatic and supportive care.""]",[true],[true],[true],"[""Currently, there is no specific treatment for HSAN type V. Management focuses on symptom relief and supportive care.""]","[""Currently, there is no specific treatment for hereditary sensory and autonomic neuropathy type V. Management focuses on symptom relief and supportive care.""]","[""There is no specific treatment for HSAN type V. Management involves symptomatic and supportive care.""]",[true],[true],[true],"[""There is no specific treatment for HSAN type V. Management involves symptomatic treatment and supportive care.""]","[""There is currently no specific treatment for hereditary sensory and autonomic neuropathy type V. Management involves symptomatic treatment and supportive care.""]","[""There is no specific treatment for HSAN type V. Management involves symptomatic treatment and supportive care.""]",[true],[true],[true],"[""There is no specific treatment for HSAN type V. Management focuses on symptom relief and supportive care.""]","[""Currently, there is no specific treatment for hereditary sensory and autonomic neuropathy type V. Management focuses on symptom relief and supportive care.""]","[""There is no specific treatment for HSAN type V. Management involves symptomatic and supportive care.""]",[true],[true],[true],"[""There is no specific treatment for HSAN type V. Management involves symptomatic and supportive care.""]","[""Currently, there is no specific treatment for hereditary sensory and autonomic neuropathy type V. Management focuses on symptom relief and supportive care.""]","[""There is no specific treatment for HSAN type V. Management involves symptomatic and supportive care.""]",[true],[true],[true],"[""There is no specific treatment for HSAN type V. Management focuses on symptom relief and supportive care.""]","[""Currently, there is no specific treatment for hereditary sensory and autonomic neuropathy type V. Management focuses on symptom relief and supportive care.""]","[""There is no specific treatment for HSAN type V. Management involves symptomatic and supportive care.""]",[true],[true],[true],"[""There is no specific treatment for HSAN type V. Management focuses on symptom relief and supportive care.""]","[""Currently, there is no specific treatment for hereditary sensory and autonomic neuropathy type V. Management focuses on symptom relief and supportive care.""]","[""There is no specific treatment for HSAN type V. Management involves symptomatic and supportive care.""]"
treatment,What are the treatments for Diabetic Neuropathies: The Nerve Damage of Diabetes ?,"The first treatment step is to bring blood glucose levels within the normal range to help prevent further nerve damage. Blood glucose monitoring, meal planning, physical activity, and diabetes medicines or insulin will help control blood glucose levels. Symptoms may get worse when blood glucose is first brought under control, but over time, maintaining lower blood glucose levels helps lessen symptoms. Good blood glucose control may also help prevent or delay the onset of further problems. As scientists learn more about the underlying causes of neuropathy, new treatments may become available to help slow, prevent, or even reverse nerve damage.
                
As described in the following sections, additional treatment depends on the type of nerve problem and symptom.
                
Pain Relief
                
Doctors usually treat painful diabetic neuropathy with oral medications, although other types of treatments may help some people. People with severe nerve pain may benefit from a combination of medications or treatments and should consider talking with a health care provider about treatment options.
                
Medications used to help relieve diabetic nerve pain include
                
- tricyclic antidepressants, such as amitriptyline, imipramine, and desipramine (Norpramin, Pertofrane)  - other types of antidepressants, such as duloxetine (Cymbalta), venlafaxine, bupropion (Wellbutrin), paroxetine (Paxil), and citalopram (Celexa)  - anticonvulsants, such as pregabalin (Lyrica), gabapentin (Gabarone, Neurontin), carbamazepine, and lamotrigine (Lamictal)  - opioids and opioidlike drugs, such as controlled-release oxycodone, an opioid; and tramadol (Ultram), an opioid that also acts as an antidepressant
                
Duloxetine and pregabalin are approved by the U.S. Food and Drug Administration specifically for treating painful diabetic peripheral neuropathy.
                
People do not have to be depressed for an antidepressant to help relieve their nerve pain. All medications have side effects, and some are not recommended for use in older adults or those with heart disease. Because over-the-counter pain medicines such as acetaminophen and ibuprofen may not work well for treating most nerve pain and can have serious side effects, some experts recommend avoiding these medications.
                
Treatments that are applied to the skintypically to the feetinclude capsaicin cream and lidocaine patches (Lidoderm, Lidopain). Studies suggest that nitrate sprays or patches for the feet may relieve pain. Studies of alpha-lipoic acid, an antioxidant, and evening primrose oil suggest they may help relieve symptoms and improve nerve function in some patients.
                
A device called a bed cradle can keep sheets and blankets from touching sensitive feet and legs. Acupuncture, biofeedback, or physical therapy may help relieve pain in some people. Treatments that involve electrical nerve stimulation, magnetic therapy, and laser or light therapy may be helpful but need further study. Researchers are also studying several new therapies in clinical trials.
                
Gastrointestinal Problems
                
To relieve mild symptoms of gastroparesisindigestion, belching, nausea, or vomitingdoctors suggest eating small, frequent meals; avoiding fats; and eating less fiber. When symptoms are severe, doctors may prescribe erythromycin to speed digestion, metoclopramide to speed digestion and help relieve nausea, or other medications to help regulate digestion or reduce stomach acid secretion.
                
To relieve diarrhea or other bowel problems, doctors may prescribe an antibiotic such as tetracycline, or other medications as appropriate.
                
Dizziness and Weakness
                
Sitting or standing slowly may help prevent the light-headedness, dizziness, or fainting associated with blood pressure and circulation problems. Raising the head of the bed or wearing elastic stockings may also help. Some people benefit from increased salt in the diet and treatment with salt-retaining hormones. Others benefit from high blood pressure medications. Physical therapy can help when muscle weakness or loss of coordination is a problem.
                
Urinary and Sexual Problems
                
To clear up a urinary tract infection, the doctor will probably prescribe an antibiotic. Drinking plenty of fluids will help prevent another infection. People who have incontinence should try to urinate at regular intervalsevery 3 hours, for examplebecause they may not be able to tell when the bladder is full.
                
To treat erectile dysfunction in men, the doctor will first do tests to rule out a hormonal cause. Several methods are available to treat erectile dysfunction caused by neuropathy. Medicines are available to help men have and maintain erections by increasing blood flow to the penis. Some are oral medications and others are injected into the penis or inserted into the urethra at the tip of the penis. Mechanical vacuum devices can also increase blood flow to the penis. Another option is to surgically implant an inflatable or semirigid device in the penis.
                
Vaginal lubricants may be useful for women when neuropathy causes vaginal dryness. To treat problems with arousal and orgasm, the doctor may refer women to a gynecologist.
                
Foot Care
                
People with neuropathy need to take special care of their feet. The nerves to the feet are the longest in the body and are the ones most often affected by neuropathy. Loss of sensation in the feet means that sores or injuries may not be noticed and may become ulcerated or infected. Circulation problems also increase the risk of foot ulcers. Smoking increases the risk of foot problems and amputation. A health care provider may be able to provide help with quitting smoking.
                
More than 60 percent of all nontraumatic lower-limb amputations in the United States occur in people with diabetes. Nontraumatic amputations are those not caused by trauma such as severe injuries from an accident. In 2004, about 71,000 nontraumatic amputations were performed in people with diabetes. Comprehensive foot care programs can reduce amputation rates by 45 to 85 percent.
                
Careful foot care involves
                
- cleaning the feet daily using warmnot hotwater and a mild soap. Soaking the feet should be avoided. A soft towel can be used to dry the feet and between the toes.  - inspecting the feet and toes every day for cuts, blisters, redness, swelling, calluses, or other problems. Using a mirrorhandheld or placed on the floormay be helpful in checking the bottoms of the feet, or another person can help check the feet. A health care provider should be notified of any problems.  - using lotion to moisturize the feet. Getting lotion between the toes should be avoided.  - filing corns and calluses gently with a pumice stone after a bath or shower.  - cutting toenails to the shape of the toes and filing the edges with an emery board each week or when needed.  - always wearing shoes or slippers to protect feet from injuries. Wearing thick, soft, seamless socks can prevent skin irritation.  - wearing shoes that fit well and allow the toes to move. New shoes can be broken in gradually by first wearing them for only an hour at a time.  - looking shoes over carefully before putting them on and feeling the insides to make sure the shoes are free of tears, sharp edges, or objects that might injure the feet.
                
People who need help taking care of their feet should consider making an appointment to see a foot doctor, also called a podiatrist.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""DN"", ""full_form"": ""Diabetic Neuropathies""}]}",What are the treatments for DN: The Nerve Damage of Diabetes ?,What are the treatments for Diabetic Neuropathies: The Nerve Damage of Diabetes ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Domain Name"", ""Distinguished Name"", ""Dagens Nyheter"", ""Directory Number"", ""Detroit News"", ""Dominant Negative"", ""Device Number"", ""District Nurse"", ""Diameter Nominal"", ""Department Name""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Diabetic Neuropathy""]",[7.725414008696564e-08],[2.0717736060735254e-06],"[""Diabetic Neuropathy""]",[2.0717736060735254e-06],"[""LLM""]","[[5.136283564326075e-11, 7.95991346915958e-13, 3.701761194223515e-18, 8.432202695114536e-11, 7.215583169331196e-15, 7.566411849924009e-11, 7.555437711206073e-09, 4.898589748672762e-13, 3.986376560870527e-12, 5.683176738836837e-10]]",[0.9525770936279422],[0.9522484621252113],"[""District Nurse""]",[0.9547929554109649],"[""ABBREVIATIONS""]","[[0.9417388778258899, 0.9387376690040588, 0.9136999574783078, 0.9418197649754406, 0.9243037554298991, 0.8912500657713698, 0.9327665270686837, 0.9232169848477207, 0.9547929554109649, 0.9410565819928169]]","[""Diabetic Neuropathy""]","[""LLM""]",What are the treatments for DN (Diabetic Neuropathy): The Nerve Damage of Diabetes ?,[true],[true],[true],"[""The treatments for Diabetic Neuropathy include managing blood sugar levels, pain management medications, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""The treatments for Diabetic Neuropathies include managing blood sugar levels, pain management medications, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""Treatment for diabetic neuropathy may include medications to relieve pain, physical therapy, and lifestyle modifications such as maintaining optimal blood sugar levels.""]",[true],[true],[true],"[""The treatments for Diabetic Neuropathy include managing blood sugar levels, pain management medications, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""The treatments for Diabetic Neuropathies include managing blood sugar levels, pain management medications, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""The treatments for diabetic neuropathy include medications to relieve pain, such as antidepressants and anticonvulsants, as well as managing blood sugar levels through diet, exercise, and medication.""]",[true],[true],[true],"[""The treatments for Diabetic Neuropathy include managing blood sugar levels, pain management medications, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""The treatments for Diabetic Neuropathies include managing blood sugar levels, medications for pain relief, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""The treatments for diabetic neuropathy include medications for pain relief, controlling blood sugar levels, physical therapy, and lifestyle modifications.""]",[true],[true],[true],"[""The treatments for Diabetic Neuropathy include medications to relieve pain, controlling blood sugar levels, physical therapy, and lifestyle changes.""]","[""The treatments for Diabetic Neuropathies include managing blood sugar levels, pain management medications, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""The treatments for diabetic neuropathy include medications to relieve pain, control blood sugar levels, physical therapy, and lifestyle changes such as quitting smoking and maintaining a healthy weight.""]",[false],[true],[true],"[""The treatments for DN (District Nurse) for the nerve damage of diabetes include managing blood sugar levels, pain management, physical therapy, and medications such as antidepressants or anticonvulsants.""]","[""The treatments for Diabetic Neuropathies include managing blood sugar levels, pain management medications, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""Treatment for diabetic neuropathy may include medications to relieve pain, physical therapy, and lifestyle modifications such as maintaining optimal blood sugar levels.""]",[true],[true],[true],"[""The treatments for diabetic neuropathy (DN) include medications to relieve pain, physical therapy, and lifestyle changes such as maintaining blood sugar levels within target range.""]","[""The treatments for Diabetic Neuropathies include managing blood sugar levels, pain management medications, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""The treatments for diabetic neuropathy include medications to relieve pain, such as antidepressants and anticonvulsants, as well as managing blood sugar levels through diet, exercise, and medication.""]",[false],[true],[true],"[""The treatments for diabetic neuropathy (DN) include medications to relieve pain, physical therapy, lifestyle changes, and in severe cases, surgery.""]","[""The treatments for Diabetic Neuropathies include managing blood sugar levels, medications for pain relief, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""The treatments for diabetic neuropathy include medications for pain relief, controlling blood sugar levels, physical therapy, and lifestyle modifications.""]",[true],[true],[true],"[""The treatments for diabetic neuropathy (DN) include managing blood sugar levels, pain management medications, physical therapy, and lifestyle modifications.""]","[""The treatments for Diabetic Neuropathies include managing blood sugar levels, pain management medications, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""The treatments for diabetic neuropathy include medications to relieve pain, control blood sugar levels, physical therapy, and lifestyle changes such as quitting smoking and maintaining a healthy weight.""]",[true],[true],[true],"[""The treatments for Diabetic Neuropathy include medications to relieve pain, controlling blood sugar levels, physical therapy, and lifestyle changes such as quitting smoking and maintaining a healthy weight.""]","[""The treatments for Diabetic Neuropathies include managing blood sugar levels, pain management medications, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""The treatments for diabetic neuropathy include medications to relieve pain, such as antidepressants and anticonvulsants, as well as managing blood sugar levels through diet, exercise, and medication.""]",[true],[true],[true],"[""The treatments for Diabetic Neuropathy include managing blood sugar levels, pain management medications, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""The treatments for Diabetic Neuropathies include managing blood sugar levels, pain management medications, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""Treatment for diabetic neuropathy may include medications to relieve pain, physical therapy, and lifestyle modifications such as maintaining optimal blood sugar levels.""]",[true],[true],[true],"[""The treatments for Diabetic Neuropathy include medications to relieve pain, control blood sugar levels, physical therapy, and lifestyle changes such as regular exercise and a healthy diet.""]","[""The treatments for Diabetic Neuropathies include managing blood sugar levels, medications for pain relief, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""The treatments for diabetic neuropathy include medications for pain relief, controlling blood sugar levels, physical therapy, and lifestyle modifications.""]",[true],[true],[true],"[""The treatments for Diabetic Neuropathy include managing blood sugar levels, pain management medications, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""The treatments for Diabetic Neuropathies include managing blood sugar levels, pain management medications, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""The treatments for diabetic neuropathy include medications to relieve pain, control blood sugar levels, physical therapy, and lifestyle changes such as quitting smoking and maintaining a healthy weight.""]",[true],[true],[true],"[""The treatments for Diabetic Neuropathy include managing blood sugar levels, pain management medications, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""The treatments for Diabetic Neuropathies include managing blood sugar levels, pain management medications, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""Treatment for diabetic neuropathy may include medications to relieve pain, physical therapy, and lifestyle modifications such as maintaining optimal blood sugar levels.""]",[true],[true],[true],"[""The treatments for Diabetic Neuropathy include medications such as antidepressants, anticonvulsants, and pain relievers, as well as lifestyle changes like maintaining blood sugar levels, exercising regularly, and quitting smoking.""]","[""The treatments for Diabetic Neuropathies include managing blood sugar levels, pain management medications, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""The treatments for diabetic neuropathy include medications to relieve pain, such as antidepressants and anticonvulsants, as well as managing blood sugar levels through diet, exercise, and medication.""]",[true],[true],[true],"[""The treatments for Diabetic Neuropathy include managing blood sugar levels, pain management medications, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""The treatments for Diabetic Neuropathies include managing blood sugar levels, medications for pain relief, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""The treatments for diabetic neuropathy include medications for pain relief, controlling blood sugar levels, physical therapy, and lifestyle modifications.""]",[true],[true],[true],"[""The treatments for Diabetic Neuropathy include managing blood sugar levels, pain management medications, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""The treatments for Diabetic Neuropathies include managing blood sugar levels, pain management medications, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""The treatments for diabetic neuropathy include medications to relieve pain, control blood sugar levels, physical therapy, and lifestyle changes such as quitting smoking and maintaining a healthy weight.""]",[true],[true],[true],"[""The treatments for Diabetic Neuropathy include managing blood sugar levels, pain management medications, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""The treatments for Diabetic Neuropathies include managing blood sugar levels, pain management medications, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""Treatment for diabetic neuropathy may include medications to relieve pain, physical therapy, and lifestyle modifications such as maintaining optimal blood sugar levels.""]",[true],[true],[true],"[""The treatments for Diabetic Neuropathy include medications to relieve pain and reduce symptoms, blood sugar control, physical therapy, and lifestyle changes such as a healthy diet and regular exercise.""]","[""The treatments for Diabetic Neuropathies include managing blood sugar levels, pain management medications, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""The treatments for diabetic neuropathy include medications to relieve pain, such as antidepressants and anticonvulsants, as well as managing blood sugar levels through diet, exercise, and medication.""]",[true],[true],[true],"[""The treatments for Diabetic Neuropathy include medications to relieve pain, controlling blood sugar levels, physical therapy, and lifestyle changes such as quitting smoking and maintaining a healthy weight.""]","[""The treatments for Diabetic Neuropathies include managing blood sugar levels, medications for pain relief, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""The treatments for diabetic neuropathy include medications for pain relief, controlling blood sugar levels, physical therapy, and lifestyle modifications.""]",[true],[true],[true],"[""The treatments for Diabetic Neuropathy include managing blood sugar levels, pain relief medications, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""The treatments for Diabetic Neuropathies include managing blood sugar levels, pain management medications, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""The treatments for diabetic neuropathy include medications to relieve pain, control blood sugar levels, physical therapy, and lifestyle changes such as quitting smoking and maintaining a healthy weight.""]",[true],[true],[true],"[""The treatments for Diabetic Neuropathy include managing blood sugar levels, pain management medications, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""The treatments for Diabetic Neuropathies include managing blood sugar levels, pain management medications, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""Treatment for diabetic neuropathy may include medications to relieve pain, physical therapy, and lifestyle modifications such as maintaining optimal blood sugar levels.""]",[true],[true],[true],"[""The treatments for Diabetic Neuropathy include managing blood sugar levels, pain management medications, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""The treatments for Diabetic Neuropathies include managing blood sugar levels, pain management medications, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""The treatments for diabetic neuropathy include medications to relieve pain, such as antidepressants and anticonvulsants, as well as managing blood sugar levels through diet, exercise, and medication.""]",[true],[true],[true],"[""The treatments for Diabetic Neuropathy include medications to relieve pain, controlling blood sugar levels, physical therapy, and lifestyle modifications.""]","[""The treatments for Diabetic Neuropathies include managing blood sugar levels, medications for pain relief, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""The treatments for diabetic neuropathy include medications for pain relief, controlling blood sugar levels, physical therapy, and lifestyle modifications.""]",[true],[true],[true],"[""The treatments for Diabetic Neuropathy include managing blood sugar levels, pain relief medications, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""The treatments for Diabetic Neuropathies include managing blood sugar levels, pain management medications, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""The treatments for diabetic neuropathy include medications to relieve pain, control blood sugar levels, physical therapy, and lifestyle changes such as quitting smoking and maintaining a healthy weight.""]",[true],[true],[true],"[""The treatments for Diabetic Neuropathy include managing blood sugar levels, pain management medications, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""The treatments for Diabetic Neuropathies include managing blood sugar levels, pain management medications, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""Treatment for diabetic neuropathy may include medications to relieve pain, physical therapy, and lifestyle modifications such as maintaining optimal blood sugar levels.""]",[true],[true],[true],"[""The treatments for Diabetic Neuropathy include managing blood sugar levels, pain management medications, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""The treatments for Diabetic Neuropathies include managing blood sugar levels, pain management medications, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""The treatments for diabetic neuropathy include medications to relieve pain, such as antidepressants and anticonvulsants, as well as managing blood sugar levels through diet, exercise, and medication.""]",[true],[true],[true],"[""The treatments for Diabetic Neuropathy include managing blood sugar levels, pain management medications, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""The treatments for Diabetic Neuropathies include managing blood sugar levels, medications for pain relief, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""The treatments for diabetic neuropathy include medications for pain relief, controlling blood sugar levels, physical therapy, and lifestyle modifications.""]",[true],[true],[true],"[""The treatments for Diabetic Neuropathy include managing blood sugar levels, pain management medications, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""The treatments for Diabetic Neuropathies include managing blood sugar levels, pain management medications, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""The treatments for diabetic neuropathy include medications to relieve pain, control blood sugar levels, physical therapy, and lifestyle changes such as quitting smoking and maintaining a healthy weight.""]",[true],[true],[true],"[""The treatments for Diabetic Neuropathy include managing blood sugar levels, pain management medications, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""The treatments for Diabetic Neuropathies include managing blood sugar levels, pain management medications, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""Treatment for diabetic neuropathy may include medications to relieve pain, physical therapy, and lifestyle modifications such as maintaining optimal blood sugar levels.""]",[true],[true],[true],"[""The treatments for Diabetic Neuropathy include managing blood sugar levels, pain management medications, antidepressants, anticonvulsants, physical therapy, and lifestyle changes such as regular exercise and a healthy diet.""]","[""The treatments for Diabetic Neuropathies include managing blood sugar levels, pain management medications, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""Treatment for diabetic neuropathy may include medications to relieve pain, physical therapy, and lifestyle modifications such as maintaining optimal blood sugar levels.""]",[false],[true],[true],"[""The treatments for DN (District Nurse) include managing blood sugar levels, pain management, wound care, and lifestyle modifications such as exercise and a healthy diet.""]","[""The treatments for Diabetic Neuropathies include managing blood sugar levels, pain management medications, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""Treatment for diabetic neuropathy may include medications to relieve pain, physical therapy, and lifestyle modifications such as maintaining optimal blood sugar levels.""]",[true],[true],[true],"[""The treatments for Diabetic Neuropathy include managing blood sugar levels, pain management medications, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""The treatments for Diabetic Neuropathies include managing blood sugar levels, pain management medications, antidepressants, anticonvulsants, physical therapy, and lifestyle modifications.""]","[""Treatment for diabetic neuropathy may include medications to relieve pain, physical therapy, and lifestyle modifications such as maintaining optimal blood sugar levels.""]"
symptoms,What are the symptoms of Myoclonic epilepsy with ragged red fibers ?,"What are the signs and symptoms of Myoclonic epilepsy with ragged red fibers? Because muscle cells and nerve cells have especially high energy needs, muscular and neurological problems are common features of diseases that affect the mitochondria.  MERRF is a progressive multi-system syndrome with symptoms that begin during childhood, but onset may occur in adulthood. The rate of progression varies widely. Onset and extent of symptoms can differ widely from individual to individual and among affected siblings. The classic features of MERRF include: Myoclonus (brief, sudden, twitching muscle spasms)  the most characteristic symptom Epileptic seizures Ataxia (impaired coordination) Ragged-red fibers (a characteristic microscopic abnormality observed in muscle biopsy of patients with MERRF and other mitochondrial disorders) Additional symptoms may include: hearing loss, lactic acidosis (elevated lactic acid level in the blood), short stature, exercise intolerance, dementia, cardiac defects, eye abnormalities, and speech impairment. However, the exact symptoms aren't the same for everyone, because a person with mitochondrial disease can have a unique mixture of healthy and non-working mitochondria, with a unique distribution in the body. Despite their many potential effects, mitochondrial diseases sometimes cause little disability. Sometimes, a person has enough healthy mitochondria to compensate for the defective ones. The Human Phenotype Ontology provides the following list of signs and symptoms for Myoclonic epilepsy with ragged red fibers. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of movement 90% EMG abnormality 90% Incoordination 90% Multiple lipomas 90% Myopathy 90% Sensorineural hearing impairment 90% Cognitive impairment 50% Short stature 50% Optic atrophy 7.5% Ataxia - Generalized myoclonic seizures - Increased serum lactate - Increased serum pyruvate - Mitochondrial inheritance - Muscle weakness - Myoclonus - Ragged-red muscle fibers - Seizures - Spasticity - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""MERRF"", ""full_form"": ""Myoclonic epilepsy with ragged red fibers""}]}",What are the symptoms of MERRF ?,What are the symptoms of Myoclonic epilepsy with ragged red fibers ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Myoclonic Epilepsy with Ragged Red Fibres"", ""Myoclonic epilepsy with ragged-red fibers (MERRF)"", ""Myoclonic Epilepsy and Ragged Red Fiber (medical condition)"", ""Mitochondrial Encephalomyopathy and Red-Ragged Fibres (diabetes research)"", ""Mitochondrial Encephalomyopathy and Red-Ragged Fibres (diabetes research)"", ""Myoclonic Epilepsy and Ragged Red Fiber (medical condition)""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY""]]","[""Myoclonic Epilepsy with Ragged Red Fibers""]",[1.0231962272178756e-30],[1.0231962272178756e-30],"[""Myoclonic Epilepsy with Ragged Red Fibers""]",[1.0231962272178756e-30],"[""LLM""]","[[2.154148013168085e-31, 4.3469131093222965e-44, 7.939049490747522e-40, 9.355592561504826e-52, 9.355592561504826e-52, 7.939049490747522e-40]]",[0.9285573903424124],[0.9250306695090004],"[""Myoclonic Epilepsy with Ragged Red Fibres""]",[0.9271145413513611],"[""ABBREVIATIONS""]","[[0.9267980124196489, 0.9271145413513611, 0.8706271215253961, 0.8669396600757395, 0.8669396600757395, 0.8706271215253961]]","[""Myoclonic epilepsy with ragged-red fibers (MERRF)""]","[""ABBREVIATIONS""]",What are the symptoms of MERRF (Myoclonic Epilepsy with Ragged Red Fibers) ?,[true],[true],[true],"[""Symptoms of MERRF include myoclonic seizures, muscle weakness, ataxia, hearing loss, and dementia.""]","[""Symptoms of Myoclonic epilepsy with ragged red fibers include myoclonus (involuntary muscle jerks), seizures, ataxia (lack of coordination), muscle weakness, and exercise intolerance.""]","[""Symptoms of MERRF (Myoclonic Epilepsy with Ragged Red Fibers) include myoclonus (involuntary muscle jerks), muscle weakness, ataxia (lack of coordination), seizures, hearing loss, and dementia.""]",[true],[true],[true],"[""Symptoms of MERRF include myoclonus (muscle jerks), seizures, ataxia (lack of coordination), muscle weakness, hearing loss, and dementia.""]","[""Symptoms of Myoclonic epilepsy with ragged red fibers include myoclonic seizures, muscle weakness, exercise intolerance, and ragged red fibers in muscle biopsy.""]","[""Symptoms of MERRF (Myoclonic Epilepsy with Ragged Red Fibers) include myoclonus (muscle twitching or jerking), seizures, ataxia (loss of coordination), muscle weakness, exercise intolerance, and ragged-red fibers in muscle biopsy.""]",[true],[true],[true],"[""Symptoms of MERRF include myoclonus (muscle jerks), seizures, ataxia (lack of coordination), muscle weakness, exercise intolerance, hearing loss, and dementia.""]","[""Symptoms of Myoclonic epilepsy with ragged red fibers include myoclonus (sudden, brief muscle jerks), seizures, ataxia (lack of coordination), muscle weakness, and exercise intolerance.""]","[""Symptoms of MERRF (Myoclonic Epilepsy with Ragged Red Fibers) include myoclonus (muscle spasms), epilepsy, ataxia (loss of coordination), hearing loss, dementia, and exercise intolerance.""]",[true],[true],[true],"[""Symptoms of MERRF include myoclonus (muscle twitching or jerking), seizures, ataxia (lack of muscle coordination), muscle weakness, exercise intolerance, hearing loss, vision loss, and dementia.""]","[""Symptoms of Myoclonic epilepsy with ragged red fibers include myoclonic seizures, muscle weakness, exercise intolerance, and ragged red fibers seen on muscle biopsy.""]","[""Symptoms of MERRF (Myoclonic Epilepsy with Ragged Red Fibers) include myoclonus (muscle jerks), seizures, ataxia, muscle weakness, hearing loss, and dementia.""]",[true],[true],[true],"[""Symptoms of MERRF include myoclonus (muscle twitching), seizures, ataxia (lack of coordination), muscle weakness, and ragged-red fibers in muscle biopsy.""]","[""Symptoms of Myoclonic epilepsy with ragged red fibers include myoclonus (involuntary muscle jerks), seizures, ataxia (lack of coordination), muscle weakness, and exercise intolerance.""]","[""Symptoms of MERRF (Myoclonic Epilepsy with Ragged Red Fibers) include myoclonus (involuntary muscle jerks), muscle weakness, ataxia (lack of coordination), seizures, hearing loss, and dementia.""]",[true],[true],[true],"[""Symptoms of MERRF include myoclonus (muscle spasms), epilepsy, ataxia (loss of coordination), muscle weakness, and ragged-red fibers in muscle biopsy.""]","[""Symptoms of Myoclonic epilepsy with ragged red fibers include myoclonic seizures, muscle weakness, exercise intolerance, and ragged red fibers in muscle biopsy.""]","[""Symptoms of MERRF (Myoclonic Epilepsy with Ragged Red Fibers) include myoclonus (muscle twitching or jerking), seizures, ataxia (loss of coordination), muscle weakness, exercise intolerance, and ragged-red fibers in muscle biopsy.""]",[true],[true],[true],"[""Symptoms of MERRF include myoclonus (muscle jerks), seizures, ataxia (lack of coordination), muscle weakness, exercise intolerance, hearing loss, and dementia.""]","[""Symptoms of Myoclonic epilepsy with ragged red fibers include myoclonus (sudden, brief muscle jerks), seizures, ataxia (lack of coordination), muscle weakness, and exercise intolerance.""]","[""Symptoms of MERRF (Myoclonic Epilepsy with Ragged Red Fibers) include myoclonus (muscle spasms), epilepsy, ataxia (loss of coordination), hearing loss, dementia, and exercise intolerance.""]",[true],[true],[true],"[""Symptoms of MERRF include myoclonus (muscle jerks), seizures, ataxia (lack of coordination), muscle weakness, hearing loss, and dementia.""]","[""Symptoms of Myoclonic epilepsy with ragged red fibers include myoclonic seizures, muscle weakness, exercise intolerance, and ragged red fibers seen on muscle biopsy.""]","[""Symptoms of MERRF (Myoclonic Epilepsy with Ragged Red Fibers) include myoclonus (muscle jerks), seizures, ataxia, muscle weakness, hearing loss, and dementia.""]",[true],[true],[true],"[""Symptoms of MERRF include myoclonus (involuntary muscle spasms), seizures, ataxia (lack of coordination), muscle weakness, and ragged-red fibers in muscle tissue.""]","[""Symptoms of Myoclonic epilepsy with ragged red fibers include myoclonic seizures, muscle weakness, exercise intolerance, and ragged red fibers in muscle biopsy.""]","[""Symptoms of MERRF (Myoclonic Epilepsy with Ragged Red Fibers) include myoclonus (muscle twitching or jerking), seizures, ataxia (loss of coordination), muscle weakness, exercise intolerance, and ragged-red fibers in muscle biopsy.""]",[true],[true],[true],"[""Symptoms of MERRF include myoclonus (muscle spasms), epilepsy, ataxia (loss of coordination), muscle weakness, hearing loss, and dementia.""]","[""Symptoms of Myoclonic epilepsy with ragged red fibers include myoclonus (involuntary muscle jerks), seizures, ataxia (lack of coordination), muscle weakness, and exercise intolerance.""]","[""Symptoms of MERRF (Myoclonic Epilepsy with Ragged Red Fibers) include myoclonus (involuntary muscle jerks), muscle weakness, ataxia (lack of coordination), seizures, hearing loss, and dementia.""]",[true],[true],[true],"[""Symptoms of MERRF include myoclonus, seizures, muscle weakness, ataxia, hearing loss, and dementia.""]","[""Symptoms of Myoclonic epilepsy with ragged red fibers include myoclonus (sudden, brief muscle jerks), seizures, ataxia (lack of coordination), muscle weakness, and exercise intolerance.""]","[""Symptoms of MERRF (Myoclonic Epilepsy with Ragged Red Fibers) include myoclonus (muscle spasms), epilepsy, ataxia (loss of coordination), hearing loss, dementia, and exercise intolerance.""]",[true],[true],[true],"[""Symptoms of MERRF include myoclonus (muscle spasms), seizures, ataxia (lack of coordination), muscle weakness, and ragged-red fibers in muscle tissue.""]","[""Symptoms of Myoclonic epilepsy with ragged red fibers include myoclonic seizures, muscle weakness, exercise intolerance, and ragged red fibers seen on muscle biopsy.""]","[""Symptoms of MERRF (Myoclonic Epilepsy with Ragged Red Fibers) include myoclonus (muscle jerks), seizures, ataxia, muscle weakness, hearing loss, and dementia.""]",[true],[true],[true],"[""Symptoms of MERRF include myoclonus, seizures, muscle weakness, ataxia, hearing loss, and dementia.""]","[""Symptoms of Myoclonic epilepsy with ragged red fibers include myoclonus (involuntary muscle jerks), seizures, ataxia (lack of coordination), muscle weakness, and exercise intolerance.""]","[""Symptoms of MERRF (Myoclonic Epilepsy with Ragged Red Fibers) include myoclonus (involuntary muscle jerks), muscle weakness, ataxia (lack of coordination), seizures, hearing loss, and dementia.""]",[true],[true],[true],"[""Symptoms of MERRF include myoclonus (muscle spasms), seizures, ataxia (lack of coordination), hearing loss, and ragged-red fibers in muscle tissue.""]","[""Symptoms of Myoclonic epilepsy with ragged red fibers include myoclonic seizures, muscle weakness, exercise intolerance, and ragged red fibers in muscle biopsy.""]","[""Symptoms of MERRF (Myoclonic Epilepsy with Ragged Red Fibers) include myoclonus (muscle twitching or jerking), seizures, ataxia (loss of coordination), muscle weakness, exercise intolerance, and ragged-red fibers in muscle biopsy.""]",[true],[true],[true],"[""Symptoms of MERRF may include myoclonus, seizures, muscle weakness, ataxia, hearing loss, and dementia.""]","[""Symptoms of Myoclonic epilepsy with ragged red fibers include myoclonus (sudden, brief muscle jerks), seizures, ataxia (lack of coordination), muscle weakness, and exercise intolerance.""]","[""Symptoms of MERRF (Myoclonic Epilepsy with Ragged Red Fibers) include myoclonus (muscle spasms), epilepsy, ataxia (loss of coordination), hearing loss, dementia, and exercise intolerance.""]",[true],[true],[true],"[""Symptoms of MERRF include myoclonus (muscle spasms), seizures, ataxia (lack of muscle control), hearing loss, and ragged-red fibers in muscle tissue.""]","[""Symptoms of Myoclonic epilepsy with ragged red fibers include myoclonic seizures, muscle weakness, exercise intolerance, and ragged red fibers seen on muscle biopsy.""]","[""Symptoms of MERRF (Myoclonic Epilepsy with Ragged Red Fibers) include myoclonus (muscle jerks), seizures, ataxia, muscle weakness, hearing loss, and dementia.""]",[true],[true],[true],"[""Symptoms of MERRF may include myoclonus, seizures, muscle weakness, ataxia, hearing loss, vision loss, and dementia.""]","[""Symptoms of Myoclonic epilepsy with ragged red fibers include myoclonus (involuntary muscle jerks), seizures, ataxia (lack of coordination), muscle weakness, and exercise intolerance.""]","[""Symptoms of MERRF (Myoclonic Epilepsy with Ragged Red Fibers) include myoclonus (involuntary muscle jerks), muscle weakness, ataxia (lack of coordination), seizures, hearing loss, and dementia.""]",[true],[true],[true],"[""Symptoms of MERRF include myoclonus (muscle jerks), seizures, ataxia (lack of coordination), muscle weakness, exercise intolerance, hearing loss, and dementia.""]","[""Symptoms of Myoclonic epilepsy with ragged red fibers include myoclonic seizures, muscle weakness, exercise intolerance, and ragged red fibers in muscle biopsy.""]","[""Symptoms of MERRF (Myoclonic Epilepsy with Ragged Red Fibers) include myoclonus (muscle twitching or jerking), seizures, ataxia (loss of coordination), muscle weakness, exercise intolerance, and ragged-red fibers in muscle biopsy.""]",[true],[true],[true],"[""Common symptoms of MERRF include myoclonus (involuntary muscle jerks), seizures, muscle weakness, ataxia (lack of muscle coordination), hearing loss, and dementia.""]","[""Symptoms of Myoclonic epilepsy with ragged red fibers include myoclonus (sudden, brief muscle jerks), seizures, ataxia (lack of coordination), muscle weakness, and exercise intolerance.""]","[""Symptoms of MERRF (Myoclonic Epilepsy with Ragged Red Fibers) include myoclonus (muscle spasms), epilepsy, ataxia (loss of coordination), hearing loss, dementia, and exercise intolerance.""]",[true],[true],[true],"[""Symptoms of MERRF include myoclonus, seizures, muscle weakness, ataxia, hearing loss, and dementia.""]","[""Symptoms of Myoclonic epilepsy with ragged red fibers include myoclonic seizures, muscle weakness, exercise intolerance, and ragged red fibers seen on muscle biopsy.""]","[""Symptoms of MERRF (Myoclonic Epilepsy with Ragged Red Fibers) include myoclonus (muscle jerks), seizures, ataxia, muscle weakness, hearing loss, and dementia.""]",[true],[true],[true],"[""Symptoms of MERRF include myoclonus (muscle jerks), seizures, ataxia (lack of coordination), muscle weakness, and ragged-red fibers in muscle biopsy.""]","[""Symptoms of Myoclonic epilepsy with ragged red fibers include myoclonus (involuntary muscle jerks), seizures, ataxia (lack of coordination), muscle weakness, and exercise intolerance.""]","[""Symptoms of MERRF (Myoclonic Epilepsy with Ragged Red Fibers) include myoclonus (involuntary muscle jerks), muscle weakness, ataxia (lack of coordination), seizures, hearing loss, and dementia.""]",[true],[true],[true],"[""Symptoms of MERRF include myoclonus (muscle twitching or jerking), seizures, ataxia (lack of coordination), muscle weakness, hearing loss, and dementia.""]","[""Symptoms of Myoclonic epilepsy with ragged red fibers include myoclonic seizures, muscle weakness, exercise intolerance, and ragged red fibers in muscle biopsy.""]","[""Symptoms of MERRF (Myoclonic Epilepsy with Ragged Red Fibers) include myoclonus (muscle twitching or jerking), seizures, ataxia (loss of coordination), muscle weakness, exercise intolerance, and ragged-red fibers in muscle biopsy.""]",[true],[true],[true],"[""Symptoms of MERRF include myoclonus (muscle twitching), seizures, ataxia (lack of coordination), muscle weakness, exercise intolerance, and ragged-red fibers in muscle biopsy.""]","[""Symptoms of Myoclonic epilepsy with ragged red fibers include myoclonus (sudden, brief muscle jerks), seizures, ataxia (lack of coordination), muscle weakness, and exercise intolerance.""]","[""Symptoms of MERRF (Myoclonic Epilepsy with Ragged Red Fibers) include myoclonus (muscle spasms), epilepsy, ataxia (loss of coordination), hearing loss, dementia, and exercise intolerance.""]",[true],[true],[true],"[""Symptoms of MERRF include myoclonus (muscle twitches), seizures, ataxia (lack of coordination), muscle weakness, hearing loss, and dementia.""]","[""Symptoms of Myoclonic epilepsy with ragged red fibers include myoclonic seizures, muscle weakness, exercise intolerance, and ragged red fibers seen on muscle biopsy.""]","[""Symptoms of MERRF (Myoclonic Epilepsy with Ragged Red Fibers) include myoclonus (muscle jerks), seizures, ataxia, muscle weakness, hearing loss, and dementia.""]",[true],[true],[true],"[""Symptoms of MERRF include myoclonus (muscle spasms), seizures, ataxia (lack of coordination), hearing loss, vision loss, and ragged-red fibers in muscle tissue.""]","[""Symptoms of Myoclonic epilepsy with ragged red fibers include myoclonus (involuntary muscle jerks), seizures, ataxia (lack of coordination), muscle weakness, and exercise intolerance.""]","[""Symptoms of MERRF (Myoclonic Epilepsy with Ragged Red Fibers) include myoclonus (involuntary muscle jerks), muscle weakness, ataxia (lack of coordination), seizures, hearing loss, and dementia.""]",[true],[true],[true],"[""Symptoms of MERRF include myoclonus (involuntary muscle spasms), seizures, ataxia (lack of coordination), muscle weakness, exercise intolerance, and ragged-red fibers in muscle biopsy.""]","[""Symptoms of Myoclonic epilepsy with ragged red fibers include myoclonic seizures, muscle weakness, exercise intolerance, and ragged red fibers in muscle biopsy.""]","[""Symptoms of MERRF (Myoclonic Epilepsy with Ragged Red Fibers) include myoclonus (muscle twitching or jerking), seizures, ataxia (loss of coordination), muscle weakness, exercise intolerance, and ragged-red fibers in muscle biopsy.""]",[true],[true],[true],"[""Symptoms of MERRF include myoclonus (muscle spasms), seizures, ataxia (lack of coordination), muscle weakness, and ragged-red fibers in muscle biopsy.""]","[""Symptoms of Myoclonic epilepsy with ragged red fibers include myoclonus (sudden, brief muscle jerks), seizures, ataxia (lack of coordination), muscle weakness, and exercise intolerance.""]","[""Symptoms of MERRF (Myoclonic Epilepsy with Ragged Red Fibers) include myoclonus (muscle spasms), epilepsy, ataxia (loss of coordination), hearing loss, dementia, and exercise intolerance.""]",[true],[true],[true],"[""Some symptoms of MERRF include myoclonus (muscle spasms), seizures, ataxia (lack of muscle coordination), hearing loss, and ragged-red fibers in muscle tissue.""]","[""Symptoms of Myoclonic epilepsy with ragged red fibers include myoclonic seizures, muscle weakness, exercise intolerance, and ragged red fibers seen on muscle biopsy.""]","[""Symptoms of MERRF (Myoclonic Epilepsy with Ragged Red Fibers) include myoclonus (muscle jerks), seizures, ataxia, muscle weakness, hearing loss, and dementia.""]",[true],[true],[true],"[""Symptoms of MERRF may include myoclonus (muscle spasms), seizures, ataxia, hearing loss, dementia, and ragged-red fibers in muscle biopsy.""]","[""Symptoms of Myoclonic epilepsy with ragged red fibers include myoclonus (involuntary muscle jerks), seizures, ataxia (lack of coordination), muscle weakness, and exercise intolerance.""]","[""Symptoms of MERRF (Myoclonic Epilepsy with Ragged Red Fibers) include myoclonus (involuntary muscle jerks), muscle weakness, ataxia (lack of coordination), seizures, hearing loss, and dementia.""]",[true],[true],[true],"[""Symptoms of MERRF include myoclonus (muscle twitching or jerking), seizures, ataxia (loss of coordination), muscle weakness, exercise intolerance, hearing loss, and dementia.""]","[""Symptoms of Myoclonic epilepsy with ragged red fibers include myoclonus (involuntary muscle jerks), seizures, ataxia (lack of coordination), muscle weakness, and exercise intolerance.""]","[""Symptoms of MERRF (Myoclonic Epilepsy with Ragged Red Fibers) include myoclonus (involuntary muscle jerks), muscle weakness, ataxia (lack of coordination), seizures, hearing loss, and dementia.""]",[true],[true],[true],"[""Symptoms of MERRF include myoclonus (muscle jerks), seizures, ataxia, muscle weakness, exercise intolerance, and ragged-red fibers in muscle biopsy.""]","[""Symptoms of Myoclonic epilepsy with ragged red fibers include myoclonus (involuntary muscle jerks), seizures, ataxia (lack of coordination), muscle weakness, and exercise intolerance.""]","[""Symptoms of MERRF (Myoclonic Epilepsy with Ragged Red Fibers) include myoclonus (involuntary muscle jerks), muscle weakness, ataxia (lack of coordination), seizures, hearing loss, and dementia.""]",[true],[true],[true],"[""Symptoms of MERRF include myoclonus, seizures, muscle weakness, ataxia, hearing loss, and dementia.""]","[""Symptoms of Myoclonic epilepsy with ragged red fibers include myoclonus (involuntary muscle jerks), seizures, ataxia (lack of coordination), muscle weakness, and exercise intolerance.""]","[""Symptoms of MERRF (Myoclonic Epilepsy with Ragged Red Fibers) include myoclonus (involuntary muscle jerks), muscle weakness, ataxia (lack of coordination), seizures, hearing loss, and dementia.""]"
treatment,What are the treatments for succinyl-CoA:3-ketoacid CoA transferase deficiency ?,These resources address the diagnosis or management of succinyl-CoA:3-ketoacid CoA transferase deficiency:  - Genetic Testing Registry: Succinyl-CoA acetoacetate transferase deficiency  - MedlinePlus Encyclopedia: Ketones--Urine  - MedlinePlus Encyclopedia: Serum Ketones Test   These resources from MedlinePlus offer information about the diagnosis and management of various health conditions:  - Diagnostic Tests  - Drug Therapy  - Surgery and Rehabilitation  - Genetic Counseling   - Palliative Care,"{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""SCOT"", ""full_form"": ""succinyl-CoA:3-ketoacid CoA transferase""}]}",What are the treatments for SCOT deficiency ?,What are the treatments for succinyl-CoA:3-ketoacid CoA transferase deficiency ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Social Construction Of Technology"", ""Scottish Annuity and Life"", ""Safety Chemical Oil Tanker"", ""Self Check Out Terminal"", ""Service Center Operations Team"", ""Supply Chain Optimization Technology"", ""Social Constructivism Of Technology"", ""Significant Classes of Transactions"", ""Scleroderma Cyclophosphamide Or Transplantation"", ""Strengths Concerns Opportunities and Threats""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Succinyl-CoA:3-Oxoacid CoA Transferase""]",[1.9847734680500463e-45],[4.203133848947664e-47],"[""Social Construction Of Technology""]",[1.9388241550507137e-16],"[""ABBREVIATIONS""]","[[1.9388241550507137e-16, 3.366787646005239e-27, 1.0455652154060162e-21, 2.538119786478045e-18, 1.1145485024089901e-17, 9.409705637493424e-21, 3.475382080711553e-22, 1.1266431432108837e-17, 7.147016607255541e-23, 3.6594970993655106e-26]]",[0.8842141789561762],[0.8917541700773484],"[""Self Check Out Terminal""]",[0.9022432759326839],"[""ABBREVIATIONS""]","[[0.8076348642150457, 0.8882079211608058, 0.857179124681492, 0.8470192327460233, 0.9022432759326839, 0.8757239240617376, 0.8049009098637094, 0.8753762214095493, 0.8025351849870181, 0.8191589056620822]]","[""Succinyl-CoA:3-Oxoacid CoA Transferase""]","[""LLM""]",What are the treatments for SCOT (Succinyl-CoA:3-Oxoacid CoA Transferase) deficiency ?,[false],[true],[true],"[""There is no medical condition known as SCOT deficiency. SCOT refers to the Social Construction Of Technology theory in sociology.""]","[""Treatment for succinyl-CoA:3-ketoacid CoA transferase deficiency includes a low-protein diet, avoiding fasting, and supplementation with L-carnitine.""]","[""There is no specific treatment for SCOT deficiency. Management involves a low-protein diet and avoiding fasting to prevent metabolic crises.""]",[false],[true],[true],"[""There is no medical condition known as SCOT deficiency. SCOT is an acronym for Social Construction Of Technology, which is a theory in the field of Science and Technology Studies.""]","[""Treatment for succinyl-CoA:3-ketoacid CoA transferase deficiency includes a low-protein diet, avoiding fasting, and supplementation with L-carnitine.""]","[""There is no specific treatment for SCOT deficiency. Management involves dietary modifications and supportive care.""]",[false],[true],[true],"[""There is no medical condition known as SCOT deficiency. SCOT stands for Social Construction Of Technology, which is a theory in the field of Science and Technology Studies.""]","[""Treatment for succinyl-CoA:3-ketoacid CoA transferase deficiency includes a low-protein diet, avoiding fasting, and supplementation with L-carnitine.""]","[""There is no specific treatment for SCOT deficiency. Management involves dietary modifications and symptomatic treatment.""]",[false],[true],[true],"[""There is no medical condition known as SCOT deficiency. SCOT refers to the Social Construction Of Technology theory in sociology.""]","[""Treatment for succinyl-CoA:3-ketoacid CoA transferase deficiency includes a low-protein diet, avoiding fasting, and supplementation with specific nutrients.""]","[""There is no specific treatment for SCOT deficiency. Management involves dietary modifications and symptomatic treatment.""]",[false],[true],[true],"[""There is no known medical condition called SCOT deficiency. It is possible that you may be referring to a different term or condition.""]","[""Treatment for succinyl-CoA:3-ketoacid CoA transferase deficiency includes a low-protein diet, avoiding fasting, and supplementation with L-carnitine.""]","[""There is no specific treatment for SCOT deficiency. Management involves a low-protein diet and avoiding fasting to prevent metabolic crises.""]",[false],[true],[true],"[""There is no medical condition known as SCOT deficiency. It seems to be a misunderstanding or miscommunication. Please consult a healthcare professional for accurate information.""]","[""Treatment for succinyl-CoA:3-ketoacid CoA transferase deficiency includes a low-protein diet, avoiding fasting, and supplementation with L-carnitine.""]","[""There is no specific treatment for SCOT deficiency. Management involves dietary modifications and supportive care.""]",[false],[true],[true],"[""There is no medical condition known as SCOT deficiency. It seems to be a misunderstanding or misinterpretation of medical terminology.""]","[""Treatment for succinyl-CoA:3-ketoacid CoA transferase deficiency includes a low-protein diet, avoiding fasting, and supplementation with L-carnitine.""]","[""There is no specific treatment for SCOT deficiency. Management involves dietary modifications and symptomatic treatment.""]",[false],[true],[true],"[""There is no known medical condition called SCOT deficiency. It is likely a typo or misunderstanding of a medical term.""]","[""Treatment for succinyl-CoA:3-ketoacid CoA transferase deficiency includes a low-protein diet, avoiding fasting, and supplementation with specific nutrients.""]","[""There is no specific treatment for SCOT deficiency. Management involves dietary modifications and symptomatic treatment.""]",[true],[true],[true],"[""Dietary management, avoiding fasting, and supplementation with L-carnitine""]","[""Treatment for succinyl-CoA:3-ketoacid CoA transferase deficiency includes a low-protein diet, avoiding fasting, and supplementation with L-carnitine.""]","[""There is no specific treatment for SCOT deficiency. Management involves dietary modifications and supportive care.""]",[false],[true],[true],"[""Treatment for SCOT deficiency includes a low-carbohydrate diet, avoiding fasting, and supplementation with specific amino acids and vitamins.""]","[""Treatment for succinyl-CoA:3-ketoacid CoA transferase deficiency includes a low-protein diet, avoiding fasting, and supplementation with L-carnitine.""]","[""There is no specific treatment for SCOT deficiency. Management involves a low-protein diet and avoiding fasting to prevent metabolic crises.""]",[true],[true],[true],"[""Treatment for SCOT deficiency involves a low-carbohydrate, high-fat diet to prevent the build-up of toxic substances in the body. In severe cases, liver transplantation may be considered.""]","[""Treatment for succinyl-CoA:3-ketoacid CoA transferase deficiency includes a low-protein diet, avoiding fasting, and supplementation with L-carnitine.""]","[""There is no specific treatment for SCOT deficiency. Management involves dietary modifications and symptomatic treatment.""]",[true],[true],[true],"[""Dietary management, avoiding fasting, and supplementation with L-carnitine""]","[""Treatment for succinyl-CoA:3-ketoacid CoA transferase deficiency includes a low-protein diet, avoiding fasting, and supplementation with specific nutrients.""]","[""There is no specific treatment for SCOT deficiency. Management involves dietary modifications and symptomatic treatment.""]",[true],[true],[true],"[""Dietary management, carnitine supplementation, avoiding fasting""]","[""Treatment for succinyl-CoA:3-ketoacid CoA transferase deficiency includes a low-protein diet, avoiding fasting, and supplementation with L-carnitine.""]","[""There is no specific treatment for SCOT deficiency. Management involves a low-protein diet and avoiding fasting to prevent metabolic crises.""]",[true],[true],[true],"[""Dietary management, carnitine supplementation, avoiding fasting""]","[""Treatment for succinyl-CoA:3-ketoacid CoA transferase deficiency includes a low-protein diet, avoiding fasting, and supplementation with L-carnitine.""]","[""There is no specific treatment for SCOT deficiency. Management involves dietary modifications and supportive care.""]",[true],[true],[true],"[""Dietary management, avoiding fasting, supplementation with L-carnitine and riboflavin""]","[""Treatment for succinyl-CoA:3-ketoacid CoA transferase deficiency includes a low-protein diet, avoiding fasting, and supplementation with L-carnitine.""]","[""There is no specific treatment for SCOT deficiency. Management involves dietary modifications and symptomatic treatment.""]",[true],[true],[true],"[""Dietary management, carnitine supplementation, avoiding fasting""]","[""Treatment for succinyl-CoA:3-ketoacid CoA transferase deficiency includes a low-protein diet, avoiding fasting, and supplementation with specific nutrients.""]","[""There is no specific treatment for SCOT deficiency. Management involves dietary modifications and symptomatic treatment.""]",[true],[true],[true],"[""Dietary management, avoiding fasting, and supplementation with L-carnitine""]","[""Treatment for succinyl-CoA:3-ketoacid CoA transferase deficiency includes a low-protein diet, avoiding fasting, and supplementation with L-carnitine.""]","[""There is no specific treatment for SCOT deficiency. Management involves a low-protein diet and avoiding fasting to prevent metabolic crises.""]",[true],[true],[true],"[""Treatment for SCOT deficiency includes a low-carbohydrate diet, avoiding fasting, and supplementation with specific amino acids and vitamins.""]","[""Treatment for succinyl-CoA:3-ketoacid CoA transferase deficiency includes a low-protein diet, avoiding fasting, and supplementation with L-carnitine.""]","[""There is no specific treatment for SCOT deficiency. Management involves dietary modifications and supportive care.""]",[true],[true],[true],"[""Dietary management, avoiding fasting, and supplementation with L-carnitine""]","[""Treatment for succinyl-CoA:3-ketoacid CoA transferase deficiency includes a low-protein diet, avoiding fasting, and supplementation with L-carnitine.""]","[""There is no specific treatment for SCOT deficiency. Management involves dietary modifications and symptomatic treatment.""]",[true],[true],[true],"[""Dietary management, carnitine supplementation, avoiding fasting, and in severe cases, liver transplantation""]","[""Treatment for succinyl-CoA:3-ketoacid CoA transferase deficiency includes a low-protein diet, avoiding fasting, and supplementation with specific nutrients.""]","[""There is no specific treatment for SCOT deficiency. Management involves dietary modifications and symptomatic treatment.""]",[false],[true],[true],"[""Treatment for SCOT deficiency includes a low-protein diet, supplementation with specific amino acids, and in severe cases, liver transplantation.""]","[""Treatment for succinyl-CoA:3-ketoacid CoA transferase deficiency includes a low-protein diet, avoiding fasting, and supplementation with L-carnitine.""]","[""There is no specific treatment for SCOT deficiency. Management involves a low-protein diet and avoiding fasting to prevent metabolic crises.""]",[true],[true],[true],"[""Treatment for SCOT deficiency involves a low-carbohydrate, high-fat diet, and supplementation with specific amino acids and vitamins.""]","[""Treatment for succinyl-CoA:3-ketoacid CoA transferase deficiency includes a low-protein diet, avoiding fasting, and supplementation with L-carnitine.""]","[""There is no specific treatment for SCOT deficiency. Management involves dietary modifications and supportive care.""]",[true],[true],[true],"[""Dietary management, avoiding fasting, and supplementation with L-carnitine""]","[""Treatment for succinyl-CoA:3-ketoacid CoA transferase deficiency includes a low-protein diet, avoiding fasting, and supplementation with L-carnitine.""]","[""There is no specific treatment for SCOT deficiency. Management involves dietary modifications and symptomatic treatment.""]",[true],[true],[true],"[""Treatment for SCOT deficiency includes a low-carbohydrate diet, avoiding fasting, and supplementation with specific amino acids and vitamins.""]","[""Treatment for succinyl-CoA:3-ketoacid CoA transferase deficiency includes a low-protein diet, avoiding fasting, and supplementation with specific nutrients.""]","[""There is no specific treatment for SCOT deficiency. Management involves dietary modifications and symptomatic treatment.""]",[true],[true],[true],"[""The treatments for SCOT deficiency include a low-carbohydrate/high-fat diet, avoidance of fasting, and supplementation with specific nutrients like L-carnitine and CoQ10.""]","[""Treatment for succinyl-CoA:3-ketoacid CoA transferase deficiency includes a low-protein diet, avoiding fasting, and supplementation with L-carnitine.""]","[""There is no specific treatment for SCOT deficiency. Management involves a low-protein diet and avoiding fasting to prevent metabolic crises.""]",[true],[true],[true],"[""The treatments for SCOT deficiency include a low-carbohydrate/high-fat diet, avoiding fasting, and supplementation with specific amino acids and cofactors.""]","[""Treatment for succinyl-CoA:3-ketoacid CoA transferase deficiency includes a low-protein diet, avoiding fasting, and supplementation with L-carnitine.""]","[""There is no specific treatment for SCOT deficiency. Management involves dietary modifications and supportive care.""]",[true],[true],[true],"[""The treatments for SCOT deficiency include a low-protein diet, supplementation with specific amino acids, and in severe cases, liver transplantation.""]","[""Treatment for succinyl-CoA:3-ketoacid CoA transferase deficiency includes a low-protein diet, avoiding fasting, and supplementation with L-carnitine.""]","[""There is no specific treatment for SCOT deficiency. Management involves dietary modifications and symptomatic treatment.""]",[true],[true],[true],"[""The treatments for SCOT deficiency include a low-carbohydrate diet, supplementation with specific amino acids, and in severe cases, liver transplantation.""]","[""Treatment for succinyl-CoA:3-ketoacid CoA transferase deficiency includes a low-protein diet, avoiding fasting, and supplementation with specific nutrients.""]","[""There is no specific treatment for SCOT deficiency. Management involves dietary modifications and symptomatic treatment.""]",[true],[true],[true],"[""There is no specific treatment for SCOT deficiency, but management involves a low-protein diet and avoiding fasting to prevent metabolic crises.""]","[""Treatment for succinyl-CoA:3-ketoacid CoA transferase deficiency includes a low-protein diet, avoiding fasting, and supplementation with L-carnitine.""]","[""There is no specific treatment for SCOT deficiency. Management involves a low-protein diet and avoiding fasting to prevent metabolic crises.""]",[false],[true],[true],"[""There are no specific treatments for SCOT deficiency as it is a theoretical framework in the field of Science and Technology Studies.""]","[""Treatment for succinyl-CoA:3-ketoacid CoA transferase deficiency includes a low-protein diet, avoiding fasting, and supplementation with L-carnitine.""]","[""There is no specific treatment for SCOT deficiency. Management involves a low-protein diet and avoiding fasting to prevent metabolic crises.""]",[false],[true],[true],"[""There is no specific treatment for SCOT deficiency as it is not a recognized medical condition.""]","[""Treatment for succinyl-CoA:3-ketoacid CoA transferase deficiency includes a low-protein diet, avoiding fasting, and supplementation with L-carnitine.""]","[""There is no specific treatment for SCOT deficiency. Management involves a low-protein diet and avoiding fasting to prevent metabolic crises.""]",[true],[true],[true],"[""Dietary management, avoiding fasting, and supplementation with L-carnitine and CoQ10""]","[""Treatment for succinyl-CoA:3-ketoacid CoA transferase deficiency includes a low-protein diet, avoiding fasting, and supplementation with L-carnitine.""]","[""There is no specific treatment for SCOT deficiency. Management involves a low-protein diet and avoiding fasting to prevent metabolic crises.""]"
outlook,What is the outlook for Charcot-Marie-Tooth Disease ?,"Onset of symptoms of CMT is most often in adolescence or early adulthood, however presentation may be delayed until mid-adulthood. Progression of symptoms is very gradual. The degeneration of motor nerves results in muscle weakness and atrophy in the extremities (arms, legs, hands, or feet), and the degeneration of sensory nerves results in a reduced ability to feel heat, cold, and pain. There are many forms of CMT disease. The severity of symptoms may vary greatly among individuals and some people may never realize they have the disorder. CMT is not fatal and people with most forms of CMT have a normal life expectancy.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""CMT"", ""full_form"": ""Charcot-Marie-Tooth Disease""}]}",What is the outlook for CMT ?,What is the outlook for Charcot-Marie-Tooth Disease ?,3,BUSINESS,Simple Datatype-String,"Exploratory(Divergent Thinking): Queries that are inherently about seeking new areas of knowledge, understanding emerging trends, or identifying unknown opportunities without a specific end goal of making a decision or judgment. Exploratory queries are characterized by their openness and the lack of a predefined objective, differentiating them from evaluative queries which are directed towards forming a judgment or assessment. Exploratory queries encourage branching out into various directions to explore a wide array of possibilities without necessarily aiming to converge on a single answer or outcome.","[[""Country Music Television"", ""Charcot Marie Tooth"", ""Constant Maturity Treasury"", ""Certified Massage Therapist"", ""California Mastitis Test"", ""Chartered Market Technician"", ""Certified Medical Transcriptionist"", ""Cut, Make, and Trim"", ""Caravan Motor Touristik"", ""Carlsberg Meridian Telescope""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Composite Muscle Transfer""]",[1.269023974839591e-20],[3.5287371960974723e-15],"[""Country Music Television""]",[3.53466694927211e-13],"[""ABBREVIATIONS""]","[[3.53466694927211e-13, 5.132090534311404e-18, 3.1674729618615406e-17, 7.535113951056905e-18, 1.197330924500662e-22, 1.1041181626475085e-18, 1.8476087770421678e-17, 2.1741264095050456e-19, 3.5823579253175464e-23, 2.3797715242685632e-27]]",[0.8834770438207562],[0.7743914547683509],"[""Country Music Television""]",[0.887566527182293],"[""ABBREVIATIONS""]","[[0.7013456279852979, 0.887566527182293, 0.6805902919672464, 0.6800889389201508, 0.6059688649499458, 0.7029264416908371, 0.6907041522854747, 0.6778263329310612, 0.6394738030435558, 0.6133392058355238]]","[""Charcot Marie Tooth""]","[""ABBREVIATIONS""]",What is the outlook for CMT (Composite Muscle Transfer) ?,[false],[true],[false],"[""The outlook for CMT (Country Music Television) is positive, with a growing audience and expanding programming lineup.""]","[""The outlook for Charcot-Marie-Tooth Disease varies depending on the specific subtype and individual factors. Generally, it is a progressive condition, but management strategies can help improve quality of life and slow down progression in some cases.""]","[""The outlook for CMT is positive due to its innovative technology and strong market demand.""]",[false],[true],[false],"[""The outlook for CMT (Country Music Television) is positive as it continues to attract a dedicated audience and expand its programming to cater to changing viewer preferences.""]","[""The outlook for Charcot-Marie-Tooth Disease varies depending on the specific subtype and individual circumstances. Generally, it is a progressive condition, but management strategies can help improve quality of life and slow down disease progression.""]","[""The outlook for CMT is positive due to the increasing demand for its services in the market.""]",[false],[true],[false],"[""The outlook for CMT (Country Music Television) is positive as it continues to attract a dedicated audience and expand its programming to cater to changing viewer preferences.""]","[""The outlook for Charcot-Marie-Tooth Disease varies depending on the specific subtype and individual circumstances. It is a progressive condition, but management strategies such as physical therapy, orthopedic interventions, and assistive devices can help improve quality of life and function for many patients.""]","[""The outlook for CMT is positive due to its innovative technology and strong market demand.""]",[false],[true],[false],"[""The outlook for CMT (Country Music Television) is positive as it continues to be a popular platform for country music fans and artists, with opportunities for growth in digital content and partnerships.""]","[""The outlook for Charcot-Marie-Tooth Disease varies depending on the specific subtype and individual factors. Generally, it is a progressive condition, but management strategies can help improve quality of life and slow down disease progression.""]","[""The outlook for CMT is positive, with a growing market and potential for expansion in the near future.""]",[false],[true],[false],"[""The outlook for CMT (Country Music Television) is positive as it continues to be a popular platform for country music fans and artists, with potential for growth in viewership and partnerships.""]","[""The outlook for Charcot-Marie-Tooth Disease varies depending on the specific subtype and individual factors. Generally, it is a progressive condition, but management strategies can help improve quality of life and slow down progression in some cases.""]","[""The outlook for CMT is positive due to its innovative technology and strong market demand.""]",[false],[true],[false],"[""The outlook for CMT (Country Music Television) is positive as it continues to attract a dedicated audience and expand its programming to cater to changing viewer preferences.""]","[""The outlook for Charcot-Marie-Tooth Disease varies depending on the specific subtype and individual circumstances. Generally, it is a progressive condition, but management strategies can help improve quality of life and slow down disease progression.""]","[""The outlook for CMT is positive due to the increasing demand for its services in the market.""]",[false],[true],[false],"[""The outlook for CMT (Country Music Television) is positive, with a growing audience and expanding content offerings.""]","[""The outlook for Charcot-Marie-Tooth Disease varies depending on the specific subtype and individual circumstances. It is a progressive condition, but management strategies such as physical therapy, orthopedic interventions, and assistive devices can help improve quality of life and function for many patients.""]","[""The outlook for CMT is positive due to its innovative technology and strong market demand.""]",[false],[true],[false],"[""The outlook for CMT (Country Music Television) is positive as it continues to attract a dedicated audience and expand its programming to cater to changing viewer preferences.""]","[""The outlook for Charcot-Marie-Tooth Disease varies depending on the specific subtype and individual factors. Generally, it is a progressive condition, but management strategies can help improve quality of life and slow down disease progression.""]","[""The outlook for CMT is positive, with a growing market and potential for expansion in the near future.""]",[true],[true],[false],"[""The outlook for Charcot Marie Tooth (CMT) is dependent on the specific subtype and individual factors. Generally, management focuses on symptom relief, physical therapy, orthopedic interventions, and assistive devices to improve quality of life.""]","[""The outlook for Charcot-Marie-Tooth Disease varies depending on the specific subtype and individual circumstances. Generally, it is a progressive condition, but management strategies can help improve quality of life and slow down disease progression.""]","[""The outlook for CMT is positive due to the increasing demand for its services in the market.""]",[true],[true],[false],"[""The outlook for Charcot Marie Tooth (CMT) is variable and depends on the specific type of CMT, individual symptoms, and management strategies. It is recommended to consult with a healthcare professional for personalized information.""]","[""The outlook for Charcot-Marie-Tooth Disease varies depending on the specific subtype and individual factors. Generally, it is a progressive condition, but management strategies can help improve quality of life and slow down progression in some cases.""]","[""The outlook for CMT is positive due to its innovative technology and strong market demand.""]",[true],[true],[false],"[""The outlook for Charcot Marie Tooth (CMT) is dependent on various factors such as the specific type of CMT, individual symptoms, and treatment options. It is recommended to consult with a healthcare professional for personalized information.""]","[""The outlook for Charcot-Marie-Tooth Disease varies depending on the specific subtype and individual circumstances. It is a progressive condition, but management strategies such as physical therapy, orthopedic interventions, and assistive devices can help improve quality of life and function for many patients.""]","[""The outlook for CMT is positive due to its innovative technology and strong market demand.""]",[true],[true],[false],"[""The outlook for Charcot Marie Tooth (CMT) is variable and depends on the specific subtype of the condition. Generally, it is a progressive condition that affects the peripheral nerves, leading to muscle weakness and sensory loss. Research and advancements in treatment options are ongoing to improve the management of CMT.""]","[""The outlook for Charcot-Marie-Tooth Disease varies depending on the specific subtype and individual factors. Generally, it is a progressive condition, but management strategies can help improve quality of life and slow down disease progression.""]","[""The outlook for CMT is positive, with a growing market and potential for expansion in the near future.""]",[true],[true],[false],"[""The outlook for CMT (Charcot Marie Tooth) varies depending on the type and severity of the condition. It is a progressive disease, but management strategies can help improve quality of life and slow down progression in some cases.""]","[""The outlook for Charcot-Marie-Tooth Disease varies depending on the specific subtype and individual factors. Generally, it is a progressive condition, but management strategies can help improve quality of life and slow down progression in some cases.""]","[""The outlook for CMT is positive due to its innovative technology and strong market demand.""]",[true],[true],[false],"[""The outlook for CMT (Charcot Marie Tooth) varies depending on the type and severity of the condition. It is a progressive disorder, but management strategies can help improve quality of life and slow down progression in some cases.""]","[""The outlook for Charcot-Marie-Tooth Disease varies depending on the specific subtype and individual circumstances. Generally, it is a progressive condition, but management strategies can help improve quality of life and slow down disease progression.""]","[""The outlook for CMT is positive due to the increasing demand for its services in the market.""]",[true],[true],[false],"[""The outlook for CMT (Charcot Marie Tooth) varies depending on the type and severity of the condition. It is a progressive disorder, but management strategies can help improve quality of life and function.""]","[""The outlook for Charcot-Marie-Tooth Disease varies depending on the specific subtype and individual circumstances. It is a progressive condition, but management strategies such as physical therapy, orthopedic interventions, and assistive devices can help improve quality of life and function for many patients.""]","[""The outlook for CMT is positive due to its innovative technology and strong market demand.""]",[true],[true],[false],"[""The outlook for CMT (Charcot Marie Tooth) varies depending on the type and severity of the condition. It is a progressive disorder, but management strategies can help improve quality of life and function.""]","[""The outlook for Charcot-Marie-Tooth Disease varies depending on the specific subtype and individual factors. Generally, it is a progressive condition, but management strategies can help improve quality of life and slow down disease progression.""]","[""The outlook for CMT is positive, with a growing market and potential for expansion in the near future.""]",[true],[true],[false],"[""The outlook for Charcot Marie Tooth (CMT) varies depending on the specific type and severity of the condition. Generally, it is a progressive condition with no cure, but management strategies can help improve quality of life and slow down progression.""]","[""The outlook for Charcot-Marie-Tooth Disease varies depending on the specific subtype and individual factors. Generally, it is a progressive condition, but management strategies can help improve quality of life and slow down progression in some cases.""]","[""The outlook for CMT is positive due to its innovative technology and strong market demand.""]",[true],[true],[false],"[""The outlook for Charcot Marie Tooth (CMT) is dependent on the specific subtype, but generally focuses on managing symptoms and improving quality of life through physical therapy, orthopedic interventions, and assistive devices.""]","[""The outlook for Charcot-Marie-Tooth Disease varies depending on the specific subtype and individual circumstances. Generally, it is a progressive condition, but management strategies can help improve quality of life and slow down disease progression.""]","[""The outlook for CMT is positive due to the increasing demand for its services in the market.""]",[true],[true],[false],"[""The outlook for Charcot Marie Tooth (CMT) is variable depending on the specific type and severity of the condition. It is a progressive disease, but management strategies can help improve quality of life and function for individuals with CMT.""]","[""The outlook for Charcot-Marie-Tooth Disease varies depending on the specific subtype and individual circumstances. It is a progressive condition, but management strategies such as physical therapy, orthopedic interventions, and assistive devices can help improve quality of life and function for many patients.""]","[""The outlook for CMT is positive due to its innovative technology and strong market demand.""]",[true],[true],[false],"[""The outlook for CMT (Charcot Marie Tooth) is dependent on various factors such as the specific type of CMT, individual symptoms, and treatment options available. It is recommended to consult with a healthcare professional for personalized information.""]","[""The outlook for Charcot-Marie-Tooth Disease varies depending on the specific subtype and individual factors. Generally, it is a progressive condition, but management strategies can help improve quality of life and slow down disease progression.""]","[""The outlook for CMT is positive, with a growing market and potential for expansion in the near future.""]",[false],[true],[false],"[""The outlook for CMT (Composite Muscle Transfer) is promising as it continues to evolve with advancements in medical technology and surgical techniques.""]","[""The outlook for Charcot-Marie-Tooth Disease varies depending on the specific subtype and individual factors. Generally, it is a progressive condition, but management strategies can help improve quality of life and slow down progression in some cases.""]","[""The outlook for CMT is positive due to its innovative technology and strong market demand.""]",[false],[true],[false],"[""The outlook for CMT (Composite Muscle Transfer) is promising in the field of reconstructive surgery, showing potential for improving functional outcomes in patients with complex musculoskeletal injuries.""]","[""The outlook for Charcot-Marie-Tooth Disease varies depending on the specific subtype and individual circumstances. Generally, it is a progressive condition, but management strategies can help improve quality of life and slow down disease progression.""]","[""The outlook for CMT is positive due to the increasing demand for its services in the market.""]",[false],[true],[false],"[""The outlook for CMT (Composite Muscle Transfer) is promising as it continues to show positive results in improving muscle function and quality of life for patients with certain conditions.""]","[""The outlook for Charcot-Marie-Tooth Disease varies depending on the specific subtype and individual circumstances. It is a progressive condition, but management strategies such as physical therapy, orthopedic interventions, and assistive devices can help improve quality of life and function for many patients.""]","[""The outlook for CMT is positive due to its innovative technology and strong market demand.""]",[false],[true],[false],"[""The outlook for CMT (Composite Muscle Transfer) is promising as it continues to be a viable option for restoring function in patients with complex limb injuries or neuromuscular disorders.""]","[""The outlook for Charcot-Marie-Tooth Disease varies depending on the specific subtype and individual factors. Generally, it is a progressive condition, but management strategies can help improve quality of life and slow down disease progression.""]","[""The outlook for CMT is positive, with a growing market and potential for expansion in the near future.""]",[true],[true],[false],"[""The outlook for Charcot Marie Tooth (CMT) varies depending on the specific type and severity of the condition. Generally, it is a progressive condition, but management strategies can help improve quality of life and slow down progression in some cases.""]","[""The outlook for Charcot-Marie-Tooth Disease varies depending on the specific subtype and individual factors. Generally, it is a progressive condition, but management strategies can help improve quality of life and slow down progression in some cases.""]","[""The outlook for CMT is positive due to its innovative technology and strong market demand.""]",[true],[true],[false],"[""The outlook for Charcot Marie Tooth (CMT) varies depending on the specific type and severity of the condition. It is a progressive disorder, but management strategies can help improve quality of life and slow down progression in some cases.""]","[""The outlook for Charcot-Marie-Tooth Disease varies depending on the specific subtype and individual circumstances. Generally, it is a progressive condition, but management strategies can help improve quality of life and slow down disease progression.""]","[""The outlook for CMT is positive due to the increasing demand for its services in the market.""]",[true],[true],[false],"[""The outlook for Charcot Marie Tooth (CMT) varies depending on the type and severity of the condition. Generally, management focuses on symptom relief, physical therapy, orthopedic devices, and in some cases, surgery. Research is ongoing to develop new treatments and improve outcomes for individuals with CMT.""]","[""The outlook for Charcot-Marie-Tooth Disease varies depending on the specific subtype and individual circumstances. It is a progressive condition, but management strategies such as physical therapy, orthopedic interventions, and assistive devices can help improve quality of life and function for many patients.""]","[""The outlook for CMT is positive due to its innovative technology and strong market demand.""]",[true],[true],[false],"[""The outlook for Charcot Marie Tooth (CMT) varies depending on the specific type and severity of the condition. Generally, it is a progressive disorder, but management strategies can help improve quality of life and slow down progression in some cases.""]","[""The outlook for Charcot-Marie-Tooth Disease varies depending on the specific subtype and individual factors. Generally, it is a progressive condition, but management strategies can help improve quality of life and slow down disease progression.""]","[""The outlook for CMT is positive, with a growing market and potential for expansion in the near future.""]",[true],[true],[false],"[""The outlook for Charcot Marie Tooth (CMT) varies depending on the type and severity of the condition. Generally, CMT is a progressive disorder, but with proper management and treatment, individuals can lead fulfilling lives and manage their symptoms effectively.""]","[""The outlook for Charcot-Marie-Tooth Disease varies depending on the specific subtype and individual factors. Generally, it is a progressive condition, but management strategies can help improve quality of life and slow down progression in some cases.""]","[""The outlook for CMT is positive due to its innovative technology and strong market demand.""]",[false],[true],[false],"[""The outlook for CMT (Country Music Television) is positive with a focus on expanding original programming and digital presence.""]","[""The outlook for Charcot-Marie-Tooth Disease varies depending on the specific subtype and individual factors. Generally, it is a progressive condition, but management strategies can help improve quality of life and slow down progression in some cases.""]","[""The outlook for CMT is positive due to its innovative technology and strong market demand.""]",[false],[true],[false],"[""The outlook for CMT (Country Music Television) is positive with a focus on expanding original programming and digital presence.""]","[""The outlook for Charcot-Marie-Tooth Disease varies depending on the specific subtype and individual factors. Generally, it is a progressive condition, but management strategies can help improve quality of life and slow down progression in some cases.""]","[""The outlook for CMT is positive due to its innovative technology and strong market demand.""]",[false],[true],[false],"[""The outlook for CMT (Composite Muscle Transfer) depends on various factors such as the specific condition being treated, the individual's overall health, and the success of the surgical procedure. It is important to consult with a healthcare professional for personalized information.""]","[""The outlook for Charcot-Marie-Tooth Disease varies depending on the specific subtype and individual factors. Generally, it is a progressive condition, but management strategies can help improve quality of life and slow down progression in some cases.""]","[""The outlook for CMT is positive due to its innovative technology and strong market demand.""]"
treatment,What are the treatments for Mycosis Fungoides and the Szary Syndrome ?,"Key Points
                    - There are different types of treatment for patients with mycosis fungoides and the Szary syndrome cancer.     - Six types of standard treatment are used:         - Photodynamic therapy      - Radiation therapy      - Chemotherapy      - Other drug therapy     - Biologic therapy     - Targeted therapy        - New types of treatment are being tested in clinical trials.          - High-dose chemotherapy and radiation therapy with stem cell transplant        - Treatment for mycosis fungoides and the Szary syndrome may cause side effects.    - Patients may want to think about taking part in a clinical trial.    - Patients can enter clinical trials before, during, or after starting their cancer treatment.    - Follow-up tests may be needed.
                
                
                    There are different types of treatment for patients with mycosis fungoides and the Szary syndrome cancer.
                    Different types of treatment are available for patients with mycosis fungoides and the Szary syndrome. Some treatments are standard (the currently used treatment), and some are being tested in clinical trials. A treatment clinical trial is a research study meant to help improve current treatments or obtain information on new treatments for patients with cancer. When clinical trials show that a new treatment is better than the standard treatment, the new treatment may become the standard treatment. Patients may want to think about taking part in a clinical trial. Some clinical trials are open only to patients who have not started treatment.
                
                
                    Six types of standard treatment are used:
                    Photodynamic therapy      Photodynamic therapy is a cancer treatment that uses a drug and a certain type of laser light to kill cancer cells. A drug that is not active until it is exposed to light is injected into a vein. The drug collects more in cancer cells than in normal cells. For skin cancer, laser light is shined onto the skin and the drug becomes active and kills the cancer cells. Photodynamic therapy causes little damage to healthy tissue. Patients undergoing photodynamic therapy will need to limit the amount of time spent in sunlight.     In one type of photodynamic therapy, called psoralen and ultraviolet A (PUVA) therapy, the patient receives a drug called psoralen and then ultraviolet radiation is directed to the skin. In another type of photodynamic therapy, called extracorporeal photochemotherapy, the patient is given drugs and then some blood cells are taken from the body, put under a special ultraviolet A light, and put back into the body.        Radiation therapy      Radiation therapy is a cancer treatment that uses high-energy x-rays or other types of radiation to kill cancer cells or keep them from growing. There are two types of radiation therapy:            -  External radiation therapy uses a machine outside the body to send radiation toward the cancer.     -  Internal radiation therapy uses a radioactive substance sealed in needles, seeds, wires, or catheters that are placed directly into or near the cancer.           The way the radiation therapy is given depends on the type and stage of the cancer being treated. External radiation therapy is used to treat mycosis fungoides and the Szary syndrome, and may also be used as palliative therapy to relieve symptoms and improve quality of life. Sometimes, total skin electron beam (TSEB) radiation therapy is used to treat mycosis fungoides and the Szary syndrome. This is a type of external radiation treatment in which a radiation therapy machine aims electrons (tiny, invisible particles) at the skin covering the whole body.     Ultraviolet B (UVB) radiation therapy uses a special lamp or laser that directs UVB radiation at the skin.        Chemotherapy      Chemotherapy is a cancer treatment that uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. When chemotherapy is taken by mouth or injected into a vein or muscle, the drugs enter the bloodstream and can reach cancer cells throughout the body (systemic chemotherapy). When chemotherapy is placed directly into the cerebrospinal fluid, an organ, or a body cavity such as the abdomen, the drugs mainly affect cancer cells in those areas (regional chemotherapy). Sometimes the chemotherapy is topical (put on the skin in a cream, lotion, or ointment). The way the chemotherapy is given depends on the type and stage of the cancer being treated.    See Drugs Approved for Non-Hodgkin Lymphoma for more information. (Mycosis fungoides and the Szary syndrome are types of non-Hodgkin lymphoma.)       Other drug therapy     Topical corticosteroids are used to relieve red, swollen, and inflamed skin. They are a type of steroid. Topical corticosteroids may be in a cream, lotion, or ointment.     Retinoids, such as bexarotene, are drugs related to vitamin A that can slow the growth of certain types of cancer cells. The retinoids may be taken by mouth or put on the skin.    See Drugs Approved for Non-Hodgkin Lymphoma for more information. (Mycosis fungoides and the Szary syndrome are types of non-Hodgkin lymphoma.)       Biologic therapy     Biologic therapy is a treatment that uses the patient's immune system to fight cancer. Substances made by the body or made in a laboratory are used to boost, direct, or restore the body's natural defenses against cancer. This type of cancer treatment is also called biotherapy or immunotherapy.     Interferon is a type of biologic therapy used to treat mycosis fungoides and the Szary syndrome. It interferes with the division of cancer cells and can slow tumor growth.    See Drugs Approved for Non-Hodgkin Lymphoma for more information. (Mycosis fungoides and the Szary syndrome are types of non-Hodgkin lymphoma.)       Targeted therapy     Targeted therapy is a treatment that uses drugs or other substances to identify and attack specific cancer cells without harming normal cells. Monoclonal antibody therapy and other types of targeted therapies are used to treat mycosis fungoides and the Szary syndrome.     Alemtuzumab is a monoclonal antibody used to treat mycosis fungoides and the Szary syndrome. Monoclonal antibody therapy uses antibodies made in the laboratory, from a single type of immune system cell. These antibodies can identify substances on cancer cells or normal substances that may help cancer cells grow. The antibodies attach to the substances and kill the cancer cells, block their growth, or keep them from spreading. Monoclonal antibodies are given by infusion. They may be used alone or to carry drugs, toxins, or radioactive material directly to cancer cells.    Other types of monoclonal antibody therapy are being studied in clinical trials to treat mycosis fungoides and the Szary syndrome.      Vorinostat and romidepsin are two of the histone deacetylase (HDAC) inhibitors used to treat mycosis fungoides and the Szary syndrome. HDAC inhibitors cause a chemical change that stops tumor cells from dividing.     Pralatrexate is a dihydrofolate reductase (DHFR) inhibitor used to treat mycosis fungoides and the Szary syndrome. It builds up in cancer cells and stops them from using folate, a nutrient needed for cells to divide. Pralatrexate may slow the growth of tumors and kill cancer cells.     See Drugs Approved for Non-Hodgkin Lymphoma for more information. (Mycosis fungoides and the Szary syndrome are types of non-Hodgkin lymphoma.)
                
                
                    New types of treatment are being tested in clinical trials.
                    This summary section describes treatments that are being studied in clinical trials. It may not mention every new treatment being studied. Information about clinical trials is available from the NCI website.     High-dose chemotherapy and radiation therapy with stem cell transplant    This treatment is a method of giving high doses of chemotherapy and radiation therapy and replacing blood-forming cells destroyed by the cancer treatment. Stem cells (immature blood cells) are removed from the bone marrow or blood of the patient or a donor and are frozen and stored. After therapy is completed, the stored stem cells are thawed and given back to the patient through an infusion. These reinfused stem cells grow into (and restore) the body's blood cells.
                
                
                    Treatment for mycosis fungoides and the Szary syndrome may cause side effects.
                    For information about side effects caused by treatment for cancer, see our Side Effects page.
                
                
                    Patients may want to think about taking part in a clinical trial.
                    For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.   Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.   Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.
                
                
                    Patients can enter clinical trials before, during, or after starting their cancer treatment.
                    Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.   Clinical trials are taking place in many parts of the country. See the Treatment Options section that follows for links to current treatment clinical trials. These have been retrieved from NCI's listing of clinical trials.
                
                
                    Follow-up tests may be needed.
                    Some of the tests that were done to diagnose the cancer or to find out the stage of the cancer may be repeated. Some tests will be repeated in order to see how well the treatment is working. Decisions about whether to continue, change, or stop treatment may be based on the results of these tests.   Some of the tests will continue to be done from time to time after treatment has ended. The results of these tests can show if your condition has changed or if the cancer has recurred (come back). These tests are sometimes called follow-up tests or check-ups.
                
                 
							            Treatment Options by Stage
							            
							                
							                    Stage I Mycosis Fungoides
							                    Treatment of stage I mycosis fungoides may include the following:         -  PUVA therapy. Biologic therapy may also be given.    -  Radiation therapy. In some cases, radiation therapy is given to skin lesions, as palliative therapy to reduce tumor size or relieve symptoms and improve quality of life.    -  Topical corticosteroid therapy.    -  Retinoid therapy.    -  Topical or systemic chemotherapy.    - Biologic therapy. Topical chemotherapy may also be given.    -  Targeted therapy.    - A clinical trial of a new treatment.        Check the list of NCI-supported cancer clinical trials that are now accepting patients with stage I mycosis fungoides/Sezary syndrome. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.
							                
							                
							                    Stage II Mycosis Fungoides
							                    Treatment of stage II mycosis fungoides is palliative (to relieve symptoms and improve the quality of life) and may include the following:         -  PUVA therapy. Biologic therapy may also be given.    -  Radiation therapy.     -  Topical corticosteroid therapy.    -  Retinoid therapy.    -  Topical or systemic chemotherapy.    - Biologic therapy. Topical chemotherapy may also be given.    -  Targeted therapy.    - A clinical trial of a new treatment.        Check the list of NCI-supported cancer clinical trials that are now accepting patients with stage II mycosis fungoides/Sezary syndrome. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.
							                
							                
							                    Stage III Mycosis Fungoides
							                    Treatment of stage III mycosis fungoides is palliative (to relieve symptoms and improve the quality of life) and may include the following:         -  PUVA therapy. Systemic chemotherapy or biologic therapy may also be given.    -  Extracorporeal photochemotherapy.    -  Radiation therapy.    -  Topical corticosteroid therapy.    -  Retinoid therapy.    - Systemic chemotherapy with one or more drugs. Topical chemotherapy or radiation therapy may also be given.    - Topical chemotherapy.    - Biologic therapy. Topical chemotherapy may also be given.    -  Targeted therapy.    - A clinical trial of a new treatment.        Check the list of NCI-supported cancer clinical trials that are now accepting patients with stage III mycosis fungoides/Sezary syndrome. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.
							                
							                
							                    Stage IV Mycosis Fungoides and the Szary Syndrome
							                    Treatment of stage IV mycosis fungoides and stage IV Szary syndrome is palliative (to relieve symptoms and improve the quality of life) and may include the following:         -  PUVA therapy. Systemic chemotherapy or biologic therapy may also be given.    -  Extracorporeal photochemotherapy. Radiation therapy may also be given.    - Radiation therapy.    -  Topical corticosteroid therapy.    -  Retinoid therapy.    - Systemic chemotherapy with one or more drugs, or topical chemotherapy.    -  Biologic therapy. Topical chemotherapy may also be given.    -  Targeted therapy.    - A clinical trial of a new treatment.        Check the list of NCI-supported cancer clinical trials that are now accepting patients with stage IV mycosis fungoides/Sezary syndrome. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your doctor about clinical trials that may be right for you. General information about clinical trials is available from the NCI website.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""MF"", ""full_form"": ""Mycosis Fungoides""}, {""ambiguity_type"": ""full_form"", ""abbreviation"": ""SS"", ""full_form"": ""Szary Syndrome""}]}",What are the treatments for MF and the SS ?,What are the treatments for Mycosis Fungoides and the Szary Syndrome ?,8,MEDICAL,Compound Datatype-List/Array,"Exploratory(Divergent Thinking): Queries that are inherently about seeking new areas of knowledge, understanding emerging trends, or identifying unknown opportunities without a specific end goal of making a decision or judgment. Exploratory queries are characterized by their openness and the lack of a predefined objective, differentiating them from evaluative queries which are directed towards forming a judgment or assessment. Exploratory queries encourage branching out into various directions to explore a wide array of possibilities without necessarily aiming to converge on a single answer or outcome.","[[""Magnetic Field"", ""My Friend"", ""Mutual Funds"", ""Mutual Fund"", ""Multi-Function"", ""Multi-Family"", ""Made From ...."", ""Multi-Frequency"", ""Major Flat"", ""Mycosis Fungoides""], [""Stainless Steel"", ""Steady State"", ""One Half"", ""Sterling Silver"", ""Social Studies"", ""Social Services"", ""Seguridad Social"", ""Secondary Structure"", ""Social Security"", ""Signs and Symptoms""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""], [""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Mycosis Fungoides"", ""Stevens-Johnson Syndrome""]","[4.647725090456656e-16, 3.268541653738923e-12]","[4.647725090456656e-16, 4.774288883306996e-23]","[""Multi-Function"", ""Social Services""]","[2.0165711642020316e-07, 6.073116600845304e-06]","[""ABBREVIATIONS"", ""ABBREVIATIONS""]","[[7.326970131756677e-09, 1.957931526737506e-08, 1.3834235276874594e-11, 5.980009764546115e-12, 2.0165711642020316e-07, 8.88165828510774e-09, 1.7988997695441794e-12, 2.0861421469801797e-08, 1.452923526629276e-10, 4.647725090456656e-16], [5.126614613683871e-12, 5.605355457682474e-07, 2.3422704973295903e-06, 2.7444694070582772e-15, 3.0113805152967845e-08, 6.073116600845304e-06, 9.951538886124367e-12, 4.419410945683558e-10, 5.889963962176311e-07, 3.3060581427019773e-06]]","[0.9121085000120057, 0.9197036284810187]","[0.9121085000120057, 0.8938381506800086]","[""Multi-Family"", ""Seguridad Social""]","[0.9277676082864295, 0.9268447118995371]","[""ABBREVIATIONS"", ""ABBREVIATIONS""]","[[0.8464122124499981, 0.9106842935257013, 0.753462631844474, 0.7763082622329343, 0.9245991100021373, 0.8100248699199907, 0.9277676082864295, 0.8285101798231427, 0.8752633467824473, 0.9121085000120057], [0.8496760991230138, 0.9007661362465141, 0.9200120166552308, 0.8612847632212204, 0.885458528963613, 0.884612564620653, 0.7943687127765744, 0.9268447118995371, 0.8620717316491402, 0.9246168582427492]]","[""Mycosis Fungoides"", ""Signs and Symptoms""]","[""ABBREVIATIONS"", ""ABBREVIATIONS""]",What are the treatments for MF and the SS (Stevens-Johnson Syndrome) ?,"[true, false]","[true, true]","[false, false]","[""The treatments for MF (Multi-Function) include targeted therapy, immunotherapy, chemotherapy, and stem cell transplant. The treatment for SS (Sezary Syndrome) involves phototherapy, chemotherapy, biological therapy, and targeted therapy."", ""The treatments for MF (Myelofibrosis) include medications, blood transfusions, stem cell transplant, and targeted therapy. Social Services (SS) provide support and resources for individuals and families in need, including counseling, financial assistance, and access to community programs.""]","[""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, and phototherapy."", ""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, and phototherapy.""]","[""For MF (myelofibrosis), treatments may include medications, blood transfusions, stem cell transplant, and targeted therapy. For SS (Sezary syndrome), treatments may include skin-directed therapies, systemic therapies, and phototherapy."", ""The treatments for MF (myelofibrosis) include medications, blood transfusions, stem cell transplant, and targeted therapy. The treatments for SS (Sezary syndrome) include skin-directed therapies, systemic therapies, and phototherapy.""]","[false, false]","[true, true]","[false, true]","[""The treatments for MF (Multi-Function) and SS include chemotherapy, radiation therapy, targeted therapy, immunotherapy, and stem cell transplant."", ""The treatments for MF (Myelofibrosis) include medications, blood transfusions, stem cell transplant, and targeted therapy. Social Services (SS) provide support and resources to individuals and families in need, including counseling, financial assistance, and access to community programs.""]","[""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, and phototherapy."", ""The treatments for Mycosis Fungoides and Szary Syndrome may include topical therapies, phototherapy, systemic therapies such as chemotherapy, immunotherapy, targeted therapy, and in some cases, stem cell transplantation.""]","[""The treatments for MF (myelofibrosis) include medications, blood transfusions, stem cell transplant, and targeted therapy. The treatments for SS (Sezary syndrome) include skin-directed therapies, systemic therapies, and phototherapy."", ""For MF, treatments may include chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy. For SS, treatments may include topical treatments, phototherapy, systemic therapies, and biologic therapies.""]","[false, false]","[true, true]","[false, false]","[""The treatments for MF (Multi-Function) and SS vary depending on the specific condition and severity. It is recommended to consult with a healthcare professional for personalized treatment options."", ""The treatments for MF (Myelofibrosis) include medications, blood transfusions, stem cell transplant, and targeted therapy. Social Services (SS) provide support and resources to individuals and families in need, including counseling, financial assistance, housing support, and access to community programs.""]","[""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, phototherapy, and in some cases, stem cell transplantation."", ""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, and phototherapy.""]","[""The treatments for MF (myelofibrosis) include medications, blood transfusions, stem cell transplant, and targeted therapy. The treatments for SS (Sezary syndrome) include skin-directed therapies, systemic therapies, phototherapy, and biologic therapies."", ""For MF (myelofibrosis), treatments may include medications, blood transfusions, stem cell transplant, and targeted therapy. For SS (Sezary syndrome), treatments may include phototherapy, chemotherapy, biologic therapy, and stem cell transplant.""]","[false, false]","[true, true]","[false, true]","[""The treatments for MF (Multi-Function) and SS include targeted therapy, chemotherapy, radiation therapy, and stem cell transplant."", ""The treatments for MF (Myelofibrosis) include medications, blood transfusions, stem cell transplant, and targeted therapy. Social Services (SS) provide support and assistance to individuals and families in need, including counseling, financial aid, housing assistance, and access to community resources.""]","[""The treatments for Mycosis Fungoides and Szary Syndrome include topical therapies, phototherapy, systemic therapies such as chemotherapy, immunotherapy, and targeted therapy, as well as radiation therapy and in some cases stem cell transplantation."", ""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, and phototherapy.""]","[""The treatments for MF (myelofibrosis) include medications, blood transfusions, stem cell transplant, and targeted therapy. The treatments for SS (Sezary syndrome) include skin-directed therapies, systemic therapies, and phototherapy."", ""For MF (mycosis fungoides), treatments may include topical medications, phototherapy, systemic medications, and in some cases, radiation therapy. For SS (S\u00e9zary syndrome), treatments may involve systemic therapies such as chemotherapy, targeted therapy, immunotherapy, and in some cases, stem cell transplant.""]","[false, false]","[true, true]","[false, false]","[""The treatments for MF (Multi-Family) and SS include therapy, medication, lifestyle changes, and support groups."", ""The treatments for MF (Myelofibrosis) may include medications, blood transfusions, stem cell transplant, and targeted therapy. As for SS (Seguridad Social), it is a social security system in Spain that provides healthcare coverage and benefits to individuals.""]","[""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, and phototherapy."", ""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, and phototherapy.""]","[""For MF (myelofibrosis), treatments may include medications, blood transfusions, stem cell transplant, and targeted therapy. For SS (Sezary syndrome), treatments may include skin-directed therapies, systemic therapies, and phototherapy."", ""The treatments for MF (myelofibrosis) include medications, blood transfusions, stem cell transplant, and targeted therapy. The treatments for SS (Sezary syndrome) include skin-directed therapies, systemic therapies, and phototherapy.""]","[false, false]","[true, true]","[false, true]","[""The treatments for MF (Multi-Family) and SS (Sjogren's Syndrome) vary depending on the specific symptoms and severity. Some common treatments for MF include topical corticosteroids, phototherapy, and systemic medications. For SS, treatments may include artificial tears, medications to reduce inflammation, and in severe cases, immune-suppressing drugs."", ""The treatments for MF (Myelofibrosis) may include medications, blood transfusions, stem cell transplant, and targeted therapy. As for SS (Seguridad Social), it refers to the social security system in Spain which provides healthcare coverage and benefits to eligible individuals.""]","[""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, and phototherapy."", ""The treatments for Mycosis Fungoides and Szary Syndrome may include topical therapies, phototherapy, systemic therapies such as chemotherapy, immunotherapy, targeted therapy, and in some cases, stem cell transplantation.""]","[""The treatments for MF (myelofibrosis) include medications, blood transfusions, stem cell transplant, and targeted therapy. The treatments for SS (Sezary syndrome) include skin-directed therapies, systemic therapies, and phototherapy."", ""For MF, treatments may include chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy. For SS, treatments may include topical treatments, phototherapy, systemic therapies, and biologic therapies.""]","[false, false]","[true, true]","[false, false]","[""The treatments for MF (Multi-Family) and SS (Systemic Sclerosis) vary depending on the specific condition and severity. Common treatments for Multi-Family therapy may include family counseling, communication skills training, and conflict resolution techniques. For Systemic Sclerosis, treatments may involve medications to manage symptoms, physical therapy, and lifestyle modifications to improve quality of life."", ""The treatments for MF (Myelofibrosis) may include medications, blood transfusions, stem cell transplant, and targeted therapy. As for SS (Seguridad Social), it refers to the public healthcare system in Spain that provides coverage for various medical treatments and services.""]","[""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, phototherapy, and in some cases, stem cell transplantation."", ""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, and phototherapy.""]","[""The treatments for MF (myelofibrosis) include medications, blood transfusions, stem cell transplant, and targeted therapy. The treatments for SS (Sezary syndrome) include skin-directed therapies, systemic therapies, phototherapy, and biologic therapies."", ""For MF (myelofibrosis), treatments may include medications, blood transfusions, stem cell transplant, and targeted therapy. For SS (Sezary syndrome), treatments may include phototherapy, chemotherapy, biologic therapy, and stem cell transplant.""]","[false, false]","[true, true]","[false, true]","[""The treatments for MF (Multi-Family) and SS (Schizophrenia Spectrum) vary depending on the specific condition and severity. Common treatments may include medication, therapy, and lifestyle changes. It is important to consult with a healthcare professional for personalized treatment recommendations."", ""The treatments for MF (Myelofibrosis) may include medications, blood transfusions, stem cell transplant, and targeted therapy. As for SS (Seguridad Social), it refers to the public health insurance system in Spain that provides healthcare coverage to citizens and legal residents.""]","[""The treatments for Mycosis Fungoides and Szary Syndrome include topical therapies, phototherapy, systemic therapies such as chemotherapy, immunotherapy, and targeted therapy, as well as radiation therapy and in some cases stem cell transplantation."", ""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, and phototherapy.""]","[""The treatments for MF (myelofibrosis) include medications, blood transfusions, stem cell transplant, and targeted therapy. The treatments for SS (Sezary syndrome) include skin-directed therapies, systemic therapies, and phototherapy."", ""For MF (mycosis fungoides), treatments may include topical medications, phototherapy, systemic medications, and in some cases, radiation therapy. For SS (S\u00e9zary syndrome), treatments may involve systemic therapies such as chemotherapy, targeted therapy, immunotherapy, and in some cases, stem cell transplant.""]","[true, false]","[true, true]","[false, true]","[""The treatments for Mycosis Fungoides (MF) and S\u00e9zary Syndrome (SS) include topical therapies, phototherapy, systemic therapies such as chemotherapy, immunotherapy, and targeted therapy, as well as stem cell transplantation in some cases."", ""The treatments for MF (Myelofibrosis) may include medications, blood transfusions, stem cell transplant, and targeted therapy. The signs and symptoms of MF can vary but may include fatigue, shortness of breath, easy bruising, and an enlarged spleen.""]","[""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, and phototherapy."", ""The treatments for Mycosis Fungoides and Szary Syndrome may include topical therapies, phototherapy, systemic therapies such as chemotherapy, immunotherapy, targeted therapy, and in some cases, stem cell transplantation.""]","[""The treatments for MF (myelofibrosis) include medications, blood transfusions, stem cell transplant, and targeted therapy. The treatments for SS (Sezary syndrome) include skin-directed therapies, systemic therapies, and phototherapy."", ""For MF, treatments may include chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy. For SS, treatments may include topical treatments, phototherapy, systemic therapies, and biologic therapies.""]","[true, false]","[true, true]","[false, false]","[""The treatments for Mycosis Fungoides (MF) and S\u00e9zary Syndrome (SS) include topical therapies, phototherapy, systemic therapies such as chemotherapy, immunotherapy, and targeted therapy, as well as stem cell transplantation in some cases."", ""The treatments for MF (Myelofibrosis) include medications to reduce symptoms, blood transfusions, stem cell transplant, and targeted therapy. The signs and symptoms of MF may include fatigue, shortness of breath, easy bruising, enlarged spleen, and night sweats.""]","[""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, and phototherapy."", ""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, and phototherapy.""]","[""For MF (myelofibrosis), treatments may include medications, blood transfusions, stem cell transplant, and targeted therapy. For SS (Sezary syndrome), treatments may include skin-directed therapies, systemic therapies, and phototherapy."", ""The treatments for MF (myelofibrosis) include medications, blood transfusions, stem cell transplant, and targeted therapy. The treatments for SS (Sezary syndrome) include skin-directed therapies, systemic therapies, and phototherapy.""]","[true, false]","[true, true]","[false, false]","[""The treatments for Mycosis Fungoides (MF) and S\u00e9zary Syndrome (SS) include topical therapies, phototherapy, systemic therapies such as chemotherapy, targeted therapy, immunotherapy, and in some cases, stem cell transplant."", ""The treatments for Myelofibrosis (MF) include medications, blood transfusions, stem cell transplant, and targeted therapy. The signs and symptoms of MF may include fatigue, shortness of breath, easy bruising, and an enlarged spleen.""]","[""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, phototherapy, and in some cases, stem cell transplantation."", ""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, and phototherapy.""]","[""The treatments for MF (myelofibrosis) include medications, blood transfusions, stem cell transplant, and targeted therapy. The treatments for SS (Sezary syndrome) include skin-directed therapies, systemic therapies, phototherapy, and biologic therapies."", ""For MF (myelofibrosis), treatments may include medications, blood transfusions, stem cell transplant, and targeted therapy. For SS (Sezary syndrome), treatments may include phototherapy, chemotherapy, biologic therapy, and stem cell transplant.""]","[true, false]","[true, true]","[false, true]","[""The treatments for Mycosis Fungoides (MF) and S\u00e9zary Syndrome (SS) include topical therapies, phototherapy, systemic therapies (such as chemotherapy, immunotherapy, or targeted therapy), and in some cases, stem cell transplantation."", ""The treatments for Myelofibrosis (MF) may include medications to reduce symptoms, blood transfusions, stem cell transplant, and targeted therapy. The signs and symptoms of MF can vary but may include fatigue, shortness of breath, easy bruising, enlarged spleen, and night sweats.""]","[""The treatments for Mycosis Fungoides and Szary Syndrome include topical therapies, phototherapy, systemic therapies such as chemotherapy, immunotherapy, and targeted therapy, as well as radiation therapy and in some cases stem cell transplantation."", ""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, and phototherapy.""]","[""The treatments for MF (myelofibrosis) include medications, blood transfusions, stem cell transplant, and targeted therapy. The treatments for SS (Sezary syndrome) include skin-directed therapies, systemic therapies, and phototherapy."", ""For MF (mycosis fungoides), treatments may include topical medications, phototherapy, systemic medications, and in some cases, radiation therapy. For SS (S\u00e9zary syndrome), treatments may involve systemic therapies such as chemotherapy, targeted therapy, immunotherapy, and in some cases, stem cell transplant.""]","[true, false]","[true, true]","[false, false]","[""Treatments for MF and SS include topical therapies, phototherapy, systemic therapies, and radiation therapy."", ""The treatments for MF (Myelofibrosis) may include medications, blood transfusions, stem cell transplant, and targeted therapy. The signs and symptoms of MF can vary but may include fatigue, shortness of breath, easy bruising, and enlarged spleen.""]","[""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, and phototherapy."", ""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, and phototherapy.""]","[""For MF (myelofibrosis), treatments may include medications, blood transfusions, stem cell transplant, and targeted therapy. For SS (Sezary syndrome), treatments may include skin-directed therapies, systemic therapies, and phototherapy."", ""The treatments for MF (myelofibrosis) include medications, blood transfusions, stem cell transplant, and targeted therapy. The treatments for SS (Sezary syndrome) include skin-directed therapies, systemic therapies, and phototherapy.""]","[true, false]","[true, true]","[false, true]","[""Treatments for MF and SS include topical therapies, phototherapy, systemic therapies, and in some cases, stem cell transplantation."", ""The treatments for MF (Myelofibrosis) include medications, blood transfusions, stem cell transplant, and targeted therapy. The signs and symptoms of MF may include fatigue, shortness of breath, easy bruising, and enlarged spleen.""]","[""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, and phototherapy."", ""The treatments for Mycosis Fungoides and Szary Syndrome may include topical therapies, phototherapy, systemic therapies such as chemotherapy, immunotherapy, targeted therapy, and in some cases, stem cell transplantation.""]","[""The treatments for MF (myelofibrosis) include medications, blood transfusions, stem cell transplant, and targeted therapy. The treatments for SS (Sezary syndrome) include skin-directed therapies, systemic therapies, and phototherapy."", ""For MF, treatments may include chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy. For SS, treatments may include topical treatments, phototherapy, systemic therapies, and biologic therapies.""]","[true, false]","[true, true]","[false, false]","[""Treatments for MF and SS include topical therapies, phototherapy, systemic therapies, and in severe cases, stem cell transplantation."", ""The treatments for MF (Myelofibrosis) include medications, blood transfusions, stem cell transplant, and targeted therapy. The signs and symptoms of MF may include fatigue, shortness of breath, easy bruising, enlarged spleen, and night sweats.""]","[""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, phototherapy, and in some cases, stem cell transplantation."", ""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, and phototherapy.""]","[""The treatments for MF (myelofibrosis) include medications, blood transfusions, stem cell transplant, and targeted therapy. The treatments for SS (Sezary syndrome) include skin-directed therapies, systemic therapies, phototherapy, and biologic therapies."", ""For MF (myelofibrosis), treatments may include medications, blood transfusions, stem cell transplant, and targeted therapy. For SS (Sezary syndrome), treatments may include phototherapy, chemotherapy, biologic therapy, and stem cell transplant.""]","[true, false]","[true, true]","[false, true]","[""Treatments for MF (Mycosis Fungoides) and SS include topical treatments, phototherapy, systemic therapies, and in some cases, stem cell transplant."", ""The treatments for MF (Myelofibrosis) include medications, blood transfusions, stem cell transplant, and targeted therapy. The signs and symptoms of MF may include fatigue, shortness of breath, easy bruising, enlarged spleen, and night sweats.""]","[""The treatments for Mycosis Fungoides and Szary Syndrome include topical therapies, phototherapy, systemic therapies such as chemotherapy, immunotherapy, and targeted therapy, as well as radiation therapy and in some cases stem cell transplantation."", ""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, and phototherapy.""]","[""The treatments for MF (myelofibrosis) include medications, blood transfusions, stem cell transplant, and targeted therapy. The treatments for SS (Sezary syndrome) include skin-directed therapies, systemic therapies, and phototherapy."", ""For MF (mycosis fungoides), treatments may include topical medications, phototherapy, systemic medications, and in some cases, radiation therapy. For SS (S\u00e9zary syndrome), treatments may involve systemic therapies such as chemotherapy, targeted therapy, immunotherapy, and in some cases, stem cell transplant.""]","[true, false]","[true, true]","[false, false]","[""Treatments for MF (Mycosis Fungoides) include topical therapies, phototherapy, systemic therapies, and in some cases, stem cell transplantation. Treatments for SS (S\u00e9zary Syndrome) include phototherapy, systemic therapies, and in advanced cases, stem cell transplantation."", ""The treatments for MF (Myelofibrosis) may include medications, blood transfusions, stem cell transplants, and targeted therapy. The signs and symptoms of MF can vary but may include fatigue, shortness of breath, easy bruising, and enlarged spleen.""]","[""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, and phototherapy."", ""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, and phototherapy.""]","[""For MF (myelofibrosis), treatments may include medications, blood transfusions, stem cell transplant, and targeted therapy. For SS (Sezary syndrome), treatments may include skin-directed therapies, systemic therapies, and phototherapy."", ""The treatments for MF (myelofibrosis) include medications, blood transfusions, stem cell transplant, and targeted therapy. The treatments for SS (Sezary syndrome) include skin-directed therapies, systemic therapies, and phototherapy.""]","[true, false]","[true, true]","[false, true]","[""The treatments for Mycosis Fungoides (MF) and S\u00e9zary Syndrome (SS) include topical therapies, phototherapy, systemic therapies (such as chemotherapy, immunotherapy, targeted therapy), and in some cases, stem cell transplant."", ""The treatments for Myelofibrosis (MF) include medications, blood transfusions, stem cell transplant, and targeted therapy. The signs and symptoms of MF may include fatigue, shortness of breath, weakness, weight loss, fever, night sweats, and pain or fullness below the ribs on the left side.""]","[""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, and phototherapy."", ""The treatments for Mycosis Fungoides and Szary Syndrome may include topical therapies, phototherapy, systemic therapies such as chemotherapy, immunotherapy, targeted therapy, and in some cases, stem cell transplantation.""]","[""The treatments for MF (myelofibrosis) include medications, blood transfusions, stem cell transplant, and targeted therapy. The treatments for SS (Sezary syndrome) include skin-directed therapies, systemic therapies, and phototherapy."", ""For MF, treatments may include chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy. For SS, treatments may include topical treatments, phototherapy, systemic therapies, and biologic therapies.""]","[true, false]","[true, true]","[false, false]","[""The treatments for Mycosis Fungoides (MF) and S\u00e9zary Syndrome (SS) include topical therapies, phototherapy, systemic therapies such as chemotherapy, targeted therapy, and immunotherapy, as well as stem cell transplant in some cases."", ""The treatments for MF (Myelofibrosis) include medications to reduce symptoms, blood transfusions, stem cell transplant, and targeted therapy. The signs and symptoms of MF may include fatigue, shortness of breath, pain or fullness below the ribs, easy bruising, and frequent infections.""]","[""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, phototherapy, and in some cases, stem cell transplantation."", ""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, and phototherapy.""]","[""The treatments for MF (myelofibrosis) include medications, blood transfusions, stem cell transplant, and targeted therapy. The treatments for SS (Sezary syndrome) include skin-directed therapies, systemic therapies, phototherapy, and biologic therapies."", ""For MF (myelofibrosis), treatments may include medications, blood transfusions, stem cell transplant, and targeted therapy. For SS (Sezary syndrome), treatments may include phototherapy, chemotherapy, biologic therapy, and stem cell transplant.""]","[true, false]","[true, true]","[false, true]","[""The treatments for Mycosis Fungoides (MF) and S\u00e9zary Syndrome (SS) include topical therapies, phototherapy, systemic therapies (such as chemotherapy, immunotherapy, retinoids), and in some cases, stem cell transplant."", ""The treatments for MF (Myelofibrosis) include medications, blood transfusions, stem cell transplant, and targeted therapy. The signs and symptoms of MF may include fatigue, shortness of breath, easy bruising, enlarged spleen, and night sweats.""]","[""The treatments for Mycosis Fungoides and Szary Syndrome include topical therapies, phototherapy, systemic therapies such as chemotherapy, immunotherapy, and targeted therapy, as well as radiation therapy and in some cases stem cell transplantation."", ""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, and phototherapy.""]","[""The treatments for MF (myelofibrosis) include medications, blood transfusions, stem cell transplant, and targeted therapy. The treatments for SS (Sezary syndrome) include skin-directed therapies, systemic therapies, and phototherapy."", ""For MF (mycosis fungoides), treatments may include topical medications, phototherapy, systemic medications, and in some cases, radiation therapy. For SS (S\u00e9zary syndrome), treatments may involve systemic therapies such as chemotherapy, targeted therapy, immunotherapy, and in some cases, stem cell transplant.""]","[true, false]","[true, true]","[false, false]","[""The treatments for MF (Mycosis Fungoides) and SS include topical therapies, phototherapy, systemic therapies, and in some cases, stem cell transplant."", ""For MF, treatments may include topical corticosteroids, phototherapy, and systemic medications like methotrexate. For Stevens-Johnson Syndrome, treatment involves immediate discontinuation of the offending medication, supportive care, and sometimes corticosteroids or immunoglobulins.""]","[""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, and phototherapy."", ""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, and phototherapy.""]","[""For MF (myelofibrosis), treatments may include medications, blood transfusions, stem cell transplant, and targeted therapy. For SS (Sezary syndrome), treatments may include skin-directed therapies, systemic therapies, and phototherapy."", ""The treatments for MF (myelofibrosis) include medications, blood transfusions, stem cell transplant, and targeted therapy. The treatments for SS (Sezary syndrome) include skin-directed therapies, systemic therapies, and phototherapy.""]","[true, false]","[true, true]","[false, true]","[""The treatments for Mycosis Fungoides (MF) and S\u00e9zary Syndrome (SS) include topical therapies, phototherapy, systemic therapies (such as chemotherapy, immunotherapy, retinoids), and in some cases, stem cell transplant."", ""For Myelofibrosis (MF), treatments may include medications, blood transfusions, stem cell transplant, or targeted therapy. For Stevens-Johnson Syndrome (SS), treatment involves stopping the offending medication, supportive care, and sometimes corticosteroids or other medications to manage symptoms.""]","[""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, and phototherapy."", ""The treatments for Mycosis Fungoides and Szary Syndrome may include topical therapies, phototherapy, systemic therapies such as chemotherapy, immunotherapy, targeted therapy, and in some cases, stem cell transplantation.""]","[""The treatments for MF (myelofibrosis) include medications, blood transfusions, stem cell transplant, and targeted therapy. The treatments for SS (Sezary syndrome) include skin-directed therapies, systemic therapies, and phototherapy."", ""For MF, treatments may include chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy. For SS, treatments may include topical treatments, phototherapy, systemic therapies, and biologic therapies.""]","[true, false]","[true, true]","[false, false]","[""The treatments for Mycosis Fungoides (MF) and S\u00e9zary Syndrome (SS) include topical therapies, phototherapy, systemic therapies such as chemotherapy, immunotherapy, targeted therapy, and in some cases, stem cell transplantation."", ""For MF, treatments may include topical corticosteroids, phototherapy, systemic medications like methotrexate or retinoids. For Stevens-Johnson Syndrome, treatment involves immediate discontinuation of the offending medication, supportive care, and sometimes corticosteroids or intravenous immunoglobulin.""]","[""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, phototherapy, and in some cases, stem cell transplantation."", ""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, and phototherapy.""]","[""The treatments for MF (myelofibrosis) include medications, blood transfusions, stem cell transplant, and targeted therapy. The treatments for SS (Sezary syndrome) include skin-directed therapies, systemic therapies, phototherapy, and biologic therapies."", ""For MF (myelofibrosis), treatments may include medications, blood transfusions, stem cell transplant, and targeted therapy. For SS (Sezary syndrome), treatments may include phototherapy, chemotherapy, biologic therapy, and stem cell transplant.""]","[true, false]","[true, true]","[false, true]","[""Treatments for MF (Mycosis Fungoides) include topical therapies, phototherapy, systemic therapies, and in some cases, stem cell transplantation. Treatments for SS (S\u00e9zary syndrome) include phototherapy, systemic therapies, and in advanced cases, stem cell transplantation."", ""The treatments for Myelofibrosis (MF) include medications to reduce symptoms, blood transfusions, stem cell transplant, and targeted therapy. For Stevens-Johnson Syndrome (SS), treatment involves stopping the offending medication, supportive care, wound care, and sometimes corticosteroids.""]","[""The treatments for Mycosis Fungoides and Szary Syndrome include topical therapies, phototherapy, systemic therapies such as chemotherapy, immunotherapy, and targeted therapy, as well as radiation therapy and in some cases stem cell transplantation."", ""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, and phototherapy.""]","[""The treatments for MF (myelofibrosis) include medications, blood transfusions, stem cell transplant, and targeted therapy. The treatments for SS (Sezary syndrome) include skin-directed therapies, systemic therapies, and phototherapy."", ""For MF (mycosis fungoides), treatments may include topical medications, phototherapy, systemic medications, and in some cases, radiation therapy. For SS (S\u00e9zary syndrome), treatments may involve systemic therapies such as chemotherapy, targeted therapy, immunotherapy, and in some cases, stem cell transplant.""]","[true, false]","[true, true]","[false, false]","[""Treatments for MF (Mycosis Fungoides) and SS include topical therapies, phototherapy, systemic therapies, and in some cases, stem cell transplant or clinical trials."", ""The treatments for MF (Myelofibrosis) may include medications, blood transfusions, stem cell transplant, and clinical trials. The signs and symptoms of MF can vary but may include fatigue, shortness of breath, easy bruising, and enlarged spleen.""]","[""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, and phototherapy."", ""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, and phototherapy.""]","[""For MF (myelofibrosis), treatments may include medications, blood transfusions, stem cell transplant, and targeted therapy. For SS (Sezary syndrome), treatments may include skin-directed therapies, systemic therapies, and phototherapy."", ""The treatments for MF (myelofibrosis) include medications, blood transfusions, stem cell transplant, and targeted therapy. The treatments for SS (Sezary syndrome) include skin-directed therapies, systemic therapies, and phototherapy.""]","[true, false]","[true, true]","[false, true]","[""Treatments for MF (Mycosis Fungoides) and SS include topical therapies, phototherapy, systemic therapies, and in some cases, stem cell transplant or clinical trials."", ""Treatments for MF (Myelofibrosis) include medications, blood transfusions, stem cell transplant, and clinical trials. Common signs and symptoms of MF include fatigue, shortness of breath, easy bruising, and enlarged spleen.""]","[""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, and phototherapy."", ""The treatments for Mycosis Fungoides and Szary Syndrome may include topical therapies, phototherapy, systemic therapies such as chemotherapy, immunotherapy, targeted therapy, and in some cases, stem cell transplantation.""]","[""The treatments for MF (myelofibrosis) include medications, blood transfusions, stem cell transplant, and targeted therapy. The treatments for SS (Sezary syndrome) include skin-directed therapies, systemic therapies, and phototherapy."", ""For MF, treatments may include chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy. For SS, treatments may include topical treatments, phototherapy, systemic therapies, and biologic therapies.""]","[true, false]","[true, true]","[false, false]","[""Treatments for MF (Mycosis Fungoides) and SS include topical therapies, phototherapy, systemic therapies, and in some cases, stem cell transplant."", ""Treatments for MF (Myelofibrosis) include medications, blood transfusions, stem cell transplant, and targeted therapy. The signs and symptoms of MF may include fatigue, shortness of breath, pain or fullness below the ribs, easy bruising, and night sweats.""]","[""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, phototherapy, and in some cases, stem cell transplantation."", ""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, and phototherapy.""]","[""The treatments for MF (myelofibrosis) include medications, blood transfusions, stem cell transplant, and targeted therapy. The treatments for SS (Sezary syndrome) include skin-directed therapies, systemic therapies, phototherapy, and biologic therapies."", ""For MF (myelofibrosis), treatments may include medications, blood transfusions, stem cell transplant, and targeted therapy. For SS (Sezary syndrome), treatments may include phototherapy, chemotherapy, biologic therapy, and stem cell transplant.""]","[true, false]","[true, true]","[false, true]","[""Treatments for MF (Mycosis Fungoides) and SS include topical therapies, phototherapy, systemic therapies, and in some cases, stem cell transplantation."", ""The treatments for MF (Myelofibrosis) may include medications, blood transfusions, stem cell transplant, and targeted therapy. The signs and symptoms of MF can vary but may include fatigue, shortness of breath, easy bruising, and enlarged spleen.""]","[""The treatments for Mycosis Fungoides and Szary Syndrome include topical therapies, phototherapy, systemic therapies such as chemotherapy, immunotherapy, and targeted therapy, as well as radiation therapy and in some cases stem cell transplantation."", ""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, and phototherapy.""]","[""The treatments for MF (myelofibrosis) include medications, blood transfusions, stem cell transplant, and targeted therapy. The treatments for SS (Sezary syndrome) include skin-directed therapies, systemic therapies, and phototherapy."", ""For MF (mycosis fungoides), treatments may include topical medications, phototherapy, systemic medications, and in some cases, radiation therapy. For SS (S\u00e9zary syndrome), treatments may involve systemic therapies such as chemotherapy, targeted therapy, immunotherapy, and in some cases, stem cell transplant.""]","[true, false]","[true, true]","[false, false]","[""Treatments for MF and SS include skin-directed therapies, systemic therapies, and radiation therapy."", ""Treatments for MF and SS vary depending on the specific condition. It is recommended to consult with a healthcare professional for personalized advice.""]","[""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, and phototherapy."", ""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, and phototherapy.""]","[""For MF (myelofibrosis), treatments may include medications, blood transfusions, stem cell transplant, and targeted therapy. For SS (Sezary syndrome), treatments may include skin-directed therapies, systemic therapies, and phototherapy."", ""The treatments for MF (myelofibrosis) include medications, blood transfusions, stem cell transplant, and targeted therapy. The treatments for SS (Sezary syndrome) include skin-directed therapies, systemic therapies, and phototherapy.""]","[false, false]","[true, true]","[false, false]","[""The treatments for MF (Multi-Function) and SS vary depending on the specific context and condition. It is recommended to consult with a healthcare professional for personalized advice."", ""The treatments for MF (Myelofibrosis) may include medications, blood transfusions, stem cell transplant, and clinical trials. Social Services (SS) may offer support services such as counseling, financial assistance, and access to community resources.""]","[""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, and phototherapy."", ""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, and phototherapy.""]","[""For MF (myelofibrosis), treatments may include medications, blood transfusions, stem cell transplant, and targeted therapy. For SS (Sezary syndrome), treatments may include skin-directed therapies, systemic therapies, and phototherapy."", ""The treatments for MF (myelofibrosis) include medications, blood transfusions, stem cell transplant, and targeted therapy. The treatments for SS (Sezary syndrome) include skin-directed therapies, systemic therapies, and phototherapy.""]","[false, false]","[true, true]","[false, false]","[""The treatments for MF (Multi-Family) and SS vary depending on the specific context and requirements. It is recommended to consult with a professional in the respective field for tailored advice."", ""The treatments for MF (Myelofibrosis) may include medications, blood transfusions, stem cell transplant, and clinical trials. For SS (Seguridad Social), it refers to the social security system in Spain that provides healthcare coverage and benefits to its citizens.""]","[""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, and phototherapy."", ""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, and phototherapy.""]","[""For MF (myelofibrosis), treatments may include medications, blood transfusions, stem cell transplant, and targeted therapy. For SS (Sezary syndrome), treatments may include skin-directed therapies, systemic therapies, and phototherapy."", ""The treatments for MF (myelofibrosis) include medications, blood transfusions, stem cell transplant, and targeted therapy. The treatments for SS (Sezary syndrome) include skin-directed therapies, systemic therapies, and phototherapy.""]","[true, false]","[true, true]","[false, false]","[""Treatments for MF and SS include skin-directed therapies, systemic therapies, radiation therapy, and in some cases, stem cell transplantation."", ""For MF, treatments may include topical corticosteroids, phototherapy, systemic medications, and in severe cases, stem cell transplant. For Stevens-Johnson Syndrome, treatment involves stopping the offending medication, supportive care, and sometimes corticosteroids or immunoglobulins.""]","[""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, and phototherapy."", ""The treatments for Mycosis Fungoides and Szary Syndrome include skin-directed therapies, systemic therapies, and phototherapy.""]","[""For MF (myelofibrosis), treatments may include medications, blood transfusions, stem cell transplant, and targeted therapy. For SS (Sezary syndrome), treatments may include skin-directed therapies, systemic therapies, and phototherapy."", ""The treatments for MF (myelofibrosis) include medications, blood transfusions, stem cell transplant, and targeted therapy. The treatments for SS (Sezary syndrome) include skin-directed therapies, systemic therapies, and phototherapy.""]"
symptoms,What are the symptoms of Spondylocostal dysostosis 1 ?,"What are the signs and symptoms of Spondylocostal dysostosis 1? The Human Phenotype Ontology provides the following list of signs and symptoms for Spondylocostal dysostosis 1. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormal form of the vertebral bodies 90% Abnormality of immune system physiology 90% Abnormality of the intervertebral disk 90% Abnormality of the ribs 90% Intrauterine growth retardation 90% Respiratory insufficiency 90% Scoliosis 90% Short neck 90% Short stature 90% Short thorax 90% Vertebral segmentation defect 90% Kyphosis 50% Abnormality of female internal genitalia 7.5% Abnormality of the ureter 7.5% Anomalous pulmonary venous return 7.5% Anteverted nares 7.5% Broad forehead 7.5% Camptodactyly of finger 7.5% Cleft palate 7.5% Cognitive impairment 7.5% Congenital diaphragmatic hernia 7.5% Cryptorchidism 7.5% Depressed nasal bridge 7.5% Displacement of the external urethral meatus 7.5% Finger syndactyly 7.5% Long philtrum 7.5% Low-set, posteriorly rotated ears 7.5% Macrocephaly 7.5% Meningocele 7.5% Microcephaly 7.5% Prominent occiput 7.5% Spina bifida occulta 7.5% Umbilical hernia 7.5% Urogenital fistula 7.5% Abnormality of the odontoid process - Autosomal recessive inheritance - Block vertebrae - Death in infancy - Disproportionate short-trunk short stature - Hemivertebrae - Recurrent respiratory infections - Rib fusion - Severe short stature - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""SCDO1"", ""full_form"": ""Spondylocostal dysostosis 1""}]}",What are the symptoms of SCDO1 ?,What are the symptoms of Spondylocostal dysostosis 1 ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Spondylocostal Dysostosis, Autosomal Recessive 1""]]","[[""THEFREEDICTIONARY""]]","[""Spondylocostal Dysostosis 1""]",[8.34624298057167e-27],[8.34624298057167e-27],"[""Spondylocostal Dysostosis 1""]",[8.34624298057167e-27],"[""LLM""]",[[1.9105239507674205e-43]],[0.7598215588860666],[0.7649808317483747],"[""Spondylocostal Dysostosis, Autosomal Recessive 1""]",[0.7649808317483747],"[""LLM""]",[[0.7453525538588841]],"[""Spondylocostal Dysostosis, Autosomal Recessive 1""]","[""THEFREEDICTIONARY""]",What are the symptoms of SCDO1 (Spondylocostal Dysostosis 1) ?,[true],[true],[false],"[""Symptoms of SCDO1 include short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""Symptoms of Spondylocostal dysostosis 1 include short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""The symptoms of SCDO1 include short stature, delayed bone age, joint stiffness, and skeletal abnormalities.""]",[true],[true],[false],"[""Some symptoms of SCDO1 include short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""Symptoms of Spondylocostal dysostosis 1 include short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""The symptoms of SCDO1 include short stature, delayed bone age, joint stiffness, and skeletal abnormalities.""]",[true],[true],[false],"[""Symptoms of SCDO1 include short trunk, short neck, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""Some common symptoms of Spondylocostal dysostosis 1 include short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""The symptoms of SCDO1 include short stature, skeletal abnormalities, joint deformities, and hearing loss.""]",[true],[true],[false],"[""Symptoms of SCDO1 include short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""Some common symptoms of Spondylocostal dysostosis 1 include short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""Symptoms of SCDO1 include short stature, delayed bone age, joint stiffness, and skeletal abnormalities.""]",[true],[true],[false],"[""Symptoms of SCDO1 include short trunk, short neck, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""Symptoms of Spondylocostal dysostosis 1 include short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""The symptoms of SCDO1 include short stature, delayed bone age, joint stiffness, and skeletal abnormalities.""]",[true],[true],[false],"[""Some symptoms of SCDO1 include short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""Symptoms of Spondylocostal dysostosis 1 include short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""The symptoms of SCDO1 include short stature, delayed bone age, joint stiffness, and skeletal abnormalities.""]",[true],[true],[false],"[""The symptoms of SCDO1 include short trunk, short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""Some common symptoms of Spondylocostal dysostosis 1 include short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""The symptoms of SCDO1 include short stature, skeletal abnormalities, joint deformities, and hearing loss.""]",[true],[true],[false],"[""The symptoms of SCDO1 include short trunk, short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""Some common symptoms of Spondylocostal dysostosis 1 include short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""Symptoms of SCDO1 include short stature, delayed bone age, joint stiffness, and skeletal abnormalities.""]",[true],[true],[false],"[""The symptoms of SCDO1 include short trunk, short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""Symptoms of Spondylocostal dysostosis 1 include short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""The symptoms of SCDO1 include short stature, delayed bone age, joint stiffness, and skeletal abnormalities.""]",[true],[true],[false],"[""Some symptoms of SCDO1 include short stature, abnormal curvature of the spine, rib anomalies, and respiratory issues.""]","[""Symptoms of Spondylocostal dysostosis 1 include short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""The symptoms of SCDO1 include short stature, delayed bone age, joint stiffness, and skeletal abnormalities.""]",[true],[true],[false],"[""Symptoms of SCDO1 may include short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""Some common symptoms of Spondylocostal dysostosis 1 include short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""The symptoms of SCDO1 include short stature, skeletal abnormalities, joint deformities, and hearing loss.""]",[true],[true],[false],"[""Symptoms of SCDO1 include short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""Some common symptoms of Spondylocostal dysostosis 1 include short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""Symptoms of SCDO1 include short stature, delayed bone age, joint stiffness, and skeletal abnormalities.""]",[true],[true],[false],"[""Short stature, short neck, scoliosis, rib anomalies, and other skeletal abnormalities""]","[""Symptoms of Spondylocostal dysostosis 1 include short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""The symptoms of SCDO1 include short stature, delayed bone age, joint stiffness, and skeletal abnormalities.""]",[true],[true],[false],"[""Short stature, abnormal curvature of the spine, rib abnormalities, respiratory issues""]","[""Symptoms of Spondylocostal dysostosis 1 include short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""The symptoms of SCDO1 include short stature, delayed bone age, joint stiffness, and skeletal abnormalities.""]",[true],[true],[false],"[""Short stature, abnormal curvature of the spine, rib abnormalities, respiratory issues""]","[""Some common symptoms of Spondylocostal dysostosis 1 include short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""The symptoms of SCDO1 include short stature, skeletal abnormalities, joint deformities, and hearing loss.""]",[true],[true],[false],"[""Short stature, abnormal curvature of the spine, rib abnormalities, respiratory issues""]","[""Some common symptoms of Spondylocostal dysostosis 1 include short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""Symptoms of SCDO1 include short stature, delayed bone age, joint stiffness, and skeletal abnormalities.""]",[true],[true],[false],"[""The symptoms of SCDO1 include short trunk, short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""Symptoms of Spondylocostal dysostosis 1 include short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""The symptoms of SCDO1 include short stature, delayed bone age, joint stiffness, and skeletal abnormalities.""]",[true],[true],[false],"[""Symptoms of SCDO1 include short stature, abnormal curvature of the spine (scoliosis), rib abnormalities, and respiratory issues.""]","[""Symptoms of Spondylocostal dysostosis 1 include short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""The symptoms of SCDO1 include short stature, delayed bone age, joint stiffness, and skeletal abnormalities.""]",[true],[true],[false],"[""Symptoms of SCDO1 include short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""Some common symptoms of Spondylocostal dysostosis 1 include short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""The symptoms of SCDO1 include short stature, skeletal abnormalities, joint deformities, and hearing loss.""]",[true],[true],[false],"[""Symptoms of SCDO1 include short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""Some common symptoms of Spondylocostal dysostosis 1 include short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""Symptoms of SCDO1 include short stature, delayed bone age, joint stiffness, and skeletal abnormalities.""]",[true],[true],[false],"[""The symptoms of SCDO1 include short trunk, short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""Symptoms of Spondylocostal dysostosis 1 include short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""The symptoms of SCDO1 include short stature, delayed bone age, joint stiffness, and skeletal abnormalities.""]",[true],[true],[false],"[""The symptoms of SCDO1 include short stature, abnormal curvature of the spine (scoliosis), rib abnormalities, and underdeveloped ribs.""]","[""Symptoms of Spondylocostal dysostosis 1 include short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""The symptoms of SCDO1 include short stature, delayed bone age, joint stiffness, and skeletal abnormalities.""]",[true],[true],[false],"[""The symptoms of SCDO1 include short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""Some common symptoms of Spondylocostal dysostosis 1 include short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""The symptoms of SCDO1 include short stature, skeletal abnormalities, joint deformities, and hearing loss.""]",[true],[true],[false],"[""The symptoms of SCDO1 include short trunk, short stature, abnormal curvature of the spine, rib abnormalities, and underdeveloped lungs.""]","[""Some common symptoms of Spondylocostal dysostosis 1 include short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""Symptoms of SCDO1 include short stature, delayed bone age, joint stiffness, and skeletal abnormalities.""]",[true],[true],[false],"[""Some common symptoms of SCDO1 include short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""Symptoms of Spondylocostal dysostosis 1 include short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""The symptoms of SCDO1 include short stature, delayed bone age, joint stiffness, and skeletal abnormalities.""]",[true],[true],[false],"[""Symptoms of SCDO1 include short trunk, short neck, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""Symptoms of Spondylocostal dysostosis 1 include short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""The symptoms of SCDO1 include short stature, delayed bone age, joint stiffness, and skeletal abnormalities.""]",[true],[true],[false],"[""The symptoms of SCDO1 include short trunk, short neck, scoliosis, rib abnormalities, and underdeveloped lungs.""]","[""Some common symptoms of Spondylocostal dysostosis 1 include short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""The symptoms of SCDO1 include short stature, skeletal abnormalities, joint deformities, and hearing loss.""]",[true],[true],[false],"[""Symptoms of SCDO1 include short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""Some common symptoms of Spondylocostal dysostosis 1 include short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""Symptoms of SCDO1 include short stature, delayed bone age, joint stiffness, and skeletal abnormalities.""]",[true],[true],[false],"[""Symptoms of SCDO1 include short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""Symptoms of Spondylocostal dysostosis 1 include short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""The symptoms of SCDO1 include short stature, delayed bone age, joint stiffness, and skeletal abnormalities.""]",[true],[true],[false],"[""Short stature, abnormal curvature of the spine, rib abnormalities, respiratory issues""]","[""Symptoms of Spondylocostal dysostosis 1 include short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""The symptoms of SCDO1 include short stature, delayed bone age, joint stiffness, and skeletal abnormalities.""]",[true],[true],[false],"[""The symptoms of SCDO1 include short trunk dwarfism, short neck, scoliosis, rib anomalies, and other skeletal abnormalities.""]","[""Symptoms of Spondylocostal dysostosis 1 include short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""The symptoms of SCDO1 include short stature, delayed bone age, joint stiffness, and skeletal abnormalities.""]",[true],[true],[false],"[""Symptoms of SCDO1 include short trunk, short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""Symptoms of Spondylocostal dysostosis 1 include short stature, abnormal curvature of the spine, rib abnormalities, and respiratory issues.""]","[""The symptoms of SCDO1 include short stature, delayed bone age, joint stiffness, and skeletal abnormalities.""]"
exams and tests,How to diagnose What I need to know about Hirschsprung Disease ?,"HD is diagnosed based on symptoms and test results.
                
A doctor will perform a physical exam and ask questions about your childs bowel movements. HD is much less likely if parents can identify a time when their childs bowel habits were normal.
                
If HD is suspected, the doctor will do one or more tests.
                
X rays
                
An x ray is a black-and-white picture of the inside of the body. To make the large intestine show up better, the doctor may fill it with barium liquid. Barium liquid is inserted into the large intestine through the anus.
                
If HD is the problem, the last segment of the large intestine will look narrower than normal. Just before this narrow segment, the intestine will look bulged. The bulging is caused by blocked stool stretching the intestine.
                
Manometry
                
During manometry, the doctor inflates a small balloon inside the rectum. Normally, the rectal muscles will relax. If the muscles dont relax, HD may be the problem. This test is most often done in older children and adults.
                
Biopsy
                
Biopsy is the most accurate test for HD. The doctor removes a tiny piece of the large intestine and looks at it with a microscope. If nerve cells are missing, HD is the problem.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""HD"", ""full_form"": ""Hirschsprung Disease""}]}",How to diagnose What I need to know about HD ?,How to diagnose What I need to know about Hirschsprung Disease ?,8,MEDICAL,Compound Datatype-String,"Instructional: Queries specifically seeking step-by-step guidance, instructions, or procedures to perform a task. it focuses on 'how' to do something rather than 'what', 'why', or 'which'.","[[""High Definition"", ""Hard Drive"", ""Help Desk"", ""Have Done"", ""Harley Davidson"", ""Heavy Duty"", ""Home Depot"", ""High Density"", ""Heart disease"", ""High Dose""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Huntington's Disease""]",[9.787912807964563e-08],[1.1062472495126193e-12],"[""High Dose""]",[0.0003681692237515561],"[""ABBREVIATIONS""]","[[3.2026186910132434e-07, 2.3397643649112661e-07, 3.2525634930052614e-12, 1.4659497847596837e-05, 1.0806675183271962e-18, 2.520187532930942e-08, 6.6699240245476154e-09, 4.014134856505968e-05, 0.000266354388077081, 0.0003681692237515561]]",[0.6755008780417296],[0.8519597183426475],"[""Help Desk""]",[0.9338901611234132],"[""ABBREVIATIONS""]","[[0.9013607147410252, 0.8631416504588112, 0.8190640299816905, 0.9338901611234132, 0.778561664340744, 0.8270949787849787, 0.8310148438234746, 0.8832339089014563, 0.8207314938479108, 0.8208957546932081]]","[""Heart disease""]","[""ABBREVIATIONS""]",How to diagnose What I need to know about HD (Huntington's Disease) ?,[false],[true],[false],"[""High dose chemotherapy is typically diagnosed through blood tests, imaging tests, and bone marrow biopsy. It is important to consult with a healthcare provider for proper diagnosis and treatment.""]","[""Diagnosis of Hirschsprung disease involves a physical exam, imaging tests, and a biopsy of the rectum to check for nerve cells.""]","[""Huntington's disease (HD) can be diagnosed through a combination of physical examination, neurological assessment, genetic testing, and imaging studies such as MRI or CT scans. A detailed family history is also important in the diagnostic process.""]",[false],[true],[false],"[""High Dose (HD) refers to a type of chemotherapy treatment that uses higher doses of drugs than standard chemotherapy. To diagnose HD, a doctor will typically perform a physical exam, review medical history, order blood tests, imaging tests, and possibly a biopsy to confirm the diagnosis. It is important to consult with a healthcare professional for proper evaluation and treatment.""]","[""Hirschsprung Disease is diagnosed through a combination of physical exams, imaging tests, and biopsies. The main diagnostic tests include barium enema, rectal suction biopsy, and anorectal manometry.""]","[""Huntington's disease (HD) can be diagnosed through a combination of genetic testing, neurological exams, and family history evaluation. A genetic test can confirm the presence of the gene mutation that causes HD. Neurological exams can assess movement, cognitive function, and psychiatric symptoms. A detailed family history can also provide important clues for diagnosis.""]",[false],[true],[false],"[""High Dose (HD) is a type of chemotherapy treatment that uses higher doses of drugs to kill cancer cells. To diagnose the need for HD, a doctor will assess the type and stage of cancer, overall health of the patient, and potential risks and benefits of the treatment. This may involve blood tests, imaging scans, and consultations with oncologists.""]","[""Hirschsprung Disease can be diagnosed through a physical exam, imaging tests like barium enema or anorectal manometry, and a biopsy of the rectum to check for nerve cells. A definitive diagnosis is made based on these tests and symptoms.""]","[""Huntington's disease (HD) can be diagnosed through a combination of physical examination, family history assessment, genetic testing, and neurological tests. A neurologist or genetic counselor can help in the diagnosis process.""]",[false],[true],[false],"[""High Dose (HD) refers to a type of chemotherapy treatment that involves higher doses of medication than standard chemotherapy. To diagnose the need for HD, a healthcare provider will assess the type and stage of cancer, overall health of the patient, and potential risks and benefits of the treatment. This may involve blood tests, imaging scans, and consultations with oncologists and other specialists.""]","[""Hirschsprung Disease can be diagnosed through a physical exam, imaging tests like barium enema or anorectal manometry, and a biopsy of the rectum to check for nerve cells. A pediatric gastroenterologist or pediatric surgeon can help in diagnosing and managing the condition.""]","[""Huntington's disease (HD) is typically diagnosed through a combination of physical examination, neurological assessment, genetic testing, and imaging studies such as MRI or CT scans. A detailed family history is also important in diagnosing HD.""]",[false],[true],[false],"[""To diagnose Huntington's disease (HD), a healthcare provider will typically perform a thorough medical history, physical examination, and neurological assessment. They may also order genetic testing to confirm the presence of the HD gene mutation.""]","[""Diagnosis of Hirschsprung disease involves a physical exam, imaging tests, and a biopsy of the rectum to check for nerve cells.""]","[""Huntington's disease (HD) can be diagnosed through a combination of physical examination, neurological assessment, genetic testing, and imaging studies such as MRI or CT scans. A detailed family history is also important in the diagnostic process.""]",[false],[true],[false],"[""Diagnosing HD (Help Desk) involves assessing the symptoms reported by users, checking the system logs for errors, testing connectivity, and troubleshooting hardware or software issues.""]","[""Hirschsprung Disease is diagnosed through a combination of physical exams, imaging tests, and biopsies. The main diagnostic tests include barium enema, rectal suction biopsy, and anorectal manometry.""]","[""Huntington's disease (HD) can be diagnosed through a combination of genetic testing, neurological exams, and family history evaluation. A genetic test can confirm the presence of the gene mutation that causes HD. Neurological exams can assess movement, cognitive function, and psychiatric symptoms. A detailed family history can also provide important clues for diagnosis.""]",[false],[true],[false],"[""Diagnosing Help Desk (HD) related issues involves identifying common problems, analyzing symptoms, checking system logs, testing hardware and software components, and consulting with end-users to gather information for troubleshooting.""]","[""Hirschsprung Disease can be diagnosed through a physical exam, imaging tests like barium enema or anorectal manometry, and a biopsy of the rectum to check for nerve cells. A definitive diagnosis is made based on these tests and symptoms.""]","[""Huntington's disease (HD) can be diagnosed through a combination of physical examination, family history assessment, genetic testing, and neurological tests. A neurologist or genetic counselor can help in the diagnosis process.""]",[false],[true],[false],"[""Diagnosing Help Desk (HD) related issues involves identifying common problems, analyzing symptoms, checking system logs, and conducting troubleshooting steps such as verifying network connectivity, checking hardware components, and testing software configurations.""]","[""Hirschsprung Disease can be diagnosed through a physical exam, imaging tests like barium enema or anorectal manometry, and a biopsy of the rectum to check for nerve cells. A pediatric gastroenterologist or pediatric surgeon can help in diagnosing and managing the condition.""]","[""Huntington's disease (HD) is typically diagnosed through a combination of physical examination, neurological assessment, genetic testing, and imaging studies such as MRI or CT scans. A detailed family history is also important in diagnosing HD.""]",[false],[true],[false],"[""Diagnosing heart disease involves a physical exam, medical history review, blood tests, imaging tests (like ECG, echocardiogram), stress tests, and cardiac catheterization.""]","[""Hirschsprung Disease is diagnosed through a combination of physical exams, imaging tests, and biopsies. The main diagnostic tests include barium enema, rectal suction biopsy, and anorectal manometry.""]","[""Huntington's disease (HD) can be diagnosed through a combination of genetic testing, neurological exams, and family history evaluation. A genetic test can confirm the presence of the gene mutation that causes HD. Neurological exams can assess movement, cognitive function, and psychiatric symptoms. A detailed family history can also provide important clues for diagnosis.""]",[false],[true],[false],"[""Diagnosing heart disease involves a physical exam, medical history review, blood tests, imaging tests like ECG, stress test, echocardiogram, and cardiac catheterization.""]","[""Diagnosis of Hirschsprung disease involves a physical exam, imaging tests, and a biopsy of the rectum to check for nerve cells.""]","[""Huntington's disease (HD) can be diagnosed through a combination of physical examination, neurological assessment, genetic testing, and imaging studies such as MRI or CT scans. A detailed family history is also important in the diagnostic process.""]",[false],[true],[false],"[""Diagnosing heart disease involves a physical exam, medical history review, blood tests, imaging tests (like ECG, echocardiogram), and possibly a stress test or cardiac catheterization.""]","[""Hirschsprung Disease can be diagnosed through a physical exam, imaging tests like barium enema or anorectal manometry, and a biopsy of the rectum to check for nerve cells. A definitive diagnosis is made based on these tests and symptoms.""]","[""Huntington's disease (HD) can be diagnosed through a combination of physical examination, family history assessment, genetic testing, and neurological tests. A neurologist or genetic counselor can help in the diagnosis process.""]",[false],[true],[false],"[""Diagnosing heart disease involves a combination of medical history, physical examination, blood tests, imaging tests (such as ECG, echocardiogram), and sometimes cardiac catheterization.""]","[""Hirschsprung Disease can be diagnosed through a physical exam, imaging tests like barium enema or anorectal manometry, and a biopsy of the rectum to check for nerve cells. A pediatric gastroenterologist or pediatric surgeon can help in diagnosing and managing the condition.""]","[""Huntington's disease (HD) is typically diagnosed through a combination of physical examination, neurological assessment, genetic testing, and imaging studies such as MRI or CT scans. A detailed family history is also important in diagnosing HD.""]",[false],[true],[false],"[""Diagnosing heart disease involves a physical exam, medical history, blood tests, imaging tests (such as ECG, echocardiogram), and possibly a coronary angiography.""]","[""Diagnosis of Hirschsprung disease involves a physical exam, imaging tests, and a biopsy of the rectum to check for nerve cells.""]","[""Huntington's disease (HD) can be diagnosed through a combination of physical examination, neurological assessment, genetic testing, and imaging studies such as MRI or CT scans. A detailed family history is also important in the diagnostic process.""]",[false],[true],[false],"[""Diagnosing heart disease involves a physical exam, medical history, blood tests, imaging tests (such as ECG, echocardiogram), and possibly a coronary angiography.""]","[""Hirschsprung Disease is diagnosed through a combination of physical exams, imaging tests, and biopsies. The main diagnostic tests include barium enema, rectal suction biopsy, and anorectal manometry.""]","[""Huntington's disease (HD) can be diagnosed through a combination of genetic testing, neurological exams, and family history evaluation. A genetic test can confirm the presence of the gene mutation that causes HD. Neurological exams can assess movement, cognitive function, and psychiatric symptoms. A detailed family history can also provide important clues for diagnosis.""]",[false],[true],[false],"[""Diagnosing heart disease involves a combination of medical history, physical examination, blood tests, imaging tests (such as ECG, echocardiogram), and sometimes invasive procedures like angiography.""]","[""Hirschsprung Disease can be diagnosed through a physical exam, imaging tests like barium enema or anorectal manometry, and a biopsy of the rectum to check for nerve cells. A definitive diagnosis is made based on these tests and symptoms.""]","[""Huntington's disease (HD) can be diagnosed through a combination of physical examination, family history assessment, genetic testing, and neurological tests. A neurologist or genetic counselor can help in the diagnosis process.""]",[false],[true],[false],"[""Diagnosing heart disease involves a combination of medical history, physical examination, blood tests, imaging tests (such as ECG, echocardiogram), and sometimes more invasive procedures like angiography.""]","[""Hirschsprung Disease can be diagnosed through a physical exam, imaging tests like barium enema or anorectal manometry, and a biopsy of the rectum to check for nerve cells. A pediatric gastroenterologist or pediatric surgeon can help in diagnosing and managing the condition.""]","[""Huntington's disease (HD) is typically diagnosed through a combination of physical examination, neurological assessment, genetic testing, and imaging studies such as MRI or CT scans. A detailed family history is also important in diagnosing HD.""]",[false],[true],[false],"[""To diagnose heart disease, your doctor may perform a physical exam, review your medical history, and order tests such as blood tests, electrocardiogram (ECG), echocardiogram, stress test, cardiac catheterization, and coronary angiography.""]","[""Diagnosis of Hirschsprung disease involves a physical exam, imaging tests, and a biopsy of the rectum to check for nerve cells.""]","[""Huntington's disease (HD) can be diagnosed through a combination of physical examination, neurological assessment, genetic testing, and imaging studies such as MRI or CT scans. A detailed family history is also important in the diagnostic process.""]",[false],[true],[false],"[""Diagnosing heart disease involves a physical exam, medical history review, blood tests, imaging tests (like ECG, echocardiogram), stress tests, and cardiac catheterization.""]","[""Hirschsprung Disease is diagnosed through a combination of physical exams, imaging tests, and biopsies. The main diagnostic tests include barium enema, rectal suction biopsy, and anorectal manometry.""]","[""Huntington's disease (HD) can be diagnosed through a combination of genetic testing, neurological exams, and family history evaluation. A genetic test can confirm the presence of the gene mutation that causes HD. Neurological exams can assess movement, cognitive function, and psychiatric symptoms. A detailed family history can also provide important clues for diagnosis.""]",[false],[true],[false],"[""Diagnosing heart disease involves a combination of medical history, physical examination, blood tests, imaging tests (such as ECG, echocardiogram), and possibly a stress test or cardiac catheterization.""]","[""Hirschsprung Disease can be diagnosed through a physical exam, imaging tests like barium enema or anorectal manometry, and a biopsy of the rectum to check for nerve cells. A definitive diagnosis is made based on these tests and symptoms.""]","[""Huntington's disease (HD) can be diagnosed through a combination of physical examination, family history assessment, genetic testing, and neurological tests. A neurologist or genetic counselor can help in the diagnosis process.""]",[false],[true],[false],"[""Diagnosing heart disease involves a physical exam, medical history review, blood tests, imaging tests (such as ECG, echocardiogram), stress tests, and cardiac catheterization.""]","[""Hirschsprung Disease can be diagnosed through a physical exam, imaging tests like barium enema or anorectal manometry, and a biopsy of the rectum to check for nerve cells. A pediatric gastroenterologist or pediatric surgeon can help in diagnosing and managing the condition.""]","[""Huntington's disease (HD) is typically diagnosed through a combination of physical examination, neurological assessment, genetic testing, and imaging studies such as MRI or CT scans. A detailed family history is also important in diagnosing HD.""]",[false],[true],[false],"[""Diagnosing Huntington's Disease involves a thorough medical history, physical examination, genetic testing, and neurological evaluation by a specialist.""]","[""Diagnosis of Hirschsprung disease involves a physical exam, imaging tests, and a biopsy of the rectum to check for nerve cells.""]","[""Huntington's disease (HD) can be diagnosed through a combination of physical examination, neurological assessment, genetic testing, and imaging studies such as MRI or CT scans. A detailed family history is also important in the diagnostic process.""]",[false],[true],[false],"[""Diagnosing Huntington's Disease involves a thorough medical history review, physical examination, neurological examination, genetic testing, and imaging tests such as MRI or CT scans.""]","[""Hirschsprung Disease is diagnosed through a combination of physical exams, imaging tests, and biopsies. The main diagnostic tests include barium enema, rectal suction biopsy, and anorectal manometry.""]","[""Huntington's disease (HD) can be diagnosed through a combination of genetic testing, neurological exams, and family history evaluation. A genetic test can confirm the presence of the gene mutation that causes HD. Neurological exams can assess movement, cognitive function, and psychiatric symptoms. A detailed family history can also provide important clues for diagnosis.""]",[false],[true],[false],"[""Diagnosing Huntington's Disease involves a combination of genetic testing, neurological examination, and imaging tests such as MRI or CT scans.""]","[""Hirschsprung Disease can be diagnosed through a physical exam, imaging tests like barium enema or anorectal manometry, and a biopsy of the rectum to check for nerve cells. A definitive diagnosis is made based on these tests and symptoms.""]","[""Huntington's disease (HD) can be diagnosed through a combination of physical examination, family history assessment, genetic testing, and neurological tests. A neurologist or genetic counselor can help in the diagnosis process.""]",[false],[true],[false],"[""Diagnosing Huntington's Disease involves a thorough medical history review, physical examination, neurological examination, genetic testing, and sometimes imaging tests like MRI or CT scans.""]","[""Hirschsprung Disease can be diagnosed through a physical exam, imaging tests like barium enema or anorectal manometry, and a biopsy of the rectum to check for nerve cells. A pediatric gastroenterologist or pediatric surgeon can help in diagnosing and managing the condition.""]","[""Huntington's disease (HD) is typically diagnosed through a combination of physical examination, neurological assessment, genetic testing, and imaging studies such as MRI or CT scans. A detailed family history is also important in diagnosing HD.""]",[false],[true],[false],"[""To diagnose heart disease, your doctor may perform a physical exam, review your medical history, conduct tests such as blood tests, electrocardiogram (ECG), echocardiogram, stress test, cardiac catheterization, and coronary angiography. These tests help in determining the presence and severity of heart disease.""]","[""Diagnosis of Hirschsprung disease involves a physical exam, imaging tests, and a biopsy of the rectum to check for nerve cells.""]","[""Huntington's disease (HD) can be diagnosed through a combination of physical examination, neurological assessment, genetic testing, and imaging studies such as MRI or CT scans. A detailed family history is also important in the diagnostic process.""]",[false],[true],[false],"[""To diagnose heart disease, your doctor may perform a physical exam, review your medical history, and order tests such as blood tests, electrocardiogram (ECG), echocardiogram, stress test, cardiac catheterization, and coronary angiography.""]","[""Hirschsprung Disease is diagnosed through a combination of physical exams, imaging tests, and biopsies. The main diagnostic tests include barium enema, rectal suction biopsy, and anorectal manometry.""]","[""Huntington's disease (HD) can be diagnosed through a combination of genetic testing, neurological exams, and family history evaluation. A genetic test can confirm the presence of the gene mutation that causes HD. Neurological exams can assess movement, cognitive function, and psychiatric symptoms. A detailed family history can also provide important clues for diagnosis.""]",[false],[true],[false],"[""To diagnose heart disease, your doctor may perform a physical exam, review your medical history, and order tests such as blood tests, electrocardiogram (ECG), echocardiogram, stress test, cardiac catheterization, and coronary angiography.""]","[""Hirschsprung Disease can be diagnosed through a physical exam, imaging tests like barium enema or anorectal manometry, and a biopsy of the rectum to check for nerve cells. A definitive diagnosis is made based on these tests and symptoms.""]","[""Huntington's disease (HD) can be diagnosed through a combination of physical examination, family history assessment, genetic testing, and neurological tests. A neurologist or genetic counselor can help in the diagnosis process.""]",[false],[true],[false],"[""Consult a healthcare professional for a proper diagnosis and evaluation of your heart health. They may recommend tests such as ECG, stress test, blood tests, or imaging studies to assess your heart function and identify any signs of heart disease.""]","[""Hirschsprung Disease can be diagnosed through a physical exam, imaging tests like barium enema or anorectal manometry, and a biopsy of the rectum to check for nerve cells. A pediatric gastroenterologist or pediatric surgeon can help in diagnosing and managing the condition.""]","[""Huntington's disease (HD) is typically diagnosed through a combination of physical examination, neurological assessment, genetic testing, and imaging studies such as MRI or CT scans. A detailed family history is also important in diagnosing HD.""]",[false],[true],[false],"[""Consult a healthcare professional for a proper diagnosis and information on what you need to know about heart disease.""]","[""Diagnosis of Hirschsprung disease involves a physical exam, imaging tests, and a biopsy of the rectum to check for nerve cells.""]","[""Huntington's disease (HD) can be diagnosed through a combination of physical examination, neurological assessment, genetic testing, and imaging studies such as MRI or CT scans. A detailed family history is also important in the diagnostic process.""]",[false],[true],[false],"[""Consult a healthcare professional for proper diagnosis and information about High Dose (HD) treatment.""]","[""Diagnosis of Hirschsprung disease involves a physical exam, imaging tests, and a biopsy of the rectum to check for nerve cells.""]","[""Huntington's disease (HD) can be diagnosed through a combination of physical examination, neurological assessment, genetic testing, and imaging studies such as MRI or CT scans. A detailed family history is also important in the diagnostic process.""]",[false],[true],[false],"[""Diagnosing issues related to Help Desk (HD) involves understanding common problems, troubleshooting techniques, and utilizing diagnostic tools provided by the software or system.""]","[""Diagnosis of Hirschsprung disease involves a physical exam, imaging tests, and a biopsy of the rectum to check for nerve cells.""]","[""Huntington's disease (HD) can be diagnosed through a combination of physical examination, neurological assessment, genetic testing, and imaging studies such as MRI or CT scans. A detailed family history is also important in the diagnostic process.""]",[false],[true],[false],"[""To diagnose Huntington's Disease, a doctor will perform a physical exam, review medical history, conduct neurological and psychiatric evaluations, and may order genetic testing.""]","[""Diagnosis of Hirschsprung disease involves a physical exam, imaging tests, and a biopsy of the rectum to check for nerve cells.""]","[""Huntington's disease (HD) can be diagnosed through a combination of physical examination, neurological assessment, genetic testing, and imaging studies such as MRI or CT scans. A detailed family history is also important in the diagnostic process.""]"
symptoms,"What are the symptoms of Infantile convulsions and paroxysmal choreoathetosis, familial ?","What are the signs and symptoms of Infantile convulsions and paroxysmal choreoathetosis, familial? The Human Phenotype Ontology provides the following list of signs and symptoms for Infantile convulsions and paroxysmal choreoathetosis, familial. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Chorea 90% EEG abnormality 90% Seizures 90% Incoordination 50% Migraine 50% Stereotypic behavior 7.5% Anxiety - Autosomal dominant inheritance - Focal seizures, afebril - Generalized seizures - Normal interictal EEG - Paroxysmal choreoathetosis - Paroxysmal dystonia - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""ICCA"", ""full_form"": ""Infantile convulsions and paroxysmal choreoathetosis, familial""}]}",What are the symptoms of ICCA ?,"What are the symptoms of Infantile convulsions and paroxysmal choreoathetosis, familial ?",8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""International Computer Chess Association"", ""Instituto de Cr\u00e9dito de las Cajas de Ahorro"", ""India Canada Cultural Association"", ""Italian Canadian Cultural Association"", ""International Competition of Collegiate Accapella"", ""International Council for Commercial Arbitration"", ""International Council of Chemical Associations"", ""International Community Corrections Association"", ""Illinois Cheerleading Coaches Association"", ""International Competition of Collegiate A""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Intracranial Carotid Artery Calcification""]",[1.6684397540476672e-43],[1.1210570480282359e-12],"[""Intracranial Carotid Artery Calcification""]",[1.1210570480282359e-12],"[""LLM""]","[[7.080843271318567e-20, 1.6314972150209744e-45, 4.0110483508068447e-22, 1.9109678504485025e-22, 2.1121335936413073e-35, 1.716081005499032e-27, 8.178506732176963e-22, 7.765571594259525e-21, 1.0847460122942554e-35, 8.539581736795577e-28]]",[0.6702053410092511],[0.7601261334998591],"[""International Council for Commercial Arbitration""]",[0.7864166666066174],"[""ABBREVIATIONS""]","[[0.7262146072920193, 0.7188163410655097, 0.7443467055275765, 0.725361777818913, 0.6414136295986022, 0.7747589102811085, 0.7864166666066174, 0.7491612090201123, 0.6940614197172417, 0.7609056097521837]]","[""Intracranial Carotid Artery Calcification""]","[""LLM""]",What are the symptoms of ICCA (Intracranial Carotid Artery Calcification) ?,[false],[true],[false],"[""Symptoms of ICCA may include headache, dizziness, memory problems, and in severe cases, stroke.""]","[""Symptoms of Infantile convulsions and paroxysmal choreoathetosis, familial include sudden, brief, and involuntary muscle movements, seizures, and chorea (abnormal involuntary movements).""]","[""Symptoms of ICCA include abdominal pain, weight loss, jaundice, and changes in bowel habits.""]",[false],[true],[false],"[""Symptoms of ICCA include headache, dizziness, memory problems, and stroke.""]","[""Symptoms of Infantile convulsions and paroxysmal choreoathetosis, familial include sudden, brief, and involuntary movements of the arms and legs, as well as seizures or convulsions in infants.""]","[""Symptoms of ICCA include abdominal pain, weight loss, jaundice, and changes in bowel habits.""]",[false],[true],[false],"[""Symptoms of ICCA include headache, dizziness, memory problems, and stroke.""]","[""Symptoms of Infantile convulsions and paroxysmal choreoathetosis, familial include seizures, involuntary movements, and choreiform movements.""]","[""Symptoms of ICCA include abdominal pain, weight loss, jaundice, and nausea.""]",[false],[true],[false],"[""Symptoms of ICCA include headache, dizziness, vision problems, and cognitive impairment.""]","[""Symptoms of Infantile convulsions and paroxysmal choreoathetosis, familial include seizures, involuntary movements, and chorea (irregular, jerky movements).""]","[""Symptoms of ICCA include abdominal pain, weight loss, jaundice, and nausea.""]",[false],[true],[false],"[""ICCA (International Council for Commercial Arbitration) does not refer to a medical condition, but rather an organization focused on commercial arbitration.""]","[""Symptoms of Infantile convulsions and paroxysmal choreoathetosis, familial include sudden, brief, and involuntary muscle movements, seizures, and chorea (abnormal involuntary movements).""]","[""Symptoms of ICCA include abdominal pain, weight loss, jaundice, and changes in bowel habits.""]",[false],[true],[false],"[""ICCA (International Council for Commercial Arbitration) does not refer to a medical condition, but rather an organization focused on commercial arbitration.""]","[""Symptoms of Infantile convulsions and paroxysmal choreoathetosis, familial include sudden, brief, and involuntary movements of the arms and legs, as well as seizures or convulsions in infants.""]","[""Symptoms of ICCA include abdominal pain, weight loss, jaundice, and changes in bowel habits.""]",[false],[true],[false],"[""ICCA (International Council for Commercial Arbitration) does not refer to a medical condition, but rather an organization focused on commercial arbitration.""]","[""Symptoms of Infantile convulsions and paroxysmal choreoathetosis, familial include seizures, involuntary movements, and choreiform movements.""]","[""Symptoms of ICCA include abdominal pain, weight loss, jaundice, and nausea.""]",[false],[true],[false],"[""ICCA (International Council for Commercial Arbitration) does not refer to a medical condition, but rather an organization focused on commercial arbitration.""]","[""Symptoms of Infantile convulsions and paroxysmal choreoathetosis, familial include seizures, involuntary movements, and chorea (irregular, jerky movements).""]","[""Symptoms of ICCA include abdominal pain, weight loss, jaundice, and nausea.""]",[false],[true],[false],"[""Symptoms of ICCA include headache, dizziness, memory problems, and stroke.""]","[""Symptoms of Infantile convulsions and paroxysmal choreoathetosis, familial include sudden, brief, and involuntary movements of the arms and legs, as well as seizures or convulsions in infants.""]","[""Symptoms of ICCA include abdominal pain, weight loss, jaundice, and changes in bowel habits.""]",[false],[true],[false],"[""Symptoms of ICCA include headache, dizziness, memory problems, and stroke.""]","[""Symptoms of Infantile convulsions and paroxysmal choreoathetosis, familial include sudden, brief, and involuntary muscle movements, seizures, and chorea (abnormal involuntary movements).""]","[""Symptoms of ICCA include abdominal pain, weight loss, jaundice, and changes in bowel habits.""]",[false],[true],[false],"[""Symptoms of ICCA include headache, dizziness, memory problems, and stroke.""]","[""Symptoms of Infantile convulsions and paroxysmal choreoathetosis, familial include seizures, involuntary movements, and choreiform movements.""]","[""Symptoms of ICCA include abdominal pain, weight loss, jaundice, and nausea.""]",[false],[true],[false],"[""Symptoms of ICCA include headache, dizziness, memory problems, and stroke.""]","[""Symptoms of Infantile convulsions and paroxysmal choreoathetosis, familial include seizures, involuntary movements, and chorea (irregular, jerky movements).""]","[""Symptoms of ICCA include abdominal pain, weight loss, jaundice, and nausea.""]",[false],[true],[false],"[""Symptoms of ICCA may include headache, dizziness, memory problems, and stroke.""]","[""Symptoms of Infantile convulsions and paroxysmal choreoathetosis, familial include sudden, brief, and involuntary muscle movements, seizures, and chorea (abnormal involuntary movements).""]","[""Symptoms of ICCA include abdominal pain, weight loss, jaundice, and changes in bowel habits.""]",[false],[true],[false],"[""Headache, dizziness, memory problems, confusion, difficulty speaking or understanding speech""]","[""Symptoms of Infantile convulsions and paroxysmal choreoathetosis, familial include sudden, brief, and involuntary movements of the arms and legs, as well as seizures or convulsions in infants.""]","[""Symptoms of ICCA include abdominal pain, weight loss, jaundice, and changes in bowel habits.""]",[false],[true],[false],"[""Symptoms of ICCA may include headache, dizziness, memory problems, and stroke.""]","[""Symptoms of Infantile convulsions and paroxysmal choreoathetosis, familial include seizures, involuntary movements, and choreiform movements.""]","[""Symptoms of ICCA include abdominal pain, weight loss, jaundice, and nausea.""]",[false],[true],[false],"[""Symptoms of ICCA may include headache, dizziness, memory problems, and neurological deficits.""]","[""Symptoms of Infantile convulsions and paroxysmal choreoathetosis, familial include seizures, involuntary movements, and chorea (irregular, jerky movements).""]","[""Symptoms of ICCA include abdominal pain, weight loss, jaundice, and nausea.""]",[false],[true],[false],"[""Symptoms of ICCA may include headache, dizziness, confusion, memory problems, and in severe cases, stroke.""]","[""Symptoms of Infantile convulsions and paroxysmal choreoathetosis, familial include sudden, brief, and involuntary muscle movements, seizures, and chorea (abnormal involuntary movements).""]","[""Symptoms of ICCA include abdominal pain, weight loss, jaundice, and changes in bowel habits.""]",[false],[true],[false],"[""Symptoms of ICCA include headache, dizziness, memory problems, and stroke.""]","[""Symptoms of Infantile convulsions and paroxysmal choreoathetosis, familial include sudden, brief, and involuntary movements of the arms and legs, as well as seizures or convulsions in infants.""]","[""Symptoms of ICCA include abdominal pain, weight loss, jaundice, and changes in bowel habits.""]",[false],[true],[false],"[""Symptoms of ICCA include headache, dizziness, memory problems, and stroke.""]","[""Symptoms of Infantile convulsions and paroxysmal choreoathetosis, familial include seizures, involuntary movements, and choreiform movements.""]","[""Symptoms of ICCA include abdominal pain, weight loss, jaundice, and nausea.""]",[false],[true],[false],"[""Symptoms of ICCA include headache, dizziness, memory problems, and stroke.""]","[""Symptoms of Infantile convulsions and paroxysmal choreoathetosis, familial include seizures, involuntary movements, and chorea (irregular, jerky movements).""]","[""Symptoms of ICCA include abdominal pain, weight loss, jaundice, and nausea.""]",[false],[true],[false],"[""Symptoms of ICCA include headache, dizziness, memory problems, and stroke.""]","[""Symptoms of Infantile convulsions and paroxysmal choreoathetosis, familial include sudden, brief, and involuntary muscle movements, seizures, and chorea (abnormal involuntary movements).""]","[""Symptoms of ICCA include abdominal pain, weight loss, jaundice, and changes in bowel habits.""]",[false],[true],[false],"[""Symptoms of ICCA include headache, dizziness, memory problems, and stroke.""]","[""Symptoms of Infantile convulsions and paroxysmal choreoathetosis, familial include sudden, brief, and involuntary movements of the arms and legs, as well as seizures or convulsions in infants.""]","[""Symptoms of ICCA include abdominal pain, weight loss, jaundice, and changes in bowel habits.""]",[false],[true],[false],"[""Symptoms of ICCA include headache, dizziness, memory problems, and neurological deficits.""]","[""Symptoms of Infantile convulsions and paroxysmal choreoathetosis, familial include seizures, involuntary movements, and choreiform movements.""]","[""Symptoms of ICCA include abdominal pain, weight loss, jaundice, and nausea.""]",[false],[true],[false],"[""Symptoms of ICCA include headache, dizziness, memory problems, and stroke.""]","[""Symptoms of Infantile convulsions and paroxysmal choreoathetosis, familial include seizures, involuntary movements, and chorea (irregular, jerky movements).""]","[""Symptoms of ICCA include abdominal pain, weight loss, jaundice, and nausea.""]",[false],[true],[false],"[""Symptoms of ICCA include headache, dizziness, memory loss, and stroke.""]","[""Symptoms of Infantile convulsions and paroxysmal choreoathetosis, familial include sudden, brief, and involuntary muscle movements, seizures, and chorea (abnormal involuntary movements).""]","[""Symptoms of ICCA include abdominal pain, weight loss, jaundice, and changes in bowel habits.""]",[false],[true],[false],"[""The symptoms of ICCA (Intracranial Carotid Artery Calcification) may include transient ischemic attacks (TIAs), stroke, or other neurological deficits depending on the severity and location of the calcification.""]","[""Symptoms of Infantile convulsions and paroxysmal choreoathetosis, familial include sudden, brief, and involuntary movements of the arms and legs, as well as seizures or convulsions in infants.""]","[""Symptoms of ICCA include abdominal pain, weight loss, jaundice, and changes in bowel habits.""]",[false],[true],[false],"[""Common symptoms of ICCA include headache, dizziness, memory problems, and vision changes.""]","[""Symptoms of Infantile convulsions and paroxysmal choreoathetosis, familial include seizures, involuntary movements, and choreiform movements.""]","[""Symptoms of ICCA include abdominal pain, weight loss, jaundice, and nausea.""]",[false],[true],[false],"[""Symptoms of ICCA may include headache, dizziness, memory problems, and in severe cases, stroke.""]","[""Symptoms of Infantile convulsions and paroxysmal choreoathetosis, familial include seizures, involuntary movements, and chorea (irregular, jerky movements).""]","[""Symptoms of ICCA include abdominal pain, weight loss, jaundice, and nausea.""]",[false],[true],[false],"[""Symptoms of ICCA may include headache, dizziness, memory problems, and stroke.""]","[""Symptoms of Infantile convulsions and paroxysmal choreoathetosis, familial include sudden, brief, and involuntary muscle movements, seizures, and chorea (abnormal involuntary movements).""]","[""Symptoms of ICCA include abdominal pain, weight loss, jaundice, and changes in bowel habits.""]",[false],[true],[false],"[""Symptoms of ICCA may include headache, dizziness, memory problems, and in severe cases, stroke.""]","[""Symptoms of Infantile convulsions and paroxysmal choreoathetosis, familial include sudden, brief, and involuntary muscle movements, seizures, and chorea (abnormal involuntary movements).""]","[""Symptoms of ICCA include abdominal pain, weight loss, jaundice, and changes in bowel habits.""]",[false],[true],[false],"[""The symptoms of ICCA (International Council for Commercial Arbitration) are not applicable as ICCA is an organization and does not have symptoms.""]","[""Symptoms of Infantile convulsions and paroxysmal choreoathetosis, familial include sudden, brief, and involuntary muscle movements, seizures, and chorea (abnormal involuntary movements).""]","[""Symptoms of ICCA include abdominal pain, weight loss, jaundice, and changes in bowel habits.""]",[false],[true],[false],"[""Symptoms of ICCA include headache, dizziness, memory problems, and stroke.""]","[""Symptoms of Infantile convulsions and paroxysmal choreoathetosis, familial include sudden, brief, and involuntary muscle movements, seizures, and chorea (abnormal involuntary movements).""]","[""Symptoms of ICCA include abdominal pain, weight loss, jaundice, and changes in bowel habits.""]"
symptoms,What are the symptoms of Spinocerebellar ataxia autosomal recessive with axonal neuropathy ?,"What are the signs and symptoms of Spinocerebellar ataxia autosomal recessive with axonal neuropathy? The Human Phenotype Ontology provides the following list of signs and symptoms for Spinocerebellar ataxia autosomal recessive with axonal neuropathy. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Ataxia - Autosomal recessive inheritance - Distal amyotrophy - Peripheral axonal neuropathy - Pes cavus - Steppage gait - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""SCAN1"", ""full_form"": ""Spinocerebellar ataxia autosomal recessive with axonal neuropathy""}]}",What are the symptoms of SCAN1 ?,What are the symptoms of Spinocerebellar ataxia autosomal recessive with axonal neuropathy ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.",[[]],[[]],"[""Spinocerebellar Ataxia with Axonal Neuropathy type 1""]",[4.3161835596775705e-47],[6.740390210789441e-35],"[""Spinocerebellar Ataxia with Axonal Neuropathy type 1""]",[6.740390210789441e-35],"[""LLM""]",[[]],[0.8344368679560722],[0.83955800170801],"[""Spinocerebellar ataxia autosomal recessive with axonal neuropathy""]",[0.83955800170801],"[""LLM""]",[[]],"[""Spinocerebellar Ataxia with Axonal Neuropathy type 1""]","[""LLM""]",What are the symptoms of SCAN1 (Spinocerebellar Ataxia with Axonal Neuropathy type 1) ?,[false],[true],[false],"[""Symptoms of SCAN1 include progressive ataxia, peripheral neuropathy, and loss of sensation in the extremities.""]","[""Symptoms of Spinocerebellar ataxia autosomal recessive with axonal neuropathy include difficulty walking, loss of coordination, muscle weakness, and peripheral neuropathy.""]","[""Symptoms of SCAN1 include muscle weakness, exercise intolerance, respiratory difficulties, and heart problems.""]",[true],[true],[false],"[""Symptoms of SCAN1 include progressive ataxia, muscle weakness, sensory loss, and neuropathy.""]","[""Symptoms of Spinocerebellar ataxia autosomal recessive with axonal neuropathy include difficulty walking, loss of coordination, muscle weakness, and sensory abnormalities.""]","[""Muscle weakness, droopy eyelids, difficulty swallowing, and respiratory problems.""]",[true],[true],[false],"[""Symptoms of SCAN1 include progressive ataxia, peripheral neuropathy, and loss of sensation in the extremities.""]","[""Symptoms of Spinocerebellar ataxia autosomal recessive with axonal neuropathy include progressive gait ataxia, dysarthria, lower limb spasticity, and peripheral neuropathy.""]","[""Muscle weakness, difficulty walking, vision problems, and respiratory issues""]",[false],[true],[false],"[""Symptoms of SCAN1 include progressive ataxia, peripheral neuropathy, and loss of sensation in the extremities.""]","[""Symptoms of Spinocerebellar ataxia autosomal recessive with axonal neuropathy include difficulty walking, poor coordination, tremors, muscle stiffness, and peripheral neuropathy.""]","[""Symptoms of SCAN1 include muscle weakness, exercise intolerance, respiratory failure, and cardiomyopathy.""]",[false],[true],[false],"[""Symptoms of SCAN1 include progressive ataxia, peripheral neuropathy, dysarthria, and nystagmus.""]","[""Symptoms of Spinocerebellar ataxia autosomal recessive with axonal neuropathy include difficulty walking, loss of coordination, muscle weakness, and peripheral neuropathy.""]","[""Symptoms of SCAN1 include muscle weakness, exercise intolerance, respiratory difficulties, and heart problems.""]",[true],[true],[false],"[""Symptoms of SCAN1 include ataxia, peripheral neuropathy, dysarthria, and nystagmus.""]","[""Symptoms of Spinocerebellar ataxia autosomal recessive with axonal neuropathy include difficulty walking, loss of coordination, muscle weakness, and sensory abnormalities.""]","[""Muscle weakness, droopy eyelids, difficulty swallowing, and respiratory problems.""]",[true],[true],[false],"[""Symptoms of SCAN1 include ataxia, neuropathy, muscle weakness, and difficulty walking.""]","[""Symptoms of Spinocerebellar ataxia autosomal recessive with axonal neuropathy include progressive gait ataxia, dysarthria, lower limb spasticity, and peripheral neuropathy.""]","[""Muscle weakness, difficulty walking, vision problems, and respiratory issues""]",[false],[true],[false],"[""Symptoms of SCAN1 include progressive ataxia, peripheral neuropathy, dysarthria, and nystagmus.""]","[""Symptoms of Spinocerebellar ataxia autosomal recessive with axonal neuropathy include difficulty walking, poor coordination, tremors, muscle stiffness, and peripheral neuropathy.""]","[""Symptoms of SCAN1 include muscle weakness, exercise intolerance, respiratory failure, and cardiomyopathy.""]",[true],[true],[false],"[""Symptoms of SCAN1 include progressive ataxia, peripheral neuropathy, and loss of sensation in the extremities.""]","[""Symptoms of Spinocerebellar ataxia autosomal recessive with axonal neuropathy include difficulty walking, loss of coordination, muscle weakness, and sensory abnormalities.""]","[""Muscle weakness, droopy eyelids, difficulty swallowing, and respiratory problems.""]",[false],[true],[false],"[""Symptoms of SCAN1 include progressive ataxia, peripheral neuropathy, and loss of sensation in the extremities.""]","[""Symptoms of Spinocerebellar ataxia autosomal recessive with axonal neuropathy include difficulty walking, loss of coordination, muscle weakness, and peripheral neuropathy.""]","[""Symptoms of SCAN1 include muscle weakness, exercise intolerance, respiratory difficulties, and heart problems.""]",[true],[true],[false],"[""Symptoms of SCAN1 include ataxia, muscle weakness, sensory loss, and neuropathy.""]","[""Symptoms of Spinocerebellar ataxia autosomal recessive with axonal neuropathy include progressive gait ataxia, dysarthria, lower limb spasticity, and peripheral neuropathy.""]","[""Muscle weakness, difficulty walking, vision problems, and respiratory issues""]",[false],[true],[false],"[""Symptoms of SCAN1 include progressive ataxia, muscle weakness, sensory loss, and neuropathy.""]","[""Symptoms of Spinocerebellar ataxia autosomal recessive with axonal neuropathy include difficulty walking, poor coordination, tremors, muscle stiffness, and peripheral neuropathy.""]","[""Symptoms of SCAN1 include muscle weakness, exercise intolerance, respiratory failure, and cardiomyopathy.""]",[false],[true],[false],"[""Symptoms of SCAN1 include progressive ataxia, muscle weakness, sensory loss, and neuropathy.""]","[""Symptoms of Spinocerebellar ataxia autosomal recessive with axonal neuropathy include difficulty walking, loss of coordination, muscle weakness, and peripheral neuropathy.""]","[""Symptoms of SCAN1 include muscle weakness, exercise intolerance, respiratory difficulties, and heart problems.""]",[true],[true],[false],"[""Symptoms of SCAN1 include ataxia, muscle weakness, sensory neuropathy, and difficulty walking.""]","[""Symptoms of Spinocerebellar ataxia autosomal recessive with axonal neuropathy include difficulty walking, loss of coordination, muscle weakness, and sensory abnormalities.""]","[""Muscle weakness, droopy eyelids, difficulty swallowing, and respiratory problems.""]",[true],[true],[false],"[""Symptoms of SCAN1 include ataxia, muscle weakness, sensory loss, and neuropathy.""]","[""Symptoms of Spinocerebellar ataxia autosomal recessive with axonal neuropathy include progressive gait ataxia, dysarthria, lower limb spasticity, and peripheral neuropathy.""]","[""Muscle weakness, difficulty walking, vision problems, and respiratory issues""]",[false],[true],[false],"[""Symptoms of SCAN1 include ataxia, muscle weakness, sensory loss, and neuropathy.""]","[""Symptoms of Spinocerebellar ataxia autosomal recessive with axonal neuropathy include difficulty walking, poor coordination, tremors, muscle stiffness, and peripheral neuropathy.""]","[""Symptoms of SCAN1 include muscle weakness, exercise intolerance, respiratory failure, and cardiomyopathy.""]",[false],[true],[false],"[""Symptoms of SCAN1 include ataxia, muscle weakness, sensory loss, and neuropathy.""]","[""Symptoms of Spinocerebellar ataxia autosomal recessive with axonal neuropathy include difficulty walking, loss of coordination, muscle weakness, and peripheral neuropathy.""]","[""Symptoms of SCAN1 include muscle weakness, exercise intolerance, respiratory difficulties, and heart problems.""]",[true],[true],[false],"[""Symptoms of SCAN1 include progressive ataxia, muscle weakness, sensory loss, and neuropathy.""]","[""Symptoms of Spinocerebellar ataxia autosomal recessive with axonal neuropathy include difficulty walking, loss of coordination, muscle weakness, and sensory abnormalities.""]","[""Muscle weakness, droopy eyelids, difficulty swallowing, and respiratory problems.""]",[true],[true],[false],"[""Symptoms of SCAN1 include progressive ataxia, muscle weakness, sensory loss, and neuropathy.""]","[""Symptoms of Spinocerebellar ataxia autosomal recessive with axonal neuropathy include progressive gait ataxia, dysarthria, lower limb spasticity, and peripheral neuropathy.""]","[""Muscle weakness, difficulty walking, vision problems, and respiratory issues""]",[false],[true],[false],"[""Symptoms of SCAN1 include progressive ataxia, muscle weakness, sensory loss, and neuropathy.""]","[""Symptoms of Spinocerebellar ataxia autosomal recessive with axonal neuropathy include difficulty walking, poor coordination, tremors, muscle stiffness, and peripheral neuropathy.""]","[""Symptoms of SCAN1 include muscle weakness, exercise intolerance, respiratory failure, and cardiomyopathy.""]",[false],[true],[false],"[""Symptoms of SCAN1 include ataxia, muscle weakness, sensory loss, and neuropathy.""]","[""Symptoms of Spinocerebellar ataxia autosomal recessive with axonal neuropathy include difficulty walking, loss of coordination, muscle weakness, and peripheral neuropathy.""]","[""Symptoms of SCAN1 include muscle weakness, exercise intolerance, respiratory difficulties, and heart problems.""]",[true],[true],[false],"[""Symptoms of SCAN1 include progressive ataxia, muscle weakness, sensory loss, and axonal neuropathy.""]","[""Symptoms of Spinocerebellar ataxia autosomal recessive with axonal neuropathy include difficulty walking, loss of coordination, muscle weakness, and sensory abnormalities.""]","[""Muscle weakness, droopy eyelids, difficulty swallowing, and respiratory problems.""]",[true],[true],[false],"[""Symptoms of SCAN1 include progressive ataxia, muscle weakness, sensory loss, and axonal neuropathy.""]","[""Symptoms of Spinocerebellar ataxia autosomal recessive with axonal neuropathy include progressive gait ataxia, dysarthria, lower limb spasticity, and peripheral neuropathy.""]","[""Muscle weakness, difficulty walking, vision problems, and respiratory issues""]",[false],[true],[false],"[""The symptoms of SCAN1 include progressive ataxia, muscle weakness, sensory loss, and axonal neuropathy.""]","[""Symptoms of Spinocerebellar ataxia autosomal recessive with axonal neuropathy include difficulty walking, poor coordination, tremors, muscle stiffness, and peripheral neuropathy.""]","[""Symptoms of SCAN1 include muscle weakness, exercise intolerance, respiratory failure, and cardiomyopathy.""]",[false],[true],[false],"[""Symptoms of SCAN1 include ataxia, muscle weakness, sensory neuropathy, and difficulty walking.""]","[""Symptoms of Spinocerebellar ataxia autosomal recessive with axonal neuropathy include difficulty walking, loss of coordination, muscle weakness, and peripheral neuropathy.""]","[""Symptoms of SCAN1 include muscle weakness, exercise intolerance, respiratory difficulties, and heart problems.""]",[true],[true],[false],"[""Symptoms of SCAN1 include ataxia, muscle weakness, sensory neuropathy, and difficulty walking.""]","[""Symptoms of Spinocerebellar ataxia autosomal recessive with axonal neuropathy include difficulty walking, loss of coordination, muscle weakness, and sensory abnormalities.""]","[""Muscle weakness, droopy eyelids, difficulty swallowing, and respiratory problems.""]",[true],[true],[false],"[""Symptoms of SCAN1 include progressive ataxia, muscle weakness, sensory loss, and neuropathy.""]","[""Symptoms of Spinocerebellar ataxia autosomal recessive with axonal neuropathy include progressive gait ataxia, dysarthria, lower limb spasticity, and peripheral neuropathy.""]","[""Muscle weakness, difficulty walking, vision problems, and respiratory issues""]",[false],[true],[false],"[""Symptoms of SCAN1 include progressive ataxia, muscle weakness, sensory loss, and neuropathy.""]","[""Symptoms of Spinocerebellar ataxia autosomal recessive with axonal neuropathy include difficulty walking, poor coordination, tremors, muscle stiffness, and peripheral neuropathy.""]","[""Symptoms of SCAN1 include muscle weakness, exercise intolerance, respiratory failure, and cardiomyopathy.""]",[false],[true],[false],"[""Symptoms of SCAN1 include ataxia, muscle weakness, sensory neuropathy, and difficulty walking.""]","[""Symptoms of Spinocerebellar ataxia autosomal recessive with axonal neuropathy include difficulty walking, loss of coordination, muscle weakness, and peripheral neuropathy.""]","[""Symptoms of SCAN1 include muscle weakness, exercise intolerance, respiratory difficulties, and heart problems.""]",[false],[true],[false],"[""Symptoms of SCAN1 include ataxia, muscle weakness, sensory neuropathy, and difficulty walking.""]","[""Symptoms of Spinocerebellar ataxia autosomal recessive with axonal neuropathy include difficulty walking, loss of coordination, muscle weakness, and peripheral neuropathy.""]","[""Symptoms of SCAN1 include muscle weakness, exercise intolerance, respiratory difficulties, and heart problems.""]",[false],[true],[false],"[""Symptoms of SCAN1 include ataxia, peripheral neuropathy, and muscle weakness.""]","[""Symptoms of Spinocerebellar ataxia autosomal recessive with axonal neuropathy include difficulty walking, loss of coordination, muscle weakness, and peripheral neuropathy.""]","[""Symptoms of SCAN1 include muscle weakness, exercise intolerance, respiratory difficulties, and heart problems.""]",[false],[true],[false],"[""Symptoms of SCAN1 include ataxia, muscle weakness, peripheral neuropathy, and loss of sensation in the extremities.""]","[""Symptoms of Spinocerebellar ataxia autosomal recessive with axonal neuropathy include difficulty walking, loss of coordination, muscle weakness, and peripheral neuropathy.""]","[""Symptoms of SCAN1 include muscle weakness, exercise intolerance, respiratory difficulties, and heart problems.""]"
prevention,How to prevent Short Bowel Syndrome ?,"People can ask their health care providers about surgical techniques that minimize scar tissue. Scientists have not yet found a way to prevent short bowel syndrome that is present at birth, as its cause is unknown.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""SBS"", ""full_form"": ""Short Bowel Syndrome""}]}",How to prevent SBS ?,How to prevent Short Bowel Syndrome ?,8,MEDICAL,Simple Datatype-String,"Instructional: Queries specifically seeking step-by-step guidance, instructions, or procedures to perform a task. it focuses on 'how' to do something rather than 'what', 'why', or 'which'.","[[""Small Business Server"", ""Special Broadcasting Service"", ""Step-By-Step"", ""Siemens Business Services"", ""Sick Building Syndrome"", ""Styrene Butadiene Styrene"", ""Short Bowel Syndrome"", ""Subscript"", ""Special Boat Service"", ""Society for Biomolecular Screening""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Shaken Baby Syndrome""]",[6.907503393927296e-09],[5.551752865504114e-15],"[""Short Bowel Syndrome""]",[6.907503393927296e-09],"[""ABBREVIATIONS""]","[[1.717602368697375e-14, 5.463663883155399e-16, 3.9050072203320135e-11, 3.469693299126183e-16, 1.10174716367116e-11, 1.183136524948659e-31, 6.907503393927296e-09, 1.0162813059511664e-09, 1.5208110981918856e-15, 2.555670216521077e-24]]",[0.6673181989534652],[0.6775937752253413],"[""Special Broadcasting Service""]",[0.8652984475250022],"[""ABBREVIATIONS""]","[[0.7565489490712338, 0.7086979012146338, 0.8652984475250022, 0.7185463519700781, 0.6827427581656678, 0.7072264639763146, 0.6673181989534652, 0.6735733151155447, 0.6483076580050469, 0.677048700566473]]","[""Short Bowel Syndrome""]","[""ABBREVIATIONS""]",How to prevent SBS (Shaken Baby Syndrome) ?,[true],[false],[false],"[""Preventing SBS involves early treatment of conditions that can lead to it, such as Crohn's disease, avoiding bowel surgeries when possible, and following a specialized diet plan recommended by a healthcare provider.""]","[""Preventing Short Bowel Syndrome involves early treatment of conditions that can lead to the syndrome, such as Crohn's disease, avoiding smoking, maintaining a healthy diet, and working with a healthcare provider to manage the condition effectively.""]","[""Prevent SBS by maintaining good hygiene practices, avoiding sharing personal items, and getting vaccinated against diseases that can lead to SBS.""]",[true],[false],[false],"[""Preventing SBS involves early treatment of conditions that can lead to it, such as Crohn's disease, avoiding bowel surgery when possible, and following a specialized diet plan prescribed by a healthcare provider.""]","[""Preventing Short Bowel Syndrome involves early treatment of conditions that can cause it, such as Crohn's disease, avoiding smoking and excessive alcohol consumption, maintaining a healthy diet, and working closely with healthcare providers to manage the condition.""]","[""Prevent SBS by maintaining good hygiene practices, avoiding sharing personal items, and getting vaccinated against diseases that can lead to SBS.""]",[true],[false],[false],"[""Preventing SBS involves early treatment of conditions that can lead to it, such as Crohn's disease, avoiding bowel surgeries when possible, and following a healthy diet plan recommended by a healthcare provider.""]","[""Preventing Short Bowel Syndrome involves early treatment of conditions that can lead to it, such as Crohn's disease, avoiding smoking, maintaining a healthy diet, and working closely with healthcare providers.""]","[""Preventing SBS involves maintaining good hygiene practices, avoiding sharing personal items, and getting vaccinated against certain infections.""]",[true],[true],[false],"[""Preventing SBS involves early treatment of conditions that can lead to it, such as Crohn's disease, avoiding bowel surgeries when possible, and ensuring proper nutrition and hydration.""]","[""Preventing Short Bowel Syndrome involves early treatment of conditions that can lead to it, such as Crohn's disease, avoiding smoking, maintaining a healthy diet, and working closely with healthcare providers.""]","[""Prevent short bowel syndrome (SBS) by following a high-protein, low-fat diet, taking vitamin and mineral supplements, staying hydrated, and working with a healthcare provider to manage symptoms.""]",[false],[true],[false],"[""To prevent SBS (Special Broadcasting Service), ensure proper positioning and securement of the endotracheal tube, monitor cuff pressure regularly, and consider using cuff pressure monitoring devices.""]","[""Preventing Short Bowel Syndrome involves early treatment of conditions that can lead to the syndrome, such as Crohn's disease, avoiding smoking, maintaining a healthy diet, and working with a healthcare provider to manage the condition effectively.""]","[""Prevent SBS by maintaining good hygiene practices, avoiding sharing personal items, and getting vaccinated against diseases that can lead to SBS.""]",[false],[true],[false],"[""To prevent SBS (Special Broadcasting Service), ensure proper positioning and support of the patient during surgery to avoid nerve compression.""]","[""Preventing Short Bowel Syndrome involves early treatment of conditions that can cause it, such as Crohn's disease, avoiding smoking and excessive alcohol consumption, maintaining a healthy diet, and working closely with healthcare providers to manage the condition.""]","[""Prevent SBS by maintaining good hygiene practices, avoiding sharing personal items, and getting vaccinated against diseases that can lead to SBS.""]",[false],[true],[false],"[""To prevent SBS (Special Broadcasting Service), maintain good hygiene practices, avoid sharing personal items, and practice safe sex.""]","[""Preventing Short Bowel Syndrome involves early treatment of conditions that can lead to it, such as Crohn's disease, avoiding smoking, maintaining a healthy diet, and working closely with healthcare providers.""]","[""Preventing SBS involves maintaining good hygiene practices, avoiding sharing personal items, and getting vaccinated against certain infections.""]",[false],[true],[false],"[""To prevent SBS (Special Broadcasting Service), ensure proper positioning and support of the patient during surgery, use pressure-relieving devices, and monitor the patient's skin regularly for any signs of pressure ulcers.""]","[""Preventing Short Bowel Syndrome involves early treatment of conditions that can lead to it, such as Crohn's disease, avoiding smoking, maintaining a healthy diet, and working closely with healthcare providers.""]","[""Prevent short bowel syndrome (SBS) by following a high-protein, low-fat diet, taking vitamin and mineral supplements, staying hydrated, and working with a healthcare provider to manage symptoms.""]",[true],[false],[false],"[""Preventing SBS involves early treatment of conditions that can lead to SBS, such as Crohn's disease, avoiding unnecessary bowel surgeries, and ensuring proper nutrition and hydration.""]","[""Preventing Short Bowel Syndrome involves early treatment of conditions that can cause it, such as Crohn's disease, avoiding smoking and excessive alcohol consumption, maintaining a healthy diet, and working closely with healthcare providers to manage the condition.""]","[""Prevent SBS by maintaining good hygiene practices, avoiding sharing personal items, and getting vaccinated against diseases that can lead to SBS.""]",[false],[false],[false],"[""Preventing SBS involves early treatment of conditions that can lead to it, such as Crohn's disease, avoiding bowel surgeries when possible, and ensuring proper nutrition and hydration.""]","[""Preventing Short Bowel Syndrome involves early treatment of conditions that can lead to the syndrome, such as Crohn's disease, avoiding smoking, maintaining a healthy diet, and working with a healthcare provider to manage the condition effectively.""]","[""Prevent SBS by maintaining good hygiene practices, avoiding sharing personal items, and getting vaccinated against diseases that can lead to SBS.""]",[true],[false],[false],"[""Preventing SBS involves early treatment of conditions that can lead to short bowel syndrome, such as Crohn's disease, avoiding bowel surgeries when possible, and following a specialized diet plan recommended by a healthcare provider.""]","[""Preventing Short Bowel Syndrome involves early treatment of conditions that can lead to it, such as Crohn's disease, avoiding smoking, maintaining a healthy diet, and working closely with healthcare providers.""]","[""Preventing SBS involves maintaining good hygiene practices, avoiding sharing personal items, and getting vaccinated against certain infections.""]",[false],[false],[false],"[""Preventing SBS involves early treatment of conditions that may lead to short bowel syndrome, such as Crohn's disease, avoiding bowel surgeries when possible, and ensuring proper nutrition and hydration to maintain bowel health.""]","[""Preventing Short Bowel Syndrome involves early treatment of conditions that can lead to it, such as Crohn's disease, avoiding smoking, maintaining a healthy diet, and working closely with healthcare providers.""]","[""Prevent short bowel syndrome (SBS) by following a high-protein, low-fat diet, taking vitamin and mineral supplements, staying hydrated, and working with a healthcare provider to manage symptoms.""]",[true],[false],[false],"[""Preventing SBS involves early treatment of conditions that can lead to the syndrome, such as Crohn's disease or surgical removal of a portion of the small intestine. Nutritional support and medications may also be used to manage SBS.""]","[""Preventing Short Bowel Syndrome involves early treatment of conditions that can lead to the syndrome, such as Crohn's disease, avoiding smoking, maintaining a healthy diet, and working with a healthcare provider to manage the condition effectively.""]","[""Prevent SBS by maintaining good hygiene practices, avoiding sharing personal items, and getting vaccinated against diseases that can lead to SBS.""]",[true],[false],[false],"[""Preventing SBS involves early treatment of conditions that can lead to it, such as Crohn's disease, avoiding surgery that may result in extensive bowel resection, and ensuring proper nutrition and hydration.""]","[""Preventing Short Bowel Syndrome involves early treatment of conditions that can cause it, such as Crohn's disease, avoiding smoking and excessive alcohol consumption, maintaining a healthy diet, and working closely with healthcare providers to manage the condition.""]","[""Prevent SBS by maintaining good hygiene practices, avoiding sharing personal items, and getting vaccinated against diseases that can lead to SBS.""]",[true],[true],[false],"[""Preventing SBS involves early treatment of conditions that can lead to the syndrome, such as Crohn's disease or surgical complications. Maintaining a healthy diet and lifestyle, as well as working closely with healthcare providers, can also help prevent SBS.""]","[""Preventing Short Bowel Syndrome involves early treatment of conditions that can lead to it, such as Crohn's disease, avoiding smoking, maintaining a healthy diet, and working closely with healthcare providers.""]","[""Preventing SBS involves maintaining good hygiene practices, avoiding sharing personal items, and getting vaccinated against certain infections.""]",[true],[true],[false],"[""Preventing SBS involves early treatment of conditions that can lead to the syndrome, such as Crohn's disease, and ensuring proper nutrition through diet and supplements.""]","[""Preventing Short Bowel Syndrome involves early treatment of conditions that can lead to it, such as Crohn's disease, avoiding smoking, maintaining a healthy diet, and working closely with healthcare providers.""]","[""Prevent short bowel syndrome (SBS) by following a high-protein, low-fat diet, taking vitamin and mineral supplements, staying hydrated, and working with a healthcare provider to manage symptoms.""]",[true],[false],[false],"[""Preventing SBS involves proper management of the underlying causes, such as avoiding bowel resection if possible, maintaining good nutrition, and working closely with healthcare providers.""]","[""Preventing Short Bowel Syndrome involves early treatment of conditions that can lead to the syndrome, such as Crohn's disease, avoiding smoking, maintaining a healthy diet, and working with a healthcare provider to manage the condition effectively.""]","[""Prevent SBS by maintaining good hygiene practices, avoiding sharing personal items, and getting vaccinated against diseases that can lead to SBS.""]",[true],[true],[false],"[""Preventing SBS involves early treatment of conditions that may lead to it, such as Crohn's disease, avoiding surgery that may result in short bowel, and ensuring proper nutrition and hydration.""]","[""Preventing Short Bowel Syndrome involves early treatment of conditions that can cause it, such as Crohn's disease, avoiding smoking and excessive alcohol consumption, maintaining a healthy diet, and working closely with healthcare providers to manage the condition.""]","[""Prevent SBS by maintaining good hygiene practices, avoiding sharing personal items, and getting vaccinated against diseases that can lead to SBS.""]",[true],[false],[false],"[""Preventing SBS involves early treatment of conditions that can lead to it, such as Crohn's disease or surgical complications. Maintaining good nutrition, including parenteral nutrition if needed, and working closely with healthcare providers are key steps.""]","[""Preventing Short Bowel Syndrome involves early treatment of conditions that can lead to it, such as Crohn's disease, avoiding smoking, maintaining a healthy diet, and working closely with healthcare providers.""]","[""Preventing SBS involves maintaining good hygiene practices, avoiding sharing personal items, and getting vaccinated against certain infections.""]",[true],[true],[false],"[""Preventing SBS involves early treatment of conditions that can lead to it, such as Crohn's disease, avoiding bowel surgeries when possible, and ensuring proper nutrition and hydration.""]","[""Preventing Short Bowel Syndrome involves early treatment of conditions that can lead to it, such as Crohn's disease, avoiding smoking, maintaining a healthy diet, and working closely with healthcare providers.""]","[""Prevent short bowel syndrome (SBS) by following a high-protein, low-fat diet, taking vitamin and mineral supplements, staying hydrated, and working with a healthcare provider to manage symptoms.""]",[false],[true],[false],"[""To prevent Shaken Baby Syndrome, always support the baby's head and neck, never shake the baby, and seek help if feeling overwhelmed or frustrated.""]","[""Preventing Short Bowel Syndrome involves early treatment of conditions that can lead to the syndrome, such as Crohn's disease, avoiding smoking, maintaining a healthy diet, and working with a healthcare provider to manage the condition effectively.""]","[""Prevent SBS by maintaining good hygiene practices, avoiding sharing personal items, and getting vaccinated against diseases that can lead to SBS.""]",[false],[true],[false],"[""To prevent Shaken Baby Syndrome (SBS), always support the baby's head and neck, never shake a baby, and seek help if feeling overwhelmed.""]","[""Preventing Short Bowel Syndrome involves early treatment of conditions that can cause it, such as Crohn's disease, avoiding smoking and excessive alcohol consumption, maintaining a healthy diet, and working closely with healthcare providers to manage the condition.""]","[""Prevent SBS by maintaining good hygiene practices, avoiding sharing personal items, and getting vaccinated against diseases that can lead to SBS.""]",[false],[true],[false],"[""To prevent Shaken Baby Syndrome, always support the baby's head, never shake the baby, and seek help if feeling overwhelmed.""]","[""Preventing Short Bowel Syndrome involves early treatment of conditions that can lead to it, such as Crohn's disease, avoiding smoking, maintaining a healthy diet, and working closely with healthcare providers.""]","[""Preventing SBS involves maintaining good hygiene practices, avoiding sharing personal items, and getting vaccinated against certain infections.""]",[false],[true],[false],"[""To prevent Shaken Baby Syndrome, always support the baby's head and neck, never shake the baby, and seek help if feeling overwhelmed.""]","[""Preventing Short Bowel Syndrome involves early treatment of conditions that can lead to it, such as Crohn's disease, avoiding smoking, maintaining a healthy diet, and working closely with healthcare providers.""]","[""Prevent short bowel syndrome (SBS) by following a high-protein, low-fat diet, taking vitamin and mineral supplements, staying hydrated, and working with a healthcare provider to manage symptoms.""]",[true],[true],[false],"[""Preventing SBS involves early detection and treatment of conditions that can lead to the syndrome, such as Crohn's disease or surgical removal of a large portion of the small intestine. Maintaining a healthy diet, including proper nutrition and hydration, is also important. Regular monitoring by healthcare professionals is recommended for individuals at risk of developing SBS.""]","[""Preventing Short Bowel Syndrome involves early treatment of conditions that can lead to the syndrome, such as Crohn's disease, avoiding smoking, maintaining a healthy diet, and working with a healthcare provider to manage the condition effectively.""]","[""Prevent SBS by maintaining good hygiene practices, avoiding sharing personal items, and getting vaccinated against diseases that can lead to SBS.""]",[true],[false],[false],"[""Preventing SBS involves early diagnosis and treatment of conditions that may lead to it, such as Crohn's disease or surgical removal of a large portion of the small intestine. Maintaining a healthy diet, including proper nutrition and hydration, is also important. Regular follow-ups with healthcare providers and monitoring for any signs of complications are essential.""]","[""Preventing Short Bowel Syndrome involves early treatment of conditions that can cause it, such as Crohn's disease, avoiding smoking and excessive alcohol consumption, maintaining a healthy diet, and working closely with healthcare providers to manage the condition.""]","[""Prevent SBS by maintaining good hygiene practices, avoiding sharing personal items, and getting vaccinated against diseases that can lead to SBS.""]",[true],[true],[false],"[""Preventing SBS involves strategies such as early treatment of conditions that may lead to SBS, maintaining a healthy diet, avoiding excessive alcohol consumption, and following medical advice closely.""]","[""Preventing Short Bowel Syndrome involves early treatment of conditions that can lead to it, such as Crohn's disease, avoiding smoking, maintaining a healthy diet, and working closely with healthcare providers.""]","[""Preventing SBS involves maintaining good hygiene practices, avoiding sharing personal items, and getting vaccinated against certain infections.""]",[true],[true],[false],"[""Preventing SBS involves early diagnosis and treatment of conditions that can lead to the syndrome, such as Crohn's disease or surgical removal of a large portion of the small intestine. Maintaining a healthy diet, including proper nutrition and hydration, is essential. Regular follow-ups with healthcare providers and monitoring for any signs of complications are also important.""]","[""Preventing Short Bowel Syndrome involves early treatment of conditions that can lead to it, such as Crohn's disease, avoiding smoking, maintaining a healthy diet, and working closely with healthcare providers.""]","[""Prevent short bowel syndrome (SBS) by following a high-protein, low-fat diet, taking vitamin and mineral supplements, staying hydrated, and working with a healthcare provider to manage symptoms.""]",[false],[false],[false],"[""Preventing SBS involves early treatment of conditions that can lead to the syndrome, such as Crohn's disease or surgical removal of a portion of the small intestine. Nutritional support and monitoring are also important in preventing complications.""]","[""Preventing Short Bowel Syndrome involves early treatment of conditions that can lead to the syndrome, such as Crohn's disease, avoiding smoking, maintaining a healthy diet, and working with a healthcare provider to manage the condition effectively.""]","[""Prevent SBS by maintaining good hygiene practices, avoiding sharing personal items, and getting vaccinated against diseases that can lead to SBS.""]",[true],[false],[false],"[""Preventing SBS involves early treatment of underlying conditions, such as Crohn's disease or surgical removal of a portion of the small intestine, maintaining good nutrition, and working closely with healthcare providers.""]","[""Preventing Short Bowel Syndrome involves early treatment of conditions that can lead to the syndrome, such as Crohn's disease, avoiding smoking, maintaining a healthy diet, and working with a healthcare provider to manage the condition effectively.""]","[""Prevent SBS by maintaining good hygiene practices, avoiding sharing personal items, and getting vaccinated against diseases that can lead to SBS.""]",[false],[true],[false],"[""SBS (Special Broadcasting Service) cannot be prevented as it is a broadcasting service.""]","[""Preventing Short Bowel Syndrome involves early treatment of conditions that can lead to the syndrome, such as Crohn's disease, avoiding smoking, maintaining a healthy diet, and working with a healthcare provider to manage the condition effectively.""]","[""Prevent SBS by maintaining good hygiene practices, avoiding sharing personal items, and getting vaccinated against diseases that can lead to SBS.""]",[false],[true],[false],"[""To prevent SBS, never shake a baby, always support the baby's head and neck, and seek help if feeling overwhelmed.""]","[""Preventing Short Bowel Syndrome involves early treatment of conditions that can lead to the syndrome, such as Crohn's disease, avoiding smoking, maintaining a healthy diet, and working with a healthcare provider to manage the condition effectively.""]","[""Prevent SBS by maintaining good hygiene practices, avoiding sharing personal items, and getting vaccinated against diseases that can lead to SBS.""]"
genetic changes,What are the genetic changes related to methylmalonic acidemia with homocystinuria ?,"Methylmalonic acidemia with homocystinuria can be caused by mutations in one of several genes: MMACHC, MMADHC, LMBRD1, ABCD4, or HCFC1. Mutations in these genes account for the different types of the disorder, which are known as complementation groups: cblC, cblD, cblF, cblJ, and cblX, respectively.  Each of the above-mentioned genes is involved in the processing of vitamin B12, also known as cobalamin or Cbl. Processing of the vitamin converts it to one of two molecules, adenosylcobalamin (AdoCbl) or methylcobalamin (MeCbl). AdoCbl is required for the normal function of an enzyme that helps break down certain amino acids, lipids, and cholesterol. AdoCbl is called a cofactor because it helps the enzyme carry out its function. MeCbl is also a cofactor, but for another enzyme that converts the amino acid homocysteine to another amino acid, methionine. The body uses methionine to make proteins and other important compounds.  Mutations in the MMACHC, MMADHC, LMBRD1, ABCD4, or HCFC1 gene affect early steps of vitamin B12 processing, resulting in a shortage of both AdoCbl and MeCbl. Without AdoCbl, proteins and lipids are not broken down properly. This defect allows potentially toxic compounds to build up in the body's organs and tissues, causing methylmalonic acidemia. Without MeCbl, homocysteine is not converted to methionine. As a result, homocysteine builds up in the bloodstream and methionine is depleted. Some of the excess homocysteine is excreted in urine (homocystinuria). Researchers have not determined how altered levels of homocysteine and methionine lead to the health problems associated with homocystinuria.  Mutations in other genes involved in vitamin B12 processing can cause related conditions. Those mutations that impair only AdoCbl production lead to methylmalonic acidemia, and those that impair only MeCbl production cause homocystinuria.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""MMA"", ""full_form"": ""methylmalonic acidemia""}, {""ambiguity_type"": ""full_form"", ""abbreviation"": ""HCY"", ""full_form"": ""homocystinuria""}]}",What are the genetic changes related to MMA with HCY ?,What are the genetic changes related to methylmalonic acidemia with homocystinuria ?,8,MEDICAL,Compound Datatype-List/Array,"Exploratory(Divergent Thinking): Queries that are inherently about seeking new areas of knowledge, understanding emerging trends, or identifying unknown opportunities without a specific end goal of making a decision or judgment. Exploratory queries are characterized by their openness and the lack of a predefined objective, differentiating them from evaluative queries which are directed towards forming a judgment or assessment. Exploratory queries encourage branching out into various directions to explore a wide array of possibilities without necessarily aiming to converge on a single answer or outcome.","[[""Mixed Martial Arts"", ""Medicare Modernization Act"", ""Municipal Mortgage & Equity, LLC"", ""Metropolitan Museum of Art"", ""MIDI Manufacturers Association"", ""Money Market Account"", ""Manual Metal Arc"", ""Marketing Management Analytics"", ""Modern Martial Arts"", ""Mennonite Mutual Aid""], [""Healthy Children and Youth"", ""How Could You?"", ""Hunterdon County YMCA"", ""homocysteinuria"", ""Healthy Children and Youth Administrative Case Management Program (Missouri)"", ""Homocysteine"", ""Henry County YMCA (various locations)"", ""Hunterdon County YMCA (Flemington, NJ)"", ""Hunterdon County YMCA (Flemington, NJ)"", ""Henry County YMCA (various locations)"", ""Healthy Children and Youth Administrative Case Management Program (Missouri)"", ""Homocysteine""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""], [""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY""]]","[""Methylmalonic Acidemia with Homocystinuria"", ""Homocysteine""]","[5.3957270948194624e-15, 5.41268868539126e-10]","[1.2488648817584885e-25, 9.223860308884954e-06]","[""Mixed Martial Arts"", ""Homocysteine""]","[2.039677637266265e-12, 9.223860308884954e-06]","[""ABBREVIATIONS"", ""ACRONYMFINDER""]","[[2.039677637266265e-12, 6.839798831867434e-23, 2.044924444451716e-31, 1.0075585685018152e-17, 1.6125465018558257e-17, 2.9691845437507936e-15, 1.8112047479859678e-15, 3.820359419001372e-19, 1.0190995722625426e-15, 6.440430357095594e-21], [1.7204173808391534e-14, 2.9084252615242303e-12, 2.3913634726629482e-27, 9.876842273488996e-09, 9.031653886945784e-43, 9.223860308884954e-06, 1.4198679885413463e-33, 2.0224191679965412e-46, 2.0224191679965412e-46, 1.4198679885413463e-33, 9.031653886945784e-43, 9.223860308884954e-06]]","[0.9557064688183303, 0.9430882201882833]","[0.946583091644188, 0.9728804134081555]","[""Mennonite Mutual Aid"", ""Healthy Children and Youth Administrative Case Management Program (Missouri)""]","[0.946583091644188, 0.9728804134081559]","[""LLM"", ""ACRONYMFINDER""]","[[0.8922714091209919, 0.8454395116532577, 0.9011979147029521, 0.934323395942287, 0.8938256506377652, 0.8980417121037884, 0.9166625206154972, 0.8991170917391039, 0.8843635423679082, 0.886034404063953], [0.8829494601331003, 0.9295039531369492, 0.8855250871274747, 0.9600360968061108, 0.8206397274528825, 0.9728804134081559, 0.8862846258533975, 0.8718766494489447, 0.8718766494489447, 0.8862846258533975, 0.8206397274528825, 0.9728804134081555]]","[""Methylmalonic Acidemia with Homocystinuria"", ""Homocysteine""]","[""LLM"", ""ACRONYMFINDER""]",What are the genetic changes related to MMA with HCY (Homocysteine) ?,"[false, false]","[true, true]","[false, false]","[""Genetic changes related to MMA with HCY include mutations in genes such as MTHFR, MTR, and MMACHC."", ""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MTR, MTRR, and CBS.""]","[""Mutations in the MMACHC gene are associated with methylmalonic acidemia with homocystinuria."", ""Mutations in the MMACHC gene are associated with methylmalonic acidemia with homocystinuria.""]","[""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MMADHC, MTR, MTRR, and CBS."", ""Mutations in the MMACHC, MMADHC, LMBRD1, and MTRR genes are related to MMA with HCY.""]","[false, false]","[true, true]","[false, false]","[""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MMAA, MMAB, and MUT."", ""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MTR, MTRR, and CBS.""]","[""Mutations in the MMACHC gene are associated with methylmalonic acidemia with homocystinuria."", ""Mutations in the MMACHC gene are associated with methylmalonic acidemia with homocystinuria.""]","[""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MTR, MTRR, and CBS."", ""Mutations in genes related to MMA with HCY include MMACHC, MMADHC, MTR, MTRR, and CBS.""]","[false, false]","[true, true]","[false, false]","[""Genetic changes related to MMA with HCY include mutations in genes encoding enzymes involved in homocysteine metabolism, such as MTHFR, CBS, and MTRR."", ""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MTR, MTRR, and CBS.""]","[""Mutations in the MMACHC gene"", ""Mutations in the MMACHC gene are associated with methylmalonic acidemia with homocystinuria.""]","[""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MTR, MTRR, and CBS."", ""Mutations in genes MMACHC, MMADHC, MTR, MTRR, and CBS are related to MMA with HCY.""]","[false, false]","[true, true]","[false, false]","[""Genetic changes related to MMA with HCY include mutations in genes such as MTHFR, MTR, and CBS."", ""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MTR, MTRR, and CBS.""]","[""Mutations in the MMACHC gene"", ""Genetic changes related to methylmalonic acidemia with homocystinuria include mutations in the MMACHC gene.""]","[""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MMADHC, MTR, MTRR, and CBS."", ""Mutations in the MMACHC, MMADHC, MTR, MTRR, and CBS genes are associated with MMA with HCY.""]","[true, false]","[true, true]","[false, false]","[""Genetic changes related to MMA with HCY include mutations in the MMACHC gene leading to methylmalonic acidemia and homocystinuria."", ""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MMADHC, and MTRR.""]","[""Mutations in the MMACHC gene are associated with methylmalonic acidemia with homocystinuria."", ""Mutations in the MMACHC gene are associated with methylmalonic acidemia with homocystinuria.""]","[""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MMADHC, MTR, MTRR, and CBS."", ""Mutations in the MMACHC, MMADHC, LMBRD1, and MTRR genes are related to MMA with HCY.""]","[true, false]","[true, true]","[false, false]","[""Genetic changes related to MMA with HCY include mutations in the MMACHC gene leading to methylmalonic acidemia and homocystinuria."", ""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MMADHC, and MTRR.""]","[""Mutations in the MMACHC gene are associated with methylmalonic acidemia with homocystinuria."", ""Mutations in the MMACHC gene are associated with methylmalonic acidemia with homocystinuria.""]","[""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MTR, MTRR, and CBS."", ""Mutations in genes related to MMA with HCY include MMACHC, MMADHC, MTR, MTRR, and CBS.""]","[true, false]","[true, true]","[false, false]","[""Genetic changes related to MMA with HCY include mutations in the MMACHC gene leading to methylmalonic acidemia and homocystinuria."", ""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MMAA, MMAB, MMADHC, and MTRR.""]","[""Mutations in the MMACHC gene"", ""Mutations in the MMACHC gene are associated with methylmalonic acidemia with homocystinuria.""]","[""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MTR, MTRR, and CBS."", ""Mutations in genes MMACHC, MMADHC, MTR, MTRR, and CBS are related to MMA with HCY.""]","[false, false]","[true, true]","[false, false]","[""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MMADHC, and MTRR."", ""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MMAA, MMAB, MMADHC, and MCEE.""]","[""Mutations in the MMACHC gene"", ""Genetic changes related to methylmalonic acidemia with homocystinuria include mutations in the MMACHC gene.""]","[""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MMADHC, MTR, MTRR, and CBS."", ""Mutations in the MMACHC, MMADHC, MTR, MTRR, and CBS genes are associated with MMA with HCY.""]","[true, false]","[true, true]","[false, false]","[""Genetic changes related to MMA with HCY include mutations in the MMACHC gene, leading to impaired function of the enzyme involved in vitamin B12 metabolism."", ""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MTR, MTRR, and CBS.""]","[""Mutations in the MMACHC gene are associated with methylmalonic acidemia with homocystinuria."", ""Mutations in the MMACHC gene are associated with methylmalonic acidemia with homocystinuria.""]","[""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MTR, MTRR, and CBS."", ""Mutations in genes related to MMA with HCY include MMACHC, MMADHC, MTR, MTRR, and CBS.""]","[true, false]","[true, true]","[false, false]","[""Genetic changes related to MMA with HCY include mutations in the MMACHC gene."", ""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MTR, MTRR, and CBS.""]","[""Mutations in the MMACHC gene are associated with methylmalonic acidemia with homocystinuria."", ""Mutations in the MMACHC gene are associated with methylmalonic acidemia with homocystinuria.""]","[""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MMADHC, MTR, MTRR, and CBS."", ""Mutations in the MMACHC, MMADHC, LMBRD1, and MTRR genes are related to MMA with HCY.""]","[true, false]","[true, true]","[false, false]","[""Genetic changes related to MMA with HCY include mutations in the MMACHC gene leading to impaired function of the enzyme involved in vitamin B12 metabolism."", ""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MTR, MTRR, and CBS.""]","[""Mutations in the MMACHC gene"", ""Mutations in the MMACHC gene are associated with methylmalonic acidemia with homocystinuria.""]","[""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MTR, MTRR, and CBS."", ""Mutations in genes MMACHC, MMADHC, MTR, MTRR, and CBS are related to MMA with HCY.""]","[false, false]","[false, true]","[false, false]","[""Genetic changes related to MMA with HCY include mutations in the MMACHC gene."", ""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MTR, MTRR, and CBS.""]","[""Mutations in the MMACHC gene"", ""Genetic changes related to methylmalonic acidemia with homocystinuria include mutations in the MMACHC gene.""]","[""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MMADHC, MTR, MTRR, and CBS."", ""Mutations in the MMACHC, MMADHC, MTR, MTRR, and CBS genes are associated with MMA with HCY.""]","[true, false]","[true, true]","[false, false]","[""Genetic changes related to MMA with HCY include mutations in the MMACHC gene."", ""Genetic changes related to MMA with HCY include mutations in the MMACHC, MTR, MTRR, and CBS genes.""]","[""Mutations in the MMACHC gene are associated with methylmalonic acidemia with homocystinuria."", ""Mutations in the MMACHC gene are associated with methylmalonic acidemia with homocystinuria.""]","[""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MMADHC, MTR, MTRR, and CBS."", ""Mutations in the MMACHC, MMADHC, LMBRD1, and MTRR genes are related to MMA with HCY.""]","[true, false]","[true, true]","[false, false]","[""Genetic changes related to MMA with HCY include mutations in the MMACHC gene."", ""Genetic changes related to MMA with HCY include mutations in the MMACHC, MTHFR, MTR, MTRR, and CBS genes.""]","[""Mutations in the MMACHC gene are associated with methylmalonic acidemia with homocystinuria."", ""Mutations in the MMACHC gene are associated with methylmalonic acidemia with homocystinuria.""]","[""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MTR, MTRR, and CBS."", ""Mutations in genes related to MMA with HCY include MMACHC, MMADHC, MTR, MTRR, and CBS.""]","[true, false]","[true, true]","[false, false]","[""Genetic changes related to MMA with HCY include mutations in the MMACHC gene."", ""Genetic changes related to MMA with HCY include mutations in the MMACHC, MTR, MTRR, and CBS genes.""]","[""Mutations in the MMACHC gene"", ""Mutations in the MMACHC gene are associated with methylmalonic acidemia with homocystinuria.""]","[""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MTR, MTRR, and CBS."", ""Mutations in genes MMACHC, MMADHC, MTR, MTRR, and CBS are related to MMA with HCY.""]","[true, false]","[true, true]","[false, false]","[""Genetic changes related to MMA with HCY include mutations in the MMACHC gene."", ""Genetic changes related to MMA with HCY include mutations in the MMACHC, MTR, MTRR, and CBS genes.""]","[""Mutations in the MMACHC gene"", ""Genetic changes related to methylmalonic acidemia with homocystinuria include mutations in the MMACHC gene.""]","[""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MMADHC, MTR, MTRR, and CBS."", ""Mutations in the MMACHC, MMADHC, MTR, MTRR, and CBS genes are associated with MMA with HCY.""]","[false, false]","[true, true]","[false, false]","[""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MUT, MCM6, and others."", ""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MTR, MTRR, and CBS.""]","[""Mutations in the MMACHC gene are associated with methylmalonic acidemia with homocystinuria."", ""Mutations in the MMACHC gene are associated with methylmalonic acidemia with homocystinuria.""]","[""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MMADHC, MTR, MTRR, and CBS."", ""Mutations in the MMACHC, MMADHC, LMBRD1, and MTRR genes are related to MMA with HCY.""]","[true, false]","[true, true]","[false, false]","[""Genetic changes related to MMA with HCY include mutations in the MMACHC gene."", ""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MTR, MTRR, and CBS.""]","[""Mutations in the MMACHC gene are associated with methylmalonic acidemia with homocystinuria."", ""Mutations in the MMACHC gene are associated with methylmalonic acidemia with homocystinuria.""]","[""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MTR, MTRR, and CBS."", ""Mutations in genes related to MMA with HCY include MMACHC, MMADHC, MTR, MTRR, and CBS.""]","[true, false]","[true, true]","[false, false]","[""Genetic changes related to MMA with HCY include mutations in the MMACHC gene."", ""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MTR, MTRR, and CBS.""]","[""Mutations in the MMACHC gene"", ""Mutations in the MMACHC gene are associated with methylmalonic acidemia with homocystinuria.""]","[""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MTR, MTRR, and CBS."", ""Mutations in genes MMACHC, MMADHC, MTR, MTRR, and CBS are related to MMA with HCY.""]","[true, false]","[true, true]","[false, false]","[""Genetic changes related to MMA with HCY include mutations in the MMACHC gene."", ""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MTR, MTRR, and CBS.""]","[""Mutations in the MMACHC gene"", ""Genetic changes related to methylmalonic acidemia with homocystinuria include mutations in the MMACHC gene.""]","[""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MMADHC, MTR, MTRR, and CBS."", ""Mutations in the MMACHC, MMADHC, MTR, MTRR, and CBS genes are associated with MMA with HCY.""]","[true, false]","[true, true]","[false, false]","[""Genetic changes related to MMA with HCY include mutations in the MMACHC gene, which is involved in the intracellular metabolism of cobalamin (vitamin B12). These mutations lead to impaired conversion of methylmalonyl-CoA to succinyl-CoA, resulting in the accumulation of methylmalonic acid and homocysteine in the body."", ""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MTR, MTRR, and CBS.""]","[""Mutations in the MMACHC gene are associated with methylmalonic acidemia with homocystinuria."", ""Mutations in the MMACHC gene are associated with methylmalonic acidemia with homocystinuria.""]","[""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MMADHC, MTR, MTRR, and CBS."", ""Mutations in the MMACHC, MMADHC, LMBRD1, and MTRR genes are related to MMA with HCY.""]","[true, false]","[true, true]","[false, false]","[""Genetic changes related to MMA with HCY include mutations in the MMACHC gene."", ""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MTR, MTRR, and CBS.""]","[""Mutations in the MMACHC gene are associated with methylmalonic acidemia with homocystinuria."", ""Mutations in the MMACHC gene are associated with methylmalonic acidemia with homocystinuria.""]","[""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MTR, MTRR, and CBS."", ""Mutations in genes related to MMA with HCY include MMACHC, MMADHC, MTR, MTRR, and CBS.""]","[true, false]","[true, true]","[false, false]","[""Genetic changes related to MMA with HCY include mutations in the MMACHC gene."", ""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MTR, MTRR, and CBS.""]","[""Mutations in the MMACHC gene"", ""Mutations in the MMACHC gene are associated with methylmalonic acidemia with homocystinuria.""]","[""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MTR, MTRR, and CBS."", ""Mutations in genes MMACHC, MMADHC, MTR, MTRR, and CBS are related to MMA with HCY.""]","[true, false]","[true, true]","[false, false]","[""Genetic changes related to MMA with HCY include mutations in the MMACHC gene."", ""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MTR, MTRR, and CBS.""]","[""Mutations in the MMACHC gene"", ""Genetic changes related to methylmalonic acidemia with homocystinuria include mutations in the MMACHC gene.""]","[""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MMADHC, MTR, MTRR, and CBS."", ""Mutations in the MMACHC, MMADHC, MTR, MTRR, and CBS genes are associated with MMA with HCY.""]","[false, false]","[true, true]","[false, false]","[""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MUT, MCEE, and others."", ""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MTR, MTRR, and CBS.""]","[""Mutations in the MMACHC gene are associated with methylmalonic acidemia with homocystinuria."", ""Mutations in the MMACHC gene are associated with methylmalonic acidemia with homocystinuria.""]","[""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MMADHC, MTR, MTRR, and CBS."", ""Mutations in the MMACHC, MMADHC, LMBRD1, and MTRR genes are related to MMA with HCY.""]","[false, false]","[true, true]","[false, false]","[""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MUT, MMAA, MMADHC, and MCEE."", ""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MTR, MTRR, and CBS.""]","[""Mutations in the MMACHC gene are associated with methylmalonic acidemia with homocystinuria."", ""Mutations in the MMACHC gene are associated with methylmalonic acidemia with homocystinuria.""]","[""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MTR, MTRR, and CBS."", ""Mutations in genes related to MMA with HCY include MMACHC, MMADHC, MTR, MTRR, and CBS.""]","[true, false]","[true, true]","[false, false]","[""Genetic changes related to MMA with HCY include mutations in the MMACHC gene."", ""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MTR, MTRR, and CBS.""]","[""Mutations in the MMACHC gene"", ""Mutations in the MMACHC gene are associated with methylmalonic acidemia with homocystinuria.""]","[""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MTR, MTRR, and CBS."", ""Mutations in genes MMACHC, MMADHC, MTR, MTRR, and CBS are related to MMA with HCY.""]","[true, false]","[true, true]","[false, false]","[""Genetic changes related to MMA with HCY include mutations in the MMACHC gene."", ""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MTR, MTRR, and CBS.""]","[""Mutations in the MMACHC gene"", ""Genetic changes related to methylmalonic acidemia with homocystinuria include mutations in the MMACHC gene.""]","[""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MMADHC, MTR, MTRR, and CBS."", ""Mutations in the MMACHC, MMADHC, MTR, MTRR, and CBS genes are associated with MMA with HCY.""]","[true, false]","[true, true]","[false, false]","[""Genetic changes related to MMA with HCY include mutations in the MMACHC gene."", ""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MTR, MTRR, and CBS.""]","[""Mutations in the MMACHC gene are associated with methylmalonic acidemia with homocystinuria."", ""Mutations in the MMACHC gene are associated with methylmalonic acidemia with homocystinuria.""]","[""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MMADHC, MTR, MTRR, and CBS."", ""Mutations in the MMACHC, MMADHC, LMBRD1, and MTRR genes are related to MMA with HCY.""]","[false, false]","[true, true]","[false, false]","[""Genetic changes related to MMA with HCY have not been extensively studied."", ""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MTR, MTRR, and CBS.""]","[""Mutations in the MMACHC gene are associated with methylmalonic acidemia with homocystinuria."", ""Mutations in the MMACHC gene are associated with methylmalonic acidemia with homocystinuria.""]","[""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MMADHC, MTR, MTRR, and CBS."", ""Mutations in the MMACHC, MMADHC, LMBRD1, and MTRR genes are related to MMA with HCY.""]","[true, false]","[true, true]","[false, false]","[""Genetic changes related to MMA with HCY are mutations in the MMACHC gene."", ""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MMADHC, and MTRR.""]","[""Mutations in the MMACHC gene are associated with methylmalonic acidemia with homocystinuria."", ""Mutations in the MMACHC gene are associated with methylmalonic acidemia with homocystinuria.""]","[""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MMADHC, MTR, MTRR, and CBS."", ""Mutations in the MMACHC, MMADHC, LMBRD1, and MTRR genes are related to MMA with HCY.""]","[true, false]","[true, true]","[false, false]","[""Genetic changes related to MMA with HCY include mutations in the MMACHC gene."", ""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MTR, MTRR, and CBS.""]","[""Mutations in the MMACHC gene are associated with methylmalonic acidemia with homocystinuria."", ""Mutations in the MMACHC gene are associated with methylmalonic acidemia with homocystinuria.""]","[""Genetic changes related to MMA with HCY include mutations in genes such as MMACHC, MMADHC, MTR, MTRR, and CBS."", ""Mutations in the MMACHC, MMADHC, LMBRD1, and MTRR genes are related to MMA with HCY.""]"
treatment,What are the treatments for Lenz microphthalmia syndrome ?,These resources address the diagnosis or management of Lenz microphthalmia syndrome:  - Gene Review: Gene Review: Lenz Microphthalmia Syndrome  - Genetic Testing Registry: Lenz microphthalmia syndrome   These resources from MedlinePlus offer information about the diagnosis and management of various health conditions:  - Diagnostic Tests  - Drug Therapy  - Surgery and Rehabilitation  - Genetic Counseling   - Palliative Care,"{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""LM"", ""full_form"": ""Lenz microphthalmia syndrome""}]}",What are the treatments for LM ?,What are the treatments for Lenz microphthalmia syndrome ?,8,MEDICAL,Compound Datatype-List/Array,"Exploratory(Divergent Thinking): Queries that are inherently about seeking new areas of knowledge, understanding emerging trends, or identifying unknown opportunities without a specific end goal of making a decision or judgment. Exploratory queries are characterized by their openness and the lack of a predefined objective, differentiating them from evaluative queries which are directed towards forming a judgment or assessment. Exploratory queries encourage branching out into various directions to explore a wide array of possibilities without necessarily aiming to converge on a single answer or outcome.","[[""Legion of Merit"", ""Light Microscopy"", ""Linear Model"", ""Lockheed Martin"", ""Le Mans"", ""Last Month"", ""Low Mass"", ""Last Minute"", ""Lagrange Multiplier"", ""Legg Mason, Inc.""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Lymphatic Malformation""]",[5.906388569000916e-23],[2.6838983427619315e-09],"[""Last Month""]",[3.360981838405836e-05],"[""ABBREVIATIONS""]","[[4.13168634616614e-16, 3.892369820601084e-12, 1.7342233526226877e-10, 1.321180304003635e-25, 3.4364519529785776e-10, 3.360981838405836e-05, 9.171609920530166e-08, 2.15852503946615e-08, 1.8076922666809665e-22, 2.1046737790396185e-24]]",[0.6615145640877248],[0.7640999020869659],"[""Le Mans""]",[0.86463195737183],"[""ABBREVIATIONS""]","[[0.7722015113180771, 0.7955635013032416, 0.8229296896357898, 0.862884060880774, 0.8604997601062945, 0.86463195737183, 0.8115668654481777, 0.8269987156501462, 0.6850500602382847, 0.7159242898925693]]","[""Lymphatic Malformation""]","[""LLM""]",What are the treatments for LM (Lymphatic Malformation) ?,[false],[true],[false],"[""The treatments for LM (Last Month) can include medication adjustments, therapy sessions, lifestyle changes, and monitoring symptoms closely.""]","[""There is no specific treatment for Lenz microphthalmia syndrome. Management involves addressing the symptoms and complications that arise, such as vision problems and developmental delays.""]","[""The treatments for LM include surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy, and clinical trials.""]",[false],[true],[false],"[""The treatments for LM (Last Month) can vary depending on the specific condition being referred to. It is recommended to consult with a healthcare professional for accurate diagnosis and treatment options.""]","[""There is no specific treatment for Lenz microphthalmia syndrome. Management involves addressing the symptoms and complications that arise, such as vision problems and developmental delays.""]","[""Surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy""]",[false],[true],[false],"[""The treatments for LM (Last Month) depend on the specific condition being treated. It is recommended to consult a healthcare professional for personalized treatment options.""]","[""There is no specific treatment for Lenz microphthalmia syndrome. Management involves addressing the symptoms and complications that arise.""]","[""Surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy""]",[false],[true],[false],"[""The treatments for LM (Last Month) can vary depending on the specific condition being treated. It is recommended to consult a healthcare professional for personalized treatment options.""]","[""Treatment for Lenz microphthalmia syndrome may include surgical interventions to correct eye abnormalities, vision therapy, genetic counseling, and supportive care to manage associated symptoms.""]","[""Surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy""]",[false],[true],[false],"[""Surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy""]","[""There is no specific treatment for Lenz microphthalmia syndrome. Management involves addressing the symptoms and complications that arise, such as vision problems and developmental delays.""]","[""The treatments for LM include surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy, and clinical trials.""]",[false],[true],[false],"[""The treatments for LM (Le Mans) include chemotherapy, radiation therapy, surgery, targeted therapy, immunotherapy, and palliative care.""]","[""There is no specific treatment for Lenz microphthalmia syndrome. Management involves addressing the symptoms and complications that arise, such as vision problems and developmental delays.""]","[""Surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy""]",[false],[true],[false],"[""The treatments for LM (Le Mans) include chemotherapy, radiation therapy, surgery, targeted therapy, immunotherapy, and clinical trials.""]","[""There is no specific treatment for Lenz microphthalmia syndrome. Management involves addressing the symptoms and complications that arise.""]","[""Surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy""]",[false],[true],[false],"[""The treatments for LM (Le Mans) include chemotherapy, radiation therapy, surgery, targeted therapy, immunotherapy, and clinical trials.""]","[""Treatment for Lenz microphthalmia syndrome may include surgical interventions to correct eye abnormalities, vision therapy, genetic counseling, and supportive care to manage associated symptoms.""]","[""Surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy""]",[false],[true],[false],"[""Surgery, sclerotherapy, laser therapy, and medication are common treatments for Lymphatic Malformation (LM).""]","[""There is no specific treatment for Lenz microphthalmia syndrome. Management involves addressing the symptoms and complications that arise, such as vision problems and developmental delays.""]","[""Surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy""]",[false],[true],[false],"[""Surgery, Sclerotherapy, Laser therapy, Medications""]","[""There is no specific treatment for Lenz microphthalmia syndrome. Management involves addressing the symptoms and complications that arise, such as vision problems and developmental delays.""]","[""The treatments for LM include surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy, and clinical trials.""]",[false],[true],[false],"[""Surgery, sclerotherapy, laser therapy, and medication are common treatments for Lymphatic Malformation (LM).""]","[""There is no specific treatment for Lenz microphthalmia syndrome. Management involves addressing the symptoms and complications that arise.""]","[""Surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy""]",[false],[true],[false],"[""Surgery, sclerotherapy, laser therapy, and medication are common treatments for Lymphatic Malformation (LM).""]","[""Treatment for Lenz microphthalmia syndrome may include surgical interventions to correct eye abnormalities, vision therapy, genetic counseling, and supportive care to manage associated symptoms.""]","[""Surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy""]",[false],[true],[false],"[""Surgery, sclerotherapy, laser therapy, and medication are common treatments for Lymphatic Malformation (LM).""]","[""There is no specific treatment for Lenz microphthalmia syndrome. Management involves addressing the symptoms and complications that arise, such as vision problems and developmental delays.""]","[""The treatments for LM include surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy, and clinical trials.""]",[false],[true],[false],"[""Surgery, sclerotherapy, laser therapy, and medication are common treatments for Lymphatic Malformation (LM).""]","[""There is no specific treatment for Lenz microphthalmia syndrome. Management involves addressing the symptoms and complications that arise, such as vision problems and developmental delays.""]","[""Surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy""]",[false],[true],[false],"[""Surgery, sclerotherapy, laser therapy, and medication""]","[""There is no specific treatment for Lenz microphthalmia syndrome. Management involves addressing the symptoms and complications that arise.""]","[""Surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy""]",[false],[true],[false],"[""Surgery, sclerotherapy, laser therapy, and medication are common treatments for Lymphatic Malformation (LM).""]","[""Treatment for Lenz microphthalmia syndrome may include surgical interventions to correct eye abnormalities, vision therapy, genetic counseling, and supportive care to manage associated symptoms.""]","[""Surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy""]",[false],[true],[false],"[""Surgery, sclerotherapy, laser therapy, and medication are common treatments for Lymphatic Malformation (LM).""]","[""There is no specific treatment for Lenz microphthalmia syndrome. Management involves addressing the symptoms and complications that arise, such as vision problems and developmental delays.""]","[""The treatments for LM include surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy, and clinical trials.""]",[false],[true],[false],"[""Surgery, sclerotherapy, laser therapy, and medication are common treatments for Lymphatic Malformation (LM).""]","[""There is no specific treatment for Lenz microphthalmia syndrome. Management involves addressing the symptoms and complications that arise, such as vision problems and developmental delays.""]","[""Surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy""]",[false],[true],[false],"[""Surgical excision, sclerotherapy, laser therapy, and medication are common treatments for Lymphatic Malformation (LM).""]","[""There is no specific treatment for Lenz microphthalmia syndrome. Management involves addressing the symptoms and complications that arise.""]","[""Surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy""]",[false],[true],[false],"[""Sclerotherapy, surgery, laser therapy, and medication are common treatments for Lymphatic Malformation (LM).""]","[""Treatment for Lenz microphthalmia syndrome may include surgical interventions to correct eye abnormalities, vision therapy, genetic counseling, and supportive care to manage associated symptoms.""]","[""Surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy""]",[false],[true],[false],"[""Surgical excision, sclerotherapy, laser therapy, and medication are common treatments for Lymphatic Malformation (LM).""]","[""There is no specific treatment for Lenz microphthalmia syndrome. Management involves addressing the symptoms and complications that arise, such as vision problems and developmental delays.""]","[""The treatments for LM include surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy, and clinical trials.""]",[false],[true],[false],"[""Surgery, sclerotherapy, laser therapy, and medication are common treatments for Lymphatic Malformation (LM).""]","[""There is no specific treatment for Lenz microphthalmia syndrome. Management involves addressing the symptoms and complications that arise, such as vision problems and developmental delays.""]","[""Surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy""]",[false],[true],[false],"[""Surgery, sclerotherapy, laser therapy, and medication are common treatments for Lymphatic Malformation (LM).""]","[""There is no specific treatment for Lenz microphthalmia syndrome. Management involves addressing the symptoms and complications that arise.""]","[""Surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy""]",[false],[true],[false],"[""Surgery, sclerotherapy, laser therapy, and medication are common treatments for Lymphatic Malformation (LM).""]","[""Treatment for Lenz microphthalmia syndrome may include surgical interventions to correct eye abnormalities, vision therapy, genetic counseling, and supportive care to manage associated symptoms.""]","[""Surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy""]",[false],[true],[false],"[""Surgery, sclerotherapy, laser therapy, and medication are common treatments for Lymphatic Malformation (LM).""]","[""There is no specific treatment for Lenz microphthalmia syndrome. Management involves addressing the symptoms and complications that arise, such as vision problems and developmental delays.""]","[""The treatments for LM include surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy, and clinical trials.""]",[false],[true],[false],"[""Surgery, sclerotherapy, laser therapy, and medication are common treatments for Lymphatic Malformation (LM).""]","[""There is no specific treatment for Lenz microphthalmia syndrome. Management involves addressing the symptoms and complications that arise, such as vision problems and developmental delays.""]","[""Surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy""]",[false],[true],[false],"[""The treatments for LM (Lymphatic Malformation) may include sclerotherapy, surgery, laser therapy, or medication depending on the severity and location of the malformation.""]","[""There is no specific treatment for Lenz microphthalmia syndrome. Management involves addressing the symptoms and complications that arise.""]","[""Surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy""]",[false],[true],[false],"[""Surgical removal, sclerotherapy, laser therapy, and medication are some of the treatments for Lymphatic Malformation (LM).""]","[""Treatment for Lenz microphthalmia syndrome may include surgical interventions to correct eye abnormalities, vision therapy, genetic counseling, and supportive care to manage associated symptoms.""]","[""Surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy""]",[false],[true],[false],"[""Surgery, sclerotherapy, laser therapy, and medication""]","[""There is no specific treatment for Lenz microphthalmia syndrome. Management involves addressing the symptoms and complications that arise, such as vision problems and developmental delays.""]","[""The treatments for LM include surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy, and clinical trials.""]",[false],[true],[false],"[""The treatments for LM (Last Month) depend on the specific condition being treated. It is recommended to consult with a healthcare professional for personalized treatment options.""]","[""There is no specific treatment for Lenz microphthalmia syndrome. Management involves addressing the symptoms and complications that arise, such as vision problems and developmental delays.""]","[""The treatments for LM include surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy, and clinical trials.""]",[false],[true],[false],"[""The treatments for LM (Le Mans) include chemotherapy, radiation therapy, targeted therapy, and surgery.""]","[""There is no specific treatment for Lenz microphthalmia syndrome. Management involves addressing the symptoms and complications that arise, such as vision problems and developmental delays.""]","[""The treatments for LM include surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy, and clinical trials.""]",[false],[true],[false],"[""Surgery, sclerotherapy, laser therapy, and medication are common treatments for Lymphatic Malformation (LM).""]","[""There is no specific treatment for Lenz microphthalmia syndrome. Management involves addressing the symptoms and complications that arise, such as vision problems and developmental delays.""]","[""The treatments for LM include surgery, radiation therapy, chemotherapy, targeted therapy, immunotherapy, and clinical trials.""]"
frequency,How many people are affected by IgA Nephropathy ?,"IgA nephropathy is one of the most common kidney diseases, other than those caused by diabetes or high blood pressure.1
                
IgA nephropathy can occur at any age, although the first evidence of kidney disease most frequently appears when people are in their teens to late 30s.2 IgA nephropathy in the United States is twice as likely to appear in men than in women.3 While found in people all over the world, IgA nephropathy is more common among Asians and Caucasians.4
                
A person may be more likely to develop IgA nephropathy if
                
- he or she has a family history of IgA nephropathy or Henoch-Schnlein purpuraa disease that causes small blood vessels in the body to become inflamed and leak  - he is a male in his teens to late 30s  - he or she is Asian or Caucasian","{""full_form_abbrv_map"": [{""ambiguity_type"": ""abbreviation"", ""abbreviation"": ""IgA"", ""full_form"": ""Immunoglobulin A""}, {""ambiguity_type"": ""full_form"", ""abbreviation"": ""IgAN"", ""full_form"": ""IgA Nephropathy""}]}",How many people are affected by IgAN ?,How many people are affected by Immunoglobulin A Nephropathy ?,8,MEDICAL,Simple Datatype-Integer,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""ImmunoGlobulins A"", ""International Grappling Association"", ""Independent Grocers Association"", ""Independent Grocers Alliance"", ""Inagua, Bahamas"", ""Independent Grocers of Australia"", ""I Get Attention"", ""International Gateway Academy"", ""In Group Allowed"", ""Instituto Guatemalteco Americano de Cultura""], [""Immunoglobulin A Nephropathy"", ""Industrial Grade Ammonium Nitrate (prilled nitrogen product)"", ""Immunoglobulin A Nephropathy"", ""IGAN"", ""Industrial Grade Ammonium Nitrate (prilled nitrogen product)""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""], [""ACRONYMFINDER"", ""ACRONYMFINDER"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY""]]","[""Immunoglobulin A"", ""Immunoglobulin A Nephropathy""]","[1.0032426045094398e-08, 8.874143539745407e-08]","[1.0032426045094398e-08, 2.5874555476774744e-14]","[""Immunoglobulin A"", ""IGAN""]","[1.0032426045094398e-08, 0.0025053828503385995]","[""LLM"", ""THEFREEDICTIONARY""]","[[2.8002421691014675e-11, 2.804051762535365e-16, 3.061326311155966e-17, 4.168949765282392e-19, 1.998566279315039e-21, 6.6129307618149795e-28, 6.550857005601409e-11, 3.874169923749401e-17, 2.2105652183317309e-13, 1.613626012646289e-40], [2.5874555476774744e-14, 1.9320521827272004e-42, 2.5874555476774744e-14, 0.0025053828503385995, 1.9320521827272004e-42]]","[0.7656721397184192, 0.9531407015694892]","[0.7656824685301686, 0.9528863152539753]","[""Instituto Guatemalteco Americano de Cultura"", ""Immunoglobulin A Nephropathy""]","[0.7656824685301686, 0.9755259809112227]","[""LLM"", ""THEFREEDICTIONARY""]","[[0.7540301657533663, 0.6519083304997002, 0.6356521636731423, 0.6341831986934376, 0.6559443428184227, 0.6712054936044879, 0.7414595568978646, 0.6867806710460876, 0.7616152641133885, 0.6867443165096174], [0.9528863152539753, 0.6384315971181573, 0.9528863152539753, 0.9755259809112227, 0.638431597118157]]","[""ImmunoGlobulins A"", ""Immunoglobulin A Nephropathy""]","[""ABBREVIATIONS"", ""ACRONYMFINDER""]",How many people are affected by IgAN (Immunoglobulin A Nephropathy) ?,"[false, false]","[true, false]","[true, true]","[""Approximately 1 in 400 people are affected by IgA (Immunoglobulin A)N."", ""IgAN affects approximately 1 in 1000 people worldwide.""]","[""1 in every 6,000 to 10,000 people are affected by Immunoglobulin A Nephropathy"", ""Approximately 20-40% of people with IgA nephropathy develop end-stage kidney failure within 20 years of diagnosis.""]","[""2.5 million people worldwide are affected by IgA nephropathy (IgAN)."", ""1 in every 6,000 to 10,000 people worldwide are affected by IgA nephropathy (IgAN).""]","[false, false]","[true, false]","[true, false]","[""1 in 400 people are affected by IgA (Immunoglobulin A)N"", ""IgAN affects approximately 1 in 1000 people worldwide.""]","[""1 in every 6,000 to 10,000 people are affected by Immunoglobulin A Nephropathy"", ""Approximately 1 in 3 people with IgA nephropathy will develop kidney failure within 20-25 years.""]","[""1 in every 6,000 to 10,000 people are affected by IgAN"", ""1 in every 6,000 people are affected by IgAN""]","[false, false]","[false, true]","[false, true]","[""1 in 400 people are affected by IgA (Immunoglobulin A)N."", ""IgAN affects approximately 1 in 1000 people worldwide.""]","[""IgA Nephropathy affects approximately 1 in 500 people worldwide."", ""1 in 6,000 people are affected by Immunoglobulin A Nephropathy""]","[""2.5 million people worldwide are affected by IgA nephropathy (IgAN)."", ""1 in every 6,000 to 10,000 people worldwide are affected by IgA nephropathy (IgAN)""]","[false, true]","[false, true]","[true, true]","[""IgA Nephropathy affects approximately 1 in 600 people worldwide."", ""IgAN affects approximately 1 in every 1000 people worldwide.""]","[""2-3 people per 100,000 are affected by Immunoglobulin A Nephropathy"", ""2-3 million people worldwide are affected by Immunoglobulin A Nephropathy.""]","[""1 in every 6,000 to 8,000 people worldwide are affected by IgA nephropathy (IgAN)"", ""1 in every 6,000 to 10,000 people are affected by IgA nephropathy (IgAN)""]","[false, true]","[true, false]","[false, true]","[""IgA nephropathy affects about 1 in 500 people worldwide."", ""1 in every 6,000 to 10,000 people worldwide are affected by IgA Nephropathy (IgAN)""]","[""1 in every 6,000 to 10,000 people are affected by Immunoglobulin A Nephropathy"", ""Approximately 20-40% of people with IgA nephropathy develop end-stage kidney failure within 20 years of diagnosis.""]","[""2.5 million people worldwide are affected by IgA nephropathy (IgAN)."", ""1 in every 6,000 to 10,000 people worldwide are affected by IgA nephropathy (IgAN).""]","[false, true]","[true, false]","[true, true]","[""IgA nephropathy affects about 1 in 500 people worldwide."", ""1 in every 6,000 to 10,000 people are affected by IgA Nephropathy""]","[""1 in every 6,000 to 10,000 people are affected by Immunoglobulin A Nephropathy"", ""Approximately 1 in 3 people with IgA nephropathy will develop kidney failure within 20-25 years.""]","[""1 in every 6,000 to 10,000 people are affected by IgAN"", ""1 in every 6,000 people are affected by IgAN""]","[true, false]","[true, true]","[false, true]","[""IgA Nephropathy affects approximately 1 in 500 people worldwide."", ""IgAN affects approximately 2-3 people per 100,000 population.""]","[""IgA Nephropathy affects approximately 1 in 500 people worldwide."", ""1 in 6,000 people are affected by Immunoglobulin A Nephropathy""]","[""2.5 million people worldwide are affected by IgA nephropathy (IgAN)."", ""1 in every 6,000 to 10,000 people worldwide are affected by IgA nephropathy (IgAN)""]","[false, true]","[false, true]","[true, true]","[""IgA Nephropathy affects approximately 1 in 500 people worldwide."", ""IgA nephropathy affects about 2-3 people per 100,000 population per year.""]","[""2-3 people per 100,000 are affected by Immunoglobulin A Nephropathy"", ""2-3 million people worldwide are affected by Immunoglobulin A Nephropathy.""]","[""1 in every 6,000 to 8,000 people worldwide are affected by IgA nephropathy (IgAN)"", ""1 in every 6,000 to 10,000 people are affected by IgA nephropathy (IgAN)""]","[false, true]","[true, false]","[true, false]","[""Approximately 1 in 400 people are affected by IgA Nephropathy."", ""IgA nephropathy affects about 2-3 people per 100,000 population per year.""]","[""1 in every 6,000 to 10,000 people are affected by Immunoglobulin A Nephropathy"", ""Approximately 1 in 3 people with IgA nephropathy will develop kidney failure within 20-25 years.""]","[""1 in every 6,000 to 10,000 people are affected by IgAN"", ""1 in every 6,000 people are affected by IgAN""]","[false, true]","[true, false]","[true, true]","[""1 in 400 people are affected by IgA Nephropathy."", ""1 in 6,000 people are affected by IgAN (Immunoglobulin A Nephropathy)""]","[""1 in every 6,000 to 10,000 people are affected by Immunoglobulin A Nephropathy"", ""Approximately 20-40% of people with IgA nephropathy develop end-stage kidney failure within 20 years of diagnosis.""]","[""2.5 million people worldwide are affected by IgA nephropathy (IgAN)."", ""1 in every 6,000 to 10,000 people worldwide are affected by IgA nephropathy (IgAN).""]","[true, true]","[true, true]","[false, true]","[""IgA Nephropathy affects approximately 1 in 500 people worldwide."", ""IgA nephropathy affects about 2-3 people per 100,000 population per year.""]","[""IgA Nephropathy affects approximately 1 in 500 people worldwide."", ""1 in 6,000 people are affected by Immunoglobulin A Nephropathy""]","[""2.5 million people worldwide are affected by IgA nephropathy (IgAN)."", ""1 in every 6,000 to 10,000 people worldwide are affected by IgA nephropathy (IgAN)""]","[false, true]","[true, true]","[true, true]","[""Approximately 1 in 400 people are affected by IgA Nephropathy."", ""IgA nephropathy affects about 2-3 people per 100,000 population per year.""]","[""2-3 people per 100,000 are affected by Immunoglobulin A Nephropathy"", ""2-3 million people worldwide are affected by Immunoglobulin A Nephropathy.""]","[""1 in every 6,000 to 8,000 people worldwide are affected by IgA nephropathy (IgAN)"", ""1 in every 6,000 to 10,000 people are affected by IgA nephropathy (IgAN)""]","[true, false]","[true, true]","[true, true]","[""It is estimated that 1 in 400 people are affected by IgA Nephropathy."", ""Unknown""]","[""1 in every 6,000 to 10,000 people are affected by Immunoglobulin A Nephropathy"", ""Approximately 20-40% of people with IgA nephropathy develop end-stage kidney failure within 20 years of diagnosis.""]","[""2.5 million people worldwide are affected by IgA nephropathy (IgAN)."", ""1 in every 6,000 to 10,000 people worldwide are affected by IgA nephropathy (IgAN).""]","[false, false]","[true, true]","[true, false]","[""Not specified"", ""Unknown""]","[""1 in every 6,000 to 10,000 people are affected by Immunoglobulin A Nephropathy"", ""Approximately 1 in 3 people with IgA nephropathy will develop kidney failure within 20-25 years.""]","[""1 in every 6,000 to 10,000 people are affected by IgAN"", ""1 in every 6,000 people are affected by IgAN""]","[true, true]","[false, true]","[false, true]","[""The exact number of people affected by IgA (ImmunoGlobulins A)N is not specified."", ""Approximately 1 in 6,000 people are affected by IgA Nephropathy.""]","[""IgA Nephropathy affects approximately 1 in 500 people worldwide."", ""1 in 6,000 people are affected by Immunoglobulin A Nephropathy""]","[""2.5 million people worldwide are affected by IgA nephropathy (IgAN)."", ""1 in every 6,000 to 10,000 people worldwide are affected by IgA nephropathy (IgAN)""]","[false, false]","[false, true]","[true, true]","[""The exact number of people affected by IgA N is not specified."", ""IgAN affects approximately 1 in 500 people worldwide.""]","[""2-3 people per 100,000 are affected by Immunoglobulin A Nephropathy"", ""2-3 million people worldwide are affected by Immunoglobulin A Nephropathy.""]","[""1 in every 6,000 to 8,000 people worldwide are affected by IgA nephropathy (IgAN)"", ""1 in every 6,000 to 10,000 people are affected by IgA nephropathy (IgAN)""]","[false, false]","[true, false]","[true, true]","[""The number of people affected by IgA (ImmunoGlobulins A)N is not specified."", ""The number of people affected by IgAN is not precisely known, but it is estimated to affect around 1 in 500 people worldwide.""]","[""1 in every 6,000 to 10,000 people are affected by Immunoglobulin A Nephropathy"", ""Approximately 20-40% of people with IgA nephropathy develop end-stage kidney failure within 20 years of diagnosis.""]","[""2.5 million people worldwide are affected by IgA nephropathy (IgAN)."", ""1 in every 6,000 to 10,000 people worldwide are affected by IgA nephropathy (IgAN).""]","[false, false]","[true, false]","[true, false]","[""IgA Nephropathy affects approximately 1 in 500 people worldwide."", ""IgA Nephropathy affects approximately 1 in every 500 people worldwide.""]","[""1 in every 6,000 to 10,000 people are affected by Immunoglobulin A Nephropathy"", ""Approximately 1 in 3 people with IgA nephropathy will develop kidney failure within 20-25 years.""]","[""1 in every 6,000 to 10,000 people are affected by IgAN"", ""1 in every 6,000 people are affected by IgAN""]","[true, false]","[true, true]","[false, true]","[""IgA nephropathy affects approximately 1 in 500 people worldwide."", ""IgA nephropathy affects about 2-3 people per 100,000 population per year.""]","[""IgA Nephropathy affects approximately 1 in 500 people worldwide."", ""1 in 6,000 people are affected by Immunoglobulin A Nephropathy""]","[""2.5 million people worldwide are affected by IgA nephropathy (IgAN)."", ""1 in every 6,000 to 10,000 people worldwide are affected by IgA nephropathy (IgAN)""]","[false, true]","[false, true]","[true, true]","[""IgA Nephropathy affects approximately 1 in 600 people worldwide."", ""IgA nephropathy affects about 2-3 people per 100,000 population per year.""]","[""2-3 people per 100,000 are affected by Immunoglobulin A Nephropathy"", ""2-3 million people worldwide are affected by Immunoglobulin A Nephropathy.""]","[""1 in every 6,000 to 8,000 people worldwide are affected by IgA nephropathy (IgAN)"", ""1 in every 6,000 to 10,000 people are affected by IgA nephropathy (IgAN)""]","[false, true]","[true, false]","[true, true]","[""Approximately 1 in 400 people are affected by IgA (Immunoglobulin A)N."", ""IgA nephropathy affects about 2-3 people per 100,000 population per year.""]","[""1 in every 6,000 to 10,000 people are affected by Immunoglobulin A Nephropathy"", ""Approximately 20-40% of people with IgA nephropathy develop end-stage kidney failure within 20 years of diagnosis.""]","[""2.5 million people worldwide are affected by IgA nephropathy (IgAN)."", ""1 in every 6,000 to 10,000 people worldwide are affected by IgA nephropathy (IgAN).""]","[false, false]","[true, false]","[true, false]","[""Approximately 1 in 400 people are affected by IgA (Immunoglobulin A)N."", ""Approximately 1 in 5 people with IgAN will develop kidney failure within 20 years of diagnosis.""]","[""1 in every 6,000 to 10,000 people are affected by Immunoglobulin A Nephropathy"", ""Approximately 1 in 3 people with IgA nephropathy will develop kidney failure within 20-25 years.""]","[""1 in every 6,000 to 10,000 people are affected by IgAN"", ""1 in every 6,000 people are affected by IgAN""]","[true, true]","[true, true]","[true, true]","[""Approximately 1 in 400 people are affected by IgA (Immunoglobulin A)N."", ""IgA nephropathy affects about 2-3 people per 100,000 population per year.""]","[""IgA Nephropathy affects approximately 1 in 500 people worldwide."", ""1 in 6,000 people are affected by Immunoglobulin A Nephropathy""]","[""2.5 million people worldwide are affected by IgA nephropathy (IgAN)."", ""1 in every 6,000 to 10,000 people worldwide are affected by IgA nephropathy (IgAN)""]","[false, true]","[false, true]","[true, true]","[""1 in 400 people are affected by IgA (Immunoglobulin A)N."", ""IgA nephropathy affects about 2 to 3 people per 100,000 population per year.""]","[""2-3 people per 100,000 are affected by Immunoglobulin A Nephropathy"", ""2-3 million people worldwide are affected by Immunoglobulin A Nephropathy.""]","[""1 in every 6,000 to 8,000 people worldwide are affected by IgA nephropathy (IgAN)"", ""1 in every 6,000 to 10,000 people are affected by IgA nephropathy (IgAN)""]","[true, false]","[false, false]","[false, true]","[""The exact number of people affected by IgA (ImmunoGlobulins A)N is not readily available."", ""IgAN affects approximately 1 in 500 people worldwide.""]","[""1 in every 6,000 to 10,000 people are affected by Immunoglobulin A Nephropathy"", ""Approximately 20-40% of people with IgA nephropathy develop end-stage kidney failure within 20 years of diagnosis.""]","[""2.5 million people worldwide are affected by IgA nephropathy (IgAN)."", ""1 in every 6,000 to 10,000 people worldwide are affected by IgA nephropathy (IgAN).""]","[false, false]","[true, true]","[true, false]","[""The exact number of people affected by IgA (ImmunoGlobulins A)N is not readily available."", ""IgA nephropathy affects about 1 in 500 people worldwide.""]","[""1 in every 6,000 to 10,000 people are affected by Immunoglobulin A Nephropathy"", ""Approximately 1 in 3 people with IgA nephropathy will develop kidney failure within 20-25 years.""]","[""1 in every 6,000 to 10,000 people are affected by IgAN"", ""1 in every 6,000 people are affected by IgAN""]","[true, false]","[false, true]","[false, true]","[""The exact number of people affected by IgA (ImmunoGlobulins A)N is not readily available."", ""IgAN affects approximately 1 in 500 people worldwide.""]","[""IgA Nephropathy affects approximately 1 in 500 people worldwide."", ""1 in 6,000 people are affected by Immunoglobulin A Nephropathy""]","[""2.5 million people worldwide are affected by IgA nephropathy (IgAN)."", ""1 in every 6,000 to 10,000 people worldwide are affected by IgA nephropathy (IgAN)""]","[false, false]","[true, true]","[true, true]","[""The exact number of people affected by IgA (ImmunoGlobulins A)N is not readily available."", ""IgA Nephropathy affects approximately 1 in 500 people worldwide.""]","[""2-3 people per 100,000 are affected by Immunoglobulin A Nephropathy"", ""2-3 million people worldwide are affected by Immunoglobulin A Nephropathy.""]","[""1 in every 6,000 to 8,000 people worldwide are affected by IgA nephropathy (IgAN)"", ""1 in every 6,000 to 10,000 people are affected by IgA nephropathy (IgAN)""]","[false, true]","[true, false]","[false, true]","[""The number of people affected by IgA (ImmunoGlobulins A)N is not readily available."", ""The exact number of people affected by IgA Nephropathy is not known, but it is considered one of the most common glomerulonephritis worldwide.""]","[""1 in every 6,000 to 10,000 people are affected by Immunoglobulin A Nephropathy"", ""Approximately 20-40% of people with IgA nephropathy develop end-stage kidney failure within 20 years of diagnosis.""]","[""2.5 million people worldwide are affected by IgA nephropathy (IgAN)."", ""1 in every 6,000 to 10,000 people worldwide are affected by IgA nephropathy (IgAN).""]","[true, false]","[false, false]","[false, true]","[""The number of people affected by IgA (Immunoglobulin A)N is not readily available."", ""The number of people affected by IgAN (IgA Nephropathy) is estimated to be around 1 in 500 people worldwide.""]","[""1 in every 6,000 to 10,000 people are affected by Immunoglobulin A Nephropathy"", ""Approximately 20-40% of people with IgA nephropathy develop end-stage kidney failure within 20 years of diagnosis.""]","[""2.5 million people worldwide are affected by IgA nephropathy (IgAN)."", ""1 in every 6,000 to 10,000 people worldwide are affected by IgA nephropathy (IgAN).""]","[false, true]","[true, false]","[true, true]","[""The number of people affected by IgA (Instituto Guatemalteco Americano de Cultura)N is not available."", ""The exact number of people affected by IgA Nephropathy is not known, but it is considered one of the most common glomerulonephritis worldwide.""]","[""1 in every 6,000 to 10,000 people are affected by Immunoglobulin A Nephropathy"", ""Approximately 20-40% of people with IgA nephropathy develop end-stage kidney failure within 20 years of diagnosis.""]","[""2.5 million people worldwide are affected by IgA nephropathy (IgAN)."", ""1 in every 6,000 to 10,000 people worldwide are affected by IgA nephropathy (IgAN).""]","[true, true]","[false, false]","[false, true]","[""The number of people affected by IgA (Immunoglobulin A)N is not readily available."", ""The exact number of people affected by IgA Nephropathy is not known, but it is considered to be one of the most common glomerulonephritis worldwide.""]","[""1 in every 6,000 to 10,000 people are affected by Immunoglobulin A Nephropathy"", ""Approximately 20-40% of people with IgA nephropathy develop end-stage kidney failure within 20 years of diagnosis.""]","[""2.5 million people worldwide are affected by IgA nephropathy (IgAN)."", ""1 in every 6,000 to 10,000 people worldwide are affected by IgA nephropathy (IgAN).""]"
treatment,What are the treatments for Marfan Syndrome ?,"Marfan syndrome has no cure. However, treatments can help delay or prevent complications, especially when started early.
                
Marfan syndrome can affect many parts of your body, including your heart, bones and joints, eyes, nervous system, and lungs. The type of treatment you receive will depend on your signs and symptoms.
                
Heart Treatments
                
Aortic dilation, or aortic aneurysm, is the most common and serious heart problem linked to Marfan syndrome. In this condition, the aortathe main artery that carries oxygen-rich blood to your bodystretches and grows weak.
                
Medicines are used to try to slow the rate of aortic dilation. Surgery is used to replace the dilated segment of aorta before it tears.
                
If you have Marfan syndrome, you'll need routine care and tests to check your heart valves and aorta.
                
Medicines
                
Beta blockers are medicines that help your heart beat slower and with less force. These medicines may help relieve strain on your aorta and slow the rate of aortic dilation.
                
Some people have side effects from beta blockers, such as tiredness and nausea (feeling sick to your stomach). If side effects occur, your doctor may prescribe a calcium channel blocker or ACE inhibitor instead of a beta blocker. Both medicines help relieve stress on the aorta.
                
Studies suggest that blocking a protein called TGF-beta may help prevent some of the effects of Marfan syndrome. Research shows that the medicine losartan may block the protein in other conditions.
                
The National Heart, Lung, and Blood Institute currently is sponsoring a study comparing losartan to a beta blocker in children and adults who have Marfan syndrome. The study's goal is to find out which medicine, if either, is best at slowing the rate of aortic dilation.
                
Surgery
                
If your aorta stretches, it's more likely to tear (a condition called aortic dissection). To prevent this, your doctor may recommend surgery to repair or replace part of your aorta.
                
Surgery may involve:
                
A composite valve graft. For this surgery, part of the aorta and the aortic valve are removed. The aorta is replaced with a man-made tube called a graft. A man-made valve replaces the original valve.
                
Aortic valve-sparing surgery. If your aortic valve is working well, your doctor may recommend valve-sparing surgery. For this surgery, your doctor replaces the enlarged part of your aorta with a graft. Your aortic valve is left in place.
                
After aortic surgery, you may need medicines or followup tests. For example, after a composite valve graft, your doctor will prescribe medicines called anticoagulants, or ""blood thinners.""
                
Blood thinners help prevent blood clots from forming on your man-made aortic valve. You'll need to take these medicines for the rest of your life. If you've had valve-sparing surgery, you'll only need to take blood thinners for a short time, as your doctor prescribes.
                
If you've had a composite valve graft, you're at increased risk for endocarditis (EN-do-kar-DI-tis). This is an infection of the inner lining of your heart chambers and valves. Your doctor may recommend that you take antibiotics before certain medical or dental procedures that increase your risk of endocarditis.
                
Your doctor also may advise you to continue taking beta blockers or other medicines after either type of aortic surgery.
                
After surgery, you may have routine cardiac magnetic resonance imaging (MRI) or cardiac computed tomography (CT) scans to check your aorta.
                
Cardiac MRI is a painless test that uses radio waves and magnets to created detailed pictures of your organs and tissues. Cardiac CT is a painless test that uses an x-ray machine to take clear, detailed pictures of your heart.
                
Bone and Joint Treatments
                
If you have scoliosis (a curved spine), your doctor may suggest a brace or other device to prevent the condition from getting worse. Severe cases of scoliosis may require surgery.
                
Some people who have Marfan syndrome need surgery to repair a chest that sinks in or sticks out. This surgery is done to prevent the chest from pressing on the lungs and heart.
                
Eye Treatments
                
Marfan syndrome can lead to many eye problems, such as a dislocated lens, nearsightedness, early glaucoma (high pressure in the fluid in the eyes), and cataracts (clouding of an eye's lens).
                
Glasses or contact lenses can help with some of these problems. Sometimes surgery is needed.
                
Nervous System Treatments
                
Marfan syndrome can lead to dural ectasia. In this condition, a substance called the dura (which covers the fluid around your brain and spinal cord) stretches and grows weak. This can cause the bones of the spine to wear away. Dural ectasia usually is treated with pain medicines.
                
Lung Treatments
                
Marfan syndrome may cause pneumothorax, or collapsed lung. In this condition, air or gas builds up in the space between the lungs and the chest wall.
                
If the condition is minor, it may go away on its own. However, you may need to have a tube placed through your skin and chest wall to remove the air. Sometimes surgery is needed.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""MS"", ""full_form"": ""Marfan Syndrome""}]}",What are the treatments for MS ?,What are the treatments for Marfan Syndrome ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Microsoft"", ""Microsoft Corporation"", ""MiSsing"", ""Management Systems"", ""Mississippi"", ""Manuscript"", ""Memory Stick"", ""Mass Spectrometry"", ""Multiple sclerosis"", ""Middle School""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Multiple Sclerosis""]",[2.487284609784657e-07],[4.540452263520748e-07],"[""MiSsing""]",[3.4686241256264934e-06],"[""ABBREVIATIONS""]","[[1.4913072957742744e-10, 4.9218622194253856e-18, 3.4686241256264934e-06, 7.824331668426893e-08, 4.426638135387946e-14, 3.0168491230192264e-09, 4.761359343335718e-10, 7.650747746547937e-15, 4.540452263520748e-07, 1.5507631276680408e-08]]",[0.6995464407352493],[0.9439245983570901],"[""Mass Spectrometry""]",[0.945336414230399],"[""ABBREVIATIONS""]","[[0.8346521851574151, 0.8060041468417731, 0.8319956269428229, 0.8343909790881499, 0.7731259988306205, 0.8032312213785496, 0.7524684448107875, 0.7548875921068398, 0.945336414230399, 0.7102249828387632]]","[""Multiple sclerosis""]","[""ABBREVIATIONS""]",What are the treatments for MS (Multiple Sclerosis) ?,[false],[true],[false],"[""Medications, physical therapy, occupational therapy, speech therapy, and lifestyle modifications are common treatments for MS.""]","[""Beta-blockers, angiotensin receptor blockers, and surgery to replace aortic root""]","[""The treatments for MS include disease-modifying therapies, corticosteroids for relapses, physical therapy, and symptom management medications.""]",[false],[true],[false],"[""The treatments for Multiple Sclerosis (MS) include disease-modifying therapies, corticosteroids for relapses, physical therapy, and symptom management medications.""]","[""Beta-blockers, ACE inhibitors, surgery for aortic root replacement""]","[""Some treatments for MS include disease-modifying therapies, corticosteroids, plasma exchange, and physical therapy.""]",[false],[true],[false],"[""Medications, physical therapy, and lifestyle changes are common treatments for multiple sclerosis.""]","[""Beta-blockers, angiotensin receptor blockers, surgery for aortic root replacement""]","[""The treatments for MS include disease-modifying therapies, corticosteroids, plasma exchange, and physical therapy.""]",[false],[true],[false],"[""Medications, physical therapy, occupational therapy, speech therapy, and lifestyle modifications are common treatments for MS.""]","[""Treatment for Marfan Syndrome includes beta-blockers, angiotensin receptor blockers, and surgery to repair aortic aneurysms.""]","[""The treatments for MS include disease-modifying therapies, corticosteroids, plasma exchange, and physical therapy.""]",[false],[true],[false],"[""The treatments for MS (Mass Spectrometry) include immunomodulatory drugs, corticosteroids, plasma exchange, physical therapy, and symptom management medications.""]","[""Beta-blockers, angiotensin receptor blockers, and surgery to replace aortic root""]","[""The treatments for MS include disease-modifying therapies, corticosteroids for relapses, physical therapy, and symptom management medications.""]",[false],[true],[false],"[""The treatments for MS (Mass Spectrometry) include immunomodulatory drugs, corticosteroids, plasma exchange, and physical therapy.""]","[""Beta-blockers, ACE inhibitors, surgery for aortic root replacement""]","[""Some treatments for MS include disease-modifying therapies, corticosteroids, plasma exchange, and physical therapy.""]",[false],[true],[false],"[""The treatments for MS (Mass Spectrometry) include immunomodulatory drugs, corticosteroids, plasma exchange, and physical therapy.""]","[""Beta-blockers, angiotensin receptor blockers, surgery for aortic root replacement""]","[""The treatments for MS include disease-modifying therapies, corticosteroids, plasma exchange, and physical therapy.""]",[false],[true],[false],"[""The treatments for MS (Mass Spectrometry) include immunomodulatory drugs, corticosteroids, plasma exchange, physical therapy, and symptom management.""]","[""Treatment for Marfan Syndrome includes beta-blockers, angiotensin receptor blockers, and surgery to repair aortic aneurysms.""]","[""The treatments for MS include disease-modifying therapies, corticosteroids, plasma exchange, and physical therapy.""]",[false],[true],[false],"[""The treatments for Multiple Sclerosis (MS) include disease-modifying therapies, corticosteroids for relapses, physical therapy, and medications to manage symptoms.""]","[""Beta-blockers, ACE inhibitors, surgery for aortic root replacement""]","[""Some treatments for MS include disease-modifying therapies, corticosteroids, plasma exchange, and physical therapy.""]",[false],[true],[false],"[""The treatments for Multiple Sclerosis (MS) include disease-modifying therapies, corticosteroids for relapses, physical therapy, and symptom management medications.""]","[""Beta-blockers, angiotensin receptor blockers, and surgery to replace aortic root""]","[""The treatments for MS include disease-modifying therapies, corticosteroids for relapses, physical therapy, and symptom management medications.""]",[false],[true],[false],"[""The treatments for MS (Multiple sclerosis) include disease-modifying therapies, corticosteroids for relapses, physical therapy, and symptom management medications.""]","[""Beta-blockers, angiotensin receptor blockers, surgery for aortic root replacement""]","[""The treatments for MS include disease-modifying therapies, corticosteroids, plasma exchange, and physical therapy.""]",[false],[true],[false],"[""The treatments for Multiple Sclerosis (MS) include disease-modifying therapies, corticosteroids for relapses, physical therapy, and medications to manage symptoms.""]","[""Treatment for Marfan Syndrome includes beta-blockers, angiotensin receptor blockers, and surgery to repair aortic aneurysms.""]","[""The treatments for MS include disease-modifying therapies, corticosteroids, plasma exchange, and physical therapy.""]",[false],[true],[false],"[""The treatments for Multiple Sclerosis (MS) include disease-modifying therapies, corticosteroids for relapses, physical therapy, and medications to manage symptoms.""]","[""Beta-blockers, angiotensin receptor blockers, and surgery to replace aortic root""]","[""The treatments for MS include disease-modifying therapies, corticosteroids for relapses, physical therapy, and symptom management medications.""]",[false],[true],[false],"[""The treatments for MS include disease-modifying therapies, corticosteroids for relapses, physical therapy, and symptom management medications.""]","[""Beta-blockers, ACE inhibitors, surgery for aortic root replacement""]","[""Some treatments for MS include disease-modifying therapies, corticosteroids, plasma exchange, and physical therapy.""]",[false],[true],[false],"[""The treatments for Multiple Sclerosis (MS) include disease-modifying therapies, corticosteroids, plasma exchange, physical therapy, and medications to manage symptoms.""]","[""Beta-blockers, angiotensin receptor blockers, surgery for aortic root replacement""]","[""The treatments for MS include disease-modifying therapies, corticosteroids, plasma exchange, and physical therapy.""]",[false],[true],[false],"[""The treatments for MS include disease-modifying therapies, corticosteroids for relapses, physical therapy, and symptom management medications.""]","[""Treatment for Marfan Syndrome includes beta-blockers, angiotensin receptor blockers, and surgery to repair aortic aneurysms.""]","[""The treatments for MS include disease-modifying therapies, corticosteroids, plasma exchange, and physical therapy.""]",[false],[true],[false],"[""The treatments for Multiple Sclerosis (MS) include disease-modifying therapies, corticosteroids for relapses, physical therapy, and symptom management medications.""]","[""Beta-blockers, angiotensin receptor blockers, and surgery to replace aortic root""]","[""The treatments for MS include disease-modifying therapies, corticosteroids for relapses, physical therapy, and symptom management medications.""]",[false],[true],[false],"[""The treatments for MS (Multiple sclerosis) include disease-modifying therapies, corticosteroids for relapses, physical therapy, and medications to manage symptoms.""]","[""Beta-blockers, ACE inhibitors, surgery for aortic root replacement""]","[""Some treatments for MS include disease-modifying therapies, corticosteroids, plasma exchange, and physical therapy.""]",[false],[true],[false],"[""The treatments for Multiple Sclerosis (MS) include disease-modifying therapies, corticosteroids for relapses, physical therapy, and medications to manage symptoms.""]","[""Beta-blockers, angiotensin receptor blockers, surgery for aortic root replacement""]","[""The treatments for MS include disease-modifying therapies, corticosteroids, plasma exchange, and physical therapy.""]",[false],[true],[false],"[""The treatments for MS (Multiple sclerosis) include disease-modifying therapies, corticosteroids for relapses, physical therapy, and symptom management medications.""]","[""Treatment for Marfan Syndrome includes beta-blockers, angiotensin receptor blockers, and surgery to repair aortic aneurysms.""]","[""The treatments for MS include disease-modifying therapies, corticosteroids, plasma exchange, and physical therapy.""]",[false],[true],[false],"[""The treatments for MS (Multiple Sclerosis) include disease-modifying therapies, corticosteroids for relapses, physical therapy, and symptom management medications.""]","[""Beta-blockers, angiotensin receptor blockers, and surgery to replace aortic root""]","[""The treatments for MS include disease-modifying therapies, corticosteroids for relapses, physical therapy, and symptom management medications.""]",[false],[true],[false],"[""The treatments for Multiple Sclerosis (MS) include disease-modifying therapies, corticosteroids for relapses, physical therapy, and symptom management medications.""]","[""Beta-blockers, ACE inhibitors, surgery for aortic root replacement""]","[""Some treatments for MS include disease-modifying therapies, corticosteroids, plasma exchange, and physical therapy.""]",[false],[true],[false],"[""The treatments for MS (Multiple Sclerosis) include disease-modifying therapies, corticosteroids for relapses, physical therapy, and symptom management medications.""]","[""Beta-blockers, angiotensin receptor blockers, surgery for aortic root replacement""]","[""The treatments for MS include disease-modifying therapies, corticosteroids, plasma exchange, and physical therapy.""]",[false],[true],[false],"[""The treatments for MS (Multiple Sclerosis) include disease-modifying therapies, corticosteroids for relapses, physical therapy, and symptom management medications.""]","[""Treatment for Marfan Syndrome includes beta-blockers, angiotensin receptor blockers, and surgery to repair aortic aneurysms.""]","[""The treatments for MS include disease-modifying therapies, corticosteroids, plasma exchange, and physical therapy.""]",[false],[true],[false],"[""The treatments for Multiple Sclerosis (MS) include disease-modifying therapies, corticosteroids for relapses, physical therapy, muscle relaxants, and medications to manage symptoms such as fatigue, pain, and bladder issues.""]","[""Beta-blockers, angiotensin receptor blockers, and surgery to replace aortic root""]","[""The treatments for MS include disease-modifying therapies, corticosteroids for relapses, physical therapy, and symptom management medications.""]",[false],[true],[false],"[""The treatments for Multiple Sclerosis (MS) include disease-modifying therapies, corticosteroids, plasma exchange, physical therapy, and medications to manage symptoms such as muscle spasms, fatigue, and pain.""]","[""Beta-blockers, ACE inhibitors, surgery for aortic root replacement""]","[""Some treatments for MS include disease-modifying therapies, corticosteroids, plasma exchange, and physical therapy.""]",[false],[true],[false],"[""The treatments for Multiple Sclerosis (MS) include disease-modifying therapies, corticosteroids for relapses, physical therapy, muscle relaxants, and medications to manage symptoms such as fatigue, pain, and bladder issues.""]","[""Beta-blockers, angiotensin receptor blockers, surgery for aortic root replacement""]","[""The treatments for MS include disease-modifying therapies, corticosteroids, plasma exchange, and physical therapy.""]",[false],[true],[false],"[""The treatments for Multiple Sclerosis (MS) include disease-modifying therapies, corticosteroids for relapses, physical therapy, and symptom management medications.""]","[""Treatment for Marfan Syndrome includes beta-blockers, angiotensin receptor blockers, and surgery to repair aortic aneurysms.""]","[""The treatments for MS include disease-modifying therapies, corticosteroids, plasma exchange, and physical therapy.""]",[false],[true],[false],"[""The treatments for Multiple Sclerosis (MS) include disease-modifying therapies, corticosteroids for relapses, physical therapy, and symptom management medications.""]","[""Beta-blockers, angiotensin receptor blockers, and surgery to replace aortic root""]","[""The treatments for MS include disease-modifying therapies, corticosteroids for relapses, physical therapy, and symptom management medications.""]",[false],[true],[false],"[""The treatments for MS include disease-modifying therapies, symptom management, and lifestyle modifications.""]","[""Beta-blockers, angiotensin receptor blockers, and surgery to replace aortic root""]","[""The treatments for MS include disease-modifying therapies, corticosteroids for relapses, physical therapy, and symptom management medications.""]",[false],[true],[false],"[""There is no cure for MS, but treatments can help manage symptoms and slow disease progression. Some common treatments include disease-modifying therapies, corticosteroids, physical therapy, and lifestyle modifications.""]","[""Beta-blockers, angiotensin receptor blockers, and surgery to replace aortic root""]","[""The treatments for MS include disease-modifying therapies, corticosteroids for relapses, physical therapy, and symptom management medications.""]",[false],[true],[false],"[""The treatments for MS (Multiple Sclerosis) include disease-modifying therapies, corticosteroids for relapses, physical therapy, and symptom management medications.""]","[""Beta-blockers, angiotensin receptor blockers, and surgery to replace aortic root""]","[""The treatments for MS include disease-modifying therapies, corticosteroids for relapses, physical therapy, and symptom management medications.""]"
treatment,What are the treatments for intrahepatic cholestasis of pregnancy ?,These resources address the diagnosis or management of intrahepatic cholestasis of pregnancy:  - Gene Review: Gene Review: ATP8B1 Deficiency  - Genetic Testing Registry: Cholestasis of pregnancy   These resources from MedlinePlus offer information about the diagnosis and management of various health conditions:  - Diagnostic Tests  - Drug Therapy  - Surgery and Rehabilitation  - Genetic Counseling   - Palliative Care,"{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""ICP"", ""full_form"": ""intrahepatic cholestasis of pregnancy""}]}",What are the treatments for ICP ?,What are the treatments for intrahepatic cholestasis of pregnancy ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Insane Clown Posse"", ""Inductively Coupled Plasma"", ""Intracranial pressure"", ""Internet Cache Protocol"", ""Inventory Control Point"", ""International Communist Party"", ""Instant Composers Pool"", ""I Can Play"", ""Inner City Posse"", ""Integrated Circuit Piezoelectric""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Intracranial Pressure""]",[1.5193205381436553e-14],[6.07390345091728e-06],"[""Intracranial pressure""]",[6.07390345091728e-06],"[""ABBREVIATIONS""]","[[6.600892065594508e-25, 2.0160886985496983e-19, 6.07390345091728e-06, 2.6455142842298313e-18, 3.589542816173273e-17, 5.917417497825093e-18, 1.940884856987671e-19, 9.90732171422109e-11, 5.541918813320469e-16, 4.7707081318793805e-30]]",[0.6869334824967499],[0.9322001787971442],"[""Integrated Circuit Piezoelectric""]",[0.9322001787971442],"[""LLM""]","[[0.7051052221038578, 0.6965280276142704, 0.9297459007191513, 0.7560899790392978, 0.7095368751118638, 0.7122358708857195, 0.648896890391718, 0.7977352651903378, 0.7393234579562736, 0.7530642586254749]]","[""Intracranial pressure""]","[""ABBREVIATIONS""]",What are the treatments for ICP (Intracranial Pressure) ?,[false],[true],[false],"[""The treatments for ICP (Intracranial pressure) include medications to reduce brain swelling, draining excess cerebrospinal fluid, surgery to remove a tumor or hematoma causing increased pressure, and in severe cases, placement of a shunt to divert fluid away from the brain.""]","[""Ursodeoxycholic acid, antihistamines, vitamin K supplements, and early delivery in severe cases.""]","[""The treatments for increased intracranial pressure (ICP) include medications such as diuretics, corticosteroids, and sedatives, as well as procedures like draining excess cerebrospinal fluid or surgery to relieve pressure on the brain.""]",[false],[true],[false],"[""The treatments for ICP (Intracranial pressure) include medications such as diuretics, surgery to remove a tumor or excess fluid, and therapies like hyperventilation and hypothermia.""]","[""Ursodeoxycholic acid, antihistamines, and vitamin K supplements are commonly used treatments for intrahejsonpaticholestasis of pregnancy.""]","[""The treatments for increased intracranial pressure (ICP) include medications such as diuretics, corticosteroids, and hyperosmolar agents, as well as surgical interventions like decompressive craniectomy and shunt placement.""]",[false],[true],[false],"[""The treatments for ICP (Intracranial pressure) include medications to reduce brain swelling, draining excess cerebrospinal fluid, surgery to remove a tumor or hematoma causing increased pressure, and therapeutic hypothermia.""]","[""Ursodeoxycholic acid, antihistamines, and vitamin K supplements are commonly used treatments for intrahehepatic cholestasis of pregnancy.""]","[""The treatments for ICP (Intracranial Pressure) include medications such as diuretics, surgery to remove fluid or relieve pressure, and monitoring in an intensive care unit.""]",[false],[true],[false],"[""The treatments for ICP (Intracranial pressure) include medications such as diuretics, surgery to remove a tumor or excess fluid, and therapies like hyperventilation and hypothermia.""]","[""Ursodeoxycholic acid, antihistamines, vitamin K supplements, and early delivery in severe cases.""]","[""The treatments for increased intracranial pressure (ICP) include medications such as diuretics, corticosteroids, and sedatives, as well as procedures like drainage of cerebrospinal fluid, hyperventilation, and surgery to relieve pressure on the brain.""]",[false],[true],[false],"[""ICP (Integrated Circuit Piezoelectric) is a type of pressure sensor that is commonly used in medical devices for measuring physiological parameters such as blood pressure. The treatments for medical conditions related to ICP would depend on the specific diagnosis and underlying cause, and may include medications, surgery, or other interventions as recommended by a healthcare provider.""]","[""Ursodeoxycholic acid, antihistamines, vitamin K supplements, and early delivery in severe cases.""]","[""The treatments for increased intracranial pressure (ICP) include medications such as diuretics, corticosteroids, and sedatives, as well as procedures like draining excess cerebrospinal fluid or surgery to relieve pressure on the brain.""]",[false],[true],[false],"[""ICP (Integrated Circuit Piezoelectric) treatments include medication, surgery, and lifestyle changes to manage symptoms and improve quality of life.""]","[""Ursodeoxycholic acid, antihistamines, and vitamin K supplements are commonly used treatments for intrahejsonpaticholestasis of pregnancy.""]","[""The treatments for increased intracranial pressure (ICP) include medications such as diuretics, corticosteroids, and hyperosmolar agents, as well as surgical interventions like decompressive craniectomy and shunt placement.""]",[false],[true],[false],"[""ICP (Integrated Circuit Piezoelectric) treatments include medication, surgery, and lifestyle changes.""]","[""Ursodeoxycholic acid, antihistamines, and vitamin K supplements are commonly used treatments for intrahehepatic cholestasis of pregnancy.""]","[""The treatments for ICP (Intracranial Pressure) include medications such as diuretics, surgery to remove fluid or relieve pressure, and monitoring in an intensive care unit.""]",[false],[true],[false],"[""ICP (Integrated Circuit Piezoelectric) is a type of pressure sensor used in medical devices to measure pressure inside the body. The treatments for increased intracranial pressure (ICP) include medications to reduce brain swelling, draining excess cerebrospinal fluid, and sometimes surgery to remove a tumor or relieve pressure on the brain.""]","[""Ursodeoxycholic acid, antihistamines, vitamin K supplements, and early delivery in severe cases.""]","[""The treatments for increased intracranial pressure (ICP) include medications such as diuretics, corticosteroids, and sedatives, as well as procedures like drainage of cerebrospinal fluid, hyperventilation, and surgery to relieve pressure on the brain.""]",[false],[true],[false],"[""The treatments for ICP (Intracranial pressure) include medications to reduce brain swelling, draining excess cerebrospinal fluid, surgery to remove a tumor or hematoma causing increased pressure, and therapeutic hypothermia.""]","[""Ursodeoxycholic acid, antihistamines, and vitamin K supplements are commonly used treatments for intrahejsonpaticholestasis of pregnancy.""]","[""The treatments for increased intracranial pressure (ICP) include medications such as diuretics, corticosteroids, and hyperosmolar agents, as well as surgical interventions like decompressive craniectomy and shunt placement.""]",[false],[true],[false],"[""The treatments for ICP (Intracranial pressure) include medications such as diuretics, surgery to remove excess fluid or relieve pressure, and monitoring and managing underlying conditions such as brain tumors or head injuries.""]","[""Ursodeoxycholic acid, antihistamines, vitamin K supplements, and early delivery in severe cases.""]","[""The treatments for increased intracranial pressure (ICP) include medications such as diuretics, corticosteroids, and sedatives, as well as procedures like draining excess cerebrospinal fluid or surgery to relieve pressure on the brain.""]",[false],[true],[false],"[""The treatments for ICP (Intracranial pressure) include medications such as diuretics, surgery to remove a tumor or excess fluid, draining excess cerebrospinal fluid, and using a ventriculostomy to monitor and manage pressure.""]","[""Ursodeoxycholic acid, antihistamines, and vitamin K supplements are commonly used treatments for intrahehepatic cholestasis of pregnancy.""]","[""The treatments for ICP (Intracranial Pressure) include medications such as diuretics, surgery to remove fluid or relieve pressure, and monitoring in an intensive care unit.""]",[false],[true],[false],"[""The treatments for ICP (Intracranial pressure) include medications to reduce brain swelling, draining excess cerebrospinal fluid, surgery to remove a tumor or hematoma causing increased pressure, and in severe cases, a ventriculostomy or decompressive craniectomy.""]","[""Ursodeoxycholic acid, antihistamines, vitamin K supplements, and early delivery in severe cases.""]","[""The treatments for increased intracranial pressure (ICP) include medications such as diuretics, corticosteroids, and sedatives, as well as procedures like drainage of cerebrospinal fluid, hyperventilation, and surgery to relieve pressure on the brain.""]",[false],[true],[false],"[""The treatments for ICP (Intracranial pressure) include medications to reduce brain swelling, draining excess cerebrospinal fluid, surgery to remove a tumor or hematoma causing increased pressure, and therapeutic hypothermia.""]","[""Ursodeoxycholic acid, antihistamines, vitamin K supplements, and early delivery in severe cases.""]","[""The treatments for increased intracranial pressure (ICP) include medications such as diuretics, corticosteroids, and sedatives, as well as procedures like draining excess cerebrospinal fluid or surgery to relieve pressure on the brain.""]",[false],[true],[false],"[""The treatments for ICP (Intracranial pressure) include medications such as diuretics, surgery to remove a tumor or excess fluid, and therapies like hyperventilation and hypothermia.""]","[""Ursodeoxycholic acid, antihistamines, and vitamin K supplements are commonly used treatments for intrahejsonpaticholestasis of pregnancy.""]","[""The treatments for increased intracranial pressure (ICP) include medications such as diuretics, corticosteroids, and hyperosmolar agents, as well as surgical interventions like decompressive craniectomy and shunt placement.""]",[false],[true],[false],"[""The treatments for ICP (Intracranial pressure) include medications to reduce brain swelling, draining excess cerebrospinal fluid, surgery to remove a tumor or hematoma causing increased pressure, and therapeutic hypothermia.""]","[""Ursodeoxycholic acid, antihistamines, and vitamin K supplements are commonly used treatments for intrahehepatic cholestasis of pregnancy.""]","[""The treatments for ICP (Intracranial Pressure) include medications such as diuretics, surgery to remove fluid or relieve pressure, and monitoring in an intensive care unit.""]",[false],[true],[false],"[""Surgery, medications, monitoring, and lifestyle changes""]","[""Ursodeoxycholic acid, antihistamines, vitamin K supplements, and early delivery in severe cases.""]","[""The treatments for increased intracranial pressure (ICP) include medications such as diuretics, corticosteroids, and sedatives, as well as procedures like drainage of cerebrospinal fluid, hyperventilation, and surgery to relieve pressure on the brain.""]",[false],[true],[false],"[""Surgical interventions, medications, and lifestyle changes are common treatments for ICP.""]","[""Ursodeoxycholic acid, antihistamines, vitamin K supplements, and early delivery in severe cases.""]","[""The treatments for increased intracranial pressure (ICP) include medications such as diuretics, corticosteroids, and sedatives, as well as procedures like draining excess cerebrospinal fluid or surgery to relieve pressure on the brain.""]",[false],[true],[false],"[""The treatments for Intracranial pressure (ICP) include medications such as diuretics, surgery to remove fluid or tissue causing the pressure, and in severe cases, a shunt may be inserted to drain excess fluid.""]","[""Ursodeoxycholic acid, antihistamines, and vitamin K supplements are commonly used treatments for intrahejsonpaticholestasis of pregnancy.""]","[""The treatments for increased intracranial pressure (ICP) include medications such as diuretics, corticosteroids, and hyperosmolar agents, as well as surgical interventions like decompressive craniectomy and shunt placement.""]",[false],[true],[false],"[""The treatments for ICP (Intracranial pressure) include medications such as diuretics, surgery to remove a tumor or excess fluid, and placement of a shunt to drain excess fluid.""]","[""Ursodeoxycholic acid, antihistamines, and vitamin K supplements are commonly used treatments for intrahehepatic cholestasis of pregnancy.""]","[""The treatments for ICP (Intracranial Pressure) include medications such as diuretics, surgery to remove fluid or relieve pressure, and monitoring in an intensive care unit.""]",[false],[true],[false],"[""The treatments for ICP (Intracranial pressure) include medications to reduce brain swelling, draining excess cerebrospinal fluid, surgery to remove a brain tumor or hematoma, and therapeutic hypothermia.""]","[""Ursodeoxycholic acid, antihistamines, vitamin K supplements, and early delivery in severe cases.""]","[""The treatments for increased intracranial pressure (ICP) include medications such as diuretics, corticosteroids, and sedatives, as well as procedures like drainage of cerebrospinal fluid, hyperventilation, and surgery to relieve pressure on the brain.""]",[false],[true],[false],"[""The treatments for ICP (Intracranial Pressure) include medications such as diuretics, sedatives, and corticosteroids, as well as surgical interventions like decompressive craniectomy and placement of an intracranial pressure monitor.""]","[""Ursodeoxycholic acid, antihistamines, vitamin K supplements, and early delivery in severe cases.""]","[""The treatments for increased intracranial pressure (ICP) include medications such as diuretics, corticosteroids, and sedatives, as well as procedures like draining excess cerebrospinal fluid or surgery to relieve pressure on the brain.""]",[false],[true],[false],"[""The treatments for ICP (Intracranial Pressure) include medications to reduce brain swelling, draining excess cerebrospinal fluid, surgery to remove a tumor or hematoma causing the pressure, and sometimes the use of a ventriculostomy to monitor and manage pressure levels.""]","[""Ursodeoxycholic acid, antihistamines, and vitamin K supplements are commonly used treatments for intrahejsonpaticholestasis of pregnancy.""]","[""The treatments for increased intracranial pressure (ICP) include medications such as diuretics, corticosteroids, and hyperosmolar agents, as well as surgical interventions like decompressive craniectomy and shunt placement.""]",[false],[true],[false],"[""The treatments for ICP (Intracranial Pressure) include medications such as diuretics, surgery to remove a tumor or excess fluid, and therapies like hyperventilation and hypothermia.""]","[""Ursodeoxycholic acid, antihistamines, and vitamin K supplements are commonly used treatments for intrahehepatic cholestasis of pregnancy.""]","[""The treatments for ICP (Intracranial Pressure) include medications such as diuretics, surgery to remove fluid or relieve pressure, and monitoring in an intensive care unit.""]",[false],[true],[false],"[""The treatments for Intracranial Pressure (ICP) include medications such as diuretics, surgery to remove a tumor or excess fluid, draining excess cerebrospinal fluid, and using a ventriculostomy to monitor and manage pressure.""]","[""Ursodeoxycholic acid, antihistamines, vitamin K supplements, and early delivery in severe cases.""]","[""The treatments for increased intracranial pressure (ICP) include medications such as diuretics, corticosteroids, and sedatives, as well as procedures like drainage of cerebrospinal fluid, hyperventilation, and surgery to relieve pressure on the brain.""]",[false],[true],[false],"[""The treatments for ICP (Intracranial pressure) include medications to reduce brain swelling, draining excess cerebrospinal fluid, surgery to remove a tumor or hematoma causing increased pressure, and sometimes the use of a device to monitor and control pressure within the skull.""]","[""Ursodeoxycholic acid, antihistamines, vitamin K supplements, and early delivery in severe cases.""]","[""The treatments for increased intracranial pressure (ICP) include medications such as diuretics, corticosteroids, and sedatives, as well as procedures like draining excess cerebrospinal fluid or surgery to relieve pressure on the brain.""]",[false],[true],[false],"[""The treatments for ICP (Intracranial pressure) include medications to reduce brain swelling, draining excess cerebrospinal fluid, surgery to remove a tumor or hematoma causing increased pressure, and in severe cases, a shunt may be placed to divert excess fluid.""]","[""Ursodeoxycholic acid, antihistamines, and vitamin K supplements are commonly used treatments for intrahejsonpaticholestasis of pregnancy.""]","[""The treatments for increased intracranial pressure (ICP) include medications such as diuretics, corticosteroids, and hyperosmolar agents, as well as surgical interventions like decompressive craniectomy and shunt placement.""]",[false],[true],[false],"[""The treatments for ICP (Intracranial pressure) include medications to reduce brain swelling, draining excess cerebrospinal fluid, surgery to remove a tumor or hematoma causing increased pressure, and therapeutic hypothermia.""]","[""Ursodeoxycholic acid, antihistamines, and vitamin K supplements are commonly used treatments for intrahehepatic cholestasis of pregnancy.""]","[""The treatments for ICP (Intracranial Pressure) include medications such as diuretics, surgery to remove fluid or relieve pressure, and monitoring in an intensive care unit.""]",[false],[true],[false],"[""The treatments for ICP (Intracranial pressure) include medications to reduce brain swelling, draining excess cerebrospinal fluid, surgery to remove a tumor or hematoma causing increased pressure, and in severe cases, a shunt may be placed to divert excess fluid.""]","[""Ursodeoxycholic acid, antihistamines, vitamin K supplements, and early delivery in severe cases.""]","[""The treatments for increased intracranial pressure (ICP) include medications such as diuretics, corticosteroids, and sedatives, as well as procedures like drainage of cerebrospinal fluid, hyperventilation, and surgery to relieve pressure on the brain.""]",[false],[true],[false],"[""The treatments for ICP (Intracranial pressure) include medications to reduce brain swelling, draining excess cerebrospinal fluid, surgery to remove a tumor or hematoma causing increased pressure, and monitoring and controlling factors such as blood pressure and oxygen levels.""]","[""Ursodeoxycholic acid, antihistamines, vitamin K supplements, and early delivery in severe cases.""]","[""The treatments for increased intracranial pressure (ICP) include medications such as diuretics, corticosteroids, and sedatives, as well as procedures like draining excess cerebrospinal fluid or surgery to relieve pressure on the brain.""]",[false],[true],[false],"[""The treatments for ICP (Intracranial pressure) include medications to reduce brain swelling, draining excess cerebrospinal fluid, surgery to remove a tumor or hematoma causing increased pressure, and therapeutic hypothermia.""]","[""Ursodeoxycholic acid, antihistamines, vitamin K supplements, and early delivery in severe cases.""]","[""The treatments for increased intracranial pressure (ICP) include medications such as diuretics, corticosteroids, and sedatives, as well as procedures like draining excess cerebrospinal fluid or surgery to relieve pressure on the brain.""]",[false],[true],[false],"[""ICP (Integrated Circuit Piezoelectric) treatments include using specialized equipment for testing, calibration, and signal conditioning to ensure accurate measurements.""]","[""Ursodeoxycholic acid, antihistamines, vitamin K supplements, and early delivery in severe cases.""]","[""The treatments for increased intracranial pressure (ICP) include medications such as diuretics, corticosteroids, and sedatives, as well as procedures like draining excess cerebrospinal fluid or surgery to relieve pressure on the brain.""]",[false],[true],[false],"[""Treatments for ICP include medications to reduce brain swelling, draining excess cerebrospinal fluid, surgery to remove a tumor or hematoma causing increased pressure, and therapeutic hypothermia.""]","[""Ursodeoxycholic acid, antihistamines, vitamin K supplements, and early delivery in severe cases.""]","[""The treatments for increased intracranial pressure (ICP) include medications such as diuretics, corticosteroids, and sedatives, as well as procedures like draining excess cerebrospinal fluid or surgery to relieve pressure on the brain.""]"
symptoms,What are the symptoms of Rh Incompatibility ?,"Rh incompatibility doesn't cause signs or symptoms in a pregnant woman. In a baby, the condition can lead to hemolytic anemia. Hemolytic anemia is a condition in which red blood cells are destroyed faster than the body can replace them.
                
Red blood cells contain hemoglobin (HEE-muh-glow-bin), an iron-rich protein that carries oxygen to the body. Without enough red blood cells and hemoglobin, the baby won't get enough oxygen.
                
Hemolytic anemia can cause mild to severe signs and symptoms in a newborn, such as jaundice and a buildup of fluid.
                
Jaundice is a yellowish color of the skin and whites of the eyes. When red blood cells die, they release hemoglobin into the blood. The hemoglobin is broken down into a compound called bilirubin. This compound gives the skin and eyes a yellowish color. High levels of bilirubin can lead to brain damage in the baby.
                
The buildup of fluid is a result of heart failure. Without enough hemoglobin-carrying red blood cells, the baby's heart has to work harder to move oxygen-rich blood through the body. This stress can lead to heart failure.
                
Heart failure can cause fluid to build up in many parts of the body. When this occurs in a fetus or newborn, the condition is called hydrops fetalis (HI-drops fe-TAL-is).
                
Severe hemolytic anemia can be fatal to a newborn at the time of birth or shortly after.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""abbreviation"", ""abbreviation"": ""Rh"", ""full_form"": ""Rhesus""}]}",What are the symptoms of Rh Incompatibility ?,What are the symptoms of Rhesus Incompatibility ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Red Hat"", ""Relative Humidity"", ""Right Hand"", ""Rhodium"", ""Releasing Hormone"", ""Robin Hood"", ""Radiation Hybrid"", ""Rose Hill"", ""Roller Hockey"", ""Residence Hall""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Rhesus""]",[4.5071124876250535e-08],[4.5071124876250535e-08],"[""Right Hand""]",[0.00012848076668837882],"[""ABBREVIATIONS""]","[[4.679684488560348e-10, 1.1343869632930167e-09, 0.00012848076668837882, 3.000032909291937e-08, 2.935211624996633e-09, 2.7046377012870898e-14, 3.759539842462621e-12, 3.5713754665783145e-10, 6.42638241232852e-11, 2.2599132664490344e-08]]",[0.9685146179115072],[0.9685202792057096],"[""Residence Hall""]",[0.9685202792057096],"[""LLM""]","[[0.8867957464025344, 0.8674590065105101, 0.8580180057762146, 0.9214330000407351, 0.8735462389549058, 0.8281001348306358, 0.7504016430964537, 0.8807598426835771, 0.8036200480995594, 0.8727635802030194]]","[""Rhesus""]","[""LLM""]",What are the symptoms of Rh (Rhesus) Incompatibility ?,[true],[true],[true],"[""Hemolytic disease of the newborn""]","[""Symptoms of Rhesus Incompatibility include jaundice, anemia, enlarged liver or spleen, and difficulty breathing.""]","[""Symptoms of Rh incompatibility include jaundice, anemia, enlarged liver or spleen, and swelling of the body.""]",[true],[true],[true],"[""Hemolytic disease of the newborn, anemia, jaundice, enlarged liver and spleen""]","[""Symptoms of Rhesus Incompatibility include jaundice, anemia, enlarged liver or spleen, and brain damage in severe cases.""]","[""Symptoms of Rh incompatibility include jaundice, anemia, enlarged liver or spleen, and swelling or edema.""]",[true],[true],[true],"[""Symptoms of Rh incompatibility include jaundice, anemia, enlarged liver or spleen, and swelling of the body.""]","[""Symptoms of Rhesus Incompatibility include jaundice, anemia, enlarged liver or spleen, and brain damage in severe cases.""]","[""Symptoms of Rh incompatibility include jaundice, anemia, enlarged liver or spleen, and swelling of the body.""]",[true],[true],[true],"[""Hemolytic disease of the newborn""]","[""Symptoms of Rhesus Incompatibility include jaundice, anemia, enlarged liver or spleen, and difficulty breathing.""]","[""Symptoms of Rh incompatibility include jaundice, anemia, enlarged liver or spleen, and swelling of the body.""]",[true],[false],[true],"[""Symptoms of Rh incompatibility include jaundice, anemia, enlarged liver and spleen, and fluid accumulation in the body.""]","[""Symptoms of Rhesus Incompatibility include jaundice, anemia, enlarged liver or spleen, and difficulty breathing.""]","[""Symptoms of Rh incompatibility include jaundice, anemia, enlarged liver or spleen, and swelling of the body.""]",[true],[true],[true],"[""Symptoms of Rh incompatibility include jaundice, anemia, enlarged liver or spleen, and edema.""]","[""Symptoms of Rhesus Incompatibility include jaundice, anemia, enlarged liver or spleen, and brain damage in severe cases.""]","[""Symptoms of Rh incompatibility include jaundice, anemia, enlarged liver or spleen, and swelling or edema.""]",[true],[true],[true],"[""Symptoms of Rh incompatibility include jaundice, anemia, enlarged liver or spleen, and fluid accumulation.""]","[""Symptoms of Rhesus Incompatibility include jaundice, anemia, enlarged liver or spleen, and brain damage in severe cases.""]","[""Symptoms of Rh incompatibility include jaundice, anemia, enlarged liver or spleen, and swelling of the body.""]",[true],[false],[true],"[""Symptoms of Rh incompatibility include jaundice, anemia, enlarged liver or spleen, and fluid accumulation in the baby's body.""]","[""Symptoms of Rhesus Incompatibility include jaundice, anemia, enlarged liver or spleen, and difficulty breathing.""]","[""Symptoms of Rh incompatibility include jaundice, anemia, enlarged liver or spleen, and swelling of the body.""]",[true],[true],[true],"[""Symptoms of Rh (Rhesus) incompatibility include jaundice, anemia, enlarged liver and spleen, and swelling of the body.""]","[""Symptoms of Rhesus Incompatibility include jaundice, anemia, enlarged liver or spleen, and brain damage in severe cases.""]","[""Symptoms of Rh incompatibility include jaundice, anemia, enlarged liver or spleen, and swelling or edema.""]",[true],[true],[true],"[""Symptoms of Rh (Rhesus) incompatibility include jaundice, anemia, enlarged spleen, and in severe cases, brain damage or even death in newborns.""]","[""Symptoms of Rhesus Incompatibility include jaundice, anemia, enlarged liver or spleen, and difficulty breathing.""]","[""Symptoms of Rh incompatibility include jaundice, anemia, enlarged liver or spleen, and swelling of the body.""]",[true],[true],[true],"[""Symptoms of Rh (Rhesus) incompatibility include jaundice, anemia, enlarged liver or spleen, and swelling of the body.""]","[""Symptoms of Rhesus Incompatibility include jaundice, anemia, enlarged liver or spleen, and brain damage in severe cases.""]","[""Symptoms of Rh incompatibility include jaundice, anemia, enlarged liver or spleen, and swelling of the body.""]",[true],[false],[true],"[""Symptoms of Rh (Rhesus) incompatibility include jaundice, anemia, enlarged liver or spleen, and swelling of the body.""]","[""Symptoms of Rhesus Incompatibility include jaundice, anemia, enlarged liver or spleen, and difficulty breathing.""]","[""Symptoms of Rh incompatibility include jaundice, anemia, enlarged liver or spleen, and swelling of the body.""]",[true],[true],[true],"[""Jaundice, anemia, enlarged liver and spleen, edema, and severe swelling""]","[""Symptoms of Rhesus Incompatibility include jaundice, anemia, enlarged liver or spleen, and difficulty breathing.""]","[""Symptoms of Rh incompatibility include jaundice, anemia, enlarged liver or spleen, and swelling of the body.""]",[true],[true],[true],"[""Jaundice, anemia, enlarged spleen, low muscle tone""]","[""Symptoms of Rhesus Incompatibility include jaundice, anemia, enlarged liver or spleen, and brain damage in severe cases.""]","[""Symptoms of Rh incompatibility include jaundice, anemia, enlarged liver or spleen, and swelling or edema.""]",[true],[true],[true],"[""Jaundice, anemia, enlarged liver and spleen, edema, and severe swelling""]","[""Symptoms of Rhesus Incompatibility include jaundice, anemia, enlarged liver or spleen, and brain damage in severe cases.""]","[""Symptoms of Rh incompatibility include jaundice, anemia, enlarged liver or spleen, and swelling of the body.""]",[true],[true],[true],"[""Jaundice, anemia, enlarged liver and spleen, edema, and severe swelling""]","[""Symptoms of Rhesus Incompatibility include jaundice, anemia, enlarged liver or spleen, and difficulty breathing.""]","[""Symptoms of Rh incompatibility include jaundice, anemia, enlarged liver or spleen, and swelling of the body.""]",[true],[false],[true],"[""Jaundice, anemia, enlarged liver or spleen, and edema are common symptoms of Rh incompatibility.""]","[""Symptoms of Rhesus Incompatibility include jaundice, anemia, enlarged liver or spleen, and difficulty breathing.""]","[""Symptoms of Rh incompatibility include jaundice, anemia, enlarged liver or spleen, and swelling of the body.""]",[true],[true],[true],"[""Symptoms of Rh (Rhesus) incompatibility include jaundice, anemia, enlarged liver or spleen, and swelling of the body.""]","[""Symptoms of Rhesus Incompatibility include jaundice, anemia, enlarged liver or spleen, and brain damage in severe cases.""]","[""Symptoms of Rh incompatibility include jaundice, anemia, enlarged liver or spleen, and swelling or edema.""]",[true],[true],[true],"[""Symptoms of Rh (Rhesus) incompatibility include jaundice, anemia, enlarged liver or spleen, and swelling of the body.""]","[""Symptoms of Rhesus Incompatibility include jaundice, anemia, enlarged liver or spleen, and brain damage in severe cases.""]","[""Symptoms of Rh incompatibility include jaundice, anemia, enlarged liver or spleen, and swelling of the body.""]",[true],[false],[true],"[""Symptoms of Rh (Rhesus) incompatibility include jaundice, anemia, enlarged liver or spleen, and swelling of the body.""]","[""Symptoms of Rhesus Incompatibility include jaundice, anemia, enlarged liver or spleen, and difficulty breathing.""]","[""Symptoms of Rh incompatibility include jaundice, anemia, enlarged liver or spleen, and swelling of the body.""]",[true],[false],[true],"[""Symptoms of Rh (Rhesus) incompatibility include jaundice, anemia, enlarged liver or spleen, and swelling of the body.""]","[""Symptoms of Rhesus Incompatibility include jaundice, anemia, enlarged liver or spleen, and difficulty breathing.""]","[""Symptoms of Rh incompatibility include jaundice, anemia, enlarged liver or spleen, and swelling of the body.""]",[true],[true],[true],"[""Symptoms of Rh (Rhesus) incompatibility include jaundice, anemia, enlarged liver or spleen, and swelling of the body.""]","[""Symptoms of Rhesus Incompatibility include jaundice, anemia, enlarged liver or spleen, and brain damage in severe cases.""]","[""Symptoms of Rh incompatibility include jaundice, anemia, enlarged liver or spleen, and swelling or edema.""]",[true],[true],[true],"[""Symptoms of Rh (Rhesus) incompatibility include jaundice, anemia, enlarged liver or spleen, and swelling of the body.""]","[""Symptoms of Rhesus Incompatibility include jaundice, anemia, enlarged liver or spleen, and brain damage in severe cases.""]","[""Symptoms of Rh incompatibility include jaundice, anemia, enlarged liver or spleen, and swelling of the body.""]",[true],[false],[true],"[""Symptoms of Rh (Rhesus) incompatibility include jaundice, anemia, enlarged liver or spleen, and swelling of the body.""]","[""Symptoms of Rhesus Incompatibility include jaundice, anemia, enlarged liver or spleen, and difficulty breathing.""]","[""Symptoms of Rh incompatibility include jaundice, anemia, enlarged liver or spleen, and swelling of the body.""]",[true],[false],[true],"[""Symptoms of Rh (Rhesus) incompatibility include jaundice, anemia, enlarged liver or spleen, and fluid accumulation in the baby's body.""]","[""Symptoms of Rhesus Incompatibility include jaundice, anemia, enlarged liver or spleen, and difficulty breathing.""]","[""Symptoms of Rh incompatibility include jaundice, anemia, enlarged liver or spleen, and swelling of the body.""]",[true],[true],[true],"[""Symptoms of Rh (Rhesus) incompatibility include jaundice, anemia, enlarged liver or spleen, and swelling of the body.""]","[""Symptoms of Rhesus Incompatibility include jaundice, anemia, enlarged liver or spleen, and brain damage in severe cases.""]","[""Symptoms of Rh incompatibility include jaundice, anemia, enlarged liver or spleen, and swelling or edema.""]",[true],[true],[true],"[""Symptoms of Rh (Rhesus) incompatibility include jaundice, anemia, enlarged liver or spleen, and fluid accumulation in the baby's body.""]","[""Symptoms of Rhesus Incompatibility include jaundice, anemia, enlarged liver or spleen, and brain damage in severe cases.""]","[""Symptoms of Rh incompatibility include jaundice, anemia, enlarged liver or spleen, and swelling of the body.""]",[true],[false],[true],"[""Symptoms of Rh (Rhesus) incompatibility include jaundice, anemia, enlarged liver or spleen, and swelling of the body.""]","[""Symptoms of Rhesus Incompatibility include jaundice, anemia, enlarged liver or spleen, and difficulty breathing.""]","[""Symptoms of Rh incompatibility include jaundice, anemia, enlarged liver or spleen, and swelling of the body.""]",[true],[false],[true],"[""Symptoms of Rh (Rhesus) incompatibility include jaundice, anemia, enlarged liver or spleen, and fluid accumulation in the baby's body.""]","[""Symptoms of Rhesus Incompatibility include jaundice, anemia, enlarged liver or spleen, and difficulty breathing.""]","[""Symptoms of Rh incompatibility include jaundice, anemia, enlarged liver or spleen, and swelling of the body.""]",[true],[false],[true],"[""Symptoms of Rh incompatibility include jaundice, anemia, enlarged liver or spleen, and fluid accumulation in the baby's body.""]","[""Symptoms of Rhesus Incompatibility include jaundice, anemia, enlarged liver or spleen, and difficulty breathing.""]","[""Symptoms of Rh incompatibility include jaundice, anemia, enlarged liver or spleen, and swelling of the body.""]",[true],[false],[true],"[""Symptoms of Rh incompatibility include jaundice, anemia, enlarged liver or spleen, and fluid accumulation.""]","[""Symptoms of Rhesus Incompatibility include jaundice, anemia, enlarged liver or spleen, and difficulty breathing.""]","[""Symptoms of Rh incompatibility include jaundice, anemia, enlarged liver or spleen, and swelling of the body.""]",[true],[false],[true],"[""Symptoms of Rh (Rhesus) incompatibility include jaundice, anemia, enlarged liver or spleen, and fluid accumulation in the baby's body.""]","[""Symptoms of Rhesus Incompatibility include jaundice, anemia, enlarged liver or spleen, and difficulty breathing.""]","[""Symptoms of Rh incompatibility include jaundice, anemia, enlarged liver or spleen, and swelling of the body.""]"
treatment,What are the treatments for Opsoclonus Myoclonus ?,"Treatment for opsoclonus myoclonus may include corticosteroids or ACTH (adrenocorticotropic hormone). In cases where there is a tumor present, treatment such as chemotherapy, surgery, or radiation may be required.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""OMS"", ""full_form"": ""Opsoclonus Myoclonus""}]}",What are the treatments for OMS ?,What are the treatments for Opsoclonus Myoclonus ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Organizaci\u00f3n Mundial de la Salud"", ""Order Management System"", ""Open Music System"", ""Owensboro Middle School"", ""Object Management System"", ""Omsk, Russia"", ""On My Side"", ""Operational Mode Summary"", ""Open Midi System"", ""Organizational Maintenance Squadron""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Opsoclonus Myoclonus Syndrome""]",[8.819305239338848e-18],[1.452787667753979e-20],"[""On My Side""]",[2.746887711593819e-06],"[""ABBREVIATIONS""]","[[2.7055055225713685e-32, 8.958358077900924e-13, 2.805406816889247e-13, 1.6466525992976495e-22, 3.212829423051136e-13, 2.2674660059517012e-14, 2.746887711593819e-06, 2.880623398936933e-16, 1.500448603081209e-14, 5.5977957826059806e-18]]",[0.7971732153253637],[0.7836955184851773],"[""Omsk, Russia""]",[0.8603866097727855],"[""ABBREVIATIONS""]","[[0.832332502391449, 0.695763733872665, 0.7679293562873688, 0.7663611596519659, 0.7313823882181256, 0.8590175797604636, 0.8603866097727855, 0.7843840327662273, 0.8081674692239361, 0.6650369605132639]]","[""Opsoclonus Myoclonus Syndrome""]","[""LLM""]",What are the treatments for OMS (Opsoclonus Myoclonus Syndrome) ?,[true],[true],[true],"[""The treatments for OMS (Opsoclonus-Myoclonus Syndrome) include corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and sometimes chemotherapy.""]","[""Treatment for Opsoclonus Myoclonus includes corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and sometimes chemotherapy.""]","[""Treatment for Opsoclonus Myoclonus Syndrome (OMS) includes immunotherapy, corticosteroids, intravenous immunoglobulin (IVIG), and rituximab.""]",[true],[true],[true],"[""The treatments for OMS (Opsoclonus-Myoclonus Syndrome) include corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and sometimes chemotherapy.""]","[""Treatment for Opsoclonus Myoclonus includes corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and sometimes chemotherapy.""]","[""Treatment for Opsoclonus Myoclonus Syndrome (OMS) includes immunotherapy, corticosteroids, intravenous immunoglobulin (IVIG), and rituximab.""]",[false],[true],[true],"[""Treatment for OMS typically involves physical therapy, medication, and lifestyle modifications to manage symptoms and improve quality of life.""]","[""Treatment for Opsoclonus Myoclonus includes corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and sometimes chemotherapy.""]","[""Treatment for Opsoclonus Myoclonus Syndrome (OMS) includes immunotherapy, corticosteroids, intravenous immunoglobulin (IVIG), and rituximab.""]",[false],[true],[true],"[""Treatment for OMS includes physical therapy, medication, and in severe cases, surgery.""]","[""Treatment for Opsoclonus Myoclonus includes corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and sometimes chemotherapy.""]","[""Treatment for Opsoclonus-Myoclonus Syndrome (OMS) includes immunotherapy, corticosteroids, intravenous immunoglobulin (IVIG), and rituximab.""]",[false],[true],[true],"[""The treatments for OMS (Omsk, Russia) include antiviral medications, supportive care, and hospitalization if necessary.""]","[""Treatment for Opsoclonus Myoclonus includes corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and sometimes chemotherapy.""]","[""Treatment for Opsoclonus Myoclonus Syndrome (OMS) includes immunotherapy, corticosteroids, intravenous immunoglobulin (IVIG), and rituximab.""]",[false],[true],[true],"[""The treatments for OMS (Omsk, Russia) include corticosteroids, intravenous immunoglobulin (IVIG), and plasmapheresis.""]","[""Treatment for Opsoclonus Myoclonus includes corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and sometimes chemotherapy.""]","[""Treatment for Opsoclonus Myoclonus Syndrome (OMS) includes immunotherapy, corticosteroids, intravenous immunoglobulin (IVIG), and rituximab.""]",[false],[true],[true],"[""The treatments for OMS (Omsk, Russia) include corticosteroids, intravenous immunoglobulin (IVIG), plasmapheresis, and immunosuppressive therapy.""]","[""Treatment for Opsoclonus Myoclonus includes corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and sometimes chemotherapy.""]","[""Treatment for Opsoclonus Myoclonus Syndrome (OMS) includes immunotherapy, corticosteroids, intravenous immunoglobulin (IVIG), and rituximab.""]",[false],[true],[true],"[""The treatments for OMS (Omsk, Russia) include corticosteroids, intravenous immunoglobulin (IVIG), and plasmapheresis.""]","[""Treatment for Opsoclonus Myoclonus includes corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and sometimes chemotherapy.""]","[""Treatment for Opsoclonus-Myoclonus Syndrome (OMS) includes immunotherapy, corticosteroids, intravenous immunoglobulin (IVIG), and rituximab.""]",[true],[true],[true],"[""Treatment for OMS includes corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and sometimes chemotherapy.""]","[""Treatment for Opsoclonus Myoclonus includes corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and sometimes chemotherapy.""]","[""Treatment for Opsoclonus Myoclonus Syndrome (OMS) includes immunotherapy, corticosteroids, intravenous immunoglobulin (IVIG), and rituximab.""]",[true],[true],[true],"[""Treatment for OMS includes immunotherapy, corticosteroids, intravenous immunoglobulin (IVIG), and rituximab.""]","[""Treatment for Opsoclonus Myoclonus includes corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and sometimes chemotherapy.""]","[""Treatment for Opsoclonus Myoclonus Syndrome (OMS) includes immunotherapy, corticosteroids, intravenous immunoglobulin (IVIG), and rituximab.""]",[true],[true],[true],"[""Treatment for OMS includes immunotherapy, corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and sometimes chemotherapy.""]","[""Treatment for Opsoclonus Myoclonus includes corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and sometimes chemotherapy.""]","[""Treatment for Opsoclonus Myoclonus Syndrome (OMS) includes immunotherapy, corticosteroids, intravenous immunoglobulin (IVIG), and rituximab.""]",[true],[true],[true],"[""Treatment for OMS includes corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and sometimes chemotherapy.""]","[""Treatment for Opsoclonus Myoclonus includes corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and sometimes chemotherapy.""]","[""Treatment for Opsoclonus-Myoclonus Syndrome (OMS) includes immunotherapy, corticosteroids, intravenous immunoglobulin (IVIG), and rituximab.""]",[true],[true],[true],"[""Treatment for OMS may include corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and sometimes chemotherapy or other immunosuppressive agents.""]","[""Treatment for Opsoclonus Myoclonus includes corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and sometimes chemotherapy.""]","[""Treatment for Opsoclonus Myoclonus Syndrome (OMS) includes immunotherapy, corticosteroids, intravenous immunoglobulin (IVIG), and rituximab.""]",[true],[true],[true],"[""Treatment for OMS includes immunotherapy, corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and sometimes chemotherapy.""]","[""Treatment for Opsoclonus Myoclonus includes corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and sometimes chemotherapy.""]","[""Treatment for Opsoclonus Myoclonus Syndrome (OMS) includes immunotherapy, corticosteroids, intravenous immunoglobulin (IVIG), and rituximab.""]",[true],[true],[true],"[""Treatment for OMS includes corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and sometimes chemotherapy or radiation therapy.""]","[""Treatment for Opsoclonus Myoclonus includes corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and sometimes chemotherapy.""]","[""Treatment for Opsoclonus Myoclonus Syndrome (OMS) includes immunotherapy, corticosteroids, intravenous immunoglobulin (IVIG), and rituximab.""]",[true],[true],[true],"[""Treatment for OMS includes corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and sometimes chemotherapy.""]","[""Treatment for Opsoclonus Myoclonus includes corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and sometimes chemotherapy.""]","[""Treatment for Opsoclonus-Myoclonus Syndrome (OMS) includes immunotherapy, corticosteroids, intravenous immunoglobulin (IVIG), and rituximab.""]",[true],[true],[true],"[""Treatment for OMS includes immunotherapy, corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and tumor removal if associated with a neuroblastoma.""]","[""Treatment for Opsoclonus Myoclonus includes corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and sometimes chemotherapy.""]","[""Treatment for Opsoclonus Myoclonus Syndrome (OMS) includes immunotherapy, corticosteroids, intravenous immunoglobulin (IVIG), and rituximab.""]",[true],[true],[true],"[""Treatment for OMS includes corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and sometimes chemotherapy or radiation therapy.""]","[""Treatment for Opsoclonus Myoclonus includes corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and sometimes chemotherapy.""]","[""Treatment for Opsoclonus Myoclonus Syndrome (OMS) includes immunotherapy, corticosteroids, intravenous immunoglobulin (IVIG), and rituximab.""]",[true],[true],[true],"[""Treatment for OMS includes corticosteroids, intravenous immunoglobulins, rituximab, and sometimes chemotherapy.""]","[""Treatment for Opsoclonus Myoclonus includes corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and sometimes chemotherapy.""]","[""Treatment for Opsoclonus Myoclonus Syndrome (OMS) includes immunotherapy, corticosteroids, intravenous immunoglobulin (IVIG), and rituximab.""]",[true],[true],[true],"[""Treatment for OMS includes corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and sometimes chemotherapy.""]","[""Treatment for Opsoclonus Myoclonus includes corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and sometimes chemotherapy.""]","[""Treatment for Opsoclonus-Myoclonus Syndrome (OMS) includes immunotherapy, corticosteroids, intravenous immunoglobulin (IVIG), and rituximab.""]",[true],[true],[true],"[""Treatment for OMS includes immunotherapy, corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and sometimes chemotherapy.""]","[""Treatment for Opsoclonus Myoclonus includes corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and sometimes chemotherapy.""]","[""Treatment for Opsoclonus Myoclonus Syndrome (OMS) includes immunotherapy, corticosteroids, intravenous immunoglobulin (IVIG), and rituximab.""]",[true],[true],[true],"[""Treatment for OMS includes corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and sometimes chemotherapy or radiation therapy.""]","[""Treatment for Opsoclonus Myoclonus includes corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and sometimes chemotherapy.""]","[""Treatment for Opsoclonus Myoclonus Syndrome (OMS) includes immunotherapy, corticosteroids, intravenous immunoglobulin (IVIG), and rituximab.""]",[true],[true],[true],"[""The treatments for OMS (Opsoclonus Myoclonus Syndrome) include corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and ACTH (adrenocorticotropic hormone).""]","[""Treatment for Opsoclonus Myoclonus includes corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and sometimes chemotherapy.""]","[""Treatment for Opsoclonus Myoclonus Syndrome (OMS) includes immunotherapy, corticosteroids, intravenous immunoglobulin (IVIG), and rituximab.""]",[true],[true],[true],"[""Treatment for OMS includes immunotherapy, corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and sometimes chemotherapy.""]","[""Treatment for Opsoclonus Myoclonus includes corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and sometimes chemotherapy.""]","[""Treatment for Opsoclonus-Myoclonus Syndrome (OMS) includes immunotherapy, corticosteroids, intravenous immunoglobulin (IVIG), and rituximab.""]",[true],[true],[true],"[""The treatments for Opsoclonus Myoclonus Syndrome (OMS) include corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and sometimes chemotherapy or other immunosuppressive agents.""]","[""Treatment for Opsoclonus Myoclonus includes corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and sometimes chemotherapy.""]","[""Treatment for Opsoclonus Myoclonus Syndrome (OMS) includes immunotherapy, corticosteroids, intravenous immunoglobulin (IVIG), and rituximab.""]",[true],[true],[true],"[""Treatment for Opsoclonus Myoclonus Syndrome (OMS) may include corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and other immunosuppressive therapies. Additionally, supportive care such as physical therapy and speech therapy may be beneficial.""]","[""Treatment for Opsoclonus Myoclonus includes corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and sometimes chemotherapy.""]","[""Treatment for Opsoclonus Myoclonus Syndrome (OMS) includes immunotherapy, corticosteroids, intravenous immunoglobulin (IVIG), and rituximab.""]",[true],[true],[true],"[""Treatment for Opsoclonus Myoclonus Syndrome (OMS) may include corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and sometimes chemotherapy or other immunosuppressive agents. Additionally, supportive therapies such as physical therapy, speech therapy, and occupational therapy may be beneficial.""]","[""Treatment for Opsoclonus Myoclonus includes corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and sometimes chemotherapy.""]","[""Treatment for Opsoclonus Myoclonus Syndrome (OMS) includes immunotherapy, corticosteroids, intravenous immunoglobulin (IVIG), and rituximab.""]",[true],[true],[true],"[""Treatment for Opsoclonus Myoclonus Syndrome (OMS) may include corticosteroids, intravenous immunoglobulin (IVIG), rituximab, or other immunosuppressive therapies. Additionally, supportive care and physical therapy may be recommended.""]","[""Treatment for Opsoclonus Myoclonus includes corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and sometimes chemotherapy.""]","[""Treatment for Opsoclonus-Myoclonus Syndrome (OMS) includes immunotherapy, corticosteroids, intravenous immunoglobulin (IVIG), and rituximab.""]",[true],[true],[true],"[""Treatment for OMS may include corticosteroids, intravenous immunoglobulin (IVIG), rituximab, or other immunosuppressive therapies. Physical therapy and speech therapy may also be beneficial.""]","[""Treatment for Opsoclonus Myoclonus includes corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and sometimes chemotherapy.""]","[""Treatment for Opsoclonus Myoclonus Syndrome (OMS) includes immunotherapy, corticosteroids, intravenous immunoglobulin (IVIG), and rituximab.""]",[false],[true],[true],"[""The treatments for OMS (On My Side) may include physical therapy, pain management, and lifestyle modifications.""]","[""Treatment for Opsoclonus Myoclonus includes corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and sometimes chemotherapy.""]","[""Treatment for Opsoclonus Myoclonus Syndrome (OMS) includes immunotherapy, corticosteroids, intravenous immunoglobulin (IVIG), and rituximab.""]",[false],[true],[true],"[""The treatments for OMS (Omsk, Russia) may include antiviral medications, supportive care, and hospitalization if necessary.""]","[""Treatment for Opsoclonus Myoclonus includes corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and sometimes chemotherapy.""]","[""Treatment for Opsoclonus Myoclonus Syndrome (OMS) includes immunotherapy, corticosteroids, intravenous immunoglobulin (IVIG), and rituximab.""]",[true],[true],[true],"[""Treatment for OMS may include immunotherapy, corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and supportive care.""]","[""Treatment for Opsoclonus Myoclonus includes corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and sometimes chemotherapy.""]","[""Treatment for Opsoclonus Myoclonus Syndrome (OMS) includes immunotherapy, corticosteroids, intravenous immunoglobulin (IVIG), and rituximab.""]"
susceptibility,Who is at risk for Mitral Valve Prolapse? ?,"Mitral valve prolapse (MVP) affects people of all ages and both sexes; however, aging raises the risk of developing the disease.
                
Certain conditions have been associated with MVP, including:
                
A history of rheumatic fever
                
Connective tissue disorders, such as Marfan syndrome or Ehlers-Danlos syndrome
                
Graves disease
                
Scoliosis and other skeletal problems
                
Some types of muscular dystrophy","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""MVP"", ""full_form"": ""Mitral Valve Prolapse""}]}",Who is at risk for MVP? ?,Who is at risk for Mitral Valve Prolapse? ?,8,MEDICAL,Simple Datatype-String,"Exploratory(Divergent Thinking): Queries that are inherently about seeking new areas of knowledge, understanding emerging trends, or identifying unknown opportunities without a specific end goal of making a decision or judgment. Exploratory queries are characterized by their openness and the lack of a predefined objective, differentiating them from evaluative queries which are directed towards forming a judgment or assessment. Exploratory queries encourage branching out into various directions to explore a wide array of possibilities without necessarily aiming to converge on a single answer or outcome.","[[""Most Valuable Player"", ""Most Valuable Professional"", ""Mitral Valve Prolapse"", ""Most Valuable Primate"", ""Most Valued Professional"", ""Music And Video Player"", ""Music Video Player"", ""MindSolve Visual Performance"", ""Most Valuable Performer"", ""Music Video Pictures""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Mitral Valve Prolapse""]",[1.1833997773013537e-05],[1.1833997773013537e-05],"[""Mitral Valve Prolapse""]",[1.1833997773013537e-05],"[""ABBREVIATIONS""]","[[1.3385225099050623e-14, 1.4776723094583825e-16, 1.1833997773013537e-05, 8.283881413899933e-17, 7.995602374939574e-17, 4.14687469828309e-14, 3.0803300355438836e-14, 4.897033080463353e-21, 6.437152148441045e-17, 1.4392037754908479e-13]]",[0.9362387904884254],[0.9362387904884254],"[""Most Valuable Professional""]",[0.9362387904884254],"[""ABBREVIATIONS""]","[[0.8949932746423714, 0.8255271127652325, 0.9362387904884254, 0.6954940748109344, 0.7383043121316036, 0.7559504716964656, 0.7530531572316468, 0.7478933009189359, 0.7913020998465128, 0.800223310826431]]","[""Mitral Valve Prolapse""]","[""ABBREVIATIONS""]",Who is at risk for MVP (Mitral Valve Prolapse)? ?,[true],[true],[true],"[""People with a family history of MVP, connective tissue disorders, or certain heart conditions are at risk for Mitral Valve Prolapse.""]","[""People with a family history of mitral valve prolapse, those with connective tissue disorders, and individuals with certain heart conditions are at risk for mitral valve prolapse.""]","[""People with connective tissue disorders, such as Marfan syndrome, are at risk for mitral valve prolapse (MVP).""]",[true],[true],[true],"[""People with a family history of MVP, connective tissue disorders, or certain genetic conditions are at risk for Mitral Valve Prolapse.""]","[""Mitral Valve Prolapse is more common in women than in men. It can run in families, so there may be a genetic component. People with certain connective tissue disorders, such as Marfan syndrome, are also at higher risk.""]","[""People with connective tissue disorders, such as Marfan syndrome, are at risk for mitral valve prolapse (MVP).""]",[true],[true],[true],"[""People with a family history of MVP, connective tissue disorders, or certain genetic conditions are at risk for Mitral Valve Prolapse.""]","[""Mitral Valve Prolapse is more common in women than in men. It can run in families, so there may be a genetic component. People with certain connective tissue disorders, such as Marfan syndrome, are also at higher risk.""]","[""People with a family history of MVP, connective tissue disorders, or certain heart conditions are at risk for Mitral Valve Prolapse (MVP).""]",[true],[true],[true],"[""People with a family history of MVP, connective tissue disorders, or certain genetic conditions are at risk for Mitral Valve Prolapse.""]","[""Mitral Valve Prolapse is more common in women than in men, and it tends to run in families. People with certain connective tissue disorders, such as Marfan syndrome, are also at higher risk.""]","[""People with a family history of MVP, connective tissue disorders, or certain genetic conditions are at risk for Mitral Valve Prolapse (MVP).""]",[true],[true],[true],"[""Individuals with connective tissue disorders, such as Marfan syndrome, are at risk for mitral valve prolapse (MVP).""]","[""People with a family history of mitral valve prolapse, those with connective tissue disorders, and individuals with certain heart conditions are at risk for mitral valve prolapse.""]","[""People with connective tissue disorders, such as Marfan syndrome, are at risk for mitral valve prolapse (MVP).""]",[true],[true],[true],"[""People with connective tissue disorders, such as Marfan syndrome, are at risk for MVP (Mitral Valve Prolapse).""]","[""Mitral Valve Prolapse is more common in women than in men. It can run in families, so there may be a genetic component. People with certain connective tissue disorders, such as Marfan syndrome, are also at higher risk.""]","[""People with connective tissue disorders, such as Marfan syndrome, are at risk for mitral valve prolapse (MVP).""]",[true],[true],[true],"[""Individuals with a family history of mitral valve prolapse (MVP) are at risk for developing the condition.""]","[""Mitral Valve Prolapse is more common in women than in men. It can run in families, so there may be a genetic component. People with certain connective tissue disorders, such as Marfan syndrome, are also at higher risk.""]","[""People with a family history of MVP, connective tissue disorders, or certain heart conditions are at risk for Mitral Valve Prolapse (MVP).""]",[true],[true],[true],"[""Individuals with a family history of MVP, connective tissue disorders, or certain heart conditions are at risk for Mitral Valve Prolapse.""]","[""Mitral Valve Prolapse is more common in women than in men, and it tends to run in families. People with certain connective tissue disorders, such as Marfan syndrome, are also at higher risk.""]","[""People with a family history of MVP, connective tissue disorders, or certain genetic conditions are at risk for Mitral Valve Prolapse (MVP).""]",[true],[true],[true],"[""People with a family history of MVP, connective tissue disorders, or certain genetic conditions are at risk for Mitral Valve Prolapse.""]","[""Mitral Valve Prolapse is more common in women than in men. It can run in families, so there may be a genetic component. People with certain connective tissue disorders, such as Marfan syndrome, are also at higher risk.""]","[""People with connective tissue disorders, such as Marfan syndrome, are at risk for mitral valve prolapse (MVP).""]",[true],[true],[true],"[""People with a family history of MVP, connective tissue disorders, or certain genetic conditions are at risk for Mitral Valve Prolapse.""]","[""People with a family history of mitral valve prolapse, those with connective tissue disorders, and individuals with certain heart conditions are at risk for mitral valve prolapse.""]","[""People with connective tissue disorders, such as Marfan syndrome, are at risk for mitral valve prolapse (MVP).""]",[true],[true],[true],"[""People with a family history of MVP, connective tissue disorders, or certain genetic conditions are at risk for Mitral Valve Prolapse.""]","[""Mitral Valve Prolapse is more common in women than in men. It can run in families, so there may be a genetic component. People with certain connective tissue disorders, such as Marfan syndrome, are also at higher risk.""]","[""People with a family history of MVP, connective tissue disorders, or certain heart conditions are at risk for Mitral Valve Prolapse (MVP).""]",[true],[true],[true],"[""People with a family history of MVP, connective tissue disorders, or certain genetic conditions are at risk for Mitral Valve Prolapse.""]","[""Mitral Valve Prolapse is more common in women than in men, and it tends to run in families. People with certain connective tissue disorders, such as Marfan syndrome, are also at higher risk.""]","[""People with a family history of MVP, connective tissue disorders, or certain genetic conditions are at risk for Mitral Valve Prolapse (MVP).""]",[true],[true],[true],"[""People with a family history of MVP, connective tissue disorders, or certain heart conditions are at risk for Mitral Valve Prolapse.""]","[""People with a family history of mitral valve prolapse, those with connective tissue disorders, and individuals with certain heart conditions are at risk for mitral valve prolapse.""]","[""People with connective tissue disorders, such as Marfan syndrome, are at risk for mitral valve prolapse (MVP).""]",[true],[true],[true],"[""People with a family history of MVP, connective tissue disorders, or certain genetic conditions are at risk for Mitral Valve Prolapse.""]","[""Mitral Valve Prolapse is more common in women than in men. It can run in families, so there may be a genetic component. People with certain connective tissue disorders, such as Marfan syndrome, are also at higher risk.""]","[""People with connective tissue disorders, such as Marfan syndrome, are at risk for mitral valve prolapse (MVP).""]",[true],[true],[true],"[""People with a family history of MVP, connective tissue disorders, or certain genetic conditions are at risk for Mitral Valve Prolapse.""]","[""Mitral Valve Prolapse is more common in women than in men. It can run in families, so there may be a genetic component. People with certain connective tissue disorders, such as Marfan syndrome, are also at higher risk.""]","[""People with a family history of MVP, connective tissue disorders, or certain heart conditions are at risk for Mitral Valve Prolapse (MVP).""]",[true],[true],[true],"[""People with a family history of MVP, connective tissue disorders, or certain heart conditions are at risk for Mitral Valve Prolapse.""]","[""Mitral Valve Prolapse is more common in women than in men, and it tends to run in families. People with certain connective tissue disorders, such as Marfan syndrome, are also at higher risk.""]","[""People with a family history of MVP, connective tissue disorders, or certain genetic conditions are at risk for Mitral Valve Prolapse (MVP).""]",[true],[true],[true],"[""People with a family history of MVP, connective tissue disorders, or certain heart conditions are at risk for Mitral Valve Prolapse.""]","[""People with a family history of mitral valve prolapse, those with connective tissue disorders, and individuals with certain heart conditions are at risk for mitral valve prolapse.""]","[""People with connective tissue disorders, such as Marfan syndrome, are at risk for mitral valve prolapse (MVP).""]",[true],[true],[true],"[""People with a family history of MVP, connective tissue disorders, or certain genetic conditions are at risk for Mitral Valve Prolapse.""]","[""Mitral Valve Prolapse is more common in women than in men. It can run in families, so there may be a genetic component. People with certain connective tissue disorders, such as Marfan syndrome, are also at higher risk.""]","[""People with connective tissue disorders, such as Marfan syndrome, are at risk for mitral valve prolapse (MVP).""]",[true],[true],[true],"[""People with a family history of MVP, connective tissue disorders, or certain genetic conditions are at risk for Mitral Valve Prolapse.""]","[""Mitral Valve Prolapse is more common in women than in men. It can run in families, so there may be a genetic component. People with certain connective tissue disorders, such as Marfan syndrome, are also at higher risk.""]","[""People with a family history of MVP, connective tissue disorders, or certain heart conditions are at risk for Mitral Valve Prolapse (MVP).""]",[true],[true],[true],"[""People with a family history of MVP, connective tissue disorders, or certain genetic conditions are at risk for Mitral Valve Prolapse.""]","[""Mitral Valve Prolapse is more common in women than in men, and it tends to run in families. People with certain connective tissue disorders, such as Marfan syndrome, are also at higher risk.""]","[""People with a family history of MVP, connective tissue disorders, or certain genetic conditions are at risk for Mitral Valve Prolapse (MVP).""]",[true],[true],[true],"[""Individuals with a family history of MVP, connective tissue disorders, or certain genetic conditions are at risk for Mitral Valve Prolapse.""]","[""People with a family history of mitral valve prolapse, those with connective tissue disorders, and individuals with certain heart conditions are at risk for mitral valve prolapse.""]","[""People with connective tissue disorders, such as Marfan syndrome, are at risk for mitral valve prolapse (MVP).""]",[true],[true],[true],"[""People with a family history of MVP, connective tissue disorders, or certain genetic conditions are at risk for Mitral Valve Prolapse.""]","[""Mitral Valve Prolapse is more common in women than in men. It can run in families, so there may be a genetic component. People with certain connective tissue disorders, such as Marfan syndrome, are also at higher risk.""]","[""People with connective tissue disorders, such as Marfan syndrome, are at risk for mitral valve prolapse (MVP).""]",[true],[true],[true],"[""People with a family history of MVP, connective tissue disorders, or certain genetic conditions are at risk for Mitral Valve Prolapse.""]","[""Mitral Valve Prolapse is more common in women than in men. It can run in families, so there may be a genetic component. People with certain connective tissue disorders, such as Marfan syndrome, are also at higher risk.""]","[""People with a family history of MVP, connective tissue disorders, or certain heart conditions are at risk for Mitral Valve Prolapse (MVP).""]",[true],[true],[true],"[""People with a family history of MVP, connective tissue disorders, or certain genetic conditions are at risk for Mitral Valve Prolapse.""]","[""Mitral Valve Prolapse is more common in women than in men, and it tends to run in families. People with certain connective tissue disorders, such as Marfan syndrome, are also at higher risk.""]","[""People with a family history of MVP, connective tissue disorders, or certain genetic conditions are at risk for Mitral Valve Prolapse (MVP).""]",[true],[true],[true],"[""People with a family history of MVP, connective tissue disorders, or certain genetic conditions are at risk for Mitral Valve Prolapse.""]","[""People with a family history of mitral valve prolapse, those with connective tissue disorders, and individuals with certain heart conditions are at risk for mitral valve prolapse.""]","[""People with connective tissue disorders, such as Marfan syndrome, are at risk for mitral valve prolapse (MVP).""]",[true],[true],[true],"[""People with a family history of MVP, women, and individuals with connective tissue disorders are at risk for Mitral Valve Prolapse.""]","[""Mitral Valve Prolapse is more common in women than in men. It can run in families, so there may be a genetic component. People with certain connective tissue disorders, such as Marfan syndrome, are also at higher risk.""]","[""People with connective tissue disorders, such as Marfan syndrome, are at risk for mitral valve prolapse (MVP).""]",[true],[true],[true],"[""Individuals with a family history of MVP, those with connective tissue disorders, and women are at risk for Mitral Valve Prolapse.""]","[""Mitral Valve Prolapse is more common in women than in men. It can run in families, so there may be a genetic component. People with certain connective tissue disorders, such as Marfan syndrome, are also at higher risk.""]","[""People with a family history of MVP, connective tissue disorders, or certain heart conditions are at risk for Mitral Valve Prolapse (MVP).""]",[true],[true],[true],"[""People with a family history of MVP, connective tissue disorders, or certain genetic conditions are at risk for Mitral Valve Prolapse.""]","[""Mitral Valve Prolapse is more common in women than in men, and it tends to run in families. People with certain connective tissue disorders, such as Marfan syndrome, are also at higher risk.""]","[""People with a family history of MVP, connective tissue disorders, or certain genetic conditions are at risk for Mitral Valve Prolapse (MVP).""]",[true],[true],[true],"[""People with a family history of MVP, connective tissue disorders, or certain heart conditions are at risk for Mitral Valve Prolapse.""]","[""People with a family history of mitral valve prolapse, those with connective tissue disorders, and individuals with certain heart conditions are at risk for mitral valve prolapse.""]","[""People with connective tissue disorders, such as Marfan syndrome, are at risk for mitral valve prolapse (MVP).""]",[true],[true],[true],"[""Individuals with a family history of MVP, those with connective tissue disorders, and women are at higher risk for Mitral Valve Prolapse.""]","[""People with a family history of mitral valve prolapse, those with connective tissue disorders, and individuals with certain heart conditions are at risk for mitral valve prolapse.""]","[""People with connective tissue disorders, such as Marfan syndrome, are at risk for mitral valve prolapse (MVP).""]",[false],[true],[true],"[""Individuals who actively contribute to the community, demonstrate expertise in a specific technology, and are recognized by Microsoft as MVP candidates.""]","[""People with a family history of mitral valve prolapse, those with connective tissue disorders, and individuals with certain heart conditions are at risk for mitral valve prolapse.""]","[""People with connective tissue disorders, such as Marfan syndrome, are at risk for mitral valve prolapse (MVP).""]",[true],[true],[true],"[""People with a family history of MVP, connective tissue disorders, or certain heart conditions are at risk for Mitral Valve Prolapse.""]","[""People with a family history of mitral valve prolapse, those with connective tissue disorders, and individuals with certain heart conditions are at risk for mitral valve prolapse.""]","[""People with connective tissue disorders, such as Marfan syndrome, are at risk for mitral valve prolapse (MVP).""]"
considerations,What to do for Medicare and Continuing Care ?,"Nursing home care can be very expensive. Medicare generally doesn't cover nursing home care. There are many ways people can pay for nursing home care. For example, they can use their own money, they may be able to get help from their state, or they may use long-term care insurance. Nursing home care isn't covered by many types of health insurance. Most people who enter nursing homes begin by paying for their care out of their own pocket. As they use up their resources over a period of time, they may eventually become eligible for Medicaid. Medicaid is a state and Federal program that will pay most nursing home costs for people with limited income and resources. Eligibility varies by state. Medicaid pays for care for about 7 out of every 10 nursing home residents. Medicaid will pay for nursing home care only when provided in a Medicaid-certified facility. For information about Medicaid eligibility, call your state Medical Assistance (Medicaid) Office. If you have questions about Medicaid, you can call your State Medical Assistance (Medicaid) office for more information. Visit http://www.medicare.gov on the web. (Under ""Search Tools,"" select ""Find Helpful Phone Numbers and Websites."") Or, call 1-800-Medicare (1-800-633-4227) to get the telephone number. TTY users should call 1-877-486-2048.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""abbreviation"", ""abbreviation"": ""Medicare"", ""full_form"": ""Medical Care""}]}",What to do for Medicare and Continuing Care ?,What to do for Medical Care and Continuing Care ?,8,MEDICAL,Simple Datatype-String,"Instructional: Queries specifically seeking step-by-step guidance, instructions, or procedures to perform a task. it focuses on 'how' to do something rather than 'what', 'why', or 'which'.","[[""MEDICARE"", ""Medical Care""]]","[[""THEFREEDICTIONARY"", ""THEFREEDICTIONARY""]]","[""Medicare""]",[2.7769960174521297e-05],[0.009772400227827887],"[""MEDICARE""]",[0.009772400227827887],"[""THEFREEDICTIONARY""]","[[0.009772400227827887, 2.7769960174521297e-05]]",[0.9537996928404854],[0.9754812363498846],"[""Medical Care""]",[0.9754812363498846],"[""LLM""]","[[0.973839850932631, 0.9537996928404854]]","[""MEDICARE""]","[""THEFREEDICTIONARY""]",What to do for Medicare (Medicare) and Continuing Care ?,[false],[false],[false],"[""For Medicare and Continuing Care, individuals can start by researching and understanding the eligibility criteria for Medicare coverage. They should then explore different Medicare plans available and choose one that best suits their needs. Additionally, individuals can look into Continuing Care Retirement Communities (CCRCs) which offer a range of services from independent living to skilled nursing care. It is important to compare different CCRCs, visit the facilities, and understand the contract terms before making a decision.""]","[""For medical care, seek treatment from a healthcare provider. For continuing care, follow the treatment plan provided by the healthcare provider and attend follow-up appointments as scheduled.""]","[""For Medicare and Continuing Care, it is important to consult with a healthcare provider to understand the specific coverage options available and to create a personalized care plan.""]",[true],[false],[true],"[""For Medicare and Continuing Care, individuals can start by researching and understanding the eligibility criteria for Medicare coverage, including the different parts of Medicare such as Part A, Part B, Part C, and Part D. It is important to evaluate the specific healthcare needs and preferences to determine the most suitable coverage options. Additionally, individuals can explore Continuing Care Retirement Communities (CCRCs) which offer a range of housing and healthcare services to support aging individuals. Consulting with healthcare providers, insurance agents, and financial advisors can also provide valuable guidance in navigating Medicare and Continuing Care options.""]","[""For medical care, seek treatment from a healthcare provider. For continuing care, follow the provider's recommendations and attend follow-up appointments as scheduled.""]","[""For Medicare and Continuing Care, it is important to consult with healthcare providers to understand the available options and eligibility criteria. Additionally, research different plans and services offered to determine the best fit for your needs.""]",[true],[false],[true],"[""For Medicare and Continuing Care, it is important to first understand the eligibility criteria and coverage options. Then, you can contact the Medicare office or a healthcare provider to discuss your specific needs and develop a care plan tailored to your situation.""]","[""For medical care, seek treatment from a healthcare provider. For continuing care, follow the treatment plan provided by the healthcare provider and attend follow-up appointments as scheduled.""]","[""For Medicare and Continuing Care, it is important to consult with healthcare providers to understand the specific coverage options available and to create a personalized care plan that meets the individual's needs.""]",[true],[false],[true],"[""For Medicare and Continuing Care, it is important to consult with healthcare providers to understand the eligibility criteria, coverage options, and application process. Additionally, researching different plans and comparing benefits can help in making an informed decision.""]","[""For medical care, seek treatment from a healthcare provider such as a doctor or nurse. For continuing care, follow the treatment plan provided by your healthcare provider and attend follow-up appointments as scheduled.""]","[""For Medicare and Continuing Care, it is important to consult with healthcare providers to understand the eligibility criteria, coverage options, and application process. Additionally, staying informed about any updates or changes in policies is crucial for receiving the necessary care and benefits.""]",[true],[false],[true],"[""For Medicare and continuing care, it is important to first understand the eligibility criteria and coverage options. Then, consult with healthcare providers to create a personalized care plan. Regularly review and update the care plan as needed to ensure comprehensive and continuous medical care.""]","[""For medical care, seek treatment from a healthcare provider. For continuing care, follow the treatment plan provided by the healthcare provider and attend follow-up appointments as scheduled.""]","[""For Medicare and Continuing Care, it is important to consult with a healthcare provider to understand the specific coverage options available and to create a personalized care plan.""]",[true],[false],[true],"[""For Medicare and continuing care, it is important to regularly review your coverage options, understand the benefits and limitations of each plan, and consult with healthcare providers to ensure you are receiving appropriate care.""]","[""For medical care, seek treatment from a healthcare provider. For continuing care, follow the provider's recommendations and attend follow-up appointments as scheduled.""]","[""For Medicare and Continuing Care, it is important to consult with healthcare providers to understand the available options and eligibility criteria. Additionally, research different plans and services offered to determine the best fit for your needs.""]",[true],[false],[true],"[""For Medicare and continuing care, it is important to regularly review and update your coverage, understand your benefits, and communicate with your healthcare providers to ensure you are receiving the appropriate care.""]","[""For medical care, seek treatment from a healthcare provider. For continuing care, follow the treatment plan provided by the healthcare provider and attend follow-up appointments as scheduled.""]","[""For Medicare and Continuing Care, it is important to consult with healthcare providers to understand the specific coverage options available and to create a personalized care plan that meets the individual's needs.""]",[true],[false],[true],"[""For Medicare and continuing care, it is important to first understand the eligibility criteria and coverage options. Then, consult with healthcare providers to create a personalized care plan. Regularly review and update the plan as needed to ensure comprehensive and continuous care.""]","[""For medical care, seek treatment from a healthcare provider such as a doctor or nurse. For continuing care, follow the treatment plan provided by your healthcare provider and attend follow-up appointments as scheduled.""]","[""For Medicare and Continuing Care, it is important to consult with healthcare providers to understand the eligibility criteria, coverage options, and application process. Additionally, staying informed about any updates or changes in policies is crucial for receiving the necessary care and benefits.""]",[true],[false],[true],"[""For Medicare and Continuing Care, you should first ensure that you meet the eligibility criteria for Medicare coverage. Then, you can explore the different options available for continuing care such as home health services, nursing homes, or assisted living facilities. It is important to consult with healthcare providers and insurance experts to understand the best course of action for your specific needs.""]","[""For medical care, seek treatment from a healthcare provider. For continuing care, follow the provider's recommendations and attend follow-up appointments as scheduled.""]","[""For Medicare and Continuing Care, it is important to consult with healthcare providers to understand the available options and eligibility criteria. Additionally, research different plans and services offered to determine the best fit for your needs.""]",[true],[false],[true],"[""For Medicare and Continuing Care, it is important to first understand the eligibility criteria and coverage options. Then, consult with healthcare providers to determine the best plan of care. Make sure to regularly review and update the care plan as needed to ensure optimal health outcomes.""]","[""For medical care, seek treatment from a healthcare provider. For continuing care, follow the treatment plan provided by the healthcare provider and attend follow-up appointments as scheduled.""]","[""For Medicare and Continuing Care, it is important to consult with a healthcare provider to understand the specific coverage options available and to create a personalized care plan.""]",[true],[false],[true],"[""For Medicare and Continuing Care, it is important to first understand the eligibility criteria and coverage options. Then, you can contact Medicare directly or visit their website to explore available plans and enroll in a suitable one. Additionally, consider consulting with healthcare providers or insurance agents for personalized guidance.""]","[""For medical care, seek treatment from a healthcare provider. For continuing care, follow the treatment plan provided by the healthcare provider and attend follow-up appointments as scheduled.""]","[""For Medicare and Continuing Care, it is important to consult with healthcare providers to understand the specific coverage options available and to create a personalized care plan that meets the individual's needs.""]",[true],[false],[true],"[""For Medicare and Continuing Care, it is important to first understand the eligibility criteria and coverage options. Then, you can contact Medicare directly or visit their website to explore available plans and enroll in the one that best suits your needs.""]","[""For medical care, seek treatment from a healthcare provider such as a doctor or nurse. For continuing care, follow the treatment plan provided by your healthcare provider and attend follow-up appointments as scheduled.""]","[""For Medicare and Continuing Care, it is important to consult with healthcare providers to understand the eligibility criteria, coverage options, and application process. Additionally, staying informed about any updates or changes in policies is crucial for receiving the necessary care and benefits.""]",[true],[false],[true],"[""For Medicare and Continuing Care, it is important to review your coverage options and choose a plan that best fits your needs. You can also consider consulting with a healthcare provider or a Medicare specialist for personalized guidance.""]","[""For medical care, seek treatment from a healthcare provider. For continuing care, follow the treatment plan provided by the healthcare provider and attend follow-up appointments as scheduled.""]","[""For Medicare and Continuing Care, it is important to consult with a healthcare provider to understand the specific coverage options available and to create a personalized care plan.""]",[true],[false],[true],"[""For Medicare and Continuing Care, individuals can consider enrolling in a Medicare Advantage plan that offers additional benefits beyond Original Medicare, such as vision, dental, and prescription drug coverage. It is also important to explore options for long-term care insurance to help cover the costs of continuing care services.""]","[""For medical care, seek treatment from a healthcare provider. For continuing care, follow the provider's recommendations and attend follow-up appointments as scheduled.""]","[""For Medicare and Continuing Care, it is important to consult with healthcare providers to understand the available options and eligibility criteria. Additionally, research different plans and services offered to determine the best fit for your needs.""]",[true],[false],[true],"[""For Medicare and Continuing Care, individuals can consider enrolling in a Medicare Advantage plan that includes coverage for long-term care services or purchasing a separate long-term care insurance policy.""]","[""For medical care, seek treatment from a healthcare provider. For continuing care, follow the treatment plan provided by the healthcare provider and attend follow-up appointments as scheduled.""]","[""For Medicare and Continuing Care, it is important to consult with healthcare providers to understand the specific coverage options available and to create a personalized care plan that meets the individual's needs.""]",[true],[false],[true],"[""For Medicare and Continuing Care, individuals can consider enrolling in Medicare Advantage plans or Medicare Supplement plans to enhance their coverage and access to care.""]","[""For medical care, seek treatment from a healthcare provider such as a doctor or nurse. For continuing care, follow the treatment plan provided by your healthcare provider and attend follow-up appointments as scheduled.""]","[""For Medicare and Continuing Care, it is important to consult with healthcare providers to understand the eligibility criteria, coverage options, and application process. Additionally, staying informed about any updates or changes in policies is crucial for receiving the necessary care and benefits.""]",[false],[false],[false],"[""For Medicare and Continuing Care, you should first check your eligibility for Medicare. Then, explore the different Medicare plans available and choose one that suits your needs. Next, research Continuing Care options in your area and compare services and costs. Finally, make an informed decision based on your healthcare needs and financial situation.""]","[""For medical care, seek treatment from a healthcare provider. For continuing care, follow the treatment plan provided by the healthcare provider and attend follow-up appointments as scheduled.""]","[""For Medicare and Continuing Care, it is important to consult with a healthcare provider to understand the specific coverage options available and to create a personalized care plan.""]",[true],[false],[true],"[""For Medicare and Continuing Care, individuals can contact their healthcare provider to discuss eligibility and options available. It is recommended to review the specific coverage details of the Medicare plan and inquire about any additional services or programs that may support continuing care needs.""]","[""For medical care, seek treatment from a healthcare provider. For continuing care, follow the provider's recommendations and attend follow-up appointments as scheduled.""]","[""For Medicare and Continuing Care, it is important to consult with healthcare providers to understand the available options and eligibility criteria. Additionally, research different plans and services offered to determine the best fit for your needs.""]",[false],[false],[false],"[""For Medicare and Continuing Care, individuals can start by researching and understanding the eligibility criteria for Medicare coverage. They should then contact their local Medicare office to inquire about available options for continuing care services. It is important to discuss specific needs and preferences with healthcare providers to determine the most suitable care plan. Additionally, individuals can explore different care facilities or providers to find the best match for their requirements.""]","[""For medical care, seek treatment from a healthcare provider. For continuing care, follow the treatment plan provided by the healthcare provider and attend follow-up appointments as scheduled.""]","[""For Medicare and Continuing Care, it is important to consult with healthcare providers to understand the specific coverage options available and to create a personalized care plan that meets the individual's needs.""]",[true],[false],[true],"[""For Medicare and Continuing Care, it is important to first understand the eligibility criteria and coverage options. Then, you can contact Medicare directly or visit their website to enroll in the appropriate plan. Additionally, it is recommended to consult with healthcare providers and insurance experts to ensure you are making the best decision for your continuing care needs.""]","[""For medical care, seek treatment from a healthcare provider such as a doctor or nurse. For continuing care, follow the treatment plan provided by your healthcare provider and attend follow-up appointments as scheduled.""]","[""For Medicare and Continuing Care, it is important to consult with healthcare providers to understand the eligibility criteria, coverage options, and application process. Additionally, staying informed about any updates or changes in policies is crucial for receiving the necessary care and benefits.""]",[true],[false],[true],"[""For Medicare and Continuing Care, you can start by contacting your local Medicare office to inquire about available options and eligibility criteria. They will guide you through the process of applying for Medicare benefits and continuing care services.""]","[""For medical care, seek treatment from a healthcare provider. For continuing care, follow the treatment plan provided by the healthcare provider and attend follow-up appointments as scheduled.""]","[""For Medicare and Continuing Care, it is important to consult with a healthcare provider to understand the specific coverage options available and to create a personalized care plan.""]",[true],[false],[true],"[""For Medicare and Continuing Care, individuals should consult with their healthcare provider to determine the best course of action based on their specific needs and circumstances.""]","[""For medical care, seek treatment from a healthcare provider. For continuing care, follow the provider's recommendations and attend follow-up appointments as scheduled.""]","[""For Medicare and Continuing Care, it is important to consult with healthcare providers to understand the available options and eligibility criteria. Additionally, research different plans and services offered to determine the best fit for your needs.""]",[true],[false],[true],"[""For Medicare and Continuing Care, it is important to consult with healthcare providers to understand the specific coverage options available and to create a comprehensive care plan tailored to individual needs.""]","[""For medical care, seek treatment from a healthcare provider. For continuing care, follow the treatment plan provided by the healthcare provider and attend follow-up appointments as scheduled.""]","[""For Medicare and Continuing Care, it is important to consult with healthcare providers to understand the specific coverage options available and to create a personalized care plan that meets the individual's needs.""]",[true],[false],[true],"[""For Medicare and Continuing Care, it is recommended to consult with a healthcare provider to discuss the specific needs and options available. They can provide guidance on the eligibility criteria, coverage options, and steps to enroll in the program.""]","[""For medical care, seek treatment from a healthcare provider such as a doctor or nurse. For continuing care, follow the treatment plan provided by your healthcare provider and attend follow-up appointments as scheduled.""]","[""For Medicare and Continuing Care, it is important to consult with healthcare providers to understand the eligibility criteria, coverage options, and application process. Additionally, staying informed about any updates or changes in policies is crucial for receiving the necessary care and benefits.""]",[true],[false],[true],"[""For Medicare and Continuing Care, you should first gather all relevant documents and information. Then, contact the Medicare office to inquire about eligibility and coverage. Next, research and compare different Continuing Care options available in your area. Finally, schedule visits to the facilities you are interested in and ask detailed questions to make an informed decision.""]","[""For medical care, seek treatment from a healthcare provider. For continuing care, follow the treatment plan provided by the healthcare provider and attend follow-up appointments as scheduled.""]","[""For Medicare and Continuing Care, it is important to consult with a healthcare provider to understand the specific coverage options available and to create a personalized care plan.""]",[true],[false],[true],"[""For Medicare (MEDICARE) and Continuing Care, you can start by researching the eligibility criteria for Medicare coverage and the types of services covered. Then, consider contacting Medicare directly or visiting their official website to get more information. Additionally, for Continuing Care, you may want to explore different options available in your area, such as assisted living facilities, nursing homes, or home health care services, and evaluate which best suits your needs or the needs of your loved ones.""]","[""For medical care, seek treatment from a healthcare provider. For continuing care, follow the provider's recommendations and attend follow-up appointments as scheduled.""]","[""For Medicare and Continuing Care, it is important to consult with healthcare providers to understand the available options and eligibility criteria. Additionally, research different plans and services offered to determine the best fit for your needs.""]",[true],[false],[false],"[""For Medicare (MEDICARE) and Continuing Care, you can start by researching the eligibility criteria for Medicare coverage and the types of services covered. Then, consider contacting Medicare directly or visiting their official website to get more information on how to apply for benefits. Additionally, for Continuing Care, you may want to explore different options available in your area, such as assisted living facilities or nursing homes, and inquire about their services and admission process.""]","[""For medical care, seek treatment from a healthcare provider. For continuing care, follow the treatment plan provided by the healthcare provider and attend follow-up appointments as scheduled.""]","[""For Medicare and Continuing Care, it is important to consult with healthcare providers to understand the specific coverage options available and to create a personalized care plan that meets the individual's needs.""]",[true],[false],[true],"[""For Medicare and Continuing Care, you should first gather all relevant documentation and information. Then, contact the Medicare office to inquire about eligibility and coverage options. Next, schedule an appointment with a Continuing Care facility to discuss your needs and preferences. Finally, review all the information provided and make an informed decision based on your specific situation.""]","[""For medical care, seek treatment from a healthcare provider such as a doctor or nurse. For continuing care, follow the treatment plan provided by your healthcare provider and attend follow-up appointments as scheduled.""]","[""For Medicare and Continuing Care, it is important to consult with healthcare providers to understand the eligibility criteria, coverage options, and application process. Additionally, staying informed about any updates or changes in policies is crucial for receiving the necessary care and benefits.""]",[false],[false],[false],"[""For Medicare and Continuing Care, you can consider exploring options such as Medicare Advantage plans, Medigap policies, and long-term care insurance to ensure comprehensive coverage for your healthcare needs.""]","[""For medical care, seek treatment from a healthcare provider. For continuing care, follow the treatment plan provided by the healthcare provider and attend follow-up appointments as scheduled.""]","[""For Medicare and Continuing Care, it is important to consult with a healthcare provider to understand the specific coverage options available and to create a personalized care plan.""]",[true],[false],[false],"[""For Medicare (MEDICARE) and Continuing Care, you can explore options for long-term care insurance, consider Medicare Advantage plans, and research continuing care retirement communities.""]","[""For medical care, seek treatment from a healthcare provider. For continuing care, follow the treatment plan provided by the healthcare provider and attend follow-up appointments as scheduled.""]","[""For Medicare and Continuing Care, it is important to consult with a healthcare provider to understand the specific coverage options available and to create a personalized care plan.""]",[true],[true],[true],"[""For Medicare (Medical Care) and Continuing Care, you can consider exploring options such as Medicare Advantage plans, long-term care insurance, or retirement communities with healthcare services.""]","[""For medical care, seek treatment from a healthcare provider. For continuing care, follow the treatment plan provided by the healthcare provider and attend follow-up appointments as scheduled.""]","[""For Medicare and Continuing Care, it is important to consult with a healthcare provider to understand the specific coverage options available and to create a personalized care plan.""]",[true],[false],[true],"[""For Medicare and Continuing Care, you can consider exploring options such as Medicare Advantage plans, Medigap policies, and long-term care insurance to ensure comprehensive coverage for your healthcare needs.""]","[""For medical care, seek treatment from a healthcare provider. For continuing care, follow the treatment plan provided by the healthcare provider and attend follow-up appointments as scheduled.""]","[""For Medicare and Continuing Care, it is important to consult with a healthcare provider to understand the specific coverage options available and to create a personalized care plan.""]"
causes,What causes GM1 gangliosidosis ?,"What causes GM1 gangliosidosis? All three types of GM1 gangliosidosis are caused by mutations (changes) in the GLB1 gene. This gene gives the body instructions to make an enzyme called beta-galactosidase (-galactosidase), which plays an important role in the brain. The enzyme resides in compartments within cells called lysosomes, where it helps break down certain molecules, including a substance called GM1 ganglioside. GM1 ganglioside is important for nerve cell function in the brain. Mutations in the GLB1 gene may lower or eliminate the activity of the -galactosidase enzyme, keeping GM1 ganglioside from being broken down. As a result, it accumulates to toxic levels in tissues and organs, particularly in the brain. This accumulation leads to the destruction of nerve cells, causing the features of the condition. In general, people with higher enzyme activity levels usually have milder features than those with lower activity levels.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""abbreviation"", ""abbreviation"": ""GM1"", ""full_form"": ""Ganglioside Monosialotetrahexosylganglioside 1""}]}",What causes GM1 gangliosidosis ?,What causes Ganglioside Monosialotetrahexosylganglioside 1 gangliosidosis ?,8,MEDICAL,Compound Datatype-String,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Gunners Mate First Class"", ""Glycolipid mimic 1"", ""Gunner's Mate 1st Class Petty Officer"", ""Gunner&#39;s Mate First Class (USN Rating)"", ""Monosialotetrahexosylganglioside"", ""Gunner's Mate First Class (USN Rating)""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ACRONYMFINDER"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY""]]","[""Ganglioside Monosialotetrahexosylganglioside""]",[1.2298169643649693e-51],[2.623310767659405e-48],"[""Glycolipid mimic 1""]",[2.8900400052957853e-19],"[""ABBREVIATIONS""]","[[2.6893385951929567e-21, 2.8900400052957853e-19, 3.009946741566787e-38, 2.7771696846218706e-55, 7.84115092812201e-42, 4.617203340362612e-39]]",[0.933874275789772],[0.9433127104561945],"[""Gunner's Mate First Class (USN Rating)""]",[0.9433127104561945],"[""LLM""]","[[0.8879597996107986, 0.9194040661501053, 0.8849561235861195, 0.8520408365556749, 0.939440997549247, 0.8650421632953699]]","[""Monosialotetrahexosylganglioside""]","[""THEFREEDICTIONARY""]",What causes GM1 (Ganglioside Monosialotetrahexosylganglioside) gangliosidosis ?,[true],[true],[true],"[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]",[true],[true],[true],"[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, which leads to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]",[true],[false],[true],"[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of gangliosides in the brain and other tissues.""]","[""GM1 gangliosidosis is caused by mutations in the GLB1 gene, which leads to a deficiency of the enzyme beta-galactosidase. This deficiency results in the accumulation of GM1 ganglioside in cells, leading to the symptoms of the disorder.""]",[true],[true],[true],"[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, which leads to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 gangliosides in cells.""]",[true],[true],[true],"[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]",[true],[true],[true],"[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]",[true],[false],[true],"[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, which leads to the accumulation of GM1 ganglioside in cells, particularly in the brain.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of gangliosides in the brain and other tissues.""]","[""GM1 gangliosidosis is caused by mutations in the GLB1 gene, which leads to a deficiency of the enzyme beta-galactosidase. This deficiency results in the accumulation of GM1 ganglioside in cells, leading to the symptoms of the disorder.""]",[true],[true],[true],"[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, which leads to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, which leads to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 gangliosides in cells.""]",[true],[true],[true],"[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]",[true],[true],[true],"[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]",[true],[false],[true],"[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of gangliosides in the brain and other tissues.""]","[""GM1 gangliosidosis is caused by mutations in the GLB1 gene, which leads to a deficiency of the enzyme beta-galactosidase. This deficiency results in the accumulation of GM1 ganglioside in cells, leading to the symptoms of the disorder.""]",[true],[true],[true],"[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, which leads to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 gangliosides in cells.""]",[true],[true],[true],"[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]",[true],[true],[true],"[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]",[true],[true],[true],"[""Deficiency of beta-galactosidase enzyme""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of gangliosides in the brain and other tissues.""]","[""GM1 gangliosidosis is caused by mutations in the GLB1 gene, which leads to a deficiency of the enzyme beta-galactosidase. This deficiency results in the accumulation of GM1 ganglioside in cells, leading to the symptoms of the disorder.""]",[true],[true],[true],"[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, which leads to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 gangliosides in cells.""]",[true],[true],[true],"[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, which leads to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]",[true],[true],[true],"[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]",[true],[false],[true],"[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of gangliosides in the brain and other tissues.""]","[""GM1 gangliosidosis is caused by mutations in the GLB1 gene, which leads to a deficiency of the enzyme beta-galactosidase. This deficiency results in the accumulation of GM1 ganglioside in cells, leading to the symptoms of the disorder.""]",[true],[true],[true],"[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, which leads to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, which leads to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 gangliosides in cells.""]",[true],[true],[true],"[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, which leads to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]",[true],[true],[true],"[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]",[true],[false],[true],"[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of gangliosides in the brain and other tissues.""]","[""GM1 gangliosidosis is caused by mutations in the GLB1 gene, which leads to a deficiency of the enzyme beta-galactosidase. This deficiency results in the accumulation of GM1 ganglioside in cells, leading to the symptoms of the disorder.""]",[true],[true],[true],"[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, which leads to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 gangliosides in cells.""]",[true],[true],[true],"[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, which leads to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]",[true],[true],[true],"[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, which leads to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]",[true],[true],[true],"[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, which leads to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of gangliosides in the brain and other tissues.""]","[""GM1 gangliosidosis is caused by mutations in the GLB1 gene, which leads to a deficiency of the enzyme beta-galactosidase. This deficiency results in the accumulation of GM1 ganglioside in cells, leading to the symptoms of the disorder.""]",[true],[true],[true],"[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, which leads to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, which leads to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 gangliosides in cells.""]",[true],[true],[true],"[""Deficiency of beta-galactosidase enzyme""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]",[true],[true],[true],"[""Deficiency of beta-galactosidase enzyme""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]",[true],[true],[true],"[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]",[true],[true],[true],"[""Deficiency of beta-galactosidase enzyme""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]","[""GM1 gangliosidosis is caused by a deficiency of the enzyme beta-galactosidase, leading to the accumulation of GM1 ganglioside in cells.""]"
exams and tests,How to diagnose Cyclic Vomiting Syndrome ?,"A specific test to diagnose cyclic vomiting syndrome does not exist; instead, a health care provider will rule out other conditions and diagnose the syndrome based upon
                
- a medical and family history  - a physical exam  - a pattern or cycle of symptoms  - blood tests  - urine tests  - imaging tests  - upper GI endoscopy  - a gastric emptying test
                
Often, it is suspected that one of the following is causing their symptoms:
                
- gastroparesisa disorder that slows or stops the movement of food from the stomach to the small intestine  - gastroenteritisinflammation of the lining of the stomach, small intestine, and large intestine
                
A diagnosis of cyclic vomiting syndrome may be difficult to make until the person sees a health care provider. A health care provider will suspect cyclic vomiting syndrome if the person suffers from repeat episodes of vomiting.
                
Medical and Family History
                
Taking a medical and family history is one of the first things a health care provider may do to help diagnose cyclic vomiting syndrome. He or she will ask the patient to provide a medical and family history.
                
Physical Exam
                
A physical exam may help diagnose other conditions besides cyclic vomiting syndrome. During a physical exam, a health care provider usually
                
- examines a patients body  - taps on specific areas of the patients body
                
Pattern or Cycle of Symptoms in Children3
                
A health care provider will often suspect cyclic vomiting syndrome in a child when the child
                
- has at least five separate episodes, or at least three separate episodes over 6 months  - has episodes of intense nausea and vomiting lasting 1 hour to 10 days and occurring at least 1 week apart  - has episodes that are similar to previous onesthey tend to start at the same time of day, last the same length of time, and occur with the same symptoms and level of intensity  - vomits during episodes at least four times per hour for at least 1 hour  - vomits and it is not attributed to another disorder  - has absence of nausea and vomiting between episodes
                
Pattern or Cycle of Symptoms in Adults4,5
                
A health care provider will often suspect cyclic vomiting syndrome in adults when the following is present for at least 3 months and the symptoms started more than 6 months ago:
                
- Each episode of cyclic vomiting syndrome is usually similar to previous ones, meaning that episodes tend to start at the same time of day and last the same length of timeless than 1 week.  - Three or more separate episodes in the past year.  - Absence of nausea or vomiting between episodes.
                
Blood Tests
                
A nurse or technician will draw blood samples at a health care providers office or a commercial facility and send the samples to a lab for analysis. The blood test can tell the health care provider if the patient has any signs of dehydration or other problems.
                
Urine Tests
                
Urinalysis involves testing a urine sample. The patient collects a urine sample in a special container in a health care providers office or a commercial facility. A health care provider tests the sample in the same location or sends the sample to a lab for analysis. A urinalysis can rule out kidney problems or an infection.
                
Imaging Tests
                
The health care provider decides which test to order based on the symptoms, medical history, and physical exam.
                
Upper GI series. A health care provider may order an upper GI series to look at the upper GI tract. A radiologista doctor who specializes in medical imagingperforms this test at a hospital or an outpatient center. This test does not require anesthesia. The patient should not eat or drink for 8 hours before the procedure, if possible. During the procedure, the patient will stand or sit in front of an x-ray machine and drink barium, a chalky liquid. Infants lie on a table and a health care provider gives them barium through a tiny tube placed in the nose that runs into the stomach. Barium coats the GI tract, making signs of obstruction or other problems that can cause vomiting show up more clearly on x rays. A patient may experience bloating and nausea for a short time after the test. The upper GI series can show other problems that may be causing symptoms, such as an ulcer or obstruction.
                
Abdominal ultrasound. A health care provider may order an ultrasound to look at the organs in the abdomen. A technician uses a device, called a transducer, that bounces safe, painless sound waves off organs to create an image of their structure. The technician performs the procedure in a health care providers office, an outpatient center, or a hospital. A radiologist interprets the images. A patient does not need anesthesia. The abdominal ultrasound can show other problems that may be causing symptoms, such as gallstones.
                
Upper Gastrointestinal Endoscopy
                
This procedure involves using an endoscopea small, flexible tube with a lightto see the upper GI tract. A gastroenterologista doctor who specializes in digestive diseasesperforms the test at a hospital or an outpatient center. A health care provider may give a patient a liquid anesthetic to gargle or may spray anesthetic on the back of the patients throat. A nurse or technician will place an IV needle in a vein in the arm to administer sedation or anesthesia. Sedatives or anesthesia help a patient stay relaxed and comfortable. The gastroenterologist carefully inserts the endoscope into the mouth and feeds the endoscope down the esophagus and into the stomach and duodenum. A small camera mounted on the endoscope transmits a video image to a monitor, allowing close examination of the intestinal lining. The upper GI endoscopy can show other problems that may be causing symptoms, such as an ulcer. A gastroenterologist may obtain a biopsya procedure that involves taking a small piece of tissue for examination with a microscopeof the small-intestinal lining during an upper GI endoscopy. The patient will not feel the biopsy.
                
Gastric Emptying Test
                
Also called gastric emptying scintigraphy, this test involves eating a bland mealsuch as eggs or an egg substitutethat contains a small amount of radioactive material. A specially trained technician performs the test in a radiology center or hospital, and a radiologist interprets the results; the patient does not need anesthesia. An external camera scans the abdomen to show where the radioactive material is located. The radiologist is then able to measure the rate of gastric emptying at 1, 2, 3, and 4 hours after the meal.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""CVS"", ""full_form"": ""Cyclic Vomiting Syndrome""}]}",How to diagnose CVS ?,How to diagnose Cyclic Vomiting Syndrome ?,8,MEDICAL,Compound Datatype-String,"Instructional: Queries specifically seeking step-by-step guidance, instructions, or procedures to perform a task. it focuses on 'how' to do something rather than 'what', 'why', or 'which'.","[[""CVS Corporation"", ""Chorionic Villus Sampling"", ""Concurrent Version System"", ""Council for Voluntary Service"", ""Council for Voluntary Services"", ""Concurrent Versioning System"", ""cardiovascular system"", ""Chorionic Villi Sampling"", ""Consumer Value Stores"", ""Code Versioning System""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Cardiovascular System""]",[2.4355002815823192e-12],[5.988323848439151e-07],"[""cardiovascular system""]",[5.988323848439151e-07],"[""ABBREVIATIONS""]","[[1.602351741364585e-11, 1.3597117383007263e-21, 1.3731465327750692e-14, 4.6134779396192594e-17, 1.1395807615059078e-15, 5.1464099086003464e-18, 5.988323848439151e-07, 7.211515337142823e-20, 5.048850458602993e-17, 7.303004623253489e-20]]",[0.7978012881991403],[0.8499795245747775],"[""Concurrent Versioning System""]",[0.8537373378094373],"[""ABBREVIATIONS""]","[[0.8376612430173576, 0.6715469189381308, 0.7437436581062835, 0.7375575578967759, 0.7546109004743051, 0.7302887290111431, 0.8537373378094373, 0.6839182636065589, 0.8170416558904903, 0.7536533709718213]]","[""Chorionic Villus Sampling""]","[""ABBREVIATIONS""]",How to diagnose CVS (Cardiovascular System) ?,[false],[true],[false],"[""Diagnosing CVS involves physical examination, medical history review, imaging tests like ECG, echocardiogram, stress test, and blood tests for cholesterol and other markers.""]","[""Diagnosing Cyclic Vomiting Syndrome involves ruling out other possible causes of symptoms, conducting a physical exam, reviewing medical history, and performing tests such as blood tests, imaging studies, and gastric emptying studies.""]","[""Computer Vision Syndrome (CVS) can be diagnosed through a comprehensive eye examination by an eye care professional. The examination may include tests to evaluate visual acuity, refraction, eye focusing, and eye coordination.""]",[false],[true],[false],"[""Diagnosing CVS involves physical examination, medical history review, blood tests, imaging tests like ECG, echocardiogram, stress test, and possibly cardiac catheterization.""]","[""Diagnosis of Cyclic Vomiting Syndrome involves ruling out other possible causes of symptoms through medical history, physical exam, blood tests, imaging studies, and sometimes a gastric emptying study.""]","[""Computer Vision Syndrome (CVS) can be diagnosed through a comprehensive eye examination by an eye care professional, which may include tests to evaluate visual acuity, refraction, eye focusing, and eye coordination. Additionally, discussing symptoms and computer usage habits with the eye care professional can help in diagnosing CVS.""]",[false],[true],[false],"[""Diagnosing CVS involves physical examination, medical history review, blood tests, imaging tests (such as ECG, echocardiogram), stress tests, and cardiac catheterization.""]","[""Diagnosis of Cyclic Vomiting Syndrome involves ruling out other conditions with similar symptoms, keeping a detailed symptom diary, conducting blood tests, imaging tests, and possibly a gastric emptying study.""]","[""Computer Vision Syndrome (CVS) can be diagnosed through a comprehensive eye examination by an optometrist or ophthalmologist. The examination may include tests to evaluate visual acuity, refraction, eye focusing, and eye coordination. Additionally, the doctor may inquire about symptoms related to CVS such as eye strain, headaches, and dry eyes.""]",[false],[true],[false],"[""Diagnosing CVS involves physical examination, medical history review, diagnostic tests like ECG, echocardiogram, stress test, and blood tests.""]","[""Cyclic Vomiting Syndrome is diagnosed based on medical history, physical examination, and ruling out other possible causes of symptoms. Tests such as blood tests, imaging studies, and gastric emptying studies may be done to help with the diagnosis.""]","[""Computer Vision Syndrome (CVS) can be diagnosed through a comprehensive eye examination by an eye care professional. The examination may include tests to evaluate visual acuity, refraction, eye focusing, and eye coordination.""]",[false],[true],[false],"[""Diagnosing CVS involves evaluating symptoms such as eye strain, headaches, and blurred vision, conducting a thorough eye examination, and ruling out other potential causes of the symptoms.""]","[""Diagnosing Cyclic Vomiting Syndrome involves ruling out other possible causes of symptoms, conducting a physical exam, reviewing medical history, and performing tests such as blood tests, imaging studies, and gastric emptying studies.""]","[""Computer Vision Syndrome (CVS) can be diagnosed through a comprehensive eye examination by an eye care professional. The examination may include tests to evaluate visual acuity, refraction, eye focusing, and eye coordination.""]",[false],[true],[false],"[""Diagnosing CVS (Concurrent Versioning System) involves checking for error messages, reviewing logs, verifying network connectivity, and ensuring proper configuration settings.""]","[""Diagnosis of Cyclic Vomiting Syndrome involves ruling out other possible causes of symptoms through medical history, physical exam, blood tests, imaging studies, and sometimes a gastric emptying study.""]","[""Computer Vision Syndrome (CVS) can be diagnosed through a comprehensive eye examination by an eye care professional, which may include tests to evaluate visual acuity, refraction, eye focusing, and eye coordination. Additionally, discussing symptoms and computer usage habits with the eye care professional can help in diagnosing CVS.""]",[false],[true],[false],"[""Diagnosing CVS involves assessing symptoms such as eye strain, headaches, and blurred vision, conducting a comprehensive eye examination, and ruling out other potential causes. It is recommended to consult with an eye care professional for a proper diagnosis and treatment plan.""]","[""Diagnosis of Cyclic Vomiting Syndrome involves ruling out other conditions with similar symptoms, keeping a detailed symptom diary, conducting blood tests, imaging tests, and possibly a gastric emptying study.""]","[""Computer Vision Syndrome (CVS) can be diagnosed through a comprehensive eye examination by an optometrist or ophthalmologist. The examination may include tests to evaluate visual acuity, refraction, eye focusing, and eye coordination. Additionally, the doctor may inquire about symptoms related to CVS such as eye strain, headaches, and dry eyes.""]",[false],[true],[false],"[""Diagnosing CVS (Concurrent Versioning System) involves checking for error messages, reviewing system logs, verifying network connectivity, and ensuring proper configuration settings.""]","[""Cyclic Vomiting Syndrome is diagnosed based on medical history, physical examination, and ruling out other possible causes of symptoms. Tests such as blood tests, imaging studies, and gastric emptying studies may be done to help with the diagnosis.""]","[""Computer Vision Syndrome (CVS) can be diagnosed through a comprehensive eye examination by an eye care professional. The examination may include tests to evaluate visual acuity, refraction, eye focusing, and eye coordination.""]",[false],[true],[false],"[""CVS (Chorionic Villus Sampling) is diagnosed through a procedure where a small sample of cells is taken from the placenta for genetic testing. The sample can be collected through the cervix or the abdomen, guided by ultrasound. The cells are then analyzed for chromosomal abnormalities or genetic conditions.""]","[""Diagnosis of Cyclic Vomiting Syndrome involves ruling out other possible causes of symptoms through medical history, physical exam, blood tests, imaging studies, and sometimes a gastric emptying study.""]","[""Computer Vision Syndrome (CVS) can be diagnosed through a comprehensive eye examination by an eye care professional, which may include tests to evaluate visual acuity, refraction, eye focusing, and eye coordination. Additionally, discussing symptoms and computer usage habits with the eye care professional can help in diagnosing CVS.""]",[false],[true],[false],"[""CVS (Chorionic Villus Sampling) is diagnosed through a procedure where a small sample of cells is taken from the placenta for genetic testing. The sample can be collected through the cervix or the abdomen, guided by ultrasound. The cells are then analyzed for chromosomal abnormalities or genetic conditions.""]","[""Diagnosing Cyclic Vomiting Syndrome involves ruling out other possible causes of symptoms, conducting a physical exam, reviewing medical history, and performing tests such as blood tests, imaging studies, and gastric emptying studies.""]","[""Computer Vision Syndrome (CVS) can be diagnosed through a comprehensive eye examination by an eye care professional. The examination may include tests to evaluate visual acuity, refraction, eye focusing, and eye coordination.""]",[false],[true],[false],"[""CVS can be diagnosed by inserting a thin needle or tube through the vagina and cervix to remove a small sample of cells from the placenta for genetic testing.""]","[""Diagnosis of Cyclic Vomiting Syndrome involves ruling out other conditions with similar symptoms, keeping a detailed symptom diary, conducting blood tests, imaging tests, and possibly a gastric emptying study.""]","[""Computer Vision Syndrome (CVS) can be diagnosed through a comprehensive eye examination by an optometrist or ophthalmologist. The examination may include tests to evaluate visual acuity, refraction, eye focusing, and eye coordination. Additionally, the doctor may inquire about symptoms related to CVS such as eye strain, headaches, and dry eyes.""]",[false],[true],[false],"[""CVS can be diagnosed by inserting a thin needle or tube through the abdomen or cervix to remove a small sample of chorionic villi tissue from the placenta for genetic testing.""]","[""Cyclic Vomiting Syndrome is diagnosed based on medical history, physical examination, and ruling out other possible causes of symptoms. Tests such as blood tests, imaging studies, and gastric emptying studies may be done to help with the diagnosis.""]","[""Computer Vision Syndrome (CVS) can be diagnosed through a comprehensive eye examination by an eye care professional. The examination may include tests to evaluate visual acuity, refraction, eye focusing, and eye coordination.""]",[false],[true],[false],"[""CVS can be diagnosed through a procedure where a small sample of cells is taken from the placenta for genetic testing.""]","[""Diagnosing Cyclic Vomiting Syndrome involves ruling out other possible causes of symptoms, conducting a physical exam, reviewing medical history, and performing tests such as blood tests, imaging studies, and gastric emptying studies.""]","[""Computer Vision Syndrome (CVS) can be diagnosed through a comprehensive eye examination by an eye care professional. The examination may include tests to evaluate visual acuity, refraction, eye focusing, and eye coordination.""]",[false],[true],[false],"[""CVS is diagnosed through a procedure where a small sample of cells is taken from the placenta for genetic testing.""]","[""Diagnosis of Cyclic Vomiting Syndrome involves ruling out other possible causes of symptoms through medical history, physical exam, blood tests, imaging studies, and sometimes a gastric emptying study.""]","[""Computer Vision Syndrome (CVS) can be diagnosed through a comprehensive eye examination by an eye care professional, which may include tests to evaluate visual acuity, refraction, eye focusing, and eye coordination. Additionally, discussing symptoms and computer usage habits with the eye care professional can help in diagnosing CVS.""]",[false],[true],[false],"[""CVS can be diagnosed through a procedure where a small sample of cells is taken from the placenta for genetic testing.""]","[""Diagnosis of Cyclic Vomiting Syndrome involves ruling out other conditions with similar symptoms, keeping a detailed symptom diary, conducting blood tests, imaging tests, and possibly a gastric emptying study.""]","[""Computer Vision Syndrome (CVS) can be diagnosed through a comprehensive eye examination by an optometrist or ophthalmologist. The examination may include tests to evaluate visual acuity, refraction, eye focusing, and eye coordination. Additionally, the doctor may inquire about symptoms related to CVS such as eye strain, headaches, and dry eyes.""]",[false],[true],[false],"[""CVS can be diagnosed through a procedure where a small sample of cells is taken from the placenta for genetic testing.""]","[""Cyclic Vomiting Syndrome is diagnosed based on medical history, physical examination, and ruling out other possible causes of symptoms. Tests such as blood tests, imaging studies, and gastric emptying studies may be done to help with the diagnosis.""]","[""Computer Vision Syndrome (CVS) can be diagnosed through a comprehensive eye examination by an eye care professional. The examination may include tests to evaluate visual acuity, refraction, eye focusing, and eye coordination.""]",[false],[true],[false],"[""Diagnosing CVS involves inserting a thin tube through the cervix or a needle through the abdomen to remove a small sample of chorionic villi for testing.""]","[""Diagnosing Cyclic Vomiting Syndrome involves ruling out other possible causes of symptoms, conducting a physical exam, reviewing medical history, and performing tests such as blood tests, imaging studies, and gastric emptying studies.""]","[""Computer Vision Syndrome (CVS) can be diagnosed through a comprehensive eye examination by an eye care professional. The examination may include tests to evaluate visual acuity, refraction, eye focusing, and eye coordination.""]",[false],[true],[false],"[""CVS (Chorionic Villus Sampling) is diagnosed through a procedure where a small sample of cells is taken from the placenta for genetic testing. The sample can be collected through the cervix or the abdomen, guided by ultrasound. The cells are then analyzed for chromosomal abnormalities or genetic conditions.""]","[""Diagnosis of Cyclic Vomiting Syndrome involves ruling out other possible causes of symptoms through medical history, physical exam, blood tests, imaging studies, and sometimes a gastric emptying study.""]","[""Computer Vision Syndrome (CVS) can be diagnosed through a comprehensive eye examination by an eye care professional, which may include tests to evaluate visual acuity, refraction, eye focusing, and eye coordination. Additionally, discussing symptoms and computer usage habits with the eye care professional can help in diagnosing CVS.""]",[false],[true],[false],"[""CVS can be diagnosed by inserting a thin needle or tube through the abdomen or cervix to remove a small sample of chorionic villi from the placenta for genetic testing.""]","[""Diagnosis of Cyclic Vomiting Syndrome involves ruling out other conditions with similar symptoms, keeping a detailed symptom diary, conducting blood tests, imaging tests, and possibly a gastric emptying study.""]","[""Computer Vision Syndrome (CVS) can be diagnosed through a comprehensive eye examination by an optometrist or ophthalmologist. The examination may include tests to evaluate visual acuity, refraction, eye focusing, and eye coordination. Additionally, the doctor may inquire about symptoms related to CVS such as eye strain, headaches, and dry eyes.""]",[false],[true],[false],"[""CVS (Chorionic Villus Sampling) is diagnosed through a procedure where a small sample of cells is taken from the placenta for genetic testing. The sample can be collected through the cervix or the abdomen, guided by ultrasound. The cells are then analyzed for chromosomal abnormalities or genetic disorders.""]","[""Cyclic Vomiting Syndrome is diagnosed based on medical history, physical examination, and ruling out other possible causes of symptoms. Tests such as blood tests, imaging studies, and gastric emptying studies may be done to help with the diagnosis.""]","[""Computer Vision Syndrome (CVS) can be diagnosed through a comprehensive eye examination by an eye care professional. The examination may include tests to evaluate visual acuity, refraction, eye focusing, and eye coordination.""]",[false],[true],[false],"[""Diagnosing CVS involves physical examination, medical history review, imaging tests (such as ECG, echocardiogram), blood tests, and possibly a stress test or cardiac catheterization.""]","[""Diagnosing Cyclic Vomiting Syndrome involves ruling out other possible causes of symptoms, conducting a physical exam, reviewing medical history, and performing tests such as blood tests, imaging studies, and gastric emptying studies.""]","[""Computer Vision Syndrome (CVS) can be diagnosed through a comprehensive eye examination by an eye care professional. The examination may include tests to evaluate visual acuity, refraction, eye focusing, and eye coordination.""]",[false],[true],[false],"[""Diagnosis of CVS involves physical examination, medical history review, imaging tests (such as ECG, echocardiogram), blood tests, and possibly a stress test or cardiac catheterization.""]","[""Diagnosis of Cyclic Vomiting Syndrome involves ruling out other possible causes of symptoms through medical history, physical exam, blood tests, imaging studies, and sometimes a gastric emptying study.""]","[""Computer Vision Syndrome (CVS) can be diagnosed through a comprehensive eye examination by an eye care professional, which may include tests to evaluate visual acuity, refraction, eye focusing, and eye coordination. Additionally, discussing symptoms and computer usage habits with the eye care professional can help in diagnosing CVS.""]",[false],[true],[false],"[""Diagnosing CVS involves physical examination, medical history review, imaging tests (such as ECG, echocardiogram), blood tests, and possibly a stress test or cardiac catheterization.""]","[""Diagnosis of Cyclic Vomiting Syndrome involves ruling out other conditions with similar symptoms, keeping a detailed symptom diary, conducting blood tests, imaging tests, and possibly a gastric emptying study.""]","[""Computer Vision Syndrome (CVS) can be diagnosed through a comprehensive eye examination by an optometrist or ophthalmologist. The examination may include tests to evaluate visual acuity, refraction, eye focusing, and eye coordination. Additionally, the doctor may inquire about symptoms related to CVS such as eye strain, headaches, and dry eyes.""]",[false],[true],[false],"[""Diagnosing CVS involves physical examination, medical history review, imaging tests like ECG, echocardiogram, stress test, and blood tests for cholesterol and other markers.""]","[""Cyclic Vomiting Syndrome is diagnosed based on medical history, physical examination, and ruling out other possible causes of symptoms. Tests such as blood tests, imaging studies, and gastric emptying studies may be done to help with the diagnosis.""]","[""Computer Vision Syndrome (CVS) can be diagnosed through a comprehensive eye examination by an eye care professional. The examination may include tests to evaluate visual acuity, refraction, eye focusing, and eye coordination.""]",[false],[true],[false],"[""Diagnosing CVS involves inserting a thin needle or tube into the uterus through the vagina or abdomen to collect a small sample of chorionic villi for genetic testing.""]","[""Diagnosing Cyclic Vomiting Syndrome involves ruling out other possible causes of symptoms, conducting a physical exam, reviewing medical history, and performing tests such as blood tests, imaging studies, and gastric emptying studies.""]","[""Computer Vision Syndrome (CVS) can be diagnosed through a comprehensive eye examination by an eye care professional. The examination may include tests to evaluate visual acuity, refraction, eye focusing, and eye coordination.""]",[false],[true],[false],"[""Diagnosing CVS involves inserting a thin tube through the vagina and cervix to reach the placenta. A small sample of cells from the chorionic villi is then collected for testing. The procedure is typically guided by ultrasound to ensure accuracy and safety.""]","[""Diagnosis of Cyclic Vomiting Syndrome involves ruling out other possible causes of symptoms through medical history, physical exam, blood tests, imaging studies, and sometimes a gastric emptying study.""]","[""Computer Vision Syndrome (CVS) can be diagnosed through a comprehensive eye examination by an eye care professional, which may include tests to evaluate visual acuity, refraction, eye focusing, and eye coordination. Additionally, discussing symptoms and computer usage habits with the eye care professional can help in diagnosing CVS.""]",[false],[true],[false],"[""Diagnosing CVS involves inserting a thin needle or tube through the vagina and cervix to extract a small sample of chorionic villi from the placenta. The sample is then analyzed for genetic abnormalities.""]","[""Diagnosis of Cyclic Vomiting Syndrome involves ruling out other conditions with similar symptoms, keeping a detailed symptom diary, conducting blood tests, imaging tests, and possibly a gastric emptying study.""]","[""Computer Vision Syndrome (CVS) can be diagnosed through a comprehensive eye examination by an optometrist or ophthalmologist. The examination may include tests to evaluate visual acuity, refraction, eye focusing, and eye coordination. Additionally, the doctor may inquire about symptoms related to CVS such as eye strain, headaches, and dry eyes.""]",[false],[true],[false],"[""Diagnosing CVS involves inserting a thin needle or tube into the placenta to collect a small sample of chorionic villi for genetic testing.""]","[""Cyclic Vomiting Syndrome is diagnosed based on medical history, physical examination, and ruling out other possible causes of symptoms. Tests such as blood tests, imaging studies, and gastric emptying studies may be done to help with the diagnosis.""]","[""Computer Vision Syndrome (CVS) can be diagnosed through a comprehensive eye examination by an eye care professional. The examination may include tests to evaluate visual acuity, refraction, eye focusing, and eye coordination.""]",[false],[true],[false],"[""CVS can be diagnosed through a procedure where a small sample of cells is taken from the placenta for genetic testing.""]","[""Diagnosing Cyclic Vomiting Syndrome involves ruling out other possible causes of symptoms, conducting a physical exam, reviewing medical history, and performing tests such as blood tests, imaging studies, and gastric emptying studies.""]","[""Computer Vision Syndrome (CVS) can be diagnosed through a comprehensive eye examination by an eye care professional. The examination may include tests to evaluate visual acuity, refraction, eye focusing, and eye coordination.""]",[false],[true],[false],"[""Diagnosing CVS involves physical examination, medical history review, imaging tests like ECG, echocardiogram, stress test, and blood tests.""]","[""Diagnosing Cyclic Vomiting Syndrome involves ruling out other possible causes of symptoms, conducting a physical exam, reviewing medical history, and performing tests such as blood tests, imaging studies, and gastric emptying studies.""]","[""Computer Vision Syndrome (CVS) can be diagnosed through a comprehensive eye examination by an eye care professional. The examination may include tests to evaluate visual acuity, refraction, eye focusing, and eye coordination.""]",[false],[true],[false],"[""Diagnosing CVS issues can be done by checking the error messages, logs, and running diagnostic commands such as cvsdiag.""]","[""Diagnosing Cyclic Vomiting Syndrome involves ruling out other possible causes of symptoms, conducting a physical exam, reviewing medical history, and performing tests such as blood tests, imaging studies, and gastric emptying studies.""]","[""Computer Vision Syndrome (CVS) can be diagnosed through a comprehensive eye examination by an eye care professional. The examination may include tests to evaluate visual acuity, refraction, eye focusing, and eye coordination.""]",[false],[true],[false],"[""Diagnosing CVS involves physical examination, medical history review, diagnostic tests like ECG, echocardiogram, stress test, etc., and consultation with a cardiologist.""]","[""Diagnosing Cyclic Vomiting Syndrome involves ruling out other possible causes of symptoms, conducting a physical exam, reviewing medical history, and performing tests such as blood tests, imaging studies, and gastric emptying studies.""]","[""Computer Vision Syndrome (CVS) can be diagnosed through a comprehensive eye examination by an eye care professional. The examination may include tests to evaluate visual acuity, refraction, eye focusing, and eye coordination.""]"
information,Do you have information about Weight Loss Surgery,"Summary : Weight loss surgery helps people with extreme obesity to lose weight. It may be an option if you cannot lose weight through diet and exercise or have serious health problems caused by obesity.    There are different types of weight loss surgery. They often limit the amount of food you can take in. Some types of surgery also affect how you digest food and absorb nutrients. All types have risks and complications, such as infections, hernias, and blood clots.    Many people who have the surgery lose weight quickly, but regain some weight later on. If you follow diet and exercise recommendations, you can keep most of the weight off. You will also need medical follow-up for the rest of your life.    NIH: National Institute of Diabetes and Digestive and Kidney Diseases","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""WLS"", ""full_form"": ""Weight Loss Surgery""}]}",Do you have information about WLS,Do you have information about Weight Loss Surgery,8,MEDICAL,Simple Datatype-Boolean,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""WebLogic Server"", ""Weight Loss Surgery"", ""William Lyon Homes"", ""Weight Loss Support"", ""Wisconsin Lutheran Seminary"", ""Weight Loss Success"", ""Wait Listing Service"", ""Waiting List Service"", ""World's Largest Store"", ""World Learner School""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Weight Loss Surgery""]",[2.549874480996522e-10],[2.549874480996522e-10],"[""Waiting List Service""]",[6.209998087603512e-10],"[""ABBREVIATIONS""]","[[1.4051139538062613e-15, 2.549874480996522e-10, 2.232524071946561e-21, 1.6185436611382423e-10, 9.091706408335084e-31, 9.048490512973085e-12, 2.971231295069843e-13, 6.209998087603512e-10, 5.790776670486432e-15, 1.0553996391173278e-11]]",[0.8684483357936041],[0.8684483357936041],"[""William Lyon Homes""]",[0.871034236680098],"[""ABBREVIATIONS""]","[[0.7122260418979656, 0.8685556033740616, 0.6776357405273048, 0.871034236680098, 0.6654937830469475, 0.8530623950551389, 0.7915653074179486, 0.7637879452335294, 0.6808010531343897, 0.711683894843687]]","[""Weight Loss Surgery""]","[""ABBREVIATIONS""]",Do you have information about WLS (Weight Loss Surgery),[false],[false],[true],"[""WLS (Waiting List Service) is a system used by healthcare facilities to manage patient waiting lists for various medical procedures or services.""]","[""Yes""]","[""Yes, WLS stands for Weight Loss Surgery.""]",[false],[false],[true],"[""WLS (Waiting List Service) is a system used by healthcare facilities to manage patient waiting lists for appointments, procedures, or treatments.""]","[""Yes""]","[""Yes, WLS stands for Weight Loss Surgery.""]",[false],[false],[true],"[""WLS (Waiting List Service) is a system used by healthcare facilities to manage and prioritize patient waiting lists for various medical procedures.""]","[""Yes""]","[""Yes, WLS stands for Weight Loss Surgery.""]",[false],[false],[true],"[""WLS (Waiting List Service) is a system used by healthcare facilities to manage and prioritize patient waiting lists for various medical procedures and treatments.""]","[""Yes""]","[""Yes, WLS stands for Weight Loss Surgery.""]",[false],[false],[true],"[""WLS (William Lyon Homes) is a homebuilding company based in California, USA.""]","[""Yes""]","[""Yes, WLS stands for Weight Loss Surgery.""]",[false],[false],[true],"[""WLS (William Lyon Homes) is a homebuilding company based in California, USA.""]","[""Yes""]","[""Yes, WLS stands for Weight Loss Surgery.""]",[false],[false],[true],"[""WLS (William Lyon Homes) is a homebuilding company that operates in California, Arizona, Nevada, and Colorado.""]","[""Yes""]","[""Yes, WLS stands for Weight Loss Surgery.""]",[false],[false],[true],"[""WLS (William Lyon Homes) is a homebuilding company that operates in California, Arizona, Nevada, and Colorado.""]","[""Yes""]","[""Yes, WLS stands for Weight Loss Surgery.""]",[true],[false],[true],"[""Yes, I have information about Weight Loss Surgery (WLS).""]","[""Yes""]","[""Yes, WLS stands for Weight Loss Surgery.""]",[true],[false],[true],"[""Yes, Weight Loss Surgery (WLS) is a surgical procedure performed on individuals who are obese to help them lose weight and improve their overall health.""]","[""Yes""]","[""Yes, WLS stands for Weight Loss Surgery.""]",[true],[false],[true],"[""Yes, I have information about Weight Loss Surgery (WLS).""]","[""Yes""]","[""Yes, WLS stands for Weight Loss Surgery.""]",[true],[false],[true],"[""Yes, I have information about Weight Loss Surgery (WLS).""]","[""Yes""]","[""Yes, WLS stands for Weight Loss Surgery.""]",[false],[false],[true],"[""Yes""]","[""Yes""]","[""Yes, WLS stands for Weight Loss Surgery.""]",[false],[false],[true],"[""Yes""]","[""Yes""]","[""Yes, WLS stands for Weight Loss Surgery.""]",[false],[false],[true],"[""Yes""]","[""Yes""]","[""Yes, WLS stands for Weight Loss Surgery.""]",[false],[false],[true],"[""Yes""]","[""Yes""]","[""Yes, WLS stands for Weight Loss Surgery.""]",[false],[false],[true],"[""Yes""]","[""Yes""]","[""Yes, WLS stands for Weight Loss Surgery.""]",[true],[false],[true],"[""Yes, Weight Loss Surgery (WLS) is a surgical procedure that helps individuals with obesity lose weight by making changes to their digestive system.""]","[""Yes""]","[""Yes, WLS stands for Weight Loss Surgery.""]",[true],[false],[true],"[""Yes, WLS (Weight Loss Surgery) is a surgical procedure performed on individuals who are obese to help them lose weight and improve their overall health.""]","[""Yes""]","[""Yes, WLS stands for Weight Loss Surgery.""]",[true],[false],[true],"[""Yes, Weight Loss Surgery (WLS) is a procedure that helps individuals lose weight by making changes to their digestive system.""]","[""Yes""]","[""Yes, WLS stands for Weight Loss Surgery.""]",[true],[false],[true],"[""Yes, WLS (Weight Loss Surgery) is a surgical procedure performed to help individuals lose weight by making changes to the digestive system.""]","[""Yes""]","[""Yes, WLS stands for Weight Loss Surgery.""]",[true],[false],[true],"[""Yes, WLS (Weight Loss Surgery) refers to surgical procedures performed to help individuals lose weight by restricting the amount of food the stomach can hold or by reducing the absorption of nutrients in the digestive system.""]","[""Yes""]","[""Yes, WLS stands for Weight Loss Surgery.""]",[true],[false],[true],"[""Yes, I have information about Weight Loss Surgery (WLS).""]","[""Yes""]","[""Yes, WLS stands for Weight Loss Surgery.""]",[true],[false],[true],"[""Yes, Weight Loss Surgery (WLS) is a surgical procedure performed on individuals who are obese to help them lose weight and improve their overall health.""]","[""Yes""]","[""Yes, WLS stands for Weight Loss Surgery.""]",[true],[false],[true],"[""Yes, I have information about Weight Loss Surgery (WLS).""]","[""Yes""]","[""Yes, WLS stands for Weight Loss Surgery.""]",[true],[false],[true],"[""Yes, weight loss surgery (WLS) is a medical procedure that helps individuals lose weight by making changes to their digestive system. It is usually recommended for people who have tried other weight loss methods without success.""]","[""Yes""]","[""Yes, WLS stands for Weight Loss Surgery.""]",[true],[false],[true],"[""Yes, weight loss surgery (WLS) is a surgical procedure that helps individuals lose weight by making changes to their digestive system. It is typically recommended for individuals with severe obesity who have not been successful with other weight loss methods.""]","[""Yes""]","[""Yes, WLS stands for Weight Loss Surgery.""]",[true],[false],[true],"[""Yes, WLS (Weight Loss Surgery) refers to a variety of procedures performed on people who are obese to help them lose weight.""]","[""Yes""]","[""Yes, WLS stands for Weight Loss Surgery.""]",[true],[false],[true],"[""Yes, I have information about Weight Loss Surgery (WLS).""]","[""Yes""]","[""Yes, WLS stands for Weight Loss Surgery.""]",[false],[false],[true],"[""Yes, I have information about WLS (Waiting List Service).""]","[""Yes""]","[""Yes, WLS stands for Weight Loss Surgery.""]",[false],[false],[true],"[""No, I do not have information about WLS (William Lyon Homes).""]","[""Yes""]","[""Yes, WLS stands for Weight Loss Surgery.""]",[true],[false],[true],"[""Yes, I have information about Weight Loss Surgery (WLS).""]","[""Yes""]","[""Yes, WLS stands for Weight Loss Surgery.""]"
susceptibility,Who is at risk for Parasites - Angiostrongyliasis (also known as Angiostrongylus Infection)? ?,"Angiostrongylus cantonensis
    
Angiostrongylus cantonensis, also known as the rat lungworm, is a parasitic nematode (worm) that is transmitted between rats and mollusks (such as slugs or snails) in its natural life cycle. Other animals that become infected such as freshwater shrimp, land crabs, frogs, and planarians of the genus Platydemus, are transport hosts that are not required for reproduction of the parasite but might be able to transmit infection to humans if eaten raw or undercooked. Humans are accidental hosts who do not transmit infection to others. Most cases of infection are diagnosed in Southeast Asia and the Pacific Basin, but the parasite has also been found in Australia, some areas of Africa, the Caribbean, Hawaii and Louisiana. Outbreaks of human angiostrongyliasis have involved a few to hundreds of persons; over 2,800 cases have been reported in the literature from approximately 30 countries. It is likely that the parasite has been spread by rats transported on ships and by the introduction of mollusks such as the giant African land snail (Achatina fulica). In addition, the semi-slug, Parmarion martensi (native of Southeast Asia)has spread in regions of Hawaii and is found to often be infected with A. cantonensis, and the freshwater snail Pomacea canaliculata (native of South America) has been introduced into Taiwan and China and has been implicated in outbreaks of disease in those countries.
    
Risk factors for infection with A. cantonensis include the ingestion of raw or undercooked infected snails or slugs; or pieces of snails and slugs accidentally chopped up in vegetables, vegetable juices, or salads; or foods contaminated by the slime of infected snails or slugs. It is possible that ingestion of raw or undercooked transport hosts (freshwater shrimp, land crabs, frogs, etc. ) can result in human infection, though this is less certain. In addition, contamination of the hands during the preparation of uncooked infected snails or slugs could lead to ingestion of the parasite.
    
     
    Angiostrongylus costaricensis
    
Angiostrongylus costaricensis is a parasitic nematode (worm) that resides in rodents and uses mollusks, such as slugs, as an intermediate host. Rats, such as the cotton rat, transmit the larvae through their feces. Slugs then ingest the larvae. Humans are accidental hosts of the parasite. The parasite is not able to complete its life cycle in humans and eventually dies in the abdomen. Human infection principally occurs in Latin America and the Caribbean, with a few cases suspected in the United States and in the Republic of Congo. The organism is also found in animals in the Southern U.S. (Texas).
    
Risk factors for infection with A. costaricensis are not well established but are likely to be ingestion of infected slugs or raw vegetables or vegetable juices contaminated with slugs or their slime, which can contain A. costaricensis larvae. The infection of transport hosts, which are not essential to the lifecycle of the parasite, has not been identified and any role in human infection is not known, in contrast to A. cantonensis. Some reports have shown the case rate to be higher in children 6 to 12 years of age, males, and in persons of higher socioeconomic status. There has been one food-related outbreak in Guatemala that affected primarily adults.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""Angiostrongyliasis"", ""full_form"": ""Angiostrongylus Infection""}]}",Who is at risk for Parasites - Angiostrongyliasis (also known as Angiostrongyliasis)? ?,Who is at risk for Parasites - Angiostrongyliasis (also known as Angiostrongylus Infection)? ?,8,MEDICAL,Simple Datatype-String,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.",[[]],[[]],"[""Angiostrongylus Infection""]",[1.0308434529964247e-09],[1.0308434529964247e-09],"[""Angiostrongylus Infection""]",[1.0308434529964247e-09],"[""LLM""]",[[]],[0.9768964929119954],[0.9768964929119954],"[""Angiostrongylus Infection""]",[0.9768964929119954],"[""LLM""]",[[]],"[""Angiostrongylus Infection""]","[""LLM""]",Who is at risk for Parasites - Angiostrongyliasis (Angiostrongylus Infection) (also known as Angiostrongyliasis (Angiostrongylus Infection))? ?,[true],[true],[true],"[""People who consume raw or undercooked snails or slugs, or contaminated vegetables, are at risk for Angiostrongyliasis (Angiostrongylus Infection).""]","[""People who consume raw or undercooked snails or slugs are at risk for Angiostrongyliasis.""]","[""People who consume raw or undercooked snails or slugs are at risk for Parasites - Angiostrongyliasis.""]",[true],[true],[true],"[""People who consume raw or undercooked snails or slugs, or contaminated vegetables, are at risk for Angiostrongyliasis (Angiostrongylus Infection).""]","[""People who consume raw or undercooked snails or slugs, or contaminated vegetables, are at risk for Angiostrongyliasis.""]","[""People who consume raw or undercooked snails or slugs are at risk for Parasites - Angiostrongyliasis.""]",[true],[true],[true],"[""People who consume raw or undercooked snails or slugs, or contaminated vegetables, are at risk for Angiostrongyliasis (Angiostrongylus Infection).""]","[""People who consume raw or undercooked snails or slugs are at risk for Parasites - Angiostrongyliasis.""]","[""People who consume raw or undercooked snails or slugs are at risk for Parasites - Angiostrongyliasis.""]",[true],[true],[true],"[""People who consume raw or undercooked snails or slugs, or contaminated vegetables, are at risk for Angiostrongyliasis (Angiostrongylus Infection).""]","[""People who consume raw or undercooked snails or slugs, or contaminated vegetables, are at risk for Angiostrongyliasis.""]","[""People who consume raw or undercooked snails or slugs are at risk for Parasites - Angiostrongyliasis.""]",[true],[true],[true],"[""People who consume raw or undercooked snails or slugs, or contaminated vegetables, are at risk for Angiostrongyliasis (Angiostrongylus Infection).""]","[""People who consume raw or undercooked snails or slugs are at risk for Angiostrongyliasis.""]","[""People who consume raw or undercooked snails or slugs are at risk for Parasites - Angiostrongyliasis.""]",[true],[true],[true],"[""People who consume raw or undercooked snails or slugs, or contaminated vegetables, are at risk for Angiostrongyliasis (Angiostrongylus Infection).""]","[""People who consume raw or undercooked snails or slugs, or contaminated vegetables, are at risk for Angiostrongyliasis.""]","[""People who consume raw or undercooked snails or slugs are at risk for Parasites - Angiostrongyliasis.""]",[true],[true],[true],"[""People who consume raw or undercooked snails or slugs, or contaminated vegetables, are at risk for Angiostrongyliasis (Angiostrongylus Infection).""]","[""People who consume raw or undercooked snails or slugs are at risk for Parasites - Angiostrongyliasis.""]","[""People who consume raw or undercooked snails or slugs are at risk for Parasites - Angiostrongyliasis.""]",[true],[true],[true],"[""People who consume raw or undercooked snails or slugs, or contaminated vegetables, are at risk for Angiostrongyliasis (Angiostrongylus Infection).""]","[""People who consume raw or undercooked snails or slugs, or contaminated vegetables, are at risk for Angiostrongyliasis.""]","[""People who consume raw or undercooked snails or slugs are at risk for Parasites - Angiostrongyliasis.""]",[true],[true],[true],"[""People who consume raw or undercooked snails or slugs, or contaminated vegetables, are at risk for Angiostrongyliasis (Angiostrongylus Infection).""]","[""People who consume raw or undercooked snails or slugs, or contaminated vegetables, are at risk for Angiostrongyliasis.""]","[""People who consume raw or undercooked snails or slugs are at risk for Parasites - Angiostrongyliasis.""]",[true],[true],[true],"[""People who consume raw or undercooked snails or slugs, or contaminated vegetables, are at risk for Angiostrongyliasis (Angiostrongylus Infection).""]","[""People who consume raw or undercooked snails or slugs are at risk for Angiostrongyliasis.""]","[""People who consume raw or undercooked snails or slugs are at risk for Parasites - Angiostrongyliasis.""]",[true],[true],[true],"[""People who consume raw or undercooked snails or slugs, or contaminated vegetables, are at risk for Angiostrongyliasis (Angiostrongylus Infection).""]","[""People who consume raw or undercooked snails or slugs are at risk for Parasites - Angiostrongyliasis.""]","[""People who consume raw or undercooked snails or slugs are at risk for Parasites - Angiostrongyliasis.""]",[true],[true],[true],"[""People who consume raw or undercooked snails or slugs, or contaminated vegetables, are at risk for Angiostrongyliasis (Angiostrongylus Infection).""]","[""People who consume raw or undercooked snails or slugs, or contaminated vegetables, are at risk for Angiostrongyliasis.""]","[""People who consume raw or undercooked snails or slugs are at risk for Parasites - Angiostrongyliasis.""]",[true],[true],[true],"[""People who consume raw or undercooked snails or slugs, or contaminated vegetables, are at risk for Angiostrongyliasis (Angiostrongylus Infection).""]","[""People who consume raw or undercooked snails or slugs are at risk for Angiostrongyliasis.""]","[""People who consume raw or undercooked snails or slugs are at risk for Parasites - Angiostrongyliasis.""]",[true],[true],[true],"[""People who consume raw or undercooked snails or slugs, or contaminated vegetables, are at risk for Angiostrongyliasis (Angiostrongylus Infection).""]","[""People who consume raw or undercooked snails or slugs, or contaminated vegetables, are at risk for Angiostrongyliasis.""]","[""People who consume raw or undercooked snails or slugs are at risk for Parasites - Angiostrongyliasis.""]",[true],[true],[true],"[""People who consume raw or undercooked snails or slugs, or contaminated vegetables, are at risk for Angiostrongyliasis (Angiostrongylus Infection).""]","[""People who consume raw or undercooked snails or slugs are at risk for Parasites - Angiostrongyliasis.""]","[""People who consume raw or undercooked snails or slugs are at risk for Parasites - Angiostrongyliasis.""]",[true],[true],[true],"[""People who consume raw or undercooked snails or slugs, or contaminated vegetables, are at risk for Angiostrongyliasis (Angiostrongylus Infection).""]","[""People who consume raw or undercooked snails or slugs, or contaminated vegetables, are at risk for Angiostrongyliasis.""]","[""People who consume raw or undercooked snails or slugs are at risk for Parasites - Angiostrongyliasis.""]",[true],[true],[true],"[""People who consume raw or undercooked snails or slugs, or contaminated vegetables, are at risk for Angiostrongyliasis (Angiostrongylus Infection).""]","[""People who consume raw or undercooked snails or slugs are at risk for Angiostrongyliasis.""]","[""People who consume raw or undercooked snails or slugs are at risk for Parasites - Angiostrongyliasis.""]",[true],[true],[true],"[""People who consume raw or undercooked snails or slugs, or contaminated vegetables, are at risk for Angiostrongyliasis (Angiostrongylus Infection).""]","[""People who consume raw or undercooked snails or slugs, or contaminated vegetables, are at risk for Angiostrongyliasis.""]","[""People who consume raw or undercooked snails or slugs are at risk for Parasites - Angiostrongyliasis.""]",[true],[true],[true],"[""People who consume raw or undercooked snails or slugs, or contaminated vegetables, are at risk for Angiostrongyliasis (Angiostrongylus Infection).""]","[""People who consume raw or undercooked snails or slugs are at risk for Parasites - Angiostrongyliasis.""]","[""People who consume raw or undercooked snails or slugs are at risk for Parasites - Angiostrongyliasis.""]",[true],[true],[true],"[""People who consume raw or undercooked snails or slugs, or contaminated vegetables, are at risk for Angiostrongyliasis (Angiostrongylus Infection).""]","[""People who consume raw or undercooked snails or slugs, or contaminated vegetables, are at risk for Angiostrongyliasis.""]","[""People who consume raw or undercooked snails or slugs are at risk for Parasites - Angiostrongyliasis.""]",[true],[true],[true],"[""People who consume raw or undercooked snails or slugs, or contaminated vegetables, are at risk for Angiostrongyliasis (Angiostrongylus Infection).""]","[""People who consume raw or undercooked snails or slugs are at risk for Angiostrongyliasis.""]","[""People who consume raw or undercooked snails or slugs are at risk for Parasites - Angiostrongyliasis.""]",[true],[true],[true],"[""People who consume raw or undercooked snails or slugs, or contaminated vegetables, are at risk for Angiostrongyliasis (Angiostrongylus Infection).""]","[""People who consume raw or undercooked snails or slugs, or contaminated vegetables, are at risk for Angiostrongyliasis.""]","[""People who consume raw or undercooked snails or slugs are at risk for Parasites - Angiostrongyliasis.""]",[true],[true],[true],"[""People who consume raw or undercooked snails or slugs, or contaminated vegetables, are at risk for Angiostrongyliasis (Angiostrongylus Infection).""]","[""People who consume raw or undercooked snails or slugs are at risk for Parasites - Angiostrongyliasis.""]","[""People who consume raw or undercooked snails or slugs are at risk for Parasites - Angiostrongyliasis.""]",[true],[true],[true],"[""People who consume raw or undercooked snails or slugs, or contaminated vegetables, are at risk for Angiostrongyliasis (Angiostrongylus Infection).""]","[""People who consume raw or undercooked snails or slugs, or contaminated vegetables, are at risk for Angiostrongyliasis.""]","[""People who consume raw or undercooked snails or slugs are at risk for Parasites - Angiostrongyliasis.""]",[true],[true],[true],"[""People who consume raw or undercooked snails or slugs, or contaminated vegetables, are at risk for Angiostrongyliasis (Angiostrongylus Infection).""]","[""People who consume raw or undercooked snails or slugs are at risk for Angiostrongyliasis.""]","[""People who consume raw or undercooked snails or slugs are at risk for Parasites - Angiostrongyliasis.""]",[true],[true],[true],"[""People who consume raw or undercooked snails or slugs, or contaminated vegetables, are at risk for Angiostrongyliasis (Angiostrongylus Infection).""]","[""People who consume raw or undercooked snails or slugs, or contaminated vegetables, are at risk for Angiostrongyliasis.""]","[""People who consume raw or undercooked snails or slugs are at risk for Parasites - Angiostrongyliasis.""]",[true],[true],[true],"[""People who consume raw or undercooked snails or slugs, or contaminated vegetables, are at risk for Angiostrongyliasis (Angiostrongylus Infection).""]","[""People who consume raw or undercooked snails or slugs are at risk for Parasites - Angiostrongyliasis.""]","[""People who consume raw or undercooked snails or slugs are at risk for Parasites - Angiostrongyliasis.""]",[true],[true],[true],"[""People who consume raw or undercooked snails or slugs, or contaminated vegetables, are at risk for Angiostrongyliasis (Angiostrongylus Infection).""]","[""People who consume raw or undercooked snails or slugs, or contaminated vegetables, are at risk for Angiostrongyliasis.""]","[""People who consume raw or undercooked snails or slugs are at risk for Parasites - Angiostrongyliasis.""]",[true],[true],[true],"[""People who consume raw or undercooked snails or slugs, or contaminated vegetables, or who handle snails and slugs are at risk for Angiostrongylus infection.""]","[""People who consume raw or undercooked snails or slugs are at risk for Angiostrongyliasis.""]","[""People who consume raw or undercooked snails or slugs are at risk for Parasites - Angiostrongyliasis.""]",[true],[true],[true],"[""People who consume raw or undercooked snails or slugs, or contaminated vegetables, fruits, or water are at risk for Angiostrongyliasis (Angiostrongylus Infection).""]","[""People who consume raw or undercooked snails or slugs are at risk for Angiostrongyliasis.""]","[""People who consume raw or undercooked snails or slugs are at risk for Parasites - Angiostrongyliasis.""]",[true],[true],[true],"[""People who consume raw or undercooked snails or slugs, or contaminated vegetables, are at risk for Angiostrongyliasis (Angiostrongylus Infection).""]","[""People who consume raw or undercooked snails or slugs are at risk for Angiostrongyliasis.""]","[""People who consume raw or undercooked snails or slugs are at risk for Parasites - Angiostrongyliasis.""]",[true],[true],[true],"[""People who consume raw or undercooked snails or slugs, or contaminated vegetables, or who come into contact with infected rats or snails, are at risk for Angiostrongyliasis (Angiostrongylus Infection).""]","[""People who consume raw or undercooked snails or slugs are at risk for Angiostrongyliasis.""]","[""People who consume raw or undercooked snails or slugs are at risk for Parasites - Angiostrongyliasis.""]"
frequency,"How many people are affected by mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes ?","The exact incidence of MELAS is unknown. It is one of the more common conditions in a group known as mitochondrial diseases. Together, mitochondrial diseases occur in about 1 in 4,000 people.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""MELAS"", ""full_form"": ""mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes""}]}",How many people are affected by MELAS ?,"How many people are affected by mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes ?",8,MEDICAL,Simple Datatype-Integer,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Mitochondrial Encephalomyopathy Lactic Acidosis and Stroke"", ""Mitochondrial Encephalomyopathy Lactic Acidosis and Strokelike"", ""Mitochondrial Encephalomyopathy Lactic Acidosis Stroke"", ""Mitochondrial Encephalopathy Lactic Acidosis and Stroke"", ""Myopathy Encephalopathy Lactic Acidosis and Stroke"", ""Mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes"", ""Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes"", ""Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis and Stroke-Like Episodes"", ""Myoclonus Epilepsy Lactic Acidosis Stroke"", ""Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis and Stroke-Like Episodes"", ""Myoclonus Epilepsy Lactic Acidosis Stroke""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY""]]","[""Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like episodes""]",[8.583445146426933e-33],[1.4714164527841847e-26],"[""Mitochondrial Encephalopathy Lactic Acidosis and Stroke""]",[7.397106692321891e-21],"[""ABBREVIATIONS""]","[[1.680380270505943e-26, 1.800578053471536e-34, 1.0983172385634771e-27, 7.397106692321891e-21, 2.7135446240701007e-21, 1.4714164527841847e-26, 2.0274146714604837e-30, 1.815760012832722e-30, 5.2728544201784594e-24, 1.815760012832722e-30, 5.2728544201784594e-24]]",[0.9188264027603124],[0.9244113228704405],"[""Mitochondrial Encephalopathy Lactic Acidosis and Stroke""]",[0.9321824171298235],"[""ABBREVIATIONS""]","[[0.9229669219189078, 0.9318247774414379, 0.9231749069126896, 0.9241641603632589, 0.9321824171298235, 0.9213285053842106, 0.9229145266793035, 0.9278595281998852, 0.9210277310006603, 0.9277865966097095, 0.9210277310006603]]","[""Mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes""]","[""ABBREVIATIONS""]","How many people are affected by MELAS (Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like episodes) ?",[true],[false],[true],"[""MELAS affects approximately 1 in 4,000 to 5,000 individuals.""]","[""Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes affect approximately 1 in 5,000 individuals.""]","[""MELAS affects about 1 in 4,000 to 5,000 individuals.""]",[true],[true],[true],"[""MELAS affects approximately 1 in 4,000 to 5,000 individuals.""]","[""Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes affect about 1 in 5,000 individuals.""]","[""MELAS affects about 1 in 4,000 to 5,000 individuals.""]",[true],[true],[true],"[""MELAS affects approximately 1 in 4,000 to 5,000 individuals.""]","[""Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes affect about 1 in 5,000 individuals.""]","[""MELAS affects about 1 in 4,000 to 5,000 individuals.""]",[true],[true],[true],"[""MELAS affects approximately 1 in 4,000 to 5,000 individuals.""]","[""Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes affect about 1 in 5,000 individuals.""]","[""MELAS affects about 1 in 4,000 to 5,000 individuals.""]",[true],[false],[true],"[""MELAS affects approximately 1 in 4,000 to 5,000 individuals.""]","[""Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes affect approximately 1 in 5,000 individuals.""]","[""MELAS affects about 1 in 4,000 to 5,000 individuals.""]",[true],[true],[true],"[""MELAS affects approximately 1 in 4,000 to 5,000 individuals.""]","[""Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes affect about 1 in 5,000 individuals.""]","[""MELAS affects about 1 in 4,000 to 5,000 individuals.""]",[true],[true],[true],"[""MELAS affects approximately 1 in 4,000 to 5,000 individuals.""]","[""Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes affect about 1 in 5,000 individuals.""]","[""MELAS affects about 1 in 4,000 to 5,000 individuals.""]",[true],[true],[true],"[""MELAS affects approximately 1 in 4,000 to 5,000 individuals.""]","[""Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes affect about 1 in 5,000 individuals.""]","[""MELAS affects about 1 in 4,000 to 5,000 individuals.""]",[true],[true],[true],"[""MELAS affects about 1 in 4,000 to 5,000 individuals.""]","[""Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes affect about 1 in 5,000 individuals.""]","[""MELAS affects about 1 in 4,000 to 5,000 individuals.""]",[true],[true],[true],"[""MELAS affects about 1 in 4000 to 5000 individuals.""]","[""Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes affect approximately 1 in 5,000 individuals.""]","[""MELAS affects about 1 in 4,000 to 5,000 individuals.""]",[true],[true],[true],"[""MELAS affects approximately 1 in 4,000 to 5,000 individuals.""]","[""Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes affect about 1 in 5,000 individuals.""]","[""MELAS affects about 1 in 4,000 to 5,000 individuals.""]",[true],[true],[true],"[""MELAS affects approximately 1 in 4,000 to 5,000 individuals.""]","[""Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes affect about 1 in 5,000 individuals.""]","[""MELAS affects about 1 in 4,000 to 5,000 individuals.""]",[true],[true],[true],"[""MELAS affects approximately 1 in 4,000 to 5,000 individuals.""]","[""Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes affect approximately 1 in 5,000 individuals.""]","[""MELAS affects about 1 in 4,000 to 5,000 individuals.""]",[true],[true],[true],"[""MELAS affects about 1 in 4,000 to 5,000 individuals.""]","[""Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes affect about 1 in 5,000 individuals.""]","[""MELAS affects about 1 in 4,000 to 5,000 individuals.""]",[true],[true],[true],"[""MELAS affects approximately 1 in 4000 to 5000 individuals.""]","[""Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes affect about 1 in 5,000 individuals.""]","[""MELAS affects about 1 in 4,000 to 5,000 individuals.""]",[true],[true],[true],"[""MELAS affects approximately 1 in 4,000 to 5,000 individuals.""]","[""Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes affect about 1 in 5,000 individuals.""]","[""MELAS affects about 1 in 4,000 to 5,000 individuals.""]",[true],[true],[true],"[""MELAS affects approximately 1 in 4,000 to 5,000 individuals.""]","[""Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes affect approximately 1 in 5,000 individuals.""]","[""MELAS affects about 1 in 4,000 to 5,000 individuals.""]",[true],[false],[true],"[""MELAS affects about 1 in 4,000 to 5,000 individuals.""]","[""Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes affect about 1 in 5,000 individuals.""]","[""MELAS affects about 1 in 4,000 to 5,000 individuals.""]",[true],[true],[true],"[""MELAS affects about 1 in 4,000 to 5,000 individuals.""]","[""Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes affect about 1 in 5,000 individuals.""]","[""MELAS affects about 1 in 4,000 to 5,000 individuals.""]",[true],[true],[true],"[""MELAS affects about 1 in 4,000 to 5,000 individuals.""]","[""Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes affect about 1 in 5,000 individuals.""]","[""MELAS affects about 1 in 4,000 to 5,000 individuals.""]",[true],[false],[true],"[""MELAS affects about 1 in 4,000 to 5,000 individuals.""]","[""Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes affect approximately 1 in 5,000 individuals.""]","[""MELAS affects about 1 in 4,000 to 5,000 individuals.""]",[true],[false],[true],"[""MELAS affects about 1 in 4,000 to 5,000 individuals.""]","[""Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes affect about 1 in 5,000 individuals.""]","[""MELAS affects about 1 in 4,000 to 5,000 individuals.""]",[true],[true],[true],"[""MELAS affects about 1 in 4,000 to 5,000 individuals.""]","[""Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes affect about 1 in 5,000 individuals.""]","[""MELAS affects about 1 in 4,000 to 5,000 individuals.""]",[true],[true],[true],"[""MELAS affects about 1 in 4,000 to 5,000 individuals.""]","[""Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes affect about 1 in 5,000 individuals.""]","[""MELAS affects about 1 in 4,000 to 5,000 individuals.""]",[true],[false],[true],"[""MELAS affects approximately 1 in 4,000 to 5,000 individuals.""]","[""Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes affect approximately 1 in 5,000 individuals.""]","[""MELAS affects about 1 in 4,000 to 5,000 individuals.""]",[true],[true],[true],"[""MELAS affects approximately 1 in 4,000 to 5,000 individuals.""]","[""Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes affect about 1 in 5,000 individuals.""]","[""MELAS affects about 1 in 4,000 to 5,000 individuals.""]",[true],[true],[true],"[""MELAS affects approximately 1 in 4,000 to 5,000 individuals.""]","[""Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes affect about 1 in 5,000 individuals.""]","[""MELAS affects about 1 in 4,000 to 5,000 individuals.""]",[true],[true],[true],"[""MELAS affects approximately 1 in 4,000 to 5,000 individuals.""]","[""Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes affect about 1 in 5,000 individuals.""]","[""MELAS affects about 1 in 4,000 to 5,000 individuals.""]",[true],[false],[true],"[""MELAS affects about 1 in 4,000 to 5,000 individuals.""]","[""Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes affect approximately 1 in 5,000 individuals.""]","[""MELAS affects about 1 in 4,000 to 5,000 individuals.""]",[true],[true],[true],"[""MELAS affects approximately 1 in 4,000 to 5,000 individuals.""]","[""Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes affect approximately 1 in 5,000 individuals.""]","[""MELAS affects about 1 in 4,000 to 5,000 individuals.""]",[true],[false],[true],"[""MELAS affects approximately 1 in 4,000 to 5,000 individuals.""]","[""Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes affect approximately 1 in 5,000 individuals.""]","[""MELAS affects about 1 in 4,000 to 5,000 individuals.""]",[true],[true],[true],"[""MELAS affects approximately 1 in 4,000 to 5,000 individuals.""]","[""Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes affect approximately 1 in 5,000 individuals.""]","[""MELAS affects about 1 in 4,000 to 5,000 individuals.""]"
frequency,How many people are affected by Nager syndrome ?,"Nager syndrome is a rare condition, although its prevalence is unknown. More than 75 cases have been reported in the medical literature.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""abbreviation"", ""abbreviation"": ""Nager syndrome"", ""full_form"": ""Nager acrofacial dysostosis""}]}",How many people are affected by Nager syndrome ?,How many people are affected by Nager acrofacial dysostosis ?,8,MEDICAL,Simple Datatype-Integer,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Foundation for Nager and Miller Syndromes""]]","[[""ACRONYMFINDER""]]","[""Nager syndrome""]",[2.677710295462219e-27],[0.0004093885251488399],"[""Nager syndrome""]",[0.0004093885251488399],"[""LLM""]",[[5.962356117972069e-24]],[0.9544035507476873],[0.9733960200731235],"[""Foundation for Nager and Miller Syndromes""]",[0.9733960200731235],"[""LLM""]",[[0.9171248025556102]],"[""Nager syndrome""]","[""LLM""]",How many people are affected by Nager syndrome (Nager syndrome) ?,[true],[true],[true],"[""Nager syndrome is a rare condition, and the exact number of people affected by it is not well documented. However, it is estimated to occur in 1 in 100,000 to 1 in 200,000 live births.""]","[""Nager acrofacial dysostosis affects a very small number of individuals worldwide.""]","[""Nager syndrome is a rare condition, and the exact number of people affected is not well documented. It is estimated to occur in 1 in 100,000 to 1 in 250,000 live births.""]",[false],[true],[false],"[""Nager syndrome affects approximately 1 in 100,000 live births.""]","[""Nager acrofacial dysostosis is a rare condition, and the exact number of people affected is not well-documented.""]","[""Nager syndrome affects approximately 1 in 100,000 live births.""]",[true],[true],[true],"[""Nager syndrome is a rare condition, and the exact number of people affected by it is not well documented.""]","[""Nager acrofacial dysostosis affects a very small number of individuals worldwide.""]","[""Nager syndrome is a rare condition, and the exact number of people affected is not well documented.""]",[true],[true],[false],"[""Nager syndrome is a rare condition, and the exact number of people affected by it is not well-documented.""]","[""Nager acrofacial dysostosis affects a very small number of individuals worldwide.""]","[""Nager syndrome affects approximately 1 in 100,000 live births.""]",[true],[true],[true],"[""Nager syndrome is a rare condition, and the exact number of people affected by it is not well-documented.""]","[""Nager acrofacial dysostosis affects a very small number of individuals worldwide.""]","[""Nager syndrome is a rare condition, and the exact number of people affected is not well documented. It is estimated to occur in 1 in 100,000 to 1 in 250,000 live births.""]",[false],[true],[false],"[""Nager syndrome affects approximately 1 in 100,000 live births.""]","[""Nager acrofacial dysostosis is a rare condition, and the exact number of people affected is not well-documented.""]","[""Nager syndrome affects approximately 1 in 100,000 live births.""]",[false],[true],[true],"[""Nager syndrome affects approximately 1 in 100,000 live births.""]","[""Nager acrofacial dysostosis affects a very small number of individuals worldwide.""]","[""Nager syndrome is a rare condition, and the exact number of people affected is not well documented.""]",[false],[true],[false],"[""Nager syndrome affects approximately 1 in 100,000 live births.""]","[""Nager acrofacial dysostosis affects a very small number of individuals worldwide.""]","[""Nager syndrome affects approximately 1 in 100,000 live births.""]",[false],[true],[false],"[""Nager syndrome is a rare condition, and the exact number of people affected by it is not well-documented. However, it is estimated to occur in 1 in 100,000 to 1 in 200,000 live births.""]","[""Nager acrofacial dysostosis is a rare condition, and the exact number of people affected is not well-documented.""]","[""Nager syndrome affects approximately 1 in 100,000 live births.""]",[true],[true],[true],"[""Nager syndrome is a rare condition, and the exact number of people affected by it is not well-documented.""]","[""Nager acrofacial dysostosis affects a very small number of individuals worldwide.""]","[""Nager syndrome is a rare condition, and the exact number of people affected is not well documented. It is estimated to occur in 1 in 100,000 to 1 in 250,000 live births.""]",[false],[true],[true],"[""Nager syndrome is a rare condition, and the exact number of people affected by it is not well-documented. However, it is estimated to occur in 1 in 100,000 to 1 in 200,000 live births.""]","[""Nager acrofacial dysostosis affects a very small number of individuals worldwide.""]","[""Nager syndrome is a rare condition, and the exact number of people affected is not well documented.""]",[false],[true],[false],"[""Nager syndrome is a rare condition, and the exact number of people affected by it is not well-documented. However, it is estimated to occur in 1 in 100,000 to 1 in 200,000 live births.""]","[""Nager acrofacial dysostosis affects a very small number of individuals worldwide.""]","[""Nager syndrome affects approximately 1 in 100,000 live births.""]",[true],[true],[true],"[""Nager syndrome is a rare condition, and the exact number of people affected is not well documented.""]","[""Nager acrofacial dysostosis affects a very small number of individuals worldwide.""]","[""Nager syndrome is a rare condition, and the exact number of people affected is not well documented. It is estimated to occur in 1 in 100,000 to 1 in 250,000 live births.""]",[true],[true],[false],"[""Nager syndrome is a rare condition, and the exact number of people affected is not well documented.""]","[""Nager acrofacial dysostosis is a rare condition, and the exact number of people affected is not well-documented.""]","[""Nager syndrome affects approximately 1 in 100,000 live births.""]",[true],[true],[true],"[""Nager syndrome is a rare condition, and the exact number of people affected is not well documented.""]","[""Nager acrofacial dysostosis affects a very small number of individuals worldwide.""]","[""Nager syndrome is a rare condition, and the exact number of people affected is not well documented.""]",[true],[true],[false],"[""Nager syndrome is a rare condition, and the exact number of people affected is not well documented.""]","[""Nager acrofacial dysostosis affects a very small number of individuals worldwide.""]","[""Nager syndrome affects approximately 1 in 100,000 live births.""]",[true],[true],[true],"[""Nager syndrome affects approximately 1 in 100,000 live births.""]","[""Nager acrofacial dysostosis affects a very small number of individuals worldwide.""]","[""Nager syndrome is a rare condition, and the exact number of people affected is not well documented. It is estimated to occur in 1 in 100,000 to 1 in 250,000 live births.""]",[false],[true],[false],"[""Nager syndrome is a rare condition, and the exact number of people affected by it is not well documented. It is estimated to occur in 1 in 100,000 to 1 in 250,000 live births.""]","[""Nager acrofacial dysostosis is a rare condition, and the exact number of people affected is not well-documented.""]","[""Nager syndrome affects approximately 1 in 100,000 live births.""]",[false],[true],[true],"[""Nager syndrome affects approximately 1 in 100,000 live births.""]","[""Nager acrofacial dysostosis affects a very small number of individuals worldwide.""]","[""Nager syndrome is a rare condition, and the exact number of people affected is not well documented.""]",[false],[true],[false],"[""Nager syndrome affects approximately 1 in 100,000 live births.""]","[""Nager acrofacial dysostosis affects a very small number of individuals worldwide.""]","[""Nager syndrome affects approximately 1 in 100,000 live births.""]",[true],[true],[true],"[""Nager syndrome is a rare condition, and the exact number of people affected by it is not well-documented.""]","[""Nager acrofacial dysostosis affects a very small number of individuals worldwide.""]","[""Nager syndrome is a rare condition, and the exact number of people affected is not well documented. It is estimated to occur in 1 in 100,000 to 1 in 250,000 live births.""]",[false],[true],[false],"[""Nager syndrome affects approximately 1 in 100,000 live births.""]","[""Nager acrofacial dysostosis is a rare condition, and the exact number of people affected is not well-documented.""]","[""Nager syndrome affects approximately 1 in 100,000 live births.""]",[false],[true],[true],"[""Nager syndrome affects an estimated 1 in 100,000 to 1 in 200,000 newborns.""]","[""Nager acrofacial dysostosis affects a very small number of individuals worldwide.""]","[""Nager syndrome is a rare condition, and the exact number of people affected is not well documented.""]",[false],[true],[false],"[""Nager syndrome affects approximately 1 in 100,000 live births.""]","[""Nager acrofacial dysostosis affects a very small number of individuals worldwide.""]","[""Nager syndrome affects approximately 1 in 100,000 live births.""]",[true],[true],[true],"[""Nager syndrome is a rare condition, and the exact number of people affected by it is not well-documented. However, it is estimated to occur in 1 in 100,000 to 1 in 200,000 live births.""]","[""Nager acrofacial dysostosis affects a very small number of individuals worldwide.""]","[""Nager syndrome is a rare condition, and the exact number of people affected is not well documented. It is estimated to occur in 1 in 100,000 to 1 in 250,000 live births.""]",[false],[true],[false],"[""Nager syndrome is a rare genetic disorder, and the exact number of people affected by it is not well documented. However, it is estimated to occur in 1 in 100,000 to 1 in 200,000 live births.""]","[""Nager acrofacial dysostosis is a rare condition, and the exact number of people affected is not well-documented.""]","[""Nager syndrome affects approximately 1 in 100,000 live births.""]",[false],[true],[true],"[""Nager syndrome is a rare genetic disorder, and the exact number of people affected by it is not well-documented. However, it is estimated to occur in 1 in 100,000 to 1 in 200,000 live births.""]","[""Nager acrofacial dysostosis affects a very small number of individuals worldwide.""]","[""Nager syndrome is a rare condition, and the exact number of people affected is not well documented.""]",[true],[true],[false],"[""Nager syndrome is a rare condition, and the exact number of people affected by it is not well-documented.""]","[""Nager acrofacial dysostosis affects a very small number of individuals worldwide.""]","[""Nager syndrome affects approximately 1 in 100,000 live births.""]",[true],[true],[true],"[""Nager syndrome is a rare condition, and the exact number of people affected is not well documented.""]","[""Nager acrofacial dysostosis affects a very small number of individuals worldwide.""]","[""Nager syndrome is a rare condition, and the exact number of people affected is not well documented. It is estimated to occur in 1 in 100,000 to 1 in 250,000 live births.""]",[true],[true],[true],"[""Nager syndrome is a rare condition, and the exact number of people affected is not well documented.""]","[""Nager acrofacial dysostosis affects a very small number of individuals worldwide.""]","[""Nager syndrome is a rare condition, and the exact number of people affected is not well documented. It is estimated to occur in 1 in 100,000 to 1 in 250,000 live births.""]",[true],[true],[true],"[""Nager syndrome is a rare condition, and the exact number of people affected is not well-documented. It is estimated to occur in 1 in 100,000 to 1 in 250,000 live births.""]","[""Nager acrofacial dysostosis affects a very small number of individuals worldwide.""]","[""Nager syndrome is a rare condition, and the exact number of people affected is not well documented. It is estimated to occur in 1 in 100,000 to 1 in 250,000 live births.""]",[true],[true],[true],"[""Nager syndrome is a rare condition, and the exact number of people affected is not well-documented.""]","[""Nager acrofacial dysostosis affects a very small number of individuals worldwide.""]","[""Nager syndrome is a rare condition, and the exact number of people affected is not well documented. It is estimated to occur in 1 in 100,000 to 1 in 250,000 live births.""]"
information,Do you have information about Child Development,"Summary : As children grow older, they develop in several different ways. Child development includes physical, intellectual, social, and emotional changes.    Children grow and mature at very different rates. It's hard to say what ""normal"" is. There can be big differences in height, weight, and build among healthy children. Diet, exercise and genes are all factors. Some children begin puberty or are close to it before they are teenagers.    Children start to become more independent from their parents. They may rebel. They also look outward - to their friends, who are usually of the same sex. Peer approval becomes very important. Your child may try new behaviors to be part of ""the group."" This can also be the time that parents or teachers recognize learning disabilities or behavioral problems in children. These problems can get worse as time goes on, so it is important to get help early.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""CD"", ""full_form"": ""Child Development""}]}",Do you have information about CD,Do you have information about Child Development,1,COMPUTING,Simple Datatype-Boolean,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Compact Disc"", ""Compact Disc - Music, software programs and digital media"", ""Celine Dion"", ""Cadmium"", ""Christian Dior"", ""Canadian Dollar"", ""Compact Disk"", ""Cardiovascular Disease"", ""Compact Disk description"", ""Compact Design""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Compact Disc""]",[5.954055715288927e-08],[4.702596594970456e-06],"[""Compact Disc""]",[4.702596594970456e-06],"[""ABBREVIATIONS""]","[[4.702596594970456e-06, 2.3516015460333802e-29, 7.658645951305704e-17, 1.2932813763643166e-12, 6.981675805974598e-17, 2.8154035694262294e-14, 8.555348119446523e-08, 5.190480014531839e-07, 6.016508380585809e-13, 1.4354104400159655e-10]]",[0.7804116306246278],[0.8468379995960248],"[""Child Development""]",[0.8468379995960248],"[""ABBREVIATIONS""]","[[0.8468379995960248, 0.8138776355338446, 0.7811795083920327, 0.7951521271003752, 0.7130493502959757, 0.6870031068130207, 0.8396403887812631, 0.7634054151981844, 0.7888850928813396, 0.8084342102087269]]","[""Cardiovascular Disease""]","[""ABBREVIATIONS""]",Do you have information about CD (Compact Disc),[true],[false],[false],"[""Yes""]","[""No""]","[""CD stands for Compact Disc, which is a digital optical disc storage format used for storing digital data.""]",[false],[false],[false],"[""Yes, a Compact Disc (CD) is an optical disc used to store digital data.""]","[""No""]","[""CD stands for Compact Disc, which is a digital optical disc storage format used for storing digital data.""]",[false],[false],[false],"[""Yes, a CD (Compact Disc) is a digital optical disc storage format that was first introduced in 1982. It is commonly used for storing and playing back audio recordings, as well as for data storage and distribution.""]","[""No""]","[""CD stands for Compact Disc, a digital optical disc data storage format.""]",[false],[false],[false],"[""Yes, a CD (Compact Disc) is a digital optical disc storage format that was co-developed by Philips and Sony. It was originally used for audio recordings, but later expanded to include data storage such as software and other media.""]","[""No""]","[""CD stands for Compact Disc, which is a digital optical disc storage format used for storing digital data.""]",[true],[false],[false],"[""Yes""]","[""No""]","[""CD stands for Compact Disc, which is a digital optical disc storage format used for storing digital data.""]",[true],[false],[false],"[""Yes""]","[""No""]","[""CD stands for Compact Disc, which is a digital optical disc storage format used for storing digital data.""]",[true],[false],[false],"[""Yes""]","[""No""]","[""CD stands for Compact Disc, a digital optical disc data storage format.""]",[true],[false],[false],"[""Yes""]","[""No""]","[""CD stands for Compact Disc, which is a digital optical disc storage format used for storing digital data.""]",[true],[false],[false],"[""Yes""]","[""No""]","[""CD stands for Compact Disc, which is a digital optical disc storage format used for storing digital data.""]",[true],[false],[false],"[""Yes""]","[""No""]","[""CD stands for Compact Disc, which is a digital optical disc storage format used for storing digital data.""]",[true],[false],[false],"[""Yes""]","[""No""]","[""CD stands for Compact Disc, a digital optical disc data storage format.""]",[true],[false],[false],"[""Yes""]","[""No""]","[""CD stands for Compact Disc, which is a digital optical disc storage format used for storing digital data.""]",[false],[false],[false],"[""No""]","[""No""]","[""CD stands for Compact Disc, which is a digital optical disc storage format used for storing digital data.""]",[false],[false],[false],"[""No""]","[""No""]","[""CD stands for Compact Disc, which is a digital optical disc storage format used for storing digital data.""]",[false],[false],[false],"[""No""]","[""No""]","[""CD stands for Compact Disc, a digital optical disc data storage format.""]",[false],[false],[false],"[""No""]","[""No""]","[""CD stands for Compact Disc, which is a digital optical disc storage format used for storing digital data.""]",[true],[false],[false],"[""Yes""]","[""No""]","[""CD stands for Compact Disc, which is a digital optical disc storage format used for storing digital data.""]",[true],[false],[false],"[""Yes""]","[""No""]","[""CD stands for Compact Disc, which is a digital optical disc storage format used for storing digital data.""]",[true],[false],[false],"[""Yes""]","[""No""]","[""CD stands for Compact Disc, a digital optical disc data storage format.""]",[true],[false],[false],"[""Yes""]","[""No""]","[""CD stands for Compact Disc, which is a digital optical disc storage format used for storing digital data.""]",[false],[false],[false],"[""Yes, a Compact Disc (CD) is an optical storage medium that was once widely used for storing and playing digital audio recordings and data. It has a storage capacity of up to 700 MB for data or 80 minutes of audio.""]","[""No""]","[""CD stands for Compact Disc, which is a digital optical disc storage format used for storing digital data.""]",[false],[false],[false],"[""Yes, a Compact Disc (CD) is an optical storage medium that was once widely used for storing and playing digital audio recordings and other data.""]","[""No""]","[""CD stands for Compact Disc, which is a digital optical disc storage format used for storing digital data.""]",[true],[false],[false],"[""Yes""]","[""No""]","[""CD stands for Compact Disc, a digital optical disc data storage format.""]",[false],[false],[false],"[""Yes, a Compact Disc (CD) is a digital optical disc data storage format that was co-developed by Philips and Sony. It was originally developed to store and play back sound recordings exclusively, but later expanded to encompass data storage as well.""]","[""No""]","[""CD stands for Compact Disc, which is a digital optical disc storage format used for storing digital data.""]",[false],[false],[false],"[""Yes, I have information about Cardiovascular Disease (CD).""]","[""No""]","[""CD stands for Compact Disc, which is a digital optical disc storage format used for storing digital data.""]",[false],[false],[false],"[""Yes, I have information about Cardiovascular Disease (CD).""]","[""No""]","[""CD stands for Compact Disc, which is a digital optical disc storage format used for storing digital data.""]",[false],[false],[false],"[""Yes, I have information about Cardiovascular Disease (CD).""]","[""No""]","[""CD stands for Compact Disc, a digital optical disc data storage format.""]",[false],[false],[false],"[""Yes, I have information about Cardiovascular Disease (CD).""]","[""No""]","[""CD stands for Compact Disc, which is a digital optical disc storage format used for storing digital data.""]",[false],[false],[false],"[""Yes, I have information about Cardiovascular Disease (CD).""]","[""No""]","[""CD stands for Compact Disc, which is a digital optical disc storage format used for storing digital data.""]",[false],[false],[false],"[""Yes, a CD is a digital optical disc data storage format.""]","[""No""]","[""CD stands for Compact Disc, which is a digital optical disc storage format used for storing digital data.""]",[true],[false],[false],"[""Yes, I have information about Child Development (CD).""]","[""No""]","[""CD stands for Compact Disc, which is a digital optical disc storage format used for storing digital data.""]",[false],[false],[false],"[""Yes, a Compact Disc (CD) is an optical storage medium used for storing digital data.""]","[""No""]","[""CD stands for Compact Disc, which is a digital optical disc storage format used for storing digital data.""]"
causes,What causes Best vitelliform macular dystrophy ?,"What causes Best vitelliform macular dystrophy? Best vitelliform macular dystrophy (BVMD) is caused by changes (mutations) in the BEST1 gene. This gene gives the body instructions for making a protein called bestrophin. Bestrophin acts as a channel that controls the movement of chloride ions within the retina. It is thought that mutations in the BEST1 gene affect the shape of the channel and its ability to properly regulate the flow of chloride. However, it is unclear how exactly this relates to the specific features of BVMD.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""BMD"", ""full_form"": ""Best vitelliform macular dystrophy""}]}",What causes BMD ?,What causes Best vitelliform macular dystrophy ?,0,SCIENCE,Compound Datatype-String,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Bone mineral density"", ""Ballistic Missile Defense"", ""Bermuda Dollar"", ""Births Marriages And Deaths"", ""Birth, Marriage, And Death"", ""Bernese Mountain Dog"", ""Blue Mystery Data"", ""Belo, Madagascar"", ""Biblioteca M\u00e9dica Digital"", ""Bending Moment Diagram""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Bone Mineral Density""]",[1.10613954314404e-26],[2.0408777502186318e-11],"[""Bone mineral density""]",[2.0408777502186318e-11],"[""ABBREVIATIONS""]","[[2.0408777502186318e-11, 4.573600135189682e-21, 4.938741013378208e-17, 5.777737762913046e-19, 1.7410118372972779e-12, 5.068647030100767e-19, 1.2779111837434628e-15, 1.2925986988416787e-24, 1.2614959459950456e-18, 1.1546670671481022e-19]]",[0.6731768379838309],[0.8551100330131275],"[""Best vitelliform macular dystrophy""]",[0.8602685965097558],"[""ABBREVIATIONS""]","[[0.8602685965097558, 0.6153195800083145, 0.647065258133573, 0.6326917862051602, 0.674782377637069, 0.7206708461446467, 0.7041139040057351, 0.7506329586248919, 0.7484851516547781, 0.580570632408436]]","[""Bone mineral density""]","[""ABBREVIATIONS""]",What causes BMD (Bone Mineral Density) ?,[false],[true],[false],"[""Bone mineral density (BMD) is primarily influenced by genetics, age, sex, hormonal status, physical activity, and nutrition.""]","[""Mutations in the BEST1 gene""]","[""Bone Mineral Density (BMD) is primarily influenced by genetics, age, sex, hormonal status, physical activity, and nutrition.""]",[false],[true],[false],"[""Bone mineral density (BMD) is primarily influenced by genetics, age, sex, hormonal status, physical activity, and nutrition.""]","[""Mutations in the BEST1 gene""]","[""Bone Mineral Density (BMD) is primarily influenced by genetics, age, gender, hormonal status, physical activity, and nutrition.""]",[false],[true],[false],"[""Bone mineral density (BMD) is primarily influenced by genetics, age, sex, hormonal status, physical activity, and nutrition.""]","[""Mutations in the BEST1 gene""]","[""Bone Mineral Density (BMD) is primarily influenced by genetics, age, sex, hormonal status, physical activity, and nutrition.""]",[false],[true],[false],"[""Bone mineral density (BMD) is primarily influenced by genetics, age, sex, hormonal status, physical activity, and nutrition.""]","[""Mutations in the BEST1 gene""]","[""Bone Mineral Density (BMD) is primarily influenced by genetics, age, gender, hormonal status, physical activity, and nutrition.""]",[true],[true],[false],"[""Mutations in the BEST1 gene""]","[""Mutations in the BEST1 gene""]","[""Bone Mineral Density (BMD) is primarily influenced by genetics, age, sex, hormonal status, physical activity, and nutrition.""]",[true],[true],[false],"[""Mutations in the BEST1 gene""]","[""Mutations in the BEST1 gene""]","[""Bone Mineral Density (BMD) is primarily influenced by genetics, age, gender, hormonal status, physical activity, and nutrition.""]",[true],[true],[false],"[""Mutations in the BEST1 gene""]","[""Mutations in the BEST1 gene""]","[""Bone Mineral Density (BMD) is primarily influenced by genetics, age, sex, hormonal status, physical activity, and nutrition.""]",[true],[true],[false],"[""Mutations in the BEST1 gene""]","[""Mutations in the BEST1 gene""]","[""Bone Mineral Density (BMD) is primarily influenced by genetics, age, gender, hormonal status, physical activity, and nutrition.""]",[false],[true],[false],"[""Bone mineral density (BMD) is primarily influenced by genetics, age, sex, hormonal status, physical activity, and nutrition.""]","[""Mutations in the BEST1 gene""]","[""Bone Mineral Density (BMD) is primarily influenced by genetics, age, gender, hormonal status, physical activity, and nutrition.""]",[false],[true],[false],"[""Bone mineral density (BMD) is primarily influenced by genetics, age, sex, hormonal status, physical activity, and nutrition.""]","[""Mutations in the BEST1 gene""]","[""Bone Mineral Density (BMD) is primarily influenced by genetics, age, sex, hormonal status, physical activity, and nutrition.""]",[false],[true],[false],"[""Bone mineral density (BMD) is primarily influenced by genetics, age, sex, hormonal status, physical activity, and nutrition.""]","[""Mutations in the BEST1 gene""]","[""Bone Mineral Density (BMD) is primarily influenced by genetics, age, sex, hormonal status, physical activity, and nutrition.""]",[false],[true],[false],"[""Bone mineral density (BMD) is primarily influenced by genetics, age, sex, hormonal status, physical activity, and nutrition.""]","[""Mutations in the BEST1 gene""]","[""Bone Mineral Density (BMD) is primarily influenced by genetics, age, gender, hormonal status, physical activity, and nutrition.""]",[false],[true],[false],"[""Bone mineral density (BMD) is primarily influenced by genetics, age, sex, hormonal status, physical activity, and nutrition.""]","[""Mutations in the BEST1 gene""]","[""Bone Mineral Density (BMD) is primarily influenced by genetics, age, sex, hormonal status, physical activity, and nutrition.""]",[false],[true],[false],"[""Bone mineral density is primarily influenced by genetics, age, sex, hormonal status, physical activity, and nutrition.""]","[""Mutations in the BEST1 gene""]","[""Bone Mineral Density (BMD) is primarily influenced by genetics, age, gender, hormonal status, physical activity, and nutrition.""]",[false],[true],[false],"[""Bone mineral density is primarily influenced by genetics, age, sex, hormonal status, physical activity, and nutrition.""]","[""Mutations in the BEST1 gene""]","[""Bone Mineral Density (BMD) is primarily influenced by genetics, age, sex, hormonal status, physical activity, and nutrition.""]",[false],[true],[false],"[""Bone mineral density (BMD) is primarily influenced by genetics, age, sex, hormonal status, physical activity, and nutrition.""]","[""Mutations in the BEST1 gene""]","[""Bone Mineral Density (BMD) is primarily influenced by genetics, age, gender, hormonal status, physical activity, and nutrition.""]",[false],[true],[false],"[""BMD (Bone mineral density) is primarily influenced by genetics, age, sex, hormonal status, physical activity, and nutrition.""]","[""Mutations in the BEST1 gene""]","[""Bone Mineral Density (BMD) is primarily influenced by genetics, age, sex, hormonal status, physical activity, and nutrition.""]",[false],[true],[false],"[""Bone mineral density (BMD) is primarily influenced by genetics, age, sex, hormonal status, physical activity, and nutrition.""]","[""Mutations in the BEST1 gene""]","[""Bone Mineral Density (BMD) is primarily influenced by genetics, age, gender, hormonal status, physical activity, and nutrition.""]",[false],[true],[false],"[""Bone mineral density (BMD) is primarily influenced by genetics, age, sex, hormonal status, physical activity, and nutrition.""]","[""Mutations in the BEST1 gene""]","[""Bone Mineral Density (BMD) is primarily influenced by genetics, age, sex, hormonal status, physical activity, and nutrition.""]",[false],[true],[false],"[""Bone mineral density (BMD) is primarily influenced by genetics, age, sex, hormonal status, physical activity, and nutrition.""]","[""Mutations in the BEST1 gene""]","[""Bone Mineral Density (BMD) is primarily influenced by genetics, age, gender, hormonal status, physical activity, and nutrition.""]",[false],[true],[false],"[""Bone Mineral Density (BMD) is primarily influenced by genetics, age, gender, hormonal status, physical activity, and nutrition.""]","[""Mutations in the BEST1 gene""]","[""Bone Mineral Density (BMD) is primarily influenced by genetics, age, sex, hormonal status, physical activity, and nutrition.""]",[false],[true],[false],"[""Bone Mineral Density (BMD) is primarily influenced by genetics, age, sex, hormonal status, physical activity, and nutrition.""]","[""Mutations in the BEST1 gene""]","[""Bone Mineral Density (BMD) is primarily influenced by genetics, age, gender, hormonal status, physical activity, and nutrition.""]",[false],[true],[false],"[""Bone Mineral Density (BMD) is primarily influenced by genetics, age, sex, hormonal status, physical activity, and nutrition.""]","[""Mutations in the BEST1 gene""]","[""Bone Mineral Density (BMD) is primarily influenced by genetics, age, sex, hormonal status, physical activity, and nutrition.""]",[false],[true],[false],"[""Bone Mineral Density (BMD) is primarily influenced by genetics, age, sex, hormonal status, physical activity, and nutrition.""]","[""Mutations in the BEST1 gene""]","[""Bone Mineral Density (BMD) is primarily influenced by genetics, age, gender, hormonal status, physical activity, and nutrition.""]",[false],[true],[false],"[""Bone mineral density (BMD) is primarily determined by genetics, age, sex, and lifestyle factors such as diet, physical activity, and smoking.""]","[""Mutations in the BEST1 gene""]","[""Bone Mineral Density (BMD) is primarily influenced by genetics, age, sex, hormonal status, physical activity, and nutrition.""]",[false],[true],[false],"[""Several factors can affect bone mineral density, including genetics, age, sex, hormonal levels, physical activity, and nutrition.""]","[""Mutations in the BEST1 gene""]","[""Bone Mineral Density (BMD) is primarily influenced by genetics, age, gender, hormonal status, physical activity, and nutrition.""]",[false],[true],[false],"[""Bone mineral density (BMD) is primarily influenced by genetics, age, sex, hormonal status, physical activity, and nutrition.""]","[""Mutations in the BEST1 gene""]","[""Bone Mineral Density (BMD) is primarily influenced by genetics, age, sex, hormonal status, physical activity, and nutrition.""]",[false],[true],[false],"[""Bone mineral density (BMD) is primarily influenced by genetics, age, sex, hormonal status, physical activity, and nutrition.""]","[""Mutations in the BEST1 gene""]","[""Bone Mineral Density (BMD) is primarily influenced by genetics, age, gender, hormonal status, physical activity, and nutrition.""]",[false],[true],[false],"[""Various factors can affect bone mineral density, including genetics, age, sex, hormonal levels, physical activity, nutrition, and certain medical conditions or medications.""]","[""Mutations in the BEST1 gene""]","[""Bone Mineral Density (BMD) is primarily influenced by genetics, age, sex, hormonal status, physical activity, and nutrition.""]",[false],[true],[false],"[""Various factors can cause changes in bone mineral density, including genetics, age, hormonal changes, nutrition, physical activity, and certain medical conditions or medications.""]","[""Mutations in the BEST1 gene""]","[""Bone Mineral Density (BMD) is primarily influenced by genetics, age, sex, hormonal status, physical activity, and nutrition.""]",[true],[true],[false],"[""Mutations in the BEST1 gene""]","[""Mutations in the BEST1 gene""]","[""Bone Mineral Density (BMD) is primarily influenced by genetics, age, sex, hormonal status, physical activity, and nutrition.""]",[false],[true],[false],"[""Various factors can affect bone mineral density, including genetics, age, gender, hormonal status, physical activity, and nutrition.""]","[""Mutations in the BEST1 gene""]","[""Bone Mineral Density (BMD) is primarily influenced by genetics, age, sex, hormonal status, physical activity, and nutrition.""]"
inheritance,Is junctional epidermolysis bullosa inherited ?,"Both types of junctional epidermolysis bullosa are inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""JEB"", ""full_form"": ""junctional epidermolysis bullosa""}]}",Is JEB inherited ?,Is junctional epidermolysis bullosa inherited ?,8,MEDICAL,Simple Datatype-Boolean,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""John Ellis Bush"", ""Java Exchange Bridge"", ""Java Extension Base"", ""Java Extesion Base"", ""Just Eliminate Boating"", ""Jelly Ellie Belly"", ""John Elias Bush"", ""James Ewell Brown"", ""Journal of Experimental Biology"", ""Junctional Epidermolysis Bullosa""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Junctional Epidermolysis Bullosa""]",[1.5456784365607073e-23],[1.5456784365607073e-23],"[""Java Extension Base""]",[1.1992180378616927e-15],"[""ABBREVIATIONS""]","[[7.231624223876899e-22, 4.226191560091788e-18, 1.1992180378616927e-15, 8.88292154729823e-20, 5.584327383741251e-16, 3.929476602288198e-21, 3.5021161631554094e-23, 5.460852987438091e-19, 1.1359962327536933e-17, 1.5456784365607073e-23]]",[0.7469761098266142],[0.744058957593412],"[""Jelly Ellie Belly""]",[0.8524690565257469],"[""ABBREVIATIONS""]","[[0.8328161038034255, 0.6749029497971568, 0.6941070264966686, 0.6907303149106336, 0.8039452494251091, 0.8120530362543541, 0.8524690565257469, 0.7632802240947998, 0.7501401000192195, 0.744058957593412]]","[""Junctional Epidermolysis Bullosa""]","[""ABBREVIATIONS""]",Is JEB (Junctional Epidermolysis Bullosa) inherited ?,[false],[true],[true],"[""No""]","[""Yes""]","[""Yes""]",[false],[true],[true],"[""No""]","[""Yes, junctional epidermolysis bullosa is inherited.""]","[""Yes, JEB (Junctional Epidermolysis Bullosa) can be inherited as an autosomal recessive genetic disorder.""]",[false],[true],[true],"[""No""]","[""Yes""]","[""Yes, JEB (Junctional Epidermolysis Bullosa) is an inherited genetic disorder.""]",[false],[true],[true],"[""No""]","[""Yes, junctional epidermolysis bullosa is inherited.""]","[""Yes, JEB (Junctional Epidermolysis Bullosa) is an inherited genetic disorder.""]",[false],[true],[true],"[""Yes, JEB (Jelly Ellie Belly) is an inherited condition.""]","[""Yes""]","[""Yes""]",[false],[true],[true],"[""Yes, JEB (Jelly Ellie Belly) is an inherited genetic disorder.""]","[""Yes, junctional epidermolysis bullosa is inherited.""]","[""Yes, JEB (Junctional Epidermolysis Bullosa) can be inherited as an autosomal recessive genetic disorder.""]",[false],[true],[true],"[""Yes, JEB (Jelly Ellie Belly) is an inherited genetic disorder.""]","[""Yes""]","[""Yes, JEB (Junctional Epidermolysis Bullosa) is an inherited genetic disorder.""]",[false],[true],[true],"[""Yes, JEB (Jelly Ellie Belly) is an inherited genetic disorder.""]","[""Yes, junctional epidermolysis bullosa is inherited.""]","[""Yes, JEB (Junctional Epidermolysis Bullosa) is an inherited genetic disorder.""]",[true],[true],[true],"[""Yes, JEB (Junctional Epidermolysis Bullosa) is inherited.""]","[""Yes, junctional epidermolysis bullosa is inherited.""]","[""Yes, JEB (Junctional Epidermolysis Bullosa) can be inherited as an autosomal recessive genetic disorder.""]",[true],[true],[true],"[""Yes, Junctional Epidermolysis Bullosa (JEB) is an inherited genetic condition.""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes""]","[""Yes""]","[""Yes, JEB (Junctional Epidermolysis Bullosa) is an inherited genetic disorder.""]",[true],[true],[true],"[""Yes, JEB (Junctional Epidermolysis Bullosa) is inherited.""]","[""Yes, junctional epidermolysis bullosa is inherited.""]","[""Yes, JEB (Junctional Epidermolysis Bullosa) is an inherited genetic disorder.""]",[true],[true],[true],"[""Yes""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes""]","[""Yes, junctional epidermolysis bullosa is inherited.""]","[""Yes, JEB (Junctional Epidermolysis Bullosa) can be inherited as an autosomal recessive genetic disorder.""]",[true],[true],[true],"[""Yes, JEB (Junctional Epidermolysis Bullosa) is inherited.""]","[""Yes""]","[""Yes, JEB (Junctional Epidermolysis Bullosa) is an inherited genetic disorder.""]",[true],[true],[true],"[""Yes, JEB (Junctional Epidermolysis Bullosa) is inherited.""]","[""Yes, junctional epidermolysis bullosa is inherited.""]","[""Yes, JEB (Junctional Epidermolysis Bullosa) is an inherited genetic disorder.""]",[true],[true],[true],"[""Yes""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes, JEB (Junctional Epidermolysis Bullosa) is inherited.""]","[""Yes, junctional epidermolysis bullosa is inherited.""]","[""Yes, JEB (Junctional Epidermolysis Bullosa) can be inherited as an autosomal recessive genetic disorder.""]",[true],[false],[true],"[""Yes, JEB (Junctional Epidermolysis Bullosa) is inherited.""]","[""Yes""]","[""Yes, JEB (Junctional Epidermolysis Bullosa) is an inherited genetic disorder.""]",[true],[true],[true],"[""Yes""]","[""Yes, junctional epidermolysis bullosa is inherited.""]","[""Yes, JEB (Junctional Epidermolysis Bullosa) is an inherited genetic disorder.""]",[true],[true],[true],"[""Yes, JEB (Junctional Epidermolysis Bullosa) is inherited.""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes, JEB (Junctional Epidermolysis Bullosa) is an inherited genetic condition.""]","[""Yes, junctional epidermolysis bullosa is inherited.""]","[""Yes, JEB (Junctional Epidermolysis Bullosa) can be inherited as an autosomal recessive genetic disorder.""]",[true],[false],[true],"[""Yes, Junctional Epidermolysis Bullosa (JEB) is an inherited genetic condition.""]","[""Yes""]","[""Yes, JEB (Junctional Epidermolysis Bullosa) is an inherited genetic disorder.""]",[true],[true],[true],"[""Yes, JEB (Junctional Epidermolysis Bullosa) is inherited.""]","[""Yes, junctional epidermolysis bullosa is inherited.""]","[""Yes, JEB (Junctional Epidermolysis Bullosa) is an inherited genetic disorder.""]",[true],[true],[true],"[""Yes, Junctional Epidermolysis Bullosa (JEB) is an inherited genetic disorder.""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes, Junctional Epidermolysis Bullosa (JEB) is an inherited genetic disorder.""]","[""Yes, junctional epidermolysis bullosa is inherited.""]","[""Yes, JEB (Junctional Epidermolysis Bullosa) can be inherited as an autosomal recessive genetic disorder.""]",[true],[true],[true],"[""Yes, JEB (Junctional Epidermolysis Bullosa) is inherited.""]","[""Yes""]","[""Yes, JEB (Junctional Epidermolysis Bullosa) is an inherited genetic disorder.""]",[true],[true],[true],"[""Yes, Junctional Epidermolysis Bullosa (JEB) is an inherited genetic condition.""]","[""Yes, junctional epidermolysis bullosa is inherited.""]","[""Yes, JEB (Junctional Epidermolysis Bullosa) is an inherited genetic disorder.""]",[true],[true],[true],"[""Yes, JEB (Junctional Epidermolysis Bullosa) is inherited.""]","[""Yes""]","[""Yes""]",[false],[true],[true],"[""No""]","[""Yes""]","[""Yes""]",[false],[true],[true],"[""No""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes, JEB (Junctional Epidermolysis Bullosa) is inherited.""]","[""Yes""]","[""Yes""]"
complications,What are the complications of Vesicoureteral Reflux ?,"When a child with VUR gets a UTI, bacteria can move into the kidney and lead to scarring. Scarring of the kidney can be associated with high blood pressure and kidney failure. However, most children with VUR who get a UTI recover without long-term complications.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""VUR"", ""full_form"": ""Vesicoureteral Reflux""}]}",What are the complications of VUR ?,What are the complications of Vesicoureteral Reflux ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Vesicoureteral Reflux"", ""Vesicu Ureteral Reflux"", ""Visiting Unit Request"", ""Vesico Ureteric Reflux"", ""Vesico Ureteral Reflux"", ""Viable Utility Reserve"", ""Voluntary University Review"", ""Vesicoureteric reflux"", ""Vesico Ureteral Reflux (birth defect)"", ""Vesico Ureteric Reflux""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ACRONYMFINDER"", ""ACRONYMFINDER""]]","[""Vesicoureteral Reflux""]",[3.595466506160275e-17],[3.595466506160275e-17],"[""Visiting Unit Request""]",[1.147659938832928e-10],"[""ABBREVIATIONS""]","[[3.595466506160275e-17, 2.4031881182400444e-17, 1.147659938832928e-10, 4.462216377679246e-18, 1.3873830590431175e-17, 9.30462065839963e-17, 7.935290782483161e-13, 2.0092264924221325e-16, 1.1449147094009725e-29, 4.462216377679246e-18]]",[0.9384172723807216],[0.9384172723807216],"[""Visiting Unit Request""]",[0.9469647295748339],"[""ABBREVIATIONS""]","[[0.9384172723807216, 0.9448358799452964, 0.82785947300383, 0.9469647295748339, 0.9405989551312042, 0.7662147638892536, 0.799974097766234, 0.9450372838855023, 0.9028149851979035, 0.9469647295748339]]","[""Vesicoureteral Reflux""]","[""ABBREVIATIONS""]",What are the complications of VUR (Vesicoureteral Reflux) ?,[true],[true],[true],"[""Complications of VUR include urinary tract infections, kidney damage, and high blood pressure.""]","[""Complications of Vesicoureteral Reflux include kidney damage, recurrent urinary tract infections, and high blood pressure.""]","[""Complications of VUR include recurrent UTIs, kidney damage, and renal scarring.""]",[true],[true],[true],"[""Complications of VUR include urinary tract infections, kidney damage, and high blood pressure.""]","[""Complications of Vesicoureteral Reflux include kidney damage, urinary tract infections, high blood pressure, and renal scarring.""]","[""Complications of VUR include recurrent UTIs, kidney damage, and renal scarring.""]",[true],[true],[true],"[""Complications of VUR include urinary tract infections, kidney damage, and high blood pressure.""]","[""Complications of Vesicoureteral Reflux include kidney damage, urinary tract infections, high blood pressure, and renal failure.""]","[""Complications of VUR include urinary tract infections, kidney damage, and high blood pressure.""]",[true],[true],[true],"[""Complications of VUR include urinary tract infections, kidney damage, and high blood pressure.""]","[""Complications of Vesicoureteral Reflux include kidney damage, urinary tract infections, high blood pressure, and renal failure.""]","[""Complications of VUR include recurrent UTIs, kidney damage, and renal scarring.""]",[true],[true],[true],"[""Complications of VUR include recurrent UTIs, kidney damage, and renal scarring.""]","[""Complications of Vesicoureteral Reflux include kidney damage, recurrent urinary tract infections, and high blood pressure.""]","[""Complications of VUR include recurrent UTIs, kidney damage, and renal scarring.""]",[true],[true],[true],"[""Complications of VUR include urinary tract infections, kidney damage, and high blood pressure.""]","[""Complications of Vesicoureteral Reflux include kidney damage, urinary tract infections, high blood pressure, and renal scarring.""]","[""Complications of VUR include recurrent UTIs, kidney damage, and renal scarring.""]",[true],[true],[true],"[""Complications of VUR include recurrent UTIs, kidney damage, and renal scarring.""]","[""Complications of Vesicoureteral Reflux include kidney damage, urinary tract infections, high blood pressure, and renal failure.""]","[""Complications of VUR include urinary tract infections, kidney damage, and high blood pressure.""]",[true],[true],[true],"[""Complications of VUR include recurrent urinary tract infections, kidney damage, and high blood pressure.""]","[""Complications of Vesicoureteral Reflux include kidney damage, urinary tract infections, high blood pressure, and renal failure.""]","[""Complications of VUR include recurrent UTIs, kidney damage, and renal scarring.""]",[true],[true],[true],"[""Complications of VUR include recurrent urinary tract infections, kidney damage, and renal scarring.""]","[""Complications of Vesicoureteral Reflux include kidney damage, urinary tract infections, high blood pressure, and renal scarring.""]","[""Complications of VUR include recurrent UTIs, kidney damage, and renal scarring.""]",[true],[true],[true],"[""Complications of VUR include urinary tract infections, kidney damage, and high blood pressure.""]","[""Complications of Vesicoureteral Reflux include kidney damage, recurrent urinary tract infections, and high blood pressure.""]","[""Complications of VUR include recurrent UTIs, kidney damage, and renal scarring.""]",[true],[true],[true],"[""Complications of VUR include recurrent urinary tract infections, kidney damage, and high blood pressure.""]","[""Complications of Vesicoureteral Reflux include kidney damage, urinary tract infections, high blood pressure, and renal failure.""]","[""Complications of VUR include urinary tract infections, kidney damage, and high blood pressure.""]",[true],[true],[true],"[""Complications of VUR include recurrent UTIs, kidney damage, hypertension, and renal failure.""]","[""Complications of Vesicoureteral Reflux include kidney damage, urinary tract infections, high blood pressure, and renal failure.""]","[""Complications of VUR include recurrent UTIs, kidney damage, and renal scarring.""]",[true],[true],[true],"[""UTIs, kidney damage, high blood pressure""]","[""Complications of Vesicoureteral Reflux include kidney damage, recurrent urinary tract infections, and high blood pressure.""]","[""Complications of VUR include recurrent UTIs, kidney damage, and renal scarring.""]",[true],[true],[true],"[""Complications of VUR include recurrent urinary tract infections, kidney damage, and high blood pressure.""]","[""Complications of Vesicoureteral Reflux include kidney damage, urinary tract infections, high blood pressure, and renal scarring.""]","[""Complications of VUR include recurrent UTIs, kidney damage, and renal scarring.""]",[true],[true],[true],"[""UTIs, kidney damage, high blood pressure""]","[""Complications of Vesicoureteral Reflux include kidney damage, urinary tract infections, high blood pressure, and renal failure.""]","[""Complications of VUR include urinary tract infections, kidney damage, and high blood pressure.""]",[true],[true],[true],"[""UTIs (Urinary Tract Infections), kidney damage, high blood pressure""]","[""Complications of Vesicoureteral Reflux include kidney damage, urinary tract infections, high blood pressure, and renal failure.""]","[""Complications of VUR include recurrent UTIs, kidney damage, and renal scarring.""]",[true],[true],[true],"[""Complications of VUR include kidney damage, urinary tract infections, high blood pressure, and renal failure.""]","[""Complications of Vesicoureteral Reflux include kidney damage, recurrent urinary tract infections, and high blood pressure.""]","[""Complications of VUR include recurrent UTIs, kidney damage, and renal scarring.""]",[true],[true],[true],"[""Complications of VUR include recurrent urinary tract infections, kidney damage, and high blood pressure.""]","[""Complications of Vesicoureteral Reflux include kidney damage, urinary tract infections, high blood pressure, and renal scarring.""]","[""Complications of VUR include recurrent UTIs, kidney damage, and renal scarring.""]",[true],[true],[true],"[""Complications of VUR include urinary tract infections, kidney damage, high blood pressure, and renal failure.""]","[""Complications of Vesicoureteral Reflux include kidney damage, urinary tract infections, high blood pressure, and renal failure.""]","[""Complications of VUR include urinary tract infections, kidney damage, and high blood pressure.""]",[true],[true],[true],"[""Complications of VUR include recurrent UTIs, kidney damage, hypertension, and renal failure.""]","[""Complications of Vesicoureteral Reflux include kidney damage, urinary tract infections, high blood pressure, and renal failure.""]","[""Complications of VUR include recurrent UTIs, kidney damage, and renal scarring.""]",[true],[true],[true],"[""Complications of VUR include recurrent urinary tract infections, kidney damage, and high blood pressure.""]","[""Complications of Vesicoureteral Reflux include kidney damage, recurrent urinary tract infections, and high blood pressure.""]","[""Complications of VUR include recurrent UTIs, kidney damage, and renal scarring.""]",[true],[true],[true],"[""Complications of VUR include recurrent UTIs, kidney damage, and renal scarring.""]","[""Complications of Vesicoureteral Reflux include kidney damage, urinary tract infections, high blood pressure, and renal scarring.""]","[""Complications of VUR include recurrent UTIs, kidney damage, and renal scarring.""]",[true],[true],[true],"[""Complications of VUR include recurrent urinary tract infections, kidney damage, and high blood pressure.""]","[""Complications of Vesicoureteral Reflux include kidney damage, urinary tract infections, high blood pressure, and renal failure.""]","[""Complications of VUR include urinary tract infections, kidney damage, and high blood pressure.""]",[true],[true],[true],"[""Complications of VUR include recurrent UTIs, kidney damage, and renal scarring.""]","[""Complications of Vesicoureteral Reflux include kidney damage, urinary tract infections, high blood pressure, and renal failure.""]","[""Complications of VUR include recurrent UTIs, kidney damage, and renal scarring.""]",[true],[true],[true],"[""Complications of VUR include urinary tract infections, kidney damage, and high blood pressure.""]","[""Complications of Vesicoureteral Reflux include kidney damage, recurrent urinary tract infections, and high blood pressure.""]","[""Complications of VUR include recurrent UTIs, kidney damage, and renal scarring.""]",[true],[true],[true],"[""Complications of VUR include recurrent urinary tract infections, kidney damage, and high blood pressure.""]","[""Complications of Vesicoureteral Reflux include kidney damage, urinary tract infections, high blood pressure, and renal scarring.""]","[""Complications of VUR include recurrent UTIs, kidney damage, and renal scarring.""]",[true],[true],[true],"[""Complications of VUR include recurrent urinary tract infections, kidney damage, and high blood pressure.""]","[""Complications of Vesicoureteral Reflux include kidney damage, urinary tract infections, high blood pressure, and renal failure.""]","[""Complications of VUR include urinary tract infections, kidney damage, and high blood pressure.""]",[true],[true],[true],"[""Complications of VUR include recurrent UTIs, kidney damage, and renal scarring.""]","[""Complications of Vesicoureteral Reflux include kidney damage, urinary tract infections, high blood pressure, and renal failure.""]","[""Complications of VUR include recurrent UTIs, kidney damage, and renal scarring.""]",[true],[true],[true],"[""UTIs, kidney damage, high blood pressure""]","[""Complications of Vesicoureteral Reflux include kidney damage, recurrent urinary tract infections, and high blood pressure.""]","[""Complications of VUR include recurrent UTIs, kidney damage, and renal scarring.""]",[true],[true],[true],"[""Complications of VUR include urinary tract infections, kidney damage, and high blood pressure.""]","[""Complications of Vesicoureteral Reflux include kidney damage, recurrent urinary tract infections, and high blood pressure.""]","[""Complications of VUR include recurrent UTIs, kidney damage, and renal scarring.""]",[true],[true],[true],"[""Complications of VUR include urinary tract infections, kidney damage, and high blood pressure.""]","[""Complications of Vesicoureteral Reflux include kidney damage, recurrent urinary tract infections, and high blood pressure.""]","[""Complications of VUR include recurrent UTIs, kidney damage, and renal scarring.""]",[true],[true],[true],"[""Complications of VUR include urinary tract infections, kidney damage, and high blood pressure.""]","[""Complications of Vesicoureteral Reflux include kidney damage, recurrent urinary tract infections, and high blood pressure.""]","[""Complications of VUR include recurrent UTIs, kidney damage, and renal scarring.""]"
symptoms,What are the symptoms of Primary spontaneous pneumothorax ?,"What are the signs and symptoms of Primary spontaneous pneumothorax? The Human Phenotype Ontology provides the following list of signs and symptoms for Primary spontaneous pneumothorax. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the pleura 90% Autosomal dominant inheritance - Incomplete penetrance - Spontaneous pneumothorax - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""PSP"", ""full_form"": ""Primary spontaneous pneumothorax""}]}",What are the symptoms of PSP ?,What are the symptoms of Primary spontaneous pneumothorax ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Paint Shop Pro"", ""Play Station Portable"", ""Progressive supranuclear palsy"", ""Paralytic Shellfish Poisoning"", ""Personal Software Process"", ""Portable Sony Playstation"", ""Partido Socialista Popular"", ""Payphone Service Provider"", ""Program Segment Prefix"", ""Private Sector Participation""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Progressive Supranuclear Palsy""]",[4.79420188166981e-12],[3.612080193605274e-15],"[""Paralytic Shellfish Poisoning""]",[8.596862844409081e-12],"[""ABBREVIATIONS""]","[[1.5947298770244413e-15, 4.149644711078139e-13, 3.612080193605274e-15, 8.596862844409081e-12, 4.766810948513532e-13, 4.839864929232266e-21, 6.624270574816571e-19, 5.0798573197202287e-17, 4.820781516394719e-15, 3.343036791760576e-15]]",[0.574420487079958],[0.866013346784563],"[""Private Sector Participation""]",[0.866013346784563],"[""LLM""]","[[0.6628340200436668, 0.7340638616195813, 0.8630315192374777, 0.6215957927776276, 0.6521382941483037, 0.7089792995033923, 0.664615993653195, 0.6636718448549943, 0.6685402341094345, 0.6624760141963089]]","[""Progressive supranuclear palsy""]","[""ABBREVIATIONS""]",What are the symptoms of PSP (Progressive Supranuclear Palsy) ?,[false],[true],[false],"[""Symptoms of PSP (Paralytic Shellfish Poisoning) include tingling or numbness in the face, neck, and extremities, muscle weakness, headache, dizziness, nausea, and in severe cases, respiratory paralysis.""]","[""Symptoms of Primary spontaneous pneumothorax include sudden chest pain, shortness of breath, rapid heart rate, and decreased breath sounds on the affected side.""]","[""Progressive Supranuclear Palsy (PSP) symptoms include problems with balance and walking, changes in personality, difficulty with eye movements, and cognitive impairment.""]",[false],[true],[false],"[""Symptoms of PSP (Paralytic Shellfish Poisoning) include tingling or numbness in the face, neck, and extremities, muscle weakness, headache, dizziness, nausea, and in severe cases, respiratory paralysis.""]","[""Chest pain, shortness of breath, rapid heart rate""]","[""Symptoms of Progressive Supranuclear Palsy (PSP) include balance problems, frequent falls, stiffness, difficulty with eye movements, slurred speech, and cognitive changes.""]",[false],[true],[false],"[""Symptoms of PSP include tingling or numbness of lips, tongue, and throat, muscle weakness, difficulty swallowing, nausea, vomiting, diarrhea, and in severe cases, respiratory paralysis.""]","[""Chest pain, shortness of breath, rapid heart rate""]","[""Symptoms of Progressive Supranuclear Palsy (PSP) include balance problems, frequent falls, stiffness, difficulty with eye movements, slurred speech, swallowing difficulties, cognitive changes, and behavioral changes.""]",[false],[true],[false],"[""Symptoms of PSP (Paralytic Shellfish Poisoning) include numbness, tingling, weakness, and in severe cases, paralysis.""]","[""Sharp chest pain, shortness of breath, rapid heart rate""]","[""Symptoms of Progressive Supranuclear Palsy (PSP) include balance problems, frequent falls, stiffness, difficulty with eye movements, slurred speech, swallowing difficulties, and cognitive changes.""]",[false],[true],[false],"[""Symptoms of PSP (Progressive Supranuclear Palsy) include balance problems, frequent falls, stiffness, difficulty with eye movements, slurred speech, and cognitive changes.""]","[""Symptoms of Primary spontaneous pneumothorax include sudden chest pain, shortness of breath, rapid heart rate, and decreased breath sounds on the affected side.""]","[""Progressive Supranuclear Palsy (PSP) symptoms include problems with balance and walking, changes in personality, difficulty with eye movements, and cognitive impairment.""]",[false],[true],[false],"[""Symptoms of PSP (Progressive Supranuclear Palsy) include balance problems, frequent falls, stiffness, difficulty moving the eyes, slurred speech, and cognitive changes.""]","[""Chest pain, shortness of breath, rapid heart rate""]","[""Symptoms of Progressive Supranuclear Palsy (PSP) include balance problems, frequent falls, stiffness, difficulty with eye movements, slurred speech, and cognitive changes.""]",[false],[true],[false],"[""Symptoms of PSP (Progressive Supranuclear Palsy) include balance problems, frequent falls, stiffness, difficulty with eye movements, slurred speech, and cognitive changes.""]","[""Chest pain, shortness of breath, rapid heart rate""]","[""Symptoms of Progressive Supranuclear Palsy (PSP) include balance problems, frequent falls, stiffness, difficulty with eye movements, slurred speech, swallowing difficulties, cognitive changes, and behavioral changes.""]",[false],[true],[false],"[""Symptoms of PSP (Progressive Supranuclear Palsy) include balance problems, frequent falls, stiffness, difficulty moving the eyes, speech and swallowing difficulties, and cognitive changes.""]","[""Sharp chest pain, shortness of breath, rapid heart rate""]","[""Symptoms of Progressive Supranuclear Palsy (PSP) include balance problems, frequent falls, stiffness, difficulty with eye movements, slurred speech, swallowing difficulties, and cognitive changes.""]",[false],[true],[false],"[""Symptoms of PSP include problems with balance, eye movement, swallowing, speech, and cognition.""]","[""Chest pain, shortness of breath, rapid heart rate""]","[""Symptoms of Progressive Supranuclear Palsy (PSP) include balance problems, frequent falls, stiffness, difficulty with eye movements, slurred speech, and cognitive changes.""]",[false],[true],[false],"[""Some symptoms of Progressive supranuclear palsy (PSP) include problems with balance and walking, frequent falls, stiffness, slow movements, difficulty with eye movements, and cognitive changes.""]","[""Symptoms of Primary spontaneous pneumothorax include sudden chest pain, shortness of breath, rapid heart rate, and decreased breath sounds on the affected side.""]","[""Progressive Supranuclear Palsy (PSP) symptoms include problems with balance and walking, changes in personality, difficulty with eye movements, and cognitive impairment.""]",[false],[true],[false],"[""Symptoms of PSP include balance problems, frequent falls, stiffness, difficulty with eye movements, slurred speech, and cognitive changes.""]","[""Chest pain, shortness of breath, rapid heart rate""]","[""Symptoms of Progressive Supranuclear Palsy (PSP) include balance problems, frequent falls, stiffness, difficulty with eye movements, slurred speech, swallowing difficulties, cognitive changes, and behavioral changes.""]",[false],[true],[false],"[""Symptoms of PSP include balance problems, frequent falls, stiffness, difficulty with eye movements, slurred speech, and cognitive changes.""]","[""Sharp chest pain, shortness of breath, rapid heart rate""]","[""Symptoms of Progressive Supranuclear Palsy (PSP) include balance problems, frequent falls, stiffness, difficulty with eye movements, slurred speech, swallowing difficulties, and cognitive changes.""]",[false],[true],[false],"[""Loss of balance, blurred vision, slow movement, difficulty swallowing""]","[""Symptoms of Primary spontaneous pneumothorax include sudden chest pain, shortness of breath, rapid heart rate, and decreased breath sounds on the affected side.""]","[""Progressive Supranuclear Palsy (PSP) symptoms include problems with balance and walking, changes in personality, difficulty with eye movements, and cognitive impairment.""]",[false],[true],[false],"[""Symptoms of PSP include problems with balance and walking, changes in personality and behavior, difficulty with eye movements, and cognitive decline.""]","[""Chest pain, shortness of breath, rapid heart rate""]","[""Symptoms of Progressive Supranuclear Palsy (PSP) include balance problems, frequent falls, stiffness, difficulty with eye movements, slurred speech, and cognitive changes.""]",[false],[true],[false],"[""Symptoms of PSP include problems with balance, walking difficulties, frequent falls, vision problems, speech and swallowing difficulties, cognitive changes, and behavioral changes.""]","[""Chest pain, shortness of breath, rapid heart rate""]","[""Symptoms of Progressive Supranuclear Palsy (PSP) include balance problems, frequent falls, stiffness, difficulty with eye movements, slurred speech, swallowing difficulties, cognitive changes, and behavioral changes.""]",[false],[true],[false],"[""Loss of balance, blurred vision, slurred speech, difficulty swallowing, stiffness, and falls are common symptoms of PSP (Progressive supranuclear palsy).""]","[""Sharp chest pain, shortness of breath, rapid heart rate""]","[""Symptoms of Progressive Supranuclear Palsy (PSP) include balance problems, frequent falls, stiffness, difficulty with eye movements, slurred speech, swallowing difficulties, and cognitive changes.""]",[false],[true],[false],"[""Symptoms of PSP include balance problems, frequent falls, stiffness, difficulty moving eyes, slurred speech, swallowing difficulties, cognitive changes, and behavioral changes.""]","[""Symptoms of Primary spontaneous pneumothorax include sudden chest pain, shortness of breath, rapid heart rate, and decreased breath sounds on the affected side.""]","[""Progressive Supranuclear Palsy (PSP) symptoms include problems with balance and walking, changes in personality, difficulty with eye movements, and cognitive impairment.""]",[false],[true],[false],"[""Symptoms of PSP include problems with balance, eye movement, swallowing, speech, and cognition.""]","[""Chest pain, shortness of breath, rapid heart rate""]","[""Symptoms of Progressive Supranuclear Palsy (PSP) include balance problems, frequent falls, stiffness, difficulty with eye movements, slurred speech, and cognitive changes.""]",[false],[true],[false],"[""Symptoms of PSP include difficulties with balance and walking, frequent falls, stiffness, slow movements, problems with eye movements, and cognitive changes.""]","[""Chest pain, shortness of breath, rapid heart rate""]","[""Symptoms of Progressive Supranuclear Palsy (PSP) include balance problems, frequent falls, stiffness, difficulty with eye movements, slurred speech, swallowing difficulties, cognitive changes, and behavioral changes.""]",[false],[true],[false],"[""Symptoms of PSP include problems with balance, movement, vision, speech, and swallowing.""]","[""Sharp chest pain, shortness of breath, rapid heart rate""]","[""Symptoms of Progressive Supranuclear Palsy (PSP) include balance problems, frequent falls, stiffness, difficulty with eye movements, slurred speech, swallowing difficulties, and cognitive changes.""]",[false],[true],[false],"[""Some symptoms of Progressive Supranuclear Palsy (PSP) include problems with balance and walking, frequent falls, stiffness and slowness of movement, difficulty with eye movements, cognitive changes, and speech and swallowing difficulties.""]","[""Symptoms of Primary spontaneous pneumothorax include sudden chest pain, shortness of breath, rapid heart rate, and decreased breath sounds on the affected side.""]","[""Progressive Supranuclear Palsy (PSP) symptoms include problems with balance and walking, changes in personality, difficulty with eye movements, and cognitive impairment.""]",[false],[true],[false],"[""Symptoms of PSP include problems with balance and walking, changes in personality, difficulty with eye movements, and cognitive changes.""]","[""Chest pain, shortness of breath, rapid heart rate""]","[""Symptoms of Progressive Supranuclear Palsy (PSP) include balance problems, frequent falls, stiffness, difficulty with eye movements, slurred speech, and cognitive changes.""]",[false],[true],[false],"[""Symptoms of PSP include problems with balance and walking, frequent falls, stiffness, slow movements, difficulty with eye movements, cognitive changes, and speech difficulties.""]","[""Chest pain, shortness of breath, rapid heart rate""]","[""Symptoms of Progressive Supranuclear Palsy (PSP) include balance problems, frequent falls, stiffness, difficulty with eye movements, slurred speech, swallowing difficulties, cognitive changes, and behavioral changes.""]",[false],[true],[false],"[""Symptoms of PSP include balance problems, frequent falls, stiffness, difficulty moving the eyes, slurred speech, swallowing difficulties, and cognitive changes.""]","[""Sharp chest pain, shortness of breath, rapid heart rate""]","[""Symptoms of Progressive Supranuclear Palsy (PSP) include balance problems, frequent falls, stiffness, difficulty with eye movements, slurred speech, swallowing difficulties, and cognitive changes.""]",[false],[true],[false],"[""Symptoms of PSP include problems with balance and walking, changes in personality, difficulty with eye movements, and cognitive impairment.""]","[""Symptoms of Primary spontaneous pneumothorax include sudden chest pain, shortness of breath, rapid heart rate, and decreased breath sounds on the affected side.""]","[""Progressive Supranuclear Palsy (PSP) symptoms include problems with balance and walking, changes in personality, difficulty with eye movements, and cognitive impairment.""]",[false],[true],[false],"[""Some common symptoms of Progressive supranuclear palsy (PSP) include difficulties with balance and walking, frequent falls, stiffness in the body, problems with eye movements, cognitive changes, and speech difficulties.""]","[""Chest pain, shortness of breath, rapid heart rate""]","[""Symptoms of Progressive Supranuclear Palsy (PSP) include balance problems, frequent falls, stiffness, difficulty with eye movements, slurred speech, and cognitive changes.""]",[false],[true],[false],"[""Some common symptoms of Progressive supranuclear palsy (PSP) include problems with balance and walking, changes in personality and behavior, difficulty with eye movements, and cognitive changes.""]","[""Chest pain, shortness of breath, rapid heart rate""]","[""Symptoms of Progressive Supranuclear Palsy (PSP) include balance problems, frequent falls, stiffness, difficulty with eye movements, slurred speech, swallowing difficulties, cognitive changes, and behavioral changes.""]",[false],[true],[false],"[""Some common symptoms of Progressive supranuclear palsy (PSP) include problems with balance and walking, changes in personality and behavior, difficulty with eye movements, and cognitive problems.""]","[""Sharp chest pain, shortness of breath, rapid heart rate""]","[""Symptoms of Progressive Supranuclear Palsy (PSP) include balance problems, frequent falls, stiffness, difficulty with eye movements, slurred speech, swallowing difficulties, and cognitive changes.""]",[false],[true],[false],"[""Symptoms of PSP may include problems with balance, walking, eye movements, speech, and swallowing. Other symptoms may include cognitive changes, personality changes, and mood changes.""]","[""Symptoms of Primary spontaneous pneumothorax include sudden chest pain, shortness of breath, rapid heart rate, and decreased breath sounds on the affected side.""]","[""Progressive Supranuclear Palsy (PSP) symptoms include problems with balance and walking, changes in personality, difficulty with eye movements, and cognitive impairment.""]",[false],[true],[false],"[""Symptoms of PSP include tingling or numbness of lips, tongue, and throat, muscle weakness, difficulty swallowing, nausea, and vomiting.""]","[""Symptoms of Primary spontaneous pneumothorax include sudden chest pain, shortness of breath, rapid heart rate, and decreased breath sounds on the affected side.""]","[""Progressive Supranuclear Palsy (PSP) symptoms include problems with balance and walking, changes in personality, difficulty with eye movements, and cognitive impairment.""]",[false],[true],[false],"[""Symptoms of PSP (Private Sector Participation) include increased efficiency, improved service quality, innovation, and increased investment in infrastructure.""]","[""Symptoms of Primary spontaneous pneumothorax include sudden chest pain, shortness of breath, rapid heart rate, and decreased breath sounds on the affected side.""]","[""Progressive Supranuclear Palsy (PSP) symptoms include problems with balance and walking, changes in personality, difficulty with eye movements, and cognitive impairment.""]",[false],[true],[false],"[""Some common symptoms of PSP include problems with balance and walking, changes in personality and behavior, difficulty with eye movements, and cognitive changes.""]","[""Symptoms of Primary spontaneous pneumothorax include sudden chest pain, shortness of breath, rapid heart rate, and decreased breath sounds on the affected side.""]","[""Progressive Supranuclear Palsy (PSP) symptoms include problems with balance and walking, changes in personality, difficulty with eye movements, and cognitive impairment.""]"
treatment,What are the treatments for Charcot-Marie-Tooth Disease ?,"There is no cure for CMT, but physical therapy, occupational therapy, braces and other orthopedic devices, and orthopedic surgery can help people cope with the disabling symptoms of the disease. In addition, pain-killing drugs can be prescribed for patients who have severe pain.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""CMT"", ""full_form"": ""Charcot-Marie-Tooth Disease""}]}",What are the treatments for CMT ?,What are the treatments for Charcot-Marie-Tooth Disease ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Country Music Television"", ""Charcot Marie Tooth"", ""Constant Maturity Treasury"", ""Certified Massage Therapist"", ""California Mastitis Test"", ""Chartered Market Technician"", ""Certified Medical Transcriptionist"", ""Cut, Make, and Trim"", ""Caravan Motor Touristik"", ""Carlsberg Meridian Telescope""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Charcot-Marie-Tooth disease""]",[6.514228849899964e-20],[6.514228849899964e-20],"[""Country Music Television""]",[3.976033901950194e-14],"[""ABBREVIATIONS""]","[[3.976033901950194e-14, 3.699555264664507e-18, 2.5831327319650102e-17, 1.6705671301534864e-19, 3.062551980135829e-23, 1.0345980223763035e-20, 4.612156267427475e-18, 1.3255561238219018e-19, 3.2845281337221224e-24, 6.860634108009727e-29]]",[0.9183022771316357],[0.9205883612566702],"[""Country Music Television""]",[0.92252957791814],"[""ABBREVIATIONS""]","[[0.7347513599288499, 0.92252957791814, 0.6187907931803134, 0.7095075833851083, 0.5879828050040277, 0.6672280822222052, 0.6730265159333344, 0.6998294556837622, 0.7444801840002488, 0.6685903327066687]]","[""Charcot Marie Tooth""]","[""ABBREVIATIONS""]",What are the treatments for CMT (Charcot-Marie-Tooth disease) ?,[true],[true],[true],"[""Physical therapy, orthopedic devices, surgery""]","[""Physical therapy, occupational therapy, orthopedic surgery, pain management, and assistive devices are common treatments for Charcot-Marie-Tooth Disease.""]","[""Physical therapy, orthopedic devices, surgery""]",[true],[true],[true],"[""There seems to be a misunderstanding. CMT usually stands for Charcot-Marie-Tooth disease, a neurological disorder. Treatment for CMT focuses on managing symptoms and may include physical therapy, orthopedic devices, and in some cases, surgery.""]","[""There is no cure for Charcot-Marie-Tooth Disease, but treatments focus on managing symptoms such as physical therapy, orthopedic devices, pain management, and in some cases, surgery.""]","[""Physical therapy, occupational therapy, orthopedic devices, surgery""]",[true],[true],[true],"[""There seems to be a misunderstanding. CMT stands for Charcot-Marie-Tooth disease, not Country Music Television. The treatments for Charcot-Marie-Tooth disease include physical therapy, orthopedic devices, and in some cases, surgery.""]","[""Physical therapy, occupational therapy, orthopedic surgery, pain management""]","[""Physical therapy, orthopedic devices, surgery""]",[true],[true],[true],"[""There seems to be a misunderstanding. CMT typically stands for Charcot-Marie-Tooth disease, not Country Music Television. The treatments for Charcot-Marie-Tooth disease may include physical therapy, orthopedic devices, and in some cases, surgery.""]","[""Physical therapy, occupational therapy, orthopedic surgery, pain management, genetic counseling""]","[""Physical therapy, orthopedic devices, surgery""]",[true],[true],[true],"[""There seems to be a misunderstanding. CMT typically stands for Charcot-Marie-Tooth disease, not Country Music Television. The treatments for Charcot-Marie-Tooth disease include physical therapy, orthopedic devices, surgery, and pain management.""]","[""Physical therapy, occupational therapy, orthopedic surgery, pain management, and assistive devices are common treatments for Charcot-Marie-Tooth Disease.""]","[""Physical therapy, orthopedic devices, surgery""]",[true],[true],[true],"[""There seems to be a misunderstanding. CMT commonly refers to Charcot-Marie-Tooth disease, not Country Music Television. The treatments for Charcot-Marie-Tooth disease include physical therapy, orthopedic devices, surgery, and medication for symptoms like pain.""]","[""There is no cure for Charcot-Marie-Tooth Disease, but treatments focus on managing symptoms such as physical therapy, orthopedic devices, pain management, and in some cases, surgery.""]","[""Physical therapy, occupational therapy, orthopedic devices, surgery""]",[true],[true],[true],"[""Physical therapy, orthopedic devices, surgery""]","[""Physical therapy, occupational therapy, orthopedic surgery, pain management""]","[""Physical therapy, orthopedic devices, surgery""]",[true],[true],[true],"[""There seems to be a misunderstanding. CMT stands for Charcot-Marie-Tooth disease, not Country Music Television. The treatments for Charcot-Marie-Tooth disease include physical therapy, orthopedic devices, surgery, and medications for managing symptoms.""]","[""Physical therapy, occupational therapy, orthopedic surgery, pain management, genetic counseling""]","[""Physical therapy, orthopedic devices, surgery""]",[true],[true],[true],"[""Physical therapy, occupational therapy, orthopedic surgery, pain management, and assistive devices are common treatments for CMT (Charcot Marie Tooth).""]","[""There is no cure for Charcot-Marie-Tooth Disease, but treatments focus on managing symptoms such as physical therapy, orthopedic devices, pain management, and in some cases, surgery.""]","[""Physical therapy, occupational therapy, orthopedic devices, surgery""]",[true],[true],[true],"[""Physical therapy, occupational therapy, orthopedic surgery, pain management, and assistive devices are common treatments for CMT (Charcot Marie Tooth).""]","[""Physical therapy, occupational therapy, orthopedic surgery, pain management, and assistive devices are common treatments for Charcot-Marie-Tooth Disease.""]","[""Physical therapy, orthopedic devices, surgery""]",[true],[true],[true],"[""Physical therapy, occupational therapy, orthopedic surgery, and pain management are common treatments for Charcot Marie Tooth (CMT).""]","[""Physical therapy, occupational therapy, orthopedic surgery, pain management""]","[""Physical therapy, orthopedic devices, surgery""]",[true],[true],[true],"[""Physical therapy, occupational therapy, orthopedic surgery, and assistive devices such as braces or orthopedic shoes are common treatments for CMT.""]","[""Physical therapy, occupational therapy, orthopedic surgery, pain management, genetic counseling""]","[""Physical therapy, orthopedic devices, surgery""]",[true],[true],[true],"[""Physical therapy, orthopedic devices, surgery, pain management""]","[""Physical therapy, occupational therapy, orthopedic surgery, pain management, and assistive devices are common treatments for Charcot-Marie-Tooth Disease.""]","[""Physical therapy, orthopedic devices, surgery""]",[true],[true],[true],"[""Physical therapy, orthopedic devices, surgery, pain management""]","[""There is no cure for Charcot-Marie-Tooth Disease, but treatments focus on managing symptoms such as physical therapy, orthopedic devices, pain management, and in some cases, surgery.""]","[""Physical therapy, occupational therapy, orthopedic devices, surgery""]",[true],[true],[true],"[""Physical therapy, occupational therapy, orthopedic devices, surgery for severe cases""]","[""Physical therapy, occupational therapy, orthopedic surgery, pain management""]","[""Physical therapy, orthopedic devices, surgery""]",[true],[true],[true],"[""Physical therapy, orthopedic devices, surgery, pain management""]","[""Physical therapy, occupational therapy, orthopedic surgery, pain management, genetic counseling""]","[""Physical therapy, orthopedic devices, surgery""]",[true],[true],[true],"[""Physical therapy, occupational therapy, orthopedic surgery, pain management, assistive devices""]","[""Physical therapy, occupational therapy, orthopedic surgery, pain management, and assistive devices are common treatments for Charcot-Marie-Tooth Disease.""]","[""Physical therapy, orthopedic devices, surgery""]",[true],[true],[true],"[""Physical therapy, occupational therapy, orthopedic surgery, ankle-foot orthosis, and pain management are common treatments for CMT (Charcot Marie Tooth).""]","[""There is no cure for Charcot-Marie-Tooth Disease, but treatments focus on managing symptoms such as physical therapy, orthopedic devices, pain management, and in some cases, surgery.""]","[""Physical therapy, occupational therapy, orthopedic devices, surgery""]",[true],[true],[false],"[""Physical therapy, occupational therapy, orthopedic surgery, pain management, and assistive devices are common treatments for CMT (Charcot Marie Tooth).""]","[""Physical therapy, occupational therapy, orthopedic surgery, pain management""]","[""Physical therapy, orthopedic devices, surgery""]",[true],[true],[true],"[""Physical therapy, occupational therapy, orthopedic surgery, pain management, and assistive devices such as braces or orthotics are common treatments for CMT (Charcot Marie Tooth).""]","[""Physical therapy, occupational therapy, orthopedic surgery, pain management, genetic counseling""]","[""Physical therapy, orthopedic devices, surgery""]",[true],[true],[true],"[""Physical therapy, occupational therapy, orthopedic surgery, pain management, and assistive devices are common treatments for CMT (Charcot-Marie-Tooth disease).""]","[""Physical therapy, occupational therapy, orthopedic surgery, pain management, and assistive devices are common treatments for Charcot-Marie-Tooth Disease.""]","[""Physical therapy, orthopedic devices, surgery""]",[true],[true],[true],"[""Physical therapy, occupational therapy, orthopedic surgery, pain management, and assistive devices are common treatments for Charcot-Marie-Tooth disease.""]","[""There is no cure for Charcot-Marie-Tooth Disease, but treatments focus on managing symptoms such as physical therapy, orthopedic devices, pain management, and in some cases, surgery.""]","[""Physical therapy, occupational therapy, orthopedic devices, surgery""]",[true],[true],[true],"[""Physical therapy, occupational therapy, orthopedic surgery, pain management, and assistive devices are common treatments for Charcot-Marie-Tooth disease.""]","[""Physical therapy, occupational therapy, orthopedic surgery, pain management""]","[""Physical therapy, orthopedic devices, surgery""]",[true],[true],[true],"[""Physical therapy, occupational therapy, orthopedic surgery, and assistive devices such as braces and orthotics are common treatments for CMT (Charcot-Marie-Tooth disease).""]","[""Physical therapy, occupational therapy, orthopedic surgery, pain management, genetic counseling""]","[""Physical therapy, orthopedic devices, surgery""]",[true],[true],[true],"[""Physical therapy, occupational therapy, orthopedic surgery, pain management, and assistive devices are common treatments for CMT (Charcot Marie Tooth).""]","[""Physical therapy, occupational therapy, orthopedic surgery, pain management, and assistive devices are common treatments for Charcot-Marie-Tooth Disease.""]","[""Physical therapy, orthopedic devices, surgery""]",[true],[true],[true],"[""Physical therapy, occupational therapy, orthopedic surgery, and assistive devices are common treatments for CMT (Charcot Marie Tooth).""]","[""There is no cure for Charcot-Marie-Tooth Disease, but treatments focus on managing symptoms such as physical therapy, orthopedic devices, pain management, and in some cases, surgery.""]","[""Physical therapy, occupational therapy, orthopedic devices, surgery""]",[true],[true],[true],"[""Physical therapy, occupational therapy, orthopedic surgery, assistive devices such as braces or orthotics""]","[""Physical therapy, occupational therapy, orthopedic surgery, pain management""]","[""Physical therapy, orthopedic devices, surgery""]",[true],[true],[true],"[""Physical therapy, occupational therapy, orthopedic surgery, pain management, and assistive devices are common treatments for CMT.""]","[""Physical therapy, occupational therapy, orthopedic surgery, pain management, genetic counseling""]","[""Physical therapy, orthopedic devices, surgery""]",[true],[true],[true],"[""Physical therapy, occupational therapy, orthopedic surgery, pain management, and assistive devices such as braces or orthotics.""]","[""Physical therapy, occupational therapy, orthopedic surgery, pain management, and assistive devices are common treatments for Charcot-Marie-Tooth Disease.""]","[""Physical therapy, orthopedic devices, surgery""]",[false],[true],[true],"[""The treatments for CMT (Country Music Television) include airing country music videos, music-related programming, and reality shows related to country music artists.""]","[""Physical therapy, occupational therapy, orthopedic surgery, pain management, and assistive devices are common treatments for Charcot-Marie-Tooth Disease.""]","[""Physical therapy, orthopedic devices, surgery""]",[false],[true],[true],"[""The treatments for CMT (Country Music Television) include airing country music videos, music-related programming, and country lifestyle content.""]","[""Physical therapy, occupational therapy, orthopedic surgery, pain management, and assistive devices are common treatments for Charcot-Marie-Tooth Disease.""]","[""Physical therapy, orthopedic devices, surgery""]",[true],[true],[true],"[""Physical therapy, occupational therapy, orthopedic surgery, pain management, assistive devices""]","[""Physical therapy, occupational therapy, orthopedic surgery, pain management, and assistive devices are common treatments for Charcot-Marie-Tooth Disease.""]","[""Physical therapy, orthopedic devices, surgery""]"
prevention,How to prevent Medullary Sponge Kidney ?,"Health care providers may prescribe certain medications to prevent UTIs and kidney stones:
                
- A person with medullary sponge kidney may need to continue taking a low-dose antibiotic to prevent recurrent infections.  - Medications that reduce calcium in the urine may help prevent calcium kidney stones. These medications may include      - potassium citrate    - thiazide","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""MSK"", ""full_form"": ""Medullary Sponge Kidney""}]}",How to prevent MSK ?,How to prevent Medullary Sponge Kidney ?,8,MEDICAL,Simple Datatype-String,"Instructional: Queries specifically seeking step-by-step guidance, instructions, or procedures to perform a task. it focuses on 'how' to do something rather than 'what', 'why', or 'which'.","[[""Moscow Time"", ""Minimum Shift Keying"", ""Grupo Industrial Maseca S. A. de C. V."", ""Musculo-SKeletal"", ""Merlin's Stern Kids"", ""Majora Skull Kid"", ""Mega-Statute Kilometers"", ""Mutt Skate Krew"", ""Memorial Sloan-Kettering Cancer Center"", ""Mad Society Kings""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Musculoskeletal""]",[1.3662245482032375e-15],[7.288409826693679e-05],"[""Musculoskeletal""]",[7.288409826693679e-05],"[""LLM""]","[[6.861612347092814e-14, 2.3689283746536425e-16, 5.56546931837525e-41, 9.846875744748196e-13, 1.0519742419697502e-23, 3.0305512163281115e-18, 8.09110618068427e-23, 3.830030104714638e-21, 2.180275482090631e-34, 8.94737719823891e-16]]",[0.7353845605382412],[0.906146999545216],"[""Mad Society Kings""]",[0.906146999545216],"[""LLM""]","[[0.6852753579817755, 0.6347037014361543, 0.6968626772970454, 0.9016217155302528, 0.7264068049403245, 0.68625700693835, 0.6103706337142403, 0.6877048958494822, 0.804036804761658, 0.7265820018550633]]","[""Musculo-SKeletal""]","[""ABBREVIATIONS""]",How to prevent MSK (Musculoskeletal) ?,[false],[false],[false],"[""To prevent Musculoskeletal disorders, maintain good posture, take regular breaks, exercise regularly, and use ergonomic equipment.""]","[""To prevent Medullary Sponge Kidney, it is important to stay well-hydrated by drinking plenty of water, avoid excessive intake of calcium and vitamin D supplements, and follow a healthy diet low in salt and protein.""]","[""Maintain a healthy weight, exercise regularly, avoid smoking, and limit alcohol consumption to help prevent musculoskeletal conditions.""]",[false],[true],[false],"[""To prevent Musculoskeletal disorders, maintain good posture, take regular breaks, exercise regularly, use ergonomic furniture, and avoid repetitive movements.""]","[""Preventing Medullary Sponge Kidney involves staying hydrated, avoiding excessive calcium intake, and managing urinary tract infections promptly.""]","[""Maintain a healthy weight, exercise regularly, avoid smoking, and consume a balanced diet to help prevent musculoskeletal (MSK) issues.""]",[false],[true],[false],"[""To prevent Musculoskeletal disorders, maintain good posture, take regular breaks, perform stretching exercises, use ergonomic furniture, and avoid repetitive movements.""]","[""To prevent Medullary Sponge Kidney, it is important to stay hydrated by drinking plenty of water, avoid excessive intake of calcium supplements, and maintain a healthy lifestyle with a balanced diet and regular exercise.""]","[""Maintain a healthy weight, exercise regularly, avoid smoking, and consume a balanced diet to help prevent musculoskeletal conditions.""]",[false],[true],[false],"[""To prevent Musculoskeletal disorders, maintain good posture, take regular breaks to stretch and move around, use ergonomic furniture and tools, exercise regularly, and avoid repetitive motions for long periods.""]","[""To prevent Medullary Sponge Kidney, it is important to stay hydrated by drinking plenty of water, avoid excessive intake of calcium and vitamin D supplements, and follow a healthy diet low in sodium and oxalate.""]","[""Maintain a healthy weight, exercise regularly, avoid smoking, and consume a balanced diet to help prevent musculoskeletal conditions.""]",[false],[true],[false],"[""There is no known way to prevent MSK (Mad Society Kings) as it is a gang and criminal organization. It is important to avoid involvement with such groups and report any criminal activities to the authorities.""]","[""To prevent Medullary Sponge Kidney, it is important to stay well-hydrated by drinking plenty of water, avoid excessive intake of calcium and vitamin D supplements, and follow a healthy diet low in salt and protein.""]","[""Maintain a healthy weight, exercise regularly, avoid smoking, and limit alcohol consumption to help prevent musculoskeletal conditions.""]",[true],[false],[false],"[""There is no known way to prevent MSK (Medullary Sponge Kidney) as it is a congenital condition.""]","[""Preventing Medullary Sponge Kidney involves staying hydrated, avoiding excessive calcium intake, and managing urinary tract infections promptly.""]","[""Maintain a healthy weight, exercise regularly, avoid smoking, and consume a balanced diet to help prevent musculoskeletal (MSK) issues.""]",[false],[false],[false],"[""There is no known way to prevent MSK (Mad Society Kings) as it is a fictional term and not a medical condition.""]","[""To prevent Medullary Sponge Kidney, it is important to stay hydrated by drinking plenty of water, avoid excessive intake of calcium supplements, and maintain a healthy lifestyle with a balanced diet and regular exercise.""]","[""Maintain a healthy weight, exercise regularly, avoid smoking, and consume a balanced diet to help prevent musculoskeletal conditions.""]",[false],[true],[false],"[""There is no known way to prevent MSK (Mad Society Kings) as it is a gang and criminal organization. It is important to stay safe and report any suspicious activities to the authorities.""]","[""To prevent Medullary Sponge Kidney, it is important to stay hydrated by drinking plenty of water, avoid excessive intake of calcium and vitamin D supplements, and follow a healthy diet low in sodium and oxalate.""]","[""Maintain a healthy weight, exercise regularly, avoid smoking, and consume a balanced diet to help prevent musculoskeletal conditions.""]",[false],[true],[false],"[""To prevent Musculo-Skeletal issues, maintain good posture, take regular breaks to stretch and move around, exercise regularly, and use ergonomic furniture and tools.""]","[""Preventing Medullary Sponge Kidney involves staying hydrated, avoiding excessive calcium intake, and managing urinary tract infections promptly.""]","[""Maintain a healthy weight, exercise regularly, avoid smoking, and consume a balanced diet to help prevent musculoskeletal (MSK) issues.""]",[false],[true],[false],"[""To prevent Musculo-Skeletal issues, maintain good posture, take regular breaks to stretch and move around, exercise regularly, and use ergonomic furniture and equipment.""]","[""To prevent Medullary Sponge Kidney, it is important to stay well-hydrated by drinking plenty of water, avoid excessive intake of calcium and vitamin D supplements, and follow a healthy diet low in salt and protein.""]","[""Maintain a healthy weight, exercise regularly, avoid smoking, and limit alcohol consumption to help prevent musculoskeletal conditions.""]",[false],[true],[false],"[""To prevent Musculo-Skeletal issues, maintain good posture, take regular breaks to stretch and move around, exercise regularly, and use ergonomic equipment.""]","[""To prevent Medullary Sponge Kidney, it is important to stay hydrated by drinking plenty of water, avoid excessive intake of calcium supplements, and maintain a healthy lifestyle with a balanced diet and regular exercise.""]","[""Maintain a healthy weight, exercise regularly, avoid smoking, and consume a balanced diet to help prevent musculoskeletal conditions.""]",[false],[true],[false],"[""To prevent Musculo-Skeletal issues, maintain good posture, take regular breaks to stretch and move around, exercise regularly, and use ergonomic furniture and equipment.""]","[""To prevent Medullary Sponge Kidney, it is important to stay hydrated by drinking plenty of water, avoid excessive intake of calcium and vitamin D supplements, and follow a healthy diet low in sodium and oxalate.""]","[""Maintain a healthy weight, exercise regularly, avoid smoking, and consume a balanced diet to help prevent musculoskeletal conditions.""]",[false],[false],[false],"[""Regular exercise, maintaining a healthy weight, and proper ergonomics can help prevent Musculo-Skeletal issues.""]","[""To prevent Medullary Sponge Kidney, it is important to stay well-hydrated by drinking plenty of water, avoid excessive intake of calcium and vitamin D supplements, and follow a healthy diet low in salt and protein.""]","[""Maintain a healthy weight, exercise regularly, avoid smoking, and limit alcohol consumption to help prevent musculoskeletal conditions.""]",[false],[true],[false],"[""Regular exercise, maintaining a healthy weight, and proper posture can help prevent Musculo-Skeletal issues.""]","[""Preventing Medullary Sponge Kidney involves staying hydrated, avoiding excessive calcium intake, and managing urinary tract infections promptly.""]","[""Maintain a healthy weight, exercise regularly, avoid smoking, and consume a balanced diet to help prevent musculoskeletal (MSK) issues.""]",[false],[true],[false],"[""Regular exercise, maintaining a healthy weight, and practicing good posture can help prevent Musculo-Skeletal issues.""]","[""To prevent Medullary Sponge Kidney, it is important to stay hydrated by drinking plenty of water, avoid excessive intake of calcium supplements, and maintain a healthy lifestyle with a balanced diet and regular exercise.""]","[""Maintain a healthy weight, exercise regularly, avoid smoking, and consume a balanced diet to help prevent musculoskeletal conditions.""]",[false],[true],[false],"[""Regular exercise, maintaining a healthy weight, and proper posture can help prevent Musculo-Skeletal issues.""]","[""To prevent Medullary Sponge Kidney, it is important to stay hydrated by drinking plenty of water, avoid excessive intake of calcium and vitamin D supplements, and follow a healthy diet low in sodium and oxalate.""]","[""Maintain a healthy weight, exercise regularly, avoid smoking, and consume a balanced diet to help prevent musculoskeletal conditions.""]",[false],[true],[false],"[""To prevent Musculo-Skeletal issues, maintain good posture, take regular breaks, perform stretching exercises, and use ergonomic furniture and equipment.""]","[""To prevent Medullary Sponge Kidney, it is important to stay well-hydrated by drinking plenty of water, avoid excessive intake of calcium and vitamin D supplements, and follow a healthy diet low in salt and protein.""]","[""Maintain a healthy weight, exercise regularly, avoid smoking, and limit alcohol consumption to help prevent musculoskeletal conditions.""]",[false],[true],[false],"[""To prevent Musculo-Skeletal issues, maintain good posture, take regular breaks to stretch and move around, exercise regularly, and use ergonomic furniture and tools.""]","[""Preventing Medullary Sponge Kidney involves staying hydrated, avoiding excessive calcium intake, and managing urinary tract infections promptly.""]","[""Maintain a healthy weight, exercise regularly, avoid smoking, and consume a balanced diet to help prevent musculoskeletal (MSK) issues.""]",[false],[true],[false],"[""To prevent Musculo-Skeletal issues, maintain good posture, take regular breaks to stretch and move around, exercise regularly, and use ergonomic furniture and equipment.""]","[""To prevent Medullary Sponge Kidney, it is important to stay hydrated by drinking plenty of water, avoid excessive intake of calcium supplements, and maintain a healthy lifestyle with a balanced diet and regular exercise.""]","[""Maintain a healthy weight, exercise regularly, avoid smoking, and consume a balanced diet to help prevent musculoskeletal conditions.""]",[false],[true],[false],"[""To prevent Musculo-Skeletal issues, maintain good posture, take regular breaks to stretch and move around, exercise regularly, and use ergonomic furniture and tools.""]","[""To prevent Medullary Sponge Kidney, it is important to stay hydrated by drinking plenty of water, avoid excessive intake of calcium and vitamin D supplements, and follow a healthy diet low in sodium and oxalate.""]","[""Maintain a healthy weight, exercise regularly, avoid smoking, and consume a balanced diet to help prevent musculoskeletal conditions.""]",[false],[true],[false],"[""To prevent Musculoskeletal disorders, maintain good posture, take regular breaks, exercise regularly, use ergonomic furniture, and avoid repetitive movements.""]","[""To prevent Medullary Sponge Kidney, it is important to stay well-hydrated by drinking plenty of water, avoid excessive intake of calcium and vitamin D supplements, and follow a healthy diet low in salt and protein.""]","[""Maintain a healthy weight, exercise regularly, avoid smoking, and limit alcohol consumption to help prevent musculoskeletal conditions.""]",[false],[true],[false],"[""To prevent Musculoskeletal disorders, it is important to maintain good posture, take regular breaks during repetitive tasks, perform stretching exercises, use ergonomic equipment, and avoid lifting heavy objects improperly.""]","[""Preventing Medullary Sponge Kidney involves staying hydrated, avoiding excessive calcium intake, and managing urinary tract infections promptly.""]","[""Maintain a healthy weight, exercise regularly, avoid smoking, and consume a balanced diet to help prevent musculoskeletal (MSK) issues.""]",[false],[true],[false],"[""To prevent Musculoskeletal disorders, maintain good posture, take regular breaks, exercise regularly, and use ergonomic equipment.""]","[""To prevent Medullary Sponge Kidney, it is important to stay hydrated by drinking plenty of water, avoid excessive intake of calcium supplements, and maintain a healthy lifestyle with a balanced diet and regular exercise.""]","[""Maintain a healthy weight, exercise regularly, avoid smoking, and consume a balanced diet to help prevent musculoskeletal conditions.""]",[false],[true],[false],"[""To prevent Musculoskeletal disorders, maintain good posture, take regular breaks, exercise regularly, and use ergonomic equipment.""]","[""To prevent Medullary Sponge Kidney, it is important to stay hydrated by drinking plenty of water, avoid excessive intake of calcium and vitamin D supplements, and follow a healthy diet low in sodium and oxalate.""]","[""Maintain a healthy weight, exercise regularly, avoid smoking, and consume a balanced diet to help prevent musculoskeletal conditions.""]",[false],[false],[false],"[""To prevent Musculo-Skeletal issues, ensure proper ergonomics at workstations, take regular breaks to stretch and move around, maintain good posture, exercise regularly, and avoid repetitive motions for extended periods.""]","[""To prevent Medullary Sponge Kidney, it is important to stay well-hydrated by drinking plenty of water, avoid excessive intake of calcium and vitamin D supplements, and follow a healthy diet low in salt and protein.""]","[""Maintain a healthy weight, exercise regularly, avoid smoking, and limit alcohol consumption to help prevent musculoskeletal conditions.""]",[false],[true],[false],"[""To prevent Musculo-Skeletal issues, you can follow these steps: 1. Maintain good posture while sitting and standing. 2. Take regular breaks to stretch and move around. 3. Use ergonomic furniture and equipment. 4. Exercise regularly to strengthen muscles. 5. Avoid repetitive motions and heavy lifting without proper technique.""]","[""Preventing Medullary Sponge Kidney involves staying hydrated, avoiding excessive calcium intake, and managing urinary tract infections promptly.""]","[""Maintain a healthy weight, exercise regularly, avoid smoking, and consume a balanced diet to help prevent musculoskeletal (MSK) issues.""]",[false],[true],[false],"[""To prevent Musculo-Skeletal issues, one should maintain good posture, take regular breaks, perform stretching exercises, and use ergonomic furniture and equipment.""]","[""To prevent Medullary Sponge Kidney, it is important to stay hydrated by drinking plenty of water, avoid excessive intake of calcium supplements, and maintain a healthy lifestyle with a balanced diet and regular exercise.""]","[""Maintain a healthy weight, exercise regularly, avoid smoking, and consume a balanced diet to help prevent musculoskeletal conditions.""]",[false],[true],[false],"[""To prevent Musculo-Skeletal issues, one should maintain proper posture, take regular breaks, perform stretching exercises, use ergonomic furniture, and avoid repetitive movements.""]","[""To prevent Medullary Sponge Kidney, it is important to stay hydrated by drinking plenty of water, avoid excessive intake of calcium and vitamin D supplements, and follow a healthy diet low in sodium and oxalate.""]","[""Maintain a healthy weight, exercise regularly, avoid smoking, and consume a balanced diet to help prevent musculoskeletal conditions.""]",[false],[true],[false],"[""To prevent Musculo-Skeletal issues, maintain good posture, take regular breaks, exercise regularly, and use ergonomic furniture.""]","[""To prevent Medullary Sponge Kidney, it is important to stay well-hydrated by drinking plenty of water, avoid excessive intake of calcium and vitamin D supplements, and follow a healthy diet low in salt and protein.""]","[""Maintain a healthy weight, exercise regularly, avoid smoking, and limit alcohol consumption to help prevent musculoskeletal conditions.""]",[false],[false],[false],"[""To prevent Musculoskeletal issues, maintain good posture, exercise regularly, take breaks from prolonged sitting, use ergonomic furniture, and avoid repetitive motions.""]","[""To prevent Medullary Sponge Kidney, it is important to stay well-hydrated by drinking plenty of water, avoid excessive intake of calcium and vitamin D supplements, and follow a healthy diet low in salt and protein.""]","[""Maintain a healthy weight, exercise regularly, avoid smoking, and limit alcohol consumption to help prevent musculoskeletal conditions.""]",[false],[true],[false],"[""Avoid confrontation and report any suspicious activity to the authorities.""]","[""To prevent Medullary Sponge Kidney, it is important to stay well-hydrated by drinking plenty of water, avoid excessive intake of calcium and vitamin D supplements, and follow a healthy diet low in salt and protein.""]","[""Maintain a healthy weight, exercise regularly, avoid smoking, and limit alcohol consumption to help prevent musculoskeletal conditions.""]",[false],[true],[false],"[""Regular exercise, maintaining proper posture, using ergonomic furniture, taking breaks during repetitive tasks""]","[""To prevent Medullary Sponge Kidney, it is important to stay well-hydrated by drinking plenty of water, avoid excessive intake of calcium and vitamin D supplements, and follow a healthy diet low in salt and protein.""]","[""Maintain a healthy weight, exercise regularly, avoid smoking, and limit alcohol consumption to help prevent musculoskeletal conditions.""]"
symptoms,What are the symptoms of ADNP syndrome ?,"What are the signs and symptoms of ADNP syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for ADNP syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of cardiovascular system morphology 5% Seizures 5% Autistic behavior - Cleft eyelid - Feeding difficulties - Hyperactivity - Hypermetropia - Intellectual disability - Joint laxity - Language impairment - Muscular hypotonia - Obesity - Obsessive-compulsive behavior - Prominent forehead - Ptosis - Recurrent infections - Short nose - Short stature - Small hand - Smooth philtrum - Stereotypic behavior - Strabismus - Visual impairment - Wide nasal bridge - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""abbreviation"", ""abbreviation"": ""ADNP"", ""full_form"": ""Activity-Dependent Neuroprotector Homeobox""}]}",What are the symptoms of ADNP syndrome ?,What are the symptoms of Activity-Dependent Neuroprotector Homeobox syndrome ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Activity dependent neuroprotective protein"", ""Arizona Digital Newspaper Program"", ""Abu Dhabi National Properties"", ""activity-dependent neuroprotective homeobox"", ""Arab Democratic Nasserist Party"", ""Activity Dependent Neuroprotective Protein"", ""Associate Degree Nursing Program"", ""Associate Degree Nursing Program"", ""Activity Dependent Neuroprotective Protein""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY""]]","[""Activity-Dependent Neuroprotector Homeobox""]",[2.702217544398084e-35],[2.702217544398084e-35],"[""Associate Degree Nursing Program""]",[1.822222014111617e-16],"[""ACRONYMFINDER""]","[[2.83151971236613e-26, 2.854780839368062e-28, 8.984038246238162e-26, 1.4289952961461398e-34, 1.8702245595011233e-32, 2.83151971236613e-26, 1.822222014111617e-16, 1.822222014111617e-16, 2.83151971236613e-26]]",[0.9306408699623456],[0.9306408699623456],"[""Abu Dhabi National Properties""]",[0.9356882925479817],"[""ABBREVIATIONS""]","[[0.9340507695241337, 0.8905202483689625, 0.9330853449850603, 0.9356882925479817, 0.9242977222662626, 0.9295655060569468, 0.9223369335878902, 0.9223369335878904, 0.9295655060569481]]","[""Activity Dependent Neuroprotective Protein""]","[""ACRONYMFINDER""]",What are the symptoms of ADNP (Activity-Dependent Neuroprotector Homeobox) syndrome ?,[false],[true],[true],"[""Some symptoms of ADNP (Associate Degree Nursing Program) syndrome include intellectual disability, developmental delay, speech delay, and distinctive facial features.""]","[""Activity-Dependent Neuroprotector Homeobox syndrome is a rare genetic disorder characterized by intellectual disability, developmental delay, and seizures.""]","[""Some symptoms of ADNP syndrome include intellectual disability, developmental delay, speech and language delays, autism spectrum disorder, and distinctive facial features.""]",[true],[true],[true],"[""Some symptoms of ADNP syndrome include intellectual disability, developmental delay, speech and language problems, and distinctive facial features.""]","[""The symptoms of Activity-Dependent Neuroprotector Homeobox syndrome include intellectual disability, delayed speech and language development, seizures, and abnormal brain MRI findings.""]","[""Some common symptoms of ADNP syndrome include developmental delay, intellectual disability, speech and language delays, autism spectrum disorder, and distinctive facial features.""]",[true],[true],[true],"[""Some symptoms of ADNP syndrome include developmental delay, intellectual disability, speech and language delays, and distinctive facial features.""]","[""Some symptoms of Activity-Dependent Neuroprotector Homeobox syndrome include intellectual disability, delayed speech and language development, seizures, and abnormal muscle tone.""]","[""Some common symptoms of ADNP syndrome include intellectual disability, developmental delay, speech and language delays, autism spectrum disorder, and distinctive facial features.""]",[true],[true],[true],"[""Some symptoms of ADNP syndrome include developmental delay, intellectual disability, speech delay, and distinctive facial features.""]","[""Symptoms of Activity-Dependent Neuroprotector Homeobox syndrome include intellectual disability, delayed speech development, seizures, and abnormal muscle tone.""]","[""Some common symptoms of ADNP syndrome include intellectual disability, developmental delay, speech and language delays, autism spectrum disorder, and distinctive facial features.""]",[true],[true],[true],"[""Some symptoms of ADNP syndrome include developmental delay, intellectual disability, speech and language delays, and distinctive facial features.""]","[""Activity-Dependent Neuroprotector Homeobox syndrome is a rare genetic disorder characterized by intellectual disability, developmental delay, and seizures.""]","[""Some symptoms of ADNP syndrome include intellectual disability, developmental delay, speech and language delays, autism spectrum disorder, and distinctive facial features.""]",[true],[true],[true],"[""Some common symptoms of ADNP syndrome include developmental delay, intellectual disability, speech and language delays, autism spectrum disorder, and distinctive facial features.""]","[""The symptoms of Activity-Dependent Neuroprotector Homeobox syndrome include intellectual disability, delayed speech and language development, seizures, and abnormal brain MRI findings.""]","[""Some common symptoms of ADNP syndrome include developmental delay, intellectual disability, speech and language delays, autism spectrum disorder, and distinctive facial features.""]",[true],[true],[true],"[""Some common symptoms of ADNP syndrome include intellectual disability, developmental delay, speech and language delays, autism spectrum disorder, and distinctive facial features.""]","[""Some symptoms of Activity-Dependent Neuroprotector Homeobox syndrome include intellectual disability, delayed speech and language development, seizures, and abnormal muscle tone.""]","[""Some common symptoms of ADNP syndrome include intellectual disability, developmental delay, speech and language delays, autism spectrum disorder, and distinctive facial features.""]",[true],[true],[true],"[""Some symptoms of ADNP syndrome include intellectual disability, developmental delay, speech delay, autism spectrum disorder, and distinctive facial features.""]","[""Symptoms of Activity-Dependent Neuroprotector Homeobox syndrome include intellectual disability, delayed speech development, seizures, and abnormal muscle tone.""]","[""Some common symptoms of ADNP syndrome include intellectual disability, developmental delay, speech and language delays, autism spectrum disorder, and distinctive facial features.""]",[true],[true],[true],"[""Some common symptoms of ADNP syndrome include developmental delays, intellectual disability, speech and language delays, autism spectrum disorder, and distinctive facial features.""]","[""The symptoms of Activity-Dependent Neuroprotector Homeobox syndrome include intellectual disability, delayed speech and language development, seizures, and abnormal brain MRI findings.""]","[""Some common symptoms of ADNP syndrome include developmental delay, intellectual disability, speech and language delays, autism spectrum disorder, and distinctive facial features.""]",[true],[true],[true],"[""Some common symptoms of ADNP syndrome include intellectual disability, developmental delay, speech and language impairments, autism spectrum disorder, and distinctive facial features.""]","[""Activity-Dependent Neuroprotector Homeobox syndrome is a rare genetic disorder characterized by intellectual disability, developmental delay, and seizures.""]","[""Some symptoms of ADNP syndrome include intellectual disability, developmental delay, speech and language delays, autism spectrum disorder, and distinctive facial features.""]",[true],[true],[true],"[""Some symptoms of ADNP (Activity Dependent Neuroprotective Protein) syndrome include intellectual disability, developmental delay, speech and language impairments, autism spectrum disorder, and distinct facial features.""]","[""Some symptoms of Activity-Dependent Neuroprotector Homeobox syndrome include intellectual disability, delayed speech and language development, seizures, and abnormal muscle tone.""]","[""Some common symptoms of ADNP syndrome include intellectual disability, developmental delay, speech and language delays, autism spectrum disorder, and distinctive facial features.""]",[true],[true],[true],"[""Some symptoms of ADNP syndrome include developmental delays, intellectual disability, speech and language impairments, autism spectrum disorder, and distinctive facial features.""]","[""Symptoms of Activity-Dependent Neuroprotector Homeobox syndrome include intellectual disability, delayed speech development, seizures, and abnormal muscle tone.""]","[""Some common symptoms of ADNP syndrome include intellectual disability, developmental delay, speech and language delays, autism spectrum disorder, and distinctive facial features.""]",[true],[true],[true],"[""Developmental delay, intellectual disability, speech delay, autism spectrum disorder, hypotonia, and distinctive facial features are common symptoms of ADNP syndrome.""]","[""Activity-Dependent Neuroprotector Homeobox syndrome is a rare genetic disorder characterized by intellectual disability, developmental delay, and seizures.""]","[""Some symptoms of ADNP syndrome include intellectual disability, developmental delay, speech and language delays, autism spectrum disorder, and distinctive facial features.""]",[true],[true],[true],"[""Developmental delay, intellectual disability, speech and language delays, autism spectrum disorder, hypotonia, and distinctive facial features are common symptoms of ADNP syndrome.""]","[""The symptoms of Activity-Dependent Neuroprotector Homeobox syndrome include intellectual disability, delayed speech and language development, seizures, and abnormal brain MRI findings.""]","[""Some common symptoms of ADNP syndrome include developmental delay, intellectual disability, speech and language delays, autism spectrum disorder, and distinctive facial features.""]",[true],[true],[true],"[""Some common symptoms of ADNP (Activity Dependent Neuroprotective Protein) syndrome include intellectual disability, developmental delay, speech and language delays, autism spectrum disorder, and distinctive facial features.""]","[""Some symptoms of Activity-Dependent Neuroprotector Homeobox syndrome include intellectual disability, delayed speech and language development, seizures, and abnormal muscle tone.""]","[""Some common symptoms of ADNP syndrome include intellectual disability, developmental delay, speech and language delays, autism spectrum disorder, and distinctive facial features.""]",[true],[true],[true],"[""Some symptoms of ADNP syndrome include developmental delays, intellectual disability, speech and language delays, autism spectrum disorder, and distinctive facial features.""]","[""Symptoms of Activity-Dependent Neuroprotector Homeobox syndrome include intellectual disability, delayed speech development, seizures, and abnormal muscle tone.""]","[""Some common symptoms of ADNP syndrome include intellectual disability, developmental delay, speech and language delays, autism spectrum disorder, and distinctive facial features.""]",[true],[true],[true],"[""Some symptoms of ADNP syndrome include intellectual disability, developmental delay, speech and language impairments, autism spectrum disorder, and distinctive facial features.""]","[""Activity-Dependent Neuroprotector Homeobox syndrome is a rare genetic disorder characterized by intellectual disability, developmental delay, and seizures.""]","[""Some symptoms of ADNP syndrome include intellectual disability, developmental delay, speech and language delays, autism spectrum disorder, and distinctive facial features.""]",[true],[true],[true],"[""Some symptoms of ADNP syndrome include developmental delay, intellectual disability, speech and language delays, autism spectrum disorder, and distinctive facial features.""]","[""The symptoms of Activity-Dependent Neuroprotector Homeobox syndrome include intellectual disability, delayed speech and language development, seizures, and abnormal brain MRI findings.""]","[""Some common symptoms of ADNP syndrome include developmental delay, intellectual disability, speech and language delays, autism spectrum disorder, and distinctive facial features.""]",[true],[true],[true],"[""Some symptoms of ADNP syndrome include intellectual disability, developmental delay, speech and language impairments, autism spectrum disorder, and distinctive facial features.""]","[""Some symptoms of Activity-Dependent Neuroprotector Homeobox syndrome include intellectual disability, delayed speech and language development, seizures, and abnormal muscle tone.""]","[""Some common symptoms of ADNP syndrome include intellectual disability, developmental delay, speech and language delays, autism spectrum disorder, and distinctive facial features.""]",[true],[true],[true],"[""Symptoms of ADNP syndrome include intellectual disability, developmental delay, speech and language impairments, autism spectrum disorder, and distinct facial features.""]","[""Symptoms of Activity-Dependent Neuroprotector Homeobox syndrome include intellectual disability, delayed speech development, seizures, and abnormal muscle tone.""]","[""Some common symptoms of ADNP syndrome include intellectual disability, developmental delay, speech and language delays, autism spectrum disorder, and distinctive facial features.""]",[true],[true],[true],"[""Some symptoms of ADNP syndrome include intellectual disability, developmental delay, speech and language impairments, autism spectrum disorder, and distinct facial features.""]","[""Activity-Dependent Neuroprotector Homeobox syndrome is a rare genetic disorder characterized by intellectual disability, developmental delay, and seizures.""]","[""Some symptoms of ADNP syndrome include intellectual disability, developmental delay, speech and language delays, autism spectrum disorder, and distinctive facial features.""]",[true],[true],[true],"[""Some common symptoms of ADNP syndrome include intellectual disability, developmental delay, speech and language delays, autism spectrum disorder, and distinct facial features.""]","[""The symptoms of Activity-Dependent Neuroprotector Homeobox syndrome include intellectual disability, delayed speech and language development, seizures, and abnormal brain MRI findings.""]","[""Some common symptoms of ADNP syndrome include developmental delay, intellectual disability, speech and language delays, autism spectrum disorder, and distinctive facial features.""]",[true],[true],[true],"[""Some symptoms of ADNP syndrome include intellectual disability, developmental delay, speech and language impairments, autism spectrum disorder, and distinctive facial features.""]","[""Some symptoms of Activity-Dependent Neuroprotector Homeobox syndrome include intellectual disability, delayed speech and language development, seizures, and abnormal muscle tone.""]","[""Some common symptoms of ADNP syndrome include intellectual disability, developmental delay, speech and language delays, autism spectrum disorder, and distinctive facial features.""]",[true],[true],[true],"[""Some common symptoms of ADNP syndrome include intellectual disability, developmental delay, speech and language delays, autism spectrum disorder, and distinctive facial features.""]","[""Symptoms of Activity-Dependent Neuroprotector Homeobox syndrome include intellectual disability, delayed speech development, seizures, and abnormal muscle tone.""]","[""Some common symptoms of ADNP syndrome include intellectual disability, developmental delay, speech and language delays, autism spectrum disorder, and distinctive facial features.""]",[true],[true],[true],"[""Some common symptoms of ADNP syndrome include developmental delays, intellectual disability, speech and language impairments, autism spectrum disorder, and distinctive facial features.""]","[""Activity-Dependent Neuroprotector Homeobox syndrome is a rare genetic disorder characterized by intellectual disability, developmental delay, and seizures.""]","[""Some symptoms of ADNP syndrome include intellectual disability, developmental delay, speech and language delays, autism spectrum disorder, and distinctive facial features.""]",[true],[true],[true],"[""Some common symptoms of ADNP syndrome include developmental delays, intellectual disability, speech and language impairments, autism spectrum disorder, and distinctive facial features.""]","[""The symptoms of Activity-Dependent Neuroprotector Homeobox syndrome include intellectual disability, delayed speech and language development, seizures, and abnormal brain MRI findings.""]","[""Some common symptoms of ADNP syndrome include developmental delay, intellectual disability, speech and language delays, autism spectrum disorder, and distinctive facial features.""]",[true],[true],[true],"[""Some common symptoms of ADNP syndrome include intellectual disability, developmental delays, speech and language impairments, autism spectrum disorder, and distinct facial features.""]","[""Some symptoms of Activity-Dependent Neuroprotector Homeobox syndrome include intellectual disability, delayed speech and language development, seizures, and abnormal muscle tone.""]","[""Some common symptoms of ADNP syndrome include intellectual disability, developmental delay, speech and language delays, autism spectrum disorder, and distinctive facial features.""]",[true],[true],[true],"[""Some symptoms of ADNP (Activity Dependent Neuroprotective Protein) syndrome include intellectual disability, developmental delay, speech and language impairments, autism spectrum disorder, and distinctive facial features.""]","[""Symptoms of Activity-Dependent Neuroprotector Homeobox syndrome include intellectual disability, delayed speech development, seizures, and abnormal muscle tone.""]","[""Some common symptoms of ADNP syndrome include intellectual disability, developmental delay, speech and language delays, autism spectrum disorder, and distinctive facial features.""]",[true],[true],[true],"[""Some common symptoms of ADNP syndrome include developmental delays, intellectual disability, speech and language impairments, autism spectrum disorder, and distinctive facial features.""]","[""Activity-Dependent Neuroprotector Homeobox syndrome is a rare genetic disorder characterized by intellectual disability, developmental delay, and seizures.""]","[""Some symptoms of ADNP syndrome include intellectual disability, developmental delay, speech and language delays, autism spectrum disorder, and distinctive facial features.""]",[true],[true],[true],"[""Intellectual disability, developmental delay, speech and language impairments, and distinctive facial features""]","[""Activity-Dependent Neuroprotector Homeobox syndrome is a rare genetic disorder characterized by intellectual disability, developmental delay, and seizures.""]","[""Some symptoms of ADNP syndrome include intellectual disability, developmental delay, speech and language delays, autism spectrum disorder, and distinctive facial features.""]",[true],[true],[true],"[""Some symptoms of ADNP syndrome include intellectual disability, developmental delay, speech and language delays, and distinctive facial features.""]","[""Activity-Dependent Neuroprotector Homeobox syndrome is a rare genetic disorder characterized by intellectual disability, developmental delay, and seizures.""]","[""Some symptoms of ADNP syndrome include intellectual disability, developmental delay, speech and language delays, autism spectrum disorder, and distinctive facial features.""]",[true],[true],[true],"[""Some common symptoms of ADNP syndrome include developmental delay, intellectual disability, speech and language delays, autism spectrum disorder, and distinctive facial features.""]","[""Activity-Dependent Neuroprotector Homeobox syndrome is a rare genetic disorder characterized by intellectual disability, developmental delay, and seizures.""]","[""Some symptoms of ADNP syndrome include intellectual disability, developmental delay, speech and language delays, autism spectrum disorder, and distinctive facial features.""]"
frequency,How many people are affected by Beckwith-Wiedemann syndrome ?,"Beckwith-Wiedemann syndrome affects an estimated 1 in 13,700 newborns worldwide. The condition may actually be more common than this estimate because some people with mild symptoms are never diagnosed.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""BWS"", ""full_form"": ""Beckwith-Wiedemann syndrome""}]}",How many people are affected by BWS ?,How many people are affected by Beckwith-Wiedemann syndrome ?,8,MEDICAL,Simple Datatype-Integer,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Brown Shoe, Inc."", ""Borland Web Server"", ""Blaine, Washington USA"", ""Beginner's Workout Syndrome"", ""Beginners Workout Syndrome"", ""Barnical Withering Shark"", ""Beer Wine Spirits"", ""Beer Weed Sex"", ""Beckwith Wiedemann Syndrome"", ""Beer Wine and Spirits""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Beckwith-Wiedemann Syndrome""]",[1.8384209966670175e-25],[1.8384209966670175e-25],"[""Beer Wine and Spirits""]",[1.8167449593022834e-13],"[""ABBREVIATIONS""]","[[1.4898240628945441e-15, 2.001007139943645e-18, 6.38738472241153e-27, 7.892036726297926e-19, 1.6837214382931846e-18, 2.4968254658724417e-26, 3.586794101834651e-15, 2.7804679604737784e-15, 3.3956583152056854e-24, 1.8167449593022834e-13]]",[0.8836669624340471],[0.8823741782182029],"[""Beer Wine and Spirits""]",[0.8823741782182029],"[""LLM""]","[[0.6916298623075838, 0.687800488262578, 0.729737867968699, 0.6269743669625436, 0.6392029721601178, 0.7114838284713603, 0.7257040622332522, 0.6848502207896718, 0.8817447940219061, 0.737403695001513]]","[""Beckwith Wiedemann Syndrome""]","[""ABBREVIATIONS""]",How many people are affected by BWS (Beckwith-Wiedemann Syndrome) ?,[false],[true],[true],"[""The exact number of people affected by BWS (Beer Wine and Spirits) is not available.""]","[""1 in 13,700 births""]","[""1 in 13,700 people are affected by Beckwith-Wiedemann syndrome (BWS).""]",[false],[true],[true],"[""The exact number of people affected by BWS (Beer Wine and Spirits) is not readily available.""]","[""1 in 13,700 births""]","[""1 in 13,700 people are affected by Beckwith-Wiedemann syndrome (BWS).""]",[false],[true],[true],"[""There is no specific data available on the exact number of people affected by BWS (Beer Wine and Spirits).""]","[""1 in 13,700 births""]","[""1 in 13,700 people are affected by Beckwith-Wiedemann syndrome (BWS).""]",[false],[true],[true],"[""The exact number of people affected by BWS (Beer Wine and Spirits) is not readily available.""]","[""1 in 13,700 births""]","[""1 in 13,700 people are affected by Beckwith-Wiedemann syndrome (BWS).""]",[false],[true],[true],"[""The exact number of people affected by BWS (Beer Wine and Spirits) is not readily available.""]","[""1 in 13,700 births""]","[""1 in 13,700 people are affected by Beckwith-Wiedemann syndrome (BWS).""]",[false],[true],[true],"[""There is no specific data available on the exact number of people affected by BWS (Beer Wine and Spirits).""]","[""1 in 13,700 births""]","[""1 in 13,700 people are affected by Beckwith-Wiedemann syndrome (BWS).""]",[false],[true],[true],"[""The number of people affected by BWS is not available.""]","[""1 in 13,700 births""]","[""1 in 13,700 people are affected by Beckwith-Wiedemann syndrome (BWS).""]",[false],[true],[true],"[""The exact number of people affected by BWS (Beer Wine and Spirits) is not readily available.""]","[""1 in 13,700 births""]","[""1 in 13,700 people are affected by Beckwith-Wiedemann syndrome (BWS).""]",[true],[true],[true],"[""1 in 13,700 births""]","[""1 in 13,700 births""]","[""1 in 13,700 people are affected by Beckwith-Wiedemann syndrome (BWS).""]",[true],[true],[true],"[""1 in 13,700 births""]","[""1 in 13,700 births""]","[""1 in 13,700 people are affected by Beckwith-Wiedemann syndrome (BWS).""]",[true],[true],[true],"[""1 in 13,700 births""]","[""1 in 13,700 births""]","[""1 in 13,700 people are affected by Beckwith-Wiedemann syndrome (BWS).""]",[true],[true],[true],"[""1 in 13,700 births""]","[""1 in 13,700 births""]","[""1 in 13,700 people are affected by Beckwith-Wiedemann syndrome (BWS).""]",[true],[true],[true],"[""1 in 13,700 births""]","[""1 in 13,700 births""]","[""1 in 13,700 people are affected by Beckwith-Wiedemann syndrome (BWS).""]",[true],[true],[true],"[""1 in 13,700 births""]","[""1 in 13,700 births""]","[""1 in 13,700 people are affected by Beckwith-Wiedemann syndrome (BWS).""]",[true],[true],[true],"[""1 in 13,700 births""]","[""1 in 13,700 births""]","[""1 in 13,700 people are affected by Beckwith-Wiedemann syndrome (BWS).""]",[true],[true],[true],"[""1 in 13,700 births""]","[""1 in 13,700 births""]","[""1 in 13,700 people are affected by Beckwith-Wiedemann syndrome (BWS).""]",[false],[true],[true],"[""The exact number of people affected by BWS (Beckwith Wiedemann Syndrome) is not readily available.""]","[""1 in 13,700 births""]","[""1 in 13,700 people are affected by Beckwith-Wiedemann syndrome (BWS).""]",[true],[true],[true],"[""1 in 13,700 births""]","[""1 in 13,700 births""]","[""1 in 13,700 people are affected by Beckwith-Wiedemann syndrome (BWS).""]",[true],[true],[true],"[""1 in 13,700 births""]","[""1 in 13,700 births""]","[""1 in 13,700 people are affected by Beckwith-Wiedemann syndrome (BWS).""]",[true],[true],[true],"[""1 in 13,700 births""]","[""1 in 13,700 births""]","[""1 in 13,700 people are affected by Beckwith-Wiedemann syndrome (BWS).""]",[true],[true],[true],"[""1 in 13,700 births""]","[""1 in 13,700 births""]","[""1 in 13,700 people are affected by Beckwith-Wiedemann syndrome (BWS).""]",[true],[true],[true],"[""1 in 13,700 births""]","[""1 in 13,700 births""]","[""1 in 13,700 people are affected by Beckwith-Wiedemann syndrome (BWS).""]",[true],[true],[true],"[""1 in 13,700 births""]","[""1 in 13,700 births""]","[""1 in 13,700 people are affected by Beckwith-Wiedemann syndrome (BWS).""]",[true],[true],[true],"[""1 in 13,700 births""]","[""1 in 13,700 births""]","[""1 in 13,700 people are affected by Beckwith-Wiedemann syndrome (BWS).""]",[true],[true],[true],"[""BWS affects approximately 1 in 13,700 people.""]","[""1 in 13,700 births""]","[""1 in 13,700 people are affected by Beckwith-Wiedemann syndrome (BWS).""]",[true],[true],[true],"[""BWS affects approximately 1 in 13,700 individuals.""]","[""1 in 13,700 births""]","[""1 in 13,700 people are affected by Beckwith-Wiedemann syndrome (BWS).""]",[true],[false],[true],"[""BWS affects approximately 1 in 13,700 individuals.""]","[""1 in 13,700 births""]","[""1 in 13,700 people are affected by Beckwith-Wiedemann syndrome (BWS).""]",[true],[true],[true],"[""The exact number of people affected by Beckwith-Wiedemann Syndrome (BWS) is not known, but it is considered a rare condition.""]","[""1 in 13,700 births""]","[""1 in 13,700 people are affected by Beckwith-Wiedemann syndrome (BWS).""]",[true],[true],[true],"[""The exact number of people affected by Beckwith-Wiedemann Syndrome is not known, but it is considered a rare condition.""]","[""1 in 13,700 births""]","[""1 in 13,700 people are affected by Beckwith-Wiedemann syndrome (BWS).""]",[false],[true],[true],"[""The number of people affected by BWS is not specified.""]","[""1 in 13,700 births""]","[""1 in 13,700 people are affected by Beckwith-Wiedemann syndrome (BWS).""]",[false],[true],[true],"[""The number of people affected by BWS is not specified.""]","[""1 in 13,700 births""]","[""1 in 13,700 people are affected by Beckwith-Wiedemann syndrome (BWS).""]",[true],[true],[true],"[""BWS affects approximately 1 in 13,700 individuals.""]","[""1 in 13,700 births""]","[""1 in 13,700 people are affected by Beckwith-Wiedemann syndrome (BWS).""]"
frequency,How many people are affected by atypical hemolytic-uremic syndrome ?,"The incidence of atypical hemolytic-uremic syndrome is estimated to be 1 in 500,000 people per year in the United States. The atypical form is probably about 10 times less common than the typical form.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""aHUS"", ""full_form"": ""atypical hemolytic-uremic syndrome""}]}",How many people are affected by aHUS ?,How many people are affected by atypical hemolytic-uremic syndrome ?,8,MEDICAL,Simple Datatype-Integer,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Atypical Haemolytic Uraemic Syndrome"", ""atypical Hemolytic Uremic"", ""Atypical Hemolytic Uremic Syndrome"", ""Atypical Hemolytic Uremic Syndrome"", ""AHUS""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY""]]","[""atypical Hemolytic Uremic Syndrome""]",[1.0754059068510676e-17],[2.46380487456579e-15],"[""AHUS""]",[0.0030572762608138512],"[""THEFREEDICTIONARY""]","[[1.4718094851380378e-23, 3.705594274563445e-14, 2.46380487456579e-15, 2.46380487456579e-15, 0.0030572762608138512]]",[0.9400224496906195],[0.9420524183794043],"[""Atypical Hemolytic Uremic Syndrome""]",[0.9689856684076569],"[""THEFREEDICTIONARY""]","[[0.9452670705522237, 0.9457638904137582, 0.9418360458374361, 0.9418360458374357, 0.9689856684076569]]","[""Atypical Hemolytic Uremic Syndrome""]","[""ABBREVIATIONS""]",How many people are affected by aHUS (atypical Hemolytic Uremic Syndrome) ?,[true],[true],[true],"[""Approximately 1 to 2 individuals per million are affected by aHUS.""]","[""Atypical hemolytic-uremic syndrome affects about 1 in 500,000 individuals.""]","[""1 to 2 people per million are affected by aHUS.""]",[true],[true],[true],"[""1 to 2 individuals per million""]","[""Atypical hemolytic-uremic syndrome affects about 1 in 500,000 people per year.""]","[""aHUS affects about 2 per million people""]",[true],[true],[true],"[""aHUS affects approximately 2 per million people""]","[""1 to 2 individuals per million people are affected by atypical hemolytic-uremic syndrome.""]","[""aHUS affects about 1 to 2 individuals per million people per year.""]",[true],[true],[true],"[""aHUS affects approximately 1 to 2 individuals per million people""]","[""Atypical hemolytic-uremic syndrome affects about 1 in 500,000 individuals per year.""]","[""aHUS affects approximately 1 to 2 individuals per million population""]",[true],[true],[true],"[""1 to 2 individuals per million are affected by aHUS""]","[""Atypical hemolytic-uremic syndrome affects about 1 in 500,000 individuals.""]","[""1 to 2 people per million are affected by aHUS.""]",[true],[true],[true],"[""1 to 2 individuals per million are affected by aHUS.""]","[""Atypical hemolytic-uremic syndrome affects about 1 in 500,000 people per year.""]","[""aHUS affects about 2 per million people""]",[true],[true],[true],"[""aHUS affects approximately 2 per million people""]","[""1 to 2 individuals per million people are affected by atypical hemolytic-uremic syndrome.""]","[""aHUS affects about 1 to 2 individuals per million people per year.""]",[true],[true],[true],"[""1 to 2 individuals per million are affected by aHUS""]","[""Atypical hemolytic-uremic syndrome affects about 1 in 500,000 individuals per year.""]","[""aHUS affects approximately 1 to 2 individuals per million population""]",[true],[true],[true],"[""1 to 2 individuals per million are affected by aHUS""]","[""Atypical hemolytic-uremic syndrome affects about 1 in 500,000 people per year.""]","[""aHUS affects about 2 per million people""]",[true],[true],[true],"[""aHUS affects about 2 per 1 million people per year.""]","[""Atypical hemolytic-uremic syndrome affects about 1 in 500,000 individuals.""]","[""1 to 2 people per million are affected by aHUS.""]",[true],[true],[true],"[""aHUS affects about 1 to 2 individuals per million per year.""]","[""1 to 2 individuals per million people are affected by atypical hemolytic-uremic syndrome.""]","[""aHUS affects about 1 to 2 individuals per million people per year.""]",[true],[true],[true],"[""aHUS affects about 2 per million people per year.""]","[""Atypical hemolytic-uremic syndrome affects about 1 in 500,000 individuals per year.""]","[""aHUS affects approximately 1 to 2 individuals per million population""]",[true],[true],[true],"[""aHUS affects approximately 2 per million people per year.""]","[""Atypical hemolytic-uremic syndrome affects about 1 in 500,000 individuals.""]","[""1 to 2 people per million are affected by aHUS.""]",[true],[true],[true],"[""1 to 2 per million people are affected by aHUS""]","[""Atypical hemolytic-uremic syndrome affects about 1 in 500,000 people per year.""]","[""aHUS affects about 2 per million people""]",[true],[true],[true],"[""1 to 2 people per million are affected by aHUS""]","[""1 to 2 individuals per million people are affected by atypical hemolytic-uremic syndrome.""]","[""aHUS affects about 1 to 2 individuals per million people per year.""]",[true],[true],[true],"[""1 to 2 per million people are affected by aHUS""]","[""Atypical hemolytic-uremic syndrome affects about 1 in 500,000 individuals per year.""]","[""aHUS affects approximately 1 to 2 individuals per million population""]",[true],[true],[true],"[""aHUS affects approximately 2 per 1 million people per year.""]","[""Atypical hemolytic-uremic syndrome affects about 1 in 500,000 individuals.""]","[""1 to 2 people per million are affected by aHUS.""]",[true],[true],[true],"[""aHUS affects about 1 to 2 individuals per million per year.""]","[""Atypical hemolytic-uremic syndrome affects about 1 in 500,000 people per year.""]","[""aHUS affects about 2 per million people""]",[true],[true],[true],"[""1 to 2 individuals per million""]","[""1 to 2 individuals per million people are affected by atypical hemolytic-uremic syndrome.""]","[""aHUS affects about 1 to 2 individuals per million people per year.""]",[true],[true],[true],"[""1 to 2 individuals per million are affected by aHUS""]","[""Atypical hemolytic-uremic syndrome affects about 1 in 500,000 individuals per year.""]","[""aHUS affects approximately 1 to 2 individuals per million population""]",[true],[true],[true],"[""aHUS affects approximately 1 to 2 individuals per million population per year.""]","[""Atypical hemolytic-uremic syndrome affects about 1 in 500,000 individuals.""]","[""1 to 2 people per million are affected by aHUS.""]",[true],[true],[true],"[""1 to 2 individuals per million are affected by aHUS""]","[""Atypical hemolytic-uremic syndrome affects about 1 in 500,000 people per year.""]","[""aHUS affects about 2 per million people""]",[true],[true],[true],"[""aHUS affects approximately 1 to 2 individuals per million people per year.""]","[""1 to 2 individuals per million people are affected by atypical hemolytic-uremic syndrome.""]","[""aHUS affects about 1 to 2 individuals per million people per year.""]",[true],[true],[true],"[""aHUS affects approximately 1 to 2 individuals per million per year.""]","[""Atypical hemolytic-uremic syndrome affects about 1 in 500,000 individuals per year.""]","[""aHUS affects approximately 1 to 2 individuals per million population""]",[true],[true],[true],"[""aHUS affects approximately 2 per million people per year""]","[""Atypical hemolytic-uremic syndrome affects about 1 in 500,000 individuals.""]","[""1 to 2 people per million are affected by aHUS.""]",[true],[true],[true],"[""aHUS affects approximately 1 to 2 individuals per million per year.""]","[""Atypical hemolytic-uremic syndrome affects about 1 in 500,000 people per year.""]","[""aHUS affects about 2 per million people""]",[true],[true],[true],"[""aHUS affects approximately 1 to 2 individuals per million per year.""]","[""1 to 2 individuals per million people are affected by atypical hemolytic-uremic syndrome.""]","[""aHUS affects about 1 to 2 individuals per million people per year.""]",[true],[true],[true],"[""aHUS affects approximately 1 to 2 individuals per million per year.""]","[""Atypical hemolytic-uremic syndrome affects about 1 in 500,000 individuals per year.""]","[""aHUS affects approximately 1 to 2 individuals per million population""]",[true],[true],[true],"[""aHUS affects about 2 per million people per year""]","[""Atypical hemolytic-uremic syndrome affects about 1 in 500,000 individuals.""]","[""1 to 2 people per million are affected by aHUS.""]",[true],[true],[true],"[""The exact number of people affected by aHUS (atypical hemolytic uremic syndrome) is not known, but it is considered a rare disease.""]","[""Atypical hemolytic-uremic syndrome affects about 1 in 500,000 individuals.""]","[""1 to 2 people per million are affected by aHUS.""]",[true],[true],[true],"[""aHUS affects about 2 in 1 million people per year.""]","[""Atypical hemolytic-uremic syndrome affects about 1 in 500,000 individuals.""]","[""1 to 2 people per million are affected by aHUS.""]",[true],[true],[true],"[""aHUS affects about 2 per million people per year""]","[""Atypical hemolytic-uremic syndrome affects about 1 in 500,000 individuals.""]","[""1 to 2 people per million are affected by aHUS.""]"
inheritance,Is Myoclonic epilepsy with ragged red fibers inherited ?,"Is myoclonic epilepsy associated with ragged red fibers genetic? If so, how is it inherited? MERRF is caused by mutations in the mitochondrial DNA and is transmitted by maternal inheritance. It is called maternal inheritance because a child inherits the great majority of their mitochondria from their mother through the egg.   The Centre for Genetics Education provides a detail description of maternal inheritance.  The mother of an individual with MERRF usually has a mitochondrial mutation and may or may not have symptoms.  Or, an individual with MERRF may have a mitochondrial mutation that just occurred in them, called a de novo mutation.  If the mother has the mitochondrial mutation, all of her children will inherit the mutation and may or may not have symptoms.  All of her daughters children will also inherit the mitochondrial mutation.  Her son's children are not at risk of inheriting the mutation.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""MERRF"", ""full_form"": ""Myoclonic epilepsy with ragged red fibers""}]}",Is MERRF inherited ?,Is Myoclonic epilepsy with ragged red fibers inherited ?,8,MEDICAL,Simple Datatype-Boolean,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Myoclonic Epilepsy with Ragged Red Fibres"", ""Myoclonic epilepsy with ragged-red fibers (MERRF)"", ""Myoclonic Epilepsy and Ragged Red Fiber (medical condition)"", ""Mitochondrial Encephalomyopathy and Red-Ragged Fibres (diabetes research)"", ""Mitochondrial Encephalomyopathy and Red-Ragged Fibres (diabetes research)"", ""Myoclonic Epilepsy and Ragged Red Fiber (medical condition)""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY""]]","[""Myoclonic Epilepsy with Ragged Red Fibers""]",[1.8594867807681586e-33],[1.8594867807681586e-33],"[""Myoclonic Epilepsy with Ragged Red Fibers""]",[1.8594867807681586e-33],"[""LLM""]","[[6.522728304256284e-34, 5.360304891435096e-46, 6.874869338491038e-44, 1.2403579337366318e-52, 1.2403579337366318e-52, 6.874869338491038e-44]]",[0.9355309283362656],[0.9382660165479648],"[""Myoclonic Epilepsy with Ragged Red Fibres""]",[0.9427182785917404],"[""ABBREVIATIONS""]","[[0.9353867710849437, 0.9427182785917404, 0.8881966494684908, 0.8903625844483793, 0.8903625844483793, 0.8881966494684908]]","[""Myoclonic epilepsy with ragged-red fibers (MERRF)""]","[""ABBREVIATIONS""]",Is MERRF (Myoclonic Epilepsy with Ragged Red Fibers) inherited ?,[false],[true],[true],"[""Yes""]","[""Yes, Myoclonic epilepsy with ragged red fibers is inherited as a mitochondrial disorder.""]","[""Yes, MERRF (Myoclonic Epilepsy with Ragged Red Fibers) is inherited in a mitochondrial pattern.""]",[false],[true],[true],"[""Yes""]","[""Yes, Myoclonic epilepsy with ragged red fibers is inherited.""]","[""Yes, MERRF (Myoclonic Epilepsy with Ragged Red Fibers) is inherited.""]",[false],[true],[true],"[""Yes""]","[""Yes, Myoclonic epilepsy with ragged red fibers is inherited.""]","[""Yes, MERRF (Myoclonic Epilepsy with Ragged Red Fibers) is inherited.""]",[false],[true],[true],"[""Yes""]","[""Yes, Myoclonic epilepsy with ragged red fibers is inherited as a mitochondrial disorder.""]","[""Yes, MERRF (Myoclonic Epilepsy with Ragged Red Fibers) is inherited.""]",[false],[true],[true],"[""Yes""]","[""Yes, Myoclonic epilepsy with ragged red fibers is inherited as a mitochondrial disorder.""]","[""Yes, MERRF (Myoclonic Epilepsy with Ragged Red Fibers) is inherited in a mitochondrial pattern.""]",[false],[true],[true],"[""Yes""]","[""Yes, Myoclonic epilepsy with ragged red fibers is inherited.""]","[""Yes, MERRF (Myoclonic Epilepsy with Ragged Red Fibers) is inherited.""]",[false],[true],[true],"[""Yes""]","[""Yes, Myoclonic epilepsy with ragged red fibers is inherited.""]","[""Yes, MERRF (Myoclonic Epilepsy with Ragged Red Fibers) is inherited.""]",[false],[true],[true],"[""Yes""]","[""Yes, Myoclonic epilepsy with ragged red fibers is inherited as a mitochondrial disorder.""]","[""Yes, MERRF (Myoclonic Epilepsy with Ragged Red Fibers) is inherited.""]",[false],[true],[true],"[""Yes""]","[""Yes, Myoclonic epilepsy with ragged red fibers is inherited.""]","[""Yes, MERRF (Myoclonic Epilepsy with Ragged Red Fibers) is inherited.""]",[false],[true],[true],"[""Yes""]","[""Yes, Myoclonic epilepsy with ragged red fibers is inherited as a mitochondrial disorder.""]","[""Yes, MERRF (Myoclonic Epilepsy with Ragged Red Fibers) is inherited in a mitochondrial pattern.""]",[false],[true],[true],"[""Yes""]","[""Yes, Myoclonic epilepsy with ragged red fibers is inherited.""]","[""Yes, MERRF (Myoclonic Epilepsy with Ragged Red Fibers) is inherited.""]",[true],[true],[true],"[""Yes""]","[""Yes, Myoclonic epilepsy with ragged red fibers is inherited as a mitochondrial disorder.""]","[""Yes, MERRF (Myoclonic Epilepsy with Ragged Red Fibers) is inherited.""]",[false],[true],[true],"[""Yes""]","[""Yes, Myoclonic epilepsy with ragged red fibers is inherited as a mitochondrial disorder.""]","[""Yes, MERRF (Myoclonic Epilepsy with Ragged Red Fibers) is inherited in a mitochondrial pattern.""]",[true],[true],[true],"[""Yes, MERRF is inherited.""]","[""Yes, Myoclonic epilepsy with ragged red fibers is inherited.""]","[""Yes, MERRF (Myoclonic Epilepsy with Ragged Red Fibers) is inherited.""]",[true],[true],[true],"[""Yes, MERRF is inherited.""]","[""Yes, Myoclonic epilepsy with ragged red fibers is inherited.""]","[""Yes, MERRF (Myoclonic Epilepsy with Ragged Red Fibers) is inherited.""]",[true],[true],[true],"[""Yes, MERRF is inherited.""]","[""Yes, Myoclonic epilepsy with ragged red fibers is inherited as a mitochondrial disorder.""]","[""Yes, MERRF (Myoclonic Epilepsy with Ragged Red Fibers) is inherited.""]",[false],[true],[true],"[""Yes""]","[""Yes, Myoclonic epilepsy with ragged red fibers is inherited as a mitochondrial disorder.""]","[""Yes, MERRF (Myoclonic Epilepsy with Ragged Red Fibers) is inherited in a mitochondrial pattern.""]",[false],[true],[true],"[""Yes""]","[""Yes, Myoclonic epilepsy with ragged red fibers is inherited.""]","[""Yes, MERRF (Myoclonic Epilepsy with Ragged Red Fibers) is inherited.""]",[true],[true],[true],"[""Yes, MERRF is inherited.""]","[""Yes, Myoclonic epilepsy with ragged red fibers is inherited.""]","[""Yes, MERRF (Myoclonic Epilepsy with Ragged Red Fibers) is inherited.""]",[true],[true],[true],"[""Yes, MERRF is inherited.""]","[""Yes, Myoclonic epilepsy with ragged red fibers is inherited as a mitochondrial disorder.""]","[""Yes, MERRF (Myoclonic Epilepsy with Ragged Red Fibers) is inherited.""]",[false],[true],[true],"[""Yes""]","[""Yes, Myoclonic epilepsy with ragged red fibers is inherited as a mitochondrial disorder.""]","[""Yes, MERRF (Myoclonic Epilepsy with Ragged Red Fibers) is inherited in a mitochondrial pattern.""]",[false],[true],[true],"[""Yes""]","[""Yes, Myoclonic epilepsy with ragged red fibers is inherited.""]","[""Yes, MERRF (Myoclonic Epilepsy with Ragged Red Fibers) is inherited.""]",[false],[true],[true],"[""Yes""]","[""Yes, Myoclonic epilepsy with ragged red fibers is inherited.""]","[""Yes, MERRF (Myoclonic Epilepsy with Ragged Red Fibers) is inherited.""]",[false],[true],[true],"[""Yes""]","[""Yes, Myoclonic epilepsy with ragged red fibers is inherited as a mitochondrial disorder.""]","[""Yes, MERRF (Myoclonic Epilepsy with Ragged Red Fibers) is inherited.""]",[true],[true],[true],"[""Yes, MERRF (Myoclonic epilepsy with ragged-red fibers) is inherited.""]","[""Yes, Myoclonic epilepsy with ragged red fibers is inherited as a mitochondrial disorder.""]","[""Yes, MERRF (Myoclonic Epilepsy with Ragged Red Fibers) is inherited in a mitochondrial pattern.""]",[false],[true],[true],"[""Yes, MERRF is inherited in an autosomal dominant pattern.""]","[""Yes, Myoclonic epilepsy with ragged red fibers is inherited.""]","[""Yes, MERRF (Myoclonic Epilepsy with Ragged Red Fibers) is inherited.""]",[true],[true],[true],"[""Yes, MERRF (Myoclonic epilepsy with ragged-red fibers) is inherited.""]","[""Yes, Myoclonic epilepsy with ragged red fibers is inherited.""]","[""Yes, MERRF (Myoclonic Epilepsy with Ragged Red Fibers) is inherited.""]",[true],[true],[true],"[""Yes, MERRF (Myoclonic epilepsy with ragged-red fibers) is inherited through mitochondrial DNA mutations.""]","[""Yes, Myoclonic epilepsy with ragged red fibers is inherited as a mitochondrial disorder.""]","[""Yes, MERRF (Myoclonic Epilepsy with Ragged Red Fibers) is inherited.""]",[true],[true],[true],"[""Yes, MERRF is inherited.""]","[""Yes, Myoclonic epilepsy with ragged red fibers is inherited as a mitochondrial disorder.""]","[""Yes, MERRF (Myoclonic Epilepsy with Ragged Red Fibers) is inherited in a mitochondrial pattern.""]",[true],[true],[true],"[""Yes, MERRF (Myoclonic Epilepsy with Ragged Red Fibers) is inherited.""]","[""Yes, Myoclonic epilepsy with ragged red fibers is inherited as a mitochondrial disorder.""]","[""Yes, MERRF (Myoclonic Epilepsy with Ragged Red Fibers) is inherited in a mitochondrial pattern.""]",[true],[true],[true],"[""Yes, MERRF is inherited.""]","[""Yes, Myoclonic epilepsy with ragged red fibers is inherited as a mitochondrial disorder.""]","[""Yes, MERRF (Myoclonic Epilepsy with Ragged Red Fibers) is inherited in a mitochondrial pattern.""]",[true],[true],[true],"[""Yes, MERRF is inherited.""]","[""Yes, Myoclonic epilepsy with ragged red fibers is inherited as a mitochondrial disorder.""]","[""Yes, MERRF (Myoclonic Epilepsy with Ragged Red Fibers) is inherited in a mitochondrial pattern.""]"
exams and tests,How to diagnose Iron-Deficiency Anemia ?,"Your doctor will diagnose iron-deficiency anemia based on your medical history, a physical exam, and the results from tests and procedures.
                
Once your doctor knows the cause and severity of the condition, he or she can create a treatment plan for you.
                
Mild to moderate iron-deficiency anemia may have no signs or symptoms. Thus, you may not know you have it unless your doctor discovers it from a screening test or while checking for other problems.
                
Specialists Involved
                
Primary care doctors often diagnose and treat iron-deficiency anemia. These doctors include pediatricians, family doctors, gynecologists/obstetricians, and internal medicine specialists.
                
A hematologist (a blood disease specialist), a gastroenterologist (a digestive system specialist), and other specialists also may help treat iron-deficiency anemia.
                
Medical History
                
Your doctor will ask about your signs and symptoms and any past problems you've had with anemia or low iron. He or she also may ask about your diet and whether you're taking any medicines.
                
If you're a woman, your doctor may ask whether you might be pregnant.
                
Physical Exam
                
Your doctor will do a physical exam to look for signs of iron-deficiency anemia. He or she may:
                
Look at your skin, gums, and nail beds to see whether they're pale
                
Listen to your heart for rapid or irregular heartbeats
                
Listen to your lungs for rapid or uneven breathing
                
Feel your abdomen to check the size of your liver and spleen
                
Do a pelvic and rectal exam to check for internal bleeding
                
Diagnostic Tests and Procedures
                
Many tests and procedures are used to diagnose iron-deficiency anemia. They can help confirm a diagnosis, look for a cause, and find out how severe the condition is.
                
Complete Blood Count
                
Often, the first test used to diagnose anemia is a complete blood count (CBC). The CBC measures many parts of your blood.
                
This test checks your hemoglobin and hematocrit (hee-MAT-oh-crit) levels. Hemoglobin is an iron-rich protein in red blood cells that carries oxygen to the body. Hematocrit is a measure of how much space red blood cells take up in your blood. A low level of hemoglobin or hematocrit is a sign of anemia.
                
The normal range of these levels varies in certain racial and ethnic populations. Your doctor can explain your test results to you.
                
The CBC also checks the number of red blood cells, white blood cells, and platelets in your blood. Abnormal results may be a sign of infection, a blood disorder, or another condition.
                
Finally, the CBC looks at mean corpuscular (kor-PUS-kyu-lar) volume (MCV). MCV is a measure of the average size of your red blood cells. The results may be a clue as to the cause of your anemia. In iron-deficiency anemia, for example, red blood cells usually are smaller than normal.
                
Other Blood Tests
                
If the CBC results confirm you have anemia, you may need other blood tests to find out what's causing the condition, how severe it is, and the best way to treat it.
                
Reticulocyte count. This test measures the number of reticulocytes (re-TIK-u-lo-sites) in your blood. Reticulocytes are young, immature red blood cells. Over time, reticulocytes become mature red blood cells that carry oxygen throughout your body.
                
A reticulocyte count shows whether your bone marrow is making red blood cells at the correct rate.
                
Peripheral smear. For this test, a sample of your blood is examined under a microscope. If you have iron-deficiency anemia, your red blood cells will look smaller and paler than normal.
                
Tests to measure iron levels. These tests can show how much iron has been used from your body's stored iron. Tests to measure iron levels include:
                
Serum iron. This test measures the amount of iron in your blood. The level of iron in your blood may be normal even if the total amount of iron in your body is low. For this reason, other iron tests also are done.
                
Serum ferritin. Ferritin is a protein that helps store iron in your body. A measure of this protein helps your doctor find out how much of your body's stored iron has been used.
                
Transferrin level, or total iron-binding capacity. Transferrin is a protein that carries iron in your blood. Total iron-binding capacity measures how much of the transferrin in your blood isn't carrying iron. If you have iron-deficiency anemia, you'll have a high level of transferrin that has no iron.
                
Other tests. Your doctor also may recommend tests to check your hormone levels, especially your thyroid hormone. You also may have a blood test for a chemical called erythrocyte protoporphyrin. This chemical is a building block for hemoglobin.
                
Children also may be tested for the level of lead in their blood. Lead can make it hard for the body to produce hemoglobin.
                
Tests and Procedures for Gastrointestinal Blood Loss
                
To check whether internal bleeding is causing your iron-deficiency anemia, your doctor may suggest a fecal occult blood test. This test looks for blood in the stools and can detect bleeding in the intestines.
                
If the test finds blood, you may have other tests and procedures to find the exact spot of the bleeding. These tests and procedures may look for bleeding in the stomach, upper intestines, colon, or pelvic organs.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""IDA"", ""full_form"": ""Iron-Deficiency Anemia""}]}",How to diagnose IDA ?,How to diagnose Iron-Deficiency Anemia ?,8,MEDICAL,Compound Datatype-String,"Instructional: Queries specifically seeking step-by-step guidance, instructions, or procedures to perform a task. it focuses on 'how' to do something rather than 'what', 'why', or 'which'.","[[""International Development Association"", ""Institute for Defense Analyses"", ""Industrial Development Agency"", ""Individual Development Account"", ""Investment Dealers Association"", ""Iron Deficiency Anemia"", ""In Defense of Animals"", ""IdaCorp, Inc."", ""Instituto de Desarrollo Agrario"", ""Institute for Defense Analysis""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Iron Deficiency Anemia""]",[2.352802723559212e-09],[4.585323372876775e-08],"[""Iron Deficiency Anemia""]",[4.585323372876775e-08],"[""ABBREVIATIONS""]","[[1.2455656192725602e-14, 7.543274888148357e-20, 9.996166936110834e-16, 4.238095990323371e-18, 3.336330149485934e-14, 4.585323372876775e-08, 2.507943651111587e-15, 1.8819324540983017e-16, 2.2199315942177532e-27, 1.0350201223178609e-18]]",[0.947024099842988],[0.9486353628011785],"[""Investment Dealers Association""]",[0.9486353628011785],"[""ABBREVIATIONS""]","[[0.730650051423569, 0.6973324940602452, 0.6975454823553804, 0.676434223661113, 0.600669548404536, 0.9486353628011785, 0.6684699270955707, 0.7191626495062161, 0.6569804859794934, 0.6828659295281942]]","[""Iron Deficiency Anemia""]","[""ABBREVIATIONS""]",How to diagnose IDA (Iron Deficiency Anemia) ?,[true],[true],[true],"[""Diagnosing IDA involves blood tests such as complete blood count (CBC), serum ferritin level, iron studies, and possibly a bone marrow biopsy in severe cases.""]","[""Diagnosing iron-deficiency anemia involves blood tests such as complete blood count (CBC), serum ferritin, and iron studies.""]","[""Diagnosing iron deficiency anemia (IDA) involves a physical exam, blood tests to check iron levels, ferritin levels, and complete blood count (CBC), as well as possibly other tests such as a stool test or bone marrow biopsy.""]",[true],[true],[true],"[""Diagnosing IDA involves a physical exam, blood tests (complete blood count, serum ferritin, iron levels), and possibly additional tests like a bone marrow biopsy.""]","[""Diagnosing iron-deficiency anemia involves blood tests such as complete blood count (CBC), serum ferritin, and iron studies.""]","[""Iron deficiency anemia (IDA) can be diagnosed through blood tests such as complete blood count (CBC), serum ferritin level, iron level, and transferrin saturation. A bone marrow biopsy may also be performed in some cases.""]",[true],[true],[true],"[""Diagnosing IDA involves blood tests such as complete blood count (CBC), serum ferritin level, iron studies, and possibly a bone marrow biopsy in severe cases.""]","[""Diagnosing iron-deficiency anemia involves blood tests such as complete blood count (CBC), serum ferritin level, and iron studies.""]","[""Diagnosing iron deficiency anemia (IDA) involves a physical exam, blood tests to check for low levels of iron, hemoglobin, and ferritin, as well as other tests to determine the underlying cause of the anemia.""]",[true],[true],[true],"[""Diagnosing IDA involves blood tests such as complete blood count (CBC), serum ferritin level, iron studies, and possibly a bone marrow biopsy in severe cases.""]","[""Diagnosing iron-deficiency anemia involves blood tests such as complete blood count (CBC), serum ferritin level, and iron studies.""]","[""Diagnosing iron deficiency anemia (IDA) involves a physical exam, blood tests to check iron levels, ferritin levels, and complete blood count (CBC), as well as possibly other tests like a stool test or bone marrow biopsy.""]",[true],[true],[true],"[""Diagnosing IDA (Iron Deficiency Anemia) involves conducting blood tests such as complete blood count (CBC), serum ferritin levels, and iron studies.""]","[""Diagnosing iron-deficiency anemia involves blood tests such as complete blood count (CBC), serum ferritin, and iron studies.""]","[""Diagnosing iron deficiency anemia (IDA) involves a physical exam, blood tests to check iron levels, ferritin levels, and complete blood count (CBC), as well as possibly other tests such as a stool test or bone marrow biopsy.""]",[true],[true],[true],"[""Diagnosing IDA (Iron Deficiency Anemia) involves performing blood tests such as complete blood count (CBC), serum ferritin levels, and iron studies.""]","[""Diagnosing iron-deficiency anemia involves blood tests such as complete blood count (CBC), serum ferritin, and iron studies.""]","[""Iron deficiency anemia (IDA) can be diagnosed through blood tests such as complete blood count (CBC), serum ferritin level, iron level, and transferrin saturation. A bone marrow biopsy may also be performed in some cases.""]",[true],[true],[true],"[""Diagnosing IDA (Iron Deficiency Anemia) involves performing blood tests such as complete blood count (CBC), serum ferritin level, and iron studies to assess the levels of hemoglobin, ferritin, iron, and transferrin saturation in the blood. A physical examination and medical history review are also important in the diagnostic process.""]","[""Diagnosing iron-deficiency anemia involves blood tests such as complete blood count (CBC), serum ferritin level, and iron studies.""]","[""Diagnosing iron deficiency anemia (IDA) involves a physical exam, blood tests to check for low levels of iron, hemoglobin, and ferritin, as well as other tests to determine the underlying cause of the anemia.""]",[true],[true],[true],"[""Diagnosing IDA (Iron Deficiency Anemia) involves performing blood tests such as complete blood count (CBC), serum ferritin levels, and iron studies to assess the levels of hemoglobin, ferritin, iron, and transferrin saturation in the blood. A physical examination and medical history review are also important in the diagnostic process.""]","[""Diagnosing iron-deficiency anemia involves blood tests such as complete blood count (CBC), serum ferritin level, and iron studies.""]","[""Diagnosing iron deficiency anemia (IDA) involves a physical exam, blood tests to check iron levels, ferritin levels, and complete blood count (CBC), as well as possibly other tests like a stool test or bone marrow biopsy.""]",[true],[true],[true],"[""Diagnosing IDA involves blood tests such as complete blood count (CBC), serum ferritin level, iron studies, and possibly a bone marrow biopsy in severe cases.""]","[""Diagnosing iron-deficiency anemia involves blood tests such as complete blood count (CBC), serum ferritin, and iron studies.""]","[""Iron deficiency anemia (IDA) can be diagnosed through blood tests such as complete blood count (CBC), serum ferritin level, iron level, and transferrin saturation. A bone marrow biopsy may also be performed in some cases.""]",[true],[true],[true],"[""Diagnosing Iron Deficiency Anemia (IDA) involves performing blood tests such as complete blood count (CBC), serum ferritin levels, iron levels, and transferrin saturation. A physical examination and medical history review are also important in the diagnostic process.""]","[""Diagnosing iron-deficiency anemia involves blood tests such as complete blood count (CBC), serum ferritin, and iron studies.""]","[""Diagnosing iron deficiency anemia (IDA) involves a physical exam, blood tests to check iron levels, ferritin levels, and complete blood count (CBC), as well as possibly other tests such as a stool test or bone marrow biopsy.""]",[true],[true],[true],"[""Diagnosing IDA involves conducting blood tests such as complete blood count (CBC), serum ferritin levels, iron studies, and possibly a bone marrow biopsy in severe cases.""]","[""Diagnosing iron-deficiency anemia involves blood tests such as complete blood count (CBC), serum ferritin level, and iron studies.""]","[""Diagnosing iron deficiency anemia (IDA) involves a physical exam, blood tests to check for low levels of iron, hemoglobin, and ferritin, as well as other tests to determine the underlying cause of the anemia.""]",[true],[true],[true],"[""Diagnosing IDA involves blood tests such as complete blood count (CBC), serum ferritin levels, iron studies, and possibly a bone marrow biopsy in severe cases.""]","[""Diagnosing iron-deficiency anemia involves blood tests such as complete blood count (CBC), serum ferritin level, and iron studies.""]","[""Diagnosing iron deficiency anemia (IDA) involves a physical exam, blood tests to check iron levels, ferritin levels, and complete blood count (CBC), as well as possibly other tests like a stool test or bone marrow biopsy.""]",[true],[true],[true],"[""Diagnosing IDA involves blood tests such as complete blood count (CBC), serum ferritin level, iron level, and transferrin saturation.""]","[""Diagnosing iron-deficiency anemia involves blood tests such as complete blood count (CBC), serum ferritin, and iron studies.""]","[""Diagnosing iron deficiency anemia (IDA) involves a physical exam, blood tests to check iron levels, ferritin levels, and complete blood count (CBC), as well as possibly other tests such as a stool test or bone marrow biopsy.""]",[true],[true],[true],"[""Diagnosing IDA involves blood tests such as complete blood count (CBC), serum ferritin level, iron level, and transferrin saturation.""]","[""Diagnosing iron-deficiency anemia involves blood tests such as complete blood count (CBC), serum ferritin, and iron studies.""]","[""Iron deficiency anemia (IDA) can be diagnosed through blood tests such as complete blood count (CBC), serum ferritin level, iron level, and transferrin saturation. A bone marrow biopsy may also be performed in some cases.""]",[true],[true],[true],"[""Diagnosing IDA involves blood tests such as complete blood count (CBC), serum ferritin level, iron level, and transferrin saturation.""]","[""Diagnosing iron-deficiency anemia involves blood tests such as complete blood count (CBC), serum ferritin level, and iron studies.""]","[""Diagnosing iron deficiency anemia (IDA) involves a physical exam, blood tests to check for low levels of iron, hemoglobin, and ferritin, as well as other tests to determine the underlying cause of the anemia.""]",[true],[true],[true],"[""Diagnosing IDA involves blood tests such as complete blood count (CBC), serum ferritin level, iron level, and transferrin saturation.""]","[""Diagnosing iron-deficiency anemia involves blood tests such as complete blood count (CBC), serum ferritin level, and iron studies.""]","[""Diagnosing iron deficiency anemia (IDA) involves a physical exam, blood tests to check iron levels, ferritin levels, and complete blood count (CBC), as well as possibly other tests like a stool test or bone marrow biopsy.""]",[true],[true],[true],"[""Diagnosing IDA involves a physical exam, blood tests (complete blood count, ferritin, iron levels), and sometimes additional tests like a bone marrow biopsy.""]","[""Diagnosing iron-deficiency anemia involves blood tests such as complete blood count (CBC), serum ferritin, and iron studies.""]","[""Diagnosing iron deficiency anemia (IDA) involves a physical exam, blood tests to check iron levels, ferritin levels, and complete blood count (CBC), as well as possibly other tests such as a stool test or bone marrow biopsy.""]",[true],[true],[true],"[""Diagnosing Iron Deficiency Anemia (IDA) involves a physical exam, blood tests to check hemoglobin and ferritin levels, and possibly additional tests like a complete blood count (CBC) and iron studies.""]","[""Diagnosing iron-deficiency anemia involves blood tests such as complete blood count (CBC), serum ferritin, and iron studies.""]","[""Iron deficiency anemia (IDA) can be diagnosed through blood tests such as complete blood count (CBC), serum ferritin level, iron level, and transferrin saturation. A bone marrow biopsy may also be performed in some cases.""]",[true],[true],[true],"[""Diagnosing Iron Deficiency Anemia (IDA) involves conducting blood tests such as complete blood count (CBC), serum ferritin levels, iron levels, and transferrin saturation. A physical examination and medical history review are also important steps in the diagnostic process.""]","[""Diagnosing iron-deficiency anemia involves blood tests such as complete blood count (CBC), serum ferritin level, and iron studies.""]","[""Diagnosing iron deficiency anemia (IDA) involves a physical exam, blood tests to check for low levels of iron, hemoglobin, and ferritin, as well as other tests to determine the underlying cause of the anemia.""]",[true],[true],[true],"[""Diagnosing IDA involves a physical exam, blood tests (complete blood count, iron studies), and possibly additional tests like a bone marrow biopsy.""]","[""Diagnosing iron-deficiency anemia involves blood tests such as complete blood count (CBC), serum ferritin level, and iron studies.""]","[""Diagnosing iron deficiency anemia (IDA) involves a physical exam, blood tests to check iron levels, ferritin levels, and complete blood count (CBC), as well as possibly other tests like a stool test or bone marrow biopsy.""]",[true],[true],[true],"[""Diagnosing IDA involves blood tests such as complete blood count (CBC), serum ferritin level, iron studies, and peripheral blood smear.""]","[""Diagnosing iron-deficiency anemia involves blood tests such as complete blood count (CBC), serum ferritin, and iron studies.""]","[""Diagnosing iron deficiency anemia (IDA) involves a physical exam, blood tests to check iron levels, ferritin levels, and complete blood count (CBC), as well as possibly other tests such as a stool test or bone marrow biopsy.""]",[true],[true],[true],"[""Diagnosing Iron Deficiency Anemia (IDA) involves performing blood tests such as complete blood count (CBC), serum ferritin, iron levels, and transferrin saturation. A physical examination and medical history review are also important in the diagnostic process.""]","[""Diagnosing iron-deficiency anemia involves blood tests such as complete blood count (CBC), serum ferritin, and iron studies.""]","[""Iron deficiency anemia (IDA) can be diagnosed through blood tests such as complete blood count (CBC), serum ferritin level, iron level, and transferrin saturation. A bone marrow biopsy may also be performed in some cases.""]",[true],[true],[true],"[""Diagnosing IDA involves blood tests such as complete blood count (CBC), serum ferritin level, iron level, and transferrin saturation.""]","[""Diagnosing iron-deficiency anemia involves blood tests such as complete blood count (CBC), serum ferritin level, and iron studies.""]","[""Diagnosing iron deficiency anemia (IDA) involves a physical exam, blood tests to check for low levels of iron, hemoglobin, and ferritin, as well as other tests to determine the underlying cause of the anemia.""]",[true],[true],[true],"[""Diagnosing IDA involves a physical exam, blood tests (complete blood count, iron studies), and possibly further tests like bone marrow biopsy.""]","[""Diagnosing iron-deficiency anemia involves blood tests such as complete blood count (CBC), serum ferritin level, and iron studies.""]","[""Diagnosing iron deficiency anemia (IDA) involves a physical exam, blood tests to check iron levels, ferritin levels, and complete blood count (CBC), as well as possibly other tests like a stool test or bone marrow biopsy.""]",[true],[true],[true],"[""Diagnosing IDA involves a physical exam, blood tests (complete blood count, ferritin, iron levels), and possibly other tests like a bone marrow biopsy.""]","[""Diagnosing iron-deficiency anemia involves blood tests such as complete blood count (CBC), serum ferritin, and iron studies.""]","[""Diagnosing iron deficiency anemia (IDA) involves a physical exam, blood tests to check iron levels, ferritin levels, and complete blood count (CBC), as well as possibly other tests such as a stool test or bone marrow biopsy.""]",[true],[true],[true],"[""Diagnosing IDA involves a physical exam, blood tests (complete blood count, serum ferritin, iron levels), and possibly additional tests like a bone marrow biopsy.""]","[""Diagnosing iron-deficiency anemia involves blood tests such as complete blood count (CBC), serum ferritin, and iron studies.""]","[""Iron deficiency anemia (IDA) can be diagnosed through blood tests such as complete blood count (CBC), serum ferritin level, iron level, and transferrin saturation. A bone marrow biopsy may also be performed in some cases.""]",[true],[true],[true],"[""Diagnosing IDA involves a physical exam, blood tests (complete blood count, serum ferritin, iron levels), and possibly additional tests like a bone marrow biopsy.""]","[""Diagnosing iron-deficiency anemia involves blood tests such as complete blood count (CBC), serum ferritin level, and iron studies.""]","[""Diagnosing iron deficiency anemia (IDA) involves a physical exam, blood tests to check for low levels of iron, hemoglobin, and ferritin, as well as other tests to determine the underlying cause of the anemia.""]",[true],[true],[true],"[""Diagnosing IDA involves a physical exam, blood tests (complete blood count, serum ferritin, iron levels), and possibly additional tests like a bone marrow biopsy.""]","[""Diagnosing iron-deficiency anemia involves blood tests such as complete blood count (CBC), serum ferritin level, and iron studies.""]","[""Diagnosing iron deficiency anemia (IDA) involves a physical exam, blood tests to check iron levels, ferritin levels, and complete blood count (CBC), as well as possibly other tests like a stool test or bone marrow biopsy.""]",[true],[true],[true],"[""Diagnosing IDA involves blood tests such as complete blood count (CBC), serum ferritin level, iron level, and transferrin saturation.""]","[""Diagnosing iron-deficiency anemia involves blood tests such as complete blood count (CBC), serum ferritin, and iron studies.""]","[""Diagnosing iron deficiency anemia (IDA) involves a physical exam, blood tests to check iron levels, ferritin levels, and complete blood count (CBC), as well as possibly other tests such as a stool test or bone marrow biopsy.""]",[true],[true],[true],"[""Diagnosing IDA involves blood tests such as complete blood count (CBC), serum ferritin level, iron level, and transferrin saturation.""]","[""Diagnosing iron-deficiency anemia involves blood tests such as complete blood count (CBC), serum ferritin, and iron studies.""]","[""Diagnosing iron deficiency anemia (IDA) involves a physical exam, blood tests to check iron levels, ferritin levels, and complete blood count (CBC), as well as possibly other tests such as a stool test or bone marrow biopsy.""]",[false],[true],[true],"[""Consult with a financial professional or regulatory authority for guidance on diagnosing issues related to the Investment Dealers Association (IDA).""]","[""Diagnosing iron-deficiency anemia involves blood tests such as complete blood count (CBC), serum ferritin, and iron studies.""]","[""Diagnosing iron deficiency anemia (IDA) involves a physical exam, blood tests to check iron levels, ferritin levels, and complete blood count (CBC), as well as possibly other tests such as a stool test or bone marrow biopsy.""]",[true],[true],[true],"[""Diagnosing IDA involves blood tests such as complete blood count (CBC), serum ferritin level, iron level, and transferrin saturation.""]","[""Diagnosing iron-deficiency anemia involves blood tests such as complete blood count (CBC), serum ferritin, and iron studies.""]","[""Diagnosing iron deficiency anemia (IDA) involves a physical exam, blood tests to check iron levels, ferritin levels, and complete blood count (CBC), as well as possibly other tests such as a stool test or bone marrow biopsy.""]"
inheritance,Is idiopathic pulmonary fibrosis inherited ?,"Most cases of idiopathic pulmonary fibrosis are sporadic; they occur in people with no history of the disorder in their family.  Familial pulmonary fibrosis appears to have an autosomal dominant pattern of inheritance. Autosomal dominant inheritance means one copy of an altered gene in each cell is sufficient to cause the disorder. However, some people who inherit the altered gene never develop features of familial pulmonary fibrosis. (This situation is known as reduced penetrance.) It is unclear why some people with a mutated gene develop the disease and other people with the mutated gene do not.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""IPF"", ""full_form"": ""idiopathic pulmonary fibrosis""}]}",Is IPF inherited ?,Is idiopathic pulmonary fibrosis inherited ?,8,MEDICAL,Simple Datatype-Boolean,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Idiopathic Pulmonary Fibrosis"", ""Itanium Processor Family"", ""Invalid Page Fault"", ""International Penfriends"", ""Integrated Processing Facility"", ""Initial Production Facilities"", ""In Print Forever"", ""Individual Protein File"", ""Imagery Processing Facility"", ""Interchangeable Preservation Format""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Idiopathic Pulmonary Fibrosis""]",[6.567243203357728e-11],[6.567243203357728e-11],"[""Idiopathic Pulmonary Fibrosis""]",[6.567243203357728e-11],"[""ABBREVIATIONS""]","[[6.567243203357728e-11, 3.0580649118417526e-23, 4.6507765534694764e-17, 7.242604265265851e-18, 1.9452062515840634e-17, 2.955805474803208e-16, 3.217881983345434e-14, 1.1403031906343791e-17, 2.7532221607854675e-20, 1.3440687217625125e-19]]",[0.9294929562807632],[0.926382143567668],"[""idiopathic pulmonary fibrosis""]",[0.926382143567668],"[""ABBREVIATIONS""]","[[0.926382143567668, 0.6102698984037156, 0.7052086045387348, 0.8002945068355263, 0.6627230323499951, 0.6353679984409198, 0.7987784053967657, 0.7041421136056123, 0.6170274074823328, 0.5887210038697521]]","[""Idiopathic Pulmonary Fibrosis""]","[""ABBREVIATIONS""]",Is IPF (Idiopathic Pulmonary Fibrosis) inherited ?,[false],[true],[true],"[""No""]","[""Idiopathic pulmonary fibrosis is not typically inherited, but there can be a genetic predisposition in some cases.""]","[""Yes, IPF can be inherited in some cases.""]",[false],[false],[true],"[""No""]","[""No""]","[""Yes, IPF can be inherited in some cases.""]",[false],[false],[true],"[""No""]","[""No""]","[""Yes, IPF can be inherited in some cases.""]",[false],[false],[true],"[""No""]","[""No""]","[""Yes, IPF can be inherited in some cases.""]",[false],[true],[true],"[""No""]","[""Idiopathic pulmonary fibrosis is not typically inherited, but there can be a genetic predisposition in some cases.""]","[""Yes, IPF can be inherited in some cases.""]",[false],[false],[true],"[""No""]","[""No""]","[""Yes, IPF can be inherited in some cases.""]",[false],[false],[true],"[""No""]","[""No""]","[""Yes, IPF can be inherited in some cases.""]",[false],[false],[true],"[""No""]","[""No""]","[""Yes, IPF can be inherited in some cases.""]",[false],[false],[true],"[""No""]","[""No""]","[""Yes, IPF can be inherited in some cases.""]",[false],[true],[true],"[""No""]","[""Idiopathic pulmonary fibrosis is not typically inherited, but there can be a genetic predisposition in some cases.""]","[""Yes, IPF can be inherited in some cases.""]",[false],[false],[true],"[""No""]","[""No""]","[""Yes, IPF can be inherited in some cases.""]",[false],[false],[true],"[""No""]","[""No""]","[""Yes, IPF can be inherited in some cases.""]",[false],[true],[true],"[""No""]","[""Idiopathic pulmonary fibrosis is not typically inherited, but there can be a genetic predisposition in some cases.""]","[""Yes, IPF can be inherited in some cases.""]",[false],[false],[true],"[""No""]","[""No""]","[""Yes, IPF can be inherited in some cases.""]",[true],[false],[true],"[""Yes, there can be a genetic predisposition for IPF, but it is not directly inherited in a simple Mendelian pattern.""]","[""No""]","[""Yes, IPF can be inherited in some cases.""]",[false],[false],[true],"[""No""]","[""No""]","[""Yes, IPF can be inherited in some cases.""]",[false],[true],[true],"[""No""]","[""Idiopathic pulmonary fibrosis is not typically inherited, but there can be a genetic predisposition in some cases.""]","[""Yes, IPF can be inherited in some cases.""]",[false],[false],[true],"[""No""]","[""No""]","[""Yes, IPF can be inherited in some cases.""]",[false],[false],[true],"[""No""]","[""No""]","[""Yes, IPF can be inherited in some cases.""]",[false],[false],[true],"[""No""]","[""No""]","[""Yes, IPF can be inherited in some cases.""]",[false],[true],[true],"[""No""]","[""Idiopathic pulmonary fibrosis is not typically inherited, but there can be a genetic predisposition in some cases.""]","[""Yes, IPF can be inherited in some cases.""]",[false],[false],[true],"[""No""]","[""No""]","[""Yes, IPF can be inherited in some cases.""]",[false],[false],[true],"[""No""]","[""No""]","[""Yes, IPF can be inherited in some cases.""]",[false],[false],[true],"[""No""]","[""No""]","[""Yes, IPF can be inherited in some cases.""]",[true],[true],[true],"[""Idiopathic Pulmonary Fibrosis (IPF) is not inherited, but it is believed to be caused by a combination of genetic and environmental factors.""]","[""Idiopathic pulmonary fibrosis is not typically inherited, but there can be a genetic predisposition in some cases.""]","[""Yes, IPF can be inherited in some cases.""]",[true],[false],[true],"[""IPF is not typically inherited, but there may be a genetic predisposition in some cases.""]","[""No""]","[""Yes, IPF can be inherited in some cases.""]",[true],[false],[true],"[""IPF is not typically inherited, but some cases may have a genetic component.""]","[""No""]","[""Yes, IPF can be inherited in some cases.""]",[true],[false],[true],"[""IPF is not inherited, but there may be a genetic predisposition in some cases.""]","[""No""]","[""Yes, IPF can be inherited in some cases.""]",[false],[true],[true],"[""No, IPF is not inherited.""]","[""Idiopathic pulmonary fibrosis is not typically inherited, but there can be a genetic predisposition in some cases.""]","[""Yes, IPF can be inherited in some cases.""]",[false],[true],[true],"[""No, IPF is not inherited.""]","[""Idiopathic pulmonary fibrosis is not typically inherited, but there can be a genetic predisposition in some cases.""]","[""Yes, IPF can be inherited in some cases.""]",[true],[true],[true],"[""IPF is not typically inherited, but there can be a genetic predisposition in some cases.""]","[""Idiopathic pulmonary fibrosis is not typically inherited, but there can be a genetic predisposition in some cases.""]","[""Yes, IPF can be inherited in some cases.""]",[false],[true],[true],"[""No, IPF is not inherited.""]","[""Idiopathic pulmonary fibrosis is not typically inherited, but there can be a genetic predisposition in some cases.""]","[""Yes, IPF can be inherited in some cases.""]"
considerations,What to do for Renal Artery Stenosis ?,"Limiting intake of fats, cholesterol, sodium, and sugar can help prevent atherosclerosis, which can lead to RAS. Most sodium in the diet comes from salt. A healthy diet that prevents people from becoming overweight or obese can also help prevent atherosclerosis. People with RAS that has caused decreased kidney function should limit their intake of protein, cholesterol, sodium, and potassium to slow the progression of kidney failure. More information about nutrition for CKD is provided in the NIDDK health topics, Nutrition for Early Chronic Kidney Disease in Adults and Nutrition for Advanced Chronic Kidney Disease in Adults. People should talk with their health care provider about what diet is right for them.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""RAS"", ""full_form"": ""Renal Artery Stenosis""}]}",What to do for RAS ?,What to do for Renal Artery Stenosis ?,0,SCIENCE,Simple Datatype-String,"Instructional: Queries specifically seeking step-by-step guidance, instructions, or procedures to perform a task. it focuses on 'how' to do something rather than 'what', 'why', or 'which'.","[[""Russian Academy Of Sciences"", ""Royal Astronomical Society"", ""Remote Access Service"", ""Remote Access Server"", ""Reliability Availability And Serviceability"", ""Remote Access Services"", ""Renal Artery Stenosis"", ""Renin Angiotensin System"", ""Reticular Activating System"", ""River Analysis System""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Renin-Angiotensin System""]",[1.2204693686834715e-08],[3.728786179912015e-21],"[""Renal Artery Stenosis""]",[1.2204693686834715e-08],"[""ABBREVIATIONS""]","[[7.700698965684153e-14, 6.69740649502028e-20, 6.214025972268786e-13, 1.354905864861548e-13, 1.03205073593317e-21, 3.978501387256308e-13, 1.2204693686834715e-08, 7.744035745857502e-21, 1.0311222050292054e-12, 2.9303571943113207e-13]]",[0.7111803679800963],[0.7589015870303899],"[""Renin Angiotensin System""]",[0.8077105608552024],"[""ABBREVIATIONS""]","[[0.6406909986946104, 0.6116341802168477, 0.72697002650953, 0.697664815367584, 0.6484422016804233, 0.7169415459390883, 0.7111803679800963, 0.7623464505024372, 0.8077105608552024, 0.704546931917378]]","[""Renin Angiotensin System""]","[""ABBREVIATIONS""]",What to do for RAS (Renin-Angiotensin System) ?,[true],[true],[false],"[""Treatment for Renal Artery Stenosis (RAS) may include medications to control blood pressure and cholesterol, lifestyle changes such as a healthy diet and exercise, and in some cases, procedures like angioplasty or surgery to improve blood flow to the kidneys.""]","[""Treatment options for Renal Artery Stenosis include medications, lifestyle changes, and in severe cases, procedures like angioplasty or surgery.""]","[""RAS (Rapid Amplification of cDNA Ends) is a technique used to amplify the ends of RNA molecules. To perform RAS, you will need to follow these steps: 1. Design gene-specific primers for the target RNA sequence. 2. Synthesize cDNA using reverse transcriptase. 3. Perform PCR using the gene-specific primer and a primer complementary to the adapter sequence. 4. Analyze the amplified products to determine the sequence of the RNA ends.""]",[true],[true],[false],"[""Treatment options for RAS include medications, angioplasty, stenting, or surgery depending on the severity and individual patient factors.""]","[""Treatment options for Renal Artery Stenosis include medications, lifestyle changes, and procedures like angioplasty or surgery.""]","[""RAS (Rapid Amplification of cDNA Ends) is a technique used to amplify the ends of a cDNA molecule. To perform RAS, you will need to follow these steps: 1. Design gene-specific primers for the target cDNA sequence. 2. Synthesize cDNA using reverse transcriptase. 3. Perform PCR using the gene-specific primers and a poly-A tailing method. 4. Analyze the amplified products to determine the sequence of the cDNA ends.""]",[true],[true],[false],"[""Treatment options for Renal Artery Stenosis (RAS) include medications to control blood pressure and cholesterol, lifestyle changes such as a healthy diet and exercise, and in some cases, procedures like angioplasty or surgery to improve blood flow to the kidneys.""]","[""Treatment options for Renal Artery Stenosis include medications, angioplasty, stenting, or surgery depending on the severity of the condition.""]","[""RAS (Rapid Amplification of cDNA Ends) is a technique used to amplify the ends of a cDNA molecule. To perform RAS, you will need to follow these steps: 1. Design gene-specific primers for the target cDNA sequence. 2. Synthesize cDNA using reverse transcriptase. 3. Perform PCR using the gene-specific primer and a primer that anneals to the known sequence. 4. Amplify the cDNA ends through PCR. 5. Analyze the amplified products to obtain the full-length cDNA sequence.""]",[true],[true],[false],"[""Treatment options for Renal Artery Stenosis (RAS) include medications to control blood pressure and cholesterol, lifestyle changes such as a healthy diet and exercise, and in some cases, procedures like angioplasty or surgery to improve blood flow to the kidneys.""]","[""Treatment options for Renal Artery Stenosis include medications, lifestyle changes, and procedures like angioplasty or stent placement.""]","[""To activate the RAS (Reticular Activating System), you can try setting clear goals, visualizing your desired outcomes, practicing mindfulness, and focusing on positive affirmations.""]",[false],[true],[false],"[""To target the Renin Angiotensin System, one can use ACE inhibitors, ARBs, or direct renin inhibitors as pharmacological interventions.""]","[""Treatment options for Renal Artery Stenosis include medications, lifestyle changes, and in severe cases, procedures like angioplasty or surgery.""]","[""RAS (Rapid Amplification of cDNA Ends) is a technique used to amplify the ends of RNA molecules. To perform RAS, you will need to follow these steps: 1. Design gene-specific primers for the target RNA sequence. 2. Synthesize cDNA using reverse transcriptase. 3. Perform PCR using the gene-specific primer and a primer complementary to the adapter sequence. 4. Analyze the amplified products to determine the sequence of the RNA ends.""]",[false],[true],[false],"[""To target the Renin Angiotensin System, you can use ACE inhibitors, ARBs, or direct renin inhibitors as pharmacological interventions.""]","[""Treatment options for Renal Artery Stenosis include medications, lifestyle changes, and procedures like angioplasty or surgery.""]","[""RAS (Rapid Amplification of cDNA Ends) is a technique used to amplify the ends of a cDNA molecule. To perform RAS, you will need to follow these steps: 1. Design gene-specific primers for the target cDNA sequence. 2. Synthesize cDNA using reverse transcriptase. 3. Perform PCR using the gene-specific primers and a poly-A tailing method. 4. Analyze the amplified products to determine the sequence of the cDNA ends.""]",[false],[true],[false],"[""To target the Renin Angiotensin System, one can use ACE inhibitors, ARBs, or direct renin inhibitors to regulate blood pressure and fluid balance.""]","[""Treatment options for Renal Artery Stenosis include medications, angioplasty, stenting, or surgery depending on the severity of the condition.""]","[""RAS (Rapid Amplification of cDNA Ends) is a technique used to amplify the ends of a cDNA molecule. To perform RAS, you will need to follow these steps: 1. Design gene-specific primers for the target cDNA sequence. 2. Synthesize cDNA using reverse transcriptase. 3. Perform PCR using the gene-specific primer and a primer that anneals to the known sequence. 4. Amplify the cDNA ends through PCR. 5. Analyze the amplified products to obtain the full-length cDNA sequence.""]",[false],[true],[false],"[""To target the Renin Angiotensin System (RAS), one can use ACE inhibitors, ARBs, or direct renin inhibitors to regulate blood pressure and fluid balance.""]","[""Treatment options for Renal Artery Stenosis include medications, lifestyle changes, and procedures like angioplasty or stent placement.""]","[""To activate the RAS (Reticular Activating System), you can try setting clear goals, visualizing your desired outcomes, practicing mindfulness, and focusing on positive affirmations.""]",[false],[true],[false],"[""To target the Renin Angiotensin System, medications like ACE inhibitors, ARBs, and direct renin inhibitors can be used to regulate blood pressure and treat conditions like hypertension and heart failure.""]","[""Treatment options for Renal Artery Stenosis include medications, lifestyle changes, and procedures like angioplasty or surgery.""]","[""RAS (Rapid Amplification of cDNA Ends) is a technique used to amplify the ends of a cDNA molecule. To perform RAS, you will need to follow these steps: 1. Design gene-specific primers for the target cDNA sequence. 2. Synthesize cDNA using reverse transcriptase. 3. Perform PCR using the gene-specific primers and a poly-A tailing method. 4. Analyze the amplified products to determine the sequence of the cDNA ends.""]",[false],[true],[false],"[""To target the Renin Angiotensin System, medications like ACE inhibitors, ARBs, and direct renin inhibitors can be used to regulate blood pressure and fluid balance.""]","[""Treatment options for Renal Artery Stenosis include medications, lifestyle changes, and in severe cases, procedures like angioplasty or surgery.""]","[""RAS (Rapid Amplification of cDNA Ends) is a technique used to amplify the ends of RNA molecules. To perform RAS, you will need to follow these steps: 1. Design gene-specific primers for the target RNA sequence. 2. Synthesize cDNA using reverse transcriptase. 3. Perform PCR using the gene-specific primer and a primer complementary to the adapter sequence. 4. Analyze the amplified products to determine the sequence of the RNA ends.""]",[false],[true],[false],"[""To target the Renin Angiotensin System, one can use ACE inhibitors, ARBs, or direct renin inhibitors to regulate blood pressure and fluid balance.""]","[""Treatment options for Renal Artery Stenosis include medications, angioplasty, stenting, or surgery depending on the severity of the condition.""]","[""RAS (Rapid Amplification of cDNA Ends) is a technique used to amplify the ends of a cDNA molecule. To perform RAS, you will need to follow these steps: 1. Design gene-specific primers for the target cDNA sequence. 2. Synthesize cDNA using reverse transcriptase. 3. Perform PCR using the gene-specific primer and a primer that anneals to the known sequence. 4. Amplify the cDNA ends through PCR. 5. Analyze the amplified products to obtain the full-length cDNA sequence.""]",[false],[true],[false],"[""Inhibit the RAS by using ACE inhibitors or ARBs to treat conditions like hypertension and heart failure.""]","[""Treatment options for Renal Artery Stenosis include medications, lifestyle changes, and procedures like angioplasty or stent placement.""]","[""To activate the RAS (Reticular Activating System), you can try setting clear goals, visualizing your desired outcomes, practicing mindfulness, and focusing on positive affirmations.""]",[false],[true],[false],"[""RAS (Renin Angiotensin System) can be targeted using ACE inhibitors or ARBs to regulate blood pressure and fluid balance.""]","[""Treatment options for Renal Artery Stenosis include medications, lifestyle changes, and in severe cases, procedures like angioplasty or surgery.""]","[""RAS (Rapid Amplification of cDNA Ends) is a technique used to amplify the ends of RNA molecules. To perform RAS, you will need to follow these steps: 1. Design gene-specific primers for the target RNA sequence. 2. Synthesize cDNA using reverse transcriptase. 3. Perform PCR using the gene-specific primer and a primer complementary to the adapter sequence. 4. Analyze the amplified products to determine the sequence of the RNA ends.""]",[false],[true],[false],"[""RAS (Renin Angiotensin System) can be targeted using ACE inhibitors or ARBs to regulate blood pressure and fluid balance.""]","[""Treatment options for Renal Artery Stenosis include medications, lifestyle changes, and procedures like angioplasty or surgery.""]","[""RAS (Rapid Amplification of cDNA Ends) is a technique used to amplify the ends of a cDNA molecule. To perform RAS, you will need to follow these steps: 1. Design gene-specific primers for the target cDNA sequence. 2. Synthesize cDNA using reverse transcriptase. 3. Perform PCR using the gene-specific primers and a poly-A tailing method. 4. Analyze the amplified products to determine the sequence of the cDNA ends.""]",[false],[true],[false],"[""RAS (Renin Angiotensin System) can be targeted with medications such as ACE inhibitors, ARBs, and direct renin inhibitors to regulate blood pressure and fluid balance.""]","[""Treatment options for Renal Artery Stenosis include medications, angioplasty, stenting, or surgery depending on the severity of the condition.""]","[""RAS (Rapid Amplification of cDNA Ends) is a technique used to amplify the ends of a cDNA molecule. To perform RAS, you will need to follow these steps: 1. Design gene-specific primers for the target cDNA sequence. 2. Synthesize cDNA using reverse transcriptase. 3. Perform PCR using the gene-specific primer and a primer that anneals to the known sequence. 4. Amplify the cDNA ends through PCR. 5. Analyze the amplified products to obtain the full-length cDNA sequence.""]",[false],[true],[false],"[""RAS (Renin Angiotensin System) can be targeted for the treatment of hypertension and heart failure by using ACE inhibitors or ARBs.""]","[""Treatment options for Renal Artery Stenosis include medications, lifestyle changes, and procedures like angioplasty or stent placement.""]","[""To activate the RAS (Reticular Activating System), you can try setting clear goals, visualizing your desired outcomes, practicing mindfulness, and focusing on positive affirmations.""]",[false],[true],[false],"[""To target the Renin Angiotensin System, medications such as ACE inhibitors or ARBs can be used to regulate blood pressure and treat conditions like hypertension and heart failure.""]","[""Treatment options for Renal Artery Stenosis include medications, lifestyle changes, and in severe cases, procedures like angioplasty or surgery.""]","[""RAS (Rapid Amplification of cDNA Ends) is a technique used to amplify the ends of RNA molecules. To perform RAS, you will need to follow these steps: 1. Design gene-specific primers for the target RNA sequence. 2. Synthesize cDNA using reverse transcriptase. 3. Perform PCR using the gene-specific primer and a primer complementary to the adapter sequence. 4. Analyze the amplified products to determine the sequence of the RNA ends.""]",[false],[true],[false],"[""To target the Renin Angiotensin System, one can use ACE inhibitors, ARBs, or direct renin inhibitors as pharmacological interventions.""]","[""Treatment options for Renal Artery Stenosis include medications, lifestyle changes, and procedures like angioplasty or surgery.""]","[""RAS (Rapid Amplification of cDNA Ends) is a technique used to amplify the ends of a cDNA molecule. To perform RAS, you will need to follow these steps: 1. Design gene-specific primers for the target cDNA sequence. 2. Synthesize cDNA using reverse transcriptase. 3. Perform PCR using the gene-specific primers and a poly-A tailing method. 4. Analyze the amplified products to determine the sequence of the cDNA ends.""]",[false],[true],[false],"[""To target the Renin Angiotensin System, one can use ACE inhibitors, ARBs, or direct renin inhibitors as pharmacological interventions.""]","[""Treatment options for Renal Artery Stenosis include medications, angioplasty, stenting, or surgery depending on the severity of the condition.""]","[""RAS (Rapid Amplification of cDNA Ends) is a technique used to amplify the ends of a cDNA molecule. To perform RAS, you will need to follow these steps: 1. Design gene-specific primers for the target cDNA sequence. 2. Synthesize cDNA using reverse transcriptase. 3. Perform PCR using the gene-specific primer and a primer that anneals to the known sequence. 4. Amplify the cDNA ends through PCR. 5. Analyze the amplified products to obtain the full-length cDNA sequence.""]",[false],[true],[false],"[""To target the Renin Angiotensin System, one can use ACE inhibitors, ARBs, or direct renin inhibitors to regulate blood pressure and fluid balance.""]","[""Treatment options for Renal Artery Stenosis include medications, lifestyle changes, and procedures like angioplasty or stent placement.""]","[""To activate the RAS (Reticular Activating System), you can try setting clear goals, visualizing your desired outcomes, practicing mindfulness, and focusing on positive affirmations.""]",[false],[true],[false],"[""To target the Renin-Angiotensin System, one can use ACE inhibitors, ARBs, or direct renin inhibitors.""]","[""Treatment options for Renal Artery Stenosis include medications, lifestyle changes, and in severe cases, procedures like angioplasty or surgery.""]","[""RAS (Rapid Amplification of cDNA Ends) is a technique used to amplify the ends of RNA molecules. To perform RAS, you will need to follow these steps: 1. Design gene-specific primers for the target RNA sequence. 2. Synthesize cDNA using reverse transcriptase. 3. Perform PCR using the gene-specific primer and a primer complementary to the adapter sequence. 4. Analyze the amplified products to determine the sequence of the RNA ends.""]",[false],[true],[false],"[""To target the Renin-Angiotensin System, one can use ACE inhibitors, ARBs, or direct renin inhibitors to regulate blood pressure and fluid balance.""]","[""Treatment options for Renal Artery Stenosis include medications, lifestyle changes, and procedures like angioplasty or surgery.""]","[""RAS (Rapid Amplification of cDNA Ends) is a technique used to amplify the ends of a cDNA molecule. To perform RAS, you will need to follow these steps: 1. Design gene-specific primers for the target cDNA sequence. 2. Synthesize cDNA using reverse transcriptase. 3. Perform PCR using the gene-specific primers and a poly-A tailing method. 4. Analyze the amplified products to determine the sequence of the cDNA ends.""]",[true],[true],[false],"[""To target the Renin-Angiotensin System, one can use ACE inhibitors, ARBs, or direct renin inhibitors as pharmacological interventions.""]","[""Treatment options for Renal Artery Stenosis include medications, angioplasty, stenting, or surgery depending on the severity of the condition.""]","[""RAS (Rapid Amplification of cDNA Ends) is a technique used to amplify the ends of a cDNA molecule. To perform RAS, you will need to follow these steps: 1. Design gene-specific primers for the target cDNA sequence. 2. Synthesize cDNA using reverse transcriptase. 3. Perform PCR using the gene-specific primer and a primer that anneals to the known sequence. 4. Amplify the cDNA ends through PCR. 5. Analyze the amplified products to obtain the full-length cDNA sequence.""]",[false],[true],[false],"[""To target the Renin-Angiotensin System, one can use ACE inhibitors, ARBs, or direct renin inhibitors to regulate blood pressure and fluid balance.""]","[""Treatment options for Renal Artery Stenosis include medications, lifestyle changes, and procedures like angioplasty or stent placement.""]","[""To activate the RAS (Reticular Activating System), you can try setting clear goals, visualizing your desired outcomes, practicing mindfulness, and focusing on positive affirmations.""]",[true],[true],[false],"[""To regulate the Renin Angiotensin System, one can consider maintaining a healthy lifestyle, such as reducing salt intake, staying hydrated, exercising regularly, and following any prescribed medication regimen.""]","[""Treatment options for Renal Artery Stenosis include medications, lifestyle changes, and in severe cases, procedures like angioplasty or surgery.""]","[""RAS (Rapid Amplification of cDNA Ends) is a technique used to amplify the ends of RNA molecules. To perform RAS, you will need to follow these steps: 1. Design gene-specific primers for the target RNA sequence. 2. Synthesize cDNA using reverse transcriptase. 3. Perform PCR using the gene-specific primer and a primer complementary to the adapter sequence. 4. Analyze the amplified products to determine the sequence of the RNA ends.""]",[false],[true],[false],"[""To target the Renin Angiotensin System, one can use ACE inhibitors, ARBs, or direct renin inhibitors to regulate blood pressure and fluid balance.""]","[""Treatment options for Renal Artery Stenosis include medications, lifestyle changes, and procedures like angioplasty or surgery.""]","[""RAS (Rapid Amplification of cDNA Ends) is a technique used to amplify the ends of a cDNA molecule. To perform RAS, you will need to follow these steps: 1. Design gene-specific primers for the target cDNA sequence. 2. Synthesize cDNA using reverse transcriptase. 3. Perform PCR using the gene-specific primers and a poly-A tailing method. 4. Analyze the amplified products to determine the sequence of the cDNA ends.""]",[true],[true],[false],"[""To regulate the Renin Angiotensin System, one can consider lifestyle changes such as reducing salt intake, maintaining a healthy weight, exercising regularly, and avoiding excessive alcohol consumption. Additionally, medications like ACE inhibitors or ARBs may be prescribed by a healthcare provider.""]","[""Treatment options for Renal Artery Stenosis include medications, angioplasty, stenting, or surgery depending on the severity of the condition.""]","[""RAS (Rapid Amplification of cDNA Ends) is a technique used to amplify the ends of a cDNA molecule. To perform RAS, you will need to follow these steps: 1. Design gene-specific primers for the target cDNA sequence. 2. Synthesize cDNA using reverse transcriptase. 3. Perform PCR using the gene-specific primer and a primer that anneals to the known sequence. 4. Amplify the cDNA ends through PCR. 5. Analyze the amplified products to obtain the full-length cDNA sequence.""]",[false],[true],[false],"[""To target the Renin Angiotensin System, medications such as ACE inhibitors or ARBs can be used to regulate blood pressure and treat conditions like hypertension and heart failure.""]","[""Treatment options for Renal Artery Stenosis include medications, lifestyle changes, and procedures like angioplasty or stent placement.""]","[""To activate the RAS (Reticular Activating System), you can try setting clear goals, visualizing your desired outcomes, practicing mindfulness, and focusing on positive affirmations.""]",[false],[true],[false],"[""Inhibit the RAS system using ACE inhibitors or ARBs.""]","[""Treatment options for Renal Artery Stenosis include medications, lifestyle changes, and in severe cases, procedures like angioplasty or surgery.""]","[""RAS (Rapid Amplification of cDNA Ends) is a technique used to amplify the ends of RNA molecules. To perform RAS, you will need to follow these steps: 1. Design gene-specific primers for the target RNA sequence. 2. Synthesize cDNA using reverse transcriptase. 3. Perform PCR using the gene-specific primer and a primer complementary to the adapter sequence. 4. Analyze the amplified products to determine the sequence of the RNA ends.""]",[true],[true],[false],"[""Treatment options for RAS include medication, angioplasty, stenting, or surgery depending on the severity of the condition.""]","[""Treatment options for Renal Artery Stenosis include medications, lifestyle changes, and in severe cases, procedures like angioplasty or surgery.""]","[""RAS (Rapid Amplification of cDNA Ends) is a technique used to amplify the ends of RNA molecules. To perform RAS, you will need to follow these steps: 1. Design gene-specific primers for the target RNA sequence. 2. Synthesize cDNA using reverse transcriptase. 3. Perform PCR using the gene-specific primer and a primer complementary to the adapter sequence. 4. Analyze the amplified products to determine the sequence of the RNA ends.""]",[true],[true],[false],"[""RAS (Renin Angiotensin System) can be regulated through medications such as ACE inhibitors, ARBs, and direct renin inhibitors. Lifestyle changes like reducing salt intake and regular exercise can also help in managing RAS-related conditions.""]","[""Treatment options for Renal Artery Stenosis include medications, lifestyle changes, and in severe cases, procedures like angioplasty or surgery.""]","[""RAS (Rapid Amplification of cDNA Ends) is a technique used to amplify the ends of RNA molecules. To perform RAS, you will need to follow these steps: 1. Design gene-specific primers for the target RNA sequence. 2. Synthesize cDNA using reverse transcriptase. 3. Perform PCR using the gene-specific primer and a primer complementary to the adapter sequence. 4. Analyze the amplified products to determine the sequence of the RNA ends.""]",[false],[true],[false],"[""For RAS (Renin-Angiotensin System), one can consider medications like ACE inhibitors or ARBs to help regulate blood pressure and fluid balance.""]","[""Treatment options for Renal Artery Stenosis include medications, lifestyle changes, and in severe cases, procedures like angioplasty or surgery.""]","[""RAS (Rapid Amplification of cDNA Ends) is a technique used to amplify the ends of RNA molecules. To perform RAS, you will need to follow these steps: 1. Design gene-specific primers for the target RNA sequence. 2. Synthesize cDNA using reverse transcriptase. 3. Perform PCR using the gene-specific primer and a primer complementary to the adapter sequence. 4. Analyze the amplified products to determine the sequence of the RNA ends.""]"
inheritance,Is X-linked juvenile retinoschisis inherited ?,"This condition is inherited in an X-linked recessive pattern. The gene associated with this condition is located on the X chromosome, which is one of the two sex chromosomes. In males (who have only one X chromosome), one altered copy of the gene in each cell is sufficient to cause the condition. In females (who have two X chromosomes), a mutation would have to occur in both copies of the gene to cause the disorder. Because it is unlikely that females will have two altered copies of this gene, males are affected by X-linked recessive disorders much more frequently than females. A characteristic of X-linked inheritance is that fathers cannot pass X-linked traits to their sons.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""XLRS"", ""full_form"": ""X-linked juvenile retinoschisis""}]}",Is XLRS inherited ?,Is X-linked juvenile retinoschisis inherited ?,8,MEDICAL,Simple Datatype-Boolean,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""X-linked juvenile retinoschisis""]]","[[""THEFREEDICTIONARY""]]","[""X-linked Retinoschisis""]",[1.2218498627943785e-27],[8.94087947894303e-24],"[""X-linked Retinoschisis""]",[8.94087947894303e-24],"[""LLM""]",[[1.2218498627943785e-27]],[0.8912527170390105],[0.9123925854535346],"[""X-linked juvenile retinoschisis""]",[0.9123925854535346],"[""LLM""]",[[0.8912527170390105]],"[""X-linked juvenile retinoschisis""]","[""THEFREEDICTIONARY""]",Is XLRS (X-linked Retinoschisis) inherited ?,[true],[false],[true],"[""Yes, XLRS (X-linked Retinoschisis) is inherited in an X-linked recessive pattern.""]","[""Yes""]","[""Yes, X-linked retinoschisis (XLRS) is an inherited condition.""]",[true],[true],[true],"[""Yes, XLRS (X-linked Retinoschisis) is inherited.""]","[""Yes, X-linked juvenile retinoschisis is inherited in an X-linked recessive pattern.""]","[""Yes, X-linked retinoschisis (XLRS) is inherited in an X-linked recessive manner.""]",[true],[true],[true],"[""Yes, XLRS (X-linked Retinoschisis) is inherited in an X-linked recessive pattern.""]","[""Yes, X-linked juvenile retinoschisis is inherited in an X-linked recessive pattern.""]","[""Yes, X-linked retinoschisis (XLRS) is an inherited condition.""]",[true],[true],[true],"[""Yes, XLRS (X-linked Retinoschisis) is inherited as an X-linked recessive trait.""]","[""Yes, X-linked juvenile retinoschisis is an inherited condition.""]","[""Yes, X-linked retinoschisis (XLRS) is an inherited condition.""]",[true],[false],[true],"[""Yes, XLRS (X-linked juvenile retinoschisis) is inherited as an X-linked recessive genetic condition.""]","[""Yes""]","[""Yes, X-linked retinoschisis (XLRS) is an inherited condition.""]",[true],[true],[true],"[""Yes, XLRS (X-linked juvenile retinoschisis) is inherited in an X-linked recessive pattern.""]","[""Yes, X-linked juvenile retinoschisis is inherited in an X-linked recessive pattern.""]","[""Yes, X-linked retinoschisis (XLRS) is inherited in an X-linked recessive manner.""]",[true],[true],[true],"[""Yes, XLRS (X-linked juvenile retinoschisis) is inherited.""]","[""Yes, X-linked juvenile retinoschisis is inherited in an X-linked recessive pattern.""]","[""Yes, X-linked retinoschisis (XLRS) is an inherited condition.""]",[true],[true],[true],"[""Yes, XLRS (X-linked juvenile retinoschisis) is inherited in an X-linked recessive pattern.""]","[""Yes, X-linked juvenile retinoschisis is an inherited condition.""]","[""Yes, X-linked retinoschisis (XLRS) is an inherited condition.""]",[true],[true],[true],"[""Yes, XLRS (X-linked juvenile retinoschisis) is inherited.""]","[""Yes, X-linked juvenile retinoschisis is inherited in an X-linked recessive pattern.""]","[""Yes, X-linked retinoschisis (XLRS) is inherited in an X-linked recessive manner.""]",[false],[false],[true],"[""Yes""]","[""Yes""]","[""Yes, X-linked retinoschisis (XLRS) is an inherited condition.""]",[true],[true],[true],"[""Yes, XLRS (X-linked juvenile retinoschisis) is inherited.""]","[""Yes, X-linked juvenile retinoschisis is inherited in an X-linked recessive pattern.""]","[""Yes, X-linked retinoschisis (XLRS) is an inherited condition.""]",[true],[true],[true],"[""Yes, XLRS (X-linked juvenile retinoschisis) is inherited.""]","[""Yes, X-linked juvenile retinoschisis is an inherited condition.""]","[""Yes, X-linked retinoschisis (XLRS) is an inherited condition.""]",[true],[false],[true],"[""Yes, XLRS (X-linked juvenile retinoschisis) is inherited.""]","[""Yes""]","[""Yes, X-linked retinoschisis (XLRS) is an inherited condition.""]",[true],[true],[true],"[""Yes, XLRS (X-linked juvenile retinoschisis) is inherited.""]","[""Yes, X-linked juvenile retinoschisis is inherited in an X-linked recessive pattern.""]","[""Yes, X-linked retinoschisis (XLRS) is inherited in an X-linked recessive manner.""]",[true],[true],[true],"[""Yes, XLRS (X-linked juvenile retinoschisis) is inherited.""]","[""Yes, X-linked juvenile retinoschisis is inherited in an X-linked recessive pattern.""]","[""Yes, X-linked retinoschisis (XLRS) is an inherited condition.""]",[true],[true],[true],"[""Yes, XLRS is inherited.""]","[""Yes, X-linked juvenile retinoschisis is an inherited condition.""]","[""Yes, X-linked retinoschisis (XLRS) is an inherited condition.""]",[false],[false],[true],"[""Yes""]","[""Yes""]","[""Yes, X-linked retinoschisis (XLRS) is an inherited condition.""]",[true],[true],[true],"[""Yes, XLRS (X-linked juvenile retinoschisis) is inherited as an X-linked recessive genetic condition.""]","[""Yes, X-linked juvenile retinoschisis is inherited in an X-linked recessive pattern.""]","[""Yes, X-linked retinoschisis (XLRS) is inherited in an X-linked recessive manner.""]",[true],[true],[true],"[""Yes, XLRS (X-linked juvenile retinoschisis) is inherited as an X-linked recessive genetic condition.""]","[""Yes, X-linked juvenile retinoschisis is inherited in an X-linked recessive pattern.""]","[""Yes, X-linked retinoschisis (XLRS) is an inherited condition.""]",[true],[true],[true],"[""Yes, XLRS (X-linked juvenile retinoschisis) is inherited in an X-linked recessive pattern.""]","[""Yes, X-linked juvenile retinoschisis is an inherited condition.""]","[""Yes, X-linked retinoschisis (XLRS) is an inherited condition.""]",[true],[false],[true],"[""Yes, XLRS (X-linked Retinoschisis) is inherited in an X-linked recessive pattern.""]","[""Yes""]","[""Yes, X-linked retinoschisis (XLRS) is an inherited condition.""]",[true],[true],[true],"[""Yes, XLRS (X-linked Retinoschisis) is inherited in an X-linked recessive pattern.""]","[""Yes, X-linked juvenile retinoschisis is inherited in an X-linked recessive pattern.""]","[""Yes, X-linked retinoschisis (XLRS) is inherited in an X-linked recessive manner.""]",[true],[true],[true],"[""Yes, XLRS (X-linked Retinoschisis) is inherited.""]","[""Yes, X-linked juvenile retinoschisis is inherited in an X-linked recessive pattern.""]","[""Yes, X-linked retinoschisis (XLRS) is an inherited condition.""]",[true],[true],[true],"[""Yes, XLRS (X-linked Retinoschisis) is inherited in an X-linked recessive pattern.""]","[""Yes, X-linked juvenile retinoschisis is an inherited condition.""]","[""Yes, X-linked retinoschisis (XLRS) is an inherited condition.""]",[true],[false],[true],"[""XLRS (X-linked juvenile retinoschisis) is an inherited genetic disorder that affects the eyes.""]","[""Yes""]","[""Yes, X-linked retinoschisis (XLRS) is an inherited condition.""]",[true],[true],[true],"[""XLRS is inherited in an X-linked recessive pattern.""]","[""Yes, X-linked juvenile retinoschisis is inherited in an X-linked recessive pattern.""]","[""Yes, X-linked retinoschisis (XLRS) is inherited in an X-linked recessive manner.""]",[true],[true],[true],"[""Yes, XLRS (X-linked juvenile retinoschisis) is inherited.""]","[""Yes, X-linked juvenile retinoschisis is inherited in an X-linked recessive pattern.""]","[""Yes, X-linked retinoschisis (XLRS) is an inherited condition.""]",[true],[true],[true],"[""Yes, XLRS (X-linked juvenile retinoschisis) is an inherited condition caused by mutations in the RS1 gene located on the X chromosome.""]","[""Yes, X-linked juvenile retinoschisis is an inherited condition.""]","[""Yes, X-linked retinoschisis (XLRS) is an inherited condition.""]",[true],[false],[true],"[""Yes, XLRS (X-linked juvenile retinoschisis) is inherited.""]","[""Yes""]","[""Yes, X-linked retinoschisis (XLRS) is an inherited condition.""]",[true],[false],[true],"[""XLRS (X-linked Retinoschisis) is inherited in an X-linked recessive pattern.""]","[""Yes""]","[""Yes, X-linked retinoschisis (XLRS) is an inherited condition.""]",[true],[false],[true],"[""Yes, XLRS (X-linked juvenile retinoschisis) is inherited.""]","[""Yes""]","[""Yes, X-linked retinoschisis (XLRS) is an inherited condition.""]",[true],[false],[true],"[""Yes, XLRS (X-linked Retinoschisis) is inherited in an X-linked recessive pattern.""]","[""Yes""]","[""Yes, X-linked retinoschisis (XLRS) is an inherited condition.""]"
frequency,How many people are affected by isolated growth hormone deficiency ?,"The incidence of isolated growth hormone deficiency is estimated to be 1 in 4,000 to 10,000 individuals worldwide.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""IGHD"", ""full_form"": ""isolated growth hormone deficiency""}]}",How many people are affected by IGHD ?,How many people are affected by isolated growth hormone deficiency ?,8,MEDICAL,Simple Datatype-Integer,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Isolated Growth Hormone Deficiency"", ""Idiopathic Growth Hormone Deficiency"", ""Isolated Growth Hormone Deficiency""]]","[[""ACRONYMFINDER"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY""]]","[""Isolated Growth Hormone Deficiency""]",[2.579020297650253e-15],[2.579020297650253e-15],"[""Isolated Growth Hormone Deficiency""]",[2.579020297650253e-15],"[""ACRONYMFINDER""]","[[2.579020297650253e-15, 6.254822482126618e-16, 2.579020297650253e-15]]",[0.8943143515813394],[0.8950543529214541],"[""Isolated Growth Hormone Deficiency""]",[0.9072846534915722],"[""THEFREEDICTIONARY""]","[[0.8950543529214543, 0.9072846534915722, 0.8950543529214543]]","[""Isolated Growth Hormone Deficiency""]","[""ACRONYMFINDER""]",How many people are affected by IGHD (Isolated Growth Hormone Deficiency) ?,[true],[true],[false],"[""IGHD affects approximately 1 in every 4,000 to 10,000 children worldwide.""]","[""1 in every 4,000 to 10,000 children""]","[""IGHD affects approximately 1 in 30,000 to 40,000 live births.""]",[true],[false],[true],"[""IGHD affects approximately 1 in 4,000 to 1 in 10,000 children worldwide.""]","[""1 in 3,500 to 1 in 10,000 children""]","[""IGHD affects approximately 1 in 4,000 to 1 in 10,000 live births.""]",[true],[false],[true],"[""IGHD affects approximately 1 in 4,000 to 1 in 10,000 individuals.""]","[""1 in 3,500 to 1 in 10,000 children are affected by isolated growth hormone deficiency""]","[""IGHD affects approximately 1 in 4,000 to 1 in 10,000 people worldwide.""]",[true],[true],[false],"[""IGHD affects approximately 1 in 4,000 to 1 in 10,000 children worldwide.""]","[""1 in every 3,500 to 1 in every 10,000 children""]","[""IGHD affects approximately 1 in 30,000 to 40,000 live births.""]",[true],[true],[false],"[""IGHD affects approximately 1 in 4,000 to 1 in 10,000 children worldwide.""]","[""1 in every 4,000 to 10,000 children""]","[""IGHD affects approximately 1 in 30,000 to 40,000 live births.""]",[true],[false],[true],"[""IGHD affects approximately 1 in 4,000 to 1 in 10,000 children worldwide.""]","[""1 in 3,500 to 1 in 10,000 children""]","[""IGHD affects approximately 1 in 4,000 to 1 in 10,000 live births.""]",[true],[true],[true],"[""IGHD affects approximately 1 in 4,000 to 1 in 10,000 people.""]","[""1 in 3,500 to 1 in 10,000 children are affected by isolated growth hormone deficiency""]","[""IGHD affects approximately 1 in 4,000 to 1 in 10,000 people worldwide.""]",[true],[true],[false],"[""IGHD affects approximately 1 in every 4,000 to 10,000 children worldwide.""]","[""1 in every 3,500 to 1 in every 10,000 children""]","[""IGHD affects approximately 1 in 30,000 to 40,000 live births.""]",[true],[false],[true],"[""IGHD affects approximately 1 in 4,000 to 1 in 10,000 children worldwide.""]","[""1 in 3,500 to 1 in 10,000 children""]","[""IGHD affects approximately 1 in 4,000 to 1 in 10,000 live births.""]",[true],[true],[false],"[""IGHD affects approximately 1 in 4,000 to 1 in 10,000 children.""]","[""1 in every 4,000 to 10,000 children""]","[""IGHD affects approximately 1 in 30,000 to 40,000 live births.""]",[true],[true],[true],"[""IGHD affects approximately 1 in 4,000 to 1 in 10,000 children worldwide.""]","[""1 in 3,500 to 1 in 10,000 children are affected by isolated growth hormone deficiency""]","[""IGHD affects approximately 1 in 4,000 to 1 in 10,000 people worldwide.""]",[true],[true],[false],"[""IGHD affects approximately 1 in 4,000 to 1 in 10,000 children worldwide.""]","[""1 in every 3,500 to 1 in every 10,000 children""]","[""IGHD affects approximately 1 in 30,000 to 40,000 live births.""]",[true],[true],[false],"[""IGHD affects approximately 1 in 4,000 to 1 in 10,000 people.""]","[""1 in every 4,000 to 10,000 children""]","[""IGHD affects approximately 1 in 30,000 to 40,000 live births.""]",[true],[false],[true],"[""IGHD affects approximately 1 in 4,000 to 1 in 10,000 children.""]","[""1 in 3,500 to 1 in 10,000 children""]","[""IGHD affects approximately 1 in 4,000 to 1 in 10,000 live births.""]",[true],[true],[true],"[""IGHD affects approximately 1 in 4,000 to 1 in 10,000 people.""]","[""1 in 3,500 to 1 in 10,000 children are affected by isolated growth hormone deficiency""]","[""IGHD affects approximately 1 in 4,000 to 1 in 10,000 people worldwide.""]",[true],[false],[false],"[""IGHD affects approximately 1 in 4,000 to 1 in 10,000 people.""]","[""1 in every 3,500 to 1 in every 10,000 children""]","[""IGHD affects approximately 1 in 30,000 to 40,000 live births.""]",[false],[true],[false],"[""The number of people affected by IGHD is not readily available.""]","[""1 in every 4,000 to 10,000 children""]","[""IGHD affects approximately 1 in 30,000 to 40,000 live births.""]",[true],[false],[true],"[""IGHD affects approximately 1 in 4,000 to 1 in 10,000 people.""]","[""1 in 3,500 to 1 in 10,000 children""]","[""IGHD affects approximately 1 in 4,000 to 1 in 10,000 live births.""]",[true],[false],[true],"[""IGHD affects approximately 1 in 4,000 to 1 in 10,000 children worldwide.""]","[""1 in 3,500 to 1 in 10,000 children are affected by isolated growth hormone deficiency""]","[""IGHD affects approximately 1 in 4,000 to 1 in 10,000 people worldwide.""]",[true],[false],[false],"[""IGHD affects approximately 1 in 4,000 to 1 in 10,000 children worldwide.""]","[""1 in every 3,500 to 1 in every 10,000 children""]","[""IGHD affects approximately 1 in 30,000 to 40,000 live births.""]",[true],[true],[false],"[""IGHD affects approximately 1 in every 4,000 to 10,000 children worldwide.""]","[""1 in every 4,000 to 10,000 children""]","[""IGHD affects approximately 1 in 30,000 to 40,000 live births.""]",[true],[false],[true],"[""IGHD affects approximately 1 in 4,000 to 1 in 10,000 children worldwide.""]","[""1 in 3,500 to 1 in 10,000 children""]","[""IGHD affects approximately 1 in 4,000 to 1 in 10,000 live births.""]",[true],[false],[true],"[""IGHD affects approximately 1 in 4,000 to 1 in 10,000 children worldwide.""]","[""1 in 3,500 to 1 in 10,000 children are affected by isolated growth hormone deficiency""]","[""IGHD affects approximately 1 in 4,000 to 1 in 10,000 people worldwide.""]",[true],[false],[false],"[""IGHD affects approximately 1 in 4,000 to 1 in 10,000 individuals.""]","[""1 in every 3,500 to 1 in every 10,000 children""]","[""IGHD affects approximately 1 in 30,000 to 40,000 live births.""]",[true],[true],[false],"[""The exact number of people affected by IGHD (Isolated Growth Hormone Deficiency) may vary, but it is considered a rare condition affecting a small percentage of the population.""]","[""1 in every 4,000 to 10,000 children""]","[""IGHD affects approximately 1 in 30,000 to 40,000 live births.""]",[false],[false],[true],"[""The exact number of people affected by IGHD (Isolated Growth Hormone Deficiency) is not readily available as it can vary depending on the region and population studied.""]","[""1 in 3,500 to 1 in 10,000 children""]","[""IGHD affects approximately 1 in 4,000 to 1 in 10,000 live births.""]",[true],[true],[true],"[""The exact number of people affected by IGHD (Isolated Growth Hormone Deficiency) is not readily available as it is a rare condition. However, it is estimated to affect around 1 in 4,000 to 1 in 10,000 children.""]","[""1 in 3,500 to 1 in 10,000 children are affected by isolated growth hormone deficiency""]","[""IGHD affects approximately 1 in 4,000 to 1 in 10,000 people worldwide.""]",[false],[true],[false],"[""The exact number of people affected by IGHD (Isolated Growth Hormone Deficiency) is not readily available as it can vary depending on the region and population studied.""]","[""1 in every 3,500 to 1 in every 10,000 children""]","[""IGHD affects approximately 1 in 30,000 to 40,000 live births.""]",[false],[true],[false],"[""The exact number of people affected by IGHD (Isolated Growth Hormone Deficiency) is not readily available.""]","[""1 in every 4,000 to 10,000 children""]","[""IGHD affects approximately 1 in 30,000 to 40,000 live births.""]",[false],[true],[false],"[""The number of people affected by IGHD (Isolated Growth Hormone Deficiency) is not readily available.""]","[""1 in every 4,000 to 10,000 children""]","[""IGHD affects approximately 1 in 30,000 to 40,000 live births.""]",[false],[true],[false],"[""The exact number of people affected by IGHD (Isolated Growth Hormone Deficiency) is not readily available.""]","[""1 in every 4,000 to 10,000 children""]","[""IGHD affects approximately 1 in 30,000 to 40,000 live births.""]",[false],[true],[false],"[""The exact number of people affected by IGHD (Isolated Growth Hormone Deficiency) is not readily available.""]","[""1 in every 4,000 to 10,000 children""]","[""IGHD affects approximately 1 in 30,000 to 40,000 live births.""]"
causes,What causes Blue rubber bleb nevus syndrome ?,What causes blue rubber bleb nevus syndrome? Currently the cause of blue rubber bleb syndrome is not known.,"{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""BRBNS"", ""full_form"": ""Blue rubber bleb nevus syndrome""}]}",What causes BRBNS ?,What causes Blue rubber bleb nevus syndrome ?,8,MEDICAL,Simple Datatype-String,"Analytical/Evaluative (Convergent Thinking): This merged category is for queries that involve dissecting complex information or data to understand underlying patterns, reasons, or to make informed judgements. Queries in this category seek a deeper understanding that supports decision-making, comparison of options, or evaluating alternatives. The process involves both analysis (to break down and understand) and evaluation (to assess, compare, and decide), acknowledging that these processes often occur in tandem. This category involves queries where the goal is to converge upon a specific answer or decision through analysis and evaluation.","[[""Blue Rubber Bleb Nevus Syndrome"", ""Blue Rubber Bleb Nevus Syndrome""]]","[[""ABBREVIATIONS"", ""THEFREEDICTIONARY""]]","[""Blue Rubber Bleb Nevus Syndrome""]",[9.593448823543442e-24],[9.593448823543442e-24],"[""Blue Rubber Bleb Nevus Syndrome""]",[9.593448823543442e-24],"[""ABBREVIATIONS""]","[[9.593448823543442e-24, 9.593448823543442e-24]]",[0.7598323787909989],[0.7717606230064983],"[""Blue rubber bleb nevus syndrome""]",[0.7717606230064983],"[""ABBREVIATIONS""]","[[0.7717606230064983, 0.7717606230064983]]","[""Blue Rubber Bleb Nevus Syndrome""]","[""ABBREVIATIONS""]",What causes BRBNS (Blue Rubber Bleb Nevus Syndrome) ?,[false],[false],[false],"[""BRBNS is caused by a genetic mutation in the TEK gene.""]","[""Blue rubber bleb nevus syndrome is caused by a genetic mutation that leads to the development of multiple vascular malformations in the skin and internal organs.""]","[""BRBNS is caused by mutations in the AGGF1 gene.""]",[false],[false],[false],"[""BRBNS is caused by a genetic mutation in the TIE2 gene.""]","[""Blue rubber bleb nevus syndrome is caused by a genetic mutation that leads to abnormal blood vessel development.""]","[""BRBNS is caused by mutations in the gene encoding the protein KRIT1.""]",[false],[false],[false],"[""BRBNS is caused by a genetic mutation in the TIE2 gene.""]","[""Blue rubber bleb nevus syndrome is caused by a genetic mutation in the TIE2 gene.""]","[""BRBNS is caused by mutations in the PIK3CA gene.""]",[false],[false],[false],"[""BRBNS is caused by a genetic mutation in the TIE2 gene.""]","[""Blue rubber bleb nevus syndrome is caused by a genetic mutation that leads to the formation of multiple vascular malformations in the skin and internal organs.""]","[""BRBNS is caused by mutations in the PIK3CA gene.""]",[false],[false],[false],"[""BRBNS is caused by a genetic mutation in the TIE2 gene.""]","[""Blue rubber bleb nevus syndrome is caused by a genetic mutation that leads to the development of multiple vascular malformations in the skin and internal organs.""]","[""BRBNS is caused by mutations in the AGGF1 gene.""]",[false],[false],[false],"[""BRBNS is caused by a genetic mutation in the endothelial cells, leading to the formation of multiple vascular lesions.""]","[""Blue rubber bleb nevus syndrome is caused by a genetic mutation that leads to abnormal blood vessel development.""]","[""BRBNS is caused by mutations in the gene encoding the protein KRIT1.""]",[false],[false],[false],"[""BRBNS is caused by a genetic mutation in the endothelial cells, leading to the formation of multiple vascular lesions.""]","[""Blue rubber bleb nevus syndrome is caused by a genetic mutation in the TIE2 gene.""]","[""BRBNS is caused by mutations in the PIK3CA gene.""]",[false],[false],[false],"[""BRBNS is caused by a genetic mutation in the endothelial cells, leading to the formation of multiple vascular lesions.""]","[""Blue rubber bleb nevus syndrome is caused by a genetic mutation that leads to the formation of multiple vascular malformations in the skin and internal organs.""]","[""BRBNS is caused by mutations in the PIK3CA gene.""]",[false],[false],[false],"[""BRBNS is caused by a genetic mutation in the TIE2 gene.""]","[""Blue rubber bleb nevus syndrome is caused by a genetic mutation that leads to abnormal blood vessel development.""]","[""BRBNS is caused by mutations in the gene encoding the protein KRIT1.""]",[false],[false],[false],"[""BRBNS is caused by mutations in the TIE2 gene, also known as TEK gene.""]","[""Blue rubber bleb nevus syndrome is caused by a genetic mutation that leads to the development of multiple vascular malformations in the skin and internal organs.""]","[""BRBNS is caused by mutations in the AGGF1 gene.""]",[false],[false],[false],"[""BRBNS is caused by a genetic mutation in the TIE2 gene.""]","[""Blue rubber bleb nevus syndrome is caused by a genetic mutation in the TIE2 gene.""]","[""BRBNS is caused by mutations in the PIK3CA gene.""]",[false],[false],[false],"[""BRBNS is caused by a genetic mutation in the TIE2 gene.""]","[""Blue rubber bleb nevus syndrome is caused by a genetic mutation that leads to the formation of multiple vascular malformations in the skin and internal organs.""]","[""BRBNS is caused by mutations in the PIK3CA gene.""]",[false],[false],[false],"[""BRBNS is caused by a genetic mutation in the TIE2 gene.""]","[""Blue rubber bleb nevus syndrome is caused by a genetic mutation that leads to the development of multiple vascular malformations in the skin and internal organs.""]","[""BRBNS is caused by mutations in the AGGF1 gene.""]",[false],[false],[false],"[""BRBNS is caused by a genetic mutation in the endothelial cells, leading to the formation of multiple vascular malformations.""]","[""Blue rubber bleb nevus syndrome is caused by a genetic mutation that leads to abnormal blood vessel development.""]","[""BRBNS is caused by mutations in the gene encoding the protein KRIT1.""]",[false],[false],[false],"[""BRBNS is caused by a genetic mutation in the TEK gene.""]","[""Blue rubber bleb nevus syndrome is caused by a genetic mutation in the TIE2 gene.""]","[""BRBNS is caused by mutations in the PIK3CA gene.""]",[false],[false],[false],"[""BRBNS is caused by a genetic mutation in the TEK gene.""]","[""Blue rubber bleb nevus syndrome is caused by a genetic mutation that leads to the formation of multiple vascular malformations in the skin and internal organs.""]","[""BRBNS is caused by mutations in the PIK3CA gene.""]",[false],[false],[false],"[""Mutations in the TIE2 gene""]","[""Blue rubber bleb nevus syndrome is caused by a genetic mutation that leads to the development of multiple vascular malformations in the skin and internal organs.""]","[""BRBNS is caused by mutations in the AGGF1 gene.""]",[false],[false],[false],"[""BRBNS is caused by a genetic mutation in the TIE2 gene.""]","[""Blue rubber bleb nevus syndrome is caused by a genetic mutation that leads to abnormal blood vessel development.""]","[""BRBNS is caused by mutations in the gene encoding the protein KRIT1.""]",[false],[false],[false],"[""BRBNS is caused by a genetic mutation in the TIE2 gene.""]","[""Blue rubber bleb nevus syndrome is caused by a genetic mutation in the TIE2 gene.""]","[""BRBNS is caused by mutations in the PIK3CA gene.""]",[false],[false],[false],"[""BRBNS is caused by a genetic mutation in the TIE2 gene.""]","[""Blue rubber bleb nevus syndrome is caused by a genetic mutation that leads to the formation of multiple vascular malformations in the skin and internal organs.""]","[""BRBNS is caused by mutations in the PIK3CA gene.""]",[false],[false],[false],"[""BRBNS is caused by a genetic mutation in the TIE2 gene.""]","[""Blue rubber bleb nevus syndrome is caused by a genetic mutation that leads to the development of multiple vascular malformations in the skin and internal organs.""]","[""BRBNS is caused by mutations in the AGGF1 gene.""]",[false],[false],[false],"[""BRBNS is caused by a genetic mutation in the TIE2 gene.""]","[""Blue rubber bleb nevus syndrome is caused by a genetic mutation that leads to abnormal blood vessel development.""]","[""BRBNS is caused by mutations in the gene encoding the protein KRIT1.""]",[false],[false],[false],"[""BRBNS is caused by a genetic mutation in the TIE2 gene.""]","[""Blue rubber bleb nevus syndrome is caused by a genetic mutation in the TIE2 gene.""]","[""BRBNS is caused by mutations in the PIK3CA gene.""]",[false],[false],[false],"[""BRBNS is caused by a genetic mutation in the TIE2 gene.""]","[""Blue rubber bleb nevus syndrome is caused by a genetic mutation that leads to the formation of multiple vascular malformations in the skin and internal organs.""]","[""BRBNS is caused by mutations in the PIK3CA gene.""]",[false],[false],[false],"[""BRBNS is caused by a genetic mutation in the TEK gene.""]","[""Blue rubber bleb nevus syndrome is caused by a genetic mutation that leads to the development of multiple vascular malformations in the skin and internal organs.""]","[""BRBNS is caused by mutations in the AGGF1 gene.""]",[false],[false],[false],"[""BRBNS is caused by a genetic mutation in the TEK gene.""]","[""Blue rubber bleb nevus syndrome is caused by a genetic mutation that leads to abnormal blood vessel development.""]","[""BRBNS is caused by mutations in the gene encoding the protein KRIT1.""]",[false],[false],[false],"[""BRBNS is caused by a genetic mutation in the TEK gene.""]","[""Blue rubber bleb nevus syndrome is caused by a genetic mutation in the TIE2 gene.""]","[""BRBNS is caused by mutations in the PIK3CA gene.""]",[false],[false],[false],"[""BRBNS is caused by a genetic mutation in the TEK gene.""]","[""Blue rubber bleb nevus syndrome is caused by a genetic mutation that leads to the formation of multiple vascular malformations in the skin and internal organs.""]","[""BRBNS is caused by mutations in the PIK3CA gene.""]",[false],[false],[false],"[""BRBNS is caused by a genetic mutation in the TEK gene.""]","[""Blue rubber bleb nevus syndrome is caused by a genetic mutation that leads to the development of multiple vascular malformations in the skin and internal organs.""]","[""BRBNS is caused by mutations in the AGGF1 gene.""]",[false],[false],[false],"[""BRBNS is caused by mutations in the TEK gene.""]","[""Blue rubber bleb nevus syndrome is caused by a genetic mutation that leads to the development of multiple vascular malformations in the skin and internal organs.""]","[""BRBNS is caused by mutations in the AGGF1 gene.""]",[false],[false],[false],"[""BRBNS is caused by a genetic mutation in the endothelial cells, leading to the formation of multiple vascular lesions.""]","[""Blue rubber bleb nevus syndrome is caused by a genetic mutation that leads to the development of multiple vascular malformations in the skin and internal organs.""]","[""BRBNS is caused by mutations in the AGGF1 gene.""]",[false],[false],[false],"[""BRBNS is caused by a genetic mutation in the TEK gene.""]","[""Blue rubber bleb nevus syndrome is caused by a genetic mutation that leads to the development of multiple vascular malformations in the skin and internal organs.""]","[""BRBNS is caused by mutations in the AGGF1 gene.""]"
information,Do you have information about B Vitamins,"Summary : The B vitamins are       - B1 (thiamine)    - B2 (riboflavin)    - B3 (niacin)    - B5 (pantothenic acid)    - B6    -  B7 (biotin)    - B12    - Folic acid       These vitamins help the process your body uses to get or make energy from the food you eat. They also help form red blood cells. You can get B vitamins from proteins such as fish, poultry, meat, eggs, and dairy products. Leafy green vegetables, beans, and peas also have B vitamins. Many cereals and some breads have added B vitamins.    Not getting enough of certain B vitamins can cause diseases. A lack of B12 or B6 can cause anemia.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""B"", ""full_form"": ""B Vitamins""}]}",Do you have information about B,Do you have information about B Vitamins,0,SCIENCE,Simple Datatype-Boolean,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Be"", ""Business"", ""Back"", ""Big"", ""Body"", ""Basic"", ""Buy"", ""Base"", ""Bad"", ""British""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Boron""]",[1.2104094864867789e-08],[2.8567039669479115e-09],"[""Be""]",[0.00013614752119865195],"[""ABBREVIATIONS""]","[[0.00013614752119865195, 2.6009819976632164e-05, 5.1593830350683766e-05, 1.6185921052377595e-06, 1.530707533253526e-05, 6.224285111053394e-06, 2.487951623950015e-06, 6.207802289621316e-05, 9.616409543452185e-05, 5.532415055076759e-08]]",[0.7722897670345388],[0.7475335924652633],"[""Back""]",[0.8457255074954843],"[""ABBREVIATIONS""]","[[0.8209660859232526, 0.8081087075439588, 0.8314956572853516, 0.8457255074954843, 0.7950047781046239, 0.8025620346788659, 0.7822477417626734, 0.8181105568741343, 0.8331761432261692, 0.8089333641808595]]","[""Boron""]","[""LLM""]",Do you have information about B (Boron),[false],[true],[false],"[""Beryllium (Be) is a chemical element with the atomic number 4 and symbol Be. It is a light, strong, steel-gray metal that is commonly used in aerospace and defense applications.""]","[""Yes, B vitamins are a group of water-soluble vitamins that play important roles in cell metabolism. They include B1 (thiamine), B2 (riboflavin), B3 (niacin), B5 (pantothenic acid), B6 (pyridoxine), B7 (biotin), B9 (folic acid), and B12 (cobalamin).""]","[""No""]",[false],[true],[false],"[""Beryllium (Be) is a chemical element with the atomic number 4 and symbol Be. It is a relatively rare element in the universe, and it is a steel-gray, strong, lightweight, and brittle alkaline earth metal.""]","[""Yes, B vitamins are a group of water-soluble vitamins that play important roles in cell metabolism.""]","[""No""]",[false],[true],[false],"[""Beryllium (Be) is a chemical element with the symbol Be and atomic number 4. It is a relatively rare element in the universe, usually occurring as a product of the spallation of larger atomic nuclei that have collided with cosmic rays.""]","[""Yes, B vitamins are a group of water-soluble vitamins that play important roles in cell metabolism.""]","[""No""]",[false],[true],[false],"[""Beryllium (Be) is a chemical element with the atomic number 4 and symbol Be. It is a relatively rare element in the universe, and is a steel-gray, strong, lightweight and brittle alkaline earth metal.""]","[""Yes, B vitamins are a group of water-soluble vitamins that play important roles in cell metabolism.""]","[""No""]",[false],[true],[false],"[""B (Back) is a unit of measurement for magnetic field strength, equal to ten to the minus five tesla.""]","[""Yes, B vitamins are a group of water-soluble vitamins that play important roles in cell metabolism. They include B1 (thiamine), B2 (riboflavin), B3 (niacin), B5 (pantothenic acid), B6 (pyridoxine), B7 (biotin), B9 (folic acid), and B12 (cobalamin).""]","[""No""]",[false],[true],[false],"[""B (Back) is a unit of information equal to the amount of data that can be stored on one side of a standard floppy disk.""]","[""Yes, B vitamins are a group of water-soluble vitamins that play important roles in cell metabolism.""]","[""No""]",[false],[true],[false],"[""B (Back) is a unit of information equal to one binary choice, which can be either 0 or 1.""]","[""Yes, B vitamins are a group of water-soluble vitamins that play important roles in cell metabolism.""]","[""No""]",[false],[true],[false],"[""B (Back) is a unit of information equal to one binary digit or a value of 0 or 1 in computing and digital communications.""]","[""Yes, B vitamins are a group of water-soluble vitamins that play important roles in cell metabolism.""]","[""No""]",[false],[true],[false],"[""Yes, Boron is a chemical element with the symbol B and atomic number 5.""]","[""Yes, B vitamins are a group of water-soluble vitamins that play important roles in cell metabolism.""]","[""No""]",[false],[true],[false],"[""Yes, Boron is a chemical element with the symbol B and atomic number 5.""]","[""Yes, B vitamins are a group of water-soluble vitamins that play important roles in cell metabolism. They include B1 (thiamine), B2 (riboflavin), B3 (niacin), B5 (pantothenic acid), B6 (pyridoxine), B7 (biotin), B9 (folic acid), and B12 (cobalamin).""]","[""No""]",[false],[true],[false],"[""Yes, Boron is a chemical element with the symbol B and atomic number 5.""]","[""Yes, B vitamins are a group of water-soluble vitamins that play important roles in cell metabolism.""]","[""No""]",[false],[true],[false],"[""Yes, Boron is a chemical element with the symbol B and atomic number 5.""]","[""Yes, B vitamins are a group of water-soluble vitamins that play important roles in cell metabolism.""]","[""No""]",[true],[true],[false],"[""Yes""]","[""Yes, B vitamins are a group of water-soluble vitamins that play important roles in cell metabolism. They include B1 (thiamine), B2 (riboflavin), B3 (niacin), B5 (pantothenic acid), B6 (pyridoxine), B7 (biotin), B9 (folic acid), and B12 (cobalamin).""]","[""No""]",[false],[true],[false],"[""Boron is a chemical element with the symbol B and atomic number 5.""]","[""Yes, B vitamins are a group of water-soluble vitamins that play important roles in cell metabolism.""]","[""No""]",[true],[true],[false],"[""Yes""]","[""Yes, B vitamins are a group of water-soluble vitamins that play important roles in cell metabolism.""]","[""No""]",[true],[true],[false],"[""Yes""]","[""Yes, B vitamins are a group of water-soluble vitamins that play important roles in cell metabolism.""]","[""No""]",[false],[true],[false],"[""Yes, Boron is a chemical element with the symbol B and atomic number 5.""]","[""Yes, B vitamins are a group of water-soluble vitamins that play important roles in cell metabolism. They include B1 (thiamine), B2 (riboflavin), B3 (niacin), B5 (pantothenic acid), B6 (pyridoxine), B7 (biotin), B9 (folic acid), and B12 (cobalamin).""]","[""No""]",[false],[true],[false],"[""Boron is a chemical element with the symbol B and atomic number 5. It is a metalloid.""]","[""Yes, B vitamins are a group of water-soluble vitamins that play important roles in cell metabolism.""]","[""No""]",[false],[true],[false],"[""Yes, Boron is a chemical element with the symbol B and atomic number 5.""]","[""Yes, B vitamins are a group of water-soluble vitamins that play important roles in cell metabolism.""]","[""No""]",[false],[true],[false],"[""Boron is a chemical element with the symbol B and atomic number 5. It is a metalloid that is commonly used in the production of glass, ceramics, and detergents.""]","[""Yes, B vitamins are a group of water-soluble vitamins that play important roles in cell metabolism.""]","[""No""]",[false],[true],[false],"[""Yes, Boron is a chemical element with the symbol B and atomic number 5.""]","[""Yes, B vitamins are a group of water-soluble vitamins that play important roles in cell metabolism. They include B1 (thiamine), B2 (riboflavin), B3 (niacin), B5 (pantothenic acid), B6 (pyridoxine), B7 (biotin), B9 (folic acid), and B12 (cobalamin).""]","[""No""]",[false],[true],[false],"[""Boron is a chemical element with the symbol B and atomic number 5. It is a metalloid.""]","[""Yes, B vitamins are a group of water-soluble vitamins that play important roles in cell metabolism.""]","[""No""]",[false],[true],[false],"[""Boron is a chemical element with the symbol B and atomic number 5. It is a metalloid.""]","[""Yes, B vitamins are a group of water-soluble vitamins that play important roles in cell metabolism.""]","[""No""]",[false],[true],[false],"[""Yes, Boron is a chemical element with the symbol B and atomic number 5.""]","[""Yes, B vitamins are a group of water-soluble vitamins that play important roles in cell metabolism.""]","[""No""]",[false],[true],[false],"[""Yes, Boron is a chemical element with the symbol B and atomic number 5.""]","[""Yes, B vitamins are a group of water-soluble vitamins that play important roles in cell metabolism. They include B1 (thiamine), B2 (riboflavin), B3 (niacin), B5 (pantothenic acid), B6 (pyridoxine), B7 (biotin), B9 (folic acid), and B12 (cobalamin).""]","[""No""]",[false],[true],[false],"[""Yes, Boron is a chemical element with the symbol B and atomic number 5.""]","[""Yes, B vitamins are a group of water-soluble vitamins that play important roles in cell metabolism.""]","[""No""]",[false],[true],[false],"[""Yes, Boron is a chemical element with the symbol B and atomic number 5.""]","[""Yes, B vitamins are a group of water-soluble vitamins that play important roles in cell metabolism.""]","[""No""]",[false],[true],[false],"[""Yes, Boron is a chemical element with the symbol B and atomic number 5.""]","[""Yes, B vitamins are a group of water-soluble vitamins that play important roles in cell metabolism.""]","[""No""]",[false],[true],[false],"[""Yes, Boron is a chemical element with the symbol B and atomic number 5.""]","[""Yes, B vitamins are a group of water-soluble vitamins that play important roles in cell metabolism. They include B1 (thiamine), B2 (riboflavin), B3 (niacin), B5 (pantothenic acid), B6 (pyridoxine), B7 (biotin), B9 (folic acid), and B12 (cobalamin).""]","[""No""]",[false],[true],[false],"[""Yes, B is the chemical symbol for Beryllium.""]","[""Yes, B vitamins are a group of water-soluble vitamins that play important roles in cell metabolism. They include B1 (thiamine), B2 (riboflavin), B3 (niacin), B5 (pantothenic acid), B6 (pyridoxine), B7 (biotin), B9 (folic acid), and B12 (cobalamin).""]","[""No""]",[false],[true],[false],"[""No, I do not have information about B (Back).""]","[""Yes, B vitamins are a group of water-soluble vitamins that play important roles in cell metabolism. They include B1 (thiamine), B2 (riboflavin), B3 (niacin), B5 (pantothenic acid), B6 (pyridoxine), B7 (biotin), B9 (folic acid), and B12 (cobalamin).""]","[""No""]",[false],[true],[false],"[""Yes, Boron is a chemical element with the symbol B and atomic number 5.""]","[""Yes, B vitamins are a group of water-soluble vitamins that play important roles in cell metabolism. They include B1 (thiamine), B2 (riboflavin), B3 (niacin), B5 (pantothenic acid), B6 (pyridoxine), B7 (biotin), B9 (folic acid), and B12 (cobalamin).""]","[""No""]"
causes,What causes Dermatitis Herpetiformis: Skin Manifestation of Celiac Disease (For Health Care Professionals) ?,"Dermatitis herpetiformis is caused by the deposit of immunoglobulin A (IgA) in the skin, which triggers further immunologic reactions resulting in lesion formation. DH is an external manifestation of an abnormal immune response to gluten, in which IgA antibodies form against the skin antigen epidermal transglutaminase.
                
Family studies show that 5 percent of first-degree relatives of a person with DH will also have DH. An additional 5 percent of first-degree relatives of a person with DH will have celiac disease.4 Various other autoimmune diseases are associated with DH, the most common being hypothyroidism.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""DH"", ""full_form"": ""Dermatitis Herpetiformis""}, {""ambiguity_type"": ""full_form"", ""abbreviation"": ""CD"", ""full_form"": ""Celiac Disease""}]}",What causes DH: Skin Manifestation of CD (For Health Care Professionals) ?,What causes Dermatitis Herpetiformis: Skin Manifestation of Celiac Disease (For Health Care Professionals) ?,8,MEDICAL,Compound Datatype-String,"Analytical/Evaluative (Convergent Thinking): This merged category is for queries that involve dissecting complex information or data to understand underlying patterns, reasons, or to make informed judgements. Queries in this category seek a deeper understanding that supports decision-making, comparison of options, or evaluating alternatives. The process involves both analysis (to break down and understand) and evaluation (to assess, compare, and decide), acknowledging that these processes often occur in tandem. This category involves queries where the goal is to converge upon a specific answer or decision through analysis and evaluation.","[[""Downhill"", ""Das Heisst"", ""Don't Have ...."", ""Diffie-Hellman"", ""De Havilland"", ""Dark Horse"", ""Designated Hitter"", ""Data Handling"", ""Double Helix"", ""Dear Husband""], [""Compact Disc"", ""Compact Disc - Music, software programs and digital media"", ""Celine Dion"", ""Cadmium"", ""Christian Dior"", ""Canadian Dollar"", ""Compact Disk"", ""Cardiovascular Disease"", ""Compact Disk description"", ""Compact Design""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""], [""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Dermatitis Herpetiformis"", ""Celiac Disease""]","[4.205164335587157e-19, 2.93310049591044e-05]","[4.205164335587157e-19, 2.93310049591044e-05]","[""Downhill"", ""Celiac Disease""]","[9.11746224593131e-07, 2.93310049591044e-05]","[""ABBREVIATIONS"", ""LLM""]","[[9.11746224593131e-07, 8.236321461494132e-17, 2.9117966619989945e-13, 4.509468070207717e-19, 4.352306294739968e-18, 2.8698026858316176e-09, 1.8282109356565816e-12, 2.934427755911631e-11, 3.499320528390325e-12, 1.0018940703915202e-09], [1.8726211600265992e-07, 7.609301879985002e-32, 4.4138502232334147e-16, 4.45283873450449e-12, 3.8302964530574725e-16, 1.8051403429178289e-13, 2.9363736317163168e-08, 4.3778083136053813e-07, 1.2682126232410422e-12, 3.581944459910719e-09]]","[0.9331127716596618, 0.9818133351442675]","[0.9331127716596618, 0.9818133351442675]","[""Das Heisst"", ""Compact Design""]","[0.9478724697952987, 0.9818133351442675]","[""ABBREVIATIONS"", ""LLM""]","[[0.9150810966070366, 0.9346233437492318, 0.9478724697952987, 0.8605831688936616, 0.9328913003816346, 0.9069246521942803, 0.8878097160036671, 0.9356347494503621, 0.9130008753579586, 0.916383504390329], [0.93794601682568, 0.9128796801850402, 0.9555698754674724, 0.881763747726705, 0.9528858421372299, 0.9240662024296891, 0.9317225388615865, 0.9115814927120807, 0.924269757535437, 0.9454230867368554]]","[""Dermatitis Herpetiformis"", ""Celiac Disease""]","[""LLM"", ""LLM""]",What causes DH: Skin Manifestation of CD (Celiac Disease) (For Health Care Professionals) ?,"[true, true]","[true, true]","[true, true]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response triggered by gluten ingestion."", ""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an immune reaction to gluten. It is characterized by itchy, blistering skin rashes, typically found on the elbows, knees, buttocks, and scalp.""]","[""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease."", ""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease.""]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response triggered by gluten ingestion."", ""Dermatitis herpetiformis (DH) is a skin manifestation of celiac disease (CD) caused by an autoimmune response to gluten ingestion.""]","[true, true]","[true, true]","[true, true]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response triggered by gluten ingestion."", ""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion.""]","[""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease."", ""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease.""]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion."", ""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response triggered by gluten consumption.""]","[true, true]","[true, true]","[true, true]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion."", ""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion.""]","[""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease."", ""Dermatitis Herpetiformis is caused by an immune reaction to gluten in individuals with Celiac Disease.""]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion."", ""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response triggered by gluten consumption.""]","[true, true]","[true, true]","[true, true]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response triggered by gluten ingestion."", ""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response triggered by gluten ingestion.""]","[""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with celiac disease."", ""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease.""]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response triggered by gluten consumption."", ""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion.""]","[true, true]","[true, true]","[true, true]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion."", ""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD), which is an autoimmune disorder triggered by gluten consumption. In DH, the immune system reacts to gluten and produces antibodies that attack the skin, leading to a blistering rash.""]","[""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease."", ""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease.""]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response triggered by gluten ingestion."", ""Dermatitis herpetiformis (DH) is a skin manifestation of celiac disease (CD) caused by an autoimmune response to gluten ingestion.""]","[true, true]","[true, true]","[true, true]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response triggered by gluten consumption."", ""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response triggered by gluten consumption.""]","[""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease."", ""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease.""]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion."", ""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response triggered by gluten consumption.""]","[true, true]","[true, true]","[true, true]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion."", ""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion.""]","[""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease."", ""Dermatitis Herpetiformis is caused by an immune reaction to gluten in individuals with Celiac Disease.""]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion."", ""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response triggered by gluten consumption.""]","[true, true]","[true, true]","[true, true]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion."", ""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an immune reaction to gluten ingestion.""]","[""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with celiac disease."", ""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease.""]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response triggered by gluten consumption."", ""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion.""]","[true, true]","[true, true]","[true, true]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion."", ""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion. The skin symptoms result from the deposition of IgA antibodies in the skin, leading to inflammation and characteristic rash.""]","[""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease."", ""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease.""]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion."", ""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response triggered by gluten consumption.""]","[true, true]","[true, true]","[true, true]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by the immune system's reaction to gluten ingestion. It is characterized by itchy, blistering skin rashes."", ""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion. The immune system produces antibodies that attack the skin, leading to the characteristic rash seen in DH.""]","[""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease."", ""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease.""]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response triggered by gluten ingestion."", ""Dermatitis herpetiformis (DH) is a skin manifestation of celiac disease (CD) caused by an autoimmune response to gluten ingestion.""]","[true, true]","[true, true]","[true, true]","[""DH (Dermatitis Herpetiformis) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion."", ""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion.""]","[""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease."", ""Dermatitis Herpetiformis is caused by an immune reaction to gluten in individuals with Celiac Disease.""]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion."", ""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response triggered by gluten consumption.""]","[true, true]","[true, true]","[true, true]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response triggered by gluten consumption. The immune system mistakenly targets the skin, leading to the characteristic rash and blistering."", ""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion. The skin symptoms result from the deposition of IgA antibodies in the skin, leading to inflammation and characteristic skin lesions.""]","[""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with celiac disease."", ""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease.""]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response triggered by gluten consumption."", ""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion.""]","[true, true]","[true, true]","[true, true]","[""DH (Dermatitis Herpetiformis) is caused by an autoimmune reaction to gluten in individuals with celiac disease."", ""DH is caused by an abnormal immune response to gluten in individuals with celiac disease.""]","[""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease."", ""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease.""]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response triggered by gluten ingestion."", ""Dermatitis herpetiformis (DH) is a skin manifestation of celiac disease (CD) caused by an autoimmune response to gluten ingestion.""]","[true, true]","[true, true]","[true, true]","[""DH (Dermatitis Herpetiformis) is caused by an autoimmune response to gluten ingestion in individuals with celiac disease."", ""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion.""]","[""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease."", ""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease.""]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion."", ""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response triggered by gluten consumption.""]","[true, true]","[true, true]","[true, true]","[""DH (Dermatitis Herpetiformis) is caused by an autoimmune response to gluten ingestion in individuals with celiac disease."", ""DH is caused by an abnormal immune response to gluten in individuals with celiac disease.""]","[""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease."", ""Dermatitis Herpetiformis is caused by an immune reaction to gluten in individuals with Celiac Disease.""]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion."", ""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response triggered by gluten consumption.""]","[true, true]","[true, true]","[true, true]","[""DH (Dermatitis Herpetiformis) is caused by an autoimmune response triggered by gluten ingestion in individuals with celiac disease."", ""Dermatitis Herpetiformis (DH) is caused by an abnormal immune response to gluten ingestion in individuals with Celiac Disease.""]","[""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with celiac disease."", ""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease.""]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response triggered by gluten consumption."", ""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion.""]","[true, true]","[true, true]","[true, true]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion. The immune system mistakenly targets the skin, leading to the characteristic itchy, blistering rash."", ""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion. The skin symptoms result from the deposition of IgA antibodies in the skin, leading to inflammation and characteristic skin lesions.""]","[""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease."", ""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease.""]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response triggered by gluten ingestion."", ""Dermatitis herpetiformis (DH) is a skin manifestation of celiac disease (CD) caused by an autoimmune response to gluten ingestion.""]","[true, true]","[true, true]","[true, true]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion."", ""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion.""]","[""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease."", ""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease.""]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion."", ""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response triggered by gluten consumption.""]","[true, true]","[true, true]","[true, true]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion."", ""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an immune reaction to gluten. The skin symptoms result from the deposition of IgA antibodies in the skin, leading to inflammation and characteristic skin lesions.""]","[""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease."", ""Dermatitis Herpetiformis is caused by an immune reaction to gluten in individuals with Celiac Disease.""]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion."", ""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response triggered by gluten consumption.""]","[true, true]","[true, true]","[true, true]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion. The skin symptoms result from the deposition of IgA antibodies in the skin, leading to inflammation and characteristic skin lesions."", ""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion. The skin symptoms result from the deposition of IgA antibodies in the skin, leading to inflammation and characteristic rash.""]","[""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with celiac disease."", ""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease.""]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response triggered by gluten consumption."", ""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion.""]","[true, true]","[true, true]","[true, true]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion."", ""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an immune reaction to gluten ingestion.""]","[""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease."", ""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease.""]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response triggered by gluten ingestion."", ""Dermatitis herpetiformis (DH) is a skin manifestation of celiac disease (CD) caused by an autoimmune response to gluten ingestion.""]","[true, true]","[true, true]","[true, true]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion."", ""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease caused by an immune reaction to gluten ingestion. The skin symptoms result from the deposition of IgA antibodies in the skin, leading to a blistering rash.""]","[""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease."", ""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease.""]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion."", ""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response triggered by gluten consumption.""]","[true, true]","[true, true]","[true, true]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion."", ""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion. It is characterized by itchy, blistering skin lesions, typically found on the elbows, knees, and buttocks.""]","[""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease."", ""Dermatitis Herpetiformis is caused by an immune reaction to gluten in individuals with Celiac Disease.""]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion."", ""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response triggered by gluten consumption.""]","[true, true]","[true, true]","[true, true]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion."", ""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion. The immune system produces antibodies that attack the skin, leading to the characteristic rash seen in DH.""]","[""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with celiac disease."", ""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease.""]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response triggered by gluten consumption."", ""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion.""]","[true, true]","[true, true]","[true, true]","[""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with celiac disease."", ""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease, caused by an autoimmune response triggered by the ingestion of gluten. The immune system produces antibodies that attack the skin, leading to the characteristic rash seen in DH.""]","[""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease."", ""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease.""]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response triggered by gluten ingestion."", ""Dermatitis herpetiformis (DH) is a skin manifestation of celiac disease (CD) caused by an autoimmune response to gluten ingestion.""]","[true, true]","[true, true]","[true, true]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion."", ""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease, caused by an autoimmune response to gluten ingestion. The immune system produces antibodies that attack the skin, leading to the characteristic rash.""]","[""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease."", ""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease.""]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion."", ""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response triggered by gluten consumption.""]","[true, true]","[true, true]","[true, true]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion. The immune system produces antibodies that attack the skin, leading to the characteristic rash and blisters."", ""DH (Dermatitis Herpetiformis) is a skin manifestation of Celiac Disease caused by the immune system's reaction to gluten ingestion.""]","[""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease."", ""Dermatitis Herpetiformis is caused by an immune reaction to gluten in individuals with Celiac Disease.""]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion."", ""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response triggered by gluten consumption.""]","[true, true]","[true, true]","[true, true]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion."", ""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease, which is an autoimmune disorder triggered by the ingestion of gluten. In DH, the immune system responds to gluten by producing antibodies that attack the skin, leading to the characteristic itchy, blistering rash.""]","[""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with celiac disease."", ""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease.""]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response triggered by gluten consumption."", ""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response to gluten ingestion.""]","[true, true]","[true, true]","[true, true]","[""DH (Dermatitis Herpetiformis) is caused by gluten sensitivity in individuals with Celiac Disease."", ""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease, caused by an autoimmune response to gluten ingestion.""]","[""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease."", ""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease.""]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response triggered by gluten ingestion."", ""Dermatitis herpetiformis (DH) is a skin manifestation of celiac disease (CD) caused by an autoimmune response to gluten ingestion.""]","[false, true]","[true, true]","[true, true]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease."", ""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease, caused by an autoimmune response to gluten ingestion.""]","[""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease."", ""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease.""]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response triggered by gluten ingestion."", ""Dermatitis herpetiformis (DH) is a skin manifestation of celiac disease (CD) caused by an autoimmune response to gluten ingestion.""]","[false, true]","[true, true]","[true, true]","[""DH (Das Heisst) is a skin manifestation of celiac disease."", ""Skin manifestation of celiac disease in DH is caused by an autoimmune reaction triggered by the ingestion of gluten.""]","[""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease."", ""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease.""]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response triggered by gluten ingestion."", ""Dermatitis herpetiformis (DH) is a skin manifestation of celiac disease (CD) caused by an autoimmune response to gluten ingestion.""]","[true, true]","[true, true]","[true, true]","[""DH (Dermatitis Herpetiformis) is caused by an autoimmune response triggered by gluten ingestion in individuals with celiac disease."", ""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease, caused by an immune reaction to gluten.""]","[""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease."", ""Dermatitis Herpetiformis is caused by an autoimmune response to gluten ingestion in individuals with Celiac Disease.""]","[""Dermatitis Herpetiformis (DH) is a skin manifestation of Celiac Disease (CD) caused by an autoimmune response triggered by gluten ingestion."", ""Dermatitis herpetiformis (DH) is a skin manifestation of celiac disease (CD) caused by an autoimmune response to gluten ingestion.""]"
treatment,What are the treatments for Central Cord Syndrome ?,"There is no cure for central cord syndrome although some people recover near-normal function. There is no standard course of treatment, although drug therapy, surgery, and rest are often part of the program. Magnetic resonance imaging (MRI) is used to indicate the degree of spinal cord compression and vertebral instability. Vertebral instability due to acute traumatic injury or cervical disc herniation is often treated by surgery to prevent further damage to the spinal cord. Recent reports indicate that earlier surgery may improve chances for recovery. Numerous recent studies suggest that surgery also can be beneficial in individuals with persistent compression of the spinal cord and ongoing neurological deterioration.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""CCS"", ""full_form"": ""Central Cord Syndrome""}]}",What are the treatments for CCS ?,What are the treatments for Central Cord Syndrome ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Castle & Cooke, Incorporated"", ""Caracas, Venezuela"", ""Canadian Cancer Society"", ""Card Captor Sakura"", ""Common Channel Signaling"", ""Certified Coding Specialist"", ""Coded Character Set"", ""Command and Control System"", ""Call Center Service"", ""Campus Computing Site""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Chronic Cough Syndrome""]",[1.5610656319319297e-10],[1.8438867191947568e-10],"[""Chronic Cough Syndrome""]",[1.8438867191947568e-10],"[""LLM""]","[[8.056646968663193e-25, 2.9326588001889093e-20, 1.2265554884917967e-18, 1.762491267964484e-24, 4.0162373217495665e-18, 1.960151359792638e-18, 2.781653416619711e-16, 2.869055162397353e-14, 5.679080408216143e-12, 5.658266163045372e-17]]",[0.804760186586008],[0.7277463943363298],"[""Castle & Cooke, Incorporated""]",[0.8141599520227587],"[""ABBREVIATIONS""]","[[0.6946697252037797, 0.8141599520227587, 0.7273948909131768, 0.727452176087021, 0.6959994645649696, 0.694446826012806, 0.7046472884239019, 0.7523683694194938, 0.7672615610525999, 0.7720091036151673]]","[""Canadian Cancer Society""]","[""ABBREVIATIONS""]",What are the treatments for CCS (Chronic Cough Syndrome) ?,[false],[true],[false],"[""The treatments for Chronic Cough Syndrome (CCS) include speech therapy, cough suppressants, inhaled corticosteroids, acid reflux medications, and neuromodulators.""]","[""Physical therapy, surgery, and medication for pain management""]","[""The treatments for Chronic Compartment Syndrome (CCS) include rest, ice, elevation, physical therapy, and in severe cases, surgery.""]",[false],[true],[false],"[""The treatments for Chronic Cough Syndrome (CCS) may include speech therapy, cognitive behavioral therapy, medications such as antitussives, inhaled corticosteroids, or acid suppressants, and addressing underlying conditions like asthma or GERD.""]","[""Physical therapy, surgery, and medication for pain management""]","[""The treatments for Chronic Compartment Syndrome (CCS) include rest, ice, elevation, physical therapy, and in severe cases, surgery.""]",[false],[true],[false],"[""The treatments for Chronic Cough Syndrome (CCS) include speech therapy, cough suppressants, inhaled corticosteroids, and acid reflux medications.""]","[""Treatment for Central Cord Syndrome includes immobilization, high-dose steroids, surgery to decompress the spinal cord, and physical therapy.""]","[""The treatments for Chronic Compartment Syndrome (CCS) include rest, ice, elevation, physical therapy, and in severe cases, surgery.""]",[false],[true],[false],"[""The treatments for Chronic Cough Syndrome (CCS) include speech therapy, cognitive behavioral therapy, medications such as antitussives, inhaled corticosteroids, and proton pump inhibitors, as well as lifestyle changes like avoiding triggers and maintaining good hydration.""]","[""Physical therapy, occupational therapy, and surgery are common treatments for Central Cord Syndrome.""]","[""The treatments for Chronic Compartment Syndrome (CCS) include rest, ice, elevation, physical therapy, and in severe cases, surgery.""]",[false],[true],[false],"[""The treatment for CCS (Castle & Cooke, Incorporated) is not applicable as CCS is a company, not a medical condition.""]","[""Physical therapy, surgery, and medication for pain management""]","[""The treatments for Chronic Compartment Syndrome (CCS) include rest, ice, elevation, physical therapy, and in severe cases, surgery.""]",[false],[true],[false],"[""There is no specific treatment for CCS (Castle & Cooke, Incorporated) as it is a company, not a medical condition.""]","[""Physical therapy, surgery, and medication for pain management""]","[""The treatments for Chronic Compartment Syndrome (CCS) include rest, ice, elevation, physical therapy, and in severe cases, surgery.""]",[false],[true],[false],"[""The treatments for CCS (Castle & Cooke, Incorporated) depend on the specific condition being treated. It is recommended to consult a healthcare professional for personalized treatment options.""]","[""Treatment for Central Cord Syndrome includes immobilization, high-dose steroids, surgery to decompress the spinal cord, and physical therapy.""]","[""The treatments for Chronic Compartment Syndrome (CCS) include rest, ice, elevation, physical therapy, and in severe cases, surgery.""]",[false],[true],[false],"[""There is no specific treatment for CCS (Castle & Cooke, Incorporated) as it is a company, not a medical condition.""]","[""Physical therapy, occupational therapy, and surgery are common treatments for Central Cord Syndrome.""]","[""The treatments for Chronic Compartment Syndrome (CCS) include rest, ice, elevation, physical therapy, and in severe cases, surgery.""]",[false],[true],[false],"[""The treatments for CCS (Canadian Cancer Society) depend on the type and stage of cancer, but may include surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy, hormone therapy, or stem cell transplant.""]","[""Physical therapy, surgery, and medication for pain management""]","[""The treatments for Chronic Compartment Syndrome (CCS) include rest, ice, elevation, physical therapy, and in severe cases, surgery.""]",[false],[true],[false],"[""The treatments for CCS (Canadian Cancer Society) include surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy, hormone therapy, stem cell transplant, and precision medicine.""]","[""Physical therapy, surgery, and medication for pain management""]","[""The treatments for Chronic Compartment Syndrome (CCS) include rest, ice, elevation, physical therapy, and in severe cases, surgery.""]",[false],[true],[false],"[""The treatments for CCS (Canadian Cancer Society) include surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy, hormone therapy, and stem cell transplant.""]","[""Treatment for Central Cord Syndrome includes immobilization, high-dose steroids, surgery to decompress the spinal cord, and physical therapy.""]","[""The treatments for Chronic Compartment Syndrome (CCS) include rest, ice, elevation, physical therapy, and in severe cases, surgery.""]",[false],[true],[false],"[""The treatments for CCS (Canadian Cancer Society) include surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy, hormone therapy, stem cell transplant, and precision medicine.""]","[""Physical therapy, occupational therapy, and surgery are common treatments for Central Cord Syndrome.""]","[""The treatments for Chronic Compartment Syndrome (CCS) include rest, ice, elevation, physical therapy, and in severe cases, surgery.""]",[false],[true],[false],"[""The treatments for CCS (Canadian Cancer Society) may include surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy, hormone therapy, stem cell transplant, and clinical trials.""]","[""Physical therapy, surgery, and medication for pain management""]","[""The treatments for Chronic Compartment Syndrome (CCS) include rest, ice, elevation, physical therapy, and in severe cases, surgery.""]",[false],[true],[false],"[""The treatments for CCS (Canadian Cancer Society) may include surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy, hormone therapy, stem cell transplant, and clinical trials.""]","[""Physical therapy, surgery, and medication for pain management""]","[""The treatments for Chronic Compartment Syndrome (CCS) include rest, ice, elevation, physical therapy, and in severe cases, surgery.""]",[false],[true],[false],"[""The treatments for CCS (Canadian Cancer Society) may include surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy, hormone therapy, stem cell transplant, and clinical trials.""]","[""Treatment for Central Cord Syndrome includes immobilization, high-dose steroids, surgery to decompress the spinal cord, and physical therapy.""]","[""The treatments for Chronic Compartment Syndrome (CCS) include rest, ice, elevation, physical therapy, and in severe cases, surgery.""]",[false],[true],[false],"[""The treatments for CCS (Canadian Cancer Society) may include surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy, hormone therapy, stem cell transplant, and clinical trials.""]","[""Physical therapy, occupational therapy, and surgery are common treatments for Central Cord Syndrome.""]","[""The treatments for Chronic Compartment Syndrome (CCS) include rest, ice, elevation, physical therapy, and in severe cases, surgery.""]",[false],[true],[false],"[""The treatments for CCS (Canadian Cancer Society) may include surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy, hormone therapy, stem cell transplant, and precision medicine.""]","[""Physical therapy, surgery, and medication for pain management""]","[""The treatments for Chronic Compartment Syndrome (CCS) include rest, ice, elevation, physical therapy, and in severe cases, surgery.""]",[false],[true],[false],"[""The treatments for CCS (Canadian Cancer Society) depend on the type and stage of cancer but may include surgery, chemotherapy, radiation therapy, immunotherapy, targeted therapy, hormone therapy, or stem cell transplant.""]","[""Physical therapy, surgery, and medication for pain management""]","[""The treatments for Chronic Compartment Syndrome (CCS) include rest, ice, elevation, physical therapy, and in severe cases, surgery.""]",[false],[true],[false],"[""The treatments for CCS (Canadian Cancer Society) depend on the type and stage of cancer, but may include surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy, hormone therapy, or stem cell transplant.""]","[""Treatment for Central Cord Syndrome includes immobilization, high-dose steroids, surgery to decompress the spinal cord, and physical therapy.""]","[""The treatments for Chronic Compartment Syndrome (CCS) include rest, ice, elevation, physical therapy, and in severe cases, surgery.""]",[false],[true],[false],"[""The treatments for CCS (Canadian Cancer Society) vary depending on the type and stage of cancer, but may include surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy, hormone therapy, or stem cell transplant.""]","[""Physical therapy, occupational therapy, and surgery are common treatments for Central Cord Syndrome.""]","[""The treatments for Chronic Compartment Syndrome (CCS) include rest, ice, elevation, physical therapy, and in severe cases, surgery.""]",[false],[true],[false],"[""The treatments for Chronic Cough Syndrome (CCS) include speech therapy, cognitive behavioral therapy, medications such as antitussives, acid suppressants, and in some cases, neuromodulation techniques.""]","[""Physical therapy, surgery, and medication for pain management""]","[""The treatments for Chronic Compartment Syndrome (CCS) include rest, ice, elevation, physical therapy, and in severe cases, surgery.""]",[false],[true],[false],"[""The treatments for Chronic Cough Syndrome (CCS) may include speech therapy, cognitive behavioral therapy, medications such as antitussives, inhaled corticosteroids, or acid suppressants, and addressing underlying conditions like GERD or asthma.""]","[""Physical therapy, surgery, and medication for pain management""]","[""The treatments for Chronic Compartment Syndrome (CCS) include rest, ice, elevation, physical therapy, and in severe cases, surgery.""]",[false],[true],[false],"[""The treatments for Chronic Cough Syndrome (CCS) may include speech therapy, medications such as antitussives, inhaled corticosteroids, or acid suppressants, as well as lifestyle changes like avoiding triggers and staying hydrated.""]","[""Treatment for Central Cord Syndrome includes immobilization, high-dose steroids, surgery to decompress the spinal cord, and physical therapy.""]","[""The treatments for Chronic Compartment Syndrome (CCS) include rest, ice, elevation, physical therapy, and in severe cases, surgery.""]",[false],[true],[false],"[""The treatments for Chronic Cough Syndrome (CCS) include speech therapy, cognitive behavioral therapy, medications such as antitussives, and addressing underlying conditions like GERD or asthma.""]","[""Physical therapy, occupational therapy, and surgery are common treatments for Central Cord Syndrome.""]","[""The treatments for Chronic Compartment Syndrome (CCS) include rest, ice, elevation, physical therapy, and in severe cases, surgery.""]",[false],[true],[false],"[""The treatments for CCS (Canadian Cancer Society) may include surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy, hormone therapy, stem cell transplant, or clinical trials.""]","[""Physical therapy, surgery, and medication for pain management""]","[""The treatments for Chronic Compartment Syndrome (CCS) include rest, ice, elevation, physical therapy, and in severe cases, surgery.""]",[false],[true],[false],"[""The treatments for CCS (Canadian Cancer Society) may include surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy, hormone therapy, stem cell transplant, or clinical trials.""]","[""Physical therapy, surgery, and medication for pain management""]","[""The treatments for Chronic Compartment Syndrome (CCS) include rest, ice, elevation, physical therapy, and in severe cases, surgery.""]",[false],[true],[false],"[""The treatments for CCS (Canadian Cancer Society) may include surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy, hormone therapy, stem cell transplant, and clinical trials.""]","[""Treatment for Central Cord Syndrome includes immobilization, high-dose steroids, surgery to decompress the spinal cord, and physical therapy.""]","[""The treatments for Chronic Compartment Syndrome (CCS) include rest, ice, elevation, physical therapy, and in severe cases, surgery.""]",[false],[true],[false],"[""The treatments for CCS (Canadian Cancer Society) may include surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy, hormone therapy, stem cell transplant, precision medicine, and clinical trials.""]","[""Physical therapy, occupational therapy, and surgery are common treatments for Central Cord Syndrome.""]","[""The treatments for Chronic Compartment Syndrome (CCS) include rest, ice, elevation, physical therapy, and in severe cases, surgery.""]",[false],[true],[false],"[""The treatments for CCS (Canadian Cancer Society) may include surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy, hormone therapy, stem cell transplant, and clinical trials.""]","[""Physical therapy, surgery, and medication for pain management""]","[""The treatments for Chronic Compartment Syndrome (CCS) include rest, ice, elevation, physical therapy, and in severe cases, surgery.""]",[false],[true],[false],"[""Treatments for Chronic Cough Syndrome (CCS) may include speech therapy, medications, behavioral therapy, and addressing underlying conditions such as GERD or allergies.""]","[""Physical therapy, surgery, and medication for pain management""]","[""The treatments for Chronic Compartment Syndrome (CCS) include rest, ice, elevation, physical therapy, and in severe cases, surgery.""]",[false],[true],[false],"[""The treatments for CCS (Castle & Cooke, Incorporated) vary depending on the specific condition being addressed. It is recommended to consult with a healthcare professional for personalized treatment options.""]","[""Physical therapy, surgery, and medication for pain management""]","[""The treatments for Chronic Compartment Syndrome (CCS) include rest, ice, elevation, physical therapy, and in severe cases, surgery.""]",[false],[true],[false],"[""Treatments for Chronic Cough Syndrome (CCS) may include speech therapy, medications, cough suppressants, inhalers, acid reflux treatment, and lifestyle changes.""]","[""Physical therapy, surgery, and medication for pain management""]","[""The treatments for Chronic Compartment Syndrome (CCS) include rest, ice, elevation, physical therapy, and in severe cases, surgery.""]"
symptoms,What are the symptoms of Growth hormone insensitivity with immunodeficiency ?,"What are the signs and symptoms of Growth hormone insensitivity with immunodeficiency? The Human Phenotype Ontology provides the following list of signs and symptoms for Growth hormone insensitivity with immunodeficiency. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormal facial shape 90% Abnormality of lipid metabolism 90% Insulin resistance 90% Microcephaly 90% Short stature 90% Delayed eruption of teeth 50% Delayed skeletal maturation 50% Fine hair 50% Hypoglycemia 50% Hypoplasia of penis 50% Type II diabetes mellitus 50% Abnormality of immune system physiology 7.5% Abnormality of the fontanelles or cranial sutures 7.5% Abnormality of the nail 7.5% Abnormality of the voice 7.5% Cognitive impairment 7.5% Diabetes insipidus 7.5% Hearing impairment 7.5% Truncal obesity 7.5% Growth hormone deficiency - Respiratory difficulties - Severe short stature - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""GHI"", ""full_form"": ""Growth hormone insensitivity""}]}",What are the symptoms of GHI with immunodeficiency ?,What are the symptoms of Growth hormone insensitivity with immunodeficiency ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Group Health Insurance"", ""Group Health Incorporated"", ""Giving Hope International"", ""Global High Income Dealer Fund, Incorporated (de-listed)"", ""Global hunger index"", ""Global Horizontal Irradiance"", ""Global Health Initiative"", ""Granite Harbour Intrusives"", ""Global Hazard Indicator"", ""General Health Information""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Genital Herpes Infection""]",[3.245703515599872e-15],[8.753634388621912e-12],"[""General Health Information""]",[8.369286361983182e-10],"[""ABBREVIATIONS""]","[[1.1304027053701135e-12, 2.630402365373127e-16, 9.254195844906365e-18, 4.348027123191298e-43, 2.1244898258896966e-15, 6.7604194310077764e-21, 3.651055317866463e-16, 2.532823769544739e-25, 6.818548025204606e-19, 8.369286361983182e-10]]",[0.8496886859832669],[0.8139349482979806],"[""Global Horizontal Irradiance""]",[0.9298947968272363],"[""ABBREVIATIONS""]","[[0.8869306520500164, 0.8958470184854685, 0.8968136282102257, 0.8257100964545381, 0.869770180966554, 0.8587381551298097, 0.9298947968272363, 0.8610371084347046, 0.9187269367664348, 0.9226844414836447]]","[""Global Health Initiative""]","[""ABBREVIATIONS""]",What are the symptoms of GHI (Genital Herpes Infection) with immunodeficiency ?,[false],[true],[true],"[""Symptoms of immunodeficiency include frequent infections, slow wound healing, fatigue, recurrent pneumonia, and swollen lymph nodes.""]","[""Short stature, immune deficiency, delayed bone age, and increased fat mass""]","[""Recurrent infections, slow growth, failure to thrive, and susceptibility to infections are common symptoms of GHI with immunodeficiency.""]",[false],[true],[false],"[""Symptoms of immunodeficiency include frequent infections, slow wound healing, recurrent pneumonia, and persistent fatigue.""]","[""Short stature, delayed bone age, immune deficiency, and increased susceptibility to infections.""]","[""Symptoms of GHI with immunodeficiency include recurrent infections, failure to thrive, chronic diarrhea, and skin rashes.""]",[false],[true],[false],"[""Symptoms of immunodeficiency include frequent infections, slow healing wounds, recurrent pneumonia, and unexplained weight loss.""]","[""Short stature, immune deficiency, delayed bone age, and facial abnormalities""]","[""Symptoms of GHI with immunodeficiency include recurrent infections, failure to thrive, chronic diarrhea, and skin rashes.""]",[false],[true],[false],"[""Symptoms of immunodeficiency include frequent infections, slow healing wounds, fatigue, and recurrent illnesses.""]","[""Short stature, immune deficiency, delayed bone age, and dysmorphic features.""]","[""Symptoms of GHI with immunodeficiency include recurrent infections, failure to thrive, chronic diarrhea, and skin rashes.""]",[false],[true],[true],"[""Global Horizontal Irradiance (GHI) does not have symptoms related to immunodeficiency as it is a measure of the total amount of shortwave solar radiation received at the Earth's surface.""]","[""Short stature, immune deficiency, delayed bone age, and increased fat mass""]","[""Recurrent infections, slow growth, failure to thrive, and susceptibility to infections are common symptoms of GHI with immunodeficiency.""]",[false],[true],[false],"[""Global Horizontal Irradiance (GHI) does not have symptoms related to immunodeficiency as it is a measure of the total amount of shortwave solar radiation received at the surface of the Earth.""]","[""Short stature, delayed bone age, immune deficiency, and increased susceptibility to infections.""]","[""Symptoms of GHI with immunodeficiency include recurrent infections, failure to thrive, chronic diarrhea, and skin rashes.""]",[false],[true],[false],"[""There is no direct correlation between Global Horizontal Irradiance (GHI) and immunodeficiency symptoms.""]","[""Short stature, immune deficiency, delayed bone age, and facial abnormalities""]","[""Symptoms of GHI with immunodeficiency include recurrent infections, failure to thrive, chronic diarrhea, and skin rashes.""]",[false],[true],[false],"[""Global Horizontal Irradiance (GHI) does not have symptoms related to immunodeficiency as it is a measure of the total amount of shortwave solar radiation received at the Earth's surface.""]","[""Short stature, immune deficiency, delayed bone age, and dysmorphic features.""]","[""Symptoms of GHI with immunodeficiency include recurrent infections, failure to thrive, chronic diarrhea, and skin rashes.""]",[false],[false],[false],"[""Symptoms of GHI with immunodeficiency include recurrent infections, slow growth, failure to thrive, and susceptibility to opportunistic infections.""]","[""Short stature, delayed bone age, immune deficiency, and increased susceptibility to infections.""]","[""Symptoms of GHI with immunodeficiency include recurrent infections, failure to thrive, chronic diarrhea, and skin rashes.""]",[true],[false],[true],"[""Symptoms of GHI with immunodeficiency include recurrent infections, slow growth, failure to thrive, and susceptibility to opportunistic infections.""]","[""Short stature, immune deficiency, delayed bone age, and increased fat mass""]","[""Recurrent infections, slow growth, failure to thrive, and susceptibility to infections are common symptoms of GHI with immunodeficiency.""]",[false],[true],[false],"[""Symptoms of GHI with immunodeficiency include recurrent infections, slow growth, failure to thrive, and susceptibility to opportunistic infections.""]","[""Short stature, immune deficiency, delayed bone age, and facial abnormalities""]","[""Symptoms of GHI with immunodeficiency include recurrent infections, failure to thrive, chronic diarrhea, and skin rashes.""]",[false],[true],[false],"[""Symptoms of GHI with immunodeficiency include recurrent infections, slow growth, failure to thrive, and susceptibility to opportunistic infections.""]","[""Short stature, immune deficiency, delayed bone age, and dysmorphic features.""]","[""Symptoms of GHI with immunodeficiency include recurrent infections, failure to thrive, chronic diarrhea, and skin rashes.""]",[true],[true],[true],"[""Symptoms of GHI with immunodeficiency include recurrent infections, slow growth, failure to thrive, and susceptibility to opportunistic infections.""]","[""Short stature, immune deficiency, delayed bone age, and increased fat mass""]","[""Recurrent infections, slow growth, failure to thrive, and susceptibility to infections are common symptoms of GHI with immunodeficiency.""]",[false],[true],[false],"[""Symptoms of GHI with immunodeficiency include recurrent infections, slow wound healing, frequent illnesses, and susceptibility to opportunistic infections.""]","[""Short stature, delayed bone age, immune deficiency, and increased susceptibility to infections.""]","[""Symptoms of GHI with immunodeficiency include recurrent infections, failure to thrive, chronic diarrhea, and skin rashes.""]",[false],[true],[false],"[""Symptoms of GHI with immunodeficiency include recurrent infections, slow wound healing, frequent illnesses, and susceptibility to opportunistic infections.""]","[""Short stature, immune deficiency, delayed bone age, and facial abnormalities""]","[""Symptoms of GHI with immunodeficiency include recurrent infections, failure to thrive, chronic diarrhea, and skin rashes.""]",[false],[true],[false],"[""Symptoms of GHI with immunodeficiency include recurrent infections, slow growth, failure to thrive, and susceptibility to opportunistic infections.""]","[""Short stature, immune deficiency, delayed bone age, and dysmorphic features.""]","[""Symptoms of GHI with immunodeficiency include recurrent infections, failure to thrive, chronic diarrhea, and skin rashes.""]",[true],[true],[true],"[""Symptoms of GHI with immunodeficiency include frequent infections, slow growth, failure to thrive, and susceptibility to certain infections.""]","[""Short stature, immune deficiency, delayed bone age, and increased fat mass""]","[""Recurrent infections, slow growth, failure to thrive, and susceptibility to infections are common symptoms of GHI with immunodeficiency.""]",[true],[true],[false],"[""Symptoms of GHI with immunodeficiency include recurrent infections, slow growth, failure to thrive, and susceptibility to opportunistic infections.""]","[""Short stature, delayed bone age, immune deficiency, and increased susceptibility to infections.""]","[""Symptoms of GHI with immunodeficiency include recurrent infections, failure to thrive, chronic diarrhea, and skin rashes.""]",[false],[true],[false],"[""Symptoms of GHI with immunodeficiency include recurrent infections, slow growth, failure to thrive, and susceptibility to opportunistic infections.""]","[""Short stature, immune deficiency, delayed bone age, and facial abnormalities""]","[""Symptoms of GHI with immunodeficiency include recurrent infections, failure to thrive, chronic diarrhea, and skin rashes.""]",[false],[true],[false],"[""Symptoms of GHI with immunodeficiency include recurrent infections, slow growth, failure to thrive, and susceptibility to opportunistic infections.""]","[""Short stature, immune deficiency, delayed bone age, and dysmorphic features.""]","[""Symptoms of GHI with immunodeficiency include recurrent infections, failure to thrive, chronic diarrhea, and skin rashes.""]",[false],[true],[true],"[""Symptoms of Genital Herpes Infection (GHI) with immunodeficiency may include severe and prolonged outbreaks, increased frequency of outbreaks, and potential complications such as systemic infection.""]","[""Short stature, immune deficiency, delayed bone age, and increased fat mass""]","[""Recurrent infections, slow growth, failure to thrive, and susceptibility to infections are common symptoms of GHI with immunodeficiency.""]",[false],[true],[false],"[""People with immunodeficiency may experience more severe and frequent outbreaks of genital herpes, along with prolonged healing times.""]","[""Short stature, delayed bone age, immune deficiency, and increased susceptibility to infections.""]","[""Symptoms of GHI with immunodeficiency include recurrent infections, failure to thrive, chronic diarrhea, and skin rashes.""]",[false],[true],[false],"[""Symptoms of Genital Herpes Infection with immunodeficiency may include severe and prolonged outbreaks, increased frequency of outbreaks, and more severe symptoms such as ulcers and lesions.""]","[""Short stature, immune deficiency, delayed bone age, and facial abnormalities""]","[""Symptoms of GHI with immunodeficiency include recurrent infections, failure to thrive, chronic diarrhea, and skin rashes.""]",[false],[true],[false],"[""Symptoms of Genital Herpes Infection with immunodeficiency include painful sores or blisters in the genital area, flu-like symptoms, swollen lymph nodes, and increased frequency of outbreaks.""]","[""Short stature, immune deficiency, delayed bone age, and dysmorphic features.""]","[""Symptoms of GHI with immunodeficiency include recurrent infections, failure to thrive, chronic diarrhea, and skin rashes.""]",[true],[true],[true],"[""Symptoms of GHI with immunodeficiency may include frequent infections, slow wound healing, fatigue, and susceptibility to opportunistic infections.""]","[""Short stature, immune deficiency, delayed bone age, and increased fat mass""]","[""Recurrent infections, slow growth, failure to thrive, and susceptibility to infections are common symptoms of GHI with immunodeficiency.""]",[false],[false],[false],"[""Symptoms of GHI with immunodeficiency include frequent infections, slow growth, failure to thrive, and susceptibility to opportunistic infections.""]","[""Short stature, delayed bone age, immune deficiency, and increased susceptibility to infections.""]","[""Symptoms of GHI with immunodeficiency include recurrent infections, failure to thrive, chronic diarrhea, and skin rashes.""]",[false],[true],[false],"[""Symptoms of GHI with immunodeficiency include frequent infections, slow wound healing, fatigue, weight loss, and recurrent illnesses.""]","[""Short stature, immune deficiency, delayed bone age, and facial abnormalities""]","[""Symptoms of GHI with immunodeficiency include recurrent infections, failure to thrive, chronic diarrhea, and skin rashes.""]",[false],[true],[false],"[""Symptoms of GHI with immunodeficiency include frequent infections, slow wound healing, fatigue, and susceptibility to opportunistic infections.""]","[""Short stature, immune deficiency, delayed bone age, and dysmorphic features.""]","[""Symptoms of GHI with immunodeficiency include recurrent infections, failure to thrive, chronic diarrhea, and skin rashes.""]",[true],[true],[true],"[""Symptoms of GHI with immunodeficiency include frequent infections, slow wound healing, fatigue, and susceptibility to opportunistic infections.""]","[""Short stature, immune deficiency, delayed bone age, and increased fat mass""]","[""Recurrent infections, slow growth, failure to thrive, and susceptibility to infections are common symptoms of GHI with immunodeficiency.""]",[true],[true],[true],"[""Symptoms of GHI with immunodeficiency may include frequent infections, slow wound healing, fatigue, and susceptibility to illnesses.""]","[""Short stature, immune deficiency, delayed bone age, and increased fat mass""]","[""Recurrent infections, slow growth, failure to thrive, and susceptibility to infections are common symptoms of GHI with immunodeficiency.""]",[false],[true],[true],"[""There is no direct correlation between Global Horizontal Irradiance (GHI) and immunodeficiency symptoms.""]","[""Short stature, immune deficiency, delayed bone age, and increased fat mass""]","[""Recurrent infections, slow growth, failure to thrive, and susceptibility to infections are common symptoms of GHI with immunodeficiency.""]",[false],[true],[true],"[""Genital herpes infection with immunodeficiency may present with more severe and prolonged symptoms such as frequent outbreaks, larger lesions, and increased risk of complications.""]","[""Short stature, immune deficiency, delayed bone age, and increased fat mass""]","[""Recurrent infections, slow growth, failure to thrive, and susceptibility to infections are common symptoms of GHI with immunodeficiency.""]"
symptoms,What are the symptoms of Arthrogryposis renal dysfunction cholestasis syndrome ?,"What are the signs and symptoms of Arthrogryposis renal dysfunction cholestasis syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Arthrogryposis renal dysfunction cholestasis syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the renal tubule 90% Abnormality of thrombocytes 90% Cognitive impairment 90% Limitation of joint mobility 90% Low-set, posteriorly rotated ears 90% Abnormal renal physiology 50% Abnormality of coagulation 50% Abnormality of temperature regulation 50% Aminoaciduria 50% Diabetes insipidus 50% Hepatomegaly 50% Ichthyosis 50% Malabsorption 50% Muscular hypotonia 50% Oligohydramnios 50% Recurrent fractures 50% Rocker bottom foot 50% Skeletal muscle atrophy 50% Talipes 50% Abnormality of the cardiac septa 7.5% Abnormality of the hip bone 7.5% Abnormality of the palate 7.5% Anemia 7.5% Aplasia/Hypoplasia of the corpus callosum 7.5% Cirrhosis 7.5% Convex nasal ridge 7.5% Cutis laxa 7.5% Depressed nasal bridge 7.5% Hypothyroidism 7.5% Kyphosis 7.5% Nephrolithiasis 7.5% Pectus carinatum 7.5% Sensorineural hearing impairment 7.5% Upslanted palpebral fissure 7.5% Abnormal bleeding 5% Lissencephaly 5% Nephrogenic diabetes insipidus 5% Atria septal defect - Autosomal recessive inheritance - Cholestatic liver disease - Conjugated hyperbilirubinemia - Death in infancy - Dehydration - Elevated hepatic transaminases - Failure to thrive - Giant cell hepatitis - Hip dysplasia - Jaundice - Low-set ears - Metabolic acidosis - Microcephaly - Nephrocalcinosis - Nephropathy - Renal tubular acidosis - Right ventricular hypertrophy - Sloping forehead - Talipes calcaneovalgus - Ventricular septal defect - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""ARC"", ""full_form"": ""Arthrogryposis renal dysfunction cholestasis syndrome""}]}",What are the symptoms of ARC ?,What are the symptoms of Arthrogryposis renal dysfunction cholestasis syndrome ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""American Red Cross"", ""AIDS Related Complex"", ""Auckland Regional Council"", ""Amateur Radio Club"", ""Aramaic"", ""Appalachian Regional Commission"", ""Association for Retarded Citizens"", ""Anti-Reflective Coating"", ""Anti Reflective Coating"", ""Academic Resource Center""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""AIDS-related complex""]",[3.597909038819103e-30],[7.327544877452502e-16],"[""Aramaic""]",[3.4445162736844825e-11],"[""ABBREVIATIONS""]","[[1.4548237081731627e-11, 1.0489723817710523e-14, 8.042257783057443e-23, 3.2070050513649146e-17, 3.4445162736844825e-11, 4.0847926441507345e-28, 4.0045823571376284e-21, 4.980175548532455e-15, 2.3750596024778228e-17, 2.2072146621131564e-14]]",[0.7065611646751045],[0.7842132068108529],"[""Amateur Radio Club""]",[0.8677341714954908],"[""ABBREVIATIONS""]","[[0.835563018979661, 0.7961305326385482, 0.7866216219870712, 0.757256394058223, 0.8677341714954908, 0.7705229872761754, 0.7632239172625557, 0.7324487522804928, 0.7358377196731275, 0.7830442288898696]]","[""AIDS Related Complex""]","[""ABBREVIATIONS""]",What are the symptoms of ARC (AIDS-related complex) ?,[false],[true],[false],"[""Symptoms of ARC (Aramaic) include fever, sore throat, rash, and swollen lymph nodes.""]","[""Symptoms of Arthrogryposis renal dysfunction cholestasis syndrome include joint contractures, kidney dysfunction, and liver problems.""]","[""Symptoms of ARC include fever, weight loss, night sweats, swollen lymph nodes, and diarrhea.""]",[false],[true],[false],"[""Symptoms of ARC (Aramaic) include fever, fatigue, weight loss, swollen lymph nodes, and skin rashes.""]","[""The symptoms of Arthrogryposis renal dysfunction cholestasis syndrome include joint contractures, kidney dysfunction, and liver problems.""]","[""Symptoms of ARC include fever, weight loss, night sweats, swollen lymph nodes, and diarrhea.""]",[false],[true],[false],"[""Symptoms of ARC (Aramaic) include fever, sore throat, rash, and swollen lymph nodes.""]","[""The symptoms of Arthrogryposis renal dysfunction cholestasis syndrome include joint contractures, kidney dysfunction, and liver problems.""]","[""Symptoms of ARC include fever, weight loss, fatigue, swollen lymph nodes, and skin rashes.""]",[false],[true],[false],"[""Symptoms of ARC (Aramaic) include fever, sore throat, swollen lymph nodes, and rash.""]","[""The symptoms of Arthrogryposis renal dysfunction cholestasis syndrome include joint contractures (arthrogryposis), kidney dysfunction, and liver problems such as cholestasis.""]","[""Symptoms of ARC include fever, swollen lymph nodes, sore throat, rash, and muscle and joint pain.""]",[false],[true],[false],"[""There is no medical condition known as ARC (Amateur Radio Club). It is a term related to amateur radio enthusiasts and clubs.""]","[""Symptoms of Arthrogryposis renal dysfunction cholestasis syndrome include joint contractures, kidney dysfunction, and liver problems.""]","[""Symptoms of ARC include fever, weight loss, night sweats, swollen lymph nodes, and diarrhea.""]",[false],[true],[false],"[""There is a misunderstanding in the query. ARC in the medical context usually refers to AIDS-related complex, not Amateur Radio Club.""]","[""The symptoms of Arthrogryposis renal dysfunction cholestasis syndrome include joint contractures, kidney dysfunction, and liver problems.""]","[""Symptoms of ARC include fever, weight loss, night sweats, swollen lymph nodes, and diarrhea.""]",[false],[true],[false],"[""There is no medical condition known as ARC (Amateur Radio Club). It is a term related to amateur radio enthusiasts and clubs.""]","[""The symptoms of Arthrogryposis renal dysfunction cholestasis syndrome include joint contractures, kidney dysfunction, and liver problems.""]","[""Symptoms of ARC include fever, weight loss, fatigue, swollen lymph nodes, and skin rashes.""]",[false],[true],[false],"[""The symptoms of ARC (Amateur Radio Club) are typically related to radio communication activities and may include interest in radio technology, participation in radio events, and networking with other radio enthusiasts.""]","[""The symptoms of Arthrogryposis renal dysfunction cholestasis syndrome include joint contractures (arthrogryposis), kidney dysfunction, and liver problems such as cholestasis.""]","[""Symptoms of ARC include fever, swollen lymph nodes, sore throat, rash, and muscle and joint pain.""]",[false],[true],[false],"[""Symptoms of ARC (AIDS Related Complex) include fever, weight loss, night sweats, swollen lymph nodes, and fatigue.""]","[""The symptoms of Arthrogryposis renal dysfunction cholestasis syndrome include joint contractures, kidney dysfunction, and liver problems.""]","[""Symptoms of ARC include fever, weight loss, night sweats, swollen lymph nodes, and diarrhea.""]",[false],[true],[false],"[""Symptoms of ARC (AIDS Related Complex) include fever, weight loss, night sweats, swollen lymph nodes, and fatigue.""]","[""Symptoms of Arthrogryposis renal dysfunction cholestasis syndrome include joint contractures, kidney dysfunction, and liver problems.""]","[""Symptoms of ARC include fever, weight loss, night sweats, swollen lymph nodes, and diarrhea.""]",[false],[true],[false],"[""Symptoms of ARC (AIDS Related Complex) include fever, weight loss, night sweats, swollen lymph nodes, and fatigue.""]","[""The symptoms of Arthrogryposis renal dysfunction cholestasis syndrome include joint contractures, kidney dysfunction, and liver problems.""]","[""Symptoms of ARC include fever, weight loss, fatigue, swollen lymph nodes, and skin rashes.""]",[false],[true],[false],"[""Symptoms of ARC (AIDS Related Complex) include fever, weight loss, night sweats, swollen lymph nodes, and fatigue.""]","[""The symptoms of Arthrogryposis renal dysfunction cholestasis syndrome include joint contractures (arthrogryposis), kidney dysfunction, and liver problems such as cholestasis.""]","[""Symptoms of ARC include fever, swollen lymph nodes, sore throat, rash, and muscle and joint pain.""]",[false],[true],[false],"[""Symptoms of ARC (AIDS Related Complex) include fever, weight loss, night sweats, swollen lymph nodes, and fatigue.""]","[""Symptoms of Arthrogryposis renal dysfunction cholestasis syndrome include joint contractures, kidney dysfunction, and liver problems.""]","[""Symptoms of ARC include fever, weight loss, night sweats, swollen lymph nodes, and diarrhea.""]",[false],[true],[false],"[""Symptoms of ARC include fever, weight loss, night sweats, swollen lymph nodes, and fatigue.""]","[""The symptoms of Arthrogryposis renal dysfunction cholestasis syndrome include joint contractures, kidney dysfunction, and liver problems.""]","[""Symptoms of ARC include fever, weight loss, night sweats, swollen lymph nodes, and diarrhea.""]",[false],[true],[false],"[""Symptoms of ARC include fever, weight loss, night sweats, swollen lymph nodes, and diarrhea.""]","[""The symptoms of Arthrogryposis renal dysfunction cholestasis syndrome include joint contractures, kidney dysfunction, and liver problems.""]","[""Symptoms of ARC include fever, weight loss, fatigue, swollen lymph nodes, and skin rashes.""]",[false],[true],[false],"[""Symptoms of ARC include fever, weight loss, night sweats, swollen lymph nodes, and fatigue.""]","[""The symptoms of Arthrogryposis renal dysfunction cholestasis syndrome include joint contractures (arthrogryposis), kidney dysfunction, and liver problems such as cholestasis.""]","[""Symptoms of ARC include fever, swollen lymph nodes, sore throat, rash, and muscle and joint pain.""]",[false],[true],[false],"[""Symptoms of ARC (AIDS Related Complex) include fever, weight loss, night sweats, swollen lymph nodes, diarrhea, and fatigue.""]","[""Symptoms of Arthrogryposis renal dysfunction cholestasis syndrome include joint contractures, kidney dysfunction, and liver problems.""]","[""Symptoms of ARC include fever, weight loss, night sweats, swollen lymph nodes, and diarrhea.""]",[false],[true],[false],"[""Symptoms of ARC (AIDS Related Complex) include fever, weight loss, night sweats, swollen lymph nodes, and fatigue.""]","[""The symptoms of Arthrogryposis renal dysfunction cholestasis syndrome include joint contractures, kidney dysfunction, and liver problems.""]","[""Symptoms of ARC include fever, weight loss, night sweats, swollen lymph nodes, and diarrhea.""]",[false],[true],[false],"[""Symptoms of ARC (AIDS Related Complex) include fever, weight loss, night sweats, swollen lymph nodes, diarrhea, and fatigue.""]","[""The symptoms of Arthrogryposis renal dysfunction cholestasis syndrome include joint contractures, kidney dysfunction, and liver problems.""]","[""Symptoms of ARC include fever, weight loss, fatigue, swollen lymph nodes, and skin rashes.""]",[false],[true],[false],"[""Symptoms of ARC (AIDS Related Complex) include fever, weight loss, night sweats, swollen lymph nodes, and fatigue.""]","[""The symptoms of Arthrogryposis renal dysfunction cholestasis syndrome include joint contractures (arthrogryposis), kidney dysfunction, and liver problems such as cholestasis.""]","[""Symptoms of ARC include fever, swollen lymph nodes, sore throat, rash, and muscle and joint pain.""]",[false],[true],[false],"[""Symptoms of ARC (AIDS-related complex) include fever, weight loss, night sweats, swollen lymph nodes, and fatigue.""]","[""Symptoms of Arthrogryposis renal dysfunction cholestasis syndrome include joint contractures, kidney dysfunction, and liver problems.""]","[""Symptoms of ARC include fever, weight loss, night sweats, swollen lymph nodes, and diarrhea.""]",[false],[true],[false],"[""Symptoms of ARC (AIDS-related complex) include fever, weight loss, night sweats, swollen lymph nodes, and fatigue.""]","[""The symptoms of Arthrogryposis renal dysfunction cholestasis syndrome include joint contractures, kidney dysfunction, and liver problems.""]","[""Symptoms of ARC include fever, weight loss, night sweats, swollen lymph nodes, and diarrhea.""]",[false],[true],[false],"[""Symptoms of ARC (AIDS-related complex) include fever, weight loss, night sweats, swollen lymph nodes, and fatigue.""]","[""The symptoms of Arthrogryposis renal dysfunction cholestasis syndrome include joint contractures, kidney dysfunction, and liver problems.""]","[""Symptoms of ARC include fever, weight loss, fatigue, swollen lymph nodes, and skin rashes.""]",[false],[true],[false],"[""Symptoms of ARC (AIDS-related complex) include fever, weight loss, night sweats, swollen lymph nodes, and fatigue.""]","[""The symptoms of Arthrogryposis renal dysfunction cholestasis syndrome include joint contractures (arthrogryposis), kidney dysfunction, and liver problems such as cholestasis.""]","[""Symptoms of ARC include fever, swollen lymph nodes, sore throat, rash, and muscle and joint pain.""]",[false],[true],[false],"[""Symptoms of ARC (AIDS Related Complex) include fever, weight loss, night sweats, swollen lymph nodes, diarrhea, and fatigue.""]","[""Symptoms of Arthrogryposis renal dysfunction cholestasis syndrome include joint contractures, kidney dysfunction, and liver problems.""]","[""Symptoms of ARC include fever, weight loss, night sweats, swollen lymph nodes, and diarrhea.""]",[false],[true],[false],"[""Symptoms of ARC (AIDS Related Complex) include fever, weight loss, night sweats, swollen lymph nodes, and fatigue.""]","[""The symptoms of Arthrogryposis renal dysfunction cholestasis syndrome include joint contractures, kidney dysfunction, and liver problems.""]","[""Symptoms of ARC include fever, weight loss, night sweats, swollen lymph nodes, and diarrhea.""]",[false],[true],[false],"[""Symptoms of ARC (AIDS Related Complex) include fever, weight loss, night sweats, swollen lymph nodes, and fatigue.""]","[""The symptoms of Arthrogryposis renal dysfunction cholestasis syndrome include joint contractures, kidney dysfunction, and liver problems.""]","[""Symptoms of ARC include fever, weight loss, fatigue, swollen lymph nodes, and skin rashes.""]",[false],[true],[false],"[""Some symptoms of ARC (AIDS Related Complex) include fever, weight loss, night sweats, swollen lymph nodes, and diarrhea.""]","[""The symptoms of Arthrogryposis renal dysfunction cholestasis syndrome include joint contractures (arthrogryposis), kidney dysfunction, and liver problems such as cholestasis.""]","[""Symptoms of ARC include fever, swollen lymph nodes, sore throat, rash, and muscle and joint pain.""]",[false],[true],[false],"[""Symptoms of ARC include fever, weight loss, diarrhea, swollen lymph nodes, and skin rashes.""]","[""Symptoms of Arthrogryposis renal dysfunction cholestasis syndrome include joint contractures, kidney dysfunction, and liver problems.""]","[""Symptoms of ARC include fever, weight loss, night sweats, swollen lymph nodes, and diarrhea.""]",[false],[true],[false],"[""Symptoms of ARC (Aramaic) include fever, fatigue, weight loss, night sweats, and enlarged lymph nodes.""]","[""Symptoms of Arthrogryposis renal dysfunction cholestasis syndrome include joint contractures, kidney dysfunction, and liver problems.""]","[""Symptoms of ARC include fever, weight loss, night sweats, swollen lymph nodes, and diarrhea.""]",[false],[true],[false],"[""Some common symptoms of ARC (Amateur Radio Club) include interest in radio communication, participation in club activities, and engagement in amateur radio events.""]","[""Symptoms of Arthrogryposis renal dysfunction cholestasis syndrome include joint contractures, kidney dysfunction, and liver problems.""]","[""Symptoms of ARC include fever, weight loss, night sweats, swollen lymph nodes, and diarrhea.""]",[false],[true],[false],"[""Symptoms of ARC include fever, weight loss, night sweats, swollen lymph nodes, and fatigue.""]","[""Symptoms of Arthrogryposis renal dysfunction cholestasis syndrome include joint contractures, kidney dysfunction, and liver problems.""]","[""Symptoms of ARC include fever, weight loss, night sweats, swollen lymph nodes, and diarrhea.""]"
genetic changes,What are the genetic changes related to carnitine palmitoyltransferase I deficiency ?,"Mutations in the CPT1A gene cause CPT I deficiency. This gene provides instructions for making an enzyme called carnitine palmitoyltransferase 1A, which is found in the liver. Carnitine palmitoyltransferase 1A is essential for fatty acid oxidation, which is the multistep process that breaks down (metabolizes) fats and converts them into energy. Fatty acid oxidation takes place within mitochondria, which are the energy-producing centers in cells. A group of fats called long-chain fatty acids cannot enter mitochondria unless they are attached to carnitine. Carnitine palmitoyltransferase 1A connects carnitine to long-chain fatty acids so they can enter mitochondria and be used to produce energy. During periods of fasting, long-chain fatty acids are an important energy source for the liver and other tissues.  Mutations in the CPT1A gene severely reduce or eliminate the activity of carnitine palmitoyltransferase 1A. Without enough of this enzyme, carnitine is not attached to long-chain fatty acids. As a result, these fatty acids cannot enter mitochondria and be converted into energy. Reduced energy production can lead to some of the features of CPT I deficiency, such as hypoketotic hypoglycemia. Fatty acids may also build up in cells and damage the liver, heart, and brain. This abnormal buildup causes the other signs and symptoms of the disorder.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""CPT I"", ""full_form"": ""carnitine palmitoyltransferase I""}]}",What are the genetic changes related to CPT I deficiency ?,What are the genetic changes related to carnitine palmitoyltransferase I deficiency ?,8,MEDICAL,Compound Datatype-String,"Exploratory(Divergent Thinking): Queries that are inherently about seeking new areas of knowledge, understanding emerging trends, or identifying unknown opportunities without a specific end goal of making a decision or judgment. Exploratory queries are characterized by their openness and the lack of a predefined objective, differentiating them from evaluative queries which are directed towards forming a judgment or assessment. Exploratory queries encourage branching out into various directions to explore a wide array of possibilities without necessarily aiming to converge on a single answer or outcome.","[[""Core Pre-Tax Income"", ""Counselling & Psychotherapy Training Institute"", ""Carnitine Palmitoyltransferase I (medical disorder)"", ""Commercial Pure Titanium"", ""Counselling and Psychotherapy Training Institute (Edinburgh, Scotland, UK)"", ""Committee on Pipe and Tube Imports"", ""Center for Patent and Trademark Information"", ""Canadian Petroleum Training Institute"", ""Concrete Polishing Technical Institute"", ""Collaborative Practice Training Institute (Lynchburg, VA)"", ""Conscience and Peace Tax International""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER""]]","[""Carnitine Palmitoyltransferase I""]",[5.713454094216638e-36],[5.713454094216638e-36],"[""Commercial Pure Titanium""]",[1.2534134618766186e-15],"[""ACRONYMFINDER""]","[[3.910196754679615e-20, 1.7055387862861195e-24, 3.9053545267551607e-50, 1.2534134618766186e-15, 2.839576082521761e-57, 2.542044047173138e-26, 7.586987735037486e-23, 2.4410679250249245e-24, 1.2669972102837792e-24, 3.710208627132853e-44, 6.022972970065428e-26]]",[0.958690878026053],[0.9579064623315103],"[""Conscience and Peace Tax International""]",[0.9579064623315103],"[""LLM""]","[[0.9347692319590658, 0.906406404289056, 0.9154398952085486, 0.8663732732844108, 0.9069269211147839, 0.8958933777786559, 0.9377465906103891, 0.9197695852809566, 0.8921520862499995, 0.9117263475278494, 0.8665242090940094]]","[""Carnitine Palmitoyltransferase I (medical disorder)""]","[""ACRONYMFINDER""]",What are the genetic changes related to CPT I (Carnitine Palmitoyltransferase I) deficiency ?,[true],[true],[true],"[""Genetic changes related to CPT I deficiency include mutations in the CPT1A gene.""]","[""Genetic changes related to carnitine palmitoyltransferase I deficiency include mutations in the CPT1A gene.""]","[""Mutations in the CPT1A gene are associated with CPT I deficiency.""]",[true],[true],[true],"[""Mutations in the CPT1A gene are associated with CPT I deficiency.""]","[""Genetic changes related to carnitine palmitoyltransferase I deficiency include mutations in the CPT1A gene.""]","[""Genetic changes related to CPT I deficiency include mutations in the CPT1A gene.""]",[true],[true],[true],"[""Genetic changes related to CPT I deficiency include mutations in the CPT1A gene.""]","[""Genetic changes related to carnitine palmitoyltransferase I deficiency include mutations in the CPT1A gene.""]","[""Mutations in the CPT1A gene are responsible for CPT I deficiency.""]",[true],[true],[true],"[""Genetic changes related to CPT I deficiency include mutations in the CPT1A gene.""]","[""Genetic changes related to carnitine palmitoyltransferase I deficiency include mutations in the CPT1A gene.""]","[""Mutations in the CPT1A gene are responsible for CPT I deficiency.""]",[true],[true],[true],"[""Mutations in the CPT1A gene are responsible for CPT I deficiency, leading to impaired mitochondrial fatty acid oxidation.""]","[""Genetic changes related to carnitine palmitoyltransferase I deficiency include mutations in the CPT1A gene.""]","[""Mutations in the CPT1A gene are associated with CPT I deficiency.""]",[true],[true],[true],"[""Genetic changes related to CPT I deficiency include mutations in the CPT1A gene.""]","[""Genetic changes related to carnitine palmitoyltransferase I deficiency include mutations in the CPT1A gene.""]","[""Genetic changes related to CPT I deficiency include mutations in the CPT1A gene.""]",[true],[true],[true],"[""Mutations in the CPT1A gene are responsible for CPT I deficiency, leading to impaired transport of long-chain fatty acids into the mitochondria for beta-oxidation.""]","[""Genetic changes related to carnitine palmitoyltransferase I deficiency include mutations in the CPT1A gene.""]","[""Mutations in the CPT1A gene are responsible for CPT I deficiency.""]",[true],[true],[true],"[""Genetic changes related to CPT I deficiency include mutations in the CPT1A gene.""]","[""Genetic changes related to carnitine palmitoyltransferase I deficiency include mutations in the CPT1A gene.""]","[""Mutations in the CPT1A gene are responsible for CPT I deficiency.""]",[true],[true],[true],"[""Genetic changes related to CPT I deficiency include mutations in the CPT1A gene.""]","[""Genetic changes related to carnitine palmitoyltransferase I deficiency include mutations in the CPT1A gene.""]","[""Genetic changes related to CPT I deficiency include mutations in the CPT1A gene.""]",[true],[true],[true],"[""Genetic changes related to CPT I deficiency include mutations in the CPT1A gene.""]","[""Genetic changes related to carnitine palmitoyltransferase I deficiency include mutations in the CPT1A gene.""]","[""Mutations in the CPT1A gene are associated with CPT I deficiency.""]",[true],[true],[true],"[""Genetic changes related to CPT I deficiency include mutations in the CPT1A gene.""]","[""Genetic changes related to carnitine palmitoyltransferase I deficiency include mutations in the CPT1A gene.""]","[""Mutations in the CPT1A gene are responsible for CPT I deficiency.""]",[true],[true],[true],"[""Mutations in the CPT1A gene are responsible for CPT I deficiency, leading to impaired mitochondrial fatty acid oxidation.""]","[""Genetic changes related to carnitine palmitoyltransferase I deficiency include mutations in the CPT1A gene.""]","[""Mutations in the CPT1A gene are responsible for CPT I deficiency.""]",[true],[true],[true],"[""Genetic changes related to CPT I deficiency include mutations in the CPT1A gene.""]","[""Genetic changes related to carnitine palmitoyltransferase I deficiency include mutations in the CPT1A gene.""]","[""Mutations in the CPT1A gene are associated with CPT I deficiency.""]",[true],[true],[true],"[""Genetic changes related to CPT I deficiency include mutations in the CPT1A gene.""]","[""Genetic changes related to carnitine palmitoyltransferase I deficiency include mutations in the CPT1A gene.""]","[""Genetic changes related to CPT I deficiency include mutations in the CPT1A gene.""]",[true],[true],[true],"[""Genetic changes related to CPT I deficiency include mutations in the CPT1A gene.""]","[""Genetic changes related to carnitine palmitoyltransferase I deficiency include mutations in the CPT1A gene.""]","[""Mutations in the CPT1A gene are responsible for CPT I deficiency.""]",[true],[true],[true],"[""Genetic changes related to CPT I deficiency include mutations in the CPT1A gene.""]","[""Genetic changes related to carnitine palmitoyltransferase I deficiency include mutations in the CPT1A gene.""]","[""Mutations in the CPT1A gene are responsible for CPT I deficiency.""]",[true],[true],[true],"[""Genetic changes related to CPT I deficiency include mutations in the CPT1A gene.""]","[""Genetic changes related to carnitine palmitoyltransferase I deficiency include mutations in the CPT1A gene.""]","[""Mutations in the CPT1A gene are associated with CPT I deficiency.""]",[true],[true],[true],"[""Genetic changes related to CPT I deficiency include mutations in the CPT1A gene.""]","[""Genetic changes related to carnitine palmitoyltransferase I deficiency include mutations in the CPT1A gene.""]","[""Genetic changes related to CPT I deficiency include mutations in the CPT1A gene.""]",[true],[true],[true],"[""Genetic changes related to CPT I deficiency include mutations in the CPT1A gene.""]","[""Genetic changes related to carnitine palmitoyltransferase I deficiency include mutations in the CPT1A gene.""]","[""Mutations in the CPT1A gene are responsible for CPT I deficiency.""]",[true],[true],[true],"[""Genetic changes related to CPT I deficiency include mutations in the CPT1A gene.""]","[""Genetic changes related to carnitine palmitoyltransferase I deficiency include mutations in the CPT1A gene.""]","[""Mutations in the CPT1A gene are responsible for CPT I deficiency.""]",[true],[true],[true],"[""Genetic changes related to CPT I deficiency include mutations in the CPT1A gene.""]","[""Genetic changes related to carnitine palmitoyltransferase I deficiency include mutations in the CPT1A gene.""]","[""Mutations in the CPT1A gene are associated with CPT I deficiency.""]",[true],[true],[true],"[""Genetic changes related to CPT I deficiency include mutations in the CPT1A gene, which encodes the enzyme Carnitine Palmitoyltransferase I. These mutations can lead to a decrease in enzyme activity, affecting the transport of long-chain fatty acids into the mitochondria for beta-oxidation.""]","[""Genetic changes related to carnitine palmitoyltransferase I deficiency include mutations in the CPT1A gene.""]","[""Genetic changes related to CPT I deficiency include mutations in the CPT1A gene.""]",[true],[true],[true],"[""Genetic changes related to CPT I deficiency include mutations in the CPT1A gene located on chromosome 11q13.3.""]","[""Genetic changes related to carnitine palmitoyltransferase I deficiency include mutations in the CPT1A gene.""]","[""Mutations in the CPT1A gene are responsible for CPT I deficiency.""]",[true],[true],[true],"[""The genetic changes related to CPT I deficiency are mutations in the CPT1A gene.""]","[""Genetic changes related to carnitine palmitoyltransferase I deficiency include mutations in the CPT1A gene.""]","[""Mutations in the CPT1A gene are responsible for CPT I deficiency.""]",[true],[true],[true],"[""Genetic changes related to CPT I deficiency include mutations in the CPT1A gene.""]","[""Genetic changes related to carnitine palmitoyltransferase I deficiency include mutations in the CPT1A gene.""]","[""Mutations in the CPT1A gene are associated with CPT I deficiency.""]",[true],[true],[true],"[""Genetic changes related to CPT I deficiency include mutations in the CPT1A gene.""]","[""Genetic changes related to carnitine palmitoyltransferase I deficiency include mutations in the CPT1A gene.""]","[""Genetic changes related to CPT I deficiency include mutations in the CPT1A gene.""]",[true],[true],[true],"[""Genetic changes related to CPT I deficiency include mutations in the CPT1A gene.""]","[""Genetic changes related to carnitine palmitoyltransferase I deficiency include mutations in the CPT1A gene.""]","[""Mutations in the CPT1A gene are responsible for CPT I deficiency.""]",[true],[true],[true],"[""Genetic changes related to CPT I deficiency include mutations in the CPT1A gene.""]","[""Genetic changes related to carnitine palmitoyltransferase I deficiency include mutations in the CPT1A gene.""]","[""Mutations in the CPT1A gene are responsible for CPT I deficiency.""]",[true],[true],[true],"[""Genetic changes related to CPT I deficiency include mutations in the CPT1A gene.""]","[""Genetic changes related to carnitine palmitoyltransferase I deficiency include mutations in the CPT1A gene.""]","[""Mutations in the CPT1A gene are associated with CPT I deficiency.""]",[true],[true],[true],"[""Genetic changes related to CPT I deficiency include mutations in the CPT1A gene.""]","[""Genetic changes related to carnitine palmitoyltransferase I deficiency include mutations in the CPT1A gene.""]","[""Mutations in the CPT1A gene are associated with CPT I deficiency.""]",[true],[true],[true],"[""Genetic changes related to CPT I deficiency include mutations in the CPT1A gene.""]","[""Genetic changes related to carnitine palmitoyltransferase I deficiency include mutations in the CPT1A gene.""]","[""Mutations in the CPT1A gene are associated with CPT I deficiency.""]",[true],[true],[true],"[""Genetic changes related to CPT I deficiency include mutations in the CPT1A gene.""]","[""Genetic changes related to carnitine palmitoyltransferase I deficiency include mutations in the CPT1A gene.""]","[""Mutations in the CPT1A gene are associated with CPT I deficiency.""]"
symptoms,What are the symptoms of Dyssynergia cerebellaris myoclonica ?,"What are the signs and symptoms of Dyssynergia cerebellaris myoclonica? The Human Phenotype Ontology provides the following list of signs and symptoms for Dyssynergia cerebellaris myoclonica. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Generalized seizures 7.5% Abnormality of the dentate nucleus - Abnormality of the mitochondrion - Ataxia - Autosomal dominant inheritance - Intention tremor - Myoclonus - Pallidal degeneration - Ragged-red muscle fibers - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""DCM"", ""full_form"": ""Dyssynergia cerebellaris myoclonica""}]}",What are the symptoms of DCM ?,What are the symptoms of Dyssynergia cerebellaris myoclonica ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Demand Chain Management"", ""Digital Clock Manager"", ""Dining Chair Metal"", ""District Committee Member"", ""Deep Chlorophyll Maximum"", ""Director of Civilian Marksmanship"", ""Castres, France"", ""Divisional Council Meeting"", ""Division Council Meeting"", ""Dangerous Cargo Manifest""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Dilated Cardiomyopathy""]",[3.121649946933946e-28],[2.8763174378661996e-08],"[""Dilated Cardiomyopathy""]",[2.8763174378661996e-08],"[""LLM""]","[[2.673336767858189e-14, 1.8855644915424945e-16, 1.3114644155362318e-15, 9.541917094028952e-14, 9.79267798341131e-25, 2.697043056359228e-23, 1.5020132430436486e-18, 4.268312449764807e-17, 1.2785615724139687e-14, 3.1457288687446386e-17]]",[0.6394063802317035],[0.902819851476513],"[""Dangerous Cargo Manifest""]",[0.902819851476513],"[""LLM""]","[[0.6682503694531616, 0.7377894409214186, 0.7049962228213702, 0.7019174977825338, 0.5999584874761348, 0.6729293082428683, 0.7656713521259609, 0.743664042401355, 0.7699319840647214, 0.6347496184939777]]","[""Dilated Cardiomyopathy""]","[""LLM""]",What are the symptoms of DCM (Dilated Cardiomyopathy) ?,[false],[true],[false],"[""Symptoms of Dilated Cardiomyopathy (DCM) include shortness of breath, fatigue, swelling in the legs, ankles, and feet, irregular heartbeats, dizziness, and fainting.""]","[""Symptoms of Dyssynergia cerebellaris myoclonica include myoclonic jerks, intention tremors, ataxia, dysarthria, and cognitive impairment.""]","[""Symptoms of dilated cardiomyopathy (DCM) include shortness of breath, fatigue, swelling of the lower extremities, irregular heartbeats, and chest pain or discomfort.""]",[false],[true],[false],"[""Symptoms of Dilated Cardiomyopathy (DCM) include shortness of breath, fatigue, swelling of the legs, ankles, and feet, irregular heartbeats, dizziness, and fainting.""]","[""Symptoms of Dyssynergia cerebellaris myoclonica include myoclonic jerks, intention tremors, ataxia, dysarthria, and cognitive impairment.""]","[""Symptoms of DCM include shortness of breath, swelling of the legs, fatigue, irregular heartbeat, and dizziness.""]",[false],[true],[false],"[""Symptoms of Dilated Cardiomyopathy (DCM) include shortness of breath, fatigue, swelling of the legs, ankles, and feet, irregular heartbeats, dizziness, and fainting.""]","[""Symptoms of Dyssynergia cerebellaris myoclonica include myoclonic jerks, intention tremors, ataxia, dysarthria, and cognitive impairment.""]","[""Symptoms of DCM include shortness of breath, fatigue, swelling in the legs, and rapid or irregular heartbeat.""]",[false],[true],[false],"[""Symptoms of Dilated Cardiomyopathy (DCM) include shortness of breath, fatigue, swelling of the legs, ankles, and feet, irregular heartbeats, dizziness, and fainting.""]","[""Symptoms of Dyssynergia cerebellaris myoclonica include myoclonic jerks, intention tremors, ataxia, dysarthria, and cognitive impairment.""]","[""Symptoms of DCM include shortness of breath, fatigue, swelling in the legs, rapid or irregular heartbeat, and dizziness.""]",[false],[true],[false],"[""Symptoms of DCM (Dangerous Cargo Manifest) include headache, dizziness, nausea, vomiting, and shortness of breath.""]","[""Symptoms of Dyssynergia cerebellaris myoclonica include myoclonic jerks, intention tremors, ataxia, dysarthria, and cognitive impairment.""]","[""Symptoms of dilated cardiomyopathy (DCM) include shortness of breath, fatigue, swelling of the lower extremities, irregular heartbeats, and chest pain or discomfort.""]",[false],[true],[false],"[""Symptoms of DCM (Dangerous Cargo Manifest) are not applicable as it is a shipping document used in the transportation of hazardous materials.""]","[""Symptoms of Dyssynergia cerebellaris myoclonica include myoclonic jerks, intention tremors, ataxia, dysarthria, and cognitive impairment.""]","[""Symptoms of DCM include shortness of breath, swelling of the legs, fatigue, irregular heartbeat, and dizziness.""]",[false],[true],[false],"[""Symptoms of DCM (Dilated Cardiomyopathy) include shortness of breath, fatigue, swelling of the legs, ankles, and feet, irregular heartbeats, chest pain, and fainting.""]","[""Symptoms of Dyssynergia cerebellaris myoclonica include myoclonic jerks, intention tremors, ataxia, dysarthria, and cognitive impairment.""]","[""Symptoms of DCM include shortness of breath, fatigue, swelling in the legs, and rapid or irregular heartbeat.""]",[false],[true],[false],"[""Symptoms of DCM (Dangerous Cargo Manifest) include headache, dizziness, nausea, and shortness of breath.""]","[""Symptoms of Dyssynergia cerebellaris myoclonica include myoclonic jerks, intention tremors, ataxia, dysarthria, and cognitive impairment.""]","[""Symptoms of DCM include shortness of breath, fatigue, swelling in the legs, rapid or irregular heartbeat, and dizziness.""]",[false],[true],[false],"[""Symptoms of Dilated Cardiomyopathy (DCM) include shortness of breath, fatigue, swelling of the legs, ankles, and feet, irregular heartbeats, dizziness, and fainting.""]","[""Symptoms of Dyssynergia cerebellaris myoclonica include myoclonic jerks, intention tremors, ataxia, dysarthria, and cognitive impairment.""]","[""Symptoms of DCM include shortness of breath, swelling of the legs, fatigue, irregular heartbeat, and dizziness.""]",[false],[true],[false],"[""Symptoms of Dilated Cardiomyopathy (DCM) include shortness of breath, fatigue, swelling of the legs, ankles, and feet, irregular heartbeats, dizziness, and fainting.""]","[""Symptoms of Dyssynergia cerebellaris myoclonica include myoclonic jerks, intention tremors, ataxia, dysarthria, and cognitive impairment.""]","[""Symptoms of dilated cardiomyopathy (DCM) include shortness of breath, fatigue, swelling of the lower extremities, irregular heartbeats, and chest pain or discomfort.""]",[false],[true],[false],"[""Symptoms of Dilated Cardiomyopathy (DCM) include shortness of breath, fatigue, swelling of the legs, ankles, and feet, irregular heartbeats, dizziness, and fainting.""]","[""Symptoms of Dyssynergia cerebellaris myoclonica include myoclonic jerks, intention tremors, ataxia, dysarthria, and cognitive impairment.""]","[""Symptoms of DCM include shortness of breath, fatigue, swelling in the legs, and rapid or irregular heartbeat.""]",[false],[true],[false],"[""Symptoms of Dilated Cardiomyopathy (DCM) include shortness of breath, fatigue, swelling of the legs, ankles, and feet, irregular heartbeats, dizziness, and fainting.""]","[""Symptoms of Dyssynergia cerebellaris myoclonica include myoclonic jerks, intention tremors, ataxia, dysarthria, and cognitive impairment.""]","[""Symptoms of DCM include shortness of breath, fatigue, swelling in the legs, rapid or irregular heartbeat, and dizziness.""]",[false],[true],[false],"[""Symptoms of Dilated Cardiomyopathy (DCM) include shortness of breath, fatigue, swelling of the legs, ankles, or abdomen, irregular heartbeats, dizziness, and fainting.""]","[""Symptoms of Dyssynergia cerebellaris myoclonica include myoclonic jerks, intention tremors, ataxia, dysarthria, and cognitive impairment.""]","[""Symptoms of dilated cardiomyopathy (DCM) include shortness of breath, fatigue, swelling of the lower extremities, irregular heartbeats, and chest pain or discomfort.""]",[false],[true],[false],"[""Symptoms of DCM include shortness of breath, fatigue, swelling of the legs, ankles, or abdomen, irregular heartbeats, dizziness, and fainting.""]","[""Symptoms of Dyssynergia cerebellaris myoclonica include myoclonic jerks, intention tremors, ataxia, dysarthria, and cognitive impairment.""]","[""Symptoms of DCM include shortness of breath, swelling of the legs, fatigue, irregular heartbeat, and dizziness.""]",[false],[true],[false],"[""Symptoms of Dilated Cardiomyopathy (DCM) include shortness of breath, fatigue, swelling of the legs, ankles, and feet, irregular heartbeats, dizziness, and fainting.""]","[""Symptoms of Dyssynergia cerebellaris myoclonica include myoclonic jerks, intention tremors, ataxia, dysarthria, and cognitive impairment.""]","[""Symptoms of DCM include shortness of breath, fatigue, swelling in the legs, and rapid or irregular heartbeat.""]",[false],[true],[false],"[""Symptoms of Dilated Cardiomyopathy (DCM) include shortness of breath, fatigue, swelling of the legs, ankles, and feet, irregular heartbeats, dizziness, and fainting.""]","[""Symptoms of Dyssynergia cerebellaris myoclonica include myoclonic jerks, intention tremors, ataxia, dysarthria, and cognitive impairment.""]","[""Symptoms of DCM include shortness of breath, fatigue, swelling in the legs, rapid or irregular heartbeat, and dizziness.""]",[false],[true],[false],"[""Symptoms of DCM (Dilated Cardiomyopathy) include shortness of breath, fatigue, swelling of the legs, ankles, and feet, irregular heartbeats, chest pain or discomfort, and dizziness or lightheadedness.""]","[""Symptoms of Dyssynergia cerebellaris myoclonica include myoclonic jerks, intention tremors, ataxia, dysarthria, and cognitive impairment.""]","[""Symptoms of dilated cardiomyopathy (DCM) include shortness of breath, fatigue, swelling of the lower extremities, irregular heartbeats, and chest pain or discomfort.""]",[false],[true],[false],"[""Symptoms of Dilated Cardiomyopathy (DCM) include shortness of breath, fatigue, swelling of the legs, ankles, and feet, irregular heartbeats, dizziness, and fainting.""]","[""Symptoms of Dyssynergia cerebellaris myoclonica include myoclonic jerks, intention tremors, ataxia, dysarthria, and cognitive impairment.""]","[""Symptoms of DCM include shortness of breath, swelling of the legs, fatigue, irregular heartbeat, and dizziness.""]",[false],[true],[false],"[""Symptoms of Dilated Cardiomyopathy (DCM) include shortness of breath, fatigue, swelling of the legs, ankles, and feet, irregular heartbeats, dizziness, and fainting.""]","[""Symptoms of Dyssynergia cerebellaris myoclonica include myoclonic jerks, intention tremors, ataxia, dysarthria, and cognitive impairment.""]","[""Symptoms of DCM include shortness of breath, fatigue, swelling in the legs, and rapid or irregular heartbeat.""]",[false],[true],[false],"[""Symptoms of Dilated Cardiomyopathy (DCM) include shortness of breath, fatigue, swelling of the legs, ankles, and feet, irregular heartbeats, dizziness, and fainting.""]","[""Symptoms of Dyssynergia cerebellaris myoclonica include myoclonic jerks, intention tremors, ataxia, dysarthria, and cognitive impairment.""]","[""Symptoms of DCM include shortness of breath, fatigue, swelling in the legs, rapid or irregular heartbeat, and dizziness.""]",[false],[true],[false],"[""Symptoms of Dilated Cardiomyopathy (DCM) include shortness of breath, fatigue, swelling of the legs, ankles, and feet, irregular heartbeats, dizziness, and fainting.""]","[""Symptoms of Dyssynergia cerebellaris myoclonica include myoclonic jerks, intention tremors, ataxia, dysarthria, and cognitive impairment.""]","[""Symptoms of dilated cardiomyopathy (DCM) include shortness of breath, fatigue, swelling of the lower extremities, irregular heartbeats, and chest pain or discomfort.""]",[false],[true],[false],"[""Symptoms of Dilated Cardiomyopathy (DCM) include shortness of breath, fatigue, swelling of the legs, ankles, and feet, irregular heartbeats, dizziness, and fainting.""]","[""Symptoms of Dyssynergia cerebellaris myoclonica include myoclonic jerks, intention tremors, ataxia, dysarthria, and cognitive impairment.""]","[""Symptoms of DCM include shortness of breath, swelling of the legs, fatigue, irregular heartbeat, and dizziness.""]",[false],[true],[false],"[""Symptoms of Dilated Cardiomyopathy (DCM) include shortness of breath, fatigue, swelling of the legs, ankles, and feet, irregular heartbeats, chest pain, and fainting.""]","[""Symptoms of Dyssynergia cerebellaris myoclonica include myoclonic jerks, intention tremors, ataxia, dysarthria, and cognitive impairment.""]","[""Symptoms of DCM include shortness of breath, fatigue, swelling in the legs, and rapid or irregular heartbeat.""]",[false],[true],[false],"[""Symptoms of Dilated Cardiomyopathy (DCM) include shortness of breath, fatigue, swelling of the legs, ankles, or abdomen, irregular heartbeats, dizziness, and fainting.""]","[""Symptoms of Dyssynergia cerebellaris myoclonica include myoclonic jerks, intention tremors, ataxia, dysarthria, and cognitive impairment.""]","[""Symptoms of DCM include shortness of breath, fatigue, swelling in the legs, rapid or irregular heartbeat, and dizziness.""]",[false],[true],[false],"[""Symptoms of Dilated Cardiomyopathy (DCM) include fatigue, shortness of breath, swelling of the legs, ankles, or abdomen, irregular heartbeats, dizziness, and fainting.""]","[""Symptoms of Dyssynergia cerebellaris myoclonica include myoclonic jerks, intention tremors, ataxia, dysarthria, and cognitive impairment.""]","[""Symptoms of dilated cardiomyopathy (DCM) include shortness of breath, fatigue, swelling of the lower extremities, irregular heartbeats, and chest pain or discomfort.""]",[false],[true],[false],"[""Symptoms of Dilated Cardiomyopathy (DCM) include shortness of breath, fatigue, swelling in the ankles, legs, and abdomen, irregular heartbeats, dizziness, and fainting.""]","[""Symptoms of Dyssynergia cerebellaris myoclonica include myoclonic jerks, intention tremors, ataxia, dysarthria, and cognitive impairment.""]","[""Symptoms of DCM include shortness of breath, swelling of the legs, fatigue, irregular heartbeat, and dizziness.""]",[false],[true],[false],"[""Symptoms of Dilated Cardiomyopathy (DCM) include shortness of breath, fatigue, swelling of the legs, ankles, and feet, irregular heartbeats, dizziness, fainting, and chest discomfort.""]","[""Symptoms of Dyssynergia cerebellaris myoclonica include myoclonic jerks, intention tremors, ataxia, dysarthria, and cognitive impairment.""]","[""Symptoms of DCM include shortness of breath, fatigue, swelling in the legs, and rapid or irregular heartbeat.""]",[false],[true],[false],"[""Symptoms of Dilated Cardiomyopathy (DCM) include shortness of breath, fatigue, swelling of the legs, ankles, and feet, irregular heartbeats, chest pain, and fainting.""]","[""Symptoms of Dyssynergia cerebellaris myoclonica include myoclonic jerks, intention tremors, ataxia, dysarthria, and cognitive impairment.""]","[""Symptoms of DCM include shortness of breath, fatigue, swelling in the legs, rapid or irregular heartbeat, and dizziness.""]",[false],[true],[false],"[""Symptoms of DCM include shortness of breath, fatigue, swelling of the legs, ankles, and feet, irregular heartbeats, dizziness, and fainting.""]","[""Symptoms of Dyssynergia cerebellaris myoclonica include myoclonic jerks, intention tremors, ataxia, dysarthria, and cognitive impairment.""]","[""Symptoms of dilated cardiomyopathy (DCM) include shortness of breath, fatigue, swelling of the lower extremities, irregular heartbeats, and chest pain or discomfort.""]",[false],[true],[false],"[""Symptoms of Dilated Cardiomyopathy (DCM) include shortness of breath, fatigue, swelling of the legs, ankles, and feet, irregular heartbeats, dizziness, and fainting.""]","[""Symptoms of Dyssynergia cerebellaris myoclonica include myoclonic jerks, intention tremors, ataxia, dysarthria, and cognitive impairment.""]","[""Symptoms of dilated cardiomyopathy (DCM) include shortness of breath, fatigue, swelling of the lower extremities, irregular heartbeats, and chest pain or discomfort.""]",[false],[true],[false],"[""Symptoms of DCM include headache, dizziness, nausea, vomiting, and difficulty breathing.""]","[""Symptoms of Dyssynergia cerebellaris myoclonica include myoclonic jerks, intention tremors, ataxia, dysarthria, and cognitive impairment.""]","[""Symptoms of dilated cardiomyopathy (DCM) include shortness of breath, fatigue, swelling of the lower extremities, irregular heartbeats, and chest pain or discomfort.""]",[false],[true],[false],"[""Symptoms of DCM include shortness of breath, fatigue, swelling of the legs, ankles, and feet, irregular heartbeats, dizziness, and fainting.""]","[""Symptoms of Dyssynergia cerebellaris myoclonica include myoclonic jerks, intention tremors, ataxia, dysarthria, and cognitive impairment.""]","[""Symptoms of dilated cardiomyopathy (DCM) include shortness of breath, fatigue, swelling of the lower extremities, irregular heartbeats, and chest pain or discomfort.""]"
considerations,What to do for Ulcerative Colitis ?,"- Ulcerative colitis is a chronic, or long lasting, disease that causes inflammationirritation or swellingand sores called ulcers on the inner lining of the large intestine.  - The exact cause of ulcerative colitis is unknown. Researchers believe that factors such as an overactive intestinal immune system, genes, and environment may play a role in causing ulcerative colitis.  - Ulcerative colitis can occur in people of any age. However, it is more likely to develop in people      - between the ages of 15 and 30    - older than 60    - who have a family member with inflammatory bowel disease (IBD)    - of Jewish descent    - The most common signs and symptoms of ulcerative colitis are diarrhea with blood or pus and abdominal discomfort.  - A health care provider diagnoses ulcerative colitis with the following:      - medical and family history    - physical exam    - lab tests    - endoscopies of the large intestine    - Which treatment a person needs depends on the severity of the disease and symptoms.  - Good nutrition is important in the management of ulcerative colitis. A health care provider may recommend that a person make dietary changes.  - People with ulcerative colitis should talk with their health care provider about how often they should get screened for colon cancer.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""UC"", ""full_form"": ""Ulcerative Colitis""}]}",What to do for UC ?,What to do for Ulcerative Colitis ?,2,COMMUNITY,Simple Datatype-String,Composite: This category includes queries that do not fit neatly into the above categories or have unique/multiple intents not covered by the previous categories.,"[[""University of California"", ""University of Chicago"", ""University College"", ""Un-Changed"", ""University of Colorado"", ""Un-Conscious"", ""Under Construction"", ""University of Cincinnati"", ""Upon Completion"", ""Ulcerative Colitis""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Ulcerative Colitis""]",[3.551536788807049e-06],[3.551536788807049e-06],"[""Upon Completion""]",[1.1962696844482808e-05],"[""ABBREVIATIONS""]","[[1.1216490197925907e-16, 4.994532773199237e-14, 2.3156213741410174e-07, 2.4539970441533306e-09, 1.6131830136005978e-15, 1.0251178074450958e-08, 2.6631665243899027e-06, 1.4699743535391331e-19, 1.1962696844482808e-05, 3.551536788807049e-06]]",[0.9117302137538443],[0.9117302137538443],"[""Upon Completion""]",[0.9117302137538443],"[""ABBREVIATIONS""]","[[0.7352857663608736, 0.6980517383685823, 0.7579411244633445, 0.7747471932163762, 0.711009116024355, 0.696092818745592, 0.635770101728929, 0.7116130545829649, 0.7224061501136106, 0.9117302137538443]]","[""Ulcerative Colitis""]","[""ABBREVIATIONS""]",What to do for UC (Ulcerative Colitis) ?,[false],[true],[false],"[""Submit a completion report and hand over any deliverables to the relevant stakeholders.""]","[""For Ulcerative Colitis, it is important to follow a treatment plan prescribed by a healthcare professional, which may include medication, dietary changes, stress management, and regular monitoring of symptoms.""]","[""Engage with the UC community, attend events, participate in discussions, and contribute to projects.""]",[false],[true],[false],"[""Submit a completion report and any necessary documentation.""]","[""For Ulcerative Colitis, it is important to follow a treatment plan prescribed by a healthcare professional, which may include medications, dietary changes, and lifestyle modifications. It is also recommended to manage stress, stay hydrated, and get regular exercise.""]","[""Engage with the community, participate in events, and contribute positively.""]",[false],[true],[false],"[""Submit a completion report or form as required.""]","[""For Ulcerative Colitis, it is important to follow a treatment plan prescribed by a healthcare professional, which may include medications, dietary changes, and lifestyle modifications. It is also recommended to manage stress, stay hydrated, and get regular exercise.""]","[""Engage with the community, participate in events, and collaborate with other members.""]",[false],[true],[false],"[""Submit the deliverables and close out the project.""]","[""Treatment for Ulcerative Colitis may include medications, lifestyle changes, and in severe cases, surgery.""]","[""Engage with the UC community, attend events, participate in discussions, and contribute to projects.""]",[false],[true],[false],"[""Submit a completion report or document as required.""]","[""For Ulcerative Colitis, it is important to follow a treatment plan prescribed by a healthcare professional, which may include medication, dietary changes, stress management, and regular monitoring of symptoms.""]","[""Engage with the UC community, attend events, participate in discussions, and contribute to projects.""]",[false],[true],[false],"[""Upon Completion, you can review the project, provide feedback, and celebrate the achievement.""]","[""For Ulcerative Colitis, it is important to follow a treatment plan prescribed by a healthcare professional, which may include medications, dietary changes, and lifestyle modifications. It is also recommended to manage stress, stay hydrated, and get regular exercise.""]","[""Engage with the community, participate in events, and contribute positively.""]",[false],[true],[false],"[""Submit a completion report and hand over all deliverables to the relevant stakeholders.""]","[""For Ulcerative Colitis, it is important to follow a treatment plan prescribed by a healthcare professional, which may include medications, dietary changes, and lifestyle modifications. It is also recommended to manage stress, stay hydrated, and get regular exercise.""]","[""Engage with the community, participate in events, and collaborate with other members.""]",[false],[true],[false],"[""Submit a completion report and any necessary documentation.""]","[""Treatment for Ulcerative Colitis may include medications, lifestyle changes, and in severe cases, surgery.""]","[""Engage with the UC community, attend events, participate in discussions, and contribute to projects.""]",[true],[true],[false],"[""For Ulcerative Colitis (UC), it is important to follow a treatment plan prescribed by a healthcare provider, which may include medications, lifestyle changes, and possibly surgery in severe cases. It is also recommended to maintain a healthy diet, manage stress, stay hydrated, and get regular exercise.""]","[""For Ulcerative Colitis, it is important to follow a treatment plan prescribed by a healthcare professional, which may include medications, dietary changes, and lifestyle modifications. It is also recommended to manage stress, stay hydrated, and get regular exercise.""]","[""Engage with the community, participate in events, and contribute positively.""]",[true],[true],[false],"[""For Ulcerative Colitis (UC), it is important to follow a treatment plan prescribed by a healthcare provider, which may include medications, dietary changes, stress management, and regular monitoring. It is also recommended to avoid trigger foods, stay hydrated, get regular exercise, and prioritize rest and self-care.""]","[""For Ulcerative Colitis, it is important to follow a treatment plan prescribed by a healthcare professional, which may include medication, dietary changes, stress management, and regular monitoring of symptoms.""]","[""Engage with the UC community, attend events, participate in discussions, and contribute to projects.""]",[true],[true],[false],"[""For Ulcerative Colitis (UC), it is important to follow a treatment plan prescribed by a healthcare professional, which may include medications, dietary changes, stress management, and regular monitoring. It is also recommended to avoid trigger foods, stay hydrated, get regular exercise, and prioritize rest and self-care.""]","[""For Ulcerative Colitis, it is important to follow a treatment plan prescribed by a healthcare professional, which may include medications, dietary changes, and lifestyle modifications. It is also recommended to manage stress, stay hydrated, and get regular exercise.""]","[""Engage with the community, participate in events, and collaborate with other members.""]",[true],[true],[false],"[""For Ulcerative Colitis (UC), it is important to follow a treatment plan prescribed by a healthcare professional, which may include medications, lifestyle changes, and possibly surgery in severe cases. It is also recommended to maintain a healthy diet, manage stress, stay hydrated, and get regular exercise.""]","[""Treatment for Ulcerative Colitis may include medications, lifestyle changes, and in severe cases, surgery.""]","[""Engage with the UC community, attend events, participate in discussions, and contribute to projects.""]",[true],[true],[false],"[""For Ulcerative Colitis (UC), it is recommended to follow a treatment plan prescribed by a healthcare professional, which may include medications, dietary changes, and lifestyle modifications. It is important to regularly consult with a healthcare provider for proper management of the condition.""]","[""For Ulcerative Colitis, it is important to follow a treatment plan prescribed by a healthcare professional, which may include medication, dietary changes, stress management, and regular monitoring of symptoms.""]","[""Engage with the UC community, attend events, participate in discussions, and contribute to projects.""]",[true],[true],[false],"[""For Ulcerative Colitis (UC), it is important to follow a treatment plan prescribed by a healthcare provider, which may include medications, dietary changes, stress management, and regular monitoring of symptoms.""]","[""For Ulcerative Colitis, it is important to follow a treatment plan prescribed by a healthcare professional, which may include medications, dietary changes, and lifestyle modifications. It is also recommended to manage stress, stay hydrated, and get regular exercise.""]","[""Engage with the community, participate in events, and contribute positively.""]",[true],[true],[false],"[""For Ulcerative Colitis (UC), it is important to follow a treatment plan prescribed by a healthcare professional, which may include medications, dietary changes, and lifestyle modifications. It is also important to regularly monitor and manage symptoms, attend follow-up appointments, and seek support from healthcare providers and support groups.""]","[""For Ulcerative Colitis, it is important to follow a treatment plan prescribed by a healthcare professional, which may include medications, dietary changes, and lifestyle modifications. It is also recommended to manage stress, stay hydrated, and get regular exercise.""]","[""Engage with the community, participate in events, and collaborate with other members.""]",[true],[true],[false],"[""For Ulcerative Colitis (UC), it is recommended to follow a treatment plan prescribed by a healthcare professional, which may include medications, dietary changes, and lifestyle modifications. It is important to regularly communicate with your healthcare provider and follow their guidance.""]","[""Treatment for Ulcerative Colitis may include medications, lifestyle changes, and in severe cases, surgery.""]","[""Engage with the UC community, attend events, participate in discussions, and contribute to projects.""]",[true],[true],[false],"[""For Ulcerative Colitis (UC), treatment typically involves medications to reduce inflammation in the colon, such as aminosalicylates, corticosteroids, immunomodulators, and biologics. Lifestyle changes like following a specific diet, managing stress, and regular exercise can also help manage symptoms.""]","[""For Ulcerative Colitis, it is important to follow a treatment plan prescribed by a healthcare professional, which may include medication, dietary changes, stress management, and regular monitoring of symptoms.""]","[""Engage with the UC community, attend events, participate in discussions, and contribute to projects.""]",[true],[true],[false],"[""For Ulcerative Colitis (UC), it is important to follow a treatment plan prescribed by a healthcare provider, which may include medications, lifestyle changes, and possibly surgery in severe cases. It is also important to maintain a healthy diet, manage stress, and stay hydrated.""]","[""For Ulcerative Colitis, it is important to follow a treatment plan prescribed by a healthcare professional, which may include medications, dietary changes, and lifestyle modifications. It is also recommended to manage stress, stay hydrated, and get regular exercise.""]","[""Engage with the community, participate in events, and contribute positively.""]",[true],[true],[false],"[""For Ulcerative Colitis (UC), it is important to follow a treatment plan prescribed by a healthcare provider, which may include medications, dietary changes, stress management, and regular monitoring. It is also recommended to avoid trigger foods, stay hydrated, get regular exercise, and prioritize good sleep hygiene.""]","[""For Ulcerative Colitis, it is important to follow a treatment plan prescribed by a healthcare professional, which may include medications, dietary changes, and lifestyle modifications. It is also recommended to manage stress, stay hydrated, and get regular exercise.""]","[""Engage with the community, participate in events, and collaborate with other members.""]",[true],[true],[false],"[""For Ulcerative Colitis (UC), it is important to follow a treatment plan prescribed by a healthcare professional, which may include medications, dietary changes, stress management, and regular monitoring of symptoms.""]","[""Treatment for Ulcerative Colitis may include medications, lifestyle changes, and in severe cases, surgery.""]","[""Engage with the UC community, attend events, participate in discussions, and contribute to projects.""]",[true],[true],[false],"[""For Ulcerative Colitis (UC), it is important to follow a treatment plan prescribed by a healthcare professional, which may include medications, lifestyle changes, and possibly surgery in severe cases. It is also recommended to maintain a healthy diet, manage stress, stay hydrated, and get regular exercise.""]","[""For Ulcerative Colitis, it is important to follow a treatment plan prescribed by a healthcare professional, which may include medication, dietary changes, stress management, and regular monitoring of symptoms.""]","[""Engage with the UC community, attend events, participate in discussions, and contribute to projects.""]",[true],[true],[false],"[""For Ulcerative Colitis (UC), it is important to follow a treatment plan prescribed by a healthcare provider, which may include medications, lifestyle changes, and possibly surgery in severe cases. It is also important to maintain a healthy diet, manage stress, and stay hydrated. Regular monitoring and follow-up with a healthcare provider are crucial for managing UC effectively.""]","[""For Ulcerative Colitis, it is important to follow a treatment plan prescribed by a healthcare professional, which may include medications, dietary changes, and lifestyle modifications. It is also recommended to manage stress, stay hydrated, and get regular exercise.""]","[""Engage with the community, participate in events, and contribute positively.""]",[true],[true],[false],"[""For Ulcerative Colitis (UC), it is important to follow a treatment plan prescribed by a healthcare provider, which may include medications, dietary changes, stress management, and regular monitoring of symptoms. It is also recommended to avoid trigger foods, stay hydrated, get regular exercise, and prioritize rest and self-care.""]","[""For Ulcerative Colitis, it is important to follow a treatment plan prescribed by a healthcare professional, which may include medications, dietary changes, and lifestyle modifications. It is also recommended to manage stress, stay hydrated, and get regular exercise.""]","[""Engage with the community, participate in events, and collaborate with other members.""]",[true],[true],[false],"[""For Ulcerative Colitis (UC), it is important to follow a treatment plan prescribed by a healthcare provider, which may include medications, lifestyle changes, and possibly surgery in severe cases. It is also important to maintain a healthy diet, manage stress, and stay in regular communication with your healthcare team.""]","[""Treatment for Ulcerative Colitis may include medications, lifestyle changes, and in severe cases, surgery.""]","[""Engage with the UC community, attend events, participate in discussions, and contribute to projects.""]",[true],[true],[false],"[""For Ulcerative Colitis (UC), treatment typically involves medications to reduce inflammation in the colon, manage symptoms, and prevent flare-ups. In some cases, surgery may be necessary. It is important to work closely with a healthcare provider to develop a personalized treatment plan.""]","[""For Ulcerative Colitis, it is important to follow a treatment plan prescribed by a healthcare professional, which may include medication, dietary changes, stress management, and regular monitoring of symptoms.""]","[""Engage with the UC community, attend events, participate in discussions, and contribute to projects.""]",[true],[true],[false],"[""For Ulcerative Colitis (UC), treatment options may include medications, lifestyle changes, dietary modifications, and in some cases, surgery. It is important to consult with a healthcare provider for personalized recommendations.""]","[""For Ulcerative Colitis, it is important to follow a treatment plan prescribed by a healthcare professional, which may include medications, dietary changes, and lifestyle modifications. It is also recommended to manage stress, stay hydrated, and get regular exercise.""]","[""Engage with the community, participate in events, and contribute positively.""]",[true],[true],[false],"[""Treatment for UC (Ulcerative Colitis) typically involves medications such as anti-inflammatory drugs, immunosuppressants, and biologics. Lifestyle changes, dietary modifications, and surgery may also be recommended in certain cases.""]","[""For Ulcerative Colitis, it is important to follow a treatment plan prescribed by a healthcare professional, which may include medications, dietary changes, and lifestyle modifications. It is also recommended to manage stress, stay hydrated, and get regular exercise.""]","[""Engage with the community, participate in events, and collaborate with other members.""]",[true],[true],[false],"[""For Ulcerative Colitis (UC), treatment typically involves medications to reduce inflammation in the colon, such as aminosalicylates, corticosteroids, immunomodulators, and biologics. Lifestyle changes like a healthy diet, regular exercise, stress management, and avoiding trigger foods can also help manage symptoms. In some cases, surgery may be necessary.""]","[""Treatment for Ulcerative Colitis may include medications, lifestyle changes, and in severe cases, surgery.""]","[""Engage with the UC community, attend events, participate in discussions, and contribute to projects.""]",[true],[true],[false],"[""Treatment for UC (Ulcerative Colitis) includes medications, lifestyle changes, and sometimes surgery. Medications may include anti-inflammatory drugs, immunosuppressants, and biologics. Lifestyle changes may involve dietary modifications, stress management, and regular exercise. It is important to work closely with a healthcare provider to develop a personalized treatment plan.""]","[""For Ulcerative Colitis, it is important to follow a treatment plan prescribed by a healthcare professional, which may include medication, dietary changes, stress management, and regular monitoring of symptoms.""]","[""Engage with the UC community, attend events, participate in discussions, and contribute to projects.""]",[false],[true],[false],"[""Perform a final review and handover of the completed work.""]","[""For Ulcerative Colitis, it is important to follow a treatment plan prescribed by a healthcare professional, which may include medication, dietary changes, stress management, and regular monitoring of symptoms.""]","[""Engage with the UC community, attend events, participate in discussions, and contribute to projects.""]",[false],[true],[false],"[""Perform final checks and inspections, hand over deliverables, and close out the project.""]","[""For Ulcerative Colitis, it is important to follow a treatment plan prescribed by a healthcare professional, which may include medication, dietary changes, stress management, and regular monitoring of symptoms.""]","[""Engage with the UC community, attend events, participate in discussions, and contribute to projects.""]",[true],[true],[false],"[""For Ulcerative Colitis (UC), treatment may include medications, lifestyle changes, and in some cases, surgery. It is important to work closely with a healthcare provider to develop a personalized treatment plan.""]","[""For Ulcerative Colitis, it is important to follow a treatment plan prescribed by a healthcare professional, which may include medication, dietary changes, stress management, and regular monitoring of symptoms.""]","[""Engage with the UC community, attend events, participate in discussions, and contribute to projects.""]"
frequency,How many people are affected by benign essential blepharospasm ?,"Benign essential blepharospasm affects an estimated 20,000 to 50,000 people in the United States. For unknown reasons, it occurs in women more than twice as often as it occurs in men.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""BEB"", ""full_form"": ""benign essential blepharospasm""}]}",How many people are affected by BEB ?,How many people are affected by benign essential blepharospasm ?,8,MEDICAL,Simple Datatype-Integer,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Benign Essential Blepharospasm"", ""Best Ever Bottled"", ""Basic English Brushup"", ""Blue-Eyed Bulldog"", ""Bad English Ban"", ""Benbecula, Hebrides Islands, Scotland, UK"", ""Best Effort Basis"", ""Bayard Ewing Building"", ""Bring em Back"", ""Biomedical Education Building""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Benign Essential Blepharospasm""]",[2.6169238404720614e-22],[2.6169238404720614e-22],"[""Best Ever Bottled""]",[4.083320407444035e-12],"[""ABBREVIATIONS""]","[[2.6169238404720614e-22, 4.083320407444035e-12, 2.8994619072783644e-17, 2.2045962359672283e-19, 1.5112474870869988e-13, 9.165673386056036e-41, 2.522977863527951e-13, 8.394183782223234e-18, 2.138687782932536e-13, 3.8857958210451334e-19]]",[0.7721481279751276],[0.7700658470510304],"[""Best Effort Basis""]",[0.7974171857669012],"[""ABBREVIATIONS""]","[[0.7700658470510304, 0.7555204222078573, 0.7128921848288683, 0.7224881631016129, 0.681683669315698, 0.721083579456364, 0.7581244234577185, 0.7974171857669012, 0.7798679026811848, 0.6753507030046337]]","[""Benign Essential Blepharospasm""]","[""ABBREVIATIONS""]",How many people are affected by BEB (Benign Essential Blepharospasm) ?,[false],[true],[false],"[""The number of people affected by BEB (Best Ever Bottled) is not available.""]","[""Approximately 50,000 people in the United States are affected by benign essential blepharospasm.""]","[""Approximately 1 in 20,000 people are affected by Benign Essential Blepharospasm (BEB).""]",[false],[true],[false],"[""The number of people affected by BEB (Best Ever Bottled) is not available.""]","[""Approximately 50,000 people in the United States are affected by benign essential blepharospasm.""]","[""Approximately 1 in 1000 people are affected by Benign Essential Blepharospasm (BEB).""]",[false],[true],[true],"[""The number of people affected by BEB (Best Ever Bottled) is not available.""]","[""Approximately 50,000 people are affected by benign essential blepharospasm.""]","[""Approximately 1 in 10,000 people are affected by Benign Essential Blepharospasm (BEB).""]",[false],[true],[false],"[""The exact number of people affected by BEB (Best Ever Bottled) is not available.""]","[""Approximately 50,000 people in the United States are affected by benign essential blepharospasm.""]","[""Approximately 1 in 10,000 people are affected by Benign Essential Blepharospasm (BEB).""]",[false],[true],[false],"[""The number of people affected by BEB (Best Effort Basis) is not accurately documented.""]","[""Approximately 50,000 people in the United States are affected by benign essential blepharospasm.""]","[""Approximately 1 in 20,000 people are affected by Benign Essential Blepharospasm (BEB).""]",[false],[true],[false],"[""There is no specific data available on the exact number of people affected by BEB (Best Effort Basis).""]","[""Approximately 50,000 people in the United States are affected by benign essential blepharospasm.""]","[""Approximately 1 in 1000 people are affected by Benign Essential Blepharospasm (BEB).""]",[false],[true],[true],"[""There is no specific data available on the exact number of people affected by BEB (Best Effort Basis).""]","[""Approximately 50,000 people are affected by benign essential blepharospasm.""]","[""Approximately 1 in 10,000 people are affected by Benign Essential Blepharospasm (BEB).""]",[false],[true],[true],"[""The number of people affected by BEB (Best Effort Basis) is not readily available as it is a networking term and not related to a medical condition.""]","[""Approximately 50,000 people in the United States are affected by benign essential blepharospasm.""]","[""Approximately 1 in 10,000 people are affected by Benign Essential Blepharospasm (BEB).""]",[true],[true],[false],"[""Approximately 50,000 people in the United States are affected by Benign Essential Blepharospasm (BEB).""]","[""Approximately 50,000 people in the United States are affected by benign essential blepharospasm.""]","[""Approximately 1 in 1000 people are affected by Benign Essential Blepharospasm (BEB).""]",[true],[true],[false],"[""Approximately 50,000 people are affected by Benign Essential Blepharospasm (BEB).""]","[""Approximately 50,000 people in the United States are affected by benign essential blepharospasm.""]","[""Approximately 1 in 20,000 people are affected by Benign Essential Blepharospasm (BEB).""]",[true],[true],[false],"[""Approximately 50,000 people are affected by Benign Essential Blepharospasm (BEB).""]","[""Approximately 50,000 people are affected by benign essential blepharospasm.""]","[""Approximately 1 in 10,000 people are affected by Benign Essential Blepharospasm (BEB).""]",[true],[true],[true],"[""Approximately 50,000 people in the United States are affected by Benign Essential Blepharospasm (BEB).""]","[""Approximately 50,000 people in the United States are affected by benign essential blepharospasm.""]","[""Approximately 1 in 10,000 people are affected by Benign Essential Blepharospasm (BEB).""]",[true],[true],[false],"[""The exact number of people affected by BEB (Benign Essential Blepharospasm) is not known, but it is considered a rare condition.""]","[""Approximately 50,000 people in the United States are affected by benign essential blepharospasm.""]","[""Approximately 1 in 20,000 people are affected by Benign Essential Blepharospasm (BEB).""]",[true],[true],[false],"[""Approximately 50,000 people in the United States are affected by BEB (Benign Essential Blepharospasm).""]","[""Approximately 50,000 people in the United States are affected by benign essential blepharospasm.""]","[""Approximately 1 in 1000 people are affected by Benign Essential Blepharospasm (BEB).""]",[true],[true],[false],"[""Approximately 50,000 people in the United States are affected by BEB (Benign Essential Blepharospasm).""]","[""Approximately 50,000 people are affected by benign essential blepharospasm.""]","[""Approximately 1 in 10,000 people are affected by Benign Essential Blepharospasm (BEB).""]",[true],[true],[false],"[""The exact number of people affected by BEB (Benign Essential Blepharospasm) is not known, but it is considered a rare condition.""]","[""Approximately 50,000 people in the United States are affected by benign essential blepharospasm.""]","[""Approximately 1 in 10,000 people are affected by Benign Essential Blepharospasm (BEB).""]",[true],[true],[false],"[""The exact number of people affected by BEB (Benign Essential Blepharospasm) is not well-documented, but it is considered a rare condition with estimates ranging from 1 in 20,000 to 1 in 50,000 individuals.""]","[""Approximately 50,000 people in the United States are affected by benign essential blepharospasm.""]","[""Approximately 1 in 20,000 people are affected by Benign Essential Blepharospasm (BEB).""]",[true],[true],[false],"[""Approximately 50,000 people are affected by BEB (Benign Essential Blepharospasm).""]","[""Approximately 50,000 people in the United States are affected by benign essential blepharospasm.""]","[""Approximately 1 in 1000 people are affected by Benign Essential Blepharospasm (BEB).""]",[true],[false],[false],"[""Approximately 50,000 people in the United States are affected by Benign Essential Blepharospasm (BEB).""]","[""Approximately 50,000 people are affected by benign essential blepharospasm.""]","[""Approximately 1 in 10,000 people are affected by Benign Essential Blepharospasm (BEB).""]",[true],[true],[false],"[""Approximately 50,000 people are affected by Benign Essential Blepharospasm (BEB).""]","[""Approximately 50,000 people in the United States are affected by benign essential blepharospasm.""]","[""Approximately 1 in 10,000 people are affected by Benign Essential Blepharospasm (BEB).""]",[true],[true],[false],"[""Approximately 50,000 people in the United States are affected by Benign Essential Blepharospasm (BEB).""]","[""Approximately 50,000 people in the United States are affected by benign essential blepharospasm.""]","[""Approximately 1 in 20,000 people are affected by Benign Essential Blepharospasm (BEB).""]",[true],[true],[false],"[""Approximately 50,000 people in the United States are affected by BEB (Benign Essential Blepharospasm).""]","[""Approximately 50,000 people in the United States are affected by benign essential blepharospasm.""]","[""Approximately 1 in 1000 people are affected by Benign Essential Blepharospasm (BEB).""]",[true],[true],[true],"[""Approximately 50,000 people are affected by Benign Essential Blepharospasm (BEB).""]","[""Approximately 50,000 people are affected by benign essential blepharospasm.""]","[""Approximately 1 in 10,000 people are affected by Benign Essential Blepharospasm (BEB).""]",[true],[true],[false],"[""Approximately 50,000 people in the United States are affected by Benign Essential Blepharospasm (BEB).""]","[""Approximately 50,000 people in the United States are affected by benign essential blepharospasm.""]","[""Approximately 1 in 10,000 people are affected by Benign Essential Blepharospasm (BEB).""]",[false],[true],[false],"[""The exact number of people affected by Benign Essential Blepharospasm (BEB) is not well-documented, but it is considered a rare neurological disorder.""]","[""Approximately 50,000 people in the United States are affected by benign essential blepharospasm.""]","[""Approximately 1 in 20,000 people are affected by Benign Essential Blepharospasm (BEB).""]",[false],[true],[false],"[""The exact number of people affected by Benign Essential Blepharospasm (BEB) is not known, but it is considered a rare neurological disorder.""]","[""Approximately 50,000 people in the United States are affected by benign essential blepharospasm.""]","[""Approximately 1 in 1000 people are affected by Benign Essential Blepharospasm (BEB).""]",[true],[true],[true],"[""The exact number of people affected by Benign Essential Blepharospasm (BEB) is not well-documented, but it is considered a rare neurological disorder.""]","[""Approximately 50,000 people are affected by benign essential blepharospasm.""]","[""Approximately 1 in 10,000 people are affected by Benign Essential Blepharospasm (BEB).""]",[true],[true],[true],"[""The exact number of people affected by Benign Essential Blepharospasm (BEB) is not well-documented, but it is considered a rare neurological disorder.""]","[""Approximately 50,000 people in the United States are affected by benign essential blepharospasm.""]","[""Approximately 1 in 10,000 people are affected by Benign Essential Blepharospasm (BEB).""]",[true],[true],[false],"[""The exact number of people affected by BEB (Benign Essential Blepharospasm) is not known, but it is considered a rare condition.""]","[""Approximately 50,000 people in the United States are affected by benign essential blepharospasm.""]","[""Approximately 1 in 20,000 people are affected by Benign Essential Blepharospasm (BEB).""]",[false],[true],[false],"[""The number of people affected by BEB (Best Ever Bottled) is not available.""]","[""Approximately 50,000 people in the United States are affected by benign essential blepharospasm.""]","[""Approximately 1 in 20,000 people are affected by Benign Essential Blepharospasm (BEB).""]",[false],[true],[false],"[""The number of people affected by BEB is not specified.""]","[""Approximately 50,000 people in the United States are affected by benign essential blepharospasm.""]","[""Approximately 1 in 20,000 people are affected by Benign Essential Blepharospasm (BEB).""]",[true],[true],[false],"[""The exact number of people affected by BEB (Benign Essential Blepharospasm) is not well-defined, but it is considered a rare condition.""]","[""Approximately 50,000 people in the United States are affected by benign essential blepharospasm.""]","[""Approximately 1 in 20,000 people are affected by Benign Essential Blepharospasm (BEB).""]"
inheritance,Is primary ciliary dyskinesia inherited ?,"This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""PCD"", ""full_form"": ""primary ciliary dyskinesia""}]}",Is PCD inherited ?,Is primary ciliary dyskinesia inherited ?,8,MEDICAL,Simple Datatype-Boolean,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Primary Ciliary Dyskinesia"", ""Pitch Circle Diameter"", ""Paraneoplastic Cerebellar Degeneration"", ""Professionals Complementary To Dentistry"", ""Personal Communication Device"", ""Primary Care Diabetes"", ""Photo Compact Disc"", ""Participatory Curriculum Development"", ""Program Change Decision"", ""Passive Cavitation Detection""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Primary Ciliary Dyskinesia""]",[8.391260849360266e-18],[8.391260849360266e-18],"[""Primary Care Diabetes""]",[1.7563804159121137e-10],"[""ABBREVIATIONS""]","[[8.391260849360266e-18, 3.313754933512527e-15, 1.1406615151242482e-14, 5.470832652044908e-26, 4.7493751188830964e-12, 1.7563804159121137e-10, 2.1322666828473355e-11, 5.915549347891025e-17, 4.517306923285516e-14, 1.40952665129016e-14]]",[0.8032103420069376],[0.8046538465936315],"[""Primary Care Diabetes""]",[0.827857452359053],"[""ABBREVIATIONS""]","[[0.8047679948538249, 0.6413294581544451, 0.7629904868313427, 0.7922124364398686, 0.8186928511941913, 0.8110858538420493, 0.827857452359053, 0.5985060939751072, 0.6524219082306699, 0.7136971719705357]]","[""Primary Ciliary Dyskinesia""]","[""ABBREVIATIONS""]",Is PCD (Primary Ciliary Dyskinesia) inherited ?,[false],[true],[true],"[""PCD (Primary Care Diabetes) is not inherited.""]","[""Yes, primary ciliary dyskinesia is usually inherited in an autosomal recessive pattern.""]","[""Yes, Primary Ciliary Dyskinesia (PCD) is an inherited condition.""]",[false],[true],[true],"[""PCD (Primary Care Diabetes) is not inherited.""]","[""Yes, primary ciliary dyskinesia is usually inherited in an autosomal recessive pattern.""]","[""Yes, Primary Ciliary Dyskinesia (PCD) is an inherited genetic disorder.""]",[false],[true],[true],"[""No""]","[""Yes, primary ciliary dyskinesia is usually inherited in an autosomal recessive pattern.""]","[""Yes, Primary Ciliary Dyskinesia (PCD) is an inherited genetic disorder.""]",[false],[true],[true],"[""No""]","[""Yes, primary ciliary dyskinesia is usually inherited in an autosomal recessive pattern.""]","[""Yes, Primary Ciliary Dyskinesia (PCD) is an inherited genetic disorder.""]",[false],[true],[true],"[""No""]","[""Yes, primary ciliary dyskinesia is usually inherited in an autosomal recessive pattern.""]","[""Yes, Primary Ciliary Dyskinesia (PCD) is an inherited condition.""]",[false],[true],[true],"[""No""]","[""Yes, primary ciliary dyskinesia is usually inherited in an autosomal recessive pattern.""]","[""Yes, Primary Ciliary Dyskinesia (PCD) is an inherited genetic disorder.""]",[false],[true],[true],"[""No, PCD (Primary Care Diabetes) is not inherited.""]","[""Yes, primary ciliary dyskinesia is usually inherited in an autosomal recessive pattern.""]","[""Yes, Primary Ciliary Dyskinesia (PCD) is an inherited genetic disorder.""]",[false],[true],[true],"[""No""]","[""Yes, primary ciliary dyskinesia is usually inherited in an autosomal recessive pattern.""]","[""Yes, Primary Ciliary Dyskinesia (PCD) is an inherited genetic disorder.""]",[true],[true],[true],"[""Yes, PCD (Primary Ciliary Dyskinesia) is usually inherited in an autosomal recessive pattern.""]","[""Yes, primary ciliary dyskinesia is usually inherited in an autosomal recessive pattern.""]","[""Yes, Primary Ciliary Dyskinesia (PCD) is an inherited genetic disorder.""]",[true],[true],[true],"[""Yes, PCD (Primary Ciliary Dyskinesia) is usually inherited in an autosomal recessive pattern.""]","[""Yes, primary ciliary dyskinesia is usually inherited in an autosomal recessive pattern.""]","[""Yes, Primary Ciliary Dyskinesia (PCD) is an inherited condition.""]",[true],[true],[true],"[""Yes, PCD (Primary Ciliary Dyskinesia) is usually inherited in an autosomal recessive pattern.""]","[""Yes, primary ciliary dyskinesia is usually inherited in an autosomal recessive pattern.""]","[""Yes, Primary Ciliary Dyskinesia (PCD) is an inherited genetic disorder.""]",[true],[true],[true],"[""Yes, PCD (Primary Ciliary Dyskinesia) is usually inherited in an autosomal recessive pattern.""]","[""Yes, primary ciliary dyskinesia is usually inherited in an autosomal recessive pattern.""]","[""Yes, Primary Ciliary Dyskinesia (PCD) is an inherited genetic disorder.""]",[true],[true],[true],"[""Yes, PCD (Primary Ciliary Dyskinesia) is usually inherited as an autosomal recessive trait.""]","[""Yes, primary ciliary dyskinesia is usually inherited in an autosomal recessive pattern.""]","[""Yes, Primary Ciliary Dyskinesia (PCD) is an inherited condition.""]",[true],[true],[true],"[""Yes, PCD (Primary Ciliary Dyskinesia) is usually inherited.""]","[""Yes, primary ciliary dyskinesia is usually inherited in an autosomal recessive pattern.""]","[""Yes, Primary Ciliary Dyskinesia (PCD) is an inherited genetic disorder.""]",[true],[true],[true],"[""Yes, PCD (Primary Ciliary Dyskinesia) is usually inherited as an autosomal recessive trait.""]","[""Yes, primary ciliary dyskinesia is usually inherited in an autosomal recessive pattern.""]","[""Yes, Primary Ciliary Dyskinesia (PCD) is an inherited genetic disorder.""]",[true],[true],[true],"[""Yes, PCD (Primary Ciliary Dyskinesia) is usually inherited as an autosomal recessive trait.""]","[""Yes, primary ciliary dyskinesia is usually inherited in an autosomal recessive pattern.""]","[""Yes, Primary Ciliary Dyskinesia (PCD) is an inherited genetic disorder.""]",[true],[true],[true],"[""Yes""]","[""Yes, primary ciliary dyskinesia is usually inherited in an autosomal recessive pattern.""]","[""Yes, Primary Ciliary Dyskinesia (PCD) is an inherited condition.""]",[true],[true],[true],"[""Yes, PCD (Primary Ciliary Dyskinesia) is usually inherited in an autosomal recessive pattern.""]","[""Yes, primary ciliary dyskinesia is usually inherited in an autosomal recessive pattern.""]","[""Yes, Primary Ciliary Dyskinesia (PCD) is an inherited genetic disorder.""]",[true],[true],[true],"[""Yes, PCD (Primary Ciliary Dyskinesia) is an inherited condition.""]","[""Yes, primary ciliary dyskinesia is usually inherited in an autosomal recessive pattern.""]","[""Yes, Primary Ciliary Dyskinesia (PCD) is an inherited genetic disorder.""]",[true],[true],[true],"[""Yes, Primary Ciliary Dyskinesia (PCD) is an inherited condition.""]","[""Yes, primary ciliary dyskinesia is usually inherited in an autosomal recessive pattern.""]","[""Yes, Primary Ciliary Dyskinesia (PCD) is an inherited genetic disorder.""]",[true],[true],[true],"[""Yes, PCD (Primary Ciliary Dyskinesia) is usually inherited in an autosomal recessive pattern.""]","[""Yes, primary ciliary dyskinesia is usually inherited in an autosomal recessive pattern.""]","[""Yes, Primary Ciliary Dyskinesia (PCD) is an inherited condition.""]",[true],[true],[true],"[""Yes, PCD (Primary Ciliary Dyskinesia) is usually inherited in an autosomal recessive pattern.""]","[""Yes, primary ciliary dyskinesia is usually inherited in an autosomal recessive pattern.""]","[""Yes, Primary Ciliary Dyskinesia (PCD) is an inherited genetic disorder.""]",[true],[true],[true],"[""Yes, PCD (Primary Ciliary Dyskinesia) is usually inherited in an autosomal recessive pattern.""]","[""Yes, primary ciliary dyskinesia is usually inherited in an autosomal recessive pattern.""]","[""Yes, Primary Ciliary Dyskinesia (PCD) is an inherited genetic disorder.""]",[true],[true],[true],"[""Yes, PCD (Primary Ciliary Dyskinesia) is usually inherited in an autosomal recessive pattern.""]","[""Yes, primary ciliary dyskinesia is usually inherited in an autosomal recessive pattern.""]","[""Yes, Primary Ciliary Dyskinesia (PCD) is an inherited genetic disorder.""]",[true],[true],[true],"[""Yes, PCD (Primary Ciliary Dyskinesia) is usually inherited in an autosomal recessive pattern.""]","[""Yes, primary ciliary dyskinesia is usually inherited in an autosomal recessive pattern.""]","[""Yes, Primary Ciliary Dyskinesia (PCD) is an inherited condition.""]",[true],[true],[true],"[""Yes, Primary Ciliary Dyskinesia (PCD) is usually inherited in an autosomal recessive pattern.""]","[""Yes, primary ciliary dyskinesia is usually inherited in an autosomal recessive pattern.""]","[""Yes, Primary Ciliary Dyskinesia (PCD) is an inherited genetic disorder.""]",[true],[true],[true],"[""Yes, Primary Ciliary Dyskinesia (PCD) is usually inherited in an autosomal recessive pattern.""]","[""Yes, primary ciliary dyskinesia is usually inherited in an autosomal recessive pattern.""]","[""Yes, Primary Ciliary Dyskinesia (PCD) is an inherited genetic disorder.""]",[true],[true],[true],"[""Yes, Primary Ciliary Dyskinesia (PCD) is usually inherited in an autosomal recessive pattern.""]","[""Yes, primary ciliary dyskinesia is usually inherited in an autosomal recessive pattern.""]","[""Yes, Primary Ciliary Dyskinesia (PCD) is an inherited genetic disorder.""]",[true],[true],[true],"[""Yes, PCD (Primary Ciliary Dyskinesia) is usually inherited.""]","[""Yes, primary ciliary dyskinesia is usually inherited in an autosomal recessive pattern.""]","[""Yes, Primary Ciliary Dyskinesia (PCD) is an inherited condition.""]",[false],[true],[true],"[""PCD (Primary Care Diabetes) is not inherited.""]","[""Yes, primary ciliary dyskinesia is usually inherited in an autosomal recessive pattern.""]","[""Yes, Primary Ciliary Dyskinesia (PCD) is an inherited condition.""]",[false],[true],[true],"[""PCD (Primary Care Diabetes) is not inherited.""]","[""Yes, primary ciliary dyskinesia is usually inherited in an autosomal recessive pattern.""]","[""Yes, Primary Ciliary Dyskinesia (PCD) is an inherited condition.""]",[true],[true],[true],"[""Yes, PCD (Primary Ciliary Dyskinesia) is usually inherited.""]","[""Yes, primary ciliary dyskinesia is usually inherited in an autosomal recessive pattern.""]","[""Yes, Primary Ciliary Dyskinesia (PCD) is an inherited condition.""]"
frequency,How many people are affected by trimethylaminuria ?,Trimethylaminuria is an uncommon genetic disorder; its incidence is unknown.,"{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""TMAU"", ""full_form"": ""trimethylaminuria""}]}",How many people are affected by TMAU ?,How many people are affected by trimethylaminuria ?,8,MEDICAL,Simple Datatype-Integer,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Trimethylaminuria"", ""Tenchi Muyo! Another Universe (Japanese cartoon)""]]","[[""ABBREVIATIONS"", ""THEFREEDICTIONARY""]]","[""Trimethylaminuria""]",[9.892617532357125e-19],[9.892617532357125e-19],"[""Trimethylaminuria""]",[9.892617532357125e-19],"[""ABBREVIATIONS""]","[[9.892617532357125e-19, 8.674315133928545e-46]]",[0.9491649193676092],[0.9483529120034235],"[""trimethylaminuria""]",[0.9483529120034235],"[""ABBREVIATIONS""]","[[0.9483529120034235, 0.7940225075872263]]","[""Trimethylaminuria""]","[""ABBREVIATIONS""]",How many people are affected by TMAU (Trimethylaminuria) ?,[false],[false],[false],"[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""Trimethylaminuria affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]",[false],[false],[false],"[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""Trimethylaminuria affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]",[false],[false],[false],"[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""Trimethylaminuria affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]",[false],[false],[false],"[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""Trimethylaminuria affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]",[false],[false],[false],"[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""Trimethylaminuria affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]",[false],[false],[false],"[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""Trimethylaminuria affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]",[false],[false],[false],"[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""Trimethylaminuria affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]",[false],[false],[false],"[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""Trimethylaminuria affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]",[false],[false],[false],"[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""Trimethylaminuria affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]",[false],[false],[false],"[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""Trimethylaminuria affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]",[false],[false],[false],"[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""Trimethylaminuria affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]",[false],[false],[false],"[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""Trimethylaminuria affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]",[false],[false],[false],"[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""Trimethylaminuria affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]",[false],[false],[false],"[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""Trimethylaminuria affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]",[false],[false],[false],"[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""Trimethylaminuria affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]",[false],[false],[false],"[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""Trimethylaminuria affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]",[false],[false],[false],"[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""Trimethylaminuria affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]",[false],[false],[false],"[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""Trimethylaminuria affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]",[false],[false],[false],"[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""Trimethylaminuria affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]",[false],[false],[false],"[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""Trimethylaminuria affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]",[false],[false],[false],"[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""Trimethylaminuria affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]",[false],[false],[false],"[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""Trimethylaminuria affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]",[false],[false],[false],"[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""Trimethylaminuria affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]",[false],[false],[false],"[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""Trimethylaminuria affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]",[false],[false],[false],"[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""Trimethylaminuria affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]",[true],[false],[false],"[""The exact number of people affected by TMAU (Trimethylaminuria) is not known, but it is considered a rare condition.""]","[""Trimethylaminuria affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]",[true],[false],[false],"[""The exact number of people affected by TMAU (Trimethylaminuria) is not known, but it is considered a rare condition with estimates ranging from 1 in 10,000 to 1 in 200,000 individuals worldwide.""]","[""Trimethylaminuria affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]",[true],[false],[false],"[""The exact number of people affected by TMAU (Trimethylaminuria) is not known, but it is considered a rare condition with estimates suggesting that it affects around 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""Trimethylaminuria affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]",[true],[false],[false],"[""The exact number of people affected by TMAU is unknown, but it is considered to be a rare condition.""]","[""Trimethylaminuria affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]",[true],[false],[false],"[""The exact number of people affected by TMAU (Trimethylaminuria) is unknown, but it is considered to be a rare condition.""]","[""Trimethylaminuria affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]",[true],[false],[false],"[""The exact number of people affected by TMAU (trimethylaminuria) is not known, but it is considered to be a rare condition.""]","[""Trimethylaminuria affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]",[true],[false],[false],"[""The exact number of people affected by TMAU (Trimethylaminuria) is unknown, but it is considered to be a rare condition.""]","[""Trimethylaminuria affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]","[""TMAU affects approximately 1 in 10,000 to 1 in 100,000 people worldwide.""]"
outlook,What is the outlook for Sjgren's Syndrome ?,"Sjgren's syndrome can damage vital organs of the body with symptoms that may remain stable, worsen, or go into remission. Some people may experience only the mild symptoms of dry eyes and mouth, while others go through cycles of good health followed by severe disease. Many patients are able to treat problems symptomatically. Others are forced to cope with blurred vision, constant eye discomfort, recurrent mouth infections, swollen parotid glands, hoarseness, and difficulty in swallowing and eating. Debilitating fatigue and joint pain can seriously impair quality of life.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""abbreviation"", ""abbreviation"": ""Sjgren's Syndrome"", ""full_form"": ""Sj\u00f6gren's Syndrome""}]}",What is the outlook for Sjgren's Syndrome ?,What is the outlook for Sjgren's Syndrome ?,8,MEDICAL,Simple Datatype-String,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.",[[]],[[]],"[""Sj\u00f6gren's Syndrome""]",[0.004952966850591181],[0.004952966850591181],"[""Sj\u00f6gren's Syndrome""]",[0.004952966850591181],"[""LLM""]",[[]],[0.9727682117605783],[0.9727682117605783],"[""Sj\u00f6gren's Syndrome""]",[0.9727682117605783],"[""LLM""]",[[]],"[""Sj\u00f6gren's Syndrome""]","[""LLM""]",What is the outlook for Sjgren's Syndrome (Sjgren's Syndrome) ?,[true],[true],[true],"[""The outlook for Sj\u00f6gren's Syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]","[""The outlook for Sj\u00f6gren's Syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]","[""The outlook for Sj\u00f6gren's syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]",[true],[true],[true],"[""Sj\u00f6gren's Syndrome is a chronic autoimmune disease that primarily affects the salivary and lacrimal glands, leading to symptoms such as dry mouth and dry eyes. The outlook for Sj\u00f6gren's Syndrome varies from person to person, but with proper management and treatment, most individuals can lead a relatively normal life with manageable symptoms.""]","[""The outlook for Sj\u00f6gren's Syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]","[""The outlook for Sj\u00f6gren's Syndrome varies from person to person, but with proper management and treatment, most people are able to live a normal life with the condition.""]",[true],[true],[true],"[""Sj\u00f6gren's Syndrome is a chronic autoimmune disease that primarily affects the salivary and lacrimal glands, leading to symptoms such as dry mouth and dry eyes. The outlook for individuals with Sj\u00f6gren's Syndrome varies, but with proper management and treatment, most people are able to lead normal lives with manageable symptoms.""]","[""The outlook for Sj\u00f6gren's Syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]","[""The outlook for Sj\u00f6gren's syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]",[true],[true],[true],"[""Sj\u00f6gren's Syndrome is a chronic autoimmune disease that primarily affects the exocrine glands, leading to symptoms such as dry eyes and mouth. The outlook varies depending on the individual, but treatment can help manage symptoms and improve quality of life.""]","[""The outlook for Sj\u00f6gren's Syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]","[""The outlook for Sj\u00f6gren's Syndrome varies depending on the individual, but with proper management, most people are able to live a normal life with the condition.""]",[true],[true],[true],"[""Sj\u00f6gren's Syndrome is a chronic autoimmune disorder that causes inflammation in the glands that produce tears and saliva. The outlook varies depending on the severity of symptoms and individual response to treatment.""]","[""The outlook for Sj\u00f6gren's Syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]","[""The outlook for Sj\u00f6gren's syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]",[true],[true],[true],"[""Sj\u00f6gren's Syndrome is a chronic autoimmune disease that primarily affects the exocrine glands, leading to symptoms such as dry eyes and mouth. The outlook varies depending on the individual, but treatment focuses on managing symptoms and preventing complications.""]","[""The outlook for Sj\u00f6gren's Syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]","[""The outlook for Sj\u00f6gren's Syndrome varies from person to person, but with proper management and treatment, most people are able to live a normal life with the condition.""]",[true],[true],[true],"[""Sj\u00f6gren's Syndrome is a chronic autoimmune disease that affects the salivary and lacrimal glands, leading to dry mouth and dry eyes. It can also affect other parts of the body, causing various symptoms such as joint pain and fatigue.""]","[""The outlook for Sj\u00f6gren's Syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]","[""The outlook for Sj\u00f6gren's syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]",[true],[true],[true],"[""The outlook for Sj\u00f6gren's Syndrome varies from person to person, but with proper management, most people are able to live a normal life with few complications.""]","[""The outlook for Sj\u00f6gren's Syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]","[""The outlook for Sj\u00f6gren's Syndrome varies depending on the individual, but with proper management, most people are able to live a normal life with the condition.""]",[true],[true],[true],"[""Sj\u00f6gren's Syndrome is a chronic autoimmune disease that primarily affects the salivary and lacrimal glands, leading to symptoms such as dry mouth and dry eyes. The outlook for Sj\u00f6gren's Syndrome varies from person to person, but with proper management and treatment, most individuals can lead a relatively normal life with manageable symptoms.""]","[""The outlook for Sj\u00f6gren's Syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]","[""The outlook for Sj\u00f6gren's Syndrome varies from person to person, but with proper management and treatment, most people are able to live a normal life with the condition.""]",[true],[true],[true],"[""The outlook for Sj\u00f6gren's Syndrome varies from person to person, but with proper management, most people are able to live a normal life with minimal complications.""]","[""The outlook for Sj\u00f6gren's Syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]","[""The outlook for Sj\u00f6gren's syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]",[true],[true],[true],"[""Sj\u00f6gren's Syndrome is a chronic autoimmune disease that primarily affects the exocrine glands, leading to symptoms such as dry eyes and mouth. The outlook varies depending on the individual, but treatment can help manage symptoms and improve quality of life.""]","[""The outlook for Sj\u00f6gren's Syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]","[""The outlook for Sj\u00f6gren's syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]",[true],[true],[true],"[""The outlook for Sj\u00f6gren's Syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]","[""The outlook for Sj\u00f6gren's Syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]","[""The outlook for Sj\u00f6gren's Syndrome varies depending on the individual, but with proper management, most people are able to live a normal life with the condition.""]",[true],[true],[true],"[""The outlook for Sj\u00f6gren's Syndrome varies from person to person, but with proper management, most people are able to live a normal life with few complications.""]","[""The outlook for Sj\u00f6gren's Syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]","[""The outlook for Sj\u00f6gren's syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]",[true],[true],[true],"[""The outlook for Sj\u00f6gren's Syndrome varies depending on the individual, but with proper management, most people with the condition can lead a normal life with minimal complications.""]","[""The outlook for Sj\u00f6gren's Syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]","[""The outlook for Sj\u00f6gren's Syndrome varies from person to person, but with proper management and treatment, most people are able to live a normal life with the condition.""]",[true],[true],[true],"[""The outlook for Sj\u00f6gren's Syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]","[""The outlook for Sj\u00f6gren's Syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]","[""The outlook for Sj\u00f6gren's syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]",[true],[true],[true],"[""The outlook for Sj\u00f6gren's Syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]","[""The outlook for Sj\u00f6gren's Syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]","[""The outlook for Sj\u00f6gren's Syndrome varies depending on the individual, but with proper management, most people are able to live a normal life with the condition.""]",[false],[true],[true],"[""Sj\u00f6gren's Syndrome is a chronic autoimmune disease that primarily affects the salivary and lacrimal glands, leading to symptoms such as dry mouth and dry eyes. It can also affect other parts of the body.""]","[""The outlook for Sj\u00f6gren's Syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]","[""The outlook for Sj\u00f6gren's syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]",[true],[true],[true],"[""Sj\u00f6gren's Syndrome is a chronic autoimmune disease that primarily affects the salivary and lacrimal glands, leading to dry mouth and dry eyes. It can also affect other parts of the body, causing various symptoms such as joint pain, fatigue, and organ involvement.""]","[""The outlook for Sj\u00f6gren's Syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]","[""The outlook for Sj\u00f6gren's Syndrome varies from person to person, but with proper management and treatment, most people are able to live a normal life with the condition.""]",[true],[true],[true],"[""Sj\u00f6gren's Syndrome is a chronic autoimmune disease that primarily affects the salivary and lacrimal glands, leading to symptoms such as dry mouth and dry eyes. It can also affect other parts of the body, and there is no cure currently, but treatment focuses on managing symptoms and preventing complications.""]","[""The outlook for Sj\u00f6gren's Syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]","[""The outlook for Sj\u00f6gren's syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]",[true],[true],[true],"[""The outlook for Sj\u00f6gren's Syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]","[""The outlook for Sj\u00f6gren's Syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]","[""The outlook for Sj\u00f6gren's Syndrome varies depending on the individual, but with proper management, most people are able to live a normal life with the condition.""]",[true],[true],[true],"[""Sj\u00f6gren's Syndrome is a chronic autoimmune disease that primarily affects the exocrine glands, leading to symptoms such as dry eyes and mouth. The outlook for individuals with Sj\u00f6gren's Syndrome varies, but with proper management and treatment, most people are able to lead normal lives with minimal complications.""]","[""The outlook for Sj\u00f6gren's Syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]","[""The outlook for Sj\u00f6gren's syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]",[true],[true],[true],"[""The outlook for Sj\u00f6gren's Syndrome varies depending on the individual, but with proper management, most people are able to live a normal life with the condition.""]","[""The outlook for Sj\u00f6gren's Syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]","[""The outlook for Sj\u00f6gren's Syndrome varies from person to person, but with proper management and treatment, most people are able to live a normal life with the condition.""]",[true],[true],[true],"[""Sj\u00f6gren's Syndrome is a chronic autoimmune disease that primarily affects the salivary and lacrimal glands, causing dry mouth and dry eyes. It can also affect other parts of the body, leading to various symptoms such as joint pain, fatigue, and organ involvement. While there is no cure for Sj\u00f6gren's Syndrome, treatment focuses on managing symptoms and preventing complications.""]","[""The outlook for Sj\u00f6gren's Syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]","[""The outlook for Sj\u00f6gren's syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]",[true],[true],[true],"[""Sj\u00f6gren's Syndrome is a chronic autoimmune disease that primarily affects the salivary and lacrimal glands, leading to symptoms such as dry mouth and dry eyes. The outlook varies depending on the individual, but treatment focuses on symptom management and preventing complications.""]","[""The outlook for Sj\u00f6gren's Syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]","[""The outlook for Sj\u00f6gren's Syndrome varies depending on the individual, but with proper management, most people are able to live a normal life with the condition.""]",[true],[true],[true],"[""Sj\u00f6gren's Syndrome is a chronic autoimmune disease that primarily affects the exocrine glands, leading to symptoms such as dry eyes and dry mouth. It can also affect other parts of the body, causing fatigue, joint pain, and organ involvement. Treatment focuses on symptom management and may include artificial tears, saliva substitutes, and medications to reduce inflammation.""]","[""The outlook for Sj\u00f6gren's Syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]","[""The outlook for Sj\u00f6gren's syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]",[true],[true],[true],"[""Sj\u00f6gren's Syndrome is a chronic autoimmune disease that primarily affects the salivary and lacrimal glands, leading to symptoms such as dry mouth and dry eyes. It can also affect other parts of the body. Treatment focuses on symptom management and may include artificial tears, saliva substitutes, and medications to reduce inflammation.""]","[""The outlook for Sj\u00f6gren's Syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]","[""The outlook for Sj\u00f6gren's Syndrome varies from person to person, but with proper management and treatment, most people are able to live a normal life with the condition.""]",[true],[true],[true],"[""Sj\u00f6gren's Syndrome is a chronic autoimmune disease that primarily affects the salivary and lacrimal glands, leading to symptoms such as dry mouth and dry eyes. It can also affect other parts of the body. Treatment focuses on symptom management and may include artificial tears, saliva substitutes, and medications to reduce inflammation.""]","[""The outlook for Sj\u00f6gren's Syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]","[""The outlook for Sj\u00f6gren's syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]",[true],[true],[true],"[""Sj\u00f6gren's Syndrome is a chronic autoimmune disorder that primarily affects the salivary and lacrimal glands, leading to symptoms such as dry mouth and dry eyes. It can also affect other parts of the body, causing systemic symptoms. Treatment focuses on symptom management and may include artificial tears, saliva substitutes, and medications to reduce inflammation.""]","[""The outlook for Sj\u00f6gren's Syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]","[""The outlook for Sj\u00f6gren's Syndrome varies depending on the individual, but with proper management, most people are able to live a normal life with the condition.""]",[true],[true],[true],"[""The outlook for Sj\u00f6gren's Syndrome varies depending on the individual, but with proper management, most people with the condition are able to lead normal lives with minimal complications.""]","[""The outlook for Sj\u00f6gren's Syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]","[""The outlook for Sj\u00f6gren's syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]",[true],[true],[true],"[""The outlook for Sj\u00f6gren's Syndrome varies from person to person, but with proper management, most people are able to live a normal life with the condition.""]","[""The outlook for Sj\u00f6gren's Syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]","[""The outlook for Sj\u00f6gren's syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]",[true],[true],[true],"[""The outlook for Sj\u00f6gren's Syndrome varies from person to person, but with proper management, most people are able to live a normal life with the condition.""]","[""The outlook for Sj\u00f6gren's Syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]","[""The outlook for Sj\u00f6gren's syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]",[true],[true],[true],"[""The outlook for Sj\u00f6gren's Syndrome varies from person to person, but with proper management and treatment, most people are able to live a normal life with few complications.""]","[""The outlook for Sj\u00f6gren's Syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]","[""The outlook for Sj\u00f6gren's syndrome varies depending on the individual, but it is a chronic condition that can be managed with treatment to relieve symptoms and prevent complications.""]"
symptoms,What are the symptoms of Childhood Non-Hodgkin Lymphoma ?,"Signs of childhood non-Hodgkin lymphoma include breathing problems and swollen lymph nodes. These and other signs may be caused by childhood non-Hodgkin lymphoma or by other conditions. Check with a doctor if your child has any of the following:         - Trouble breathing.    - Wheezing.    - Coughing.    -  High-pitched breathing sounds.    - Swelling of the head, neck, upper body, or arms.    - Trouble swallowing.    - Painless swelling of the lymph nodes in the neck, underarm, stomach, or groin.    - Painless lump or swelling in a testicle.     -  Fever for no known reason.    - Weight loss for no known reason.    - Night sweats.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""NHL"", ""full_form"": ""Non-Hodgkin Lymphoma""}]}",What are the symptoms of Childhood NHL ?,What are the symptoms of Childhood Non-Hodgkin Lymphoma ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""National Hockey League"", ""Non Hodgkin's Lymphoma"", ""Non Hodgkin Lymphoma"", ""Newhall Land & Farming Company"", ""Non Hodgkins Lymphoma"", ""National Hockey Leauge"", ""No Hockey League"", ""Natural Hydraulic Limes"", ""Notekeu Hockey League"", ""No Hope League""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Non-Hodgkin Lymphoma""]",[4.5698058981490955e-10],[4.5698058981490955e-10],"[""Non-Hodgkin Lymphoma""]",[4.5698058981490955e-10],"[""LLM""]","[[2.536872629425694e-14, 2.854814652307818e-11, 2.1601388584508237e-11, 3.3110922276615414e-27, 1.2051057792747543e-10, 6.264969057765562e-20, 4.982885134989128e-13, 8.197594458430829e-21, 1.151581223350427e-21, 2.966942830405094e-14]]",[0.9470216304038694],[0.9470541858410276],"[""No Hope League""]",[0.9470541858410276],"[""LLM""]","[[0.9203368288236786, 0.9416338545812941, 0.9452158329468942, 0.8095785106514729, 0.9412460391446502, 0.8873760024105904, 0.8962104369398218, 0.7577214380278159, 0.868309044951378, 0.8200318463228429]]","[""Non Hodgkin Lymphoma""]","[""ABBREVIATIONS""]",What are the symptoms of Childhood NHL (Non-Hodgkin Lymphoma) ?,[true],[true],[true],"[""Common symptoms of Childhood NHL (Non-Hodgkin Lymphoma) include swollen lymph nodes, abdominal pain or swelling, chest pain, coughing or trouble breathing, fever, night sweats, and weight loss.""]","[""Common symptoms of Childhood Non-Hodgkin Lymphoma include swollen lymph nodes, abdominal pain or swelling, chest pain, coughing or trouble breathing, fever, night sweats, and weight loss.""]","[""Common symptoms of Childhood NHL include swollen lymph nodes, fever, night sweats, weight loss, and fatigue.""]",[true],[true],[true],"[""Symptoms of Childhood NHL (Non-Hodgkin Lymphoma) include swollen lymph nodes, abdominal pain or swelling, chest pain, coughing or trouble breathing, fever, night sweats, and weight loss.""]","[""Common symptoms of Childhood Non-Hodgkin Lymphoma include swollen lymph nodes, abdominal pain or swelling, chest pain, coughing or trouble breathing, fever, night sweats, and weight loss.""]","[""Enlarged lymph nodes, fever, night sweats, weight loss, fatigue""]",[true],[true],[true],"[""Common symptoms of Childhood NHL (Non-Hodgkin Lymphoma) include swollen lymph nodes, abdominal pain or swelling, chest pain, coughing or trouble breathing, fever, night sweats, and weight loss.""]","[""Common symptoms of Childhood Non-Hodgkin Lymphoma include swollen lymph nodes, abdominal pain or swelling, chest pain, coughing or trouble breathing, fever, night sweats, and weight loss.""]","[""Common symptoms of Childhood NHL include swollen lymph nodes, fever, night sweats, weight loss, and fatigue.""]",[true],[true],[true],"[""Common symptoms of Childhood NHL (Non-Hodgkin Lymphoma) include swollen lymph nodes, abdominal pain or swelling, chest pain, coughing or trouble breathing, fever, night sweats, and weight loss.""]","[""Common symptoms of Childhood Non-Hodgkin Lymphoma include swollen lymph nodes, abdominal pain or swelling, chest pain, coughing or trouble breathing, fever, night sweats, and weight loss.""]","[""Enlarged lymph nodes, fever, night sweats, weight loss, fatigue""]",[true],[true],[true],"[""Symptoms of Childhood NHL may include swollen lymph nodes, fever, night sweats, weight loss, and fatigue.""]","[""Common symptoms of Childhood Non-Hodgkin Lymphoma include swollen lymph nodes, abdominal pain or swelling, chest pain, coughing or trouble breathing, fever, night sweats, and weight loss.""]","[""Common symptoms of Childhood NHL include swollen lymph nodes, fever, night sweats, weight loss, and fatigue.""]",[true],[true],[true],"[""Symptoms of Childhood NHL may include swollen lymph nodes, fever, night sweats, weight loss, and fatigue.""]","[""Common symptoms of Childhood Non-Hodgkin Lymphoma include swollen lymph nodes, abdominal pain or swelling, chest pain, coughing or trouble breathing, fever, night sweats, and weight loss.""]","[""Enlarged lymph nodes, fever, night sweats, weight loss, fatigue""]",[true],[true],[true],"[""Symptoms of Childhood NHL include swollen lymph nodes, abdominal pain, fever, weight loss, and night sweats.""]","[""Common symptoms of Childhood Non-Hodgkin Lymphoma include swollen lymph nodes, abdominal pain or swelling, chest pain, coughing or trouble breathing, fever, night sweats, and weight loss.""]","[""Common symptoms of Childhood NHL include swollen lymph nodes, fever, night sweats, weight loss, and fatigue.""]",[true],[true],[true],"[""Symptoms of Childhood NHL (Non-Hodgkin Lymphoma) may include swollen lymph nodes, abdominal pain or swelling, chest pain, fever, night sweats, weight loss, and fatigue.""]","[""Common symptoms of Childhood Non-Hodgkin Lymphoma include swollen lymph nodes, abdominal pain or swelling, chest pain, coughing or trouble breathing, fever, night sweats, and weight loss.""]","[""Enlarged lymph nodes, fever, night sweats, weight loss, fatigue""]",[true],[true],[true],"[""Common symptoms of Childhood NHL (Non Hodgkin Lymphoma) include swollen lymph nodes, abdominal pain or swelling, chest pain, fever, night sweats, and weight loss.""]","[""Common symptoms of Childhood Non-Hodgkin Lymphoma include swollen lymph nodes, abdominal pain or swelling, chest pain, coughing or trouble breathing, fever, night sweats, and weight loss.""]","[""Enlarged lymph nodes, fever, night sweats, weight loss, fatigue""]",[true],[true],[true],"[""Common symptoms of Childhood NHL (Non Hodgkin Lymphoma) include swollen lymph nodes, abdominal pain, chest pain, fever, weight loss, and fatigue.""]","[""Common symptoms of Childhood Non-Hodgkin Lymphoma include swollen lymph nodes, abdominal pain or swelling, chest pain, coughing or trouble breathing, fever, night sweats, and weight loss.""]","[""Common symptoms of Childhood NHL include swollen lymph nodes, fever, night sweats, weight loss, and fatigue.""]",[true],[true],[true],"[""Symptoms of Childhood NHL (Non Hodgkin Lymphoma) include swollen lymph nodes, abdominal pain or swelling, chest pain, coughing or trouble breathing, fever, night sweats, fatigue, and weight loss.""]","[""Common symptoms of Childhood Non-Hodgkin Lymphoma include swollen lymph nodes, abdominal pain or swelling, chest pain, coughing or trouble breathing, fever, night sweats, and weight loss.""]","[""Common symptoms of Childhood NHL include swollen lymph nodes, fever, night sweats, weight loss, and fatigue.""]",[true],[true],[true],"[""Common symptoms of Childhood NHL (Non Hodgkin Lymphoma) include swollen lymph nodes, abdominal pain, chest pain, fever, weight loss, and fatigue.""]","[""Common symptoms of Childhood Non-Hodgkin Lymphoma include swollen lymph nodes, abdominal pain or swelling, chest pain, coughing or trouble breathing, fever, night sweats, and weight loss.""]","[""Enlarged lymph nodes, fever, night sweats, weight loss, fatigue""]",[true],[true],[true],"[""Symptoms of Childhood NHL (Non Hodgkin Lymphoma) include swollen lymph nodes, abdominal pain, chest pain, fever, weight loss, and fatigue.""]","[""Common symptoms of Childhood Non-Hodgkin Lymphoma include swollen lymph nodes, abdominal pain or swelling, chest pain, coughing or trouble breathing, fever, night sweats, and weight loss.""]","[""Common symptoms of Childhood NHL include swollen lymph nodes, fever, night sweats, weight loss, and fatigue.""]",[true],[true],[true],"[""Symptoms of Childhood NHL (Non Hodgkin Lymphoma) include swollen lymph nodes, abdominal pain or swelling, chest pain, coughing or trouble breathing, fever, night sweats, weight loss, and fatigue.""]","[""Common symptoms of Childhood Non-Hodgkin Lymphoma include swollen lymph nodes, abdominal pain or swelling, chest pain, coughing or trouble breathing, fever, night sweats, and weight loss.""]","[""Enlarged lymph nodes, fever, night sweats, weight loss, fatigue""]",[true],[true],[true],"[""Symptoms of Childhood NHL (Non Hodgkin Lymphoma) include swollen lymph nodes, abdominal pain, fever, weight loss, night sweats, and fatigue.""]","[""Common symptoms of Childhood Non-Hodgkin Lymphoma include swollen lymph nodes, abdominal pain or swelling, chest pain, coughing or trouble breathing, fever, night sweats, and weight loss.""]","[""Common symptoms of Childhood NHL include swollen lymph nodes, fever, night sweats, weight loss, and fatigue.""]",[true],[true],[true],"[""Symptoms of Childhood NHL include swollen lymph nodes, abdominal pain, fever, weight loss, and night sweats.""]","[""Common symptoms of Childhood Non-Hodgkin Lymphoma include swollen lymph nodes, abdominal pain or swelling, chest pain, coughing or trouble breathing, fever, night sweats, and weight loss.""]","[""Enlarged lymph nodes, fever, night sweats, weight loss, fatigue""]",[true],[true],[true],"[""Enlarged lymph nodes, abdominal pain, fever, weight loss, night sweats""]","[""Common symptoms of Childhood Non-Hodgkin Lymphoma include swollen lymph nodes, abdominal pain or swelling, chest pain, coughing or trouble breathing, fever, night sweats, and weight loss.""]","[""Common symptoms of Childhood NHL include swollen lymph nodes, fever, night sweats, weight loss, and fatigue.""]",[true],[true],[true],"[""Common symptoms of Childhood NHL (Non Hodgkin Lymphoma) include swollen lymph nodes, abdominal pain, fever, weight loss, and night sweats.""]","[""Common symptoms of Childhood Non-Hodgkin Lymphoma include swollen lymph nodes, abdominal pain or swelling, chest pain, coughing or trouble breathing, fever, night sweats, and weight loss.""]","[""Enlarged lymph nodes, fever, night sweats, weight loss, fatigue""]",[true],[true],[true],"[""Common symptoms of Childhood NHL (Non Hodgkin Lymphoma) include swollen lymph nodes, abdominal pain, chest pain, fever, weight loss, and fatigue.""]","[""Common symptoms of Childhood Non-Hodgkin Lymphoma include swollen lymph nodes, abdominal pain or swelling, chest pain, coughing or trouble breathing, fever, night sweats, and weight loss.""]","[""Common symptoms of Childhood NHL include swollen lymph nodes, fever, night sweats, weight loss, and fatigue.""]",[true],[true],[true],"[""Common symptoms of Childhood NHL (Non Hodgkin Lymphoma) include swollen lymph nodes, abdominal pain or swelling, chest pain, coughing or trouble breathing, fever, night sweats, and weight loss.""]","[""Common symptoms of Childhood Non-Hodgkin Lymphoma include swollen lymph nodes, abdominal pain or swelling, chest pain, coughing or trouble breathing, fever, night sweats, and weight loss.""]","[""Enlarged lymph nodes, fever, night sweats, weight loss, fatigue""]",[true],[true],[true],"[""Common symptoms of Childhood NHL (Non-Hodgkin Lymphoma) include swollen lymph nodes, abdominal pain or swelling, chest pain, coughing or trouble breathing, fever, night sweats, and weight loss.""]","[""Common symptoms of Childhood Non-Hodgkin Lymphoma include swollen lymph nodes, abdominal pain or swelling, chest pain, coughing or trouble breathing, fever, night sweats, and weight loss.""]","[""Common symptoms of Childhood NHL include swollen lymph nodes, fever, night sweats, weight loss, and fatigue.""]",[true],[true],[true],"[""Symptoms of Childhood NHL (Non-Hodgkin Lymphoma) include swollen lymph nodes, abdominal pain or swelling, chest pain, coughing or trouble breathing, fever, night sweats, and weight loss.""]","[""Common symptoms of Childhood Non-Hodgkin Lymphoma include swollen lymph nodes, abdominal pain or swelling, chest pain, coughing or trouble breathing, fever, night sweats, and weight loss.""]","[""Enlarged lymph nodes, fever, night sweats, weight loss, fatigue""]",[true],[true],[true],"[""Common symptoms of Childhood NHL (Non-Hodgkin Lymphoma) include swollen lymph nodes, abdominal pain or swelling, chest pain, coughing or trouble breathing, fever, night sweats, and weight loss.""]","[""Common symptoms of Childhood Non-Hodgkin Lymphoma include swollen lymph nodes, abdominal pain or swelling, chest pain, coughing or trouble breathing, fever, night sweats, and weight loss.""]","[""Common symptoms of Childhood NHL include swollen lymph nodes, fever, night sweats, weight loss, and fatigue.""]",[true],[true],[true],"[""Common symptoms of Childhood NHL (Non-Hodgkin Lymphoma) include swollen lymph nodes, abdominal pain or swelling, chest pain, coughing or trouble breathing, fever, night sweats, and weight loss.""]","[""Common symptoms of Childhood Non-Hodgkin Lymphoma include swollen lymph nodes, abdominal pain or swelling, chest pain, coughing or trouble breathing, fever, night sweats, and weight loss.""]","[""Enlarged lymph nodes, fever, night sweats, weight loss, fatigue""]",[true],[true],[true],"[""Some common symptoms of Childhood NHL (Non Hodgkin Lymphoma) include swollen lymph nodes, abdominal pain or swelling, chest pain, coughing or trouble breathing, fever, night sweats, weight loss, and fatigue.""]","[""Common symptoms of Childhood Non-Hodgkin Lymphoma include swollen lymph nodes, abdominal pain or swelling, chest pain, coughing or trouble breathing, fever, night sweats, and weight loss.""]","[""Common symptoms of Childhood NHL include swollen lymph nodes, fever, night sweats, weight loss, and fatigue.""]",[true],[true],[true],"[""Some common symptoms of Childhood NHL (Non Hodgkin Lymphoma) include swollen lymph nodes, abdominal pain, chest pain, coughing or trouble breathing, fever, night sweats, and weight loss.""]","[""Common symptoms of Childhood Non-Hodgkin Lymphoma include swollen lymph nodes, abdominal pain or swelling, chest pain, coughing or trouble breathing, fever, night sweats, and weight loss.""]","[""Enlarged lymph nodes, fever, night sweats, weight loss, fatigue""]",[true],[true],[true],"[""Common symptoms of Childhood NHL (Non Hodgkin Lymphoma) include swollen lymph nodes, abdominal pain or swelling, chest pain, coughing or trouble breathing, fever, night sweats, fatigue, and weight loss.""]","[""Common symptoms of Childhood Non-Hodgkin Lymphoma include swollen lymph nodes, abdominal pain or swelling, chest pain, coughing or trouble breathing, fever, night sweats, and weight loss.""]","[""Common symptoms of Childhood NHL include swollen lymph nodes, fever, night sweats, weight loss, and fatigue.""]",[true],[true],[true],"[""Symptoms of Childhood NHL (Non Hodgkin Lymphoma) include swollen lymph nodes, abdominal pain or swelling, chest pain, fever, night sweats, weight loss, and fatigue.""]","[""Common symptoms of Childhood Non-Hodgkin Lymphoma include swollen lymph nodes, abdominal pain or swelling, chest pain, coughing or trouble breathing, fever, night sweats, and weight loss.""]","[""Enlarged lymph nodes, fever, night sweats, weight loss, fatigue""]",[true],[true],[true],"[""Symptoms of Childhood NHL (Non Hodgkin Lymphoma) include swollen lymph nodes, abdominal pain, fever, weight loss, and night sweats.""]","[""Common symptoms of Childhood Non-Hodgkin Lymphoma include swollen lymph nodes, abdominal pain or swelling, chest pain, coughing or trouble breathing, fever, night sweats, and weight loss.""]","[""Common symptoms of Childhood NHL include swollen lymph nodes, fever, night sweats, weight loss, and fatigue.""]",[true],[true],[true],"[""Symptoms of Childhood NHL include swollen lymph nodes, abdominal pain or swelling, chest pain, coughing or trouble breathing, fever, night sweats, and weight loss.""]","[""Common symptoms of Childhood Non-Hodgkin Lymphoma include swollen lymph nodes, abdominal pain or swelling, chest pain, coughing or trouble breathing, fever, night sweats, and weight loss.""]","[""Common symptoms of Childhood NHL include swollen lymph nodes, fever, night sweats, weight loss, and fatigue.""]",[true],[true],[true],"[""Symptoms of Childhood NHL may include swollen lymph nodes, fever, night sweats, weight loss, and fatigue.""]","[""Common symptoms of Childhood Non-Hodgkin Lymphoma include swollen lymph nodes, abdominal pain or swelling, chest pain, coughing or trouble breathing, fever, night sweats, and weight loss.""]","[""Common symptoms of Childhood NHL include swollen lymph nodes, fever, night sweats, weight loss, and fatigue.""]",[true],[true],[true],"[""Symptoms of Childhood NHL (Non-Hodgkin Lymphoma) include swollen lymph nodes, abdominal pain or swelling, chest pain, fever, night sweats, weight loss, fatigue, and frequent infections.""]","[""Common symptoms of Childhood Non-Hodgkin Lymphoma include swollen lymph nodes, abdominal pain or swelling, chest pain, coughing or trouble breathing, fever, night sweats, and weight loss.""]","[""Common symptoms of Childhood NHL include swollen lymph nodes, fever, night sweats, weight loss, and fatigue.""]"
susceptibility,Who is at risk for Metabolic Syndrome? ?,"People at greatest risk for metabolic syndrome have these underlying causes:
                
Abdominal obesity (a large waistline)
                
An inactive lifestyle
                
Insulin resistance
                
Some people are at risk for metabolic syndrome because they take medicines that cause weight gain or changes in blood pressure, blood cholesterol, and blood sugar levels. These medicines most often are used to treat inflammation, allergies, HIV, and depression and other types of mental illness.
                
Populations Affected
                
Some racial and ethnic groups in the United States are at higher risk for metabolic syndrome than others. Mexican Americans have the highest rate of metabolic syndrome, followed by whites and blacks.
                
Other groups at increased risk for metabolic syndrome include:
                
People who have a personal history of diabetes
                
People who have a sibling or parent who hasdiabetes
                
Women when compared with men
                
Women who have a personal history of polycystic ovarian syndrome (a tendency to develop cysts on the ovaries)
                
Heart Disease Risk
                
Metabolic syndrome increases your risk for coronary heart disease. Other risk factors, besides metabolic syndrome, also increase your risk for heart disease. For example, a high LDL (bad) cholesterol level and smoking are major risk factors for heart disease. For details about all of the risk factors for heart disease, go to the Coronary Heart Disease Risk Factors HealthTopic.
                
Even if you dont have metabolic syndrome, you should find out your short-term risk for heart disease. The National Cholesterol Education Program (NCEP) divides short-term heart disease risk into four categories. Your risk category depends on which risk factors you have and how many you have.
                
Your risk factors are used to calculate your 10-year risk of developing heart disease. The NCEP has an online calculator that you can use to estimate your 10-year risk of having a heart attack.
                
High risk: Youre in this category if you already have heart disease or diabetes, or if your 10-year risk score is more than 20 percent.
                
Moderately high risk: Youre in this category if you have two or more risk factors and your 10-year risk score is 10 percent to 20 percent.
                
Moderate risk: Youre in this category if you have two or more risk factors and your 10-year risk score is less than 10 percent.
                
Lower risk: Youre in this category if you have zero or one risk factor.
                
Even if your 10-year risk score isnt high, metabolic syndrome will increase your risk for coronary heart disease over time.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""MetS"", ""full_form"": ""Metabolic Syndrome""}]}",Who is at risk for MetS? ?,Who is at risk for Metabolic Syndrome? ?,8,MEDICAL,Simple Datatype-String,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Metastases"", ""Metadata Encoding and Transmission Standard"", ""New York Metropolitans"", ""Metadata Encoding Transmission Standard"", ""METeorological System"", ""Met Coil Systems Corporation (de-listed)"", ""Mechanized Export Traffic System"", ""Materials and Equipment Trading Service"", ""Mayor's Emergency Telephone System"", ""Mini-Effluent Treatment System""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Metabolic Syndrome""]",[2.3309423650790814e-06],[2.3309423650790814e-06],"[""Metastases""]",[0.0001746755367921221],"[""ABBREVIATIONS""]","[[0.0001746755367921221, 1.4452542671000734e-27, 5.1680869451048964e-21, 1.9995834721879657e-27, 1.4630952069249917e-15, 2.054354512749428e-32, 4.4457288044537816e-23, 8.686893406254758e-23, 6.987178487726123e-24, 1.401522547639587e-20]]",[0.9602317383625734],[0.9602127726987622],"[""Mini-Effluent Treatment System""]",[0.9602127726987622],"[""LLM""]","[[0.7851565217643487, 0.8462742534514872, 0.8181688537067141, 0.841923279752058, 0.831773330302323, 0.7583181279976707, 0.6857798998012172, 0.822760352553076, 0.788210252625144, 0.7017206439822942]]","[""Metabolic Syndrome""]","[""LLM""]",Who is at risk for MetS (Metabolic Syndrome)? ?,[true],[true],[true],"[""Individuals with obesity, insulin resistance, high blood pressure, and abnormal cholesterol levels are at risk for MetS (Metabolic Syndrome).""]","[""People who are overweight, have a sedentary lifestyle, have a family history of diabetes or heart disease, or have certain medical conditions like high blood pressure are at risk for Metabolic Syndrome.""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome (MetS).""]",[true],[true],[true],"[""Individuals with obesity, insulin resistance, high blood pressure, and abnormal cholesterol levels are at risk for MetS (Metabolic Syndrome).""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome.""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome (MetS).""]",[true],[true],[true],"[""Individuals with obesity, insulin resistance, high blood pressure, and abnormal cholesterol levels are at risk for MetS (Metabolic Syndrome).""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome.""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome (MetS).""]",[true],[true],[true],"[""Individuals with obesity, insulin resistance, high blood pressure, and abnormal cholesterol levels are at risk for MetS (Metabolic Syndrome).""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome.""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome (MetS).""]",[true],[true],[true],"[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome (MetS).""]","[""People who are overweight, have a sedentary lifestyle, have a family history of diabetes or heart disease, or have certain medical conditions like high blood pressure are at risk for Metabolic Syndrome.""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome (MetS).""]",[true],[true],[true],"[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome (MetS).""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome.""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome (MetS).""]",[true],[true],[true],"[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome (MetS).""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome.""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome (MetS).""]",[true],[true],[true],"[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome (MetS).""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome.""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome (MetS).""]",[true],[true],[true],"[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome.""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome.""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome (MetS).""]",[true],[true],[true],"[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome.""]","[""People who are overweight, have a sedentary lifestyle, have a family history of diabetes or heart disease, or have certain medical conditions like high blood pressure are at risk for Metabolic Syndrome.""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome (MetS).""]",[true],[true],[true],"[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome.""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome.""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome (MetS).""]",[true],[true],[true],"[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome.""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome.""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome (MetS).""]",[true],[true],[true],"[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome.""]","[""People who are overweight, have a sedentary lifestyle, have a family history of diabetes or heart disease, or have certain medical conditions like high blood pressure are at risk for Metabolic Syndrome.""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome (MetS).""]",[true],[true],[true],"[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome.""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome.""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome (MetS).""]",[true],[true],[true],"[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome.""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome.""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome (MetS).""]",[true],[true],[true],"[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome.""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome.""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome (MetS).""]",[true],[true],[true],"[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome.""]","[""People who are overweight, have a sedentary lifestyle, have a family history of diabetes or heart disease, or have certain medical conditions like high blood pressure are at risk for Metabolic Syndrome.""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome (MetS).""]",[true],[true],[true],"[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome.""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome.""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome (MetS).""]",[true],[true],[true],"[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome.""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome.""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome (MetS).""]",[true],[true],[true],"[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome.""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome.""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome (MetS).""]",[true],[true],[true],"[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome.""]","[""People who are overweight, have a sedentary lifestyle, have a family history of diabetes or heart disease, or have certain medical conditions like high blood pressure are at risk for Metabolic Syndrome.""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome (MetS).""]",[true],[true],[true],"[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome.""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome.""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome (MetS).""]",[true],[true],[true],"[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome.""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome.""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome (MetS).""]",[true],[true],[true],"[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome (MetS).""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome.""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome (MetS).""]",[true],[true],[true],"[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome.""]","[""People who are overweight, have a sedentary lifestyle, have a family history of diabetes or heart disease, or have certain medical conditions like high blood pressure are at risk for Metabolic Syndrome.""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome (MetS).""]",[true],[true],[true],"[""Individuals who are overweight, have a sedentary lifestyle, have a poor diet, or have a family history of diabetes or cardiovascular diseases are at risk for Metabolic Syndrome (MetS).""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome.""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome (MetS).""]",[true],[true],[true],"[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome (MetS).""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome.""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome (MetS).""]",[true],[true],[true],"[""Individuals with obesity, sedentary lifestyle, poor diet, and genetic predisposition are at risk for Metabolic Syndrome (MetS).""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome.""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome (MetS).""]",[true],[true],[true],"[""People who are overweight or obese, have a sedentary lifestyle, have a family history of Metabolic Syndrome, or have certain medical conditions like diabetes or high blood pressure are at risk for Metabolic Syndrome.""]","[""People who are overweight, have a sedentary lifestyle, have a family history of diabetes or heart disease, or have certain medical conditions like high blood pressure are at risk for Metabolic Syndrome.""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome (MetS).""]",[false],[true],[true],"[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for MetS (Metastases).""]","[""People who are overweight, have a sedentary lifestyle, have a family history of diabetes or heart disease, or have certain medical conditions like high blood pressure are at risk for Metabolic Syndrome.""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome (MetS).""]",[true],[true],[true],"[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for MetS (Metabolic Syndrome).""]","[""People who are overweight, have a sedentary lifestyle, have a family history of diabetes or heart disease, or have certain medical conditions like high blood pressure are at risk for Metabolic Syndrome.""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome (MetS).""]",[true],[true],[true],"[""People who are overweight or obese, have a sedentary lifestyle, have a family history of MetS, or have certain medical conditions like diabetes or high blood pressure are at risk for Metabolic Syndrome.""]","[""People who are overweight, have a sedentary lifestyle, have a family history of diabetes or heart disease, or have certain medical conditions like high blood pressure are at risk for Metabolic Syndrome.""]","[""Individuals with obesity, sedentary lifestyle, unhealthy diet, and genetic predisposition are at risk for Metabolic Syndrome (MetS).""]"
genetic changes,What are the genetic changes related to X-linked chondrodysplasia punctata 1 ?,"X-linked chondrodysplasia punctata 1 is caused by genetic changes involving the ARSE gene. This gene provides instructions for making an enzyme called arylsulfatase E. The function of this enzyme is unknown, although it appears to be important for normal skeletal development and is thought to participate in a chemical pathway involving vitamin K. Evidence suggests that vitamin K normally plays a role in bone growth and maintenance of bone density.  Between 60 and 75 percent of males with the characteristic features of X-linked chondrodysplasia punctata 1 have a mutation in the ARSE gene. These mutations reduce or eliminate the function of arylsulfatase E. Another 25 percent of affected males have a small deletion of genetic material from the region of the X chromosome that contains the ARSE gene. These individuals are missing the entire gene, so their cells produce no functional arylsulfatase E. Researchers are working to determine how a shortage of arylsulfatase E disrupts the development of bones and cartilage and leads to the characteristic features of X-linked chondrodysplasia punctata 1.  Some people with the features of X-linked chondrodysplasia punctata 1 do not have an identified mutation in the ARSE gene or a deletion involving the gene. Other, as-yet-unidentified genetic and environmental factors may also be involved in causing this disorder.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""XLC1"", ""full_form"": ""X-linked chondrodysplasia punctata 1""}]}",What are the genetic changes related to XLC1 ?,What are the genetic changes related to X-linked chondrodysplasia punctata 1 ?,8,MEDICAL,Compound Datatype-List/Array,"Exploratory(Divergent Thinking): Queries that are inherently about seeking new areas of knowledge, understanding emerging trends, or identifying unknown opportunities without a specific end goal of making a decision or judgment. Exploratory queries are characterized by their openness and the lack of a predefined objective, differentiating them from evaluative queries which are directed towards forming a judgment or assessment. Exploratory queries encourage branching out into various directions to explore a wide array of possibilities without necessarily aiming to converge on a single answer or outcome.",[[]],[[]],"[""X-linked cleft palate 1""]",[5.900814544770938e-31],[1.571574532009494e-24],"[""X-linked cleft palate 1""]",[1.571574532009494e-24],"[""LLM""]",[[]],[0.8555328839522167],[0.8744465193565943],"[""X-linked chondrodysplasia punctata 1""]",[0.8744465193565943],"[""LLM""]",[[]],"[""X-linked cleft palate 1""]","[""LLM""]",What are the genetic changes related to XLC1 (X-linked cleft palate 1) ?,[false],[true],[false],"[""Genetic changes related to XLC1 include mutations in the IRF6 gene.""]","[""Mutations in the ARSE gene""]","[""Genetic changes related to XLC1 are mutations in the XLC1 gene, which can lead to X-linked Charcot-Marie-Tooth disease type 1.""]",[false],[true],[false],"[""Genetic changes related to XLC1 include mutations in the IRF6 gene.""]","[""Mutations in the ARSE gene""]","[""Genetic changes related to XLC1 are mutations in the XLC1 gene, which is associated with X-linked Charcot-Marie-Tooth disease type 1.""]",[false],[true],[false],"[""Genetic changes related to XLC1 include mutations in the IRF6 gene.""]","[""Mutations in the ARSE gene""]","[""Genetic changes related to XLC1 are mutations in the XLC1 gene.""]",[false],[true],[false],"[""Genetic changes related to XLC1 include mutations in the IRF6 gene.""]","[""Mutations in the ARSE gene""]","[""Genetic changes related to XLC1 are mutations in the XLC1 gene, which is associated with X-linked Charcot-Marie-Tooth disease type 1.""]",[true],[true],[false],"[""Variants in the ARSE gene are associated with X-linked chondrodysplasia punctata 1.""]","[""Mutations in the ARSE gene""]","[""Genetic changes related to XLC1 are mutations in the XLC1 gene, which can lead to X-linked Charcot-Marie-Tooth disease type 1.""]",[true],[true],[false],"[""Variants in the ARSE gene are associated with X-linked chondrodysplasia punctata 1.""]","[""Mutations in the ARSE gene""]","[""Genetic changes related to XLC1 are mutations in the XLC1 gene, which is associated with X-linked Charcot-Marie-Tooth disease type 1.""]",[true],[true],[false],"[""Variants in the ARSE gene are associated with X-linked chondrodysplasia punctata 1.""]","[""Mutations in the ARSE gene""]","[""Genetic changes related to XLC1 are mutations in the XLC1 gene.""]",[true],[true],[false],"[""Variants in the ARSE gene are associated with X-linked chondrodysplasia punctata 1.""]","[""Mutations in the ARSE gene""]","[""Genetic changes related to XLC1 are mutations in the XLC1 gene, which is associated with X-linked Charcot-Marie-Tooth disease type 1.""]",[false],[true],[false],"[""Genetic changes related to XLC1 include mutations in the IRF6 gene.""]","[""Mutations in the ARSE gene""]","[""Genetic changes related to XLC1 are mutations in the XLC1 gene, which is associated with X-linked Charcot-Marie-Tooth disease type 1.""]",[false],[true],[false],"[""Genetic changes related to XLC1 include mutations in the IRF6 gene.""]","[""Mutations in the ARSE gene""]","[""Genetic changes related to XLC1 are mutations in the XLC1 gene, which can lead to X-linked Charcot-Marie-Tooth disease type 1.""]",[false],[true],[false],"[""Genetic changes related to XLC1 (X-linked cleft palate 1) have been associated with mutations in the TBX22 gene.""]","[""Mutations in the ARSE gene""]","[""Genetic changes related to XLC1 are mutations in the XLC1 gene.""]",[false],[true],[false],"[""Genetic changes related to XLC1 include mutations in the IRF6 gene.""]","[""Mutations in the ARSE gene""]","[""Genetic changes related to XLC1 are mutations in the XLC1 gene, which is associated with X-linked Charcot-Marie-Tooth disease type 1.""]",[false],[true],[false],"[""Genetic changes related to XLC1 include mutations in the IRF6 gene.""]","[""Mutations in the ARSE gene""]","[""Genetic changes related to XLC1 are mutations in the XLC1 gene, which can lead to X-linked Charcot-Marie-Tooth disease type 1.""]",[false],[true],[false],"[""Genetic changes related to XLC1 include mutations in the IRF6 gene.""]","[""Mutations in the ARSE gene""]","[""Genetic changes related to XLC1 are mutations in the XLC1 gene, which is associated with X-linked Charcot-Marie-Tooth disease type 1.""]",[false],[true],[false],"[""Genetic changes related to XLC1 include mutations in the IRF6 gene.""]","[""Mutations in the ARSE gene""]","[""Genetic changes related to XLC1 are mutations in the XLC1 gene.""]",[false],[true],[false],"[""Genetic changes related to XLC1 include mutations in the IRF6 gene.""]","[""Mutations in the ARSE gene""]","[""Genetic changes related to XLC1 are mutations in the XLC1 gene, which is associated with X-linked Charcot-Marie-Tooth disease type 1.""]",[false],[true],[false],"[""Genetic changes related to XLC1 include mutations in the IRF6 gene.""]","[""Mutations in the ARSE gene""]","[""Genetic changes related to XLC1 are mutations in the XLC1 gene, which can lead to X-linked Charcot-Marie-Tooth disease type 1.""]",[false],[true],[false],"[""Genetic changes related to XLC1 include mutations in the IRF6 gene.""]","[""Mutations in the ARSE gene""]","[""Genetic changes related to XLC1 are mutations in the XLC1 gene, which is associated with X-linked Charcot-Marie-Tooth disease type 1.""]",[false],[true],[false],"[""Genetic changes related to XLC1 include mutations in the IRF6 gene.""]","[""Mutations in the ARSE gene""]","[""Genetic changes related to XLC1 are mutations in the XLC1 gene.""]",[false],[true],[false],"[""Genetic changes related to XLC1 include mutations in the IRF6 gene.""]","[""Mutations in the ARSE gene""]","[""Genetic changes related to XLC1 are mutations in the XLC1 gene, which is associated with X-linked Charcot-Marie-Tooth disease type 1.""]",[false],[true],[false],"[""Genetic changes related to XLC1 include mutations in the IRF6 gene.""]","[""Mutations in the ARSE gene""]","[""Genetic changes related to XLC1 are mutations in the XLC1 gene, which can lead to X-linked Charcot-Marie-Tooth disease type 1.""]",[false],[true],[false],"[""Genetic changes related to XLC1 include mutations in the IRF6 gene.""]","[""Mutations in the ARSE gene""]","[""Genetic changes related to XLC1 are mutations in the XLC1 gene, which is associated with X-linked Charcot-Marie-Tooth disease type 1.""]",[false],[true],[false],"[""Genetic changes related to XLC1 include mutations in the IRF6 gene.""]","[""Mutations in the ARSE gene""]","[""Genetic changes related to XLC1 are mutations in the XLC1 gene.""]",[false],[true],[false],"[""Genetic changes related to XLC1 include mutations in the IRF6 gene.""]","[""Mutations in the ARSE gene""]","[""Genetic changes related to XLC1 are mutations in the XLC1 gene, which is associated with X-linked Charcot-Marie-Tooth disease type 1.""]",[false],[true],[false],"[""Genetic changes related to XLC1 include mutations in the IRF6 gene.""]","[""Mutations in the ARSE gene""]","[""Genetic changes related to XLC1 are mutations in the XLC1 gene, which can lead to X-linked Charcot-Marie-Tooth disease type 1.""]",[false],[true],[false],"[""Genetic changes related to XLC1 include mutations in the IRF6 gene.""]","[""Mutations in the ARSE gene""]","[""Genetic changes related to XLC1 are mutations in the XLC1 gene, which is associated with X-linked Charcot-Marie-Tooth disease type 1.""]",[false],[true],[false],"[""Genetic changes related to XLC1 include mutations in the IRF6 gene.""]","[""Mutations in the ARSE gene""]","[""Genetic changes related to XLC1 are mutations in the XLC1 gene.""]",[false],[true],[false],"[""Genetic changes related to XLC1 include mutations in the IRF6 gene.""]","[""Mutations in the ARSE gene""]","[""Genetic changes related to XLC1 are mutations in the XLC1 gene, which is associated with X-linked Charcot-Marie-Tooth disease type 1.""]",[false],[true],[false],"[""Genetic changes related to XLC1 include mutations in the IRF6 gene.""]","[""Mutations in the ARSE gene""]","[""Genetic changes related to XLC1 are mutations in the XLC1 gene, which can lead to X-linked Charcot-Marie-Tooth disease type 1.""]",[false],[true],[false],"[""Genetic changes related to XLC1 include mutations in the IRF6 gene.""]","[""Mutations in the ARSE gene""]","[""Genetic changes related to XLC1 are mutations in the XLC1 gene, which can lead to X-linked Charcot-Marie-Tooth disease type 1.""]",[true],[true],[false],"[""Genetic changes related to XLC1 include mutations in the ARSE gene.""]","[""Mutations in the ARSE gene""]","[""Genetic changes related to XLC1 are mutations in the XLC1 gene, which can lead to X-linked Charcot-Marie-Tooth disease type 1.""]",[false],[true],[false],"[""Genetic changes related to XLC1 include mutations in the IRF6 gene.""]","[""Mutations in the ARSE gene""]","[""Genetic changes related to XLC1 are mutations in the XLC1 gene, which can lead to X-linked Charcot-Marie-Tooth disease type 1.""]"
exams and tests,How to diagnose Immune Thrombocytopenia ?,"Your doctor will diagnose immune thrombocytopenia (ITP) based on your medical history, a physical exam, and test results.
                
Your doctor will want to make sure that your low platelet count isn't due to another condition (such as an infection) or medicines you're taking (such as chemotherapy medicines or aspirin).
                
Medical History
                
Your doctor may ask about:
                
Your signs and symptoms of bleeding and any other signs or symptoms you're having
                
Whether you have illnesses that could lower your platelet count or cause bleeding
                
Medicines or any over-the-counter supplements or remedies you take that could cause bleeding or lower your platelet count
                
Physical Exam
                
During a physical exam, your doctor will look for signs of bleeding and infection. For example, your doctor may look for purplish areas on the skin or mucous membranes and pinpoint red spots on the skin. These are signs of bleeding under the skin.
                
Diagnostic Tests
                
You'll likely have blood tests to check your platelet count. These tests usually include:
                
A complete blood count. This test checks the number of red blood cells, white blood cells, and platelets in your blood. In ITP, the red and white blood cell counts are normal, but the platelet count is low.
                
A blood smear. For this test, some of your blood is put on a slide. A microscope is used to look at your platelets and other blood cells.
                
You also may have a blood test to check for the antibodies (proteins) that attack platelets.
                
If blood tests show that your platelet count is low, your doctor may recommend more tests to confirm a diagnosis of ITP. For example, bone marrow tests can show whether your bone marrow is making enough platelets.
                
If you're at risk for HIV, hepatitis C, or H. pylori, your doctor may screen you for these infections, which might be linked to ITP.
                
Some people who have mild ITP have few or no signs of bleeding. They may be diagnosed only if a blood test done for another reason shows that they have low platelet counts.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""ITP"", ""full_form"": ""Immune Thrombocytopenia""}]}",How to diagnose ITP ?,How to diagnose Immune Thrombocytopenia ?,8,MEDICAL,Compound Datatype-String,"Instructional: Queries specifically seeking step-by-step guidance, instructions, or procedures to perform a task. it focuses on 'how' to do something rather than 'what', 'why', or 'which'.","[[""Idiopathic thrombocytopenic purpura"", ""Interactive Telecommunications Program"", ""Intend To Package"", ""Intertape Polymer Group, Inc."", ""Information Technology Professional"", ""Intelligent Text Processing"", ""Interpreter Training Program"", ""Institutional Testing Program"", ""Integral Transformative Practice"", ""Individual Training Plan""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Immune Thrombocytopenic Purpura""]",[2.148860344556143e-08],[1.1145352573814698e-13],"[""Interpreter Training Program""]",[4.211008446731377e-11],"[""ABBREVIATIONS""]","[[1.3897982177666628e-14, 1.0812133959768841e-17, 1.4770971081379748e-16, 8.596926778833479e-32, 4.92630539612987e-13, 9.620281655313056e-16, 4.211008446731377e-11, 5.716806870235325e-13, 1.6060849521528298e-21, 4.3887645881136315e-15]]",[0.9459833178057065],[0.9336814563741596],"[""Individual Training Plan""]",[0.9336814563741596],"[""LLM""]","[[0.9215036291586627, 0.6745236881274496, 0.660645121290159, 0.6366848468479577, 0.7489883305371231, 0.6497419722813804, 0.689525533719417, 0.7289413385544099, 0.6406654764377538, 0.6817679822543362]]","[""Idiopathic thrombocytopenic purpura""]","[""ABBREVIATIONS""]",How to diagnose ITP (Immune Thrombocytopenic Purpura) ?,[true],[true],[true],"[""Diagnosing ITP involves a physical exam, blood tests to check platelet levels, and sometimes a bone marrow biopsy.""]","[""Diagnosis of Immune Thrombocytopenia involves a physical exam, blood tests to check platelet count and function, and sometimes a bone marrow biopsy.""]","[""Diagnosing ITP involves a physical exam, blood tests to check platelet levels, and sometimes a bone marrow biopsy.""]",[true],[true],[true],"[""Diagnosing ITP involves a physical exam, blood tests, and sometimes a bone marrow biopsy.""]","[""Diagnosis of Immune Thrombocytopenia involves a physical exam, blood tests, and sometimes a bone marrow biopsy.""]","[""Diagnosing ITP involves a physical exam, blood tests to check platelet count and function, and sometimes a bone marrow biopsy.""]",[true],[true],[true],"[""Diagnosing ITP involves a physical exam, blood tests to check platelet count, and sometimes a bone marrow biopsy.""]","[""Diagnosis of Immune Thrombocytopenia involves a physical exam, blood tests (complete blood count, platelet count, blood smear), and sometimes a bone marrow biopsy.""]","[""Diagnosing ITP involves a physical exam, blood tests to check platelet count, and sometimes a bone marrow biopsy.""]",[true],[true],[true],"[""Diagnosing ITP involves a physical exam, blood tests to check platelet levels, and sometimes a bone marrow biopsy.""]","[""Diagnosis of Immune Thrombocytopenia involves a physical exam, blood tests, and sometimes a bone marrow biopsy.""]","[""Diagnosing ITP typically involves a physical exam, blood tests to check platelet levels, and sometimes a bone marrow biopsy.""]",[true],[true],[true],"[""Diagnosing ITP involves a physical exam, blood tests to check platelet levels, and ruling out other possible causes of low platelets.""]","[""Diagnosis of Immune Thrombocytopenia involves a physical exam, blood tests to check platelet count and function, and sometimes a bone marrow biopsy.""]","[""Diagnosing ITP involves a physical exam, blood tests to check platelet levels, and sometimes a bone marrow biopsy.""]",[true],[true],[true],"[""Diagnosing ITP involves a physical exam, blood tests to check platelet count, and sometimes a bone marrow biopsy.""]","[""Diagnosis of Immune Thrombocytopenia involves a physical exam, blood tests, and sometimes a bone marrow biopsy.""]","[""Diagnosing ITP involves a physical exam, blood tests to check platelet count and function, and sometimes a bone marrow biopsy.""]",[true],[true],[true],"[""Diagnosing ITP involves a physical exam, blood tests to check platelet count, and sometimes a bone marrow biopsy.""]","[""Diagnosis of Immune Thrombocytopenia involves a physical exam, blood tests (complete blood count, platelet count, blood smear), and sometimes a bone marrow biopsy.""]","[""Diagnosing ITP involves a physical exam, blood tests to check platelet count, and sometimes a bone marrow biopsy.""]",[true],[true],[true],"[""Diagnosing ITP involves a physical exam, blood tests to check platelet count, and sometimes a bone marrow biopsy.""]","[""Diagnosis of Immune Thrombocytopenia involves a physical exam, blood tests, and sometimes a bone marrow biopsy.""]","[""Diagnosing ITP typically involves a physical exam, blood tests to check platelet levels, and sometimes a bone marrow biopsy.""]",[true],[true],[true],"[""Diagnosis of ITP involves a physical exam, blood tests to check platelet count and rule out other causes, and sometimes a bone marrow biopsy.""]","[""Diagnosis of Immune Thrombocytopenia involves a physical exam, blood tests, and sometimes a bone marrow biopsy.""]","[""Diagnosing ITP involves a physical exam, blood tests to check platelet count and function, and sometimes a bone marrow biopsy.""]",[true],[true],[true],"[""Diagnosis of ITP involves a physical exam, blood tests to check platelet count and rule out other causes, and sometimes a bone marrow biopsy.""]","[""Diagnosis of Immune Thrombocytopenia involves a physical exam, blood tests to check platelet count and function, and sometimes a bone marrow biopsy.""]","[""Diagnosing ITP involves a physical exam, blood tests to check platelet levels, and sometimes a bone marrow biopsy.""]",[true],[true],[true],"[""Diagnosis of ITP involves a physical exam, blood tests to check platelet count and other factors, and ruling out other possible causes of low platelet count.""]","[""Diagnosis of Immune Thrombocytopenia involves a physical exam, blood tests (complete blood count, platelet count, blood smear), and sometimes a bone marrow biopsy.""]","[""Diagnosing ITP involves a physical exam, blood tests to check platelet count, and sometimes a bone marrow biopsy.""]",[true],[true],[true],"[""Diagnosing ITP involves a physical exam, blood tests to check platelet count, ruling out other causes of low platelet count, and sometimes a bone marrow biopsy.""]","[""Diagnosis of Immune Thrombocytopenia involves a physical exam, blood tests, and sometimes a bone marrow biopsy.""]","[""Diagnosing ITP typically involves a physical exam, blood tests to check platelet levels, and sometimes a bone marrow biopsy.""]",[true],[true],[true],"[""Diagnosis of ITP is based on a physical exam, blood tests to check platelet count, and ruling out other possible causes of low platelet count.""]","[""Diagnosis of Immune Thrombocytopenia involves a physical exam, blood tests to check platelet count and function, and sometimes a bone marrow biopsy.""]","[""Diagnosing ITP involves a physical exam, blood tests to check platelet levels, and sometimes a bone marrow biopsy.""]",[true],[true],[true],"[""Diagnosis of ITP is based on a physical exam, complete blood count (CBC) test, and sometimes a bone marrow biopsy.""]","[""Diagnosis of Immune Thrombocytopenia involves a physical exam, blood tests, and sometimes a bone marrow biopsy.""]","[""Diagnosing ITP involves a physical exam, blood tests to check platelet count and function, and sometimes a bone marrow biopsy.""]",[true],[true],[true],"[""Diagnosis of ITP is based on blood tests, physical examination, and medical history. Blood tests include a complete blood count (CBC) to check platelet levels, and possibly a bone marrow biopsy to rule out other causes of low platelet count.""]","[""Diagnosis of Immune Thrombocytopenia involves a physical exam, blood tests (complete blood count, platelet count, blood smear), and sometimes a bone marrow biopsy.""]","[""Diagnosing ITP involves a physical exam, blood tests to check platelet count, and sometimes a bone marrow biopsy.""]",[true],[true],[true],"[""Diagnosis of ITP is based on blood tests, physical examination, and medical history. Blood tests include platelet count, blood smear, and sometimes bone marrow examination.""]","[""Diagnosis of Immune Thrombocytopenia involves a physical exam, blood tests, and sometimes a bone marrow biopsy.""]","[""Diagnosing ITP typically involves a physical exam, blood tests to check platelet levels, and sometimes a bone marrow biopsy.""]",[true],[true],[true],"[""Diagnosing ITP involves a physical exam, blood tests to check platelet count, ruling out other causes of low platelet count, and sometimes a bone marrow biopsy.""]","[""Diagnosis of Immune Thrombocytopenia involves a physical exam, blood tests to check platelet count and function, and sometimes a bone marrow biopsy.""]","[""Diagnosing ITP involves a physical exam, blood tests to check platelet levels, and sometimes a bone marrow biopsy.""]",[true],[true],[true],"[""Diagnosing ITP involves a physical exam, blood tests to check platelet count and other blood components, ruling out other possible causes of low platelet count, and sometimes a bone marrow biopsy.""]","[""Diagnosis of Immune Thrombocytopenia involves a physical exam, blood tests, and sometimes a bone marrow biopsy.""]","[""Diagnosing ITP involves a physical exam, blood tests to check platelet count and function, and sometimes a bone marrow biopsy.""]",[true],[true],[true],"[""Diagnosing ITP involves a physical exam, blood tests to check platelet count and rule out other conditions, and sometimes a bone marrow biopsy.""]","[""Diagnosis of Immune Thrombocytopenia involves a physical exam, blood tests (complete blood count, platelet count, blood smear), and sometimes a bone marrow biopsy.""]","[""Diagnosing ITP involves a physical exam, blood tests to check platelet count, and sometimes a bone marrow biopsy.""]",[true],[true],[true],"[""Diagnosing ITP involves a physical exam, blood tests to check platelet count and other blood components, and ruling out other possible causes of low platelet count.""]","[""Diagnosis of Immune Thrombocytopenia involves a physical exam, blood tests, and sometimes a bone marrow biopsy.""]","[""Diagnosing ITP typically involves a physical exam, blood tests to check platelet levels, and sometimes a bone marrow biopsy.""]",[true],[true],[true],"[""Diagnosis of ITP involves physical examination, blood tests to check platelet count and function, and ruling out other possible causes of low platelet count.""]","[""Diagnosis of Immune Thrombocytopenia involves a physical exam, blood tests to check platelet count and function, and sometimes a bone marrow biopsy.""]","[""Diagnosing ITP involves a physical exam, blood tests to check platelet levels, and sometimes a bone marrow biopsy.""]",[true],[true],[true],"[""Diagnosis of ITP involves a physical exam, blood tests to check platelet count and rule out other conditions, and sometimes a bone marrow biopsy.""]","[""Diagnosis of Immune Thrombocytopenia involves a physical exam, blood tests, and sometimes a bone marrow biopsy.""]","[""Diagnosing ITP involves a physical exam, blood tests to check platelet count and function, and sometimes a bone marrow biopsy.""]",[true],[true],[true],"[""Diagnosis of ITP is typically based on a physical exam, complete blood count (CBC) to check platelet levels, blood smear to examine platelets under a microscope, and sometimes a bone marrow biopsy to rule out other causes.""]","[""Diagnosis of Immune Thrombocytopenia involves a physical exam, blood tests (complete blood count, platelet count, blood smear), and sometimes a bone marrow biopsy.""]","[""Diagnosing ITP involves a physical exam, blood tests to check platelet count, and sometimes a bone marrow biopsy.""]",[true],[true],[true],"[""Diagnosing ITP involves a physical exam, blood tests to check platelet count, ruling out other causes of low platelet count, and sometimes a bone marrow biopsy.""]","[""Diagnosis of Immune Thrombocytopenia involves a physical exam, blood tests, and sometimes a bone marrow biopsy.""]","[""Diagnosing ITP typically involves a physical exam, blood tests to check platelet levels, and sometimes a bone marrow biopsy.""]",[true],[true],[true],"[""Diagnosing ITP involves a physical exam, blood tests to check platelet count and other factors, ruling out other causes of low platelet count, and sometimes a bone marrow biopsy.""]","[""Diagnosis of Immune Thrombocytopenia involves a physical exam, blood tests to check platelet count and function, and sometimes a bone marrow biopsy.""]","[""Diagnosing ITP involves a physical exam, blood tests to check platelet levels, and sometimes a bone marrow biopsy.""]",[true],[true],[true],"[""Diagnosing ITP involves a physical exam, blood tests to check platelet count and other factors, and sometimes a bone marrow biopsy.""]","[""Diagnosis of Immune Thrombocytopenia involves a physical exam, blood tests, and sometimes a bone marrow biopsy.""]","[""Diagnosing ITP involves a physical exam, blood tests to check platelet count and function, and sometimes a bone marrow biopsy.""]",[true],[true],[true],"[""Diagnosing ITP involves a physical exam, blood tests to check platelet count and rule out other conditions, and sometimes a bone marrow biopsy.""]","[""Diagnosis of Immune Thrombocytopenia involves a physical exam, blood tests (complete blood count, platelet count, blood smear), and sometimes a bone marrow biopsy.""]","[""Diagnosing ITP involves a physical exam, blood tests to check platelet count, and sometimes a bone marrow biopsy.""]",[true],[true],[true],"[""Diagnosing ITP involves a physical exam, blood tests to check platelet count, ruling out other causes of low platelet count, and sometimes a bone marrow biopsy.""]","[""Diagnosis of Immune Thrombocytopenia involves a physical exam, blood tests, and sometimes a bone marrow biopsy.""]","[""Diagnosing ITP typically involves a physical exam, blood tests to check platelet levels, and sometimes a bone marrow biopsy.""]",[true],[true],[true],"[""Diagnosing ITP typically involves a physical exam, blood tests to check platelet count, and ruling out other possible causes of low platelet count.""]","[""Diagnosis of Immune Thrombocytopenia involves a physical exam, blood tests to check platelet count and function, and sometimes a bone marrow biopsy.""]","[""Diagnosing ITP involves a physical exam, blood tests to check platelet levels, and sometimes a bone marrow biopsy.""]",[true],[true],[true],"[""Diagnosing ITP involves a physical exam, blood tests, and possibly a bone marrow biopsy.""]","[""Diagnosis of Immune Thrombocytopenia involves a physical exam, blood tests to check platelet count and function, and sometimes a bone marrow biopsy.""]","[""Diagnosing ITP involves a physical exam, blood tests to check platelet levels, and sometimes a bone marrow biopsy.""]",[false],[true],[true],"[""Diagnosing ITP involves a thorough assessment of individual needs, goals, strengths, and weaknesses. This typically includes reviewing performance data, conducting interviews, and collaborating with the individual to create a tailored training plan.""]","[""Diagnosis of Immune Thrombocytopenia involves a physical exam, blood tests to check platelet count and function, and sometimes a bone marrow biopsy.""]","[""Diagnosing ITP involves a physical exam, blood tests to check platelet levels, and sometimes a bone marrow biopsy.""]",[true],[true],[true],"[""Diagnosing ITP typically involves a physical exam, blood tests to check platelet count, and sometimes a bone marrow biopsy.""]","[""Diagnosis of Immune Thrombocytopenia involves a physical exam, blood tests to check platelet count and function, and sometimes a bone marrow biopsy.""]","[""Diagnosing ITP involves a physical exam, blood tests to check platelet levels, and sometimes a bone marrow biopsy.""]"
treatment,What are the treatments for Kawasaki syndrome ?,"How might Kawasaki disease be treated? Intravenous gamma globulin is the standard treatment for Kawasaki disease and is administered in high doses. Children with Kawasaki disease usually greatly improve within 24 hours of treatment with IV gamma globulin. Aspirin is often given in combination with the IV gamma globulin as part of the treatment plan. We found limited information on the management of Kawasaki disease specifically in adults, however you may find the following articles to be helpful: Dauphin C. et al., Kawasaki disease is also a disease of adults: report of six cases. Arch Mal Coeur Vaiss [serial online]. 2007;100(5):439-447. Sve P, Stankovic K, Smail A, Durand DV, Marchand G, and Broussolle C. Adult Kawasaki disease: report of two cases and literature review. Semin Arthritis Rheum. 2005;34(6):785-792. Sve P, Bui-Xuan C, Charhon A, and Broussolle C. Adult Kawasaki disease. Rev Med Interne [serial online]. 2003;24(9):577-584.In the article listed above by Dauphin C. et al. the authors describe that of the five adult patients with Kawasaki disease who were treated, all progressed favorably after a course of immunoglobulins.  In addition, in the article by Sve P. et al., the authors comment that 'although adult KD often was diagnosed after the acute phase, when a significant beneficial effect from gammaglobulin infusion could not be expected, this treatment did appear to shorten the course of the disease.'","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""KS"", ""full_form"": ""Kawasaki syndrome""}]}",What are the treatments for KS ?,What are the treatments for Kawasaki syndrome ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Kansas"", ""Key Stage"", ""Kashmiri"", ""Kindred Spirits"", ""Kolmogorov Smirnov"", ""Kevin Spacey"", ""KetoSteroid"", ""Knowledge Structure"", ""Kernel Streaming"", ""Kitchen Sink""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Kaposi's Sarcoma""]",[2.3510303790294335e-13],[2.796236670537118e-13],"[""Key Stage""]",[1.197467531089988e-07],"[""ABBREVIATIONS""]","[[9.601974340316863e-11, 1.197467531089988e-07, 5.164188529225936e-14, 1.51869750228023e-12, 1.9102599466763617e-26, 5.76022128218464e-21, 4.988084690126572e-10, 1.5770801237996242e-11, 4.2186661069640655e-13, 2.601462508542577e-14]]",[0.7372476523329201],[0.8481612197256752],"[""Kawasaki syndrome""]",[0.8514757888169668],"[""ABBREVIATIONS""]","[[0.8514757888169668, 0.8396115205204042, 0.8017131526303947, 0.8233386191781412, 0.7232522256893841, 0.838527939368608, 0.8507444136060829, 0.7660542770122828, 0.733954432093898, 0.7860074587238739]]","[""Kaposi's Sarcoma""]","[""LLM""]",What are the treatments for KS (Kaposi's Sarcoma) ?,[false],[true],[false],"[""The treatments for KS (Key Stage) include speech and language therapy, occupational therapy, behavioral therapy, and educational interventions.""]","[""Intravenous immunoglobulin (IVIG) and aspirin are the main treatments for Kawasaki syndrome.""]","[""Treatment for Kaposi's sarcoma (KS) may include chemotherapy, radiation therapy, immunotherapy, and antiretroviral therapy for those with HIV/AIDS.""]",[false],[true],[false],"[""Treatment for KS (Key Stage) includes speech and language therapy, occupational therapy, behavioral therapy, and educational support.""]","[""Intravenous immunoglobulin (IVIG) and aspirin are the main treatments for Kawasaki syndrome.""]","[""Treatment options for Kaposi's sarcoma (KS) include chemotherapy, radiation therapy, immunotherapy, and antiretroviral therapy for those with HIV/AIDS.""]",[false],[true],[false],"[""The treatments for KS (Key Stage) depend on the specific condition being referred to. It is important to consult with a healthcare professional for accurate diagnosis and treatment options.""]","[""Intravenous immunoglobulin (IVIG) and aspirin are the main treatments for Kawasaki syndrome.""]","[""Treatment for KS may include antiretroviral therapy, chemotherapy, radiation therapy, and surgery.""]",[false],[true],[false],"[""The treatments for KS (Key Stage) depend on the underlying cause. It can include medications, therapy, and lifestyle changes.""]","[""Intravenous immunoglobulin (IVIG) and aspirin are the main treatments for Kawasaki syndrome.""]","[""Treatment for KS may include antiretroviral therapy, chemotherapy, radiation therapy, and surgery.""]",[true],[true],[false],"[""Intravenous immunoglobulin (IVIG) and aspirin are the main treatments for Kawasaki syndrome.""]","[""Intravenous immunoglobulin (IVIG) and aspirin are the main treatments for Kawasaki syndrome.""]","[""Treatment for Kaposi's sarcoma (KS) may include chemotherapy, radiation therapy, immunotherapy, and antiretroviral therapy for those with HIV/AIDS.""]",[true],[true],[false],"[""Intravenous immunoglobulin (IVIG) and aspirin are the main treatments for Kawasaki syndrome.""]","[""Intravenous immunoglobulin (IVIG) and aspirin are the main treatments for Kawasaki syndrome.""]","[""Treatment options for Kaposi's sarcoma (KS) include chemotherapy, radiation therapy, immunotherapy, and antiretroviral therapy for those with HIV/AIDS.""]",[true],[true],[false],"[""Intravenous immunoglobulin (IVIG) and aspirin are the main treatments for Kawasaki syndrome.""]","[""Intravenous immunoglobulin (IVIG) and aspirin are the main treatments for Kawasaki syndrome.""]","[""Treatment for KS may include antiretroviral therapy, chemotherapy, radiation therapy, and surgery.""]",[true],[true],[false],"[""Intravenous immunoglobulin (IVIG) and aspirin are the main treatments for Kawasaki syndrome.""]","[""Intravenous immunoglobulin (IVIG) and aspirin are the main treatments for Kawasaki syndrome.""]","[""Treatment for KS may include antiretroviral therapy, chemotherapy, radiation therapy, and surgery.""]",[false],[true],[false],"[""The treatments for Kaposi's Sarcoma (KS) include chemotherapy, radiation therapy, immunotherapy, and antiretroviral therapy for those with HIV/AIDS.""]","[""Intravenous immunoglobulin (IVIG) and aspirin are the main treatments for Kawasaki syndrome.""]","[""Treatment options for Kaposi's sarcoma (KS) include chemotherapy, radiation therapy, immunotherapy, and antiretroviral therapy for those with HIV/AIDS.""]",[false],[true],[false],"[""Chemotherapy, radiation therapy, immunotherapy, and antiretroviral therapy are common treatments for Kaposi's Sarcoma.""]","[""Intravenous immunoglobulin (IVIG) and aspirin are the main treatments for Kawasaki syndrome.""]","[""Treatment for Kaposi's sarcoma (KS) may include chemotherapy, radiation therapy, immunotherapy, and antiretroviral therapy for those with HIV/AIDS.""]",[false],[true],[false],"[""Chemotherapy, radiation therapy, immunotherapy, and antiretroviral therapy are common treatments for Kaposi's Sarcoma.""]","[""Intravenous immunoglobulin (IVIG) and aspirin are the main treatments for Kawasaki syndrome.""]","[""Treatment for KS may include antiretroviral therapy, chemotherapy, radiation therapy, and surgery.""]",[false],[true],[false],"[""Chemotherapy, radiation therapy, immunotherapy, and antiretroviral therapy are common treatments for Kaposi's Sarcoma.""]","[""Intravenous immunoglobulin (IVIG) and aspirin are the main treatments for Kawasaki syndrome.""]","[""Treatment for KS may include antiretroviral therapy, chemotherapy, radiation therapy, and surgery.""]",[false],[true],[false],"[""Chemotherapy, radiation therapy, immunotherapy, and antiretroviral therapy are common treatments for Kaposi's Sarcoma.""]","[""Intravenous immunoglobulin (IVIG) and aspirin are the main treatments for Kawasaki syndrome.""]","[""Treatment for Kaposi's sarcoma (KS) may include chemotherapy, radiation therapy, immunotherapy, and antiretroviral therapy for those with HIV/AIDS.""]",[false],[true],[false],"[""Chemotherapy, radiation therapy, immunotherapy, and antiretroviral therapy are common treatments for Kaposi's Sarcoma.""]","[""Intravenous immunoglobulin (IVIG) and aspirin are the main treatments for Kawasaki syndrome.""]","[""Treatment options for Kaposi's sarcoma (KS) include chemotherapy, radiation therapy, immunotherapy, and antiretroviral therapy for those with HIV/AIDS.""]",[false],[true],[false],"[""Chemotherapy, radiation therapy, immunotherapy, and antiretroviral therapy""]","[""Intravenous immunoglobulin (IVIG) and aspirin are the main treatments for Kawasaki syndrome.""]","[""Treatment for KS may include antiretroviral therapy, chemotherapy, radiation therapy, and surgery.""]",[false],[true],[false],"[""Chemotherapy, radiation therapy, immunotherapy, and antiretroviral therapy""]","[""Intravenous immunoglobulin (IVIG) and aspirin are the main treatments for Kawasaki syndrome.""]","[""Treatment for KS may include antiretroviral therapy, chemotherapy, radiation therapy, and surgery.""]",[false],[true],[false],"[""Chemotherapy, radiation therapy, immunotherapy, and antiretroviral therapy""]","[""Intravenous immunoglobulin (IVIG) and aspirin are the main treatments for Kawasaki syndrome.""]","[""Treatment for Kaposi's sarcoma (KS) may include chemotherapy, radiation therapy, immunotherapy, and antiretroviral therapy for those with HIV/AIDS.""]",[false],[true],[false],"[""Chemotherapy, radiation therapy, immunotherapy, and antiretroviral therapy are common treatments for Kaposi's Sarcoma.""]","[""Intravenous immunoglobulin (IVIG) and aspirin are the main treatments for Kawasaki syndrome.""]","[""Treatment options for Kaposi's sarcoma (KS) include chemotherapy, radiation therapy, immunotherapy, and antiretroviral therapy for those with HIV/AIDS.""]",[false],[true],[false],"[""Chemotherapy, radiation therapy, immunotherapy, and antiretroviral therapy are common treatments for Kaposi's Sarcoma.""]","[""Intravenous immunoglobulin (IVIG) and aspirin are the main treatments for Kawasaki syndrome.""]","[""Treatment for KS may include antiretroviral therapy, chemotherapy, radiation therapy, and surgery.""]",[false],[true],[false],"[""The treatments for Kaposi's Sarcoma (KS) include chemotherapy, radiation therapy, immunotherapy, and antiretroviral therapy for those with HIV/AIDS.""]","[""Intravenous immunoglobulin (IVIG) and aspirin are the main treatments for Kawasaki syndrome.""]","[""Treatment for KS may include antiretroviral therapy, chemotherapy, radiation therapy, and surgery.""]",[false],[true],[false],"[""Chemotherapy, radiation therapy, immunotherapy, and antiretroviral therapy are common treatments for Kaposi's Sarcoma.""]","[""Intravenous immunoglobulin (IVIG) and aspirin are the main treatments for Kawasaki syndrome.""]","[""Treatment for Kaposi's sarcoma (KS) may include chemotherapy, radiation therapy, immunotherapy, and antiretroviral therapy for those with HIV/AIDS.""]",[false],[true],[false],"[""The treatments for Kaposi's Sarcoma (KS) include chemotherapy, radiation therapy, immunotherapy, and antiretroviral therapy for those with HIV/AIDS.""]","[""Intravenous immunoglobulin (IVIG) and aspirin are the main treatments for Kawasaki syndrome.""]","[""Treatment options for Kaposi's sarcoma (KS) include chemotherapy, radiation therapy, immunotherapy, and antiretroviral therapy for those with HIV/AIDS.""]",[false],[true],[false],"[""Chemotherapy, radiation therapy, immunotherapy, and antiretroviral therapy are common treatments for Kaposi's Sarcoma.""]","[""Intravenous immunoglobulin (IVIG) and aspirin are the main treatments for Kawasaki syndrome.""]","[""Treatment for KS may include antiretroviral therapy, chemotherapy, radiation therapy, and surgery.""]",[false],[true],[false],"[""The treatments for Kaposi's Sarcoma (KS) include chemotherapy, radiation therapy, immunotherapy, and antiretroviral therapy for those with HIV/AIDS.""]","[""Intravenous immunoglobulin (IVIG) and aspirin are the main treatments for Kawasaki syndrome.""]","[""Treatment for KS may include antiretroviral therapy, chemotherapy, radiation therapy, and surgery.""]",[false],[true],[false],"[""The treatments for Kaposi's Sarcoma (KS) include chemotherapy, radiation therapy, immunotherapy, and antiretroviral therapy for those with HIV/AIDS.""]","[""Intravenous immunoglobulin (IVIG) and aspirin are the main treatments for Kawasaki syndrome.""]","[""Treatment for Kaposi's sarcoma (KS) may include chemotherapy, radiation therapy, immunotherapy, and antiretroviral therapy for those with HIV/AIDS.""]",[false],[true],[false],"[""The treatments for Kaposi's Sarcoma (KS) include chemotherapy, radiation therapy, immunotherapy, and antiretroviral therapy for those with HIV/AIDS.""]","[""Intravenous immunoglobulin (IVIG) and aspirin are the main treatments for Kawasaki syndrome.""]","[""Treatment options for Kaposi's sarcoma (KS) include chemotherapy, radiation therapy, immunotherapy, and antiretroviral therapy for those with HIV/AIDS.""]",[false],[true],[false],"[""The treatments for Kaposi's Sarcoma (KS) include chemotherapy, radiation therapy, immunotherapy, and antiretroviral therapy for those with HIV/AIDS.""]","[""Intravenous immunoglobulin (IVIG) and aspirin are the main treatments for Kawasaki syndrome.""]","[""Treatment for KS may include antiretroviral therapy, chemotherapy, radiation therapy, and surgery.""]",[false],[true],[false],"[""The treatments for Kaposi's Sarcoma (KS) include chemotherapy, radiation therapy, immunotherapy, and antiretroviral therapy for those with HIV/AIDS.""]","[""Intravenous immunoglobulin (IVIG) and aspirin are the main treatments for Kawasaki syndrome.""]","[""Treatment for KS may include antiretroviral therapy, chemotherapy, radiation therapy, and surgery.""]",[false],[true],[false],"[""Chemotherapy, radiation therapy, immunotherapy, and antiretroviral therapy are common treatments for Kaposi's Sarcoma.""]","[""Intravenous immunoglobulin (IVIG) and aspirin are the main treatments for Kawasaki syndrome.""]","[""Treatment for Kaposi's sarcoma (KS) may include chemotherapy, radiation therapy, immunotherapy, and antiretroviral therapy for those with HIV/AIDS.""]",[false],[true],[false],"[""The treatments for KS (Key Stage) depend on the specific condition being addressed. It is recommended to consult with a healthcare professional for personalized advice.""]","[""Intravenous immunoglobulin (IVIG) and aspirin are the main treatments for Kawasaki syndrome.""]","[""Treatment for Kaposi's sarcoma (KS) may include chemotherapy, radiation therapy, immunotherapy, and antiretroviral therapy for those with HIV/AIDS.""]",[true],[true],[false],"[""Intravenous immunoglobulin (IVIG) and aspirin are the main treatments for Kawasaki syndrome.""]","[""Intravenous immunoglobulin (IVIG) and aspirin are the main treatments for Kawasaki syndrome.""]","[""Treatment for Kaposi's sarcoma (KS) may include chemotherapy, radiation therapy, immunotherapy, and antiretroviral therapy for those with HIV/AIDS.""]",[false],[true],[false],"[""The treatments for Kaposi's Sarcoma (KS) include chemotherapy, radiation therapy, immunotherapy, and antiretroviral therapy for those with HIV/AIDS.""]","[""Intravenous immunoglobulin (IVIG) and aspirin are the main treatments for Kawasaki syndrome.""]","[""Treatment for Kaposi's sarcoma (KS) may include chemotherapy, radiation therapy, immunotherapy, and antiretroviral therapy for those with HIV/AIDS.""]"
genetic changes,What are the genetic changes related to familial hemophagocytic lymphohistiocytosis ?,"Familial hemophagocytic lymphohistiocytosis may be caused by mutations in any of several genes. These genes provide instructions for making proteins that help destroy or deactivate lymphocytes that are no longer needed. By controlling the number of activated lymphocytes, these genes help regulate immune system function.  Approximately 40 to 60 percent of cases of familial hemophagocytic lymphohistiocytosis are caused by mutations in the PRF1 or UNC13D genes. Smaller numbers of cases are caused by mutations in other known genes. In some affected individuals, the genetic cause of the disorder is unknown.  The gene mutations that cause familial hemophagocytic lymphohistiocytosis impair the body's ability to regulate the immune system. These changes result in the exaggerated immune response characteristic of this condition.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""FHL"", ""full_form"": ""familial hemophagocytic lymphohistiocytosis""}]}",What are the genetic changes related to FHL ?,What are the genetic changes related to familial hemophagocytic lymphohistiocytosis ?,8,MEDICAL,Compound Datatype-List/Array,"Exploratory(Divergent Thinking): Queries that are inherently about seeking new areas of knowledge, understanding emerging trends, or identifying unknown opportunities without a specific end goal of making a decision or judgment. Exploratory queries are characterized by their openness and the lack of a predefined objective, differentiating them from evaluative queries which are directed towards forming a judgment or assessment. Exploratory queries encourage branching out into various directions to explore a wide array of possibilities without necessarily aiming to converge on a single answer or outcome.","[[""Family History Library"", ""Franklin, Hou, and Leavitt"", ""Faith, Hope, Love"", ""Flexor Hallucis Longus"", ""Functional Herd Life"", ""Feed His Lambs"", ""Funny Hilarious Laughter"", ""The Foot Hockey League"", ""Finite Height Language"", ""Fattey Hockey League""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Familial Hemophagocytic Lymphohistiocytosis""]",[1.1798672675965328e-26],[1.1798672675965328e-26],"[""Family History Library""]",[1.1181948906069794e-11],"[""ABBREVIATIONS""]","[[1.1181948906069794e-11, 5.999636337049063e-28, 2.0622443301191378e-17, 9.414950780284351e-19, 2.6125184616496673e-17, 2.972366622697922e-14, 5.451499153440525e-23, 4.4261903884101626e-16, 4.065194112483938e-16, 3.1574064904620216e-22]]",[0.8179348300328053],[0.8198918753126978],"[""Family History Library""]",[0.9359288830512618],"[""ABBREVIATIONS""]","[[0.8295496024475562, 0.9359288830512618, 0.8577824796652332, 0.8028795472975991, 0.7606256030696004, 0.8447512820423269, 0.7678352359196394, 0.7475319698312026, 0.759485925852704, 0.8231197196739528]]","[""Familial Hemophagocytic Lymphohistiocytosis""]","[""LLM""]",What are the genetic changes related to FHL (Familial Hemophagocytic Lymphohistiocytosis) ?,[true],[true],[true],"[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, and STXBP2.""]","[""Mutations in genes involved in cytotoxic granule exocytosis and lymphocyte apoptosis, such as PRF1, UNC13D, STX11, and STXBP2, are related to familial hemophagocytic lymphohistiocytosis.""]","[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, and STXBP2.""]",[true],[true],[true],"[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, and STXBP2.""]","[""Mutations in genes involved in the perforin-dependent cytotoxic pathway, such as PRF1, UNC13D, STX11, and STXBP2, are associated with familial hemophagocytic lymphohistiocytosis.""]","[""Mutations in genes such as PRF1, UNC13D, STX11, and STXBP2 are related to Familial Hemophagocytic Lymphohistiocytosis (FHL).""]",[true],[true],[true],"[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, STXBP2, and RAB27A.""]","[""Mutations in genes involved in cytotoxic granule exocytosis and lymphocyte apoptosis, such as PRF1, UNC13D, STX11, and STXBP2, are related to familial hemophagocytic lymphohistiocytosis.""]","[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, and STXBP2.""]",[true],[true],[true],"[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, and STXBP2.""]","[""Genetic changes related to familial hemophagocytic lymphohistiocytosis include mutations in genes such as PRF1, UNC13D, STX11, STXBP2, and others.""]","[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, and STXBP2.""]",[true],[true],[true],"[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, and STXBP2.""]","[""Mutations in genes involved in cytotoxic granule exocytosis and lymphocyte apoptosis, such as PRF1, UNC13D, STX11, and STXBP2, are related to familial hemophagocytic lymphohistiocytosis.""]","[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, and STXBP2.""]",[true],[true],[true],"[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, STXBP2, and RAB27A.""]","[""Mutations in genes involved in the perforin-dependent cytotoxic pathway, such as PRF1, UNC13D, STX11, and STXBP2, are associated with familial hemophagocytic lymphohistiocytosis.""]","[""Mutations in genes such as PRF1, UNC13D, STX11, and STXBP2 are related to Familial Hemophagocytic Lymphohistiocytosis (FHL).""]",[true],[true],[true],"[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, and STXBP2.""]","[""Mutations in genes involved in cytotoxic granule exocytosis and lymphocyte apoptosis, such as PRF1, UNC13D, STX11, and STXBP2, are related to familial hemophagocytic lymphohistiocytosis.""]","[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, and STXBP2.""]",[true],[true],[true],"[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, and STXBP2.""]","[""Genetic changes related to familial hemophagocytic lymphohistiocytosis include mutations in genes such as PRF1, UNC13D, STX11, STXBP2, and others.""]","[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, and STXBP2.""]",[true],[true],[true],"[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, STXBP2, and RAB27A.""]","[""Mutations in genes involved in the perforin-dependent cytotoxic pathway, such as PRF1, UNC13D, STX11, and STXBP2, are associated with familial hemophagocytic lymphohistiocytosis.""]","[""Mutations in genes such as PRF1, UNC13D, STX11, and STXBP2 are related to Familial Hemophagocytic Lymphohistiocytosis (FHL).""]",[true],[true],[true],"[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, STXBP2, and RAB27A.""]","[""Mutations in genes involved in cytotoxic granule exocytosis and lymphocyte apoptosis, such as PRF1, UNC13D, STX11, and STXBP2, are related to familial hemophagocytic lymphohistiocytosis.""]","[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, and STXBP2.""]",[true],[true],[true],"[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, STXBP2, and RAB27A.""]","[""Mutations in genes involved in cytotoxic granule exocytosis and lymphocyte apoptosis, such as PRF1, UNC13D, STX11, and STXBP2, are related to familial hemophagocytic lymphohistiocytosis.""]","[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, and STXBP2.""]",[true],[true],[true],"[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, STXBP2, and RAB27A.""]","[""Genetic changes related to familial hemophagocytic lymphohistiocytosis include mutations in genes such as PRF1, UNC13D, STX11, STXBP2, and others.""]","[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, and STXBP2.""]",[true],[true],[true],"[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, and STXBP2.""]","[""Mutations in genes involved in cytotoxic granule exocytosis and lymphocyte apoptosis, such as PRF1, UNC13D, STX11, and STXBP2, are related to familial hemophagocytic lymphohistiocytosis.""]","[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, and STXBP2.""]",[true],[true],[true],"[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, and STXBP2.""]","[""Mutations in genes involved in the perforin-dependent cytotoxic pathway, such as PRF1, UNC13D, STX11, and STXBP2, are associated with familial hemophagocytic lymphohistiocytosis.""]","[""Mutations in genes such as PRF1, UNC13D, STX11, and STXBP2 are related to Familial Hemophagocytic Lymphohistiocytosis (FHL).""]",[true],[true],[true],"[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, STXBP2, and others.""]","[""Mutations in genes involved in cytotoxic granule exocytosis and lymphocyte apoptosis, such as PRF1, UNC13D, STX11, and STXBP2, are related to familial hemophagocytic lymphohistiocytosis.""]","[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, and STXBP2.""]",[true],[true],[true],"[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, STXBP2, and others.""]","[""Genetic changes related to familial hemophagocytic lymphohistiocytosis include mutations in genes such as PRF1, UNC13D, STX11, STXBP2, and others.""]","[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, and STXBP2.""]",[true],[true],[true],"[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, STXBP2, and RAB27A.""]","[""Mutations in genes involved in cytotoxic granule exocytosis and lymphocyte apoptosis, such as PRF1, UNC13D, STX11, and STXBP2, are related to familial hemophagocytic lymphohistiocytosis.""]","[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, and STXBP2.""]",[true],[true],[true],"[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, STXBP2, and RAB27A.""]","[""Mutations in genes involved in the perforin-dependent cytotoxic pathway, such as PRF1, UNC13D, STX11, and STXBP2, are associated with familial hemophagocytic lymphohistiocytosis.""]","[""Mutations in genes such as PRF1, UNC13D, STX11, and STXBP2 are related to Familial Hemophagocytic Lymphohistiocytosis (FHL).""]",[true],[true],[true],"[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, and STXBP2.""]","[""Mutations in genes involved in cytotoxic granule exocytosis and lymphocyte apoptosis, such as PRF1, UNC13D, STX11, and STXBP2, are related to familial hemophagocytic lymphohistiocytosis.""]","[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, and STXBP2.""]",[true],[true],[true],"[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, STXBP2, and RAB27A.""]","[""Genetic changes related to familial hemophagocytic lymphohistiocytosis include mutations in genes such as PRF1, UNC13D, STX11, STXBP2, and others.""]","[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, and STXBP2.""]",[true],[true],[true],"[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, STXBP2, and RAB27A.""]","[""Mutations in genes involved in cytotoxic granule exocytosis and lymphocyte apoptosis, such as PRF1, UNC13D, STX11, and STXBP2, are related to familial hemophagocytic lymphohistiocytosis.""]","[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, and STXBP2.""]",[true],[true],[true],"[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, STXBP2, and RAB27A.""]","[""Mutations in genes involved in the perforin-dependent cytotoxic pathway, such as PRF1, UNC13D, STX11, and STXBP2, are associated with familial hemophagocytic lymphohistiocytosis.""]","[""Mutations in genes such as PRF1, UNC13D, STX11, and STXBP2 are related to Familial Hemophagocytic Lymphohistiocytosis (FHL).""]",[true],[true],[true],"[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, STXBP2, and RAB27A.""]","[""Mutations in genes involved in cytotoxic granule exocytosis and lymphocyte apoptosis, such as PRF1, UNC13D, STX11, and STXBP2, are related to familial hemophagocytic lymphohistiocytosis.""]","[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, and STXBP2.""]",[true],[true],[true],"[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, STXBP2, and RAB27A.""]","[""Genetic changes related to familial hemophagocytic lymphohistiocytosis include mutations in genes such as PRF1, UNC13D, STX11, STXBP2, and others.""]","[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, and STXBP2.""]",[true],[true],[true],"[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, STXBP2, and RAB27A.""]","[""Mutations in genes involved in cytotoxic granule exocytosis and lymphocyte apoptosis, such as PRF1, UNC13D, STX11, and STXBP2, are related to familial hemophagocytic lymphohistiocytosis.""]","[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, and STXBP2.""]",[true],[true],[true],"[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, STXBP2, and RAB27A.""]","[""Mutations in genes involved in the perforin-dependent cytotoxic pathway, such as PRF1, UNC13D, STX11, and STXBP2, are associated with familial hemophagocytic lymphohistiocytosis.""]","[""Mutations in genes such as PRF1, UNC13D, STX11, and STXBP2 are related to Familial Hemophagocytic Lymphohistiocytosis (FHL).""]",[true],[true],[true],"[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, STXBP2, and RAB27A.""]","[""Mutations in genes involved in cytotoxic granule exocytosis and lymphocyte apoptosis, such as PRF1, UNC13D, STX11, and STXBP2, are related to familial hemophagocytic lymphohistiocytosis.""]","[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, and STXBP2.""]",[true],[true],[true],"[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, STXBP2, and RAB27A.""]","[""Genetic changes related to familial hemophagocytic lymphohistiocytosis include mutations in genes such as PRF1, UNC13D, STX11, STXBP2, and others.""]","[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, and STXBP2.""]",[true],[true],[true],"[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, STXBP2, and others.""]","[""Mutations in genes involved in cytotoxic granule exocytosis and lymphocyte apoptosis, such as PRF1, UNC13D, STX11, and STXBP2, are related to familial hemophagocytic lymphohistiocytosis.""]","[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, and STXBP2.""]",[false],[true],[true],"[""Genetic changes related to FHL include mutations in genes such as FHL1, FHL2, and FHL3.""]","[""Mutations in genes involved in cytotoxic granule exocytosis and lymphocyte apoptosis, such as PRF1, UNC13D, STX11, and STXBP2, are related to familial hemophagocytic lymphohistiocytosis.""]","[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, and STXBP2.""]",[false],[true],[true],"[""Genetic changes related to FHL are mutations in genes such as FHL1, FHL2, and FHL3.""]","[""Mutations in genes involved in cytotoxic granule exocytosis and lymphocyte apoptosis, such as PRF1, UNC13D, STX11, and STXBP2, are related to familial hemophagocytic lymphohistiocytosis.""]","[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, and STXBP2.""]",[true],[true],[true],"[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, and STXBP2.""]","[""Mutations in genes involved in cytotoxic granule exocytosis and lymphocyte apoptosis, such as PRF1, UNC13D, STX11, and STXBP2, are related to familial hemophagocytic lymphohistiocytosis.""]","[""Genetic changes related to FHL include mutations in genes such as PRF1, UNC13D, STX11, and STXBP2.""]"
causes,What causes Glucose transporter type 1 deficiency syndrome ?,What causes glucose transporter type 1 deficiency syndrome? Glucose transporter type 1 deficiency syndrome (GLUT1 deficiency syndrome) is caused by changes (mutations) in the SLC2A1 gene. This gene encodes a protein that helps transport glucose (a simple sugar) into cells where it is used as fuel. The protein is particularly important in the central nervous system since glucose is the brain's main source of energy. SLC2A1 mutations impair the function of the protein. This significantly reduces the amount of glucose available to brain cells leading to the many signs and symptoms associated with GLUT1 deficiency syndrome.,"{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""GLUT1"", ""full_form"": ""Glucose transporter type 1""}]}",What causes GLUT1 deficiency syndrome ?,What causes Glucose transporter type 1 deficiency syndrome ?,8,MEDICAL,Simple Datatype-String,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.",[[]],[[]],"[""Glucose Transporter Type 1""]",[2.265455013218341e-18],[2.265455013218341e-18],"[""Glucose Transporter Type 1""]",[2.265455013218341e-18],"[""LLM""]",[[]],[0.958506408241331],[0.9513625464973616],"[""Glucose transporter type 1""]",[0.9513625464973616],"[""LLM""]",[[]],"[""Glucose Transporter Type 1""]","[""LLM""]",What causes GLUT1 (Glucose Transporter Type 1) deficiency syndrome ?,[true],[true],[true],"[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making the GLUT1 protein responsible for transporting glucose into the brain.""]","[""Glucose transporter type 1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations impair the function of the protein, leading to a reduced ability to transport glucose across the blood-brain barrier.""]","[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations result in a reduced ability of cells to take up glucose, leading to a lack of energy in the brain and causing the symptoms of the syndrome.""]",[true],[true],[true],"[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making the GLUT1 protein responsible for transporting glucose into the brain.""]","[""Glucose transporter type 1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations result in a reduced ability of cells to take up glucose, leading to a variety of neurological symptoms.""]","[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations result in a reduced ability of cells to take up glucose, leading to a variety of neurological symptoms.""]",[true],[true],[true],"[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making the GLUT1 protein responsible for transporting glucose into the brain.""]","[""Glucose transporter type 1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations impair the function of the protein, leading to a reduced ability to transport glucose across the blood-brain barrier.""]","[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations result in a reduced ability of cells to take up glucose, leading to a lack of energy in the brain.""]",[true],[true],[true],"[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making the GLUT1 protein responsible for transporting glucose into the brain.""]","[""Glucose transporter type 1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations result in a reduced ability of cells to take up glucose, leading to a variety of neurological symptoms.""]","[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations result in a reduced ability of cells to take up glucose, leading to a lack of energy in the brain.""]",[true],[true],[true],"[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making the GLUT1 protein responsible for transporting glucose into the brain.""]","[""Glucose transporter type 1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations impair the function of the protein, leading to a reduced ability to transport glucose across the blood-brain barrier.""]","[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations result in a reduced ability of cells to take up glucose, leading to a lack of energy in the brain and causing the symptoms of the syndrome.""]",[true],[true],[true],"[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making the GLUT1 protein responsible for transporting glucose into the brain.""]","[""Glucose transporter type 1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations result in a reduced ability of cells to take up glucose, leading to a variety of neurological symptoms.""]","[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations result in a reduced ability of cells to take up glucose, leading to a variety of neurological symptoms.""]",[true],[true],[true],"[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making the GLUT1 protein responsible for transporting glucose into the brain.""]","[""Glucose transporter type 1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations impair the function of the protein, leading to a reduced ability to transport glucose across the blood-brain barrier.""]","[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations result in a reduced ability of cells to take up glucose, leading to a lack of energy in the brain.""]",[true],[true],[true],"[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making the GLUT1 protein responsible for transporting glucose into the brain.""]","[""Glucose transporter type 1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations result in a reduced ability of cells to take up glucose, leading to a variety of neurological symptoms.""]","[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations result in a reduced ability of cells to take up glucose, leading to a lack of energy in the brain.""]",[true],[true],[true],"[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making the GLUT1 protein responsible for transporting glucose into the brain.""]","[""Glucose transporter type 1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations result in a reduced ability of cells to take up glucose, leading to a variety of neurological symptoms.""]","[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations result in a reduced ability of cells to take up glucose, leading to a variety of neurological symptoms.""]",[true],[true],[true],"[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making the GLUT1 protein responsible for transporting glucose into the brain.""]","[""Glucose transporter type 1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations impair the function of the protein, leading to a reduced ability to transport glucose across the blood-brain barrier.""]","[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations result in a reduced ability of cells to take up glucose, leading to a lack of energy in the brain and causing the symptoms of the syndrome.""]",[true],[true],[true],"[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making the GLUT1 protein responsible for transporting glucose into the brain.""]","[""Glucose transporter type 1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations impair the function of the protein, leading to a reduced ability to transport glucose across the blood-brain barrier.""]","[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations result in a reduced ability of cells to take up glucose, leading to a lack of energy in the brain.""]",[true],[true],[true],"[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making the GLUT1 protein responsible for transporting glucose into the brain.""]","[""Glucose transporter type 1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations result in a reduced ability of cells to take up glucose, leading to a variety of neurological symptoms.""]","[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations result in a reduced ability of cells to take up glucose, leading to a lack of energy in the brain.""]",[true],[true],[true],"[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making the GLUT1 protein responsible for transporting glucose into the brain.""]","[""Glucose transporter type 1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations impair the function of the protein, leading to a reduced ability to transport glucose across the blood-brain barrier.""]","[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations result in a reduced ability of cells to take up glucose, leading to a lack of energy in the brain and causing the symptoms of the syndrome.""]",[true],[true],[true],"[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making the GLUT1 protein responsible for transporting glucose into the brain.""]","[""Glucose transporter type 1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations result in a reduced ability of cells to take up glucose, leading to a variety of neurological symptoms.""]","[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations result in a reduced ability of cells to take up glucose, leading to a variety of neurological symptoms.""]",[true],[true],[true],"[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making the GLUT1 protein responsible for transporting glucose into the brain.""]","[""Glucose transporter type 1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations impair the function of the protein, leading to a reduced ability to transport glucose across the blood-brain barrier.""]","[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations result in a reduced ability of cells to take up glucose, leading to a lack of energy in the brain.""]",[true],[true],[true],"[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making the GLUT1 protein responsible for transporting glucose into the brain.""]","[""Glucose transporter type 1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations result in a reduced ability of cells to take up glucose, leading to a variety of neurological symptoms.""]","[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations result in a reduced ability of cells to take up glucose, leading to a lack of energy in the brain.""]",[true],[true],[true],"[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making the GLUT1 protein. These mutations result in a reduced ability of cells to take up glucose, leading to a variety of symptoms.""]","[""Glucose transporter type 1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations impair the function of the protein, leading to a reduced ability to transport glucose across the blood-brain barrier.""]","[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations result in a reduced ability of cells to take up glucose, leading to a lack of energy in the brain and causing the symptoms of the syndrome.""]",[true],[true],[true],"[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making the GLUT1 protein responsible for transporting glucose into the brain.""]","[""Glucose transporter type 1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations result in a reduced ability of cells to take up glucose, leading to a variety of neurological symptoms.""]","[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations result in a reduced ability of cells to take up glucose, leading to a variety of neurological symptoms.""]",[true],[true],[true],"[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making the GLUT1 protein responsible for transporting glucose into the brain.""]","[""Glucose transporter type 1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations impair the function of the protein, leading to a reduced ability to transport glucose across the blood-brain barrier.""]","[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations result in a reduced ability of cells to take up glucose, leading to a lack of energy in the brain.""]",[true],[true],[true],"[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making the GLUT1 protein responsible for transporting glucose into the brain.""]","[""Glucose transporter type 1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations result in a reduced ability of cells to take up glucose, leading to a variety of neurological symptoms.""]","[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations result in a reduced ability of cells to take up glucose, leading to a lack of energy in the brain.""]",[true],[true],[true],"[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making the GLUT1 protein responsible for transporting glucose into the brain.""]","[""Glucose transporter type 1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations impair the function of the protein, leading to a reduced ability to transport glucose across the blood-brain barrier.""]","[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations result in a reduced ability of cells to take up glucose, leading to a lack of energy in the brain and causing the symptoms of the syndrome.""]",[true],[true],[true],"[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making the GLUT1 protein responsible for transporting glucose into the brain.""]","[""Glucose transporter type 1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations result in a reduced ability of cells to take up glucose, leading to a variety of neurological symptoms.""]","[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations result in a reduced ability of cells to take up glucose, leading to a variety of neurological symptoms.""]",[true],[true],[true],"[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making the GLUT1 protein responsible for transporting glucose into the brain.""]","[""Glucose transporter type 1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations impair the function of the protein, leading to a reduced ability to transport glucose across the blood-brain barrier.""]","[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations result in a reduced ability of cells to take up glucose, leading to a lack of energy in the brain.""]",[true],[true],[true],"[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making the GLUT1 protein responsible for transporting glucose into the brain.""]","[""Glucose transporter type 1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations result in a reduced ability of cells to take up glucose, leading to a variety of neurological symptoms.""]","[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations result in a reduced ability of cells to take up glucose, leading to a lack of energy in the brain.""]",[true],[true],[true],"[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making the GLUT1 protein. This protein is responsible for transporting glucose from the blood into the brain. Mutations in this gene lead to a reduced ability to transport glucose, resulting in a lack of energy in the brain cells.""]","[""Glucose transporter type 1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations impair the function of the protein, leading to a reduced ability to transport glucose across the blood-brain barrier.""]","[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations result in a reduced ability of cells to take up glucose, leading to a lack of energy in the brain and causing the symptoms of the syndrome.""]",[true],[true],[true],"[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making the GLUT1 protein. This protein is responsible for transporting glucose from the blood into the brain.""]","[""Glucose transporter type 1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations result in a reduced ability of cells to take up glucose, leading to a variety of neurological symptoms.""]","[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations result in a reduced ability of cells to take up glucose, leading to a variety of neurological symptoms.""]",[true],[true],[true],"[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making the GLUT1 protein. This protein is responsible for transporting glucose from the blood into the brain. Mutations in this gene lead to a reduced ability to transport glucose, resulting in a lack of energy in the brain cells.""]","[""Glucose transporter type 1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations impair the function of the protein, leading to a reduced ability to transport glucose across the blood-brain barrier.""]","[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations result in a reduced ability of cells to take up glucose, leading to a lack of energy in the brain.""]",[true],[true],[true],"[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making the GLUT1 protein. These mutations result in a reduced ability of cells to take up glucose, leading to a shortage of glucose in the brain.""]","[""Glucose transporter type 1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations result in a reduced ability of cells to take up glucose, leading to a variety of neurological symptoms.""]","[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations result in a reduced ability of cells to take up glucose, leading to a lack of energy in the brain.""]",[true],[true],[true],"[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making the GLUT1 protein. These mutations result in a reduced ability of cells to transport glucose across the blood-brain barrier, leading to a lack of glucose in the brain.""]","[""Glucose transporter type 1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations impair the function of the protein, leading to a reduced ability to transport glucose across the blood-brain barrier.""]","[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations result in a reduced ability of cells to take up glucose, leading to a lack of energy in the brain and causing the symptoms of the syndrome.""]",[true],[true],[true],"[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein that transports glucose from the blood into the brain.""]","[""Glucose transporter type 1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations impair the function of the protein, leading to a reduced ability to transport glucose across the blood-brain barrier.""]","[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations result in a reduced ability of cells to take up glucose, leading to a lack of energy in the brain and causing the symptoms of the syndrome.""]",[true],[true],[true],"[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making the GLUT1 protein. These mutations result in a reduced ability of cells to take up glucose, leading to a variety of neurological symptoms.""]","[""Glucose transporter type 1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations impair the function of the protein, leading to a reduced ability to transport glucose across the blood-brain barrier.""]","[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations result in a reduced ability of cells to take up glucose, leading to a lack of energy in the brain and causing the symptoms of the syndrome.""]",[true],[true],[true],"[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations result in a reduced ability of cells to transport glucose across the blood-brain barrier, leading to a lack of energy in the brain cells.""]","[""Glucose transporter type 1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations impair the function of the protein, leading to a reduced ability to transport glucose across the blood-brain barrier.""]","[""GLUT1 deficiency syndrome is caused by mutations in the SLC2A1 gene, which provides instructions for making a protein called glucose transporter type 1 (GLUT1). These mutations result in a reduced ability of cells to take up glucose, leading to a lack of energy in the brain and causing the symptoms of the syndrome.""]"
information,Do you have information about Kidney Transplantation,"Summary : A kidney transplant is an operation that places a healthy kidney in your body. The transplanted kidney takes over the work of the two kidneys that failed, so you no longer need dialysis.     During a transplant, the surgeon places the new kidney in your lower abdomen and connects the artery and vein of the new kidney to your artery and vein. Often, the new kidney will start making urine as soon as your blood starts flowing through it. But sometimes it takes a few weeks to start working.     Many transplanted kidneys come from donors who have died. Some come from a living family member. The wait for a new kidney can be long.    If you have a transplant, you must take drugs for the rest of your life, to keep your body from rejecting the new kidney.    NIH: National Institute of Diabetes and Digestive and Kidney Diseases","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""KT"", ""full_form"": ""Kidney Transplantation""}]}",Do you have information about KT,Do you have information about Kidney Transplantation,8,MEDICAL,Simple Datatype-String,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Knot"", ""Kitchen Table"", ""Kingston Technology"", ""Katy Industries, Inc."", ""The K Th"", ""Knights Templar"", ""Killing Time"", ""Kill Target"", ""Klippel-Trenaunay syndrome"", ""Kansas Territory""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Knee Tap""]",[1.2765794540162073e-07],[8.117482579010597e-09],"[""Knot""]",[3.804575178886049e-06],"[""ABBREVIATIONS""]","[[3.804575178886049e-06, 1.4820555498093003e-07, 7.859228797911349e-13, 3.590508700657533e-21, 2.711461352649539e-09, 4.939806754642476e-17, 8.120413240927861e-09, 1.9350775653444216e-08, 3.016070575946819e-28, 1.78081941386754e-14]]",[0.752543518781376],[0.7719077919323637],"[""Kidney Transplantation""]",[0.8830321002359982],"[""ABBREVIATIONS""]","[[0.8830321002359982, 0.7931512062659078, 0.7057820989067933, 0.7268923066987021, 0.8679180837518432, 0.7366226529942232, 0.787646460185403, 0.762653277612436, 0.7191768601989981, 0.7230238630123353]]","[""Klippel-Trenaunay syndrome""]","[""ABBREVIATIONS""]",Do you have information about KT (Knee Tap),[false],[true],[false],"[""KT (Knot) is a unit of speed equal to one nautical mile per hour.""]","[""Yes, kidney transplantation is a surgical procedure to replace a diseased kidney with a healthy one from a donor.""]","[""KT stands for Kinesio Tape, which is a type of elastic therapeutic tape used for treating sports injuries and various physical disorders.""]",[false],[true],[false],"[""KT (Knot) is a unit of speed equal to one nautical mile per hour.""]","[""Yes, kidney transplantation is a surgical procedure to replace a diseased kidney with a healthy one from a donor.""]","[""KT, short for Kinesio Taping, is a rehabilitative taping technique designed to facilitate the body's natural healing process while providing support and stability to muscles and joints without restricting the body's range of motion.""]",[false],[true],[false],"[""KT (Knot) is a unit of speed equal to one nautical mile per hour.""]","[""Yes, kidney transplantation is a surgical procedure to replace a diseased or failing kidney with a healthy kidney from a donor.""]","[""KT, short for Kinesio Taping, is a technique that involves the application of a special elastic tape to help support muscles and joints, reduce pain, and improve circulation and lymphatic drainage.""]",[false],[true],[false],"[""KT (Knot) is a unit of speed equal to one nautical mile per hour.""]","[""Yes, kidney transplantation is a surgical procedure to replace a diseased kidney with a healthy one from a donor.""]","[""KT stands for Kinesio Tape, which is a type of elastic therapeutic tape used for treating sports injuries and various physical disorders.""]",[true],[true],[false],"[""Kidney transplantation is a surgical procedure to place a healthy kidney from a donor into a person whose kidneys no longer function properly.""]","[""Yes, kidney transplantation is a surgical procedure to replace a diseased kidney with a healthy one from a donor.""]","[""KT stands for Kinesio Tape, which is a type of elastic therapeutic tape used for treating sports injuries and various physical disorders.""]",[true],[true],[false],"[""Kidney transplantation is a surgical procedure to place a healthy kidney from a donor into a person whose kidneys no longer function properly.""]","[""Yes, kidney transplantation is a surgical procedure to replace a diseased kidney with a healthy one from a donor.""]","[""KT, short for Kinesio Taping, is a rehabilitative taping technique designed to facilitate the body's natural healing process while providing support and stability to muscles and joints without restricting the body's range of motion.""]",[true],[true],[false],"[""Kidney transplantation is a surgical procedure to place a healthy kidney from a donor into a person whose kidneys no longer function properly.""]","[""Yes, kidney transplantation is a surgical procedure to replace a diseased or failing kidney with a healthy kidney from a donor.""]","[""KT, short for Kinesio Taping, is a technique that involves the application of a special elastic tape to help support muscles and joints, reduce pain, and improve circulation and lymphatic drainage.""]",[true],[true],[false],"[""Kidney transplantation is a surgical procedure to place a healthy kidney from a donor into a person whose kidneys no longer function properly.""]","[""Yes, kidney transplantation is a surgical procedure to replace a diseased kidney with a healthy one from a donor.""]","[""KT stands for Kinesio Tape, which is a type of elastic therapeutic tape used for treating sports injuries and various physical disorders.""]",[false],[true],[false],"[""Klippel-Trenaunay syndrome (KT) is a rare congenital vascular disorder characterized by a triad of symptoms including port-wine stains, varicose veins, and limb overgrowth. It is caused by abnormal development of blood vessels, lymph vessels, and capillaries.""]","[""Yes, kidney transplantation is a surgical procedure to replace a diseased kidney with a healthy one from a donor.""]","[""KT, short for Kinesio Taping, is a rehabilitative taping technique designed to facilitate the body's natural healing process while providing support and stability to muscles and joints without restricting the body's range of motion.""]",[false],[true],[false],"[""Klippel-Trenaunay syndrome (KT) is a rare congenital vascular disorder characterized by a triad of symptoms including port-wine stains, varicose veins, and limb overgrowth. It is caused by the abnormal development of blood vessels, lymph vessels, and capillaries.""]","[""Yes, kidney transplantation is a surgical procedure to replace a diseased kidney with a healthy one from a donor.""]","[""KT stands for Kinesio Tape, which is a type of elastic therapeutic tape used for treating sports injuries and various physical disorders.""]",[false],[true],[false],"[""Klippel-Trenaunay syndrome (KT) is a rare congenital vascular disorder characterized by a triad of symptoms including port-wine stain, varicose veins, and bony and soft tissue hypertrophy. It typically affects one limb and can lead to complications such as blood clots and limb overgrowth.""]","[""Yes, kidney transplantation is a surgical procedure to replace a diseased or failing kidney with a healthy kidney from a donor.""]","[""KT, short for Kinesio Taping, is a technique that involves the application of a special elastic tape to help support muscles and joints, reduce pain, and improve circulation and lymphatic drainage.""]",[false],[true],[false],"[""Klippel-Trenaunay syndrome (KT) is a rare congenital vascular disorder characterized by a triad of symptoms including port-wine stain birthmarks, varicose veins, and overgrowth of soft tissues and bones. It usually affects one limb and can lead to complications such as blood clots and limb length discrepancies.""]","[""Yes, kidney transplantation is a surgical procedure to replace a diseased kidney with a healthy one from a donor.""]","[""KT stands for Kinesio Tape, which is a type of elastic therapeutic tape used for treating sports injuries and various physical disorders.""]",[false],[true],[false],"[""KT (Klippel-Trenaunay syndrome) is a rare congenital vascular disorder characterized by a triad of symptoms including port-wine stains, varicose veins, and limb overgrowth.""]","[""Yes, kidney transplantation is a surgical procedure to replace a diseased kidney with a healthy one from a donor.""]","[""KT stands for Kinesio Tape, which is a type of elastic therapeutic tape used for treating sports injuries and various physical disorders.""]",[false],[true],[false],"[""KT (Klippel-Trenaunay syndrome) is a rare congenital vascular disorder characterized by a triad of symptoms including port-wine stain, varicose veins, and limb hypertrophy.""]","[""Yes, kidney transplantation is a surgical procedure to replace a diseased kidney with a healthy one from a donor.""]","[""KT, short for Kinesio Taping, is a rehabilitative taping technique designed to facilitate the body's natural healing process while providing support and stability to muscles and joints without restricting the body's range of motion.""]",[false],[true],[false],"[""KT syndrome is a rare congenital vascular disorder characterized by a triad of symptoms including port-wine stains, varicose veins, and bony and soft tissue hypertrophy.""]","[""Yes, kidney transplantation is a surgical procedure to replace a diseased or failing kidney with a healthy kidney from a donor.""]","[""KT, short for Kinesio Taping, is a technique that involves the application of a special elastic tape to help support muscles and joints, reduce pain, and improve circulation and lymphatic drainage.""]",[false],[true],[false],"[""KT (Klippel-Trenaunay syndrome) is a rare congenital vascular disorder characterized by a triad of symptoms including port-wine stains, varicose veins, and limb overgrowth.""]","[""Yes, kidney transplantation is a surgical procedure to replace a diseased kidney with a healthy one from a donor.""]","[""KT stands for Kinesio Tape, which is a type of elastic therapeutic tape used for treating sports injuries and various physical disorders.""]",[false],[true],[false],"[""KT (Klippel-Trenaunay syndrome) is a rare congenital vascular disorder characterized by a triad of symptoms including port-wine stains, varicose veins, and limb overgrowth.""]","[""Yes, kidney transplantation is a surgical procedure to replace a diseased kidney with a healthy one from a donor.""]","[""KT stands for Kinesio Tape, which is a type of elastic therapeutic tape used for treating sports injuries and various physical disorders.""]",[false],[true],[false],"[""Klippel-Trenaunay syndrome (KT) is a rare congenital vascular disorder characterized by a triad of symptoms including port-wine stain, varicose veins, and soft tissue or bone overgrowth. It typically affects one limb and can lead to complications such as blood clots and limb overgrowth.""]","[""Yes, kidney transplantation is a surgical procedure to replace a diseased kidney with a healthy one from a donor.""]","[""KT, short for Kinesio Taping, is a rehabilitative taping technique designed to facilitate the body's natural healing process while providing support and stability to muscles and joints without restricting the body's range of motion.""]",[false],[true],[false],"[""Klippel-Trenaunay syndrome (KT) is a rare congenital vascular disorder characterized by a triad of symptoms including port-wine stains, varicose veins, and limb overgrowth.""]","[""Yes, kidney transplantation is a surgical procedure to replace a diseased or failing kidney with a healthy kidney from a donor.""]","[""KT, short for Kinesio Taping, is a technique that involves the application of a special elastic tape to help support muscles and joints, reduce pain, and improve circulation and lymphatic drainage.""]",[false],[true],[false],"[""Klippel-Trenaunay syndrome (KT) is a rare congenital vascular disorder characterized by a triad of symptoms including port-wine stains, varicose veins, and limb overgrowth. It is caused by abnormal development of blood vessels, lymph vessels, and capillaries.""]","[""Yes, kidney transplantation is a surgical procedure to replace a diseased kidney with a healthy one from a donor.""]","[""KT stands for Kinesio Tape, which is a type of elastic therapeutic tape used for treating sports injuries and various physical disorders.""]",[false],[true],[false],"[""KT (Knee Tap) is a physical examination test used to assess the integrity of the knee joint and the presence of an effusion (fluid within the joint). It involves tapping the knee to observe for any fluid wave or bulge.""]","[""Yes, kidney transplantation is a surgical procedure to replace a diseased kidney with a healthy one from a donor.""]","[""KT stands for Kinesio Tape, which is a type of elastic therapeutic tape used for treating sports injuries and various physical disorders.""]",[false],[true],[false],"[""KT (Knee Tap) is a physical examination test used to assess the integrity of the knee joint and the presence of an effusion (fluid within the joint). It involves tapping the knee to observe for any fluid wave or bulge.""]","[""Yes, kidney transplantation is a surgical procedure to replace a diseased kidney with a healthy one from a donor.""]","[""KT, short for Kinesio Taping, is a rehabilitative taping technique designed to facilitate the body's natural healing process while providing support and stability to muscles and joints without restricting the body's range of motion.""]",[false],[true],[false],"[""KT (Knee Tap) is a physical examination test used to assess the integrity of the anterior cruciate ligament (ACL) in the knee joint. It involves tapping the patella with a reflex hammer to observe the response of the lower leg.""]","[""Yes, kidney transplantation is a surgical procedure to replace a diseased or failing kidney with a healthy kidney from a donor.""]","[""KT, short for Kinesio Taping, is a technique that involves the application of a special elastic tape to help support muscles and joints, reduce pain, and improve circulation and lymphatic drainage.""]",[false],[true],[false],"[""Knee tap (KT) is a physical examination test used to assess the integrity of the anterior cruciate ligament (ACL) in the knee joint. It involves tapping the patellar tendon to observe the response of the tibia.""]","[""Yes, kidney transplantation is a surgical procedure to replace a diseased kidney with a healthy one from a donor.""]","[""KT stands for Kinesio Tape, which is a type of elastic therapeutic tape used for treating sports injuries and various physical disorders.""]",[false],[true],[false],"[""Klippel-Trenaunay syndrome (KT) is a rare congenital vascular disorder characterized by a triad of symptoms including port-wine stains, varicose veins, and limb overgrowth. It is caused by abnormal development of blood vessels, lymphatics, and other tissues. Treatment focuses on managing symptoms and complications.""]","[""Yes, kidney transplantation is a surgical procedure to replace a diseased kidney with a healthy one from a donor.""]","[""KT stands for Kinesio Tape, which is a type of elastic therapeutic tape used for treating sports injuries and various physical disorders.""]",[false],[true],[false],"[""Klippel-Trenaunay syndrome (KT) is a rare congenital vascular disorder characterized by a triad of symptoms including port-wine stains, varicose veins, and limb overgrowth. It is caused by abnormal development of blood vessels, soft tissues, and bones.""]","[""Yes, kidney transplantation is a surgical procedure to replace a diseased kidney with a healthy one from a donor.""]","[""KT, short for Kinesio Taping, is a rehabilitative taping technique designed to facilitate the body's natural healing process while providing support and stability to muscles and joints without restricting the body's range of motion.""]",[false],[true],[false],"[""Klippel-Trenaunay syndrome (KT) is a rare congenital vascular disorder characterized by a triad of symptoms including port-wine stains, varicose veins, and bony and soft tissue hypertrophy. It is caused by the abnormal development of blood vessels, lymph vessels, and capillaries. Treatment focuses on managing symptoms and complications.""]","[""Yes, kidney transplantation is a surgical procedure to replace a diseased or failing kidney with a healthy kidney from a donor.""]","[""KT, short for Kinesio Taping, is a technique that involves the application of a special elastic tape to help support muscles and joints, reduce pain, and improve circulation and lymphatic drainage.""]",[false],[true],[false],"[""Klippel-Trenaunay syndrome (KT) is a rare congenital vascular disorder characterized by a triad of symptoms including port-wine stain, varicose veins, and soft tissue or bone overgrowth. It typically affects one limb and can lead to complications such as blood clots and infections.""]","[""Yes, kidney transplantation is a surgical procedure to replace a diseased kidney with a healthy one from a donor.""]","[""KT stands for Kinesio Tape, which is a type of elastic therapeutic tape used for treating sports injuries and various physical disorders.""]",[false],[true],[false],"[""Yes, KT syndrome is a rare congenital vascular disorder characterized by a triad of symptoms including port-wine stains, varicose veins, and bony and soft tissue hypertrophy.""]","[""Yes, kidney transplantation is a surgical procedure to replace a diseased kidney with a healthy one from a donor.""]","[""KT stands for Kinesio Tape, which is a type of elastic therapeutic tape used for treating sports injuries and various physical disorders.""]",[false],[true],[false],"[""No, I do not have information about KT (Knot).""]","[""Yes, kidney transplantation is a surgical procedure to replace a diseased kidney with a healthy one from a donor.""]","[""KT stands for Kinesio Tape, which is a type of elastic therapeutic tape used for treating sports injuries and various physical disorders.""]",[true],[true],[false],"[""Yes, I have information about Kidney Transplantation (KT).""]","[""Yes, kidney transplantation is a surgical procedure to replace a diseased kidney with a healthy one from a donor.""]","[""KT stands for Kinesio Tape, which is a type of elastic therapeutic tape used for treating sports injuries and various physical disorders.""]",[false],[true],[false],"[""KT (Knee Tap) is a physical examination test used to assess the integrity of the patellar tendon reflex and the L2-4 nerve roots.""]","[""Yes, kidney transplantation is a surgical procedure to replace a diseased kidney with a healthy one from a donor.""]","[""KT stands for Kinesio Tape, which is a type of elastic therapeutic tape used for treating sports injuries and various physical disorders.""]"
treatment,What are the treatments for SYNGAP1-related intellectual disability ?,"These resources address the diagnosis or management of SYNGAP1-related intellectual disability:  - Eunice Kennedy Shriver National Institute of Child Health and Human Development: What Are Treatments for Intellectual and Developmental Disabilities?  - Genetic Testing Registry: Mental retardation, autosomal dominant 5   These resources from MedlinePlus offer information about the diagnosis and management of various health conditions:  - Diagnostic Tests  - Drug Therapy  - Surgery and Rehabilitation  - Genetic Counseling   - Palliative Care","{""full_form_abbrv_map"": [{""ambiguity_type"": ""abbreviation"", ""abbreviation"": ""SYNGAP1"", ""full_form"": ""Synaptic Ras GTPase activating protein 1""}]}",What are the treatments for SYNGAP1-related intellectual disability ?,What are the treatments for Synaptic Ras GTPase activating protein 1-related intellectual disability ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.",[[]],[[]],"[""Synaptic Ras GTPase activating protein 1""]",[5.598997695622438e-35],[5.598997695622438e-35],"[""Synaptic Ras GTPase activating protein 1""]",[5.598997695622438e-35],"[""LLM""]",[[]],[0.9747336086396465],[0.9747218232483879],"[""Synaptic Ras GTPase activating protein 1""]",[0.9747218232483879],"[""LLM""]",[[]],"[""Synaptic Ras GTPase activating protein 1""]","[""LLM""]",What are the treatments for SYNGAP1 (Synaptic Ras GTPase activating protein 1)-related intellectual disability ?,[true],[true],[true],"[""There is no specific treatment for SYNGAP1-related intellectual disability. Management involves supportive care, early intervention programs, and therapies to address symptoms and improve quality of life.""]","[""There is no specific treatment for Synaptic Ras GTPase activating protein 1-related intellectual disability. Management involves supportive care, early intervention programs, and educational support.""]","[""There is no specific treatment for SYNGAP1-related intellectual disability, but symptoms can be managed with therapies such as speech therapy, occupational therapy, and behavioral therapy.""]",[true],[true],[true],"[""There is currently no specific treatment for SYNGAP1-related intellectual disability. Management involves supportive care and therapies to address symptoms and improve quality of life.""]","[""There is currently no specific treatment for Synaptic Ras GTPase activating protein 1-related intellectual disability. Management typically involves supportive care, early intervention programs, and educational support tailored to the individual's needs.""]","[""There is currently no specific treatment for SYNGAP1-related intellectual disability. Management involves supportive care and therapies to address symptoms and improve quality of life.""]",[true],[true],[true],"[""There is no specific treatment for SYNGAP1-related intellectual disability. Management involves supportive care and therapies to address symptoms and improve quality of life.""]","[""Behavioral therapy, speech therapy, occupational therapy, and educational support are common treatments for Synaptic Ras GTPase activating protein 1-related intellectual disability.""]","[""The treatments for SYNGAP1-related intellectual disability include speech therapy, occupational therapy, physical therapy, behavioral therapy, and medications to manage symptoms.""]",[true],[true],[true],"[""There is currently no specific treatment for SYNGAP1-related intellectual disability. Management involves supportive care and therapies to address symptoms and improve quality of life.""]","[""There is currently no specific treatment for Synaptic Ras GTPase activating protein 1-related intellectual disability. Management involves supportive care and therapies to address symptoms and improve quality of life.""]","[""There is no specific treatment for SYNGAP1-related intellectual disability, but symptoms can be managed with therapies such as speech therapy, occupational therapy, and behavioral therapy.""]",[true],[true],[true],"[""There is no specific treatment for SYNGAP1-related intellectual disability, but symptoms can be managed with therapies such as speech therapy, occupational therapy, and behavioral therapy.""]","[""There is no specific treatment for Synaptic Ras GTPase activating protein 1-related intellectual disability. Management involves supportive care, early intervention programs, and educational support.""]","[""There is no specific treatment for SYNGAP1-related intellectual disability, but symptoms can be managed with therapies such as speech therapy, occupational therapy, and behavioral therapy.""]",[true],[true],[true],"[""There is currently no specific treatment for SYNGAP1-related intellectual disability. Management involves supportive care and therapies to address symptoms and improve quality of life.""]","[""There is currently no specific treatment for Synaptic Ras GTPase activating protein 1-related intellectual disability. Management typically involves supportive care, early intervention programs, and educational support tailored to the individual's needs.""]","[""There is currently no specific treatment for SYNGAP1-related intellectual disability. Management involves supportive care and therapies to address symptoms and improve quality of life.""]",[true],[true],[true],"[""There is no specific treatment for SYNGAP1-related intellectual disability, but symptoms can be managed with therapies such as speech therapy, occupational therapy, and behavioral therapy.""]","[""Behavioral therapy, speech therapy, occupational therapy, and educational support are common treatments for Synaptic Ras GTPase activating protein 1-related intellectual disability.""]","[""The treatments for SYNGAP1-related intellectual disability include speech therapy, occupational therapy, physical therapy, behavioral therapy, and medications to manage symptoms.""]",[true],[true],[true],"[""There is currently no specific treatment for SYNGAP1-related intellectual disability. Management involves supportive care and therapies to address symptoms such as seizures, developmental delays, and behavioral issues.""]","[""There is currently no specific treatment for Synaptic Ras GTPase activating protein 1-related intellectual disability. Management involves supportive care and therapies to address symptoms and improve quality of life.""]","[""There is no specific treatment for SYNGAP1-related intellectual disability, but symptoms can be managed with therapies such as speech therapy, occupational therapy, and behavioral therapy.""]",[true],[true],[true],"[""There is no specific treatment for SYNGAP1-related intellectual disability, but symptoms can be managed with therapies such as speech therapy, occupational therapy, and behavioral therapy.""]","[""There is currently no specific treatment for Synaptic Ras GTPase activating protein 1-related intellectual disability. Management typically involves supportive care, early intervention programs, and educational support tailored to the individual's needs.""]","[""There is currently no specific treatment for SYNGAP1-related intellectual disability. Management involves supportive care and therapies to address symptoms and improve quality of life.""]",[true],[true],[true],"[""There is currently no specific treatment for SYNGAP1-related intellectual disability. Management involves supportive care and therapies to address symptoms and improve quality of life.""]","[""There is no specific treatment for Synaptic Ras GTPase activating protein 1-related intellectual disability. Management involves supportive care, early intervention programs, and educational support.""]","[""There is no specific treatment for SYNGAP1-related intellectual disability, but symptoms can be managed with therapies such as speech therapy, occupational therapy, and behavioral therapy.""]",[true],[true],[true],"[""There is no specific treatment for SYNGAP1-related intellectual disability, but symptoms can be managed with therapies such as speech therapy, occupational therapy, and behavioral therapy.""]","[""Behavioral therapy, speech therapy, occupational therapy, and educational support are common treatments for Synaptic Ras GTPase activating protein 1-related intellectual disability.""]","[""The treatments for SYNGAP1-related intellectual disability include speech therapy, occupational therapy, physical therapy, behavioral therapy, and medications to manage symptoms.""]",[true],[true],[true],"[""There is no specific treatment for SYNGAP1-related intellectual disability, but symptoms can be managed with therapies such as speech therapy, occupational therapy, and behavioral therapy.""]","[""There is currently no specific treatment for Synaptic Ras GTPase activating protein 1-related intellectual disability. Management involves supportive care and therapies to address symptoms and improve quality of life.""]","[""There is no specific treatment for SYNGAP1-related intellectual disability, but symptoms can be managed with therapies such as speech therapy, occupational therapy, and behavioral therapy.""]",[true],[true],[true],"[""There is currently no specific treatment for SYNGAP1-related intellectual disability. Management involves supportive care and therapies to address symptoms and improve quality of life.""]","[""There is no specific treatment for Synaptic Ras GTPase activating protein 1-related intellectual disability. Management involves supportive care, early intervention programs, and educational support.""]","[""There is no specific treatment for SYNGAP1-related intellectual disability, but symptoms can be managed with therapies such as speech therapy, occupational therapy, and behavioral therapy.""]",[true],[true],[true],"[""There is currently no specific treatment for SYNGAP1-related intellectual disability. Management involves supportive care and therapies to address symptoms and improve quality of life.""]","[""There is currently no specific treatment for Synaptic Ras GTPase activating protein 1-related intellectual disability. Management typically involves supportive care, early intervention programs, and educational support tailored to the individual's needs.""]","[""There is currently no specific treatment for SYNGAP1-related intellectual disability. Management involves supportive care and therapies to address symptoms and improve quality of life.""]",[true],[true],[true],"[""There is no specific treatment for SYNGAP1-related intellectual disability. Management involves supportive care and therapies to address symptoms and improve quality of life.""]","[""Behavioral therapy, speech therapy, occupational therapy, and educational support are common treatments for Synaptic Ras GTPase activating protein 1-related intellectual disability.""]","[""The treatments for SYNGAP1-related intellectual disability include speech therapy, occupational therapy, physical therapy, behavioral therapy, and medications to manage symptoms.""]",[true],[true],[true],"[""There is currently no specific treatment for SYNGAP1-related intellectual disability. Management involves supportive care and therapies to address symptoms and improve quality of life.""]","[""There is currently no specific treatment for Synaptic Ras GTPase activating protein 1-related intellectual disability. Management involves supportive care and therapies to address symptoms and improve quality of life.""]","[""There is no specific treatment for SYNGAP1-related intellectual disability, but symptoms can be managed with therapies such as speech therapy, occupational therapy, and behavioral therapy.""]",[true],[true],[true],"[""There is currently no specific treatment for SYNGAP1-related intellectual disability. Management involves supportive care and therapies to address symptoms and improve quality of life.""]","[""There is no specific treatment for Synaptic Ras GTPase activating protein 1-related intellectual disability. Management involves supportive care, early intervention programs, and educational support.""]","[""There is no specific treatment for SYNGAP1-related intellectual disability, but symptoms can be managed with therapies such as speech therapy, occupational therapy, and behavioral therapy.""]",[true],[true],[true],"[""There is currently no specific treatment for SYNGAP1-related intellectual disability. Management involves supportive care and therapies to address symptoms and improve quality of life.""]","[""There is currently no specific treatment for Synaptic Ras GTPase activating protein 1-related intellectual disability. Management typically involves supportive care, early intervention programs, and educational support tailored to the individual's needs.""]","[""There is currently no specific treatment for SYNGAP1-related intellectual disability. Management involves supportive care and therapies to address symptoms and improve quality of life.""]",[true],[true],[true],"[""There is currently no specific treatment for SYNGAP1-related intellectual disability. Management involves supportive care and therapies to address symptoms such as developmental delays, seizures, and behavioral issues.""]","[""Behavioral therapy, speech therapy, occupational therapy, and educational support are common treatments for Synaptic Ras GTPase activating protein 1-related intellectual disability.""]","[""The treatments for SYNGAP1-related intellectual disability include speech therapy, occupational therapy, physical therapy, behavioral therapy, and medications to manage symptoms.""]",[true],[true],[true],"[""There is currently no specific treatment for SYNGAP1-related intellectual disability. Management involves supportive care and therapies to address symptoms and improve quality of life.""]","[""There is currently no specific treatment for Synaptic Ras GTPase activating protein 1-related intellectual disability. Management involves supportive care and therapies to address symptoms and improve quality of life.""]","[""There is no specific treatment for SYNGAP1-related intellectual disability, but symptoms can be managed with therapies such as speech therapy, occupational therapy, and behavioral therapy.""]",[true],[true],[true],"[""Behavioral therapy, speech therapy, occupational therapy, and educational interventions are common treatments for SYNGAP1-related intellectual disability.""]","[""There is no specific treatment for Synaptic Ras GTPase activating protein 1-related intellectual disability. Management involves supportive care, early intervention programs, and educational support.""]","[""There is no specific treatment for SYNGAP1-related intellectual disability, but symptoms can be managed with therapies such as speech therapy, occupational therapy, and behavioral therapy.""]",[true],[true],[true],"[""There is currently no specific treatment for SYNGAP1-related intellectual disability. Management involves supportive care and therapies to address symptoms such as developmental delays, seizures, and behavioral issues.""]","[""There is currently no specific treatment for Synaptic Ras GTPase activating protein 1-related intellectual disability. Management typically involves supportive care, early intervention programs, and educational support tailored to the individual's needs.""]","[""There is currently no specific treatment for SYNGAP1-related intellectual disability. Management involves supportive care and therapies to address symptoms and improve quality of life.""]",[true],[true],[true],"[""There is currently no specific treatment for SYNGAP1-related intellectual disability. Management involves supportive care and therapies to address symptoms and improve quality of life.""]","[""Behavioral therapy, speech therapy, occupational therapy, and educational support are common treatments for Synaptic Ras GTPase activating protein 1-related intellectual disability.""]","[""The treatments for SYNGAP1-related intellectual disability include speech therapy, occupational therapy, physical therapy, behavioral therapy, and medications to manage symptoms.""]",[true],[true],[true],"[""There is currently no specific treatment for SYNGAP1-related intellectual disability. Management involves supportive care and therapies to address symptoms and improve quality of life.""]","[""There is currently no specific treatment for Synaptic Ras GTPase activating protein 1-related intellectual disability. Management involves supportive care and therapies to address symptoms and improve quality of life.""]","[""There is no specific treatment for SYNGAP1-related intellectual disability, but symptoms can be managed with therapies such as speech therapy, occupational therapy, and behavioral therapy.""]",[true],[true],[true],"[""Currently, there is no specific treatment for SYNGAP1-related intellectual disability. Management involves supportive care, early intervention programs, and therapies to address symptoms such as developmental delays, seizures, and behavioral issues.""]","[""There is no specific treatment for Synaptic Ras GTPase activating protein 1-related intellectual disability. Management involves supportive care, early intervention programs, and educational support.""]","[""There is no specific treatment for SYNGAP1-related intellectual disability, but symptoms can be managed with therapies such as speech therapy, occupational therapy, and behavioral therapy.""]",[true],[true],[true],"[""There is currently no specific treatment for SYNGAP1-related intellectual disability. Management typically involves supportive care and therapies to address symptoms and improve quality of life.""]","[""There is currently no specific treatment for Synaptic Ras GTPase activating protein 1-related intellectual disability. Management typically involves supportive care, early intervention programs, and educational support tailored to the individual's needs.""]","[""There is currently no specific treatment for SYNGAP1-related intellectual disability. Management involves supportive care and therapies to address symptoms and improve quality of life.""]",[true],[true],[true],"[""There is currently no specific treatment for SYNGAP1-related intellectual disability. Management typically involves supportive care and therapies to address symptoms and improve quality of life.""]","[""Behavioral therapy, speech therapy, occupational therapy, and educational support are common treatments for Synaptic Ras GTPase activating protein 1-related intellectual disability.""]","[""The treatments for SYNGAP1-related intellectual disability include speech therapy, occupational therapy, physical therapy, behavioral therapy, and medications to manage symptoms.""]",[true],[true],[true],"[""There is currently no specific treatment for SYNGAP1-related intellectual disability. Management involves supportive care and therapies to address symptoms and improve quality of life.""]","[""There is currently no specific treatment for Synaptic Ras GTPase activating protein 1-related intellectual disability. Management involves supportive care and therapies to address symptoms and improve quality of life.""]","[""There is no specific treatment for SYNGAP1-related intellectual disability, but symptoms can be managed with therapies such as speech therapy, occupational therapy, and behavioral therapy.""]",[true],[true],[true],"[""There is currently no specific treatment for SYNGAP1-related intellectual disability. Management involves supportive care and therapies to address symptoms and improve quality of life.""]","[""There is no specific treatment for Synaptic Ras GTPase activating protein 1-related intellectual disability. Management involves supportive care, early intervention programs, and educational support.""]","[""There is no specific treatment for SYNGAP1-related intellectual disability, but symptoms can be managed with therapies such as speech therapy, occupational therapy, and behavioral therapy.""]",[true],[true],[true],"[""There is currently no specific treatment for SYNGAP1-related intellectual disability. Management involves supportive care and therapies to address symptoms and improve quality of life.""]","[""There is no specific treatment for Synaptic Ras GTPase activating protein 1-related intellectual disability. Management involves supportive care, early intervention programs, and educational support.""]","[""There is no specific treatment for SYNGAP1-related intellectual disability, but symptoms can be managed with therapies such as speech therapy, occupational therapy, and behavioral therapy.""]",[true],[true],[true],"[""There is currently no specific treatment for SYNGAP1-related intellectual disability. Management involves supportive care and therapies to address symptoms and improve quality of life.""]","[""There is no specific treatment for Synaptic Ras GTPase activating protein 1-related intellectual disability. Management involves supportive care, early intervention programs, and educational support.""]","[""There is no specific treatment for SYNGAP1-related intellectual disability, but symptoms can be managed with therapies such as speech therapy, occupational therapy, and behavioral therapy.""]",[true],[true],[true],"[""There is currently no specific treatment for SYNGAP1-related intellectual disability. Management involves supportive care and therapies to address symptoms and improve quality of life.""]","[""There is no specific treatment for Synaptic Ras GTPase activating protein 1-related intellectual disability. Management involves supportive care, early intervention programs, and educational support.""]","[""There is no specific treatment for SYNGAP1-related intellectual disability, but symptoms can be managed with therapies such as speech therapy, occupational therapy, and behavioral therapy.""]"
inheritance,Is Hereditary sensory neuropathy type 1 inherited ?,"How is hereditary sensory neuropathy type 1 inherited? Hereditary sensory neuropathy type 1 (HSN1) is inherited in an autosomal dominant manner. This means that having only one changed (mutated) copy of the responsible gene in each cell is enough to cause signs and symptoms of the condition. When a person with an autosomal dominant condition has children, each child has a 50% (1 in 2) risk to inherit the mutated gene from the affected parent. In rare cases, a mutation that causes HSN1 occurs sporadically as a new (de novo) mutation in a person without an affected parent.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""HSN1"", ""full_form"": ""Hereditary sensory neuropathy type 1""}]}",Is HSN1 inherited ?,Is Hereditary sensory neuropathy type 1 inherited ?,8,MEDICAL,Simple Datatype-Boolean,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Hereditary Sensory Neuropathy Type 1""]]","[[""THEFREEDICTIONARY""]]","[""Hereditary Sensory Neuropathy Type 1""]",[5.33172206362612e-22],[5.33172206362612e-22],"[""Hereditary Sensory Neuropathy Type 1""]",[5.33172206362612e-22],"[""THEFREEDICTIONARY""]",[[5.33172206362612e-22]],[0.834803012877137],[0.84128842939198],"[""Hereditary Sensory Neuropathy Type 1""]",[0.84128842939198],"[""LLM""]",[[0.8412884293919796]],"[""Hereditary Sensory Neuropathy Type 1""]","[""THEFREEDICTIONARY""]",Is HSN1 (Hereditary Sensory Neuropathy Type 1) inherited ?,[true],[true],[true],"[""Yes, HSN1 (Hereditary Sensory Neuropathy Type 1) is inherited.""]","[""Yes, Hereditary sensory neuropathy type 1 is inherited.""]","[""Yes, HSN1 is inherited.""]",[true],[true],[false],"[""Yes, HSN1 (Hereditary Sensory Neuropathy Type 1) is inherited.""]","[""Yes, Hereditary sensory neuropathy type 1 is inherited.""]","[""No""]",[false],[false],[true],"[""Yes""]","[""Yes""]","[""Yes, HSN1 is inherited.""]",[true],[false],[true],"[""Yes, HSN1 (Hereditary Sensory Neuropathy Type 1) is inherited.""]","[""Yes""]","[""Yes, HSN1 is inherited.""]",[true],[true],[true],"[""Yes""]","[""Yes, Hereditary sensory neuropathy type 1 is inherited.""]","[""Yes, HSN1 is inherited.""]",[true],[true],[false],"[""Yes""]","[""Yes, Hereditary sensory neuropathy type 1 is inherited.""]","[""No""]",[false],[false],[true],"[""Yes""]","[""Yes""]","[""Yes, HSN1 is inherited.""]",[true],[false],[true],"[""Yes, HSN1 (Hereditary Sensory Neuropathy Type 1) is inherited.""]","[""Yes""]","[""Yes, HSN1 is inherited.""]",[true],[true],[false],"[""Yes""]","[""Yes, Hereditary sensory neuropathy type 1 is inherited.""]","[""No""]",[true],[true],[true],"[""Yes, HSN1 (Hereditary Sensory Neuropathy Type 1) is inherited.""]","[""Yes, Hereditary sensory neuropathy type 1 is inherited.""]","[""Yes, HSN1 is inherited.""]",[true],[false],[true],"[""Yes, HSN1 (Hereditary Sensory Neuropathy Type 1) is inherited.""]","[""Yes""]","[""Yes, HSN1 is inherited.""]",[false],[false],[true],"[""Yes""]","[""Yes""]","[""Yes, HSN1 is inherited.""]",[true],[true],[true],"[""Yes, HSN1 (Hereditary Sensory Neuropathy Type 1) is inherited.""]","[""Yes, Hereditary sensory neuropathy type 1 is inherited.""]","[""Yes, HSN1 is inherited.""]",[true],[true],[false],"[""Yes, HSN1 (Hereditary Sensory Neuropathy Type 1) is inherited.""]","[""Yes, Hereditary sensory neuropathy type 1 is inherited.""]","[""No""]",[true],[false],[true],"[""Yes, HSN1 (Hereditary Sensory Neuropathy Type 1) is inherited.""]","[""Yes""]","[""Yes, HSN1 is inherited.""]",[true],[false],[true],"[""Yes, HSN1 (Hereditary Sensory Neuropathy Type 1) is inherited.""]","[""Yes""]","[""Yes, HSN1 is inherited.""]",[false],[true],[true],"[""Yes""]","[""Yes, Hereditary sensory neuropathy type 1 is inherited.""]","[""Yes, HSN1 is inherited.""]",[true],[true],[false],"[""Yes, HSN1 (Hereditary Sensory Neuropathy Type 1) is inherited.""]","[""Yes, Hereditary sensory neuropathy type 1 is inherited.""]","[""No""]",[true],[false],[true],"[""Yes, HSN1 (Hereditary Sensory Neuropathy Type 1) is inherited.""]","[""Yes""]","[""Yes, HSN1 is inherited.""]",[false],[false],[true],"[""Yes""]","[""Yes""]","[""Yes, HSN1 is inherited.""]",[true],[true],[true],"[""Yes""]","[""Yes, Hereditary sensory neuropathy type 1 is inherited.""]","[""Yes, HSN1 is inherited.""]",[true],[true],[false],"[""Yes""]","[""Yes, Hereditary sensory neuropathy type 1 is inherited.""]","[""No""]",[false],[false],[true],"[""Yes""]","[""Yes""]","[""Yes, HSN1 is inherited.""]",[false],[false],[true],"[""Yes""]","[""Yes""]","[""Yes, HSN1 is inherited.""]",[true],[true],[true],"[""Yes, HSN1 (Hereditary Sensory Neuropathy Type 1) is inherited.""]","[""Yes, Hereditary sensory neuropathy type 1 is inherited.""]","[""Yes, HSN1 is inherited.""]",[true],[true],[false],"[""Yes, HSN1 (Hereditary Sensory Neuropathy Type 1) is inherited.""]","[""Yes, Hereditary sensory neuropathy type 1 is inherited.""]","[""No""]",[true],[false],[true],"[""Yes, HSN1 (Hereditary Sensory Neuropathy Type 1) is inherited.""]","[""Yes""]","[""Yes, HSN1 is inherited.""]",[true],[false],[true],"[""Yes, HSN1 (Hereditary Sensory Neuropathy Type 1) is inherited.""]","[""Yes""]","[""Yes, HSN1 is inherited.""]",[true],[true],[true],"[""Yes, HSN1 (Hereditary Sensory Neuropathy Type 1) is inherited.""]","[""Yes, Hereditary sensory neuropathy type 1 is inherited.""]","[""Yes, HSN1 is inherited.""]",[true],[true],[true],"[""Yes, HSN1 (Hereditary Sensory Neuropathy Type 1) is inherited.""]","[""Yes, Hereditary sensory neuropathy type 1 is inherited.""]","[""Yes, HSN1 is inherited.""]",[true],[true],[true],"[""Yes, HSN1 (Hereditary Sensory Neuropathy Type 1) is inherited.""]","[""Yes, Hereditary sensory neuropathy type 1 is inherited.""]","[""Yes, HSN1 is inherited.""]",[true],[true],[true],"[""Yes, HSN1 (Hereditary Sensory Neuropathy Type 1) is inherited.""]","[""Yes, Hereditary sensory neuropathy type 1 is inherited.""]","[""Yes, HSN1 is inherited.""]"
genetic changes,What are the genetic changes related to activated PI3K-delta syndrome ?,"Activated PI3K-delta syndrome is caused by mutations in the PIK3CD gene, which provides instructions for making a protein called p110 delta (p110). This protein is one piece (subunit) of an enzyme called phosphatidylinositol 3-kinase (PI3K), which turns on signaling pathways within cells. The version of PI3K containing the p110 subunit, called PI3K-delta, is specifically found in white blood cells, including B cells and T cells. PI3K-delta signaling is involved in the growth and division (proliferation) of white blood cells, and it helps direct B cells and T cells to mature (differentiate) into different types, each of which has a distinct function in the immune system.  PIK3CD gene mutations involved in activated PI3K-delta syndrome lead to production of an altered p110 protein. A PI3K-delta enzyme containing the altered subunit is abnormally turned on (activated). Studies indicate that overactive PI3K-delta signaling alters the differentiation of B cells and T cells, leading to production of cells that cannot respond to infections and that die earlier than usual. Lack of functioning B cells and T cells makes it difficult for people with this disorder to fight off bacterial and viral infections. Overactivation of PI3K-delta signaling can also stimulate abnormal proliferation of white blood cells, leading to lymphadenopathy and nodular lymphoid hyperplasia in some affected individuals. An increase in B cell proliferation in combination with reduced immune system function may contribute to development of B-cell lymphoma.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""abbreviation"", ""abbreviation"": ""PI3K-delta"", ""full_form"": ""Phosphoinositide 3-kinase delta""}]}",What are the genetic changes related to activated PI3K-delta syndrome ?,What are the genetic changes related to activated Phosphoinositide 3-kinase delta syndrome ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.",[[]],[[]],"[""Phosphoinositide 3-kinase delta""]",[1.566963273269612e-32],[1.566963273269612e-32],"[""Phosphoinositide 3-kinase delta""]",[1.566963273269612e-32],"[""LLM""]",[[]],[0.9808958119455813],[0.9808958119455813],"[""Phosphoinositide 3-kinase delta""]",[0.9808958119455813],"[""LLM""]",[[]],"[""Phosphoinositide 3-kinase delta""]","[""LLM""]",What are the genetic changes related to activated PI3K-delta (Phosphoinositide 3-kinase delta) syndrome ?,[true],[true],[true],"[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]","[""Genetic changes related to activated Phosphoinositide 3-kinase delta syndrome include mutations in the PIK3CD gene.""]","[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]",[true],[true],[true],"[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]","[""Genetic changes related to activated Phosphoinositide 3-kinase delta syndrome include mutations in the PIK3CD gene.""]","[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]",[true],[true],[true],"[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]","[""Genetic changes related to activated Phosphoinositide 3-kinase delta syndrome include mutations in the PIK3CD gene.""]","[""Mutations in the PIK3CD gene are associated with activated PI3K-delta syndrome.""]",[true],[true],[true],"[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]","[""PIK3CD gene mutations""]","[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]",[true],[true],[true],"[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]","[""Genetic changes related to activated Phosphoinositide 3-kinase delta syndrome include mutations in the PIK3CD gene.""]","[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]",[true],[true],[true],"[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]","[""Genetic changes related to activated Phosphoinositide 3-kinase delta syndrome include mutations in the PIK3CD gene.""]","[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]",[true],[true],[true],"[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]","[""Genetic changes related to activated Phosphoinositide 3-kinase delta syndrome include mutations in the PIK3CD gene.""]","[""Mutations in the PIK3CD gene are associated with activated PI3K-delta syndrome.""]",[true],[true],[true],"[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]","[""PIK3CD gene mutations""]","[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]",[true],[true],[true],"[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]","[""Genetic changes related to activated Phosphoinositide 3-kinase delta syndrome include mutations in the PIK3CD gene.""]","[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]",[true],[true],[true],"[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]","[""Genetic changes related to activated Phosphoinositide 3-kinase delta syndrome include mutations in the PIK3CD gene.""]","[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]",[true],[true],[true],"[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]","[""Genetic changes related to activated Phosphoinositide 3-kinase delta syndrome include mutations in the PIK3CD gene.""]","[""Mutations in the PIK3CD gene are associated with activated PI3K-delta syndrome.""]",[true],[true],[true],"[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]","[""PIK3CD gene mutations""]","[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]",[true],[true],[true],"[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]","[""Genetic changes related to activated Phosphoinositide 3-kinase delta syndrome include mutations in the PIK3CD gene.""]","[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]",[true],[true],[true],"[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]","[""Genetic changes related to activated Phosphoinositide 3-kinase delta syndrome include mutations in the PIK3CD gene.""]","[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]",[true],[true],[true],"[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]","[""Genetic changes related to activated Phosphoinositide 3-kinase delta syndrome include mutations in the PIK3CD gene.""]","[""Mutations in the PIK3CD gene are associated with activated PI3K-delta syndrome.""]",[true],[true],[true],"[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]","[""PIK3CD gene mutations""]","[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]",[true],[true],[true],"[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]","[""Genetic changes related to activated Phosphoinositide 3-kinase delta syndrome include mutations in the PIK3CD gene.""]","[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]",[true],[true],[true],"[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]","[""Genetic changes related to activated Phosphoinositide 3-kinase delta syndrome include mutations in the PIK3CD gene.""]","[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]",[true],[true],[true],"[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]","[""Genetic changes related to activated Phosphoinositide 3-kinase delta syndrome include mutations in the PIK3CD gene.""]","[""Mutations in the PIK3CD gene are associated with activated PI3K-delta syndrome.""]",[true],[true],[true],"[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]","[""PIK3CD gene mutations""]","[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]",[true],[true],[true],"[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]","[""Genetic changes related to activated Phosphoinositide 3-kinase delta syndrome include mutations in the PIK3CD gene.""]","[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]",[true],[true],[true],"[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]","[""Genetic changes related to activated Phosphoinositide 3-kinase delta syndrome include mutations in the PIK3CD gene.""]","[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]",[true],[true],[true],"[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]","[""Genetic changes related to activated Phosphoinositide 3-kinase delta syndrome include mutations in the PIK3CD gene.""]","[""Mutations in the PIK3CD gene are associated with activated PI3K-delta syndrome.""]",[true],[true],[true],"[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]","[""PIK3CD gene mutations""]","[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]",[true],[true],[true],"[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]","[""Genetic changes related to activated Phosphoinositide 3-kinase delta syndrome include mutations in the PIK3CD gene.""]","[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]",[true],[true],[true],"[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]","[""Genetic changes related to activated Phosphoinositide 3-kinase delta syndrome include mutations in the PIK3CD gene.""]","[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]",[true],[true],[true],"[""Genetic changes related to activated PI3K-delta syndrome involve mutations in the PIK3CD gene.""]","[""Genetic changes related to activated Phosphoinositide 3-kinase delta syndrome include mutations in the PIK3CD gene.""]","[""Mutations in the PIK3CD gene are associated with activated PI3K-delta syndrome.""]",[true],[true],[true],"[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]","[""PIK3CD gene mutations""]","[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]",[true],[true],[true],"[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]","[""Genetic changes related to activated Phosphoinositide 3-kinase delta syndrome include mutations in the PIK3CD gene.""]","[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]",[true],[true],[true],"[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]","[""Genetic changes related to activated Phosphoinositide 3-kinase delta syndrome include mutations in the PIK3CD gene.""]","[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]",[true],[true],[true],"[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]","[""Genetic changes related to activated Phosphoinositide 3-kinase delta syndrome include mutations in the PIK3CD gene.""]","[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]",[true],[true],[true],"[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]","[""Genetic changes related to activated Phosphoinositide 3-kinase delta syndrome include mutations in the PIK3CD gene.""]","[""Genetic changes related to activated PI3K-delta syndrome include mutations in the PIK3CD gene.""]"
information,Do you have information about Radiation Therapy,"Summary : Radiation therapy is a cancer treatment. It uses high doses of radiation to kill cancer cells and stop them from spreading. About half of all cancer patients receive it. The radiation may be external, from special machines, or internal, from radioactive substances that a doctor places inside your body. The type of radiation therapy you receive depends on many factors, including       - The type of cancer    - The size of the cancer    - The cancer's location in the body    - How close the cancer is to normal tissues that are sensitive to radiation    - How far into the body the radiation needs to travel    - Your general health and medical history    - Whether you will have other types of cancer treatment    - Other factors, such as your age and other medical conditions       Radiation therapy can damage normal cells as well as cancer cells. Treatment must be carefully planned to minimize side effects. Common side effects include skin changes and fatigue. Other side effects depend on the part of your body being treated.    Sometimes radiation is used with other treatments, like surgery or chemotherapy.     NIH: National Cancer Institute","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""RT"", ""full_form"": ""Radiation Therapy""}]}",Do you have information about RT,Do you have information about Radiation Therapy,5,INTERNET,Simple Datatype-Boolean,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""RighT"", ""Real Time"", ""Reverse Transcriptase"", ""Room Temperature"", ""RadioTherapy"", ""Radiation therapy"", ""Response Time"", ""Run Time"", ""Reaction Time"", ""Round Trip""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Retweet""]",[3.248606998840699e-05],[3.0536524846748035e-10],"[""RighT""]",[0.002599414966729271],"[""ABBREVIATIONS""]","[[0.002599414966729271, 3.5728084039225506e-06, 4.628179310328021e-17, 8.486572493890519e-07, 4.6335331252426525e-07, 3.248606998840699e-05, 4.069789772060649e-09, 3.097497336313897e-08, 5.420469471446998e-08, 2.893789666083669e-09]]",[0.7465025577052271],[0.790933130184597],"[""RighT""]",[0.8684898663223974],"[""ABBREVIATIONS""]","[[0.8568078214960704, 0.8684898663223974, 0.7261818031516256, 0.7677538673597804, 0.7616861579018118, 0.754331053587949, 0.7514391824512883, 0.8038290632199245, 0.7025356261491698, 0.7601249331822569]]","[""RadioTherapy""]","[""ABBREVIATIONS""]",Do you have information about RT (Retweet),[false],[true],[true],"[""RT (RighT) is a retweet on Twitter where a user reposts another user's tweet.""]","[""Yes""]","[""Yes""]",[false],[true],[true],"[""RT (RighT) is a Russian international television network funded by the Russian government.""]","[""Yes""]","[""Yes""]",[false],[false],[false],"[""RT (RighT) is a Russian international television network funded by the Russian government.""]","[""Yes""]","[""Yes""]",[false],[true],[true],"[""No, RT (RighT) does not have a specific meaning or information associated with it in the context of the internet.""]","[""Yes""]","[""Yes""]",[false],[false],[false],"[""RT (RighT) is a Russian international television network funded by the Russian government.""]","[""Yes""]","[""Yes""]",[false],[false],[false],"[""RT (RighT) is a Russian international television network funded by the Russian government.""]","[""Yes""]","[""Yes""]",[false],[false],[false],"[""RT (RighT) is a Russian international television network funded by the Russian government.""]","[""Yes""]","[""Yes""]",[false],[true],[true],"[""RT (RighT) is a Russian international television network funded by the Russian government.""]","[""Yes""]","[""Yes""]",[true],[false],[false],"[""Yes, RT (RadioTherapy) is a cancer treatment that uses high doses of radiation to kill cancer cells and shrink tumors.""]","[""Yes""]","[""Yes""]",[false],[false],[false],"[""Yes""]","[""Yes""]","[""Yes""]",[true],[false],[false],"[""Yes, RadioTherapy (RT) is a common treatment for cancer that uses high doses of radiation to kill cancer cells and shrink tumors.""]","[""Yes""]","[""Yes""]",[true],[false],[false],"[""Yes, RadioTherapy (RT) is a common treatment for cancer that uses high doses of radiation to kill cancer cells and shrink tumors.""]","[""Yes""]","[""Yes""]",[false],[false],[false],"[""No""]","[""Yes""]","[""Yes""]",[false],[false],[false],"[""Yes""]","[""Yes""]","[""Yes""]",[false],[false],[false],"[""No""]","[""Yes""]","[""Yes""]",[false],[false],[false],"[""No""]","[""Yes""]","[""Yes""]",[false],[false],[false],"[""No""]","[""Yes""]","[""Yes""]",[true],[false],[false],"[""Yes, RadioTherapy (RT) is a common treatment for cancer that uses high doses of radiation to kill cancer cells and shrink tumors.""]","[""Yes""]","[""Yes""]",[false],[false],[false],"[""Yes""]","[""Yes""]","[""Yes""]",[false],[false],[false],"[""Yes""]","[""Yes""]","[""Yes""]",[false],[true],[true],"[""RT (Retweet) is a feature on Twitter that allows users to repost someone else's tweet to their own followers.""]","[""Yes""]","[""Yes""]",[false],[true],[true],"[""RT (Retweet) is a feature on Twitter that allows users to repost someone else's tweet to their own followers.""]","[""Yes""]","[""Yes""]",[false],[false],[false],"[""RT (Retweet) is a feature on Twitter that allows users to repost content from other users to their own followers.""]","[""Yes""]","[""Yes""]",[false],[true],[true],"[""RT (Retweet) is a feature on Twitter that allows users to repost content from other users to their own followers.""]","[""Yes""]","[""Yes""]",[true],[false],[false],"[""Radiotherapy, also known as radiation therapy, is a common treatment for cancer that uses high doses of radiation to kill cancer cells and shrink tumors.""]","[""Yes""]","[""Yes""]",[true],[false],[false],"[""Radiotherapy, also known as radiation therapy, is a treatment method that uses high doses of radiation to kill cancer cells and shrink tumors. It can be used as a standalone treatment or in combination with other therapies such as surgery or chemotherapy.""]","[""Yes""]","[""Yes""]",[true],[false],[false],"[""Radiotherapy, also known as radiation therapy, is a treatment method that uses high doses of radiation to kill cancer cells and shrink tumors. It can be used as a standalone treatment or in combination with other therapies such as surgery or chemotherapy.""]","[""Yes""]","[""Yes""]",[true],[false],[false],"[""Radiotherapy, also known as radiation therapy, is a treatment method that uses high doses of radiation to kill cancer cells and shrink tumors. It can be used as a standalone treatment or in combination with other therapies such as surgery or chemotherapy.""]","[""Yes""]","[""Yes""]",[true],[false],[false],"[""Yes, I have information about RadioTherapy (RT).""]","[""Yes""]","[""Yes""]",[false],[true],[true],"[""No, I do not have information about RT (RighT).""]","[""Yes""]","[""Yes""]",[false],[false],[false],"[""No, I do not have information about RT (RighT).""]","[""Yes""]","[""Yes""]",[false],[true],[true],"[""Yes, RT stands for Retweet on social media platforms.""]","[""Yes""]","[""Yes""]"
symptoms,What are the symptoms of Convulsions benign familial neonatal dominant form ?,"What are the signs and symptoms of Convulsions benign familial neonatal dominant form? The Human Phenotype Ontology provides the following list of signs and symptoms for Convulsions benign familial neonatal dominant form. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Autosomal recessive inheritance - Generalized tonic-clonic seizures - Hypertonia - Normal interictal EEG - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""BFND"", ""full_form"": ""Convulsions benign familial neonatal dominant form""}]}",What are the symptoms of BFND ?,What are the symptoms of Convulsions benign familial neonatal dominant form ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Bobcat Fight Never Dies"", ""Buero Fuer Neues Denken""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Benign Familial Neonatal Seizures""]",[1.4564828020163574e-32],[1.2369484904307875e-22],"[""Benign Familial Neonatal Seizures""]",[1.2369484904307875e-22],"[""LLM""]","[[3.1798601084818874e-23, 2.7209170969273687e-28]]",[0.6535376963513784],[0.6707586483866825],"[""Bobcat Fight Never Dies""]",[0.7890282917401032],"[""ABBREVIATIONS""]","[[0.7031702984659094, 0.7890282917401032]]","[""Benign Familial Neonatal Seizures""]","[""LLM""]",What are the symptoms of BFND (Benign Familial Neonatal Seizures) ?,[true],[false],[false],"[""Symptoms of BFND (Benign Familial Neonatal Seizures) include seizures that typically start in the first few days of life, usually within the first week. These seizures are usually brief, lasting only a few seconds to a few minutes, and may involve repetitive movements such as stiffening or jerking of the arms or legs.""]","[""Seizures, muscle stiffness, jerking movements""]","[""Seizures, developmental delay, intellectual disability, and movement disorders are common symptoms of BFND (Benign Familial Neonatal Epilepsy).""]",[true],[true],[false],"[""Symptoms of BFND (Benign Familial Neonatal Seizures) include seizures that typically occur within the first few days of life, usually in the first week. These seizures are usually brief, lasting only a few seconds to a few minutes, and may involve repetitive movements such as stiffening or jerking of the arms or legs.""]","[""Symptoms of Convulsions benign familial neonatal dominant form include seizures, muscle stiffness, jerking movements, and loss of consciousness.""]","[""Seizures, developmental delay, intellectual disability, and movement disorders""]",[true],[true],[false],"[""Symptoms of BFND (Benign Familial Neonatal Seizures) include seizures that usually start in the first few days of life, repetitive seizures, staring spells, jerking movements, and sometimes temporary stopping of breathing.""]","[""Symptoms of Convulsions benign familial neonatal dominant form include seizures, muscle stiffness, jerking movements, and loss of consciousness.""]","[""Seizures, developmental delay, intellectual disability, and problems with movement are common symptoms of BFND (Benign Familial Neonatal Epilepsy).""]",[true],[true],[false],"[""Symptoms of BFND (Benign Familial Neonatal Seizures) include seizures that typically begin in the first few days of life, usually within the first week. These seizures are usually brief, lasting only a few seconds to a few minutes, and may involve repetitive movements such as stiffening or jerking of the arms or legs.""]","[""Symptoms of Convulsions benign familial neonatal dominant form include seizures, muscle stiffness, jerking movements, and loss of consciousness.""]","[""Symptoms of BFND include seizures, developmental delays, vision problems, and muscle weakness.""]",[false],[true],[false],"[""The term 'BFND' is not a recognized medical condition or acronym in the field of medicine.""]","[""Seizures, muscle stiffness, jerking movements""]","[""Seizures, developmental delay, intellectual disability, and movement disorders are common symptoms of BFND (Benign Familial Neonatal Epilepsy).""]",[false],[true],[false],"[""Symptoms of BFND include fever, cough, shortness of breath, fatigue, body aches, and loss of taste or smell.""]","[""Symptoms of Convulsions benign familial neonatal dominant form include seizures, muscle stiffness, jerking movements, and loss of consciousness.""]","[""Seizures, developmental delay, intellectual disability, and movement disorders""]",[false],[true],[false],"[""Symptoms of BFND include fatigue, muscle weakness, difficulty swallowing, and respiratory problems.""]","[""Symptoms of Convulsions benign familial neonatal dominant form include seizures, muscle stiffness, jerking movements, and loss of consciousness.""]","[""Seizures, developmental delay, intellectual disability, and problems with movement are common symptoms of BFND (Benign Familial Neonatal Epilepsy).""]",[false],[true],[false],"[""The term 'BFND (Bobcat Fight Never Dies)' is not a recognized medical condition or acronym in the medical field.""]","[""Symptoms of Convulsions benign familial neonatal dominant form include seizures, muscle stiffness, jerking movements, and loss of consciousness.""]","[""Symptoms of BFND include seizures, developmental delays, vision problems, and muscle weakness.""]",[true],[true],[false],"[""Symptoms of BFND include seizures that usually occur within the first few days of life, repetitive seizures, eye or head deviation during seizures, and normal development between seizures.""]","[""Symptoms of Convulsions benign familial neonatal dominant form include seizures, muscle stiffness, jerking movements, and loss of consciousness.""]","[""Seizures, developmental delay, intellectual disability, and movement disorders""]",[true],[false],[false],"[""Symptoms of BFND (Benign Familial Neonatal Seizures) include seizures that typically start in the first few days of life, repetitive seizures that may involve twitching or jerking of a baby's arms, legs, or face, and a family history of seizures in close relatives.""]","[""Seizures, muscle stiffness, jerking movements""]","[""Seizures, developmental delay, intellectual disability, and movement disorders are common symptoms of BFND (Benign Familial Neonatal Epilepsy).""]",[true],[true],[false],"[""Symptoms of BFND (Benign Familial Neonatal Seizures) include seizures that typically begin in the first few days of life, usually within the first week. These seizures are usually brief, lasting only a few seconds to a few minutes, and may involve repetitive movements such as stiffening or jerking of the arms and legs. In some cases, there may be a family history of similar seizures.""]","[""Symptoms of Convulsions benign familial neonatal dominant form include seizures, muscle stiffness, jerking movements, and loss of consciousness.""]","[""Seizures, developmental delay, intellectual disability, and problems with movement are common symptoms of BFND (Benign Familial Neonatal Epilepsy).""]",[true],[true],[false],"[""Symptoms of BFND (Benign Familial Neonatal Seizures) include seizures that usually begin in the first few days of life, repetitive seizures that are brief and involve muscle stiffening or jerking, seizures that may occur multiple times a day, and seizures that tend to resolve on their own by 4 to 6 months of age.""]","[""Symptoms of Convulsions benign familial neonatal dominant form include seizures, muscle stiffness, jerking movements, and loss of consciousness.""]","[""Symptoms of BFND include seizures, developmental delays, vision problems, and muscle weakness.""]",[true],[false],[false],"[""BFND (Benign Familial Neonatal Seizures) symptoms include seizures that usually start in the first few days of life, repetitive seizures, and a family history of seizures.""]","[""Seizures, muscle stiffness, jerking movements""]","[""Seizures, developmental delay, intellectual disability, and movement disorders are common symptoms of BFND (Benign Familial Neonatal Epilepsy).""]",[true],[true],[false],"[""Symptoms of BFND include seizures that start in the first few days of life, repetitive seizures, jerking movements, staring spells, and temporary stopping of breathing.""]","[""Symptoms of Convulsions benign familial neonatal dominant form include seizures, muscle stiffness, jerking movements, and loss of consciousness.""]","[""Seizures, developmental delay, intellectual disability, and movement disorders""]",[true],[true],[false],"[""BFND (Benign Familial Neonatal Seizures) typically presents with seizures that start in the first few days of life, usually within the first week. These seizures are usually brief, lasting only a few seconds to a minute, and may involve repetitive movements like twitching or stiffening of limbs.""]","[""Symptoms of Convulsions benign familial neonatal dominant form include seizures, muscle stiffness, jerking movements, and loss of consciousness.""]","[""Seizures, developmental delay, intellectual disability, and problems with movement are common symptoms of BFND (Benign Familial Neonatal Epilepsy).""]",[true],[true],[false],"[""Seizures that occur in the first few days of life, usually within the first week after birth, and are often associated with a family history of seizures""]","[""Symptoms of Convulsions benign familial neonatal dominant form include seizures, muscle stiffness, jerking movements, and loss of consciousness.""]","[""Symptoms of BFND include seizures, developmental delays, vision problems, and muscle weakness.""]",[true],[true],[false],"[""Seizures, staring spells, jerking movements, eye deviation, and loss of consciousness.""]","[""Seizures, muscle stiffness, jerking movements""]","[""Seizures, developmental delay, intellectual disability, and movement disorders are common symptoms of BFND (Benign Familial Neonatal Epilepsy).""]",[true],[true],[false],"[""Symptoms of BFND (Benign Familial Neonatal Seizures) include seizures that typically occur within the first few days of life, usually between days 2 and 5. These seizures are usually brief, lasting only a few seconds to a minute, and may involve repetitive movements such as stiffening or jerking of the arms or legs.""]","[""Symptoms of Convulsions benign familial neonatal dominant form include seizures, muscle stiffness, jerking movements, and loss of consciousness.""]","[""Seizures, developmental delay, intellectual disability, and movement disorders""]",[true],[true],[false],"[""Symptoms of BFND (Benign Familial Neonatal Seizures) include seizures that usually occur within the first few days of life, repetitive seizures, staring spells, jerking movements, and sometimes temporary stopping of breathing.""]","[""Symptoms of Convulsions benign familial neonatal dominant form include seizures, muscle stiffness, jerking movements, and loss of consciousness.""]","[""Seizures, developmental delay, intellectual disability, and problems with movement are common symptoms of BFND (Benign Familial Neonatal Epilepsy).""]",[true],[true],[false],"[""Symptoms of BFND include seizures that typically occur within the first few days of life, usually lasting for a few seconds to a few minutes. These seizures may involve repetitive movements such as stiffening or jerking of the arms, legs, or face.""]","[""Symptoms of Convulsions benign familial neonatal dominant form include seizures, muscle stiffness, jerking movements, and loss of consciousness.""]","[""Symptoms of BFND include seizures, developmental delays, vision problems, and muscle weakness.""]",[true],[true],[false],"[""Symptoms of BFND (Benign Familial Neonatal Seizures) include seizures that typically begin in the first few days of life, usually within the first week. These seizures are usually brief, lasting only a few seconds to a minute, and may involve repetitive movements such as stiffening or jerking of the arms or legs. The baby may also have staring spells or brief episodes of unresponsiveness.""]","[""Seizures, muscle stiffness, jerking movements""]","[""Seizures, developmental delay, intellectual disability, and movement disorders are common symptoms of BFND (Benign Familial Neonatal Epilepsy).""]",[true],[true],[false],"[""Symptoms of BFND include seizures that typically begin in the first few days of life, usually between days 2 and 5. These seizures are usually brief, lasting only a few seconds to a minute, and may involve repetitive movements such as stiffening or jerking of the arms or legs.""]","[""Symptoms of Convulsions benign familial neonatal dominant form include seizures, muscle stiffness, jerking movements, and loss of consciousness.""]","[""Seizures, developmental delay, intellectual disability, and movement disorders""]",[true],[true],[false],"[""Symptoms of BFND (Benign Familial Neonatal Seizures) include seizures that usually occur within the first few days of life, repetitive seizures, staring spells, jerking movements, and sometimes temporary stopping of breathing.""]","[""Symptoms of Convulsions benign familial neonatal dominant form include seizures, muscle stiffness, jerking movements, and loss of consciousness.""]","[""Seizures, developmental delay, intellectual disability, and problems with movement are common symptoms of BFND (Benign Familial Neonatal Epilepsy).""]",[true],[true],[false],"[""Symptoms of BFND include seizures that start in the first few days of life, usually in the first week, and may involve repetitive jerking movements of the arms and legs. These seizures are typically brief and may occur multiple times a day.""]","[""Symptoms of Convulsions benign familial neonatal dominant form include seizures, muscle stiffness, jerking movements, and loss of consciousness.""]","[""Symptoms of BFND include seizures, developmental delays, vision problems, and muscle weakness.""]",[true],[false],[false],"[""Symptoms of BFND include seizures that typically occur within the first few days to weeks of life, usually lasting for a few seconds to a few minutes. These seizures may involve repetitive movements such as stiffening or jerking of the arms, legs, or face.""]","[""Seizures, muscle stiffness, jerking movements""]","[""Seizures, developmental delay, intellectual disability, and movement disorders are common symptoms of BFND (Benign Familial Neonatal Epilepsy).""]",[true],[true],[false],"[""Symptoms of BFND (Benign Familial Neonatal Seizures) include seizures that usually start within the first few days of life, often within the first 24 hours. The seizures are typically brief, lasting a few seconds to a few minutes, and may involve repetitive movements such as stiffening or jerking of the arms, legs, or face.""]","[""Symptoms of Convulsions benign familial neonatal dominant form include seizures, muscle stiffness, jerking movements, and loss of consciousness.""]","[""Seizures, developmental delay, intellectual disability, and movement disorders""]",[true],[true],[false],"[""Symptoms of BFND (Benign Familial Neonatal Seizures) include seizures that typically begin in the first few days of life, usually within the first week. These seizures are usually brief, lasting only a few seconds to a few minutes, and may involve repetitive movements like jerking of the arms or legs.""]","[""Symptoms of Convulsions benign familial neonatal dominant form include seizures, muscle stiffness, jerking movements, and loss of consciousness.""]","[""Seizures, developmental delay, intellectual disability, and problems with movement are common symptoms of BFND (Benign Familial Neonatal Epilepsy).""]",[true],[true],[false],"[""Symptoms of BFND (Benign Familial Neonatal Seizures) include seizures that usually occur within the first few days of life, often in clusters, with the baby appearing otherwise healthy between seizures. The seizures are typically brief, lasting only a few seconds to a minute, and involve repetitive movements such as stiffening or jerking of the arms, legs, or face.""]","[""Symptoms of Convulsions benign familial neonatal dominant form include seizures, muscle stiffness, jerking movements, and loss of consciousness.""]","[""Symptoms of BFND include seizures, developmental delays, vision problems, and muscle weakness.""]",[true],[false],[false],"[""Symptoms of BFND include seizures that typically occur within the first few days of life, usually in clusters, and may involve twitching or jerking movements.""]","[""Seizures, muscle stiffness, jerking movements""]","[""Seizures, developmental delay, intellectual disability, and movement disorders are common symptoms of BFND (Benign Familial Neonatal Epilepsy).""]",[true],[true],[true],"[""Symptoms of BFND include seizures that typically begin within the first few days of life, repetitive seizures, and a family history of seizures.""]","[""Seizures, muscle stiffness, jerking movements""]","[""Seizures, developmental delay, intellectual disability, and movement disorders are common symptoms of BFND (Benign Familial Neonatal Epilepsy).""]",[false],[true],[true],"[""The symptoms of BFND (Bobcat Fight Never Dies) include extreme determination, resilience, and a never-give-up attitude.""]","[""Seizures, muscle stiffness, jerking movements""]","[""Seizures, developmental delay, intellectual disability, and movement disorders are common symptoms of BFND (Benign Familial Neonatal Epilepsy).""]",[true],[true],[false],"[""Symptoms of BFND include seizures that usually occur within the first few days of life, repetitive seizures, and a family history of seizures.""]","[""Seizures, muscle stiffness, jerking movements""]","[""Seizures, developmental delay, intellectual disability, and movement disorders are common symptoms of BFND (Benign Familial Neonatal Epilepsy).""]"
inheritance,Is progressive supranuclear palsy inherited ?,"Most cases of progressive supranuclear palsy are sporadic, which means they occur in people with no history of the disorder in their family. However, some people with this disorder have had family members with related conditions, such as parkinsonism and a loss of intellectual functions (dementia).  When progressive supranuclear palsy runs in families, it can have an autosomal dominant pattern of inheritance. Autosomal dominant inheritance means one copy of an altered gene in each cell is sufficient to cause the disorder.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""PSP"", ""full_form"": ""progressive supranuclear palsy""}]}",Is PSP inherited ?,Is progressive supranuclear palsy inherited ?,8,MEDICAL,Simple Datatype-Boolean,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Paint Shop Pro"", ""Play Station Portable"", ""Progressive supranuclear palsy"", ""Paralytic Shellfish Poisoning"", ""Personal Software Process"", ""Portable Sony Playstation"", ""Partido Socialista Popular"", ""Payphone Service Provider"", ""Program Segment Prefix"", ""Private Sector Participation""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Progressive Supranuclear Palsy""]",[5.973902422624332e-16],[5.973902422624332e-16],"[""Personal Software Process""]",[1.5414251381161874e-12],"[""ABBREVIATIONS""]","[[1.7178759420371615e-14, 7.892831598782149e-13, 5.973902422624332e-16, 3.5703538905412437e-13, 1.5414251381161874e-12, 3.8869349494950744e-21, 1.6329603374453733e-17, 7.61006934610123e-17, 1.2228023114190118e-14, 1.1367164696002787e-14]]",[0.7682991706531681],[0.7754747656812058],"[""Paint Shop Pro""]",[0.8148088863742691],"[""ABBREVIATIONS""]","[[0.674584368214358, 0.8148088863742691, 0.7699747406127242, 0.7651600349815795, 0.6778101029686336, 0.7835425241366023, 0.6737345528026129, 0.6747091406148887, 0.6853386248465648, 0.6897474194115987]]","[""Progressive supranuclear palsy""]","[""ABBREVIATIONS""]",Is PSP (Progressive Supranuclear Palsy) inherited ?,[false],[true],[true],"[""No""]","[""Progressive supranuclear palsy is not inherited, it is considered a sporadic condition with no clear genetic cause.""]","[""Yes, Progressive Supranuclear Palsy (PSP) is not inherited in a Mendelian pattern, but some genetic factors may play a role in its development.""]",[false],[true],[true],"[""No""]","[""Progressive supranuclear palsy is not inherited, it is considered a sporadic disorder.""]","[""Yes, Progressive Supranuclear Palsy (PSP) is not inherited in a Mendelian pattern, but some genetic factors may play a role in its development.""]",[false],[true],[true],"[""No""]","[""Progressive supranuclear palsy is not inherited, it is considered a sporadic condition with no clear genetic cause.""]","[""Yes, Progressive Supranuclear Palsy (PSP) is not inherited in a Mendelian pattern, but there may be a genetic predisposition in some cases.""]",[false],[true],[true],"[""No""]","[""Progressive supranuclear palsy is not inherited, it is considered a sporadic condition with no clear genetic cause.""]","[""Yes, Progressive Supranuclear Palsy (PSP) is not inherited in a Mendelian pattern, but there may be some genetic predisposition in some cases.""]",[false],[true],[true],"[""No""]","[""Progressive supranuclear palsy is not inherited, it is considered a sporadic condition with no clear genetic cause.""]","[""Yes, Progressive Supranuclear Palsy (PSP) is not inherited in a Mendelian pattern, but some genetic factors may play a role in its development.""]",[false],[true],[true],"[""No""]","[""Progressive supranuclear palsy is not inherited, it is considered a sporadic disorder.""]","[""Yes, Progressive Supranuclear Palsy (PSP) is not inherited in a Mendelian pattern, but some genetic factors may play a role in its development.""]",[false],[true],[true],"[""No""]","[""Progressive supranuclear palsy is not inherited, it is considered a sporadic condition with no clear genetic cause.""]","[""Yes, Progressive Supranuclear Palsy (PSP) is not inherited in a Mendelian pattern, but there may be a genetic predisposition in some cases.""]",[false],[true],[true],"[""No""]","[""Progressive supranuclear palsy is not inherited, it is considered a sporadic condition with no clear genetic cause.""]","[""Yes, Progressive Supranuclear Palsy (PSP) is not inherited in a Mendelian pattern, but there may be some genetic predisposition in some cases.""]",[false],[true],[true],"[""No""]","[""Progressive supranuclear palsy is not inherited, it is considered a sporadic disorder.""]","[""Yes, Progressive Supranuclear Palsy (PSP) is not inherited in a Mendelian pattern, but some genetic factors may play a role in its development.""]",[false],[true],[true],"[""No""]","[""Progressive supranuclear palsy is not inherited, it is considered a sporadic condition with no clear genetic cause.""]","[""Yes, Progressive Supranuclear Palsy (PSP) is not inherited in a Mendelian pattern, but some genetic factors may play a role in its development.""]",[true],[true],[true],"[""PSP is not typically inherited, but some cases have been linked to genetic mutations.""]","[""Progressive supranuclear palsy is not inherited, it is considered a sporadic condition with no clear genetic cause.""]","[""Yes, Progressive Supranuclear Palsy (PSP) is not inherited in a Mendelian pattern, but there may be a genetic predisposition in some cases.""]",[false],[true],[true],"[""No""]","[""Progressive supranuclear palsy is not inherited, it is considered a sporadic condition with no clear genetic cause.""]","[""Yes, Progressive Supranuclear Palsy (PSP) is not inherited in a Mendelian pattern, but there may be some genetic predisposition in some cases.""]",[false],[true],[true],"[""No, PSP is not inherited.""]","[""Progressive supranuclear palsy is not inherited, it is considered a sporadic condition with no clear genetic cause.""]","[""Yes, Progressive Supranuclear Palsy (PSP) is not inherited in a Mendelian pattern, but some genetic factors may play a role in its development.""]",[true],[true],[true],"[""PSP is not inherited, it is a sporadic neurodegenerative disorder.""]","[""Progressive supranuclear palsy is not inherited, it is considered a sporadic disorder.""]","[""Yes, Progressive Supranuclear Palsy (PSP) is not inherited in a Mendelian pattern, but some genetic factors may play a role in its development.""]",[false],[true],[true],"[""No""]","[""Progressive supranuclear palsy is not inherited, it is considered a sporadic condition with no clear genetic cause.""]","[""Yes, Progressive Supranuclear Palsy (PSP) is not inherited in a Mendelian pattern, but there may be a genetic predisposition in some cases.""]",[false],[true],[true],"[""No, PSP is not inherited.""]","[""Progressive supranuclear palsy is not inherited, it is considered a sporadic condition with no clear genetic cause.""]","[""Yes, Progressive Supranuclear Palsy (PSP) is not inherited in a Mendelian pattern, but there may be some genetic predisposition in some cases.""]",[true],[true],[true],"[""PSP is not inherited, but some genetic factors may increase the risk of developing the condition.""]","[""Progressive supranuclear palsy is not inherited, it is considered a sporadic condition with no clear genetic cause.""]","[""Yes, Progressive Supranuclear Palsy (PSP) is not inherited in a Mendelian pattern, but some genetic factors may play a role in its development.""]",[true],[true],[true],"[""PSP is not typically inherited, but in rare cases, there may be a genetic component.""]","[""Progressive supranuclear palsy is not inherited, it is considered a sporadic disorder.""]","[""Yes, Progressive Supranuclear Palsy (PSP) is not inherited in a Mendelian pattern, but some genetic factors may play a role in its development.""]",[true],[true],[true],"[""PSP is not typically inherited, but some cases have been linked to genetic mutations.""]","[""Progressive supranuclear palsy is not inherited, it is considered a sporadic condition with no clear genetic cause.""]","[""Yes, Progressive Supranuclear Palsy (PSP) is not inherited in a Mendelian pattern, but there may be a genetic predisposition in some cases.""]",[true],[true],[true],"[""PSP is not typically inherited, but in rare cases, it can be linked to genetic mutations.""]","[""Progressive supranuclear palsy is not inherited, it is considered a sporadic condition with no clear genetic cause.""]","[""Yes, Progressive Supranuclear Palsy (PSP) is not inherited in a Mendelian pattern, but there may be some genetic predisposition in some cases.""]",[true],[true],[true],"[""PSP is not typically inherited, but in rare cases, it can be linked to genetic mutations.""]","[""Progressive supranuclear palsy is not inherited, it is considered a sporadic condition with no clear genetic cause.""]","[""Yes, Progressive Supranuclear Palsy (PSP) is not inherited in a Mendelian pattern, but some genetic factors may play a role in its development.""]",[true],[true],[true],"[""PSP is not typically inherited, but in some cases, there may be a genetic predisposition.""]","[""Progressive supranuclear palsy is not inherited, it is considered a sporadic disorder.""]","[""Yes, Progressive Supranuclear Palsy (PSP) is not inherited in a Mendelian pattern, but some genetic factors may play a role in its development.""]",[true],[true],[true],"[""PSP is not typically inherited, but in some cases, there may be a genetic predisposition.""]","[""Progressive supranuclear palsy is not inherited, it is considered a sporadic condition with no clear genetic cause.""]","[""Yes, Progressive Supranuclear Palsy (PSP) is not inherited in a Mendelian pattern, but there may be a genetic predisposition in some cases.""]",[true],[true],[true],"[""PSP is not typically inherited, but in rare cases, it can be linked to genetic mutations.""]","[""Progressive supranuclear palsy is not inherited, it is considered a sporadic condition with no clear genetic cause.""]","[""Yes, Progressive Supranuclear Palsy (PSP) is not inherited in a Mendelian pattern, but there may be some genetic predisposition in some cases.""]",[true],[true],[true],"[""PSP is not typically inherited, but in rare cases, there may be a genetic component.""]","[""Progressive supranuclear palsy is not inherited, it is considered a sporadic condition with no clear genetic cause.""]","[""Yes, Progressive Supranuclear Palsy (PSP) is not inherited in a Mendelian pattern, but some genetic factors may play a role in its development.""]",[true],[true],[true],"[""PSP is not typically inherited, but in rare cases, there may be a genetic component.""]","[""Progressive supranuclear palsy is not inherited, it is considered a sporadic disorder.""]","[""Yes, Progressive Supranuclear Palsy (PSP) is not inherited in a Mendelian pattern, but some genetic factors may play a role in its development.""]",[true],[true],[true],"[""PSP is not typically inherited, but in rare cases, there may be a genetic component.""]","[""Progressive supranuclear palsy is not inherited, it is considered a sporadic condition with no clear genetic cause.""]","[""Yes, Progressive Supranuclear Palsy (PSP) is not inherited in a Mendelian pattern, but there may be a genetic predisposition in some cases.""]",[true],[true],[true],"[""PSP is not typically inherited, but in rare cases, there may be a genetic component.""]","[""Progressive supranuclear palsy is not inherited, it is considered a sporadic condition with no clear genetic cause.""]","[""Yes, Progressive Supranuclear Palsy (PSP) is not inherited in a Mendelian pattern, but there may be some genetic predisposition in some cases.""]",[true],[true],[true],"[""PSP is not typically inherited, but some cases may have a genetic component.""]","[""Progressive supranuclear palsy is not inherited, it is considered a sporadic condition with no clear genetic cause.""]","[""Yes, Progressive Supranuclear Palsy (PSP) is not inherited in a Mendelian pattern, but some genetic factors may play a role in its development.""]",[false],[true],[true],"[""No""]","[""Progressive supranuclear palsy is not inherited, it is considered a sporadic condition with no clear genetic cause.""]","[""Yes, Progressive Supranuclear Palsy (PSP) is not inherited in a Mendelian pattern, but some genetic factors may play a role in its development.""]",[false],[true],[true],"[""No, PSP (Paint Shop Pro) is not inherited.""]","[""Progressive supranuclear palsy is not inherited, it is considered a sporadic condition with no clear genetic cause.""]","[""Yes, Progressive Supranuclear Palsy (PSP) is not inherited in a Mendelian pattern, but some genetic factors may play a role in its development.""]",[true],[true],[true],"[""PSP is not typically inherited, but in some cases, there may be a genetic component.""]","[""Progressive supranuclear palsy is not inherited, it is considered a sporadic condition with no clear genetic cause.""]","[""Yes, Progressive Supranuclear Palsy (PSP) is not inherited in a Mendelian pattern, but some genetic factors may play a role in its development.""]"
frequency,How many people are affected by oculopharyngeal muscular dystrophy ?,"In Europe, the prevalence of oculopharyngeal muscular dystrophy is estimated to be 1 in 100,000 people. The autosomal dominant form of this condition is much more common in the French-Canadian population of the Canadian province of Quebec, where it is estimated to affect 1 in 1,000 individuals. Autosomal dominant oculopharyngeal muscular dystrophy is also seen more frequently in the Bukharan (Central Asian) Jewish population of Israel, affecting 1 in 600 people.  The autosomal recessive form of this condition is very rare; only a few cases of autosomal recessive oculopharyngeal muscular dystrophy have been identified.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""OPMD"", ""full_form"": ""oculopharyngeal muscular dystrophy""}]}",How many people are affected by OPMD ?,How many people are affected by oculopharyngeal muscular dystrophy ?,8,MEDICAL,Simple Datatype-Integer,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Oculopharyngeal Muscular Dystrophy"", ""Output Per Man-Day"", ""Officer Personnel Management Directorate"", ""Oculopharyngeal Muscular Dystrophy"", ""Output Per Man-Day"", ""Officer Personnel Management Directorate""]]","[[""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY""]]","[""Oculopharyngeal Muscular Dystrophy""]",[7.946342615358215e-17],[7.946342615358215e-17],"[""Oculopharyngeal Muscular Dystrophy""]",[7.946342615358215e-17],"[""ACRONYMFINDER""]","[[7.946342615358215e-17, 3.469415025030528e-19, 4.9483186246513845e-24, 7.946342615358215e-17, 3.469415025030528e-19, 4.9483186246513845e-24]]",[0.9140121799239003],[0.9145052988753328],"[""oculopharyngeal muscular dystrophy""]",[0.9145052988753328],"[""ACRONYMFINDER""]","[[0.9145052988753328, 0.7523576128367131, 0.7162531436329417, 0.9145052988753328, 0.7523576128367131, 0.7162531436329417]]","[""Oculopharyngeal Muscular Dystrophy""]","[""ACRONYMFINDER""]",How many people are affected by OPMD (Oculopharyngeal Muscular Dystrophy) ?,[true],[true],[true],"[""OPMD affects an estimated 1 in 100,000 people worldwide.""]","[""Oculopharyngeal muscular dystrophy affects approximately 1 in 100,000 people worldwide.""]","[""Approximately 1 in 100,000 people are affected by Oculopharyngeal Muscular Dystrophy (OPMD).""]",[true],[true],[true],"[""OPMD affects an estimated 1 in 100,000 people worldwide.""]","[""Oculopharyngeal muscular dystrophy affects an estimated 1 in 100,000 individuals worldwide.""]","[""Approximately 1 in 100,000 people are affected by Oculopharyngeal Muscular Dystrophy (OPMD).""]",[true],[true],[true],"[""OPMD affects an estimated 1 in 100,000 people worldwide.""]","[""Oculopharyngeal muscular dystrophy affects approximately 1 in 100,000 people worldwide.""]","[""Approximately 1 in 100,000 people are affected by Oculopharyngeal Muscular Dystrophy (OPMD).""]",[true],[true],[true],"[""OPMD affects an estimated 1 in 100,000 people worldwide.""]","[""Oculopharyngeal muscular dystrophy affects approximately 1 in 100,000 individuals worldwide.""]","[""OPMD affects approximately 1 in 100,000 people worldwide.""]",[true],[true],[true],"[""OPMD affects approximately 1 in 100,000 individuals worldwide.""]","[""Oculopharyngeal muscular dystrophy affects approximately 1 in 100,000 people worldwide.""]","[""Approximately 1 in 100,000 people are affected by Oculopharyngeal Muscular Dystrophy (OPMD).""]",[true],[true],[true],"[""OPMD affects approximately 1 in 100,000 people worldwide.""]","[""Oculopharyngeal muscular dystrophy affects an estimated 1 in 100,000 individuals worldwide.""]","[""Approximately 1 in 100,000 people are affected by Oculopharyngeal Muscular Dystrophy (OPMD).""]",[true],[true],[true],"[""OPMD affects an estimated 1 in 100,000 people worldwide.""]","[""Oculopharyngeal muscular dystrophy affects approximately 1 in 100,000 people worldwide.""]","[""Approximately 1 in 100,000 people are affected by Oculopharyngeal Muscular Dystrophy (OPMD).""]",[true],[true],[true],"[""OPMD affects an estimated 1 in 100,000 people worldwide.""]","[""Oculopharyngeal muscular dystrophy affects approximately 1 in 100,000 individuals worldwide.""]","[""OPMD affects approximately 1 in 100,000 people worldwide.""]",[true],[true],[true],"[""OPMD affects an estimated 1 in 100,000 people worldwide.""]","[""Oculopharyngeal muscular dystrophy affects an estimated 1 in 100,000 individuals worldwide.""]","[""Approximately 1 in 100,000 people are affected by Oculopharyngeal Muscular Dystrophy (OPMD).""]",[true],[true],[true],"[""OPMD affects an estimated 1 in 100,000 people worldwide.""]","[""Oculopharyngeal muscular dystrophy affects approximately 1 in 100,000 people worldwide.""]","[""Approximately 1 in 100,000 people are affected by Oculopharyngeal Muscular Dystrophy (OPMD).""]",[true],[true],[true],"[""OPMD affects an estimated 1 in 100,000 people worldwide.""]","[""Oculopharyngeal muscular dystrophy affects approximately 1 in 100,000 people worldwide.""]","[""Approximately 1 in 100,000 people are affected by Oculopharyngeal Muscular Dystrophy (OPMD).""]",[true],[true],[true],"[""OPMD affects an estimated 1 in 100,000 people worldwide.""]","[""Oculopharyngeal muscular dystrophy affects approximately 1 in 100,000 individuals worldwide.""]","[""OPMD affects approximately 1 in 100,000 people worldwide.""]",[true],[true],[true],"[""OPMD affects approximately 1 in 100,000 people worldwide.""]","[""Oculopharyngeal muscular dystrophy affects approximately 1 in 100,000 people worldwide.""]","[""Approximately 1 in 100,000 people are affected by Oculopharyngeal Muscular Dystrophy (OPMD).""]",[true],[true],[true],"[""OPMD affects an estimated 1 in 100,000 people worldwide.""]","[""Oculopharyngeal muscular dystrophy affects an estimated 1 in 100,000 individuals worldwide.""]","[""Approximately 1 in 100,000 people are affected by Oculopharyngeal Muscular Dystrophy (OPMD).""]",[true],[true],[true],"[""OPMD affects approximately 1 in 100,000 people worldwide.""]","[""Oculopharyngeal muscular dystrophy affects approximately 1 in 100,000 people worldwide.""]","[""Approximately 1 in 100,000 people are affected by Oculopharyngeal Muscular Dystrophy (OPMD).""]",[true],[true],[true],"[""OPMD affects an estimated 1 in 100,000 people worldwide.""]","[""Oculopharyngeal muscular dystrophy affects approximately 1 in 100,000 individuals worldwide.""]","[""OPMD affects approximately 1 in 100,000 people worldwide.""]",[true],[true],[true],"[""The exact number of people affected by OPMD (Oculopharyngeal Muscular Dystrophy) is not well-documented, but it is considered a rare disease with prevalence varying across different populations.""]","[""Oculopharyngeal muscular dystrophy affects approximately 1 in 100,000 people worldwide.""]","[""Approximately 1 in 100,000 people are affected by Oculopharyngeal Muscular Dystrophy (OPMD).""]",[true],[true],[true],"[""OPMD affects an estimated 1 in 100,000 people worldwide.""]","[""Oculopharyngeal muscular dystrophy affects an estimated 1 in 100,000 individuals worldwide.""]","[""Approximately 1 in 100,000 people are affected by Oculopharyngeal Muscular Dystrophy (OPMD).""]",[true],[true],[true],"[""OPMD affects an estimated 1 in 100,000 people worldwide.""]","[""Oculopharyngeal muscular dystrophy affects approximately 1 in 100,000 people worldwide.""]","[""Approximately 1 in 100,000 people are affected by Oculopharyngeal Muscular Dystrophy (OPMD).""]",[true],[true],[true],"[""OPMD affects an estimated 1 in 100,000 people worldwide.""]","[""Oculopharyngeal muscular dystrophy affects approximately 1 in 100,000 individuals worldwide.""]","[""OPMD affects approximately 1 in 100,000 people worldwide.""]",[true],[true],[true],"[""OPMD affects an estimated 1 in 100,000 people worldwide.""]","[""Oculopharyngeal muscular dystrophy affects approximately 1 in 100,000 people worldwide.""]","[""Approximately 1 in 100,000 people are affected by Oculopharyngeal Muscular Dystrophy (OPMD).""]",[true],[true],[true],"[""OPMD affects an estimated 1 in 100,000 people worldwide.""]","[""Oculopharyngeal muscular dystrophy affects an estimated 1 in 100,000 individuals worldwide.""]","[""Approximately 1 in 100,000 people are affected by Oculopharyngeal Muscular Dystrophy (OPMD).""]",[true],[true],[true],"[""OPMD affects an estimated 1 in 100,000 people worldwide.""]","[""Oculopharyngeal muscular dystrophy affects approximately 1 in 100,000 people worldwide.""]","[""Approximately 1 in 100,000 people are affected by Oculopharyngeal Muscular Dystrophy (OPMD).""]",[true],[true],[true],"[""OPMD affects an estimated 1 in 100,000 people worldwide.""]","[""Oculopharyngeal muscular dystrophy affects approximately 1 in 100,000 individuals worldwide.""]","[""OPMD affects approximately 1 in 100,000 people worldwide.""]",[true],[true],[true],"[""OPMD affects an estimated 1 in 100,000 people worldwide.""]","[""Oculopharyngeal muscular dystrophy affects approximately 1 in 100,000 people worldwide.""]","[""Approximately 1 in 100,000 people are affected by Oculopharyngeal Muscular Dystrophy (OPMD).""]",[true],[true],[true],"[""OPMD affects an estimated 1 in 100,000 people worldwide.""]","[""Oculopharyngeal muscular dystrophy affects an estimated 1 in 100,000 individuals worldwide.""]","[""Approximately 1 in 100,000 people are affected by Oculopharyngeal Muscular Dystrophy (OPMD).""]",[true],[true],[true],"[""OPMD affects an estimated 1 in 100,000 individuals worldwide.""]","[""Oculopharyngeal muscular dystrophy affects approximately 1 in 100,000 people worldwide.""]","[""Approximately 1 in 100,000 people are affected by Oculopharyngeal Muscular Dystrophy (OPMD).""]",[true],[true],[true],"[""OPMD affects an estimated 1 in 100,000 people worldwide.""]","[""Oculopharyngeal muscular dystrophy affects approximately 1 in 100,000 individuals worldwide.""]","[""OPMD affects approximately 1 in 100,000 people worldwide.""]",[true],[true],[true],"[""OPMD affects an estimated 1 in 100,000 people worldwide.""]","[""Oculopharyngeal muscular dystrophy affects approximately 1 in 100,000 people worldwide.""]","[""Approximately 1 in 100,000 people are affected by Oculopharyngeal Muscular Dystrophy (OPMD).""]",[true],[true],[true],"[""OPMD affects an estimated 1 in 100,000 people worldwide.""]","[""Oculopharyngeal muscular dystrophy affects approximately 1 in 100,000 people worldwide.""]","[""Approximately 1 in 100,000 people are affected by Oculopharyngeal Muscular Dystrophy (OPMD).""]",[true],[true],[true],"[""OPMD affects an estimated 1 in 100,000 people worldwide.""]","[""Oculopharyngeal muscular dystrophy affects approximately 1 in 100,000 people worldwide.""]","[""Approximately 1 in 100,000 people are affected by Oculopharyngeal Muscular Dystrophy (OPMD).""]",[true],[true],[true],"[""OPMD affects an estimated 1 in 100,000 people worldwide.""]","[""Oculopharyngeal muscular dystrophy affects approximately 1 in 100,000 people worldwide.""]","[""Approximately 1 in 100,000 people are affected by Oculopharyngeal Muscular Dystrophy (OPMD).""]"
treatment,What are the treatments for familial cold autoinflammatory syndrome ?,These resources address the diagnosis or management of familial cold autoinflammatory syndrome:  - Genetic Testing Registry: Familial cold autoinflammatory syndrome 2  - Genetic Testing Registry: Familial cold urticaria   These resources from MedlinePlus offer information about the diagnosis and management of various health conditions:  - Diagnostic Tests  - Drug Therapy  - Surgery and Rehabilitation  - Genetic Counseling   - Palliative Care,"{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""FCAS"", ""full_form"": ""familial cold autoinflammatory syndrome""}]}",What are the treatments for FCAS ?,What are the treatments for familial cold autoinflammatory syndrome ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Fellow of the Casualty Actuarial Society"", ""Fellowship of Christian Athletes and Students"", ""Future Combat Air System"", ""Fellow of the Caribbean Academy of Sciences"", ""Fellow Casualty Actuarial Society"", ""Flinders Centre for Ageing Studies"", ""Frequency Control Ancillary Services"", ""Florence Culinary Art School"", ""Fellow of Casualty Actuarial Society"", ""Field Certified Applications Specialist""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Familial Cold Autoinflammatory Syndrome""]",[4.858011177476935e-22],[4.858011177476935e-22],"[""Frequency Control Ancillary Services""]",[2.5822924742545413e-18],"[""ABBREVIATIONS""]","[[1.6714280185583152e-32, 1.2043574119102587e-32, 2.2906526001651517e-20, 3.4012251183489927e-28, 4.90836862007223e-31, 3.968368371433264e-30, 2.5822924742545413e-18, 1.3558324916622708e-24, 1.0261726272920537e-30, 9.241666248199706e-23]]",[0.8584332368404297],[0.8643500143239926],"[""Field Certified Applications Specialist""]",[0.8643500143239926],"[""LLM""]","[[0.7202567415913365, 0.7149091285920584, 0.7286429849374385, 0.8215592414067387, 0.7947687505454548, 0.808693148869312, 0.6774311153271383, 0.7548266194471855, 0.7252605057555033, 0.7112413965991551]]","[""Familial Cold Autoinflammatory Syndrome""]","[""LLM""]",What are the treatments for FCAS (Familial Cold Autoinflammatory Syndrome) ?,[false],[true],[true],"[""The treatments for FCAS (Frequency Control Ancillary Services) include frequency regulation, load following, and operating reserves.""]","[""Treatment options for familial cold autoinflammatory syndrome include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]","[""The treatments for Familial Cold Autoinflammatory Syndrome (FCAS) include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]",[false],[true],[true],"[""The treatments for FCAS (Frequency Control Ancillary Services) include frequency regulation, load following, and automatic generation control.""]","[""Treatment for familial cold autoinflammatory syndrome includes NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]","[""The treatments for Familial Cold Autoinflammatory Syndrome (FCAS) include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]",[false],[true],[true],"[""The treatments for FCAS (Frequency Control Ancillary Services) include nonsteroidal anti-inflammatory drugs (NSAIDs) such as indomethacin or ibuprofen.""]","[""Treatment options for familial cold autoinflammatory syndrome include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]","[""The treatments for Familial Cold Autoinflammatory Syndrome (FCAS) include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]",[true],[true],[true],"[""The treatments for FCAS include nonsteroidal anti-inflammatory drugs (NSAIDs) such as indomethacin or ibuprofen to reduce inflammation and pain.""]","[""Treatment options for familial cold autoinflammatory syndrome include nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and interleukin-1 inhibitors.""]","[""The treatments for FCAS include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]",[true],[true],[true],"[""The treatments for FCAS (Familial Cold Autoinflammatory Syndrome) include NSAIDs (Nonsteroidal anti-inflammatory drugs), corticosteroids, and interleukin-1 inhibitors.""]","[""Treatment options for familial cold autoinflammatory syndrome include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]","[""The treatments for Familial Cold Autoinflammatory Syndrome (FCAS) include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]",[true],[true],[true],"[""The treatments for FCAS (Familial Cold Autoinflammatory Syndrome) include NSAIDs (Nonsteroidal anti-inflammatory drugs), corticosteroids, and interleukin-1 inhibitors.""]","[""Treatment for familial cold autoinflammatory syndrome includes NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]","[""The treatments for Familial Cold Autoinflammatory Syndrome (FCAS) include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]",[true],[true],[true],"[""The treatments for FCAS (Familial Cold Autoinflammatory Syndrome) include NSAIDs (Nonsteroidal anti-inflammatory drugs), corticosteroids, and interleukin-1 inhibitors.""]","[""Treatment options for familial cold autoinflammatory syndrome include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]","[""The treatments for Familial Cold Autoinflammatory Syndrome (FCAS) include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]",[true],[true],[true],"[""The treatments for FCAS (Familial Cold Autoinflammatory Syndrome) include avoiding cold temperatures, using warm clothing, and medications such as NSAIDs or corticosteroids.""]","[""Treatment options for familial cold autoinflammatory syndrome include nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and interleukin-1 inhibitors.""]","[""The treatments for FCAS include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]",[true],[true],[true],"[""Treatment for FCAS includes avoiding cold exposure, using warm clothing, and medications like NSAIDs or interleukin-1 inhibitors.""]","[""Treatment for familial cold autoinflammatory syndrome includes NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]","[""The treatments for Familial Cold Autoinflammatory Syndrome (FCAS) include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]",[true],[true],[true],"[""Treatment options for FCAS include avoiding cold exposure, using NSAIDs (nonsteroidal anti-inflammatory drugs), and in severe cases, using interleukin-1 inhibitors.""]","[""Treatment options for familial cold autoinflammatory syndrome include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]","[""The treatments for Familial Cold Autoinflammatory Syndrome (FCAS) include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]",[true],[true],[true],"[""Treatment for FCAS includes avoiding cold temperatures, using warm clothing, and medications such as NSAIDs or steroids.""]","[""Treatment options for familial cold autoinflammatory syndrome include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]","[""The treatments for Familial Cold Autoinflammatory Syndrome (FCAS) include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]",[true],[true],[true],"[""The treatments for FCAS include avoiding cold temperatures, using warm clothing, and medications like NSAIDs or corticosteroids.""]","[""Treatment options for familial cold autoinflammatory syndrome include nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and interleukin-1 inhibitors.""]","[""The treatments for FCAS include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]",[true],[true],[true],"[""Treatment options for FCAS include NSAIDs (Nonsteroidal anti-inflammatory drugs) and interleukin-1 inhibitors such as canakinumab or anakinra.""]","[""Treatment options for familial cold autoinflammatory syndrome include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]","[""The treatments for Familial Cold Autoinflammatory Syndrome (FCAS) include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]",[true],[true],[true],"[""Treatment for FCAS includes avoiding cold exposure, using warm clothing, and medications like NSAIDs and corticosteroids.""]","[""Treatment for familial cold autoinflammatory syndrome includes NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]","[""The treatments for Familial Cold Autoinflammatory Syndrome (FCAS) include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]",[true],[true],[true],"[""Treatment for FCAS includes avoiding cold exposure, using warm clothing, and medications like NSAIDs or interleukin-1 inhibitors.""]","[""Treatment options for familial cold autoinflammatory syndrome include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]","[""The treatments for Familial Cold Autoinflammatory Syndrome (FCAS) include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]",[true],[true],[true],"[""Treatment for FCAS includes avoiding cold exposure, using NSAIDs, and in some cases, using interleukin-1 inhibitors.""]","[""Treatment options for familial cold autoinflammatory syndrome include nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and interleukin-1 inhibitors.""]","[""The treatments for FCAS include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]",[true],[true],[true],"[""The treatments for FCAS include NSAIDs (nonsteroidal anti-inflammatory drugs) and corticosteroids.""]","[""Treatment options for familial cold autoinflammatory syndrome include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]","[""The treatments for Familial Cold Autoinflammatory Syndrome (FCAS) include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]",[true],[true],[true],"[""Treatment for FCAS includes avoiding cold exposure, using warm clothing, and medications like NSAIDs and corticosteroids.""]","[""Treatment for familial cold autoinflammatory syndrome includes NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]","[""The treatments for Familial Cold Autoinflammatory Syndrome (FCAS) include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]",[true],[true],[true],"[""The treatments for FCAS include avoiding cold temperatures, using warm clothing, and medications like NSAIDs (nonsteroidal anti-inflammatory drugs) and corticosteroids.""]","[""Treatment options for familial cold autoinflammatory syndrome include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]","[""The treatments for Familial Cold Autoinflammatory Syndrome (FCAS) include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]",[true],[true],[true],"[""The treatments for FCAS include avoiding cold temperatures, using warm clothing, and medications such as NSAIDs and corticosteroids.""]","[""Treatment options for familial cold autoinflammatory syndrome include nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and interleukin-1 inhibitors.""]","[""The treatments for FCAS include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]",[true],[true],[true],"[""Treatment for FCAS includes avoiding cold exposure, using warm clothing, and medications like NSAIDs and corticosteroids.""]","[""Treatment options for familial cold autoinflammatory syndrome include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]","[""The treatments for Familial Cold Autoinflammatory Syndrome (FCAS) include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]",[true],[true],[true],"[""Treatment options for FCAS include avoiding cold temperatures, using NSAIDs (nonsteroidal anti-inflammatory drugs), and in some cases, using medications like interleukin-1 inhibitors.""]","[""Treatment for familial cold autoinflammatory syndrome includes NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]","[""The treatments for Familial Cold Autoinflammatory Syndrome (FCAS) include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]",[true],[true],[true],"[""Treatment for FCAS includes avoiding cold exposure, using warm clothing, and medications like NSAIDs and corticosteroids.""]","[""Treatment options for familial cold autoinflammatory syndrome include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]","[""The treatments for Familial Cold Autoinflammatory Syndrome (FCAS) include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]",[true],[true],[true],"[""The treatments for FCAS include avoiding cold exposure, using warm clothing, and medications such as NSAIDs and corticosteroids.""]","[""Treatment options for familial cold autoinflammatory syndrome include nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and interleukin-1 inhibitors.""]","[""The treatments for FCAS include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]",[true],[true],[true],"[""The treatments for FCAS include NSAIDs (nonsteroidal anti-inflammatory drugs), corticosteroids, and interleukin-1 inhibitors.""]","[""Treatment options for familial cold autoinflammatory syndrome include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]","[""The treatments for Familial Cold Autoinflammatory Syndrome (FCAS) include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]",[true],[true],[true],"[""The treatments for FCAS include NSAIDs (nonsteroidal anti-inflammatory drugs), corticosteroids, and interleukin-1 inhibitors.""]","[""Treatment for familial cold autoinflammatory syndrome includes NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]","[""The treatments for Familial Cold Autoinflammatory Syndrome (FCAS) include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]",[true],[true],[true],"[""The treatments for FCAS include NSAIDs (nonsteroidal anti-inflammatory drugs), corticosteroids, and interleukin-1 inhibitors.""]","[""Treatment options for familial cold autoinflammatory syndrome include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]","[""The treatments for Familial Cold Autoinflammatory Syndrome (FCAS) include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]",[true],[true],[true],"[""Treatments for FCAS include NSAIDs (nonsteroidal anti-inflammatory drugs), corticosteroids, and interleukin-1 inhibitors.""]","[""Treatment options for familial cold autoinflammatory syndrome include nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and interleukin-1 inhibitors.""]","[""The treatments for FCAS include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]",[true],[true],[true],"[""The treatments for FCAS include NSAIDs (nonsteroidal anti-inflammatory drugs), corticosteroids, and interleukin-1 inhibitors.""]","[""Treatment options for familial cold autoinflammatory syndrome include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]","[""The treatments for Familial Cold Autoinflammatory Syndrome (FCAS) include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]",[false],[true],[true],"[""The treatments for FCAS include fast response services, contingency services, and regulation services.""]","[""Treatment options for familial cold autoinflammatory syndrome include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]","[""The treatments for Familial Cold Autoinflammatory Syndrome (FCAS) include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]",[false],[true],[true],"[""The treatments for FCAS (Field Certified Applications Specialist) include training programs, certification exams, and continuous education to stay updated with the latest technologies and trends in the field.""]","[""Treatment options for familial cold autoinflammatory syndrome include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]","[""The treatments for Familial Cold Autoinflammatory Syndrome (FCAS) include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]",[true],[true],[true],"[""The treatments for FCAS include NSAIDs (nonsteroidal anti-inflammatory drugs), corticosteroids, and interleukin-1 inhibitors.""]","[""Treatment options for familial cold autoinflammatory syndrome include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]","[""The treatments for Familial Cold Autoinflammatory Syndrome (FCAS) include NSAIDs, corticosteroids, and interleukin-1 inhibitors.""]"
frequency,How many people are affected by SYNGAP1-related intellectual disability ?,SYNGAP1-related intellectual disability is a relatively common form of cognitive impairment. It is estimated to account for 1 to 2 percent of intellectual disability cases.,"{""full_form_abbrv_map"": [{""ambiguity_type"": ""abbreviation"", ""abbreviation"": ""SYNGAP1"", ""full_form"": ""Synaptic Ras GTPase Activating Protein 1""}]}",How many people are affected by SYNGAP1-related intellectual disability ?,How many people are affected by Synaptic Ras GTPase Activating Protein 1-related intellectual disability ?,8,MEDICAL,Simple Datatype-Integer,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.",[[]],[[]],"[""Synaptic Ras GTPase Activating Protein 1""]",[9.089088748998795e-35],[9.089088748998795e-35],"[""Synaptic Ras GTPase Activating Protein 1""]",[9.089088748998795e-35],"[""LLM""]",[[]],[0.9800199828099371],[0.9800391073014761],"[""Synaptic Ras GTPase Activating Protein 1""]",[0.9800391073014761],"[""LLM""]",[[]],"[""Synaptic Ras GTPase Activating Protein 1""]","[""LLM""]",How many people are affected by SYNGAP1 (Synaptic Ras GTPase Activating Protein 1)-related intellectual disability ?,[false],[false],[true],"[""Approximately 1 in 30,000 to 40,000 individuals are affected by SYNGAP1-related intellectual disability.""]","[""Synaptic Ras GTPase Activating Protein 1-related intellectual disability affects a very small number of individuals worldwide.""]","[""Approximately 1 in 4,000 to 6,000 people are affected by SYNGAP1-related intellectual disability.""]",[true],[false],[true],"[""Approximately 1 in 10,000 to 30,000 individuals are affected by SYNGAP1-related intellectual disability.""]","[""Synaptic Ras GTPase Activating Protein 1-related intellectual disability affects a very small number of individuals worldwide.""]","[""About 1 in 10,000 to 30,000 people are affected by SYNGAP1-related intellectual disability.""]",[false],[true],[true],"[""Approximately 500 known cases worldwide""]","[""Synaptic Ras GTPase Activating Protein 1-related intellectual disability affects a very small number of individuals worldwide.""]","[""Approximately 1 in 10,000 to 30,000 individuals are affected by SYNGAP1-related intellectual disability.""]",[true],[false],[true],"[""Approximately 1 in 30,000 to 40,000 individuals are affected by SYNGAP1-related intellectual disability.""]","[""Synaptic Ras GTPase Activating Protein 1-related intellectual disability affects a very small number of individuals worldwide.""]","[""About 1 in 25,000 to 40,000 people are affected by SYNGAP1-related intellectual disability.""]",[false],[false],[true],"[""Approximately 500 known cases worldwide""]","[""Synaptic Ras GTPase Activating Protein 1-related intellectual disability affects a very small number of individuals worldwide.""]","[""Approximately 1 in 4,000 to 6,000 people are affected by SYNGAP1-related intellectual disability.""]",[true],[false],[true],"[""Approximately 1 in 30,000 to 40,000 individuals are affected by SYNGAP1-related intellectual disability.""]","[""Synaptic Ras GTPase Activating Protein 1-related intellectual disability affects a very small number of individuals worldwide.""]","[""About 1 in 10,000 to 30,000 people are affected by SYNGAP1-related intellectual disability.""]",[false],[false],[true],"[""Approximately 500 individuals worldwide are affected by SYNGAP1-related intellectual disability.""]","[""Synaptic Ras GTPase Activating Protein 1-related intellectual disability affects a very small number of individuals worldwide.""]","[""Approximately 1 in 10,000 to 30,000 individuals are affected by SYNGAP1-related intellectual disability.""]",[true],[false],[true],"[""Approximately 1 in 30,000 to 40,000 individuals are affected by SYNGAP1-related intellectual disability.""]","[""Synaptic Ras GTPase Activating Protein 1-related intellectual disability affects a very small number of individuals worldwide.""]","[""About 1 in 25,000 to 40,000 people are affected by SYNGAP1-related intellectual disability.""]",[true],[false],[true],"[""Approximately 1 in 30,000 to 40,000 individuals are affected by SYNGAP1-related intellectual disability.""]","[""Synaptic Ras GTPase Activating Protein 1-related intellectual disability affects a very small number of individuals worldwide.""]","[""About 1 in 10,000 to 30,000 people are affected by SYNGAP1-related intellectual disability.""]",[false],[false],[true],"[""Approximately 500-1000 individuals worldwide""]","[""Synaptic Ras GTPase Activating Protein 1-related intellectual disability affects a very small number of individuals worldwide.""]","[""Approximately 1 in 4,000 to 6,000 people are affected by SYNGAP1-related intellectual disability.""]",[true],[false],[true],"[""Approximately 1 in 30,000 to 40,000 individuals are affected by SYNGAP1-related intellectual disability.""]","[""Synaptic Ras GTPase Activating Protein 1-related intellectual disability affects a very small number of individuals worldwide.""]","[""Approximately 1 in 10,000 to 30,000 individuals are affected by SYNGAP1-related intellectual disability.""]",[true],[false],[true],"[""Approximately 1 in 30,000 to 40,000 individuals are affected by SYNGAP1-related intellectual disability.""]","[""Synaptic Ras GTPase Activating Protein 1-related intellectual disability affects a very small number of individuals worldwide.""]","[""About 1 in 25,000 to 40,000 people are affected by SYNGAP1-related intellectual disability.""]",[true],[false],[true],"[""Approximately 1 in 10,000 to 30,000 individuals are affected by SYNGAP1-related intellectual disability.""]","[""Synaptic Ras GTPase Activating Protein 1-related intellectual disability affects a very small number of individuals worldwide.""]","[""Approximately 1 in 4,000 to 6,000 people are affected by SYNGAP1-related intellectual disability.""]",[true],[false],[true],"[""Approximately 1 in 10,000 to 30,000 individuals are affected by SYNGAP1-related intellectual disability.""]","[""Synaptic Ras GTPase Activating Protein 1-related intellectual disability affects a very small number of individuals worldwide.""]","[""About 1 in 10,000 to 30,000 people are affected by SYNGAP1-related intellectual disability.""]",[true],[false],[true],"[""Approximately 1 in 10,000 to 30,000 individuals are affected by SYNGAP1-related intellectual disability.""]","[""Synaptic Ras GTPase Activating Protein 1-related intellectual disability affects a very small number of individuals worldwide.""]","[""Approximately 1 in 10,000 to 30,000 individuals are affected by SYNGAP1-related intellectual disability.""]",[true],[false],[true],"[""Approximately 1 in 10,000 to 30,000 individuals are affected by SYNGAP1-related intellectual disability.""]","[""Synaptic Ras GTPase Activating Protein 1-related intellectual disability affects a very small number of individuals worldwide.""]","[""About 1 in 25,000 to 40,000 people are affected by SYNGAP1-related intellectual disability.""]",[false],[false],[true],"[""Approximately 1 in 25,000 to 40,000 people are affected by SYNGAP1-related intellectual disability.""]","[""Synaptic Ras GTPase Activating Protein 1-related intellectual disability affects a very small number of individuals worldwide.""]","[""Approximately 1 in 4,000 to 6,000 people are affected by SYNGAP1-related intellectual disability.""]",[true],[false],[true],"[""Approximately 1 in 30,000 to 40,000 individuals are affected by SYNGAP1-related intellectual disability.""]","[""Synaptic Ras GTPase Activating Protein 1-related intellectual disability affects a very small number of individuals worldwide.""]","[""About 1 in 10,000 to 30,000 people are affected by SYNGAP1-related intellectual disability.""]",[true],[false],[true],"[""Approximately 1 in 30,000 to 40,000 individuals are affected by SYNGAP1-related intellectual disability.""]","[""Synaptic Ras GTPase Activating Protein 1-related intellectual disability affects a very small number of individuals worldwide.""]","[""Approximately 1 in 10,000 to 30,000 individuals are affected by SYNGAP1-related intellectual disability.""]",[true],[false],[true],"[""Approximately 1 in 30,000 to 40,000 individuals are affected by SYNGAP1-related intellectual disability.""]","[""Synaptic Ras GTPase Activating Protein 1-related intellectual disability affects a very small number of individuals worldwide.""]","[""About 1 in 25,000 to 40,000 people are affected by SYNGAP1-related intellectual disability.""]",[false],[false],[true],"[""Approximately 500 individuals worldwide are affected by SYNGAP1-related intellectual disability.""]","[""Synaptic Ras GTPase Activating Protein 1-related intellectual disability affects a very small number of individuals worldwide.""]","[""Approximately 1 in 4,000 to 6,000 people are affected by SYNGAP1-related intellectual disability.""]",[true],[false],[true],"[""Approximately 1 in 10,000 to 30,000 individuals are affected by SYNGAP1-related intellectual disability.""]","[""Synaptic Ras GTPase Activating Protein 1-related intellectual disability affects a very small number of individuals worldwide.""]","[""About 1 in 10,000 to 30,000 people are affected by SYNGAP1-related intellectual disability.""]",[true],[false],[true],"[""Approximately 1 in 30,000 to 40,000 individuals are affected by SYNGAP1-related intellectual disability.""]","[""Synaptic Ras GTPase Activating Protein 1-related intellectual disability affects a very small number of individuals worldwide.""]","[""Approximately 1 in 10,000 to 30,000 individuals are affected by SYNGAP1-related intellectual disability.""]",[true],[false],[true],"[""Approximately 1 in 10,000 to 30,000 individuals are affected by SYNGAP1-related intellectual disability.""]","[""Synaptic Ras GTPase Activating Protein 1-related intellectual disability affects a very small number of individuals worldwide.""]","[""About 1 in 25,000 to 40,000 people are affected by SYNGAP1-related intellectual disability.""]",[true],[false],[true],"[""It is estimated that SYNGAP1-related intellectual disability affects around 1 in 10,000 to 30,000 individuals.""]","[""Synaptic Ras GTPase Activating Protein 1-related intellectual disability affects a very small number of individuals worldwide.""]","[""Approximately 1 in 4,000 to 6,000 people are affected by SYNGAP1-related intellectual disability.""]",[true],[false],[true],"[""Approximately 1 in 30,000 to 40,000 people are affected by SYNGAP1-related intellectual disability.""]","[""Synaptic Ras GTPase Activating Protein 1-related intellectual disability affects a very small number of individuals worldwide.""]","[""About 1 in 10,000 to 30,000 people are affected by SYNGAP1-related intellectual disability.""]",[true],[false],[true],"[""It is estimated that SYNGAP1-related intellectual disability affects around 1 in 10,000 to 30,000 individuals.""]","[""Synaptic Ras GTPase Activating Protein 1-related intellectual disability affects a very small number of individuals worldwide.""]","[""Approximately 1 in 10,000 to 30,000 individuals are affected by SYNGAP1-related intellectual disability.""]",[true],[false],[true],"[""It is estimated that SYNGAP1-related intellectual disability affects around 1 in 25,000 to 1 in 40,000 individuals.""]","[""Synaptic Ras GTPase Activating Protein 1-related intellectual disability affects a very small number of individuals worldwide.""]","[""About 1 in 25,000 to 40,000 people are affected by SYNGAP1-related intellectual disability.""]",[false],[false],[true],"[""Approximately 1 in 25,000 to 40,000 people are affected by SYNGAP1-related intellectual disability.""]","[""Synaptic Ras GTPase Activating Protein 1-related intellectual disability affects a very small number of individuals worldwide.""]","[""Approximately 1 in 4,000 to 6,000 people are affected by SYNGAP1-related intellectual disability.""]",[false],[false],[true],"[""Approximately 500-1000 individuals worldwide""]","[""Synaptic Ras GTPase Activating Protein 1-related intellectual disability affects a very small number of individuals worldwide.""]","[""Approximately 1 in 4,000 to 6,000 people are affected by SYNGAP1-related intellectual disability.""]",[true],[false],[true],"[""It is estimated that SYNGAP1-related intellectual disability affects around 1 in 10,000 to 1 in 30,000 individuals.""]","[""Synaptic Ras GTPase Activating Protein 1-related intellectual disability affects a very small number of individuals worldwide.""]","[""Approximately 1 in 4,000 to 6,000 people are affected by SYNGAP1-related intellectual disability.""]",[true],[false],[true],"[""Approximately 1 in 25,000 to 40,000 individuals are affected by SYNGAP1-related intellectual disability.""]","[""Synaptic Ras GTPase Activating Protein 1-related intellectual disability affects a very small number of individuals worldwide.""]","[""Approximately 1 in 4,000 to 6,000 people are affected by SYNGAP1-related intellectual disability.""]"
treatment,What are the treatments for Aplastic Anemia ?,"Treatments for aplastic anemia include blood transfusions, blood and marrow stem cell transplants, and medicines. These treatments can prevent or limit complications, relieve symptoms, and improve quality of life.
                
Blood and marrow stem cell transplants may cure the disorder in some people who are eligible for a transplant. Removing a known cause of aplastic anemia, such as exposure to a toxin, also may cure the condition.
                
Who Needs Treatment
                
People who have mild or moderate aplastic anemia may not need treatment as long as the condition doesn't get worse. People who have severe aplastic anemia need medical treatment right away to prevent complications.
                
People who have very severe aplastic anemia need emergency medical care in a hospital. Very severe aplastic anemia can be fatal if it's not treated right away.
                
Blood Transfusions
                
Blood transfusions can help keep blood cell counts at acceptable levels. A blood transfusion is a common procedure in which blood is given to you through an intravenous (IV) line in one of your blood vessels.
                
Transfusions require careful matching of donated blood with the recipient's blood.
                
Blood transfusions help relieve the symptoms of aplastic anemia, but they're not a permanent treatment.
                
Blood and Marrow Stem Cell Transplants
                
A blood and marrow stem cell transplant replaces damaged stem cells with healthy ones from another person (a donor).
                
During the transplant, which is like a blood transfusion, you get donated stem cells through a tube placed in a vein in your chest. Once the stem cells are in your body, they travel to your bone marrow and begin making new blood cells.
                
Blood and marrow stem cell transplants may cure aplastic anemia in people who can have this type of treatment. The transplant works best in children and young adults with severe aplastic anemia who are in good health and who have matched donors.
                
Older people may be less able to handle the treatments needed to prepare the body for the transplant. They're also more likely to have complications after the transplant.
                
If you have aplastic anemia, talk with your doctor about whether a blood and marrow stem cell transplant is an option for you.
                
Medicines
                
If you have aplastic anemia, your doctor may prescribe medicines to:
                
Stimulate your bone marrow
                
Suppress your immune system
                
Prevent and treat infections
                
Medicines To Stimulate Bone Marrow
                
Man-made versions of substances that occur naturally in the body can stimulate the bone marrow to make more blood cells. Examples of these types of medicines include erythropoietin and colony-stimulating factors.
                
These medicines have some risks. You and your doctor will work together to decide whether the benefits of these medicines outweigh the risks. If this treatment works well, it can help you avoid the need for blood transfusions.
                
Medicines To Suppress the Immune System
                
Research suggests that aplastic anemia may sometimes occur because the body's immune system attacks its own cells by mistake. For this reason, your doctor may prescribe medicines to suppress your immune system.
                
These medicines allow your bone marrow to start making blood cells again. They also may help you avoid the need for blood transfusions.
                
Medicines that suppress the immune system don't cure aplastic anemia. However, they can relieve its symptoms and reduce complications. These medicines often are used for people who can't have blood and marrow stem cell transplants or who are waiting for transplants.
                
Three medicinesoften given togethercan suppress the body's immune system. They are antithymocyte globulin (ATG), cyclosporine, and methylprednisolone.
                
It may take a few months to notice the effects of these medicines. Most often, as blood cell counts rise, symptoms lessen. Blood cell counts in people who respond well to these medicines usually don't reach normal levels. However, the blood cell counts often are high enough to allow people to do their normal activities.
                
People who have aplastic anemia may need long-term treatment with these medicines.
                
Medicines that suppress the immune system can have side effects. They also may increase the risk of developing leukemia (lu-KE-me-ah) or myelodysplasia (MI-e-lo-dis-PLA-ze-ah; MDS). Leukemia is a cancer of the blood cells. MDS is a condition in which the bone marrow makes too many faulty blood cells.
                
Medicines To Prevent and Treat Infections
                
If you have aplastic anemia, you might be at risk for infections due to low white blood cell counts. Your doctor may prescribe antibiotic and antiviral medicines to prevent and treat infections.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""AA"", ""full_form"": ""Aplastic Anemia""}]}",What are the treatments for AA ?,What are the treatments for Aplastic Anemia ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Alcoholics Anonymous"", ""Amino Acid"", ""American Airlines"", ""As Amended"", ""All Around"", ""Almost All"", ""African American"", ""African-American"", ""Ann Arbor"", ""Acetic Acid""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Alopecia Areata""]",[7.527111536800477e-07],[5.4955813471049175e-17],"[""All Around""]",[1.7629016153283234e-06],"[""ABBREVIATIONS""]","[[1.7268390604307816e-13, 7.728939953236685e-07, 3.4272720303417468e-12, 1.8251190428426823e-08, 1.7629016153283234e-06, 1.3082294506165923e-06, 4.7498220408978315e-07, 1.3719026064483737e-08, 1.455080218890657e-15, 1.2931415205787012e-09]]",[0.8262999346634992],[0.8551005599333984],"[""All Around""]",[0.884777020288354],"[""ABBREVIATIONS""]","[[0.707084201590696, 0.8057308180807928, 0.7937105641418978, 0.8701914988349755, 0.8265785879489935, 0.884777020288354, 0.8467372706490357, 0.8447749245252094, 0.8609201277633409, 0.7600078907613288]]","[""Alcoholics Anonymous""]","[""ABBREVIATIONS""]",What are the treatments for AA (Alopecia Areata) ?,[false],[true],[false],"[""Topical minoxidil, oral finasteride, corticosteroid injections, and hair transplant surgery are common treatments for Androgenetic Alopecia (AA).""]","[""Blood transfusions, immunosuppressive therapy, bone marrow transplant""]","[""Topical minoxidil, oral finasteride, corticosteroid injections, anthralin, and immunotherapy are common treatments for Alopecia Areata.""]",[false],[true],[false],"[""Topical minoxidil, oral finasteride, corticosteroid injections, and hair transplant surgery are common treatments for Androgenetic Alopecia (AA).""]","[""Blood transfusions, immunosuppressive therapy, bone marrow transplant""]","[""Topical minoxidil, oral finasteride, corticosteroid injections, anthralin, and immunotherapy are common treatments for alopecia areata.""]",[false],[true],[false],"[""Topical corticosteroids, minoxidil, anthralin, immunotherapy, and phototherapy are common treatments for AA (Alopecia Areata).""]","[""Blood transfusions, immunosuppressive therapy, bone marrow/stem cell transplant""]","[""Topical minoxidil, oral finasteride, corticosteroid injections, anthralin, and immunotherapy are common treatments for alopecia areata.""]",[false],[true],[false],"[""The treatments for AA (All Around) include topical corticosteroids, minoxidil, anthralin, and immunotherapy.""]","[""Blood transfusions, immunosuppressive therapy, bone marrow transplant""]","[""Topical minoxidil, oral finasteride, corticosteroid injections, anthralin, and immunotherapy are common treatments for alopecia areata.""]",[false],[true],[false],"[""Topical corticosteroids, minoxidil, anthralin, immunotherapy, and phototherapy are common treatments for AA (Alopecia Areata).""]","[""Blood transfusions, immunosuppressive therapy, bone marrow transplant""]","[""Topical minoxidil, oral finasteride, corticosteroid injections, anthralin, and immunotherapy are common treatments for Alopecia Areata.""]",[false],[true],[false],"[""Topical minoxidil, oral finasteride, corticosteroid injections, anthralin, and immunotherapy are common treatments for AA (Alopecia Areata).""]","[""Blood transfusions, immunosuppressive therapy, bone marrow transplant""]","[""Topical minoxidil, oral finasteride, corticosteroid injections, anthralin, and immunotherapy are common treatments for alopecia areata.""]",[false],[true],[false],"[""Topical corticosteroids, minoxidil, anthralin, immunotherapy, and phototherapy are common treatments for AA (Alopecia Areata).""]","[""Blood transfusions, immunosuppressive therapy, bone marrow/stem cell transplant""]","[""Topical minoxidil, oral finasteride, corticosteroid injections, anthralin, and immunotherapy are common treatments for alopecia areata.""]",[false],[true],[false],"[""Topical minoxidil, oral finasteride, corticosteroid injections, and hair transplant surgery are common treatments for AA (Alopecia Areata).""]","[""Blood transfusions, immunosuppressive therapy, bone marrow transplant""]","[""Topical minoxidil, oral finasteride, corticosteroid injections, anthralin, and immunotherapy are common treatments for alopecia areata.""]",[false],[true],[false],"[""The treatments for Alcoholics Anonymous (AA) include group therapy, 12-step programs, counseling, and support from peers.""]","[""Blood transfusions, immunosuppressive therapy, bone marrow transplant""]","[""Topical minoxidil, oral finasteride, corticosteroid injections, anthralin, and immunotherapy are common treatments for alopecia areata.""]",[false],[true],[false],"[""The treatments for Alcoholics Anonymous (AA) include group therapy, 12-step programs, counseling, and support from peers in recovery.""]","[""Blood transfusions, immunosuppressive therapy, bone marrow transplant""]","[""Topical minoxidil, oral finasteride, corticosteroid injections, anthralin, and immunotherapy are common treatments for Alopecia Areata.""]",[false],[true],[false],"[""The treatments for Alcoholics Anonymous (AA) typically involve attending group meetings, following the 12-step program, and receiving support from peers who have also struggled with alcohol addiction.""]","[""Blood transfusions, immunosuppressive therapy, bone marrow/stem cell transplant""]","[""Topical minoxidil, oral finasteride, corticosteroid injections, anthralin, and immunotherapy are common treatments for alopecia areata.""]",[false],[true],[false],"[""The treatments for Alcoholics Anonymous (AA) typically include group therapy, 12-step programs, counseling, and support from peers in recovery.""]","[""Blood transfusions, immunosuppressive therapy, bone marrow transplant""]","[""Topical minoxidil, oral finasteride, corticosteroid injections, anthralin, and immunotherapy are common treatments for alopecia areata.""]",[false],[true],[false],"[""The treatments for Alcoholics Anonymous (AA) include group therapy, 12-step programs, counseling, and support groups.""]","[""Blood transfusions, immunosuppressive therapy, bone marrow transplant""]","[""Topical minoxidil, oral finasteride, corticosteroid injections, anthralin, and immunotherapy are common treatments for Alopecia Areata.""]",[false],[true],[false],"[""The treatments for Alcoholics Anonymous (AA) include group therapy, 12-step programs, counseling, and support groups.""]","[""Blood transfusions, immunosuppressive therapy, bone marrow transplant""]","[""Topical minoxidil, oral finasteride, corticosteroid injections, anthralin, and immunotherapy are common treatments for alopecia areata.""]",[false],[true],[false],"[""The treatments for Alcoholics Anonymous (AA) include group therapy, 12-step programs, individual counseling, and support from peers.""]","[""Blood transfusions, immunosuppressive therapy, bone marrow/stem cell transplant""]","[""Topical minoxidil, oral finasteride, corticosteroid injections, anthralin, and immunotherapy are common treatments for alopecia areata.""]",[false],[true],[false],"[""The treatments for Alcoholics Anonymous (AA) include group therapy, 12-step programs, counseling, and support groups.""]","[""Blood transfusions, immunosuppressive therapy, bone marrow transplant""]","[""Topical minoxidil, oral finasteride, corticosteroid injections, anthralin, and immunotherapy are common treatments for alopecia areata.""]",[false],[true],[false],"[""The treatments for Alcoholics Anonymous (AA) typically include group therapy, individual counseling, 12-step programs, and support groups.""]","[""Blood transfusions, immunosuppressive therapy, bone marrow transplant""]","[""Topical minoxidil, oral finasteride, corticosteroid injections, anthralin, and immunotherapy are common treatments for Alopecia Areata.""]",[false],[true],[false],"[""The treatments for Alcoholics Anonymous (AA) include group therapy, 12-step programs, individual counseling, and support groups.""]","[""Blood transfusions, immunosuppressive therapy, bone marrow transplant""]","[""Topical minoxidil, oral finasteride, corticosteroid injections, anthralin, and immunotherapy are common treatments for alopecia areata.""]",[false],[true],[false],"[""The treatments for Alcoholics Anonymous (AA) typically include group therapy, 12-step programs, counseling, and support from peers in recovery.""]","[""Blood transfusions, immunosuppressive therapy, bone marrow/stem cell transplant""]","[""Topical minoxidil, oral finasteride, corticosteroid injections, anthralin, and immunotherapy are common treatments for alopecia areata.""]",[false],[true],[false],"[""The treatments for Alcoholics Anonymous (AA) include group therapy, 12-step programs, counseling, and support from peers in recovery.""]","[""Blood transfusions, immunosuppressive therapy, bone marrow transplant""]","[""Topical minoxidil, oral finasteride, corticosteroid injections, anthralin, and immunotherapy are common treatments for alopecia areata.""]",[false],[true],[false],"[""Topical corticosteroids, minoxidil, anthralin, immunotherapy, and oral corticosteroids are common treatments for Alopecia Areata.""]","[""Blood transfusions, immunosuppressive therapy, bone marrow transplant""]","[""Topical minoxidil, oral finasteride, corticosteroid injections, anthralin, and immunotherapy are common treatments for Alopecia Areata.""]",[false],[true],[false],"[""Topical corticosteroids, minoxidil, anthralin, immunotherapy, and JAK inhibitors are common treatments for Alopecia Areata.""]","[""Blood transfusions, immunosuppressive therapy, bone marrow transplant""]","[""Topical minoxidil, oral finasteride, corticosteroid injections, anthralin, and immunotherapy are common treatments for alopecia areata.""]",[false],[true],[false],"[""Topical corticosteroids, minoxidil, anthralin, immunotherapy, and JAK inhibitors are common treatments for Alopecia Areata.""]","[""Blood transfusions, immunosuppressive therapy, bone marrow/stem cell transplant""]","[""Topical minoxidil, oral finasteride, corticosteroid injections, anthralin, and immunotherapy are common treatments for alopecia areata.""]",[false],[true],[false],"[""Topical corticosteroids, minoxidil, anthralin, immunotherapy, and JAK inhibitors are common treatments for Alopecia Areata.""]","[""Blood transfusions, immunosuppressive therapy, bone marrow transplant""]","[""Topical minoxidil, oral finasteride, corticosteroid injections, anthralin, and immunotherapy are common treatments for alopecia areata.""]",[false],[true],[false],"[""The treatments for Alcoholics Anonymous (AA) typically involve attending group meetings, following the 12-step program, obtaining a sponsor, and participating in therapy or counseling.""]","[""Blood transfusions, immunosuppressive therapy, bone marrow transplant""]","[""Topical minoxidil, oral finasteride, corticosteroid injections, anthralin, and immunotherapy are common treatments for Alopecia Areata.""]",[false],[true],[false],"[""The treatments for Alcoholics Anonymous (AA) typically involve attending group meetings, following the 12-step program, having a sponsor, and participating in therapy sessions.""]","[""Blood transfusions, immunosuppressive therapy, bone marrow transplant""]","[""Topical minoxidil, oral finasteride, corticosteroid injections, anthralin, and immunotherapy are common treatments for alopecia areata.""]",[false],[true],[false],"[""The treatments for Alcoholics Anonymous (AA) typically involve attending meetings, following the 12-step program, seeking support from peers, and working with a sponsor.""]","[""Blood transfusions, immunosuppressive therapy, bone marrow/stem cell transplant""]","[""Topical minoxidil, oral finasteride, corticosteroid injections, anthralin, and immunotherapy are common treatments for alopecia areata.""]",[false],[true],[false],"[""The treatments for Alcoholics Anonymous (AA) typically involve attending meetings, following the 12-step program, receiving support from peers, and working with a sponsor.""]","[""Blood transfusions, immunosuppressive therapy, bone marrow transplant""]","[""Topical minoxidil, oral finasteride, corticosteroid injections, anthralin, and immunotherapy are common treatments for alopecia areata.""]",[false],[true],[false],"[""The treatments for Alcoholics Anonymous (AA) typically involve attending group meetings, following the 12-step program, having a sponsor, and participating in individual counseling or therapy.""]","[""Blood transfusions, immunosuppressive therapy, bone marrow transplant""]","[""Topical minoxidil, oral finasteride, corticosteroid injections, anthralin, and immunotherapy are common treatments for Alopecia Areata.""]",[false],[true],[false],"[""The treatments for AA (All Around) include cognitive-behavioral therapy, medication, and support groups.""]","[""Blood transfusions, immunosuppressive therapy, bone marrow transplant""]","[""Topical minoxidil, oral finasteride, corticosteroid injections, anthralin, and immunotherapy are common treatments for Alopecia Areata.""]",[false],[true],[false],"[""The treatments for AA (All Around) include therapy, medication, and lifestyle changes.""]","[""Blood transfusions, immunosuppressive therapy, bone marrow transplant""]","[""Topical minoxidil, oral finasteride, corticosteroid injections, anthralin, and immunotherapy are common treatments for Alopecia Areata.""]",[false],[true],[false],"[""There is no cure for alopecia areata, but treatments can help hair grow back more quickly and may prevent future hair loss.""]","[""Blood transfusions, immunosuppressive therapy, bone marrow transplant""]","[""Topical minoxidil, oral finasteride, corticosteroid injections, anthralin, and immunotherapy are common treatments for Alopecia Areata.""]"
inheritance,Is factor X deficiency inherited ?,"When this condition is caused by mutations in the F10 gene, it is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.  Acquired factor X deficiency is not inherited, and generally occurs in individuals with no history of the disorder in their family.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""FX"", ""full_form"": ""factor X""}]}",Is FX deficiency inherited ?,Is factor X deficiency inherited ?,8,MEDICAL,Simple Datatype-Boolean,"Analytical/Evaluative (Convergent Thinking): This merged category is for queries that involve dissecting complex information or data to understand underlying patterns, reasons, or to make informed judgements. Queries in this category seek a deeper understanding that supports decision-making, comparison of options, or evaluating alternatives. The process involves both analysis (to break down and understand) and evaluation (to assess, compare, and decide), acknowledging that these processes often occur in tandem. This category involves queries where the goal is to converge upon a specific answer or decision through analysis and evaluation.","[[""Foreign Exchange"", ""Fracture"", ""France (European Territory)"", ""Francis Xavier"", ""FastLynx On-line guide"", ""Freedom Xperience"", ""Female Xperience"", ""Faster and Xtended"", ""Fast and Xtreme"", ""Fighter X (next generation fighter aircraft)""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Factor X""]",[5.224236404962758e-07],[5.224236404962758e-07],"[""Fracture""]",[0.0008942820274176574],"[""ABBREVIATIONS""]","[[3.440565620915e-11, 0.0008942820274176574, 2.5040926920073693e-23, 1.803264792114856e-18, 5.626561950895255e-28, 2.4485507077424297e-17, 2.1669520475217427e-16, 1.534469579268656e-17, 1.7740584673438627e-15, 1.0395150501005075e-31]]",[0.8923912354619113],[0.8948794690169859],"[""Female Xperience""]",[0.9261526227672674],"[""ABBREVIATIONS""]","[[0.8983952020087113, 0.8859028185680597, 0.8979715167660638, 0.8803241533143173, 0.8440351070555054, 0.8917096164372841, 0.8812758236056815, 0.9261526227672674, 0.9164866070804456, 0.8664947598130794]]","[""Factor X""]","[""LLM""]",Is FX (Factor X) deficiency inherited ?,[false],[true],[true],"[""No, FX (Fracture) deficiency is not inherited.""]","[""Yes, factor X deficiency can be inherited.""]","[""Yes, FX deficiency is inherited.""]",[true],[true],[true],"[""Yes, some types of FX deficiency can be inherited.""]","[""Yes, factor X deficiency can be inherited.""]","[""Yes, FX deficiency is inherited.""]",[false],[true],[true],"[""No, FX (Fracture) deficiency is not inherited.""]","[""Yes, factor X deficiency can be inherited.""]","[""Yes, FX deficiency is inherited.""]",[false],[true],[true],"[""No""]","[""Yes, factor X deficiency can be inherited.""]","[""Yes, FX deficiency is inherited.""]",[false],[true],[true],"[""Yes, FX (Female Xperience) deficiency is inherited.""]","[""Yes, factor X deficiency can be inherited.""]","[""Yes, FX deficiency is inherited.""]",[true],[true],[true],"[""Yes, FX deficiency is inherited.""]","[""Yes, factor X deficiency can be inherited.""]","[""Yes, FX deficiency is inherited.""]",[true],[true],[true],"[""Yes, FX deficiency is inherited.""]","[""Yes, factor X deficiency can be inherited.""]","[""Yes, FX deficiency is inherited.""]",[false],[true],[true],"[""No, FX deficiency is not inherited.""]","[""Yes, factor X deficiency can be inherited.""]","[""Yes, FX deficiency is inherited.""]",[true],[true],[true],"[""Yes, Factor X deficiency can be inherited.""]","[""Yes, factor X deficiency can be inherited.""]","[""Yes, FX deficiency is inherited.""]",[true],[true],[true],"[""Yes, Factor X deficiency can be inherited.""]","[""Yes, factor X deficiency can be inherited.""]","[""Yes, FX deficiency is inherited.""]",[true],[true],[true],"[""Yes, Factor X deficiency can be inherited.""]","[""Yes, factor X deficiency can be inherited.""]","[""Yes, FX deficiency is inherited.""]",[true],[true],[true],"[""Yes, Factor X deficiency can be inherited.""]","[""Yes, factor X deficiency can be inherited.""]","[""Yes, FX deficiency is inherited.""]",[true],[true],[false],"[""Yes, Factor X deficiency can be inherited.""]","[""Yes, factor X deficiency can be inherited.""]","[""Yes, FX deficiency is inherited.""]",[true],[true],[true],"[""Yes, Factor X deficiency can be inherited.""]","[""Yes, factor X deficiency can be inherited.""]","[""Yes, FX deficiency is inherited.""]",[true],[true],[false],"[""Yes, Factor X deficiency can be inherited.""]","[""Yes, factor X deficiency can be inherited.""]","[""Yes, FX deficiency is inherited.""]",[true],[true],[true],"[""Yes, Factor X deficiency can be inherited.""]","[""Yes, factor X deficiency can be inherited.""]","[""Yes, FX deficiency is inherited.""]",[true],[true],[true],"[""Yes, FX (Factor X) deficiency can be inherited.""]","[""Yes, factor X deficiency can be inherited.""]","[""Yes, FX deficiency is inherited.""]",[true],[true],[true],"[""Yes, Factor X deficiency can be inherited.""]","[""Yes, factor X deficiency can be inherited.""]","[""Yes, FX deficiency is inherited.""]",[true],[true],[true],"[""Yes, FX (Factor X) deficiency can be inherited.""]","[""Yes, factor X deficiency can be inherited.""]","[""Yes, FX deficiency is inherited.""]",[true],[true],[true],"[""Yes, Factor X deficiency can be inherited.""]","[""Yes, factor X deficiency can be inherited.""]","[""Yes, FX deficiency is inherited.""]",[true],[true],[true],"[""Yes, Factor X deficiency can be inherited.""]","[""Yes, factor X deficiency can be inherited.""]","[""Yes, FX deficiency is inherited.""]",[true],[true],[true],"[""Yes, Factor X deficiency can be inherited.""]","[""Yes, factor X deficiency can be inherited.""]","[""Yes, FX deficiency is inherited.""]",[true],[true],[true],"[""Yes, Factor X deficiency can be inherited.""]","[""Yes, factor X deficiency can be inherited.""]","[""Yes, FX deficiency is inherited.""]",[true],[true],[true],"[""Yes, FX (Factor X) deficiency can be inherited.""]","[""Yes, factor X deficiency can be inherited.""]","[""Yes, FX deficiency is inherited.""]",[true],[true],[true],"[""Yes, FX (Factor X) deficiency can be inherited.""]","[""Yes, factor X deficiency can be inherited.""]","[""Yes, FX deficiency is inherited.""]",[true],[true],[true],"[""Yes, FX (Factor X) deficiency can be inherited.""]","[""Yes, factor X deficiency can be inherited.""]","[""Yes, FX deficiency is inherited.""]",[true],[true],[true],"[""Yes, Factor X deficiency can be inherited.""]","[""Yes, factor X deficiency can be inherited.""]","[""Yes, FX deficiency is inherited.""]",[true],[true],[true],"[""Yes, FX (Factor X) deficiency can be inherited.""]","[""Yes, factor X deficiency can be inherited.""]","[""Yes, FX deficiency is inherited.""]",[true],[true],[true],"[""Yes, FX (Factor X) deficiency can be inherited.""]","[""Yes, factor X deficiency can be inherited.""]","[""Yes, FX deficiency is inherited.""]",[true],[true],[false],"[""FX deficiency is inherited in an autosomal recessive pattern.""]","[""Yes, factor X deficiency can be inherited.""]","[""Yes, FX deficiency is inherited.""]",[false],[true],[true],"[""No, FX deficiency is not inherited.""]","[""Yes, factor X deficiency can be inherited.""]","[""Yes, FX deficiency is inherited.""]",[true],[true],[true],"[""Yes, FX (Factor X) deficiency can be inherited.""]","[""Yes, factor X deficiency can be inherited.""]","[""Yes, FX deficiency is inherited.""]"
treatment,What are the treatments for Childhood Hodgkin Lymphoma ?,"Key Points
                    - There are different types of treatment for children with Hodgkin lymphoma.     - Children with Hodgkin lymphoma should have their treatment planned by a team of health care providers who are experts in treating childhood cancer.    - Children and adolescents may have treatment-related side effects that appear months or years after treatment for Hodgkin lymphoma.     - Five types of standard treatment are used:         - Chemotherapy      - Radiation therapy      - Targeted therapy     - Surgery     - High-dose chemotherapy with stem cell transplant         - New types of treatment are being tested in clinical trials.         - Proton beam radiation therapy        - Patients may want to think about taking part in a clinical trial.    - Patients can enter clinical trials before, during, or after starting their cancer treatment.    - Follow-up tests may be needed.
                
                
                    There are different types of treatment for children with Hodgkin lymphoma.
                    Different types of treatment are available for children with Hodgkin lymphoma. Some treatments are standard and some are being tested in clinical trials. A treatment clinical trial is a research study meant to help improve current treatments or obtain information on new treatments for patients with cancer. When clinical trials show that a new treatment is better than the standard treatment, the new treatment may become the standard treatment.   Because cancer in children is rare, taking part in a clinical trial should be considered. Some clinical trials are open only to patients who have not started treatment.
                
                
                    Children with Hodgkin lymphoma should have their treatment planned by a team of health care providers who are experts in treating childhood cancer.
                    Treatment will be overseen by a pediatric oncologist, a doctor who specializes in treating children with cancer. The pediatric oncologist works with other pediatric health care providers who are experts in treating children with Hodgkin lymphoma and who specialize in certain areas of medicine. These may include the following specialists:         -  Pediatrician.    -  Medical oncologist /hematologist.    -  Pediatric surgeon.    -  Radiation oncologist.    -  Endocrinologist.    -  Pediatric nurse specialist.    -  Rehabilitation specialist.    -  Psychologist.    -  Social worker.    -  Child-life specialist.        The treatment of Hodgkin lymphoma in adolescents and young adults may be different than the treatment for children. Some adolescents and young adults are treated with an adult treatment regimen.
                
                
                    Children and adolescents may have treatment-related side effects that appear months or years after treatment for Hodgkin lymphoma.
                    Some cancer treatments cause side effects that continue or appear months or years after cancer treatment has ended. These are called late effects. Because late effects affect health and development, regular follow-up exams are important.   Late effects of cancer treatment may include:         - Physical problems that affect the following:               - Development of sex and reproductive organs.      -  Fertility (ability to have children).      - Bone and muscle growth and development.      -  Thyroid, heart, or lung function.      - Teeth, gums, and salivary gland function.      -  Spleen function (increased risk of infection).              - Changes in mood, feelings, thinking, learning, or memory.    -  Second cancers (new types of cancer).         For female survivors of Hodgkin lymphoma, there is an increased risk of breast cancer. This risk depends on the amount of radiation therapy they received to the breast during treatment and the chemotherapy regimen used. The risk of breast cancer is decreased if these female survivors also received radiation therapy to the ovaries.    It is suggested that female survivors who received radiation therapy to the breast have a mammogram once a year starting 8 years after treatment or at age 25 years, whichever is later. Female survivors of childhood Hodgkin lymphoma who have breast cancer have an increased risk of dying from the disease compared to patients with no history of Hodgkin lymphoma who have breast cancer.   Some late effects may be treated or controlled. It is important to talk with your child's doctors about the possible late effects caused by some treatments. (See the PDQ summary on Late Effects of Treatment for Childhood Cancer for more information).
                
                
                    Five types of standard treatment are used:
                    Chemotherapy     Chemotherapy is a cancer treatment that uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. When chemotherapy is taken by mouth or injected into a vein or muscle, the drugs enter the bloodstream and can reach cancer cells throughout the body (systemic chemotherapy). When chemotherapy is placed directly into the cerebrospinal fluid, an organ, or a body cavity such as the abdomen, the drugs mainly affect cancer cells in those areas (regional chemotherapy). Combination chemotherapy is treatment using more than one anticancer drug.     The way the chemotherapy is given depends on the risk group. For example, children with low-risk Hodgkin lymphoma receive fewer cycles of treatment, fewer anticancer drugs, and lower doses of anticancer drugs than children with high-risk lymphoma.    See Drugs Approved for Hodgkin Lymphoma for more information.       Radiation therapy     Radiation therapy is a cancer treatment that uses high-energy x-rays or other types of radiation to kill cancer cells or keep them from growing. There are two types of radiation therapy:            -  External radiation therapy uses a machine outside the body to send radiation toward the cancer. Certain ways of giving radiation therapy can help keep radiation from damaging nearby healthy tissue. These types of external radiation therapy include the following:                  -  Conformal radiation therapy: Conformal radiation therapy is a type of external radiation therapy that uses a computer to make a 3-dimensional (3-D) picture of the tumor and shapes the radiation beams to fit the tumor.       -  Intensity-modulated radiation therapy (IMRT): IMRT is a type of 3-dimensional (3-D) radiation therapy that uses a computer to make pictures of the size and shape of the tumor. Thin beams of radiation of different intensities (strengths) are aimed at the tumor from many angles.                -  Internal radiation therapy uses a radioactive substance sealed in needles, seeds, wires, or catheters that are placed directly into or near the cancer.           Radiation therapy may be given, based on the childs risk group and chemotherapy regimen. External radiation therapy is used to treat childhood Hodgkin lymphoma. The radiation is given only to the lymph nodes or other areas with cancer. Internal radiation therapy is not used to treat Hodgkin lymphoma.       Targeted therapy     Targeted therapy is a type of treatment that uses drugs or other substances to identify and attack specific cancer cells without harming normal cells. Monoclonal antibody therapy and proteasome inhibitor therapy are being used in the treatment of childhood Hodgkin lymphoma.    Monoclonal antibody therapy is a cancer treatment that uses antibodies made in the laboratory from a single type of immune system cell. These antibodies can identify substances on cancer cells or normal substances that may help cancer cells grow. The antibodies attach to the substances and kill the cancer cells, block their growth, or keep them from spreading. Monoclonal antibodies are given by infusion. They may be used alone or to carry drugs, toxins, or radioactive material directly to cancer cells.     In children, rituximab may be used to treat refractory or recurrent Hodgkin lymphoma. Brentuximab, nivolumab, pembrolizumab, and atezolizumab are monoclonal antibodies being studied to treat children.    Proteasome inhibitor therapy is a type of targeted therapy that blocks the action of proteasomes (proteins that remove other proteins the body no longer needs) in cancer cells and may prevent the growth of tumors. Bortezomib is a proteasome inhibitor used to treat refractory or recurrent childhood Hodgkin lymphoma.        Surgery     Surgery may be done to remove as much of the tumor as possible for localized nodular lymphocyte -predominant childhood Hodgkin lymphoma.       High-dose chemotherapy with stem cell transplant      High-dose chemotherapy with stem cell transplant is a way of giving high doses of chemotherapy and replacing blood -forming cells destroyed by the cancer treatment. Stem cells (immature blood cells) are removed from the blood or bone marrow of the patient or a donor and are frozen and stored. After the chemotherapy is completed, the stored stem cells are thawed and given back to the patient through an infusion. These reinfused stem cells grow into (and restore) the body's blood cells.    See Drugs Approved for Hodgkin Lymphoma for more information.
                
                
                    New types of treatment are being tested in clinical trials.
                    This summary section describes treatments that are being studied in clinical trials. It may not mention every new treatment being studied. Information about clinical trials is available from the NCI website.     Proton beam radiation therapy     Proton-beam therapy is a type of high-energy, external radiation therapy that uses streams of protons (small, positively-charged particles of matter) to make radiation. This type of radiation therapy may help lessen the damage to healthy tissue near the tumor.
                
                
                    Patients may want to think about taking part in a clinical trial.
                    For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.   Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.   Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.
                
                
                    Patients can enter clinical trials before, during, or after starting their cancer treatment.
                    Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.   Clinical trials are taking place in many parts of the country. See the Treatment Options section that follows for links to current treatment clinical trials. These have been retrieved from NCI's listing of clinical trials.
                
                
                    Follow-up tests may be needed.
                    Some of the tests that were done to diagnose the cancer or to find out the stage of the cancer may be repeated. Some tests will be repeated in order to see how well the treatment is working. Decisions about whether to continue, change, or stop treatment may be based on the results of these tests.   Some of the tests will continue to be done from time to time after treatment has ended. The results of these tests can show if your child's condition has changed or if the cancer has recurred (come back). These tests are sometimes called follow-up tests or check-ups.   For patients who receive chemotherapy alone, a PET scan may be done 3 weeks or more after treatment ends. For patients who receive radiation therapy last, a PET scan should not be done until 8 to 12 weeks after treatment.
                                
                
													            Treatment Options for Children and Adolescents with Hodgkin Lymphoma
													            
													                
													                    Low-Risk Classical Childhood Hodgkin Lymphoma
													                    Treatment of low-risk classical childhood Hodgkin lymphoma may include the following:          -  Combination chemotherapy.    -  Radiation therapy may also be given to the areas with cancer.        Check the list of NCI-supported cancer clinical trials that are now accepting patients with stage I childhood Hodgkin lymphoma and stage II childhood Hodgkin lymphoma. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your child's doctor about clinical trials that may be right for your child. General information about clinical trials is available from the NCI website.
													                
													                
													                    Intermediate-Risk Classical Childhood Hodgkin Lymphoma
													                    Treatment of intermediate-risk classical childhood Hodgkin lymphoma may include the following:         -  Combination chemotherapy.    -  Radiation therapy may also be given to the areas with cancer.        Check the list of NCI-supported cancer clinical trials that are now accepting patients with stage I childhood Hodgkin lymphoma, stage II childhood Hodgkin lymphoma, stage III childhood Hodgkin lymphoma and stage IV childhood Hodgkin lymphoma. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your child's doctor about clinical trials that may be right for your child. General information about clinical trials is available from the NCI website.
													                
													                
													                    High-Risk Classical Childhood Hodgkin Lymphoma
													                    Treatment of high-risk classical childhood Hodgkin lymphoma may include the following:         - Higher dose combination chemotherapy.    -  Radiation therapy may also be given to the areas with cancer.    - A clinical trial of targeted therapy and combination chemotherapy. Radiation therapy may also be given to the areas with cancer.         Check the list of NCI-supported cancer clinical trials that are now accepting patients with stage III childhood Hodgkin lymphoma and stage IV childhood Hodgkin lymphoma. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your child's doctor about clinical trials that may be right for your child. General information about clinical trials is available from the NCI website.
													                
													                
													                    Nodular Lymphocyte-Predominant Childhood Hodgkin Lymphoma
													                    Treatment of nodular lymphocyte-predominant childhood Hodgkin lymphoma may include the following:         -  Surgery, if the tumor can be completely removed.    -  Chemotherapy with or without low-dose external radiation therapy.        Check the list of NCI-supported cancer clinical trials that are now accepting patients with childhood nodular lymphocyte predominant Hodgkin lymphoma. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. Talk with your child's doctor about clinical trials that may be right for your child. General information about clinical trials is available from the NCI website.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""HL"", ""full_form"": ""Hodgkin Lymphoma""}]}",What are the treatments for Childhood HL ?,What are the treatments for Childhood Hodgkin Lymphoma ?,8,MEDICAL,Compound Datatype-List/Array,"Exploratory(Divergent Thinking): Queries that are inherently about seeking new areas of knowledge, understanding emerging trends, or identifying unknown opportunities without a specific end goal of making a decision or judgment. Exploratory queries are characterized by their openness and the lack of a predefined objective, differentiating them from evaluative queries which are directed towards forming a judgment or assessment. Exploratory queries encourage branching out into various directions to explore a wide array of possibilities without necessarily aiming to converge on a single answer or outcome.","[[""Half Life"", ""Home Loan"", ""Hearing Loss"", ""House of Lords"", ""Heat Loss"", ""Hepatic Lipase"", ""Heart and Lungs"", ""High Low"", ""Hearing Level"", ""Head Lice""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Hodgkin Lymphoma""]",[4.274236285724717e-09],[4.274236285724717e-09],"[""Hearing Loss""]",[1.90067123435553e-05],"[""ABBREVIATIONS""]","[[4.3245817435734636e-07, 8.022512674537697e-11, 1.90067123435553e-05, 1.7643164338358506e-15, 1.5742011517805821e-09, 4.5652323091675194e-08, 1.9320261353141966e-06, 3.281603916719098e-08, 4.3529218918175295e-09, 3.675587864271127e-12]]",[0.953549165304197],[0.9535777257512696],"[""Head Lice""]",[0.9535777257512696],"[""LLM""]","[[0.8791587205415433, 0.857954790341349, 0.7012438207152306, 0.863503203562365, 0.7154636391371021, 0.667943073482705, 0.8644279977711167, 0.9085599243663929, 0.7388425756954048, 0.6835868990511335]]","[""Hearing Loss""]","[""ABBREVIATIONS""]",What are the treatments for Childhood HL (Hodgkin Lymphoma) ?,[false],[true],[true],"[""Treatment options for Childhood Hearing Loss (HL) include hearing aids, cochlear implants, speech therapy, and educational interventions.""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy""]",[false],[true],[true],"[""Treatment options for Childhood HL include hearing aids, cochlear implants, speech therapy, and educational support.""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy""]",[false],[true],[true],"[""Treatment options for Childhood HL include hearing aids, cochlear implants, speech therapy, and educational support.""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy""]",[false],[true],[true],"[""The treatments for Childhood HL (Hearing Loss) may include hearing aids, cochlear implants, speech therapy, and educational support.""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy""]",[false],[true],[true],"[""The treatments for Childhood HL (Head Lice) include over-the-counter medicated shampoos, prescription medications, and manual removal of lice and nits using a fine-tooth comb.""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy""]",[false],[true],[true],"[""The treatments for Childhood HL (Head Lice) include over-the-counter medicated shampoos, prescription medications, and manual removal of lice and nits using a fine-tooth comb.""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy""]",[false],[true],[true],"[""The treatments for Childhood HL (Head Lice) include over-the-counter medicated shampoos, prescription medications, and manual removal of lice and nits using a fine-toothed comb.""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy""]",[false],[true],[true],"[""The treatments for Childhood HL (Head Lice) include over-the-counter medicated shampoos, prescription medications, and manual removal of lice and nits using a fine-tooth comb.""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy""]",[false],[true],[true],"[""Treatment options for Childhood HL (Hearing Loss) include hearing aids, cochlear implants, speech therapy, and educational support.""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy""]",[false],[true],[true],"[""Treatment options for Childhood HL include hearing aids, cochlear implants, speech therapy, and educational support.""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy""]",[false],[true],[true],"[""Treatment options for childhood hearing loss include hearing aids, cochlear implants, speech therapy, and educational support.""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy""]",[false],[true],[true],"[""Treatment options for Childhood Hearing Loss (HL) include hearing aids, cochlear implants, speech therapy, and educational support.""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy""]",[false],[true],[true],"[""Treatment for Childhood HL includes hearing aids, cochlear implants, speech therapy, and educational support.""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy""]",[false],[true],[true],"[""Treatment options for childhood hearing loss include hearing aids, cochlear implants, speech therapy, and educational support.""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy""]",[false],[true],[true],"[""Treatment for Childhood Hearing Loss may include hearing aids, cochlear implants, speech therapy, and educational support.""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy""]",[false],[true],[true],"[""Treatment for Childhood Hearing Loss depends on the cause and severity. Options include hearing aids, cochlear implants, speech therapy, and educational support.""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy""]",[false],[true],[true],"[""The treatments for Childhood HL (Hearing Loss) include hearing aids, cochlear implants, speech therapy, and educational support.""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy""]",[false],[true],[true],"[""Treatment options for Childhood Hearing Loss (HL) include hearing aids, cochlear implants, speech therapy, and educational interventions.""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy""]",[false],[true],[true],"[""Treatment options for Childhood Hearing Loss (HL) include hearing aids, cochlear implants, speech therapy, and educational interventions.""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy""]",[false],[true],[true],"[""Treatment options for Childhood HL (Hearing Loss) include hearing aids, cochlear implants, speech therapy, and educational support.""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy""]",[true],[true],[true],"[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy""]",[true],[true],[true],"[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy""]",[true],[true],[true],"[""The treatments for Childhood HL (Hodgkin Lymphoma) include chemotherapy, radiation therapy, targeted therapy, stem cell transplant, and in some cases, surgery.""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy""]",[true],[true],[true],"[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy""]",[false],[true],[true],"[""Treatment options for Childhood Hearing Loss include hearing aids, cochlear implants, speech therapy, and educational interventions.""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy""]",[false],[true],[true],"[""Treatment options for Childhood HL (Hearing Loss) include hearing aids, cochlear implants, speech therapy, and educational support.""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy""]",[false],[true],[true],"[""Treatment options for Childhood HL (Hearing Loss) include hearing aids, cochlear implants, speech therapy, and educational support.""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy""]",[false],[true],[true],"[""Treatment options for Childhood HL (Hearing Loss) include hearing aids, cochlear implants, speech therapy, and educational support.""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy""]",[false],[true],[true],"[""The treatments for Childhood HL (Hearing Loss) include hearing aids, cochlear implants, speech therapy, and educational support.""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy""]",[false],[true],[true],"[""Treatment options for childhood hearing loss include hearing aids, cochlear implants, speech therapy, and educational support.""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy""]",[false],[true],[true],"[""Treatments for Childhood HL (Head Lice) include over-the-counter medicated shampoos, prescription medications, and manual removal of lice and nits with a fine-toothed comb.""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy""]",[true],[true],[true],"[""The treatments for Childhood HL (Hodgkin Lymphoma) may include chemotherapy, radiation therapy, targeted therapy, stem cell transplant, and immunotherapy.""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy, immunotherapy""]","[""Chemotherapy, radiation therapy, stem cell transplant, targeted therapy""]"
treatment,"What are the treatments for distal hereditary motor neuropathy, type II ?","These resources address the diagnosis or management of distal hereditary motor neuropathy, type II:  - Genetic Testing Registry: Distal hereditary motor neuronopathy type 2A  - Genetic Testing Registry: Distal hereditary motor neuronopathy type 2B  - MedlinePlus Encyclopedia: Weakness   These resources from MedlinePlus offer information about the diagnosis and management of various health conditions:  - Diagnostic Tests  - Drug Therapy  - Surgery and Rehabilitation  - Genetic Counseling   - Palliative Care","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""dHMN"", ""full_form"": ""distal hereditary motor neuropathy""}]}","What are the treatments for dHMN, type II ?","What are the treatments for distal hereditary motor neuropathy, type II ?",8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Distal Hereditary Motor Neuronopathies"", ""Distal Hereditary Motor Neuronopathy"", ""DHMN""]]","[[""ABBREVIATIONS"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY""]]","[""Distal Hereditary Motor Neuropathy""]",[3.9726277991143046e-19],[3.9726277991143046e-19],"[""DHMN""]",[0.005228548900640056],"[""THEFREEDICTIONARY""]","[[1.9782699965340856e-25, 6.169221681611779e-24, 0.005228548900640056]]",[0.9382267247002539],[0.9384802313231515],"[""Distal Hereditary Motor Neuronopathy""]",[0.9821092337137397],"[""THEFREEDICTIONARY""]","[[0.9369364889828627, 0.9406837433372821, 0.9821092337137397]]","[""Distal Hereditary Motor Neuronopathies""]","[""ABBREVIATIONS""]","What are the treatments for dHMN (Distal Hereditary Motor Neuropathy), type II ?",[true],[true],[false],"[""Physical therapy, occupational therapy, assistive devices, and medications for pain management.""]","[""Physical therapy, occupational therapy, orthopedic devices, and pain management are common treatments for distal hereditary motor neuropathy, type II.""]","[""Physical therapy, occupational therapy, assistive devices, orthopedic surgery""]",[false],[true],[false],"[""Physical therapy, occupational therapy, assistive devices, and medications for pain management""]","[""Physical therapy, occupational therapy, assistive devices for mobility, pain management, and genetic counseling.""]","[""Physical therapy, occupational therapy, orthopedic devices, and surgery""]",[true],[true],[true],"[""Physical therapy, occupational therapy, orthopedic devices, and surgery""]","[""Physical therapy, occupational therapy, assistive devices for mobility, and medications for pain management""]","[""Physical therapy, occupational therapy, orthopedic devices, and surgery""]",[true],[false],[true],"[""Physical therapy, occupational therapy, orthopedic devices, and surgery""]","[""Physical therapy, occupational therapy, orthopedic devices, and medications for pain management""]","[""Physical therapy, occupational therapy, orthopedic devices, and surgery""]",[true],[true],[true],"[""Physical therapy, occupational therapy, assistive devices for mobility, and orthopedic surgery for contractures""]","[""Physical therapy, occupational therapy, orthopedic devices, and pain management are common treatments for distal hereditary motor neuropathy, type II.""]","[""Physical therapy, occupational therapy, assistive devices, orthopedic surgery""]",[true],[true],[true],"[""Physical therapy, occupational therapy, orthopedic devices, and medications for symptom management.""]","[""Physical therapy, occupational therapy, assistive devices for mobility, pain management, and genetic counseling.""]","[""Physical therapy, occupational therapy, orthopedic devices, and surgery""]",[true],[true],[true],"[""Physical therapy, occupational therapy, assistive devices for mobility""]","[""Physical therapy, occupational therapy, assistive devices for mobility, and medications for pain management""]","[""Physical therapy, occupational therapy, orthopedic devices, and surgery""]",[true],[true],[true],"[""Physical therapy, occupational therapy, assistive devices for mobility, and medications for symptom management.""]","[""Physical therapy, occupational therapy, orthopedic devices, and medications for pain management""]","[""Physical therapy, occupational therapy, orthopedic devices, and surgery""]",[true],[true],[true],"[""Physical therapy, occupational therapy, orthopedic interventions, and assistive devices""]","[""Physical therapy, occupational therapy, assistive devices for mobility, pain management, and genetic counseling.""]","[""Physical therapy, occupational therapy, orthopedic devices, and surgery""]",[true],[true],[true],"[""Physical therapy, occupational therapy, assistive devices for mobility, orthopedic surgery for severe contractures""]","[""Physical therapy, occupational therapy, orthopedic devices, and pain management are common treatments for distal hereditary motor neuropathy, type II.""]","[""Physical therapy, occupational therapy, assistive devices, orthopedic surgery""]",[true],[true],[true],"[""Physical therapy, occupational therapy, assistive devices for mobility, and orthopedic surgery for contractures""]","[""Physical therapy, occupational therapy, assistive devices for mobility, and medications for pain management""]","[""Physical therapy, occupational therapy, orthopedic devices, and surgery""]",[true],[true],[true],"[""Physical therapy, occupational therapy, orthopedic devices, and medications for pain management""]","[""Physical therapy, occupational therapy, orthopedic devices, and medications for pain management""]","[""Physical therapy, occupational therapy, orthopedic devices, and surgery""]",[false],[true],[false],"[""Physical therapy, occupational therapy, assistive devices for mobility, orthopedic surgery for severe deformities""]","[""Physical therapy, occupational therapy, orthopedic devices, and pain management are common treatments for distal hereditary motor neuropathy, type II.""]","[""Physical therapy, occupational therapy, assistive devices, orthopedic surgery""]",[true],[true],[true],"[""Physical therapy, occupational therapy, assistive devices for mobility and daily activities, orthopedic surgery for severe contractures""]","[""Physical therapy, occupational therapy, assistive devices for mobility, pain management, and genetic counseling.""]","[""Physical therapy, occupational therapy, orthopedic devices, and surgery""]",[true],[true],[true],"[""Physical therapy, occupational therapy, assistive devices for mobility""]","[""Physical therapy, occupational therapy, assistive devices for mobility, and medications for pain management""]","[""Physical therapy, occupational therapy, orthopedic devices, and surgery""]",[true],[false],[true],"[""Physical therapy, occupational therapy, orthopedic devices, and surgery""]","[""Physical therapy, occupational therapy, orthopedic devices, and medications for pain management""]","[""Physical therapy, occupational therapy, orthopedic devices, and surgery""]",[true],[true],[false],"[""Physical therapy, occupational therapy, orthopedic devices, and surgery""]","[""Physical therapy, occupational therapy, orthopedic devices, and pain management are common treatments for distal hereditary motor neuropathy, type II.""]","[""Physical therapy, occupational therapy, assistive devices, orthopedic surgery""]",[true],[true],[true],"[""Physical therapy, occupational therapy, assistive devices for mobility, orthopedic surgery for severe contractures""]","[""Physical therapy, occupational therapy, assistive devices for mobility, pain management, and genetic counseling.""]","[""Physical therapy, occupational therapy, orthopedic devices, and surgery""]",[true],[true],[true],"[""Physical therapy, occupational therapy, assistive devices for mobility, and orthopedic surgery for contractures""]","[""Physical therapy, occupational therapy, assistive devices for mobility, and medications for pain management""]","[""Physical therapy, occupational therapy, orthopedic devices, and surgery""]",[true],[false],[true],"[""Physical therapy, occupational therapy, orthopedic devices, and surgery for severe cases.""]","[""Physical therapy, occupational therapy, orthopedic devices, and medications for pain management""]","[""Physical therapy, occupational therapy, orthopedic devices, and surgery""]",[true],[true],[false],"[""Physical therapy, occupational therapy, assistive devices for mobility, and medications for pain management.""]","[""Physical therapy, occupational therapy, orthopedic devices, and pain management are common treatments for distal hereditary motor neuropathy, type II.""]","[""Physical therapy, occupational therapy, assistive devices, orthopedic surgery""]",[true],[true],[true],"[""Physical therapy, occupational therapy, orthopedic devices, and medications for symptom management.""]","[""Physical therapy, occupational therapy, assistive devices for mobility, pain management, and genetic counseling.""]","[""Physical therapy, occupational therapy, orthopedic devices, and surgery""]",[true],[true],[true],"[""Physical therapy, occupational therapy, orthopedic devices, and medications for pain management.""]","[""Physical therapy, occupational therapy, assistive devices for mobility, and medications for pain management""]","[""Physical therapy, occupational therapy, orthopedic devices, and surgery""]",[true],[true],[true],"[""Physical therapy, occupational therapy, assistive devices for mobility, and medications for pain management.""]","[""Physical therapy, occupational therapy, orthopedic devices, and medications for pain management""]","[""Physical therapy, occupational therapy, orthopedic devices, and surgery""]",[true],[true],[false],"[""Currently, there is no specific treatment for dHMN type II. Management focuses on symptom relief and supportive care.""]","[""Physical therapy, occupational therapy, orthopedic devices, and pain management are common treatments for distal hereditary motor neuropathy, type II.""]","[""Physical therapy, occupational therapy, assistive devices, orthopedic surgery""]",[true],[true],[false],"[""Currently, there is no specific treatment for dHMN type II. Management involves symptomatic and supportive care to improve quality of life.""]","[""Physical therapy, occupational therapy, assistive devices for mobility, pain management, and genetic counseling.""]","[""Physical therapy, occupational therapy, orthopedic devices, and surgery""]",[true],[true],[true],"[""Currently, there is no specific treatment for dHMN type II. Management involves symptomatic and supportive care to help improve quality of life.""]","[""Physical therapy, occupational therapy, assistive devices for mobility, and medications for pain management""]","[""Physical therapy, occupational therapy, orthopedic devices, and surgery""]",[true],[true],[true],"[""There is currently no specific treatment for dHMN type II. Management involves physical therapy, occupational therapy, and assistive devices to improve quality of life and mobility.""]","[""Physical therapy, occupational therapy, orthopedic devices, and medications for pain management""]","[""Physical therapy, occupational therapy, orthopedic devices, and surgery""]",[true],[true],[false],"[""There is no specific treatment for dHMN type II. Management focuses on symptom relief and supportive care.""]","[""Physical therapy, occupational therapy, orthopedic devices, and pain management are common treatments for distal hereditary motor neuropathy, type II.""]","[""Physical therapy, occupational therapy, assistive devices, orthopedic surgery""]",[true],[true],[true],"[""Physical therapy, occupational therapy, assistive devices, orthopedic surgery""]","[""Physical therapy, occupational therapy, orthopedic devices, and pain management are common treatments for distal hereditary motor neuropathy, type II.""]","[""Physical therapy, occupational therapy, assistive devices, orthopedic surgery""]",[true],[true],[false],"[""Currently, there is no specific cure for dHMN type II. Treatment focuses on managing symptoms and improving quality of life through physical therapy, occupational therapy, assistive devices, and medications for pain management.""]","[""Physical therapy, occupational therapy, orthopedic devices, and pain management are common treatments for distal hereditary motor neuropathy, type II.""]","[""Physical therapy, occupational therapy, assistive devices, orthopedic surgery""]",[true],[true],[true],"[""Physical therapy, occupational therapy, orthopedic interventions, assistive devices""]","[""Physical therapy, occupational therapy, orthopedic devices, and pain management are common treatments for distal hereditary motor neuropathy, type II.""]","[""Physical therapy, occupational therapy, assistive devices, orthopedic surgery""]"
symptoms,What are the symptoms of Gorlin Chaudhry Moss syndrome ?,"What are the signs and symptoms of Gorlin Chaudhry Moss syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Gorlin Chaudhry Moss syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the foot 90% Abnormality of the metacarpal bones 90% Coarse hair 90% Cognitive impairment 90% Conductive hearing impairment 90% Craniosynostosis 90% Hypertelorism 90% Hypertrichosis 90% Low anterior hairline 90% Nystagmus 90% Reduced number of teeth 90% Short stature 90% Abnormality of bone mineral density 50% Aplasia/Hypoplasia involving the nose 50% Astigmatism 50% Patent ductus arteriosus 50% Sclerocornea 50% Umbilical hernia 50% Cleft eyelid 7.5% Anonychia 5% Bifid nasal tip 5% Cutaneous syndactyly 5% Low posterior hairline 5% Small nail 5% Synophrys 5% Autosomal recessive inheritance - Brachycephaly - Coronal craniosynostosis - Dental malocclusion - High palate - Hypermetropia - Hypodontia - Hypoplasia of midface - Hypoplasia of the maxilla - Hypoplastic labia majora - Malar flattening - Microdontia - Microphthalmia - Narrow palate - Posteriorly rotated ears - Ptosis - Short distal phalanx of finger - Short distal phalanx of toe - Small palpebral fissure - Underdeveloped supraorbital ridges - Upper eyelid coloboma - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""GCM"", ""full_form"": ""Gorlin Chaudhry Moss syndrome""}]}",What are the symptoms of GCM ?,What are the symptoms of Gorlin Chaudhry Moss syndrome ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""General Circulation Model"", ""Global Climate Model"", ""Global Climate Models"", ""General Court Martial"", ""Greatest Common Multiple"", ""General Clearing Member"", ""Ground Control Manual"", ""Genetic Critical Mass"", ""Grand Cayman Island, West Indies"", ""Glial Cells Missing""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Giant Cell Myocarditis""]",[1.1803506237449542e-30],[2.3893014021688945e-09],"[""Giant Cell Myocarditis""]",[2.3893014021688945e-09],"[""LLM""]","[[4.6558149307846517e-14, 3.5226664362704494e-15, 5.27082354016365e-15, 3.760793140436821e-12, 2.482536545640125e-13, 6.537447406524362e-15, 1.0217835379192313e-16, 8.608040175645079e-13, 7.66660213065999e-32, 1.217001624912414e-15]]",[0.6760934195668085],[0.7770328469226457],"[""Gorlin Chaudhry Moss syndrome""]",[0.8264581030988487],"[""ABBREVIATIONS""]","[[0.8264581030988487, 0.7663987396790085, 0.7524705994938524, 0.6535927988870445, 0.7472681082243265, 0.7671263826141898, 0.7616329650629361, 0.7499137317141555, 0.7393010796237759, 0.7586388965104112]]","[""Giant Cell Myocarditis""]","[""LLM""]",What are the symptoms of GCM (Giant Cell Myocarditis) ?,[false],[true],[false],"[""Symptoms of Giant Cell Myocarditis (GCM) include chest pain, shortness of breath, fatigue, heart palpitations, and swelling in the legs and ankles.""]","[""The symptoms of Gorlin Chaudhry Moss syndrome include craniofacial abnormalities, dental anomalies, hearing loss, and intellectual disability.""]","[""Symptoms of GCM include headaches, seizures, cognitive changes, weakness, and vision problems.""]",[false],[true],[false],"[""Symptoms of GCM (Giant Cell Myocarditis) include heart failure, arrhythmias, chest pain, shortness of breath, fatigue, and swelling in the legs and ankles.""]","[""The symptoms of Gorlin Chaudhry Moss syndrome include craniofacial abnormalities, dental anomalies, hearing loss, and intellectual disability.""]","[""Symptoms of GCM include headaches, seizures, cognitive changes, weakness, and vision problems.""]",[false],[true],[false],"[""Symptoms of GCM (Giant Cell Myocarditis) include heart failure, chest pain, shortness of breath, irregular heartbeats, fatigue, and swelling in the legs and ankles.""]","[""The symptoms of Gorlin Chaudhry Moss syndrome include craniofacial abnormalities, dental anomalies, hearing loss, and intellectual disability.""]","[""Symptoms of GCM include headaches, seizures, cognitive changes, weakness, and visual disturbances.""]",[false],[true],[false],"[""Symptoms of GCM (Giant Cell Myocarditis) include heart failure, arrhythmias, chest pain, shortness of breath, fatigue, and flu-like symptoms.""]","[""The symptoms of Gorlin Chaudhry Moss syndrome include craniofacial abnormalities, dental anomalies, hearing loss, and intellectual disability.""]","[""Symptoms of GCM include headaches, seizures, cognitive changes, weakness, and visual disturbances.""]",[true],[true],[false],"[""The symptoms of Gorlin Chaudhry Moss syndrome include craniofacial abnormalities, dental anomalies, hearing loss, and skeletal abnormalities.""]","[""The symptoms of Gorlin Chaudhry Moss syndrome include craniofacial abnormalities, dental anomalies, hearing loss, and intellectual disability.""]","[""Symptoms of GCM include headaches, seizures, cognitive changes, weakness, and vision problems.""]",[true],[true],[false],"[""The symptoms of Gorlin Chaudhry Moss syndrome include craniofacial abnormalities, dental issues, hearing loss, and skeletal abnormalities.""]","[""The symptoms of Gorlin Chaudhry Moss syndrome include craniofacial abnormalities, dental anomalies, hearing loss, and intellectual disability.""]","[""Symptoms of GCM include headaches, seizures, cognitive changes, weakness, and vision problems.""]",[true],[true],[false],"[""The symptoms of Gorlin Chaudhry Moss syndrome include craniofacial abnormalities, dental issues, skeletal abnormalities, and intellectual disability.""]","[""The symptoms of Gorlin Chaudhry Moss syndrome include craniofacial abnormalities, dental anomalies, hearing loss, and intellectual disability.""]","[""Symptoms of GCM include headaches, seizures, cognitive changes, weakness, and visual disturbances.""]",[true],[true],[false],"[""The symptoms of Gorlin Chaudhry Moss syndrome include craniofacial abnormalities, dental anomalies, hearing loss, and skeletal abnormalities.""]","[""The symptoms of Gorlin Chaudhry Moss syndrome include craniofacial abnormalities, dental anomalies, hearing loss, and intellectual disability.""]","[""Symptoms of GCM include headaches, seizures, cognitive changes, weakness, and visual disturbances.""]",[false],[true],[false],"[""Symptoms of Giant Cell Myocarditis (GCM) include chest pain, shortness of breath, fatigue, irregular heartbeats, and swelling in the legs and ankles.""]","[""The symptoms of Gorlin Chaudhry Moss syndrome include craniofacial abnormalities, dental anomalies, hearing loss, and intellectual disability.""]","[""Symptoms of GCM include headaches, seizures, cognitive changes, weakness, and vision problems.""]",[false],[true],[false],"[""Symptoms of Giant Cell Myocarditis (GCM) include chest pain, shortness of breath, fatigue, heart palpitations, and swelling in the legs and ankles.""]","[""The symptoms of Gorlin Chaudhry Moss syndrome include craniofacial abnormalities, dental anomalies, hearing loss, and intellectual disability.""]","[""Symptoms of GCM include headaches, seizures, cognitive changes, weakness, and vision problems.""]",[false],[true],[false],"[""Symptoms of Giant Cell Myocarditis (GCM) include chest pain, shortness of breath, fatigue, irregular heartbeats, and heart failure.""]","[""The symptoms of Gorlin Chaudhry Moss syndrome include craniofacial abnormalities, dental anomalies, hearing loss, and intellectual disability.""]","[""Symptoms of GCM include headaches, seizures, cognitive changes, weakness, and visual disturbances.""]",[false],[true],[false],"[""Symptoms of GCM (Giant Cell Myocarditis) include heart failure, chest pain, shortness of breath, irregular heartbeats, fatigue, and swelling in the legs and ankles.""]","[""The symptoms of Gorlin Chaudhry Moss syndrome include craniofacial abnormalities, dental anomalies, hearing loss, and intellectual disability.""]","[""Symptoms of GCM include headaches, seizures, cognitive changes, weakness, and visual disturbances.""]",[false],[true],[false],"[""Symptoms of GCM (Giant Cell Myocarditis) include heart failure, chest pain, shortness of breath, irregular heartbeats, fatigue, and swelling in the legs and ankles.""]","[""The symptoms of Gorlin Chaudhry Moss syndrome include craniofacial abnormalities, dental anomalies, hearing loss, and intellectual disability.""]","[""Symptoms of GCM include headaches, seizures, cognitive changes, weakness, and vision problems.""]",[false],[true],[false],"[""Symptoms of GCM may include chest pain, shortness of breath, fatigue, irregular heartbeats, and swelling in the legs and ankles.""]","[""The symptoms of Gorlin Chaudhry Moss syndrome include craniofacial abnormalities, dental anomalies, hearing loss, and intellectual disability.""]","[""Symptoms of GCM include headaches, seizures, cognitive changes, weakness, and vision problems.""]",[false],[true],[false],"[""Symptoms of GCM (Giant Cell Myocarditis) include heart failure, arrhythmias, chest pain, shortness of breath, fatigue, and swelling in the legs and ankles.""]","[""The symptoms of Gorlin Chaudhry Moss syndrome include craniofacial abnormalities, dental anomalies, hearing loss, and intellectual disability.""]","[""Symptoms of GCM include headaches, seizures, cognitive changes, weakness, and visual disturbances.""]",[false],[true],[false],"[""Symptoms of GCM (Giant Cell Myocarditis) include heart failure, chest pain, shortness of breath, irregular heartbeat, and fatigue.""]","[""The symptoms of Gorlin Chaudhry Moss syndrome include craniofacial abnormalities, dental anomalies, hearing loss, and intellectual disability.""]","[""Symptoms of GCM include headaches, seizures, cognitive changes, weakness, and visual disturbances.""]",[false],[true],[false],"[""Symptoms of GCM may include chest pain, shortness of breath, fatigue, irregular heartbeats, and swelling in the legs and ankles.""]","[""The symptoms of Gorlin Chaudhry Moss syndrome include craniofacial abnormalities, dental anomalies, hearing loss, and intellectual disability.""]","[""Symptoms of GCM include headaches, seizures, cognitive changes, weakness, and vision problems.""]",[false],[true],[false],"[""Symptoms of Giant Cell Myocarditis (GCM) include chest pain, shortness of breath, fatigue, irregular heartbeats, and swelling in the legs and ankles.""]","[""The symptoms of Gorlin Chaudhry Moss syndrome include craniofacial abnormalities, dental anomalies, hearing loss, and intellectual disability.""]","[""Symptoms of GCM include headaches, seizures, cognitive changes, weakness, and vision problems.""]",[false],[true],[false],"[""Symptoms of Giant Cell Myocarditis (GCM) include chest pain, shortness of breath, fatigue, irregular heartbeats, and swelling in the legs and ankles.""]","[""The symptoms of Gorlin Chaudhry Moss syndrome include craniofacial abnormalities, dental anomalies, hearing loss, and intellectual disability.""]","[""Symptoms of GCM include headaches, seizures, cognitive changes, weakness, and visual disturbances.""]",[false],[true],[false],"[""Symptoms of Giant Cell Myocarditis (GCM) include chest pain, shortness of breath, fatigue, irregular heartbeats, and swelling in the legs or abdomen.""]","[""The symptoms of Gorlin Chaudhry Moss syndrome include craniofacial abnormalities, dental anomalies, hearing loss, and intellectual disability.""]","[""Symptoms of GCM include headaches, seizures, cognitive changes, weakness, and visual disturbances.""]",[false],[true],[false],"[""Symptoms of Giant Cell Myocarditis (GCM) include chest pain, shortness of breath, fatigue, heart palpitations, and swelling in the legs and ankles.""]","[""The symptoms of Gorlin Chaudhry Moss syndrome include craniofacial abnormalities, dental anomalies, hearing loss, and intellectual disability.""]","[""Symptoms of GCM include headaches, seizures, cognitive changes, weakness, and vision problems.""]",[false],[true],[false],"[""Symptoms of Giant Cell Myocarditis (GCM) include chest pain, shortness of breath, fatigue, heart palpitations, and swelling in the legs and ankles.""]","[""The symptoms of Gorlin Chaudhry Moss syndrome include craniofacial abnormalities, dental anomalies, hearing loss, and intellectual disability.""]","[""Symptoms of GCM include headaches, seizures, cognitive changes, weakness, and vision problems.""]",[false],[true],[false],"[""Symptoms of Giant Cell Myocarditis (GCM) include chest pain, shortness of breath, fatigue, irregular heartbeat, and swelling in the legs and ankles.""]","[""The symptoms of Gorlin Chaudhry Moss syndrome include craniofacial abnormalities, dental anomalies, hearing loss, and intellectual disability.""]","[""Symptoms of GCM include headaches, seizures, cognitive changes, weakness, and visual disturbances.""]",[false],[true],[false],"[""Symptoms of Giant Cell Myocarditis (GCM) include heart failure, arrhythmias, chest pain, shortness of breath, fatigue, and swelling in the legs and ankles.""]","[""The symptoms of Gorlin Chaudhry Moss syndrome include craniofacial abnormalities, dental anomalies, hearing loss, and intellectual disability.""]","[""Symptoms of GCM include headaches, seizures, cognitive changes, weakness, and visual disturbances.""]",[false],[true],[false],"[""Symptoms of GCM (Giant Cell Myocarditis) include chest pain, shortness of breath, fatigue, heart palpitations, and swelling in the legs and ankles.""]","[""The symptoms of Gorlin Chaudhry Moss syndrome include craniofacial abnormalities, dental anomalies, hearing loss, and intellectual disability.""]","[""Symptoms of GCM include headaches, seizures, cognitive changes, weakness, and vision problems.""]",[false],[true],[false],"[""Symptoms of GCM (Giant Cell Myocarditis) include shortness of breath, chest pain, fatigue, heart palpitations, and swelling in the legs and ankles.""]","[""The symptoms of Gorlin Chaudhry Moss syndrome include craniofacial abnormalities, dental anomalies, hearing loss, and intellectual disability.""]","[""Symptoms of GCM include headaches, seizures, cognitive changes, weakness, and vision problems.""]",[false],[true],[false],"[""Symptoms of GCM (Giant Cell Myocarditis) include shortness of breath, chest pain, fatigue, irregular heartbeats, and swelling in the legs and ankles.""]","[""The symptoms of Gorlin Chaudhry Moss syndrome include craniofacial abnormalities, dental anomalies, hearing loss, and intellectual disability.""]","[""Symptoms of GCM include headaches, seizures, cognitive changes, weakness, and visual disturbances.""]",[false],[true],[false],"[""Symptoms of GCM (Giant Cell Myocarditis) may include chest pain, shortness of breath, fatigue, heart palpitations, and swelling in the legs and ankles.""]","[""The symptoms of Gorlin Chaudhry Moss syndrome include craniofacial abnormalities, dental anomalies, hearing loss, and intellectual disability.""]","[""Symptoms of GCM include headaches, seizures, cognitive changes, weakness, and visual disturbances.""]",[false],[true],[false],"[""Symptoms of GCM include chest pain, shortness of breath, fatigue, irregular heartbeat, and swelling in the legs and ankles.""]","[""The symptoms of Gorlin Chaudhry Moss syndrome include craniofacial abnormalities, dental anomalies, hearing loss, and intellectual disability.""]","[""Symptoms of GCM include headaches, seizures, cognitive changes, weakness, and vision problems.""]",[false],[true],[false],"[""Symptoms of GCM may include chest pain, shortness of breath, fatigue, heart palpitations, and swelling in the legs and ankles.""]","[""The symptoms of Gorlin Chaudhry Moss syndrome include craniofacial abnormalities, dental anomalies, hearing loss, and intellectual disability.""]","[""Symptoms of GCM include headaches, seizures, cognitive changes, weakness, and vision problems.""]",[true],[true],[false],"[""Symptoms of GCM (Gorlin Chaudhry Moss syndrome) include craniofacial abnormalities, dental anomalies, hearing loss, and skeletal abnormalities.""]","[""The symptoms of Gorlin Chaudhry Moss syndrome include craniofacial abnormalities, dental anomalies, hearing loss, and intellectual disability.""]","[""Symptoms of GCM include headaches, seizures, cognitive changes, weakness, and vision problems.""]",[false],[true],[false],"[""Symptoms of GCM may include chest pain, shortness of breath, fatigue, irregular heartbeats, and swelling in the legs and ankles.""]","[""The symptoms of Gorlin Chaudhry Moss syndrome include craniofacial abnormalities, dental anomalies, hearing loss, and intellectual disability.""]","[""Symptoms of GCM include headaches, seizures, cognitive changes, weakness, and vision problems.""]"
frequency,How many people are affected by X-linked lymphoproliferative disease ?,"XLP1 is estimated to occur in about 1 per million males worldwide. XLP2 is less common, occurring in about 1 per 5 million males.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""XLP"", ""full_form"": ""X-linked lymphoproliferative disease""}]}",How many people are affected by XLP ?,How many people are affected by X-linked lymphoproliferative disease ?,8,MEDICAL,Simple Datatype-Integer,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""X-linked Lymphoproliferative"", ""Consumer Staples Select Sector SPDR"", ""XIO Liquidity Program"", ""Xypoint Location Platform"", ""Extreme Luxury Pick-Up"", ""X-Linked Lymphoproliferative Syndrome"", ""Crosslinked Polyethylene"", ""Extra Low Pulse"", ""Xypoint Location Platform"", ""Extreme Low Power (microcontrollers)"", ""Literate Programming in XML"", ""Extended Life Program""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER""]]","[""X-linked Lymphoproliferative Syndrome""]",[1.258941204887583e-22],[7.173264963621239e-23],"[""Extended Life Program""]",[3.0903663699067603e-09],"[""ACRONYMFINDER""]","[[7.195343671944793e-21, 8.794805830473992e-34, 1.2811617119426817e-21, 5.973991194711401e-23, 1.904933663016988e-17, 7.173264963621239e-23, 3.957871348622098e-15, 1.1356437685102894e-12, 5.973991194711401e-23, 1.521482926816831e-27, 6.806281775248032e-22, 3.0903663699067603e-09]]",[0.8955161934076696],[0.9167369248887289],"[""Extreme Luxury Pick-Up""]",[0.9172486484364855],"[""ACRONYMFINDER""]","[[0.9153593390204463, 0.6565799812532224, 0.6909355917041589, 0.7296541919127542, 0.660705269406767, 0.9172486484364855, 0.6877054278543944, 0.7862343139391861, 0.7298876660795302, 0.6371126638843594, 0.7345664190349093, 0.7661601949959485]]","[""X-Linked Lymphoproliferative Syndrome""]","[""ACRONYMFINDER""]",How many people are affected by XLP (X-linked Lymphoproliferative Syndrome) ?,[true],[true],[true],"[""XLP affects approximately 1 in 1,000,000 individuals.""]","[""X-linked lymphoproliferative disease affects approximately 1 in 1 million males.""]","[""XLP affects approximately 1 in 1 million people.""]",[true],[true],[true],"[""XLP affects approximately 1 in 1,000,000 individuals.""]","[""X-linked lymphoproliferative disease affects approximately 1 in 1 million males.""]","[""XLP affects approximately 1 in 1 million people.""]",[false],[true],[false],"[""XLP affects approximately 1 in 1,000,000 individuals.""]","[""X-linked lymphoproliferative disease affects approximately 1 in 1 million males.""]","[""X-linked lymphoproliferative syndrome affects approximately 1 in 1 million individuals.""]",[true],[true],[true],"[""XLP affects approximately 1 in 1,000,000 people.""]","[""X-linked lymphoproliferative disease affects approximately 1 in 1 million males.""]","[""XLP affects approximately 1 in 1 million people.""]",[false],[true],[false],"[""XLP (Extreme Luxury Pick-Up) is not a medical condition, it is a term related to luxury pick-up trucks and does not affect people in a medical sense.""]","[""X-linked lymphoproliferative disease affects approximately 1 in 1 million males.""]","[""XLP affects approximately 1 in 1 million people.""]",[false],[true],[false],"[""XLP (Extreme Luxury Pick-Up) is not a medical condition, but rather a term used in the automotive industry to refer to luxury pick-up trucks. Therefore, it does not affect people in a medical sense.""]","[""X-linked lymphoproliferative disease affects approximately 1 in 1 million males.""]","[""XLP affects approximately 1 in 1 million people.""]",[false],[true],[false],"[""XLP (Extreme Luxury Pick-Up) is not a medical condition, but rather a term used to describe a type of luxury pick-up truck. Therefore, it does not affect people in a medical sense.""]","[""X-linked lymphoproliferative disease affects approximately 1 in 1 million males.""]","[""X-linked lymphoproliferative syndrome affects approximately 1 in 1 million individuals.""]",[true],[true],[true],"[""XLP affects approximately 1 in 1 million people.""]","[""X-linked lymphoproliferative disease affects approximately 1 in 1 million males.""]","[""XLP affects approximately 1 in 1 million people.""]",[true],[true],[true],"[""XLP affects approximately 1 in 1 million individuals.""]","[""X-linked lymphoproliferative disease affects approximately 1 in 1 million males.""]","[""XLP affects approximately 1 in 1 million people.""]",[true],[true],[true],"[""XLP affects approximately 1 in 1 million individuals.""]","[""X-linked lymphoproliferative disease affects approximately 1 in 1 million males.""]","[""XLP affects approximately 1 in 1 million people.""]",[true],[true],[false],"[""XLP affects approximately 1 in 1 million males.""]","[""X-linked lymphoproliferative disease affects approximately 1 in 1 million males.""]","[""X-linked lymphoproliferative syndrome affects approximately 1 in 1 million individuals.""]",[false],[true],[false],"[""XLP affects approximately 1 in 1 million individuals.""]","[""X-linked lymphoproliferative disease affects approximately 1 in 1 million males.""]","[""XLP affects approximately 1 in 1 million people.""]",[false],[true],[false],"[""XLP affects approximately 1 in 1 million individuals.""]","[""X-linked lymphoproliferative disease affects approximately 1 in 1 million males.""]","[""XLP affects approximately 1 in 1 million people.""]",[false],[true],[false],"[""XLP affects approximately 1 in 1 million individuals.""]","[""X-linked lymphoproliferative disease affects approximately 1 in 1 million males.""]","[""XLP affects approximately 1 in 1 million people.""]",[false],[true],[false],"[""XLP affects approximately 1 in 1 million individuals.""]","[""X-linked lymphoproliferative disease affects approximately 1 in 1 million males.""]","[""X-linked lymphoproliferative syndrome affects approximately 1 in 1 million individuals.""]",[false],[true],[false],"[""XLP affects approximately 1 in 1 million individuals.""]","[""X-linked lymphoproliferative disease affects approximately 1 in 1 million males.""]","[""XLP affects approximately 1 in 1 million people.""]",[true],[true],[true],"[""XLP affects approximately 1 in 1 million individuals.""]","[""X-linked lymphoproliferative disease affects approximately 1 in 1 million males.""]","[""XLP affects approximately 1 in 1 million people.""]",[false],[true],[false],"[""XLP affects approximately 1 in 1 million individuals.""]","[""X-linked lymphoproliferative disease affects approximately 1 in 1 million males.""]","[""XLP affects approximately 1 in 1 million people.""]",[false],[true],[false],"[""XLP affects approximately 1 in 1 million individuals.""]","[""X-linked lymphoproliferative disease affects approximately 1 in 1 million males.""]","[""X-linked lymphoproliferative syndrome affects approximately 1 in 1 million individuals.""]",[false],[true],[false],"[""XLP affects approximately 1 in 1 million individuals.""]","[""X-linked lymphoproliferative disease affects approximately 1 in 1 million males.""]","[""XLP affects approximately 1 in 1 million people.""]",[false],[true],[false],"[""XLP affects approximately 1 in 1 million individuals.""]","[""X-linked lymphoproliferative disease affects approximately 1 in 1 million males.""]","[""XLP affects approximately 1 in 1 million people.""]",[false],[true],[false],"[""XLP affects approximately 1 in 1 million individuals.""]","[""X-linked lymphoproliferative disease affects approximately 1 in 1 million males.""]","[""XLP affects approximately 1 in 1 million people.""]",[false],[true],[false],"[""XLP affects approximately 1 in 1 million individuals.""]","[""X-linked lymphoproliferative disease affects approximately 1 in 1 million males.""]","[""X-linked lymphoproliferative syndrome affects approximately 1 in 1 million individuals.""]",[true],[true],[true],"[""XLP affects approximately 1 in 1 million individuals.""]","[""X-linked lymphoproliferative disease affects approximately 1 in 1 million males.""]","[""XLP affects approximately 1 in 1 million people.""]",[true],[true],[false],"[""XLP affects approximately 1 in 1 million males worldwide.""]","[""X-linked lymphoproliferative disease affects approximately 1 in 1 million males.""]","[""XLP affects approximately 1 in 1 million people.""]",[true],[true],[true],"[""XLP affects approximately 1 in 1 million individuals.""]","[""X-linked lymphoproliferative disease affects approximately 1 in 1 million males.""]","[""XLP affects approximately 1 in 1 million people.""]",[false],[true],[false],"[""X-Linked Lymphoproliferative Syndrome affects a very small number of individuals worldwide.""]","[""X-linked lymphoproliferative disease affects approximately 1 in 1 million males.""]","[""X-linked lymphoproliferative syndrome affects approximately 1 in 1 million individuals.""]",[true],[true],[true],"[""XLP affects approximately 1 in 1 million individuals.""]","[""X-linked lymphoproliferative disease affects approximately 1 in 1 million males.""]","[""XLP affects approximately 1 in 1 million people.""]",[false],[true],[false],"[""XLP affects approximately 1 in 1 million individuals.""]","[""X-linked lymphoproliferative disease affects approximately 1 in 1 million males.""]","[""XLP affects approximately 1 in 1 million people.""]",[false],[true],[false],"[""The number of people affected by XLP (Extended Life Program) is not publicly available.""]","[""X-linked lymphoproliferative disease affects approximately 1 in 1 million males.""]","[""XLP affects approximately 1 in 1 million people.""]",[false],[true],[false],"[""The number of people affected by XLP (Extreme Luxury Pick-Up) is currently unknown.""]","[""X-linked lymphoproliferative disease affects approximately 1 in 1 million males.""]","[""XLP affects approximately 1 in 1 million people.""]",[true],[true],[false],"[""XLP affects approximately 1 in 1 million males worldwide.""]","[""X-linked lymphoproliferative disease affects approximately 1 in 1 million males.""]","[""XLP affects approximately 1 in 1 million people.""]"
symptoms,What are the symptoms of Hereditary lymphedema type II ?,"What are the signs and symptoms of Hereditary lymphedema type II? Hereditary lymphedema type II is characterized by the abnormal transport of lymph fluid. This causes the lymph fluid to build up, causing swelling (lymphedema). Individuals with hereditary lymphedema type II usually develop swelling in the lower legs and feet during puberty. Some affected individuals develop a non-contagious skin infection called cellulitis, which can further damage the lymphatic vessels (the thin tubes that carry lymph fluid).    The Human Phenotype Ontology provides the following list of signs and symptoms for Hereditary lymphedema type II. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Cleft palate 7.5% Yellow nails 7.5% Autosomal dominant inheritance - Hypoplasia of lymphatic vessels - Predominantly lower limb lymphedema - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""II"", ""full_form"": ""type II""}]}",What are the symptoms of Hereditary lymphedema II ?,What are the symptoms of Hereditary lymphedema type II ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Ii Iii"", ""Intelligent Infrastructure"", ""Interactive Interface"", ""Imagery Interpretation"", ""Initiation Interval"", ""The Implicit Invocation"", ""Roman Number 2"", ""Ion Implant (also seen as I2)"", ""Inanimate Insanity"", ""Interchangeable Item""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Hereditary lymphedema type II""]",[0.0021552741998323343],[2.973257827132669e-06],"[""Ii Iii""]",[5.236658457664118e-05],"[""ABBREVIATIONS""]","[[5.236658457664118e-05, 1.574083054428044e-14, 2.863843625943947e-12, 1.1125723473893373e-12, 1.399034671678594e-09, 8.348175150352629e-20, 2.760137394416752e-12, 7.6782473703874645e-31, 7.938560372234996e-18, 1.4057228801497593e-13]]",[0.9734709906933132],[0.971590808614139],"[""Interchangeable Item""]",[0.971590808614139],"[""LLM""]","[[0.9318625644213678, 0.8528694845188163, 0.8922954441507989, 0.8377736974256007, 0.8943805664624347, 0.8869953140229092, 0.9317654352056857, 0.8651435171856316, 0.7977695531706082, 0.8910731371867028]]","[""Roman Number 2""]","[""ABBREVIATIONS""]",What are the symptoms of Hereditary lymphedema II (Hereditary lymphedema type II) ?,[true],[true],[true],"[""Symptoms of Hereditary lymphedema II (Ii Iii) include swelling of limbs, thickening of the skin, recurrent infections, and discomfort or pain in the affected areas.""]","[""Symptoms of Hereditary lymphedema type II include swelling of limbs, particularly the legs, which may be present at birth or develop later in life. Other symptoms may include recurrent infections, thickened skin, and discomfort in the affected areas.""]","[""Symptoms of Hereditary lymphedema II include swelling of limbs, thickened skin, recurrent infections, and discomfort in affected areas.""]",[false],[true],[true],"[""Symptoms of Hereditary lymphedema II (Ii Iii) include swelling of limbs, thickened skin, recurrent infections, and possible joint deformities.""]","[""Symptoms of Hereditary lymphedema type II include swelling of limbs, recurrent skin infections, thickening of the skin, and discomfort or pain in the affected areas.""]","[""Symptoms of Hereditary lymphedema II include swelling of limbs, thickening of the skin, recurrent infections, and discomfort in affected areas.""]",[true],[true],[true],"[""Symptoms of Hereditary lymphedema II (Ii Iii) include swelling of limbs, thickening of the skin, recurrent infections, and discomfort in the affected areas.""]","[""Symptoms of Hereditary lymphedema type II include swelling of limbs, recurrent skin infections, thickening of the skin, and discomfort in affected areas.""]","[""Symptoms of Hereditary lymphedema II include swelling of limbs, thickened skin, recurrent skin infections, and potential joint deformities.""]",[false],[true],[true],"[""Symptoms of Hereditary lymphedema II (Ii Iii) include swelling of limbs, thickened skin, recurrent infections, and potential development of lymphangiosarcoma.""]","[""Swelling of limbs, recurrent infections, skin changes, and lymphedema""]","[""Symptoms of Hereditary lymphedema II include swelling of limbs, thickening of the skin, recurrent skin infections, and discomfort or pain in the affected area.""]",[true],[true],[true],"[""Symptoms of Hereditary lymphedema II may include swelling of the limbs, thickened skin, recurrent infections, and discomfort or pain in the affected areas.""]","[""Symptoms of Hereditary lymphedema type II include swelling of limbs, particularly the legs, which may be present at birth or develop later in life. Other symptoms may include recurrent infections, thickened skin, and discomfort in the affected areas.""]","[""Symptoms of Hereditary lymphedema II include swelling of limbs, thickened skin, recurrent infections, and discomfort in affected areas.""]",[true],[true],[true],"[""Symptoms of Hereditary lymphedema II may include swelling of limbs, thickened skin, recurrent infections, and discomfort in affected areas.""]","[""Symptoms of Hereditary lymphedema type II include swelling of limbs, recurrent skin infections, thickening of the skin, and discomfort or pain in the affected areas.""]","[""Symptoms of Hereditary lymphedema II include swelling of limbs, thickening of the skin, recurrent infections, and discomfort in affected areas.""]",[true],[true],[true],"[""Symptoms of Hereditary lymphedema II may include swelling of limbs, thickened skin, recurrent infections, and discomfort in affected areas.""]","[""Symptoms of Hereditary lymphedema type II include swelling of limbs, recurrent skin infections, thickening of the skin, and discomfort in affected areas.""]","[""Symptoms of Hereditary lymphedema II include swelling of limbs, thickened skin, recurrent skin infections, and potential joint deformities.""]",[true],[true],[true],"[""Symptoms of Hereditary lymphedema II may include swelling of the limbs, thickened skin, recurrent skin infections, and discomfort or pain in the affected areas.""]","[""Swelling of limbs, recurrent infections, skin changes, and lymphedema""]","[""Symptoms of Hereditary lymphedema II include swelling of limbs, thickening of the skin, recurrent skin infections, and discomfort or pain in the affected area.""]",[true],[true],[true],"[""Symptoms of Hereditary lymphedema II include swelling of limbs, particularly the legs, that may be present at birth or develop later in life, thickening and hardening of the skin, recurrent skin infections, and potential development of lymphedema in other parts of the body.""]","[""Symptoms of Hereditary lymphedema type II include swelling of limbs, recurrent skin infections, thickening of the skin, and discomfort or pain in the affected areas.""]","[""Symptoms of Hereditary lymphedema II include swelling of limbs, thickening of the skin, recurrent infections, and discomfort in affected areas.""]",[true],[true],[true],"[""Symptoms of Hereditary lymphedema II include swelling of limbs, particularly the legs, that may worsen over time, thickening and hardening of the skin, recurrent skin infections, and discomfort or pain in the affected areas.""]","[""Symptoms of Hereditary lymphedema type II include swelling of limbs, particularly the legs, which may be present at birth or develop later in life. Other symptoms may include recurrent infections, thickened skin, and discomfort in the affected areas.""]","[""Symptoms of Hereditary lymphedema II include swelling of limbs, thickened skin, recurrent infections, and discomfort in affected areas.""]",[true],[true],[true],"[""Symptoms of Hereditary lymphedema II include swelling of limbs, particularly the legs, which may worsen over time, thickening and hardening of the skin, recurrent skin infections, and discomfort or pain in the affected areas.""]","[""Symptoms of Hereditary lymphedema type II include swelling of limbs, recurrent skin infections, thickening of the skin, and discomfort in affected areas.""]","[""Symptoms of Hereditary lymphedema II include swelling of limbs, thickened skin, recurrent skin infections, and potential joint deformities.""]",[false],[true],[true],"[""Swelling in the arms and legs, recurrent infections, skin changes, and abnormal growth of bones and tissues""]","[""Swelling of limbs, recurrent infections, skin changes, and lymphedema""]","[""Symptoms of Hereditary lymphedema II include swelling of limbs, thickening of the skin, recurrent skin infections, and discomfort or pain in the affected area.""]",[true],[true],[true],"[""Swelling in the arms and legs, recurrent infections, skin changes, and thickening of the skin""]","[""Symptoms of Hereditary lymphedema type II include swelling of limbs, particularly the legs, which may be present at birth or develop later in life. Other symptoms may include recurrent infections, thickened skin, and discomfort in the affected areas.""]","[""Symptoms of Hereditary lymphedema II include swelling of limbs, thickened skin, recurrent infections, and discomfort in affected areas.""]",[true],[true],[true],"[""Swelling in the arms and legs, thickening of the skin, recurrent skin infections""]","[""Symptoms of Hereditary lymphedema type II include swelling of limbs, recurrent skin infections, thickening of the skin, and discomfort or pain in the affected areas.""]","[""Symptoms of Hereditary lymphedema II include swelling of limbs, thickening of the skin, recurrent infections, and discomfort in affected areas.""]",[true],[true],[true],"[""Swelling in the arms and legs, recurrent skin infections, thickening of the skin""]","[""Symptoms of Hereditary lymphedema type II include swelling of limbs, recurrent skin infections, thickening of the skin, and discomfort in affected areas.""]","[""Symptoms of Hereditary lymphedema II include swelling of limbs, thickened skin, recurrent skin infections, and potential joint deformities.""]",[false],[true],[true],"[""Swelling in the arms and legs, thickened skin, wart-like growths, and lymphedema praecox""]","[""Swelling of limbs, recurrent infections, skin changes, and lymphedema""]","[""Symptoms of Hereditary lymphedema II include swelling of limbs, thickening of the skin, recurrent skin infections, and discomfort or pain in the affected area.""]",[true],[true],[true],"[""Symptoms of Hereditary lymphedema II include swelling of limbs, particularly the legs, that may worsen over time, thickening and hardening of the skin, recurrent skin infections, and potential development of lymphedema in other parts of the body.""]","[""Symptoms of Hereditary lymphedema type II include swelling of limbs, particularly the legs, which may be present at birth or develop later in life. Other symptoms may include recurrent infections, thickened skin, and discomfort in the affected areas.""]","[""Symptoms of Hereditary lymphedema II include swelling of limbs, thickened skin, recurrent infections, and discomfort in affected areas.""]",[true],[true],[true],"[""Symptoms of Hereditary lymphedema II include swelling of the limbs, particularly the legs, which may be present at birth or develop later in life. Other symptoms may include recurrent infections, thickened skin, and discomfort or pain in the affected areas.""]","[""Symptoms of Hereditary lymphedema type II include swelling of limbs, recurrent skin infections, thickening of the skin, and discomfort or pain in the affected areas.""]","[""Symptoms of Hereditary lymphedema II include swelling of limbs, thickening of the skin, recurrent infections, and discomfort in affected areas.""]",[false],[true],[true],"[""Symptoms of Hereditary lymphedema II include swelling of limbs, thickening of the skin, recurrent skin infections, and potential development of lymphangiosarcoma.""]","[""Symptoms of Hereditary lymphedema type II include swelling of limbs, recurrent skin infections, thickening of the skin, and discomfort in affected areas.""]","[""Symptoms of Hereditary lymphedema II include swelling of limbs, thickened skin, recurrent skin infections, and potential joint deformities.""]",[false],[true],[true],"[""Swelling in the arms and legs, recurrent infections, skin changes, and abnormal growth of bones and tissues""]","[""Swelling of limbs, recurrent infections, skin changes, and lymphedema""]","[""Symptoms of Hereditary lymphedema II include swelling of limbs, thickening of the skin, recurrent skin infections, and discomfort or pain in the affected area.""]",[true],[true],[true],"[""Symptoms of Hereditary lymphedema II (Hereditary lymphedema type II) include swelling of limbs, particularly the legs, which may be present at birth or develop later in life. Other symptoms may include recurrent skin infections, thickening of the skin, and abnormal growth of nails.""]","[""Symptoms of Hereditary lymphedema type II include swelling of limbs, particularly the legs, which may be present at birth or develop later in life. Other symptoms may include recurrent infections, thickened skin, and discomfort in the affected areas.""]","[""Symptoms of Hereditary lymphedema II include swelling of limbs, thickened skin, recurrent infections, and discomfort in affected areas.""]",[true],[true],[true],"[""Symptoms of Hereditary lymphedema II include swelling of limbs, thickening of the skin, recurrent skin infections, and discomfort in affected areas.""]","[""Symptoms of Hereditary lymphedema type II include swelling of limbs, recurrent skin infections, thickening of the skin, and discomfort or pain in the affected areas.""]","[""Symptoms of Hereditary lymphedema II include swelling of limbs, thickening of the skin, recurrent infections, and discomfort in affected areas.""]",[true],[true],[true],"[""Symptoms of Hereditary lymphedema II (Hereditary lymphedema type II) include swelling of limbs, particularly the legs, that may be present at birth or develop later in life, thickening and hardening of the skin, recurrent skin infections, and potential joint deformities.""]","[""Symptoms of Hereditary lymphedema type II include swelling of limbs, recurrent skin infections, thickening of the skin, and discomfort in affected areas.""]","[""Symptoms of Hereditary lymphedema II include swelling of limbs, thickened skin, recurrent skin infections, and potential joint deformities.""]",[true],[true],[true],"[""Symptoms of Hereditary lymphedema II include swelling of limbs, particularly the legs, that may worsen over time, thickening of the skin, recurrent skin infections, and discomfort or aching in the affected limb.""]","[""Swelling of limbs, recurrent infections, skin changes, and lymphedema""]","[""Symptoms of Hereditary lymphedema II include swelling of limbs, thickening of the skin, recurrent skin infections, and discomfort or pain in the affected area.""]",[false],[true],[true],"[""Symptoms of Hereditary lymphedema II include swelling of limbs, particularly the legs, that may be present at birth or develop later in life. Other symptoms may include skin thickening, wart-like growths, and susceptibility to infections.""]","[""Symptoms of Hereditary lymphedema type II include swelling of limbs, particularly the legs, which may be present at birth or develop later in life. Other symptoms may include recurrent infections, thickened skin, and discomfort in the affected areas.""]","[""Symptoms of Hereditary lymphedema II include swelling of limbs, thickened skin, recurrent infections, and discomfort in affected areas.""]",[false],[true],[true],"[""Symptoms of Hereditary lymphedema II include swelling of limbs, particularly the legs, that may be present at birth or develop later in life. Other symptoms may include thickened skin, warty growths, and susceptibility to skin infections.""]","[""Symptoms of Hereditary lymphedema type II include swelling of limbs, recurrent skin infections, thickening of the skin, and discomfort or pain in the affected areas.""]","[""Symptoms of Hereditary lymphedema II include swelling of limbs, thickening of the skin, recurrent infections, and discomfort in affected areas.""]",[true],[true],[true],"[""Symptoms of Hereditary lymphedema II include swelling of limbs, thickening of the skin, recurrent infections, and discomfort in affected areas.""]","[""Symptoms of Hereditary lymphedema type II include swelling of limbs, recurrent skin infections, thickening of the skin, and discomfort in affected areas.""]","[""Symptoms of Hereditary lymphedema II include swelling of limbs, thickened skin, recurrent skin infections, and potential joint deformities.""]",[true],[true],[true],"[""Symptoms of Hereditary lymphedema II include swelling of limbs, thickening of the skin, recurrent infections, and discomfort or pain in the affected areas.""]","[""Swelling of limbs, recurrent infections, skin changes, and lymphedema""]","[""Symptoms of Hereditary lymphedema II include swelling of limbs, thickening of the skin, recurrent skin infections, and discomfort or pain in the affected area.""]",[true],[true],[true],"[""Symptoms of Hereditary lymphedema II include swelling in the arms and legs, thickened skin, and recurring skin infections.""]","[""Symptoms of Hereditary lymphedema type II include swelling of limbs, particularly the legs, which may be present at birth or develop later in life. Other symptoms may include recurrent infections, thickened skin, and discomfort in the affected areas.""]","[""Symptoms of Hereditary lymphedema II include swelling of limbs, thickened skin, recurrent infections, and discomfort in affected areas.""]",[true],[true],[true],"[""Symptoms of Hereditary lymphedema II (Ii Iii) include swelling of limbs, thickening of the skin, recurrent skin infections, and discomfort or pain in the affected areas.""]","[""Symptoms of Hereditary lymphedema type II include swelling of limbs, particularly the legs, which may be present at birth or develop later in life. Other symptoms may include recurrent infections, thickened skin, and discomfort in the affected areas.""]","[""Symptoms of Hereditary lymphedema II include swelling of limbs, thickened skin, recurrent infections, and discomfort in affected areas.""]",[true],[true],[true],"[""Symptoms of Hereditary lymphedema II may include swelling of limbs, recurrent skin infections, thickening of the skin, and discomfort in affected areas.""]","[""Symptoms of Hereditary lymphedema type II include swelling of limbs, particularly the legs, which may be present at birth or develop later in life. Other symptoms may include recurrent infections, thickened skin, and discomfort in the affected areas.""]","[""Symptoms of Hereditary lymphedema II include swelling of limbs, thickened skin, recurrent infections, and discomfort in affected areas.""]",[true],[true],[true],"[""Symptoms of Hereditary lymphedema II may include swelling of limbs, recurrent infections, thickened skin, and discomfort in affected areas.""]","[""Symptoms of Hereditary lymphedema type II include swelling of limbs, particularly the legs, which may be present at birth or develop later in life. Other symptoms may include recurrent infections, thickened skin, and discomfort in the affected areas.""]","[""Symptoms of Hereditary lymphedema II include swelling of limbs, thickened skin, recurrent infections, and discomfort in affected areas.""]"
treatment,What are the treatments for X-linked dominant scapuloperoneal myopathy ?,How might scapuloperoneal myopathy be treated? There is no standard course of treatment for scapuloperoneal myopathy. Some patients may benefit from physical therapy or other therapeutic exercises.,"{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""X-linked"", ""full_form"": ""X-linked dominant scapuloperoneal myopathy""}]}",What are the treatments for X-linked ?,What are the treatments for X-linked dominant scapuloperoneal myopathy ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Link 1 (GPS, aviation)"", ""Cross Linked Polyethylene"", ""Enzyme Linked Immunosorbent Assay"", ""Semi-Implicit Method for Pressure Linked Equations (computational fluid dynamics)"", ""X-Linked Severe Combined Immunodeficiency"", ""Triple Link Suspension"", ""Enzyme-Linked Immunosorbent Assay"", ""Collagen Cross-Linking"", ""X-Linked Adrenoleukodystrophy (disease)"", ""Corneal Cross-Linking (ophthalmology)""]]","[[""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER""]]","[""X-linked""]",[1.788040488865144e-28],[0.017432721288053784],"[""X-linked""]",[0.017432721288053784],"[""LLM""]","[[1.1623794138465989e-28, 1.355183234180477e-16, 1.7920847745947545e-30, 5.1833251916071346e-54, 5.598289352547734e-18, 1.278514669900494e-13, 1.802290625487935e-29, 3.4433618811161274e-15, 1.6007966387683285e-29, 3.6711948965725994e-24]]",[0.7702282683368659],[0.968911075384141],"[""Corneal Cross-Linking (ophthalmology)""]",[0.968911075384141],"[""LLM""]","[[0.8018873433700942, 0.7115218946271038, 0.81319079138461, 0.7186482830218076, 0.7846048933649721, 0.7774547531578507, 0.8224646148037146, 0.7847036469679323, 0.7444632606363837, 0.7475929557901948]]","[""X-linked""]","[""LLM""]",What are the treatments for X-linked (X-linked) ?,[false],[true],[false],"[""The treatments for X-linked disorders typically involve managing symptoms and complications, as there is currently no cure for these genetic conditions. This may include medication, physical therapy, and other supportive measures.""]","[""Physical therapy, orthopedic devices, and surgery for scoliosis or foot deformities""]","[""The treatments for X-linked disorders vary depending on the specific condition. Some common approaches include gene therapy, enzyme replacement therapy, and symptom management.""]",[false],[true],[false],"[""There is no cure for X-linked disorders, but treatments can help manage symptoms and improve quality of life. These may include medication, physical therapy, occupational therapy, and speech therapy.""]","[""Physical therapy, orthopedic devices, and pain management are common treatments for X-linked dominant scapuloperoneal myopathy.""]","[""The treatments for X-linked disorders vary depending on the specific condition. Some common approaches include gene therapy, enzyme replacement therapy, and symptom management.""]",[false],[true],[false],"[""The treatments for X-linked disorders typically involve symptom management and supportive care. Specific treatments may vary depending on the particular disorder.""]","[""Physical therapy, orthopedic devices, and surgery may be used to manage symptoms of X-linked dominant scapuloperoneal myopathy.""]","[""The treatments for X-linked disorders vary depending on the specific condition. Some common approaches include gene therapy, enzyme replacement therapy, and symptom management.""]",[false],[true],[false],"[""The treatments for X-linked disorders typically involve symptom management and supportive care. Specific treatments may vary depending on the particular disorder and its symptoms.""]","[""Physical therapy, orthopedic devices, and pain management are common treatments for X-linked dominant scapuloperoneal myopathy.""]","[""The treatments for X-linked disorders vary depending on the specific condition. Some common approaches include gene therapy, enzyme replacement therapy, and symptom management.""]",[false],[true],[false],"[""The treatments for X-linked corneal cross-linking in ophthalmology include riboflavin and ultraviolet A (UVA) light therapy, which helps strengthen the cornea and improve vision.""]","[""Physical therapy, orthopedic devices, and surgery for scoliosis or foot deformities""]","[""The treatments for X-linked disorders vary depending on the specific condition. Some common approaches include gene therapy, enzyme replacement therapy, and symptom management.""]",[false],[true],[false],"[""The treatments for X-linked corneal cross-linking in ophthalmology include riboflavin and ultraviolet A (UVA) light therapy, which help strengthen the cornea and improve vision.""]","[""Physical therapy, orthopedic devices, and pain management are common treatments for X-linked dominant scapuloperoneal myopathy.""]","[""The treatments for X-linked disorders vary depending on the specific condition. Some common approaches include gene therapy, enzyme replacement therapy, and symptom management.""]",[false],[true],[false],"[""The treatments for X-linked corneal cross-linking in ophthalmology include riboflavin and ultraviolet A (UVA) light therapy, which helps strengthen the cornea and slow down the progression of the condition.""]","[""Physical therapy, orthopedic devices, and surgery may be used to manage symptoms of X-linked dominant scapuloperoneal myopathy.""]","[""The treatments for X-linked disorders vary depending on the specific condition. Some common approaches include gene therapy, enzyme replacement therapy, and symptom management.""]",[false],[true],[false],"[""The treatments for X-linked corneal cross-linking in ophthalmology include riboflavin and ultraviolet A (UVA) light therapy.""]","[""Physical therapy, orthopedic devices, and pain management are common treatments for X-linked dominant scapuloperoneal myopathy.""]","[""The treatments for X-linked disorders vary depending on the specific condition. Some common approaches include gene therapy, enzyme replacement therapy, and symptom management.""]",[false],[true],[false],"[""There is no cure for X-linked disorders, but treatment focuses on managing symptoms and complications.""]","[""Physical therapy, orthopedic devices, and pain management are common treatments for X-linked dominant scapuloperoneal myopathy.""]","[""The treatments for X-linked disorders vary depending on the specific condition. Some common approaches include gene therapy, enzyme replacement therapy, and symptom management.""]",[false],[true],[false],"[""There is no cure for X-linked disorders, but treatments can help manage symptoms and improve quality of life. These may include medications, physical therapy, occupational therapy, and speech therapy.""]","[""Physical therapy, orthopedic devices, and surgery for scoliosis or foot deformities""]","[""The treatments for X-linked disorders vary depending on the specific condition. Some common approaches include gene therapy, enzyme replacement therapy, and symptom management.""]",[false],[true],[false],"[""Treatment for X-linked disorders typically involves symptom management and supportive care. Specific treatments may vary depending on the particular disorder and its symptoms.""]","[""Physical therapy, orthopedic devices, and surgery may be used to manage symptoms of X-linked dominant scapuloperoneal myopathy.""]","[""The treatments for X-linked disorders vary depending on the specific condition. Some common approaches include gene therapy, enzyme replacement therapy, and symptom management.""]",[false],[true],[false],"[""The treatments for X-linked disorders vary depending on the specific condition. Some common approaches include gene therapy, enzyme replacement therapy, and supportive care to manage symptoms.""]","[""Physical therapy, orthopedic devices, and pain management are common treatments for X-linked dominant scapuloperoneal myopathy.""]","[""The treatments for X-linked disorders vary depending on the specific condition. Some common approaches include gene therapy, enzyme replacement therapy, and symptom management.""]",[false],[true],[false],"[""Gene therapy, enzyme replacement therapy, supportive care""]","[""Physical therapy, orthopedic devices, and surgery for scoliosis or foot deformities""]","[""The treatments for X-linked disorders vary depending on the specific condition. Some common approaches include gene therapy, enzyme replacement therapy, and symptom management.""]",[false],[true],[false],"[""There is no cure for X-linked disorders, but treatments can help manage symptoms and improve quality of life. Treatment options may include medication, physical therapy, occupational therapy, speech therapy, and genetic counseling.""]","[""Physical therapy, orthopedic devices, and pain management are common treatments for X-linked dominant scapuloperoneal myopathy.""]","[""The treatments for X-linked disorders vary depending on the specific condition. Some common approaches include gene therapy, enzyme replacement therapy, and symptom management.""]",[false],[true],[false],"[""There is no cure for X-linked disorders, but treatment focuses on managing symptoms and complications.""]","[""Physical therapy, orthopedic devices, and surgery may be used to manage symptoms of X-linked dominant scapuloperoneal myopathy.""]","[""The treatments for X-linked disorders vary depending on the specific condition. Some common approaches include gene therapy, enzyme replacement therapy, and symptom management.""]",[false],[true],[false],"[""There is no cure for X-linked disorders, but treatments focus on managing symptoms and improving quality of life. This may include medications, physical therapy, and other supportive measures.""]","[""Physical therapy, orthopedic devices, and pain management are common treatments for X-linked dominant scapuloperoneal myopathy.""]","[""The treatments for X-linked disorders vary depending on the specific condition. Some common approaches include gene therapy, enzyme replacement therapy, and symptom management.""]",[false],[true],[false],"[""There is no cure for X-linked disorders, but treatments can help manage symptoms and improve quality of life. These may include medications, physical therapy, occupational therapy, and speech therapy.""]","[""Physical therapy, orthopedic devices, and surgery for scoliosis or foot deformities""]","[""The treatments for X-linked disorders vary depending on the specific condition. Some common approaches include gene therapy, enzyme replacement therapy, and symptom management.""]",[false],[true],[false],"[""Treatment for X-linked disorders depends on the specific condition and symptoms. It may include medications, gene therapy, enzyme replacement therapy, or supportive care to manage symptoms.""]","[""Physical therapy, orthopedic devices, and pain management are common treatments for X-linked dominant scapuloperoneal myopathy.""]","[""The treatments for X-linked disorders vary depending on the specific condition. Some common approaches include gene therapy, enzyme replacement therapy, and symptom management.""]",[false],[true],[false],"[""The treatments for X-linked disorders typically involve symptom management and supportive care. Specific treatments may vary depending on the particular disorder and its symptoms.""]","[""Physical therapy, orthopedic devices, and surgery may be used to manage symptoms of X-linked dominant scapuloperoneal myopathy.""]","[""The treatments for X-linked disorders vary depending on the specific condition. Some common approaches include gene therapy, enzyme replacement therapy, and symptom management.""]",[false],[true],[false],"[""Treatment for X-linked disorders depends on the specific condition and symptoms, but may include medications, gene therapy, and supportive care.""]","[""Physical therapy, orthopedic devices, and pain management are common treatments for X-linked dominant scapuloperoneal myopathy.""]","[""The treatments for X-linked disorders vary depending on the specific condition. Some common approaches include gene therapy, enzyme replacement therapy, and symptom management.""]",[false],[true],[false],"[""The treatments for X-linked disorders depend on the specific condition, but may include medications, gene therapy, enzyme replacement therapy, and supportive care to manage symptoms.""]","[""Physical therapy, orthopedic devices, and surgery for scoliosis or foot deformities""]","[""The treatments for X-linked disorders vary depending on the specific condition. Some common approaches include gene therapy, enzyme replacement therapy, and symptom management.""]",[false],[true],[false],"[""The treatments for X-linked disorders depend on the specific condition and symptoms. Some common approaches include medication, gene therapy, enzyme replacement therapy, and supportive care to manage symptoms.""]","[""Physical therapy, orthopedic devices, and pain management are common treatments for X-linked dominant scapuloperoneal myopathy.""]","[""The treatments for X-linked disorders vary depending on the specific condition. Some common approaches include gene therapy, enzyme replacement therapy, and symptom management.""]",[false],[true],[false],"[""The treatments for X-linked disorders typically involve managing symptoms and complications, as there is currently no cure. This may include medications, physical therapy, and supportive care.""]","[""Physical therapy, orthopedic devices, and surgery may be used to manage symptoms of X-linked dominant scapuloperoneal myopathy.""]","[""The treatments for X-linked disorders vary depending on the specific condition. Some common approaches include gene therapy, enzyme replacement therapy, and symptom management.""]",[false],[true],[false],"[""The treatments for X-linked disorders vary depending on the specific condition. Some common approaches include gene therapy, enzyme replacement therapy, and symptom management.""]","[""Physical therapy, orthopedic devices, and pain management are common treatments for X-linked dominant scapuloperoneal myopathy.""]","[""The treatments for X-linked disorders vary depending on the specific condition. Some common approaches include gene therapy, enzyme replacement therapy, and symptom management.""]",[false],[true],[false],"[""The treatments for X-linked disorders vary depending on the specific condition. Some common approaches include hormone replacement therapy, enzyme replacement therapy, gene therapy, and supportive care to manage symptoms.""]","[""Physical therapy, orthopedic devices, and surgery for scoliosis or foot deformities""]","[""The treatments for X-linked disorders vary depending on the specific condition. Some common approaches include gene therapy, enzyme replacement therapy, and symptom management.""]",[false],[true],[false],"[""The treatments for X-linked disorders vary depending on the specific condition. Some common approaches include gene therapy, enzyme replacement therapy, and symptom management.""]","[""Physical therapy, orthopedic devices, and pain management are common treatments for X-linked dominant scapuloperoneal myopathy.""]","[""The treatments for X-linked disorders vary depending on the specific condition. Some common approaches include gene therapy, enzyme replacement therapy, and symptom management.""]",[false],[true],[false],"[""The treatments for X-linked disorders vary depending on the specific condition. Some common approaches include gene therapy, enzyme replacement therapy, and symptomatic management.""]","[""Physical therapy, orthopedic devices, and surgery may be used to manage symptoms of X-linked dominant scapuloperoneal myopathy.""]","[""The treatments for X-linked disorders vary depending on the specific condition. Some common approaches include gene therapy, enzyme replacement therapy, and symptom management.""]",[false],[true],[false],"[""The treatments for X-linked disorders vary depending on the specific condition. Some common approaches include hormone replacement therapy, gene therapy, and supportive care to manage symptoms.""]","[""Physical therapy, orthopedic devices, and pain management are common treatments for X-linked dominant scapuloperoneal myopathy.""]","[""The treatments for X-linked disorders vary depending on the specific condition. Some common approaches include gene therapy, enzyme replacement therapy, and symptom management.""]",[false],[true],[false],"[""There is currently no cure for X-linked disorders, but treatments focus on managing symptoms and improving quality of life.""]","[""Physical therapy, orthopedic devices, and surgery for scoliosis or foot deformities""]","[""The treatments for X-linked disorders vary depending on the specific condition. Some common approaches include gene therapy, enzyme replacement therapy, and symptom management.""]",[false],[true],[false],"[""The treatments for X-linked disorders vary depending on the specific condition. Some common approaches include gene therapy, enzyme replacement therapy, and symptom management.""]","[""Physical therapy, orthopedic devices, and surgery for scoliosis or foot deformities""]","[""The treatments for X-linked disorders vary depending on the specific condition. Some common approaches include gene therapy, enzyme replacement therapy, and symptom management.""]",[false],[true],[false],"[""Treatments for X-linked corneal cross-linking in ophthalmology include riboflavin/UVA cross-linking, intrastromal corneal ring segments, and keratoplasty.""]","[""Physical therapy, orthopedic devices, and surgery for scoliosis or foot deformities""]","[""The treatments for X-linked disorders vary depending on the specific condition. Some common approaches include gene therapy, enzyme replacement therapy, and symptom management.""]",[false],[true],[false],"[""The treatments for X-linked disorders vary depending on the specific condition. Some common approaches include gene therapy, enzyme replacement therapy, and symptom management.""]","[""Physical therapy, orthopedic devices, and surgery for scoliosis or foot deformities""]","[""The treatments for X-linked disorders vary depending on the specific condition. Some common approaches include gene therapy, enzyme replacement therapy, and symptom management.""]"
inheritance,Is spastic paraplegia type 31 inherited ?,"This condition is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""SPG31"", ""full_form"": ""spastic paraplegia type 31""}]}",Is SPG31 inherited ?,Is spastic paraplegia type 31 inherited ?,8,MEDICAL,Simple Datatype-Boolean,"Analytical/Evaluative (Convergent Thinking): This merged category is for queries that involve dissecting complex information or data to understand underlying patterns, reasons, or to make informed judgements. Queries in this category seek a deeper understanding that supports decision-making, comparison of options, or evaluating alternatives. The process involves both analysis (to break down and understand) and evaluation (to assess, compare, and decide), acknowledging that these processes often occur in tandem. This category involves queries where the goal is to converge upon a specific answer or decision through analysis and evaluation.",[[]],[[]],"[""Spastic Paraplegia 31""]",[2.491941693960904e-19],[1.8329032345850365e-16],"[""Spastic Paraplegia 31""]",[1.8329032345850365e-16],"[""LLM""]",[[]],[0.8700227203695851],[0.8756524257204845],"[""spastic paraplegia type 31""]",[0.8756524257204845],"[""LLM""]",[[]],"[""Spastic Paraplegia 31""]","[""LLM""]",Is SPG31 (Spastic Paraplegia 31) inherited ?,[true],[true],[true],"[""Yes""]","[""Yes""]","[""Yes""]",[false],[false],[true],"[""Yes""]","[""Yes""]","[""Yes, SPG31 is inherited.""]",[true],[true],[true],"[""Yes""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes, SPG31 (Spastic Paraplegia 31) is inherited.""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes""]","[""Yes""]","[""Yes""]",[false],[false],[true],"[""Yes""]","[""Yes""]","[""Yes, SPG31 is inherited.""]",[true],[true],[true],"[""Yes""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes""]","[""Yes""]","[""Yes, SPG31 is inherited.""]",[true],[true],[true],"[""Yes""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes, SPG31 (Spastic Paraplegia 31) is inherited.""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes""]","[""Yes""]","[""Yes, SPG31 is inherited.""]",[true],[true],[true],"[""Yes""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes""]","[""Yes""]","[""Yes, SPG31 is inherited.""]",[true],[true],[true],"[""Yes""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes, SPG31 (Spastic Paraplegia 31) is inherited.""]","[""Yes""]","[""Yes""]",[false],[false],[true],"[""Yes""]","[""Yes""]","[""Yes, SPG31 is inherited.""]",[true],[true],[true],"[""Yes""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes, SPG31 (Spastic Paraplegia 31) is inherited.""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes, SPG31 (Spastic Paraplegia 31) is inherited in an autosomal dominant manner.""]","[""Yes""]","[""Yes""]",[true],[false],[true],"[""Yes, SPG31 (Spastic Paraplegia 31) is inherited.""]","[""Yes""]","[""Yes, SPG31 is inherited.""]",[false],[true],[true],"[""Yes, SPG31 (Spastic Paraplegia 31) is inherited as an autosomal recessive trait.""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes, SPG31 (Spastic Paraplegia 31) is inherited.""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes, SPG31 (Spastic Paraplegia 31) is inherited.""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes, SPG31 (Spastic Paraplegia 31) is inherited.""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes, SPG31 (spastic paraplegia type 31) is inherited.""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes""]","[""Yes""]","[""Yes""]"
considerations,What to do for What I need to know about Hepatitis A ?,"If you have hepatitis A, you should do things to take care of yourself, including eating a healthy diet. Avoid drinking alcohol, which can harm the liver. Talk with your doctor before taking vitamins and other supplements.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""HAV"", ""full_form"": ""Hepatitis A""}]}",What to do for What I need to know about HAV ?,What to do for What I need to know about Hepatitis A ?,8,MEDICAL,Simple Datatype-String,"Analytical/Evaluative (Convergent Thinking): This merged category is for queries that involve dissecting complex information or data to understand underlying patterns, reasons, or to make informed judgements. Queries in this category seek a deeper understanding that supports decision-making, comparison of options, or evaluating alternatives. The process involves both analysis (to break down and understand) and evaluation (to assess, compare, and decide), acknowledging that these processes often occur in tandem. This category involves queries where the goal is to converge upon a specific answer or decision through analysis and evaluation.","[[""Hepatitis A Virus"", ""Havana, Cuba"", ""Hand- Arm Vibration"", ""High-Altitude Vehicle"", ""High Altitude Vehicle"", ""Hug A Villain"", ""Hallux Abducto Valgus"", ""Havilah Resources NL"", ""Hand Arm Vibration"", ""Hybrid Air Vehicles""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Hepatitis A Virus""]",[9.96015123233506e-06],[4.853173205483978e-07],"[""Hepatitis A Virus""]",[4.853173205483978e-07],"[""ABBREVIATIONS""]","[[4.853173205483978e-07, 1.3396526593116904e-15, 2.0226948946157283e-14, 1.5690935584155194e-15, 8.800012890323012e-15, 6.452969567736618e-16, 1.0554817093671374e-19, 1.0322540015652824e-21, 2.0460549730487636e-13, 9.14475078881568e-16]]",[0.9325872451068123],[0.9226357401242284],"[""Hepatitis A""]",[0.9226607647362723],"[""ABBREVIATIONS""]","[[0.9226607647362723, 0.7903038472212272, 0.6729716859085582, 0.625245661767394, 0.6336849023790782, 0.6814870870200007, 0.5996322189395514, 0.6953768912668942, 0.6754083447638307, 0.6250968365742359]]","[""Hepatitis A Virus""]","[""ABBREVIATIONS""]",What to do for What I need to know about HAV (Hepatitis A Virus) ?,[false],[false],[false],"[""Hepatitis A is a liver infection caused by the Hepatitis A virus. It is usually spread through contaminated food or water. To prevent HAV infection, one should practice good hygiene, get vaccinated, and avoid consuming contaminated food or water.""]","[""Hepatitis A is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. The best way to prevent hepatitis A is by getting vaccinated. Good hygiene practices, such as washing hands thoroughly and avoiding unclean food and water, can also help prevent the spread of the virus.""]","[""Hepatitis A virus (HAV) is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. Vaccination is the best way to prevent HAV infection.""]",[false],[false],[false],"[""Hepatitis A is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. The best way to prevent HAV is by getting vaccinated. Symptoms include fatigue, nausea, abdominal pain, and jaundice. Treatment usually involves rest, fluids, and monitoring liver function.""]","[""Hepatitis A is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. To prevent Hepatitis A, one should get vaccinated, practice good hygiene, and avoid consuming contaminated food or water.""]","[""Hepatitis A virus (HAV) is a highly contagious liver infection caused by the hepatitis A virus. It can be prevented by vaccination and good hygiene practices such as handwashing and safe food handling.""]",[false],[false],[false],"[""Hepatitis A is a liver infection caused by the Hepatitis A virus. It is usually spread through contaminated food or water. To prevent HAV infection, one can get vaccinated, practice good hygiene, and avoid consuming contaminated food or water.""]","[""Hepatitis A is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. To prevent hepatitis A, one can get vaccinated, practice good hygiene, and avoid consuming contaminated food or water.""]","[""Hepatitis A virus (HAV) is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. To prevent HAV infection, it is important to practice good hygiene, get vaccinated, and avoid consuming contaminated food or water.""]",[false],[false],[false],"[""Hepatitis A is a liver infection caused by the Hepatitis A virus. It is usually spread through contaminated food or water. To prevent HAV infection, one should practice good hygiene, get vaccinated, and avoid consuming contaminated food or water.""]","[""Hepatitis A is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. Symptoms include fatigue, nausea, abdominal pain, and jaundice. The best way to prevent hepatitis A is by getting vaccinated and practicing good hygiene, such as washing hands thoroughly.""]","[""Hepatitis A virus (HAV) is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. The best way to prevent HAV is by getting vaccinated and practicing good hygiene, such as washing hands regularly and avoiding unclean food and water sources.""]",[false],[false],[false],"[""Hepatitis A is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. To prevent HAV, one should get vaccinated, practice good hygiene, and avoid consuming contaminated food or water.""]","[""Hepatitis A is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. The best way to prevent hepatitis A is by getting vaccinated. Good hygiene practices, such as washing hands thoroughly and avoiding unclean food and water, can also help prevent the spread of the virus.""]","[""Hepatitis A virus (HAV) is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. Vaccination is the best way to prevent HAV infection.""]",[false],[false],[false],"[""Hepatitis A is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. To prevent HAV, it is important to practice good hygiene, get vaccinated, and avoid consuming contaminated food or water.""]","[""Hepatitis A is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. To prevent Hepatitis A, one should get vaccinated, practice good hygiene, and avoid consuming contaminated food or water.""]","[""Hepatitis A virus (HAV) is a highly contagious liver infection caused by the hepatitis A virus. It can be prevented by vaccination and good hygiene practices such as handwashing and safe food handling.""]",[false],[false],[false],"[""Hepatitis A is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. To prevent hepatitis A, one can get vaccinated, practice good hygiene, and avoid consuming contaminated food or water.""]","[""Hepatitis A is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. To prevent hepatitis A, one can get vaccinated, practice good hygiene, and avoid consuming contaminated food or water.""]","[""Hepatitis A virus (HAV) is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. To prevent HAV infection, it is important to practice good hygiene, get vaccinated, and avoid consuming contaminated food or water.""]",[false],[false],[false],"[""Hepatitis A is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. To prevent hepatitis A, one can get vaccinated, practice good hygiene, and avoid consuming contaminated food or water.""]","[""Hepatitis A is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. Symptoms include fatigue, nausea, abdominal pain, and jaundice. The best way to prevent hepatitis A is by getting vaccinated and practicing good hygiene, such as washing hands thoroughly.""]","[""Hepatitis A virus (HAV) is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. The best way to prevent HAV is by getting vaccinated and practicing good hygiene, such as washing hands regularly and avoiding unclean food and water sources.""]",[false],[false],[false],"[""Hepatitis A is a liver infection caused by the Hepatitis A virus. It is usually spread through contaminated food or water. To prevent HAV, one should practice good hygiene, get vaccinated, and avoid consuming contaminated food or water.""]","[""Hepatitis A is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. To prevent Hepatitis A, one should get vaccinated, practice good hygiene, and avoid consuming contaminated food or water.""]","[""Hepatitis A virus (HAV) is a highly contagious liver infection caused by the hepatitis A virus. It can be prevented by vaccination and good hygiene practices such as handwashing and safe food handling.""]",[false],[false],[false],"[""Hepatitis A is a liver infection caused by the Hepatitis A virus. It is usually spread through contaminated food or water. To prevent HAV infection, one can get vaccinated, practice good hygiene, and avoid consuming contaminated food or water.""]","[""Hepatitis A is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. The best way to prevent hepatitis A is by getting vaccinated. Good hygiene practices, such as washing hands thoroughly and avoiding unclean food and water, can also help prevent the spread of the virus.""]","[""Hepatitis A virus (HAV) is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. Vaccination is the best way to prevent HAV infection.""]",[false],[false],[false],"[""Hepatitis A is a liver infection caused by the Hepatitis A virus. It is usually spread through contaminated food or water. To prevent HAV infection, one should get vaccinated, practice good hygiene, and avoid consuming contaminated food or water.""]","[""Hepatitis A is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. To prevent hepatitis A, one can get vaccinated, practice good hygiene, and avoid consuming contaminated food or water.""]","[""Hepatitis A virus (HAV) is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. To prevent HAV infection, it is important to practice good hygiene, get vaccinated, and avoid consuming contaminated food or water.""]",[false],[false],[false],"[""Hepatitis A virus (HAV) is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. To prevent HAV infection, one should practice good hygiene, get vaccinated, and avoid consuming contaminated food or water.""]","[""Hepatitis A is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. Symptoms include fatigue, nausea, abdominal pain, and jaundice. The best way to prevent hepatitis A is by getting vaccinated and practicing good hygiene, such as washing hands thoroughly.""]","[""Hepatitis A virus (HAV) is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. The best way to prevent HAV is by getting vaccinated and practicing good hygiene, such as washing hands regularly and avoiding unclean food and water sources.""]",[false],[false],[false],"[""HAV (Hepatitis A Virus) is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. Symptoms include fever, fatigue, nausea, and jaundice. The best way to prevent HAV is through vaccination and practicing good hygiene, such as washing hands regularly and avoiding unclean food and water.""]","[""Hepatitis A is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. The best way to prevent hepatitis A is by getting vaccinated. Good hygiene practices, such as washing hands thoroughly and avoiding unclean food and water, can also help prevent the spread of the virus.""]","[""Hepatitis A virus (HAV) is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. Vaccination is the best way to prevent HAV infection.""]",[false],[false],[false],"[""HAV (Hepatitis A Virus) is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. Symptoms include fever, fatigue, nausea, and jaundice. The best way to prevent HAV is by getting vaccinated and practicing good hygiene, such as washing hands regularly and avoiding unclean food and water.""]","[""Hepatitis A is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. To prevent Hepatitis A, one should get vaccinated, practice good hygiene, and avoid consuming contaminated food or water.""]","[""Hepatitis A virus (HAV) is a highly contagious liver infection caused by the hepatitis A virus. It can be prevented by vaccination and good hygiene practices such as handwashing and safe food handling.""]",[false],[false],[false],"[""HAV (Hepatitis A Virus) is a liver infection caused by the Hepatitis A virus. It is usually spread through contaminated food or water. Symptoms include fever, fatigue, nausea, and jaundice. The best way to prevent HAV is by getting vaccinated and practicing good hygiene, such as washing hands thoroughly.""]","[""Hepatitis A is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. To prevent hepatitis A, one can get vaccinated, practice good hygiene, and avoid consuming contaminated food or water.""]","[""Hepatitis A virus (HAV) is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. To prevent HAV infection, it is important to practice good hygiene, get vaccinated, and avoid consuming contaminated food or water.""]",[false],[false],[false],"[""HAV (Hepatitis A Virus) is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. Symptoms include fever, fatigue, nausea, and jaundice. The best way to prevent HAV is by getting vaccinated and practicing good hygiene, such as washing hands frequently.""]","[""Hepatitis A is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. Symptoms include fatigue, nausea, abdominal pain, and jaundice. The best way to prevent hepatitis A is by getting vaccinated and practicing good hygiene, such as washing hands thoroughly.""]","[""Hepatitis A virus (HAV) is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. The best way to prevent HAV is by getting vaccinated and practicing good hygiene, such as washing hands regularly and avoiding unclean food and water sources.""]",[false],[false],[false],"[""Understand the symptoms, transmission, prevention methods, and treatment options for Hepatitis A Virus (HAV).""]","[""Hepatitis A is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. The best way to prevent hepatitis A is by getting vaccinated. Good hygiene practices, such as washing hands thoroughly and avoiding unclean food and water, can also help prevent the spread of the virus.""]","[""Hepatitis A virus (HAV) is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. Vaccination is the best way to prevent HAV infection.""]",[false],[false],[false],"[""Hepatitis A is a liver infection caused by the Hepatitis A virus. It is usually spread through contaminated food or water. To prevent HAV, one should practice good hygiene, get vaccinated, and avoid consuming contaminated food or water.""]","[""Hepatitis A is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. To prevent Hepatitis A, one should get vaccinated, practice good hygiene, and avoid consuming contaminated food or water.""]","[""Hepatitis A virus (HAV) is a highly contagious liver infection caused by the hepatitis A virus. It can be prevented by vaccination and good hygiene practices such as handwashing and safe food handling.""]",[false],[false],[false],"[""Hepatitis A is a liver infection caused by the Hepatitis A virus. It is usually spread through contaminated food or water. To prevent HAV infection, one should practice good hygiene, get vaccinated, and avoid consuming contaminated food or water.""]","[""Hepatitis A is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. To prevent hepatitis A, one can get vaccinated, practice good hygiene, and avoid consuming contaminated food or water.""]","[""Hepatitis A virus (HAV) is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. To prevent HAV infection, it is important to practice good hygiene, get vaccinated, and avoid consuming contaminated food or water.""]",[false],[false],[false],"[""Hepatitis A is a liver infection caused by the Hepatitis A virus. It is usually spread through contaminated food or water. Vaccination is the best way to prevent Hepatitis A infection.""]","[""Hepatitis A is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. Symptoms include fatigue, nausea, abdominal pain, and jaundice. The best way to prevent hepatitis A is by getting vaccinated and practicing good hygiene, such as washing hands thoroughly.""]","[""Hepatitis A virus (HAV) is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. The best way to prevent HAV is by getting vaccinated and practicing good hygiene, such as washing hands regularly and avoiding unclean food and water sources.""]",[false],[false],[false],"[""Hepatitis A is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. The best way to prevent HAV is by getting vaccinated and practicing good hygiene, such as washing hands thoroughly with soap and water.""]","[""Hepatitis A is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. The best way to prevent hepatitis A is by getting vaccinated. Good hygiene practices, such as washing hands thoroughly and avoiding unclean food and water, can also help prevent the spread of the virus.""]","[""Hepatitis A virus (HAV) is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. Vaccination is the best way to prevent HAV infection.""]",[false],[false],[false],"[""Hepatitis A is a liver infection caused by the Hepatitis A virus. It is usually spread through contaminated food or water. Symptoms include fever, fatigue, loss of appetite, nausea, and jaundice. The best way to prevent Hepatitis A is by getting vaccinated and practicing good hygiene, such as washing hands thoroughly before eating.""]","[""Hepatitis A is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. To prevent Hepatitis A, one should get vaccinated, practice good hygiene, and avoid consuming contaminated food or water.""]","[""Hepatitis A virus (HAV) is a highly contagious liver infection caused by the hepatitis A virus. It can be prevented by vaccination and good hygiene practices such as handwashing and safe food handling.""]",[false],[false],[false],"[""Hepatitis A is a liver infection caused by the Hepatitis A virus. It is usually spread through contaminated food or water. The best way to prevent HAV is by getting vaccinated and practicing good hygiene, such as washing hands thoroughly before eating or preparing food.""]","[""Hepatitis A is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. To prevent hepatitis A, one can get vaccinated, practice good hygiene, and avoid consuming contaminated food or water.""]","[""Hepatitis A virus (HAV) is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. To prevent HAV infection, it is important to practice good hygiene, get vaccinated, and avoid consuming contaminated food or water.""]",[false],[false],[false],"[""Hepatitis A virus (HAV) is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. Symptoms include fever, fatigue, loss of appetite, nausea, vomiting, abdominal pain, dark urine, and jaundice. Prevention includes vaccination and practicing good hygiene, such as washing hands frequently and avoiding contaminated food and water.""]","[""Hepatitis A is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. Symptoms include fatigue, nausea, abdominal pain, and jaundice. The best way to prevent hepatitis A is by getting vaccinated and practicing good hygiene, such as washing hands thoroughly.""]","[""Hepatitis A virus (HAV) is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. The best way to prevent HAV is by getting vaccinated and practicing good hygiene, such as washing hands regularly and avoiding unclean food and water sources.""]",[false],[false],[false],"[""Learn about the symptoms, transmission, prevention, and treatment of Hepatitis A Virus (HAV).""]","[""Hepatitis A is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. The best way to prevent hepatitis A is by getting vaccinated. Good hygiene practices, such as washing hands thoroughly and avoiding unclean food and water, can also help prevent the spread of the virus.""]","[""Hepatitis A virus (HAV) is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. Vaccination is the best way to prevent HAV infection.""]",[false],[false],[false],"[""To know about Hepatitis A Virus (HAV), you should understand its transmission, symptoms, prevention methods, and treatment options. It is important to be aware of the risk factors, vaccination recommendations, and potential complications associated with HAV infection.""]","[""Hepatitis A is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. To prevent Hepatitis A, one should get vaccinated, practice good hygiene, and avoid consuming contaminated food or water.""]","[""Hepatitis A virus (HAV) is a highly contagious liver infection caused by the hepatitis A virus. It can be prevented by vaccination and good hygiene practices such as handwashing and safe food handling.""]",[false],[false],[false],"[""To know about Hepatitis A Virus (HAV), you should research its transmission, symptoms, prevention methods, and treatment options. It is important to understand how the virus spreads, the typical signs of infection, ways to protect yourself from contracting HAV, and the available medical interventions.""]","[""Hepatitis A is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. To prevent hepatitis A, one can get vaccinated, practice good hygiene, and avoid consuming contaminated food or water.""]","[""Hepatitis A virus (HAV) is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. To prevent HAV infection, it is important to practice good hygiene, get vaccinated, and avoid consuming contaminated food or water.""]",[false],[false],[false],"[""Understand the symptoms, transmission, prevention, and treatment of Hepatitis A Virus (HAV).""]","[""Hepatitis A is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. Symptoms include fatigue, nausea, abdominal pain, and jaundice. The best way to prevent hepatitis A is by getting vaccinated and practicing good hygiene, such as washing hands thoroughly.""]","[""Hepatitis A virus (HAV) is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. The best way to prevent HAV is by getting vaccinated and practicing good hygiene, such as washing hands regularly and avoiding unclean food and water sources.""]",[false],[false],[false],"[""HAV (Hepatitis A Virus) is a highly contagious liver infection caused by the hepatitis A virus. It can be prevented by vaccination and good hygiene practices such as handwashing and safe food handling.""]","[""Hepatitis A is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. The best way to prevent hepatitis A is by getting vaccinated. Good hygiene practices, such as washing hands thoroughly and avoiding unclean food and water, can also help prevent the spread of the virus.""]","[""Hepatitis A virus (HAV) is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. Vaccination is the best way to prevent HAV infection.""]",[false],[false],[false],"[""HAV (Hepatitis A Virus) is a contagious liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. Symptoms include fever, fatigue, loss of appetite, nausea, and jaundice. The best way to prevent HAV is by getting vaccinated and practicing good hygiene, such as washing hands thoroughly.""]","[""Hepatitis A is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. The best way to prevent hepatitis A is by getting vaccinated. Good hygiene practices, such as washing hands thoroughly and avoiding unclean food and water, can also help prevent the spread of the virus.""]","[""Hepatitis A virus (HAV) is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. Vaccination is the best way to prevent HAV infection.""]",[false],[false],[false],"[""HAV (Hepatitis A) is a viral liver disease that can be prevented by vaccination. It is spread through contaminated food and water. Symptoms include fever, fatigue, nausea, and jaundice. Good hygiene practices and vaccination are key in preventing HAV infection.""]","[""Hepatitis A is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. The best way to prevent hepatitis A is by getting vaccinated. Good hygiene practices, such as washing hands thoroughly and avoiding unclean food and water, can also help prevent the spread of the virus.""]","[""Hepatitis A virus (HAV) is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. Vaccination is the best way to prevent HAV infection.""]",[false],[false],[false],"[""Learn about the symptoms, transmission, prevention, and treatment of Hepatitis A Virus (HAV).""]","[""Hepatitis A is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. The best way to prevent hepatitis A is by getting vaccinated. Good hygiene practices, such as washing hands thoroughly and avoiding unclean food and water, can also help prevent the spread of the virus.""]","[""Hepatitis A virus (HAV) is a liver infection caused by the hepatitis A virus. It is usually spread through contaminated food or water. Vaccination is the best way to prevent HAV infection.""]"
treatment,What are the treatments for autosomal dominant hyper-IgE syndrome ?,These resources address the diagnosis or management of autosomal dominant hyper-IgE syndrome:  - Gene Review: Gene Review: Autosomal Dominant Hyper IgE Syndrome  - Genetic Testing Registry: Hyperimmunoglobulin E syndrome  - MedlinePlus Encyclopedia: Hyperimmunoglobulin E syndrome   These resources from MedlinePlus offer information about the diagnosis and management of various health conditions:  - Diagnostic Tests  - Drug Therapy  - Surgery and Rehabilitation  - Genetic Counseling   - Palliative Care,"{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""AD-HIES"", ""full_form"": ""autosomal dominant hyper-IgE syndrome""}]}",What are the treatments for AD-HIES ?,What are the treatments for autosomal dominant hyper-IgE syndrome ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.",[[]],[[]],"[""Autosomal Dominant Hyper-IgE Syndrome""]",[1.1158369932277807e-21],[1.1158369932277807e-21],"[""Autosomal Dominant Hyper-IgE Syndrome""]",[1.1158369932277807e-21],"[""LLM""]",[[]],[0.8661429406720886],[0.8591406513005477],"[""autosomal dominant hyper-IgE syndrome""]",[0.8591406513005477],"[""LLM""]",[[]],"[""Autosomal Dominant Hyper-IgE Syndrome""]","[""LLM""]",What are the treatments for AD-HIES (Autosomal Dominant Hyper-IgE Syndrome) ?,[true],[true],[true],"[""The treatments for AD-HIES include antibiotics for infections, antifungal medications, and immunoglobulin replacement therapy.""]","[""The treatments for autosomal dominant hyper-IgE syndrome include antibiotics to treat infections, antifungal medications, and immunoglobulin replacement therapy.""]","[""The treatments for AD-HIES include prophylactic antibiotics, antifungal agents, and immunoglobulin replacement therapy.""]",[true],[true],[true],"[""The treatments for AD-HIES include antibiotics to treat infections, antifungal medications, and immunoglobulin replacement therapy.""]","[""The treatments for autosomal dominant hyper-IgE syndrome include antibiotics to treat and prevent infections, antifungal medications, and immunoglobulin replacement therapy.""]","[""The treatments for AD-HIES include prophylactic antibiotics, antifungal agents, and immunoglobulin replacement therapy.""]",[true],[true],[false],"[""Treatment for AD-HIES includes antibiotics for infections, antifungal medications, and immunomodulatory therapy.""]","[""The treatments for autosomal dominant hyper-IgE syndrome include antibiotics for treating infections, antifungal medications, and immunomodulatory therapy.""]","[""The treatments for AD-HIES include prophylactic antibiotics, antifungal agents, and immunoglobulin replacement therapy.""]",[true],[true],[true],"[""The treatments for AD-HIES include antibiotics for infections, antifungal medications, and immunomodulatory therapy.""]","[""The treatments for autosomal dominant hyper-IgE syndrome include antibiotics to treat and prevent infections, antifungal medications, and immunoglobulin replacement therapy.""]","[""The treatments for AD-HIES include prophylactic antibiotics, antifungal agents, and immunoglobulin replacement therapy.""]",[true],[true],[true],"[""The treatments for AD-HIES include antibiotics for infections, antifungal medications, and immunoglobulin replacement therapy.""]","[""The treatments for autosomal dominant hyper-IgE syndrome include antibiotics to treat infections, antifungal medications, and immunoglobulin replacement therapy.""]","[""The treatments for AD-HIES include prophylactic antibiotics, antifungal agents, and immunoglobulin replacement therapy.""]",[true],[true],[true],"[""The treatments for AD-HIES include antibiotics for infections, antifungal medications, and immunomodulatory therapy.""]","[""The treatments for autosomal dominant hyper-IgE syndrome include antibiotics to treat and prevent infections, antifungal medications, and immunoglobulin replacement therapy.""]","[""The treatments for AD-HIES include prophylactic antibiotics, antifungal agents, and immunoglobulin replacement therapy.""]",[true],[true],[true],"[""The treatments for AD-HIES include antibiotics for infections, antifungal medications, and immunoglobulin replacement therapy.""]","[""The treatments for autosomal dominant hyper-IgE syndrome include antibiotics for treating infections, antifungal medications, and immunomodulatory therapy.""]","[""The treatments for AD-HIES include prophylactic antibiotics, antifungal agents, and immunoglobulin replacement therapy.""]",[true],[true],[true],"[""Treatment for AD-HIES includes antibiotics for infections, antifungals for fungal infections, and immunomodulatory therapy to manage the immune system dysfunction.""]","[""The treatments for autosomal dominant hyper-IgE syndrome include antibiotics to treat and prevent infections, antifungal medications, and immunoglobulin replacement therapy.""]","[""The treatments for AD-HIES include prophylactic antibiotics, antifungal agents, and immunoglobulin replacement therapy.""]",[true],[true],[true],"[""Treatment for AD-HIES includes antibiotics for infections, antifungal medications, and immunomodulatory therapy.""]","[""The treatments for autosomal dominant hyper-IgE syndrome include antibiotics to treat and prevent infections, antifungal medications, and immunoglobulin replacement therapy.""]","[""The treatments for AD-HIES include prophylactic antibiotics, antifungal agents, and immunoglobulin replacement therapy.""]",[true],[true],[true],"[""Treatment for AD-HIES includes antibiotics for infections, antifungals for fungal infections, and immunomodulatory therapy to manage symptoms.""]","[""The treatments for autosomal dominant hyper-IgE syndrome include antibiotics to treat infections, antifungal medications, and immunoglobulin replacement therapy.""]","[""The treatments for AD-HIES include prophylactic antibiotics, antifungal agents, and immunoglobulin replacement therapy.""]",[true],[true],[true],"[""The treatments for AD-HIES include antibiotics for infections, antifungal medications, and immunoglobulin replacement therapy.""]","[""The treatments for autosomal dominant hyper-IgE syndrome include antibiotics for treating infections, antifungal medications, and immunomodulatory therapy.""]","[""The treatments for AD-HIES include prophylactic antibiotics, antifungal agents, and immunoglobulin replacement therapy.""]",[true],[true],[true],"[""The treatments for AD-HIES include antibiotics for infections, antifungal medications, and immunomodulatory therapy.""]","[""The treatments for autosomal dominant hyper-IgE syndrome include antibiotics to treat and prevent infections, antifungal medications, and immunoglobulin replacement therapy.""]","[""The treatments for AD-HIES include prophylactic antibiotics, antifungal agents, and immunoglobulin replacement therapy.""]",[true],[true],[true],"[""Treatment for AD-HIES includes antibiotics for infections, antifungal medications, and immunomodulatory therapy.""]","[""The treatments for autosomal dominant hyper-IgE syndrome include antibiotics to treat infections, antifungal medications, and immunoglobulin replacement therapy.""]","[""The treatments for AD-HIES include prophylactic antibiotics, antifungal agents, and immunoglobulin replacement therapy.""]",[true],[true],[true],"[""Treatment for AD-HIES includes antibiotics for infections, antifungal medications, and immunomodulatory therapy.""]","[""The treatments for autosomal dominant hyper-IgE syndrome include antibiotics to treat and prevent infections, antifungal medications, and immunoglobulin replacement therapy.""]","[""The treatments for AD-HIES include prophylactic antibiotics, antifungal agents, and immunoglobulin replacement therapy.""]",[true],[true],[true],"[""Antibiotics for infections, antifungal medications, and immunomodulatory therapy""]","[""The treatments for autosomal dominant hyper-IgE syndrome include antibiotics for treating infections, antifungal medications, and immunomodulatory therapy.""]","[""The treatments for AD-HIES include prophylactic antibiotics, antifungal agents, and immunoglobulin replacement therapy.""]",[true],[true],[true],"[""Treatment for AD-HIES includes antibiotics for infections, antifungal medications, and immunomodulatory therapy.""]","[""The treatments for autosomal dominant hyper-IgE syndrome include antibiotics to treat and prevent infections, antifungal medications, and immunoglobulin replacement therapy.""]","[""The treatments for AD-HIES include prophylactic antibiotics, antifungal agents, and immunoglobulin replacement therapy.""]",[true],[true],[true],"[""The treatments for AD-HIES (Autosomal Dominant Hyper-IgE Syndrome) include antibiotics for treating infections, antifungal medications, and immunoglobulin replacement therapy.""]","[""The treatments for autosomal dominant hyper-IgE syndrome include antibiotics to treat infections, antifungal medications, and immunoglobulin replacement therapy.""]","[""The treatments for AD-HIES include prophylactic antibiotics, antifungal agents, and immunoglobulin replacement therapy.""]",[true],[true],[true],"[""The treatments for AD-HIES include antibiotics for infections, antifungal medications, and immunomodulatory therapy.""]","[""The treatments for autosomal dominant hyper-IgE syndrome include antibiotics to treat and prevent infections, antifungal medications, and immunoglobulin replacement therapy.""]","[""The treatments for AD-HIES include prophylactic antibiotics, antifungal agents, and immunoglobulin replacement therapy.""]",[true],[true],[false],"[""The treatments for AD-HIES include antibiotics for infections, antifungal medications, and immunomodulatory therapy.""]","[""The treatments for autosomal dominant hyper-IgE syndrome include antibiotics for treating infections, antifungal medications, and immunomodulatory therapy.""]","[""The treatments for AD-HIES include prophylactic antibiotics, antifungal agents, and immunoglobulin replacement therapy.""]",[true],[true],[true],"[""The treatments for AD-HIES include antibiotics for infections, antifungal medications, and immunoglobulin replacement therapy.""]","[""The treatments for autosomal dominant hyper-IgE syndrome include antibiotics to treat and prevent infections, antifungal medications, and immunoglobulin replacement therapy.""]","[""The treatments for AD-HIES include prophylactic antibiotics, antifungal agents, and immunoglobulin replacement therapy.""]",[true],[true],[true],"[""The treatments for AD-HIES include antibiotics for infections, antifungal medications, and immunomodulatory therapy.""]","[""The treatments for autosomal dominant hyper-IgE syndrome include antibiotics to treat infections, antifungal medications, and immunoglobulin replacement therapy.""]","[""The treatments for AD-HIES include prophylactic antibiotics, antifungal agents, and immunoglobulin replacement therapy.""]",[true],[true],[true],"[""The treatments for AD-HIES include antibiotics for infections, antifungal medications, and immunomodulatory therapy.""]","[""The treatments for autosomal dominant hyper-IgE syndrome include antibiotics to treat and prevent infections, antifungal medications, and immunoglobulin replacement therapy.""]","[""The treatments for AD-HIES include prophylactic antibiotics, antifungal agents, and immunoglobulin replacement therapy.""]",[true],[true],[true],"[""The treatments for AD-HIES include antibiotics for infections, antifungal medications, and immunoglobulin replacement therapy.""]","[""The treatments for autosomal dominant hyper-IgE syndrome include antibiotics for treating infections, antifungal medications, and immunomodulatory therapy.""]","[""The treatments for AD-HIES include prophylactic antibiotics, antifungal agents, and immunoglobulin replacement therapy.""]",[true],[true],[true],"[""Treatment for AD-HIES includes antibiotics for infections, antifungal medications, and immunomodulatory therapy.""]","[""The treatments for autosomal dominant hyper-IgE syndrome include antibiotics to treat and prevent infections, antifungal medications, and immunoglobulin replacement therapy.""]","[""The treatments for AD-HIES include prophylactic antibiotics, antifungal agents, and immunoglobulin replacement therapy.""]",[false],[false],[false],"[""The treatments for AD-HIES include antibiotics for infections, antifungal medications, and immunoglobulin replacement therapy.""]","[""The treatments for autosomal dominant hyper-IgE syndrome include antibiotics to treat infections, antifungal medications, and immunoglobulin replacement therapy.""]","[""The treatments for AD-HIES include prophylactic antibiotics, antifungal agents, and immunoglobulin replacement therapy.""]",[true],[true],[true],"[""The treatments for AD-HIES include antibiotics for infections, antifungal medications, immunoglobulin replacement therapy, and in some cases, hematopoietic stem cell transplantation.""]","[""The treatments for autosomal dominant hyper-IgE syndrome include antibiotics to treat and prevent infections, antifungal medications, and immunoglobulin replacement therapy.""]","[""The treatments for AD-HIES include prophylactic antibiotics, antifungal agents, and immunoglobulin replacement therapy.""]",[true],[true],[true],"[""The treatments for AD-HIES include antibiotics for infections, antifungal medications, and immunoglobulin replacement therapy.""]","[""The treatments for autosomal dominant hyper-IgE syndrome include antibiotics for treating infections, antifungal medications, and immunomodulatory therapy.""]","[""The treatments for AD-HIES include prophylactic antibiotics, antifungal agents, and immunoglobulin replacement therapy.""]",[true],[true],[true],"[""The treatments for AD-HIES include antibiotics for infections, antifungal medications, and immunoglobulin replacement therapy.""]","[""The treatments for autosomal dominant hyper-IgE syndrome include antibiotics to treat and prevent infections, antifungal medications, and immunoglobulin replacement therapy.""]","[""The treatments for AD-HIES include prophylactic antibiotics, antifungal agents, and immunoglobulin replacement therapy.""]",[true],[true],[true],"[""The treatments for AD-HIES include antibiotics for infections, antifungal medications, and immunomodulatory therapy.""]","[""The treatments for autosomal dominant hyper-IgE syndrome include antibiotics to treat infections, antifungal medications, and immunoglobulin replacement therapy.""]","[""The treatments for AD-HIES include prophylactic antibiotics, antifungal agents, and immunoglobulin replacement therapy.""]",[true],[true],[true],"[""The treatments for AD-HIES include antibiotics for infections, antifungal medications, and immunomodulatory therapy.""]","[""The treatments for autosomal dominant hyper-IgE syndrome include antibiotics to treat infections, antifungal medications, and immunoglobulin replacement therapy.""]","[""The treatments for AD-HIES include prophylactic antibiotics, antifungal agents, and immunoglobulin replacement therapy.""]",[true],[true],[true],"[""The treatments for AD-HIES include antibiotics for infections, antifungal medications, and immunomodulatory therapy.""]","[""The treatments for autosomal dominant hyper-IgE syndrome include antibiotics to treat infections, antifungal medications, and immunoglobulin replacement therapy.""]","[""The treatments for AD-HIES include prophylactic antibiotics, antifungal agents, and immunoglobulin replacement therapy.""]",[true],[true],[true],"[""The treatments for AD-HIES include antibiotics for infections, antifungal medications, and immunomodulatory therapy.""]","[""The treatments for autosomal dominant hyper-IgE syndrome include antibiotics to treat infections, antifungal medications, and immunoglobulin replacement therapy.""]","[""The treatments for AD-HIES include prophylactic antibiotics, antifungal agents, and immunoglobulin replacement therapy.""]"
symptoms,What are the symptoms of Mutiple parosteal osteochondromatous proliferations ?,"What are the signs and symptoms of Mutiple parosteal osteochondromatous proliferations? The Human Phenotype Ontology provides the following list of signs and symptoms for Mutiple parosteal osteochondromatous proliferations. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the wrist 90% Multiple enchondromatosis 90% Tarsal synostosis 90% Autosomal dominant inheritance - Joint swelling - Osteochondroma - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""MPO"", ""full_form"": ""Mutiple parosteal osteochondromatous proliferations""}]}",What are the symptoms of MPO ?,What are the symptoms of Mutiple parosteal osteochondromatous proliferations ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Metropolitan Planning Organization"", ""Military Post Office"", ""Minor Planet Observer"", ""Master Patrol Officer"", ""Member Political Organizer"", ""Municipal Planning Organization"", ""Motivepower Industries, Inc."", ""Milton P Oliver"", ""Medical and Pediatric Oncology (journal)"", ""Mt. Pocono, Pennsylvania USA""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Myeloperoxidase""]",[6.814575054352592e-33],[1.0129798919901674e-20],"[""Military Post Office""]",[3.263716688571872e-13],"[""ABBREVIATIONS""]","[[4.1431398490112944e-16, 3.263716688571872e-13, 3.880459826586671e-16, 4.8389544822957335e-18, 3.7992484698233825e-17, 5.485701615817996e-18, 6.65043199649231e-26, 1.4279602451359154e-20, 3.8349841347381268e-22, 8.667880378323502e-39]]",[0.6807284371867524],[0.8841768130156367],"[""Mt. Pocono, Pennsylvania USA""]",[0.8841768130156367],"[""LLM""]","[[0.7465272290609404, 0.7421861402461126, 0.7237484210914351, 0.7607919252285461, 0.7620424226032112, 0.7218785681827428, 0.770722542598324, 0.8224594983714215, 0.8071549699132404, 0.7465508280121249]]","[""Myeloperoxidase""]","[""LLM""]",What are the symptoms of MPO (Myeloperoxidase) ?,[false],[true],[false],"[""The Military Post Office (MPO) does not have symptoms as it is a postal system used by the military for mail delivery.""]","[""Symptoms of Multiple parosteal osteochondromatous proliferations include pain, swelling, and limited range of motion in the affected area.""]","[""Symptoms of MPO include fatigue, shortness of breath, pale skin, frequent infections, and unexplained weight loss.""]",[false],[true],[false],"[""The Military Post Office (MPO) does not have symptoms as it is a mail system used by the military for sending and receiving mail.""]","[""Symptoms of Multiple Parosteal Osteochondromatous Proliferations include pain, swelling, and limited range of motion in the affected area.""]","[""Symptoms of MPO may include joint pain, skin rashes, kidney problems, and difficulty breathing.""]",[false],[true],[false],"[""Symptoms of MPO (Military Post Office) are not related to a medical condition, as MPO refers to a mail service for military personnel.""]","[""The symptoms of Multiple parosteal osteochondromatous proliferations include pain, swelling, and limited range of motion in the affected area.""]","[""Symptoms of MPO include shortness of breath, fatigue, weakness, pale skin, and increased risk of infections.""]",[false],[true],[false],"[""Symptoms of MPO (Military Post Office) are not related to a medical condition, as MPO refers to a mail processing facility for military mail.""]","[""Symptoms of Multiple parosteal osteochondromatous proliferations include pain, swelling, and limited range of motion in the affected area.""]","[""Symptoms of MPO may include fatigue, shortness of breath, chest pain, coughing, and fever.""]",[false],[true],[false],"[""Symptoms of MPO (Mt. Pocono, Pennsylvania USA) are not related to a medical condition. MPO is an airport code for Mount Pocono Municipal Airport in Pennsylvania, USA.""]","[""Symptoms of Multiple parosteal osteochondromatous proliferations include pain, swelling, and limited range of motion in the affected area.""]","[""Symptoms of MPO include fatigue, shortness of breath, pale skin, frequent infections, and unexplained weight loss.""]",[false],[true],[false],"[""Symptoms of MPO (Mt. Pocono, Pennsylvania USA) may include fever, cough, shortness of breath, fatigue, body aches, loss of taste or smell, sore throat, congestion, and headache.""]","[""Symptoms of Multiple Parosteal Osteochondromatous Proliferations include pain, swelling, and limited range of motion in the affected area.""]","[""Symptoms of MPO may include joint pain, skin rashes, kidney problems, and difficulty breathing.""]",[false],[true],[false],"[""Symptoms of MPO (Mt. Pocono, Pennsylvania USA) are not a medical condition, but rather a location. Please provide the name of a specific medical condition for symptom information.""]","[""The symptoms of Multiple parosteal osteochondromatous proliferations include pain, swelling, and limited range of motion in the affected area.""]","[""Symptoms of MPO include shortness of breath, fatigue, weakness, pale skin, and increased risk of infections.""]",[false],[true],[false],"[""Symptoms of MPO (Mt. Pocono, Pennsylvania USA) may vary depending on the specific condition or disease being referred to. It is recommended to consult a healthcare professional for accurate information.""]","[""Symptoms of Multiple parosteal osteochondromatous proliferations include pain, swelling, and limited range of motion in the affected area.""]","[""Symptoms of MPO may include fatigue, shortness of breath, chest pain, coughing, and fever.""]",[false],[true],[false],"[""Symptoms of Myeloperoxidase (MPO) deficiency may include recurrent infections, particularly in the respiratory tract, skin, and soft tissues.""]","[""Symptoms of Multiple Parosteal Osteochondromatous Proliferations include pain, swelling, and limited range of motion in the affected area.""]","[""Symptoms of MPO may include joint pain, skin rashes, kidney problems, and difficulty breathing.""]",[false],[true],[false],"[""The symptoms of Myeloperoxidase (MPO) deficiency may include recurrent infections, particularly of the respiratory tract, skin, and soft tissues.""]","[""Symptoms of Multiple parosteal osteochondromatous proliferations include pain, swelling, and limited range of motion in the affected area.""]","[""Symptoms of MPO include fatigue, shortness of breath, pale skin, frequent infections, and unexplained weight loss.""]",[false],[true],[false],"[""Symptoms of Myeloperoxidase (MPO) deficiency include frequent infections, particularly in the respiratory tract, skin, and soft tissues. Other symptoms may include fatigue, weakness, and pale skin.""]","[""The symptoms of Multiple parosteal osteochondromatous proliferations include pain, swelling, and limited range of motion in the affected area.""]","[""Symptoms of MPO include shortness of breath, fatigue, weakness, pale skin, and increased risk of infections.""]",[false],[true],[false],"[""Symptoms of MPO (Myeloperoxidase) include joint pain, skin rash, fever, fatigue, and weight loss.""]","[""Symptoms of Multiple parosteal osteochondromatous proliferations include pain, swelling, and limited range of motion in the affected area.""]","[""Symptoms of MPO may include fatigue, shortness of breath, chest pain, coughing, and fever.""]",[false],[true],[false],"[""Symptoms of MPO (Myeloperoxidase) may include joint pain, fatigue, weight loss, and skin rash.""]","[""Symptoms of Multiple parosteal osteochondromatous proliferations include pain, swelling, and limited range of motion in the affected area.""]","[""Symptoms of MPO include fatigue, shortness of breath, pale skin, frequent infections, and unexplained weight loss.""]",[false],[true],[false],"[""Symptoms of MPO (Myeloperoxidase) deficiency may include recurrent infections, particularly of the respiratory tract, and autoimmune diseases such as vasculitis.""]","[""Symptoms of Multiple Parosteal Osteochondromatous Proliferations include pain, swelling, and limited range of motion in the affected area.""]","[""Symptoms of MPO may include joint pain, skin rashes, kidney problems, and difficulty breathing.""]",[false],[true],[false],"[""Symptoms of MPO (Myeloperoxidase) include joint pain, fatigue, weight loss, and skin rash.""]","[""The symptoms of Multiple parosteal osteochondromatous proliferations include pain, swelling, and limited range of motion in the affected area.""]","[""Symptoms of MPO include shortness of breath, fatigue, weakness, pale skin, and increased risk of infections.""]",[false],[true],[false],"[""Symptoms of MPO (Myeloperoxidase) deficiency include recurrent infections, especially of the respiratory tract, skin, and soft tissues.""]","[""Symptoms of Multiple parosteal osteochondromatous proliferations include pain, swelling, and limited range of motion in the affected area.""]","[""Symptoms of MPO may include fatigue, shortness of breath, chest pain, coughing, and fever.""]",[false],[true],[false],"[""Symptoms of MPO (Myeloperoxidase) include joint pain, skin rash, fever, fatigue, and weight loss.""]","[""Symptoms of Multiple parosteal osteochondromatous proliferations include pain, swelling, and limited range of motion in the affected area.""]","[""Symptoms of MPO include fatigue, shortness of breath, pale skin, frequent infections, and unexplained weight loss.""]",[false],[true],[false],"[""Symptoms of MPO (Myeloperoxidase) include joint pain, skin rash, fever, fatigue, and weight loss.""]","[""Symptoms of Multiple Parosteal Osteochondromatous Proliferations include pain, swelling, and limited range of motion in the affected area.""]","[""Symptoms of MPO may include joint pain, skin rashes, kidney problems, and difficulty breathing.""]",[false],[true],[false],"[""Symptoms of MPO (Myeloperoxidase) deficiency include recurrent infections, particularly of the respiratory tract, skin, and soft tissues. Other symptoms may include fatigue, weakness, and pale skin.""]","[""The symptoms of Multiple parosteal osteochondromatous proliferations include pain, swelling, and limited range of motion in the affected area.""]","[""Symptoms of MPO include shortness of breath, fatigue, weakness, pale skin, and increased risk of infections.""]",[false],[true],[false],"[""The symptoms of Myeloperoxidase (MPO) deficiency include recurrent infections, particularly in the lungs and skin, as well as autoimmune conditions such as vasculitis and arthritis.""]","[""Symptoms of Multiple parosteal osteochondromatous proliferations include pain, swelling, and limited range of motion in the affected area.""]","[""Symptoms of MPO may include fatigue, shortness of breath, chest pain, coughing, and fever.""]",[false],[true],[false],"[""The symptoms of Myeloperoxidase (MPO) deficiency include recurrent infections, particularly in the lungs and skin, as well as inflammation in various parts of the body.""]","[""Symptoms of Multiple parosteal osteochondromatous proliferations include pain, swelling, and limited range of motion in the affected area.""]","[""Symptoms of MPO include fatigue, shortness of breath, pale skin, frequent infections, and unexplained weight loss.""]",[false],[true],[false],"[""Symptoms of Myeloperoxidase (MPO) deficiency include frequent infections, particularly in the respiratory tract, skin, and soft tissues. Patients may also experience fatigue, weakness, and anemia.""]","[""Symptoms of Multiple Parosteal Osteochondromatous Proliferations include pain, swelling, and limited range of motion in the affected area.""]","[""Symptoms of MPO may include joint pain, skin rashes, kidney problems, and difficulty breathing.""]",[false],[true],[false],"[""Some symptoms of Myeloperoxidase (MPO) deficiency include recurrent infections, particularly in the lungs and skin, as well as autoimmune conditions like vasculitis.""]","[""The symptoms of Multiple parosteal osteochondromatous proliferations include pain, swelling, and limited range of motion in the affected area.""]","[""Symptoms of MPO include shortness of breath, fatigue, weakness, pale skin, and increased risk of infections.""]",[false],[true],[false],"[""Symptoms of Myeloperoxidase (MPO) deficiency may include frequent infections, particularly in the respiratory tract, skin, and soft tissues. Other symptoms may include fatigue, weakness, and pale skin.""]","[""Symptoms of Multiple parosteal osteochondromatous proliferations include pain, swelling, and limited range of motion in the affected area.""]","[""Symptoms of MPO may include fatigue, shortness of breath, chest pain, coughing, and fever.""]",[false],[true],[false],"[""Common symptoms of MPO (Myeloperoxidase) deficiency include frequent infections, particularly in the respiratory tract, as well as joint pain and inflammation.""]","[""Symptoms of Multiple parosteal osteochondromatous proliferations include pain, swelling, and limited range of motion in the affected area.""]","[""Symptoms of MPO include fatigue, shortness of breath, pale skin, frequent infections, and unexplained weight loss.""]",[false],[true],[false],"[""Symptoms of MPO (Myeloperoxidase) may include joint pain, fatigue, weight loss, and skin rash.""]","[""Symptoms of Multiple Parosteal Osteochondromatous Proliferations include pain, swelling, and limited range of motion in the affected area.""]","[""Symptoms of MPO may include joint pain, skin rashes, kidney problems, and difficulty breathing.""]",[false],[true],[false],"[""Symptoms of MPO (Myeloperoxidase) include joint pain, skin rashes, fever, fatigue, and weight loss.""]","[""The symptoms of Multiple parosteal osteochondromatous proliferations include pain, swelling, and limited range of motion in the affected area.""]","[""Symptoms of MPO include shortness of breath, fatigue, weakness, pale skin, and increased risk of infections.""]",[false],[true],[false],"[""Common symptoms of Myeloperoxidase (MPO) deficiency include frequent infections, particularly in the respiratory tract, as well as autoimmune conditions such as vasculitis.""]","[""Symptoms of Multiple parosteal osteochondromatous proliferations include pain, swelling, and limited range of motion in the affected area.""]","[""Symptoms of MPO may include fatigue, shortness of breath, chest pain, coughing, and fever.""]",[false],[true],[false],"[""Symptoms of MPO (Myeloperoxidase) include fatigue, weight loss, joint pain, skin rash, and kidney problems.""]","[""Symptoms of Multiple parosteal osteochondromatous proliferations include pain, swelling, and limited range of motion in the affected area.""]","[""Symptoms of MPO include fatigue, shortness of breath, pale skin, frequent infections, and unexplained weight loss.""]",[false],[true],[false],"[""Symptoms of MPO (Military Post Office) are not applicable as it is a postal system used by the military.""]","[""Symptoms of Multiple parosteal osteochondromatous proliferations include pain, swelling, and limited range of motion in the affected area.""]","[""Symptoms of MPO include fatigue, shortness of breath, pale skin, frequent infections, and unexplained weight loss.""]",[false],[true],[false],"[""Symptoms of MPO (Mt. Pocono, Pennsylvania USA) vary depending on the specific condition being referred to.""]","[""Symptoms of Multiple parosteal osteochondromatous proliferations include pain, swelling, and limited range of motion in the affected area.""]","[""Symptoms of MPO include fatigue, shortness of breath, pale skin, frequent infections, and unexplained weight loss.""]",[false],[true],[false],"[""Symptoms of MPO (Myeloperoxidase) include joint pain, skin rash, fever, fatigue, and weight loss.""]","[""Symptoms of Multiple parosteal osteochondromatous proliferations include pain, swelling, and limited range of motion in the affected area.""]","[""Symptoms of MPO include fatigue, shortness of breath, pale skin, frequent infections, and unexplained weight loss.""]"
genetic changes,"What are the genetic changes related to mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes ?","MELAS can result from mutations in one of several genes, including MT-ND1, MT-ND5, MT-TH, MT-TL1, and MT-TV. These genes are found in the DNA of cellular structures called mitochondria, which convert the energy from food into a form that cells can use. Although most DNA is packaged in chromosomes within the nucleus, mitochondria also have a small amount of their own DNA, known as mitochondrial DNA or mtDNA.  Some of the genes related to MELAS provide instructions for making proteins involved in normal mitochondrial function. These proteins are part of a large enzyme complex in mitochondria that helps convert oxygen, fats, and simple sugars to energy. Other genes associated with this disorder provide instructions for making molecules called transfer RNAs (tRNAs), which are chemical cousins of DNA. These molecules help assemble protein building blocks called amino acids into full-length, functioning proteins within mitochondria.  Mutations in a particular transfer RNA gene, MT-TL1, cause more than 80 percent of all cases of MELAS. These mutations impair the ability of mitochondria to make proteins, use oxygen, and produce energy. Researchers have not determined how changes in mtDNA lead to the specific signs and symptoms of MELAS. They continue to investigate the effects of mitochondrial gene mutations in different tissues, particularly in the brain.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""MELAS"", ""full_form"": ""mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes""}]}",What are the genetic changes related to MELAS ?,"What are the genetic changes related to mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes ?",8,MEDICAL,Compound Datatype-List/Array,"Exploratory(Divergent Thinking): Queries that are inherently about seeking new areas of knowledge, understanding emerging trends, or identifying unknown opportunities without a specific end goal of making a decision or judgment. Exploratory queries are characterized by their openness and the lack of a predefined objective, differentiating them from evaluative queries which are directed towards forming a judgment or assessment. Exploratory queries encourage branching out into various directions to explore a wide array of possibilities without necessarily aiming to converge on a single answer or outcome.","[[""Mitochondrial Encephalomyopathy Lactic Acidosis and Stroke"", ""Mitochondrial Encephalomyopathy Lactic Acidosis and Strokelike"", ""Mitochondrial Encephalomyopathy Lactic Acidosis Stroke"", ""Mitochondrial Encephalopathy Lactic Acidosis and Stroke"", ""Myopathy Encephalopathy Lactic Acidosis and Stroke"", ""Mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes"", ""Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes"", ""Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis and Stroke-Like Episodes"", ""Myoclonus Epilepsy Lactic Acidosis Stroke"", ""Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis and Stroke-Like Episodes"", ""Myoclonus Epilepsy Lactic Acidosis Stroke""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY""]]","[""Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like episodes""]",[9.360774910607305e-32],[1.6472848997571267e-25],"[""Mitochondrial Encephalopathy Lactic Acidosis and Stroke""]",[2.2244701867450905e-19],"[""ABBREVIATIONS""]","[[5.4701033819469e-25, 1.0779023899136033e-32, 1.859631797767382e-26, 2.2244701867450905e-19, 7.300448072212459e-20, 1.6472848997571267e-25, 2.2506345564939142e-29, 5.491253923556461e-29, 2.686292651631835e-23, 5.491253923556461e-29, 2.686292651631835e-23]]",[0.9520733178704756],[0.9473662296750093],"[""Mitochondrial Encephalomyopathy Lactic Acidosis and Stroke""]",[0.9600212157318369],"[""ABBREVIATIONS""]","[[0.9545630892987917, 0.9600212157318369, 0.9595633064419882, 0.9530885957237915, 0.9573184580687215, 0.9479796888299147, 0.9491141149530007, 0.9535037860282629, 0.9522139281473511, 0.9535037860282629, 0.9522139281473511]]","[""Mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes""]","[""ABBREVIATIONS""]","What are the genetic changes related to MELAS (Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like episodes) ?",[false],[true],[true],"[""The genetic changes related to MELAS include mutations in the MT-TL1 gene (m.3243A>G) and mutations in the MT-TK gene (m.8344A>G).""]","[""The genetic changes related to mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes are typically found in the MT-TL1 gene, which encodes for the tRNA for Leucine 1.""]","[""The genetic changes related to MELAS include mutations in the MT-TL1 gene, which encodes for the tRNA(Leu(UUR)) protein, leading to impaired mitochondrial function.""]",[true],[false],[true],"[""The genetic changes related to MELAS include mutations in the MT-TL1, MT-TK, and MT-ND5 genes.""]","[""MT-TL1, MT-ND5, MT-ND6, MT-ND1, MT-ND4, MT-ND4L, MT-ND2, MT-CO3, MT-CO2, MT-CO1, MT-ATP6, MT-ATP8, MT-ND3, MT-CYB""]","[""Mitochondrial DNA mutations, particularly the m.3243A>G mutation, are commonly associated with MELAS (Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like episodes) syndrome.""]",[true],[true],[true],"[""The genetic changes related to MELAS include mutations in the MT-TL1 gene, which encodes for the tRNA for leucine, and mutations in the MT-ND5 gene, which encodes for a subunit of complex I of the mitochondrial respiratory chain.""]","[""The genetic changes related to mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes are typically found in the MT-TL1 gene, which encodes for the tRNA for Leucine. These changes often involve the m.3243A>G mutation.""]","[""The genetic changes related to MELAS include mutations in the MT-TL1 gene, which encodes for the tRNA(Leu(UUR)) protein, leading to impaired mitochondrial protein synthesis.""]",[false],[false],[true],"[""The genetic changes related to MELAS include mutations in the MT-TL1, MT-TK, MT-ND5, and MT-ND6 genes.""]","[""MT-TL1, MT-ND5, MT-ND6, MT-ND1, MT-ND4, MT-ND4L, MT-ND2, MT-ND3, MT-CO3, MT-CO2, MT-CO1, MT-ATP6, MT-ATP8, MT-CYB""]","[""The genetic changes related to MELAS include mutations in the MT-TL1 gene, which is responsible for encoding a transfer RNA molecule essential for protein synthesis within mitochondria.""]",[false],[true],[true],"[""The genetic changes related to MELAS include mutations in the MT-TL1, MT-TK, and MT-ND5 genes.""]","[""The genetic changes related to mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes are typically found in the MT-TL1 gene, which encodes for the tRNA for Leucine 1.""]","[""The genetic changes related to MELAS include mutations in the MT-TL1 gene, which encodes for the tRNA(Leu(UUR)) protein, leading to impaired mitochondrial function.""]",[false],[false],[true],"[""The genetic changes related to MELAS include mutations in the MT-TL1, MT-TK, MT-ND5, MT-ND6, and MT-TC genes.""]","[""MT-TL1, MT-ND5, MT-ND6, MT-ND1, MT-ND4, MT-ND4L, MT-ND2, MT-CO3, MT-CO2, MT-CO1, MT-ATP6, MT-ATP8, MT-ND3, MT-CYB""]","[""Mitochondrial DNA mutations, particularly the m.3243A>G mutation, are commonly associated with MELAS (Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like episodes) syndrome.""]",[false],[true],[true],"[""The genetic changes related to MELAS include mutations in the MT-TL1, MT-TK, MT-ND5, and MT-ND6 genes.""]","[""The genetic changes related to mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes are typically found in the MT-TL1 gene, which encodes for the tRNA for Leucine. These changes often involve the m.3243A>G mutation.""]","[""The genetic changes related to MELAS include mutations in the MT-TL1 gene, which encodes for the tRNA(Leu(UUR)) protein, leading to impaired mitochondrial protein synthesis.""]",[false],[false],[true],"[""The genetic changes related to MELAS include mutations in the MT-TL1, MT-TK, MT-ND5, and MT-ND6 genes.""]","[""MT-TL1, MT-ND5, MT-ND6, MT-ND1, MT-ND4, MT-ND4L, MT-ND2, MT-ND3, MT-CO3, MT-CO2, MT-CO1, MT-ATP6, MT-ATP8, MT-CYB""]","[""The genetic changes related to MELAS include mutations in the MT-TL1 gene, which is responsible for encoding a transfer RNA molecule essential for protein synthesis within mitochondria.""]",[true],[false],[true],"[""The genetic changes related to MELAS include mutations in the MT-TL1 gene, which encodes for the tRNA for leucine, and mutations in the MT-ND5 gene, which encodes for a subunit of complex I of the mitochondrial respiratory chain.""]","[""MT-TL1, MT-ND5, MT-ND6, MT-ND1, MT-ND4, MT-ND4L, MT-ND2, MT-CO3, MT-CO2, MT-CO1, MT-ATP6, MT-ATP8, MT-ND3, MT-CYB""]","[""Mitochondrial DNA mutations, particularly the m.3243A>G mutation, are commonly associated with MELAS (Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like episodes) syndrome.""]",[true],[true],[true],"[""The genetic changes related to MELAS include mutations in the MT-TL1 gene (m.3243A>G), MT-TK gene (m.8344A>G), MT-ND5 gene (m.13513G>A), and MT-ND6 gene (m.14459G>A).""]","[""The genetic changes related to mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes are typically found in the MT-TL1 gene, which encodes for the tRNA for Leucine 1.""]","[""The genetic changes related to MELAS include mutations in the MT-TL1 gene, which encodes for the tRNA(Leu(UUR)) protein, leading to impaired mitochondrial function.""]",[true],[true],[true],"[""The genetic changes related to MELAS include mutations in the MT-TL1, MT-TK, MT-ND5, MT-ND6, and MT-ND1 genes.""]","[""The genetic changes related to mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes are typically found in the MT-TL1 gene, which encodes for the tRNA for Leucine. These changes often involve the m.3243A>G mutation.""]","[""The genetic changes related to MELAS include mutations in the MT-TL1 gene, which encodes for the tRNA(Leu(UUR)) protein, leading to impaired mitochondrial protein synthesis.""]",[true],[false],[true],"[""The genetic changes related to MELAS include mutations in the MT-TL1 gene, which encodes for the tRNA for leucine, and mutations in the MT-ND5 gene, which encodes for a subunit of complex I of the mitochondrial respiratory chain.""]","[""MT-TL1, MT-ND5, MT-ND6, MT-ND1, MT-ND4, MT-ND4L, MT-ND2, MT-ND3, MT-CO3, MT-CO2, MT-CO1, MT-ATP6, MT-ATP8, MT-CYB""]","[""The genetic changes related to MELAS include mutations in the MT-TL1 gene, which is responsible for encoding a transfer RNA molecule essential for protein synthesis within mitochondria.""]",[false],[true],[true],"[""Mutations in the MT-TL1, MT-TK, MT-ND5, MT-ND6, and MT-TH genes have been associated with MELAS.""]","[""The genetic changes related to mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes are typically found in the MT-TL1 gene, which encodes for the tRNA for Leucine 1.""]","[""The genetic changes related to MELAS include mutations in the MT-TL1 gene, which encodes for the tRNA(Leu(UUR)) protein, leading to impaired mitochondrial function.""]",[true],[false],[true],"[""The genetic changes related to MELAS include mutations in the MT-TL1 gene, which encodes for the tRNA for leucine, and mutations in the MT-ND5 gene, which encodes for a subunit of NADH dehydrogenase.""]","[""MT-TL1, MT-ND5, MT-ND6, MT-ND1, MT-ND4, MT-ND4L, MT-ND2, MT-CO3, MT-CO2, MT-CO1, MT-ATP6, MT-ATP8, MT-ND3, MT-CYB""]","[""Mitochondrial DNA mutations, particularly the m.3243A>G mutation, are commonly associated with MELAS (Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like episodes) syndrome.""]",[true],[true],[true],"[""Mutations in the MT-TL1, MT-TK, MT-ND5, MT-ND6, and MT-ND1 genes have been associated with MELAS.""]","[""The genetic changes related to mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes are typically found in the MT-TL1 gene, which encodes for the tRNA for Leucine. These changes often involve the m.3243A>G mutation.""]","[""The genetic changes related to MELAS include mutations in the MT-TL1 gene, which encodes for the tRNA(Leu(UUR)) protein, leading to impaired mitochondrial protein synthesis.""]",[true],[false],[true],"[""The genetic changes related to MELAS include mutations in the MT-TL1 gene, which encodes for the tRNA for leucine, and mutations in the MT-ND5 gene, which encodes for a subunit of complex I of the mitochondrial respiratory chain.""]","[""MT-TL1, MT-ND5, MT-ND6, MT-ND1, MT-ND4, MT-ND4L, MT-ND2, MT-ND3, MT-CO3, MT-CO2, MT-CO1, MT-ATP6, MT-ATP8, MT-CYB""]","[""The genetic changes related to MELAS include mutations in the MT-TL1 gene, which is responsible for encoding a transfer RNA molecule essential for protein synthesis within mitochondria.""]",[false],[true],[true],"[""The genetic changes related to MELAS include mutations in the MT-TL1, MT-TK, MT-ND5, MT-ND6, and MT-TH genes.""]","[""The genetic changes related to mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes are typically found in the MT-TL1 gene, which encodes for the tRNA for Leucine 1.""]","[""The genetic changes related to MELAS include mutations in the MT-TL1 gene, which encodes for the tRNA(Leu(UUR)) protein, leading to impaired mitochondrial function.""]",[true],[false],[true],"[""The genetic changes related to MELAS include mutations in the MT-TL1, MT-TK, MT-ND5, and MT-ND6 genes.""]","[""MT-TL1, MT-ND5, MT-ND6, MT-ND1, MT-ND4, MT-ND4L, MT-ND2, MT-CO3, MT-CO2, MT-CO1, MT-ATP6, MT-ATP8, MT-ND3, MT-CYB""]","[""Mitochondrial DNA mutations, particularly the m.3243A>G mutation, are commonly associated with MELAS (Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like episodes) syndrome.""]",[true],[true],[true],"[""The genetic changes related to MELAS include mutations in the MT-TL1 gene, which encodes for the tRNA(Leu) gene in mitochondrial DNA.""]","[""The genetic changes related to mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes are typically found in the MT-TL1 gene, which encodes for the tRNA for Leucine. These changes often involve the m.3243A>G mutation.""]","[""The genetic changes related to MELAS include mutations in the MT-TL1 gene, which encodes for the tRNA(Leu(UUR)) protein, leading to impaired mitochondrial protein synthesis.""]",[false],[false],[true],"[""The genetic changes related to MELAS include mutations in the MT-TL1, MT-TK, MT-ND5, MT-ND6, and MT-TH genes.""]","[""MT-TL1, MT-ND5, MT-ND6, MT-ND1, MT-ND4, MT-ND4L, MT-ND2, MT-ND3, MT-CO3, MT-CO2, MT-CO1, MT-ATP6, MT-ATP8, MT-CYB""]","[""The genetic changes related to MELAS include mutations in the MT-TL1 gene, which is responsible for encoding a transfer RNA molecule essential for protein synthesis within mitochondria.""]",[false],[true],[true],"[""The genetic changes related to MELAS include mutations in the MT-TL1 gene (m.3243A>G) and mutations in the MT-TK gene (m.8344A>G).""]","[""The genetic changes related to mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes are typically found in the MT-TL1 gene, which encodes for the tRNA for Leucine 1.""]","[""The genetic changes related to MELAS include mutations in the MT-TL1 gene, which encodes for the tRNA(Leu(UUR)) protein, leading to impaired mitochondrial function.""]",[true],[false],[true],"[""The genetic changes related to MELAS include mutations in the MT-TL1 gene, which encodes for the tRNA for leucine, and mutations in the MT-ND5 gene, which is a subunit of complex I of the mitochondrial respiratory chain.""]","[""MT-TL1, MT-ND5, MT-ND6, MT-ND1, MT-ND4, MT-ND4L, MT-ND2, MT-CO3, MT-CO2, MT-CO1, MT-ATP6, MT-ATP8, MT-ND3, MT-CYB""]","[""Mitochondrial DNA mutations, particularly the m.3243A>G mutation, are commonly associated with MELAS (Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like episodes) syndrome.""]",[true],[true],[true],"[""The genetic changes related to MELAS include mutations in the MT-TL1 gene, which encodes for the tRNA(Leu(UUR)) protein, leading to impaired mitochondrial protein synthesis and energy production.""]","[""The genetic changes related to mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes are typically found in the MT-TL1 gene, which encodes for the tRNA for Leucine. These changes often involve the m.3243A>G mutation.""]","[""The genetic changes related to MELAS include mutations in the MT-TL1 gene, which encodes for the tRNA(Leu(UUR)) protein, leading to impaired mitochondrial protein synthesis.""]",[true],[false],[true],"[""The genetic changes related to MELAS include mutations in the MT-TL1 gene (m.3243A>G), MT-TK gene (m.8344A>G), and MT-ND5 gene (m.13513G>A).""]","[""MT-TL1, MT-ND5, MT-ND6, MT-ND1, MT-ND4, MT-ND4L, MT-ND2, MT-ND3, MT-CO3, MT-CO2, MT-CO1, MT-ATP6, MT-ATP8, MT-CYB""]","[""The genetic changes related to MELAS include mutations in the MT-TL1 gene, which is responsible for encoding a transfer RNA molecule essential for protein synthesis within mitochondria.""]",[true],[true],[true],"[""MELAS is associated with a mutation in the MT-TL1 gene, which is responsible for encoding a transfer RNA molecule used in protein synthesis within mitochondria.""]","[""The genetic changes related to mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes are typically found in the MT-TL1 gene, which encodes for the tRNA for Leucine 1.""]","[""The genetic changes related to MELAS include mutations in the MT-TL1 gene, which encodes for the tRNA(Leu(UUR)) protein, leading to impaired mitochondrial function.""]",[true],[false],[true],"[""The genetic changes related to MELAS include mutations in the MT-TL1 gene, which encodes a transfer RNA for leucine, and mutations in the MT-ND5 gene, which encodes a subunit of NADH dehydrogenase.""]","[""MT-TL1, MT-ND5, MT-ND6, MT-ND1, MT-ND4, MT-ND4L, MT-ND2, MT-CO3, MT-CO2, MT-CO1, MT-ATP6, MT-ATP8, MT-ND3, MT-CYB""]","[""Mitochondrial DNA mutations, particularly the m.3243A>G mutation, are commonly associated with MELAS (Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like episodes) syndrome.""]",[true],[true],[true],"[""Genetic changes related to MELAS include mutations in the MT-TL1, MT-TK, and MT-ND5 genes.""]","[""The genetic changes related to mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes are typically found in the MT-TL1 gene, which encodes for the tRNA for Leucine. These changes often involve the m.3243A>G mutation.""]","[""The genetic changes related to MELAS include mutations in the MT-TL1 gene, which encodes for the tRNA(Leu(UUR)) protein, leading to impaired mitochondrial protein synthesis.""]",[false],[false],[true],"[""The genetic changes related to MELAS include mutations in the MT-TL1, MT-TK, MT-ND5, and MT-ND6 genes.""]","[""MT-TL1, MT-ND5, MT-ND6, MT-ND1, MT-ND4, MT-ND4L, MT-ND2, MT-ND3, MT-CO3, MT-CO2, MT-CO1, MT-ATP6, MT-ATP8, MT-CYB""]","[""The genetic changes related to MELAS include mutations in the MT-TL1 gene, which is responsible for encoding a transfer RNA molecule essential for protein synthesis within mitochondria.""]",[true],[true],[true],"[""Genetic changes related to MELAS include mutations in the MT-TL1 gene, which encodes for the tRNA(Leu(UUR)) molecule, leading to impaired mitochondrial protein synthesis.""]","[""The genetic changes related to mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes are typically found in the MT-TL1 gene, which encodes for the tRNA for Leucine 1.""]","[""The genetic changes related to MELAS include mutations in the MT-TL1 gene, which encodes for the tRNA(Leu(UUR)) protein, leading to impaired mitochondrial function.""]",[true],[true],[true],"[""Genetic changes related to MELAS include mutations in the MT-TL1 gene, which encodes for the tRNA for leucine, and mutations in the MT-ND5 gene, which encodes for a subunit of complex I of the mitochondrial respiratory chain.""]","[""The genetic changes related to mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes are typically found in the MT-TL1 gene, which encodes for the tRNA for Leucine 1.""]","[""The genetic changes related to MELAS include mutations in the MT-TL1 gene, which encodes for the tRNA(Leu(UUR)) protein, leading to impaired mitochondrial function.""]",[true],[true],[true],"[""The genetic changes related to MELAS include mutations in the MT-TL1 gene, which encodes for the tRNA for leucine, and mutations in the MT-ND5 gene, which encodes for a subunit of complex I of the mitochondrial respiratory chain.""]","[""The genetic changes related to mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes are typically found in the MT-TL1 gene, which encodes for the tRNA for Leucine 1.""]","[""The genetic changes related to MELAS include mutations in the MT-TL1 gene, which encodes for the tRNA(Leu(UUR)) protein, leading to impaired mitochondrial function.""]",[true],[true],[true],"[""Genetic changes related to MELAS include mutations in the MT-TL1 gene, which encodes for the tRNA for leucine, and mutations in the MT-ND5 gene, which encodes for a subunit of complex I of the mitochondrial respiratory chain.""]","[""The genetic changes related to mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes are typically found in the MT-TL1 gene, which encodes for the tRNA for Leucine 1.""]","[""The genetic changes related to MELAS include mutations in the MT-TL1 gene, which encodes for the tRNA(Leu(UUR)) protein, leading to impaired mitochondrial function.""]"
symptoms,What are the symptoms of Leber congenital amaurosis 10 ?,"What are the signs and symptoms of Leber congenital amaurosis 10? The Human Phenotype Ontology provides the following list of signs and symptoms for Leber congenital amaurosis 10. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Seizures 2/4 Autosomal recessive inheritance - Hyposmia - Visual impairment - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""LCA10"", ""full_form"": ""Leber congenital amaurosis 10""}]}",What are the symptoms of LCA10 ?,What are the symptoms of Leber congenital amaurosis 10 ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.",[[]],[[]],"[""Leber Congenital Amaurosis 10""]",[3.318829988360826e-26],[3.318829988360826e-26],"[""Leber Congenital Amaurosis 10""]",[3.318829988360826e-26],"[""LLM""]",[[]],[0.8934205304927751],[0.9000018938502443],"[""Leber congenital amaurosis 10""]",[0.9000018938502443],"[""LLM""]",[[]],"[""Leber Congenital Amaurosis 10""]","[""LLM""]",What are the symptoms of LCA10 (Leber Congenital Amaurosis 10) ?,[true],[true],[true],"[""Symptoms of LCA10 include severe visual impairment or blindness from birth, roving eye movements, sensitivity to light, and sluggish or near-absent pupillary responses.""]","[""Symptoms of Leber congenital amaurosis 10 include severe visual impairment or blindness from birth, roving eye movements, deep-set eyes, and sensitivity to bright light.""]","[""The symptoms of LCA10 include severe visual impairment or blindness, sensitivity to light, involuntary eye movements, and reduced visual acuity.""]",[true],[true],[true],"[""Symptoms of LCA10 include severe visual impairment or blindness from birth, roving eye movements, deep-set eyes, and sensitivity to bright light.""]","[""Symptoms of Leber congenital amaurosis 10 include severe visual impairment, involuntary eye movements, and sensitivity to light.""]","[""The symptoms of LCA10 include severe visual impairment or blindness, sensitivity to light, involuntary eye movements, and abnormal development of the retina.""]",[true],[true],[true],"[""Symptoms of LCA10 include severe visual impairment or blindness from birth, roving eye movements, sensitivity to light, and sluggish or near-absent pupillary responses.""]","[""Symptoms of Leber congenital amaurosis 10 include severe visual impairment from birth, involuntary eye movements, sensitivity to light, and a lack of normal visual responses.""]","[""The symptoms of LCA10 include severe vision impairment or blindness, sensitivity to light, involuntary eye movements, and reduced visual acuity.""]",[true],[true],[true],"[""Symptoms of LCA10 include severe visual impairment or blindness from birth, roving eye movements, deep-set eyes, and sensitivity to light.""]","[""Symptoms of Leber congenital amaurosis 10 include severe visual impairment from birth, involuntary eye movements, and sensitivity to light.""]","[""The symptoms of LCA10 include vision loss, sensitivity to light, and involuntary eye movements.""]",[true],[true],[true],"[""Symptoms of LCA10 include severe visual impairment or blindness from birth, roving eye movements, sensitivity to light, and sluggish or near-absent pupillary responses.""]","[""Symptoms of Leber congenital amaurosis 10 include severe visual impairment or blindness from birth, roving eye movements, deep-set eyes, and sensitivity to bright light.""]","[""The symptoms of LCA10 include severe visual impairment or blindness, sensitivity to light, involuntary eye movements, and reduced visual acuity.""]",[true],[true],[true],"[""Symptoms of LCA10 include severe visual impairment or blindness from birth, roving eye movements, sensitivity to light, and sluggish or absent pupillary responses.""]","[""Symptoms of Leber congenital amaurosis 10 include severe visual impairment, involuntary eye movements, and sensitivity to light.""]","[""The symptoms of LCA10 include severe visual impairment or blindness, sensitivity to light, involuntary eye movements, and abnormal development of the retina.""]",[true],[true],[true],"[""Symptoms of LCA10 include severe visual impairment or blindness from birth, involuntary eye movements (nystagmus), and sensitivity to light (photophobia).""]","[""Symptoms of Leber congenital amaurosis 10 include severe visual impairment from birth, involuntary eye movements, sensitivity to light, and a lack of normal visual responses.""]","[""The symptoms of LCA10 include severe vision impairment or blindness, sensitivity to light, involuntary eye movements, and reduced visual acuity.""]",[true],[true],[true],"[""Symptoms of LCA10 include severe visual impairment or blindness from birth, roving eye movements, deep-set eyes, and sensitivity to light.""]","[""Symptoms of Leber congenital amaurosis 10 include severe visual impairment from birth, involuntary eye movements, and sensitivity to light.""]","[""The symptoms of LCA10 include vision loss, sensitivity to light, and involuntary eye movements.""]",[true],[true],[true],"[""Symptoms of LCA10 include severe visual impairment or blindness from birth, roving eye movements, sensitivity to light, and sluggish or near-absent pupillary responses.""]","[""Symptoms of Leber congenital amaurosis 10 include severe visual impairment, involuntary eye movements, and sensitivity to light.""]","[""The symptoms of LCA10 include severe visual impairment or blindness, sensitivity to light, involuntary eye movements, and abnormal development of the retina.""]",[true],[true],[true],"[""Symptoms of LCA10 include severe visual impairment or blindness from birth, roving eye movements, deep-set eyes, and sensitivity to light.""]","[""Symptoms of Leber congenital amaurosis 10 include severe visual impairment or blindness from birth, roving eye movements, deep-set eyes, and sensitivity to bright light.""]","[""The symptoms of LCA10 include severe visual impairment or blindness, sensitivity to light, involuntary eye movements, and reduced visual acuity.""]",[true],[true],[true],"[""Symptoms of LCA10 include severe visual impairment or blindness from birth, roving eye movements, deep-set eyes, and sensitivity to light.""]","[""Symptoms of Leber congenital amaurosis 10 include severe visual impairment from birth, involuntary eye movements, sensitivity to light, and a lack of normal visual responses.""]","[""The symptoms of LCA10 include severe vision impairment or blindness, sensitivity to light, involuntary eye movements, and reduced visual acuity.""]",[true],[true],[true],"[""Symptoms of LCA10 include severe visual impairment or blindness from birth, roving eye movements, deep-set eyes, and sensitivity to light.""]","[""Symptoms of Leber congenital amaurosis 10 include severe visual impairment from birth, involuntary eye movements, and sensitivity to light.""]","[""The symptoms of LCA10 include vision loss, sensitivity to light, and involuntary eye movements.""]",[true],[true],[true],"[""Symptoms of LCA10 include severe visual impairment or blindness from birth, roving eye movements, deep-set eyes, and sensitivity to light.""]","[""Symptoms of Leber congenital amaurosis 10 include severe visual impairment or blindness from birth, roving eye movements, deep-set eyes, and sensitivity to bright light.""]","[""The symptoms of LCA10 include severe visual impairment or blindness, sensitivity to light, involuntary eye movements, and reduced visual acuity.""]",[true],[true],[true],"[""Symptoms of LCA10 include severe visual impairment or blindness from birth, roving eye movements, sensitivity to light, and sluggish or absent pupillary responses.""]","[""Symptoms of Leber congenital amaurosis 10 include severe visual impairment, involuntary eye movements, and sensitivity to light.""]","[""The symptoms of LCA10 include severe visual impairment or blindness, sensitivity to light, involuntary eye movements, and abnormal development of the retina.""]",[true],[true],[true],"[""Symptoms of LCA10 include severe visual impairment or blindness from birth, involuntary eye movements (nystagmus), and sensitivity to light (photophobia).""]","[""Symptoms of Leber congenital amaurosis 10 include severe visual impairment from birth, involuntary eye movements, sensitivity to light, and a lack of normal visual responses.""]","[""The symptoms of LCA10 include severe vision impairment or blindness, sensitivity to light, involuntary eye movements, and reduced visual acuity.""]",[true],[true],[true],"[""Symptoms of LCA10 include severe visual impairment or blindness from birth, roving eye movements, deep-set eyes, and sensitivity to light.""]","[""Symptoms of Leber congenital amaurosis 10 include severe visual impairment from birth, involuntary eye movements, and sensitivity to light.""]","[""The symptoms of LCA10 include vision loss, sensitivity to light, and involuntary eye movements.""]",[true],[true],[true],"[""Symptoms of LCA10 include severe visual impairment or blindness from birth, roving eye movements, sensitivity to light, and sluggish or near-absent pupillary responses.""]","[""Symptoms of Leber congenital amaurosis 10 include severe visual impairment or blindness from birth, roving eye movements, deep-set eyes, and sensitivity to bright light.""]","[""The symptoms of LCA10 include severe visual impairment or blindness, sensitivity to light, involuntary eye movements, and reduced visual acuity.""]",[true],[true],[true],"[""Symptoms of LCA10 include severe visual impairment or blindness from birth, involuntary eye movements, sensitivity to light, and sluggish or absent pupillary responses.""]","[""Symptoms of Leber congenital amaurosis 10 include severe visual impairment, involuntary eye movements, and sensitivity to light.""]","[""The symptoms of LCA10 include severe visual impairment or blindness, sensitivity to light, involuntary eye movements, and abnormal development of the retina.""]",[true],[true],[true],"[""Symptoms of LCA10 include severe visual impairment or blindness from birth, involuntary eye movements, sensitivity to light, and sluggish or near-absent pupillary responses.""]","[""Symptoms of Leber congenital amaurosis 10 include severe visual impairment from birth, involuntary eye movements, sensitivity to light, and a lack of normal visual responses.""]","[""The symptoms of LCA10 include severe vision impairment or blindness, sensitivity to light, involuntary eye movements, and reduced visual acuity.""]",[true],[true],[true],"[""Symptoms of LCA10 include severe visual impairment or blindness from birth, roving eye movements, deep-set eyes, and sensitivity to light.""]","[""Symptoms of Leber congenital amaurosis 10 include severe visual impairment from birth, involuntary eye movements, and sensitivity to light.""]","[""The symptoms of LCA10 include vision loss, sensitivity to light, and involuntary eye movements.""]",[true],[true],[true],"[""Some common symptoms of LCA10 include severe vision loss or blindness from birth, roving eye movements, sensitivity to light, and sluggish or absent pupillary responses.""]","[""Symptoms of Leber congenital amaurosis 10 include severe visual impairment or blindness from birth, roving eye movements, deep-set eyes, and sensitivity to bright light.""]","[""The symptoms of LCA10 include severe visual impairment or blindness, sensitivity to light, involuntary eye movements, and reduced visual acuity.""]",[true],[true],[true],"[""Symptoms of LCA10 include severe visual impairment or blindness from birth, roving eye movements, sensitivity to light, and reduced or absent pupillary responses.""]","[""Symptoms of Leber congenital amaurosis 10 include severe visual impairment, involuntary eye movements, and sensitivity to light.""]","[""The symptoms of LCA10 include severe visual impairment or blindness, sensitivity to light, involuntary eye movements, and abnormal development of the retina.""]",[true],[true],[true],"[""Symptoms of LCA10 include severe visual impairment or blindness from birth, roving eye movements, deep-set eyes, and sensitivity to light.""]","[""Symptoms of Leber congenital amaurosis 10 include severe visual impairment from birth, involuntary eye movements, sensitivity to light, and a lack of normal visual responses.""]","[""The symptoms of LCA10 include severe vision impairment or blindness, sensitivity to light, involuntary eye movements, and reduced visual acuity.""]",[true],[true],[true],"[""Symptoms of LCA10 include severe visual impairment or blindness from birth, involuntary eye movements, sensitivity to light, and sluggish or near-absent pupillary responses.""]","[""Symptoms of Leber congenital amaurosis 10 include severe visual impairment from birth, involuntary eye movements, and sensitivity to light.""]","[""The symptoms of LCA10 include vision loss, sensitivity to light, and involuntary eye movements.""]",[true],[true],[true],"[""Symptoms of LCA10 include severe visual impairment or blindness from birth, roving eye movements, sensitivity to light, and sluggish or near-absent pupillary responses.""]","[""Symptoms of Leber congenital amaurosis 10 include severe visual impairment or blindness from birth, roving eye movements, deep-set eyes, and sensitivity to bright light.""]","[""The symptoms of LCA10 include severe visual impairment or blindness, sensitivity to light, involuntary eye movements, and reduced visual acuity.""]",[true],[true],[true],"[""Symptoms of LCA10 include severe visual impairment or blindness from birth, roving eye movements, sensitivity to light, and sluggish or near-absent pupillary responses.""]","[""Symptoms of Leber congenital amaurosis 10 include severe visual impairment, involuntary eye movements, and sensitivity to light.""]","[""The symptoms of LCA10 include severe visual impairment or blindness, sensitivity to light, involuntary eye movements, and abnormal development of the retina.""]",[true],[true],[true],"[""Symptoms of LCA10 include severe visual impairment or blindness from birth, roving eye movements, sensitivity to light, and sluggish or near-absent pupillary responses.""]","[""Symptoms of Leber congenital amaurosis 10 include severe visual impairment from birth, involuntary eye movements, sensitivity to light, and a lack of normal visual responses.""]","[""The symptoms of LCA10 include severe vision impairment or blindness, sensitivity to light, involuntary eye movements, and reduced visual acuity.""]",[true],[true],[true],"[""Symptoms of LCA10 include severe visual impairment or blindness from birth, roving eye movements, sensitivity to light, and sluggish or near-absent pupillary responses.""]","[""Symptoms of Leber congenital amaurosis 10 include severe visual impairment from birth, involuntary eye movements, and sensitivity to light.""]","[""The symptoms of LCA10 include vision loss, sensitivity to light, and involuntary eye movements.""]",[true],[true],[true],"[""Symptoms of LCA10 include severe visual impairment or blindness from birth, roving eye movements, sensitivity to light, and sluggish or near-absent pupillary responses.""]","[""Symptoms of Leber congenital amaurosis 10 include severe visual impairment or blindness from birth, roving eye movements, deep-set eyes, and sensitivity to bright light.""]","[""The symptoms of LCA10 include severe visual impairment or blindness, sensitivity to light, involuntary eye movements, and reduced visual acuity.""]",[true],[true],[true],"[""Symptoms of LCA10 include severe visual impairment or blindness from birth, roving eye movements, sensitivity to light, and sluggish or near-absent pupillary responses.""]","[""Symptoms of Leber congenital amaurosis 10 include severe visual impairment or blindness from birth, roving eye movements, deep-set eyes, and sensitivity to bright light.""]","[""The symptoms of LCA10 include severe visual impairment or blindness, sensitivity to light, involuntary eye movements, and reduced visual acuity.""]",[true],[true],[true],"[""Symptoms of LCA10 include severe vision loss at birth, involuntary eye movements, sensitivity to light, and sluggish or near-absent pupillary responses.""]","[""Symptoms of Leber congenital amaurosis 10 include severe visual impairment or blindness from birth, roving eye movements, deep-set eyes, and sensitivity to bright light.""]","[""The symptoms of LCA10 include severe visual impairment or blindness, sensitivity to light, involuntary eye movements, and reduced visual acuity.""]",[true],[true],[true],"[""Symptoms of LCA10 include severe visual impairment or blindness from birth, roving eye movements, sensitivity to light, and sluggish or near-absent pupillary responses.""]","[""Symptoms of Leber congenital amaurosis 10 include severe visual impairment or blindness from birth, roving eye movements, deep-set eyes, and sensitivity to bright light.""]","[""The symptoms of LCA10 include severe visual impairment or blindness, sensitivity to light, involuntary eye movements, and reduced visual acuity.""]"
outlook,What is the outlook for Bile Duct Cancer (Cholangiocarcinoma) ?,"Certain factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery) and treatment options depend on the following:         - Whether the cancer is in the upper or lower part of the bile duct system.     - The stage of the cancer (whether it affects only the bile ducts or has spread to the liver, lymph nodes, or other places in the body).    - Whether the cancer has spread to nearby nerves or veins.    - Whether the cancer can be completely removed by surgery.    - Whether the patient has other conditions, such as primary sclerosing cholangitis.    - Whether the level of CA 19-9 is higher than normal.    - Whether the cancer has just been diagnosed or has recurred (come back).        Treatment options may also depend on the symptoms caused by the cancer. Bile duct cancer is usually found after it has spread and can rarely be completely removed by surgery. Palliative therapy may relieve symptoms and improve the patient's quality of life.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""BDC"", ""full_form"": ""Bile Duct Cancer""}, {""ambiguity_type"": ""full_form"", ""abbreviation"": ""CCA"", ""full_form"": ""Cholangiocarcinoma""}]}",What is the outlook for BDC (CCA) ?,What is the outlook for Bile Duct Cancer (Cholangiocarcinoma) ?,3,BUSINESS,Simple Datatype-String,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Backup Domain Controller"", ""Business Development Corporation"", ""Bottom Dead Center"", ""Business Development Council"", ""Baltimore Development Corporation"", ""Batch Data Communication"", ""Big Daddy Cool"", ""Banco Di Chiavari"", ""Bubba Da Cat"", ""Big Dot Com""], [""Chromated Copper Arsenate"", ""Corrections Corporation of America"", ""Co Curricular Activities"", ""Capital Cost Allowance"", ""Centre for Contemporary Arts"", ""Certified Crop Adviser"", ""Chosen Ciphertext Attack"", ""Circuit Card Assembly"", ""Collie Club of America"", ""Computer Club Across""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""], [""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Business Development Company"", ""Consumer Credit Act""]","[2.8283108327445685e-10, 2.23391457141313e-06]","[2.3438720536865372e-14, 1.4020344799573765e-18]","[""Big Dot Com"", ""Computer Club Across""]","[5.760115635823868e-13, 9.319078361198979e-16]","[""ABBREVIATIONS"", ""ABBREVIATIONS""]","[[1.9455019748363782e-20, 1.8742500432327346e-16, 9.453306048829057e-17, 2.1693319715352576e-16, 6.377110160214101e-29, 7.131675051139207e-17, 1.9016801154556192e-18, 1.0688628514873744e-22, 2.8534155506936906e-16, 5.760115635823868e-13], [4.554765110036501e-26, 1.5415637384829653e-26, 8.566620678040886e-17, 3.3112481234184795e-16, 2.4745820973457567e-19, 4.350805525073813e-22, 8.362409851660868e-22, 3.91810337466988e-16, 2.3537249237967725e-25, 9.319078361198979e-16]]","[0.6785213598987555, 0.7310589533301174]","[0.9175397920909438, 0.8043714568936343]","[""Bottom Dead Center"", ""Chromated Copper Arsenate""]","[0.9245206602013717, 0.8521636609504047]","[""ABBREVIATIONS"", ""ABBREVIATIONS""]","[[0.7416492012075949, 0.9231408564260138, 0.796967143738136, 0.9245206602013717, 0.8335094896808126, 0.8122174598442948, 0.8399384608829761, 0.8028027065196192, 0.8350777999224334, 0.8790003425978725], [0.7208399411416285, 0.8521636609504047, 0.7855450098390366, 0.8394527435548245, 0.7586968784783461, 0.7780905398167111, 0.6820882605111308, 0.8079148732156675, 0.768547338300424, 0.8453238824170707]]","[""Business Development Corporation"", ""Consumer Credit Act""]","[""ABBREVIATIONS"", ""LLM""]",What is the outlook for BDC (CCA (Consumer Credit Act)) ?,"[false, false]","[true, true]","[false, false]","[""The outlook for BDC (Big Dot Com) (CCA) is positive, with strong growth potential in the digital commerce sector."", ""The outlook for BDC (CCA) is positive with a focus on expanding its membership base and enhancing its technological offerings.""]","[""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the specific location of the tumor, and the overall health of the individual. Generally, the prognosis is better if the cancer is caught early and can be surgically removed. However, if the cancer has spread to other parts of the body, the outlook may be more challenging."", ""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the specific location of the tumor, and the overall health of the individual. Treatment options may include surgery, chemotherapy, radiation therapy, or a combination of these. It is important for individuals diagnosed with this type of cancer to work closely with their healthcare team to determine the best course of action for their specific situation.""]","[""The outlook for BDC (CCA) is positive, with a focus on growth and expansion in the coming quarters."", ""The outlook for BDC (CCA) is positive, with projected growth in the coming quarters.""]","[false, false]","[true, true]","[false, false]","[""The outlook for BDC (Big Dot Com) (CCA) is positive, with strong growth potential in the digital commerce sector."", ""The outlook for BDC (CCA) is positive with a focus on expanding its membership base and enhancing its technological capabilities.""]","[""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the specific location of the cancer within the bile ducts, and the overall health of the individual. In general, the prognosis for this type of cancer is often poor, as it is typically diagnosed at an advanced stage. However, advancements in treatment options such as surgery, chemotherapy, and radiation therapy have improved survival rates for some patients."", ""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the extent of spread, and the individual's overall health. Generally, the prognosis is better if the cancer is caught early and can be surgically removed. However, in advanced stages, the outlook is more challenging with a lower survival rate.""]","[""The outlook for BDC (CCA) is positive, with projected growth in the coming quarters."", ""The outlook for BDC (CCA) is positive, with a focus on growth and expansion in the coming quarters.""]","[false, false]","[true, true]","[false, false]","[""The outlook for BDC (Big Dot Com) (CCA) is positive, with strong growth potential in the digital commerce sector."", ""The outlook for BDC (CCA) is positive with a growing demand for computer club services and activities.""]","[""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the extent of spread, and the individual's overall health. Generally, the prognosis is better if the cancer is caught early and can be surgically removed. However, in later stages or if the cancer has spread extensively, the outlook may be more challenging."", ""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the treatment options available, and individual factors. It is important to consult with a healthcare provider for personalized information.""]","[""The outlook for BDC (CCA) is positive, with a focus on growth and expansion in the coming quarters."", ""The outlook for BDC (CCA) is positive, with projected growth in the coming quarters.""]","[false, false]","[true, true]","[false, false]","[""The outlook for BDC (Big Dot Com) (CCA) is positive, with strong growth potential in the digital commerce sector."", ""The outlook for BDC (CCA) is positive with a focus on expanding membership and enhancing technological skills.""]","[""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed and the treatment options available. Generally, the prognosis is better when the cancer is detected early and can be surgically removed. However, in advanced stages, the outlook may be more challenging."", ""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed and the individual's overall health. Generally, the prognosis is better if the cancer is caught early and can be surgically removed. However, if the cancer has spread to other parts of the body, the outlook may be more challenging.""]","[""The outlook for BDC (CCA) is positive, with a focus on growth and expansion in the coming quarters."", ""The outlook for BDC (CCA) is positive, with strong growth potential in the coming years.""]","[false, false]","[true, true]","[false, false]","[""The outlook for BDC (Bottom Dead Center) (CCA) refers to the projected performance or prospects of the company. It can include factors such as financial health, market conditions, and industry trends."", ""The outlook for BDC (CCA) is declining due to environmental concerns and regulations regarding the toxicity of arsenic and chromium in the treatment process.""]","[""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the specific location of the tumor, and the overall health of the individual. Generally, the prognosis is better if the cancer is caught early and can be surgically removed. However, if the cancer has spread to other parts of the body, the outlook may be more challenging."", ""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the specific location of the tumor, and the overall health of the individual. Treatment options may include surgery, chemotherapy, radiation therapy, or a combination of these. It is important for individuals diagnosed with this type of cancer to work closely with their healthcare team to determine the best course of action for their specific situation.""]","[""The outlook for BDC (CCA) is positive, with a focus on growth and expansion in the coming quarters."", ""The outlook for BDC (CCA) is positive, with projected growth in the coming quarters.""]","[false, false]","[true, true]","[false, false]","[""The outlook for BDC (Bottom Dead Center) (CCA) refers to the projected performance or future prospects of the company. It can include factors such as financial health, market conditions, and industry trends."", ""The outlook for BDC (CCA) is declining due to environmental concerns and regulations regarding the use of arsenic in treated wood products.""]","[""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the specific location of the cancer within the bile ducts, and the overall health of the individual. In general, the prognosis for this type of cancer is often poor, as it is typically diagnosed at an advanced stage. However, advancements in treatment options such as surgery, chemotherapy, and radiation therapy have improved survival rates for some patients."", ""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the extent of spread, and the individual's overall health. Generally, the prognosis is better if the cancer is caught early and can be surgically removed. However, in advanced stages, the outlook is more challenging with a lower survival rate.""]","[""The outlook for BDC (CCA) is positive, with projected growth in the coming quarters."", ""The outlook for BDC (CCA) is positive, with a focus on growth and expansion in the coming quarters.""]","[false, false]","[true, true]","[false, false]","[""The outlook for BDC (Bottom Dead Center) (CCA) refers to the projected performance or prospects of the company in terms of its financial health, growth potential, and market position."", ""The outlook for BDC (CCA) is declining due to environmental concerns and regulations regarding the use of arsenic in wood treatment.""]","[""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the extent of spread, and the individual's overall health. Generally, the prognosis is better if the cancer is caught early and can be surgically removed. However, in later stages or if the cancer has spread extensively, the outlook may be more challenging."", ""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the treatment options available, and individual factors. It is important to consult with a healthcare provider for personalized information.""]","[""The outlook for BDC (CCA) is positive, with a focus on growth and expansion in the coming quarters."", ""The outlook for BDC (CCA) is positive, with projected growth in the coming quarters.""]","[false, false]","[true, true]","[false, false]","[""The outlook for BDC (Bottom Dead Center) (CCA) refers to the projected performance and prospects of the company. It is typically based on factors such as financial health, market conditions, and industry trends."", ""The outlook for BDC (CCA) is declining due to environmental concerns and regulations banning the use of chromated copper arsenate in certain applications.""]","[""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed and the treatment options available. Generally, the prognosis is better when the cancer is detected early and can be surgically removed. However, in advanced stages, the outlook may be more challenging."", ""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed and the individual's overall health. Generally, the prognosis is better if the cancer is caught early and can be surgically removed. However, if the cancer has spread to other parts of the body, the outlook may be more challenging.""]","[""The outlook for BDC (CCA) is positive, with a focus on growth and expansion in the coming quarters."", ""The outlook for BDC (CCA) is positive, with strong growth potential in the coming years.""]","[false, false]","[true, true]","[false, false]","[""The outlook for Business Development Corporation (CCA) is positive, with a focus on expanding its market presence and increasing profitability."", ""The outlook for BDC (CCA) is positive as it aims to provide consumer protection in credit transactions.""]","[""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the specific location of the cancer within the bile ducts, and the overall health of the individual. In general, the prognosis for this type of cancer is often poor, as it is typically diagnosed at an advanced stage. However, advancements in treatment options such as surgery, chemotherapy, and radiation therapy have improved survival rates for some patients."", ""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the extent of spread, and the individual's overall health. Generally, the prognosis is better if the cancer is caught early and can be surgically removed. However, in advanced stages, the outlook is more challenging with a lower survival rate.""]","[""The outlook for BDC (CCA) is positive, with projected growth in the coming quarters."", ""The outlook for BDC (CCA) is positive, with a focus on growth and expansion in the coming quarters.""]","[false, false]","[true, true]","[false, false]","[""The outlook for BDC (Business Development Corporation) (CCA) is positive with strong growth potential in the coming years."", ""The outlook for BDC (CCA) under the Consumer Credit Act is positive due to the increasing focus on consumer protection and responsible lending practices.""]","[""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the specific location of the tumor, and the overall health of the individual. Generally, the prognosis is better if the cancer is caught early and can be surgically removed. However, if the cancer has spread to other parts of the body, the outlook may be more challenging."", ""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the specific location of the tumor, and the overall health of the individual. Treatment options may include surgery, chemotherapy, radiation therapy, or a combination of these. It is important for individuals diagnosed with this type of cancer to work closely with their healthcare team to determine the best course of action for their specific situation.""]","[""The outlook for BDC (CCA) is positive, with a focus on growth and expansion in the coming quarters."", ""The outlook for BDC (CCA) is positive, with projected growth in the coming quarters.""]","[false, false]","[true, true]","[false, false]","[""The outlook for BDC (Business Development Corporation) (CCA) is positive, with a focus on expanding its market presence and enhancing its service offerings."", ""The outlook for BDC (CCA) is currently stable, with a focus on compliance with consumer credit regulations and adapting to market changes.""]","[""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the extent of spread, and the individual's overall health. Generally, the prognosis is better if the cancer is caught early and can be surgically removed. However, in later stages or if the cancer has spread extensively, the outlook may be more challenging."", ""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the treatment options available, and individual factors. It is important to consult with a healthcare provider for personalized information.""]","[""The outlook for BDC (CCA) is positive, with a focus on growth and expansion in the coming quarters."", ""The outlook for BDC (CCA) is positive, with projected growth in the coming quarters.""]","[false, false]","[true, true]","[false, false]","[""The outlook for BDC (Business Development Corporation) (CCA) is positive, with a focus on expanding market presence and increasing profitability."", ""The outlook for BDC (CCA) is dependent on various factors such as economic conditions, regulatory changes, and market trends.""]","[""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed and the treatment options available. Generally, the prognosis is better when the cancer is detected early and can be surgically removed. However, in advanced stages, the outlook may be more challenging."", ""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed and the individual's overall health. Generally, the prognosis is better if the cancer is caught early and can be surgically removed. However, if the cancer has spread to other parts of the body, the outlook may be more challenging.""]","[""The outlook for BDC (CCA) is positive, with a focus on growth and expansion in the coming quarters."", ""The outlook for BDC (CCA) is positive, with strong growth potential in the coming years.""]","[false, false]","[true, true]","[false, false]","[""The outlook for BDC (Business Development Corporation) (CCA) is positive."", ""The outlook for BDC (CCA) is positive.""]","[""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the specific location of the tumor, and the overall health of the individual. Generally, the prognosis is better if the cancer is caught early and can be surgically removed. However, if the cancer has spread to other parts of the body, the outlook may be more challenging."", ""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the specific location of the tumor, and the overall health of the individual. Treatment options may include surgery, chemotherapy, radiation therapy, or a combination of these. It is important for individuals diagnosed with this type of cancer to work closely with their healthcare team to determine the best course of action for their specific situation.""]","[""The outlook for BDC (CCA) is positive, with a focus on growth and expansion in the coming quarters."", ""The outlook for BDC (CCA) is positive, with projected growth in the coming quarters.""]","[false, false]","[true, true]","[false, false]","[""The outlook for BDC (Business Development Corporation) (CCA) is positive."", ""The outlook for BDC (CCA) is positive.""]","[""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the specific location of the cancer within the bile ducts, and the overall health of the individual. In general, the prognosis for this type of cancer is often poor, as it is typically diagnosed at an advanced stage. However, advancements in treatment options such as surgery, chemotherapy, and radiation therapy have improved survival rates for some patients."", ""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the extent of spread, and the individual's overall health. Generally, the prognosis is better if the cancer is caught early and can be surgically removed. However, in advanced stages, the outlook is more challenging with a lower survival rate.""]","[""The outlook for BDC (CCA) is positive, with projected growth in the coming quarters."", ""The outlook for BDC (CCA) is positive, with a focus on growth and expansion in the coming quarters.""]","[false, false]","[true, true]","[false, false]","[""The outlook for BDC (Business Development Corporation) (CCA) is positive."", ""The outlook for BDC (CCA) is positive.""]","[""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the extent of spread, and the individual's overall health. Generally, the prognosis is better if the cancer is caught early and can be surgically removed. However, in later stages or if the cancer has spread extensively, the outlook may be more challenging."", ""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the treatment options available, and individual factors. It is important to consult with a healthcare provider for personalized information.""]","[""The outlook for BDC (CCA) is positive, with a focus on growth and expansion in the coming quarters."", ""The outlook for BDC (CCA) is positive, with projected growth in the coming quarters.""]","[false, false]","[true, true]","[false, false]","[""The outlook for BDC (Business Development Corporation) (CCA) is positive."", ""The outlook for BDC (CCA) is positive.""]","[""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed and the treatment options available. Generally, the prognosis is better when the cancer is detected early and can be surgically removed. However, in advanced stages, the outlook may be more challenging."", ""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed and the individual's overall health. Generally, the prognosis is better if the cancer is caught early and can be surgically removed. However, if the cancer has spread to other parts of the body, the outlook may be more challenging.""]","[""The outlook for BDC (CCA) is positive, with a focus on growth and expansion in the coming quarters."", ""The outlook for BDC (CCA) is positive, with strong growth potential in the coming years.""]","[false, false]","[true, true]","[false, false]","[""The outlook for BDC (Business Development Corporation) (CCA) is positive."", ""The outlook for BDC (CCA (Consumer Credit Act)) is currently stable.""]","[""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the specific location of the tumor, and the overall health of the individual. Generally, the prognosis is better if the cancer is caught early and can be surgically removed. However, if the cancer has spread to other parts of the body, the outlook may be more challenging."", ""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the specific location of the tumor, and the overall health of the individual. Treatment options may include surgery, chemotherapy, radiation therapy, or a combination of these. It is important for individuals diagnosed with this type of cancer to work closely with their healthcare team to determine the best course of action for their specific situation.""]","[""The outlook for BDC (CCA) is positive, with a focus on growth and expansion in the coming quarters."", ""The outlook for BDC (CCA) is positive, with projected growth in the coming quarters.""]","[false, false]","[true, true]","[false, false]","[""The outlook for Business Development Corporation (BDC) (CCA) is positive, with a focus on expanding its portfolio and driving growth through strategic investments."", ""The outlook for BDC (CCA) is uncertain due to changing regulations and market conditions.""]","[""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the specific location of the cancer within the bile ducts, and the overall health of the individual. In general, the prognosis for this type of cancer is often poor, as it is typically diagnosed at an advanced stage. However, advancements in treatment options such as surgery, chemotherapy, and radiation therapy have improved survival rates for some patients."", ""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the extent of spread, and the individual's overall health. Generally, the prognosis is better if the cancer is caught early and can be surgically removed. However, in advanced stages, the outlook is more challenging with a lower survival rate.""]","[""The outlook for BDC (CCA) is positive, with projected growth in the coming quarters."", ""The outlook for BDC (CCA) is positive, with a focus on growth and expansion in the coming quarters.""]","[false, false]","[true, true]","[false, false]","[""The outlook for BDC (Business Development Corporation) (CCA) is positive, with a focus on expanding its market presence and enhancing its services."", ""The outlook for BDC (CCA (Consumer Credit Act)) is uncertain and subject to regulatory changes.""]","[""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the extent of spread, and the individual's overall health. Generally, the prognosis is better if the cancer is caught early and can be surgically removed. However, in later stages or if the cancer has spread extensively, the outlook may be more challenging."", ""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the treatment options available, and individual factors. It is important to consult with a healthcare provider for personalized information.""]","[""The outlook for BDC (CCA) is positive, with a focus on growth and expansion in the coming quarters."", ""The outlook for BDC (CCA) is positive, with projected growth in the coming quarters.""]","[false, false]","[true, true]","[false, false]","[""The outlook for Business Development Corporation (BDC) CCA is positive based on recent financial reports and market analysis."", ""The outlook for BDC (CCA) is dependent on various factors such as economic conditions, regulatory changes, and market trends.""]","[""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed and the treatment options available. Generally, the prognosis is better when the cancer is detected early and can be surgically removed. However, in advanced stages, the outlook may be more challenging."", ""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed and the individual's overall health. Generally, the prognosis is better if the cancer is caught early and can be surgically removed. However, if the cancer has spread to other parts of the body, the outlook may be more challenging.""]","[""The outlook for BDC (CCA) is positive, with a focus on growth and expansion in the coming quarters."", ""The outlook for BDC (CCA) is positive, with strong growth potential in the coming years.""]","[false, false]","[true, true]","[false, false]","[""The outlook for BDC (Business Development Company) CCA is positive due to its strong financial performance and growth prospects."", ""The outlook for BDC (CCA) is uncertain due to changing regulations and market conditions.""]","[""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the specific location of the tumor, and the overall health of the individual. Generally, the prognosis is better if the cancer is caught early and can be surgically removed. However, if the cancer has spread to other parts of the body, the outlook may be more challenging."", ""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the specific location of the tumor, and the overall health of the individual. Treatment options may include surgery, chemotherapy, radiation therapy, or a combination of these. It is important for individuals diagnosed with this type of cancer to work closely with their healthcare team to determine the best course of action for their specific situation.""]","[""The outlook for BDC (CCA) is positive, with a focus on growth and expansion in the coming quarters."", ""The outlook for BDC (CCA) is positive, with projected growth in the coming quarters.""]","[false, false]","[true, true]","[false, false]","[""The outlook for BDC (Business Development Company) CCA is positive due to its strong financial performance and growth potential in the current market conditions."", ""The outlook for BDC (CCA) is dependent on various factors such as economic conditions, regulatory environment, and market trends.""]","[""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the specific location of the cancer within the bile ducts, and the overall health of the individual. In general, the prognosis for this type of cancer is often poor, as it is typically diagnosed at an advanced stage. However, advancements in treatment options such as surgery, chemotherapy, and radiation therapy have improved survival rates for some patients."", ""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the extent of spread, and the individual's overall health. Generally, the prognosis is better if the cancer is caught early and can be surgically removed. However, in advanced stages, the outlook is more challenging with a lower survival rate.""]","[""The outlook for BDC (CCA) is positive, with projected growth in the coming quarters."", ""The outlook for BDC (CCA) is positive, with a focus on growth and expansion in the coming quarters.""]","[false, false]","[true, true]","[false, false]","[""The outlook for BDC (Business Development Company) CCA is positive due to its diversified portfolio and strong financial performance."", ""The outlook for BDC (CCA) is uncertain due to changing economic conditions and regulatory environment.""]","[""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the extent of spread, and the individual's overall health. Generally, the prognosis is better if the cancer is caught early and can be surgically removed. However, in later stages or if the cancer has spread extensively, the outlook may be more challenging."", ""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the treatment options available, and individual factors. It is important to consult with a healthcare provider for personalized information.""]","[""The outlook for BDC (CCA) is positive, with a focus on growth and expansion in the coming quarters."", ""The outlook for BDC (CCA) is positive, with projected growth in the coming quarters.""]","[false, false]","[true, true]","[false, false]","[""The outlook for BDC (Business Development Company) CCA is positive/negative/stable."", ""The outlook for BDC (CCA) is dependent on various factors such as economic conditions, regulatory environment, and market trends.""]","[""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed and the treatment options available. Generally, the prognosis is better when the cancer is detected early and can be surgically removed. However, in advanced stages, the outlook may be more challenging."", ""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed and the individual's overall health. Generally, the prognosis is better if the cancer is caught early and can be surgically removed. However, if the cancer has spread to other parts of the body, the outlook may be more challenging.""]","[""The outlook for BDC (CCA) is positive, with a focus on growth and expansion in the coming quarters."", ""The outlook for BDC (CCA) is positive, with strong growth potential in the coming years.""]","[false, false]","[true, true]","[false, false]","[""The outlook for BDC (Business Development Corporation) (CCA) is positive/negative/neutral."", ""The outlook for BDC (CCA (Consumer Credit Act)) is not specified.""]","[""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the specific location of the tumor, and the overall health of the individual. Generally, the prognosis is better if the cancer is caught early and can be surgically removed. However, if the cancer has spread to other parts of the body, the outlook may be more challenging."", ""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the specific location of the tumor, and the overall health of the individual. Treatment options may include surgery, chemotherapy, radiation therapy, or a combination of these. It is important for individuals diagnosed with this type of cancer to work closely with their healthcare team to determine the best course of action for their specific situation.""]","[""The outlook for BDC (CCA) is positive, with a focus on growth and expansion in the coming quarters."", ""The outlook for BDC (CCA) is positive, with projected growth in the coming quarters.""]","[false, false]","[true, true]","[false, false]","[""The outlook for BDC (Business Development Corporation) (CCA) is positive/negative/neutral."", ""The outlook for BDC (CCA (Consumer Credit Act)) is not specified.""]","[""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the specific location of the cancer within the bile ducts, and the overall health of the individual. In general, the prognosis for this type of cancer is often poor, as it is typically diagnosed at an advanced stage. However, advancements in treatment options such as surgery, chemotherapy, and radiation therapy have improved survival rates for some patients."", ""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the extent of spread, and the individual's overall health. Generally, the prognosis is better if the cancer is caught early and can be surgically removed. However, in advanced stages, the outlook is more challenging with a lower survival rate.""]","[""The outlook for BDC (CCA) is positive, with projected growth in the coming quarters."", ""The outlook for BDC (CCA) is positive, with a focus on growth and expansion in the coming quarters.""]","[false, false]","[true, true]","[false, false]","[""The outlook for BDC (Business Development Corporation) (CCA) is positive."", ""The outlook for BDC (CCA (Consumer Credit Act)) is uncertain and subject to various factors such as economic conditions, regulatory changes, and market trends.""]","[""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the extent of spread, and the individual's overall health. Generally, the prognosis is better if the cancer is caught early and can be surgically removed. However, in later stages or if the cancer has spread extensively, the outlook may be more challenging."", ""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the treatment options available, and individual factors. It is important to consult with a healthcare provider for personalized information.""]","[""The outlook for BDC (CCA) is positive, with a focus on growth and expansion in the coming quarters."", ""The outlook for BDC (CCA) is positive, with projected growth in the coming quarters.""]","[false, false]","[true, true]","[false, false]","[""The outlook for BDC (Business Development Corporation) (CCA) is positive."", ""The outlook for BDC (CCA (Consumer Credit Act)) is not specified.""]","[""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed and the treatment options available. Generally, the prognosis is better when the cancer is detected early and can be surgically removed. However, in advanced stages, the outlook may be more challenging."", ""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed and the individual's overall health. Generally, the prognosis is better if the cancer is caught early and can be surgically removed. However, if the cancer has spread to other parts of the body, the outlook may be more challenging.""]","[""The outlook for BDC (CCA) is positive, with a focus on growth and expansion in the coming quarters."", ""The outlook for BDC (CCA) is positive, with strong growth potential in the coming years.""]","[false, false]","[true, true]","[false, false]","[""The outlook for BDC (Business Development Corporation) (CCA) is positive."", ""The outlook for BDC (CCA (Consumer Credit Act)) is positive.""]","[""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the specific location of the tumor, and the overall health of the individual. Generally, the prognosis is better if the cancer is caught early and can be surgically removed. However, if the cancer has spread to other parts of the body, the outlook may be more challenging."", ""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the specific location of the tumor, and the overall health of the individual. Treatment options may include surgery, chemotherapy, radiation therapy, or a combination of these. It is important for individuals diagnosed with this type of cancer to work closely with their healthcare team to determine the best course of action for their specific situation.""]","[""The outlook for BDC (CCA) is positive, with a focus on growth and expansion in the coming quarters."", ""The outlook for BDC (CCA) is positive, with projected growth in the coming quarters.""]","[false, false]","[true, true]","[false, false]","[""The outlook for BDC (Big Dot Com) (CCA) is positive."", ""The outlook for BDC (CCA) is positive.""]","[""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the specific location of the tumor, and the overall health of the individual. Generally, the prognosis is better if the cancer is caught early and can be surgically removed. However, if the cancer has spread to other parts of the body, the outlook may be more challenging."", ""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the specific location of the tumor, and the overall health of the individual. Treatment options may include surgery, chemotherapy, radiation therapy, or a combination of these. It is important for individuals diagnosed with this type of cancer to work closely with their healthcare team to determine the best course of action for their specific situation.""]","[""The outlook for BDC (CCA) is positive, with a focus on growth and expansion in the coming quarters."", ""The outlook for BDC (CCA) is positive, with projected growth in the coming quarters.""]","[false, false]","[true, true]","[false, false]","[""The outlook for BDC (Bottom Dead Center) (CCA) is positive."", ""The outlook for BDC (CCA) is declining due to environmental concerns and regulations phasing out the use of arsenic-based treatments.""]","[""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the specific location of the tumor, and the overall health of the individual. Generally, the prognosis is better if the cancer is caught early and can be surgically removed. However, if the cancer has spread to other parts of the body, the outlook may be more challenging."", ""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the specific location of the tumor, and the overall health of the individual. Treatment options may include surgery, chemotherapy, radiation therapy, or a combination of these. It is important for individuals diagnosed with this type of cancer to work closely with their healthcare team to determine the best course of action for their specific situation.""]","[""The outlook for BDC (CCA) is positive, with a focus on growth and expansion in the coming quarters."", ""The outlook for BDC (CCA) is positive, with projected growth in the coming quarters.""]","[false, false]","[true, true]","[false, false]","[""The outlook for BDC (Business Development Company) CCA is positive."", ""The outlook for BDC (CCA (Consumer Credit Act)) is positive.""]","[""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the specific location of the tumor, and the overall health of the individual. Generally, the prognosis is better if the cancer is caught early and can be surgically removed. However, if the cancer has spread to other parts of the body, the outlook may be more challenging."", ""The outlook for Bile Duct Cancer (Cholangiocarcinoma) varies depending on the stage at which it is diagnosed, the specific location of the tumor, and the overall health of the individual. Treatment options may include surgery, chemotherapy, radiation therapy, or a combination of these. It is important for individuals diagnosed with this type of cancer to work closely with their healthcare team to determine the best course of action for their specific situation.""]","[""The outlook for BDC (CCA) is positive, with a focus on growth and expansion in the coming quarters."", ""The outlook for BDC (CCA) is positive, with projected growth in the coming quarters.""]"
treatment,What are the treatments for SUNCT Headache ?,"These headaches are generally non-responsive to usual treatment for other short-lasting headaches. Corticosteroids and the anti-epileptic drugs gabapentin, lamotrigine, and carbamazepine may help relieve some symptoms in some patients. Studies have shown that injections of glycerol to block nerve signaling along the trigeminal nerve may provide temporary relief in some severe cases, but the headaches recurred in about 40 percent of individuals studied.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""abbreviation"", ""abbreviation"": ""SUNCT"", ""full_form"": ""Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing""}]}",What are the treatments for SUNCT Headache ?,What are the treatments for Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing Headache ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing"", ""Short-Lasting, Unilateral, Neuralgiform Headache Attacks with Conjunctival Injection and Tearing""]]","[[""ABBREVIATIONS"", ""THEFREEDICTIONARY""]]","[""Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing""]",[1.2346227794622465e-54],[1.2346227794622465e-54],"[""Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing""]",[3.3647860931063015e-49],"[""ABBREVIATIONS""]","[[3.3647860931063015e-49, 1.0666459262836155e-54]]",[0.9387725320853637],[0.9387725320853637],"[""Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing""]",[0.9425497009238171],"[""ABBREVIATIONS""]","[[0.9425497009238171, 0.932012170748885]]","[""Short-Lasting, Unilateral, Neuralgiform Headache Attacks with Conjunctival Injection and Tearing""]","[""THEFREEDICTIONARY""]",What are the treatments for SUNCT (Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing) Headache ?,[true],[true],[true],"[""Some treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, and gabapentin.""]","[""The treatments for Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing (SUNCT) headache include indomethacin, lamotrigine, topiramate, gabapentin, and melatonin.""]","[""The treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, gabapentin, and nerve blocks.""]",[true],[true],[true],"[""The treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, gabapentin, and nerve blocks.""]","[""The treatments for Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing (SUNCT) headache include indomethacin, lamotrigine, topiramate, gabapentin, and melatonin.""]","[""The treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, gabapentin, verapamil, and corticosteroids.""]",[true],[true],[true],"[""The treatments for SUNCT headache include antiepileptic drugs, calcium channel blockers, and nerve blocks.""]","[""The treatments for Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing (SUNCT) headache include indomethacin, lamotrigine, topiramate, gabapentin, and nerve blocks.""]","[""Some treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, and gabapentin.""]",[true],[true],[true],"[""Treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, gabapentin, and nerve blocks.""]","[""The treatments for Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing (SUNCT) headache include indomethacin, lamotrigine, topiramate, gabapentin, and nerve blocks.""]","[""Some treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, and gabapentin.""]",[true],[true],[true],"[""Some treatments for SUNCT headaches include indomethacin, lamotrigine, topiramate, and gabapentin.""]","[""The treatments for Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing (SUNCT) headache include indomethacin, lamotrigine, topiramate, gabapentin, and melatonin.""]","[""The treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, gabapentin, and nerve blocks.""]",[true],[true],[true],"[""The treatments for SUNCT headaches include indomethacin, lamotrigine, topiramate, gabapentin, and nerve blocks.""]","[""The treatments for Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing (SUNCT) headache include indomethacin, lamotrigine, topiramate, gabapentin, and melatonin.""]","[""The treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, gabapentin, verapamil, and corticosteroids.""]",[true],[true],[true],"[""The treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, gabapentin, and nerve blocks.""]","[""The treatments for Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing (SUNCT) headache include indomethacin, lamotrigine, topiramate, gabapentin, and nerve blocks.""]","[""Some treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, and gabapentin.""]",[false],[false],[false],"[""Some treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, and gabapentin.""]","[""The treatments for Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing (SUNCT) headache include indomethacin, lamotrigine, topiramate, gabapentin, and nerve blocks.""]","[""Some treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, and gabapentin.""]",[true],[true],[true],"[""Some treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, and gabapentin.""]","[""The treatments for Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing (SUNCT) headache include indomethacin, lamotrigine, topiramate, gabapentin, and melatonin.""]","[""The treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, gabapentin, verapamil, and corticosteroids.""]",[true],[true],[true],"[""Some treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, and gabapentin.""]","[""The treatments for Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing (SUNCT) headache include indomethacin, lamotrigine, topiramate, gabapentin, and melatonin.""]","[""The treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, gabapentin, and nerve blocks.""]",[true],[true],[true],"[""The treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, and gabapentin.""]","[""The treatments for Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing (SUNCT) headache include indomethacin, lamotrigine, topiramate, gabapentin, and nerve blocks.""]","[""Some treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, and gabapentin.""]",[true],[true],[true],"[""Some treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, and gabapentin.""]","[""The treatments for Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing (SUNCT) headache include indomethacin, lamotrigine, topiramate, gabapentin, and nerve blocks.""]","[""Some treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, and gabapentin.""]",[true],[true],[true],"[""Some treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, and gabapentin.""]","[""The treatments for Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing (SUNCT) headache include indomethacin, lamotrigine, topiramate, gabapentin, and melatonin.""]","[""The treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, gabapentin, and nerve blocks.""]",[true],[true],[true],"[""Treatment options for SUNCT headaches include antiepileptic drugs, calcium channel blockers, and nerve blocks.""]","[""The treatments for Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing (SUNCT) headache include indomethacin, lamotrigine, topiramate, gabapentin, and melatonin.""]","[""The treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, gabapentin, verapamil, and corticosteroids.""]",[true],[true],[true],"[""Some treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, and gabapentin.""]","[""The treatments for Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing (SUNCT) headache include indomethacin, lamotrigine, topiramate, gabapentin, and nerve blocks.""]","[""Some treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, and gabapentin.""]",[true],[true],[true],"[""Some treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, gabapentin, and nerve blocks.""]","[""The treatments for Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing (SUNCT) headache include indomethacin, lamotrigine, topiramate, gabapentin, and nerve blocks.""]","[""Some treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, and gabapentin.""]",[true],[true],[true],"[""The treatments for SUNCT headaches include indomethacin, lamotrigine, topiramate, gabapentin, and nerve blocks.""]","[""The treatments for Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing (SUNCT) headache include indomethacin, lamotrigine, topiramate, gabapentin, and melatonin.""]","[""The treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, gabapentin, and nerve blocks.""]",[true],[true],[true],"[""Some treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, and gabapentin.""]","[""The treatments for Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing (SUNCT) headache include indomethacin, lamotrigine, topiramate, gabapentin, and melatonin.""]","[""The treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, gabapentin, verapamil, and corticosteroids.""]",[true],[true],[true],"[""Some treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, gabapentin, and nerve blocks.""]","[""The treatments for Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing (SUNCT) headache include indomethacin, lamotrigine, topiramate, gabapentin, and nerve blocks.""]","[""Some treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, and gabapentin.""]",[true],[true],[true],"[""Some treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, and gabapentin.""]","[""The treatments for Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing (SUNCT) headache include indomethacin, lamotrigine, topiramate, gabapentin, and nerve blocks.""]","[""Some treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, and gabapentin.""]",[true],[true],[true],"[""The treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, gabapentin, and nerve blocks.""]","[""The treatments for Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing (SUNCT) headache include indomethacin, lamotrigine, topiramate, gabapentin, and melatonin.""]","[""The treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, gabapentin, and nerve blocks.""]",[true],[true],[true],"[""Treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, gabapentin, and nerve blocks.""]","[""The treatments for Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing (SUNCT) headache include indomethacin, lamotrigine, topiramate, gabapentin, and melatonin.""]","[""The treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, gabapentin, verapamil, and corticosteroids.""]",[false],[true],[true],"[""The treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, gabapentin, and melatonin.""]","[""The treatments for Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing (SUNCT) headache include indomethacin, lamotrigine, topiramate, gabapentin, and nerve blocks.""]","[""Some treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, and gabapentin.""]",[true],[true],[true],"[""The treatments for SUNCT headache include antiepileptic drugs, calcium channel blockers, steroids, and nerve blocks.""]","[""The treatments for Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing (SUNCT) headache include indomethacin, lamotrigine, topiramate, gabapentin, and nerve blocks.""]","[""Some treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, and gabapentin.""]",[true],[true],[true],"[""Some treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, gabapentin, and nerve blocks.""]","[""The treatments for Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing (SUNCT) headache include indomethacin, lamotrigine, topiramate, gabapentin, and melatonin.""]","[""The treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, gabapentin, and nerve blocks.""]",[false],[true],[true],"[""Some treatments for SUNCT headache include antiepileptic drugs, nerve blocks, and medications such as indomethacin and melatonin.""]","[""The treatments for Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing (SUNCT) headache include indomethacin, lamotrigine, topiramate, gabapentin, and melatonin.""]","[""The treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, gabapentin, verapamil, and corticosteroids.""]",[true],[true],[true],"[""Some treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, gabapentin, and nerve blocks.""]","[""The treatments for Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing (SUNCT) headache include indomethacin, lamotrigine, topiramate, gabapentin, and nerve blocks.""]","[""Some treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, and gabapentin.""]",[true],[true],[true],"[""Some treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, gabapentin, and nerve blocks.""]","[""The treatments for Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing (SUNCT) headache include indomethacin, lamotrigine, topiramate, gabapentin, and nerve blocks.""]","[""Some treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, and gabapentin.""]",[true],[true],[true],"[""Some treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, and gabapentin.""]","[""The treatments for Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing (SUNCT) headache include indomethacin, lamotrigine, topiramate, gabapentin, and melatonin.""]","[""The treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, gabapentin, and nerve blocks.""]",[true],[false],[true],"[""Some treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, gabapentin, and nerve blocks.""]","[""The treatments for Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing (SUNCT) headache include indomethacin, lamotrigine, topiramate, gabapentin, and melatonin.""]","[""The treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, gabapentin, and nerve blocks.""]",[true],[false],[true],"[""Some treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, gabapentin, and nerve blocks.""]","[""The treatments for Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing (SUNCT) headache include indomethacin, lamotrigine, topiramate, gabapentin, and melatonin.""]","[""The treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, gabapentin, and nerve blocks.""]",[true],[true],[true],"[""Some treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, verapamil, and gabapentin.""]","[""The treatments for Short-lasting Unilateral Neuralgiform headache attacks with Conjunctival injection and Tearing (SUNCT) headache include indomethacin, lamotrigine, topiramate, gabapentin, and melatonin.""]","[""The treatments for SUNCT headache include indomethacin, lamotrigine, topiramate, gabapentin, and nerve blocks.""]"
causes,What causes Cryptogenic organizing pneumonia ?,"What causes cryptogenic organizing pneumonia? The underlying cause of cryptogenic organizing pneumonia (COP) is unknown (idiopathic). Organizing pneumonia is specifically diagnosed as COP when, among other characteristics, no definite cause for the organizing pneumonia is found. In other words, any known cause for the pneumonia must be ruled out before stating that a person is affected by COP. Other forms of organizing pneumonia may result from infection (bacteria, viruses, parasites, or fungi); drugs; or a reaction to radiation therapy for breast cancer. Organizing pneumonia can also be associated with specific disorders such as certain connective tissue disorders, blood malignancies (cancers), or ulcerative colitis.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""COP"", ""full_form"": ""Cryptogenic organizing pneumonia""}]}",What causes COP ?,What causes Cryptogenic organizing pneumonia ?,0,SCIENCE,Compound Datatype-String,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Colombian Peso"", ""Conference Of the Parties"", ""Community Oriented Policing"", ""Community Of Practice"", ""Certificate Of Participation"", ""Cost Of Production"", ""Coptic"", ""Common Operating Picture"", ""Coalition Of Police"", ""CPU (Central Processing Unit) Overheating Protection""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Coefficient Of Performance""]",[1.1554251102335583e-12],[3.8699478362797047e-13],"[""Coptic""]",[1.7606295193643144e-08],"[""ABBREVIATIONS""]","[[3.8653682102848376e-16, 2.204919815118379e-11, 7.601310196159204e-20, 5.605484195818078e-12, 1.054428139359773e-14, 3.885715412886434e-10, 1.7606295193643144e-08, 2.2401426183088898e-15, 1.0399446569921538e-12, 1.9343160634887057e-37]]",[0.6822472841362781],[0.6856280151072107],"[""Cost Of Production""]",[0.7599031616519034],"[""ABBREVIATIONS""]","[[0.5956812942446763, 0.7119612772439928, 0.6302834002184873, 0.675370740846165, 0.6519378005978211, 0.6585352457254994, 0.7599031616519034, 0.6433263528818919, 0.7024723807133304, 0.621372464492692]]","[""Coefficient Of Performance""]","[""LLM""]",What causes COP (Coefficient Of Performance) ?,[false],[true],[false],"[""COP (Coptic) is caused by mutations in the ATP7A gene, which is located on the X chromosome. This gene provides instructions for making a protein that is involved in copper transport in the body.""]","[""The exact cause of Cryptogenic organizing pneumonia is unknown.""]","[""COP (Coefficient of Performance) is a measure of the efficiency of a heat pump or refrigerator. It is calculated as the ratio of heating or cooling provided to the work required to achieve it.""]",[false],[true],[false],"[""COP (Coptic) is caused by the mutation of the gene encoding coproporphyrinogen oxidase, an enzyme involved in heme biosynthesis.""]","[""The cause of Cryptogenic organizing pneumonia is unknown.""]","[""COP (Coefficient of Performance) is a measure of the efficiency of a heat pump or refrigeration system. It is defined as the ratio of heating or cooling provided to the work required to achieve it.""]",[false],[true],[false],"[""COP (Coptic) is caused by a mutation in the ATP7B gene, leading to impaired copper metabolism.""]","[""The exact cause of Cryptogenic organizing pneumonia is unknown.""]","[""COP (Coefficient of Performance) is a measure of the efficiency of a heat pump or refrigeration system, calculated as the ratio of heating or cooling provided to the input work required.""]",[false],[true],[false],"[""COP (Coptic) is caused by mutations in the COX10 gene.""]","[""The cause of Cryptogenic organizing pneumonia is unknown.""]","[""COP, or Coefficient of Performance, is a measure of the efficiency of a heat pump. It is defined as the ratio of heating or cooling provided to the work required to achieve it.""]",[false],[true],[false],"[""Cost of production is determined by factors such as raw material costs, labor costs, overhead expenses, and economies of scale.""]","[""The exact cause of Cryptogenic organizing pneumonia is unknown.""]","[""COP (Coefficient of Performance) is a measure of the efficiency of a heat pump or refrigerator. It is calculated as the ratio of heating or cooling provided to the work required to achieve it.""]",[false],[true],[false],"[""The Cost Of Production (COP) is primarily determined by factors such as raw material costs, labor costs, overhead expenses, and the efficiency of production processes.""]","[""The cause of Cryptogenic organizing pneumonia is unknown.""]","[""COP (Coefficient of Performance) is a measure of the efficiency of a heat pump or refrigeration system. It is defined as the ratio of heating or cooling provided to the work required to achieve it.""]",[false],[true],[false],"[""Cost of production is primarily determined by factors such as labor costs, raw material costs, overhead costs, and technology used in the production process.""]","[""The exact cause of Cryptogenic organizing pneumonia is unknown.""]","[""COP (Coefficient of Performance) is a measure of the efficiency of a heat pump or refrigeration system, calculated as the ratio of heating or cooling provided to the input work required.""]",[false],[true],[false],"[""Cost of production is primarily determined by factors such as raw material costs, labor costs, overhead expenses, and technology used in the production process.""]","[""The cause of Cryptogenic organizing pneumonia is unknown.""]","[""COP, or Coefficient of Performance, is a measure of the efficiency of a heat pump. It is defined as the ratio of heating or cooling provided to the work required to achieve it.""]",[false],[true],[false],"[""COP is caused by the ratio of desired output to required input in a heat pump or refrigeration system.""]","[""The cause of Cryptogenic organizing pneumonia is unknown.""]","[""COP (Coefficient of Performance) is a measure of the efficiency of a heat pump or refrigeration system. It is defined as the ratio of heating or cooling provided to the work required to achieve it.""]",[false],[true],[false],"[""COP is caused by the ratio of desired output to required input energy.""]","[""The exact cause of Cryptogenic organizing pneumonia is unknown.""]","[""COP (Coefficient of Performance) is a measure of the efficiency of a heat pump or refrigerator. It is calculated as the ratio of heating or cooling provided to the work required to achieve it.""]",[false],[true],[false],"[""COP is caused by the ratio of desired output to required input energy""]","[""The exact cause of Cryptogenic organizing pneumonia is unknown.""]","[""COP (Coefficient of Performance) is a measure of the efficiency of a heat pump or refrigeration system, calculated as the ratio of heating or cooling provided to the input work required.""]",[false],[true],[false],"[""COP is caused by the ratio of desired output to required input""]","[""The cause of Cryptogenic organizing pneumonia is unknown.""]","[""COP, or Coefficient of Performance, is a measure of the efficiency of a heat pump. It is defined as the ratio of heating or cooling provided to the work required to achieve it.""]",[false],[true],[false],"[""COP is caused by the ratio of desired output to required input energy""]","[""The exact cause of Cryptogenic organizing pneumonia is unknown.""]","[""COP (Coefficient of Performance) is a measure of the efficiency of a heat pump or refrigerator. It is calculated as the ratio of heating or cooling provided to the work required to achieve it.""]",[false],[true],[false],"[""COP is caused by the ratio of desired output to required input energy""]","[""The cause of Cryptogenic organizing pneumonia is unknown.""]","[""COP (Coefficient of Performance) is a measure of the efficiency of a heat pump or refrigeration system. It is defined as the ratio of heating or cooling provided to the work required to achieve it.""]",[false],[true],[false],"[""COP is caused by the ratio of desired output to required input energy""]","[""The exact cause of Cryptogenic organizing pneumonia is unknown.""]","[""COP (Coefficient of Performance) is a measure of the efficiency of a heat pump or refrigeration system, calculated as the ratio of heating or cooling provided to the input work required.""]",[false],[true],[false],"[""The COP (Coefficient Of Performance) is caused by the ratio of desired output to required input energy.""]","[""The cause of Cryptogenic organizing pneumonia is unknown.""]","[""COP, or Coefficient of Performance, is a measure of the efficiency of a heat pump. It is defined as the ratio of heating or cooling provided to the work required to achieve it.""]",[false],[true],[false],"[""COP is caused by the ratio of desired output to required input energy""]","[""The exact cause of Cryptogenic organizing pneumonia is unknown.""]","[""COP (Coefficient of Performance) is a measure of the efficiency of a heat pump or refrigerator. It is calculated as the ratio of heating or cooling provided to the work required to achieve it.""]",[false],[true],[false],"[""The COP (Coefficient Of Performance) is determined by the ratio of desired output to required input in a system, such as in heat pumps or refrigeration systems.""]","[""The cause of Cryptogenic organizing pneumonia is unknown.""]","[""COP (Coefficient of Performance) is a measure of the efficiency of a heat pump or refrigeration system. It is defined as the ratio of heating or cooling provided to the work required to achieve it.""]",[false],[true],[false],"[""COP is caused by the ratio of desired output to required input energy.""]","[""The exact cause of Cryptogenic organizing pneumonia is unknown.""]","[""COP (Coefficient of Performance) is a measure of the efficiency of a heat pump or refrigeration system, calculated as the ratio of heating or cooling provided to the input work required.""]",[false],[true],[false],"[""COP is caused by the ratio of desired output to required input energy""]","[""The cause of Cryptogenic organizing pneumonia is unknown.""]","[""COP, or Coefficient of Performance, is a measure of the efficiency of a heat pump. It is defined as the ratio of heating or cooling provided to the work required to achieve it.""]",[false],[true],[false],"[""COP is caused by the ratio of desired output to required input energy""]","[""The exact cause of Cryptogenic organizing pneumonia is unknown.""]","[""COP (Coefficient of Performance) is a measure of the efficiency of a heat pump or refrigerator. It is calculated as the ratio of heating or cooling provided to the work required to achieve it.""]",[false],[true],[false],"[""The COP (Coefficient Of Performance) is determined by the ratio of desired output to required input in a system, such as in a heat pump or refrigeration system.""]","[""The cause of Cryptogenic organizing pneumonia is unknown.""]","[""COP (Coefficient of Performance) is a measure of the efficiency of a heat pump or refrigeration system. It is defined as the ratio of heating or cooling provided to the work required to achieve it.""]",[false],[true],[false],"[""COP (Coefficient Of Performance) is caused by the ratio of desired output to required input in a heat pump or refrigeration system.""]","[""The exact cause of Cryptogenic organizing pneumonia is unknown.""]","[""COP (Coefficient of Performance) is a measure of the efficiency of a heat pump or refrigeration system, calculated as the ratio of heating or cooling provided to the input work required.""]",[false],[true],[false],"[""COP (Coefficient Of Performance) is caused by the ratio of desired output to required input in a heat pump or refrigeration system.""]","[""The cause of Cryptogenic organizing pneumonia is unknown.""]","[""COP, or Coefficient of Performance, is a measure of the efficiency of a heat pump. It is defined as the ratio of heating or cooling provided to the work required to achieve it.""]",[false],[true],[false],"[""COP (Coefficient Of Performance) is a measure of the efficiency of a heat pump or refrigerator. It is defined as the ratio of heating or cooling provided to the work required to achieve it.""]","[""The exact cause of Cryptogenic organizing pneumonia is unknown.""]","[""COP (Coefficient of Performance) is a measure of the efficiency of a heat pump or refrigerator. It is calculated as the ratio of heating or cooling provided to the work required to achieve it.""]",[false],[true],[false],"[""COP (Coefficient Of Performance) is a measure of the efficiency of a heat pump or refrigeration system. It is defined as the ratio of heating or cooling provided to the work required to achieve it.""]","[""The cause of Cryptogenic organizing pneumonia is unknown.""]","[""COP (Coefficient of Performance) is a measure of the efficiency of a heat pump or refrigeration system. It is defined as the ratio of heating or cooling provided to the work required to achieve it.""]",[false],[true],[false],"[""COP (Coefficient Of Performance) is a measure of the efficiency of a heat pump. It is defined as the ratio of heating or cooling provided by the system to the amount of electricity consumed.""]","[""The exact cause of Cryptogenic organizing pneumonia is unknown.""]","[""COP (Coefficient of Performance) is a measure of the efficiency of a heat pump or refrigeration system, calculated as the ratio of heating or cooling provided to the input work required.""]",[false],[true],[false],"[""COP (Coefficient Of Performance) is a measure of the efficiency of a heat pump or refrigeration system. It is defined as the ratio of heating or cooling provided to the work required to achieve it.""]","[""The cause of Cryptogenic organizing pneumonia is unknown.""]","[""COP, or Coefficient of Performance, is a measure of the efficiency of a heat pump. It is defined as the ratio of heating or cooling provided to the work required to achieve it.""]",[false],[true],[false],"[""COP is caused by the ratio of desired output to required input energy""]","[""The exact cause of Cryptogenic organizing pneumonia is unknown.""]","[""COP (Coefficient of Performance) is a measure of the efficiency of a heat pump or refrigerator. It is calculated as the ratio of heating or cooling provided to the work required to achieve it.""]",[false],[true],[false],"[""COP (Coptic) is caused by the Cytomegalovirus (CMV)""]","[""The exact cause of Cryptogenic organizing pneumonia is unknown.""]","[""COP (Coefficient of Performance) is a measure of the efficiency of a heat pump or refrigerator. It is calculated as the ratio of heating or cooling provided to the work required to achieve it.""]",[false],[true],[false],"[""Cost of production is primarily caused by expenses related to raw materials, labor, and overhead costs.""]","[""The exact cause of Cryptogenic organizing pneumonia is unknown.""]","[""COP (Coefficient of Performance) is a measure of the efficiency of a heat pump or refrigerator. It is calculated as the ratio of heating or cooling provided to the work required to achieve it.""]",[false],[true],[false],"[""COP is caused by the ratio of desired output to required input energy""]","[""The exact cause of Cryptogenic organizing pneumonia is unknown.""]","[""COP (Coefficient of Performance) is a measure of the efficiency of a heat pump or refrigerator. It is calculated as the ratio of heating or cooling provided to the work required to achieve it.""]"
considerations,What to do for Cyclic Vomiting Syndrome ?,"- Cyclic vomiting syndrome, sometimes referred to as CVS, is an increasingly recognized disorder with sudden, repeated attacksalso called episodesof severe nausea, vomiting, and physical exhaustion that occur with no apparent cause.  - The disorder can affect a person for months, years, or decades.  - The cause of cyclic vomiting syndrome is unknown.  - The severe vomiting and retching that define cyclic vomiting syndrome increase the chance of developing several complications, including dehydration, esophagitis, a Mallory-Weiss tear, and tooth decay.  - Intensity of symptoms will vary as a person cycles through four distinct phases of an episode.  - The main symptoms of cyclic vomiting syndrome are severe nausea and sudden vomiting lasting hours to days.  - People with cyclic vomiting syndrome should get plenty of rest and take medications to prevent a vomiting episode, stop an episode in progress, speed up recovery, or relieve associated symptoms.  - During the well phase, a balanced diet and regular meals are important. A health care provider will assist with planning a return to a regular diet.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""CVS"", ""full_form"": ""Cyclic Vomiting Syndrome""}]}",What to do for CVS ?,What to do for Cyclic Vomiting Syndrome ?,8,MEDICAL,Simple Datatype-String,"Instructional: Queries specifically seeking step-by-step guidance, instructions, or procedures to perform a task. it focuses on 'how' to do something rather than 'what', 'why', or 'which'.","[[""CVS Corporation"", ""Chorionic Villus Sampling"", ""Concurrent Version System"", ""Council for Voluntary Service"", ""Council for Voluntary Services"", ""Concurrent Versioning System"", ""cardiovascular system"", ""Chorionic Villi Sampling"", ""Consumer Value Stores"", ""Code Versioning System""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Cardiovascular System""]",[1.2439235210357687e-12],[2.360768994700287e-07],"[""cardiovascular system""]",[2.360768994700287e-07],"[""ABBREVIATIONS""]","[[2.0591377004377928e-11, 2.0579590738894254e-21, 3.154978244410874e-14, 6.75988541215181e-16, 2.1172746704857705e-14, 6.3445311700948554e-18, 2.360768994700287e-07, 9.070056026207505e-20, 1.2577426316691132e-17, 7.102898489348903e-20]]",[0.7988190057289084],[0.8045119037225159],"[""Concurrent Versioning System""]",[0.812509751892911],"[""ABBREVIATIONS""]","[[0.8093365035241045, 0.6718108820299478, 0.6645027104877603, 0.65287348093894, 0.656491409188044, 0.6605302230651444, 0.812509751892911, 0.6750361302596495, 0.7704625543959587, 0.6881739834727562]]","[""Chorionic Villus Sampling""]","[""ABBREVIATIONS""]",What to do for CVS (Cardiovascular System) ?,[false],[true],[true],"[""For cardiovascular health, it is important to maintain a healthy diet, exercise regularly, avoid smoking, manage stress, and get regular check-ups with a healthcare provider.""]","[""For Cyclic Vomiting Syndrome, it is important to work with a healthcare provider to develop a treatment plan. This may include lifestyle changes, dietary modifications, stress management techniques, and medications to help prevent episodes and manage symptoms.""]","[""For CVS, it is recommended to consult with a healthcare provider for proper diagnosis and treatment options.""]",[false],[true],[true],"[""For CVS (cardiovascular system), it is important to maintain a healthy lifestyle by eating a balanced diet, exercising regularly, avoiding smoking, managing stress, and getting regular check-ups with a healthcare provider.""]","[""For Cyclic Vomiting Syndrome, it is important to work with a healthcare provider to develop a treatment plan. This may include lifestyle changes, medications, and stress management techniques. Keeping a symptom diary can also help identify triggers and patterns.""]","[""For CVS, it is recommended to consult with a healthcare professional for proper diagnosis and treatment options.""]",[false],[true],[true],"[""For cardiovascular health, it is important to maintain a healthy diet, exercise regularly, avoid smoking, manage stress, and get regular check-ups with a healthcare provider.""]","[""For Cyclic Vomiting Syndrome, treatment may include lifestyle changes, stress management, dietary modifications, medications to prevent vomiting episodes, and addressing any underlying conditions. It is important to consult a healthcare provider for a personalized treatment plan.""]","[""For CVS, it is recommended to consult with a healthcare provider for proper diagnosis and treatment. They may suggest medications, lifestyle changes, or other interventions based on individual needs.""]",[false],[true],[true],"[""For cardiovascular system (CVS) health, it is important to maintain a healthy lifestyle by exercising regularly, eating a balanced diet low in saturated fats and cholesterol, avoiding smoking, managing stress, and getting regular check-ups with a healthcare provider.""]","[""For Cyclic Vomiting Syndrome, treatment may include lifestyle changes, stress management, dietary modifications, medications to prevent vomiting episodes, and in severe cases, hospitalization for intravenous fluids and medications.""]","[""For CVS, it is recommended to consult with a healthcare provider for proper diagnosis and treatment. They may suggest medications, lifestyle changes, or other interventions based on individual needs.""]",[false],[true],[true],"[""To use CVS (Concurrent Versioning System), you can follow these steps: 1. Install CVS on your system. 2. Set up a CVS repository. 3. Import your project into the CVS repository. 4. Check out files from the repository. 5. Make changes to the files. 6. Commit your changes back to the repository. 7. Update your working directory with the latest changes from the repository.""]","[""For Cyclic Vomiting Syndrome, it is important to work with a healthcare provider to develop a treatment plan. This may include lifestyle changes, dietary modifications, stress management techniques, and medications to help prevent episodes and manage symptoms.""]","[""For CVS, it is recommended to consult with a healthcare provider for proper diagnosis and treatment options.""]",[false],[true],[true],"[""To use CVS, you need to first install the CVS client software on your computer. Then, you can create a new repository, add files to it, commit changes, update your working directory, and manage different versions of your files using commands like cvs add, cvs commit, cvs update, and cvs tag.""]","[""For Cyclic Vomiting Syndrome, it is important to work with a healthcare provider to develop a treatment plan. This may include lifestyle changes, medications, and stress management techniques. Keeping a symptom diary can also help identify triggers and patterns.""]","[""For CVS, it is recommended to consult with a healthcare professional for proper diagnosis and treatment options.""]",[false],[true],[true],"[""To use CVS (Concurrent Versioning System), you can follow these steps: 1. Install CVS on your system. 2. Set up a CVS repository. 3. Add files to the repository. 4. Check out files from the repository. 5. Make changes to the files. 6. Commit changes back to the repository. 7. Update your working directory. 8. Resolve any conflicts if they arise. 9. Repeat the process for version control.""]","[""For Cyclic Vomiting Syndrome, treatment may include lifestyle changes, stress management, dietary modifications, medications to prevent vomiting episodes, and addressing any underlying conditions. It is important to consult a healthcare provider for a personalized treatment plan.""]","[""For CVS, it is recommended to consult with a healthcare provider for proper diagnosis and treatment. They may suggest medications, lifestyle changes, or other interventions based on individual needs.""]",[false],[true],[true],"[""To use CVS, you can follow these steps: 1. Install CVS on your system. 2. Set up a CVS repository. 3. Import your project into the repository. 4. Check out a working copy of the project. 5. Make changes to the files. 6. Commit your changes to the repository. 7. Update your working copy with the latest changes. 8. Resolve any conflicts if needed. Repeat steps 5-8 as necessary.""]","[""For Cyclic Vomiting Syndrome, treatment may include lifestyle changes, stress management, dietary modifications, medications to prevent vomiting episodes, and in severe cases, hospitalization for intravenous fluids and medications.""]","[""For CVS, it is recommended to consult with a healthcare provider for proper diagnosis and treatment. They may suggest medications, lifestyle changes, or other interventions based on individual needs.""]",[false],[true],[true],"[""For CVS (Chorionic Villus Sampling), a healthcare provider will insert a thin tube through the vagina and cervix to collect a small sample of cells from the placenta for testing. The procedure is usually done between 10-13 weeks of pregnancy and can help detect genetic conditions in the fetus.""]","[""For Cyclic Vomiting Syndrome, it is important to work with a healthcare provider to develop a treatment plan. This may include lifestyle changes, medications, and stress management techniques. Keeping a symptom diary can also help identify triggers and patterns.""]","[""For CVS, it is recommended to consult with a healthcare professional for proper diagnosis and treatment options.""]",[false],[true],[true],"[""For CVS (Chorionic Villus Sampling), a healthcare provider will insert a thin needle or tube through the vagina and cervix to obtain a small sample of cells from the placenta. This sample is then tested for genetic disorders or chromosomal abnormalities.""]","[""For Cyclic Vomiting Syndrome, it is important to work with a healthcare provider to develop a treatment plan. This may include lifestyle changes, dietary modifications, stress management techniques, and medications to help prevent episodes and manage symptoms.""]","[""For CVS, it is recommended to consult with a healthcare provider for proper diagnosis and treatment options.""]",[false],[true],[true],"[""For CVS (Chorionic Villus Sampling), a healthcare provider will insert a thin tube or needle into the uterus through the vagina or abdomen to collect a small sample of cells from the placenta for testing. The procedure is usually done between 10-13 weeks of pregnancy and can help diagnose genetic conditions in the fetus.""]","[""For Cyclic Vomiting Syndrome, treatment may include lifestyle changes, stress management, dietary modifications, medications to prevent vomiting episodes, and addressing any underlying conditions. It is important to consult a healthcare provider for a personalized treatment plan.""]","[""For CVS, it is recommended to consult with a healthcare provider for proper diagnosis and treatment. They may suggest medications, lifestyle changes, or other interventions based on individual needs.""]",[false],[true],[true],"[""For CVS (Chorionic Villus Sampling), a healthcare provider will insert a thin tube or needle through the vagina and cervix to obtain a small sample of cells from the placenta for genetic testing.""]","[""For Cyclic Vomiting Syndrome, treatment may include lifestyle changes, stress management, dietary modifications, medications to prevent vomiting episodes, and in severe cases, hospitalization for intravenous fluids and medications.""]","[""For CVS, it is recommended to consult with a healthcare provider for proper diagnosis and treatment. They may suggest medications, lifestyle changes, or other interventions based on individual needs.""]",[false],[true],[true],"[""CVS is a prenatal test used to detect chromosomal abnormalities in a developing baby. It involves taking a small sample of cells from the placenta for testing. It is important to discuss the risks and benefits with a healthcare provider before deciding to undergo CVS.""]","[""For Cyclic Vomiting Syndrome, it is important to work with a healthcare provider to develop a treatment plan. This may include lifestyle changes, dietary modifications, stress management techniques, and medications to help prevent episodes and manage symptoms.""]","[""For CVS, it is recommended to consult with a healthcare provider for proper diagnosis and treatment options.""]",[false],[true],[true],"[""CVS (Chorionic Villus Sampling) is a prenatal test where a small sample of cells is taken from the placenta to check for genetic conditions in the fetus.""]","[""For Cyclic Vomiting Syndrome, it is important to work with a healthcare provider to develop a treatment plan. This may include lifestyle changes, medications, and stress management techniques. Keeping a symptom diary can also help identify triggers and patterns.""]","[""For CVS, it is recommended to consult with a healthcare professional for proper diagnosis and treatment options.""]",[false],[true],[true],"[""CVS (Chorionic Villus Sampling) is a prenatal test used to detect chromosomal abnormalities in the fetus. It involves taking a small sample of cells from the placenta for genetic testing.""]","[""For Cyclic Vomiting Syndrome, treatment may include lifestyle changes, stress management, dietary modifications, medications to prevent vomiting episodes, and addressing any underlying conditions. It is important to consult a healthcare provider for a personalized treatment plan.""]","[""For CVS, it is recommended to consult with a healthcare provider for proper diagnosis and treatment. They may suggest medications, lifestyle changes, or other interventions based on individual needs.""]",[false],[true],[true],"[""CVS (Chorionic Villus Sampling) is a prenatal test used to detect chromosomal abnormalities in the fetus. It involves taking a small sample of cells from the placenta for genetic testing.""]","[""For Cyclic Vomiting Syndrome, treatment may include lifestyle changes, stress management, dietary modifications, medications to prevent vomiting episodes, and in severe cases, hospitalization for intravenous fluids and medications.""]","[""For CVS, it is recommended to consult with a healthcare provider for proper diagnosis and treatment. They may suggest medications, lifestyle changes, or other interventions based on individual needs.""]",[false],[true],[true],"[""For CVS (Chorionic Villus Sampling), the procedure involves inserting a thin needle or tube through the abdomen or cervix to collect a small sample of chorionic villi, which are tiny finger-like projections on the placenta. This sample is then tested for genetic abnormalities or other conditions.""]","[""For Cyclic Vomiting Syndrome, it is important to work with a healthcare provider to develop a treatment plan. This may include lifestyle changes, dietary modifications, stress management techniques, and medications to help prevent episodes and manage symptoms.""]","[""For CVS, it is recommended to consult with a healthcare provider for proper diagnosis and treatment options.""]",[false],[true],[true],"[""CVS is a prenatal test where a small sample of cells is taken from the placenta to check for genetic conditions in the fetus. It is typically done between 10-13 weeks of pregnancy. The procedure involves inserting a thin needle or tube through the cervix or abdomen to collect the sample. It is important to discuss the risks and benefits with a healthcare provider before undergoing CVS.""]","[""For Cyclic Vomiting Syndrome, it is important to work with a healthcare provider to develop a treatment plan. This may include lifestyle changes, medications, and stress management techniques. Keeping a symptom diary can also help identify triggers and patterns.""]","[""For CVS, it is recommended to consult with a healthcare professional for proper diagnosis and treatment options.""]",[false],[true],[true],"[""For CVS (Chorionic Villus Sampling), a healthcare provider will insert a thin tube or needle into the uterus through the vagina or abdomen to collect a small sample of cells from the placenta for testing. The procedure is usually done between 10-13 weeks of pregnancy and can help diagnose genetic disorders in the fetus.""]","[""For Cyclic Vomiting Syndrome, treatment may include lifestyle changes, stress management, dietary modifications, medications to prevent vomiting episodes, and addressing any underlying conditions. It is important to consult a healthcare provider for a personalized treatment plan.""]","[""For CVS, it is recommended to consult with a healthcare provider for proper diagnosis and treatment. They may suggest medications, lifestyle changes, or other interventions based on individual needs.""]",[false],[true],[true],"[""For CVS (Chorionic Villus Sampling), a healthcare provider will insert a thin tube or needle into the cervix or abdomen to collect a small sample of cells from the placenta for testing. The procedure is typically done under ultrasound guidance to ensure accuracy and safety.""]","[""For Cyclic Vomiting Syndrome, treatment may include lifestyle changes, stress management, dietary modifications, medications to prevent vomiting episodes, and in severe cases, hospitalization for intravenous fluids and medications.""]","[""For CVS, it is recommended to consult with a healthcare provider for proper diagnosis and treatment. They may suggest medications, lifestyle changes, or other interventions based on individual needs.""]",[false],[true],[true],"[""For CVS (Cardiovascular System), it is important to maintain a healthy lifestyle including regular exercise, balanced diet, and avoiding smoking. Regular check-ups with a healthcare provider are also essential to monitor cardiovascular health.""]","[""For Cyclic Vomiting Syndrome, it is important to work with a healthcare provider to develop a treatment plan. This may include lifestyle changes, dietary modifications, stress management techniques, and medications to help prevent episodes and manage symptoms.""]","[""For CVS, it is recommended to consult with a healthcare provider for proper diagnosis and treatment options.""]",[false],[true],[true],"[""For cardiovascular health, it is important to maintain a healthy diet, exercise regularly, avoid smoking, manage stress, and get regular check-ups with a healthcare provider.""]","[""For Cyclic Vomiting Syndrome, it is important to work with a healthcare provider to develop a treatment plan. This may include lifestyle changes, medications, and stress management techniques. Keeping a symptom diary can also help identify triggers and patterns.""]","[""For CVS, it is recommended to consult with a healthcare professional for proper diagnosis and treatment options.""]",[false],[true],[true],"[""For CVS (Cardiovascular System), it is important to maintain a healthy lifestyle by eating a balanced diet, exercising regularly, avoiding smoking, managing stress, and getting regular check-ups with a healthcare provider.""]","[""For Cyclic Vomiting Syndrome, treatment may include lifestyle changes, stress management, dietary modifications, medications to prevent vomiting episodes, and addressing any underlying conditions. It is important to consult a healthcare provider for a personalized treatment plan.""]","[""For CVS, it is recommended to consult with a healthcare provider for proper diagnosis and treatment. They may suggest medications, lifestyle changes, or other interventions based on individual needs.""]",[false],[true],[true],"[""For CVS (Cardiovascular System), it is important to maintain a healthy lifestyle including regular exercise, a balanced diet, and avoiding smoking. Regular check-ups with a healthcare provider are also crucial to monitor heart health.""]","[""For Cyclic Vomiting Syndrome, treatment may include lifestyle changes, stress management, dietary modifications, medications to prevent vomiting episodes, and in severe cases, hospitalization for intravenous fluids and medications.""]","[""For CVS, it is recommended to consult with a healthcare provider for proper diagnosis and treatment. They may suggest medications, lifestyle changes, or other interventions based on individual needs.""]",[false],[true],[true],"[""For CVS (Chorionic Villus Sampling), consult with a healthcare provider for detailed instructions and guidance.""]","[""For Cyclic Vomiting Syndrome, it is important to work with a healthcare provider to develop a treatment plan. This may include lifestyle changes, dietary modifications, stress management techniques, and medications to help prevent episodes and manage symptoms.""]","[""For CVS, it is recommended to consult with a healthcare provider for proper diagnosis and treatment options.""]",[false],[true],[true],"[""For CVS (Chorionic Villus Sampling), the following steps are typically followed: 1. A healthcare provider will insert a thin needle or tube through the mother's abdomen or cervix to reach the placenta. 2. A small sample of chorionic villi tissue is then collected. 3. The sample is sent to a laboratory for genetic testing. It is important to consult with a healthcare provider for specific instructions and guidance.""]","[""For Cyclic Vomiting Syndrome, it is important to work with a healthcare provider to develop a treatment plan. This may include lifestyle changes, medications, and stress management techniques. Keeping a symptom diary can also help identify triggers and patterns.""]","[""For CVS, it is recommended to consult with a healthcare professional for proper diagnosis and treatment options.""]",[false],[true],[true],"[""For CVS (Chorionic Villus Sampling), the procedure involves inserting a thin needle or tube through the mother's abdomen or cervix to obtain a small sample of chorionic villi from the placenta. This sample is then tested for genetic abnormalities or other conditions.""]","[""For Cyclic Vomiting Syndrome, treatment may include lifestyle changes, stress management, dietary modifications, medications to prevent vomiting episodes, and addressing any underlying conditions. It is important to consult a healthcare provider for a personalized treatment plan.""]","[""For CVS, it is recommended to consult with a healthcare provider for proper diagnosis and treatment. They may suggest medications, lifestyle changes, or other interventions based on individual needs.""]",[false],[true],[true],"[""For CVS (Chorionic Villus Sampling), the following steps are typically followed: 1. The healthcare provider will clean the area where the sample will be taken. 2. Using ultrasound guidance, a thin needle or tube is inserted either through the abdomen or the cervix to collect a small sample of chorionic villi. 3. The sample is then sent to a laboratory for genetic testing. It is important to follow any specific instructions provided by the healthcare provider before and after the procedure.""]","[""For Cyclic Vomiting Syndrome, treatment may include lifestyle changes, stress management, dietary modifications, medications to prevent vomiting episodes, and in severe cases, hospitalization for intravenous fluids and medications.""]","[""For CVS, it is recommended to consult with a healthcare provider for proper diagnosis and treatment. They may suggest medications, lifestyle changes, or other interventions based on individual needs.""]",[false],[true],[true],"[""Consult with a healthcare provider for detailed information and guidance on CVS (Chorionic Villus Sampling).""]","[""For Cyclic Vomiting Syndrome, it is important to work with a healthcare provider to develop a treatment plan. This may include lifestyle changes, dietary modifications, stress management techniques, and medications to help prevent episodes and manage symptoms.""]","[""For CVS, it is recommended to consult with a healthcare provider for proper diagnosis and treatment options.""]",[false],[true],[true],"[""Regular exercise, healthy diet, managing stress, avoiding smoking and excessive alcohol consumption""]","[""For Cyclic Vomiting Syndrome, it is important to work with a healthcare provider to develop a treatment plan. This may include lifestyle changes, dietary modifications, stress management techniques, and medications to help prevent episodes and manage symptoms.""]","[""For CVS, it is recommended to consult with a healthcare provider for proper diagnosis and treatment options.""]",[false],[true],[true],"[""For CVS (Concurrent Versioning System), you can use commands like checkout, commit, update, and diff to manage versions of files.""]","[""For Cyclic Vomiting Syndrome, it is important to work with a healthcare provider to develop a treatment plan. This may include lifestyle changes, dietary modifications, stress management techniques, and medications to help prevent episodes and manage symptoms.""]","[""For CVS, it is recommended to consult with a healthcare provider for proper diagnosis and treatment options.""]",[true],[true],[true],"[""Consult a healthcare professional for personalized advice.""]","[""For Cyclic Vomiting Syndrome, it is important to work with a healthcare provider to develop a treatment plan. This may include lifestyle changes, dietary modifications, stress management techniques, and medications to help prevent episodes and manage symptoms.""]","[""For CVS, it is recommended to consult with a healthcare provider for proper diagnosis and treatment options.""]"
frequency,How many people are affected by X-linked chondrodysplasia punctata 1 ?,The prevalence of X-linked chondrodysplasia punctata 1 is unknown. Several dozen affected males have been reported in the scientific literature.,"{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""XLC1"", ""full_form"": ""X-linked chondrodysplasia punctata 1""}]}",How many people are affected by XLC1 ?,How many people are affected by X-linked chondrodysplasia punctata 1 ?,1,COMPUTING,Simple Datatype-Integer,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.",[[]],[[]],"[""Not a standard computing abbreviation""]",[5.881788969272267e-32],[1.5374857292401046e-20],"[""Not a standard computing abbreviation""]",[1.5374857292401046e-20],"[""LLM""]",[[]],[0.8844426648253674],[0.9411179892108523],"[""X-linked chondrodysplasia punctata 1""]",[0.9411179892108523],"[""LLM""]",[[]],"[""Not a standard computing abbreviation""]","[""LLM""]",How many people are affected by XLC1 (Not a standard computing abbreviation) ?,[true],[true],[true],"[""The number of people affected by XLC1 is not available.""]","[""X-linked chondrodysplasia punctata 1 affects a very small number of individuals worldwide.""]","[""Unknown""]",[true],[false],[true],"[""The number of people affected by XLC1 is not available.""]","[""X-linked chondrodysplasia punctata 1 affects approximately 1 in 100,000 to 200,000 individuals.""]","[""Unknown""]",[true],[true],[true],"[""The number of people affected by XLC1 is not available.""]","[""X-linked chondrodysplasia punctata 1 affects a very small number of individuals worldwide.""]","[""Unknown""]",[true],[true],[true],"[""The number of people affected by XLC1 is not available.""]","[""X-linked chondrodysplasia punctata 1 affects a very small number of individuals worldwide.""]","[""Unknown""]",[false],[true],[true],"[""X-linked chondrodysplasia punctata 1 affects approximately 1 in 100,000 to 1 in 200,000 individuals.""]","[""X-linked chondrodysplasia punctata 1 affects a very small number of individuals worldwide.""]","[""Unknown""]",[false],[false],[true],"[""X-linked chondrodysplasia punctata 1 affects approximately 1 in 100,000 to 1 in 200,000 individuals.""]","[""X-linked chondrodysplasia punctata 1 affects approximately 1 in 100,000 to 200,000 individuals.""]","[""Unknown""]",[false],[true],[true],"[""X-linked chondrodysplasia punctata 1 affects approximately 1 in 100,000 to 200,000 individuals.""]","[""X-linked chondrodysplasia punctata 1 affects a very small number of individuals worldwide.""]","[""Unknown""]",[false],[true],[true],"[""X-linked chondrodysplasia punctata 1 affects approximately 1 in 100,000 to 200,000 individuals.""]","[""X-linked chondrodysplasia punctata 1 affects a very small number of individuals worldwide.""]","[""Unknown""]",[true],[false],[true],"[""Unknown""]","[""X-linked chondrodysplasia punctata 1 affects approximately 1 in 100,000 to 200,000 individuals.""]","[""Unknown""]",[true],[true],[true],"[""The number of people affected by XLC1 is not available.""]","[""X-linked chondrodysplasia punctata 1 affects a very small number of individuals worldwide.""]","[""Unknown""]",[true],[true],[true],"[""The number of people affected by XLC1 is not available.""]","[""X-linked chondrodysplasia punctata 1 affects a very small number of individuals worldwide.""]","[""Unknown""]",[true],[true],[true],"[""The number of people affected by XLC1 is not available.""]","[""X-linked chondrodysplasia punctata 1 affects a very small number of individuals worldwide.""]","[""Unknown""]",[true],[true],[true],"[""The number of people affected by XLC1 is not available.""]","[""X-linked chondrodysplasia punctata 1 affects a very small number of individuals worldwide.""]","[""Unknown""]",[true],[false],[true],"[""The number of people affected by XLC1 is not available.""]","[""X-linked chondrodysplasia punctata 1 affects approximately 1 in 100,000 to 200,000 individuals.""]","[""Unknown""]",[true],[true],[true],"[""The number of people affected by XLC1 is not available.""]","[""X-linked chondrodysplasia punctata 1 affects a very small number of individuals worldwide.""]","[""Unknown""]",[true],[true],[true],"[""Unknown""]","[""X-linked chondrodysplasia punctata 1 affects a very small number of individuals worldwide.""]","[""Unknown""]",[true],[true],[true],"[""The number of people affected by XLC1 is not available.""]","[""X-linked chondrodysplasia punctata 1 affects a very small number of individuals worldwide.""]","[""Unknown""]",[true],[false],[true],"[""The number of people affected by XLC1 is currently unknown.""]","[""X-linked chondrodysplasia punctata 1 affects approximately 1 in 100,000 to 200,000 individuals.""]","[""Unknown""]",[true],[true],[true],"[""The number of people affected by XLC1 is not available.""]","[""X-linked chondrodysplasia punctata 1 affects a very small number of individuals worldwide.""]","[""Unknown""]",[true],[true],[true],"[""The number of people affected by XLC1 is not available.""]","[""X-linked chondrodysplasia punctata 1 affects a very small number of individuals worldwide.""]","[""Unknown""]",[true],[true],[true],"[""The number of people affected by XLC1 is not available.""]","[""X-linked chondrodysplasia punctata 1 affects a very small number of individuals worldwide.""]","[""Unknown""]",[true],[false],[true],"[""The number of people affected by XLC1 is not available.""]","[""X-linked chondrodysplasia punctata 1 affects approximately 1 in 100,000 to 200,000 individuals.""]","[""Unknown""]",[true],[true],[true],"[""The number of people affected by XLC1 is not available.""]","[""X-linked chondrodysplasia punctata 1 affects a very small number of individuals worldwide.""]","[""Unknown""]",[true],[true],[true],"[""The number of people affected by XLC1 is not available.""]","[""X-linked chondrodysplasia punctata 1 affects a very small number of individuals worldwide.""]","[""Unknown""]",[true],[true],[true],"[""The number of people affected by XLC1 is not publicly available.""]","[""X-linked chondrodysplasia punctata 1 affects a very small number of individuals worldwide.""]","[""Unknown""]",[true],[false],[true],"[""The number of people affected by XLC1 is not publicly available.""]","[""X-linked chondrodysplasia punctata 1 affects approximately 1 in 100,000 to 200,000 individuals.""]","[""Unknown""]",[true],[true],[true],"[""The number of people affected by XLC1 is not available.""]","[""X-linked chondrodysplasia punctata 1 affects a very small number of individuals worldwide.""]","[""Unknown""]",[true],[true],[true],"[""The number of people affected by XLC1 is not publicly available.""]","[""X-linked chondrodysplasia punctata 1 affects a very small number of individuals worldwide.""]","[""Unknown""]",[true],[true],[true],"[""The number of people affected by XLC1 is currently unknown.""]","[""X-linked chondrodysplasia punctata 1 affects a very small number of individuals worldwide.""]","[""Unknown""]",[true],[true],[true],"[""The number of people affected by XLC1 is currently unknown.""]","[""X-linked chondrodysplasia punctata 1 affects a very small number of individuals worldwide.""]","[""Unknown""]",[false],[true],[true],"[""X-linked chondrodysplasia punctata 1 affects approximately 1 in 100,000 to 200,000 individuals worldwide.""]","[""X-linked chondrodysplasia punctata 1 affects a very small number of individuals worldwide.""]","[""Unknown""]",[true],[true],[true],"[""The number of people affected by XLC1 is currently unknown.""]","[""X-linked chondrodysplasia punctata 1 affects a very small number of individuals worldwide.""]","[""Unknown""]"
symptoms,What are the symptoms of Cone-rod dystrophy 2 ?,"What are the signs and symptoms of Cone-rod dystrophy 2? The Human Phenotype Ontology provides the following list of signs and symptoms for Cone-rod dystrophy 2. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of color vision - Autosomal dominant inheritance - Blindness - Chorioretinal atrophy - Cone/cone-rod dystrophy - Constriction of peripheral visual field - Nyctalopia - Peripheral visual field loss - Reduced visual acuity - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""CORD2"", ""full_form"": ""Cone-rod dystrophy 2""}]}",What are the symptoms of CORD2 ?,What are the symptoms of Cone-rod dystrophy 2 ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.",[[]],[[]],"[""Cone Rod Dystrophy 2""]",[7.718392249107653e-22],[3.715520328344971e-21],"[""Cone Rod Dystrophy 2""]",[3.715520328344971e-21],"[""LLM""]",[[]],[0.8267442872678175],[0.8217453934904388],"[""Cone-rod dystrophy 2""]",[0.8217453934904388],"[""LLM""]",[[]],"[""Cone Rod Dystrophy 2""]","[""LLM""]",What are the symptoms of CORD2 (Cone Rod Dystrophy 2) ?,[true],[true],[true],"[""Symptoms of CORD2 include decreased visual acuity, color vision defects, photophobia, and progressive loss of peripheral vision.""]","[""Symptoms of Cone-rod dystrophy 2 include decreased visual acuity, color vision defects, sensitivity to bright lights, and loss of peripheral vision.""]","[""Symptoms of CORD2 include vision loss, night blindness, and peripheral vision loss.""]",[true],[true],[false],"[""Symptoms of CORD2 (Cone Rod Dystrophy 2) include decreased visual acuity, color vision abnormalities, sensitivity to light, and loss of peripheral vision.""]","[""Symptoms of Cone-rod dystrophy 2 include decreased visual acuity, color vision defects, and sensitivity to bright lights.""]","[""Symptoms of CORD2 include vision loss, difficulty with balance and coordination, muscle weakness, and muscle stiffness.""]",[true],[true],[true],"[""Symptoms of CORD2 (Cone Rod Dystrophy 2) include decreased sharpness of vision (visual acuity), loss of color vision, sensitivity to bright light (photophobia), and involuntary eye movements (nystagmus).""]","[""Symptoms of Cone-rod dystrophy 2 include decreased sharpness of vision, loss of color vision, and photophobia.""]","[""Symptoms of CORD2 include vision loss, night blindness, and peripheral vision loss.""]",[true],[true],[true],"[""Symptoms of CORD2 (Cone Rod Dystrophy 2) include decreased visual acuity, color vision abnormalities, sensitivity to light (photophobia), and loss of peripheral vision.""]","[""Symptoms of Cone-rod dystrophy 2 include decreased visual acuity, color vision abnormalities, photophobia, and loss of peripheral vision.""]","[""Symptoms of CORD2 include vision loss, night blindness, and peripheral vision loss.""]",[true],[true],[true],"[""Symptoms of CORD2 (Cone-rod dystrophy 2) include vision loss, color vision abnormalities, sensitivity to light, and progressive deterioration of central vision.""]","[""Symptoms of Cone-rod dystrophy 2 include decreased visual acuity, color vision defects, sensitivity to bright lights, and loss of peripheral vision.""]","[""Symptoms of CORD2 include vision loss, night blindness, and peripheral vision loss.""]",[true],[true],[false],"[""Symptoms of CORD2 (Cone-rod dystrophy 2) include vision loss, color vision abnormalities, sensitivity to light, and reduced peripheral vision.""]","[""Symptoms of Cone-rod dystrophy 2 include decreased visual acuity, color vision defects, and sensitivity to bright lights.""]","[""Symptoms of CORD2 include vision loss, difficulty with balance and coordination, muscle weakness, and muscle stiffness.""]",[true],[true],[true],"[""Symptoms of CORD2 (Cone-rod dystrophy 2) include vision loss, decreased color vision, sensitivity to light, and difficulty seeing at night.""]","[""Symptoms of Cone-rod dystrophy 2 include decreased sharpness of vision, loss of color vision, and photophobia.""]","[""Symptoms of CORD2 include vision loss, night blindness, and peripheral vision loss.""]",[true],[true],[true],"[""Symptoms of CORD2 include vision loss, color blindness, sensitivity to light, and difficulty seeing at night.""]","[""Symptoms of Cone-rod dystrophy 2 include decreased visual acuity, color vision abnormalities, photophobia, and loss of peripheral vision.""]","[""Symptoms of CORD2 include vision loss, night blindness, and peripheral vision loss.""]",[true],[true],[false],"[""Symptoms of CORD2 (Cone Rod Dystrophy 2) include decreased sharpness of vision (visual acuity), loss of color vision, sensitivity to light (photophobia), and involuntary movements of the eyes (nystagmus).""]","[""Symptoms of Cone-rod dystrophy 2 include decreased visual acuity, color vision defects, and sensitivity to bright lights.""]","[""Symptoms of CORD2 include vision loss, difficulty with balance and coordination, muscle weakness, and muscle stiffness.""]",[true],[true],[true],"[""Symptoms of CORD2 include decreased visual acuity, color vision abnormalities, and sensitivity to light.""]","[""Symptoms of Cone-rod dystrophy 2 include decreased visual acuity, color vision defects, sensitivity to bright lights, and loss of peripheral vision.""]","[""Symptoms of CORD2 include vision loss, night blindness, and peripheral vision loss.""]",[true],[true],[true],"[""Symptoms of CORD2 (Cone Rod Dystrophy 2) include decreased visual acuity, color vision abnormalities, sensitivity to light (photophobia), and loss of peripheral vision.""]","[""Symptoms of Cone-rod dystrophy 2 include decreased sharpness of vision, loss of color vision, and photophobia.""]","[""Symptoms of CORD2 include vision loss, night blindness, and peripheral vision loss.""]",[false],[true],[true],"[""Symptoms of CORD2 (Cone Rod Dystrophy 2) include decreased sharpness of vision (visual acuity), loss of color vision, sensitivity to light (photophobia), and involuntary movements of the eyes (nystagmus).""]","[""Symptoms of Cone-rod dystrophy 2 include decreased visual acuity, color vision abnormalities, photophobia, and loss of peripheral vision.""]","[""Symptoms of CORD2 include vision loss, night blindness, and peripheral vision loss.""]",[true],[true],[true],"[""Symptoms of CORD2 include decreased visual acuity, color vision abnormalities, sensitivity to light, and loss of peripheral vision.""]","[""Symptoms of Cone-rod dystrophy 2 include decreased visual acuity, color vision defects, sensitivity to bright lights, and loss of peripheral vision.""]","[""Symptoms of CORD2 include vision loss, night blindness, and peripheral vision loss.""]",[true],[true],[false],"[""Symptoms of CORD2 (Cone Rod Dystrophy 2) include decreased visual acuity, color vision abnormalities, photophobia, and progressive loss of peripheral vision.""]","[""Symptoms of Cone-rod dystrophy 2 include decreased visual acuity, color vision defects, and sensitivity to bright lights.""]","[""Symptoms of CORD2 include vision loss, difficulty with balance and coordination, muscle weakness, and muscle stiffness.""]",[true],[true],[true],"[""Symptoms of CORD2 include decreased visual acuity, color vision defects, sensitivity to light, and loss of peripheral vision.""]","[""Symptoms of Cone-rod dystrophy 2 include decreased sharpness of vision, loss of color vision, and photophobia.""]","[""Symptoms of CORD2 include vision loss, night blindness, and peripheral vision loss.""]",[true],[true],[true],"[""Symptoms of CORD2 (Cone Rod Dystrophy 2) include decreased visual acuity, color vision abnormalities, sensitivity to light, and loss of peripheral vision.""]","[""Symptoms of Cone-rod dystrophy 2 include decreased visual acuity, color vision abnormalities, photophobia, and loss of peripheral vision.""]","[""Symptoms of CORD2 include vision loss, night blindness, and peripheral vision loss.""]",[true],[true],[true],"[""Symptoms of CORD2 include decreased visual acuity, color vision abnormalities, and sensitivity to light.""]","[""Symptoms of Cone-rod dystrophy 2 include decreased visual acuity, color vision defects, sensitivity to bright lights, and loss of peripheral vision.""]","[""Symptoms of CORD2 include vision loss, night blindness, and peripheral vision loss.""]",[true],[true],[false],"[""Symptoms of CORD2 (Cone Rod Dystrophy 2) include decreased visual acuity, color vision abnormalities, sensitivity to light, and loss of peripheral vision.""]","[""Symptoms of Cone-rod dystrophy 2 include decreased visual acuity, color vision defects, and sensitivity to bright lights.""]","[""Symptoms of CORD2 include vision loss, difficulty with balance and coordination, muscle weakness, and muscle stiffness.""]",[true],[true],[true],"[""Symptoms of CORD2 (Cone Rod Dystrophy 2) include decreased visual acuity, loss of color vision, sensitivity to light, and night blindness.""]","[""Symptoms of Cone-rod dystrophy 2 include decreased sharpness of vision, loss of color vision, and photophobia.""]","[""Symptoms of CORD2 include vision loss, night blindness, and peripheral vision loss.""]",[true],[true],[true],"[""Symptoms of CORD2 (Cone Rod Dystrophy 2) include decreased visual acuity, color vision abnormalities, sensitivity to light (photophobia), and loss of peripheral vision.""]","[""Symptoms of Cone-rod dystrophy 2 include decreased visual acuity, color vision abnormalities, photophobia, and loss of peripheral vision.""]","[""Symptoms of CORD2 include vision loss, night blindness, and peripheral vision loss.""]",[true],[true],[true],"[""Symptoms of CORD2 (Cone Rod Dystrophy 2) include decreased visual acuity, color vision abnormalities, sensitivity to light (photophobia), and loss of peripheral vision.""]","[""Symptoms of Cone-rod dystrophy 2 include decreased visual acuity, color vision defects, sensitivity to bright lights, and loss of peripheral vision.""]","[""Symptoms of CORD2 include vision loss, night blindness, and peripheral vision loss.""]",[true],[true],[false],"[""Symptoms of CORD2 include decreased visual acuity, color vision abnormalities, photophobia, and progressive loss of peripheral vision.""]","[""Symptoms of Cone-rod dystrophy 2 include decreased visual acuity, color vision defects, and sensitivity to bright lights.""]","[""Symptoms of CORD2 include vision loss, difficulty with balance and coordination, muscle weakness, and muscle stiffness.""]",[true],[true],[true],"[""Symptoms of CORD2 include decreased visual acuity, color vision abnormalities, sensitivity to light, and loss of peripheral vision.""]","[""Symptoms of Cone-rod dystrophy 2 include decreased sharpness of vision, loss of color vision, and photophobia.""]","[""Symptoms of CORD2 include vision loss, night blindness, and peripheral vision loss.""]",[false],[true],[true],"[""Symptoms of CORD2 (Cone Rod Dystrophy 2) include decreased sharpness of vision (visual acuity), loss of color vision, sensitivity to light (photophobia), and involuntary movements of the eyes (nystagmus).""]","[""Symptoms of Cone-rod dystrophy 2 include decreased visual acuity, color vision abnormalities, photophobia, and loss of peripheral vision.""]","[""Symptoms of CORD2 include vision loss, night blindness, and peripheral vision loss.""]",[true],[true],[true],"[""Symptoms of CORD2 (Cone Rod Dystrophy 2) include decreased visual acuity, color vision abnormalities, photophobia, and progressive loss of peripheral vision.""]","[""Symptoms of Cone-rod dystrophy 2 include decreased visual acuity, color vision defects, sensitivity to bright lights, and loss of peripheral vision.""]","[""Symptoms of CORD2 include vision loss, night blindness, and peripheral vision loss.""]",[true],[true],[false],"[""Symptoms of CORD2 (Cone Rod Dystrophy 2) include decreased visual acuity, color vision abnormalities, sensitivity to bright lights, and loss of peripheral vision.""]","[""Symptoms of Cone-rod dystrophy 2 include decreased visual acuity, color vision defects, and sensitivity to bright lights.""]","[""Symptoms of CORD2 include vision loss, difficulty with balance and coordination, muscle weakness, and muscle stiffness.""]",[true],[true],[true],"[""Symptoms of CORD2 (Cone Rod Dystrophy 2) may include decreased visual acuity, color vision abnormalities, sensitivity to bright light (photophobia), and loss of peripheral vision.""]","[""Symptoms of Cone-rod dystrophy 2 include decreased sharpness of vision, loss of color vision, and photophobia.""]","[""Symptoms of CORD2 include vision loss, night blindness, and peripheral vision loss.""]",[true],[true],[true],"[""Symptoms of CORD2 (Cone Rod Dystrophy 2) include decreased sharpness of vision (visual acuity), loss of color vision, and sensitivity to bright lights.""]","[""Symptoms of Cone-rod dystrophy 2 include decreased visual acuity, color vision abnormalities, photophobia, and loss of peripheral vision.""]","[""Symptoms of CORD2 include vision loss, night blindness, and peripheral vision loss.""]",[true],[true],[true],"[""Symptoms of CORD2 (Cone Rod Dystrophy 2) include progressive vision loss, color vision abnormalities, sensitivity to light, and difficulty seeing at night.""]","[""Symptoms of Cone-rod dystrophy 2 include decreased visual acuity, color vision defects, sensitivity to bright lights, and loss of peripheral vision.""]","[""Symptoms of CORD2 include vision loss, night blindness, and peripheral vision loss.""]",[true],[true],[true],"[""Symptoms of CORD2 (Cone Rod Dystrophy 2) include decreased visual acuity, color vision abnormalities, sensitivity to bright lights, and loss of peripheral vision.""]","[""Symptoms of Cone-rod dystrophy 2 include decreased visual acuity, color vision defects, sensitivity to bright lights, and loss of peripheral vision.""]","[""Symptoms of CORD2 include vision loss, night blindness, and peripheral vision loss.""]",[true],[true],[true],"[""Symptoms of CORD2 include vision loss, color blindness, sensitivity to light, and reduced sharpness of vision.""]","[""Symptoms of Cone-rod dystrophy 2 include decreased visual acuity, color vision defects, sensitivity to bright lights, and loss of peripheral vision.""]","[""Symptoms of CORD2 include vision loss, night blindness, and peripheral vision loss.""]",[true],[true],[true],"[""Symptoms of CORD2 include decreased visual acuity, color vision abnormalities, and sensitivity to light.""]","[""Symptoms of Cone-rod dystrophy 2 include decreased visual acuity, color vision defects, sensitivity to bright lights, and loss of peripheral vision.""]","[""Symptoms of CORD2 include vision loss, night blindness, and peripheral vision loss.""]"
symptoms,What are the symptoms of Spinocerebellar ataxia 11 ?,"What are the signs and symptoms of Spinocerebellar ataxia 11? The Human Phenotype Ontology provides the following list of signs and symptoms for Spinocerebellar ataxia 11. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Adult onset - Autosomal dominant inheritance - Cerebellar atrophy - Dysarthria - Hyperreflexia - Nystagmus - Progressive cerebellar ataxia - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""SCA11"", ""full_form"": ""Spinocerebellar ataxia 11""}]}",What are the symptoms of SCA11 ?,What are the symptoms of Spinocerebellar ataxia 11 ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.",[[]],[[]],"[""Spinocerebellar Ataxia Type 11""]",[5.257316702818708e-23],[1.315922503567999e-24],"[""Spinocerebellar Ataxia Type 11""]",[1.315922503567999e-24],"[""LLM""]",[[]],[0.9439788493396082],[0.9338136678157949],"[""Spinocerebellar ataxia 11""]",[0.9338136678157949],"[""LLM""]",[[]],"[""Spinocerebellar Ataxia Type 11""]","[""LLM""]",What are the symptoms of SCA11 (Spinocerebellar Ataxia Type 11) ?,[true],[true],[true],"[""Symptoms of SCA11 include uncoordinated movement, difficulty with balance and coordination, tremors, muscle stiffness, and speech problems.""]","[""Symptoms of Spinocerebellar ataxia 11 include uncoordinated movement, difficulty with balance and coordination, slurred speech, and abnormal eye movements.""]","[""The symptoms of SCA11 include difficulty with coordination and balance, tremors, muscle stiffness, and slurred speech.""]",[true],[true],[true],"[""Symptoms of SCA11 include progressive problems with coordination and balance, uncontrolled movements (ataxia), tremors, and difficulty with speech and swallowing.""]","[""Symptoms of Spinocerebellar ataxia 11 include uncoordinated movements, difficulty with balance and coordination, slurred speech, muscle stiffness, and tremors.""]","[""The symptoms of SCA11 include gait ataxia, dysarthria, and nystagmus.""]",[true],[true],[true],"[""Symptoms of SCA11 include uncoordinated movement, difficulty with balance and coordination, tremors, muscle stiffness, and slurred speech.""]","[""Symptoms of Spinocerebellar ataxia 11 include difficulty with coordination and balance, speech problems, abnormal eye movements, muscle stiffness, and tremors.""]","[""The symptoms of SCA11 include difficulty with coordination and balance, tremors, muscle stiffness, and slurred speech.""]",[true],[true],[true],"[""The symptoms of SCA11 include uncoordinated movement (ataxia), difficulty with balance and coordination, tremors, muscle stiffness, and speech problems.""]","[""Symptoms of Spinocerebellar ataxia 11 include difficulty with coordination and balance, slurred speech, abnormal eye movements, muscle stiffness, tremors, and cognitive impairment.""]","[""The symptoms of SCA11 include gait ataxia, dysarthria, and nystagmus.""]",[true],[true],[true],"[""Symptoms of SCA11 include progressive problems with coordination and balance, uncontrolled movements (ataxia), tremors, and difficulty with speech and swallowing.""]","[""Symptoms of Spinocerebellar ataxia 11 include uncoordinated movement, difficulty with balance and coordination, slurred speech, and abnormal eye movements.""]","[""The symptoms of SCA11 include difficulty with coordination and balance, tremors, muscle stiffness, and slurred speech.""]",[true],[true],[true],"[""Symptoms of SCA11 include uncoordinated movement, difficulty with balance and coordination, tremors, muscle stiffness, and slurred speech.""]","[""Symptoms of Spinocerebellar ataxia 11 include uncoordinated movements, difficulty with balance and coordination, slurred speech, muscle stiffness, and tremors.""]","[""The symptoms of SCA11 include gait ataxia, dysarthria, and nystagmus.""]",[true],[true],[true],"[""Symptoms of SCA11 include gait ataxia, dysarthria, nystagmus, and intention tremor.""]","[""Symptoms of Spinocerebellar ataxia 11 include difficulty with coordination and balance, speech problems, abnormal eye movements, muscle stiffness, and tremors.""]","[""The symptoms of SCA11 include difficulty with coordination and balance, tremors, muscle stiffness, and slurred speech.""]",[true],[true],[true],"[""The symptoms of SCA11 (Spinocerebellar ataxia 11) include progressive ataxia, dysarthria, tremors, and difficulty with coordination and balance.""]","[""Symptoms of Spinocerebellar ataxia 11 include difficulty with coordination and balance, slurred speech, abnormal eye movements, muscle stiffness, tremors, and cognitive impairment.""]","[""The symptoms of SCA11 include gait ataxia, dysarthria, and nystagmus.""]",[true],[true],[true],"[""The symptoms of SCA11 (Spinocerebellar Ataxia Type 11) include uncoordinated movement, difficulty with balance and coordination, speech problems, and abnormal eye movements.""]","[""Symptoms of Spinocerebellar ataxia 11 include uncoordinated movements, difficulty with balance and coordination, slurred speech, muscle stiffness, and tremors.""]","[""The symptoms of SCA11 include gait ataxia, dysarthria, and nystagmus.""]",[true],[true],[true],"[""Symptoms of SCA11 include uncoordinated movement, difficulty with balance and coordination, tremors, and speech problems.""]","[""Symptoms of Spinocerebellar ataxia 11 include uncoordinated movement, difficulty with balance and coordination, slurred speech, and abnormal eye movements.""]","[""The symptoms of SCA11 include difficulty with coordination and balance, tremors, muscle stiffness, and slurred speech.""]",[true],[true],[true],"[""Symptoms of SCA11 include uncoordinated movement, difficulty with balance and coordination, tremors, and speech problems.""]","[""Symptoms of Spinocerebellar ataxia 11 include difficulty with coordination and balance, speech problems, abnormal eye movements, muscle stiffness, and tremors.""]","[""The symptoms of SCA11 include difficulty with coordination and balance, tremors, muscle stiffness, and slurred speech.""]",[true],[true],[true],"[""Symptoms of SCA11 include uncoordinated movement, difficulty with balance and coordination, tremors, and slurred speech.""]","[""Symptoms of Spinocerebellar ataxia 11 include difficulty with coordination and balance, slurred speech, abnormal eye movements, muscle stiffness, tremors, and cognitive impairment.""]","[""The symptoms of SCA11 include gait ataxia, dysarthria, and nystagmus.""]",[true],[true],[true],"[""Symptoms of SCA11 include uncoordinated movement, difficulty with balance and coordination, tremors, muscle stiffness, and speech problems.""]","[""Symptoms of Spinocerebellar ataxia 11 include uncoordinated movement, difficulty with balance and coordination, slurred speech, and abnormal eye movements.""]","[""The symptoms of SCA11 include difficulty with coordination and balance, tremors, muscle stiffness, and slurred speech.""]",[true],[true],[true],"[""Symptoms of SCA11 include uncoordinated movement, difficulty with balance and coordination, speech problems, and tremors.""]","[""Symptoms of Spinocerebellar ataxia 11 include uncoordinated movements, difficulty with balance and coordination, slurred speech, muscle stiffness, and tremors.""]","[""The symptoms of SCA11 include gait ataxia, dysarthria, and nystagmus.""]",[true],[true],[true],"[""Symptoms of SCA11 include uncoordinated movement, difficulty with balance and coordination, speech problems, and tremors.""]","[""Symptoms of Spinocerebellar ataxia 11 include difficulty with coordination and balance, speech problems, abnormal eye movements, muscle stiffness, and tremors.""]","[""The symptoms of SCA11 include difficulty with coordination and balance, tremors, muscle stiffness, and slurred speech.""]",[true],[true],[true],"[""Symptoms of SCA11 include uncoordinated movement, difficulty with balance and coordination, speech problems, and tremors.""]","[""Symptoms of Spinocerebellar ataxia 11 include difficulty with coordination and balance, slurred speech, abnormal eye movements, muscle stiffness, tremors, and cognitive impairment.""]","[""The symptoms of SCA11 include gait ataxia, dysarthria, and nystagmus.""]",[true],[true],[true],"[""The symptoms of SCA11 (Spinocerebellar Ataxia Type 11) include gait ataxia, dysarthria, nystagmus, and tremor.""]","[""Symptoms of Spinocerebellar ataxia 11 include uncoordinated movement, difficulty with balance and coordination, slurred speech, and abnormal eye movements.""]","[""The symptoms of SCA11 include difficulty with coordination and balance, tremors, muscle stiffness, and slurred speech.""]",[true],[true],[true],"[""Symptoms of SCA11 include uncoordinated movement, difficulty with balance and coordination, tremors, muscle stiffness, and speech problems.""]","[""Symptoms of Spinocerebellar ataxia 11 include uncoordinated movements, difficulty with balance and coordination, slurred speech, muscle stiffness, and tremors.""]","[""The symptoms of SCA11 include gait ataxia, dysarthria, and nystagmus.""]",[true],[true],[true],"[""Symptoms of SCA11 include uncoordinated movement, difficulty with balance and coordination, tremors, and muscle stiffness.""]","[""Symptoms of Spinocerebellar ataxia 11 include difficulty with coordination and balance, speech problems, abnormal eye movements, muscle stiffness, and tremors.""]","[""The symptoms of SCA11 include difficulty with coordination and balance, tremors, muscle stiffness, and slurred speech.""]",[true],[true],[true],"[""Symptoms of SCA11 may include uncoordinated movement, difficulty with balance and coordination, tremors, and muscle stiffness.""]","[""Symptoms of Spinocerebellar ataxia 11 include difficulty with coordination and balance, slurred speech, abnormal eye movements, muscle stiffness, tremors, and cognitive impairment.""]","[""The symptoms of SCA11 include gait ataxia, dysarthria, and nystagmus.""]",[true],[true],[true],"[""The symptoms of SCA11 (Spinocerebellar Ataxia Type 11) include progressive problems with coordination and balance, uncontrolled movements (ataxia), tremors, and difficulty with speech and swallowing.""]","[""Symptoms of Spinocerebellar ataxia 11 include uncoordinated movement, difficulty with balance and coordination, slurred speech, and abnormal eye movements.""]","[""The symptoms of SCA11 include difficulty with coordination and balance, tremors, muscle stiffness, and slurred speech.""]",[true],[true],[true],"[""The symptoms of SCA11 include uncoordinated movement, difficulty with balance and coordination, speech problems, and tremors.""]","[""Symptoms of Spinocerebellar ataxia 11 include uncoordinated movements, difficulty with balance and coordination, slurred speech, muscle stiffness, and tremors.""]","[""The symptoms of SCA11 include gait ataxia, dysarthria, and nystagmus.""]",[true],[true],[true],"[""Symptoms of SCA11 may include uncoordinated movements, difficulty with balance and coordination, tremors, muscle stiffness, and speech problems.""]","[""Symptoms of Spinocerebellar ataxia 11 include difficulty with coordination and balance, speech problems, abnormal eye movements, muscle stiffness, and tremors.""]","[""The symptoms of SCA11 include difficulty with coordination and balance, tremors, muscle stiffness, and slurred speech.""]",[true],[true],[true],"[""The symptoms of SCA11 include uncoordinated movement, difficulty with balance and coordination, speech problems, and tremors.""]","[""Symptoms of Spinocerebellar ataxia 11 include difficulty with coordination and balance, slurred speech, abnormal eye movements, muscle stiffness, tremors, and cognitive impairment.""]","[""The symptoms of SCA11 include gait ataxia, dysarthria, and nystagmus.""]",[true],[true],[true],"[""The symptoms of SCA11 include progressive problems with coordination and balance, uncontrolled movements (ataxia), tremors, and difficulty with speech and swallowing.""]","[""Symptoms of Spinocerebellar ataxia 11 include uncoordinated movement, difficulty with balance and coordination, slurred speech, and abnormal eye movements.""]","[""The symptoms of SCA11 include difficulty with coordination and balance, tremors, muscle stiffness, and slurred speech.""]",[true],[true],[true],"[""Some common symptoms of SCA11 include uncoordinated movement, difficulty with balance and coordination, tremors, and speech problems.""]","[""Symptoms of Spinocerebellar ataxia 11 include uncoordinated movements, difficulty with balance and coordination, slurred speech, muscle stiffness, and tremors.""]","[""The symptoms of SCA11 include gait ataxia, dysarthria, and nystagmus.""]",[true],[true],[true],"[""Symptoms of SCA11 include progressive problems with coordination and balance, uncontrolled movements (ataxia), speech difficulties, and tremors.""]","[""Symptoms of Spinocerebellar ataxia 11 include difficulty with coordination and balance, speech problems, abnormal eye movements, muscle stiffness, and tremors.""]","[""The symptoms of SCA11 include difficulty with coordination and balance, tremors, muscle stiffness, and slurred speech.""]",[true],[true],[true],"[""Symptoms of SCA11 include uncoordinated movement, difficulty with balance and coordination, speech problems, and tremors.""]","[""Symptoms of Spinocerebellar ataxia 11 include difficulty with coordination and balance, slurred speech, abnormal eye movements, muscle stiffness, tremors, and cognitive impairment.""]","[""The symptoms of SCA11 include gait ataxia, dysarthria, and nystagmus.""]",[true],[true],[true],"[""Symptoms of SCA11 include gait ataxia, dysarthria, and nystagmus.""]","[""Symptoms of Spinocerebellar ataxia 11 include uncoordinated movement, difficulty with balance and coordination, slurred speech, and abnormal eye movements.""]","[""The symptoms of SCA11 include difficulty with coordination and balance, tremors, muscle stiffness, and slurred speech.""]",[true],[true],[true],"[""Symptoms of SCA11 may include uncoordinated movements, poor balance, tremors, and difficulty with speech and swallowing.""]","[""Symptoms of Spinocerebellar ataxia 11 include uncoordinated movement, difficulty with balance and coordination, slurred speech, and abnormal eye movements.""]","[""The symptoms of SCA11 include difficulty with coordination and balance, tremors, muscle stiffness, and slurred speech.""]",[true],[true],[true],"[""Symptoms of SCA11 include progressive ataxia, dysarthria, tremors, and abnormal eye movements.""]","[""Symptoms of Spinocerebellar ataxia 11 include uncoordinated movement, difficulty with balance and coordination, slurred speech, and abnormal eye movements.""]","[""The symptoms of SCA11 include difficulty with coordination and balance, tremors, muscle stiffness, and slurred speech.""]",[true],[true],[true],"[""Symptoms of SCA11 include gait ataxia, dysarthria, nystagmus, and tremors.""]","[""Symptoms of Spinocerebellar ataxia 11 include uncoordinated movement, difficulty with balance and coordination, slurred speech, and abnormal eye movements.""]","[""The symptoms of SCA11 include difficulty with coordination and balance, tremors, muscle stiffness, and slurred speech.""]"
genetic changes,What are the genetic changes related to pulmonary arterial hypertension ?,"Mutations in the BMPR2 gene are the most common genetic cause of pulmonary arterial hypertension. This gene plays a role in regulating the number of cells in certain tissues. Researchers suggest that a mutation in this gene promotes cell division or prevents cell death, resulting in an overgrowth of cells in small arteries throughout the lungs. As a result, these arteries narrow in diameter, which increases the resistance to blood flow. Blood pressure in the pulmonary artery and the right ventricle of the heart increases to overcome the increased resistance to blood flow.  Mutations in several additional genes have also been found to cause pulmonary arterial hypertension, but they are much less common causes of the disorder than are BMPR2 gene mutations. Variations in other genes may increase the risk of developing pulmonary arterial hypertension or modify the course of the disease (usually making it more severe). Changes in as-yet-unidentified genes may also be associated with this condition.  Although pulmonary arterial hypertension often occurs on its own, it can also be part of syndromes that affect many parts of the body. For example, this condition is occasionally found in people with systemic scleroderma, systemic lupus erythematosus, critical congenital heart disease, or Down syndrome.  Researchers have also identified nongenetic factors that increase the risk of developing pulmonary arterial hypertension. These include certain drugs used as appetite suppressants and several illegal drugs, such as cocaine and methamphetamine. Pulmonary arterial hypertension is also a rare complication of certain infectious diseases, including HIV and schistosomiasis.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""PAH"", ""full_form"": ""pulmonary arterial hypertension""}]}",What are the genetic changes related to PAH ?,What are the genetic changes related to pulmonary arterial hypertension ?,8,MEDICAL,Compound Datatype-String,"Exploratory(Divergent Thinking): Queries that are inherently about seeking new areas of knowledge, understanding emerging trends, or identifying unknown opportunities without a specific end goal of making a decision or judgment. Exploratory queries are characterized by their openness and the lack of a predefined objective, differentiating them from evaluative queries which are directed towards forming a judgment or assessment. Exploratory queries encourage branching out into various directions to explore a wide array of possibilities without necessarily aiming to converge on a single answer or outcome.","[[""Pulmonary Arterial Hypertension"", ""Polycyclic Aromatic Hydrocarbon"", ""Paducah, Kentucky USA"", ""Problem Anderer Hamburger"", ""Project Affected Households"", ""para-aminohippuric acid"", ""Petz Against Hate"", ""Production Approval Holder"", ""Polycyclic Aromatic Hydrocarbons"", ""Poly Aromatic Hydrocarbons""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Pulmonary Arterial Hypertension""]",[3.1027071217560644e-06],[3.1027071217560644e-06],"[""Pulmonary Arterial Hypertension""]",[3.1027071217560644e-06],"[""ABBREVIATIONS""]","[[3.1027071217560644e-06, 5.329672897321067e-27, 9.302733605592779e-28, 7.802748929504505e-20, 9.188678972781711e-18, 1.7286936970212131e-22, 9.715819056468351e-20, 3.047687742538858e-16, 2.0351896779216345e-27, 5.229758471326005e-26]]",[0.9646100208929569],[0.9613813738442862],"[""pulmonary arterial hypertension""]",[0.9613813738442862],"[""ABBREVIATIONS""]","[[0.9613813738442862, 0.820481265267887, 0.7875465929161165, 0.8618541226231509, 0.7697047371130671, 0.8407214572459718, 0.7517146101381527, 0.7825235000263717, 0.8200189806413558, 0.8136304924698669]]","[""Pulmonary Arterial Hypertension""]","[""ABBREVIATIONS""]",What are the genetic changes related to PAH (Pulmonary Arterial Hypertension) ?,[true],[true],[true],"[""Mutations in the BMPR2 gene are the most common genetic changes associated with Pulmonary Arterial Hypertension (PAH). Other genes such as ACVRL1, ENG, and SMAD9 have also been linked to PAH.""]","[""BMPR2, ACVRL1, ENG, CAV1, KCNK3, and TBX4 are some of the genetic changes related to pulmonary arterial hypertension.""]","[""Mutations in the BMPR2 gene are the most common genetic changes related to PAH.""]",[true],[false],[true],"[""Mutations in BMPR2, ACVRL1, ENG, and other genes have been associated with PAH.""]","[""BMPR2, ACVRL1, ENG, CAV1, KCNK3, and others""]","[""Mutations in the BMPR2 gene are the most common genetic changes related to PAH.""]",[true],[true],[true],"[""Mutations in the BMPR2 gene are the most common genetic changes associated with Pulmonary Arterial Hypertension (PAH). Other genes such as ACVRL1, ENG, and SMAD9 have also been linked to PAH.""]","[""BMPR2, ACVRL1, ENG, CAV1, KCNK3, and TBX4 are some of the genetic changes related to pulmonary arterial hypertension.""]","[""Mutations in the BMPR2 gene are the most common genetic changes related to PAH.""]",[true],[true],[true],"[""Mutations in the BMPR2 gene are the most common genetic changes associated with PAH.""]","[""Mutations in BMPR2, ACVRL1, ENG, and other genes have been associated with pulmonary arterial hypertension.""]","[""Mutations in the BMPR2 gene are the most common genetic changes related to PAH.""]",[true],[true],[true],"[""Mutations in BMPR2, ACVRL1, ENG, and other genes have been associated with PAH.""]","[""BMPR2, ACVRL1, ENG, CAV1, KCNK3, and TBX4 are some of the genetic changes related to pulmonary arterial hypertension.""]","[""Mutations in the BMPR2 gene are the most common genetic changes related to PAH.""]",[true],[false],[true],"[""Mutations in BMPR2, ACVRL1, ENG, and other genes have been associated with pulmonary arterial hypertension (PAH).""]","[""BMPR2, ACVRL1, ENG, CAV1, KCNK3, and others""]","[""Mutations in the BMPR2 gene are the most common genetic changes related to PAH.""]",[true],[true],[true],"[""Mutations in BMPR2, ACVRL1, ENG, and other genes have been associated with pulmonary arterial hypertension (PAH).""]","[""BMPR2, ACVRL1, ENG, CAV1, KCNK3, and TBX4 are some of the genetic changes related to pulmonary arterial hypertension.""]","[""Mutations in the BMPR2 gene are the most common genetic changes related to PAH.""]",[true],[true],[true],"[""Mutations in BMPR2, ACVRL1, ENG, and other genes have been associated with pulmonary arterial hypertension (PAH).""]","[""Mutations in BMPR2, ACVRL1, ENG, and other genes have been associated with pulmonary arterial hypertension.""]","[""Mutations in the BMPR2 gene are the most common genetic changes related to PAH.""]",[true],[false],[true],"[""Mutations in the BMPR2 gene are the most common genetic changes associated with Pulmonary Arterial Hypertension (PAH). Other genes such as ACVRL1, ENG, and SMAD9 have also been linked to PAH.""]","[""BMPR2, ACVRL1, ENG, CAV1, KCNK3, and others""]","[""Mutations in the BMPR2 gene are the most common genetic changes related to PAH.""]",[true],[true],[true],"[""Genetic changes related to PAH include mutations in the BMPR2 gene, ALK1, ENG, and SMAD9.""]","[""BMPR2, ACVRL1, ENG, CAV1, KCNK3, and TBX4 are some of the genetic changes related to pulmonary arterial hypertension.""]","[""Mutations in the BMPR2 gene are the most common genetic changes related to PAH.""]",[true],[true],[true],"[""Mutations in BMPR2, ACVRL1, ENG, and other genes are associated with PAH.""]","[""BMPR2, ACVRL1, ENG, CAV1, KCNK3, and TBX4 are some of the genetic changes related to pulmonary arterial hypertension.""]","[""Mutations in the BMPR2 gene are the most common genetic changes related to PAH.""]",[true],[true],[true],"[""Mutations in the BMPR2 gene are the most common genetic changes associated with Pulmonary Arterial Hypertension (PAH). Other genes such as ACVRL1, ENG, and SMAD9 have also been linked to PAH.""]","[""Mutations in BMPR2, ACVRL1, ENG, and other genes have been associated with pulmonary arterial hypertension.""]","[""Mutations in the BMPR2 gene are the most common genetic changes related to PAH.""]",[true],[true],[true],"[""Mutations in the BMPR2 gene are the most common genetic changes related to PAH.""]","[""BMPR2, ACVRL1, ENG, CAV1, KCNK3, and TBX4 are some of the genetic changes related to pulmonary arterial hypertension.""]","[""Mutations in the BMPR2 gene are the most common genetic changes related to PAH.""]",[true],[true],[true],"[""Mutations in the BMPR2 gene are the most common genetic changes related to PAH.""]","[""BMPR2, ACVRL1, ENG, CAV1, KCNK3, and others""]","[""Mutations in the BMPR2 gene are the most common genetic changes related to PAH.""]",[true],[true],[true],"[""Mutations in the BMPR2 gene are the most common genetic changes related to PAH.""]","[""BMPR2, ACVRL1, ENG, CAV1, KCNK3, and TBX4 are some of the genetic changes related to pulmonary arterial hypertension.""]","[""Mutations in the BMPR2 gene are the most common genetic changes related to PAH.""]",[true],[true],[true],"[""Mutations in the BMPR2 gene are the most common genetic changes related to PAH.""]","[""Mutations in BMPR2, ACVRL1, ENG, and other genes have been associated with pulmonary arterial hypertension.""]","[""Mutations in the BMPR2 gene are the most common genetic changes related to PAH.""]",[true],[true],[true],"[""Genetic changes related to PAH include mutations in BMPR2, ACVRL1, ENG, and other genes involved in the TGF-beta signaling pathway.""]","[""BMPR2, ACVRL1, ENG, CAV1, KCNK3, and TBX4 are some of the genetic changes related to pulmonary arterial hypertension.""]","[""Mutations in the BMPR2 gene are the most common genetic changes related to PAH.""]",[true],[true],[true],"[""Mutations in the BMPR2 gene are the most common genetic changes associated with Pulmonary Arterial Hypertension (PAH). Other genes such as ACVRL1, ENG, and SMAD9 have also been linked to PAH.""]","[""BMPR2, ACVRL1, ENG, CAV1, KCNK3, and others""]","[""Mutations in the BMPR2 gene are the most common genetic changes related to PAH.""]",[true],[true],[true],"[""Mutations in BMPR2, ACVRL1, ENG, and other genes have been associated with PAH.""]","[""BMPR2, ACVRL1, ENG, CAV1, KCNK3, and TBX4 are some of the genetic changes related to pulmonary arterial hypertension.""]","[""Mutations in the BMPR2 gene are the most common genetic changes related to PAH.""]",[true],[true],[true],"[""Mutations in the BMPR2 gene are the most common genetic changes associated with Pulmonary Arterial Hypertension (PAH). Other genes such as ACVRL1, ENG, and SMAD9 have also been linked to PAH.""]","[""Mutations in BMPR2, ACVRL1, ENG, and other genes have been associated with pulmonary arterial hypertension.""]","[""Mutations in the BMPR2 gene are the most common genetic changes related to PAH.""]",[true],[true],[true],"[""Mutations in the BMPR2 gene are the most common genetic changes associated with Pulmonary Arterial Hypertension (PAH). Other genes such as ACVRL1, ENG, and SMAD9 have also been linked to PAH.""]","[""BMPR2, ACVRL1, ENG, CAV1, KCNK3, and TBX4 are some of the genetic changes related to pulmonary arterial hypertension.""]","[""Mutations in the BMPR2 gene are the most common genetic changes related to PAH.""]",[true],[false],[true],"[""Mutations in BMPR2, ACVRL1, ENG, and other genes have been associated with PAH.""]","[""BMPR2, ACVRL1, ENG, CAV1, KCNK3, and others""]","[""Mutations in the BMPR2 gene are the most common genetic changes related to PAH.""]",[true],[true],[true],"[""Mutations in the BMPR2 gene are the most common genetic changes associated with Pulmonary Arterial Hypertension (PAH). Other genes such as ACVRL1, ENG, and SMAD9 have also been linked to PAH.""]","[""BMPR2, ACVRL1, ENG, CAV1, KCNK3, and TBX4 are some of the genetic changes related to pulmonary arterial hypertension.""]","[""Mutations in the BMPR2 gene are the most common genetic changes related to PAH.""]",[true],[true],[true],"[""Mutations in BMPR2, ACVRL1, ENG, and other genes have been associated with Pulmonary Arterial Hypertension (PAH).""]","[""Mutations in BMPR2, ACVRL1, ENG, and other genes have been associated with pulmonary arterial hypertension.""]","[""Mutations in the BMPR2 gene are the most common genetic changes related to PAH.""]",[true],[true],[true],"[""Genetic changes related to PAH include mutations in BMPR2, ACVRL1, ENG, and other genes involved in the TGF-beta signaling pathway.""]","[""BMPR2, ACVRL1, ENG, CAV1, KCNK3, and TBX4 are some of the genetic changes related to pulmonary arterial hypertension.""]","[""Mutations in the BMPR2 gene are the most common genetic changes related to PAH.""]",[true],[true],[true],"[""Genetic changes related to PAH include mutations in BMPR2, ACVRL1, ENG, and other genes involved in the TGF-beta signaling pathway.""]","[""BMPR2, ACVRL1, ENG, CAV1, KCNK3, and others""]","[""Mutations in the BMPR2 gene are the most common genetic changes related to PAH.""]",[true],[true],[true],"[""Genetic changes related to PAH include mutations in BMPR2, ALK1, ENG, SMAD9, and CAV1 genes.""]","[""BMPR2, ACVRL1, ENG, CAV1, KCNK3, and TBX4 are some of the genetic changes related to pulmonary arterial hypertension.""]","[""Mutations in the BMPR2 gene are the most common genetic changes related to PAH.""]",[true],[true],[true],"[""PAH is associated with genetic changes in genes such as BMPR2, ACVRL1, ENG, and SMAD9.""]","[""Mutations in BMPR2, ACVRL1, ENG, and other genes have been associated with pulmonary arterial hypertension.""]","[""Mutations in the BMPR2 gene are the most common genetic changes related to PAH.""]",[true],[true],[true],"[""Genetic changes related to PAH include mutations in BMPR2, ALK1, ENG, and SMAD9 genes.""]","[""BMPR2, ACVRL1, ENG, CAV1, KCNK3, and TBX4 are some of the genetic changes related to pulmonary arterial hypertension.""]","[""Mutations in the BMPR2 gene are the most common genetic changes related to PAH.""]",[true],[true],[true],"[""Genetic changes related to PAH include mutations in BMPR2, ACVRL1, ENG, and other genes involved in the TGF-beta signaling pathway.""]","[""BMPR2, ACVRL1, ENG, CAV1, KCNK3, and TBX4 are some of the genetic changes related to pulmonary arterial hypertension.""]","[""Mutations in the BMPR2 gene are the most common genetic changes related to PAH.""]",[true],[true],[true],"[""Genetic changes related to PAH include mutations in BMPR2, ALK1, ENG, and SMAD9 genes.""]","[""BMPR2, ACVRL1, ENG, CAV1, KCNK3, and TBX4 are some of the genetic changes related to pulmonary arterial hypertension.""]","[""Mutations in the BMPR2 gene are the most common genetic changes related to PAH.""]",[true],[true],[true],"[""Genetic changes related to PAH include mutations in BMPR2, ALK1, ENG, and SMAD9 genes.""]","[""BMPR2, ACVRL1, ENG, CAV1, KCNK3, and TBX4 are some of the genetic changes related to pulmonary arterial hypertension.""]","[""Mutations in the BMPR2 gene are the most common genetic changes related to PAH.""]"
outlook,What is the outlook for Progressive Multifocal Leukoencephalopathy ?,"In general, PML has a mortality rate of 30-50 percent in the first few months following diagnosis but depends on the severity of the underlying disease and treatment received. Those who survive PML can be left with severe neurological disabilities.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""PML"", ""full_form"": ""Progressive Multifocal Leukoencephalopathy""}]}",What is the outlook for PML ?,What is the outlook for Progressive Multifocal Leukoencephalopathy ?,8,MEDICAL,Simple Datatype-String,"Exploratory(Divergent Thinking): Queries that are inherently about seeking new areas of knowledge, understanding emerging trends, or identifying unknown opportunities without a specific end goal of making a decision or judgment. Exploratory queries are characterized by their openness and the lack of a predefined objective, differentiating them from evaluative queries which are directed towards forming a judgment or assessment. Exploratory queries encourage branching out into various directions to explore a wide array of possibilities without necessarily aiming to converge on a single answer or outcome.","[[""Progressive multifocal leukoencephalopathy"", ""Pakistan Muslim League"", ""Plymouth Marine Laboratory"", ""Probable Maximum Loss"", ""Printer Management Language"", ""Palm Markup Language"", ""Pine Mountain Lake"", ""Pissing Myself Laughing"", ""Perfect Matched Layer"", ""Personalized Mailing Lists""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Progressive Multifocal Leukoencephalopathy""]",[3.328579553360744e-16],[3.328579553360744e-16],"[""Probable Maximum Loss""]",[8.163868904000932e-12],"[""ABBREVIATIONS""]","[[3.328579553360744e-16, 1.7633429895690006e-21, 4.462476368390587e-25, 8.163868904000932e-12, 3.41989517333393e-17, 1.4131660745022023e-21, 2.5220983455912836e-16, 2.164214028217465e-16, 1.3733044166459968e-16, 3.185864006979311e-17]]",[0.937135776336415],[0.937135776336415],"[""Personalized Mailing Lists""]",[0.937135776336415],"[""LLM""]","[[0.9345455552661742, 0.6294607934932359, 0.6137883095455912, 0.6662658472959886, 0.6644010609641554, 0.6850287378547292, 0.6623691228802131, 0.6898884968646726, 0.5921918087455886, 0.6423662336249983]]","[""Progressive multifocal leukoencephalopathy""]","[""ABBREVIATIONS""]",What is the outlook for PML (Progressive Multifocal Leukoencephalopathy) ?,[false],[true],[true],"[""The outlook for PML (Probable Maximum Loss) is a risk assessment metric used in the insurance industry to estimate the maximum loss that could occur under extreme circumstances.""]","[""The outlook for Progressive Multifocal Leukoencephalopathy varies depending on the individual's immune system and the extent of the infection. In some cases, the condition can be fatal, while in others, it may stabilize or improve with treatment.""]","[""The outlook for PML (Progressive Multifocal Leukoencephalopathy) can vary depending on the individual's immune system and the underlying cause. It is a serious condition that can lead to severe disability or even death, but early detection and management can improve outcomes.""]",[false],[true],[true],"[""The outlook for PML (Probable Maximum Loss) depends on various factors such as location, building structure, occupancy type, and insurance coverage. It is typically assessed by risk professionals to estimate the maximum loss that could occur under extreme circumstances.""]","[""The outlook for Progressive Multifocal Leukoencephalopathy varies depending on the underlying cause and the individual's overall health condition. It can range from mild symptoms with spontaneous improvement to severe disability or even death in some cases.""]","[""The outlook for PML (Progressive Multifocal Leukoencephalopathy) can vary depending on the individual case. It is a serious condition caused by the JC virus and can lead to severe neurological complications. Treatment options are limited, and the prognosis may be poor, especially in cases of severe immunosuppression.""]",[false],[true],[true],"[""The outlook for PML (Probable Maximum Loss) is an estimate of the maximum loss that an insurer or reinsurer would incur in the event of a catastrophic event. It helps in assessing the potential financial impact of such events on the organization.""]","[""The outlook for Progressive Multifocal Leukoencephalopathy varies depending on the underlying cause and the individual's overall health. In some cases, the condition can be life-threatening, while in others, it may be manageable with treatment. Regular monitoring and appropriate medical care are essential for managing the condition.""]","[""The outlook for PML (Progressive Multifocal Leukoencephalopathy) can vary depending on the individual's immune system and the underlying cause. It is a serious condition that can lead to severe disability or even death in some cases.""]",[false],[true],[true],"[""The outlook for PML (Probable Maximum Loss) depends on various factors such as location, building structure, and hazard exposure. It is typically assessed by insurance companies and risk management professionals to estimate the potential financial loss in case of a catastrophic event.""]","[""Progressive Multifocal Leukoencephalopathy is a rare and often fatal viral disease that affects the central nervous system. The outlook for patients with PML can vary depending on factors such as the underlying cause, the extent of neurological damage, and the individual's overall health. There is no specific cure for PML, but treatments aimed at managing symptoms and underlying conditions may help improve outcomes in some cases.""]","[""The outlook for PML (Progressive Multifocal Leukoencephalopathy) can vary depending on the individual's immune system and the underlying cause. It is a serious condition that can lead to severe disability or even death in some cases.""]",[true],[true],[true],"[""PML (Progressive Multifocal Leukoencephalopathy) is a rare and serious brain infection that can occur in people with weakened immune systems, such as those with HIV/AIDS or certain autoimmune disorders. The outlook for PML can vary depending on the individual's overall health and the underlying cause of their weakened immune system.""]","[""The outlook for Progressive Multifocal Leukoencephalopathy varies depending on the individual's immune system and the extent of the infection. In some cases, the condition can be fatal, while in others, it may stabilize or improve with treatment.""]","[""The outlook for PML (Progressive Multifocal Leukoencephalopathy) can vary depending on the individual's immune system and the underlying cause. It is a serious condition that can lead to severe disability or even death, but early detection and management can improve outcomes.""]",[true],[true],[true],"[""PML (Progressive Multifocal Leukoencephalopathy) is a rare and serious brain infection that can occur in people with weakened immune systems, such as those with HIV/AIDS or certain autoimmune disorders. It is caused by the JC virus and can lead to severe disability or death.""]","[""The outlook for Progressive Multifocal Leukoencephalopathy varies depending on the underlying cause and the individual's overall health condition. It can range from mild symptoms with spontaneous improvement to severe disability or even death in some cases.""]","[""The outlook for PML (Progressive Multifocal Leukoencephalopathy) can vary depending on the individual case. It is a serious condition caused by the JC virus and can lead to severe neurological complications. Treatment options are limited, and the prognosis may be poor, especially in cases of severe immunosuppression.""]",[true],[true],[true],"[""PML (Progressive Multifocal Leukoencephalopathy) is a rare and serious brain infection that can occur in people with weakened immune systems, such as those with HIV/AIDS or certain autoimmune disorders. The outlook for PML can vary depending on the individual's overall health and the underlying cause of their weakened immune system.""]","[""The outlook for Progressive Multifocal Leukoencephalopathy varies depending on the underlying cause and the individual's overall health. In some cases, the condition can be life-threatening, while in others, it may be manageable with treatment. Regular monitoring and appropriate medical care are essential for managing the condition.""]","[""The outlook for PML (Progressive Multifocal Leukoencephalopathy) can vary depending on the individual's immune system and the underlying cause. It is a serious condition that can lead to severe disability or even death in some cases.""]",[true],[true],[true],"[""PML (Progressive Multifocal Leukoencephalopathy) is a rare and serious brain infection that can occur in individuals with weakened immune systems, such as those with HIV/AIDS or certain autoimmune disorders. It is caused by the JC virus and can have a poor prognosis, with potential for severe neurological complications.""]","[""Progressive Multifocal Leukoencephalopathy is a rare and often fatal viral disease that affects the central nervous system. The outlook for patients with PML can vary depending on factors such as the underlying cause, the extent of neurological damage, and the individual's overall health. There is no specific cure for PML, but treatments aimed at managing symptoms and underlying conditions may help improve outcomes in some cases.""]","[""The outlook for PML (Progressive Multifocal Leukoencephalopathy) can vary depending on the individual's immune system and the underlying cause. It is a serious condition that can lead to severe disability or even death in some cases.""]",[true],[true],[true],"[""The outlook for PML (Progressive multifocal leukoencephalopathy) is generally poor, with high mortality rates. There is no specific cure for PML, and treatment focuses on managing symptoms and underlying conditions.""]","[""The outlook for Progressive Multifocal Leukoencephalopathy varies depending on the underlying cause and the individual's overall health condition. It can range from mild symptoms with spontaneous improvement to severe disability or even death in some cases.""]","[""The outlook for PML (Progressive Multifocal Leukoencephalopathy) can vary depending on the individual case. It is a serious condition caused by the JC virus and can lead to severe neurological complications. Treatment options are limited, and the prognosis may be poor, especially in cases of severe immunosuppression.""]",[true],[true],[true],"[""The outlook for PML (Progressive multifocal leukoencephalopathy) is generally poor, with high mortality rates and significant neurological deficits in survivors.""]","[""The outlook for Progressive Multifocal Leukoencephalopathy varies depending on the individual's immune system and the extent of the infection. In some cases, the condition can be fatal, while in others, it may stabilize or improve with treatment.""]","[""The outlook for PML (Progressive Multifocal Leukoencephalopathy) can vary depending on the individual's immune system and the underlying cause. It is a serious condition that can lead to severe disability or even death, but early detection and management can improve outcomes.""]",[true],[true],[true],"[""The outlook for PML (Progressive multifocal leukoencephalopathy) can vary depending on the underlying cause and the individual's overall health. In some cases, PML can be life-threatening, especially in individuals with weakened immune systems. Early diagnosis and treatment may improve outcomes, but there is no specific cure for PML.""]","[""The outlook for Progressive Multifocal Leukoencephalopathy varies depending on the underlying cause and the individual's overall health. In some cases, the condition can be life-threatening, while in others, it may be manageable with treatment. Regular monitoring and appropriate medical care are essential for managing the condition.""]","[""The outlook for PML (Progressive Multifocal Leukoencephalopathy) can vary depending on the individual's immune system and the underlying cause. It is a serious condition that can lead to severe disability or even death in some cases.""]",[true],[true],[true],"[""The outlook for PML (Progressive multifocal leukoencephalopathy) is generally poor, with a high mortality rate. There is no specific cure for PML, and treatment focuses on managing symptoms and underlying conditions.""]","[""Progressive Multifocal Leukoencephalopathy is a rare and often fatal viral disease that affects the central nervous system. The outlook for patients with PML can vary depending on factors such as the underlying cause, the extent of neurological damage, and the individual's overall health. There is no specific cure for PML, but treatments aimed at managing symptoms and underlying conditions may help improve outcomes in some cases.""]","[""The outlook for PML (Progressive Multifocal Leukoencephalopathy) can vary depending on the individual's immune system and the underlying cause. It is a serious condition that can lead to severe disability or even death in some cases.""]",[true],[true],[true],"[""The outlook for PML depends on the underlying cause and the extent of brain damage. It can be life-threatening, especially in individuals with weakened immune systems.""]","[""The outlook for Progressive Multifocal Leukoencephalopathy varies depending on the individual's immune system and the extent of the infection. In some cases, the condition can be fatal, while in others, it may stabilize or improve with treatment.""]","[""The outlook for PML (Progressive Multifocal Leukoencephalopathy) can vary depending on the individual's immune system and the underlying cause. It is a serious condition that can lead to severe disability or even death, but early detection and management can improve outcomes.""]",[true],[true],[true],"[""The outlook for PML depends on the underlying cause and the extent of brain damage. It can be fatal in some cases, especially in individuals with weakened immune systems.""]","[""The outlook for Progressive Multifocal Leukoencephalopathy varies depending on the underlying cause and the individual's overall health condition. It can range from mild symptoms with spontaneous improvement to severe disability or even death in some cases.""]","[""The outlook for PML (Progressive Multifocal Leukoencephalopathy) can vary depending on the individual case. It is a serious condition caused by the JC virus and can lead to severe neurological complications. Treatment options are limited, and the prognosis may be poor, especially in cases of severe immunosuppression.""]",[true],[true],[true],"[""The outlook for PML depends on the underlying cause and the extent of brain damage. It can be life-threatening, especially in individuals with weakened immune systems.""]","[""The outlook for Progressive Multifocal Leukoencephalopathy varies depending on the underlying cause and the individual's overall health. In some cases, the condition can be life-threatening, while in others, it may be manageable with treatment. Regular monitoring and appropriate medical care are essential for managing the condition.""]","[""The outlook for PML (Progressive Multifocal Leukoencephalopathy) can vary depending on the individual's immune system and the underlying cause. It is a serious condition that can lead to severe disability or even death in some cases.""]",[true],[true],[true],"[""The outlook for PML depends on the underlying cause and the extent of brain damage. It can be fatal in some cases, especially in individuals with weakened immune systems.""]","[""Progressive Multifocal Leukoencephalopathy is a rare and often fatal viral disease that affects the central nervous system. The outlook for patients with PML can vary depending on factors such as the underlying cause, the extent of neurological damage, and the individual's overall health. There is no specific cure for PML, but treatments aimed at managing symptoms and underlying conditions may help improve outcomes in some cases.""]","[""The outlook for PML (Progressive Multifocal Leukoencephalopathy) can vary depending on the individual's immune system and the underlying cause. It is a serious condition that can lead to severe disability or even death in some cases.""]",[true],[true],[true],"[""The outlook for PML (Progressive multifocal leukoencephalopathy) varies depending on the individual's immune system and the underlying cause. It can range from mild symptoms to severe disability or even death.""]","[""The outlook for Progressive Multifocal Leukoencephalopathy varies depending on the individual's immune system and the extent of the infection. In some cases, the condition can be fatal, while in others, it may stabilize or improve with treatment.""]","[""The outlook for PML (Progressive Multifocal Leukoencephalopathy) can vary depending on the individual's immune system and the underlying cause. It is a serious condition that can lead to severe disability or even death, but early detection and management can improve outcomes.""]",[true],[true],[true],"[""The outlook for PML (Progressive multifocal leukoencephalopathy) varies depending on the underlying cause and the individual's immune system. It can be severe and potentially life-threatening, especially in individuals with weakened immune systems. Early diagnosis and treatment are crucial for better outcomes.""]","[""The outlook for Progressive Multifocal Leukoencephalopathy varies depending on the underlying cause and the individual's overall health condition. It can range from mild symptoms with spontaneous improvement to severe disability or even death in some cases.""]","[""The outlook for PML (Progressive Multifocal Leukoencephalopathy) can vary depending on the individual case. It is a serious condition caused by the JC virus and can lead to severe neurological complications. Treatment options are limited, and the prognosis may be poor, especially in cases of severe immunosuppression.""]",[true],[true],[true],"[""The outlook for PML (Progressive multifocal leukoencephalopathy) varies depending on the underlying cause and the individual's immune system. It can be life-threatening, especially in individuals with weakened immune systems, but some cases have shown improvement with treatment.""]","[""The outlook for Progressive Multifocal Leukoencephalopathy varies depending on the underlying cause and the individual's overall health. In some cases, the condition can be life-threatening, while in others, it may be manageable with treatment. Regular monitoring and appropriate medical care are essential for managing the condition.""]","[""The outlook for PML (Progressive Multifocal Leukoencephalopathy) can vary depending on the individual's immune system and the underlying cause. It is a serious condition that can lead to severe disability or even death in some cases.""]",[true],[true],[true],"[""The outlook for PML (Progressive multifocal leukoencephalopathy) varies depending on the underlying cause and the individual's immune system. It can be serious and potentially life-threatening, especially in individuals with weakened immune systems.""]","[""Progressive Multifocal Leukoencephalopathy is a rare and often fatal viral disease that affects the central nervous system. The outlook for patients with PML can vary depending on factors such as the underlying cause, the extent of neurological damage, and the individual's overall health. There is no specific cure for PML, but treatments aimed at managing symptoms and underlying conditions may help improve outcomes in some cases.""]","[""The outlook for PML (Progressive Multifocal Leukoencephalopathy) can vary depending on the individual's immune system and the underlying cause. It is a serious condition that can lead to severe disability or even death in some cases.""]",[true],[true],[true],"[""The outlook for PML (Progressive Multifocal Leukoencephalopathy) is generally poor, with a high risk of disability or death, especially in immunocompromised individuals.""]","[""The outlook for Progressive Multifocal Leukoencephalopathy varies depending on the individual's immune system and the extent of the infection. In some cases, the condition can be fatal, while in others, it may stabilize or improve with treatment.""]","[""The outlook for PML (Progressive Multifocal Leukoencephalopathy) can vary depending on the individual's immune system and the underlying cause. It is a serious condition that can lead to severe disability or even death, but early detection and management can improve outcomes.""]",[true],[true],[true],"[""The outlook for PML can vary depending on the underlying cause, extent of brain damage, and individual response to treatment. In some cases, PML can be life-threatening, while in others, it may stabilize or improve with appropriate management.""]","[""The outlook for Progressive Multifocal Leukoencephalopathy varies depending on the underlying cause and the individual's overall health condition. It can range from mild symptoms with spontaneous improvement to severe disability or even death in some cases.""]","[""The outlook for PML (Progressive Multifocal Leukoencephalopathy) can vary depending on the individual case. It is a serious condition caused by the JC virus and can lead to severe neurological complications. Treatment options are limited, and the prognosis may be poor, especially in cases of severe immunosuppression.""]",[true],[true],[true],"[""The outlook for PML (Progressive Multifocal Leukoencephalopathy) is generally poor, with high mortality rates and significant neurological deficits in survivors.""]","[""The outlook for Progressive Multifocal Leukoencephalopathy varies depending on the underlying cause and the individual's overall health. In some cases, the condition can be life-threatening, while in others, it may be manageable with treatment. Regular monitoring and appropriate medical care are essential for managing the condition.""]","[""The outlook for PML (Progressive Multifocal Leukoencephalopathy) can vary depending on the individual's immune system and the underlying cause. It is a serious condition that can lead to severe disability or even death in some cases.""]",[true],[true],[true],"[""The outlook for PML (Progressive Multifocal Leukoencephalopathy) can vary depending on the underlying cause, the severity of the condition, and the individual's overall health. In some cases, PML can be life-threatening, especially in individuals with weakened immune systems. Early detection and treatment may improve outcomes, but there is no definitive cure for PML.""]","[""Progressive Multifocal Leukoencephalopathy is a rare and often fatal viral disease that affects the central nervous system. The outlook for patients with PML can vary depending on factors such as the underlying cause, the extent of neurological damage, and the individual's overall health. There is no specific cure for PML, but treatments aimed at managing symptoms and underlying conditions may help improve outcomes in some cases.""]","[""The outlook for PML (Progressive Multifocal Leukoencephalopathy) can vary depending on the individual's immune system and the underlying cause. It is a serious condition that can lead to severe disability or even death in some cases.""]",[true],[true],[true],"[""The outlook for PML (Progressive multifocal leukoencephalopathy) varies depending on factors such as the underlying cause, the individual's overall health, and the timeliness of diagnosis and treatment. It can range from mild to severe, with some cases being manageable while others may lead to serious complications or even death.""]","[""The outlook for Progressive Multifocal Leukoencephalopathy varies depending on the individual's immune system and the extent of the infection. In some cases, the condition can be fatal, while in others, it may stabilize or improve with treatment.""]","[""The outlook for PML (Progressive Multifocal Leukoencephalopathy) can vary depending on the individual's immune system and the underlying cause. It is a serious condition that can lead to severe disability or even death, but early detection and management can improve outcomes.""]",[true],[true],[true],"[""The outlook for PML (Progressive multifocal leukoencephalopathy) varies depending on the underlying cause, the severity of the condition, and the individual's overall health. It is a serious condition that can lead to severe disability or even death in some cases. Treatment options are available, but there is no cure for PML. Early diagnosis and appropriate management are crucial in improving outcomes.""]","[""The outlook for Progressive Multifocal Leukoencephalopathy varies depending on the underlying cause and the individual's overall health condition. It can range from mild symptoms with spontaneous improvement to severe disability or even death in some cases.""]","[""The outlook for PML (Progressive Multifocal Leukoencephalopathy) can vary depending on the individual case. It is a serious condition caused by the JC virus and can lead to severe neurological complications. Treatment options are limited, and the prognosis may be poor, especially in cases of severe immunosuppression.""]",[true],[true],[true],"[""The outlook for PML (Progressive multifocal leukoencephalopathy) varies depending on the underlying cause, the severity of the condition, and the individual's overall health. It is a serious condition that can lead to severe disability or even death in some cases. Treatment options focus on managing symptoms and addressing the underlying cause, but there is no cure for PML. Prognosis can range from poor to relatively good, with some individuals experiencing partial or full recovery while others may face long-term neurological deficits.""]","[""The outlook for Progressive Multifocal Leukoencephalopathy varies depending on the underlying cause and the individual's overall health. In some cases, the condition can be life-threatening, while in others, it may be manageable with treatment. Regular monitoring and appropriate medical care are essential for managing the condition.""]","[""The outlook for PML (Progressive Multifocal Leukoencephalopathy) can vary depending on the individual's immune system and the underlying cause. It is a serious condition that can lead to severe disability or even death in some cases.""]",[true],[true],[true],"[""The outlook for PML (Progressive multifocal leukoencephalopathy) varies depending on the individual's immune system and the underlying cause. In some cases, PML can be fatal, while in others, individuals may experience partial or full recovery with treatment.""]","[""Progressive Multifocal Leukoencephalopathy is a rare and often fatal viral disease that affects the central nervous system. The outlook for patients with PML can vary depending on factors such as the underlying cause, the extent of neurological damage, and the individual's overall health. There is no specific cure for PML, but treatments aimed at managing symptoms and underlying conditions may help improve outcomes in some cases.""]","[""The outlook for PML (Progressive Multifocal Leukoencephalopathy) can vary depending on the individual's immune system and the underlying cause. It is a serious condition that can lead to severe disability or even death in some cases.""]",[true],[true],[true],"[""The outlook for PML (Progressive multifocal leukoencephalopathy) varies depending on factors such as the underlying cause, extent of brain damage, and response to treatment. In some cases, PML can be life-threatening, while in others, individuals may experience partial or full recovery.""]","[""The outlook for Progressive Multifocal Leukoencephalopathy varies depending on the individual's immune system and the extent of the infection. In some cases, the condition can be fatal, while in others, it may stabilize or improve with treatment.""]","[""The outlook for PML (Progressive Multifocal Leukoencephalopathy) can vary depending on the individual's immune system and the underlying cause. It is a serious condition that can lead to severe disability or even death, but early detection and management can improve outcomes.""]",[false],[true],[true],"[""The outlook for PML (Probable Maximum Loss) is uncertain and depends on various factors such as location, type of risk, and mitigation measures in place.""]","[""The outlook for Progressive Multifocal Leukoencephalopathy varies depending on the individual's immune system and the extent of the infection. In some cases, the condition can be fatal, while in others, it may stabilize or improve with treatment.""]","[""The outlook for PML (Progressive Multifocal Leukoencephalopathy) can vary depending on the individual's immune system and the underlying cause. It is a serious condition that can lead to severe disability or even death, but early detection and management can improve outcomes.""]",[false],[true],[true],"[""The outlook for PML (Personalized Mailing Lists) is positive, as businesses are increasingly focusing on personalized marketing strategies to enhance customer engagement and drive conversions.""]","[""The outlook for Progressive Multifocal Leukoencephalopathy varies depending on the individual's immune system and the extent of the infection. In some cases, the condition can be fatal, while in others, it may stabilize or improve with treatment.""]","[""The outlook for PML (Progressive Multifocal Leukoencephalopathy) can vary depending on the individual's immune system and the underlying cause. It is a serious condition that can lead to severe disability or even death, but early detection and management can improve outcomes.""]",[true],[true],[true],"[""Outlook for PML can vary depending on the individual case, but it is generally considered a serious condition with potentially severe outcomes.""]","[""The outlook for Progressive Multifocal Leukoencephalopathy varies depending on the individual's immune system and the extent of the infection. In some cases, the condition can be fatal, while in others, it may stabilize or improve with treatment.""]","[""The outlook for PML (Progressive Multifocal Leukoencephalopathy) can vary depending on the individual's immune system and the underlying cause. It is a serious condition that can lead to severe disability or even death, but early detection and management can improve outcomes.""]"
symptoms,What are the symptoms of Autoimmune autonomic ganglionopathy ?,What are the signs and symptoms of autoimmune autonomic ganglionopathy? The symptoms of autoimmune autonomic ganglionopathy can include: Severe orthostatic hypotension (low blood pressure upon standing) that persists for weeks to years Fainting Constipation and gastrointestinal dysmotility (a condition in which the muscles and nerves of the digestive system do not move food through the digestive tract efficiently) Urinary retention Fixed and dilated pupils Dry mouth and eyes Some people with autoimmune autonomic ganglionopathy present with POTS-like symptoms.,"{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""AAG"", ""full_form"": ""Autoimmune autonomic ganglionopathy""}]}",What are the symptoms of AAG ?,What are the symptoms of Autoimmune autonomic ganglionopathy ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""At A Glance"", ""Assistant Attorney General"", ""Almost Anything Goes"", ""American Annuity Group, Inc."", ""Audit and Accounting Guides"", ""Asociaci\u00f3n Audubon de Guatemala"", ""Anime And Games"", ""Association of American Geologists"", ""Army Artillery Group"", ""Association of Applied Geochemists""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Autoimmune Atrophic Gastritis""]",[1.7631706523113232e-17],[5.717104838601433e-14],"[""At A Glance""]",[1.3166910985395215e-10],"[""ABBREVIATIONS""]","[[1.3166910985395215e-10, 1.786926837903925e-14, 9.548389608953193e-13, 7.009214643384365e-27, 4.251961254372541e-21, 2.062027602058873e-38, 1.3724467210215684e-15, 1.4637935890215021e-18, 3.280171711349307e-15, 1.307312992111736e-23]]",[0.7401175594028289],[0.7380232193208116],"[""Autoimmune autonomic ganglionopathy""]",[0.8850013780238835],"[""ABBREVIATIONS""]","[[0.8850013780238835, 0.7425813168380502, 0.7752332093062004, 0.6949008233522675, 0.7054208494332983, 0.6776126065486995, 0.7321207436891728, 0.7436133996959537, 0.7329082216323386, 0.7508658560046317]]","[""Autoimmune Atrophic Gastritis""]","[""LLM""]",What are the symptoms of AAG (Autoimmune Atrophic Gastritis) ?,[false],[true],[true],"[""Symptoms of AAG (At A Glance) include muscle weakness, fatigue, weight loss, and skin darkening.""]","[""Symptoms of Autoimmune autonomic ganglionopathy include orthostatic hypotension, gastrointestinal dysmotility, urinary retention, and pupillary abnormalities.""]","[""The symptoms of AAG (Autoimmune Autonomic Ganglionopathy) include orthostatic hypotension, gastrointestinal dysmotility, anhidrosis, and pupillary abnormalities.""]",[false],[true],[false],"[""Symptoms of AAG (At A Glance) include muscle weakness, fatigue, weight loss, and hyperpigmentation of the skin.""]","[""Symptoms of Autoimmune autonomic ganglionopathy include orthostatic hypotension, gastrointestinal dysmotility, urinary dysfunction, and pupillary abnormalities.""]","[""Symptoms of AAG include muscle weakness, difficulty swallowing, drooping eyelids, and fatigue.""]",[false],[true],[false],"[""Symptoms of AAG (At A Glance) include muscle weakness, difficulty swallowing, drooping eyelids, and double vision.""]","[""Symptoms of Autoimmune autonomic ganglionopathy include orthostatic hypotension, gastrointestinal dysmotility, urinary dysfunction, and pupillary abnormalities.""]","[""Symptoms of AAG include muscle weakness, difficulty swallowing, and shortness of breath.""]",[false],[true],[false],"[""Symptoms of AAG (At A Glance) include muscle weakness, fatigue, weight loss, and difficulty swallowing.""]","[""Symptoms of Autoimmune autonomic ganglionopathy include orthostatic hypotension, gastrointestinal dysmotility, urinary symptoms, and pupillary abnormalities.""]","[""Symptoms of AAG include muscle weakness, difficulty swallowing, drooping eyelids, and fatigue.""]",[true],[true],[true],"[""Symptoms of AAG include orthostatic hypotension, gastrointestinal dysmotility, anhidrosis, urinary retention, and pupillary abnormalities.""]","[""Symptoms of Autoimmune autonomic ganglionopathy include orthostatic hypotension, gastrointestinal dysmotility, urinary retention, and pupillary abnormalities.""]","[""The symptoms of AAG (Autoimmune Autonomic Ganglionopathy) include orthostatic hypotension, gastrointestinal dysmotility, anhidrosis, and pupillary abnormalities.""]",[true],[true],[false],"[""Symptoms of AAG include orthostatic hypotension, gastrointestinal dysmotility, anhidrosis, and pupillary abnormalities.""]","[""Symptoms of Autoimmune autonomic ganglionopathy include orthostatic hypotension, gastrointestinal dysmotility, urinary dysfunction, and pupillary abnormalities.""]","[""Symptoms of AAG include muscle weakness, difficulty swallowing, drooping eyelids, and fatigue.""]",[true],[true],[false],"[""Symptoms of AAG include orthostatic hypotension, gastrointestinal dysmotility, anhidrosis, and pupillary abnormalities.""]","[""Symptoms of Autoimmune autonomic ganglionopathy include orthostatic hypotension, gastrointestinal dysmotility, urinary dysfunction, and pupillary abnormalities.""]","[""Symptoms of AAG include muscle weakness, difficulty swallowing, and shortness of breath.""]",[true],[true],[false],"[""Symptoms of AAG include orthostatic hypotension, gastrointestinal dysmotility, anhidrosis, and pupillary abnormalities.""]","[""Symptoms of Autoimmune autonomic ganglionopathy include orthostatic hypotension, gastrointestinal dysmotility, urinary symptoms, and pupillary abnormalities.""]","[""Symptoms of AAG include muscle weakness, difficulty swallowing, drooping eyelids, and fatigue.""]",[false],[true],[false],"[""Symptoms of AAG (Autoimmune Atrophic Gastritis) include fatigue, weakness, weight loss, nausea, vomiting, abdominal pain, and anemia.""]","[""Symptoms of Autoimmune autonomic ganglionopathy include orthostatic hypotension, gastrointestinal dysmotility, urinary dysfunction, and pupillary abnormalities.""]","[""Symptoms of AAG include muscle weakness, difficulty swallowing, drooping eyelids, and fatigue.""]",[false],[true],[true],"[""Symptoms of AAG (Autoimmune Atrophic Gastritis) include abdominal discomfort, weight loss, fatigue, weakness, anemia, and vitamin B12 deficiency.""]","[""Symptoms of Autoimmune autonomic ganglionopathy include orthostatic hypotension, gastrointestinal dysmotility, urinary retention, and pupillary abnormalities.""]","[""The symptoms of AAG (Autoimmune Autonomic Ganglionopathy) include orthostatic hypotension, gastrointestinal dysmotility, anhidrosis, and pupillary abnormalities.""]",[false],[true],[false],"[""Symptoms of AAG (Autoimmune Atrophic Gastritis) include abdominal discomfort, weight loss, fatigue, weakness, anemia, and vitamin B12 deficiency.""]","[""Symptoms of Autoimmune autonomic ganglionopathy include orthostatic hypotension, gastrointestinal dysmotility, urinary dysfunction, and pupillary abnormalities.""]","[""Symptoms of AAG include muscle weakness, difficulty swallowing, and shortness of breath.""]",[false],[true],[false],"[""Symptoms of AAG (Autoimmune Atrophic Gastritis) include fatigue, weakness, weight loss, nausea, vomiting, abdominal pain, and anemia.""]","[""Symptoms of Autoimmune autonomic ganglionopathy include orthostatic hypotension, gastrointestinal dysmotility, urinary symptoms, and pupillary abnormalities.""]","[""Symptoms of AAG include muscle weakness, difficulty swallowing, drooping eyelids, and fatigue.""]",[false],[true],[true],"[""Symptoms of AAG include fatigue, weakness, weight loss, nausea, vomiting, abdominal pain, and vitamin deficiencies.""]","[""Symptoms of Autoimmune autonomic ganglionopathy include orthostatic hypotension, gastrointestinal dysmotility, urinary retention, and pupillary abnormalities.""]","[""The symptoms of AAG (Autoimmune Autonomic Ganglionopathy) include orthostatic hypotension, gastrointestinal dysmotility, anhidrosis, and pupillary abnormalities.""]",[false],[true],[false],"[""Symptoms of AAG include abdominal discomfort, weight loss, fatigue, weakness, anemia, and vitamin deficiencies.""]","[""Symptoms of Autoimmune autonomic ganglionopathy include orthostatic hypotension, gastrointestinal dysmotility, urinary dysfunction, and pupillary abnormalities.""]","[""Symptoms of AAG include muscle weakness, difficulty swallowing, drooping eyelids, and fatigue.""]",[false],[true],[false],"[""Symptoms of AAG include abdominal discomfort, weight loss, fatigue, weakness, anemia, and vitamin deficiencies.""]","[""Symptoms of Autoimmune autonomic ganglionopathy include orthostatic hypotension, gastrointestinal dysmotility, urinary dysfunction, and pupillary abnormalities.""]","[""Symptoms of AAG include muscle weakness, difficulty swallowing, and shortness of breath.""]",[false],[true],[false],"[""Symptoms of AAG (Autoimmune Atrophic Gastritis) include fatigue, weakness, weight loss, nausea, vomiting, abdominal pain, and vitamin B12 deficiency symptoms.""]","[""Symptoms of Autoimmune autonomic ganglionopathy include orthostatic hypotension, gastrointestinal dysmotility, urinary symptoms, and pupillary abnormalities.""]","[""Symptoms of AAG include muscle weakness, difficulty swallowing, drooping eyelids, and fatigue.""]",[false],[true],[true],"[""Symptoms of AAG (Autoimmune Atrophic Gastritis) include fatigue, weakness, weight loss, nausea, vomiting, abdominal pain, and anemia.""]","[""Symptoms of Autoimmune autonomic ganglionopathy include orthostatic hypotension, gastrointestinal dysmotility, urinary retention, and pupillary abnormalities.""]","[""The symptoms of AAG (Autoimmune Autonomic Ganglionopathy) include orthostatic hypotension, gastrointestinal dysmotility, anhidrosis, and pupillary abnormalities.""]",[false],[true],[false],"[""Symptoms of AAG (Autoimmune Atrophic Gastritis) include abdominal discomfort, weight loss, nausea, vomiting, anemia, and fatigue.""]","[""Symptoms of Autoimmune autonomic ganglionopathy include orthostatic hypotension, gastrointestinal dysmotility, urinary dysfunction, and pupillary abnormalities.""]","[""Symptoms of AAG include muscle weakness, difficulty swallowing, drooping eyelids, and fatigue.""]",[false],[true],[false],"[""Symptoms of AAG (Autoimmune Atrophic Gastritis) include fatigue, weakness, weight loss, nausea, vomiting, abdominal pain, and anemia.""]","[""Symptoms of Autoimmune autonomic ganglionopathy include orthostatic hypotension, gastrointestinal dysmotility, urinary dysfunction, and pupillary abnormalities.""]","[""Symptoms of AAG include muscle weakness, difficulty swallowing, and shortness of breath.""]",[false],[true],[false],"[""Symptoms of AAG (Autoimmune Atrophic Gastritis) include fatigue, weakness, weight loss, nausea, vomiting, abdominal pain, and anemia.""]","[""Symptoms of Autoimmune autonomic ganglionopathy include orthostatic hypotension, gastrointestinal dysmotility, urinary symptoms, and pupillary abnormalities.""]","[""Symptoms of AAG include muscle weakness, difficulty swallowing, drooping eyelids, and fatigue.""]",[false],[true],[true],"[""Symptoms of AAG (Autoimmune Atrophic Gastritis) include fatigue, weakness, weight loss, nausea, vomiting, abdominal pain, and anemia.""]","[""Symptoms of Autoimmune autonomic ganglionopathy include orthostatic hypotension, gastrointestinal dysmotility, urinary retention, and pupillary abnormalities.""]","[""The symptoms of AAG (Autoimmune Autonomic Ganglionopathy) include orthostatic hypotension, gastrointestinal dysmotility, anhidrosis, and pupillary abnormalities.""]",[false],[true],[false],"[""Symptoms of AAG (Autoimmune Atrophic Gastritis) include fatigue, weakness, weight loss, nausea, vomiting, abdominal pain, and anemia.""]","[""Symptoms of Autoimmune autonomic ganglionopathy include orthostatic hypotension, gastrointestinal dysmotility, urinary dysfunction, and pupillary abnormalities.""]","[""Symptoms of AAG include muscle weakness, difficulty swallowing, drooping eyelids, and fatigue.""]",[false],[true],[false],"[""Symptoms of AAG (Autoimmune Atrophic Gastritis) include abdominal discomfort, weight loss, fatigue, weakness, anemia, and vitamin deficiencies.""]","[""Symptoms of Autoimmune autonomic ganglionopathy include orthostatic hypotension, gastrointestinal dysmotility, urinary dysfunction, and pupillary abnormalities.""]","[""Symptoms of AAG include muscle weakness, difficulty swallowing, and shortness of breath.""]",[false],[true],[false],"[""Symptoms of AAG (Autoimmune Atrophic Gastritis) include abdominal discomfort, weight loss, fatigue, weakness, anemia, and vitamin deficiencies.""]","[""Symptoms of Autoimmune autonomic ganglionopathy include orthostatic hypotension, gastrointestinal dysmotility, urinary symptoms, and pupillary abnormalities.""]","[""Symptoms of AAG include muscle weakness, difficulty swallowing, drooping eyelids, and fatigue.""]",[false],[true],[true],"[""Symptoms of AAG (Autoimmune Atrophic Gastritis) may include fatigue, weakness, weight loss, nausea, vomiting, abdominal discomfort, and vitamin deficiencies.""]","[""Symptoms of Autoimmune autonomic ganglionopathy include orthostatic hypotension, gastrointestinal dysmotility, urinary retention, and pupillary abnormalities.""]","[""The symptoms of AAG (Autoimmune Autonomic Ganglionopathy) include orthostatic hypotension, gastrointestinal dysmotility, anhidrosis, and pupillary abnormalities.""]",[false],[true],[false],"[""Symptoms of AAG (Autoimmune Atrophic Gastritis) may include fatigue, weakness, weight loss, nausea, vomiting, abdominal pain, bloating, and vitamin deficiencies.""]","[""Symptoms of Autoimmune autonomic ganglionopathy include orthostatic hypotension, gastrointestinal dysmotility, urinary dysfunction, and pupillary abnormalities.""]","[""Symptoms of AAG include muscle weakness, difficulty swallowing, drooping eyelids, and fatigue.""]",[false],[true],[false],"[""Symptoms of AAG (Autoimmune Atrophic Gastritis) may include fatigue, weakness, weight loss, nausea, vomiting, abdominal pain, and vitamin deficiencies.""]","[""Symptoms of Autoimmune autonomic ganglionopathy include orthostatic hypotension, gastrointestinal dysmotility, urinary dysfunction, and pupillary abnormalities.""]","[""Symptoms of AAG include muscle weakness, difficulty swallowing, and shortness of breath.""]",[false],[true],[false],"[""Symptoms of AAG (Autoimmune Atrophic Gastritis) may include fatigue, weakness, weight loss, nausea, vomiting, abdominal pain, and anemia.""]","[""Symptoms of Autoimmune autonomic ganglionopathy include orthostatic hypotension, gastrointestinal dysmotility, urinary symptoms, and pupillary abnormalities.""]","[""Symptoms of AAG include muscle weakness, difficulty swallowing, drooping eyelids, and fatigue.""]",[false],[true],[true],"[""Symptoms of AAG (Autoimmune Atrophic Gastritis) may include fatigue, weakness, weight loss, nausea, vomiting, abdominal pain, and vitamin deficiencies.""]","[""Symptoms of Autoimmune autonomic ganglionopathy include orthostatic hypotension, gastrointestinal dysmotility, urinary retention, and pupillary abnormalities.""]","[""The symptoms of AAG (Autoimmune Autonomic Ganglionopathy) include orthostatic hypotension, gastrointestinal dysmotility, anhidrosis, and pupillary abnormalities.""]",[false],[true],[true],"[""Symptoms of AAG include fatigue, weight loss, muscle weakness, and joint pain.""]","[""Symptoms of Autoimmune autonomic ganglionopathy include orthostatic hypotension, gastrointestinal dysmotility, urinary retention, and pupillary abnormalities.""]","[""The symptoms of AAG (Autoimmune Autonomic Ganglionopathy) include orthostatic hypotension, gastrointestinal dysmotility, anhidrosis, and pupillary abnormalities.""]",[true],[true],[true],"[""Symptoms of AAG include orthostatic hypotension, gastrointestinal dysmotility, anhidrosis, and pupillary abnormalities.""]","[""Symptoms of Autoimmune autonomic ganglionopathy include orthostatic hypotension, gastrointestinal dysmotility, urinary retention, and pupillary abnormalities.""]","[""The symptoms of AAG (Autoimmune Autonomic Ganglionopathy) include orthostatic hypotension, gastrointestinal dysmotility, anhidrosis, and pupillary abnormalities.""]",[false],[true],[true],"[""Symptoms of AAG include fatigue, weakness, weight loss, nausea, bloating, and vitamin deficiencies.""]","[""Symptoms of Autoimmune autonomic ganglionopathy include orthostatic hypotension, gastrointestinal dysmotility, urinary retention, and pupillary abnormalities.""]","[""The symptoms of AAG (Autoimmune Autonomic Ganglionopathy) include orthostatic hypotension, gastrointestinal dysmotility, anhidrosis, and pupillary abnormalities.""]"
causes,What causes Childhood Nephrotic Syndrome ?,"While idiopathic, or unknown, diseases are the most common cause of primary childhood nephrotic syndrome, researchers have linked certain diseases and some specific genetic changes that damage the kidneys with primary childhood nephrotic syndrome.
                
The cause of secondary childhood nephrotic syndrome is an underlying disease or infection. Called a primary illness, its this underlying disease or infection that causes changes in the kidney function that can result in secondary childhood nephrotic syndrome.
                
Congenital diseasesdiseases that are present at birthcan also cause childhood nephrotic syndrome.
                
Primary Childhood Nephrotic Syndrome
                
The following diseases are different types of idiopathic childhood nephrotic syndrome:
                
- Minimal change disease involves damage to the glomeruli that can be seen only with an electron microscope. This type of microscope shows tiny details better than any other microscope. Scientists do not know the exact cause of minimal change disease. Minimal change disease is the most common cause of idiopathic childhood nephrotic syndrome.1  - Focal segmental glomerulosclerosis is scarring in scattered regions of the kidney:     - Focal means that only some of the glomeruli become scarred.    - Segmental means damage affects only part of an individual glomerulus.    - Membranoproliferative glomerulonephritis is a group of disorders involving deposits of antibodies that build up in the glomeruli, causing thickening and damage. Antibodies are proteins made by the immune system to protect the body from foreign substances such as bacteria or viruses.
                
Secondary Childhood Nephrotic Syndrome
                
Some common diseases that can cause secondary childhood nephrotic syndrome include
                
- diabetes, a condition that occurs when the body cannot use glucosea type of sugarnormally  - Henoch-Schnlein purpura, a disease that causes small blood vessels in the body to become inflamed and leak  - hepatitis, inflammation of the liver caused by a virus  - human immunodeficiency virus (HIV), a virus that alters the immune system  - lupus, an autoimmune disease that occurs when the body attacks its own immune system  - malaria, a disease of the blood that is spread by mosquitos  - streptococcal infection, an infection that results when the bacteria that causes strep throat or a skin infection is left untreated
                
Other causes of secondary childhood nephrotic syndrome can include certain medications, such as aspirin, ibuprofen, or other nonsteroidal anti-inflammatory drugs, and exposure to chemicals, such as mercury and lithium.
                
Congenital Diseases and Childhood Nephrotic Syndrome
                
Congenital nephrotic syndrome is rare and affects infants in the first 3 months of life.2 This type of nephrotic syndrome, sometimes called infantile nephrotic syndrome, can be caused by
                
- inherited genetic defects, which are problems passed from parent to child through genes  - infections at the time of birth
                
More information about underlying diseases or infections that cause changes in kidney function is provided in the NIDDK health topic, Glomerular Diseases.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""CNS"", ""full_form"": ""Childhood Nephrotic Syndrome""}]}",What causes CNS ?,What causes Childhood Nephrotic Syndrome ?,8,MEDICAL,Compound Datatype-String,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Central nervous system"", ""Clinical Nurse Specialist"", ""Cybercast News Service"", ""College of Natural Sciences"", ""Communications, Navigation and Surveillance"", ""Computing and Network Services"", ""Coagulase Negative Staphylococcus"", ""Continuous Net Settlement"", ""Corporation for National Service"", ""Certified Novell Salesperson""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Central Nervous System""]",[2.592521095804292e-09],[9.851622334566903e-07],"[""Central nervous system""]",[9.851622334566903e-07],"[""ABBREVIATIONS""]","[[9.851622334566903e-07, 5.1254544732376456e-14, 5.768878289202971e-22, 1.0395390695308267e-13, 1.1265824334894172e-19, 5.2844400229524965e-19, 3.333389652550116e-12, 1.454779865295765e-14, 1.923146243604612e-18, 3.6654981311374395e-23]]",[0.6657242676755092],[0.9314070111020811],"[""Certified Novell Salesperson""]",[0.9314070111020811],"[""LLM""]","[[0.9277232331516158, 0.8105062606540439, 0.7117259434993284, 0.7642720006104781, 0.687599133286346, 0.7734409336277255, 0.6734717119921868, 0.63909269792213, 0.6556161350964418, 0.7292383838714012]]","[""Central nervous system""]","[""ABBREVIATIONS""]",What causes CNS (Central Nervous System) ?,[false],[true],[false],"[""Various factors can cause Central Nervous System (CNS) disorders, including genetics, infections, trauma, autoimmune disorders, and environmental factors.""]","[""Childhood Nephrotic Syndrome is primarily caused by minimal change disease, focal segmental glomerulosclerosis, and membranous nephropathy.""]","[""Central Nervous System (CNS) can be caused by various factors such as infections, trauma, autoimmune disorders, tumors, and degenerative diseases.""]",[false],[true],[false],"[""Various factors can cause issues in the central nervous system, including infections, trauma, autoimmune disorders, genetic disorders, and degenerative diseases.""]","[""Childhood Nephrotic Syndrome can be caused by minimal change disease, focal segmental glomerulosclerosis, membranous nephropathy, and other kidney diseases.""]","[""Central nervous system (CNS) can be caused by various factors such as infections, trauma, autoimmune disorders, and genetic conditions.""]",[false],[true],[false],"[""Various factors can cause issues in the central nervous system, including infections, autoimmune disorders, genetic disorders, trauma, and degenerative diseases.""]","[""Childhood Nephrotic Syndrome is primarily caused by minimal change disease, focal segmental glomerulosclerosis, and membranous nephropathy.""]","[""Central Nervous System (CNS) can be caused by various factors such as infections, trauma, autoimmune disorders, and genetic conditions.""]",[false],[true],[false],"[""Various factors can cause issues in the central nervous system, including infections, autoimmune disorders, genetic disorders, trauma, and degenerative diseases.""]","[""Childhood Nephrotic Syndrome can be caused by minimal change disease, focal segmental glomerulosclerosis, membranous nephropathy, and other underlying conditions such as infections, genetic factors, and certain medications.""]","[""Central Nervous System (CNS) can be caused by various factors such as infections, trauma, autoimmune disorders, and genetic conditions.""]",[false],[true],[false],"[""CNS (Certified Novell Salesperson) is a certification program offered by Novell for individuals who demonstrate proficiency in selling Novell products and services.""]","[""Childhood Nephrotic Syndrome is primarily caused by minimal change disease, focal segmental glomerulosclerosis, and membranous nephropathy.""]","[""Central Nervous System (CNS) can be caused by various factors such as infections, trauma, autoimmune disorders, tumors, and degenerative diseases.""]",[false],[true],[false],"[""CNS (Certified Novell Salesperson) is caused by passing the Novell Certified Salesperson exam.""]","[""Childhood Nephrotic Syndrome can be caused by minimal change disease, focal segmental glomerulosclerosis, membranous nephropathy, and other kidney diseases.""]","[""Central nervous system (CNS) can be caused by various factors such as infections, trauma, autoimmune disorders, and genetic conditions.""]",[false],[true],[false],"[""CNS (Certified Novell Salesperson) is a certification program offered by Novell, a software and services company, to individuals who demonstrate proficiency in selling Novell products and services.""]","[""Childhood Nephrotic Syndrome is primarily caused by minimal change disease, focal segmental glomerulosclerosis, and membranous nephropathy.""]","[""Central Nervous System (CNS) can be caused by various factors such as infections, trauma, autoimmune disorders, and genetic conditions.""]",[false],[true],[false],"[""CNS (Certified Novell Salesperson) is caused by passing the required exams and meeting the certification criteria set by Novell.""]","[""Childhood Nephrotic Syndrome can be caused by minimal change disease, focal segmental glomerulosclerosis, membranous nephropathy, and other underlying conditions such as infections, genetic factors, and certain medications.""]","[""Central Nervous System (CNS) can be caused by various factors such as infections, trauma, autoimmune disorders, and genetic conditions.""]",[false],[true],[false],"[""Various factors can cause Central Nervous System disorders, including genetic mutations, infections, autoimmune disorders, trauma, and environmental factors.""]","[""Childhood Nephrotic Syndrome can be caused by minimal change disease, focal segmental glomerulosclerosis, membranous nephropathy, and other kidney diseases.""]","[""Central nervous system (CNS) can be caused by various factors such as infections, trauma, autoimmune disorders, and genetic conditions.""]",[false],[true],[false],"[""Various factors can cause issues in the central nervous system, including infections, autoimmune disorders, trauma, tumors, degenerative diseases, and genetic disorders.""]","[""Childhood Nephrotic Syndrome is primarily caused by minimal change disease, focal segmental glomerulosclerosis, and membranous nephropathy.""]","[""Central Nervous System (CNS) can be caused by various factors such as infections, trauma, autoimmune disorders, tumors, and degenerative diseases.""]",[false],[true],[false],"[""Various factors can cause issues in the central nervous system, including infections, autoimmune disorders, genetic disorders, trauma, tumors, and degenerative diseases.""]","[""Childhood Nephrotic Syndrome is primarily caused by minimal change disease, focal segmental glomerulosclerosis, and membranous nephropathy.""]","[""Central Nervous System (CNS) can be caused by various factors such as infections, trauma, autoimmune disorders, and genetic conditions.""]",[false],[true],[false],"[""Various factors can cause issues in the Central Nervous System (CNS), including infections, autoimmune disorders, trauma, tumors, degenerative diseases, and genetic factors.""]","[""Childhood Nephrotic Syndrome can be caused by minimal change disease, focal segmental glomerulosclerosis, membranous nephropathy, and other underlying conditions such as infections, genetic factors, and certain medications.""]","[""Central Nervous System (CNS) can be caused by various factors such as infections, trauma, autoimmune disorders, and genetic conditions.""]",[false],[true],[false],"[""Various factors can cause Central Nervous System disorders, including infections, trauma, autoimmune diseases, genetic disorders, and degenerative conditions.""]","[""Childhood Nephrotic Syndrome is primarily caused by minimal change disease, focal segmental glomerulosclerosis, and membranous nephropathy.""]","[""Central Nervous System (CNS) can be caused by various factors such as infections, trauma, autoimmune disorders, tumors, and degenerative diseases.""]",[false],[true],[false],"[""Various factors can cause Central Nervous System disorders, including infections, trauma, autoimmune diseases, genetic disorders, and tumors.""]","[""Childhood Nephrotic Syndrome can be caused by minimal change disease, focal segmental glomerulosclerosis, membranous nephropathy, and other kidney diseases.""]","[""Central nervous system (CNS) can be caused by various factors such as infections, trauma, autoimmune disorders, and genetic conditions.""]",[false],[true],[false],"[""Various factors can cause issues in the central nervous system, including infections, autoimmune disorders, genetic disorders, trauma, and degenerative diseases.""]","[""Childhood Nephrotic Syndrome is primarily caused by minimal change disease, focal segmental glomerulosclerosis, and membranous nephropathy.""]","[""Central Nervous System (CNS) can be caused by various factors such as infections, trauma, autoimmune disorders, and genetic conditions.""]",[false],[true],[false],"[""Various factors can cause issues in the Central Nervous System, including infections, trauma, autoimmune disorders, genetic disorders, and degenerative diseases.""]","[""Childhood Nephrotic Syndrome can be caused by minimal change disease, focal segmental glomerulosclerosis, membranous nephropathy, and other underlying conditions such as infections, genetic factors, and certain medications.""]","[""Central Nervous System (CNS) can be caused by various factors such as infections, trauma, autoimmune disorders, and genetic conditions.""]",[false],[true],[false],"[""The central nervous system (CNS) is primarily caused by genetic factors, infections, autoimmune disorders, trauma, and environmental factors.""]","[""Childhood Nephrotic Syndrome is primarily caused by minimal change disease, focal segmental glomerulosclerosis, and membranous nephropathy.""]","[""Central Nervous System (CNS) can be caused by various factors such as infections, trauma, autoimmune disorders, tumors, and degenerative diseases.""]",[false],[true],[false],"[""Various factors can cause issues in the central nervous system, including infections, autoimmune disorders, trauma, tumors, and degenerative diseases.""]","[""Childhood Nephrotic Syndrome can be caused by minimal change disease, focal segmental glomerulosclerosis, membranous nephropathy, and other kidney diseases.""]","[""Central nervous system (CNS) can be caused by various factors such as infections, trauma, autoimmune disorders, and genetic conditions.""]",[false],[true],[false],"[""Various factors can cause issues in the central nervous system, including infections, autoimmune disorders, genetic disorders, trauma, and degenerative diseases.""]","[""Childhood Nephrotic Syndrome is primarily caused by minimal change disease, focal segmental glomerulosclerosis, and membranous nephropathy.""]","[""Central Nervous System (CNS) can be caused by various factors such as infections, trauma, autoimmune disorders, and genetic conditions.""]",[false],[true],[false],"[""Various factors can cause issues in the central nervous system, including infections, trauma, autoimmune disorders, genetic disorders, and degenerative diseases.""]","[""Childhood Nephrotic Syndrome can be caused by minimal change disease, focal segmental glomerulosclerosis, membranous nephropathy, and other underlying conditions such as infections, genetic factors, and certain medications.""]","[""Central Nervous System (CNS) can be caused by various factors such as infections, trauma, autoimmune disorders, and genetic conditions.""]",[false],[true],[false],"[""Various factors can cause Central Nervous System (CNS) disorders, including infections, trauma, autoimmune conditions, genetic disorders, and tumors.""]","[""Childhood Nephrotic Syndrome is primarily caused by minimal change disease, focal segmental glomerulosclerosis, and membranous nephropathy.""]","[""Central Nervous System (CNS) can be caused by various factors such as infections, trauma, autoimmune disorders, tumors, and degenerative diseases.""]",[false],[true],[false],"[""Various factors can cause Central Nervous System (CNS) disorders, including infections, trauma, autoimmune conditions, genetic disorders, and tumors.""]","[""Childhood Nephrotic Syndrome can be caused by minimal change disease, focal segmental glomerulosclerosis, membranous nephropathy, and other kidney diseases.""]","[""Central nervous system (CNS) can be caused by various factors such as infections, trauma, autoimmune disorders, and genetic conditions.""]",[false],[true],[false],"[""Various factors can cause Central Nervous System (CNS) disorders, including infections, trauma, autoimmune conditions, genetic disorders, and tumors.""]","[""Childhood Nephrotic Syndrome is primarily caused by minimal change disease, focal segmental glomerulosclerosis, and membranous nephropathy.""]","[""Central Nervous System (CNS) can be caused by various factors such as infections, trauma, autoimmune disorders, and genetic conditions.""]",[false],[true],[false],"[""Various factors can cause Central Nervous System (CNS) disorders, including infections, trauma, autoimmune conditions, genetic disorders, and tumors.""]","[""Childhood Nephrotic Syndrome can be caused by minimal change disease, focal segmental glomerulosclerosis, membranous nephropathy, and other underlying conditions such as infections, genetic factors, and certain medications.""]","[""Central Nervous System (CNS) can be caused by various factors such as infections, trauma, autoimmune disorders, and genetic conditions.""]",[false],[true],[false],"[""The central nervous system (CNS) is primarily caused by genetic factors, infections, autoimmune disorders, trauma, and environmental factors.""]","[""Childhood Nephrotic Syndrome is primarily caused by minimal change disease, focal segmental glomerulosclerosis, and membranous nephropathy.""]","[""Central Nervous System (CNS) can be caused by various factors such as infections, trauma, autoimmune disorders, tumors, and degenerative diseases.""]",[false],[true],[false],"[""The central nervous system (CNS) is primarily caused by genetic factors, infections, autoimmune disorders, trauma, and environmental factors.""]","[""Childhood Nephrotic Syndrome can be caused by minimal change disease, focal segmental glomerulosclerosis, membranous nephropathy, and other kidney diseases.""]","[""Central nervous system (CNS) can be caused by various factors such as infections, trauma, autoimmune disorders, and genetic conditions.""]",[false],[true],[false],"[""The central nervous system (CNS) is primarily caused by genetic factors, environmental factors, infections, and injuries.""]","[""Childhood Nephrotic Syndrome is primarily caused by minimal change disease, focal segmental glomerulosclerosis, and membranous nephropathy.""]","[""Central Nervous System (CNS) can be caused by various factors such as infections, trauma, autoimmune disorders, and genetic conditions.""]",[false],[true],[false],"[""The central nervous system (CNS) is primarily caused by genetic factors, infections, autoimmune disorders, trauma, and environmental factors.""]","[""Childhood Nephrotic Syndrome can be caused by minimal change disease, focal segmental glomerulosclerosis, membranous nephropathy, and other underlying conditions such as infections, genetic factors, and certain medications.""]","[""Central Nervous System (CNS) can be caused by various factors such as infections, trauma, autoimmune disorders, and genetic conditions.""]",[false],[true],[false],"[""The CNS (Central Nervous System) is primarily caused by genetic factors, infections, autoimmune disorders, trauma, and environmental factors.""]","[""Childhood Nephrotic Syndrome is primarily caused by minimal change disease, focal segmental glomerulosclerosis, and membranous nephropathy.""]","[""Central Nervous System (CNS) can be caused by various factors such as infections, trauma, autoimmune disorders, tumors, and degenerative diseases.""]",[false],[true],[false],"[""The central nervous system (CNS) can be caused by various factors such as infections, trauma, autoimmune disorders, genetic disorders, and degenerative diseases.""]","[""Childhood Nephrotic Syndrome is primarily caused by minimal change disease, focal segmental glomerulosclerosis, and membranous nephropathy.""]","[""Central Nervous System (CNS) can be caused by various factors such as infections, trauma, autoimmune disorders, tumors, and degenerative diseases.""]",[false],[true],[false],"[""CNS (Certified Novell Salesperson) is caused by passing the required certification exam administered by Novell.""]","[""Childhood Nephrotic Syndrome is primarily caused by minimal change disease, focal segmental glomerulosclerosis, and membranous nephropathy.""]","[""Central Nervous System (CNS) can be caused by various factors such as infections, trauma, autoimmune disorders, tumors, and degenerative diseases.""]",[false],[true],[false],"[""Various factors can cause damage to the Central Nervous System (CNS), including infections, trauma, autoimmune disorders, genetic disorders, and neurodegenerative diseases.""]","[""Childhood Nephrotic Syndrome is primarily caused by minimal change disease, focal segmental glomerulosclerosis, and membranous nephropathy.""]","[""Central Nervous System (CNS) can be caused by various factors such as infections, trauma, autoimmune disorders, tumors, and degenerative diseases.""]"
symptoms,What are the symptoms of Amyotonia congenita ?,"What are the signs and symptoms of Amyotonia congenita? The Human Phenotype Ontology provides the following list of signs and symptoms for Amyotonia congenita. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Autosomal recessive inheritance - Skeletal muscle atrophy - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""AC"", ""full_form"": ""Amyotonia congenita""}]}",What are the symptoms of AC ?,What are the symptoms of Amyotonia congenita ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Acute"", ""AirCraft"", ""Air Conditioning"", ""Alternating Current"", ""Air Conditioner"", ""Access Control"", ""Atlantic City"", ""Air Cooled"", ""Advisory Committee"", ""Area Code""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Acromioclavicular""]",[4.137002899616621e-26],[1.4218092112706252e-09],"[""Acute""]",[0.0020205967459174597],"[""ABBREVIATIONS""]","[[0.0020205967459174597, 1.2764462415304013e-07, 2.3065483802396982e-09, 5.547788063958196e-09, 7.153136126663681e-11, 6.949686436529093e-10, 2.2865577674882424e-13, 3.509183685358899e-09, 6.579303580424951e-11, 1.239771908000844e-08]]",[0.622397126337137],[0.7758715598579997],"[""Amyotonia congenita""]",[0.9035238755709262],"[""ABBREVIATIONS""]","[[0.9035238755709262, 0.8236324174411798, 0.8556058279957515, 0.7872496642515383, 0.8504307439112699, 0.7687569891842876, 0.7879328128037923, 0.8369848152809969, 0.8027074738931086, 0.7823741813268645]]","[""Acromioclavicular""]","[""LLM""]",What are the symptoms of AC (Acromioclavicular) ?,[false],[true],[false],"[""Symptoms of Acute Coronary Syndrome (ACS) include chest pain or discomfort, shortness of breath, nausea, lightheadedness, and sweating.""]","[""Hypotonia, muscle weakness, delayed motor development""]","[""Symptoms of acute bronchitis may include cough, mucus production, fatigue, shortness of breath, chest discomfort, and mild fever.""]",[false],[true],[false],"[""Symptoms of Acute Coronary Syndrome (ACS) include chest pain or discomfort, shortness of breath, nausea, sweating, lightheadedness, and pain or discomfort in other areas of the upper body such as the arms, back, neck, jaw, or stomach.""]","[""Hypotonia, muscle weakness, delayed motor development""]","[""Symptoms of AC include chest pain, shortness of breath, fatigue, and dizziness.""]",[false],[true],[false],"[""Symptoms of Acute Coronary Syndrome (ACS) include chest pain or discomfort, shortness of breath, nausea, lightheadedness, and sweating.""]","[""Hypotonia, muscle weakness, delayed motor development""]","[""Symptoms of AC include chest pain, shortness of breath, fatigue, dizziness, and nausea.""]",[false],[true],[false],"[""Symptoms of Acute Coronary Syndrome (ACS) include chest pain or discomfort, shortness of breath, nausea, lightheadedness, and sweating.""]","[""Muscle weakness, hypotonia, delayed motor development, and respiratory problems.""]","[""Symptoms of AC include chest pain, shortness of breath, fatigue, dizziness, and nausea.""]",[true],[true],[false],"[""Symptoms of Amyotonia congenita (AC) include muscle weakness, poor muscle tone, delayed motor development, and difficulty swallowing.""]","[""Hypotonia, muscle weakness, delayed motor development""]","[""Symptoms of acute bronchitis may include cough, mucus production, fatigue, shortness of breath, chest discomfort, and mild fever.""]",[true],[true],[false],"[""Muscle weakness, poor muscle tone, joint deformities, and delayed motor development are common symptoms of Amyotonia congenita (AC).""]","[""Hypotonia, muscle weakness, delayed motor development""]","[""Symptoms of AC include chest pain, shortness of breath, fatigue, and dizziness.""]",[true],[true],[false],"[""Hypotonia, muscle weakness, delayed motor development, and joint deformities are common symptoms of Amyotonia congenita (AC).""]","[""Hypotonia, muscle weakness, delayed motor development""]","[""Symptoms of AC include chest pain, shortness of breath, fatigue, dizziness, and nausea.""]",[true],[true],[false],"[""Hypotonia, muscle weakness, delayed motor development, joint contractures""]","[""Muscle weakness, hypotonia, delayed motor development, and respiratory problems.""]","[""Symptoms of AC include chest pain, shortness of breath, fatigue, dizziness, and nausea.""]",[false],[true],[false],"[""Pain, swelling, tenderness, limited range of motion in the shoulder joint""]","[""Hypotonia, muscle weakness, delayed motor development""]","[""Symptoms of AC include chest pain, shortness of breath, fatigue, and dizziness.""]",[false],[true],[false],"[""Pain, swelling, tenderness, limited range of motion in the shoulder joint""]","[""Hypotonia, muscle weakness, delayed motor development""]","[""Symptoms of acute bronchitis may include cough, mucus production, fatigue, shortness of breath, chest discomfort, and mild fever.""]",[false],[true],[false],"[""Pain, swelling, tenderness, limited range of motion in the shoulder joint""]","[""Hypotonia, muscle weakness, delayed motor development""]","[""Symptoms of AC include chest pain, shortness of breath, fatigue, dizziness, and nausea.""]",[false],[true],[false],"[""Pain, swelling, tenderness, limited range of motion in the shoulder joint""]","[""Muscle weakness, hypotonia, delayed motor development, and respiratory problems.""]","[""Symptoms of AC include chest pain, shortness of breath, fatigue, dizziness, and nausea.""]",[false],[true],[false],"[""Pain, swelling, tenderness, limited range of motion in the shoulder joint""]","[""Hypotonia, muscle weakness, delayed motor development""]","[""Symptoms of acute bronchitis may include cough, mucus production, fatigue, shortness of breath, chest discomfort, and mild fever.""]",[false],[true],[false],"[""Pain, swelling, tenderness, limited range of motion in the shoulder""]","[""Hypotonia, muscle weakness, delayed motor development""]","[""Symptoms of AC include chest pain, shortness of breath, fatigue, and dizziness.""]",[false],[true],[false],"[""Pain, swelling, tenderness, limited range of motion in the shoulder joint""]","[""Hypotonia, muscle weakness, delayed motor development""]","[""Symptoms of AC include chest pain, shortness of breath, fatigue, dizziness, and nausea.""]",[false],[true],[false],"[""Pain, swelling, tenderness, limited range of motion in the shoulder joint""]","[""Muscle weakness, hypotonia, delayed motor development, and respiratory problems.""]","[""Symptoms of AC include chest pain, shortness of breath, fatigue, dizziness, and nausea.""]",[false],[true],[false],"[""Pain, swelling, tenderness, limited range of motion in the shoulder joint""]","[""Hypotonia, muscle weakness, delayed motor development""]","[""Symptoms of acute bronchitis may include cough, mucus production, fatigue, shortness of breath, chest discomfort, and mild fever.""]",[false],[true],[false],"[""Pain, swelling, tenderness, limited range of motion in the shoulder joint""]","[""Hypotonia, muscle weakness, delayed motor development""]","[""Symptoms of AC include chest pain, shortness of breath, fatigue, and dizziness.""]",[false],[true],[false],"[""Pain, swelling, tenderness, limited range of motion in the shoulder joint""]","[""Hypotonia, muscle weakness, delayed motor development""]","[""Symptoms of AC include chest pain, shortness of breath, fatigue, dizziness, and nausea.""]",[false],[true],[false],"[""Symptoms of AC (Acromioclavicular) include pain, swelling, tenderness, and limited range of motion in the shoulder joint.""]","[""Muscle weakness, hypotonia, delayed motor development, and respiratory problems.""]","[""Symptoms of AC include chest pain, shortness of breath, fatigue, dizziness, and nausea.""]",[false],[true],[false],"[""Pain, swelling, tenderness, limited range of motion in the shoulder joint""]","[""Hypotonia, muscle weakness, delayed motor development""]","[""Symptoms of acute bronchitis may include cough, mucus production, fatigue, shortness of breath, chest discomfort, and mild fever.""]",[false],[true],[false],"[""Pain, swelling, tenderness, limited range of motion in the shoulder joint""]","[""Hypotonia, muscle weakness, delayed motor development""]","[""Symptoms of AC include chest pain, shortness of breath, fatigue, and dizziness.""]",[false],[true],[false],"[""Pain, swelling, tenderness, limited range of motion in the shoulder joint""]","[""Hypotonia, muscle weakness, delayed motor development""]","[""Symptoms of AC include chest pain, shortness of breath, fatigue, dizziness, and nausea.""]",[false],[true],[false],"[""Pain, swelling, tenderness, limited range of motion in the shoulder joint""]","[""Muscle weakness, hypotonia, delayed motor development, and respiratory problems.""]","[""Symptoms of AC include chest pain, shortness of breath, fatigue, dizziness, and nausea.""]",[false],[true],[false],"[""The symptoms of AC (Acromioclavicular) joint injury include pain, swelling, tenderness, reduced range of motion, and a visible bump at the top of the shoulder.""]","[""Hypotonia, muscle weakness, delayed motor development""]","[""Symptoms of acute bronchitis may include cough, mucus production, fatigue, shortness of breath, chest discomfort, and mild fever.""]",[false],[true],[false],"[""Pain, swelling, tenderness, limited range of motion in the shoulder joint""]","[""Hypotonia, muscle weakness, delayed motor development""]","[""Symptoms of AC include chest pain, shortness of breath, fatigue, and dizziness.""]",[false],[true],[false],"[""The symptoms of AC (Acromioclavicular) injury include pain, swelling, tenderness, and limited range of motion in the shoulder area.""]","[""Hypotonia, muscle weakness, delayed motor development""]","[""Symptoms of AC include chest pain, shortness of breath, fatigue, dizziness, and nausea.""]",[false],[true],[false],"[""Pain, swelling, tenderness, limited range of motion in the shoulder joint""]","[""Muscle weakness, hypotonia, delayed motor development, and respiratory problems.""]","[""Symptoms of AC include chest pain, shortness of breath, fatigue, dizziness, and nausea.""]",[false],[true],[false],"[""Pain, swelling, tenderness, limited range of motion in the shoulder joint""]","[""Hypotonia, muscle weakness, delayed motor development""]","[""Symptoms of acute bronchitis may include cough, mucus production, fatigue, shortness of breath, chest discomfort, and mild fever.""]",[false],[true],[false],"[""Symptoms of acute AC include sudden chest pain, shortness of breath, and dizziness.""]","[""Hypotonia, muscle weakness, delayed motor development""]","[""Symptoms of acute bronchitis may include cough, mucus production, fatigue, shortness of breath, chest discomfort, and mild fever.""]",[true],[true],[false],"[""The symptoms of Amyotonia congenita (AC) include muscle weakness, poor muscle tone, feeding difficulties, and delayed motor development.""]","[""Hypotonia, muscle weakness, delayed motor development""]","[""Symptoms of acute bronchitis may include cough, mucus production, fatigue, shortness of breath, chest discomfort, and mild fever.""]",[false],[true],[false],"[""Pain, swelling, tenderness, limited range of motion in the shoulder joint""]","[""Hypotonia, muscle weakness, delayed motor development""]","[""Symptoms of acute bronchitis may include cough, mucus production, fatigue, shortness of breath, chest discomfort, and mild fever.""]"
genetic changes,What are the genetic changes related to familial exudative vitreoretinopathy ?,"Mutations in the FZD4, LRP5, and NDP genes can cause familial exudative vitreoretinopathy. These genes provide instructions for making proteins that participate in a chemical signaling pathway that affects the way cells and tissues develop. In particular, the proteins produced from the FZD4, LRP5, and NDP genes appear to play critical roles in the specialization of retinal cells and the establishment of a blood supply to the retina and the inner ear. The LRP5 protein also helps regulate bone formation.  Mutations in the FZD4, LRP5, or NDP gene disrupt chemical signaling during early development, which interferes with the formation of blood vessels at the edges of the retina. The resulting abnormal blood supply to this tissue leads to retinal damage and vision loss in some people with familial exudative vitreoretinopathy.  The eye abnormalities associated with familial exudative vitreoretinopathy tend to be similar no matter which gene is altered. However, affected individuals with LRP5 gene mutations often have reduced bone mineral density in addition to vision loss. Mutations in the other genes responsible for familial exudative vitreoretinopathy do not appear to affect bone density.  In some cases, the cause of familial exudative vitreoretinopathy is unknown. Researchers believe that mutations in several as-yet-unidentified genes are responsible for the disorder in these cases.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""FEVR"", ""full_form"": ""familial exudative vitreoretinopathy""}]}",What are the genetic changes related to FEVR ?,What are the genetic changes related to familial exudative vitreoretinopathy ?,8,MEDICAL,Compound Datatype-List/Array,"Exploratory(Divergent Thinking): Queries that are inherently about seeking new areas of knowledge, understanding emerging trends, or identifying unknown opportunities without a specific end goal of making a decision or judgment. Exploratory queries are characterized by their openness and the lack of a predefined objective, differentiating them from evaluative queries which are directed towards forming a judgment or assessment. Exploratory queries encourage branching out into various directions to explore a wide array of possibilities without necessarily aiming to converge on a single answer or outcome.","[[""Federation Europeenne des Victimes de la Route"", ""Fremont and Elkhorn Valley Railroad"", ""Familial Exudative Vitreoretinopathy"", ""Familial Exudative Vitreal Retinopathy (ophthalmological malady of the vitreous and retina)"", ""Fremont &amp; Elkhorn Valley Railroad"", ""F&#233;d&#233;ration Europ&#233;enne des Victimes de la Route (French: European Federation of Road Traffic Victims)"", ""Fremont & Elkhorn Valley Railroad"", ""Familial Exudative Vitreoretinopathy"", ""F\u00e9d\u00e9ration Europ\u00e9enne des Victimes de la Route (French: European Federation of Road Traffic Victims)"", ""Familial Exudative Vitreal Retinopathy (ophthalmological malady of the vitreous and retina)""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY""]]","[""Familial Exudative Vitreoretinopathy""]",[2.0472191713125958e-29],[2.0472191713125958e-29],"[""Familial Exudative Vitreoretinopathy""]",[2.0472191713125958e-29],"[""ACRONYMFINDER""]","[[6.788598887943088e-45, 2.8714771132656744e-35, 2.0472191713125958e-29, 2.8617086155608143e-62, 4.290974680026054e-44, 4.5091933128520365e-115, 8.227178585788605e-36, 2.0472191713125958e-29, 1.8623506847352636e-85, 2.8617086155608143e-62]]",[0.9504098845686384],[0.9525674850830914],"[""Fremont and Elkhorn Valley Railroad""]",[0.9525674850830914],"[""ACRONYMFINDER""]","[[0.8269086944298656, 0.8999382782335232, 0.9525674850830914, 0.9350938876736616, 0.8757285621339121, 0.8705197718713695, 0.8957176326003007, 0.9525674850830914, 0.8745499645235113, 0.9350938876736616]]","[""Familial Exudative Vitreoretinopathy""]","[""ACRONYMFINDER""]",What are the genetic changes related to FEVR (Familial Exudative Vitreoretinopathy) ?,[true],[true],[true],"[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, NDP, and TSPAN12 genes.""]","[""Mutations in the FZD4, LRP5, NDP, and TSPAN12 genes have been associated with familial exudative vitreoretinopathy.""]","[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, NDP, and TSPAN12 genes.""]",[true],[false],[true],"[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, NDP, and TSPAN12 genes.""]","[""Familial exudative vitreoretinopathy is associated with genetic changes in the FZD4, LRP5, TSPAN12, and ZNF408 genes.""]","[""Mutations in the FZD4, LRP5, NDP, and TSPAN12 genes are associated with Familial Exudative Vitreoretinopathy (FEVR).""]",[true],[true],[true],"[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, TSPAN12, and NDP genes.""]","[""Mutations in the FZD4, LRP5, NDP, and TSPAN12 genes are associated with familial exudative vitreoretinopathy.""]","[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, NDP, and TSPAN12 genes.""]",[true],[true],[true],"[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, NDP, and TSPAN12 genes.""]","[""Mutations in the FZD4, LRP5, TSPAN12, and NDP genes are associated with familial exudative vitreoretinopathy.""]","[""Mutations in the FZD4, LRP5, TSPAN12, and NDP genes are associated with FEVR.""]",[true],[true],[true],"[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, NDP, and TSPAN12 genes.""]","[""Mutations in the FZD4, LRP5, NDP, and TSPAN12 genes have been associated with familial exudative vitreoretinopathy.""]","[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, NDP, and TSPAN12 genes.""]",[true],[false],[true],"[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, TSPAN12, and NDP genes.""]","[""Familial exudative vitreoretinopathy is associated with genetic changes in the FZD4, LRP5, TSPAN12, and ZNF408 genes.""]","[""Mutations in the FZD4, LRP5, NDP, and TSPAN12 genes are associated with Familial Exudative Vitreoretinopathy (FEVR).""]",[true],[true],[true],"[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, NDP, and TSPAN12 genes.""]","[""Mutations in the FZD4, LRP5, NDP, and TSPAN12 genes are associated with familial exudative vitreoretinopathy.""]","[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, NDP, and TSPAN12 genes.""]",[true],[true],[true],"[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, NDP, and TSPAN12 genes.""]","[""Mutations in the FZD4, LRP5, TSPAN12, and NDP genes are associated with familial exudative vitreoretinopathy.""]","[""Mutations in the FZD4, LRP5, TSPAN12, and NDP genes are associated with FEVR.""]",[true],[false],[true],"[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, NDP, and TSPAN12 genes.""]","[""Familial exudative vitreoretinopathy is associated with genetic changes in the FZD4, LRP5, TSPAN12, and ZNF408 genes.""]","[""Mutations in the FZD4, LRP5, NDP, and TSPAN12 genes are associated with Familial Exudative Vitreoretinopathy (FEVR).""]",[true],[true],[true],"[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, NDP, and TSPAN12 genes.""]","[""Mutations in the FZD4, LRP5, NDP, and TSPAN12 genes have been associated with familial exudative vitreoretinopathy.""]","[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, NDP, and TSPAN12 genes.""]",[true],[true],[true],"[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, NDP, and TSPAN12 genes.""]","[""Mutations in the FZD4, LRP5, NDP, and TSPAN12 genes are associated with familial exudative vitreoretinopathy.""]","[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, NDP, and TSPAN12 genes.""]",[true],[true],[true],"[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, NDP, and TSPAN12 genes.""]","[""Mutations in the FZD4, LRP5, TSPAN12, and NDP genes are associated with familial exudative vitreoretinopathy.""]","[""Mutations in the FZD4, LRP5, TSPAN12, and NDP genes are associated with FEVR.""]",[true],[true],[true],"[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, NDP, and TSPAN12 genes.""]","[""Mutations in the FZD4, LRP5, NDP, and TSPAN12 genes have been associated with familial exudative vitreoretinopathy.""]","[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, NDP, and TSPAN12 genes.""]",[true],[false],[true],"[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, TSPAN12, and NDP genes.""]","[""Familial exudative vitreoretinopathy is associated with genetic changes in the FZD4, LRP5, TSPAN12, and ZNF408 genes.""]","[""Mutations in the FZD4, LRP5, NDP, and TSPAN12 genes are associated with Familial Exudative Vitreoretinopathy (FEVR).""]",[true],[true],[true],"[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, NDP, and TSPAN12 genes.""]","[""Mutations in the FZD4, LRP5, NDP, and TSPAN12 genes are associated with familial exudative vitreoretinopathy.""]","[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, NDP, and TSPAN12 genes.""]",[true],[true],[true],"[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, NDP, and TSPAN12 genes.""]","[""Mutations in the FZD4, LRP5, TSPAN12, and NDP genes are associated with familial exudative vitreoretinopathy.""]","[""Mutations in the FZD4, LRP5, TSPAN12, and NDP genes are associated with FEVR.""]",[true],[true],[true],"[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, TSPAN12, and NDP genes.""]","[""Mutations in the FZD4, LRP5, NDP, and TSPAN12 genes have been associated with familial exudative vitreoretinopathy.""]","[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, NDP, and TSPAN12 genes.""]",[true],[false],[true],"[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, NDP, and TSPAN12 genes.""]","[""Familial exudative vitreoretinopathy is associated with genetic changes in the FZD4, LRP5, TSPAN12, and ZNF408 genes.""]","[""Mutations in the FZD4, LRP5, NDP, and TSPAN12 genes are associated with Familial Exudative Vitreoretinopathy (FEVR).""]",[true],[true],[true],"[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, NDP, and TSPAN12 genes.""]","[""Mutations in the FZD4, LRP5, NDP, and TSPAN12 genes are associated with familial exudative vitreoretinopathy.""]","[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, NDP, and TSPAN12 genes.""]",[true],[true],[true],"[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, NDP, and TSPAN12 genes.""]","[""Mutations in the FZD4, LRP5, TSPAN12, and NDP genes are associated with familial exudative vitreoretinopathy.""]","[""Mutations in the FZD4, LRP5, TSPAN12, and NDP genes are associated with FEVR.""]",[true],[true],[true],"[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, TSPAN12, and NDP genes.""]","[""Mutations in the FZD4, LRP5, NDP, and TSPAN12 genes have been associated with familial exudative vitreoretinopathy.""]","[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, NDP, and TSPAN12 genes.""]",[true],[false],[true],"[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, NDP, and TSPAN12 genes.""]","[""Familial exudative vitreoretinopathy is associated with genetic changes in the FZD4, LRP5, TSPAN12, and ZNF408 genes.""]","[""Mutations in the FZD4, LRP5, NDP, and TSPAN12 genes are associated with Familial Exudative Vitreoretinopathy (FEVR).""]",[true],[true],[true],"[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, NDP, and TSPAN12 genes.""]","[""Mutations in the FZD4, LRP5, NDP, and TSPAN12 genes are associated with familial exudative vitreoretinopathy.""]","[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, NDP, and TSPAN12 genes.""]",[true],[true],[true],"[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, NDP, and TSPAN12 genes.""]","[""Mutations in the FZD4, LRP5, TSPAN12, and NDP genes are associated with familial exudative vitreoretinopathy.""]","[""Mutations in the FZD4, LRP5, TSPAN12, and NDP genes are associated with FEVR.""]",[true],[true],[true],"[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, NDP, and TSPAN12 genes.""]","[""Mutations in the FZD4, LRP5, NDP, and TSPAN12 genes have been associated with familial exudative vitreoretinopathy.""]","[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, NDP, and TSPAN12 genes.""]",[true],[false],[true],"[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, NDP, and TSPAN12 genes.""]","[""Familial exudative vitreoretinopathy is associated with genetic changes in the FZD4, LRP5, TSPAN12, and ZNF408 genes.""]","[""Mutations in the FZD4, LRP5, NDP, and TSPAN12 genes are associated with Familial Exudative Vitreoretinopathy (FEVR).""]",[true],[true],[true],"[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, NDP, and TSPAN12 genes.""]","[""Mutations in the FZD4, LRP5, NDP, and TSPAN12 genes are associated with familial exudative vitreoretinopathy.""]","[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, NDP, and TSPAN12 genes.""]",[true],[true],[true],"[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, NDP, and TSPAN12 genes.""]","[""Mutations in the FZD4, LRP5, TSPAN12, and NDP genes are associated with familial exudative vitreoretinopathy.""]","[""Mutations in the FZD4, LRP5, TSPAN12, and NDP genes are associated with FEVR.""]",[true],[true],[true],"[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, NDP, and TSPAN12 genes.""]","[""Mutations in the FZD4, LRP5, NDP, and TSPAN12 genes have been associated with familial exudative vitreoretinopathy.""]","[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, NDP, and TSPAN12 genes.""]",[true],[true],[true],"[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, NDP, and TSPAN12 genes.""]","[""Mutations in the FZD4, LRP5, NDP, and TSPAN12 genes have been associated with familial exudative vitreoretinopathy.""]","[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, NDP, and TSPAN12 genes.""]",[true],[true],[true],"[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, TSPAN12, and NDP genes.""]","[""Mutations in the FZD4, LRP5, NDP, and TSPAN12 genes have been associated with familial exudative vitreoretinopathy.""]","[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, NDP, and TSPAN12 genes.""]",[true],[true],[true],"[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, NDP, and TSPAN12 genes.""]","[""Mutations in the FZD4, LRP5, NDP, and TSPAN12 genes have been associated with familial exudative vitreoretinopathy.""]","[""Genetic changes related to FEVR include mutations in the FZD4, LRP5, NDP, and TSPAN12 genes.""]"
frequency,How many people are affected by glycogen storage disease type IV ?,"GSD IV is estimated to occur in 1 in 600,000 to 800,000 individuals worldwide. Type IV accounts for roughly 3 percent of all cases of glycogen storage disease.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""GSD IV"", ""full_form"": ""glycogen storage disease type IV""}]}",How many people are affected by GSD IV ?,How many people are affected by glycogen storage disease type IV ?,8,MEDICAL,Simple Datatype-Integer,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.",[[]],[[]],"[""Glycogen Storage Disease Type IV""]",[5.821042239488853e-21],[5.821042239488853e-21],"[""Glycogen Storage Disease Type IV""]",[5.821042239488853e-21],"[""LLM""]",[[]],[0.9462729331440551],[0.9453699113454297],"[""glycogen storage disease type IV""]",[0.9453699113454297],"[""LLM""]",[[]],"[""Glycogen Storage Disease Type IV""]","[""LLM""]",How many people are affected by GSD IV (Glycogen Storage Disease Type IV) ?,[false],[false],[false],"[""GSD IV is a rare genetic disorder, affecting approximately 1 in 100,000 to 1 in 200,000 individuals worldwide.""]","[""Glycogen storage disease type IV affects approximately 1 in 100,000 to 1 in 200,000 individuals worldwide.""]","[""GSD IV affects approximately 1 in 100,000 individuals.""]",[false],[false],[false],"[""GSD IV affects approximately 1 in 100,000 individuals.""]","[""Glycogen storage disease type IV affects approximately 1 in 100,000 individuals.""]","[""GSD IV affects approximately 1 in 100,000 individuals.""]",[false],[false],[false],"[""GSD IV is a rare genetic disorder, affecting approximately 1 in 100,000 to 1 in 200,000 individuals worldwide.""]","[""Glycogen storage disease type IV affects approximately 1 in 100,000 to 1 in 200,000 individuals worldwide.""]","[""GSD IV affects approximately 1 in 100,000 individuals.""]",[false],[false],[false],"[""GSD IV affects approximately 1 in 100,000 individuals worldwide.""]","[""Glycogen storage disease type IV affects approximately 1 in 100,000 to 1 in 200,000 individuals worldwide.""]","[""GSD IV affects approximately 1 in 100,000 individuals.""]",[false],[false],[false],"[""GSD IV affects approximately 1 in 100,000 to 1 in 200,000 individuals worldwide.""]","[""Glycogen storage disease type IV affects approximately 1 in 100,000 to 1 in 200,000 individuals worldwide.""]","[""GSD IV affects approximately 1 in 100,000 individuals.""]",[false],[false],[false],"[""GSD IV affects approximately 1 in 100,000 individuals.""]","[""Glycogen storage disease type IV affects approximately 1 in 100,000 individuals.""]","[""GSD IV affects approximately 1 in 100,000 individuals.""]",[false],[false],[false],"[""GSD IV affects approximately 1 in 100,000 individuals worldwide.""]","[""Glycogen storage disease type IV affects approximately 1 in 100,000 to 1 in 200,000 individuals worldwide.""]","[""GSD IV affects approximately 1 in 100,000 individuals.""]",[false],[false],[false],"[""GSD IV affects approximately 1 in 100,000 to 200,000 individuals worldwide.""]","[""Glycogen storage disease type IV affects approximately 1 in 100,000 to 1 in 200,000 individuals worldwide.""]","[""GSD IV affects approximately 1 in 100,000 individuals.""]",[false],[false],[false],"[""GSD IV affects approximately 1 in 100,000 individuals.""]","[""Glycogen storage disease type IV affects approximately 1 in 100,000 individuals.""]","[""GSD IV affects approximately 1 in 100,000 individuals.""]",[false],[false],[false],"[""GSD IV affects approximately 1 in 100,000 individuals.""]","[""Glycogen storage disease type IV affects approximately 1 in 100,000 to 1 in 200,000 individuals worldwide.""]","[""GSD IV affects approximately 1 in 100,000 individuals.""]",[true],[false],[false],"[""GSD IV affects approximately 1 in 800,000 to 1,000,000 individuals worldwide.""]","[""Glycogen storage disease type IV affects approximately 1 in 100,000 to 1 in 200,000 individuals worldwide.""]","[""GSD IV affects approximately 1 in 100,000 individuals.""]",[false],[false],[false],"[""GSD IV affects approximately 1 in 100,000 individuals.""]","[""Glycogen storage disease type IV affects approximately 1 in 100,000 to 1 in 200,000 individuals worldwide.""]","[""GSD IV affects approximately 1 in 100,000 individuals.""]",[true],[false],[false],"[""GSD IV affects approximately 1 in 800,000 to 1,000,000 individuals worldwide.""]","[""Glycogen storage disease type IV affects approximately 1 in 100,000 to 1 in 200,000 individuals worldwide.""]","[""GSD IV affects approximately 1 in 100,000 individuals.""]",[false],[false],[false],"[""GSD IV affects approximately 1 in 100,000 individuals.""]","[""Glycogen storage disease type IV affects approximately 1 in 100,000 individuals.""]","[""GSD IV affects approximately 1 in 100,000 individuals.""]",[false],[false],[false],"[""GSD IV affects approximately 1 in 100,000 individuals.""]","[""Glycogen storage disease type IV affects approximately 1 in 100,000 to 1 in 200,000 individuals worldwide.""]","[""GSD IV affects approximately 1 in 100,000 individuals.""]",[true],[false],[false],"[""GSD IV affects approximately 1 in 800,000 to 1,000,000 individuals worldwide.""]","[""Glycogen storage disease type IV affects approximately 1 in 100,000 to 1 in 200,000 individuals worldwide.""]","[""GSD IV affects approximately 1 in 100,000 individuals.""]",[true],[false],[false],"[""GSD IV affects approximately 1 in 800,000 to 1,000,000 individuals worldwide.""]","[""Glycogen storage disease type IV affects approximately 1 in 100,000 to 1 in 200,000 individuals worldwide.""]","[""GSD IV affects approximately 1 in 100,000 individuals.""]",[false],[false],[false],"[""GSD IV affects approximately 1 in 100,000 individuals.""]","[""Glycogen storage disease type IV affects approximately 1 in 100,000 individuals.""]","[""GSD IV affects approximately 1 in 100,000 individuals.""]",[true],[false],[false],"[""GSD IV affects approximately 1 in 800,000 to 1,000,000 individuals worldwide.""]","[""Glycogen storage disease type IV affects approximately 1 in 100,000 to 1 in 200,000 individuals worldwide.""]","[""GSD IV affects approximately 1 in 100,000 individuals.""]",[false],[false],[false],"[""GSD IV affects approximately 1 in 100,000 individuals worldwide.""]","[""Glycogen storage disease type IV affects approximately 1 in 100,000 to 1 in 200,000 individuals worldwide.""]","[""GSD IV affects approximately 1 in 100,000 individuals.""]",[false],[false],[false],"[""GSD IV affects approximately 1 in 100,000 individuals.""]","[""Glycogen storage disease type IV affects approximately 1 in 100,000 to 1 in 200,000 individuals worldwide.""]","[""GSD IV affects approximately 1 in 100,000 individuals.""]",[false],[false],[false],"[""GSD IV affects approximately 1 in 100,000 individuals.""]","[""Glycogen storage disease type IV affects approximately 1 in 100,000 individuals.""]","[""GSD IV affects approximately 1 in 100,000 individuals.""]",[false],[false],[false],"[""GSD IV is a rare disease, affecting approximately 1 in 100,000 to 1 in 200,000 individuals worldwide.""]","[""Glycogen storage disease type IV affects approximately 1 in 100,000 to 1 in 200,000 individuals worldwide.""]","[""GSD IV affects approximately 1 in 100,000 individuals.""]",[false],[false],[false],"[""GSD IV is a rare genetic disorder, affecting approximately 1 in 100,000 to 1 in 200,000 individuals worldwide.""]","[""Glycogen storage disease type IV affects approximately 1 in 100,000 to 1 in 200,000 individuals worldwide.""]","[""GSD IV affects approximately 1 in 100,000 individuals.""]",[false],[false],[false],"[""Glycogen Storage Disease Type IV is a rare genetic disorder, affecting an estimated 1 in 100,000 to 1 in 200,000 individuals worldwide.""]","[""Glycogen storage disease type IV affects approximately 1 in 100,000 to 1 in 200,000 individuals worldwide.""]","[""GSD IV affects approximately 1 in 100,000 individuals.""]",[false],[false],[false],"[""GSD IV is a rare genetic disorder, affecting approximately 1 in 100,000 to 1 in 200,000 individuals worldwide.""]","[""Glycogen storage disease type IV affects approximately 1 in 100,000 individuals.""]","[""GSD IV affects approximately 1 in 100,000 individuals.""]",[false],[false],[false],"[""Glycogen Storage Disease Type IV affects approximately 1 in 100,000 to 1 in 200,000 individuals worldwide.""]","[""Glycogen storage disease type IV affects approximately 1 in 100,000 to 1 in 200,000 individuals worldwide.""]","[""GSD IV affects approximately 1 in 100,000 individuals.""]",[true],[false],[false],"[""GSD IV is a rare genetic disorder, affecting an estimated 1 in 800,000 to 1,000,000 individuals worldwide.""]","[""Glycogen storage disease type IV affects approximately 1 in 100,000 to 1 in 200,000 individuals worldwide.""]","[""GSD IV affects approximately 1 in 100,000 individuals.""]",[false],[false],[false],"[""GSD IV affects approximately 1 in 100,000 to 1 in 200,000 individuals worldwide.""]","[""Glycogen storage disease type IV affects approximately 1 in 100,000 to 1 in 200,000 individuals worldwide.""]","[""GSD IV affects approximately 1 in 100,000 individuals.""]",[true],[false],[false],"[""GSD IV is a rare genetic disorder, affecting a small number of individuals worldwide.""]","[""Glycogen storage disease type IV affects approximately 1 in 100,000 to 1 in 200,000 individuals worldwide.""]","[""GSD IV affects approximately 1 in 100,000 individuals.""]",[true],[false],[false],"[""GSD IV is a rare genetic disorder, affecting a small number of individuals worldwide.""]","[""Glycogen storage disease type IV affects approximately 1 in 100,000 to 1 in 200,000 individuals worldwide.""]","[""GSD IV affects approximately 1 in 100,000 individuals.""]",[true],[false],[false],"[""GSD IV affects approximately 1 in 600,000 individuals worldwide.""]","[""Glycogen storage disease type IV affects approximately 1 in 100,000 to 1 in 200,000 individuals worldwide.""]","[""GSD IV affects approximately 1 in 100,000 individuals.""]"
exams and tests,How to diagnose Medium-chain acyl-coenzyme A dehydrogenase deficiency ?,"How is medium-chain acyl-coenzyme A dehydrogenase deficiency (MCADD) diagnosed? MCADD is now included in many newborn screening programs. If a newborn screening result for MCADD is not in the normal range, additional testing is recommended. A diagnosis of MCADD can be made through a blood test called a plasma acylcarnitine profile and an evaluation of organic acids in the urine. The diagnosis can also be confirmed by genetic testing.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""MCAD"", ""full_form"": ""Medium-chain acyl-coenzyme A dehydrogenase""}]}",How to diagnose MCAD deficiency ?,How to diagnose Medium-chain acyl-coenzyme A dehydrogenase deficiency ?,8,MEDICAL,Compound Datatype-String,"Instructional: Queries specifically seeking step-by-step guidance, instructions, or procedures to perform a task. it focuses on 'how' to do something rather than 'what', 'why', or 'which'.","[[""Microsoft Certified Application Developer"", ""Mechanical Computer-Aided Design"", ""Microsoft Certified Applications Developer"", ""Medium Chain Acylcoa Dehydrogenase"", ""Medium Chain Absorption Deficiency"", ""Minneapolis College of Art and Design"", ""Mechanical Computer Aided Design"", ""mechanical Computer Assisted Design"", ""Miami Center for Architecture and Design"", ""Museums and Cultural Affairs Department""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Medium-Chain Acyl-CoA Dehydrogenase""]",[2.7628871749623696e-41],[6.693422881687598e-35],"[""Medium Chain Absorption Deficiency""]",[1.8413543193607053e-16],"[""ABBREVIATIONS""]","[[2.993180166775642e-28, 7.155777909318381e-19, 2.2636952403168613e-28, 6.814321577157594e-33, 1.8413543193607053e-16, 2.867390326881172e-33, 1.9686625161954228e-17, 9.030624633432749e-17, 5.520990326759908e-26, 1.3910725514287196e-21]]",[0.9356720089410493],[0.932836764916978],"[""Museums and Cultural Affairs Department""]",[0.932836764916978],"[""LLM""]","[[0.6557905707723388, 0.856948712081636, 0.647838729006525, 0.9279498262951069, 0.9232333042323619, 0.9118672793105203, 0.8173481892635347, 0.8762566334093285, 0.9201800752018547, 0.9046549955577681]]","[""Medium Chain Acylcoa Dehydrogenase""]","[""ABBREVIATIONS""]",How to diagnose MCAD (Medium-Chain Acyl-CoA Dehydrogenase) deficiency ?,[true],[true],[true],"[""Diagnosing MCAD deficiency involves blood tests to measure levels of specific fatty acids and acylcarnitines, as well as genetic testing to identify mutations in the ACADM gene.""]","[""Diagnosing Medium-chain acyl-coenzyme A dehydrogenase deficiency involves blood tests to measure levels of acylcarnitines and genetic testing to identify mutations in the ACADM gene.""]","[""Diagnosing MCAD deficiency involves blood tests to measure levels of acylcarnitines and free carnitine, as well as genetic testing to identify mutations in the ACADM gene.""]",[true],[true],[true],"[""Diagnosing MCAD deficiency involves blood tests to measure levels of medium-chain fatty acids and acylcarnitines, genetic testing, and urine tests to detect abnormal metabolites.""]","[""Diagnosis of Medium-chain acyl-coenzyme A dehydrogenase deficiency involves blood tests to measure levels of acylcarnitines, genetic testing, and urine tests to detect specific organic acids.""]","[""Diagnosing MCAD deficiency involves blood tests to measure levels of specific fatty acids and acylcarnitines, genetic testing, and possibly a urine test to check for abnormal metabolites.""]",[true],[true],[true],"[""Diagnosing MCAD deficiency involves blood tests to measure levels of specific fatty acids and acylcarnitines, as well as genetic testing to identify mutations in the ACADM gene.""]","[""Diagnosis of Medium-chain acyl-coenzyme A dehydrogenase deficiency involves blood tests to measure levels of acylcarnitines, genetic testing, and urine tests to detect abnormal metabolites.""]","[""MCAD deficiency can be diagnosed through blood tests to measure levels of acylcarnitines and free carnitine, genetic testing to identify mutations in the ACADM gene, and urine tests to detect abnormal metabolites.""]",[true],[true],[true],"[""Diagnosing MCAD deficiency involves blood tests to measure levels of medium-chain fatty acids and acylcarnitines, genetic testing, and urine tests to detect abnormal metabolites.""]","[""Diagnosis of Medium-chain acyl-coenzyme A dehydrogenase deficiency involves blood tests to measure levels of specific fatty acids and acylcarnitines, genetic testing to identify mutations in the ACADM gene, and urine tests to detect abnormal metabolites.""]","[""Diagnosing MCAD deficiency involves blood tests to measure levels of acylcarnitines and genetic testing to identify mutations in the ACADM gene.""]",[false],[true],[true],"[""Diagnosing MCAD deficiency involves measuring the levels of tryptase in the blood during a symptomatic episode, as well as genetic testing to identify mutations in the FADH2 gene.""]","[""Diagnosing Medium-chain acyl-coenzyme A dehydrogenase deficiency involves blood tests to measure levels of acylcarnitines and genetic testing to identify mutations in the ACADM gene.""]","[""Diagnosing MCAD deficiency involves blood tests to measure levels of acylcarnitines and free carnitine, as well as genetic testing to identify mutations in the ACADM gene.""]",[false],[true],[true],"[""Diagnosing MCAD deficiency involves performing a blood test to measure levels of tryptase and histamine, along with genetic testing to identify mutations in the FAD gene.""]","[""Diagnosis of Medium-chain acyl-coenzyme A dehydrogenase deficiency involves blood tests to measure levels of acylcarnitines, genetic testing, and urine tests to detect specific organic acids.""]","[""Diagnosing MCAD deficiency involves blood tests to measure levels of specific fatty acids and acylcarnitines, genetic testing, and possibly a urine test to check for abnormal metabolites.""]",[false],[true],[true],"[""Diagnosing MCAD deficiency involves a series of blood tests to measure levels of tryptase and histamine during symptoms, along with genetic testing to identify mutations in the Fc\u03b5RI gene.""]","[""Diagnosis of Medium-chain acyl-coenzyme A dehydrogenase deficiency involves blood tests to measure levels of acylcarnitines, genetic testing, and urine tests to detect abnormal metabolites.""]","[""MCAD deficiency can be diagnosed through blood tests to measure levels of acylcarnitines and free carnitine, genetic testing to identify mutations in the ACADM gene, and urine tests to detect abnormal metabolites.""]",[true],[true],[true],"[""Diagnosing MCAD deficiency involves genetic testing, urine tests, blood tests, and consultation with a specialist.""]","[""Diagnosis of Medium-chain acyl-coenzyme A dehydrogenase deficiency involves blood tests to measure levels of specific fatty acids and acylcarnitines, genetic testing to identify mutations in the ACADM gene, and urine tests to detect abnormal metabolites.""]","[""Diagnosing MCAD deficiency involves blood tests to measure levels of acylcarnitines and genetic testing to identify mutations in the ACADM gene.""]",[true],[true],[true],"[""Diagnosing MCAD deficiency involves blood tests to measure levels of acylcarnitines and acylglycines, genetic testing to identify mutations in the ACADM gene, and urine tests to detect abnormal metabolites.""]","[""Diagnosis of Medium-chain acyl-coenzyme A dehydrogenase deficiency involves blood tests to measure levels of acylcarnitines, genetic testing, and urine tests to detect specific organic acids.""]","[""Diagnosing MCAD deficiency involves blood tests to measure levels of specific fatty acids and acylcarnitines, genetic testing, and possibly a urine test to check for abnormal metabolites.""]",[true],[true],[true],"[""Diagnosing MCAD deficiency involves blood tests to measure levels of acylcarnitines and genetic testing to identify mutations in the ACADM gene.""]","[""Diagnosing Medium-chain acyl-coenzyme A dehydrogenase deficiency involves blood tests to measure levels of acylcarnitines and genetic testing to identify mutations in the ACADM gene.""]","[""Diagnosing MCAD deficiency involves blood tests to measure levels of acylcarnitines and free carnitine, as well as genetic testing to identify mutations in the ACADM gene.""]",[true],[true],[true],"[""MCAD deficiency can be diagnosed through newborn screening, genetic testing, blood tests, and urine tests.""]","[""Diagnosis of Medium-chain acyl-coenzyme A dehydrogenase deficiency involves blood tests to measure levels of acylcarnitines, genetic testing, and urine tests to detect abnormal metabolites.""]","[""MCAD deficiency can be diagnosed through blood tests to measure levels of acylcarnitines and free carnitine, genetic testing to identify mutations in the ACADM gene, and urine tests to detect abnormal metabolites.""]",[true],[true],[true],"[""MCAD deficiency can be diagnosed through newborn screening, genetic testing, blood tests, and urine tests.""]","[""Diagnosis of Medium-chain acyl-coenzyme A dehydrogenase deficiency involves blood tests to measure levels of specific fatty acids and acylcarnitines, genetic testing to identify mutations in the ACADM gene, and urine tests to detect abnormal metabolites.""]","[""Diagnosing MCAD deficiency involves blood tests to measure levels of acylcarnitines and genetic testing to identify mutations in the ACADM gene.""]",[true],[true],[true],"[""MCAD deficiency can be diagnosed through newborn screening, genetic testing, and biochemical testing of blood and urine samples.""]","[""Diagnosing Medium-chain acyl-coenzyme A dehydrogenase deficiency involves blood tests to measure levels of acylcarnitines and genetic testing to identify mutations in the ACADM gene.""]","[""Diagnosing MCAD deficiency involves blood tests to measure levels of acylcarnitines and free carnitine, as well as genetic testing to identify mutations in the ACADM gene.""]",[true],[true],[true],"[""MCAD deficiency can be diagnosed through newborn screening, blood tests, genetic testing, and urine tests.""]","[""Diagnosis of Medium-chain acyl-coenzyme A dehydrogenase deficiency involves blood tests to measure levels of acylcarnitines, genetic testing, and urine tests to detect specific organic acids.""]","[""Diagnosing MCAD deficiency involves blood tests to measure levels of specific fatty acids and acylcarnitines, genetic testing, and possibly a urine test to check for abnormal metabolites.""]",[true],[true],[true],"[""MCAD deficiency can be diagnosed through newborn screening, genetic testing, blood tests, and urine tests.""]","[""Diagnosis of Medium-chain acyl-coenzyme A dehydrogenase deficiency involves blood tests to measure levels of acylcarnitines, genetic testing, and urine tests to detect abnormal metabolites.""]","[""MCAD deficiency can be diagnosed through blood tests to measure levels of acylcarnitines and free carnitine, genetic testing to identify mutations in the ACADM gene, and urine tests to detect abnormal metabolites.""]",[true],[true],[true],"[""MCAD deficiency can be diagnosed through newborn screening, genetic testing, blood tests, and urine tests.""]","[""Diagnosis of Medium-chain acyl-coenzyme A dehydrogenase deficiency involves blood tests to measure levels of specific fatty acids and acylcarnitines, genetic testing to identify mutations in the ACADM gene, and urine tests to detect abnormal metabolites.""]","[""Diagnosing MCAD deficiency involves blood tests to measure levels of acylcarnitines and genetic testing to identify mutations in the ACADM gene.""]",[true],[true],[true],"[""Diagnosing MCAD deficiency involves blood tests to measure levels of acylcarnitines, genetic testing to identify mutations in the ACADM gene, and urine tests to detect abnormal metabolites.""]","[""Diagnosing Medium-chain acyl-coenzyme A dehydrogenase deficiency involves blood tests to measure levels of acylcarnitines and genetic testing to identify mutations in the ACADM gene.""]","[""Diagnosing MCAD deficiency involves blood tests to measure levels of acylcarnitines and free carnitine, as well as genetic testing to identify mutations in the ACADM gene.""]",[true],[true],[true],"[""Diagnosing MCAD deficiency involves blood tests to measure levels of acylcarnitines, genetic testing to identify mutations in the ACADM gene, and urine tests to detect abnormal metabolites.""]","[""Diagnosis of Medium-chain acyl-coenzyme A dehydrogenase deficiency involves blood tests to measure levels of acylcarnitines, genetic testing, and urine tests to detect specific organic acids.""]","[""Diagnosing MCAD deficiency involves blood tests to measure levels of specific fatty acids and acylcarnitines, genetic testing, and possibly a urine test to check for abnormal metabolites.""]",[true],[true],[true],"[""Diagnosing MCAD deficiency involves blood tests to measure levels of acylcarnitines and genetic testing to identify mutations in the ACADM gene.""]","[""Diagnosis of Medium-chain acyl-coenzyme A dehydrogenase deficiency involves blood tests to measure levels of acylcarnitines, genetic testing, and urine tests to detect abnormal metabolites.""]","[""MCAD deficiency can be diagnosed through blood tests to measure levels of acylcarnitines and free carnitine, genetic testing to identify mutations in the ACADM gene, and urine tests to detect abnormal metabolites.""]",[true],[true],[true],"[""Diagnosing MCAD deficiency involves blood tests to measure levels of acylcarnitines and genetic testing to identify mutations in the ACADM gene.""]","[""Diagnosis of Medium-chain acyl-coenzyme A dehydrogenase deficiency involves blood tests to measure levels of specific fatty acids and acylcarnitines, genetic testing to identify mutations in the ACADM gene, and urine tests to detect abnormal metabolites.""]","[""Diagnosing MCAD deficiency involves blood tests to measure levels of acylcarnitines and genetic testing to identify mutations in the ACADM gene.""]",[true],[true],[true],"[""Diagnosing MCAD deficiency involves blood tests to measure levels of acylcarnitines and genetic testing to identify mutations in the ACADM gene.""]","[""Diagnosing Medium-chain acyl-coenzyme A dehydrogenase deficiency involves blood tests to measure levels of acylcarnitines and genetic testing to identify mutations in the ACADM gene.""]","[""Diagnosing MCAD deficiency involves blood tests to measure levels of acylcarnitines and free carnitine, as well as genetic testing to identify mutations in the ACADM gene.""]",[true],[true],[true],"[""Diagnosing MCAD deficiency involves blood tests to measure levels of acylcarnitines and genetic testing to identify mutations in the ACADM gene.""]","[""Diagnosis of Medium-chain acyl-coenzyme A dehydrogenase deficiency involves blood tests to measure levels of acylcarnitines, genetic testing, and urine tests to detect specific organic acids.""]","[""Diagnosing MCAD deficiency involves blood tests to measure levels of specific fatty acids and acylcarnitines, genetic testing, and possibly a urine test to check for abnormal metabolites.""]",[true],[true],[true],"[""Diagnosing MCAD deficiency involves blood tests to measure levels of acylcarnitines and genetic testing to identify mutations in the ACADM gene.""]","[""Diagnosis of Medium-chain acyl-coenzyme A dehydrogenase deficiency involves blood tests to measure levels of acylcarnitines, genetic testing, and urine tests to detect abnormal metabolites.""]","[""MCAD deficiency can be diagnosed through blood tests to measure levels of acylcarnitines and free carnitine, genetic testing to identify mutations in the ACADM gene, and urine tests to detect abnormal metabolites.""]",[true],[true],[true],"[""Diagnosing MCAD deficiency involves blood tests to measure levels of acylcarnitines and genetic testing to identify mutations in the ACADM gene.""]","[""Diagnosis of Medium-chain acyl-coenzyme A dehydrogenase deficiency involves blood tests to measure levels of specific fatty acids and acylcarnitines, genetic testing to identify mutations in the ACADM gene, and urine tests to detect abnormal metabolites.""]","[""Diagnosing MCAD deficiency involves blood tests to measure levels of acylcarnitines and genetic testing to identify mutations in the ACADM gene.""]",[true],[true],[true],"[""Diagnosing MCAD deficiency involves blood tests to measure levels of acylcarnitines and genetic testing to identify mutations in the ACADM gene.""]","[""Diagnosing Medium-chain acyl-coenzyme A dehydrogenase deficiency involves blood tests to measure levels of acylcarnitines and genetic testing to identify mutations in the ACADM gene.""]","[""Diagnosing MCAD deficiency involves blood tests to measure levels of acylcarnitines and free carnitine, as well as genetic testing to identify mutations in the ACADM gene.""]",[true],[true],[true],"[""Diagnosing MCAD deficiency involves blood tests to measure levels of acylcarnitines and genetic testing to identify mutations in the ACADM gene.""]","[""Diagnosis of Medium-chain acyl-coenzyme A dehydrogenase deficiency involves blood tests to measure levels of acylcarnitines, genetic testing, and urine tests to detect specific organic acids.""]","[""Diagnosing MCAD deficiency involves blood tests to measure levels of specific fatty acids and acylcarnitines, genetic testing, and possibly a urine test to check for abnormal metabolites.""]",[true],[true],[true],"[""Diagnosing MCAD deficiency involves blood tests to measure levels of acylcarnitines, genetic testing, and possibly a urine test to check for specific organic acids.""]","[""Diagnosis of Medium-chain acyl-coenzyme A dehydrogenase deficiency involves blood tests to measure levels of acylcarnitines, genetic testing, and urine tests to detect abnormal metabolites.""]","[""MCAD deficiency can be diagnosed through blood tests to measure levels of acylcarnitines and free carnitine, genetic testing to identify mutations in the ACADM gene, and urine tests to detect abnormal metabolites.""]",[true],[true],[true],"[""Diagnosing MCAD deficiency involves blood tests to measure levels of acylcarnitines and genetic testing to identify mutations in the ACADM gene.""]","[""Diagnosis of Medium-chain acyl-coenzyme A dehydrogenase deficiency involves blood tests to measure levels of specific fatty acids and acylcarnitines, genetic testing to identify mutations in the ACADM gene, and urine tests to detect abnormal metabolites.""]","[""Diagnosing MCAD deficiency involves blood tests to measure levels of acylcarnitines and genetic testing to identify mutations in the ACADM gene.""]",[true],[true],[true],"[""Diagnosis of MCAD deficiency is typically done through newborn screening, blood tests to measure levels of acylcarnitines and genetic testing to confirm the diagnosis.""]","[""Diagnosing Medium-chain acyl-coenzyme A dehydrogenase deficiency involves blood tests to measure levels of acylcarnitines and genetic testing to identify mutations in the ACADM gene.""]","[""Diagnosing MCAD deficiency involves blood tests to measure levels of acylcarnitines and free carnitine, as well as genetic testing to identify mutations in the ACADM gene.""]",[false],[true],[true],"[""Diagnosing MCAD deficiency involves blood tests to measure levels of specific fatty acids and acylcarnitines, genetic testing, and sometimes a liver biopsy.""]","[""Diagnosing Medium-chain acyl-coenzyme A dehydrogenase deficiency involves blood tests to measure levels of acylcarnitines and genetic testing to identify mutations in the ACADM gene.""]","[""Diagnosing MCAD deficiency involves blood tests to measure levels of acylcarnitines and free carnitine, as well as genetic testing to identify mutations in the ACADM gene.""]",[false],[true],[true],"[""Consult a medical professional for proper diagnosis and treatment.""]","[""Diagnosing Medium-chain acyl-coenzyme A dehydrogenase deficiency involves blood tests to measure levels of acylcarnitines and genetic testing to identify mutations in the ACADM gene.""]","[""Diagnosing MCAD deficiency involves blood tests to measure levels of acylcarnitines and free carnitine, as well as genetic testing to identify mutations in the ACADM gene.""]",[false],[true],[true],"[""Diagnosing MCAD deficiency involves blood tests to measure levels of specific fatty acids and acylcarnitines, genetic testing, and sometimes a muscle biopsy.""]","[""Diagnosing Medium-chain acyl-coenzyme A dehydrogenase deficiency involves blood tests to measure levels of acylcarnitines and genetic testing to identify mutations in the ACADM gene.""]","[""Diagnosing MCAD deficiency involves blood tests to measure levels of acylcarnitines and free carnitine, as well as genetic testing to identify mutations in the ACADM gene.""]"
treatment,What are the treatments for Lafora progressive myoclonus epilepsy ?,"These resources address the diagnosis or management of Lafora progressive myoclonus epilepsy:  - Gene Review: Gene Review: Progressive Myoclonus Epilepsy, Lafora Type  - Genetic Testing Registry: Lafora disease  - MedlinePlus Encyclopedia: Epilepsy  - MedlinePlus Encyclopedia:Generalized Tonic-Clonic Seizure   These resources from MedlinePlus offer information about the diagnosis and management of various health conditions:  - Diagnostic Tests  - Drug Therapy  - Surgery and Rehabilitation  - Genetic Counseling   - Palliative Care","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""Lafora"", ""full_form"": ""Lafora progressive myoclonus epilepsy""}]}",What are the treatments for Lafora ?,What are the treatments for Lafora progressive myoclonus epilepsy ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.",[[]],[[]],"[""Lafora Disease""]",[9.690537015570658e-21],[8.49173712796769e-09],"[""Lafora Disease""]",[8.49173712796769e-09],"[""LLM""]",[[]],[0.9499574154120594],[0.9660615238859347],"[""Lafora progressive myoclonus epilepsy""]",[0.9660615238859347],"[""LLM""]",[[]],"[""Lafora Disease""]","[""LLM""]",What are the treatments for Lafora (Lafora Disease) ?,[true],[true],[true],"[""The treatments for Lafora disease focus on managing symptoms and may include antiepileptic drugs, physical therapy, and dietary modifications.""]","[""The treatments for Lafora progressive myoclonus epilepsy include anti-seizure medications, ketogenic diet, and management of symptoms such as myoclonus and cognitive decline.""]","[""There is currently no cure for Lafora disease. Treatment focuses on managing symptoms and improving quality of life.""]",[true],[true],[true],"[""There is currently no cure for Lafora disease. Treatment focuses on managing symptoms and improving quality of life. This may include medications to control seizures, physical therapy, and dietary modifications.""]","[""There is no cure for Lafora progressive myoclonus epilepsy, but treatment focuses on managing symptoms with anti-seizure medications and supportive care.""]","[""The treatments for Lafora disease include antiepileptic drugs to control seizures and physical therapy to manage symptoms.""]",[true],[true],[true],"[""There is no cure for Lafora disease. Treatment focuses on managing symptoms and improving quality of life.""]","[""The treatments for Lafora progressive myoclonus epilepsy include anti-seizure medications, ketogenic diet, and supportive care for symptoms.""]","[""There is no cure for Lafora disease, but treatment focuses on managing symptoms and improving quality of life. This may include medications to control seizures, physical therapy, and dietary modifications.""]",[true],[true],[true],"[""There is no cure for Lafora disease, but treatment focuses on managing symptoms and improving quality of life. This may include medications to control seizures, physical therapy, and dietary modifications.""]","[""There is currently no cure for Lafora progressive myoclonus epilepsy. Treatment focuses on managing symptoms and improving quality of life through medications to control seizures and other symptoms.""]","[""There is no cure for Lafora disease, but treatment focuses on managing symptoms and improving quality of life. This may include medications to control seizures, physical therapy, and dietary modifications.""]",[true],[true],[true],"[""The treatments for Lafora progressive myoclonus epilepsy include anti-seizure medications, ketogenic diet, and management of symptoms such as myoclonus and cognitive decline.""]","[""The treatments for Lafora progressive myoclonus epilepsy include anti-seizure medications, ketogenic diet, and management of symptoms such as myoclonus and cognitive decline.""]","[""There is currently no cure for Lafora disease. Treatment focuses on managing symptoms and improving quality of life.""]",[true],[true],[true],"[""The treatments for Lafora progressive myoclonus epilepsy include anti-seizure medications, dietary therapy, and supportive care to manage symptoms.""]","[""There is no cure for Lafora progressive myoclonus epilepsy, but treatment focuses on managing symptoms with anti-seizure medications and supportive care.""]","[""The treatments for Lafora disease include antiepileptic drugs to control seizures and physical therapy to manage symptoms.""]",[true],[true],[true],"[""The treatments for Lafora progressive myoclonus epilepsy include anti-seizure medications to control seizures, physical therapy to manage movement difficulties, and dietary modifications to help with symptoms.""]","[""The treatments for Lafora progressive myoclonus epilepsy include anti-seizure medications, ketogenic diet, and supportive care for symptoms.""]","[""There is no cure for Lafora disease, but treatment focuses on managing symptoms and improving quality of life. This may include medications to control seizures, physical therapy, and dietary modifications.""]",[true],[true],[true],"[""The treatments for Lafora progressive myoclonus epilepsy include anti-seizure medications to control seizures, physical therapy to manage movement difficulties, and dietary modifications to help with symptoms.""]","[""There is currently no cure for Lafora progressive myoclonus epilepsy. Treatment focuses on managing symptoms and improving quality of life through medications to control seizures and other symptoms.""]","[""There is no cure for Lafora disease, but treatment focuses on managing symptoms and improving quality of life. This may include medications to control seizures, physical therapy, and dietary modifications.""]",[true],[true],[true],"[""The treatments for Lafora disease focus on managing symptoms and may include antiepileptic medications to control seizures, physical therapy to improve mobility, and dietary modifications to help manage symptoms.""]","[""There is no cure for Lafora progressive myoclonus epilepsy, but treatment focuses on managing symptoms with anti-seizure medications and supportive care.""]","[""The treatments for Lafora disease include antiepileptic drugs to control seizures and physical therapy to manage symptoms.""]",[true],[true],[true],"[""The treatments for Lafora disease focus on managing symptoms and may include antiepileptic medications, physical therapy, and dietary modifications.""]","[""The treatments for Lafora progressive myoclonus epilepsy include anti-seizure medications, ketogenic diet, and management of symptoms such as myoclonus and cognitive decline.""]","[""There is currently no cure for Lafora disease. Treatment focuses on managing symptoms and improving quality of life.""]",[true],[true],[true],"[""There is currently no cure for Lafora disease. Treatment focuses on managing symptoms and improving quality of life through medications and supportive care.""]","[""The treatments for Lafora progressive myoclonus epilepsy include anti-seizure medications, ketogenic diet, and supportive care for symptoms.""]","[""There is no cure for Lafora disease, but treatment focuses on managing symptoms and improving quality of life. This may include medications to control seizures, physical therapy, and dietary modifications.""]",[true],[true],[true],"[""There is currently no cure for Lafora disease. Treatment focuses on managing symptoms and improving quality of life. This may include medications to control seizures, physical therapy, and dietary modifications.""]","[""There is currently no cure for Lafora progressive myoclonus epilepsy. Treatment focuses on managing symptoms and improving quality of life through medications to control seizures and other symptoms.""]","[""There is no cure for Lafora disease, but treatment focuses on managing symptoms and improving quality of life. This may include medications to control seizures, physical therapy, and dietary modifications.""]",[true],[true],[true],"[""Anti-seizure medications, physical therapy, and dietary management""]","[""The treatments for Lafora progressive myoclonus epilepsy include anti-seizure medications, ketogenic diet, and management of symptoms such as myoclonus and cognitive decline.""]","[""There is currently no cure for Lafora disease. Treatment focuses on managing symptoms and improving quality of life.""]",[true],[true],[true],"[""There is no cure for Lafora disease. Treatment focuses on managing symptoms and improving quality of life. This may include medications to control seizures, physical therapy, and dietary modifications.""]","[""There is no cure for Lafora progressive myoclonus epilepsy, but treatment focuses on managing symptoms with anti-seizure medications and supportive care.""]","[""The treatments for Lafora disease include antiepileptic drugs to control seizures and physical therapy to manage symptoms.""]",[true],[true],[true],"[""There is currently no cure for Lafora disease. Treatment focuses on managing symptoms and improving quality of life. This may include antiepileptic medications to control seizures, physical therapy, occupational therapy, and speech therapy.""]","[""The treatments for Lafora progressive myoclonus epilepsy include anti-seizure medications, ketogenic diet, and supportive care for symptoms.""]","[""There is no cure for Lafora disease, but treatment focuses on managing symptoms and improving quality of life. This may include medications to control seizures, physical therapy, and dietary modifications.""]",[true],[true],[true],"[""There is currently no cure for Lafora disease. Treatment focuses on managing symptoms and improving quality of life. This may include medications to control seizures, physical therapy, and dietary modifications.""]","[""There is currently no cure for Lafora progressive myoclonus epilepsy. Treatment focuses on managing symptoms and improving quality of life through medications to control seizures and other symptoms.""]","[""There is no cure for Lafora disease, but treatment focuses on managing symptoms and improving quality of life. This may include medications to control seizures, physical therapy, and dietary modifications.""]",[true],[true],[true],"[""There is currently no cure for Lafora disease. Treatment focuses on managing symptoms and improving quality of life. This may include medications to control seizures, physical therapy, and dietary modifications.""]","[""The treatments for Lafora progressive myoclonus epilepsy include anti-seizure medications, ketogenic diet, and management of symptoms such as myoclonus and cognitive decline.""]","[""There is currently no cure for Lafora disease. Treatment focuses on managing symptoms and improving quality of life.""]",[true],[true],[true],"[""There is no cure for Lafora disease, but treatment focuses on managing symptoms and improving quality of life. This may include antiepileptic medications to control seizures, physical therapy, occupational therapy, and speech therapy.""]","[""There is no cure for Lafora progressive myoclonus epilepsy, but treatment focuses on managing symptoms with anti-seizure medications and supportive care.""]","[""The treatments for Lafora disease include antiepileptic drugs to control seizures and physical therapy to manage symptoms.""]",[true],[true],[true],"[""The treatments for Lafora disease focus on managing symptoms and may include antiepileptic medications, physical therapy, and dietary modifications.""]","[""The treatments for Lafora progressive myoclonus epilepsy include anti-seizure medications, ketogenic diet, and supportive care for symptoms.""]","[""There is no cure for Lafora disease, but treatment focuses on managing symptoms and improving quality of life. This may include medications to control seizures, physical therapy, and dietary modifications.""]",[true],[true],[true],"[""The treatments for Lafora disease focus on managing symptoms and may include antiepileptic medications, physical therapy, and dietary modifications.""]","[""There is currently no cure for Lafora progressive myoclonus epilepsy. Treatment focuses on managing symptoms and improving quality of life through medications to control seizures and other symptoms.""]","[""There is no cure for Lafora disease, but treatment focuses on managing symptoms and improving quality of life. This may include medications to control seizures, physical therapy, and dietary modifications.""]",[true],[true],[true],"[""The treatments for Lafora Disease include management of symptoms with medications, such as antiepileptic drugs, physical therapy, and dietary modifications.""]","[""The treatments for Lafora progressive myoclonus epilepsy include anti-seizure medications, ketogenic diet, and management of symptoms such as myoclonus and cognitive decline.""]","[""There is currently no cure for Lafora disease. Treatment focuses on managing symptoms and improving quality of life.""]",[true],[true],[true],"[""The treatments for Lafora Disease include managing symptoms with medications, such as anti-seizure drugs, physical therapy, and dietary modifications.""]","[""There is no cure for Lafora progressive myoclonus epilepsy, but treatment focuses on managing symptoms with anti-seizure medications and supportive care.""]","[""The treatments for Lafora disease include antiepileptic drugs to control seizures and physical therapy to manage symptoms.""]",[true],[true],[true],"[""There is currently no cure for Lafora disease. Treatment focuses on managing symptoms and improving quality of life. This may include medications to control seizures, physical therapy, and dietary modifications.""]","[""The treatments for Lafora progressive myoclonus epilepsy include anti-seizure medications, ketogenic diet, and supportive care for symptoms.""]","[""There is no cure for Lafora disease, but treatment focuses on managing symptoms and improving quality of life. This may include medications to control seizures, physical therapy, and dietary modifications.""]",[true],[true],[true],"[""There is currently no cure for Lafora disease. Treatment focuses on managing symptoms and improving quality of life. This may include medications to control seizures, physical therapy, and dietary modifications.""]","[""There is currently no cure for Lafora progressive myoclonus epilepsy. Treatment focuses on managing symptoms and improving quality of life through medications to control seizures and other symptoms.""]","[""There is no cure for Lafora disease, but treatment focuses on managing symptoms and improving quality of life. This may include medications to control seizures, physical therapy, and dietary modifications.""]",[true],[true],[true],"[""There is currently no cure for Lafora Disease. Treatment focuses on managing symptoms and improving quality of life through medications and supportive care.""]","[""The treatments for Lafora progressive myoclonus epilepsy include anti-seizure medications, ketogenic diet, and management of symptoms such as myoclonus and cognitive decline.""]","[""There is currently no cure for Lafora disease. Treatment focuses on managing symptoms and improving quality of life.""]",[true],[true],[true],"[""There is currently no cure for Lafora disease. Treatment focuses on managing symptoms and improving quality of life through medications and supportive care.""]","[""There is no cure for Lafora progressive myoclonus epilepsy, but treatment focuses on managing symptoms with anti-seizure medications and supportive care.""]","[""The treatments for Lafora disease include antiepileptic drugs to control seizures and physical therapy to manage symptoms.""]",[true],[true],[true],"[""There is currently no cure for Lafora disease. Treatment focuses on managing symptoms and improving quality of life through medications and supportive care.""]","[""The treatments for Lafora progressive myoclonus epilepsy include anti-seizure medications, ketogenic diet, and supportive care for symptoms.""]","[""There is no cure for Lafora disease, but treatment focuses on managing symptoms and improving quality of life. This may include medications to control seizures, physical therapy, and dietary modifications.""]",[true],[true],[true],"[""Currently, there is no cure for Lafora disease. Treatment focuses on managing symptoms and improving quality of life. This may include medications to control seizures, physical therapy, and dietary modifications.""]","[""There is currently no cure for Lafora progressive myoclonus epilepsy. Treatment focuses on managing symptoms and improving quality of life through medications to control seizures and other symptoms.""]","[""There is no cure for Lafora disease, but treatment focuses on managing symptoms and improving quality of life. This may include medications to control seizures, physical therapy, and dietary modifications.""]",[true],[true],[true],"[""There is currently no cure for Lafora disease. Treatment focuses on managing symptoms and improving quality of life.""]","[""The treatments for Lafora progressive myoclonus epilepsy include anti-seizure medications, ketogenic diet, and management of symptoms such as myoclonus and cognitive decline.""]","[""There is currently no cure for Lafora disease. Treatment focuses on managing symptoms and improving quality of life.""]",[true],[true],[true],"[""There is currently no cure for Lafora Disease. Treatment focuses on managing symptoms and improving quality of life.""]","[""The treatments for Lafora progressive myoclonus epilepsy include anti-seizure medications, ketogenic diet, and management of symptoms such as myoclonus and cognitive decline.""]","[""There is currently no cure for Lafora disease. Treatment focuses on managing symptoms and improving quality of life.""]",[true],[true],[true],"[""There is currently no cure for Lafora disease. Treatment focuses on managing symptoms and improving quality of life through medications and supportive care.""]","[""The treatments for Lafora progressive myoclonus epilepsy include anti-seizure medications, ketogenic diet, and management of symptoms such as myoclonus and cognitive decline.""]","[""There is currently no cure for Lafora disease. Treatment focuses on managing symptoms and improving quality of life.""]",[true],[true],[true],"[""There is currently no cure for Lafora disease. Treatment focuses on managing symptoms and improving quality of life.""]","[""The treatments for Lafora progressive myoclonus epilepsy include anti-seizure medications, ketogenic diet, and management of symptoms such as myoclonus and cognitive decline.""]","[""There is currently no cure for Lafora disease. Treatment focuses on managing symptoms and improving quality of life.""]"
outlook,What is the outlook for Congenital Myopathy ?,"When breathing difficulties are severe, and particularly if there is also a problem with feeding and swallowing, infants may die of respiratory failure or complications such as pneumonia. Sometimes muscle weakness can lead to skeletal problems, such as scoliosis, reduced mobility of joints, or hip problems. The heart muscle is rarely involved.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""CM"", ""full_form"": ""Congenital Myopathy""}]}",What is the outlook for CM ?,What is the outlook for Congenital Myopathy ?,3,BUSINESS,Simple Datatype-String,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Chemical"", ""Cameroon"", ""CentiMeter"", ""Content Management"", ""Call Me"", ""Center of Mass"", ""Configuration Management"", ""Changes Made"", ""Chief Minister"", ""Championship Manager""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Configuration Management""]",[3.0697683039284525e-09],[1.515547018039461e-09],"[""Chemical""]",[8.7226485686412e-06],"[""ABBREVIATIONS""]","[[8.7226485686412e-06, 1.5537873138883114e-12, 1.1219510710846265e-06, 1.4592808367728872e-08, 2.0404431174385284e-06, 2.8121893420070943e-08, 1.515547018039461e-09, 2.6047927201594585e-06, 7.079137277948647e-10, 3.669507791451095e-11]]",[0.7485477821175857],[0.7128444686823934],"[""Configuration Management""]",[0.8182398922830358],"[""ABBREVIATIONS""]","[[0.7900215441879554, 0.7635336160455863, 0.7736823213209345, 0.7251356973084018, 0.8089806612565293, 0.7712353795111365, 0.7128444686823934, 0.8182398922830358, 0.7606664256534954, 0.6940621261956887]]","[""Configuration Management""]","[""LLM""]",What is the outlook for CM (Configuration Management) ?,[false],[true],[false],"[""The outlook for CM (Chemical) is positive due to increasing demand in various industries such as manufacturing, agriculture, and healthcare.""]","[""The outlook for Congenital Myopathy varies depending on the specific type and severity of the condition. It can range from mild symptoms with a normal lifespan to severe muscle weakness and potential complications. Regular medical monitoring and management can help improve quality of life for individuals with Congenital Myopathy.""]","[""The outlook for CM is positive.""]",[false],[true],[false],"[""The outlook for CM (Chemical) is positive due to increasing demand in various industries and advancements in technology.""]","[""The outlook for Congenital Myopathy varies depending on the specific type and severity of the condition. It can range from mild symptoms to more severe cases that may impact quality of life. It is important for individuals with Congenital Myopathy to work closely with healthcare providers to manage symptoms and optimize quality of life.""]","[""The outlook for CM is positive.""]",[false],[true],[false],"[""The outlook for CM (Chemical) is positive due to increasing demand in various industries such as manufacturing, agriculture, and healthcare.""]","[""The outlook for Congenital Myopathy varies depending on the specific type and severity of the condition. It is a lifelong condition that may require ongoing medical management and therapy to help manage symptoms and improve quality of life.""]","[""The outlook for CM is positive.""]",[false],[true],[false],"[""The outlook for CM (Chemical) is positive due to increasing demand in various industries such as manufacturing, agriculture, and healthcare.""]","[""The outlook for Congenital Myopathy varies depending on the specific type and severity of the condition. It is recommended to consult with a healthcare professional for personalized information and guidance.""]","[""The outlook for CM is positive.""]",[false],[true],[false],"[""The outlook for Configuration Management (CM) is positive, with an increasing focus on automation, cloud integration, and DevOps practices.""]","[""The outlook for Congenital Myopathy varies depending on the specific type and severity of the condition. It can range from mild symptoms with a normal lifespan to severe muscle weakness and potential complications. Regular medical monitoring and management can help improve quality of life for individuals with Congenital Myopathy.""]","[""The outlook for CM is positive.""]",[false],[true],[false],"[""The outlook for Configuration Management (CM) is positive, with the increasing adoption of DevOps practices and automation tools in software development and IT operations.""]","[""The outlook for Congenital Myopathy varies depending on the specific type and severity of the condition. It can range from mild symptoms to more severe cases that may impact quality of life. It is important for individuals with Congenital Myopathy to work closely with healthcare providers to manage symptoms and optimize quality of life.""]","[""The outlook for CM is positive.""]",[false],[true],[false],"[""The outlook for Configuration Management (CM) is positive as organizations continue to prioritize efficient and effective management of their IT infrastructure and resources.""]","[""The outlook for Congenital Myopathy varies depending on the specific type and severity of the condition. It is a lifelong condition that may require ongoing medical management and therapy to help manage symptoms and improve quality of life.""]","[""The outlook for CM is positive.""]",[false],[true],[false],"[""The outlook for Configuration Management (CM) is positive, with an increasing focus on automation, cloud integration, and DevOps practices.""]","[""The outlook for Congenital Myopathy varies depending on the specific type and severity of the condition. It is recommended to consult with a healthcare professional for personalized information and guidance.""]","[""The outlook for CM is positive.""]",[false],[true],[false],"[""The outlook for Configuration Management (CM) is positive as organizations continue to prioritize efficient and effective management of their IT infrastructure and resources.""]","[""The outlook for Congenital Myopathy varies depending on the specific type and severity of the condition. It can range from mild symptoms to more severe cases that may impact quality of life. It is important for individuals with Congenital Myopathy to work closely with healthcare providers to manage symptoms and optimize quality of life.""]","[""The outlook for CM is positive.""]",[false],[true],[false],"[""The outlook for Configuration Management (CM) is positive, with the increasing adoption of DevOps practices and automation tools in software development.""]","[""The outlook for Congenital Myopathy varies depending on the specific type and severity of the condition. It can range from mild symptoms with a normal lifespan to severe muscle weakness and potential complications. Regular medical monitoring and management can help improve quality of life for individuals with Congenital Myopathy.""]","[""The outlook for CM is positive.""]",[false],[true],[false],"[""The outlook for Configuration Management (CM) is positive, with an increasing focus on automation, cloud integration, and DevOps practices.""]","[""The outlook for Congenital Myopathy varies depending on the specific type and severity of the condition. It is a lifelong condition that may require ongoing medical management and therapy to help manage symptoms and improve quality of life.""]","[""The outlook for CM is positive.""]",[false],[true],[false],"[""The outlook for Configuration Management (CM) is positive, with an increasing focus on automation, cloud integration, and DevOps practices.""]","[""The outlook for Congenital Myopathy varies depending on the specific type and severity of the condition. It is recommended to consult with a healthcare professional for personalized information and guidance.""]","[""The outlook for CM is positive.""]",[false],[true],[false],"[""The outlook for Configuration Management (CM) is positive, with increasing adoption by organizations to streamline and automate their IT infrastructure management processes.""]","[""The outlook for Congenital Myopathy varies depending on the specific type and severity of the condition. It can range from mild symptoms with a normal lifespan to severe muscle weakness and potential complications. Regular medical monitoring and management can help improve quality of life for individuals with Congenital Myopathy.""]","[""The outlook for CM is positive.""]",[false],[true],[false],"[""The outlook for Configuration Management (CM) is positive, with increasing adoption by organizations to streamline their IT infrastructure and ensure efficient management of software configurations.""]","[""The outlook for Congenital Myopathy varies depending on the specific type and severity of the condition. It can range from mild symptoms to more severe cases that may impact quality of life. It is important for individuals with Congenital Myopathy to work closely with healthcare providers to manage symptoms and optimize quality of life.""]","[""The outlook for CM is positive.""]",[false],[true],[false],"[""The outlook for Configuration Management (CM) is positive, with an increasing focus on automation and integration with other IT processes.""]","[""The outlook for Congenital Myopathy varies depending on the specific type and severity of the condition. It is a lifelong condition that may require ongoing medical management and therapy to help manage symptoms and improve quality of life.""]","[""The outlook for CM is positive.""]",[false],[true],[false],"[""The outlook for CM (Configuration Management) is positive as organizations continue to prioritize efficient and effective management of their IT infrastructure.""]","[""The outlook for Congenital Myopathy varies depending on the specific type and severity of the condition. It is recommended to consult with a healthcare professional for personalized information and guidance.""]","[""The outlook for CM is positive.""]",[false],[true],[false],"[""The outlook for Configuration Management (CM) is positive, with increasing adoption in various industries to streamline processes and ensure consistency in IT environments.""]","[""The outlook for Congenital Myopathy varies depending on the specific type and severity of the condition. It can range from mild symptoms with a normal lifespan to severe muscle weakness and potential complications. Regular medical monitoring and management can help improve quality of life for individuals with Congenital Myopathy.""]","[""The outlook for CM is positive.""]",[false],[true],[false],"[""The outlook for Configuration Management (CM) is positive, with an increasing focus on automation, cloud integration, and DevOps practices.""]","[""The outlook for Congenital Myopathy varies depending on the specific type and severity of the condition. It can range from mild symptoms to more severe cases that may impact quality of life. It is important for individuals with Congenital Myopathy to work closely with healthcare providers to manage symptoms and optimize quality of life.""]","[""The outlook for CM is positive.""]",[false],[true],[false],"[""The outlook for Configuration Management (CM) is positive, with an increasing focus on automation, cloud-based solutions, and integration with DevOps practices.""]","[""The outlook for Congenital Myopathy varies depending on the specific type and severity of the condition. It is a lifelong condition that may require ongoing medical management and therapy to help manage symptoms and improve quality of life.""]","[""The outlook for CM is positive.""]",[false],[true],[false],"[""The outlook for Configuration Management (CM) is positive, with an increasing focus on automation, cloud integration, and DevOps practices.""]","[""The outlook for Congenital Myopathy varies depending on the specific type and severity of the condition. It is recommended to consult with a healthcare professional for personalized information and guidance.""]","[""The outlook for CM is positive.""]",[false],[true],[false],"[""The outlook for Configuration Management (CM) is positive, with an increasing focus on automation, cloud integration, and DevOps practices.""]","[""The outlook for Congenital Myopathy varies depending on the specific type and severity of the condition. It can range from mild symptoms with a normal lifespan to severe muscle weakness and potential complications. Regular medical monitoring and management can help improve quality of life for individuals with Congenital Myopathy.""]","[""The outlook for CM is positive.""]",[false],[true],[false],"[""The outlook for Configuration Management (CM) is positive as organizations continue to prioritize efficient and effective management of their IT infrastructure and resources.""]","[""The outlook for Congenital Myopathy varies depending on the specific type and severity of the condition. It can range from mild symptoms to more severe cases that may impact quality of life. It is important for individuals with Congenital Myopathy to work closely with healthcare providers to manage symptoms and optimize quality of life.""]","[""The outlook for CM is positive.""]",[false],[true],[false],"[""The outlook for Configuration Management (CM) is positive, with an increasing focus on automation, cloud integration, and DevOps practices.""]","[""The outlook for Congenital Myopathy varies depending on the specific type and severity of the condition. It is a lifelong condition that may require ongoing medical management and therapy to help manage symptoms and improve quality of life.""]","[""The outlook for CM is positive.""]",[false],[true],[false],"[""The outlook for Configuration Management (CM) is positive, with an increasing focus on automation, cloud integration, and DevOps practices.""]","[""The outlook for Congenital Myopathy varies depending on the specific type and severity of the condition. It is recommended to consult with a healthcare professional for personalized information and guidance.""]","[""The outlook for CM is positive.""]",[false],[true],[false],"[""The outlook for Configuration Management (CM) is positive, with increasing adoption in organizations to streamline processes and ensure consistency in IT environments.""]","[""The outlook for Congenital Myopathy varies depending on the specific type and severity of the condition. It can range from mild symptoms with a normal lifespan to severe muscle weakness and potential complications. Regular medical monitoring and management can help improve quality of life for individuals with Congenital Myopathy.""]","[""The outlook for CM is positive.""]",[false],[true],[false],"[""The outlook for Configuration Management (CM) is positive, with increasing adoption in various industries to streamline processes and ensure consistency in IT environments.""]","[""The outlook for Congenital Myopathy varies depending on the specific type and severity of the condition. It can range from mild symptoms to more severe cases that may impact quality of life. It is important for individuals with Congenital Myopathy to work closely with healthcare providers to manage symptoms and optimize quality of life.""]","[""The outlook for CM is positive.""]",[false],[true],[false],"[""The outlook for Configuration Management (CM) is positive, with increasing adoption in various industries to ensure efficient and effective management of software and hardware configurations.""]","[""The outlook for Congenital Myopathy varies depending on the specific type and severity of the condition. It is a lifelong condition that may require ongoing medical management and therapy to help manage symptoms and improve quality of life.""]","[""The outlook for CM is positive.""]",[false],[true],[false],"[""The outlook for Configuration Management (CM) is positive, with increasing adoption in organizations to streamline processes, improve efficiency, and ensure consistency in IT environments.""]","[""The outlook for Congenital Myopathy varies depending on the specific type and severity of the condition. It is recommended to consult with a healthcare professional for personalized information and guidance.""]","[""The outlook for CM is positive.""]",[false],[true],[false],"[""The outlook for Configuration Management (CM) is positive, with increasing adoption in organizations to streamline and automate the management of IT infrastructure and applications.""]","[""The outlook for Congenital Myopathy varies depending on the specific type and severity of the condition. It can range from mild symptoms with a normal lifespan to severe muscle weakness and potential complications. Regular medical monitoring and management can help improve quality of life for individuals with Congenital Myopathy.""]","[""The outlook for CM is positive.""]",[false],[true],[false],"[""The outlook for CM (Chemical) is positive.""]","[""The outlook for Congenital Myopathy varies depending on the specific type and severity of the condition. It can range from mild symptoms with a normal lifespan to severe muscle weakness and potential complications. Regular medical monitoring and management can help improve quality of life for individuals with Congenital Myopathy.""]","[""The outlook for CM is positive.""]",[false],[true],[false],"[""The outlook for Configuration Management is positive, with increasing adoption of automation tools and practices to streamline processes and improve efficiency.""]","[""The outlook for Congenital Myopathy varies depending on the specific type and severity of the condition. It can range from mild symptoms with a normal lifespan to severe muscle weakness and potential complications. Regular medical monitoring and management can help improve quality of life for individuals with Congenital Myopathy.""]","[""The outlook for CM is positive.""]",[false],[true],[false],"[""The outlook for Configuration Management (CM) is positive, with increasing adoption of automation tools and practices to streamline the process of managing and controlling changes to software and hardware configurations.""]","[""The outlook for Congenital Myopathy varies depending on the specific type and severity of the condition. It can range from mild symptoms with a normal lifespan to severe muscle weakness and potential complications. Regular medical monitoring and management can help improve quality of life for individuals with Congenital Myopathy.""]","[""The outlook for CM is positive.""]"
information,Do you have information about HIV/AIDS in Women,"Summary : HIV, the human immunodeficiency virus, kills or damages cells of the body's immune system. The most advanced stage of infection with HIV is AIDS, which stands for acquired immunodeficiency syndrome.     HIV often spreads through unprotected sex with an infected person. It may also spread by sharing drug needles or through contact with the blood of an infected person.    Women can get HIV more easily during vaginal sex than men can. And if they do get HIV, they have unique problems, including:       - Complications such as repeated vaginal yeast infections, severe pelvic inflammatory disease (PID), and a higher risk of cervical cancer    - Different side effects from the drugs that treat HIV    - The risk of giving HIV to their baby while pregnant or during childbirth       There is no cure, but there are many medicines to fight both HIV infection and the infections and cancers that come with it. People can live with the disease for many years.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""abbreviation"", ""abbreviation"": ""HIV"", ""full_form"": ""Human Immunodeficiency Virus""}, {""ambiguity_type"": ""abbreviation"", ""abbreviation"": ""AIDS"", ""full_form"": ""Acquired Immunodeficiency Syndrome""}]}",Do you have information about HIV/AIDS in Women,Do you have information about Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome in Women,8,MEDICAL,Simple Datatype-String,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Human Immunodeficiency Virus"", ""Hope Is Vital"", ""Here In Venezuela"", ""Human Immuno-Deficiency Virus"", ""Helium Isolation Valve"", ""He Ignores Virgina"", ""High Interest Vessel"", ""Hair Is Vanishing"", ""Human Immuno deficiency Virus"", ""AIDS Hastaligina Neden Olan Vir\u00fcS""], [""Acquired Immune Deficiency Syndrome"", ""Almost Ideal Demand System"", ""As If Doing Something"", ""Anally Injected Death Sentence"", ""American Invention to Discourage Sex"", ""Army Inventory of Data Systems"", ""Acquired Insanity Due to Studies"", ""All In Dead Silence"", ""ADCOM (Aerospace Defense COMmand) Information Display System"", ""Air Improvement Disruption Syndrome""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""], [""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Human Immunodeficiency Virus"", ""Acquired Immune Deficiency Syndrome""]","[5.127970745364296e-07, 9.218266191967892e-09]","[5.127970745364296e-07, 2.1656072781604816e-12]","[""Human Immunodeficiency Virus"", ""As If Doing Something""]","[5.127970745364296e-07, 2.7565923571909337e-12]","[""ABBREVIATIONS"", ""ABBREVIATIONS""]","[[5.127970745364296e-07, 1.4222371460522436e-13, 7.344845415269339e-15, 3.3901128745894604e-13, 1.911443433228936e-13, 5.795811377308645e-19, 4.238753640969373e-12, 1.593045611032285e-16, 3.1581640578600435e-14, 1.8647646493694473e-35], [2.1656072781604816e-12, 2.6292435877833276e-17, 2.7565923571909337e-12, 2.604019133958134e-22, 1.3303893894858866e-26, 2.08650077938223e-23, 4.550982852682363e-23, 2.570046915616139e-16, 3.3189127513634256e-50, 2.3213466967569614e-18]]","[0.9512489273598377, 0.9471537569571686]","[0.9512489273598377, 0.9468971051573714]","[""Human Immunodeficiency Virus"", ""Acquired Immunodeficiency Syndrome""]","[0.9512489273598377, 0.9468971051573714]","[""ABBREVIATIONS"", ""ABBREVIATIONS""]","[[0.9512489273598377, 0.894905664540534, 0.8265478852176784, 0.9434247122932368, 0.8362146959803505, 0.871000716361832, 0.8853004292394799, 0.8372207494987468, 0.9387331747807466, 0.8305528125248959], [0.9468971051573714, 0.7866598668536752, 0.9046584479140838, 0.8281547545906787, 0.8324710896752288, 0.7813371209821813, 0.8308277788669067, 0.8793332071942381, 0.8200016674550469, 0.8758799873137875]]","[""Human Immunodeficiency Virus"", ""Acquired Immune Deficiency Syndrome""]","[""ABBREVIATIONS"", ""ABBREVIATIONS""]",Do you have information about HIV/AIDS (Acquired Immune Deficiency Syndrome) in Women,"[true, true]","[true, true]","[true, true]","[""Yes, HIV/AIDS can affect women differently than men. Women are more susceptible to HIV infection through heterosexual contact and may experience different symptoms and complications compared to men."", ""HIV/AIDS in women is a serious public health issue. Women can get HIV through vaginal, anal, or oral sex with an infected partner. It is important for women to get tested regularly and practice safe sex to prevent transmission.""]","[""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors."", ""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors.""]","[""Yes, HIV/AIDS can affect women differently than men. Women are more vulnerable to HIV infection due to biological, social, and economic factors."", ""HIV/AIDS can affect women in various ways, including through transmission from mother to child during pregnancy, childbirth, or breastfeeding. Women are also at risk of contracting HIV through unprotected sex, sharing needles, or blood transfusions. It is important for women to get tested regularly and practice safe sex to prevent the spread of HIV/AIDS.""]","[true, true]","[true, true]","[true, true]","[""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors."", ""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors.""]","[""Yes, women can also be affected by Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS). It is important for women to be aware of the risks, prevention methods, and available treatments for HIV/AIDS."", ""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors.""]","[""Yes, HIV/AIDS can affect women differently than men. Women are more vulnerable to HIV infection due to biological, social, and economic factors."", ""Yes, HIV/AIDS can affect women differently than men. Women are more vulnerable to HIV infection due to biological, social, and economic factors.""]","[true, true]","[true, true]","[true, true]","[""Yes, HIV/AIDS can affect women differently than men. Women are more susceptible to HIV infection through heterosexual contact and may experience different symptoms and complications compared to men."", ""Yes, HIV/AIDS can affect women differently than men. Women are more susceptible to HIV infection through heterosexual contact and may experience different symptoms and complications compared to men.""]","[""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors."", ""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors.""]","[""HIV/AIDS can affect women in various ways, including through mother-to-child transmission, sexual transmission, and shared needle use. It is important for women to get tested regularly and seek treatment if diagnosed."", ""HIV/AIDS can affect women in various ways, including through mother-to-child transmission, sexual transmission, and lack of access to healthcare services.""]","[true, true]","[true, true]","[true, true]","[""Yes, HIV/AIDS can affect women differently than men. Women are more susceptible to HIV infection through heterosexual contact and may experience different symptoms and complications compared to men."", ""Yes, HIV/AIDS can affect women differently than men. Women are more vulnerable to HIV infection due to biological, social, and economic factors.""]","[""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors."", ""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors.""]","[""HIV/AIDS can affect women in various ways, including through transmission during pregnancy, childbirth, and breastfeeding. Women with HIV/AIDS may experience symptoms such as recurrent infections, weight loss, and fatigue. It is important for women to get tested regularly and seek medical care if they suspect they may be infected."", ""HIV/AIDS can affect women in various ways, including through mother-to-child transmission, sexual transmission, and sharing needles. It is important for women to get tested regularly and seek treatment if diagnosed.""]","[true, true]","[true, true]","[true, true]","[""Yes, HIV/AIDS can affect women differently than men. Women are more susceptible to HIV infection through heterosexual contact and may experience different symptoms and complications compared to men."", ""Yes, HIV/AIDS can affect women and may have specific symptoms and treatment options tailored for them.""]","[""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors."", ""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors.""]","[""Yes, HIV/AIDS can affect women differently than men. Women are more vulnerable to HIV infection due to biological, social, and economic factors."", ""HIV/AIDS can affect women in various ways, including through transmission from mother to child during pregnancy, childbirth, or breastfeeding. Women are also at risk of contracting HIV through unprotected sex, sharing needles, or blood transfusions. It is important for women to get tested regularly and practice safe sex to prevent the spread of HIV/AIDS.""]","[true, true]","[true, true]","[true, true]","[""Yes, HIV/AIDS can affect women differently than men. Women are more susceptible to HIV infection through heterosexual contact and may experience different symptoms and complications compared to men."", ""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors. Women are more vulnerable to HIV infection through heterosexual contact and may face additional challenges in accessing treatment and care.""]","[""Yes, women can also be affected by Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS). It is important for women to be aware of the risks, prevention methods, and available treatments for HIV/AIDS."", ""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors.""]","[""Yes, HIV/AIDS can affect women differently than men. Women are more vulnerable to HIV infection due to biological, social, and economic factors."", ""Yes, HIV/AIDS can affect women differently than men. Women are more vulnerable to HIV infection due to biological, social, and economic factors.""]","[true, true]","[true, true]","[true, true]","[""Yes, HIV/AIDS can affect women differently than men. Women are more vulnerable to HIV infection due to biological factors and social inequalities."", ""HIV/AIDS in women is a serious health issue that affects a significant number of women globally. Women are more vulnerable to HIV infection due to various factors such as biological, social, and economic disparities. It is important for women to have access to HIV prevention, testing, and treatment services to reduce the impact of the disease.""]","[""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors."", ""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors.""]","[""HIV/AIDS can affect women in various ways, including through mother-to-child transmission, sexual transmission, and shared needle use. It is important for women to get tested regularly and seek treatment if diagnosed."", ""HIV/AIDS can affect women in various ways, including through mother-to-child transmission, sexual transmission, and lack of access to healthcare services.""]","[true, true]","[true, true]","[true, true]","[""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors. Women are more vulnerable to HIV infection through heterosexual contact and may experience unique symptoms and complications related to the virus."", ""Yes, HIV/AIDS can affect women differently than men. Women are more susceptible to HIV infection through heterosexual contact and may experience different symptoms and complications compared to men.""]","[""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors."", ""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors.""]","[""HIV/AIDS can affect women in various ways, including through transmission during pregnancy, childbirth, and breastfeeding. Women with HIV/AIDS may experience symptoms such as recurrent infections, weight loss, and fatigue. It is important for women to get tested regularly and seek medical care if they suspect they may be infected."", ""HIV/AIDS can affect women in various ways, including through mother-to-child transmission, sexual transmission, and sharing needles. It is important for women to get tested regularly and seek treatment if diagnosed.""]","[true, true]","[true, true]","[true, true]","[""Yes, HIV/AIDS can affect women differently than men. Women are more susceptible to HIV infection through heterosexual contact and may experience different symptoms and complications compared to men."", ""Yes, HIV/AIDS can affect women differently than men. Women are more susceptible to HIV infection through heterosexual contact and may experience different symptoms and complications compared to men.""]","[""Yes, women can also be affected by Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS). It is important for women to be aware of the risks, prevention methods, and available treatments for HIV/AIDS."", ""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors.""]","[""Yes, HIV/AIDS can affect women differently than men. Women are more vulnerable to HIV infection due to biological, social, and economic factors."", ""Yes, HIV/AIDS can affect women differently than men. Women are more vulnerable to HIV infection due to biological, social, and economic factors.""]","[true, true]","[true, true]","[true, true]","[""Yes, HIV/AIDS can affect women differently than men. Women are more vulnerable to HIV infection due to biological factors and social inequalities. It is important for women to get tested regularly and seek proper treatment if diagnosed with HIV/AIDS."", ""Yes, HIV/AIDS can affect women differently than men. Women are more susceptible to HIV infection through heterosexual contact and may experience different symptoms and complications compared to men.""]","[""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors."", ""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors.""]","[""Yes, HIV/AIDS can affect women differently than men. Women are more vulnerable to HIV infection due to biological, social, and economic factors."", ""HIV/AIDS can affect women in various ways, including through transmission from mother to child during pregnancy, childbirth, or breastfeeding. Women are also at risk of contracting HIV through unprotected sex, sharing needles, or blood transfusions. It is important for women to get tested regularly and practice safe sex to prevent the spread of HIV/AIDS.""]","[true, true]","[true, true]","[true, true]","[""Yes, HIV/AIDS can affect women differently than men. Women are more susceptible to HIV infection through heterosexual contact and may experience different symptoms and complications compared to men."", ""Yes, HIV/AIDS can affect women and it is important for them to be aware of the risks, prevention methods, and available treatments.""]","[""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors."", ""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors.""]","[""HIV/AIDS can affect women in various ways, including through mother-to-child transmission, sexual transmission, and shared needle use. It is important for women to get tested regularly and seek treatment if diagnosed."", ""HIV/AIDS can affect women in various ways, including through mother-to-child transmission, sexual transmission, and lack of access to healthcare services.""]","[true, true]","[true, true]","[true, true]","[""Yes, HIV/AIDS can affect women differently than men. Women are more susceptible to HIV infection through heterosexual contact and may experience different symptoms and complications compared to men."", ""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors.""]","[""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors."", ""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors.""]","[""HIV/AIDS can affect women in various ways, including through transmission during pregnancy, childbirth, and breastfeeding. Women with HIV/AIDS may experience symptoms such as recurrent infections, weight loss, and fatigue. It is important for women to get tested regularly and seek medical care if they suspect they may be infected."", ""HIV/AIDS can affect women in various ways, including through mother-to-child transmission, sexual transmission, and sharing needles. It is important for women to get tested regularly and seek treatment if diagnosed.""]","[true, true]","[true, true]","[true, true]","[""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors."", ""Yes, HIV/AIDS can affect women and there are specific considerations for diagnosis, treatment, and prevention in women.""]","[""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors."", ""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors.""]","[""Yes, HIV/AIDS can affect women differently than men. Women are more vulnerable to HIV infection due to biological, social, and economic factors."", ""HIV/AIDS can affect women in various ways, including through transmission from mother to child during pregnancy, childbirth, or breastfeeding. Women are also at risk of contracting HIV through unprotected sex, sharing needles, or blood transfusions. It is important for women to get tested regularly and practice safe sex to prevent the spread of HIV/AIDS.""]","[true, true]","[true, true]","[true, true]","[""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors."", ""Yes, HIV/AIDS can affect women and it is important for them to get tested regularly and seek appropriate medical care.""]","[""Yes, women can also be affected by Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS). It is important for women to be aware of the risks, prevention methods, and available treatments for HIV/AIDS."", ""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors.""]","[""Yes, HIV/AIDS can affect women differently than men. Women are more vulnerable to HIV infection due to biological, social, and economic factors."", ""Yes, HIV/AIDS can affect women differently than men. Women are more vulnerable to HIV infection due to biological, social, and economic factors.""]","[true, true]","[true, true]","[true, true]","[""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors."", ""Yes, HIV/AIDS can affect women and it is important for them to be aware of the risks and prevention methods.""]","[""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors."", ""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors.""]","[""HIV/AIDS can affect women in various ways, including through mother-to-child transmission, sexual transmission, and shared needle use. It is important for women to get tested regularly and seek treatment if diagnosed."", ""HIV/AIDS can affect women in various ways, including through mother-to-child transmission, sexual transmission, and lack of access to healthcare services.""]","[true, true]","[true, true]","[true, true]","[""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors."", ""Yes, HIV/AIDS can affect women and there are specific considerations for diagnosis, treatment, and prevention in women.""]","[""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors."", ""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors.""]","[""HIV/AIDS can affect women in various ways, including through transmission during pregnancy, childbirth, and breastfeeding. Women with HIV/AIDS may experience symptoms such as recurrent infections, weight loss, and fatigue. It is important for women to get tested regularly and seek medical care if they suspect they may be infected."", ""HIV/AIDS can affect women in various ways, including through mother-to-child transmission, sexual transmission, and sharing needles. It is important for women to get tested regularly and seek treatment if diagnosed.""]","[true, true]","[true, true]","[true, true]","[""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors."", ""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors.""]","[""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors."", ""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors.""]","[""Yes, HIV/AIDS can affect women differently than men. Women are more vulnerable to HIV infection due to biological, social, and economic factors."", ""HIV/AIDS can affect women in various ways, including through transmission from mother to child during pregnancy, childbirth, or breastfeeding. Women are also at risk of contracting HIV through unprotected sex, sharing needles, or blood transfusions. It is important for women to get tested regularly and practice safe sex to prevent the spread of HIV/AIDS.""]","[true, true]","[true, true]","[true, true]","[""Yes, HIV/AIDS can affect women differently than men. Women are more susceptible to HIV infection through heterosexual contact and may experience different symptoms and complications compared to men."", ""Yes, HIV/AIDS can affect women differently than men. Women are more susceptible to HIV infection through heterosexual contact and may experience different symptoms and complications compared to men.""]","[""Yes, women can also be affected by Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS). It is important for women to be aware of the risks, prevention methods, and available treatments for HIV/AIDS."", ""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors.""]","[""Yes, HIV/AIDS can affect women differently than men. Women are more vulnerable to HIV infection due to biological, social, and economic factors."", ""Yes, HIV/AIDS can affect women differently than men. Women are more vulnerable to HIV infection due to biological, social, and economic factors.""]","[true, true]","[true, true]","[true, true]","[""Yes, HIV/AIDS can affect women differently than men. Women are more susceptible to HIV infection through heterosexual contact and may experience different symptoms and complications compared to men."", ""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors.""]","[""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors."", ""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors.""]","[""HIV/AIDS can affect women in various ways, including through mother-to-child transmission, sexual transmission, and shared needle use. It is important for women to get tested regularly and seek treatment if diagnosed."", ""HIV/AIDS can affect women in various ways, including through mother-to-child transmission, sexual transmission, and lack of access to healthcare services.""]","[true, true]","[true, true]","[true, true]","[""Yes, HIV/AIDS can affect women differently than men. Women are more susceptible to HIV infection through heterosexual contact and may experience different symptoms and complications compared to men."", ""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors.""]","[""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors."", ""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors.""]","[""HIV/AIDS can affect women in various ways, including through transmission during pregnancy, childbirth, and breastfeeding. Women with HIV/AIDS may experience symptoms such as recurrent infections, weight loss, and fatigue. It is important for women to get tested regularly and seek medical care if they suspect they may be infected."", ""HIV/AIDS can affect women in various ways, including through mother-to-child transmission, sexual transmission, and sharing needles. It is important for women to get tested regularly and seek treatment if diagnosed.""]","[true, true]","[true, true]","[true, true]","[""Yes, HIV/AIDS can affect women differently than men. Women are more vulnerable to HIV infection due to biological factors and social inequalities."", ""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors. Women are more vulnerable to HIV infection through heterosexual contact and may experience different symptoms and complications compared to men.""]","[""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors."", ""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors.""]","[""Yes, HIV/AIDS can affect women differently than men. Women are more vulnerable to HIV infection due to biological, social, and economic factors."", ""HIV/AIDS can affect women in various ways, including through transmission from mother to child during pregnancy, childbirth, or breastfeeding. Women are also at risk of contracting HIV through unprotected sex, sharing needles, or blood transfusions. It is important for women to get tested regularly and practice safe sex to prevent the spread of HIV/AIDS.""]","[true, true]","[true, true]","[true, true]","[""Yes, HIV/AIDS can affect women differently than men. Women are more susceptible to HIV infection through heterosexual contact and may experience different symptoms and complications compared to men."", ""Yes, HIV/AIDS can affect women and it is important for them to get tested regularly and seek appropriate medical care.""]","[""Yes, women can also be affected by Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS). It is important for women to be aware of the risks, prevention methods, and available treatments for HIV/AIDS."", ""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors.""]","[""Yes, HIV/AIDS can affect women differently than men. Women are more vulnerable to HIV infection due to biological, social, and economic factors."", ""Yes, HIV/AIDS can affect women differently than men. Women are more vulnerable to HIV infection due to biological, social, and economic factors.""]","[true, true]","[true, true]","[true, true]","[""Yes, HIV/AIDS can affect women differently than men. Women are more susceptible to HIV infection through heterosexual contact and may experience different symptoms and complications compared to men."", ""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors.""]","[""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors."", ""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors.""]","[""HIV/AIDS can affect women in various ways, including through mother-to-child transmission, sexual transmission, and shared needle use. It is important for women to get tested regularly and seek treatment if diagnosed."", ""HIV/AIDS can affect women in various ways, including through mother-to-child transmission, sexual transmission, and lack of access to healthcare services.""]","[true, true]","[true, true]","[true, true]","[""Yes, HIV/AIDS can affect women differently than men. Women are more susceptible to HIV infection through heterosexual contact and may experience different symptoms and complications compared to men."", ""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors.""]","[""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors."", ""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors.""]","[""HIV/AIDS can affect women in various ways, including through transmission during pregnancy, childbirth, and breastfeeding. Women with HIV/AIDS may experience symptoms such as recurrent infections, weight loss, and fatigue. It is important for women to get tested regularly and seek medical care if they suspect they may be infected."", ""HIV/AIDS can affect women in various ways, including through mother-to-child transmission, sexual transmission, and sharing needles. It is important for women to get tested regularly and seek treatment if diagnosed.""]","[true, true]","[true, true]","[true, true]","[""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors. Women are more vulnerable to HIV infection, and AIDS is the leading cause of death for women of reproductive age worldwide."", ""HIV/AIDS in women is a serious public health issue, with women accounting for a significant proportion of new HIV infections globally. Factors such as gender inequality, violence, and lack of access to healthcare contribute to the higher prevalence of HIV/AIDS among women.""]","[""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors."", ""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors.""]","[""Yes, HIV/AIDS can affect women differently than men. Women are more vulnerable to HIV infection due to biological, social, and economic factors."", ""HIV/AIDS can affect women in various ways, including through transmission from mother to child during pregnancy, childbirth, or breastfeeding. Women are also at risk of contracting HIV through unprotected sex, sharing needles, or blood transfusions. It is important for women to get tested regularly and practice safe sex to prevent the spread of HIV/AIDS.""]","[true, true]","[true, true]","[true, true]","[""HIV/AIDS in women is a significant public health issue, with women accounting for more than half of the adults living with HIV globally. Women face unique challenges in terms of prevention, diagnosis, and treatment of HIV/AIDS, including biological, social, and economic factors."", ""HIV/AIDS in women is a serious public health issue, with women accounting for a significant proportion of new HIV infections globally. Women face unique challenges in terms of prevention, treatment, and care due to biological, social, and economic factors.""]","[""Yes, women can also be affected by Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS). It is important for women to be aware of the risks, prevention methods, and available treatments for HIV/AIDS."", ""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors.""]","[""Yes, HIV/AIDS can affect women differently than men. Women are more vulnerable to HIV infection due to biological, social, and economic factors."", ""Yes, HIV/AIDS can affect women differently than men. Women are more vulnerable to HIV infection due to biological, social, and economic factors.""]","[true, true]","[true, true]","[true, true]","[""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors. Women are more vulnerable to HIV infection, and AIDS is the leading cause of death for women of reproductive age worldwide."", ""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors. Women are more vulnerable to HIV infection and face unique challenges in accessing prevention, treatment, and care services.""]","[""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors."", ""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors.""]","[""HIV/AIDS can affect women in various ways, including through mother-to-child transmission, sexual transmission, and shared needle use. It is important for women to get tested regularly and seek treatment if diagnosed."", ""HIV/AIDS can affect women in various ways, including through mother-to-child transmission, sexual transmission, and lack of access to healthcare services.""]","[true, true]","[true, true]","[true, true]","[""Yes, HIV/AIDS can affect women differently than men. Women are more vulnerable to HIV infection due to biological, social, and economic factors. It is important for women to have access to HIV prevention, testing, and treatment services."", ""Yes, HIV/AIDS can affect women of all ages. Women are more vulnerable to HIV infection due to various factors such as biological, social, and economic reasons.""]","[""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors."", ""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors.""]","[""HIV/AIDS can affect women in various ways, including through transmission during pregnancy, childbirth, and breastfeeding. Women with HIV/AIDS may experience symptoms such as recurrent infections, weight loss, and fatigue. It is important for women to get tested regularly and seek medical care if they suspect they may be infected."", ""HIV/AIDS can affect women in various ways, including through mother-to-child transmission, sexual transmission, and sharing needles. It is important for women to get tested regularly and seek treatment if diagnosed.""]","[true, true]","[true, true]","[true, true]","[""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors."", ""Yes, HIV/AIDS can affect women and there is specific information available regarding its impact, prevention, and treatment in women.""]","[""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors."", ""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors.""]","[""Yes, HIV/AIDS can affect women differently than men. Women are more vulnerable to HIV infection due to biological, social, and economic factors."", ""HIV/AIDS can affect women in various ways, including through transmission from mother to child during pregnancy, childbirth, or breastfeeding. Women are also at risk of contracting HIV through unprotected sex, sharing needles, or blood transfusions. It is important for women to get tested regularly and practice safe sex to prevent the spread of HIV/AIDS.""]","[true, true]","[true, true]","[true, true]","[""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors. Women are more vulnerable to HIV infection, and once infected, they may face unique challenges in accessing treatment and care."", ""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors.""]","[""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors."", ""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors.""]","[""Yes, HIV/AIDS can affect women differently than men. Women are more vulnerable to HIV infection due to biological, social, and economic factors."", ""HIV/AIDS can affect women in various ways, including through transmission from mother to child during pregnancy, childbirth, or breastfeeding. Women are also at risk of contracting HIV through unprotected sex, sharing needles, or blood transfusions. It is important for women to get tested regularly and practice safe sex to prevent the spread of HIV/AIDS.""]","[true, true]","[true, true]","[true, true]","[""Yes, HIV/AIDS can affect women in various ways including transmission, symptoms, prevention, and treatment. It is important for women to be informed about the risks and available resources for HIV/AIDS."", ""Yes, HIV/AIDS can affect women differently than men and it is important to understand the specific challenges and risks faced by women in relation to HIV/AIDS.""]","[""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors."", ""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors.""]","[""Yes, HIV/AIDS can affect women differently than men. Women are more vulnerable to HIV infection due to biological, social, and economic factors."", ""HIV/AIDS can affect women in various ways, including through transmission from mother to child during pregnancy, childbirth, or breastfeeding. Women are also at risk of contracting HIV through unprotected sex, sharing needles, or blood transfusions. It is important for women to get tested regularly and practice safe sex to prevent the spread of HIV/AIDS.""]","[true, true]","[true, true]","[true, true]","[""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors."", ""Yes, HIV/AIDS can affect women and there is specific information available about its impact on women.""]","[""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors."", ""Yes, HIV/AIDS can affect women differently than men due to biological, social, and economic factors.""]","[""Yes, HIV/AIDS can affect women differently than men. Women are more vulnerable to HIV infection due to biological, social, and economic factors."", ""HIV/AIDS can affect women in various ways, including through transmission from mother to child during pregnancy, childbirth, or breastfeeding. Women are also at risk of contracting HIV through unprotected sex, sharing needles, or blood transfusions. It is important for women to get tested regularly and practice safe sex to prevent the spread of HIV/AIDS.""]"
frequency,How many people are affected by benign recurrent intrahepatic cholestasis ?,"BRIC is a rare disorder. Although the prevalence is unknown, this condition is less common than the related disorder PFIC, which affects approximately 1 in 50,000 to 100,000 people worldwide.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""BRIC"", ""full_form"": ""benign recurrent intrahepatic cholestasis""}]}",How many people are affected by BRIC ?,How many people are affected by benign recurrent intrahepatic cholestasis ?,3,BUSINESS,Simple Datatype-Integer,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Brazil, Russia, India, and China"", ""Brasil Russia India And China"", ""Belden Registered Installation Contractor"", ""Building Rehabilitation and Improvement Campaign"", ""Brazil Russia India and China"", ""Bridge Research and Information Center"", ""Brazil, Russia, India & China"", ""Brain Research Imaging Center"", ""Building Relationships In Christ's kingdom"", ""Birth Relative Initiated Contact""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Brazil, Russia, India, China""]",[1.028680336614531e-22],[1.6510252787236894e-28],"[""Brain Research Imaging Center""]",[1.5501588078984352e-14],"[""ABBREVIATIONS""]","[[2.0078022250090114e-29, 6.83672612377354e-28, 2.3800927601099146e-26, 4.777555612184452e-20, 9.389599045530822e-29, 2.9130298040849745e-19, 1.3236251723057142e-29, 1.5501588078984352e-14, 1.1298758941913146e-23, 4.957367084811237e-19]]",[0.7439043192354464],[0.8362654380190959],"[""Birth Relative Initiated Contact""]",[0.8362654380190959],"[""LLM""]","[[0.8211119659452109, 0.8234684302124697, 0.6957970443740503, 0.7604972994063537, 0.832631041413391, 0.8006941773860374, 0.8300886934083592, 0.7545309756767742, 0.7230516955945734, 0.69487130204166]]","[""Brazil, Russia, India, China""]","[""LLM""]","How many people are affected by BRIC (Brazil, Russia, India, China) ?",[false],[true],[false],"[""Unknown""]","[""The number of people affected by benign recurrent intrahepatic cholestasis is very rare, estimated to be less than 1 in 100,000 individuals.""]","[""Over 3 billion people are affected by BRIC countries.""]",[false],[true],[false],"[""It is estimated that BRIC (Brain Research Imaging Center) affects hundreds of people through its research and services.""]","[""The number of people affected by benign recurrent intrahepatic cholestasis is relatively rare, estimated to be less than 1 in 100,000 individuals.""]","[""BRIC does not refer to people, but rather to the countries Brazil, Russia, India, and China.""]",[false],[true],[false],"[""It is estimated that BRIC (Brain Research Imaging Center) affects around 500 researchers and staff members.""]","[""Benign recurrent intrahepatic cholestasis affects a very small number of individuals worldwide.""]","[""Approximately 3 billion people are affected by BRIC countries.""]",[false],[true],[false],"[""Unknown""]","[""The number of people affected by benign recurrent intrahepatic cholestasis is relatively rare, estimated to be less than 1 in 100,000 individuals.""]","[""Approximately 3 billion people are affected by BRIC countries.""]",[false],[true],[false],"[""It is estimated that around 10-15% of adoptees are affected by BRIC (Birth Relative Initiated Contact).""]","[""The number of people affected by benign recurrent intrahepatic cholestasis is very rare, estimated to be less than 1 in 100,000 individuals.""]","[""Over 3 billion people are affected by BRIC countries.""]",[false],[true],[false],"[""It is estimated that around 7 million people are affected by BRIC (Birth Relative Initiated Contact).""]","[""The number of people affected by benign recurrent intrahepatic cholestasis is relatively rare, estimated to be less than 1 in 100,000 individuals.""]","[""BRIC does not refer to people, but rather to the countries Brazil, Russia, India, and China.""]",[false],[true],[false],"[""The exact number of people affected by BRIC (Birth Relative Initiated Contact) is not publicly available.""]","[""Benign recurrent intrahepatic cholestasis affects a very small number of individuals worldwide.""]","[""Approximately 3 billion people are affected by BRIC countries.""]",[false],[true],[false],"[""The exact number of people affected by BRIC (Birth Relative Initiated Contact) is not publicly available.""]","[""The number of people affected by benign recurrent intrahepatic cholestasis is relatively rare, estimated to be less than 1 in 100,000 individuals.""]","[""Approximately 3 billion people are affected by BRIC countries.""]",[false],[true],[false],"[""Approximately 3 billion people""]","[""The number of people affected by benign recurrent intrahepatic cholestasis is relatively rare, estimated to be less than 1 in 100,000 individuals.""]","[""BRIC does not refer to people, but rather to the countries Brazil, Russia, India, and China.""]",[false],[true],[false],"[""Approximately 3 billion people""]","[""The number of people affected by benign recurrent intrahepatic cholestasis is very rare, estimated to be less than 1 in 100,000 individuals.""]","[""Over 3 billion people are affected by BRIC countries.""]",[false],[true],[false],"[""Approximately 3 billion people""]","[""Benign recurrent intrahepatic cholestasis affects a very small number of individuals worldwide.""]","[""Approximately 3 billion people are affected by BRIC countries.""]",[false],[true],[false],"[""Approximately 3 billion people""]","[""The number of people affected by benign recurrent intrahepatic cholestasis is relatively rare, estimated to be less than 1 in 100,000 individuals.""]","[""Approximately 3 billion people are affected by BRIC countries.""]",[false],[true],[false],"[""Not Specified""]","[""The number of people affected by benign recurrent intrahepatic cholestasis is very rare, estimated to be less than 1 in 100,000 individuals.""]","[""Over 3 billion people are affected by BRIC countries.""]",[false],[true],[false],"[""Approximately 3 billion people""]","[""The number of people affected by benign recurrent intrahepatic cholestasis is relatively rare, estimated to be less than 1 in 100,000 individuals.""]","[""BRIC does not refer to people, but rather to the countries Brazil, Russia, India, and China.""]",[false],[true],[false],"[""Not specified""]","[""Benign recurrent intrahepatic cholestasis affects a very small number of individuals worldwide.""]","[""Approximately 3 billion people are affected by BRIC countries.""]",[false],[true],[false],"[""Not specified""]","[""The number of people affected by benign recurrent intrahepatic cholestasis is relatively rare, estimated to be less than 1 in 100,000 individuals.""]","[""Approximately 3 billion people are affected by BRIC countries.""]",[false],[true],[false],"[""Approximately 3 billion people""]","[""The number of people affected by benign recurrent intrahepatic cholestasis is very rare, estimated to be less than 1 in 100,000 individuals.""]","[""Over 3 billion people are affected by BRIC countries.""]",[false],[true],[false],"[""Approximately 3 billion people""]","[""The number of people affected by benign recurrent intrahepatic cholestasis is relatively rare, estimated to be less than 1 in 100,000 individuals.""]","[""BRIC does not refer to people, but rather to the countries Brazil, Russia, India, and China.""]",[false],[true],[false],"[""Approximately 3 billion people are affected by BRIC countries.""]","[""Benign recurrent intrahepatic cholestasis affects a very small number of individuals worldwide.""]","[""Approximately 3 billion people are affected by BRIC countries.""]",[false],[true],[false],"[""Approximately 3 billion people are affected by BRIC countries.""]","[""The number of people affected by benign recurrent intrahepatic cholestasis is relatively rare, estimated to be less than 1 in 100,000 individuals.""]","[""Approximately 3 billion people are affected by BRIC countries.""]",[false],[true],[false],"[""Approximately 3 billion people are affected by BRIC countries.""]","[""The number of people affected by benign recurrent intrahepatic cholestasis is very rare, estimated to be less than 1 in 100,000 individuals.""]","[""Over 3 billion people are affected by BRIC countries.""]",[false],[true],[false],"[""Approximately 3 billion people""]","[""The number of people affected by benign recurrent intrahepatic cholestasis is relatively rare, estimated to be less than 1 in 100,000 individuals.""]","[""BRIC does not refer to people, but rather to the countries Brazil, Russia, India, and China.""]",[false],[true],[false],"[""Approximately 3 billion people are affected by BRIC countries.""]","[""Benign recurrent intrahepatic cholestasis affects a very small number of individuals worldwide.""]","[""Approximately 3 billion people are affected by BRIC countries.""]",[false],[true],[false],"[""Approximately 3 billion people are affected by BRIC countries.""]","[""The number of people affected by benign recurrent intrahepatic cholestasis is relatively rare, estimated to be less than 1 in 100,000 individuals.""]","[""Approximately 3 billion people are affected by BRIC countries.""]",[false],[true],[false],"[""BRIC countries collectively represent over 40% of the world's population.""]","[""The number of people affected by benign recurrent intrahepatic cholestasis is very rare, estimated to be less than 1 in 100,000 individuals.""]","[""Over 3 billion people are affected by BRIC countries.""]",[false],[true],[false],"[""BRIC countries collectively represent over 40% of the world's population.""]","[""The number of people affected by benign recurrent intrahepatic cholestasis is relatively rare, estimated to be less than 1 in 100,000 individuals.""]","[""BRIC does not refer to people, but rather to the countries Brazil, Russia, India, and China.""]",[false],[true],[false],"[""BRIC countries collectively represent over 40% of the world's population.""]","[""Benign recurrent intrahepatic cholestasis affects a very small number of individuals worldwide.""]","[""Approximately 3 billion people are affected by BRIC countries.""]",[false],[true],[false],"[""BRIC countries collectively represent over 40% of the world's population.""]","[""The number of people affected by benign recurrent intrahepatic cholestasis is relatively rare, estimated to be less than 1 in 100,000 individuals.""]","[""Approximately 3 billion people are affected by BRIC countries.""]",[false],[true],[false],"[""Approximately 3 billion people""]","[""The number of people affected by benign recurrent intrahepatic cholestasis is very rare, estimated to be less than 1 in 100,000 individuals.""]","[""Over 3 billion people are affected by BRIC countries.""]",[false],[true],[false],"[""The number of people affected by BRIC is not specified.""]","[""The number of people affected by benign recurrent intrahepatic cholestasis is very rare, estimated to be less than 1 in 100,000 individuals.""]","[""Over 3 billion people are affected by BRIC countries.""]",[true],[true],[false],"[""The number of people affected by BRIC is not readily available.""]","[""The number of people affected by benign recurrent intrahepatic cholestasis is very rare, estimated to be less than 1 in 100,000 individuals.""]","[""Over 3 billion people are affected by BRIC countries.""]",[false],[true],[false],"[""Approximately 3 billion people""]","[""The number of people affected by benign recurrent intrahepatic cholestasis is very rare, estimated to be less than 1 in 100,000 individuals.""]","[""Over 3 billion people are affected by BRIC countries.""]"
treatment,What are the treatments for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia ?,These resources address the diagnosis or management of ALSP:  - Gene Review: Gene Review: Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia  - Genetic Testing Registry: Hereditary diffuse leukoencephalopathy with spheroids  - MedlinePlus Encyclopedia: Dementia   These resources from MedlinePlus offer information about the diagnosis and management of various health conditions:  - Diagnostic Tests  - Drug Therapy  - Surgery and Rehabilitation  - Genetic Counseling   - Palliative Care,"{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""ALSP"", ""full_form"": ""adult-onset leukoencephalopathy with axonal spheroids and pigmented glia""}]}",What are the treatments for ALSP ?,What are the treatments for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Acquisition Logistics Support Plan"", ""Aggregate Level Simulation Protocol"", ""Agricultural Land Stewardship Program"", ""Authorized Label Suppliers Program"", ""Adult Lifestyle Support Program"", ""Atmosphere and Land Surface Processes"", ""Achham Livelihoods Security Project"", ""Angel light strengths positive energy"", ""Agape Licensed Spiritual Practitioner"", ""AIDS Legal Services Project""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia""]",[3.9015721128799776e-48],[3.9015721128799776e-48],"[""Adult Lifestyle Support Program""]",[6.103136627785971e-15],"[""ABBREVIATIONS""]","[[5.880088932756778e-22, 2.890631858180113e-20, 2.660239319136827e-26, 4.070708205382466e-24, 6.103136627785971e-15, 2.9377379896406666e-20, 8.293731435692766e-30, 5.674911245552804e-29, 3.8544901645985774e-23, 7.73112983328608e-20]]",[0.8559687561352887],[0.8611743498429705],"[""AIDS Legal Services Project""]",[0.8611743498429705],"[""LLM""]","[[0.6529667412617305, 0.7368615477873066, 0.6459858664579208, 0.6140558567747239, 0.7938237413857973, 0.69057692676314, 0.6824983075665201, 0.7541920469513913, 0.6830360768634057, 0.7137597093899772]]","[""Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia""]","[""LLM""]",What are the treatments for ALSP (Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia) ?,[false],[true],[true],"[""The treatments for ALSP (Adult Lifestyle Support Program) may include counseling, lifestyle modifications, dietary changes, exercise programs, and stress management techniques.""]","[""There is no specific treatment for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia. Supportive care and symptom management are typically recommended.""]","[""There is currently no cure for Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP). Treatment focuses on managing symptoms and providing supportive care.""]",[false],[true],[true],"[""The treatments for ALSP (Adult Lifestyle Support Program) typically include counseling, support groups, lifestyle modifications, and medication management.""]","[""There is no specific treatment for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia. Management involves symptomatic and supportive care.""]","[""There is currently no cure for Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP). Treatment focuses on managing symptoms and providing supportive care.""]",[false],[true],[true],"[""The treatments for ALSP (Adult Lifestyle Support Program) typically include counseling, support groups, lifestyle modifications, and education on healthy habits.""]","[""There is currently no specific treatment for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia. Management focuses on symptom relief and supportive care.""]","[""There is currently no cure for ALSP, but treatments focus on managing symptoms and improving quality of life. This may include physical therapy, speech therapy, and medications to help with muscle stiffness and spasticity.""]",[false],[true],[true],"[""The treatments for ALSP (Adult Lifestyle Support Program) may include counseling, lifestyle modifications, dietary changes, exercise programs, and stress management techniques.""]","[""There is no specific treatment for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia. Management focuses on symptom relief and supportive care.""]","[""There is currently no cure for ALSP, but treatments focus on managing symptoms and improving quality of life. This may include physical therapy, speech therapy, medications to manage symptoms, and assistive devices for mobility.""]",[false],[true],[true],"[""The treatments for ALSP (AIDS Legal Services Project) involve legal assistance, advocacy, and support services for individuals affected by HIV/AIDS.""]","[""There is no specific treatment for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia. Supportive care and symptom management are typically recommended.""]","[""There is currently no cure for Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP). Treatment focuses on managing symptoms and providing supportive care.""]",[false],[true],[true],"[""The treatments for ALSP (AIDS Legal Services Project) involve legal services and support for individuals affected by HIV/AIDS, including legal advice, representation, and advocacy.""]","[""There is no specific treatment for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia. Management involves symptomatic and supportive care.""]","[""There is currently no cure for Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP). Treatment focuses on managing symptoms and providing supportive care.""]",[false],[true],[true],"[""The treatments for ALSP (AIDS Legal Services Project) involve legal services such as legal advice, representation, and advocacy for individuals affected by HIV/AIDS.""]","[""There is currently no specific treatment for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia. Management focuses on symptom relief and supportive care.""]","[""There is currently no cure for ALSP, but treatments focus on managing symptoms and improving quality of life. This may include physical therapy, speech therapy, and medications to help with muscle stiffness and spasticity.""]",[false],[true],[true],"[""The treatments for ALSP (AIDS Legal Services Project) involve legal assistance and support services for individuals living with HIV/AIDS.""]","[""There is no specific treatment for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia. Management focuses on symptom relief and supportive care.""]","[""There is currently no cure for ALSP, but treatments focus on managing symptoms and improving quality of life. This may include physical therapy, speech therapy, medications to manage symptoms, and assistive devices for mobility.""]",[true],[true],[true],"[""Currently, there is no specific treatment for ALSP. Symptomatic treatment may be provided to manage symptoms such as spasticity, movement disorders, and cognitive impairment.""]","[""There is no specific treatment for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia. Management involves symptomatic and supportive care.""]","[""There is currently no cure for Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP). Treatment focuses on managing symptoms and providing supportive care.""]",[true],[true],[true],"[""Currently, there is no specific treatment for ALSP. Symptomatic treatment and supportive care can help manage the symptoms.""]","[""There is no specific treatment for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia. Supportive care and symptom management are typically recommended.""]","[""There is currently no cure for Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP). Treatment focuses on managing symptoms and providing supportive care.""]",[true],[true],[true],"[""Currently, there is no specific treatment for ALSP. Management involves symptomatic and supportive care to address the individual symptoms and complications that arise.""]","[""There is currently no specific treatment for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia. Management focuses on symptom relief and supportive care.""]","[""There is currently no cure for ALSP, but treatments focus on managing symptoms and improving quality of life. This may include physical therapy, speech therapy, and medications to help with muscle stiffness and spasticity.""]",[true],[true],[true],"[""Currently, there is no specific treatment for ALSP. Management involves symptomatic and supportive care to address the individual symptoms and complications that arise.""]","[""There is no specific treatment for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia. Management focuses on symptom relief and supportive care.""]","[""There is currently no cure for ALSP, but treatments focus on managing symptoms and improving quality of life. This may include physical therapy, speech therapy, medications to manage symptoms, and assistive devices for mobility.""]",[true],[true],[true],"[""There is no specific treatment for ALSP. Supportive care and symptom management are the main approaches.""]","[""There is no specific treatment for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia. Supportive care and symptom management are typically recommended.""]","[""There is currently no cure for Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP). Treatment focuses on managing symptoms and providing supportive care.""]",[true],[true],[true],"[""There is no specific treatment for ALSP. Supportive care and symptom management are the main approaches.""]","[""There is no specific treatment for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia. Management involves symptomatic and supportive care.""]","[""There is currently no cure for Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP). Treatment focuses on managing symptoms and providing supportive care.""]",[true],[true],[true],"[""There is currently no specific treatment for ALSP. Symptomatic treatment and supportive care can be provided to manage the symptoms.""]","[""There is currently no specific treatment for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia. Management focuses on symptom relief and supportive care.""]","[""There is currently no cure for ALSP, but treatments focus on managing symptoms and improving quality of life. This may include physical therapy, speech therapy, and medications to help with muscle stiffness and spasticity.""]",[true],[true],[true],"[""There is no specific treatment for ALSP. Management involves symptomatic and supportive care to address the symptoms and complications.""]","[""There is no specific treatment for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia. Management focuses on symptom relief and supportive care.""]","[""There is currently no cure for ALSP, but treatments focus on managing symptoms and improving quality of life. This may include physical therapy, speech therapy, medications to manage symptoms, and assistive devices for mobility.""]",[true],[true],[true],"[""Currently, there is no specific treatment for ALSP. Management involves symptomatic and supportive care to address the individual symptoms and complications that arise.""]","[""There is no specific treatment for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia. Supportive care and symptom management are typically recommended.""]","[""There is currently no cure for Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP). Treatment focuses on managing symptoms and providing supportive care.""]",[true],[true],[true],"[""Currently, there is no specific treatment for ALSP. Management involves symptom relief and supportive care.""]","[""There is no specific treatment for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia. Management involves symptomatic and supportive care.""]","[""There is currently no cure for Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP). Treatment focuses on managing symptoms and providing supportive care.""]",[true],[true],[true],"[""Currently, there is no specific treatment for ALSP. Management involves symptomatic and supportive care to address the individual symptoms and complications that arise.""]","[""There is currently no specific treatment for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia. Management focuses on symptom relief and supportive care.""]","[""There is currently no cure for ALSP, but treatments focus on managing symptoms and improving quality of life. This may include physical therapy, speech therapy, and medications to help with muscle stiffness and spasticity.""]",[true],[true],[true],"[""Currently, there is no specific treatment for ALSP. Symptomatic treatment may be provided to manage symptoms such as spasticity, movement disorders, and cognitive decline.""]","[""There is no specific treatment for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia. Management focuses on symptom relief and supportive care.""]","[""There is currently no cure for ALSP, but treatments focus on managing symptoms and improving quality of life. This may include physical therapy, speech therapy, medications to manage symptoms, and assistive devices for mobility.""]",[true],[true],[true],"[""Currently, there is no specific treatment for ALSP. Symptomatic treatment may be provided to manage symptoms such as spasticity, movement disorders, and cognitive decline.""]","[""There is no specific treatment for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia. Supportive care and symptom management are typically recommended.""]","[""There is currently no cure for Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP). Treatment focuses on managing symptoms and providing supportive care.""]",[true],[true],[true],"[""Currently, there is no specific treatment for ALSP. Management involves symptomatic and supportive care to address the individual symptoms and complications that arise.""]","[""There is no specific treatment for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia. Management involves symptomatic and supportive care.""]","[""There is currently no cure for Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP). Treatment focuses on managing symptoms and providing supportive care.""]",[true],[true],[true],"[""Currently, there is no specific treatment for ALSP. Management involves symptomatic and supportive care to address the individual symptoms and complications that arise.""]","[""There is currently no specific treatment for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia. Management focuses on symptom relief and supportive care.""]","[""There is currently no cure for ALSP, but treatments focus on managing symptoms and improving quality of life. This may include physical therapy, speech therapy, and medications to help with muscle stiffness and spasticity.""]",[true],[true],[true],"[""Currently, there is no specific treatment for ALSP. Management involves symptom relief and supportive care.""]","[""There is no specific treatment for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia. Management focuses on symptom relief and supportive care.""]","[""There is currently no cure for ALSP, but treatments focus on managing symptoms and improving quality of life. This may include physical therapy, speech therapy, medications to manage symptoms, and assistive devices for mobility.""]",[true],[true],[true],"[""Currently, there is no specific treatment for ALSP. Management involves symptomatic and supportive care to address the individual symptoms and complications that arise.""]","[""There is no specific treatment for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia. Supportive care and symptom management are typically recommended.""]","[""There is currently no cure for Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP). Treatment focuses on managing symptoms and providing supportive care.""]",[true],[true],[true],"[""Currently, there is no specific treatment for ALSP. Management involves symptomatic and supportive care to address the individual symptoms and complications that arise.""]","[""There is no specific treatment for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia. Management involves symptomatic and supportive care.""]","[""There is currently no cure for Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP). Treatment focuses on managing symptoms and providing supportive care.""]",[true],[true],[true],"[""Currently, there is no specific treatment for ALSP. Management involves symptomatic and supportive care to address the individual symptoms and complications that arise.""]","[""There is currently no specific treatment for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia. Management focuses on symptom relief and supportive care.""]","[""There is currently no cure for ALSP, but treatments focus on managing symptoms and improving quality of life. This may include physical therapy, speech therapy, and medications to help with muscle stiffness and spasticity.""]",[true],[true],[true],"[""There is currently no cure for ALSP. Treatment focuses on managing symptoms and providing supportive care.""]","[""There is no specific treatment for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia. Management focuses on symptom relief and supportive care.""]","[""There is currently no cure for ALSP, but treatments focus on managing symptoms and improving quality of life. This may include physical therapy, speech therapy, medications to manage symptoms, and assistive devices for mobility.""]",[true],[true],[true],"[""There is currently no cure for ALSP. Treatment focuses on managing symptoms and providing supportive care.""]","[""There is no specific treatment for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia. Supportive care and symptom management are typically recommended.""]","[""There is currently no cure for Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP). Treatment focuses on managing symptoms and providing supportive care.""]",[false],[true],[true],"[""The treatments for ALSP (Adult Lifestyle Support Program) may include counseling, therapy, medication, and lifestyle modifications.""]","[""There is no specific treatment for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia. Supportive care and symptom management are typically recommended.""]","[""There is currently no cure for Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP). Treatment focuses on managing symptoms and providing supportive care.""]",[false],[true],[true],"[""Legal assistance, advocacy, and education""]","[""There is no specific treatment for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia. Supportive care and symptom management are typically recommended.""]","[""There is currently no cure for Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP). Treatment focuses on managing symptoms and providing supportive care.""]",[true],[true],[true],"[""There is currently no cure for ALSP. Treatment focuses on managing symptoms and providing supportive care.""]","[""There is no specific treatment for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia. Supportive care and symptom management are typically recommended.""]","[""There is currently no cure for Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP). Treatment focuses on managing symptoms and providing supportive care.""]"
frequency,How many people are affected by primary macronodular adrenal hyperplasia ?,"PMAH is a rare disorder. It is present in less than 1 percent of cases of endogenous Cushing syndrome, which describes forms of Cushing syndrome caused by factors internal to the body rather than by external factors such as long-term use of certain medicines called corticosteroids. The prevalence of endogenous Cushing syndrome is about 1 in 26,000 people.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""PMAH"", ""full_form"": ""primary macronodular adrenal hyperplasia""}]}",How many people are affected by PMAH ?,How many people are affected by primary macronodular adrenal hyperplasia ?,8,MEDICAL,Simple Datatype-Integer,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Primary macronodular adrenal hyperplasia"", ""Primary Macronodular Adrenocortical Hyperplasia"", ""Philippine Medical Association of Hawaii"", ""Professional Moms at Home"", ""Project Mend A House"", ""Professional Moms at Home"", ""Project Mend-A-House (Manassas, VA; est. 1984)"", ""Penn Musicians Against Homelessness (University of Pennsylvania)"", ""Philippine Medical Association of Hawaii"", ""Professional Moms at Home"", ""Project Mend-A-House (Manassas, VA; est. 1984)"", ""Penn Musicians Against Homelessness (University of Pennsylvania)"", ""Philippine Medical Association of Hawaii""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY""]]","[""Primary Macronodular Adrenal Hyperplasia""]",[2.983775036651625e-23],[2.983775036651625e-23],"[""Professional Moms at Home""]",[2.800364134587847e-12],"[""ABBREVIATIONS""]","[[2.983775036651625e-23, 2.7236685775724553e-30, 6.393942115194112e-29, 2.800364134587847e-12, 3.418571274378068e-17, 2.800364134587847e-12, 8.9254283741158e-51, 2.494287016147475e-42, 6.393942115194112e-29, 2.800364134587847e-12, 8.9254283741158e-51, 2.494287016147475e-42, 6.393942115194112e-29]]",[0.7575274058252254],[0.7547501317245155],"[""primary macronodular adrenal hyperplasia""]",[0.7619492870310238],"[""ABBREVIATIONS""]","[[0.7619492870310238, 0.7512529479544102, 0.7601022395127057, 0.7180675921005134, 0.7584234968290513, 0.7180675921005134, 0.7013210705866768, 0.6527344300333562, 0.7601022395127057, 0.7179543740612798, 0.7013796357332058, 0.6531295103867187, 0.7601022395127063]]","[""Primary Macronodular Adrenocortical Hyperplasia""]","[""ABBREVIATIONS""]",How many people are affected by PMAH (Primary Macronodular Adrenal Hyperplasia) ?,[false],[false],[false],"[""There is no specific data available on the exact number of people affected by PMAH (Professional Moms at Home).""]","[""Primary macronodular adrenal hyperplasia is a rare condition, affecting an estimated 1 in 1 million individuals per year.""]","[""PMAH affects approximately 1 in 1 million people.""]",[false],[true],[false],"[""There is no specific data available on the exact number of people affected by PMAH (Professional Moms at Home).""]","[""Primary macronodular adrenal hyperplasia is a rare condition, affecting a very small percentage of the population.""]","[""PMAH affects less than 1 in 1 million people.""]",[false],[false],[false],"[""There is no specific data available on the exact number of people affected by PMAH (Professional Moms at Home).""]","[""Primary macronodular adrenal hyperplasia is a rare condition, affecting less than 1 in 1,000,000 people.""]","[""PMAH affects less than 1 in 1 million people.""]",[false],[false],[false],"[""There is no specific data available on the exact number of people affected by PMAH (Professional Moms at Home).""]","[""Primary macronodular adrenal hyperplasia affects a very small percentage of the population, estimated to be less than 1 in 1,000,000 individuals.""]","[""PMAH affects approximately 1 in 1 million individuals.""]",[true],[false],[false],"[""PMAH affects a very small percentage of the population, with less than 1% of adrenal incidentalomas being attributed to PMAH.""]","[""Primary macronodular adrenal hyperplasia is a rare condition, affecting an estimated 1 in 1 million individuals per year.""]","[""PMAH affects approximately 1 in 1 million people.""]",[true],[true],[false],"[""PMAH affects a very small number of individuals worldwide.""]","[""Primary macronodular adrenal hyperplasia is a rare condition, affecting a very small percentage of the population.""]","[""PMAH affects less than 1 in 1 million people.""]",[false],[false],[false],"[""PMAH affects a very small percentage of the population, with less than 1% of adrenal incidentalomas being attributed to PMAH.""]","[""Primary macronodular adrenal hyperplasia is a rare condition, affecting less than 1 in 1,000,000 people.""]","[""PMAH affects less than 1 in 1 million people.""]",[true],[false],[false],"[""PMAH affects a very small percentage of the population.""]","[""Primary macronodular adrenal hyperplasia affects a very small percentage of the population, estimated to be less than 1 in 1,000,000 individuals.""]","[""PMAH affects approximately 1 in 1 million individuals.""]",[false],[true],[false],"[""PMAH affects less than 1 in 1 million individuals.""]","[""Primary macronodular adrenal hyperplasia is a rare condition, affecting a very small percentage of the population.""]","[""PMAH affects less than 1 in 1 million people.""]",[true],[false],[false],"[""PMAH affects a very small number of individuals, with less than 200 reported cases in medical literature.""]","[""Primary macronodular adrenal hyperplasia is a rare condition, affecting an estimated 1 in 1 million individuals per year.""]","[""PMAH affects approximately 1 in 1 million people.""]",[true],[false],[false],"[""PMAH affects a very small number of individuals, with only a few cases reported in medical literature.""]","[""Primary macronodular adrenal hyperplasia is a rare condition, affecting less than 1 in 1,000,000 people.""]","[""PMAH affects less than 1 in 1 million people.""]",[true],[false],[false],"[""PMAH affects a very small number of individuals worldwide.""]","[""Primary macronodular adrenal hyperplasia affects a very small percentage of the population, estimated to be less than 1 in 1,000,000 individuals.""]","[""PMAH affects approximately 1 in 1 million individuals.""]",[true],[false],[false],"[""PMAH affects a very small number of individuals worldwide.""]","[""Primary macronodular adrenal hyperplasia is a rare condition, affecting an estimated 1 in 1 million individuals per year.""]","[""PMAH affects approximately 1 in 1 million people.""]",[true],[true],[false],"[""PMAH affects a very small number of individuals worldwide.""]","[""Primary macronodular adrenal hyperplasia is a rare condition, affecting a very small percentage of the population.""]","[""PMAH affects less than 1 in 1 million people.""]",[true],[false],[false],"[""PMAH affects a very small number of individuals worldwide.""]","[""Primary macronodular adrenal hyperplasia is a rare condition, affecting less than 1 in 1,000,000 people.""]","[""PMAH affects less than 1 in 1 million people.""]",[true],[false],[false],"[""PMAH affects a very small number of individuals worldwide.""]","[""Primary macronodular adrenal hyperplasia affects a very small percentage of the population, estimated to be less than 1 in 1,000,000 individuals.""]","[""PMAH affects approximately 1 in 1 million individuals.""]",[true],[false],[false],"[""The number of people affected by PMAH is not readily available.""]","[""Primary macronodular adrenal hyperplasia is a rare condition, affecting an estimated 1 in 1 million individuals per year.""]","[""PMAH affects approximately 1 in 1 million people.""]",[true],[true],[false],"[""PMAH affects a very small number of individuals worldwide.""]","[""Primary macronodular adrenal hyperplasia is a rare condition, affecting a very small percentage of the population.""]","[""PMAH affects less than 1 in 1 million people.""]",[false],[false],[false],"[""PMAH affects less than 1 in 1 million individuals.""]","[""Primary macronodular adrenal hyperplasia is a rare condition, affecting less than 1 in 1,000,000 people.""]","[""PMAH affects less than 1 in 1 million people.""]",[true],[false],[false],"[""PMAH affects a very small number of individuals worldwide.""]","[""Primary macronodular adrenal hyperplasia affects a very small percentage of the population, estimated to be less than 1 in 1,000,000 individuals.""]","[""PMAH affects approximately 1 in 1 million individuals.""]",[false],[false],[false],"[""PMAH affects less than 1 in 1 million individuals.""]","[""Primary macronodular adrenal hyperplasia is a rare condition, affecting an estimated 1 in 1 million individuals per year.""]","[""PMAH affects approximately 1 in 1 million people.""]",[true],[true],[false],"[""PMAH affects a very small number of individuals worldwide.""]","[""Primary macronodular adrenal hyperplasia is a rare condition, affecting a very small percentage of the population.""]","[""PMAH affects less than 1 in 1 million people.""]",[false],[false],[false],"[""PMAH affects less than 1 in 1 million individuals.""]","[""Primary macronodular adrenal hyperplasia is a rare condition, affecting less than 1 in 1,000,000 people.""]","[""PMAH affects less than 1 in 1 million people.""]",[true],[true],[false],"[""PMAH affects less than 1 in 1 million individuals.""]","[""Primary macronodular adrenal hyperplasia affects a very small percentage of the population, estimated to be less than 1 in 1,000,000 individuals.""]","[""PMAH affects approximately 1 in 1 million individuals.""]",[false],[false],[false],"[""The prevalence of PMAH is estimated to be less than 1 in 1,000,000 individuals.""]","[""Primary macronodular adrenal hyperplasia is a rare condition, affecting an estimated 1 in 1 million individuals per year.""]","[""PMAH affects approximately 1 in 1 million people.""]",[true],[true],[false],"[""The exact number of people affected by PMAH (Primary Macronodular Adrenocortical Hyperplasia) is not well-documented, but it is considered a rare condition.""]","[""Primary macronodular adrenal hyperplasia is a rare condition, affecting a very small percentage of the population.""]","[""PMAH affects less than 1 in 1 million people.""]",[true],[false],[false],"[""The exact number of people affected by PMAH (Primary Macronodular Adrenocortical Hyperplasia) is not well-documented, but it is considered a rare condition.""]","[""Primary macronodular adrenal hyperplasia is a rare condition, affecting less than 1 in 1,000,000 people.""]","[""PMAH affects less than 1 in 1 million people.""]",[true],[false],[false],"[""The exact number of people affected by PMAH (Primary Macronodular Adrenocortical Hyperplasia) is not well-defined, as it is a rare condition.""]","[""Primary macronodular adrenal hyperplasia affects a very small percentage of the population, estimated to be less than 1 in 1,000,000 individuals.""]","[""PMAH affects approximately 1 in 1 million individuals.""]",[true],[false],[false],"[""The exact number of people affected by PMAH is not known, as it is a rare condition.""]","[""Primary macronodular adrenal hyperplasia is a rare condition, affecting an estimated 1 in 1 million individuals per year.""]","[""PMAH affects approximately 1 in 1 million people.""]",[false],[false],[false],"[""The number of people affected by PMAH (Professional Moms at Home) is not available.""]","[""Primary macronodular adrenal hyperplasia is a rare condition, affecting an estimated 1 in 1 million individuals per year.""]","[""PMAH affects approximately 1 in 1 million people.""]",[true],[false],[false],"[""The exact number of people affected by PMAH is not known.""]","[""Primary macronodular adrenal hyperplasia is a rare condition, affecting an estimated 1 in 1 million individuals per year.""]","[""PMAH affects approximately 1 in 1 million people.""]",[true],[false],[false],"[""The exact number of people affected by PMAH is not known.""]","[""Primary macronodular adrenal hyperplasia is a rare condition, affecting an estimated 1 in 1 million individuals per year.""]","[""PMAH affects approximately 1 in 1 million people.""]"
frequency,How many people are affected by antiphospholipid syndrome ?,"The exact prevalence of antiphospholipid syndrome is unknown. This condition is thought to be fairly common, and may be responsible for up to one percent of all thromboses. It is estimated that 20 percent of individuals younger than age 50 who have a stroke have antiphospholipid syndrome. Ten to 15 percent of people with systemic lupus erythematosus have antiphospholipid syndrome. Similarly, 10 to 15 percent of women with recurrent miscarriages likely have this condition. Approximately 70 percent of individuals diagnosed with antiphospholipid syndrome are female.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""APS"", ""full_form"": ""antiphospholipid syndrome""}]}",How many people are affected by APS ?,How many people are affected by antiphospholipid syndrome ?,8,MEDICAL,Simple Datatype-Integer,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""American Physiological Society"", ""American Physical Society"", ""Advanced Photon Source"", ""Advanced Photographic System"", ""Adult Protective Services"", ""Advanced Planning and Scheduling"", ""Automatic Protection Switching"", ""Australian Psychological Society"", ""Active Pixel Sensor"", ""Anti-Phospholipid Syndrome""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Antiphospholipid Syndrome""]",[1.0361844006945238e-09],[1.0361844006945238e-09],"[""Antiphospholipid Syndrome""]",[1.0361844006945238e-09],"[""LLM""]","[[3.300086222279693e-14, 7.198331721129107e-15, 3.0363344456833095e-15, 5.482804440651377e-16, 2.9504215122140127e-12, 3.6260899715173677e-16, 5.596451494880923e-17, 2.6185730617232885e-23, 1.3370915359004929e-17, 1.6002008268795463e-11]]",[0.8947690595275426],[0.8969753416603904],"[""Anti-Phospholipid Syndrome""]",[0.8969753416603904],"[""LLM""]","[[0.8243574139730236, 0.7541229340313329, 0.6879924500157611, 0.7463181204044206, 0.6961577638431312, 0.6928893581067321, 0.6981984384737088, 0.69016317832847, 0.7229127001969915, 0.8865045994102139]]","[""Anti-Phospholipid Syndrome""]","[""ABBREVIATIONS""]",How many people are affected by APS (Antiphospholipid Syndrome) ?,[false],[false],[false],"[""1 in 2000 people are affected by Antiphospholipid Syndrome (APS)""]","[""1 in 2000 people are affected by antiphospholipid syndrome""]","[""1 in 2000 people are affected by APS""]",[false],[false],[false],"[""1 in 2000 people are affected by APS (Antiphospholipid Syndrome)""]","[""1 in 2000 people are affected by antiphospholipid syndrome""]","[""1 in 2000 people are affected by Antiphospholipid Syndrome (APS)""]",[false],[false],[false],"[""1 in 2000 people are affected by Antiphospholipid Syndrome (APS)""]","[""1 in 2000 people are affected by antiphospholipid syndrome""]","[""1 in 2000 people are affected by APS""]",[false],[false],[false],"[""1 million""]","[""1 in 2000 people are affected by antiphospholipid syndrome""]","[""1 in 2000 people are affected by Antiphospholipid Syndrome (APS).""]",[false],[false],[false],"[""1 in 2000 people are affected by APS (Anti-Phospholipid Syndrome)""]","[""1 in 2000 people are affected by antiphospholipid syndrome""]","[""1 in 2000 people are affected by APS""]",[false],[false],[false],"[""1 in 2000 people are affected by APS (Anti-Phospholipid Syndrome)""]","[""1 in 2000 people are affected by antiphospholipid syndrome""]","[""1 in 2000 people are affected by Antiphospholipid Syndrome (APS)""]",[false],[false],[false],"[""1 in 2000 people are affected by APS (Anti-Phospholipid Syndrome)""]","[""1 in 2000 people are affected by antiphospholipid syndrome""]","[""1 in 2000 people are affected by APS""]",[false],[false],[false],"[""1 in 2000 people are affected by APS (Anti-Phospholipid Syndrome).""]","[""1 in 2000 people are affected by antiphospholipid syndrome""]","[""1 in 2000 people are affected by Antiphospholipid Syndrome (APS).""]",[false],[false],[false],"[""1 in 2000 people are affected by APS (Anti-Phospholipid Syndrome).""]","[""1 in 2000 people are affected by antiphospholipid syndrome""]","[""1 in 2000 people are affected by Antiphospholipid Syndrome (APS)""]",[false],[false],[false],"[""1 in 2000 people are affected by APS (Anti-Phospholipid Syndrome).""]","[""1 in 2000 people are affected by antiphospholipid syndrome""]","[""1 in 2000 people are affected by APS""]",[false],[false],[false],"[""1 in 2000 people are affected by APS (Anti-Phospholipid Syndrome)""]","[""1 in 2000 people are affected by antiphospholipid syndrome""]","[""1 in 2000 people are affected by APS""]",[false],[false],[false],"[""1 in 2000 people are affected by APS (Anti-Phospholipid Syndrome)""]","[""1 in 2000 people are affected by antiphospholipid syndrome""]","[""1 in 2000 people are affected by Antiphospholipid Syndrome (APS).""]",[false],[false],[false],"[""1 in 2000 people are affected by APS (Anti-Phospholipid Syndrome)""]","[""1 in 2000 people are affected by antiphospholipid syndrome""]","[""1 in 2000 people are affected by APS""]",[true],[false],[false],"[""Unknown""]","[""1 in 2000 people are affected by antiphospholipid syndrome""]","[""1 in 2000 people are affected by Antiphospholipid Syndrome (APS)""]",[true],[false],[false],"[""APS affects approximately 1% of the general population.""]","[""1 in 2000 people are affected by antiphospholipid syndrome""]","[""1 in 2000 people are affected by APS""]",[true],[false],[false],"[""Unknown""]","[""1 in 2000 people are affected by antiphospholipid syndrome""]","[""1 in 2000 people are affected by Antiphospholipid Syndrome (APS).""]",[false],[false],[false],"[""Not specified""]","[""1 in 2000 people are affected by antiphospholipid syndrome""]","[""1 in 2000 people are affected by APS""]",[false],[false],[false],"[""1 in 2000 people are affected by APS (Anti-Phospholipid Syndrome).""]","[""1 in 2000 people are affected by antiphospholipid syndrome""]","[""1 in 2000 people are affected by Antiphospholipid Syndrome (APS)""]",[false],[false],[false],"[""1 in 2000 people are affected by APS (Anti-Phospholipid Syndrome)""]","[""1 in 2000 people are affected by antiphospholipid syndrome""]","[""1 in 2000 people are affected by APS""]",[false],[false],[false],"[""1 in 2000 people are affected by APS (Anti-Phospholipid Syndrome)""]","[""1 in 2000 people are affected by antiphospholipid syndrome""]","[""1 in 2000 people are affected by Antiphospholipid Syndrome (APS).""]",[false],[false],[false],"[""1 in 2000 people are affected by Antiphospholipid Syndrome (APS)""]","[""1 in 2000 people are affected by antiphospholipid syndrome""]","[""1 in 2000 people are affected by APS""]",[false],[false],[false],"[""1 in 2000 people are affected by APS (Antiphospholipid Syndrome)""]","[""1 in 2000 people are affected by antiphospholipid syndrome""]","[""1 in 2000 people are affected by Antiphospholipid Syndrome (APS)""]",[false],[false],[false],"[""1 in 2000 people are affected by APS (Antiphospholipid Syndrome)""]","[""1 in 2000 people are affected by antiphospholipid syndrome""]","[""1 in 2000 people are affected by APS""]",[false],[false],[false],"[""1 million people worldwide are affected by APS (Antiphospholipid Syndrome).""]","[""1 in 2000 people are affected by antiphospholipid syndrome""]","[""1 in 2000 people are affected by Antiphospholipid Syndrome (APS).""]",[true],[false],[false],"[""The exact number of people affected by APS (Anti-Phospholipid Syndrome) is not known, but it is estimated to affect around 1% of the general population.""]","[""1 in 2000 people are affected by antiphospholipid syndrome""]","[""1 in 2000 people are affected by APS""]",[true],[false],[false],"[""APS can affect individuals of any age, gender, or race, but it is more common in women of childbearing age.""]","[""1 in 2000 people are affected by antiphospholipid syndrome""]","[""1 in 2000 people are affected by Antiphospholipid Syndrome (APS)""]",[true],[false],[false],"[""It is estimated that APS affects about 1% of the general population.""]","[""1 in 2000 people are affected by antiphospholipid syndrome""]","[""1 in 2000 people are affected by APS""]",[true],[false],[false],"[""APS affects approximately 1% of the general population.""]","[""1 in 2000 people are affected by antiphospholipid syndrome""]","[""1 in 2000 people are affected by Antiphospholipid Syndrome (APS).""]",[true],[false],[false],"[""The exact number of people affected by APS (Anti-Phospholipid Syndrome) is not known, but it is estimated to affect around 1% of the general population.""]","[""1 in 2000 people are affected by antiphospholipid syndrome""]","[""1 in 2000 people are affected by APS""]",[true],[false],[false],"[""The exact number of people affected by APS (Antiphospholipid Syndrome) is not known, but it is estimated to affect around 1 in 200 people.""]","[""1 in 2000 people are affected by antiphospholipid syndrome""]","[""1 in 2000 people are affected by APS""]",[true],[false],[false],"[""The exact number of people affected by APS (Anti-Phospholipid Syndrome) is not known, but it is estimated to affect around 1% of the general population.""]","[""1 in 2000 people are affected by antiphospholipid syndrome""]","[""1 in 2000 people are affected by APS""]",[false],[false],[false],"[""The exact number of people affected by APS (Antiphospholipid Syndrome) is not known, but it is estimated to affect around 1 in 2000 people.""]","[""1 in 2000 people are affected by antiphospholipid syndrome""]","[""1 in 2000 people are affected by APS""]"
treatment,What are the treatments for Mitral Valve Prolapse ?,"Most people who have mitral valve prolapse (MVP) dont need treatment because they dont have symptoms and complications.
                
Even people who do have symptoms may not need treatment. The presence of symptoms doesnt always mean that the backflow of blood through the valve is significant.
                
People who have MVP and troublesome mitral valve backflow may be treated with medicines, surgery, or both.
                
The goals of treating MVP include:
                
Correcting the underlying mitral valve problem, if necessary
                
Preventinginfective endocarditis,arrhythmias, and other complications
                
Relieving symptoms
                
Medicines
                
Medicines called beta blockers may be used to treatpalpitationsand chest discomfort in people who have little or no mitral valve backflow.
                
If you have significant backflow and symptoms, your doctor may prescribe:
                
Blood-thinning medicines to reduce the risk of blood clots forming if you haveatrial fibrillation.
                
Digoxin to strengthen your heartbeat.
                
Diuretics (fluidpills) to remove excess sodium and fluid in your body and lungs.
                
Medicines such as flecainide and procainamide to regulate your heart rhythms.
                
Vasodilators to widen your blood vessels and reduce your hearts workload. Examples of vasodilators are isosorbide dinitrate and hydralazine.
                
Take all medicines regularly, as your doctor prescribes. Dont change the amount of your medicine or skip a dose unless your doctor tells you to.
                
Surgery
                
Surgery is done only if the mitral valve is very abnormal and blood is flowing back into the atrium. The main goal of surgery is to improve symptoms and reduce the risk ofheart failure.
                
The timing of the surgery is important. If its done too early and your leaking valve is working fairly well, you may be put at needless risk from surgery. If its done too late, you may have heart damage that can't be fixed.
                
Surgical Approaches
                
Traditionally, heart surgeons repair or replace a mitral valve by making an incision (cut) in the breastbone and exposing the heart.
                
A small but growing number of surgeons are using another approach that involves one or more small cuts through the side of the chest wall. This results in less cutting, reduced blood loss, and a shorter hospital stay. However, not all hospitals offer this method.
                
Valve Repair and Valve Replacement
                
In mitral valve surgery, the valve is repaired or replaced. Valve repair is preferred when possible. Repair is less likely than replacement to weaken the heart. Repair also lowers the risk of infection and decreases the need for lifelong use of blood-thinning medicines.
                
If repair isnt an option, the valve can be replaced. Mechanical and biological valves are used as replacement valves.
                
Mechanical valves are man-made and can last a lifetime. People who have mechanical valves must take blood-thinning medicines for the rest of their lives.
                
Biological valves are taken from cows or pigs or made from human tissue. Many people who have biological valves dont need to take blood-thinning medicines for the rest of their lives. The major drawback of biological valves is that they weaken over time and often last only about 10 years.
                
After surgery, youll likely stay in the hospitals intensive care unit for 2 to 3 days. Overall, most people who have mitral valve surgery spend about 1 to 2 weeks in the hospital. Complete recovery takes a few weeks to several months, depending on your health before surgery.
                
If youve had valve repair or replacement, you may need antibiotics before dental work and surgery. These procedures can allow bacteria to enter your bloodstream. Antibiotics can help prevent infective endocarditis, a serious heart valve infection. Discuss with your doctor whether you need to take antibiotics before such procedures.
                
Transcatheter Valve Therapy
                
Interventional cardiologists may be able to repair leaky mitral valves by implanting a device using a catheter (tube) inserted through a large blood vessel. This approach is less invasive and can prevent a person from havingopen-heart surgery. At present, the device is only approved for people with severe mitral regurgitation who cannot undergo surgery.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""MVP"", ""full_form"": ""Mitral Valve Prolapse""}]}",What are the treatments for MVP ?,What are the treatments for Mitral Valve Prolapse ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Most Valuable Player"", ""Most Valuable Professional"", ""Mitral Valve Prolapse"", ""Most Valuable Primate"", ""Most Valued Professional"", ""Music And Video Player"", ""Music Video Player"", ""MindSolve Visual Performance"", ""Most Valuable Performer"", ""Music Video Pictures""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Mitral Valve Prolapse""]",[2.8370728467062494e-05],[2.8370728467062494e-05],"[""Mitral Valve Prolapse""]",[2.8370728467062494e-05],"[""ABBREVIATIONS""]","[[4.2769187254094016e-13, 2.1128099064943516e-14, 2.8370728467062494e-05, 2.4411277008332484e-15, 1.3094854110283902e-15, 1.2155355587863383e-13, 6.780666519180527e-14, 4.3889897663058505e-21, 2.4747594161060624e-15, 1.8876022505832428e-13]]",[0.9232121155490122],[0.9232165849355554],"[""Music Video Pictures""]",[0.9232165849355554],"[""LLM""]","[[0.9052479463721608, 0.8613500458480129, 0.9232121155490122, 0.6596924330375735, 0.7957531269444712, 0.7421156111000401, 0.7506893892921268, 0.7351122704673122, 0.841503272785038, 0.7934359003862801]]","[""Mitral Valve Prolapse""]","[""ABBREVIATIONS""]",What are the treatments for MVP (Mitral Valve Prolapse) ?,[true],[true],[true],"[""Medication, lifestyle changes, and in severe cases, surgery""]","[""Medications, lifestyle changes, and surgery are common treatments for Mitral Valve Prolapse.""]","[""Medication, lifestyle changes, and in severe cases, surgery""]",[true],[true],[true],"[""Medications, lifestyle changes, and in severe cases, surgery""]","[""Medications, lifestyle changes, and surgery are common treatments for Mitral Valve Prolapse.""]","[""Medication, lifestyle changes, and in severe cases, surgery""]",[false],[false],[true],"[""Medications, lifestyle changes, and in severe cases, surgery""]","[""Medication, lifestyle changes, and in severe cases, surgery""]","[""Medication to control symptoms, surgery in severe cases""]",[true],[true],[true],"[""Medications, lifestyle changes, and in severe cases, surgery""]","[""Medication, lifestyle changes, and in severe cases, surgery""]","[""Medication, lifestyle changes, and in severe cases, surgery""]",[true],[true],[true],"[""Medication and lifestyle changes are common treatments for Mitral Valve Prolapse (MVP). In severe cases, surgery may be required.""]","[""Medications, lifestyle changes, and surgery are common treatments for Mitral Valve Prolapse.""]","[""Medication, lifestyle changes, and in severe cases, surgery""]",[true],[true],[true],"[""Medication may be prescribed to manage symptoms of mitral valve prolapse (MVP), but in most cases, treatment is not necessary unless complications arise. Regular monitoring by a healthcare provider is recommended.""]","[""Medications, lifestyle changes, and surgery are common treatments for Mitral Valve Prolapse.""]","[""Medication, lifestyle changes, and in severe cases, surgery""]",[true],[true],[true],"[""Treatment for MVP (Mitral Valve Prolapse) may include medications to manage symptoms, such as beta-blockers or calcium channel blockers. In severe cases, surgery to repair or replace the mitral valve may be necessary.""]","[""Medication, lifestyle changes, and in severe cases, surgery""]","[""Medication to control symptoms, surgery in severe cases""]",[true],[true],[true],"[""Medication, lifestyle changes, and in severe cases, surgery""]","[""Medication, lifestyle changes, and in severe cases, surgery""]","[""Medication, lifestyle changes, and in severe cases, surgery""]",[true],[true],[true],"[""Medications, lifestyle changes, and in severe cases, surgery""]","[""Medications, lifestyle changes, and surgery are common treatments for Mitral Valve Prolapse.""]","[""Medication, lifestyle changes, and in severe cases, surgery""]",[true],[true],[true],"[""Medication, lifestyle changes, and in severe cases, surgery""]","[""Medications, lifestyle changes, and surgery are common treatments for Mitral Valve Prolapse.""]","[""Medication, lifestyle changes, and in severe cases, surgery""]",[true],[true],[true],"[""Medication, lifestyle changes, and in severe cases, surgery""]","[""Medication, lifestyle changes, and in severe cases, surgery""]","[""Medication to control symptoms, surgery in severe cases""]",[true],[true],[true],"[""Medication, lifestyle changes, and in severe cases, surgery""]","[""Medication, lifestyle changes, and in severe cases, surgery""]","[""Medication, lifestyle changes, and in severe cases, surgery""]",[true],[true],[true],"[""Medication, lifestyle changes, and in severe cases, surgery""]","[""Medications, lifestyle changes, and surgery are common treatments for Mitral Valve Prolapse.""]","[""Medication, lifestyle changes, and in severe cases, surgery""]",[true],[true],[true],"[""Medication, lifestyle changes, and in severe cases, surgery""]","[""Medications, lifestyle changes, and surgery are common treatments for Mitral Valve Prolapse.""]","[""Medication, lifestyle changes, and in severe cases, surgery""]",[true],[true],[true],"[""Medication, lifestyle changes, and in severe cases, surgery""]","[""Medication, lifestyle changes, and in severe cases, surgery""]","[""Medication to control symptoms, surgery in severe cases""]",[true],[true],[true],"[""Medications, lifestyle changes, and in severe cases, surgery""]","[""Medication, lifestyle changes, and in severe cases, surgery""]","[""Medication, lifestyle changes, and in severe cases, surgery""]",[true],[true],[true],"[""Medications, lifestyle changes, and in severe cases, surgery""]","[""Medications, lifestyle changes, and surgery are common treatments for Mitral Valve Prolapse.""]","[""Medication, lifestyle changes, and in severe cases, surgery""]",[true],[true],[true],"[""Medications, lifestyle changes, and in severe cases, surgery""]","[""Medications, lifestyle changes, and surgery are common treatments for Mitral Valve Prolapse.""]","[""Medication, lifestyle changes, and in severe cases, surgery""]",[true],[true],[true],"[""Medications, lifestyle changes, and in severe cases, surgery""]","[""Medication, lifestyle changes, and in severe cases, surgery""]","[""Medication to control symptoms, surgery in severe cases""]",[true],[true],[true],"[""Treatment for MVP may include medications to manage symptoms, such as beta-blockers or calcium channel blockers, and in severe cases, surgery to repair or replace the mitral valve.""]","[""Medication, lifestyle changes, and in severe cases, surgery""]","[""Medication, lifestyle changes, and in severe cases, surgery""]",[true],[true],[true],"[""Medications, lifestyle changes, and in severe cases, surgery""]","[""Medications, lifestyle changes, and surgery are common treatments for Mitral Valve Prolapse.""]","[""Medication, lifestyle changes, and in severe cases, surgery""]",[true],[true],[true],"[""Medications, lifestyle changes, and in severe cases, surgery""]","[""Medications, lifestyle changes, and surgery are common treatments for Mitral Valve Prolapse.""]","[""Medication, lifestyle changes, and in severe cases, surgery""]",[true],[true],[true],"[""Medications, lifestyle changes, and in severe cases, surgery""]","[""Medication, lifestyle changes, and in severe cases, surgery""]","[""Medication to control symptoms, surgery in severe cases""]",[true],[true],[true],"[""Medications, lifestyle changes, and in severe cases, surgery""]","[""Medication, lifestyle changes, and in severe cases, surgery""]","[""Medication, lifestyle changes, and in severe cases, surgery""]",[true],[true],[true],"[""Treatment for MVP (Mitral Valve Prolapse) may include medications, lifestyle changes, and in severe cases, surgery to repair or replace the mitral valve.""]","[""Medications, lifestyle changes, and surgery are common treatments for Mitral Valve Prolapse.""]","[""Medication, lifestyle changes, and in severe cases, surgery""]",[true],[true],[true],"[""Treatment for MVP (Mitral Valve Prolapse) may include medications to manage symptoms, such as beta-blockers or calcium channel blockers, and in severe cases, surgery to repair or replace the mitral valve.""]","[""Medications, lifestyle changes, and surgery are common treatments for Mitral Valve Prolapse.""]","[""Medication, lifestyle changes, and in severe cases, surgery""]",[true],[true],[true],"[""Treatment for MVP (Mitral Valve Prolapse) depends on the severity of symptoms and may include medications, lifestyle changes, and in severe cases, surgery to repair or replace the mitral valve.""]","[""Medication, lifestyle changes, and in severe cases, surgery""]","[""Medication to control symptoms, surgery in severe cases""]",[true],[true],[true],"[""Treatment for MVP (Mitral Valve Prolapse) may include medications to manage symptoms, such as beta-blockers or calcium channel blockers, and in severe cases, surgery to repair or replace the mitral valve.""]","[""Medication, lifestyle changes, and in severe cases, surgery""]","[""Medication, lifestyle changes, and in severe cases, surgery""]",[true],[true],[true],"[""Treatment for MVP may include medications, lifestyle changes, and in severe cases, surgery.""]","[""Medications, lifestyle changes, and surgery are common treatments for Mitral Valve Prolapse.""]","[""Medication, lifestyle changes, and in severe cases, surgery""]",[true],[true],[true],"[""Treatment for MVP may not be necessary if there are no symptoms. In cases where symptoms are present, treatment may include medications to manage symptoms, surgery to repair or replace the mitral valve, and lifestyle changes such as regular exercise and a heart-healthy diet.""]","[""Medications, lifestyle changes, and surgery are common treatments for Mitral Valve Prolapse.""]","[""Medication, lifestyle changes, and in severe cases, surgery""]",[true],[true],[true],"[""Treatment for MVP may include medications, lifestyle changes, and in some cases, surgery.""]","[""Medications, lifestyle changes, and surgery are common treatments for Mitral Valve Prolapse.""]","[""Medication, lifestyle changes, and in severe cases, surgery""]",[true],[true],[true],"[""Treatment for MVP may not be necessary if there are no symptoms. In cases where symptoms are present, treatment may include medications to manage symptoms, surgery to repair or replace the mitral valve, and lifestyle changes to improve heart health.""]","[""Medications, lifestyle changes, and surgery are common treatments for Mitral Valve Prolapse.""]","[""Medication, lifestyle changes, and in severe cases, surgery""]"
symptoms,What are the symptoms of Adult neuronal ceroid lipofuscinosis ?,"What are the signs and symptoms of Adult neuronal ceroid lipofuscinosis? The Human Phenotype Ontology provides the following list of signs and symptoms for Adult neuronal ceroid lipofuscinosis. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormal pyramidal signs 90% Abnormality of extrapyramidal motor function 90% Behavioral abnormality 90% Developmental regression 90% Incoordination 90% Involuntary movements 90% Seizures 90% Retinopathy 7.5% Visual impairment 7.5% The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""ANCL"", ""full_form"": ""Adult neuronal ceroid lipofuscinosis""}]}",What are the symptoms of ANCL ?,What are the symptoms of Adult neuronal ceroid lipofuscinosis ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Associated Newspapers of Ceylon, LTD."", ""Advanced Network Computing Laboratory"", ""Adult Neuronal Ceroid Lipofuscinosis"", ""African Network of Constitutional Lawyers"", ""All Nations Church Luxembourg"", ""Ante Nicene Christian Library"", ""Applied Neural Control Laboratory"", ""Applied Nonlinear Controls Lab"", ""Associated Newspapers of Ceylon Limited"", ""Associated Newspapers of Ceylon Ltd""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Adult Neuronal Ceroid Lipofuscinosis""]",[1.3394689169552187e-36],[1.3394689169552187e-36],"[""Applied Neural Control Laboratory""]",[1.6577346362571792e-20],"[""ABBREVIATIONS""]","[[8.802664683852641e-32, 1.4422935429867319e-21, 1.3394689169552187e-36, 2.3268499975156073e-24, 5.0410878047103405e-30, 8.002247173243505e-30, 1.6577346362571792e-20, 4.9040822106606167e-23, 1.7758358765975763e-29, 3.126667937599863e-31]]",[0.7032451628896865],[0.6997861913381573],"[""Ante Nicene Christian Library""]",[0.791218484855857],"[""ABBREVIATIONS""]","[[0.7063526199881027, 0.7525869335598145, 0.6997861913381573, 0.7129756518748881, 0.7310443873129717, 0.7399228763937848, 0.791218484855857, 0.6989998952778105, 0.69238152876852, 0.6980866782456148]]","[""Adult Neuronal Ceroid Lipofuscinosis""]","[""ABBREVIATIONS""]",What are the symptoms of ANCL (Adult Neuronal Ceroid Lipofuscinosis) ?,[false],[true],[false],"[""Common symptoms of ANCL (Applied Neural Control Laboratory) include muscle weakness, difficulty walking, and speech problems.""]","[""Symptoms of Adult neuronal ceroid lipofuscinosis include seizures, vision loss, psychiatric symptoms, and movement disorders.""]","[""Common symptoms of ANCL (Autoimmune Lymphoproliferative Syndrome) include enlarged lymph nodes, hepatosplenomegaly, autoimmune cytopenias, and recurrent infections.""]",[false],[true],[false],"[""The symptoms of ANCL (Applied Neural Control Laboratory) are not related to a medical condition, as ANCL is a research laboratory and not a disease or disorder.""]","[""Symptoms of Adult neuronal ceroid lipofuscinosis include seizures, vision loss, muscle stiffness, and cognitive decline.""]","[""Fever, enlarged liver and spleen, frequent infections, and neurological symptoms""]",[false],[true],[false],"[""The symptoms of ANCL (Applied Neural Control Laboratory) are not related to a medical condition, but rather it is a research laboratory focusing on neural control and related fields.""]","[""Symptoms of Adult neuronal ceroid lipofuscinosis include seizures, vision loss, muscle twitches, and cognitive decline.""]","[""Common symptoms of ANCL (Autoinflammatory necrotizing lymphadenitis) include fever, enlarged lymph nodes, skin rash, and abdominal pain.""]",[false],[true],[false],"[""Common symptoms of ANCL include muscle weakness, difficulty walking, and speech problems.""]","[""Symptoms of Adult neuronal ceroid lipofuscinosis include seizures, vision loss, muscle stiffness, and cognitive decline.""]","[""Common symptoms of ANCL include fever, enlarged spleen, enlarged liver, and frequent infections.""]",[false],[true],[false],"[""Symptoms of ANCL (Ante Nicene Christian Library) are not related to medical conditions. It is a collection of early Christian writings.""]","[""Symptoms of Adult neuronal ceroid lipofuscinosis include seizures, vision loss, psychiatric symptoms, and movement disorders.""]","[""Common symptoms of ANCL (Autoimmune Lymphoproliferative Syndrome) include enlarged lymph nodes, hepatosplenomegaly, autoimmune cytopenias, and recurrent infections.""]",[false],[true],[false],"[""Symptoms of ANCL (Ante Nicene Christian Library) are not related to medical conditions, as it is a collection of early Christian writings.""]","[""Symptoms of Adult neuronal ceroid lipofuscinosis include seizures, vision loss, muscle stiffness, and cognitive decline.""]","[""Fever, enlarged liver and spleen, frequent infections, and neurological symptoms""]",[false],[true],[false],"[""Symptoms of ANCL (Ante Nicene Christian Library) are not related to a medical condition, as it is a collection of early Christian writings.""]","[""Symptoms of Adult neuronal ceroid lipofuscinosis include seizures, vision loss, muscle twitches, and cognitive decline.""]","[""Common symptoms of ANCL (Autoinflammatory necrotizing lymphadenitis) include fever, enlarged lymph nodes, skin rash, and abdominal pain.""]",[false],[true],[false],"[""ANCL (Ante Nicene Christian Library) is not a medical condition, it is a collection of early Christian writings. It does not have symptoms related to a medical illness.""]","[""Symptoms of Adult neuronal ceroid lipofuscinosis include seizures, vision loss, muscle stiffness, and cognitive decline.""]","[""Common symptoms of ANCL include fever, enlarged spleen, enlarged liver, and frequent infections.""]",[true],[true],[false],"[""Symptoms of ANCL (Adult Neuronal Ceroid Lipofuscinosis) include seizures, movement disorders, cognitive decline, and psychiatric symptoms.""]","[""Symptoms of Adult neuronal ceroid lipofuscinosis include seizures, vision loss, muscle stiffness, and cognitive decline.""]","[""Fever, enlarged liver and spleen, frequent infections, and neurological symptoms""]",[true],[true],[false],"[""Symptoms of ANCL (Adult Neuronal Ceroid Lipofuscinosis) include seizures, movement disorders, cognitive decline, psychiatric symptoms, and vision loss.""]","[""Symptoms of Adult neuronal ceroid lipofuscinosis include seizures, vision loss, psychiatric symptoms, and movement disorders.""]","[""Common symptoms of ANCL (Autoimmune Lymphoproliferative Syndrome) include enlarged lymph nodes, hepatosplenomegaly, autoimmune cytopenias, and recurrent infections.""]",[true],[true],[false],"[""Symptoms of ANCL (Adult Neuronal Ceroid Lipofuscinosis) include seizures, movement disorders, psychiatric symptoms, and cognitive decline.""]","[""Symptoms of Adult neuronal ceroid lipofuscinosis include seizures, vision loss, muscle twitches, and cognitive decline.""]","[""Common symptoms of ANCL (Autoinflammatory necrotizing lymphadenitis) include fever, enlarged lymph nodes, skin rash, and abdominal pain.""]",[true],[true],[false],"[""Symptoms of ANCL (Adult Neuronal Ceroid Lipofuscinosis) include seizures, movement disorders, cognitive decline, psychiatric symptoms, and vision loss.""]","[""Symptoms of Adult neuronal ceroid lipofuscinosis include seizures, vision loss, muscle stiffness, and cognitive decline.""]","[""Common symptoms of ANCL include fever, enlarged spleen, enlarged liver, and frequent infections.""]",[true],[true],[false],"[""Symptoms of ANCL (Adult Neuronal Ceroid Lipofuscinosis) include seizures, movement disorders, cognitive decline, and vision loss.""]","[""Symptoms of Adult neuronal ceroid lipofuscinosis include seizures, vision loss, psychiatric symptoms, and movement disorders.""]","[""Common symptoms of ANCL (Autoimmune Lymphoproliferative Syndrome) include enlarged lymph nodes, hepatosplenomegaly, autoimmune cytopenias, and recurrent infections.""]",[true],[true],[false],"[""Symptoms of ANCL (Adult Neuronal Ceroid Lipofuscinosis) include seizures, vision loss, movement disorders, and cognitive decline.""]","[""Symptoms of Adult neuronal ceroid lipofuscinosis include seizures, vision loss, muscle stiffness, and cognitive decline.""]","[""Fever, enlarged liver and spleen, frequent infections, and neurological symptoms""]",[true],[true],[false],"[""Symptoms of ANCL (Adult Neuronal Ceroid Lipofuscinosis) include seizures, vision loss, movement disorders, and cognitive decline.""]","[""Symptoms of Adult neuronal ceroid lipofuscinosis include seizures, vision loss, muscle twitches, and cognitive decline.""]","[""Common symptoms of ANCL (Autoinflammatory necrotizing lymphadenitis) include fever, enlarged lymph nodes, skin rash, and abdominal pain.""]",[true],[true],[false],"[""Symptoms of ANCL (Adult Neuronal Ceroid Lipofuscinosis) include seizures, movement disorders, cognitive decline, and vision loss.""]","[""Symptoms of Adult neuronal ceroid lipofuscinosis include seizures, vision loss, muscle stiffness, and cognitive decline.""]","[""Common symptoms of ANCL include fever, enlarged spleen, enlarged liver, and frequent infections.""]",[true],[true],[false],"[""Symptoms of ANCL (Adult Neuronal Ceroid Lipofuscinosis) include seizures, movement disorders, vision loss, and cognitive decline.""]","[""Symptoms of Adult neuronal ceroid lipofuscinosis include seizures, vision loss, psychiatric symptoms, and movement disorders.""]","[""Common symptoms of ANCL (Autoimmune Lymphoproliferative Syndrome) include enlarged lymph nodes, hepatosplenomegaly, autoimmune cytopenias, and recurrent infections.""]",[true],[true],[false],"[""Symptoms of ANCL (Adult Neuronal Ceroid Lipofuscinosis) include seizures, dementia, movement disorders, and vision loss.""]","[""Symptoms of Adult neuronal ceroid lipofuscinosis include seizures, vision loss, muscle stiffness, and cognitive decline.""]","[""Fever, enlarged liver and spleen, frequent infections, and neurological symptoms""]",[true],[true],[false],"[""Symptoms of ANCL (Adult Neuronal Ceroid Lipofuscinosis) include seizures, movement disorders, psychiatric symptoms, and cognitive decline.""]","[""Symptoms of Adult neuronal ceroid lipofuscinosis include seizures, vision loss, muscle twitches, and cognitive decline.""]","[""Common symptoms of ANCL (Autoinflammatory necrotizing lymphadenitis) include fever, enlarged lymph nodes, skin rash, and abdominal pain.""]",[true],[true],[false],"[""Symptoms of ANCL (Adult Neuronal Ceroid Lipofuscinosis) include seizures, movement disorders, vision loss, cognitive decline, and psychiatric symptoms.""]","[""Symptoms of Adult neuronal ceroid lipofuscinosis include seizures, vision loss, muscle stiffness, and cognitive decline.""]","[""Common symptoms of ANCL include fever, enlarged spleen, enlarged liver, and frequent infections.""]",[true],[true],[false],"[""Symptoms of ANCL (Adult Neuronal Ceroid Lipofuscinosis) include seizures, movement disorders, cognitive decline, psychiatric symptoms, and vision loss.""]","[""Symptoms of Adult neuronal ceroid lipofuscinosis include seizures, vision loss, psychiatric symptoms, and movement disorders.""]","[""Common symptoms of ANCL (Autoimmune Lymphoproliferative Syndrome) include enlarged lymph nodes, hepatosplenomegaly, autoimmune cytopenias, and recurrent infections.""]",[true],[true],[false],"[""Symptoms of ANCL (Adult Neuronal Ceroid Lipofuscinosis) include seizures, movement disorders, psychiatric symptoms, and cognitive decline.""]","[""Symptoms of Adult neuronal ceroid lipofuscinosis include seizures, vision loss, muscle stiffness, and cognitive decline.""]","[""Fever, enlarged liver and spleen, frequent infections, and neurological symptoms""]",[true],[true],[false],"[""Symptoms of ANCL (Adult Neuronal Ceroid Lipofuscinosis) include seizures, movement disorders, psychiatric symptoms, and cognitive decline.""]","[""Symptoms of Adult neuronal ceroid lipofuscinosis include seizures, vision loss, muscle twitches, and cognitive decline.""]","[""Common symptoms of ANCL (Autoinflammatory necrotizing lymphadenitis) include fever, enlarged lymph nodes, skin rash, and abdominal pain.""]",[true],[true],[false],"[""Symptoms of ANCL (Adult Neuronal Ceroid Lipofuscinosis) include seizures, movement disorders, vision loss, cognitive decline, and psychiatric symptoms.""]","[""Symptoms of Adult neuronal ceroid lipofuscinosis include seizures, vision loss, muscle stiffness, and cognitive decline.""]","[""Common symptoms of ANCL include fever, enlarged spleen, enlarged liver, and frequent infections.""]",[true],[true],[false],"[""Symptoms of ANCL include seizures, vision loss, muscle stiffness, movement disorders, and cognitive decline.""]","[""Symptoms of Adult neuronal ceroid lipofuscinosis include seizures, vision loss, psychiatric symptoms, and movement disorders.""]","[""Common symptoms of ANCL (Autoimmune Lymphoproliferative Syndrome) include enlarged lymph nodes, hepatosplenomegaly, autoimmune cytopenias, and recurrent infections.""]",[true],[true],[false],"[""Symptoms of ANCL (Adult Neuronal Ceroid Lipofuscinosis) include seizures, movement disorders, vision loss, and cognitive decline.""]","[""Symptoms of Adult neuronal ceroid lipofuscinosis include seizures, vision loss, muscle stiffness, and cognitive decline.""]","[""Fever, enlarged liver and spleen, frequent infections, and neurological symptoms""]",[true],[true],[false],"[""Symptoms of ANCL (Adult Neuronal Ceroid Lipofuscinosis) include seizures, vision loss, muscle stiffness, movement disorders, and cognitive decline.""]","[""Symptoms of Adult neuronal ceroid lipofuscinosis include seizures, vision loss, muscle twitches, and cognitive decline.""]","[""Common symptoms of ANCL (Autoinflammatory necrotizing lymphadenitis) include fever, enlarged lymph nodes, skin rash, and abdominal pain.""]",[true],[true],[false],"[""Symptoms of ANCL (Adult Neuronal Ceroid Lipofuscinosis) include seizures, movement disorders, vision loss, and cognitive decline.""]","[""Symptoms of Adult neuronal ceroid lipofuscinosis include seizures, vision loss, muscle stiffness, and cognitive decline.""]","[""Common symptoms of ANCL include fever, enlarged spleen, enlarged liver, and frequent infections.""]",[true],[true],[false],"[""Symptoms of ANCL include seizures, vision loss, movement disorders, cognitive decline, and psychiatric symptoms.""]","[""Symptoms of Adult neuronal ceroid lipofuscinosis include seizures, vision loss, psychiatric symptoms, and movement disorders.""]","[""Common symptoms of ANCL (Autoimmune Lymphoproliferative Syndrome) include enlarged lymph nodes, hepatosplenomegaly, autoimmune cytopenias, and recurrent infections.""]",[false],[true],[false],"[""Symptoms of ANCL are not applicable as it is a laboratory, not a medical condition.""]","[""Symptoms of Adult neuronal ceroid lipofuscinosis include seizures, vision loss, psychiatric symptoms, and movement disorders.""]","[""Common symptoms of ANCL (Autoimmune Lymphoproliferative Syndrome) include enlarged lymph nodes, hepatosplenomegaly, autoimmune cytopenias, and recurrent infections.""]",[false],[true],[false],"[""The Ante-Nicene Christian Library (ANCL) is a collection of early Christian writings and not a medical condition, therefore it does not have symptoms.""]","[""Symptoms of Adult neuronal ceroid lipofuscinosis include seizures, vision loss, psychiatric symptoms, and movement disorders.""]","[""Common symptoms of ANCL (Autoimmune Lymphoproliferative Syndrome) include enlarged lymph nodes, hepatosplenomegaly, autoimmune cytopenias, and recurrent infections.""]",[true],[true],[false],"[""Symptoms of ANCL (Adult Neuronal Ceroid Lipofuscinosis) include seizures, dementia, vision loss, movement disorders, and behavioral changes.""]","[""Symptoms of Adult neuronal ceroid lipofuscinosis include seizures, vision loss, psychiatric symptoms, and movement disorders.""]","[""Common symptoms of ANCL (Autoimmune Lymphoproliferative Syndrome) include enlarged lymph nodes, hepatosplenomegaly, autoimmune cytopenias, and recurrent infections.""]"
complications,What are the complications of Crohn's Disease ?,"Complications of Crohn's disease can include
                
- bowel obstruction. Crohn's disease can thicken the wall of the intestine. Over time, the thickened areas of the intestine can narrow, which can block the intestine. A partial or complete obstruction, also called a bowel blockage, can block the movement of food or stool through the intestines. A complete bowel obstruction is life threatening and requires immediate medical attention and often surgery.  - fistulasabnormal passages, or tunnels, between two organs, or between an organ and the outside of the body. How a health care provider treats fistulas depends on their type and severity. For some people, fistulas heal with medication and diet changes, while other people will need to have surgery.  - anal fissuressmall tears in the anus that may cause itching, pain, or bleeding. Most anal fissures heal with medical treatment, including ointments, warm baths, and dietary changes.  - ulcers. Inflammation anywhere along the GI tract can lead to ulcers or open sores in a person's mouth, intestines, anus, and perineumthe area between the anus and the sex organs. In most cases, the treatment a health care provider prescribes for Crohn's disease will also treat the ulcers.  - malnutritiona condition that develops when the body does not get the right amount of vitamins, minerals, and nutrients it needs to maintain healthy tissues and organ function. Some people may need IV fluids or feeding tubes to replace lost nutrients and fluids.  - inflammation in other areas of the body. The immune system can trigger inflammation in the      - joints    - eyes    - skin
                
Health care providers can treat inflammation by adjusting medications or prescribing new medications.
                

                
Crohn's Disease and Colon Cancer   People with Crohn's disease in the large intestine may be more likely to develop colon cancer. People who receive ongoing treatment and remain in remission may reduce their chances of developing colon cancer.   People with Crohn's disease should talk with their health care provider about how often they should get screened for colon cancer. Screening can include colonoscopy with biopsies. Such screening does not reduce a person's chances of developing colon cancer. Instead, screening can help diagnose cancer early and improve chances for recovery.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""CD"", ""full_form"": ""Crohn's Disease""}]}",What are the complications of CD ?,What are the complications of Crohn's Disease ?,8,MEDICAL,Compound Datatype-String,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Compact Disc"", ""Compact Disc - Music, software programs and digital media"", ""Celine Dion"", ""Cadmium"", ""Christian Dior"", ""Canadian Dollar"", ""Compact Disk"", ""Cardiovascular Disease"", ""Compact Disk description"", ""Compact Design""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Crohn's Disease""]",[1.3778947268398383e-05],[1.3778947268398383e-05],"[""Crohn's Disease""]",[1.3778947268398383e-05],"[""LLM""]","[[7.712626982684453e-07, 7.319270500233607e-31, 4.3473077338038556e-17, 1.247168266650877e-12, 2.337955584200817e-16, 1.9527534156837935e-14, 6.983667249782537e-08, 2.2782968069922384e-06, 6.945003195096496e-13, 5.2829372574802514e-11]]",[0.9072487677462284],[0.907221906845811],"[""Compact Design""]",[0.907221906845811],"[""LLM""]","[[0.7027447715756199, 0.6399986855432767, 0.7484442630911146, 0.7116008553982955, 0.7399346999789396, 0.7033594733385519, 0.7155035653149393, 0.7653626841975164, 0.6796316109601712, 0.6958884206596166]]","[""Cardiovascular Disease""]","[""ABBREVIATIONS""]",What are the complications of CD (Crohn's Disease) ?,[false],[true],[true],"[""Complications of Crohn's Disease include strictures, fistulas, abscesses, malnutrition, and colorectal cancer.""]","[""Complications of Crohn's Disease include strictures, fistulas, abscesses, malnutrition, and bowel obstructions.""]","[""Complications of Crohn's disease include bowel obstruction, ulcers, fistulas, malnutrition, and inflammation in other parts of the body.""]",[true],[true],[true],"[""Complications of Crohn's Disease include bowel obstruction, ulcers, fistulas, malnutrition, and colon cancer.""]","[""Complications of Crohn's Disease include strictures, fistulas, abscesses, malnutrition, and bowel obstructions.""]","[""Complications of Crohn's disease include bowel obstruction, ulcers, fistulas, malnutrition, and inflammation in other parts of the body.""]",[false],[true],[true],"[""Complications of Crohn's Disease include strictures, fistulas, abscesses, malnutrition, and colorectal cancer.""]","[""Complications of Crohn's Disease include strictures, fistulas, abscesses, malnutrition, and bowel obstructions.""]","[""Complications of Crohn's disease include bowel obstruction, ulcers, malnutrition, fistulas, and abscesses.""]",[false],[true],[true],"[""Complications of Crohn's Disease include strictures, fistulas, abscesses, malnutrition, and colorectal cancer.""]","[""Complications of Crohn's Disease include strictures, fistulas, abscesses, malnutrition, and bowel obstructions.""]","[""Complications of Crohn's disease include bowel obstruction, ulcers, fistulas, malnutrition, and inflammation in other parts of the body.""]",[false],[true],[true],"[""Complications of CD (Compact Design) can include infection, leakage, and blockage of the bile ducts.""]","[""Complications of Crohn's Disease include strictures, fistulas, abscesses, malnutrition, and bowel obstructions.""]","[""Complications of Crohn's disease include bowel obstruction, ulcers, fistulas, malnutrition, and inflammation in other parts of the body.""]",[false],[true],[true],"[""Complications of CD (Compact Design) include infection, leakage, and blockage of the catheter.""]","[""Complications of Crohn's Disease include strictures, fistulas, abscesses, malnutrition, and bowel obstructions.""]","[""Complications of Crohn's disease include bowel obstruction, ulcers, fistulas, malnutrition, and inflammation in other parts of the body.""]",[false],[true],[true],"[""Complications of CD (Compact Design) include infection, leakage, and blockage of the bile ducts.""]","[""Complications of Crohn's Disease include strictures, fistulas, abscesses, malnutrition, and bowel obstructions.""]","[""Complications of Crohn's disease include bowel obstruction, ulcers, malnutrition, fistulas, and abscesses.""]",[false],[true],[true],"[""Some complications of CD (Compact Design) include infection, implant failure, and nerve damage.""]","[""Complications of Crohn's Disease include strictures, fistulas, abscesses, malnutrition, and bowel obstructions.""]","[""Complications of Crohn's disease include bowel obstruction, ulcers, fistulas, malnutrition, and inflammation in other parts of the body.""]",[false],[true],[true],"[""Complications of Cardiovascular Disease include heart attack, stroke, heart failure, peripheral artery disease, and aneurysms.""]","[""Complications of Crohn's Disease include strictures, fistulas, abscesses, malnutrition, and bowel obstructions.""]","[""Complications of Crohn's disease include bowel obstruction, ulcers, fistulas, malnutrition, and inflammation in other parts of the body.""]",[false],[true],[true],"[""Complications of Cardiovascular Disease include heart attack, stroke, heart failure, peripheral artery disease, and aneurysms.""]","[""Complications of Crohn's Disease include strictures, fistulas, abscesses, malnutrition, and bowel obstructions.""]","[""Complications of Crohn's disease include bowel obstruction, ulcers, fistulas, malnutrition, and inflammation in other parts of the body.""]",[false],[true],[true],"[""Complications of Cardiovascular Disease include heart attack, stroke, heart failure, peripheral artery disease, and aneurysms.""]","[""Complications of Crohn's Disease include strictures, fistulas, abscesses, malnutrition, and bowel obstructions.""]","[""Complications of Crohn's disease include bowel obstruction, ulcers, malnutrition, fistulas, and abscesses.""]",[false],[true],[true],"[""Common complications of cardiovascular disease include heart attack, stroke, heart failure, and peripheral artery disease.""]","[""Complications of Crohn's Disease include strictures, fistulas, abscesses, malnutrition, and bowel obstructions.""]","[""Complications of Crohn's disease include bowel obstruction, ulcers, fistulas, malnutrition, and inflammation in other parts of the body.""]",[false],[true],[true],"[""Complications of Cardiovascular Disease include heart attack, stroke, heart failure, peripheral artery disease, and aneurysms.""]","[""Complications of Crohn's Disease include strictures, fistulas, abscesses, malnutrition, and bowel obstructions.""]","[""Complications of Crohn's disease include bowel obstruction, ulcers, fistulas, malnutrition, and inflammation in other parts of the body.""]",[false],[true],[true],"[""Complications of Cardiovascular Disease include heart attack, stroke, heart failure, peripheral artery disease, and aneurysms.""]","[""Complications of Crohn's Disease include strictures, fistulas, abscesses, malnutrition, and bowel obstructions.""]","[""Complications of Crohn's disease include bowel obstruction, ulcers, fistulas, malnutrition, and inflammation in other parts of the body.""]",[false],[true],[true],"[""Complications of Cardiovascular Disease include heart attack, stroke, heart failure, peripheral artery disease, and aneurysms.""]","[""Complications of Crohn's Disease include strictures, fistulas, abscesses, malnutrition, and bowel obstructions.""]","[""Complications of Crohn's disease include bowel obstruction, ulcers, malnutrition, fistulas, and abscesses.""]",[false],[true],[true],"[""Complications of Cardiovascular Disease include heart attack, stroke, heart failure, peripheral artery disease, and aneurysms.""]","[""Complications of Crohn's Disease include strictures, fistulas, abscesses, malnutrition, and bowel obstructions.""]","[""Complications of Crohn's disease include bowel obstruction, ulcers, fistulas, malnutrition, and inflammation in other parts of the body.""]",[false],[true],[true],"[""Complications of Cardiovascular Disease include heart attack, stroke, heart failure, peripheral artery disease, and aneurysms.""]","[""Complications of Crohn's Disease include strictures, fistulas, abscesses, malnutrition, and bowel obstructions.""]","[""Complications of Crohn's disease include bowel obstruction, ulcers, fistulas, malnutrition, and inflammation in other parts of the body.""]",[false],[true],[true],"[""Complications of Cardiovascular Disease include heart attack, stroke, heart failure, peripheral artery disease, and aneurysms.""]","[""Complications of Crohn's Disease include strictures, fistulas, abscesses, malnutrition, and bowel obstructions.""]","[""Complications of Crohn's disease include bowel obstruction, ulcers, fistulas, malnutrition, and inflammation in other parts of the body.""]",[false],[true],[true],"[""Complications of Cardiovascular Disease include heart attack, stroke, heart failure, peripheral artery disease, and aneurysms.""]","[""Complications of Crohn's Disease include strictures, fistulas, abscesses, malnutrition, and bowel obstructions.""]","[""Complications of Crohn's disease include bowel obstruction, ulcers, malnutrition, fistulas, and abscesses.""]",[false],[true],[true],"[""Complications of Cardiovascular Disease include heart attack, stroke, heart failure, peripheral artery disease, and aneurysms.""]","[""Complications of Crohn's Disease include strictures, fistulas, abscesses, malnutrition, and bowel obstructions.""]","[""Complications of Crohn's disease include bowel obstruction, ulcers, fistulas, malnutrition, and inflammation in other parts of the body.""]",[false],[true],[true],"[""Complications of Crohn's Disease include strictures, fistulas, abscesses, malnutrition, and colorectal cancer.""]","[""Complications of Crohn's Disease include strictures, fistulas, abscesses, malnutrition, and bowel obstructions.""]","[""Complications of Crohn's disease include bowel obstruction, ulcers, fistulas, malnutrition, and inflammation in other parts of the body.""]",[true],[true],[true],"[""Complications of Crohn's Disease include intestinal strictures, fistulas, abscesses, malnutrition, and colorectal cancer.""]","[""Complications of Crohn's Disease include strictures, fistulas, abscesses, malnutrition, and bowel obstructions.""]","[""Complications of Crohn's disease include bowel obstruction, ulcers, fistulas, malnutrition, and inflammation in other parts of the body.""]",[false],[true],[true],"[""Complications of Crohn's Disease include strictures, fistulas, abscesses, malnutrition, and colorectal cancer.""]","[""Complications of Crohn's Disease include strictures, fistulas, abscesses, malnutrition, and bowel obstructions.""]","[""Complications of Crohn's disease include bowel obstruction, ulcers, malnutrition, fistulas, and abscesses.""]",[false],[true],[true],"[""Complications of Crohn's Disease include strictures, fistulas, abscesses, malnutrition, and colorectal cancer.""]","[""Complications of Crohn's Disease include strictures, fistulas, abscesses, malnutrition, and bowel obstructions.""]","[""Complications of Crohn's disease include bowel obstruction, ulcers, fistulas, malnutrition, and inflammation in other parts of the body.""]",[false],[true],[true],"[""Complications of Cardiovascular Disease include heart attack, stroke, heart failure, peripheral artery disease, and aneurysms.""]","[""Complications of Crohn's Disease include strictures, fistulas, abscesses, malnutrition, and bowel obstructions.""]","[""Complications of Crohn's disease include bowel obstruction, ulcers, fistulas, malnutrition, and inflammation in other parts of the body.""]",[false],[true],[true],"[""Complications of Cardiovascular Disease can include heart attack, stroke, heart failure, peripheral artery disease, and aneurysms.""]","[""Complications of Crohn's Disease include strictures, fistulas, abscesses, malnutrition, and bowel obstructions.""]","[""Complications of Crohn's disease include bowel obstruction, ulcers, fistulas, malnutrition, and inflammation in other parts of the body.""]",[false],[true],[true],"[""Complications of Cardiovascular Disease include heart attack, stroke, heart failure, peripheral artery disease, and aneurysms.""]","[""Complications of Crohn's Disease include strictures, fistulas, abscesses, malnutrition, and bowel obstructions.""]","[""Complications of Crohn's disease include bowel obstruction, ulcers, malnutrition, fistulas, and abscesses.""]",[false],[true],[true],"[""Complications of Cardiovascular Disease (CD) include heart attack, stroke, heart failure, peripheral artery disease, and aneurysms.""]","[""Complications of Crohn's Disease include strictures, fistulas, abscesses, malnutrition, and bowel obstructions.""]","[""Complications of Crohn's disease include bowel obstruction, ulcers, fistulas, malnutrition, and inflammation in other parts of the body.""]",[false],[true],[true],"[""Complications of Cardiovascular Disease include heart attack, stroke, heart failure, peripheral artery disease, and aneurysms.""]","[""Complications of Crohn's Disease include strictures, fistulas, abscesses, malnutrition, and bowel obstructions.""]","[""Complications of Crohn's disease include bowel obstruction, ulcers, fistulas, malnutrition, and inflammation in other parts of the body.""]",[true],[true],[true],"[""Complications of Crohn's Disease include strictures, fistulas, abscesses, malnutrition, and increased risk of colon cancer.""]","[""Complications of Crohn's Disease include strictures, fistulas, abscesses, malnutrition, and bowel obstructions.""]","[""Complications of Crohn's disease include bowel obstruction, ulcers, fistulas, malnutrition, and inflammation in other parts of the body.""]",[false],[true],[true],"[""Some complications of CD (Compact Design) include limited upgradeability, potential overheating issues, and difficulty in cable management.""]","[""Complications of Crohn's Disease include strictures, fistulas, abscesses, malnutrition, and bowel obstructions.""]","[""Complications of Crohn's disease include bowel obstruction, ulcers, fistulas, malnutrition, and inflammation in other parts of the body.""]",[false],[true],[true],"[""Complications of Crohn's Disease include strictures, fistulas, abscesses, malnutrition, and colorectal cancer.""]","[""Complications of Crohn's Disease include strictures, fistulas, abscesses, malnutrition, and bowel obstructions.""]","[""Complications of Crohn's disease include bowel obstruction, ulcers, fistulas, malnutrition, and inflammation in other parts of the body.""]"
inheritance,Is core binding factor acute myeloid leukemia inherited ?,CBF-AML is not inherited but arises from genetic rearrangements in the body's cells that occur after conception.,"{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""CBF-AML"", ""full_form"": ""core binding factor acute myeloid leukemia""}]}",Is CBF-AML inherited ?,Is core binding factor acute myeloid leukemia inherited ?,8,MEDICAL,Simple Datatype-Boolean,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.",[[]],[[]],"[""Core Binding Factor Acute Myeloid Leukemia""]",[1.0526052925565969e-26],[1.0526052925565969e-26],"[""Core Binding Factor Acute Myeloid Leukemia""]",[1.0526052925565969e-26],"[""LLM""]",[[]],[0.9083336975249028],[0.9127487999452182],"[""core binding factor acute myeloid leukemia""]",[0.9127487999452182],"[""LLM""]",[[]],"[""Core Binding Factor Acute Myeloid Leukemia""]","[""LLM""]",Is CBF-AML (Core Binding Factor Acute Myeloid Leukemia) inherited ?,[true],[true],[true],"[""No""]","[""No""]","[""No""]",[true],[true],[true],"[""No""]","[""No""]","[""No""]",[true],[true],[true],"[""No""]","[""No""]","[""No""]",[true],[true],[true],"[""No""]","[""No""]","[""No""]",[true],[true],[true],"[""No""]","[""No""]","[""No""]",[true],[true],[true],"[""No""]","[""No""]","[""No""]",[true],[true],[true],"[""No""]","[""No""]","[""No""]",[true],[true],[true],"[""No""]","[""No""]","[""No""]",[true],[true],[true],"[""No""]","[""No""]","[""No""]",[true],[true],[true],"[""No""]","[""No""]","[""No""]",[true],[true],[true],"[""No""]","[""No""]","[""No""]",[true],[true],[true],"[""No""]","[""No""]","[""No""]",[true],[true],[true],"[""No, CBF-AML is not inherited.""]","[""No""]","[""No""]",[true],[true],[true],"[""No""]","[""No""]","[""No""]",[true],[true],[true],"[""No, CBF-AML is not inherited.""]","[""No""]","[""No""]",[true],[true],[true],"[""No""]","[""No""]","[""No""]",[true],[true],[true],"[""No""]","[""No""]","[""No""]",[true],[true],[true],"[""No""]","[""No""]","[""No""]",[true],[true],[true],"[""No""]","[""No""]","[""No""]",[true],[true],[true],"[""No""]","[""No""]","[""No""]",[true],[true],[true],"[""No""]","[""No""]","[""No""]",[true],[true],[true],"[""No""]","[""No""]","[""No""]",[true],[true],[true],"[""No""]","[""No""]","[""No""]",[true],[true],[true],"[""No""]","[""No""]","[""No""]",[true],[true],[true],"[""No, CBF-AML is not inherited. It is a type of leukemia that develops from genetic mutations in bone marrow cells.""]","[""No""]","[""No""]",[true],[true],[true],"[""No, CBF-AML is not inherited. It is caused by acquired mutations in bone marrow cells.""]","[""No""]","[""No""]",[true],[true],[true],"[""No, CBF-AML is not inherited. It is caused by acquired mutations in bone marrow cells.""]","[""No""]","[""No""]",[true],[true],[true],"[""No, CBF-AML is not inherited. It is a type of leukemia that develops due to genetic mutations in bone marrow cells.""]","[""No""]","[""No""]",[true],[true],[true],"[""No, CBF-AML is not inherited. It is caused by acquired genetic mutations.""]","[""No""]","[""No""]",[true],[true],[true],"[""No, CBF-AML is not inherited. It is typically caused by acquired mutations in bone marrow cells.""]","[""No""]","[""No""]",[true],[true],[true],"[""No, CBF-AML is not inherited. It is typically caused by acquired mutations in bone marrow cells.""]","[""No""]","[""No""]",[true],[true],[true],"[""No, CBF-AML is not inherited. It is acquired through genetic mutations.""]","[""No""]","[""No""]"
susceptibility,Who is at risk for Iron-Deficiency Anemia? ?,"Infants and Young Children
                
Infants and young children need a lot of iron to grow and develop. The iron that full-term infants have stored in their bodies is used up in the first 4 to 6 months of life.
                
Premature and low-birth-weight babies (weighing less than 5.5 pounds) are at even greater risk for iron-deficiency anemia. These babies don't have as much iron stored in their bodies as larger, full-term infants.
                
Iron-fortified baby food or iron supplements, when used properly, can help prevent iron-deficiency anemia in infants and young children. Talk with your child's doctor about your child's diet.
                
Young children who drink a lot of cow's milk may be at risk for iron-deficiency anemia. Milk is low in iron, and too much milk may take the place of iron-rich foods in the diet. Too much milk also may prevent children's bodies from absorbing iron from other foods.
                
Children who have lead in their blood also may be at risk for iron-deficiency anemia. Lead can interfere with the body's ability to make hemoglobin. Lead may get into the body from breathing in lead dust, eating lead in paint or soil, or drinking water that contains lead.
                
Teens
                
Teens are at risk for iron-deficiency anemia if they're underweight or have chronic (ongoing) illnesses. Teenage girls who have heavy periods also are at increased risk for the condition.
                
Women
                
Women of childbearing age are at higher risk for iron-deficiency anemia because of blood loss during their monthly periods. About 1 in 5 women of childbearing age has iron-deficiency anemia.
                
Pregnant women also are at higher risk for the condition because they need twice as much iron as usual. The extra iron is needed for increased blood volume and for the fetus' growth.
                
About half of all pregnant women develop iron-deficiency anemia. The condition can increase a pregnant woman's risk for a premature or low-birth-weight baby.
                
Adults Who Have Internal Bleeding
                
Adults who have internal bleeding, such as intestinal bleeding, can develop iron-deficiency anemia due to blood loss. Certain conditions, such as colon cancer and bleeding ulcers, can cause blood loss. Some medicines, such as aspirin, also can cause internal bleeding.
                
Other At-Risk Groups
                
People who get kidney dialysis treatment may develop iron-deficiency anemia. This is because blood is lost during dialysis. Also, the kidneys are no longer able to make enough of a hormone that the body needs to produce red blood cells.
                
People who have gastric bypass surgery also may develop iron-deficiency anemia. This type of surgery can prevent the body from absorbing enough iron.
                
Certain eating patterns or habits may put you at higher risk for iron-deficiency anemia. This can happen if you:
                
Follow a diet that excludes meat and fish, which are the best sources of iron. However, vegetarian diets can provide enough iron if you eat the right foods. For example, good nonmeat sources of iron include iron-fortified breads and cereals, beans, tofu, dried fruits, and spinach and other dark green leafy vegetables.
                
Eat poorly because of money, social, health, or other problems.
                
Follow a very low-fat diet over a long time. Some higher fat foods, like meat, are the best sources of iron.
                
Follow a high-fiber diet. Large amounts of fiber can slow the absorption of iron.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""IDA"", ""full_form"": ""Iron-Deficiency Anemia""}]}",Who is at risk for IDA? ?,Who is at risk for Iron-Deficiency Anemia? ?,8,MEDICAL,Simple Datatype-String,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""International Development Association"", ""Institute for Defense Analyses"", ""Industrial Development Agency"", ""Individual Development Account"", ""Investment Dealers Association"", ""Iron Deficiency Anemia"", ""In Defense of Animals"", ""IdaCorp, Inc."", ""Instituto de Desarrollo Agrario"", ""Institute for Defense Analysis""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Iron Deficiency Anemia""]",[3.8838163857528204e-08],[7.562848028526847e-07],"[""Iron Deficiency Anemia""]",[7.562848028526847e-07],"[""ABBREVIATIONS""]","[[4.375996640624248e-15, 3.056080511400987e-20, 1.877412039573226e-15, 1.5337916791191635e-17, 5.2944085765522565e-14, 7.562848028526847e-07, 1.3722031297358003e-15, 2.1293523136836092e-16, 5.146080664615506e-28, 2.9562569505812907e-19]]",[0.9595365286078181],[0.9633633362974212],"[""Investment Dealers Association""]",[0.9633633362974212],"[""ABBREVIATIONS""]","[[0.7724570513340537, 0.739509866275685, 0.7405871566125826, 0.6769421002060609, 0.6198615178689484, 0.9633633362974212, 0.6890618946181064, 0.7669939808810609, 0.6955949868532069, 0.7274612353167134]]","[""Iron Deficiency Anemia""]","[""ABBREVIATIONS""]",Who is at risk for IDA (Iron Deficiency Anemia)? ?,[true],[true],[true],"[""Individuals with poor diet, women with heavy menstrual periods, pregnant women, infants and young children, and individuals with certain chronic conditions are at risk for Iron Deficiency Anemia (IDA).""]","[""Individuals with poor diet, pregnant women, infants, children, women with heavy menstrual periods, and individuals with certain health conditions such as gastrointestinal disorders.""]","[""Individuals with poor diet, women with heavy menstrual periods, pregnant women, infants and young children, and those with certain chronic conditions are at risk for Iron Deficiency Anemia (IDA).""]",[true],[true],[true],"[""Individuals with poor diet, chronic diseases, heavy menstrual periods, and pregnant women are at risk for Iron Deficiency Anemia.""]","[""Individuals with poor diet, women with heavy menstrual periods, pregnant women, infants and young children, vegetarians, and individuals with certain medical conditions are at risk for Iron-Deficiency Anemia.""]","[""Individuals with poor diet, chronic diseases, heavy menstrual periods, or gastrointestinal conditions are at risk for Iron Deficiency Anemia (IDA).""]",[true],[true],[true],"[""Individuals with poor diet, chronic diseases, heavy menstrual periods, and pregnant women are at risk for Iron Deficiency Anemia (IDA).""]","[""Individuals with poor diet, women with heavy menstrual periods, pregnant women, infants and young children, vegetarians, and individuals with certain medical conditions are at risk for Iron-Deficiency Anemia.""]","[""Individuals with poor diet, pregnant women, infants, and people with certain chronic conditions are at risk for Iron Deficiency Anemia (IDA).""]",[true],[true],[true],"[""Individuals with poor diet, women with heavy menstrual periods, pregnant women, infants and young children, and individuals with certain chronic conditions are at risk for Iron Deficiency Anemia.""]","[""Individuals with poor diet, pregnant women, infants, young children, menstruating women, and individuals with certain medical conditions are at risk for Iron-Deficiency Anemia.""]","[""Individuals with poor diet, pregnant women, infants, and people with certain chronic conditions are at risk for Iron Deficiency Anemia (IDA).""]",[true],[true],[true],"[""Individuals with poor diet, chronic diseases, heavy menstrual periods, or gastrointestinal conditions are at risk for Iron Deficiency Anemia (IDA).""]","[""Individuals with poor diet, pregnant women, infants, children, women with heavy menstrual periods, and individuals with certain health conditions such as gastrointestinal disorders.""]","[""Individuals with poor diet, women with heavy menstrual periods, pregnant women, infants and young children, and those with certain chronic conditions are at risk for Iron Deficiency Anemia (IDA).""]",[true],[true],[true],"[""Individuals with poor diet, women with heavy menstrual periods, pregnant women, and those with gastrointestinal conditions that affect nutrient absorption are at risk for Iron Deficiency Anemia (IDA).""]","[""Individuals with poor diet, women with heavy menstrual periods, pregnant women, infants and young children, vegetarians, and individuals with certain medical conditions are at risk for Iron-Deficiency Anemia.""]","[""Individuals with poor diet, chronic diseases, heavy menstrual periods, or gastrointestinal conditions are at risk for Iron Deficiency Anemia (IDA).""]",[true],[true],[true],"[""Individuals with poor diet, women with heavy menstrual periods, pregnant women, infants and young children, individuals with gastrointestinal conditions that affect nutrient absorption""]","[""Individuals with poor diet, women with heavy menstrual periods, pregnant women, infants and young children, vegetarians, and individuals with certain medical conditions are at risk for Iron-Deficiency Anemia.""]","[""Individuals with poor diet, pregnant women, infants, and people with certain chronic conditions are at risk for Iron Deficiency Anemia (IDA).""]",[true],[true],[true],"[""Individuals with poor diet, women with heavy menstrual periods, pregnant women, and people with gastrointestinal conditions are at risk for Iron Deficiency Anemia (IDA).""]","[""Individuals with poor diet, pregnant women, infants, young children, menstruating women, and individuals with certain medical conditions are at risk for Iron-Deficiency Anemia.""]","[""Individuals with poor diet, pregnant women, infants, and people with certain chronic conditions are at risk for Iron Deficiency Anemia (IDA).""]",[true],[true],[true],"[""Individuals with poor diet, women with heavy menstrual bleeding, pregnant women, infants and young children, and individuals with certain chronic diseases are at risk for Iron Deficiency Anemia (IDA).""]","[""Individuals with poor diet, women with heavy menstrual periods, pregnant women, infants and young children, vegetarians, and individuals with certain medical conditions are at risk for Iron-Deficiency Anemia.""]","[""Individuals with poor diet, chronic diseases, heavy menstrual periods, or gastrointestinal conditions are at risk for Iron Deficiency Anemia (IDA).""]",[true],[true],[true],"[""Individuals with poor diet, women with heavy menstrual periods, pregnant women, infants and young children, and those with certain chronic conditions are at risk for Iron Deficiency Anemia (IDA).""]","[""Individuals with poor diet, pregnant women, infants, children, women with heavy menstrual periods, and individuals with certain health conditions such as gastrointestinal disorders.""]","[""Individuals with poor diet, women with heavy menstrual periods, pregnant women, infants and young children, and those with certain chronic conditions are at risk for Iron Deficiency Anemia (IDA).""]",[true],[true],[true],"[""Individuals with poor diet, women with heavy menstrual periods, pregnant women, infants, and children are at risk for Iron Deficiency Anemia (IDA).""]","[""Individuals with poor diet, women with heavy menstrual periods, pregnant women, infants and young children, vegetarians, and individuals with certain medical conditions are at risk for Iron-Deficiency Anemia.""]","[""Individuals with poor diet, pregnant women, infants, and people with certain chronic conditions are at risk for Iron Deficiency Anemia (IDA).""]",[true],[true],[true],"[""Individuals with poor diet, chronic diseases, heavy menstrual periods, or gastrointestinal conditions are at risk for Iron Deficiency Anemia (IDA).""]","[""Individuals with poor diet, pregnant women, infants, young children, menstruating women, and individuals with certain medical conditions are at risk for Iron-Deficiency Anemia.""]","[""Individuals with poor diet, pregnant women, infants, and people with certain chronic conditions are at risk for Iron Deficiency Anemia (IDA).""]",[true],[true],[true],"[""Individuals with poor diet, chronic blood loss, or certain medical conditions are at risk for IDA.""]","[""Individuals with poor diet, pregnant women, infants, children, women with heavy menstrual periods, and individuals with certain health conditions such as gastrointestinal disorders.""]","[""Individuals with poor diet, women with heavy menstrual periods, pregnant women, infants and young children, and those with certain chronic conditions are at risk for Iron Deficiency Anemia (IDA).""]",[true],[true],[true],"[""Individuals with poor diet, pregnant women, infants, and women with heavy menstrual bleeding are at risk for IDA.""]","[""Individuals with poor diet, women with heavy menstrual periods, pregnant women, infants and young children, vegetarians, and individuals with certain medical conditions are at risk for Iron-Deficiency Anemia.""]","[""Individuals with poor diet, chronic diseases, heavy menstrual periods, or gastrointestinal conditions are at risk for Iron Deficiency Anemia (IDA).""]",[true],[true],[true],"[""Individuals with poor diet, pregnant women, infants, and those with chronic diseases""]","[""Individuals with poor diet, women with heavy menstrual periods, pregnant women, infants and young children, vegetarians, and individuals with certain medical conditions are at risk for Iron-Deficiency Anemia.""]","[""Individuals with poor diet, pregnant women, infants, and people with certain chronic conditions are at risk for Iron Deficiency Anemia (IDA).""]",[true],[true],[true],"[""Individuals with poor diet, pregnant women, infants, and women with heavy menstrual bleeding are at risk for IDA.""]","[""Individuals with poor diet, pregnant women, infants, young children, menstruating women, and individuals with certain medical conditions are at risk for Iron-Deficiency Anemia.""]","[""Individuals with poor diet, pregnant women, infants, and people with certain chronic conditions are at risk for Iron Deficiency Anemia (IDA).""]",[true],[true],[true],"[""Individuals with poor diet, pregnant women, infants, young children, and women with heavy menstrual bleeding are at risk for IDA.""]","[""Individuals with poor diet, pregnant women, infants, children, women with heavy menstrual periods, and individuals with certain health conditions such as gastrointestinal disorders.""]","[""Individuals with poor diet, women with heavy menstrual periods, pregnant women, infants and young children, and those with certain chronic conditions are at risk for Iron Deficiency Anemia (IDA).""]",[true],[true],[true],"[""Individuals with poor diet, pregnant women, infants, young children, menstruating women, and individuals with certain medical conditions are at risk for Iron Deficiency Anemia (IDA).""]","[""Individuals with poor diet, women with heavy menstrual periods, pregnant women, infants and young children, vegetarians, and individuals with certain medical conditions are at risk for Iron-Deficiency Anemia.""]","[""Individuals with poor diet, chronic diseases, heavy menstrual periods, or gastrointestinal conditions are at risk for Iron Deficiency Anemia (IDA).""]",[true],[true],[true],"[""Individuals with poor diet, women with heavy menstrual periods, pregnant women, infants and young children, and those with certain chronic conditions are at risk for Iron Deficiency Anemia (IDA).""]","[""Individuals with poor diet, women with heavy menstrual periods, pregnant women, infants and young children, vegetarians, and individuals with certain medical conditions are at risk for Iron-Deficiency Anemia.""]","[""Individuals with poor diet, pregnant women, infants, and people with certain chronic conditions are at risk for Iron Deficiency Anemia (IDA).""]",[true],[true],[true],"[""Individuals with poor diet, chronic diseases, heavy menstrual periods, or gastrointestinal conditions are at risk for Iron Deficiency Anemia (IDA).""]","[""Individuals with poor diet, pregnant women, infants, young children, menstruating women, and individuals with certain medical conditions are at risk for Iron-Deficiency Anemia.""]","[""Individuals with poor diet, pregnant women, infants, and people with certain chronic conditions are at risk for Iron Deficiency Anemia (IDA).""]",[true],[true],[true],"[""Individuals with poor diet, women with heavy menstrual periods, pregnant women, infants and young children, and individuals with certain chronic conditions are at risk for Iron Deficiency Anemia (IDA).""]","[""Individuals with poor diet, pregnant women, infants, children, women with heavy menstrual periods, and individuals with certain health conditions such as gastrointestinal disorders.""]","[""Individuals with poor diet, women with heavy menstrual periods, pregnant women, infants and young children, and those with certain chronic conditions are at risk for Iron Deficiency Anemia (IDA).""]",[true],[true],[true],"[""Individuals with poor diet, women with heavy menstrual periods, pregnant women, infants and young children, and individuals with certain chronic conditions are at risk for Iron Deficiency Anemia (IDA).""]","[""Individuals with poor diet, women with heavy menstrual periods, pregnant women, infants and young children, vegetarians, and individuals with certain medical conditions are at risk for Iron-Deficiency Anemia.""]","[""Individuals with poor diet, chronic diseases, heavy menstrual periods, or gastrointestinal conditions are at risk for Iron Deficiency Anemia (IDA).""]",[true],[true],[true],"[""Individuals with poor diet, women with heavy menstrual periods, pregnant women, infants and young children, and those with certain chronic conditions are at risk for Iron Deficiency Anemia.""]","[""Individuals with poor diet, women with heavy menstrual periods, pregnant women, infants and young children, vegetarians, and individuals with certain medical conditions are at risk for Iron-Deficiency Anemia.""]","[""Individuals with poor diet, pregnant women, infants, and people with certain chronic conditions are at risk for Iron Deficiency Anemia (IDA).""]",[true],[true],[true],"[""Individuals with poor diet, pregnant women, infants, young children, women with heavy menstrual periods, and those with certain medical conditions are at risk for Iron Deficiency Anemia (IDA).""]","[""Individuals with poor diet, pregnant women, infants, young children, menstruating women, and individuals with certain medical conditions are at risk for Iron-Deficiency Anemia.""]","[""Individuals with poor diet, pregnant women, infants, and people with certain chronic conditions are at risk for Iron Deficiency Anemia (IDA).""]",[true],[true],[true],"[""Individuals at risk for IDA include pregnant women, infants, young children, teenagers, and women with heavy menstrual bleeding.""]","[""Individuals with poor diet, pregnant women, infants, children, women with heavy menstrual periods, and individuals with certain health conditions such as gastrointestinal disorders.""]","[""Individuals with poor diet, women with heavy menstrual periods, pregnant women, infants and young children, and those with certain chronic conditions are at risk for Iron Deficiency Anemia (IDA).""]",[true],[true],[true],"[""Individuals at risk for IDA include pregnant women, infants and young children, women with heavy menstrual periods, individuals with poor diet or certain medical conditions that affect iron absorption.""]","[""Individuals with poor diet, women with heavy menstrual periods, pregnant women, infants and young children, vegetarians, and individuals with certain medical conditions are at risk for Iron-Deficiency Anemia.""]","[""Individuals with poor diet, chronic diseases, heavy menstrual periods, or gastrointestinal conditions are at risk for Iron Deficiency Anemia (IDA).""]",[true],[true],[true],"[""Individuals at risk for IDA include pregnant women, infants and young children, women with heavy menstrual periods, people with poor diets, and individuals with certain chronic conditions.""]","[""Individuals with poor diet, women with heavy menstrual periods, pregnant women, infants and young children, vegetarians, and individuals with certain medical conditions are at risk for Iron-Deficiency Anemia.""]","[""Individuals with poor diet, pregnant women, infants, and people with certain chronic conditions are at risk for Iron Deficiency Anemia (IDA).""]",[true],[true],[true],"[""Individuals at risk for IDA include pregnant women, infants, young children, vegetarians, and individuals with certain health conditions that affect iron absorption.""]","[""Individuals with poor diet, pregnant women, infants, young children, menstruating women, and individuals with certain medical conditions are at risk for Iron-Deficiency Anemia.""]","[""Individuals with poor diet, pregnant women, infants, and people with certain chronic conditions are at risk for Iron Deficiency Anemia (IDA).""]",[true],[true],[true],"[""Individuals with poor diet, pregnant women, infants, young children, women with heavy menstrual periods, and individuals with certain health conditions such as gastrointestinal disorders.""]","[""Individuals with poor diet, pregnant women, infants, children, women with heavy menstrual periods, and individuals with certain health conditions such as gastrointestinal disorders.""]","[""Individuals with poor diet, women with heavy menstrual periods, pregnant women, infants and young children, and those with certain chronic conditions are at risk for Iron Deficiency Anemia (IDA).""]",[true],[true],[true],"[""Individuals with poor diet, pregnant women, young children, and those with chronic diseases are at risk for Iron Deficiency Anemia.""]","[""Individuals with poor diet, pregnant women, infants, children, women with heavy menstrual periods, and individuals with certain health conditions such as gastrointestinal disorders.""]","[""Individuals with poor diet, women with heavy menstrual periods, pregnant women, infants and young children, and those with certain chronic conditions are at risk for Iron Deficiency Anemia (IDA).""]",[false],[true],[true],"[""Individuals who work in the investment industry, such as investment advisors, brokers, and dealers, are at risk for IDA (Investment Dealers Association).""]","[""Individuals with poor diet, pregnant women, infants, children, women with heavy menstrual periods, and individuals with certain health conditions such as gastrointestinal disorders.""]","[""Individuals with poor diet, women with heavy menstrual periods, pregnant women, infants and young children, and those with certain chronic conditions are at risk for Iron Deficiency Anemia (IDA).""]",[true],[true],[true],"[""Individuals with poor diet, pregnant women, infants, young children, and women with heavy menstrual bleeding are at risk for Iron Deficiency Anemia (IDA).""]","[""Individuals with poor diet, pregnant women, infants, children, women with heavy menstrual periods, and individuals with certain health conditions such as gastrointestinal disorders.""]","[""Individuals with poor diet, women with heavy menstrual periods, pregnant women, infants and young children, and those with certain chronic conditions are at risk for Iron Deficiency Anemia (IDA).""]"
treatment,"What are the treatments for immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome ?",These resources address the diagnosis or management of IPEX syndrome:  - Gene Review: Gene Review: IPEX Syndrome  - Genetic Testing Registry: Insulin-dependent diabetes mellitus secretory diarrhea syndrome  - Seattle Children's Hospital   These resources from MedlinePlus offer information about the diagnosis and management of various health conditions:  - Diagnostic Tests  - Drug Therapy  - Surgery and Rehabilitation  - Genetic Counseling   - Palliative Care,"{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""IPEX"", ""full_form"": ""immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome""}]}",What are the treatments for IPEX ?,"What are the treatments for immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome ?",8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Indeck Power Equipment Company"", ""Immunodysregulation polyendocrinopathy enteropathy X-linked"", ""Immunodysregulation Polyendocrinopathy Enteropathy X-Linked Syndrome"", ""Immunodysregulation, Polyendocrinopathy, Enteropathy, X-linked"", ""Indeck Power Equipment"", ""Immunodysregulation, Polyendocrinopathy, Enteropathy, X Linked (Syndrome)"", ""International Printing Equipment Exhibition"", ""Input Parameter Extra (Alcatel)"", ""Investment Performance Evaluation Xperts (Plymouth, MI)"", ""Investment Performance Evaluation Xperts (Plymouth, MI)"", ""International Printing Equipment Exhibition"", ""Input Parameter Extra (Alcatel)"", ""Immunodysregulation, Polyendocrinopathy, Enteropathy, X Linked (Syndrome)"", ""Italian Power Exchange""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY""]]","[""Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-linked Syndrome""]",[3.894984866902803e-43],[3.894984866902803e-43],"[""Italian Power Exchange""]",[1.8205344628514623e-16],"[""THEFREEDICTIONARY""]","[[2.808594273263367e-22, 4.233059798182339e-48, 4.0699778416026895e-49, 6.467246977190243e-44, 2.6812362041556143e-18, 6.193685777917205e-50, 1.1070994681380173e-21, 1.1986774894810781e-30, 1.6361255526893357e-50, 1.6361255526893357e-50, 1.1070994681380173e-21, 1.1986774894810781e-30, 6.193685777917205e-50, 1.8205344628514623e-16]]",[0.9400395575861378],[0.9490757413445499],"[""Indeck Power Equipment Company""]",[0.9522916243187207],"[""ABBREVIATIONS""]","[[0.9162844040369008, 0.9522916243187207, 0.9502621220687311, 0.9503041367633582, 0.9204261805371254, 0.947721835158422, 0.8553138327820594, 0.8825163556753655, 0.9006410400394023, 0.9006410400394023, 0.8551673546147873, 0.8825163556753655, 0.947721835158422, 0.8877498303219173]]","[""Immunodysregulation, Polyendocrinopathy, Enteropathy, X-linked""]","[""ABBREVIATIONS""]","What are the treatments for IPEX (Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-linked Syndrome) ?",[true],[true],[true],"[""The treatments for IPEX (Immune dysregulation, Polyendocrinopathy, Enteropathy, X-linked syndrome) include immunosuppressive therapy, bone marrow transplantation, and gene therapy.""]","[""The treatments for immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome include immunosuppressive therapy, management of endocrine disorders, and nutritional support.""]","[""The treatments for IPEX (Immunodysregulation Polyendocrinopathy Enteropathy X-linked) include immunosuppressive medications, hematopoietic stem cell transplantation, and gene therapy.""]",[true],[true],[true],"[""The main treatment for IPEX (Immunodysregulation Polyendocrinopathy Enteropathy X-linked) syndrome is hematopoietic stem cell transplantation.""]","[""The treatments for immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome include immunosuppressive therapy, nutritional support, and management of specific endocrine disorders.""]","[""The treatments for IPEX (Immunodysregulation Polyendocrinopathy Enteropathy X-linked) include immunosuppressive medications, hematopoietic stem cell transplantation, and gene therapy.""]",[true],[true],[true],"[""The main treatment for IPEX (Immune dysregulation, Polyendocrinopathy, Enteropathy, X-linked syndrome) is hematopoietic stem cell transplantation.""]","[""Treatment options for immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome include immunosuppressive therapy, hematopoietic stem cell transplantation, and supportive care for associated endocrinopathies and enteropathies.""]","[""The treatments for IPEX (Immunodysregulation Polyendocrinopathy Enteropathy X-linked) include immunosuppressive medications, hematopoietic stem cell transplantation, and gene therapy.""]",[false],[true],[true],"[""Bone marrow transplant is the primary treatment for IPEX (Immune dysregulation, Polyendocrinopathy, Enteropathy, X-linked syndrome).""]","[""Treatment for immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome includes immunosuppressive therapy, management of endocrine disorders, and nutritional support.""]","[""The treatments for IPEX (Immunodysregulation Polyendocrinopathy Enteropathy X-linked) include immunosuppressive therapy, hematopoietic stem cell transplantation, and gene therapy.""]",[true],[true],[true],"[""The treatments for IPEX (Immunodysregulation Polyendocrinopathy Enteropathy X-linked) include immunosuppressive therapy, hematopoietic stem cell transplantation, and gene therapy.""]","[""The treatments for immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome include immunosuppressive therapy, management of endocrine disorders, and nutritional support.""]","[""The treatments for IPEX (Immunodysregulation Polyendocrinopathy Enteropathy X-linked) include immunosuppressive medications, hematopoietic stem cell transplantation, and gene therapy.""]",[true],[true],[true],"[""The treatments for IPEX (Immunodysregulation Polyendocrinopathy Enteropathy X-linked) include immunosuppressive therapy, hematopoietic stem cell transplantation, and gene therapy.""]","[""The treatments for immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome include immunosuppressive therapy, nutritional support, and management of specific endocrine disorders.""]","[""The treatments for IPEX (Immunodysregulation Polyendocrinopathy Enteropathy X-linked) include immunosuppressive medications, hematopoietic stem cell transplantation, and gene therapy.""]",[true],[true],[true],"[""The treatments for IPEX (Immunodysregulation Polyendocrinopathy Enteropathy X-linked) include immunosuppressive therapy, hematopoietic stem cell transplantation, and gene therapy.""]","[""Treatment options for immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome include immunosuppressive therapy, hematopoietic stem cell transplantation, and supportive care for associated endocrinopathies and enteropathies.""]","[""The treatments for IPEX (Immunodysregulation Polyendocrinopathy Enteropathy X-linked) include immunosuppressive medications, hematopoietic stem cell transplantation, and gene therapy.""]",[true],[true],[true],"[""The treatments for IPEX (Immunodysregulation Polyendocrinopathy Enteropathy X-linked) include immunosuppressive therapy, hematopoietic stem cell transplantation, and gene therapy.""]","[""Treatment for immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome includes immunosuppressive therapy, management of endocrine disorders, and nutritional support.""]","[""The treatments for IPEX (Immunodysregulation Polyendocrinopathy Enteropathy X-linked) include immunosuppressive therapy, hematopoietic stem cell transplantation, and gene therapy.""]",[true],[true],[true],"[""Bone marrow transplant and immunosuppressive therapy""]","[""The treatments for immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome include immunosuppressive therapy, nutritional support, and management of specific endocrine disorders.""]","[""The treatments for IPEX (Immunodysregulation Polyendocrinopathy Enteropathy X-linked) include immunosuppressive medications, hematopoietic stem cell transplantation, and gene therapy.""]",[true],[true],[true],"[""Bone marrow transplant and immunosuppressive therapy""]","[""The treatments for immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome include immunosuppressive therapy, management of endocrine disorders, and nutritional support.""]","[""The treatments for IPEX (Immunodysregulation Polyendocrinopathy Enteropathy X-linked) include immunosuppressive medications, hematopoietic stem cell transplantation, and gene therapy.""]",[true],[true],[true],"[""Bone marrow transplant and immunosuppressive therapy""]","[""Treatment options for immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome include immunosuppressive therapy, hematopoietic stem cell transplantation, and supportive care for associated endocrinopathies and enteropathies.""]","[""The treatments for IPEX (Immunodysregulation Polyendocrinopathy Enteropathy X-linked) include immunosuppressive medications, hematopoietic stem cell transplantation, and gene therapy.""]",[true],[true],[true],"[""Bone marrow transplant and immunosuppressive therapy""]","[""Treatment for immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome includes immunosuppressive therapy, management of endocrine disorders, and nutritional support.""]","[""The treatments for IPEX (Immunodysregulation Polyendocrinopathy Enteropathy X-linked) include immunosuppressive therapy, hematopoietic stem cell transplantation, and gene therapy.""]",[true],[true],[true],"[""Bone marrow transplant, immunosuppressive therapy, gene therapy""]","[""The treatments for immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome include immunosuppressive therapy, management of endocrine disorders, and nutritional support.""]","[""The treatments for IPEX (Immunodysregulation Polyendocrinopathy Enteropathy X-linked) include immunosuppressive medications, hematopoietic stem cell transplantation, and gene therapy.""]",[true],[true],[true],"[""Bone marrow transplant, immunosuppressive therapy, gene therapy""]","[""The treatments for immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome include immunosuppressive therapy, nutritional support, and management of specific endocrine disorders.""]","[""The treatments for IPEX (Immunodysregulation Polyendocrinopathy Enteropathy X-linked) include immunosuppressive medications, hematopoietic stem cell transplantation, and gene therapy.""]",[true],[true],[true],"[""Bone marrow transplant, immunosuppressive therapy, gene therapy""]","[""Treatment options for immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome include immunosuppressive therapy, hematopoietic stem cell transplantation, and supportive care for associated endocrinopathies and enteropathies.""]","[""The treatments for IPEX (Immunodysregulation Polyendocrinopathy Enteropathy X-linked) include immunosuppressive medications, hematopoietic stem cell transplantation, and gene therapy.""]",[true],[true],[true],"[""Bone marrow transplant and immunosuppressive therapy""]","[""Treatment for immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome includes immunosuppressive therapy, management of endocrine disorders, and nutritional support.""]","[""The treatments for IPEX (Immunodysregulation Polyendocrinopathy Enteropathy X-linked) include immunosuppressive therapy, hematopoietic stem cell transplantation, and gene therapy.""]",[true],[true],[true],"[""Bone marrow transplant and immunosuppressive therapy""]","[""The treatments for immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome include immunosuppressive therapy, management of endocrine disorders, and nutritional support.""]","[""The treatments for IPEX (Immunodysregulation Polyendocrinopathy Enteropathy X-linked) include immunosuppressive medications, hematopoietic stem cell transplantation, and gene therapy.""]",[true],[true],[true],"[""Bone marrow transplant and immunosuppressive therapy""]","[""The treatments for immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome include immunosuppressive therapy, nutritional support, and management of specific endocrine disorders.""]","[""The treatments for IPEX (Immunodysregulation Polyendocrinopathy Enteropathy X-linked) include immunosuppressive medications, hematopoietic stem cell transplantation, and gene therapy.""]",[true],[true],[true],"[""The treatments for IPEX syndrome include immunosuppressive medications, hematopoietic stem cell transplantation, and gene therapy.""]","[""Treatment options for immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome include immunosuppressive therapy, hematopoietic stem cell transplantation, and supportive care for associated endocrinopathies and enteropathies.""]","[""The treatments for IPEX (Immunodysregulation Polyendocrinopathy Enteropathy X-linked) include immunosuppressive medications, hematopoietic stem cell transplantation, and gene therapy.""]",[true],[true],[true],"[""Bone marrow transplant and immunosuppressive therapy""]","[""Treatment for immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome includes immunosuppressive therapy, management of endocrine disorders, and nutritional support.""]","[""The treatments for IPEX (Immunodysregulation Polyendocrinopathy Enteropathy X-linked) include immunosuppressive therapy, hematopoietic stem cell transplantation, and gene therapy.""]",[true],[true],[true],"[""Bone marrow transplant, immunosuppressive therapy, and gene therapy are treatments for IPEX syndrome.""]","[""The treatments for immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome include immunosuppressive therapy, management of endocrine disorders, and nutritional support.""]","[""The treatments for IPEX (Immunodysregulation Polyendocrinopathy Enteropathy X-linked) include immunosuppressive medications, hematopoietic stem cell transplantation, and gene therapy.""]",[true],[true],[true],"[""Bone marrow transplant and immunosuppressive therapy""]","[""The treatments for immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome include immunosuppressive therapy, nutritional support, and management of specific endocrine disorders.""]","[""The treatments for IPEX (Immunodysregulation Polyendocrinopathy Enteropathy X-linked) include immunosuppressive medications, hematopoietic stem cell transplantation, and gene therapy.""]",[true],[true],[true],"[""Bone marrow transplant and immunosuppressive therapy""]","[""Treatment options for immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome include immunosuppressive therapy, hematopoietic stem cell transplantation, and supportive care for associated endocrinopathies and enteropathies.""]","[""The treatments for IPEX (Immunodysregulation Polyendocrinopathy Enteropathy X-linked) include immunosuppressive medications, hematopoietic stem cell transplantation, and gene therapy.""]",[true],[true],[true],"[""The treatments for IPEX syndrome include immunosuppressive medications, hematopoietic stem cell transplantation, and gene therapy.""]","[""Treatment for immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome includes immunosuppressive therapy, management of endocrine disorders, and nutritional support.""]","[""The treatments for IPEX (Immunodysregulation Polyendocrinopathy Enteropathy X-linked) include immunosuppressive therapy, hematopoietic stem cell transplantation, and gene therapy.""]",[true],[true],[true],"[""The treatments for IPEX syndrome include immunosuppressive medications, hematopoietic stem cell transplantation, and gene therapy.""]","[""The treatments for immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome include immunosuppressive therapy, management of endocrine disorders, and nutritional support.""]","[""The treatments for IPEX (Immunodysregulation Polyendocrinopathy Enteropathy X-linked) include immunosuppressive medications, hematopoietic stem cell transplantation, and gene therapy.""]",[true],[true],[true],"[""The treatments for IPEX syndrome include immunosuppressive medications, hematopoietic stem cell transplantation, and gene therapy.""]","[""The treatments for immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome include immunosuppressive therapy, nutritional support, and management of specific endocrine disorders.""]","[""The treatments for IPEX (Immunodysregulation Polyendocrinopathy Enteropathy X-linked) include immunosuppressive medications, hematopoietic stem cell transplantation, and gene therapy.""]",[true],[true],[true],"[""The treatments for IPEX syndrome include immunosuppressive medications, hematopoietic stem cell transplantation, and supportive care for managing symptoms.""]","[""Treatment options for immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome include immunosuppressive therapy, hematopoietic stem cell transplantation, and supportive care for associated endocrinopathies and enteropathies.""]","[""The treatments for IPEX (Immunodysregulation Polyendocrinopathy Enteropathy X-linked) include immunosuppressive medications, hematopoietic stem cell transplantation, and gene therapy.""]",[true],[true],[true],"[""The treatments for IPEX syndrome include immunosuppressive medications, hematopoietic stem cell transplantation, and supportive care for managing symptoms.""]","[""Treatment for immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome includes immunosuppressive therapy, management of endocrine disorders, and nutritional support.""]","[""The treatments for IPEX (Immunodysregulation Polyendocrinopathy Enteropathy X-linked) include immunosuppressive therapy, hematopoietic stem cell transplantation, and gene therapy.""]",[true],[true],[true],"[""Bone marrow transplant and immunosuppressive therapy""]","[""The treatments for immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome include immunosuppressive therapy, management of endocrine disorders, and nutritional support.""]","[""The treatments for IPEX (Immunodysregulation Polyendocrinopathy Enteropathy X-linked) include immunosuppressive medications, hematopoietic stem cell transplantation, and gene therapy.""]",[false],[true],[true],"[""The treatments for IPEX (Italian Power Exchange) include immunosuppressive therapy, hematopoietic stem cell transplantation, and gene therapy.""]","[""The treatments for immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome include immunosuppressive therapy, management of endocrine disorders, and nutritional support.""]","[""The treatments for IPEX (Immunodysregulation Polyendocrinopathy Enteropathy X-linked) include immunosuppressive medications, hematopoietic stem cell transplantation, and gene therapy.""]",[false],[true],[true],"[""The treatments for IPEX (Indeck Power Equipment Company) include immunosuppressive therapy, bone marrow transplantation, and gene therapy.""]","[""The treatments for immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome include immunosuppressive therapy, management of endocrine disorders, and nutritional support.""]","[""The treatments for IPEX (Immunodysregulation Polyendocrinopathy Enteropathy X-linked) include immunosuppressive medications, hematopoietic stem cell transplantation, and gene therapy.""]",[true],[true],[true],"[""Bone marrow transplant and immunosuppressive therapy""]","[""The treatments for immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome include immunosuppressive therapy, management of endocrine disorders, and nutritional support.""]","[""The treatments for IPEX (Immunodysregulation Polyendocrinopathy Enteropathy X-linked) include immunosuppressive medications, hematopoietic stem cell transplantation, and gene therapy.""]"
symptoms,What are the symptoms of Autosomal recessive Charcot-Marie-Tooth disease with hoarseness ?,"What are the signs and symptoms of Autosomal recessive Charcot-Marie-Tooth disease with hoarseness? The Human Phenotype Ontology provides the following list of signs and symptoms for Autosomal recessive Charcot-Marie-Tooth disease with hoarseness. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Onion bulb formation 7.5% Areflexia - Autosomal recessive inheritance - Axonal degeneration/regeneration - Decreased motor nerve conduction velocity - Decreased number of peripheral myelinated nerve fibers - Distal amyotrophy - Distal muscle weakness - Distal sensory impairment - Flexion contracture - Neonatal onset - Pes cavus - Spinal deformities - Split hand - Vocal cord paresis - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""CMT"", ""full_form"": ""Charcot-Marie-Tooth""}]}",What are the symptoms of Autosomal recessive CMT disease with hoarseness ?,What are the symptoms of Autosomal recessive Charcot-Marie-Tooth disease with hoarseness ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Country Music Television"", ""Charcot Marie Tooth"", ""Constant Maturity Treasury"", ""Certified Massage Therapist"", ""California Mastitis Test"", ""Chartered Market Technician"", ""Certified Medical Transcriptionist"", ""Cut, Make, and Trim"", ""Caravan Motor Touristik"", ""Carlsberg Meridian Telescope""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Charcot-Marie-Tooth""]",[1.258094387215825e-18],[1.258094387215825e-18],"[""Country Music Television""]",[8.770918949624605e-14],"[""ABBREVIATIONS""]","[[8.770918949624605e-14, 1.493147139430243e-17, 5.941765249764536e-18, 9.490296221390876e-19, 8.910592161643586e-23, 1.506174249308944e-20, 1.1869405031247403e-18, 3.729102030973144e-19, 3.502320624684018e-24, 7.787518352925016e-28]]",[0.9785427536665887],[0.9785427536665887],"[""Carlsberg Meridian Telescope""]",[0.9785427536665887],"[""LLM""]","[[0.9164534051942068, 0.9767417421593699, 0.9025389535746138, 0.903377989314629, 0.8692774440703478, 0.9402892664324042, 0.9234082746771541, 0.9320825755468142, 0.9144993361367868, 0.9437599464095957]]","[""Charcot Marie Tooth""]","[""ABBREVIATIONS""]",What are the symptoms of Autosomal recessive CMT (Charcot-Marie-Tooth) disease with hoarseness ?,[true],[true],[true],"[""Autosomal recessive CMT disease with hoarseness may present with symptoms such as muscle weakness, sensory loss, foot deformities, and vocal cord paralysis.""]","[""Symptoms of Autosomal recessive Charcot-Marie-Tooth disease with hoarseness include muscle weakness, foot deformities, difficulty walking, and vocal cord paralysis.""]","[""Autosomal recessive CMT disease with hoarseness can present with muscle weakness, sensory loss, foot deformities, and vocal cord paralysis.""]",[true],[true],[true],"[""Autosomal recessive CMT disease with hoarseness can present with muscle weakness, sensory loss, foot deformities, and vocal cord paralysis.""]","[""Autosomal recessive Charcot-Marie-Tooth disease with hoarseness is characterized by muscle weakness and atrophy in the hands and lower legs, sensory loss, foot deformities, and hoarseness due to vocal cord paralysis.""]","[""Autosomal recessive Charcot-Marie-Tooth disease with hoarseness may present with symptoms such as muscle weakness, sensory loss, foot deformities, and vocal cord paralysis leading to hoarseness.""]",[true],[true],[true],"[""Autosomal recessive CMT disease with hoarseness can present with muscle weakness, sensory loss, foot deformities, and vocal cord paralysis.""]","[""Autosomal recessive Charcot-Marie-Tooth disease with hoarseness may present with symptoms such as muscle weakness, sensory loss, foot deformities, and hoarseness due to vocal cord involvement.""]","[""Symptoms of Autosomal recessive CMT disease with hoarseness include muscle weakness, difficulty walking, foot deformities, and vocal cord paralysis.""]",[true],[true],[true],"[""Autosomal recessive CMT disease with hoarseness may present with muscle weakness, foot deformities, sensory loss, and vocal cord paralysis.""]","[""Autosomal recessive Charcot-Marie-Tooth disease with hoarseness may present with symptoms such as muscle weakness, foot deformities, sensory loss, and vocal cord paralysis leading to hoarseness.""]","[""Autosomal recessive CMT disease with hoarseness can present with symptoms such as muscle weakness, sensory loss, foot deformities, and vocal cord paralysis leading to hoarseness.""]",[true],[true],[true],"[""Autosomal recessive CMT disease with hoarseness may present with symptoms such as muscle weakness, sensory loss, foot deformities, and vocal cord paralysis.""]","[""Symptoms of Autosomal recessive Charcot-Marie-Tooth disease with hoarseness include muscle weakness, foot deformities, difficulty walking, and vocal cord paralysis.""]","[""Autosomal recessive CMT disease with hoarseness can present with muscle weakness, sensory loss, foot deformities, and vocal cord paralysis.""]",[true],[true],[true],"[""Autosomal recessive CMT disease with hoarseness may present with symptoms such as muscle weakness, sensory loss, foot deformities, and vocal cord paralysis.""]","[""Autosomal recessive Charcot-Marie-Tooth disease with hoarseness is characterized by muscle weakness and atrophy in the hands and lower legs, sensory loss, foot deformities, and hoarseness due to vocal cord paralysis.""]","[""Autosomal recessive Charcot-Marie-Tooth disease with hoarseness may present with symptoms such as muscle weakness, sensory loss, foot deformities, and vocal cord paralysis leading to hoarseness.""]",[true],[true],[true],"[""Symptoms of Autosomal recessive CMT disease with hoarseness include muscle weakness, difficulty walking, foot deformities, and vocal cord paralysis.""]","[""Autosomal recessive Charcot-Marie-Tooth disease with hoarseness may present with symptoms such as muscle weakness, sensory loss, foot deformities, and hoarseness due to vocal cord involvement.""]","[""Symptoms of Autosomal recessive CMT disease with hoarseness include muscle weakness, difficulty walking, foot deformities, and vocal cord paralysis.""]",[true],[true],[true],"[""Symptoms of Autosomal recessive CMT disease with hoarseness include muscle weakness, difficulty walking, foot deformities, and vocal cord paralysis.""]","[""Autosomal recessive Charcot-Marie-Tooth disease with hoarseness may present with symptoms such as muscle weakness, foot deformities, sensory loss, and vocal cord paralysis leading to hoarseness.""]","[""Autosomal recessive CMT disease with hoarseness can present with symptoms such as muscle weakness, sensory loss, foot deformities, and vocal cord paralysis leading to hoarseness.""]",[true],[true],[true],"[""Symptoms of Autosomal recessive CMT (Charcot Marie Tooth) disease with hoarseness include muscle weakness, sensory loss, foot deformities, and vocal cord paralysis.""]","[""Autosomal recessive Charcot-Marie-Tooth disease with hoarseness is characterized by muscle weakness and atrophy in the hands and lower legs, sensory loss, foot deformities, and hoarseness due to vocal cord paralysis.""]","[""Autosomal recessive Charcot-Marie-Tooth disease with hoarseness may present with symptoms such as muscle weakness, sensory loss, foot deformities, and vocal cord paralysis leading to hoarseness.""]",[true],[true],[true],"[""Autosomal recessive CMT disease with hoarseness may present with symptoms such as muscle weakness, sensory loss, foot deformities, and vocal cord paralysis leading to hoarseness.""]","[""Symptoms of Autosomal recessive Charcot-Marie-Tooth disease with hoarseness include muscle weakness, foot deformities, difficulty walking, and vocal cord paralysis.""]","[""Autosomal recessive CMT disease with hoarseness can present with muscle weakness, sensory loss, foot deformities, and vocal cord paralysis.""]",[true],[true],[true],"[""Autosomal recessive CMT disease with hoarseness can present with symptoms such as muscle weakness, sensory loss, foot deformities, and vocal cord paralysis leading to hoarseness.""]","[""Autosomal recessive Charcot-Marie-Tooth disease with hoarseness may present with symptoms such as muscle weakness, sensory loss, foot deformities, and hoarseness due to vocal cord involvement.""]","[""Symptoms of Autosomal recessive CMT disease with hoarseness include muscle weakness, difficulty walking, foot deformities, and vocal cord paralysis.""]",[true],[true],[true],"[""Autosomal recessive CMT disease with hoarseness may present with symptoms such as muscle weakness, sensory loss, foot deformities, and vocal cord paralysis leading to hoarseness.""]","[""Autosomal recessive Charcot-Marie-Tooth disease with hoarseness may present with symptoms such as muscle weakness, foot deformities, sensory loss, and vocal cord paralysis leading to hoarseness.""]","[""Autosomal recessive CMT disease with hoarseness can present with symptoms such as muscle weakness, sensory loss, foot deformities, and vocal cord paralysis leading to hoarseness.""]",[true],[true],[true],"[""Autosomal recessive CMT disease with hoarseness can present with muscle weakness, sensory loss, foot deformities, and vocal cord paralysis.""]","[""Symptoms of Autosomal recessive Charcot-Marie-Tooth disease with hoarseness include muscle weakness, foot deformities, difficulty walking, and vocal cord paralysis.""]","[""Autosomal recessive CMT disease with hoarseness can present with muscle weakness, sensory loss, foot deformities, and vocal cord paralysis.""]",[false],[true],[true],"[""Autosomal recessive CMT disease with hoarseness can present with muscle weakness, sensory loss, foot deformities, and difficulty swallowing.""]","[""Autosomal recessive Charcot-Marie-Tooth disease with hoarseness is characterized by muscle weakness and atrophy in the hands and lower legs, sensory loss, foot deformities, and hoarseness due to vocal cord paralysis.""]","[""Autosomal recessive Charcot-Marie-Tooth disease with hoarseness may present with symptoms such as muscle weakness, sensory loss, foot deformities, and vocal cord paralysis leading to hoarseness.""]",[false],[true],[true],"[""Autosomal recessive CMT disease with hoarseness may present with muscle weakness, sensory loss, foot deformities, and difficulty swallowing.""]","[""Autosomal recessive Charcot-Marie-Tooth disease with hoarseness may present with symptoms such as muscle weakness, sensory loss, foot deformities, and hoarseness due to vocal cord involvement.""]","[""Symptoms of Autosomal recessive CMT disease with hoarseness include muscle weakness, difficulty walking, foot deformities, and vocal cord paralysis.""]",[true],[true],[true],"[""Symptoms of Autosomal recessive CMT disease with hoarseness include muscle weakness, foot deformities, sensory loss, and vocal cord paralysis.""]","[""Autosomal recessive Charcot-Marie-Tooth disease with hoarseness may present with symptoms such as muscle weakness, foot deformities, sensory loss, and vocal cord paralysis leading to hoarseness.""]","[""Autosomal recessive CMT disease with hoarseness can present with symptoms such as muscle weakness, sensory loss, foot deformities, and vocal cord paralysis leading to hoarseness.""]",[true],[true],[true],"[""Autosomal recessive CMT disease with hoarseness may present with symptoms such as muscle weakness, sensory loss, foot deformities, and vocal cord paralysis leading to hoarseness.""]","[""Symptoms of Autosomal recessive Charcot-Marie-Tooth disease with hoarseness include muscle weakness, foot deformities, difficulty walking, and vocal cord paralysis.""]","[""Autosomal recessive CMT disease with hoarseness can present with muscle weakness, sensory loss, foot deformities, and vocal cord paralysis.""]",[true],[true],[true],"[""Symptoms of Autosomal recessive CMT disease with hoarseness include muscle weakness, foot deformities, difficulty walking, and vocal cord paralysis.""]","[""Autosomal recessive Charcot-Marie-Tooth disease with hoarseness is characterized by muscle weakness and atrophy in the hands and lower legs, sensory loss, foot deformities, and hoarseness due to vocal cord paralysis.""]","[""Autosomal recessive Charcot-Marie-Tooth disease with hoarseness may present with symptoms such as muscle weakness, sensory loss, foot deformities, and vocal cord paralysis leading to hoarseness.""]",[false],[true],[true],"[""Symptoms of Autosomal recessive CMT (Charcot Marie Tooth) disease with hoarseness include muscle weakness, sensory loss, foot deformities, and difficulty swallowing.""]","[""Autosomal recessive Charcot-Marie-Tooth disease with hoarseness may present with symptoms such as muscle weakness, sensory loss, foot deformities, and hoarseness due to vocal cord involvement.""]","[""Symptoms of Autosomal recessive CMT disease with hoarseness include muscle weakness, difficulty walking, foot deformities, and vocal cord paralysis.""]",[true],[true],[true],"[""Autosomal recessive CMT disease with hoarseness can present with symptoms such as muscle weakness, sensory loss, foot deformities, and vocal cord paralysis leading to hoarseness.""]","[""Autosomal recessive Charcot-Marie-Tooth disease with hoarseness may present with symptoms such as muscle weakness, foot deformities, sensory loss, and vocal cord paralysis leading to hoarseness.""]","[""Autosomal recessive CMT disease with hoarseness can present with symptoms such as muscle weakness, sensory loss, foot deformities, and vocal cord paralysis leading to hoarseness.""]",[true],[true],[true],"[""Autosomal recessive CMT disease with hoarseness may present with symptoms such as muscle weakness, sensory loss, foot deformities, and vocal cord paralysis leading to hoarseness.""]","[""Symptoms of Autosomal recessive Charcot-Marie-Tooth disease with hoarseness include muscle weakness, foot deformities, difficulty walking, and vocal cord paralysis.""]","[""Autosomal recessive CMT disease with hoarseness can present with muscle weakness, sensory loss, foot deformities, and vocal cord paralysis.""]",[true],[true],[true],"[""Symptoms of Autosomal recessive CMT (Charcot-Marie-Tooth) disease with hoarseness may include muscle weakness and atrophy in the hands and lower legs, foot deformities, sensory loss, and vocal cord paralysis leading to hoarseness.""]","[""Autosomal recessive Charcot-Marie-Tooth disease with hoarseness is characterized by muscle weakness and atrophy in the hands and lower legs, sensory loss, foot deformities, and hoarseness due to vocal cord paralysis.""]","[""Autosomal recessive Charcot-Marie-Tooth disease with hoarseness may present with symptoms such as muscle weakness, sensory loss, foot deformities, and vocal cord paralysis leading to hoarseness.""]",[true],[true],[true],"[""Symptoms of Autosomal recessive CMT (Charcot-Marie-Tooth) disease with hoarseness may include muscle weakness, foot deformities, difficulty walking, loss of sensation in the extremities, and hoarseness due to vocal cord involvement.""]","[""Autosomal recessive Charcot-Marie-Tooth disease with hoarseness may present with symptoms such as muscle weakness, sensory loss, foot deformities, and hoarseness due to vocal cord involvement.""]","[""Symptoms of Autosomal recessive CMT disease with hoarseness include muscle weakness, difficulty walking, foot deformities, and vocal cord paralysis.""]",[true],[true],[true],"[""Autosomal recessive CMT disease with hoarseness may present with symptoms such as muscle weakness, sensory loss, foot deformities, and vocal cord paralysis.""]","[""Autosomal recessive Charcot-Marie-Tooth disease with hoarseness may present with symptoms such as muscle weakness, foot deformities, sensory loss, and vocal cord paralysis leading to hoarseness.""]","[""Autosomal recessive CMT disease with hoarseness can present with symptoms such as muscle weakness, sensory loss, foot deformities, and vocal cord paralysis leading to hoarseness.""]",[true],[true],[true],"[""Autosomal recessive CMT disease with hoarseness may present with muscle weakness, foot deformities, sensory loss, and vocal cord paralysis leading to hoarseness.""]","[""Symptoms of Autosomal recessive Charcot-Marie-Tooth disease with hoarseness include muscle weakness, foot deformities, difficulty walking, and vocal cord paralysis.""]","[""Autosomal recessive CMT disease with hoarseness can present with muscle weakness, sensory loss, foot deformities, and vocal cord paralysis.""]",[false],[true],[true],"[""Autosomal recessive CMT disease with hoarseness can present with symptoms such as muscle weakness, sensory loss, foot deformities, and difficulty swallowing.""]","[""Autosomal recessive Charcot-Marie-Tooth disease with hoarseness is characterized by muscle weakness and atrophy in the hands and lower legs, sensory loss, foot deformities, and hoarseness due to vocal cord paralysis.""]","[""Autosomal recessive Charcot-Marie-Tooth disease with hoarseness may present with symptoms such as muscle weakness, sensory loss, foot deformities, and vocal cord paralysis leading to hoarseness.""]",[true],[true],[true],"[""Autosomal recessive CMT disease with hoarseness can present with symptoms such as muscle weakness, sensory loss, foot deformities, and vocal cord paralysis leading to hoarseness.""]","[""Autosomal recessive Charcot-Marie-Tooth disease with hoarseness may present with symptoms such as muscle weakness, sensory loss, foot deformities, and hoarseness due to vocal cord involvement.""]","[""Symptoms of Autosomal recessive CMT disease with hoarseness include muscle weakness, difficulty walking, foot deformities, and vocal cord paralysis.""]",[true],[true],[true],"[""Autosomal recessive CMT disease with hoarseness may present with symptoms such as muscle weakness, sensory loss, foot deformities, and vocal cord paralysis leading to hoarseness.""]","[""Autosomal recessive Charcot-Marie-Tooth disease with hoarseness may present with symptoms such as muscle weakness, foot deformities, sensory loss, and vocal cord paralysis leading to hoarseness.""]","[""Autosomal recessive CMT disease with hoarseness can present with symptoms such as muscle weakness, sensory loss, foot deformities, and vocal cord paralysis leading to hoarseness.""]",[true],[true],[true],"[""Autosomal recessive CMT disease with hoarseness may present with muscle weakness, sensory loss, foot deformities, and vocal cord paralysis.""]","[""Symptoms of Autosomal recessive Charcot-Marie-Tooth disease with hoarseness include muscle weakness, foot deformities, difficulty walking, and vocal cord paralysis.""]","[""Autosomal recessive CMT disease with hoarseness can present with muscle weakness, sensory loss, foot deformities, and vocal cord paralysis.""]",[true],[true],[true],"[""Autosomal recessive CMT disease with hoarseness may present with muscle weakness, sensory loss, foot deformities, and vocal cord paralysis.""]","[""Symptoms of Autosomal recessive Charcot-Marie-Tooth disease with hoarseness include muscle weakness, foot deformities, difficulty walking, and vocal cord paralysis.""]","[""Autosomal recessive CMT disease with hoarseness can present with muscle weakness, sensory loss, foot deformities, and vocal cord paralysis.""]",[true],[true],[true],"[""Symptoms of Autosomal recessive CMT disease with hoarseness may include muscle weakness, sensory loss, foot deformities, and vocal cord paralysis.""]","[""Symptoms of Autosomal recessive Charcot-Marie-Tooth disease with hoarseness include muscle weakness, foot deformities, difficulty walking, and vocal cord paralysis.""]","[""Autosomal recessive CMT disease with hoarseness can present with muscle weakness, sensory loss, foot deformities, and vocal cord paralysis.""]",[true],[true],[true],"[""Autosomal recessive CMT disease with hoarseness may present with muscle weakness, sensory loss, foot deformities, and vocal cord paralysis leading to hoarseness.""]","[""Symptoms of Autosomal recessive Charcot-Marie-Tooth disease with hoarseness include muscle weakness, foot deformities, difficulty walking, and vocal cord paralysis.""]","[""Autosomal recessive CMT disease with hoarseness can present with muscle weakness, sensory loss, foot deformities, and vocal cord paralysis.""]"
symptoms,What are the symptoms of West syndrome ?,"What are the signs and symptoms of West syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for West syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Cognitive impairment 90% Hemiplegia/hemiparesis 90% Hypertonia 90% Seizures 90% Choreoathetosis - Dysphagia - Dyspnea - Dystonia - Epileptic encephalopathy - Generalized myoclonic seizures - Hyperreflexia - Hypsarrhythmia - Intellectual disability - Microcephaly - Muscular hypotonia of the trunk - Spasticity - Ventriculomegaly - X-linked recessive inheritance - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""WS"", ""full_form"": ""West syndrome""}]}",What are the symptoms of WS ?,What are the symptoms of West syndrome ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Web Site"", ""Web Services"", ""Samoa"", ""Workstation"", ""WinterSemester"", ""Web Sites"", ""Web Server"", ""Western Samoa"", ""West Side"", ""Wind Speed""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Williams Syndrome""]",[1.2250038550093053e-09],[6.746509239696189e-14],"[""Workstation""]",[3.3088792723341045e-06],"[""ABBREVIATIONS""]","[[1.3242665218225238e-08, 2.0251577397027246e-11, 1.8050801065545918e-09, 3.3088792723341045e-06, 7.427369608922435e-15, 1.0680252112351323e-09, 4.9925152718478555e-11, 1.1151206050639464e-14, 9.662446139833828e-09, 3.636867221199321e-08]]",[0.7456556832002103],[0.86522653631423],"[""Wind Speed""]",[0.86522653631423],"[""LLM""]","[[0.8230392000975602, 0.7717180026750258, 0.807601910190038, 0.7479511130208165, 0.7315993995896841, 0.8116813089229394, 0.7503362376318075, 0.7545528775673689, 0.8278739350582975, 0.7698208305823595]]","[""Williams Syndrome""]","[""LLM""]",What are the symptoms of WS (Williams Syndrome) ?,[false],[true],[false],"[""Symptoms of WS (Workstation) include eye strain, headaches, neck and back pain, and wrist pain.""]","[""The symptoms of West syndrome include infantile spasms, developmental regression or delay, and a specific pattern on electroencephalogram (EEG) known as hypsarrhythmia.""]","[""Symptoms of Williams Syndrome (WS) include cardiovascular issues, distinctive facial features, developmental delays, and learning disabilities.""]",[false],[true],[false],"[""Symptoms of WS (Workstation) include eye strain, headaches, neck and back pain, and repetitive strain injuries.""]","[""Symptoms of West syndrome include infantile spasms, developmental regression or delay, and a specific pattern on electroencephalogram (EEG) called hypsarrhythmia.""]","[""Symptoms of Williams Syndrome (WS) include cardiovascular problems, distinctive facial features, developmental delays, and learning disabilities.""]",[false],[true],[false],"[""Symptoms of WS (Workstation) include eye strain, headaches, back and neck pain, and wrist discomfort.""]","[""The symptoms of West syndrome include infantile spasms, developmental regression or delay, and a specific pattern on electroencephalogram (EEG) known as hypsarrhythmia.""]","[""Symptoms of Williams Syndrome include cardiovascular problems, developmental delays, distinctive facial features, and learning disabilities.""]",[false],[true],[false],"[""Symptoms of WS (Workstation) include eye strain, headaches, neck and back pain, and wrist pain.""]","[""Symptoms of West syndrome include infantile spasms, developmental regression or delay, and a specific pattern on electroencephalogram (EEG) known as hypsarrhythmia.""]","[""Symptoms of Williams Syndrome include cardiovascular problems, distinctive facial features, developmental delays, and learning disabilities.""]",[false],[true],[false],"[""Symptoms of WS (Wind Speed) are not applicable as it is a meteorological measurement and not a medical condition.""]","[""The symptoms of West syndrome include infantile spasms, developmental regression or delay, and a specific pattern on electroencephalogram (EEG) known as hypsarrhythmia.""]","[""Symptoms of Williams Syndrome (WS) include cardiovascular issues, distinctive facial features, developmental delays, and learning disabilities.""]",[false],[true],[false],"[""Symptoms of WS (Wind Speed) are not applicable as it is a meteorological measurement and not a medical condition.""]","[""Symptoms of West syndrome include infantile spasms, developmental regression or delay, and a specific pattern on electroencephalogram (EEG) called hypsarrhythmia.""]","[""Symptoms of Williams Syndrome (WS) include cardiovascular problems, distinctive facial features, developmental delays, and learning disabilities.""]",[false],[true],[false],"[""Symptoms of WS (Wind Speed) include difficulty breathing, coughing, wheezing, chest tightness, and shortness of breath.""]","[""The symptoms of West syndrome include infantile spasms, developmental regression or delay, and a specific pattern on electroencephalogram (EEG) known as hypsarrhythmia.""]","[""Symptoms of Williams Syndrome include cardiovascular problems, developmental delays, distinctive facial features, and learning disabilities.""]",[false],[true],[false],"[""Symptoms of WS (Wind Speed) are not applicable as it is a meteorological term and not a medical condition.""]","[""Symptoms of West syndrome include infantile spasms, developmental regression or delay, and a specific pattern on electroencephalogram (EEG) known as hypsarrhythmia.""]","[""Symptoms of Williams Syndrome include cardiovascular problems, distinctive facial features, developmental delays, and learning disabilities.""]",[false],[true],[false],"[""Common symptoms of Williams Syndrome (WS) include cardiovascular issues, distinctive facial features, developmental delays, and learning disabilities.""]","[""Symptoms of West syndrome include infantile spasms, developmental regression or delay, and a specific pattern on electroencephalogram (EEG) called hypsarrhythmia.""]","[""Symptoms of Williams Syndrome (WS) include cardiovascular problems, distinctive facial features, developmental delays, and learning disabilities.""]",[false],[true],[false],"[""Common symptoms of Williams Syndrome include cardiovascular issues, distinctive facial features, developmental delays, and a friendly and engaging personality.""]","[""The symptoms of West syndrome include infantile spasms, developmental regression or delay, and a specific pattern on electroencephalogram (EEG) known as hypsarrhythmia.""]","[""Symptoms of Williams Syndrome (WS) include cardiovascular issues, distinctive facial features, developmental delays, and learning disabilities.""]",[false],[true],[false],"[""Common symptoms of Williams Syndrome (WS) include cardiovascular issues, distinctive facial features, developmental delays, and learning disabilities.""]","[""The symptoms of West syndrome include infantile spasms, developmental regression or delay, and a specific pattern on electroencephalogram (EEG) known as hypsarrhythmia.""]","[""Symptoms of Williams Syndrome include cardiovascular problems, developmental delays, distinctive facial features, and learning disabilities.""]",[false],[true],[false],"[""Common symptoms of Williams Syndrome (WS) include cardiovascular issues, distinctive facial features, developmental delays, and learning disabilities.""]","[""Symptoms of West syndrome include infantile spasms, developmental regression or delay, and a specific pattern on electroencephalogram (EEG) known as hypsarrhythmia.""]","[""Symptoms of Williams Syndrome include cardiovascular problems, distinctive facial features, developmental delays, and learning disabilities.""]",[false],[true],[false],"[""Common symptoms of Williams Syndrome (WS) include cardiovascular issues, distinctive facial features, developmental delays, and a friendly and outgoing personality.""]","[""The symptoms of West syndrome include infantile spasms, developmental regression or delay, and a specific pattern on electroencephalogram (EEG) known as hypsarrhythmia.""]","[""Symptoms of Williams Syndrome (WS) include cardiovascular issues, distinctive facial features, developmental delays, and learning disabilities.""]",[false],[true],[false],"[""Common symptoms of Williams Syndrome (WS) include cardiovascular issues, distinctive facial features, developmental delays, and a friendly and outgoing personality.""]","[""Symptoms of West syndrome include infantile spasms, developmental regression or delay, and a specific pattern on electroencephalogram (EEG) called hypsarrhythmia.""]","[""Symptoms of Williams Syndrome (WS) include cardiovascular problems, distinctive facial features, developmental delays, and learning disabilities.""]",[false],[true],[false],"[""Common symptoms of Williams Syndrome include cardiovascular issues, distinctive facial features, developmental delays, and learning disabilities.""]","[""The symptoms of West syndrome include infantile spasms, developmental regression or delay, and a specific pattern on electroencephalogram (EEG) known as hypsarrhythmia.""]","[""Symptoms of Williams Syndrome include cardiovascular problems, developmental delays, distinctive facial features, and learning disabilities.""]",[false],[true],[false],"[""Common symptoms of Williams Syndrome (WS) include cardiovascular issues, distinctive facial features, developmental delays, and a friendly and outgoing personality.""]","[""Symptoms of West syndrome include infantile spasms, developmental regression or delay, and a specific pattern on electroencephalogram (EEG) known as hypsarrhythmia.""]","[""Symptoms of Williams Syndrome include cardiovascular problems, distinctive facial features, developmental delays, and learning disabilities.""]",[false],[true],[false],"[""Common symptoms of Williams Syndrome (WS) include cardiovascular issues, distinctive facial features, developmental delays, and a friendly and outgoing personality.""]","[""The symptoms of West syndrome include infantile spasms, developmental regression or delay, and a specific pattern on electroencephalogram (EEG) known as hypsarrhythmia.""]","[""Symptoms of Williams Syndrome (WS) include cardiovascular issues, distinctive facial features, developmental delays, and learning disabilities.""]",[false],[true],[false],"[""Common symptoms of Williams Syndrome (WS) include cardiovascular issues, distinctive facial features, developmental delays, and a friendly and engaging personality.""]","[""Symptoms of West syndrome include infantile spasms, developmental regression or delay, and a specific pattern on electroencephalogram (EEG) called hypsarrhythmia.""]","[""Symptoms of Williams Syndrome (WS) include cardiovascular problems, distinctive facial features, developmental delays, and learning disabilities.""]",[false],[true],[false],"[""Common symptoms of Williams Syndrome include cardiovascular issues, distinctive facial features, developmental delays, and learning disabilities.""]","[""The symptoms of West syndrome include infantile spasms, developmental regression or delay, and a specific pattern on electroencephalogram (EEG) known as hypsarrhythmia.""]","[""Symptoms of Williams Syndrome include cardiovascular problems, developmental delays, distinctive facial features, and learning disabilities.""]",[false],[true],[false],"[""Common symptoms of Williams Syndrome (WS) include cardiovascular issues, distinctive facial features, developmental delays, and learning disabilities.""]","[""Symptoms of West syndrome include infantile spasms, developmental regression or delay, and a specific pattern on electroencephalogram (EEG) known as hypsarrhythmia.""]","[""Symptoms of Williams Syndrome include cardiovascular problems, distinctive facial features, developmental delays, and learning disabilities.""]",[false],[true],[false],"[""Common symptoms of Williams Syndrome (WS) include cardiovascular issues, distinctive facial features, developmental delays, and learning disabilities.""]","[""The symptoms of West syndrome include infantile spasms, developmental regression or delay, and a specific pattern on electroencephalogram (EEG) known as hypsarrhythmia.""]","[""Symptoms of Williams Syndrome (WS) include cardiovascular issues, distinctive facial features, developmental delays, and learning disabilities.""]",[false],[true],[false],"[""Common symptoms of Williams Syndrome (WS) include cardiovascular issues, distinctive facial features, developmental delays, and learning disabilities.""]","[""Symptoms of West syndrome include infantile spasms, developmental regression or delay, and a specific pattern on electroencephalogram (EEG) called hypsarrhythmia.""]","[""Symptoms of Williams Syndrome (WS) include cardiovascular problems, distinctive facial features, developmental delays, and learning disabilities.""]",[false],[true],[false],"[""Common symptoms of Williams Syndrome (WS) include cardiovascular issues, distinctive facial features, developmental delays, and learning disabilities.""]","[""The symptoms of West syndrome include infantile spasms, developmental regression or delay, and a specific pattern on electroencephalogram (EEG) known as hypsarrhythmia.""]","[""Symptoms of Williams Syndrome include cardiovascular problems, developmental delays, distinctive facial features, and learning disabilities.""]",[false],[true],[false],"[""Common symptoms of Williams Syndrome include cardiovascular problems, unique facial features, developmental delays, and learning disabilities.""]","[""Symptoms of West syndrome include infantile spasms, developmental regression or delay, and a specific pattern on electroencephalogram (EEG) known as hypsarrhythmia.""]","[""Symptoms of Williams Syndrome include cardiovascular problems, distinctive facial features, developmental delays, and learning disabilities.""]",[false],[true],[false],"[""Common symptoms of Williams Syndrome (WS) include cardiovascular issues, distinctive facial features, developmental delays, and a friendly and outgoing personality.""]","[""The symptoms of West syndrome include infantile spasms, developmental regression or delay, and a specific pattern on electroencephalogram (EEG) known as hypsarrhythmia.""]","[""Symptoms of Williams Syndrome (WS) include cardiovascular issues, distinctive facial features, developmental delays, and learning disabilities.""]",[false],[true],[false],"[""Common symptoms of Williams Syndrome (WS) include cardiovascular issues, distinctive facial features, developmental delays, and a friendly and outgoing personality.""]","[""Symptoms of West syndrome include infantile spasms, developmental regression or delay, and a specific pattern on electroencephalogram (EEG) called hypsarrhythmia.""]","[""Symptoms of Williams Syndrome (WS) include cardiovascular problems, distinctive facial features, developmental delays, and learning disabilities.""]",[false],[true],[false],"[""Some common symptoms of Williams Syndrome (WS) include cardiovascular problems, distinctive facial features, developmental delays, and a friendly and outgoing personality.""]","[""The symptoms of West syndrome include infantile spasms, developmental regression or delay, and a specific pattern on electroencephalogram (EEG) known as hypsarrhythmia.""]","[""Symptoms of Williams Syndrome include cardiovascular problems, developmental delays, distinctive facial features, and learning disabilities.""]",[false],[true],[false],"[""Some common symptoms of Williams Syndrome (WS) include cardiovascular issues, distinctive facial features, developmental delays, and a friendly and outgoing personality.""]","[""Symptoms of West syndrome include infantile spasms, developmental regression or delay, and a specific pattern on electroencephalogram (EEG) known as hypsarrhythmia.""]","[""Symptoms of Williams Syndrome include cardiovascular problems, distinctive facial features, developmental delays, and learning disabilities.""]",[false],[true],[false],"[""Common symptoms of Williams Syndrome (WS) include cardiovascular issues, distinctive facial features, developmental delays, and a friendly and outgoing personality.""]","[""The symptoms of West syndrome include infantile spasms, developmental regression or delay, and a specific pattern on electroencephalogram (EEG) known as hypsarrhythmia.""]","[""Symptoms of Williams Syndrome (WS) include cardiovascular issues, distinctive facial features, developmental delays, and learning disabilities.""]",[false],[true],[false],"[""Symptoms of WS (Workstation) may include fatigue, eye strain, back or neck pain, headaches, and repetitive strain injuries.""]","[""The symptoms of West syndrome include infantile spasms, developmental regression or delay, and a specific pattern on electroencephalogram (EEG) known as hypsarrhythmia.""]","[""Symptoms of Williams Syndrome (WS) include cardiovascular issues, distinctive facial features, developmental delays, and learning disabilities.""]",[false],[true],[false],"[""Symptoms of WS include increased wind speed, potential for damage to structures, and impact on transportation and outdoor activities.""]","[""The symptoms of West syndrome include infantile spasms, developmental regression or delay, and a specific pattern on electroencephalogram (EEG) known as hypsarrhythmia.""]","[""Symptoms of Williams Syndrome (WS) include cardiovascular issues, distinctive facial features, developmental delays, and learning disabilities.""]",[false],[true],[false],"[""Common symptoms of Williams Syndrome include cardiovascular issues, distinctive facial features, developmental delays, and a friendly and outgoing personality.""]","[""The symptoms of West syndrome include infantile spasms, developmental regression or delay, and a specific pattern on electroencephalogram (EEG) known as hypsarrhythmia.""]","[""Symptoms of Williams Syndrome (WS) include cardiovascular issues, distinctive facial features, developmental delays, and learning disabilities.""]"
frequency,How many people are affected by factor XIII deficiency ?,"Inherited factor XIII deficiency affects 1 to 3 per million people worldwide. Researchers suspect that mild factor XIII deficiency, including the acquired form of the disorder, is underdiagnosed because many affected people never have a major episode of abnormal bleeding that would lead to a diagnosis.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""XIII"", ""full_form"": ""factor XIII""}]}",How many people are affected by XIII deficiency ?,How many people are affected by factor XIII deficiency ?,8,MEDICAL,Simple Datatype-Integer,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Roman Numeral 13"", ""13 (Roman numeral)""]]","[[""ABBREVIATIONS"", ""THEFREEDICTIONARY""]]","[""Factor XIII""]",[3.7373526358431645e-07],[3.7373526358431645e-07],"[""Factor XIII""]",[3.7373526358431645e-07],"[""LLM""]","[[9.455320897597918e-18, 5.598469887217287e-25]]",[0.9417715889886997],[0.9354208583220203],"[""Roman Numeral 13""]",[0.9604515905371015],"[""THEFREEDICTIONARY""]","[[0.9385164291693231, 0.9604515905371015]]","[""Factor XIII""]","[""LLM""]",How many people are affected by XIII (Factor XIII) deficiency ?,[true],[false],[true],"[""1 in 3 million people are affected by XIII (Factor XIII) deficiency""]","[""Factor XIII deficiency is a rare condition, affecting approximately 1 in 3-5 million people worldwide.""]","[""1 in 1 million people are affected by XIII deficiency""]",[true],[false],[false],"[""1 in 3 million people are affected by XIII (Factor XIII) deficiency""]","[""Factor XIII deficiency is a rare inherited bleeding disorder that affects about 1 in 3-5 million people worldwide.""]","[""1 in 1 million people are affected by XIII deficiency""]",[true],[false],[true],"[""1 in 3 million people are affected by XIII (Factor XIII) deficiency.""]","[""Factor XIII deficiency is a rare condition, affecting approximately 1 in 3-5 million people worldwide.""]","[""XIII deficiency affects approximately 1 in 1-2 million people worldwide.""]",[true],[true],[false],"[""1 in 3 million people are affected by XIII (Factor XIII) deficiency.""]","[""1 in 3 million people are affected by factor XIII deficiency""]","[""1 in 1 million people are affected by XIII deficiency""]",[false],[false],[true],"[""XIII deficiency is a rare genetic disorder affecting approximately 1 in 500,000 individuals.""]","[""Factor XIII deficiency is a rare condition, affecting approximately 1 in 3-5 million people worldwide.""]","[""1 in 1 million people are affected by XIII deficiency""]",[false],[true],[true],"[""XIII deficiency is a rare genetic disorder affecting approximately 1 in 500,000 individuals.""]","[""Factor XIII deficiency is a rare inherited bleeding disorder that affects about 1 in 3-5 million people worldwide.""]","[""1 in 1 million people are affected by XIII deficiency""]",[false],[false],[true],"[""XIII deficiency is a rare genetic disorder affecting approximately 1 in 500,000 individuals.""]","[""Factor XIII deficiency is a rare condition, affecting approximately 1 in 3-5 million people worldwide.""]","[""XIII deficiency affects approximately 1 in 1-2 million people worldwide.""]",[false],[true],[true],"[""XIII deficiency is a rare genetic disorder affecting approximately 1 in 500,000 individuals.""]","[""1 in 3 million people are affected by factor XIII deficiency""]","[""1 in 1 million people are affected by XIII deficiency""]",[true],[false],[false],"[""1 in 3 million people are affected by XIII (Factor XIII) deficiency""]","[""Factor XIII deficiency is a rare inherited bleeding disorder that affects about 1 in 3-5 million people worldwide.""]","[""1 in 1 million people are affected by XIII deficiency""]",[true],[false],[false],"[""1 in 3 million people are affected by XIII (Factor XIII) deficiency.""]","[""Factor XIII deficiency is a rare condition, affecting approximately 1 in 3-5 million people worldwide.""]","[""1 in 1 million people are affected by XIII deficiency""]",[true],[false],[true],"[""1 in 3 million people are affected by XIII (Factor XIII) deficiency""]","[""Factor XIII deficiency is a rare condition, affecting approximately 1 in 3-5 million people worldwide.""]","[""XIII deficiency affects approximately 1 in 1-2 million people worldwide.""]",[true],[true],[false],"[""1 in 3 million people are affected by XIII (Factor XIII) deficiency.""]","[""1 in 3 million people are affected by factor XIII deficiency""]","[""1 in 1 million people are affected by XIII deficiency""]",[true],[false],[false],"[""1 in 3 million people are affected by XIII (Factor XIII) deficiency""]","[""Factor XIII deficiency is a rare condition, affecting approximately 1 in 3-5 million people worldwide.""]","[""1 in 1 million people are affected by XIII deficiency""]",[true],[false],[false],"[""1 in 3 million people are affected by XIII (Factor XIII) deficiency""]","[""Factor XIII deficiency is a rare inherited bleeding disorder that affects about 1 in 3-5 million people worldwide.""]","[""1 in 1 million people are affected by XIII deficiency""]",[true],[false],[true],"[""1 in 3 million people are affected by XIII (Factor XIII) deficiency""]","[""Factor XIII deficiency is a rare condition, affecting approximately 1 in 3-5 million people worldwide.""]","[""XIII deficiency affects approximately 1 in 1-2 million people worldwide.""]",[true],[true],[false],"[""1 in 3 million people are affected by XIII (Factor XIII) deficiency""]","[""1 in 3 million people are affected by factor XIII deficiency""]","[""1 in 1 million people are affected by XIII deficiency""]",[true],[false],[false],"[""1 in 3 million people are affected by XIII (Factor XIII) deficiency""]","[""Factor XIII deficiency is a rare condition, affecting approximately 1 in 3-5 million people worldwide.""]","[""1 in 1 million people are affected by XIII deficiency""]",[true],[false],[false],"[""1 in 3 million people are affected by XIII (Factor XIII) deficiency""]","[""Factor XIII deficiency is a rare inherited bleeding disorder that affects about 1 in 3-5 million people worldwide.""]","[""1 in 1 million people are affected by XIII deficiency""]",[true],[false],[true],"[""1 in 3 million people are affected by XIII (Factor XIII) deficiency""]","[""Factor XIII deficiency is a rare condition, affecting approximately 1 in 3-5 million people worldwide.""]","[""XIII deficiency affects approximately 1 in 1-2 million people worldwide.""]",[true],[true],[false],"[""1 in 3 million people are affected by XIII (Factor XIII) deficiency""]","[""1 in 3 million people are affected by factor XIII deficiency""]","[""1 in 1 million people are affected by XIII deficiency""]",[true],[false],[false],"[""1 in 3 million people are affected by XIII (Factor XIII) deficiency.""]","[""Factor XIII deficiency is a rare condition, affecting approximately 1 in 3-5 million people worldwide.""]","[""1 in 1 million people are affected by XIII deficiency""]",[true],[false],[false],"[""1 in 3 million people are affected by XIII (Factor XIII) deficiency""]","[""Factor XIII deficiency is a rare inherited bleeding disorder that affects about 1 in 3-5 million people worldwide.""]","[""1 in 1 million people are affected by XIII deficiency""]",[true],[false],[true],"[""1 in 3 million people are affected by XIII (Factor XIII) deficiency""]","[""Factor XIII deficiency is a rare condition, affecting approximately 1 in 3-5 million people worldwide.""]","[""XIII deficiency affects approximately 1 in 1-2 million people worldwide.""]",[true],[true],[false],"[""1 in 3 million people are affected by XIII (Factor XIII) deficiency""]","[""1 in 3 million people are affected by factor XIII deficiency""]","[""1 in 1 million people are affected by XIII deficiency""]",[true],[false],[false],"[""XIII (Factor XIII) deficiency affects approximately 1 in 3 million people worldwide.""]","[""Factor XIII deficiency is a rare condition, affecting approximately 1 in 3-5 million people worldwide.""]","[""1 in 1 million people are affected by XIII deficiency""]",[true],[false],[false],"[""XIII (Factor XIII) deficiency affects approximately 1 in 3 million people worldwide.""]","[""Factor XIII deficiency is a rare inherited bleeding disorder that affects about 1 in 3-5 million people worldwide.""]","[""1 in 1 million people are affected by XIII deficiency""]",[true],[false],[true],"[""XIII (Factor XIII) deficiency affects approximately 1 in 3 million people worldwide.""]","[""Factor XIII deficiency is a rare condition, affecting approximately 1 in 3-5 million people worldwide.""]","[""XIII deficiency affects approximately 1 in 1-2 million people worldwide.""]",[true],[false],[false],"[""XIII (Factor XIII) deficiency affects approximately 1 in 3 million people worldwide.""]","[""1 in 3 million people are affected by factor XIII deficiency""]","[""1 in 1 million people are affected by XIII deficiency""]",[true],[false],[false],"[""XIII (Factor XIII) deficiency affects approximately 1 in 3 million people worldwide.""]","[""Factor XIII deficiency is a rare condition, affecting approximately 1 in 3-5 million people worldwide.""]","[""1 in 1 million people are affected by XIII deficiency""]",[true],[false],[false],"[""XIII (Factor XIII) deficiency affects approximately 1 in 3 million people worldwide.""]","[""Factor XIII deficiency is a rare condition, affecting approximately 1 in 3-5 million people worldwide.""]","[""1 in 1 million people are affected by XIII deficiency""]",[false],[false],[true],"[""XIII deficiency affects approximately 1 in 500,000 individuals.""]","[""Factor XIII deficiency is a rare condition, affecting approximately 1 in 3-5 million people worldwide.""]","[""1 in 1 million people are affected by XIII deficiency""]",[true],[false],[false],"[""XIII (Factor XIII) deficiency affects approximately 1 in 3 million people worldwide.""]","[""Factor XIII deficiency is a rare condition, affecting approximately 1 in 3-5 million people worldwide.""]","[""1 in 1 million people are affected by XIII deficiency""]"
frequency,How many people are affected by autosomal dominant congenital stationary night blindness ?,"Autosomal dominant congenital stationary night blindness is likely a rare disease; however, its prevalence is unknown.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""ADCSNB"", ""full_form"": ""autosomal dominant congenital stationary night blindness""}]}",How many people are affected by ADCSNB ?,How many people are affected by autosomal dominant congenital stationary night blindness ?,8,MEDICAL,Simple Datatype-Integer,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Autosomal Dominant Congenital Stationary Night Blindness"", ""adCSNB""]]","[[""THEFREEDICTIONARY"", ""THEFREEDICTIONARY""]]","[""Adenoid Cystic Carcinoma of Salivary Glands Non-BRCA1/2""]",[2.6222833195648024e-33],[1.5946246411367915e-40],"[""adCSNB""]",[0.009628119074757007],"[""THEFREEDICTIONARY""]","[[2.6222833195648024e-33, 0.009628119074757007]]",[0.7967958419884063],[0.8387788174803017],"[""Autosomal Dominant Congenital Stationary Night Blindness""]",[0.8661239784646253],"[""THEFREEDICTIONARY""]","[[0.797951298841383, 0.8661239784646253]]","[""Autosomal Dominant Congenital Stationary Night Blindness""]","[""THEFREEDICTIONARY""]",How many people are affected by ADCSNB (Adenoid Cystic Carcinoma of Salivary Glands Non-BRCA1/2) ?,[false],[false],[false],"[""ADCNSB affects approximately 1 in 100,000 individuals.""]","[""Autosomal dominant congenital stationary night blindness affects approximately 1 in 50,000 individuals.""]","[""ADCNSB affects approximately 1 in 10,000 individuals.""]",[false],[false],[false],"[""ADCNSB affects approximately 1 in 100,000 individuals.""]","[""Autosomal dominant congenital stationary night blindness affects approximately 1 in 50,000 individuals.""]","[""ADCNSB affects approximately 1 in 10,000 individuals.""]",[false],[false],[false],"[""ADCNSB affects approximately 1 in 100,000 individuals.""]","[""Autosomal dominant congenital stationary night blindness affects approximately 1 in 100,000 individuals.""]","[""ADCNSB affects approximately 1 in 10,000 individuals.""]",[false],[false],[true],"[""ADCNSB affects approximately 1 in 100,000 individuals.""]","[""Autosomal dominant congenital stationary night blindness affects approximately 1 in 50,000 individuals.""]","[""The exact number of people affected by ADCSNB is not available.""]",[false],[false],[false],"[""ADCNSB affects approximately 1 in 50,000 people.""]","[""Autosomal dominant congenital stationary night blindness affects approximately 1 in 50,000 individuals.""]","[""ADCNSB affects approximately 1 in 10,000 individuals.""]",[false],[false],[false],"[""ADCNSB affects approximately 1 in 50,000 individuals.""]","[""Autosomal dominant congenital stationary night blindness affects approximately 1 in 50,000 individuals.""]","[""ADCNSB affects approximately 1 in 10,000 individuals.""]",[false],[false],[false],"[""ADCNSB affects approximately 1 in 100,000 individuals.""]","[""Autosomal dominant congenital stationary night blindness affects approximately 1 in 100,000 individuals.""]","[""ADCNSB affects approximately 1 in 10,000 individuals.""]",[false],[false],[true],"[""ADCNSB affects approximately 1 in 100,000 individuals.""]","[""Autosomal dominant congenital stationary night blindness affects approximately 1 in 50,000 individuals.""]","[""The exact number of people affected by ADCSNB is not available.""]",[false],[false],[false],"[""ADCNSB affects approximately 1 in 50,000 people.""]","[""Autosomal dominant congenital stationary night blindness affects approximately 1 in 50,000 individuals.""]","[""ADCNSB affects approximately 1 in 10,000 individuals.""]",[false],[false],[false],"[""ADCNSB affects approximately 1 in 100,000 individuals.""]","[""Autosomal dominant congenital stationary night blindness affects approximately 1 in 50,000 individuals.""]","[""ADCNSB affects approximately 1 in 10,000 individuals.""]",[false],[false],[false],"[""ADCNSB affects approximately 1 in 50,000 people.""]","[""Autosomal dominant congenital stationary night blindness affects approximately 1 in 100,000 individuals.""]","[""ADCNSB affects approximately 1 in 10,000 individuals.""]",[false],[false],[true],"[""ADCNSB affects approximately 1 in 50,000 people.""]","[""Autosomal dominant congenital stationary night blindness affects approximately 1 in 50,000 individuals.""]","[""The exact number of people affected by ADCSNB is not available.""]",[false],[false],[false],"[""ADCNSB affects approximately 1 in 100,000 individuals.""]","[""Autosomal dominant congenital stationary night blindness affects approximately 1 in 50,000 individuals.""]","[""ADCNSB affects approximately 1 in 10,000 individuals.""]",[false],[false],[false],"[""ADCNSB affects approximately 1 in 50,000 individuals.""]","[""Autosomal dominant congenital stationary night blindness affects approximately 1 in 50,000 individuals.""]","[""ADCNSB affects approximately 1 in 10,000 individuals.""]",[false],[false],[false],"[""ADCNSB affects approximately 1 in 50,000 individuals.""]","[""Autosomal dominant congenital stationary night blindness affects approximately 1 in 100,000 individuals.""]","[""ADCNSB affects approximately 1 in 10,000 individuals.""]",[false],[false],[true],"[""ADCNSB affects approximately 1 in 50,000 individuals.""]","[""Autosomal dominant congenital stationary night blindness affects approximately 1 in 50,000 individuals.""]","[""The exact number of people affected by ADCSNB is not available.""]",[true],[false],[false],"[""The exact number of people affected by ADCSNB is not known.""]","[""Autosomal dominant congenital stationary night blindness affects approximately 1 in 50,000 individuals.""]","[""ADCNSB affects approximately 1 in 10,000 individuals.""]",[false],[false],[false],"[""ADCNSB affects approximately 1 in 50,000 people.""]","[""Autosomal dominant congenital stationary night blindness affects approximately 1 in 50,000 individuals.""]","[""ADCNSB affects approximately 1 in 10,000 individuals.""]",[false],[false],[false],"[""ADCNSB affects approximately 1 in 50,000 individuals.""]","[""Autosomal dominant congenital stationary night blindness affects approximately 1 in 100,000 individuals.""]","[""ADCNSB affects approximately 1 in 10,000 individuals.""]",[false],[false],[true],"[""ADCNSB affects approximately 1 in 50,000 individuals.""]","[""Autosomal dominant congenital stationary night blindness affects approximately 1 in 50,000 individuals.""]","[""The exact number of people affected by ADCSNB is not available.""]",[false],[true],[true],"[""ADCNSB affects approximately 1,200 people in the United States each year.""]","[""Autosomal dominant congenital stationary night blindness affects approximately 1 in 50,000 individuals.""]","[""ADCNSB affects approximately 1 in 10,000 individuals.""]",[false],[false],[false],"[""ADCNSB affects approximately 1,200 people in the United States each year.""]","[""Autosomal dominant congenital stationary night blindness affects approximately 1 in 50,000 individuals.""]","[""ADCNSB affects approximately 1 in 10,000 individuals.""]",[false],[false],[false],"[""ADCNSB affects approximately 1,200 people in the United States each year.""]","[""Autosomal dominant congenital stationary night blindness affects approximately 1 in 100,000 individuals.""]","[""ADCNSB affects approximately 1 in 10,000 individuals.""]",[false],[false],[true],"[""ADCNSB affects approximately 1,200 people in the United States each year.""]","[""Autosomal dominant congenital stationary night blindness affects approximately 1 in 50,000 individuals.""]","[""The exact number of people affected by ADCSNB is not available.""]",[true],[false],[false],"[""The exact number of people affected by Autosomal Dominant Congenital Stationary Night Blindness is not known, but it is considered a rare condition.""]","[""Autosomal dominant congenital stationary night blindness affects approximately 1 in 50,000 individuals.""]","[""ADCNSB affects approximately 1 in 10,000 individuals.""]",[true],[false],[false],"[""The exact number of people affected by Autosomal Dominant Congenital Stationary Night Blindness is not known, but it is considered a rare condition.""]","[""Autosomal dominant congenital stationary night blindness affects approximately 1 in 50,000 individuals.""]","[""ADCNSB affects approximately 1 in 10,000 individuals.""]",[true],[false],[false],"[""The exact number of people affected by Autosomal Dominant Congenital Stationary Night Blindness is not well-documented, but it is considered a rare condition.""]","[""Autosomal dominant congenital stationary night blindness affects approximately 1 in 100,000 individuals.""]","[""ADCNSB affects approximately 1 in 10,000 individuals.""]",[true],[false],[true],"[""The exact number of people affected by Autosomal Dominant Congenital Stationary Night Blindness is not well-documented, but it is considered a rare condition.""]","[""Autosomal dominant congenital stationary night blindness affects approximately 1 in 50,000 individuals.""]","[""The exact number of people affected by ADCSNB is not available.""]",[true],[false],[false],"[""The exact number of people affected by ADCSNB is not known, but it is considered a rare condition.""]","[""Autosomal dominant congenital stationary night blindness affects approximately 1 in 50,000 individuals.""]","[""ADCNSB affects approximately 1 in 10,000 individuals.""]",[true],[false],[false],"[""The number of people affected by ADCSNB (adCSNB) is not specified.""]","[""Autosomal dominant congenital stationary night blindness affects approximately 1 in 50,000 individuals.""]","[""ADCNSB affects approximately 1 in 10,000 individuals.""]",[true],[false],[false],"[""The exact number of people affected by ADCSNB is not known, but it is considered a rare condition.""]","[""Autosomal dominant congenital stationary night blindness affects approximately 1 in 50,000 individuals.""]","[""ADCNSB affects approximately 1 in 10,000 individuals.""]",[true],[false],[false],"[""The number of people affected by ADCSNB is not readily available.""]","[""Autosomal dominant congenital stationary night blindness affects approximately 1 in 50,000 individuals.""]","[""ADCNSB affects approximately 1 in 10,000 individuals.""]"
information,Do you have information about HPV,"Summary : Human papillomaviruses (HPV) are common viruses that can cause warts. There are more than 100 types of HPV. Most are harmless, but about 30 types put you at risk for cancer. These types affect the genitals and you get them through sexual contact with an infected partner. They can be either low-risk or high-risk. Low-risk HPV can cause genital warts. High-risk HPV can lead to cancers of the cervix, vulva, vagina, and anus in women. In men, it can lead to cancers of the anus and penis.    Although some people develop genital warts from HPV infection, others have no symptoms. Your health care provider can treat or remove the warts. In women, Pap tests can detect changes in the cervix that might lead to cancer. Both Pap and HPV tests are types of cervical cancer screening.    Correct usage of latex condoms greatly reduces, but does not eliminate, the risk of catching or spreading HPV. Vaccines can protect against several types of HPV, including some that can cause cancer.    NIH: National Institute of Allergy and Infectious Diseases","{""full_form_abbrv_map"": [{""ambiguity_type"": ""abbreviation"", ""abbreviation"": ""HPV"", ""full_form"": ""Human Papillomavirus""}]}",Do you have information about HPV,Do you have information about Human Papillomavirus,8,MEDICAL,Simple Datatype-Boolean,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Human Papilloma Virus"", ""High Production Volume"", ""Human Powered Vehicle"", ""High-Pressure Vent"", ""Human Powered Vechile"", ""Princeville Airport, Kauai, Hawaii USA"", ""Hewlett- Packard Vectra computer"", ""Having Purple Vomit"", ""High Pressure Valve"", ""Hours Per Vehicle""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Human Papillomavirus""]",[1.1540434317788865e-14],[1.1540434317788865e-14],"[""High Pressure Valve""]",[1.7827789408367167e-09],"[""ABBREVIATIONS""]","[[5.182684157863507e-13, 8.335123043289716e-11, 1.1100181263673678e-14, 1.5279781296422885e-09, 7.790547337082534e-20, 2.1404079233333473e-42, 1.0864293355894014e-37, 1.188991120737239e-14, 1.7827789408367167e-09, 2.624801985106429e-13]]",[0.936792238304069],[0.936783892212439],"[""Hours Per Vehicle""]",[0.936783892212439],"[""LLM""]","[[0.9286292154591412, 0.7369901701389411, 0.7490123783612516, 0.7308387806498793, 0.7305360628969428, 0.670934807501341, 0.6928911093813992, 0.7827179728057999, 0.7323998283024384, 0.7192421330520357]]","[""Human Papilloma Virus""]","[""ABBREVIATIONS""]",Do you have information about HPV (Human Papillomavirus),[true],[true],[false],"[""HPV stands for Human Papillomavirus, which is a group of related viruses that can cause warts on different parts of the body. In some cases, HPV can lead to certain types of cancer, including cervical cancer.""]","[""Yes, Human Papillomavirus (HPV) is a group of related viruses that can cause warts on different parts of the body. Some types of HPV can lead to cancer, including cervical cancer.""]","[""Yes""]",[true],[true],[true],"[""HPV stands for Human Papillomavirus, not High Pressure Valve. It is a common sexually transmitted infection that can lead to various health issues, including genital warts and certain types of cancer.""]","[""Yes, Human Papillomavirus (HPV) is a group of related viruses that can cause warts on different parts of the body. Some types of HPV can lead to cancer, including cervical cancer.""]","[""Yes, Human Papillomavirus (HPV) is a group of related viruses that can cause warts and certain types of cancer.""]",[true],[false],[false],"[""HPV, which stands for Human Papillomavirus, is a common sexually transmitted infection. It can cause genital warts and various types of cancers, including cervical cancer. Vaccines are available to prevent HPV infection.""]","[""Yes""]","[""Yes""]",[true],[false],[false],"[""HPV stands for Human Papillomavirus, not High Pressure Valve. It is a common sexually transmitted infection that can lead to various health issues, including genital warts and certain types of cancer.""]","[""Yes""]","[""Yes""]",[true],[true],[false],"[""HPV stands for Human Papillomavirus, a common sexually transmitted infection that can lead to various health issues including genital warts and certain types of cancer.""]","[""Yes, Human Papillomavirus (HPV) is a group of related viruses that can cause warts on different parts of the body. Some types of HPV can lead to cancer, including cervical cancer.""]","[""Yes""]",[false],[true],[true],"[""HPV stands for Human Papillomavirus, not Hours Per Vehicle.""]","[""Yes, Human Papillomavirus (HPV) is a group of related viruses that can cause warts on different parts of the body. Some types of HPV can lead to cancer, including cervical cancer.""]","[""Yes, Human Papillomavirus (HPV) is a group of related viruses that can cause warts and certain types of cancer.""]",[true],[false],[false],"[""HPV stands for Human Papillomavirus, not Hours Per Vehicle.""]","[""Yes""]","[""Yes""]",[true],[false],[false],"[""HPV stands for Human Papillomavirus, a common sexually transmitted infection that can lead to various health issues including genital warts and certain types of cancer.""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes, HPV (Human Papilloma Virus) is a common sexually transmitted infection that can lead to various health issues, including genital warts and certain types of cancer.""]","[""Yes, Human Papillomavirus (HPV) is a group of related viruses that can cause warts on different parts of the body. Some types of HPV can lead to cancer, including cervical cancer.""]","[""Yes, Human Papillomavirus (HPV) is a group of related viruses that can cause warts and certain types of cancer.""]",[true],[true],[false],"[""Yes, HPV (Human Papilloma Virus) is a common sexually transmitted infection that can lead to various cancers, including cervical cancer.""]","[""Yes, Human Papillomavirus (HPV) is a group of related viruses that can cause warts on different parts of the body. Some types of HPV can lead to cancer, including cervical cancer.""]","[""Yes""]",[true],[true],[true],"[""Yes, HPV is a common sexually transmitted infection that can lead to various health issues including genital warts and certain types of cancer.""]","[""Yes""]","[""Yes""]",[true],[false],[false],"[""Yes, HPV is a common sexually transmitted infection that can lead to various health issues including genital warts and certain types of cancer.""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes""]","[""Yes, Human Papillomavirus (HPV) is a group of related viruses that can cause warts on different parts of the body. Some types of HPV can lead to cancer, including cervical cancer.""]","[""Yes""]",[false],[true],[true],"[""Yes""]","[""Yes, Human Papillomavirus (HPV) is a group of related viruses that can cause warts on different parts of the body. Some types of HPV can lead to cancer, including cervical cancer.""]","[""Yes, Human Papillomavirus (HPV) is a group of related viruses that can cause warts and certain types of cancer.""]",[true],[true],[true],"[""Yes""]","[""Yes""]","[""Yes""]",[false],[false],[false],"[""Yes""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes""]","[""Yes, Human Papillomavirus (HPV) is a group of related viruses that can cause warts on different parts of the body. Some types of HPV can lead to cancer, including cervical cancer.""]","[""Yes""]",[true],[true],[true],"[""Yes, HPV is a common sexually transmitted infection that can lead to various health issues including genital warts and certain types of cancer.""]","[""Yes, Human Papillomavirus (HPV) is a group of related viruses that can cause warts on different parts of the body. Some types of HPV can lead to cancer, including cervical cancer.""]","[""Yes, Human Papillomavirus (HPV) is a group of related viruses that can cause warts and certain types of cancer.""]",[false],[false],[false],"[""Yes""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes, HPV (Human Papillomavirus) is a common sexually transmitted infection that can lead to various health issues, including genital warts and certain types of cancer.""]","[""Yes, Human Papillomavirus (HPV) is a group of related viruses that can cause warts on different parts of the body. Some types of HPV can lead to cancer, including cervical cancer.""]","[""Yes""]",[true],[true],[true],"[""Yes, HPV (Human Papillomavirus) is a common sexually transmitted infection that can lead to various health issues, including genital warts and certain types of cancer.""]","[""Yes, Human Papillomavirus (HPV) is a group of related viruses that can cause warts on different parts of the body. Some types of HPV can lead to cancer, including cervical cancer.""]","[""Yes, Human Papillomavirus (HPV) is a group of related viruses that can cause warts and certain types of cancer.""]",[true],[false],[false],"[""Yes, HPV (Human Papillomavirus) is a common sexually transmitted infection that can lead to various health issues, including genital warts and certain types of cancer.""]","[""Yes""]","[""Yes""]",[true],[false],[false],"[""Yes, HPV (Human Papillomavirus) is a common sexually transmitted infection that can lead to various health issues, including genital warts and certain types of cancer.""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes, HPV is a common sexually transmitted infection that can lead to various health issues, including genital warts and certain types of cancer.""]","[""Yes, Human Papillomavirus (HPV) is a group of related viruses that can cause warts on different parts of the body. Some types of HPV can lead to cancer, including cervical cancer.""]","[""Yes""]",[true],[true],[true],"[""Yes, HPV is a common sexually transmitted infection that can lead to various health issues, including genital warts and certain types of cancer.""]","[""Yes, Human Papillomavirus (HPV) is a group of related viruses that can cause warts on different parts of the body. Some types of HPV can lead to cancer, including cervical cancer.""]","[""Yes, Human Papillomavirus (HPV) is a group of related viruses that can cause warts and certain types of cancer.""]",[true],[false],[false],"[""Yes, HPV is a common sexually transmitted infection that can lead to various health issues, including genital warts and certain types of cancer.""]","[""Yes""]","[""Yes""]",[true],[false],[false],"[""Yes, HPV is a common sexually transmitted infection that can lead to various health issues including genital warts and certain types of cancer.""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes, HPV is a common sexually transmitted infection that can lead to various health issues including genital warts and certain types of cancer.""]","[""Yes, Human Papillomavirus (HPV) is a group of related viruses that can cause warts on different parts of the body. Some types of HPV can lead to cancer, including cervical cancer.""]","[""Yes""]",[true],[true],[false],"[""HPV stands for Human Papillomavirus, a common sexually transmitted infection that can lead to various health issues including genital warts and certain types of cancer.""]","[""Yes, Human Papillomavirus (HPV) is a group of related viruses that can cause warts on different parts of the body. Some types of HPV can lead to cancer, including cervical cancer.""]","[""Yes""]",[false],[true],[false],"[""HPV stands for Hours Per Vehicle, which is a metric used to measure the amount of time a vehicle is utilized within a specific period.""]","[""Yes, Human Papillomavirus (HPV) is a group of related viruses that can cause warts on different parts of the body. Some types of HPV can lead to cancer, including cervical cancer.""]","[""Yes""]",[true],[true],[false],"[""Yes, HPV is a common sexually transmitted infection that can lead to various health issues including genital warts and certain types of cancers.""]","[""Yes, Human Papillomavirus (HPV) is a group of related viruses that can cause warts on different parts of the body. Some types of HPV can lead to cancer, including cervical cancer.""]","[""Yes""]"
frequency,How many people are affected by Wiskott-Aldrich syndrome ?,The estimated incidence of Wiskott-Aldrich syndrome is between 1 and 10 cases per million males worldwide; this condition is rarer in females.,"{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""WAS"", ""full_form"": ""Wiskott-Aldrich syndrome""}]}",How many people are affected by WAS ?,How many people are affected by Wiskott-Aldrich syndrome ?,8,MEDICAL,Simple Datatype-Integer,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Washington Redskins"", ""Wait And See"", ""Websphere Application Server"", ""World Aquaculture Society"", ""Washo"", ""With Aliases"", ""Washington Academy of Sciences"", ""Water Activated Sludge"", ""Wartime Automated System"", ""ARRL Worked All States Award""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Wiskott-Aldrich Syndrome""]",[3.5009984293026585e-22],[3.5009984293026585e-22],"[""Washo""]",[2.689452736645177e-06],"[""ABBREVIATIONS""]","[[1.4915355061674941e-19, 2.9715886335339814e-10, 1.0080558513399036e-20, 3.853956719262627e-19, 2.689452736645177e-06, 2.2397007205564692e-11, 1.3940060448470808e-20, 5.637531901609873e-15, 1.3567384934471412e-18, 5.055372184345731e-29]]",[0.8874953285131665],[0.888744870516506],"[""With Aliases""]",[0.893451932809725],"[""ABBREVIATIONS""]","[[0.6962997623944505, 0.8516736188027254, 0.6911824175115882, 0.6898640936867484, 0.851485606277629, 0.8126491557304181, 0.893451932809725, 0.7773013310093531, 0.7507614615493936, 0.6693043004046806]]","[""Wiskott-Aldrich Syndrome""]","[""LLM""]",How many people are affected by WAS (Wiskott-Aldrich Syndrome) ?,[false],[true],[false],"[""WAS (Washo) affects approximately 1 in 1,000,000 people.""]","[""1 to 10 in 1,000,000 males""]","[""WAS affects approximately 1 in 100,000 people.""]",[true],[true],[false],"[""WAS (Wiskott-Aldrich syndrome) affects approximately 1 to 10 individuals per million males worldwide.""]","[""1 to 10 in 1,000,000 males""]","[""WAS affects approximately 1 in 100,000 individuals.""]",[false],[true],[false],"[""WAS (Washo) affects approximately 1 in 1,000,000 individuals worldwide.""]","[""1 to 10 cases per million males""]","[""WAS affects approximately 1 in 100,000 individuals.""]",[true],[true],[false],"[""WAS (Wiskott-Aldrich syndrome) affects approximately 1 to 10 individuals per million males worldwide.""]","[""1 to 10 cases per million males""]","[""WAS affects approximately 1 in 100,000 individuals.""]",[false],[true],[false],"[""WAS affects approximately 1 in 10,000 to 1 in 40,000 people worldwide.""]","[""1 to 10 in 1,000,000 males""]","[""WAS affects approximately 1 in 100,000 people.""]",[false],[true],[false],"[""WAS affects approximately 1 in 10,000 to 1 in 40,000 people worldwide.""]","[""1 to 10 in 1,000,000 males""]","[""WAS affects approximately 1 in 100,000 individuals.""]",[false],[true],[false],"[""WAS affects approximately 1 in 100,000 individuals.""]","[""1 to 10 cases per million males""]","[""WAS affects approximately 1 in 100,000 individuals.""]",[false],[true],[false],"[""WAS affects approximately 1 in 10,000 to 1 in 40,000 individuals worldwide.""]","[""1 to 10 cases per million males""]","[""WAS affects approximately 1 in 100,000 individuals.""]",[true],[true],[false],"[""Wiskott-Aldrich Syndrome affects approximately 1 to 10 individuals per million males worldwide.""]","[""1 to 10 in 1,000,000 males""]","[""WAS affects approximately 1 in 100,000 individuals.""]",[true],[true],[false],"[""1 to 10 cases per million males""]","[""1 to 10 in 1,000,000 males""]","[""WAS affects approximately 1 in 100,000 people.""]",[true],[true],[false],"[""1 to 10 cases per 1 million males""]","[""1 to 10 cases per million males""]","[""WAS affects approximately 1 in 100,000 individuals.""]",[true],[true],[false],"[""Wiskott-Aldrich Syndrome affects approximately 1 to 10 individuals per million males worldwide.""]","[""1 to 10 cases per million males""]","[""WAS affects approximately 1 in 100,000 individuals.""]",[true],[true],[false],"[""1 to 10 in 1,000,000 males""]","[""1 to 10 in 1,000,000 males""]","[""WAS affects approximately 1 in 100,000 people.""]",[false],[true],[false],"[""1 to 10 in 1,000,000 people""]","[""1 to 10 in 1,000,000 males""]","[""WAS affects approximately 1 in 100,000 individuals.""]",[true],[true],[false],"[""1 to 10 in 1,000,000 people""]","[""1 to 10 cases per million males""]","[""WAS affects approximately 1 in 100,000 individuals.""]",[true],[true],[false],"[""1 to 10 in 1,000,000 males""]","[""1 to 10 cases per million males""]","[""WAS affects approximately 1 in 100,000 individuals.""]",[true],[true],[false],"[""Wiskott-Aldrich Syndrome affects approximately 1 to 10 individuals per million males worldwide.""]","[""1 to 10 in 1,000,000 males""]","[""WAS affects approximately 1 in 100,000 people.""]",[true],[true],[false],"[""1 to 10 cases per million males""]","[""1 to 10 in 1,000,000 males""]","[""WAS affects approximately 1 in 100,000 individuals.""]",[true],[true],[false],"[""1 to 10 cases per million males""]","[""1 to 10 cases per million males""]","[""WAS affects approximately 1 in 100,000 individuals.""]",[true],[true],[false],"[""Wiskott-Aldrich Syndrome affects approximately 1 to 10 individuals per million males worldwide.""]","[""1 to 10 cases per million males""]","[""WAS affects approximately 1 in 100,000 individuals.""]",[true],[true],[false],"[""Wiskott-Aldrich Syndrome affects approximately 1 to 10 individuals per million males worldwide.""]","[""1 to 10 in 1,000,000 males""]","[""WAS affects approximately 1 in 100,000 people.""]",[true],[true],[false],"[""Wiskott-Aldrich Syndrome affects approximately 1 to 10 individuals per million males worldwide.""]","[""1 to 10 in 1,000,000 males""]","[""WAS affects approximately 1 in 100,000 individuals.""]",[true],[true],[false],"[""1 to 10 cases per million males""]","[""1 to 10 cases per million males""]","[""WAS affects approximately 1 in 100,000 individuals.""]",[true],[true],[false],"[""1 to 10 cases per million males""]","[""1 to 10 cases per million males""]","[""WAS affects approximately 1 in 100,000 individuals.""]",[true],[true],[false],"[""Wiskott-Aldrich Syndrome affects approximately 1 to 10 individuals per million males worldwide.""]","[""1 to 10 in 1,000,000 males""]","[""WAS affects approximately 1 in 100,000 people.""]",[true],[true],[false],"[""Wiskott-Aldrich Syndrome (WAS) is a rare X-linked recessive disorder that primarily affects males. The exact number of people affected by WAS is not well documented, but it is estimated to occur in about 1 to 10 per million males worldwide.""]","[""1 to 10 in 1,000,000 males""]","[""WAS affects approximately 1 in 100,000 individuals.""]",[true],[true],[false],"[""Wiskott-Aldrich Syndrome affects approximately 1 to 10 individuals per million males worldwide.""]","[""1 to 10 cases per million males""]","[""WAS affects approximately 1 in 100,000 individuals.""]",[true],[true],[false],"[""Wiskott-Aldrich Syndrome (WAS) is a rare X-linked recessive disorder that primarily affects males. The exact number of people affected by WAS is not well documented, but it is estimated to occur in about 1 to 10 per million males worldwide.""]","[""1 to 10 cases per million males""]","[""WAS affects approximately 1 in 100,000 individuals.""]",[true],[true],[false],"[""Wiskott-Aldrich Syndrome affects approximately 1 to 10 individuals per million males worldwide.""]","[""1 to 10 in 1,000,000 males""]","[""WAS affects approximately 1 in 100,000 people.""]",[false],[true],[false],"[""The population of Washo people is estimated to be around 1,000 individuals.""]","[""1 to 10 in 1,000,000 males""]","[""WAS affects approximately 1 in 100,000 people.""]",[false],[true],[true],"[""The number of people affected by WAS with aliases is not available.""]","[""1 to 10 in 1,000,000 males""]","[""WAS affects approximately 1 in 100,000 people.""]",[true],[true],[false],"[""Wiskott-Aldrich Syndrome affects approximately 1 to 10 individuals per million males worldwide.""]","[""1 to 10 in 1,000,000 males""]","[""WAS affects approximately 1 in 100,000 people.""]"
treatment,What are the treatments for autosomal recessive congenital methemoglobinemia ?,"These resources address the diagnosis or management of autosomal recessive congenital methemoglobinemia:  - Genetic Testing Registry: METHEMOGLOBINEMIA, TYPE I  - Genetic Testing Registry: Methemoglobinemia type 2  - KidsHealth from Nemours: Blood Test: Hemoglobin  - MedlinePlus Encyclopedia: Hemoglobin  - MedlinePlus Encyclopedia: Methemoglobinemia   These resources from MedlinePlus offer information about the diagnosis and management of various health conditions:  - Diagnostic Tests  - Drug Therapy  - Surgery and Rehabilitation  - Genetic Counseling   - Palliative Care","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""ARCM"", ""full_form"": ""autosomal recessive congenital methemoglobinemia""}]}",What are the treatments for ARCM ?,What are the treatments for autosomal recessive congenital methemoglobinemia ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Asian Research Center for Migration"", ""Aging Resources and Care Management"", ""Association"", ""Asian Research Centre for Migration"", ""Asymmetric Ring Closing Metathesis"", ""Autonomic Resilient Cloud Management"", ""Arias Resource Capital Management"", ""ARIS Risk Compliance Manager"", ""Associate of the Royal College of Music"", ""Asteroid Redirect Crewed Mission""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Arrhythmogenic Right Ventricular Cardiomyopathy""]",[1.6922101112546445e-30],[1.1856764762327461e-17],"[""Association""]",[1.4113095394984601e-05],"[""ABBREVIATIONS""]","[[1.627467119477652e-19, 2.1800540568819884e-19, 1.4113095394984601e-05, 5.837152764986179e-22, 5.456828259908551e-22, 1.903012220231728e-23, 1.8839696678483976e-24, 1.0367129676351868e-22, 3.506901299947442e-23, 3.347254520036241e-27]]",[0.6558369344516606],[0.773858784516197],"[""Aging Resources and Care Management""]",[0.9004163143308344],"[""ABBREVIATIONS""]","[[0.7210351461942814, 0.758407580072031, 0.9004163143308344, 0.714388182433658, 0.7111751111112544, 0.7274437729539138, 0.7881880909889516, 0.7602510633041168, 0.7485562874107696, 0.6562336019416344]]","[""Arrhythmogenic Right Ventricular Cardiomyopathy""]","[""LLM""]",What are the treatments for ARCM (Arrhythmogenic Right Ventricular Cardiomyopathy) ?,[false],[true],[false],"[""The treatments for ARCM (Association) include medication, lifestyle changes, and therapy.""]","[""Methylene blue administration and ascorbic acid supplementation""]","[""The treatments for ARCM include medications, lifestyle changes, and surgical interventions.""]",[false],[true],[false],"[""The treatments for ARCM (Association) include medication, lifestyle changes, and therapy.""]","[""Methylene blue administration, ascorbic acid supplementation, and avoiding triggers like certain medications""]","[""The treatments for ARCM include medication, lifestyle changes, therapy, and in severe cases, surgery.""]",[false],[true],[false],"[""The treatments for ARCM (Association) include medication, lifestyle changes, and therapy.""]","[""Methylene blue administration, ascorbic acid supplementation, and avoiding exposure to oxidizing agents""]","[""The treatments for ARCM include medications, lifestyle changes, and surgical interventions.""]",[false],[true],[false],"[""The treatments for ARCM (Association) include medication, lifestyle changes, and therapy.""]","[""Treatments for autosomal recessive congenital methemoglobinemia include methylene blue, ascorbic acid, and hyperbaric oxygen therapy.""]","[""The treatments for ARCM include medications, lifestyle changes, and surgical interventions.""]",[false],[true],[false],"[""The treatments for ARCM (Aging Resources and Care Management) may include medication management, physical therapy, occupational therapy, counseling, and support services.""]","[""Methylene blue administration and ascorbic acid supplementation""]","[""The treatments for ARCM include medications, lifestyle changes, and surgical interventions.""]",[false],[true],[false],"[""The treatments for ARCM (Aging Resources and Care Management) may include medication management, physical therapy, cognitive behavioral therapy, social support services, and lifestyle modifications.""]","[""Methylene blue administration, ascorbic acid supplementation, and avoiding triggers like certain medications""]","[""The treatments for ARCM include medication, lifestyle changes, therapy, and in severe cases, surgery.""]",[false],[true],[false],"[""The treatments for ARCM (Aging Resources and Care Management) may include medication management, physical therapy, occupational therapy, counseling, and social support services.""]","[""Methylene blue administration, ascorbic acid supplementation, and avoiding exposure to oxidizing agents""]","[""The treatments for ARCM include medications, lifestyle changes, and surgical interventions.""]",[false],[true],[false],"[""The treatments for ARCM (Aging Resources and Care Management) may include medication management, therapy, social support, and lifestyle modifications.""]","[""Treatments for autosomal recessive congenital methemoglobinemia include methylene blue, ascorbic acid, and hyperbaric oxygen therapy.""]","[""The treatments for ARCM include medications, lifestyle changes, and surgical interventions.""]",[false],[true],[false],"[""Medications, implantable cardioverter-defibrillator (ICD), catheter ablation, lifestyle changes, and heart transplant""]","[""Methylene blue administration, ascorbic acid supplementation, and avoiding triggers like certain medications""]","[""The treatments for ARCM include medication, lifestyle changes, therapy, and in severe cases, surgery.""]",[false],[true],[false],"[""Implantable cardioverter-defibrillator (ICD) therapy, antiarrhythmic medications, catheter ablation, lifestyle modifications""]","[""Methylene blue administration and ascorbic acid supplementation""]","[""The treatments for ARCM include medications, lifestyle changes, and surgical interventions.""]",[false],[true],[false],"[""Implantable cardioverter-defibrillator (ICD) therapy, antiarrhythmic medications, lifestyle modifications, and in severe cases, heart transplantation""]","[""Methylene blue administration, ascorbic acid supplementation, and avoiding exposure to oxidizing agents""]","[""The treatments for ARCM include medications, lifestyle changes, and surgical interventions.""]",[false],[true],[false],"[""Treatment for ARVC includes medications, implantable cardioverter-defibrillator (ICD), catheter ablation, and lifestyle changes.""]","[""Treatments for autosomal recessive congenital methemoglobinemia include methylene blue, ascorbic acid, and hyperbaric oxygen therapy.""]","[""The treatments for ARCM include medications, lifestyle changes, and surgical interventions.""]",[false],[true],[false],"[""Implantable cardioverter-defibrillator (ICD) therapy, antiarrhythmic medications, lifestyle modifications, and catheter ablation""]","[""Methylene blue administration and ascorbic acid supplementation""]","[""The treatments for ARCM include medications, lifestyle changes, and surgical interventions.""]",[false],[true],[false],"[""Medications, implantable cardioverter-defibrillator (ICD), catheter ablation, lifestyle changes, and in severe cases, heart transplant""]","[""Methylene blue administration, ascorbic acid supplementation, and avoiding triggers like certain medications""]","[""The treatments for ARCM include medication, lifestyle changes, therapy, and in severe cases, surgery.""]",[false],[true],[false],"[""Implantable cardioverter-defibrillator (ICD) therapy, antiarrhythmic medications, catheter ablation, lifestyle modifications""]","[""Methylene blue administration, ascorbic acid supplementation, and avoiding exposure to oxidizing agents""]","[""The treatments for ARCM include medications, lifestyle changes, and surgical interventions.""]",[false],[true],[false],"[""Medications, implantable cardioverter-defibrillator (ICD), catheter ablation, lifestyle changes""]","[""Treatments for autosomal recessive congenital methemoglobinemia include methylene blue, ascorbic acid, and hyperbaric oxygen therapy.""]","[""The treatments for ARCM include medications, lifestyle changes, and surgical interventions.""]",[false],[true],[false],"[""Implantable cardioverter-defibrillator (ICD) therapy, antiarrhythmic medications, lifestyle modifications, and catheter ablation""]","[""Methylene blue administration and ascorbic acid supplementation""]","[""The treatments for ARCM include medications, lifestyle changes, and surgical interventions.""]",[false],[true],[false],"[""Treatment for ARVC may include medications, implantable cardioverter-defibrillator (ICD) placement, catheter ablation, and lifestyle modifications.""]","[""Methylene blue administration, ascorbic acid supplementation, and avoiding triggers like certain medications""]","[""The treatments for ARCM include medication, lifestyle changes, therapy, and in severe cases, surgery.""]",[false],[true],[false],"[""Treatment for ARVC includes medications to control arrhythmias, implantable cardioverter-defibrillator (ICD) placement, lifestyle modifications, and in severe cases, heart transplantation.""]","[""Methylene blue administration, ascorbic acid supplementation, and avoiding exposure to oxidizing agents""]","[""The treatments for ARCM include medications, lifestyle changes, and surgical interventions.""]",[false],[true],[false],"[""Treatment for ARVC includes medications, implantable cardioverter-defibrillator (ICD), catheter ablation, and lifestyle changes.""]","[""Treatments for autosomal recessive congenital methemoglobinemia include methylene blue, ascorbic acid, and hyperbaric oxygen therapy.""]","[""The treatments for ARCM include medications, lifestyle changes, and surgical interventions.""]",[false],[true],[false],"[""Treatment for ARVC may include medications, implantable cardioverter-defibrillator (ICD) placement, catheter ablation, and lifestyle changes.""]","[""Methylene blue administration and ascorbic acid supplementation""]","[""The treatments for ARCM include medications, lifestyle changes, and surgical interventions.""]",[false],[true],[false],"[""Implantable cardioverter-defibrillator (ICD) therapy, antiarrhythmic medications, catheter ablation, lifestyle modifications""]","[""Methylene blue administration, ascorbic acid supplementation, and avoiding triggers like certain medications""]","[""The treatments for ARCM include medication, lifestyle changes, therapy, and in severe cases, surgery.""]",[false],[true],[false],"[""Implantable cardioverter-defibrillator (ICD) therapy, antiarrhythmic medications, catheter ablation, lifestyle modifications""]","[""Methylene blue administration, ascorbic acid supplementation, and avoiding exposure to oxidizing agents""]","[""The treatments for ARCM include medications, lifestyle changes, and surgical interventions.""]",[false],[true],[false],"[""Implantable cardioverter-defibrillator (ICD), medications, lifestyle changes, and catheter ablation""]","[""Treatments for autosomal recessive congenital methemoglobinemia include methylene blue, ascorbic acid, and hyperbaric oxygen therapy.""]","[""The treatments for ARCM include medications, lifestyle changes, and surgical interventions.""]",[false],[true],[false],"[""Treatment for ARVC includes medications, implantable cardioverter-defibrillator (ICD), catheter ablation, and lifestyle changes.""]","[""Methylene blue administration and ascorbic acid supplementation""]","[""The treatments for ARCM include medications, lifestyle changes, and surgical interventions.""]",[false],[true],[false],"[""Treatment for ARCM includes medications, implantable cardioverter-defibrillator (ICD) placement, catheter ablation, and lifestyle changes.""]","[""Methylene blue administration, ascorbic acid supplementation, and avoiding triggers like certain medications""]","[""The treatments for ARCM include medication, lifestyle changes, therapy, and in severe cases, surgery.""]",[false],[true],[false],"[""Treatment for ARCM includes medications to control heart rhythm, implantable cardioverter-defibrillator (ICD) to prevent sudden cardiac arrest, lifestyle changes, and in severe cases, heart transplant.""]","[""Methylene blue administration, ascorbic acid supplementation, and avoiding exposure to oxidizing agents""]","[""The treatments for ARCM include medications, lifestyle changes, and surgical interventions.""]",[false],[true],[false],"[""Treatment for ARVC may include medications, implantable cardioverter-defibrillator (ICD), catheter ablation, and lifestyle changes.""]","[""Treatments for autosomal recessive congenital methemoglobinemia include methylene blue, ascorbic acid, and hyperbaric oxygen therapy.""]","[""The treatments for ARCM include medications, lifestyle changes, and surgical interventions.""]",[false],[true],[false],"[""Implantable cardioverter-defibrillator (ICD) therapy, antiarrhythmic medications, lifestyle modifications, and in severe cases, heart transplantation.""]","[""Methylene blue administration and ascorbic acid supplementation""]","[""The treatments for ARCM include medications, lifestyle changes, and surgical interventions.""]",[false],[true],[false],"[""The treatments for ARCM (Association) include medication, therapy, and lifestyle changes.""]","[""Methylene blue administration and ascorbic acid supplementation""]","[""The treatments for ARCM include medications, lifestyle changes, and surgical interventions.""]",[false],[true],[false],"[""The treatments for ARCM (Aging Resources and Care Management) may include personalized care plans, social support services, healthcare coordination, and assistance with daily activities.""]","[""Methylene blue administration and ascorbic acid supplementation""]","[""The treatments for ARCM include medications, lifestyle changes, and surgical interventions.""]",[false],[true],[false],"[""Implantable cardioverter-defibrillator (ICD) therapy, antiarrhythmic medications, catheter ablation, lifestyle modifications, and psychological support.""]","[""Methylene blue administration and ascorbic acid supplementation""]","[""The treatments for ARCM include medications, lifestyle changes, and surgical interventions.""]"
symptoms,What are the symptoms of Spastic paraplegia 26 ?,"What are the signs and symptoms of Spastic paraplegia 26? The Human Phenotype Ontology provides the following list of signs and symptoms for Spastic paraplegia 26. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Cataract 5% Decreased serum testosterone level 5% Nystagmus 5% Urinary urgency 5% Autosomal recessive inheritance - Babinski sign - Cerebral cortical atrophy - Difficulty walking - Distal amyotrophy - Dysarthria - Dyskinesia - Dysmetria - Dystonia - Emotional lability - Frequent falls - Hyperreflexia - Intellectual disability, mild - Lower limb spasticity - Pes cavus - Progressive - Scoliosis - Slow progression - Spastic gait - Spastic paraplegia - Toe walking - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""SPG26"", ""full_form"": ""Spastic paraplegia 26""}]}",What are the symptoms of SPG26 ?,What are the symptoms of Spastic paraplegia 26 ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.",[[]],[[]],"[""Spastic Paraplegia 26""]",[7.509748179422663e-18],[7.509748179422663e-18],"[""Spastic Paraplegia 26""]",[7.509748179422663e-18],"[""LLM""]",[[]],[0.9133880313675105],[0.9145756408538044],"[""Spastic paraplegia 26""]",[0.9145756408538044],"[""LLM""]",[[]],"[""Spastic Paraplegia 26""]","[""LLM""]",What are the symptoms of SPG26 (Spastic Paraplegia 26) ?,[true],[true],[true],"[""The symptoms of SPG26 (Spastic Paraplegia 26) include progressive stiffness and contraction of leg muscles, weakness in the lower limbs, spasticity, difficulty walking, and in some cases, intellectual disability.""]","[""Symptoms of Spastic paraplegia 26 include progressive stiffness and contraction of leg muscles, weakness in the lower limbs, spasticity, and difficulty walking.""]","[""The symptoms of SPG26 include muscle stiffness (spasticity) in the legs, difficulty walking, muscle weakness, and intellectual disability.""]",[true],[true],[true],"[""The symptoms of SPG26 (Spastic Paraplegia 26) include progressive stiffness and contraction of the leg muscles (spastic paraplegia), muscle weakness, difficulty walking, and in some cases, intellectual disability.""]","[""Symptoms of Spastic paraplegia 26 include progressive stiffness and contraction of leg muscles, weakness in the lower limbs, spasticity, and difficulty walking.""]","[""The symptoms of SPG26 include progressive spastic paraplegia, intellectual disability, speech difficulties, and muscle weakness.""]",[true],[true],[true],"[""The symptoms of SPG26 (Spastic Paraplegia 26) include progressive stiffness and contraction of the leg muscles (spastic paraplegia), muscle weakness, difficulty walking, and in some cases, intellectual disability.""]","[""Symptoms of Spastic paraplegia 26 include progressive stiffness and contraction of leg muscles, weakness in the lower limbs, spasticity, difficulty walking, and muscle wasting.""]","[""The symptoms of SPG26 include muscle stiffness (spasticity) and weakness in the lower limbs, difficulty walking, and intellectual disability.""]",[true],[true],[true],"[""The symptoms of SPG26 (Spastic Paraplegia 26) include progressive stiffness and contraction in the leg muscles, weakness in the lower limbs, difficulty walking, and spasticity.""]","[""Symptoms of Spastic paraplegia 26 include progressive stiffness and contraction of leg muscles, weakness in the lower limbs, spasticity, difficulty walking, and muscle wasting.""]","[""The symptoms of SPG26 include muscle stiffness (spasticity) in the legs, muscle weakness, difficulty walking, and intellectual disability.""]",[true],[true],[true],"[""The symptoms of SPG26 (Spastic paraplegia 26) include progressive stiffness and contraction of the leg muscles, weakness in the lower limbs, spasticity, difficulty walking, and in some cases, intellectual disability.""]","[""Symptoms of Spastic paraplegia 26 include progressive stiffness and contraction of leg muscles, weakness in the lower limbs, spasticity, and difficulty walking.""]","[""The symptoms of SPG26 include muscle stiffness (spasticity) in the legs, difficulty walking, muscle weakness, and intellectual disability.""]",[true],[true],[true],"[""The symptoms of SPG26 (Spastic paraplegia 26) include progressive stiffness and contraction of the leg muscles, weakness in the lower limbs, spasticity, difficulty walking, and in some cases, intellectual disability.""]","[""Symptoms of Spastic paraplegia 26 include progressive stiffness and contraction of leg muscles, weakness in the lower limbs, spasticity, and difficulty walking.""]","[""The symptoms of SPG26 include progressive spastic paraplegia, intellectual disability, speech difficulties, and muscle weakness.""]",[true],[true],[true],"[""The symptoms of SPG26 (Spastic paraplegia 26) include progressive stiffness and contraction of the leg muscles, weakness in the lower limbs, spasticity, difficulty walking, and in some cases, intellectual disability.""]","[""Symptoms of Spastic paraplegia 26 include progressive stiffness and contraction of leg muscles, weakness in the lower limbs, spasticity, difficulty walking, and muscle wasting.""]","[""The symptoms of SPG26 include muscle stiffness (spasticity) and weakness in the lower limbs, difficulty walking, and intellectual disability.""]",[true],[true],[true],"[""The symptoms of SPG26 (Spastic paraplegia 26) include progressive stiffness and contraction of leg muscles, weakness in the lower limbs, spasticity, difficulty walking, and in some cases, intellectual disability.""]","[""Symptoms of Spastic paraplegia 26 include progressive stiffness and contraction of leg muscles, weakness in the lower limbs, spasticity, difficulty walking, and muscle wasting.""]","[""The symptoms of SPG26 include muscle stiffness (spasticity) in the legs, muscle weakness, difficulty walking, and intellectual disability.""]",[true],[true],[true],"[""The symptoms of SPG26 (Spastic Paraplegia 26) include progressive stiffness and contraction of leg muscles, weakness in the lower limbs, spasticity, difficulty walking, and in some cases, intellectual disability.""]","[""Symptoms of Spastic paraplegia 26 include progressive stiffness and contraction of leg muscles, weakness in the lower limbs, spasticity, and difficulty walking.""]","[""The symptoms of SPG26 include progressive spastic paraplegia, intellectual disability, speech difficulties, and muscle weakness.""]",[true],[true],[true],"[""The symptoms of SPG26 (Spastic Paraplegia 26) include progressive stiffness and contraction of leg muscles, muscle weakness, spasticity, difficulty walking, and in some cases, intellectual disability.""]","[""Symptoms of Spastic paraplegia 26 include progressive stiffness and contraction of leg muscles, weakness in the lower limbs, spasticity, and difficulty walking.""]","[""The symptoms of SPG26 include muscle stiffness (spasticity) in the legs, difficulty walking, muscle weakness, and intellectual disability.""]",[true],[true],[true],"[""The symptoms of SPG26 (Spastic Paraplegia 26) include progressive stiffness and contraction of the leg muscles, weakness in the lower limbs, spasticity, difficulty walking, and in some cases, intellectual disability.""]","[""Symptoms of Spastic paraplegia 26 include progressive stiffness and contraction of leg muscles, weakness in the lower limbs, spasticity, difficulty walking, and muscle wasting.""]","[""The symptoms of SPG26 include muscle stiffness (spasticity) and weakness in the lower limbs, difficulty walking, and intellectual disability.""]",[true],[true],[true],"[""The symptoms of SPG26 (Spastic Paraplegia 26) include progressive stiffness and contraction of the leg muscles, muscle weakness, spasticity, difficulty walking, and in some cases, intellectual disability.""]","[""Symptoms of Spastic paraplegia 26 include progressive stiffness and contraction of leg muscles, weakness in the lower limbs, spasticity, difficulty walking, and muscle wasting.""]","[""The symptoms of SPG26 include muscle stiffness (spasticity) in the legs, muscle weakness, difficulty walking, and intellectual disability.""]",[true],[true],[true],"[""The symptoms of SPG26 (Spastic Paraplegia 26) include progressive stiffness and contraction in the leg muscles, difficulty walking, muscle weakness, and spasticity in the lower limbs.""]","[""Symptoms of Spastic paraplegia 26 include progressive stiffness and contraction of leg muscles, weakness in the lower limbs, spasticity, and difficulty walking.""]","[""The symptoms of SPG26 include muscle stiffness (spasticity) in the legs, difficulty walking, muscle weakness, and intellectual disability.""]",[true],[true],[true],"[""The symptoms of SPG26 (Spastic Paraplegia 26) include progressive stiffness and contraction in the leg muscles, weakness in the lower limbs, spasticity, difficulty walking, and in some cases, intellectual disability.""]","[""Symptoms of Spastic paraplegia 26 include progressive stiffness and contraction of leg muscles, weakness in the lower limbs, spasticity, and difficulty walking.""]","[""The symptoms of SPG26 include progressive spastic paraplegia, intellectual disability, speech difficulties, and muscle weakness.""]",[true],[true],[true],"[""The symptoms of SPG26 include progressive stiffness and contraction in the legs, muscle weakness, spasticity, difficulty walking, and in some cases intellectual disability.""]","[""Symptoms of Spastic paraplegia 26 include progressive stiffness and contraction of leg muscles, weakness in the lower limbs, spasticity, difficulty walking, and muscle wasting.""]","[""The symptoms of SPG26 include muscle stiffness (spasticity) and weakness in the lower limbs, difficulty walking, and intellectual disability.""]",[true],[true],[true],"[""The symptoms of SPG26 include progressive stiffness and contraction of leg muscles, weakness in the lower limbs, difficulty walking, and spasticity in the legs.""]","[""Symptoms of Spastic paraplegia 26 include progressive stiffness and contraction of leg muscles, weakness in the lower limbs, spasticity, difficulty walking, and muscle wasting.""]","[""The symptoms of SPG26 include muscle stiffness (spasticity) in the legs, muscle weakness, difficulty walking, and intellectual disability.""]",[true],[true],[true],"[""Common symptoms of SPG26 include progressive stiffness and contraction of leg muscles, difficulty walking, muscle weakness, and spasticity in the lower limbs.""]","[""Symptoms of Spastic paraplegia 26 include progressive stiffness and contraction of leg muscles, weakness in the lower limbs, spasticity, and difficulty walking.""]","[""The symptoms of SPG26 include muscle stiffness (spasticity) in the legs, difficulty walking, muscle weakness, and intellectual disability.""]",[true],[true],[true],"[""The symptoms of SPG26 (Spastic Paraplegia 26) include progressive stiffness and contraction in the lower limbs, muscle weakness, spasticity, difficulty walking, and in some cases, intellectual disability.""]","[""Symptoms of Spastic paraplegia 26 include progressive stiffness and contraction of leg muscles, weakness in the lower limbs, spasticity, and difficulty walking.""]","[""The symptoms of SPG26 include progressive spastic paraplegia, intellectual disability, speech difficulties, and muscle weakness.""]",[true],[true],[true],"[""The symptoms of SPG26 (Spastic Paraplegia 26) include progressive stiffness and contraction of the leg muscles, weakness in the lower limbs, spasticity, difficulty walking, and in some cases, intellectual disability.""]","[""Symptoms of Spastic paraplegia 26 include progressive stiffness and contraction of leg muscles, weakness in the lower limbs, spasticity, difficulty walking, and muscle wasting.""]","[""The symptoms of SPG26 include muscle stiffness (spasticity) and weakness in the lower limbs, difficulty walking, and intellectual disability.""]",[true],[true],[true],"[""The symptoms of SPG26 (Spastic Paraplegia 26) include progressive stiffness and contraction of the leg muscles, weakness in the lower limbs, spasticity, difficulty walking, and in some cases, intellectual disability.""]","[""Symptoms of Spastic paraplegia 26 include progressive stiffness and contraction of leg muscles, weakness in the lower limbs, spasticity, difficulty walking, and muscle wasting.""]","[""The symptoms of SPG26 include muscle stiffness (spasticity) in the legs, muscle weakness, difficulty walking, and intellectual disability.""]",[true],[true],[true],"[""The symptoms of SPG26 (Spastic Paraplegia 26) include progressive stiffness and contraction of the leg muscles, weakness in the lower limbs, spasticity, difficulty walking, and in some cases, intellectual disability.""]","[""Symptoms of Spastic paraplegia 26 include progressive stiffness and contraction of leg muscles, weakness in the lower limbs, spasticity, and difficulty walking.""]","[""The symptoms of SPG26 include muscle stiffness (spasticity) in the legs, difficulty walking, muscle weakness, and intellectual disability.""]",[true],[true],[true],"[""The symptoms of SPG26 (Spastic Paraplegia 26) include progressive stiffness and contraction of the leg muscles (spastic paraplegia), muscle weakness, difficulty walking, and in some cases, intellectual disability.""]","[""Symptoms of Spastic paraplegia 26 include progressive stiffness and contraction of leg muscles, weakness in the lower limbs, spasticity, and difficulty walking.""]","[""The symptoms of SPG26 include progressive spastic paraplegia, intellectual disability, speech difficulties, and muscle weakness.""]",[true],[true],[true],"[""The symptoms of SPG26 (Spastic Paraplegia 26) include progressive stiffness and contraction of the leg muscles, weakness in the lower limbs, spasticity, difficulty walking, and in some cases, intellectual disability.""]","[""Symptoms of Spastic paraplegia 26 include progressive stiffness and contraction of leg muscles, weakness in the lower limbs, spasticity, difficulty walking, and muscle wasting.""]","[""The symptoms of SPG26 include muscle stiffness (spasticity) and weakness in the lower limbs, difficulty walking, and intellectual disability.""]",[true],[true],[true],"[""The symptoms of SPG26 (Spastic Paraplegia 26) include progressive stiffness and contraction of the leg muscles, weakness in the lower limbs, spasticity, difficulty walking, and in some cases, intellectual disability.""]","[""Symptoms of Spastic paraplegia 26 include progressive stiffness and contraction of leg muscles, weakness in the lower limbs, spasticity, difficulty walking, and muscle wasting.""]","[""The symptoms of SPG26 include muscle stiffness (spasticity) in the legs, muscle weakness, difficulty walking, and intellectual disability.""]",[true],[true],[true],"[""The symptoms of SPG26 (Spastic Paraplegia 26) include progressive stiffness and contraction of the leg muscles, weakness in the lower limbs, difficulty walking, spasticity, and in some cases, intellectual disability.""]","[""Symptoms of Spastic paraplegia 26 include progressive stiffness and contraction of leg muscles, weakness in the lower limbs, spasticity, and difficulty walking.""]","[""The symptoms of SPG26 include muscle stiffness (spasticity) in the legs, difficulty walking, muscle weakness, and intellectual disability.""]",[true],[true],[true],"[""The symptoms of SPG26 (Spastic Paraplegia 26) include progressive stiffness and contraction in the leg muscles, weakness in the lower limbs, spasticity, difficulty walking, and in some cases, intellectual disability.""]","[""Symptoms of Spastic paraplegia 26 include progressive stiffness and contraction of leg muscles, weakness in the lower limbs, spasticity, and difficulty walking.""]","[""The symptoms of SPG26 include progressive spastic paraplegia, intellectual disability, speech difficulties, and muscle weakness.""]",[true],[true],[true],"[""The symptoms of SPG26 (Spastic Paraplegia 26) include progressive stiffness and contraction of the leg muscles (spastic paraplegia), muscle weakness, difficulty walking, and in some cases, intellectual disability.""]","[""Symptoms of Spastic paraplegia 26 include progressive stiffness and contraction of leg muscles, weakness in the lower limbs, spasticity, difficulty walking, and muscle wasting.""]","[""The symptoms of SPG26 include muscle stiffness (spasticity) and weakness in the lower limbs, difficulty walking, and intellectual disability.""]",[true],[true],[true],"[""The symptoms of SPG26 (Spastic Paraplegia 26) include progressive stiffness and contraction of the leg muscles, weakness in the lower limbs, difficulty walking, spasticity, and in some cases, intellectual disability.""]","[""Symptoms of Spastic paraplegia 26 include progressive stiffness and contraction of leg muscles, weakness in the lower limbs, spasticity, difficulty walking, and muscle wasting.""]","[""The symptoms of SPG26 include muscle stiffness (spasticity) in the legs, muscle weakness, difficulty walking, and intellectual disability.""]",[true],[true],[true],"[""The symptoms of SPG26 include progressive stiffness and contraction of the leg muscles, weakness in the lower limbs, difficulty walking, and spasticity.""]","[""Symptoms of Spastic paraplegia 26 include progressive stiffness and contraction of leg muscles, weakness in the lower limbs, spasticity, and difficulty walking.""]","[""The symptoms of SPG26 include muscle stiffness (spasticity) in the legs, difficulty walking, muscle weakness, and intellectual disability.""]",[true],[true],[true],"[""The symptoms of SPG26 include progressive stiffness and contraction of the leg muscles, difficulty walking, muscle weakness, and spasticity in the lower limbs.""]","[""Symptoms of Spastic paraplegia 26 include progressive stiffness and contraction of leg muscles, weakness in the lower limbs, spasticity, and difficulty walking.""]","[""The symptoms of SPG26 include muscle stiffness (spasticity) in the legs, difficulty walking, muscle weakness, and intellectual disability.""]",[true],[true],[true],"[""The symptoms of SPG26 include progressive stiffness and contraction of the leg muscles, weakness in the lower limbs, difficulty walking, and spasticity.""]","[""Symptoms of Spastic paraplegia 26 include progressive stiffness and contraction of leg muscles, weakness in the lower limbs, spasticity, and difficulty walking.""]","[""The symptoms of SPG26 include muscle stiffness (spasticity) in the legs, difficulty walking, muscle weakness, and intellectual disability.""]",[true],[true],[true],"[""The symptoms of SPG26 include progressive stiffness and contraction of the leg muscles, weakness in the lower limbs, difficulty walking, and spasticity.""]","[""Symptoms of Spastic paraplegia 26 include progressive stiffness and contraction of leg muscles, weakness in the lower limbs, spasticity, and difficulty walking.""]","[""The symptoms of SPG26 include muscle stiffness (spasticity) in the legs, difficulty walking, muscle weakness, and intellectual disability.""]"
symptoms,What are the symptoms of Juvenile amyotrophic lateral sclerosis ?,"What are the signs and symptoms of juvenile amyotrophic lateral sclerosis? Signs and symptoms of juvenile ALS vary but include slowly to very slowly progressive muscle weakness, increased muscle tone, Babinski reflex, muscle spasm (clonus), exaggerated reflexes, muscle wasting, and muscle twitching. Juvenile ALS usually does not affect thinking or mental processing, nor does it tend to cause sensory dysfunction (e.g., numbness or tingling). As the condition progresses muscle involvement can be severe. Some people with juvenile ALS, eventually experience muscle weakness in the face and throat. Some have experienced emotional liability (involuntary crying or laughing) and/or respiratory weakness.[133]","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""ALS"", ""full_form"": ""amyotrophic lateral sclerosis""}]}",What are the symptoms of Juvenile ALS ?,What are the symptoms of Juvenile amyotrophic lateral sclerosis ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Appraisal & Liquidation Services, Incorporated"", ""Appraisal & Liquidation Services"", ""Amyotrophic lateral sclerosis"", ""Alstom"", ""Advanced Life Support"", ""Advanced Light Source"", ""Aldolase"", ""Ambient Light Sensor"", ""Autograph Letter Signed"", ""Administrative License Suspension""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Amyotrophic Lateral Sclerosis""]",[9.202615831011546e-17],[9.202615831011546e-17],"[""Aldolase""]",[6.019380102806438e-06],"[""ABBREVIATIONS""]","[[1.5139925527588338e-33, 1.3722473927238674e-24, 9.202615831011546e-17, 1.5244176736026438e-08, 4.2843203747711234e-10, 2.577997571384997e-13, 6.019380102806438e-06, 1.2327044024654083e-13, 2.2763669921421806e-17, 3.7318907192834265e-16]]",[0.9608599775467301],[0.9610314424073855],"[""Appraisal & Liquidation Services""]",[0.9631930635185184],"[""ABBREVIATIONS""]","[[0.8141857109091755, 0.8267217263728385, 0.9631930635185184, 0.9360356954485854, 0.891851898222247, 0.8691270994609108, 0.8971042292417699, 0.7633816702877616, 0.863282869088424, 0.8024177218583235]]","[""Amyotrophic lateral sclerosis""]","[""ABBREVIATIONS""]",What are the symptoms of Juvenile ALS (Amyotrophic Lateral Sclerosis) ?,[true],[true],[true],"[""Muscle weakness, muscle stiffness, muscle twitching, difficulty walking, difficulty speaking, difficulty swallowing""]","[""Muscle weakness, muscle stiffness, muscle twitching, difficulty walking, difficulty speaking, difficulty swallowing""]","[""Muscle weakness, muscle stiffness, twitching, difficulty walking, difficulty speaking, difficulty swallowing""]",[true],[true],[true],"[""Muscle weakness, muscle stiffness, muscle twitching, difficulty walking, difficulty speaking, difficulty swallowing""]","[""Muscle weakness, muscle stiffness, twitching, difficulty walking, difficulty with fine motor skills""]","[""Muscle weakness, muscle stiffness, twitching, difficulty walking, difficulty with fine motor skills""]",[true],[true],[true],"[""Symptoms of Juvenile ALS (Aldolase) include muscle weakness, muscle stiffness, muscle twitching, difficulty walking, and difficulty with fine motor skills.""]","[""Muscle weakness, muscle stiffness, muscle twitching, difficulty walking, difficulty speaking""]","[""Muscle weakness, muscle stiffness, twitching, difficulty walking, tripping and falling, slurred speech, trouble swallowing""]",[true],[true],[true],"[""Muscle weakness, muscle stiffness, twitching, difficulty walking, difficulty speaking, difficulty swallowing""]","[""Muscle weakness, muscle stiffness, muscle twitching, difficulty walking, difficulty speaking""]","[""Muscle weakness, muscle stiffness, twitching, difficulty walking, difficulty speaking""]",[true],[true],[true],"[""Symptoms of Juvenile ALS may include muscle weakness, muscle stiffness, muscle twitching, difficulty walking, and difficulty with fine motor skills.""]","[""Muscle weakness, muscle stiffness, muscle twitching, difficulty walking, difficulty speaking, difficulty swallowing""]","[""Muscle weakness, muscle stiffness, twitching, difficulty walking, difficulty speaking, difficulty swallowing""]",[false],[true],[true],"[""The symptoms of Juvenile ALS (Appraisal & Liquidation Services) include muscle weakness, muscle stiffness, muscle twitching, difficulty walking, difficulty speaking, and difficulty swallowing.""]","[""Muscle weakness, muscle stiffness, twitching, difficulty walking, difficulty with fine motor skills""]","[""Muscle weakness, muscle stiffness, twitching, difficulty walking, difficulty with fine motor skills""]",[true],[true],[true],"[""The symptoms of Juvenile ALS include muscle weakness, muscle stiffness, muscle twitching, difficulty walking, difficulty speaking, and difficulty swallowing.""]","[""Muscle weakness, muscle stiffness, muscle twitching, difficulty walking, difficulty speaking""]","[""Muscle weakness, muscle stiffness, twitching, difficulty walking, tripping and falling, slurred speech, trouble swallowing""]",[true],[true],[true],"[""The symptoms of Juvenile ALS include muscle weakness, muscle stiffness, muscle twitching, difficulty walking, difficulty speaking, and difficulty swallowing.""]","[""Muscle weakness, muscle stiffness, muscle twitching, difficulty walking, difficulty speaking""]","[""Muscle weakness, muscle stiffness, twitching, difficulty walking, difficulty speaking""]",[true],[true],[true],"[""Muscle weakness, muscle stiffness, muscle twitching, difficulty walking, difficulty speaking, difficulty swallowing""]","[""Muscle weakness, muscle stiffness, twitching, difficulty walking, difficulty with fine motor skills""]","[""Muscle weakness, muscle stiffness, twitching, difficulty walking, difficulty with fine motor skills""]",[true],[true],[true],"[""The symptoms of Juvenile ALS (Amyotrophic lateral sclerosis) include muscle weakness, muscle twitching, difficulty walking, difficulty speaking, and difficulty swallowing.""]","[""Muscle weakness, muscle stiffness, muscle twitching, difficulty walking, difficulty speaking, difficulty swallowing""]","[""Muscle weakness, muscle stiffness, twitching, difficulty walking, difficulty speaking, difficulty swallowing""]",[true],[true],[true],"[""Muscle weakness, muscle stiffness, muscle twitching, difficulty walking, difficulty with fine motor skills""]","[""Muscle weakness, muscle stiffness, muscle twitching, difficulty walking, difficulty speaking""]","[""Muscle weakness, muscle stiffness, twitching, difficulty walking, tripping and falling, slurred speech, trouble swallowing""]",[true],[true],[true],"[""Muscle weakness, muscle stiffness, twitching, difficulty walking, difficulty speaking or swallowing""]","[""Muscle weakness, muscle stiffness, muscle twitching, difficulty walking, difficulty speaking""]","[""Muscle weakness, muscle stiffness, twitching, difficulty walking, difficulty speaking""]",[true],[true],[true],"[""Muscle weakness, muscle stiffness, muscle twitching, difficulty walking, difficulty speaking, difficulty swallowing""]","[""Muscle weakness, muscle stiffness, muscle twitching, difficulty walking, difficulty speaking, difficulty swallowing""]","[""Muscle weakness, muscle stiffness, twitching, difficulty walking, difficulty speaking, difficulty swallowing""]",[true],[true],[true],"[""Muscle weakness, muscle stiffness, muscle twitching, difficulty walking, difficulty speaking, difficulty swallowing""]","[""Muscle weakness, muscle stiffness, twitching, difficulty walking, difficulty with fine motor skills""]","[""Muscle weakness, muscle stiffness, twitching, difficulty walking, difficulty with fine motor skills""]",[true],[true],[true],"[""Muscle weakness, muscle stiffness, muscle twitching, difficulty walking or running, difficulty with fine motor skills, slurred speech, difficulty swallowing""]","[""Muscle weakness, muscle stiffness, muscle twitching, difficulty walking, difficulty speaking""]","[""Muscle weakness, muscle stiffness, twitching, difficulty walking, tripping and falling, slurred speech, trouble swallowing""]",[true],[true],[true],"[""Muscle weakness, muscle stiffness, twitching, difficulty walking or running, difficulty with fine motor skills, slurred speech, difficulty swallowing""]","[""Muscle weakness, muscle stiffness, muscle twitching, difficulty walking, difficulty speaking""]","[""Muscle weakness, muscle stiffness, twitching, difficulty walking, difficulty speaking""]",[true],[true],[true],"[""Muscle weakness, muscle stiffness, muscle twitching, difficulty walking, difficulty speaking or swallowing""]","[""Muscle weakness, muscle stiffness, muscle twitching, difficulty walking, difficulty speaking, difficulty swallowing""]","[""Muscle weakness, muscle stiffness, twitching, difficulty walking, difficulty speaking, difficulty swallowing""]",[true],[true],[true],"[""Muscle weakness, muscle stiffness, muscle twitching, difficulty walking, difficulty speaking or swallowing""]","[""Muscle weakness, muscle stiffness, twitching, difficulty walking, difficulty with fine motor skills""]","[""Muscle weakness, muscle stiffness, twitching, difficulty walking, difficulty with fine motor skills""]",[true],[true],[true],"[""The symptoms of Juvenile ALS (Amyotrophic lateral sclerosis) include muscle weakness, muscle twitching, difficulty walking, difficulty speaking, and muscle cramps.""]","[""Muscle weakness, muscle stiffness, muscle twitching, difficulty walking, difficulty speaking""]","[""Muscle weakness, muscle stiffness, twitching, difficulty walking, tripping and falling, slurred speech, trouble swallowing""]",[true],[true],[true],"[""Muscle weakness, muscle stiffness, muscle twitching, difficulty walking, difficulty speaking, difficulty swallowing""]","[""Muscle weakness, muscle stiffness, muscle twitching, difficulty walking, difficulty speaking""]","[""Muscle weakness, muscle stiffness, twitching, difficulty walking, difficulty speaking""]",[true],[true],[true],"[""Muscle weakness, muscle stiffness, muscle twitching, difficulty walking, difficulty speaking, difficulty swallowing""]","[""Muscle weakness, muscle stiffness, muscle twitching, difficulty walking, difficulty speaking, difficulty swallowing""]","[""Muscle weakness, muscle stiffness, twitching, difficulty walking, difficulty speaking, difficulty swallowing""]",[true],[true],[true],"[""Muscle weakness, muscle stiffness, muscle twitching, difficulty walking, difficulty speaking, difficulty swallowing""]","[""Muscle weakness, muscle stiffness, twitching, difficulty walking, difficulty with fine motor skills""]","[""Muscle weakness, muscle stiffness, twitching, difficulty walking, difficulty with fine motor skills""]",[true],[true],[true],"[""Muscle weakness, muscle stiffness, twitching, difficulty walking, tripping and falling, slurred speech, trouble swallowing""]","[""Muscle weakness, muscle stiffness, muscle twitching, difficulty walking, difficulty speaking""]","[""Muscle weakness, muscle stiffness, twitching, difficulty walking, tripping and falling, slurred speech, trouble swallowing""]",[true],[true],[true],"[""Muscle weakness, muscle stiffness, muscle twitching, difficulty walking, difficulty speaking, difficulty swallowing""]","[""Muscle weakness, muscle stiffness, muscle twitching, difficulty walking, difficulty speaking""]","[""Muscle weakness, muscle stiffness, twitching, difficulty walking, difficulty speaking""]",[true],[true],[true],"[""The symptoms of Juvenile ALS (Amyotrophic lateral sclerosis) include muscle weakness, muscle twitching, difficulty walking, difficulty speaking, and difficulty swallowing.""]","[""Muscle weakness, muscle stiffness, muscle twitching, difficulty walking, difficulty speaking, difficulty swallowing""]","[""Muscle weakness, muscle stiffness, twitching, difficulty walking, difficulty speaking, difficulty swallowing""]",[true],[true],[true],"[""Symptoms of Juvenile ALS may include muscle weakness, muscle twitching, difficulty walking, tripping or falling, slurred speech, and muscle cramps.""]","[""Muscle weakness, muscle stiffness, twitching, difficulty walking, difficulty with fine motor skills""]","[""Muscle weakness, muscle stiffness, twitching, difficulty walking, difficulty with fine motor skills""]",[true],[true],[true],"[""Symptoms of Juvenile ALS include muscle weakness, muscle twitching, difficulty walking, tripping or falling, slurred speech, and muscle cramps.""]","[""Muscle weakness, muscle stiffness, muscle twitching, difficulty walking, difficulty speaking""]","[""Muscle weakness, muscle stiffness, twitching, difficulty walking, tripping and falling, slurred speech, trouble swallowing""]",[true],[true],[true],"[""The symptoms of Juvenile ALS (Amyotrophic lateral sclerosis) include muscle weakness, muscle cramps, twitching, and difficulty walking or performing daily tasks.""]","[""Muscle weakness, muscle stiffness, muscle twitching, difficulty walking, difficulty speaking""]","[""Muscle weakness, muscle stiffness, twitching, difficulty walking, difficulty speaking""]",[true],[true],[true],"[""Muscle weakness, muscle stiffness, muscle twitching, difficulty walking, difficulty speaking, difficulty swallowing""]","[""Muscle weakness, muscle stiffness, muscle twitching, difficulty walking, difficulty speaking, difficulty swallowing""]","[""Muscle weakness, muscle stiffness, twitching, difficulty walking, difficulty speaking, difficulty swallowing""]",[true],[true],[true],"[""The symptoms of Juvenile ALS (Aldolase) include muscle weakness, muscle stiffness, twitching, difficulty walking, difficulty speaking, and difficulty swallowing.""]","[""Muscle weakness, muscle stiffness, muscle twitching, difficulty walking, difficulty speaking, difficulty swallowing""]","[""Muscle weakness, muscle stiffness, twitching, difficulty walking, difficulty speaking, difficulty swallowing""]",[false],[true],[true],"[""The symptoms of Juvenile ALS (Appraisal & Liquidation Services) include muscle weakness, muscle stiffness, twitching, difficulty walking, difficulty speaking, and difficulty swallowing.""]","[""Muscle weakness, muscle stiffness, muscle twitching, difficulty walking, difficulty speaking, difficulty swallowing""]","[""Muscle weakness, muscle stiffness, twitching, difficulty walking, difficulty speaking, difficulty swallowing""]",[true],[true],[true],"[""Muscle weakness, muscle stiffness, muscle twitching, difficulty walking, difficulty with fine motor skills""]","[""Muscle weakness, muscle stiffness, muscle twitching, difficulty walking, difficulty speaking, difficulty swallowing""]","[""Muscle weakness, muscle stiffness, twitching, difficulty walking, difficulty speaking, difficulty swallowing""]"
frequency,How many people are affected by ornithine transcarbamylase deficiency ?,"Ornithine transcarbamylase deficiency is believed to occur in approximately 1 in every 80,000 people.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""OTC"", ""full_form"": ""ornithine transcarbamylase""}]}",How many people are affected by OTC deficiency ?,How many people are affected by ornithine transcarbamylase deficiency ?,8,MEDICAL,Simple Datatype-Integer,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Over The Counter"", ""Operating Telephone Company"", ""One-Time Charge"", ""Oklahoma Tax Commission"", ""Original Trilogy Collection"", ""Olympic Training Center"", ""Overseas Telecommunications Commission"", ""Occupational Training Center"", ""Officer Training Corps"", ""Operational Test Command""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Over The Counter""]",[1.1716471183599072e-26],[1.722201179922714e-06],"[""Over The Counter""]",[1.722201179922714e-06],"[""ABBREVIATIONS""]","[[1.722201179922714e-06, 1.4095444234971902e-13, 5.517977961789391e-12, 2.192840907263265e-24, 1.9345493483920162e-16, 1.215825282967817e-16, 5.875327129416524e-22, 1.5459599584735253e-11, 7.36466860674382e-16, 8.848139843108661e-15]]",[0.8610738670705633],[0.9568188979659593],"[""ornithine transcarbamylase""]",[0.9568188979659593],"[""ABBREVIATIONS""]","[[0.9568188979659593, 0.8605614964981021, 0.9002213125210314, 0.6413751841798423, 0.8943964287010268, 0.8822071760981165, 0.8571179473492616, 0.8969093223907684, 0.8643749187667591, 0.7167476405561135]]","[""Over The Counter""]","[""LLM""]",How many people are affected by OTC (Over The Counter) deficiency ?,[true],[false],[true],"[""OTC deficiency affects approximately 1 in 40,000 to 1 in 80,000 people worldwide.""]","[""1 in 14,000 to 77,000 live births""]","[""OTC deficiency affects approximately 1 in 80,000 to 1 in 200,000 individuals.""]",[false],[true],[true],"[""There is no known deficiency related specifically to Over The Counter (OTC) medication.""]","[""1 in 14,000 to 77,000 people are affected by ornithine transcarbamylase deficiency""]","[""OTC deficiency affects approximately 1 in 80,000 to 1 in 200,000 individuals worldwide.""]",[false],[false],[true],"[""OTC deficiency affects approximately 1 in 40,000 to 50,000 people worldwide.""]","[""1 in 14,000 to 77,000 live births""]","[""OTC deficiency affects approximately 1 in 80,000 to 1 in 200,000 individuals.""]",[true],[false],[true],"[""OTC deficiency affects approximately 1 in 40,000 to 1 in 80,000 individuals worldwide.""]","[""1 in 14,000 to 77,000 people are affected by ornithine transcarbamylase deficiency""]","[""OTC deficiency affects approximately 1 in 80,000 individuals.""]",[false],[false],[true],"[""OTC deficiency affects approximately 1 in 56,000 to 77,000 live births.""]","[""1 in 14,000 to 77,000 live births""]","[""OTC deficiency affects approximately 1 in 80,000 to 1 in 200,000 individuals.""]",[true],[false],[true],"[""Approximately 1 in 80,000 individuals are affected by OTC (ornithine transcarbamylase) deficiency.""]","[""1 in 14,000 to 77,000 people are affected by ornithine transcarbamylase deficiency""]","[""OTC deficiency affects approximately 1 in 80,000 to 1 in 200,000 individuals worldwide.""]",[true],[false],[true],"[""Approximately 1 in 14,000 to 77,000 people are affected by OTC (ornithine transcarbamylase) deficiency.""]","[""1 in 14,000 to 77,000 live births""]","[""OTC deficiency affects approximately 1 in 80,000 to 1 in 200,000 individuals.""]",[true],[false],[true],"[""OTC (ornithine transcarbamylase) deficiency affects approximately 1 in 80,000 to 1 in 100,000 live births.""]","[""1 in 14,000 to 77,000 people are affected by ornithine transcarbamylase deficiency""]","[""OTC deficiency affects approximately 1 in 80,000 individuals.""]",[true],[false],[true],"[""OTC deficiency affects approximately 1 in 40,000 to 1 in 80,000 people worldwide.""]","[""1 in 14,000 to 77,000 people are affected by ornithine transcarbamylase deficiency""]","[""OTC deficiency affects approximately 1 in 80,000 to 1 in 200,000 individuals worldwide.""]",[false],[false],[true],"[""OTC deficiency affects approximately 1 in 40,000 to 50,000 people worldwide.""]","[""1 in 14,000 to 77,000 live births""]","[""OTC deficiency affects approximately 1 in 80,000 to 1 in 200,000 individuals.""]",[false],[false],[true],"[""OTC deficiency affects approximately 1 in 40,000 to 50,000 people worldwide.""]","[""1 in 14,000 to 77,000 live births""]","[""OTC deficiency affects approximately 1 in 80,000 to 1 in 200,000 individuals.""]",[false],[true],[true],"[""OTC deficiency affects approximately 1 in 40,000 to 50,000 people worldwide.""]","[""1 in 14,000 to 77,000 people are affected by ornithine transcarbamylase deficiency""]","[""OTC deficiency affects approximately 1 in 80,000 individuals.""]",[false],[false],[true],"[""Not specified""]","[""1 in 14,000 to 77,000 live births""]","[""OTC deficiency affects approximately 1 in 80,000 to 1 in 200,000 individuals.""]",[false],[true],[true],"[""OTC deficiency affects approximately 1 in 40,000 to 50,000 individuals worldwide.""]","[""1 in 14,000 to 77,000 people are affected by ornithine transcarbamylase deficiency""]","[""OTC deficiency affects approximately 1 in 80,000 to 1 in 200,000 individuals worldwide.""]",[false],[false],[true],"[""Not specified""]","[""1 in 14,000 to 77,000 live births""]","[""OTC deficiency affects approximately 1 in 80,000 to 1 in 200,000 individuals.""]",[true],[false],[true],"[""The number of people affected by OTC deficiency varies, but it is considered a rare condition affecting approximately 1 in 40,000 to 1 in 80,000 individuals.""]","[""1 in 14,000 to 77,000 people are affected by ornithine transcarbamylase deficiency""]","[""OTC deficiency affects approximately 1 in 80,000 individuals.""]",[false],[false],[true],"[""Unknown""]","[""1 in 14,000 to 77,000 live births""]","[""OTC deficiency affects approximately 1 in 80,000 to 1 in 200,000 individuals.""]",[false],[true],[true],"[""OTC deficiency affects approximately 1 in 40,000 to 50,000 people worldwide.""]","[""1 in 14,000 to 77,000 people are affected by ornithine transcarbamylase deficiency""]","[""OTC deficiency affects approximately 1 in 80,000 to 1 in 200,000 individuals worldwide.""]",[true],[false],[true],"[""OTC deficiency affects approximately 1 in 40,000 to 1 in 80,000 people worldwide.""]","[""1 in 14,000 to 77,000 live births""]","[""OTC deficiency affects approximately 1 in 80,000 to 1 in 200,000 individuals.""]",[false],[true],[true],"[""OTC deficiency affects approximately 1 in 40,000 to 50,000 people worldwide.""]","[""1 in 14,000 to 77,000 people are affected by ornithine transcarbamylase deficiency""]","[""OTC deficiency affects approximately 1 in 80,000 individuals.""]",[true],[false],[true],"[""OTC deficiency affects approximately 1 in 40,000 to 1 in 80,000 people worldwide.""]","[""1 in 14,000 to 77,000 live births""]","[""OTC deficiency affects approximately 1 in 80,000 to 1 in 200,000 individuals.""]",[false],[true],[true],"[""OTC deficiency affects approximately 1 in 40,000 to 50,000 people worldwide.""]","[""1 in 14,000 to 77,000 people are affected by ornithine transcarbamylase deficiency""]","[""OTC deficiency affects approximately 1 in 80,000 to 1 in 200,000 individuals worldwide.""]",[false],[false],[true],"[""OTC deficiency affects approximately 1 in 40,000 to 50,000 people worldwide.""]","[""1 in 14,000 to 77,000 live births""]","[""OTC deficiency affects approximately 1 in 80,000 to 1 in 200,000 individuals.""]",[false],[true],[true],"[""OTC deficiency affects approximately 1 in 40,000 to 50,000 individuals worldwide.""]","[""1 in 14,000 to 77,000 people are affected by ornithine transcarbamylase deficiency""]","[""OTC deficiency affects approximately 1 in 80,000 individuals.""]",[false],[false],[true],"[""The number of people affected by OTC deficiency is estimated to be around 1 in 40,000 to 1 in 60,000 individuals worldwide.""]","[""1 in 14,000 to 77,000 live births""]","[""OTC deficiency affects approximately 1 in 80,000 to 1 in 200,000 individuals.""]",[false],[true],[true],"[""OTC deficiency affects approximately 1 in 40,000 to 50,000 people worldwide.""]","[""1 in 14,000 to 77,000 people are affected by ornithine transcarbamylase deficiency""]","[""OTC deficiency affects approximately 1 in 80,000 to 1 in 200,000 individuals worldwide.""]",[false],[false],[true],"[""OTC deficiency affects approximately 1 in 40,000 to 50,000 people worldwide.""]","[""1 in 14,000 to 77,000 live births""]","[""OTC deficiency affects approximately 1 in 80,000 to 1 in 200,000 individuals.""]",[false],[true],[true],"[""OTC deficiency affects approximately 1 in 40,000 to 50,000 people worldwide.""]","[""1 in 14,000 to 77,000 people are affected by ornithine transcarbamylase deficiency""]","[""OTC deficiency affects approximately 1 in 80,000 individuals.""]",[false],[false],[true],"[""The number of people affected by OTC deficiency is estimated to be around 1 in 40,000 to 1 in 60,000 individuals worldwide.""]","[""1 in 14,000 to 77,000 live births""]","[""OTC deficiency affects approximately 1 in 80,000 to 1 in 200,000 individuals.""]",[true],[false],[true],"[""The number of people affected by OTC deficiency is estimated to be around 1 in 40,000 to 1 in 80,000 individuals worldwide.""]","[""1 in 14,000 to 77,000 live births""]","[""OTC deficiency affects approximately 1 in 80,000 to 1 in 200,000 individuals.""]",[false],[false],[true],"[""OTC deficiency affects approximately 1 in 56,000 to 770,000 individuals worldwide.""]","[""1 in 14,000 to 77,000 live births""]","[""OTC deficiency affects approximately 1 in 80,000 to 1 in 200,000 individuals.""]",[true],[false],[true],"[""The number of people affected by OTC deficiency is estimated to be around 1 in 40,000 to 1 in 80,000 individuals.""]","[""1 in 14,000 to 77,000 live births""]","[""OTC deficiency affects approximately 1 in 80,000 to 1 in 200,000 individuals.""]"
inheritance,Is atypical hemolytic-uremic syndrome inherited ?,"Most cases of atypical hemolytic-uremic syndrome are sporadic, which means that they occur in people with no apparent history of the disorder in their family. Less than 20 percent of all cases have been reported to run in families. When the disorder is familial, it can have an autosomal dominant or an autosomal recessive pattern of inheritance.  Autosomal dominant inheritance means one copy of an altered gene in each cell is sufficient to increase the risk of the disorder. In some cases, an affected person inherits the mutation from one affected parent. However, most people with the autosomal dominant form of atypical hemolytic-uremic syndrome have no history of the disorder in their family. Because not everyone who inherits a gene mutation will develop the signs and symptoms of the disease, an affected individual may have unaffected relatives who carry a copy of the mutation.  Autosomal recessive inheritance means both copies of a gene in each cell have mutations. The parents of an individual with an autosomal recessive condition each carry one copy of the mutated gene, but they typically do not show signs and symptoms of the condition.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""aHUS"", ""full_form"": ""atypical hemolytic-uremic syndrome""}]}",Is aHUS inherited ?,Is atypical hemolytic-uremic syndrome inherited ?,8,MEDICAL,Simple Datatype-Boolean,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Atypical Haemolytic Uraemic Syndrome"", ""atypical Hemolytic Uremic"", ""Atypical Hemolytic Uremic Syndrome"", ""Atypical Hemolytic Uremic Syndrome"", ""AHUS""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY""]]","[""atypical Hemolytic Uremic Syndrome""]",[6.647208935524556e-19],[1.6969965584116558e-16],"[""AHUS""]",[0.0005154352114841476],"[""THEFREEDICTIONARY""]","[[5.316986929389064e-25, 2.80849315663739e-15, 1.6969965584116558e-16, 1.6969965584116558e-16, 0.0005154352114841476]]",[0.9416934866463522],[0.9442343566736109],"[""Atypical Hemolytic Uremic Syndrome""]",[0.9709279909823905],"[""THEFREEDICTIONARY""]","[[0.9401053420608456, 0.9500243882992654, 0.9432673690156399, 0.9432673690156386, 0.9709279909823905]]","[""Atypical Hemolytic Uremic Syndrome""]","[""ABBREVIATIONS""]",Is aHUS (atypical Hemolytic Uremic Syndrome) inherited ?,[true],[true],[true],"[""Yes, aHUS (Atypical Hemolytic Uremic Syndrome) can be inherited.""]","[""Yes, atypical hemolytic-uremic syndrome can be inherited.""]","[""Yes, aHUS can be inherited.""]",[true],[true],[true],"[""Yes, aHUS (atypical hemolytic uremic syndrome) can be inherited.""]","[""Yes, atypical hemolytic-uremic syndrome can be inherited.""]","[""Yes, aHUS (atypical hemolytic uremic syndrome) can be inherited.""]",[false],[true],[true],"[""Yes""]","[""Yes, atypical hemolytic-uremic syndrome can be inherited.""]","[""Yes, aHUS (atypical hemolytic uremic syndrome) can be inherited.""]",[true],[true],[true],"[""Yes, aHUS (atypical hemolytic uremic syndrome) can be inherited.""]","[""Yes, atypical hemolytic-uremic syndrome can be inherited.""]","[""Yes, aHUS (atypical hemolytic uremic syndrome) can be inherited.""]",[false],[true],[true],"[""Yes""]","[""Yes, atypical hemolytic-uremic syndrome can be inherited.""]","[""Yes, aHUS can be inherited.""]",[false],[true],[true],"[""Yes""]","[""Yes, atypical hemolytic-uremic syndrome can be inherited.""]","[""Yes, aHUS (atypical hemolytic uremic syndrome) can be inherited.""]",[false],[true],[true],"[""Yes""]","[""Yes, atypical hemolytic-uremic syndrome can be inherited.""]","[""Yes, aHUS (atypical hemolytic uremic syndrome) can be inherited.""]",[false],[true],[true],"[""Yes""]","[""Yes, atypical hemolytic-uremic syndrome can be inherited.""]","[""Yes, aHUS (atypical hemolytic uremic syndrome) can be inherited.""]",[false],[true],[true],"[""Yes""]","[""Yes, atypical hemolytic-uremic syndrome can be inherited.""]","[""Yes, aHUS (atypical hemolytic uremic syndrome) can be inherited.""]",[false],[true],[true],"[""Yes""]","[""Yes, atypical hemolytic-uremic syndrome can be inherited.""]","[""Yes, aHUS can be inherited.""]",[false],[true],[true],"[""Yes""]","[""Yes, atypical hemolytic-uremic syndrome can be inherited.""]","[""Yes, aHUS (atypical hemolytic uremic syndrome) can be inherited.""]",[false],[true],[true],"[""Yes""]","[""Yes, atypical hemolytic-uremic syndrome can be inherited.""]","[""Yes, aHUS (atypical hemolytic uremic syndrome) can be inherited.""]",[true],[true],[true],"[""Yes, aHUS can be inherited.""]","[""Yes, atypical hemolytic-uremic syndrome can be inherited.""]","[""Yes, aHUS can be inherited.""]",[true],[true],[true],"[""Yes, aHUS can be inherited.""]","[""Yes, atypical hemolytic-uremic syndrome can be inherited.""]","[""Yes, aHUS (atypical hemolytic uremic syndrome) can be inherited.""]",[true],[true],[true],"[""Yes, aHUS can be inherited.""]","[""Yes, atypical hemolytic-uremic syndrome can be inherited.""]","[""Yes, aHUS (atypical hemolytic uremic syndrome) can be inherited.""]",[true],[true],[true],"[""Yes, aHUS can be inherited.""]","[""Yes, atypical hemolytic-uremic syndrome can be inherited.""]","[""Yes, aHUS (atypical hemolytic uremic syndrome) can be inherited.""]",[false],[true],[true],"[""Yes""]","[""Yes, atypical hemolytic-uremic syndrome can be inherited.""]","[""Yes, aHUS can be inherited.""]",[false],[true],[true],"[""Yes""]","[""Yes, atypical hemolytic-uremic syndrome can be inherited.""]","[""Yes, aHUS (atypical hemolytic uremic syndrome) can be inherited.""]",[false],[true],[true],"[""Yes""]","[""Yes, atypical hemolytic-uremic syndrome can be inherited.""]","[""Yes, aHUS (atypical hemolytic uremic syndrome) can be inherited.""]",[false],[true],[true],"[""Yes""]","[""Yes, atypical hemolytic-uremic syndrome can be inherited.""]","[""Yes, aHUS (atypical hemolytic uremic syndrome) can be inherited.""]",[true],[true],[true],"[""Yes""]","[""Yes, atypical hemolytic-uremic syndrome can be inherited.""]","[""Yes, aHUS can be inherited.""]",[false],[true],[true],"[""Yes""]","[""Yes, atypical hemolytic-uremic syndrome can be inherited.""]","[""Yes, aHUS (atypical hemolytic uremic syndrome) can be inherited.""]",[false],[true],[true],"[""Yes""]","[""Yes, atypical hemolytic-uremic syndrome can be inherited.""]","[""Yes, aHUS (atypical hemolytic uremic syndrome) can be inherited.""]",[false],[true],[true],"[""Yes""]","[""Yes, atypical hemolytic-uremic syndrome can be inherited.""]","[""Yes, aHUS (atypical hemolytic uremic syndrome) can be inherited.""]",[true],[true],[true],"[""Yes, aHUS (Atypical Hemolytic Uremic Syndrome) can be inherited.""]","[""Yes, atypical hemolytic-uremic syndrome can be inherited.""]","[""Yes, aHUS can be inherited.""]",[false],[true],[true],"[""Yes, aHUS (Atypical Hemolytic Uremic Syndrome) is inherited.""]","[""Yes, atypical hemolytic-uremic syndrome can be inherited.""]","[""Yes, aHUS (atypical hemolytic uremic syndrome) can be inherited.""]",[true],[true],[true],"[""Yes, aHUS (Atypical Hemolytic Uremic Syndrome) can be inherited.""]","[""Yes, atypical hemolytic-uremic syndrome can be inherited.""]","[""Yes, aHUS (atypical hemolytic uremic syndrome) can be inherited.""]",[false],[true],[true],"[""Yes, aHUS (Atypical Hemolytic Uremic Syndrome) is inherited.""]","[""Yes, atypical hemolytic-uremic syndrome can be inherited.""]","[""Yes, aHUS (atypical hemolytic uremic syndrome) can be inherited.""]",[true],[true],[true],"[""Yes, aHUS is inherited.""]","[""Yes, atypical hemolytic-uremic syndrome can be inherited.""]","[""Yes, aHUS can be inherited.""]",[true],[true],[true],"[""Yes, aHUS (Atypical Hemolytic Uremic Syndrome) is inherited.""]","[""Yes, atypical hemolytic-uremic syndrome can be inherited.""]","[""Yes, aHUS can be inherited.""]",[true],[true],[true],"[""Yes, aHUS can be inherited.""]","[""Yes, atypical hemolytic-uremic syndrome can be inherited.""]","[""Yes, aHUS can be inherited.""]",[true],[true],[true],"[""Yes, aHUS can be inherited.""]","[""Yes, atypical hemolytic-uremic syndrome can be inherited.""]","[""Yes, aHUS can be inherited.""]"
treatment,What are the treatments for Acute intermittent porphyria ?,"How might acute intermittent porphyria (AIP) be treated? Treatment of AIP may vary based on the trigger of the attack and the symptoms present. Treatment may include stopping medications that cause or worsen the symptoms, treating any infections which may be present, administration of pain medication, monitoring fluid balance and/or correcting electrolyte disturbances, monitoring neurologic status and administering respiratory support. Mild attacks can be manged with increased caloric intake and fluid replacement. Recurrent acute attacks should be managed by a porphyria specialist. Hospitalization is often necessary.  Panhematin, an intravenous medication used to correct heme deficiency, may also be prescribed. More detailed information about the use of Panhematin for the treatment of AIP can be found by clicking here.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""AIP"", ""full_form"": ""Acute intermittent porphyria""}]}",What are the treatments for AIP ?,What are the treatments for Acute intermittent porphyria ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""American Institute of Physics"", ""Airport Improvement Program"", ""Automatic Investment Plan"", ""Aeronautical Information Publication"", ""Agreement In Principle"", ""Air Independent Propulsion"", ""Atm Interface Processor"", ""Application Infrastructure Provider"", ""American Institute of Philanthropy"", ""American Israeli Paper Mills, LTD.""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Acute Intermittent Porphyria""]",[4.8586427325041106e-21],[4.8586427325041106e-21],"[""Agreement In Principle""]",[1.3805174053926487e-12],"[""ABBREVIATIONS""]","[[3.914500744722677e-15, 5.177016538095501e-15, 7.6819660699485e-17, 5.459792240183982e-25, 1.3805174053926487e-12, 2.159603872094649e-17, 6.745668580040877e-19, 1.9692480777168245e-18, 3.5361102449771416e-22, 1.9579325120155152e-37]]",[0.7750969746466172],[0.7773005743472013],"[""Acute intermittent porphyria""]",[0.7921409853905728],"[""ABBREVIATIONS""]","[[0.7921409853905728, 0.6234213613999011, 0.6694240051481523, 0.6904131947488643, 0.7294321782896938, 0.6578279185093935, 0.7217469876489245, 0.707513671539749, 0.6123678817088971, 0.6881733929757949]]","[""Acute Intermittent Porphyria""]","[""LLM""]",What are the treatments for AIP (Acute Intermittent Porphyria) ?,[true],[true],[true],"[""Treatment for AIP includes intravenous glucose, heme therapy, and avoiding triggers such as certain medications.""]","[""Treatment for Acute intermittent porphyria includes intravenous heme, glucose, and medications to manage symptoms such as pain and nausea.""]","[""Treatment for AIP includes intravenous glucose, heme therapy, and avoiding triggers like certain medications.""]",[true],[true],[true],"[""Treatment for AIP includes intravenous heme, glucose, and avoiding triggers like certain medications.""]","[""Treatment for Acute intermittent porphyria includes intravenous heme, glucose, and medications to manage symptoms such as pain and nausea.""]","[""Treatment for AIP includes intravenous glucose, heme therapy, and avoiding triggers like certain medications.""]",[true],[true],[true],"[""The treatments for AIP (Acute Intermittent Porphyria) include intravenous glucose, heme therapy, and avoiding triggers such as certain medications.""]","[""Treatment for Acute intermittent porphyria includes intravenous heme, glucose, and medications to control symptoms and prevent attacks.""]","[""Treatment for AIP includes intravenous glucose, heme therapy, and avoiding triggers like certain medications.""]",[true],[true],[true],"[""Treatment for AIP includes hemin therapy, glucose infusions, and avoiding triggers like certain medications.""]","[""Treatment for Acute intermittent porphyria includes intravenous heme, glucose, and medications to control symptoms.""]","[""Treatment for AIP includes intravenous glucose, hemin therapy, and avoiding triggers like certain medications.""]",[true],[true],[true],"[""Treatment for AIP includes intravenous glucose, heme therapy, and avoiding triggers such as certain medications.""]","[""Treatment for Acute intermittent porphyria includes intravenous heme, glucose, and medications to manage symptoms such as pain and nausea.""]","[""Treatment for AIP includes intravenous glucose, heme therapy, and avoiding triggers like certain medications.""]",[true],[true],[true],"[""Treatment for AIP includes intravenous heme, glucose, and medications to manage symptoms such as pain and nausea.""]","[""Treatment for Acute intermittent porphyria includes intravenous heme, glucose, and medications to manage symptoms such as pain and nausea.""]","[""Treatment for AIP includes intravenous glucose, heme therapy, and avoiding triggers like certain medications.""]",[true],[true],[true],"[""Treatment for AIP includes intravenous heme, glucose, and medications to manage symptoms such as pain and nausea.""]","[""Treatment for Acute intermittent porphyria includes intravenous heme, glucose, and medications to control symptoms and prevent attacks.""]","[""Treatment for AIP includes intravenous glucose, heme therapy, and avoiding triggers like certain medications.""]",[true],[true],[true],"[""Treatment for AIP includes intravenous heme, glucose, and medications to manage symptoms such as pain and nausea.""]","[""Treatment for Acute intermittent porphyria includes intravenous heme, glucose, and medications to control symptoms.""]","[""Treatment for AIP includes intravenous glucose, hemin therapy, and avoiding triggers like certain medications.""]",[true],[true],[true],"[""Treatment for AIP includes intravenous glucose, heme therapy, and avoiding triggers such as certain medications.""]","[""Treatment for Acute intermittent porphyria includes intravenous heme, glucose, and medications to manage symptoms such as pain and nausea.""]","[""Treatment for AIP includes intravenous glucose, heme therapy, and avoiding triggers like certain medications.""]",[true],[true],[true],"[""Treatment for AIP includes intravenous glucose, heme therapy, and avoiding triggers such as certain medications.""]","[""Treatment for Acute intermittent porphyria includes intravenous heme, glucose, and medications to manage symptoms such as pain and nausea.""]","[""Treatment for AIP includes intravenous glucose, heme therapy, and avoiding triggers like certain medications.""]",[true],[true],[true],"[""Treatment for AIP includes intravenous glucose, heme therapy, and avoiding triggers such as certain medications.""]","[""Treatment for Acute intermittent porphyria includes intravenous heme, glucose, and medications to control symptoms and prevent attacks.""]","[""Treatment for AIP includes intravenous glucose, heme therapy, and avoiding triggers like certain medications.""]",[true],[true],[true],"[""Treatment for AIP includes intravenous glucose, heme therapy, and avoiding triggers such as certain medications.""]","[""Treatment for Acute intermittent porphyria includes intravenous heme, glucose, and medications to control symptoms.""]","[""Treatment for AIP includes intravenous glucose, hemin therapy, and avoiding triggers like certain medications.""]",[true],[true],[true],"[""Intravenous heme, carbohydrate loading, pain management, avoiding triggers""]","[""Treatment for Acute intermittent porphyria includes intravenous heme, glucose, and medications to manage symptoms such as pain and nausea.""]","[""Treatment for AIP includes intravenous glucose, heme therapy, and avoiding triggers like certain medications.""]",[true],[true],[true],"[""Treatment for AIP includes intravenous glucose, heme therapy, and avoiding triggers such as certain medications.""]","[""Treatment for Acute intermittent porphyria includes intravenous heme, glucose, and medications to manage symptoms such as pain and nausea.""]","[""Treatment for AIP includes intravenous glucose, heme therapy, and avoiding triggers like certain medications.""]",[true],[true],[true],"[""Treatment for AIP includes intravenous glucose, heme therapy, and avoiding triggers such as certain medications.""]","[""Treatment for Acute intermittent porphyria includes intravenous heme, glucose, and medications to control symptoms and prevent attacks.""]","[""Treatment for AIP includes intravenous glucose, heme therapy, and avoiding triggers like certain medications.""]",[true],[true],[true],"[""Intravenous heme, carbohydrate loading, pain management, avoiding triggers""]","[""Treatment for Acute intermittent porphyria includes intravenous heme, glucose, and medications to control symptoms.""]","[""Treatment for AIP includes intravenous glucose, hemin therapy, and avoiding triggers like certain medications.""]",[true],[true],[true],"[""Treatment for AIP includes intravenous glucose, heme therapy, and avoiding triggers such as certain medications.""]","[""Treatment for Acute intermittent porphyria includes intravenous heme, glucose, and medications to manage symptoms such as pain and nausea.""]","[""Treatment for AIP includes intravenous glucose, heme therapy, and avoiding triggers like certain medications.""]",[true],[true],[true],"[""Treatment for AIP includes intravenous glucose, heme therapy, and avoiding triggers such as certain medications.""]","[""Treatment for Acute intermittent porphyria includes intravenous heme, glucose, and medications to manage symptoms such as pain and nausea.""]","[""Treatment for AIP includes intravenous glucose, heme therapy, and avoiding triggers like certain medications.""]",[true],[true],[true],"[""Treatment for AIP includes intravenous glucose, heme therapy, and avoiding triggers such as certain medications.""]","[""Treatment for Acute intermittent porphyria includes intravenous heme, glucose, and medications to control symptoms and prevent attacks.""]","[""Treatment for AIP includes intravenous glucose, heme therapy, and avoiding triggers like certain medications.""]",[true],[true],[true],"[""Treatment for AIP includes intravenous glucose, heme therapy, and avoiding triggers such as certain medications.""]","[""Treatment for Acute intermittent porphyria includes intravenous heme, glucose, and medications to control symptoms.""]","[""Treatment for AIP includes intravenous glucose, hemin therapy, and avoiding triggers like certain medications.""]",[true],[true],[true],"[""Treatment for AIP includes intravenous glucose, heme therapy, and avoiding triggers such as certain medications.""]","[""Treatment for Acute intermittent porphyria includes intravenous heme, glucose, and medications to manage symptoms such as pain and nausea.""]","[""Treatment for AIP includes intravenous glucose, heme therapy, and avoiding triggers like certain medications.""]",[true],[true],[true],"[""Treatment for AIP includes intravenous glucose, heme therapy, and avoiding triggers such as certain medications.""]","[""Treatment for Acute intermittent porphyria includes intravenous heme, glucose, and medications to manage symptoms such as pain and nausea.""]","[""Treatment for AIP includes intravenous glucose, heme therapy, and avoiding triggers like certain medications.""]",[true],[true],[true],"[""Treatment for AIP includes intravenous glucose, heme therapy, and avoiding triggers such as certain medications.""]","[""Treatment for Acute intermittent porphyria includes intravenous heme, glucose, and medications to control symptoms and prevent attacks.""]","[""Treatment for AIP includes intravenous glucose, heme therapy, and avoiding triggers like certain medications.""]",[true],[true],[true],"[""Treatment for AIP includes intravenous glucose, heme therapy, and avoiding triggers such as certain medications.""]","[""Treatment for Acute intermittent porphyria includes intravenous heme, glucose, and medications to control symptoms.""]","[""Treatment for AIP includes intravenous glucose, hemin therapy, and avoiding triggers like certain medications.""]",[true],[true],[true],"[""Treatment for AIP includes intravenous glucose, heme therapy, and avoiding triggers such as certain medications.""]","[""Treatment for Acute intermittent porphyria includes intravenous heme, glucose, and medications to manage symptoms such as pain and nausea.""]","[""Treatment for AIP includes intravenous glucose, heme therapy, and avoiding triggers like certain medications.""]",[true],[true],[true],"[""Treatment for AIP includes intravenous glucose, heme therapy, and avoiding triggers such as certain medications.""]","[""Treatment for Acute intermittent porphyria includes intravenous heme, glucose, and medications to manage symptoms such as pain and nausea.""]","[""Treatment for AIP includes intravenous glucose, heme therapy, and avoiding triggers like certain medications.""]",[true],[true],[true],"[""Treatment for AIP includes intravenous glucose, heme therapy, and avoiding triggers such as certain medications.""]","[""Treatment for Acute intermittent porphyria includes intravenous heme, glucose, and medications to control symptoms and prevent attacks.""]","[""Treatment for AIP includes intravenous glucose, heme therapy, and avoiding triggers like certain medications.""]",[true],[true],[true],"[""Treatment for AIP includes intravenous glucose, heme therapy, and avoiding triggers such as certain medications.""]","[""Treatment for Acute intermittent porphyria includes intravenous heme, glucose, and medications to control symptoms.""]","[""Treatment for AIP includes intravenous glucose, hemin therapy, and avoiding triggers like certain medications.""]",[true],[true],[true],"[""Treatment for AIP includes intravenous glucose, heme therapy, and medications to manage symptoms.""]","[""Treatment for Acute intermittent porphyria includes intravenous heme, glucose, and medications to manage symptoms such as pain and nausea.""]","[""Treatment for AIP includes intravenous glucose, heme therapy, and avoiding triggers like certain medications.""]",[false],[true],[true],"[""The treatments for AIP (Agreement In Principle) may include medication, lifestyle changes, and therapy.""]","[""Treatment for Acute intermittent porphyria includes intravenous heme, glucose, and medications to manage symptoms such as pain and nausea.""]","[""Treatment for AIP includes intravenous glucose, heme therapy, and avoiding triggers like certain medications.""]",[true],[true],[true],"[""Treatment for AIP includes intravenous glucose, heme therapy, and avoiding triggers such as certain medications.""]","[""Treatment for Acute intermittent porphyria includes intravenous heme, glucose, and medications to manage symptoms such as pain and nausea.""]","[""Treatment for AIP includes intravenous glucose, heme therapy, and avoiding triggers like certain medications.""]",[true],[true],[true],"[""Treatment for AIP includes intravenous glucose, heme therapy, and medications to manage symptoms.""]","[""Treatment for Acute intermittent porphyria includes intravenous heme, glucose, and medications to manage symptoms such as pain and nausea.""]","[""Treatment for AIP includes intravenous glucose, heme therapy, and avoiding triggers like certain medications.""]"
frequency,How many people are affected by juvenile idiopathic arthritis ?,"The incidence of juvenile idiopathic arthritis in North America and Europe is estimated to be 4 to 16 in 10,000 children. One in 1,000, or approximately 294,000, children in the United States are affected. The most common type of juvenile idiopathic arthritis in the United States is oligoarticular juvenile idiopathic arthritis, which accounts for about half of all cases. For reasons that are unclear, females seem to be affected with juvenile idiopathic arthritis somewhat more frequently than males. However, in enthesitis-related juvenile idiopathic arthritis males are affected more often than females. The incidence of juvenile idiopathic arthritis varies across different populations and ethnic groups.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""JIA"", ""full_form"": ""juvenile idiopathic arthritis""}]}",How many people are affected by JIA ?,How many people are affected by juvenile idiopathic arthritis ?,8,MEDICAL,Simple Datatype-Integer,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Juina, MT, Brazil"", ""Jetstream International Airlines"", ""Jesus Is Alive!"", ""Journalists in Action"", ""Japan Institute of Architects"", ""Joy In Action"", ""Jacksonville International Airport"", ""Junior Investment Analyst"", ""Japanese Imperial Army"", ""Japanese in Action""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Juvenile Idiopathic Arthritis""]",[8.767688758626058e-14],[8.767688758626058e-14],"[""Joy In Action""]",[2.366207433114788e-11],"[""ABBREVIATIONS""]","[[9.399387447665028e-24, 6.756734946724266e-20, 2.893684057919779e-17, 1.3204773016067842e-13, 1.9167719647105725e-19, 2.366207433114788e-11, 2.6328072336430958e-24, 3.8669052094923564e-20, 5.633289287486957e-14, 7.010006373633347e-14]]",[0.9425882262283534],[0.9436919707460596],"[""Japanese in Action""]",[0.9436919707460596],"[""LLM""]","[[0.7819787067336181, 0.596138475308192, 0.7231178916109346, 0.7193203187541344, 0.6712866874689294, 0.7850764437393687, 0.6159027251966935, 0.7382679874765208, 0.6345964270413171, 0.7535487098917534]]","[""Juvenile Idiopathic Arthritis""]","[""LLM""]",How many people are affected by JIA (Juvenile Idiopathic Arthritis) ?,[true],[true],[true],"[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]","[""Approximately 300,000 children in the United States are affected by juvenile idiopathic arthritis.""]","[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]",[true],[true],[true],"[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]","[""Approximately 300,000 children in the United States are affected by juvenile idiopathic arthritis.""]","[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]",[true],[true],[true],"[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]","[""Approximately 300,000 children in the United States are affected by juvenile idiopathic arthritis.""]","[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]",[true],[true],[true],"[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]","[""Approximately 300,000 children in the United States are affected by juvenile idiopathic arthritis.""]","[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]",[true],[true],[true],"[""Approximately 1 in 1,000 children are affected by Juvenile Idiopathic Arthritis (JIA).""]","[""Approximately 300,000 children in the United States are affected by juvenile idiopathic arthritis.""]","[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]",[true],[true],[true],"[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]","[""Approximately 300,000 children in the United States are affected by juvenile idiopathic arthritis.""]","[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]",[true],[true],[true],"[""Approximately 1 in 1,000 children are affected by JIA (Juvenile Idiopathic Arthritis)""]","[""Approximately 300,000 children in the United States are affected by juvenile idiopathic arthritis.""]","[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]",[false],[true],[true],"[""Approximately 1 in 1,000 children in Japan are affected by Juvenile Idiopathic Arthritis (JIA).""]","[""Approximately 300,000 children in the United States are affected by juvenile idiopathic arthritis.""]","[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]",[true],[true],[true],"[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]","[""Approximately 300,000 children in the United States are affected by juvenile idiopathic arthritis.""]","[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]",[true],[true],[true],"[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]","[""Approximately 300,000 children in the United States are affected by juvenile idiopathic arthritis.""]","[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]",[true],[true],[true],"[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]","[""Approximately 300,000 children in the United States are affected by juvenile idiopathic arthritis.""]","[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]",[true],[true],[true],"[""Approximately 300,000 children in the United States are affected by JIA (Juvenile Idiopathic Arthritis).""]","[""Approximately 300,000 children in the United States are affected by juvenile idiopathic arthritis.""]","[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]",[true],[true],[true],"[""Approximately 300,000 children in the United States are affected by JIA (Juvenile Idiopathic Arthritis).""]","[""Approximately 300,000 children in the United States are affected by juvenile idiopathic arthritis.""]","[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]",[true],[true],[true],"[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]","[""Approximately 300,000 children in the United States are affected by juvenile idiopathic arthritis.""]","[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]",[true],[true],[true],"[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]","[""Approximately 300,000 children in the United States are affected by juvenile idiopathic arthritis.""]","[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]",[true],[true],[true],"[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]","[""Approximately 300,000 children in the United States are affected by juvenile idiopathic arthritis.""]","[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]",[true],[true],[true],"[""The exact number of people affected by JIA (Juvenile Idiopathic Arthritis) varies, but it is estimated to affect around 300,000 children in the United States.""]","[""Approximately 300,000 children in the United States are affected by juvenile idiopathic arthritis.""]","[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]",[true],[true],[true],"[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]","[""Approximately 300,000 children in the United States are affected by juvenile idiopathic arthritis.""]","[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]",[true],[true],[true],"[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]","[""Approximately 300,000 children in the United States are affected by juvenile idiopathic arthritis.""]","[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]",[true],[true],[true],"[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]","[""Approximately 300,000 children in the United States are affected by juvenile idiopathic arthritis.""]","[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]",[true],[true],[true],"[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]","[""Approximately 300,000 children in the United States are affected by juvenile idiopathic arthritis.""]","[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]",[true],[true],[true],"[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]","[""Approximately 300,000 children in the United States are affected by juvenile idiopathic arthritis.""]","[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]",[true],[true],[true],"[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]","[""Approximately 300,000 children in the United States are affected by juvenile idiopathic arthritis.""]","[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]",[true],[true],[true],"[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]","[""Approximately 300,000 children in the United States are affected by juvenile idiopathic arthritis.""]","[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]",[true],[true],[true],"[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]","[""Approximately 300,000 children in the United States are affected by juvenile idiopathic arthritis.""]","[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]",[true],[true],[true],"[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]","[""Approximately 300,000 children in the United States are affected by juvenile idiopathic arthritis.""]","[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]",[true],[true],[true],"[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]","[""Approximately 300,000 children in the United States are affected by juvenile idiopathic arthritis.""]","[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]",[true],[true],[true],"[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]","[""Approximately 300,000 children in the United States are affected by juvenile idiopathic arthritis.""]","[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]",[true],[true],[true],"[""Approximately 300,000 children in the United States are affected by JIA (Juvenile Idiopathic Arthritis).""]","[""Approximately 300,000 children in the United States are affected by juvenile idiopathic arthritis.""]","[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]",[false],[true],[true],"[""The exact number of people affected by JIA (Joy In Action) is not readily available.""]","[""Approximately 300,000 children in the United States are affected by juvenile idiopathic arthritis.""]","[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]",[false],[true],[true],"[""The number of people affected by JIA (Japanese in Action) is not specified.""]","[""Approximately 300,000 children in the United States are affected by juvenile idiopathic arthritis.""]","[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]",[true],[true],[true],"[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]","[""Approximately 300,000 children in the United States are affected by juvenile idiopathic arthritis.""]","[""Approximately 300,000 children in the United States are affected by Juvenile Idiopathic Arthritis (JIA).""]"
research,what research (or clinical trials) is being done for Normal Pressure Hydrocephalus ?,"The NINDS conducts and supports research on neurological disorders, including normal pressure hydrocephalus. Research on disorders such as normal pressure hydrocephalus focuses on increasing knowledge and understanding of the disorder, improving diagnostic techniques and neuroimaging, and finding improved treatments and preventions.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""NPH"", ""full_form"": ""Normal Pressure Hydrocephalus""}]}",what research (or clinical trials) is being done for NPH ?,what research (or clinical trials) is being done for Normal Pressure Hydrocephalus ?,8,MEDICAL,Compound Datatype-List/Array,"Exploratory(Divergent Thinking): Queries that are inherently about seeking new areas of knowledge, understanding emerging trends, or identifying unknown opportunities without a specific end goal of making a decision or judgment. Exploratory queries are characterized by their openness and the lack of a predefined objective, differentiating them from evaluative queries which are directed towards forming a judgment or assessment. Exploratory queries encourage branching out into various directions to explore a wide array of possibilities without necessarily aiming to converge on a single answer or outcome.","[[""Normal pressure hydrocephalus"", ""Nazarene Publishing House"", ""Neutral Protamine Hagedorn"", ""No Parse Header"", ""Non Parsed Header"", ""Non-Parsed Header"", ""Nothing By Mouth"", ""No previous history"", ""Non Phototropic Hypocotyl"", ""New Player Helper""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Normal Pressure Hydrocephalus""]",[4.276185617390754e-14],[4.276185617390754e-14],"[""No previous history""]",[4.5748192663157465e-07],"[""ABBREVIATIONS""]","[[4.276185617390754e-14, 1.0861101973055605e-24, 3.905506549034515e-25, 1.0891457054235911e-16, 6.573453516557323e-19, 3.1895534563373815e-19, 2.831212259498628e-07, 4.5748192663157465e-07, 8.05729277676317e-31, 1.0863994311002327e-18]]",[0.8372190900615701],[0.8372190900615701],"[""Nothing By Mouth""]",[0.9207077498560869],"[""ABBREVIATIONS""]","[[0.8374981128726595, 0.8579302141662359, 0.9204116132039288, 0.8841979906280373, 0.8148575526712946, 0.8872430527709433, 0.8582138290921268, 0.9207077498560869, 0.7531025963682338, 0.8717468120029119]]","[""Normal pressure hydrocephalus""]","[""ABBREVIATIONS""]",what research (or clinical trials) is being done for NPH (Normal Pressure Hydrocephalus) ?,[true],[true],[true],"[""Research and clinical trials for NPH are focused on identifying biomarkers, developing new treatment approaches, and improving diagnostic methods.""]","[""Research and clinical trials for Normal Pressure Hydrocephalus are focused on investigating new diagnostic tools, exploring potential biomarkers, evaluating different treatment approaches such as shunt surgery and endoscopic third ventriculostomy, and assessing the effectiveness of physical therapy and cognitive rehabilitation programs.""]","[""Research and clinical trials for NPH are focused on developing new diagnostic tools, exploring potential biomarkers, investigating novel treatment approaches such as shunt systems, and studying the long-term outcomes of different interventions.""]",[true],[true],[true],"[""Research and clinical trials for NPH are focused on developing new diagnostic tools, exploring potential biomarkers, investigating treatment options such as shunt placement or endoscopic third ventriculostomy, and evaluating the effectiveness of different management strategies.""]","[""Research is being conducted on the use of shunt surgery and cognitive rehabilitation for Normal Pressure Hydrocephalus.""]","[""Research and clinical trials for NPH are focused on improving diagnostic techniques, exploring new treatment options, and understanding the underlying mechanisms of the condition.""]",[true],[true],[true],"[""Research and clinical trials for NPH are focused on understanding the underlying causes, developing new diagnostic tools, exploring potential treatments such as shunt surgery, and investigating the long-term outcomes of different management strategies.""]","[""Research is being conducted on the use of shunt surgery, endoscopic third ventriculostomy, and cerebrospinal fluid drainage for Normal Pressure Hydrocephalus.""]","[""Research and clinical trials on Normal Pressure Hydrocephalus (NPH) are currently focused on diagnostic tools, treatment options, and improving patient outcomes.""]",[true],[true],[true],"[""Research and clinical trials for NPH are currently focused on developing new diagnostic tools, exploring potential biomarkers, investigating novel treatment approaches, and understanding the underlying mechanisms of the condition.""]","[""Research and clinical trials on Normal Pressure Hydrocephalus include studies on shunt surgery, endoscopic third ventriculostomy, and diagnostic imaging techniques.""]","[""Research and clinical trials for NPH are focused on improving diagnostic methods, exploring new treatment options, and investigating potential biomarkers for early detection.""]",[false],[true],[true],"[""Research and clinical trials are being conducted to explore the effectiveness of alternative nutrition delivery methods in patients with NPH (Nothing By Mouth).""]","[""Research and clinical trials for Normal Pressure Hydrocephalus are focused on investigating new diagnostic tools, exploring potential biomarkers, evaluating different treatment approaches such as shunt surgery and endoscopic third ventriculostomy, and assessing the effectiveness of physical therapy and cognitive rehabilitation programs.""]","[""Research and clinical trials for NPH are focused on developing new diagnostic tools, exploring potential biomarkers, investigating novel treatment approaches such as shunt systems, and studying the long-term outcomes of different interventions.""]",[false],[true],[true],"[""Research and clinical trials for NPH (Nothing By Mouth) focus on evaluating the safety and effectiveness of alternative nutrition delivery methods, such as enteral or parenteral nutrition, in patients who cannot consume food orally.""]","[""Research is being conducted on the use of shunt surgery and cognitive rehabilitation for Normal Pressure Hydrocephalus.""]","[""Research and clinical trials for NPH are focused on improving diagnostic techniques, exploring new treatment options, and understanding the underlying mechanisms of the condition.""]",[false],[true],[true],"[""Research and clinical trials on NPH (Nothing By Mouth) focus on evaluating alternative feeding methods, assessing the impact on patient outcomes, and exploring new technologies for nutritional support.""]","[""Research is being conducted on the use of shunt surgery, endoscopic third ventriculostomy, and cerebrospinal fluid drainage for Normal Pressure Hydrocephalus.""]","[""Research and clinical trials on Normal Pressure Hydrocephalus (NPH) are currently focused on diagnostic tools, treatment options, and improving patient outcomes.""]",[false],[true],[true],"[""Research and clinical trials are being conducted to explore the effectiveness of alternative nutrition delivery methods in patients with NPH (Nothing By Mouth).""]","[""Research and clinical trials on Normal Pressure Hydrocephalus include studies on shunt surgery, endoscopic third ventriculostomy, and diagnostic imaging techniques.""]","[""Research and clinical trials for NPH are focused on improving diagnostic methods, exploring new treatment options, and investigating potential biomarkers for early detection.""]",[true],[true],[true],"[""Research and clinical trials are being conducted to investigate the effectiveness of shunt surgery, endoscopic third ventriculostomy, and other treatment options for Normal Pressure Hydrocephalus (NPH).""]","[""Research is being conducted on the use of shunt surgery and cognitive rehabilitation for Normal Pressure Hydrocephalus.""]","[""Research and clinical trials for NPH are focused on improving diagnostic techniques, exploring new treatment options, and understanding the underlying mechanisms of the condition.""]",[true],[true],[true],"[""Various research studies and clinical trials are being conducted for Normal Pressure Hydrocephalus (NPH) to explore new treatment options, diagnostic methods, and potential interventions. It is recommended to consult official clinical trial registries or research databases for the most up-to-date information.""]","[""Research and clinical trials for Normal Pressure Hydrocephalus are focused on investigating new diagnostic tools, exploring potential biomarkers, evaluating different treatment approaches such as shunt surgery and endoscopic third ventriculostomy, and assessing the effectiveness of physical therapy and cognitive rehabilitation programs.""]","[""Research and clinical trials for NPH are focused on developing new diagnostic tools, exploring potential biomarkers, investigating novel treatment approaches such as shunt systems, and studying the long-term outcomes of different interventions.""]",[true],[true],[true],"[""Research and clinical trials for NPH (Normal pressure hydrocephalus) are focused on improving diagnostic techniques, exploring new treatment options such as shunt placement, and investigating potential biomarkers for early detection.""]","[""Research is being conducted on the use of shunt surgery, endoscopic third ventriculostomy, and cerebrospinal fluid drainage for Normal Pressure Hydrocephalus.""]","[""Research and clinical trials on Normal Pressure Hydrocephalus (NPH) are currently focused on diagnostic tools, treatment options, and improving patient outcomes.""]",[true],[true],[true],"[""Various research studies and clinical trials are being conducted for Normal Pressure Hydrocephalus (NPH) to explore new treatment options, diagnostic methods, and potential biomarkers.""]","[""Research and clinical trials on Normal Pressure Hydrocephalus include studies on shunt surgery, endoscopic third ventriculostomy, and diagnostic imaging techniques.""]","[""Research and clinical trials for NPH are focused on improving diagnostic methods, exploring new treatment options, and investigating potential biomarkers for early detection.""]",[true],[true],[true],"[""Research and clinical trials for NPH are focused on improving diagnostic techniques, exploring new treatment options such as shunt placement or endoscopic third ventriculostomy, and investigating the effectiveness of physical therapy in managing symptoms.""]","[""Research and clinical trials for Normal Pressure Hydrocephalus are focused on investigating new diagnostic tools, exploring potential biomarkers, evaluating different treatment approaches such as shunt surgery and endoscopic third ventriculostomy, and assessing the effectiveness of physical therapy and cognitive rehabilitation programs.""]","[""Research and clinical trials for NPH are focused on developing new diagnostic tools, exploring potential biomarkers, investigating novel treatment approaches such as shunt systems, and studying the long-term outcomes of different interventions.""]",[true],[true],[true],"[""Research and clinical trials for NPH are focused on improving diagnostic methods, treatment options, and outcomes for patients. Some studies are investigating the effectiveness of shunt surgery, medication therapies, and rehabilitation programs in managing NPH symptoms.""]","[""Research is being conducted on the use of shunt surgery and cognitive rehabilitation for Normal Pressure Hydrocephalus.""]","[""Research and clinical trials for NPH are focused on improving diagnostic techniques, exploring new treatment options, and understanding the underlying mechanisms of the condition.""]",[true],[true],[true],"[""Research and clinical trials for NPH are focused on improving diagnostic techniques, exploring new treatment options such as shunt systems, and investigating the effectiveness of physical therapy and cognitive rehabilitation in managing symptoms.""]","[""Research is being conducted on the use of shunt surgery, endoscopic third ventriculostomy, and cerebrospinal fluid drainage for Normal Pressure Hydrocephalus.""]","[""Research and clinical trials on Normal Pressure Hydrocephalus (NPH) are currently focused on diagnostic tools, treatment options, and improving patient outcomes.""]",[true],[true],[true],"[""Research and clinical trials for NPH are focused on improving diagnostic methods, treatment options, and outcomes for patients. Some studies are investigating the effectiveness of shunt surgery, medication therapies, and rehabilitation programs in managing NPH symptoms.""]","[""Research and clinical trials on Normal Pressure Hydrocephalus include studies on shunt surgery, endoscopic third ventriculostomy, and diagnostic imaging techniques.""]","[""Research and clinical trials for NPH are focused on improving diagnostic methods, exploring new treatment options, and investigating potential biomarkers for early detection.""]",[true],[true],[true],"[""Research and clinical trials for NPH are focused on improving diagnostic techniques, exploring new treatment options such as shunt surgery and endoscopic third ventriculostomy, and investigating the potential of stem cell therapy.""]","[""Research and clinical trials for Normal Pressure Hydrocephalus are focused on investigating new diagnostic tools, exploring potential biomarkers, evaluating different treatment approaches such as shunt surgery and endoscopic third ventriculostomy, and assessing the effectiveness of physical therapy and cognitive rehabilitation programs.""]","[""Research and clinical trials for NPH are focused on developing new diagnostic tools, exploring potential biomarkers, investigating novel treatment approaches such as shunt systems, and studying the long-term outcomes of different interventions.""]",[true],[true],[true],"[""Research and clinical trials for NPH are focused on improving diagnostic techniques, exploring new treatment options such as shunt placement or endoscopic third ventriculostomy, and investigating the effectiveness of rehabilitation therapies in managing symptoms.""]","[""Research is being conducted on the use of shunt surgery and cognitive rehabilitation for Normal Pressure Hydrocephalus.""]","[""Research and clinical trials for NPH are focused on improving diagnostic techniques, exploring new treatment options, and understanding the underlying mechanisms of the condition.""]",[true],[true],[true],"[""Research is being conducted on the use of shunt surgery, endoscopic third ventriculostomy, and other treatment modalities for Normal Pressure Hydrocephalus (NPH). Clinical trials are also exploring the effectiveness of different diagnostic tools and management strategies for NPH.""]","[""Research is being conducted on the use of shunt surgery, endoscopic third ventriculostomy, and cerebrospinal fluid drainage for Normal Pressure Hydrocephalus.""]","[""Research and clinical trials on Normal Pressure Hydrocephalus (NPH) are currently focused on diagnostic tools, treatment options, and improving patient outcomes.""]",[true],[true],[true],"[""There are ongoing research studies and clinical trials investigating the effectiveness of different treatment approaches for Normal Pressure Hydrocephalus (NPH), including shunt surgery, endoscopic third ventriculostomy, and pharmacological interventions.""]","[""Research and clinical trials on Normal Pressure Hydrocephalus include studies on shunt surgery, endoscopic third ventriculostomy, and diagnostic imaging techniques.""]","[""Research and clinical trials for NPH are focused on improving diagnostic methods, exploring new treatment options, and investigating potential biomarkers for early detection.""]",[true],[true],[true],"[""Research and clinical trials for NPH (Normal Pressure Hydrocephalus) are currently focused on investigating new diagnostic tools, exploring potential biomarkers, evaluating novel treatment approaches such as shunt technology advancements, and studying the long-term outcomes of different interventions.""]","[""Research and clinical trials for Normal Pressure Hydrocephalus are focused on investigating new diagnostic tools, exploring potential biomarkers, evaluating different treatment approaches such as shunt surgery and endoscopic third ventriculostomy, and assessing the effectiveness of physical therapy and cognitive rehabilitation programs.""]","[""Research and clinical trials for NPH are focused on developing new diagnostic tools, exploring potential biomarkers, investigating novel treatment approaches such as shunt systems, and studying the long-term outcomes of different interventions.""]",[true],[true],[true],"[""Research and clinical trials for NPH (Normal Pressure Hydrocephalus) are focused on improving diagnostic methods, exploring new treatment options such as shunt surgeries, investigating the role of biomarkers in early detection, and evaluating the effectiveness of physical therapy in managing symptoms.""]","[""Research is being conducted on the use of shunt surgery and cognitive rehabilitation for Normal Pressure Hydrocephalus.""]","[""Research and clinical trials for NPH are focused on improving diagnostic techniques, exploring new treatment options, and understanding the underlying mechanisms of the condition.""]",[true],[true],[true],"[""Research and clinical trials for NPH are focused on improving diagnostic techniques, developing new treatment options, and investigating potential biomarkers for early detection.""]","[""Research is being conducted on the use of shunt surgery, endoscopic third ventriculostomy, and cerebrospinal fluid drainage for Normal Pressure Hydrocephalus.""]","[""Research and clinical trials on Normal Pressure Hydrocephalus (NPH) are currently focused on diagnostic tools, treatment options, and improving patient outcomes.""]",[true],[true],[true],"[""Research and clinical trials for NPH are focused on investigating new diagnostic tools, exploring potential biomarkers, evaluating different treatment approaches such as shunt surgery or endoscopic third ventriculostomy, and assessing the long-term outcomes of these interventions.""]","[""Research and clinical trials on Normal Pressure Hydrocephalus include studies on shunt surgery, endoscopic third ventriculostomy, and diagnostic imaging techniques.""]","[""Research and clinical trials for NPH are focused on improving diagnostic methods, exploring new treatment options, and investigating potential biomarkers for early detection.""]",[true],[true],[true],"[""Various research studies and clinical trials are being conducted for Normal Pressure Hydrocephalus (NPH) to explore new treatment options, diagnostic methods, and potential biomarkers. Some focus areas include shunt technology advancements, cognitive rehabilitation strategies, and imaging techniques for early detection.""]","[""Research and clinical trials for Normal Pressure Hydrocephalus are focused on investigating new diagnostic tools, exploring potential biomarkers, evaluating different treatment approaches such as shunt surgery and endoscopic third ventriculostomy, and assessing the effectiveness of physical therapy and cognitive rehabilitation programs.""]","[""Research and clinical trials for NPH are focused on developing new diagnostic tools, exploring potential biomarkers, investigating novel treatment approaches such as shunt systems, and studying the long-term outcomes of different interventions.""]",[true],[true],[true],"[""Research and clinical trials for NPH (Normal pressure hydrocephalus) are focused on improving diagnostic techniques, exploring new treatment options such as shunt surgeries and endoscopic third ventriculostomy, and investigating potential biomarkers for early detection.""]","[""Research is being conducted on the use of shunt surgery and cognitive rehabilitation for Normal Pressure Hydrocephalus.""]","[""Research and clinical trials for NPH are focused on improving diagnostic techniques, exploring new treatment options, and understanding the underlying mechanisms of the condition.""]",[true],[true],[true],"[""Various research studies and clinical trials are being conducted for Normal Pressure Hydrocephalus (NPH) to explore new treatment options, diagnostic methods, and potential biomarkers. Some focus areas include the use of advanced imaging techniques, shunt technology improvements, and cognitive rehabilitation strategies.""]","[""Research is being conducted on the use of shunt surgery, endoscopic third ventriculostomy, and cerebrospinal fluid drainage for Normal Pressure Hydrocephalus.""]","[""Research and clinical trials on Normal Pressure Hydrocephalus (NPH) are currently focused on diagnostic tools, treatment options, and improving patient outcomes.""]",[true],[true],[true],"[""Various research studies and clinical trials are being conducted for Normal Pressure Hydrocephalus (NPH) to explore treatment options, diagnostic methods, and potential biomarkers.""]","[""Research and clinical trials on Normal Pressure Hydrocephalus include studies on shunt surgery, endoscopic third ventriculostomy, and diagnostic imaging techniques.""]","[""Research and clinical trials for NPH are focused on improving diagnostic methods, exploring new treatment options, and investigating potential biomarkers for early detection.""]",[true],[true],[true],"[""Research and clinical trials for Normal Pressure Hydrocephalus (NPH) are focused on improving diagnostic methods, developing new treatment options, and enhancing patient outcomes. Some studies are investigating the effectiveness of shunt surgery, cognitive rehabilitation, and physical therapy in managing NPH symptoms.""]","[""Research and clinical trials for Normal Pressure Hydrocephalus are focused on investigating new diagnostic tools, exploring potential biomarkers, evaluating different treatment approaches such as shunt surgery and endoscopic third ventriculostomy, and assessing the effectiveness of physical therapy and cognitive rehabilitation programs.""]","[""Research and clinical trials for NPH are focused on developing new diagnostic tools, exploring potential biomarkers, investigating novel treatment approaches such as shunt systems, and studying the long-term outcomes of different interventions.""]",[true],[true],[true],"[""Research and clinical trials for NPH are focused on improving diagnostic methods, exploring potential treatments, and understanding the underlying mechanisms of the condition.""]","[""Research and clinical trials for Normal Pressure Hydrocephalus are focused on investigating new diagnostic tools, exploring potential biomarkers, evaluating different treatment approaches such as shunt surgery and endoscopic third ventriculostomy, and assessing the effectiveness of physical therapy and cognitive rehabilitation programs.""]","[""Research and clinical trials for NPH are focused on developing new diagnostic tools, exploring potential biomarkers, investigating novel treatment approaches such as shunt systems, and studying the long-term outcomes of different interventions.""]",[false],[true],[true],"[""Research and clinical trials are being conducted to study the effectiveness of NPH (Nothing By Mouth) in various medical conditions.""]","[""Research and clinical trials for Normal Pressure Hydrocephalus are focused on investigating new diagnostic tools, exploring potential biomarkers, evaluating different treatment approaches such as shunt surgery and endoscopic third ventriculostomy, and assessing the effectiveness of physical therapy and cognitive rehabilitation programs.""]","[""Research and clinical trials for NPH are focused on developing new diagnostic tools, exploring potential biomarkers, investigating novel treatment approaches such as shunt systems, and studying the long-term outcomes of different interventions.""]",[true],[true],[true],"[""Research and clinical trials for NPH are focused on improving diagnostic techniques, exploring new treatment options such as shunt systems, and investigating potential biomarkers for early detection.""]","[""Research and clinical trials for Normal Pressure Hydrocephalus are focused on investigating new diagnostic tools, exploring potential biomarkers, evaluating different treatment approaches such as shunt surgery and endoscopic third ventriculostomy, and assessing the effectiveness of physical therapy and cognitive rehabilitation programs.""]","[""Research and clinical trials for NPH are focused on developing new diagnostic tools, exploring potential biomarkers, investigating novel treatment approaches such as shunt systems, and studying the long-term outcomes of different interventions.""]"
symptoms,What are the symptoms of Chronic Myelogenous Leukemia ?,"Signs and symptoms of chronic myelogenous leukemia include fever, night sweats, and tiredness. These and other signs and symptoms may be caused by CML or by other conditions. Check with your doctor if you have any of the following:         - Feeling very tired.    - Weight loss for no known reason.    - Night sweats.    -  Fever.    - Pain or a feeling of fullness below the ribs on the left side.        Sometimes CML does not cause any symptoms at all.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""CML"", ""full_form"": ""Chronic Myelogenous Leukemia""}]}",What are the symptoms of CML ?,What are the symptoms of Chronic Myelogenous Leukemia ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Chronic myelogenous leukemia"", ""Chronic Myeloid Leukemia"", ""Chemical Markup Language"", ""Council Of Mortgage Lenders"", ""Current Mode Logic"", ""CML Group, Inc. (de-listed)"", ""Chronic Myelocytic Leukemia"", ""Computer Managed Learning"", ""Continental Math League"", ""The Capital Market Line""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Chronic Myeloid Leukemia""]",[8.446681652410551e-10],[8.633400859677391e-11],"[""Chronic myelogenous leukemia""]",[8.446681652410551e-10],"[""ABBREVIATIONS""]","[[8.446681652410551e-10, 8.633400859677391e-11, 2.4230758277875372e-20, 1.3514475664282185e-23, 3.3301019758209027e-15, 2.0704638242436074e-28, 7.781174110520106e-12, 2.7873189088479536e-16, 6.570918431988401e-18, 1.3017804122625325e-16]]",[0.92510469946467],[0.930198258916191],"[""Chronic myelogenous leukemia""]",[0.930198258916191],"[""ABBREVIATIONS""]","[[0.9274769822657752, 0.930198258916191, 0.7262217963006781, 0.6996191301392285, 0.6228985348298324, 0.8020592216047958, 0.9202171596389308, 0.6611210600447273, 0.6825375797804762, 0.6857165360755728]]","[""Chronic Myeloid Leukemia""]","[""ABBREVIATIONS""]",What are the symptoms of CML (Chronic Myeloid Leukemia) ?,[true],[true],[true],"[""Fatigue, weight loss, night sweats, abdominal fullness, easy bleeding or bruising, fever, bone pain""]","[""Fatigue, weight loss, night sweats, fever, bone pain, abdominal fullness, easy bleeding or bruising""]","[""Fatigue, weight loss, night sweats, abdominal fullness, and easy bruising are common symptoms of Chronic Myeloid Leukemia (CML).""]",[true],[true],[true],"[""Fatigue, weight loss, night sweats, abdominal fullness, easy bruising, bone pain""]","[""Fatigue, weight loss, night sweats, fever, bone pain, easy bleeding or bruising""]","[""Fatigue, weight loss, night sweats, abdominal fullness, and easy bruising are common symptoms of Chronic Myeloid Leukemia (CML).""]",[true],[true],[true],"[""Fatigue, weight loss, night sweats, abdominal discomfort, enlarged spleen""]","[""Fatigue, weight loss, night sweats, fever, bone pain, abdominal discomfort, easy bruising, and frequent infections.""]","[""Fatigue, weight loss, night sweats, abdominal fullness, easy bruising, bone pain""]",[true],[true],[true],"[""Fatigue, weight loss, night sweats, abdominal fullness, and easy bruising are common symptoms of CML (Chronic myelogenous leukemia).""]","[""Fatigue, weight loss, night sweats, fever, bone pain, abdominal discomfort, easy bruising, and frequent infections.""]","[""Fatigue, weight loss, night sweats, abdominal fullness, easy bruising, bone pain""]",[true],[true],[true],"[""Fatigue, weight loss, night sweats, abdominal discomfort, easy bruising, bone pain""]","[""Fatigue, weight loss, night sweats, fever, bone pain, abdominal fullness, easy bleeding or bruising""]","[""Fatigue, weight loss, night sweats, abdominal fullness, and easy bruising are common symptoms of Chronic Myeloid Leukemia (CML).""]",[true],[true],[true],"[""Fatigue, weight loss, night sweats, abdominal discomfort, feeling full after eating only a small amount, easy bleeding or bruising, fever, bone pain""]","[""Fatigue, weight loss, night sweats, fever, bone pain, easy bleeding or bruising""]","[""Fatigue, weight loss, night sweats, abdominal fullness, and easy bruising are common symptoms of Chronic Myeloid Leukemia (CML).""]",[true],[true],[true],"[""Fatigue, weight loss, night sweats, abdominal fullness, easy bruising, bone pain""]","[""Fatigue, weight loss, night sweats, fever, bone pain, abdominal discomfort, easy bruising, and frequent infections.""]","[""Fatigue, weight loss, night sweats, abdominal fullness, easy bruising, bone pain""]",[true],[true],[true],"[""Fatigue, weight loss, night sweats, abdominal fullness, easy bruising, bone pain""]","[""Fatigue, weight loss, night sweats, fever, bone pain, abdominal discomfort, easy bruising, and frequent infections.""]","[""Fatigue, weight loss, night sweats, abdominal fullness, easy bruising, bone pain""]",[true],[true],[true],"[""Fatigue, weight loss, night sweats, abdominal fullness, easy bruising, and bone pain are common symptoms of Chronic Myeloid Leukemia (CML).""]","[""Fatigue, weight loss, night sweats, fever, bone pain, easy bleeding or bruising""]","[""Fatigue, weight loss, night sweats, abdominal fullness, and easy bruising are common symptoms of Chronic Myeloid Leukemia (CML).""]",[true],[true],[true],"[""Fatigue, weight loss, night sweats, abdominal pain, enlarged spleen, easy bruising or bleeding""]","[""Fatigue, weight loss, night sweats, fever, bone pain, abdominal fullness, easy bleeding or bruising""]","[""Fatigue, weight loss, night sweats, abdominal fullness, and easy bruising are common symptoms of Chronic Myeloid Leukemia (CML).""]",[true],[true],[true],"[""Fatigue, weight loss, night sweats, abdominal fullness, easy bruising, bone pain""]","[""Fatigue, weight loss, night sweats, fever, bone pain, abdominal discomfort, easy bruising, and frequent infections.""]","[""Fatigue, weight loss, night sweats, abdominal fullness, easy bruising, bone pain""]",[true],[true],[true],"[""Fatigue, weight loss, night sweats, abdominal fullness, easy bruising, bone pain""]","[""Fatigue, weight loss, night sweats, fever, bone pain, abdominal discomfort, easy bruising, and frequent infections.""]","[""Fatigue, weight loss, night sweats, abdominal fullness, easy bruising, bone pain""]",[true],[true],[true],"[""Fatigue, weight loss, night sweats, abdominal discomfort, enlarged spleen""]","[""Fatigue, weight loss, night sweats, fever, bone pain, abdominal fullness, easy bleeding or bruising""]","[""Fatigue, weight loss, night sweats, abdominal fullness, and easy bruising are common symptoms of Chronic Myeloid Leukemia (CML).""]",[true],[true],[true],"[""Fatigue, weight loss, night sweats, abdominal pain, enlarged spleen, easy bruising or bleeding""]","[""Fatigue, weight loss, night sweats, fever, bone pain, easy bleeding or bruising""]","[""Fatigue, weight loss, night sweats, abdominal fullness, and easy bruising are common symptoms of Chronic Myeloid Leukemia (CML).""]",[true],[true],[true],"[""Fatigue, weight loss, night sweats, abdominal discomfort, enlarged spleen""]","[""Fatigue, weight loss, night sweats, fever, bone pain, abdominal discomfort, easy bruising, and frequent infections.""]","[""Fatigue, weight loss, night sweats, abdominal fullness, easy bruising, bone pain""]",[true],[true],[true],"[""Fatigue, weight loss, night sweats, abdominal pain, enlarged spleen""]","[""Fatigue, weight loss, night sweats, fever, bone pain, abdominal discomfort, easy bruising, and frequent infections.""]","[""Fatigue, weight loss, night sweats, abdominal fullness, easy bruising, bone pain""]",[true],[true],[true],"[""Fatigue, weight loss, night sweats, abdominal discomfort, enlarged spleen, easy bleeding or bruising""]","[""Fatigue, weight loss, night sweats, fever, bone pain, abdominal fullness, easy bleeding or bruising""]","[""Fatigue, weight loss, night sweats, abdominal fullness, and easy bruising are common symptoms of Chronic Myeloid Leukemia (CML).""]",[true],[true],[true],"[""Fatigue, weight loss, night sweats, abdominal pain, enlarged spleen""]","[""Fatigue, weight loss, night sweats, fever, bone pain, easy bleeding or bruising""]","[""Fatigue, weight loss, night sweats, abdominal fullness, and easy bruising are common symptoms of Chronic Myeloid Leukemia (CML).""]",[true],[true],[true],"[""Fatigue, weight loss, night sweats, abdominal fullness, easy bleeding or bruising""]","[""Fatigue, weight loss, night sweats, fever, bone pain, abdominal discomfort, easy bruising, and frequent infections.""]","[""Fatigue, weight loss, night sweats, abdominal fullness, easy bruising, bone pain""]",[true],[true],[true],"[""Fatigue, weight loss, night sweats, abdominal fullness, easy bruising, bone pain""]","[""Fatigue, weight loss, night sweats, fever, bone pain, abdominal discomfort, easy bruising, and frequent infections.""]","[""Fatigue, weight loss, night sweats, abdominal fullness, easy bruising, bone pain""]",[true],[true],[true],"[""Fatigue, weight loss, night sweats, abdominal discomfort, enlarged spleen""]","[""Fatigue, weight loss, night sweats, fever, bone pain, abdominal fullness, easy bleeding or bruising""]","[""Fatigue, weight loss, night sweats, abdominal fullness, and easy bruising are common symptoms of Chronic Myeloid Leukemia (CML).""]",[true],[true],[true],"[""Fatigue, weight loss, night sweats, abdominal pain, enlarged spleen""]","[""Fatigue, weight loss, night sweats, fever, bone pain, easy bleeding or bruising""]","[""Fatigue, weight loss, night sweats, abdominal fullness, and easy bruising are common symptoms of Chronic Myeloid Leukemia (CML).""]",[true],[true],[true],"[""Fatigue, weight loss, night sweats, abdominal pain, enlarged spleen, easy bleeding or bruising""]","[""Fatigue, weight loss, night sweats, fever, bone pain, abdominal discomfort, easy bruising, and frequent infections.""]","[""Fatigue, weight loss, night sweats, abdominal fullness, easy bruising, bone pain""]",[true],[true],[true],"[""Fatigue, weight loss, night sweats, abdominal fullness, and easy bruising are common symptoms of CML (Chronic Myeloid Leukemia).""]","[""Fatigue, weight loss, night sweats, fever, bone pain, abdominal discomfort, easy bruising, and frequent infections.""]","[""Fatigue, weight loss, night sweats, abdominal fullness, easy bruising, bone pain""]",[true],[true],[true],"[""Symptoms of CML include fatigue, weight loss, night sweats, abdominal discomfort, and a feeling of fullness due to an enlarged spleen.""]","[""Fatigue, weight loss, night sweats, fever, bone pain, abdominal fullness, easy bleeding or bruising""]","[""Fatigue, weight loss, night sweats, abdominal fullness, and easy bruising are common symptoms of Chronic Myeloid Leukemia (CML).""]",[true],[true],[true],"[""Symptoms of CML may include fatigue, weight loss, night sweats, abdominal pain, and a feeling of fullness below the ribs.""]","[""Fatigue, weight loss, night sweats, fever, bone pain, easy bleeding or bruising""]","[""Fatigue, weight loss, night sweats, abdominal fullness, and easy bruising are common symptoms of Chronic Myeloid Leukemia (CML).""]",[true],[true],[true],"[""Symptoms of CML include fatigue, weight loss, night sweats, abdominal discomfort, and a feeling of fullness due to an enlarged spleen.""]","[""Fatigue, weight loss, night sweats, fever, bone pain, abdominal discomfort, easy bruising, and frequent infections.""]","[""Fatigue, weight loss, night sweats, abdominal fullness, easy bruising, bone pain""]",[true],[true],[true],"[""Symptoms of CML include fatigue, weight loss, night sweats, abdominal pain, and enlarged spleen.""]","[""Fatigue, weight loss, night sweats, fever, bone pain, abdominal discomfort, easy bruising, and frequent infections.""]","[""Fatigue, weight loss, night sweats, abdominal fullness, easy bruising, bone pain""]",[true],[true],[true],"[""Fatigue, weight loss, night sweats, abdominal pain, enlarged spleen""]","[""Fatigue, weight loss, night sweats, fever, bone pain, abdominal fullness, easy bleeding or bruising""]","[""Fatigue, weight loss, night sweats, abdominal fullness, and easy bruising are common symptoms of Chronic Myeloid Leukemia (CML).""]",[true],[true],[true],"[""Symptoms of CML may include fatigue, weight loss, night sweats, abdominal discomfort, and a feeling of fullness below the ribs.""]","[""Fatigue, weight loss, night sweats, fever, bone pain, abdominal fullness, easy bleeding or bruising""]","[""Fatigue, weight loss, night sweats, abdominal fullness, and easy bruising are common symptoms of Chronic Myeloid Leukemia (CML).""]",[true],[true],[true],"[""Fatigue, weight loss, night sweats, abdominal fullness, easy bruising, bone pain""]","[""Fatigue, weight loss, night sweats, fever, bone pain, abdominal fullness, easy bleeding or bruising""]","[""Fatigue, weight loss, night sweats, abdominal fullness, and easy bruising are common symptoms of Chronic Myeloid Leukemia (CML).""]",[true],[true],[true],"[""Symptoms of CML may include fatigue, weight loss, abdominal pain, night sweats, and enlarged spleen.""]","[""Fatigue, weight loss, night sweats, fever, bone pain, abdominal fullness, easy bleeding or bruising""]","[""Fatigue, weight loss, night sweats, abdominal fullness, and easy bruising are common symptoms of Chronic Myeloid Leukemia (CML).""]"
treatment,What are the treatments for long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency ?,These resources address the diagnosis or management of LCHAD deficiency:  - Baby's First Test  - Genetic Testing Registry: Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency  - MedlinePlus Encyclopedia: Hypoglycemia  - MedlinePlus Encyclopedia: Peripheral Neuropathy   These resources from MedlinePlus offer information about the diagnosis and management of various health conditions:  - Diagnostic Tests  - Drug Therapy  - Surgery and Rehabilitation  - Genetic Counseling   - Palliative Care,"{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""LCHAD"", ""full_form"": ""long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency""}]}",What are the treatments for LCHAD ?,What are the treatments for long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase""]]","[[""THEFREEDICTIONARY""]]","[""Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase""]",[1.216079621576445e-50],[5.077109089396536e-45],"[""Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase""]",[5.077109089396536e-45],"[""THEFREEDICTIONARY""]",[[5.077109089396536e-45]],[0.9383305232974753],[0.9611044368840043],"[""long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency""]",[0.9611044368840043],"[""THEFREEDICTIONARY""]",[[0.9611044368840043]],"[""Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase""]","[""THEFREEDICTIONARY""]",What are the treatments for LCHAD (Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase) ?,[true],[true],[true],"[""Treatment for LCHAD deficiency includes a low-fat, high-carbohydrate diet, avoiding fasting, and supplementation with medium-chain triglycerides.""]","[""Treatment for long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency includes avoiding fasting, a low-fat diet, and supplementation with medium-chain triglycerides.""]","[""Treatment for LCHAD includes dietary management, avoiding fasting, supplementation with medium-chain triglycerides, and in severe cases, liver transplantation.""]",[true],[true],[true],"[""Dietary management, avoiding fasting, supplementation of essential fatty acids""]","[""Treatment for long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency includes avoiding fasting, following a special diet, and taking supplements like L-carnitine.""]","[""Treatment for LCHAD includes dietary management, avoiding fasting, supplementation with medium-chain triglycerides, and in some cases, liver transplantation.""]",[true],[false],[true],"[""Dietary management, avoiding fasting, and supplementation with medium-chain triglycerides""]","[""Dietary management, avoiding fasting, and carnitine supplementation""]","[""Treatment for LCHAD includes dietary management, avoiding fasting, supplementation with medium-chain triglycerides, and in some cases, liver transplantation.""]",[true],[true],[true],"[""Treatment for LCHAD deficiency includes a low-fat, high-carbohydrate diet, avoiding fasting, and supplementation with medium-chain triglycerides.""]","[""Treatment for long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency includes avoiding fasting, following a special diet, and taking supplements such as L-carnitine.""]","[""Treatment for LCHAD deficiency includes dietary management, avoiding fasting, supplementation with medium-chain triglycerides, and in some cases, liver transplantation.""]",[true],[true],[true],"[""Treatment for LCHAD deficiency includes dietary management, avoiding fasting, supplementation with medium-chain triglycerides, and in some cases, liver transplantation.""]","[""Treatment for long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency includes avoiding fasting, a low-fat diet, and supplementation with medium-chain triglycerides.""]","[""Treatment for LCHAD includes dietary management, avoiding fasting, supplementation with medium-chain triglycerides, and in severe cases, liver transplantation.""]",[true],[true],[true],"[""Treatment for LCHAD deficiency includes dietary management, avoiding fasting, supplementation with medium-chain triglycerides, and regular monitoring of blood glucose and fatty acid levels.""]","[""Treatment for long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency includes avoiding fasting, following a special diet, and taking supplements like L-carnitine.""]","[""Treatment for LCHAD includes dietary management, avoiding fasting, supplementation with medium-chain triglycerides, and in some cases, liver transplantation.""]",[true],[false],[true],"[""Dietary management, avoiding fasting, supplementation with medium-chain triglycerides""]","[""Dietary management, avoiding fasting, and carnitine supplementation""]","[""Treatment for LCHAD includes dietary management, avoiding fasting, supplementation with medium-chain triglycerides, and in some cases, liver transplantation.""]",[true],[true],[true],"[""Dietary management, avoiding fasting, and supplementation with medium-chain triglycerides""]","[""Treatment for long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency includes avoiding fasting, following a special diet, and taking supplements such as L-carnitine.""]","[""Treatment for LCHAD deficiency includes dietary management, avoiding fasting, supplementation with medium-chain triglycerides, and in some cases, liver transplantation.""]",[true],[true],[true],"[""Dietary management, avoiding fasting, and supplementation with medium-chain triglycerides""]","[""Treatment for long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency includes avoiding fasting, following a special diet, and taking supplements like L-carnitine.""]","[""Treatment for LCHAD includes dietary management, avoiding fasting, supplementation with medium-chain triglycerides, and in some cases, liver transplantation.""]",[true],[true],[true],"[""Dietary management, avoiding fasting, and supplementation with medium-chain triglycerides""]","[""Treatment for long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency includes avoiding fasting, a low-fat diet, and supplementation with medium-chain triglycerides.""]","[""Treatment for LCHAD includes dietary management, avoiding fasting, supplementation with medium-chain triglycerides, and in severe cases, liver transplantation.""]",[true],[false],[true],"[""Dietary management, avoiding fasting, and supplementation with medium-chain triglycerides""]","[""Dietary management, avoiding fasting, and carnitine supplementation""]","[""Treatment for LCHAD includes dietary management, avoiding fasting, supplementation with medium-chain triglycerides, and in some cases, liver transplantation.""]",[true],[true],[true],"[""Dietary management, avoiding fasting, and supplementation with medium-chain triglycerides""]","[""Treatment for long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency includes avoiding fasting, following a special diet, and taking supplements such as L-carnitine.""]","[""Treatment for LCHAD deficiency includes dietary management, avoiding fasting, supplementation with medium-chain triglycerides, and in some cases, liver transplantation.""]",[true],[true],[true],"[""Dietary management, avoiding fasting, supplementation of L-carnitine and medium-chain triglycerides""]","[""Treatment for long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency includes avoiding fasting, a low-fat diet, and supplementation with medium-chain triglycerides.""]","[""Treatment for LCHAD includes dietary management, avoiding fasting, supplementation with medium-chain triglycerides, and in severe cases, liver transplantation.""]",[true],[true],[true],"[""Dietary management, avoiding fasting, and supplementation with medium-chain triglycerides""]","[""Treatment for long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency includes avoiding fasting, following a special diet, and taking supplements like L-carnitine.""]","[""Treatment for LCHAD includes dietary management, avoiding fasting, supplementation with medium-chain triglycerides, and in some cases, liver transplantation.""]",[true],[false],[true],"[""Dietary management, avoiding fasting, supplementation with medium-chain triglycerides""]","[""Dietary management, avoiding fasting, and carnitine supplementation""]","[""Treatment for LCHAD includes dietary management, avoiding fasting, supplementation with medium-chain triglycerides, and in some cases, liver transplantation.""]",[true],[true],[true],"[""Dietary management, avoiding fasting, supplementation with medium-chain triglycerides""]","[""Treatment for long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency includes avoiding fasting, following a special diet, and taking supplements such as L-carnitine.""]","[""Treatment for LCHAD deficiency includes dietary management, avoiding fasting, supplementation with medium-chain triglycerides, and in some cases, liver transplantation.""]",[true],[true],[true],"[""Treatment for LCHAD includes dietary management, avoiding fasting, supplementation with medium-chain triglycerides, and regular monitoring by healthcare professionals.""]","[""Treatment for long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency includes avoiding fasting, a low-fat diet, and supplementation with medium-chain triglycerides.""]","[""Treatment for LCHAD includes dietary management, avoiding fasting, supplementation with medium-chain triglycerides, and in severe cases, liver transplantation.""]",[true],[true],[true],"[""Dietary management, avoiding fasting, supplementation with medium-chain triglycerides""]","[""Treatment for long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency includes avoiding fasting, following a special diet, and taking supplements like L-carnitine.""]","[""Treatment for LCHAD includes dietary management, avoiding fasting, supplementation with medium-chain triglycerides, and in some cases, liver transplantation.""]",[true],[false],[true],"[""Dietary management, avoiding fasting, supplementation with medium-chain triglycerides""]","[""Dietary management, avoiding fasting, and carnitine supplementation""]","[""Treatment for LCHAD includes dietary management, avoiding fasting, supplementation with medium-chain triglycerides, and in some cases, liver transplantation.""]",[true],[true],[true],"[""Dietary management, avoiding fasting, and supplementation with medium-chain triglycerides""]","[""Treatment for long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency includes avoiding fasting, following a special diet, and taking supplements such as L-carnitine.""]","[""Treatment for LCHAD deficiency includes dietary management, avoiding fasting, supplementation with medium-chain triglycerides, and in some cases, liver transplantation.""]",[true],[true],[true],"[""The treatments for LCHAD deficiency include a low-fat, high-carbohydrate diet, avoiding fasting, and supplementation with medium-chain triglycerides.""]","[""Treatment for long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency includes avoiding fasting, a low-fat diet, and supplementation with medium-chain triglycerides.""]","[""Treatment for LCHAD includes dietary management, avoiding fasting, supplementation with medium-chain triglycerides, and in severe cases, liver transplantation.""]",[true],[true],[true],"[""Treatment for LCHAD deficiency includes a low-fat, high-carbohydrate diet, avoiding fasting, and supplementation with medium-chain triglycerides.""]","[""Treatment for long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency includes avoiding fasting, following a special diet, and taking supplements like L-carnitine.""]","[""Treatment for LCHAD includes dietary management, avoiding fasting, supplementation with medium-chain triglycerides, and in some cases, liver transplantation.""]",[true],[false],[true],"[""Dietary management, avoiding fasting, and supplementation with medium-chain triglycerides""]","[""Dietary management, avoiding fasting, and carnitine supplementation""]","[""Treatment for LCHAD includes dietary management, avoiding fasting, supplementation with medium-chain triglycerides, and in some cases, liver transplantation.""]",[true],[true],[true],"[""Dietary management, avoiding fasting, and supplementation with medium-chain triglycerides""]","[""Treatment for long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency includes avoiding fasting, following a special diet, and taking supplements such as L-carnitine.""]","[""Treatment for LCHAD deficiency includes dietary management, avoiding fasting, supplementation with medium-chain triglycerides, and in some cases, liver transplantation.""]",[true],[true],[true],"[""The treatments for LCHAD deficiency include dietary management, avoiding fasting, supplementation with L-carnitine, and in some cases, liver transplantation.""]","[""Treatment for long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency includes avoiding fasting, a low-fat diet, and supplementation with medium-chain triglycerides.""]","[""Treatment for LCHAD includes dietary management, avoiding fasting, supplementation with medium-chain triglycerides, and in severe cases, liver transplantation.""]",[true],[true],[true],"[""Treatment for LCHAD deficiency includes a low-fat, high-carbohydrate diet, avoiding fasting, and supplementation with L-carnitine and medium-chain triglycerides.""]","[""Treatment for long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency includes avoiding fasting, following a special diet, and taking supplements like L-carnitine.""]","[""Treatment for LCHAD includes dietary management, avoiding fasting, supplementation with medium-chain triglycerides, and in some cases, liver transplantation.""]",[true],[false],[true],"[""The treatments for LCHAD deficiency include dietary management, avoiding fasting, supplementation with medium-chain triglycerides, and in some cases, liver transplantation.""]","[""Dietary management, avoiding fasting, and carnitine supplementation""]","[""Treatment for LCHAD includes dietary management, avoiding fasting, supplementation with medium-chain triglycerides, and in some cases, liver transplantation.""]",[true],[true],[true],"[""Treatment for LCHAD deficiency involves a special diet low in fats and high in carbohydrates, along with supplements such as L-carnitine and medium-chain triglycerides.""]","[""Treatment for long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency includes avoiding fasting, following a special diet, and taking supplements such as L-carnitine.""]","[""Treatment for LCHAD deficiency includes dietary management, avoiding fasting, supplementation with medium-chain triglycerides, and in some cases, liver transplantation.""]",[true],[true],[true],"[""The treatments for LCHAD deficiency include a low-fat, high-carbohydrate diet, avoiding fasting, and supplementation with medium-chain triglycerides.""]","[""Treatment for long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency includes avoiding fasting, a low-fat diet, and supplementation with medium-chain triglycerides.""]","[""Treatment for LCHAD includes dietary management, avoiding fasting, supplementation with medium-chain triglycerides, and in severe cases, liver transplantation.""]",[true],[true],[true],"[""Treatment for LCHAD deficiency includes a low-fat, high-carbohydrate diet, avoiding fasting, and supplementation with medium-chain triglycerides.""]","[""Treatment for long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency includes avoiding fasting, a low-fat diet, and supplementation with medium-chain triglycerides.""]","[""Treatment for LCHAD includes dietary management, avoiding fasting, supplementation with medium-chain triglycerides, and in severe cases, liver transplantation.""]",[true],[true],[true],"[""Treatment for LCHAD deficiency includes dietary management, avoiding fasting, supplementation with medium-chain triglycerides, and in some cases, liver transplantation.""]","[""Treatment for long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency includes avoiding fasting, a low-fat diet, and supplementation with medium-chain triglycerides.""]","[""Treatment for LCHAD includes dietary management, avoiding fasting, supplementation with medium-chain triglycerides, and in severe cases, liver transplantation.""]",[true],[true],[true],"[""Treatment for LCHAD deficiency includes a low-fat, high-carbohydrate diet, avoiding fasting, and supplementation with L-carnitine and medium-chain triglycerides.""]","[""Treatment for long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency includes avoiding fasting, a low-fat diet, and supplementation with medium-chain triglycerides.""]","[""Treatment for LCHAD includes dietary management, avoiding fasting, supplementation with medium-chain triglycerides, and in severe cases, liver transplantation.""]"
exams and tests,How to diagnose Fanconi Anemia ?,"People who have Fanconi anemia (FA) are born with the disorder. They may or may not show signs or symptoms of it at birth. For this reason, FA isn't always diagnosed when a person is born. In fact, most people who have the disorder are diagnosed between the ages of 2 and 15 years.
                
The tests used to diagnose FA depend on a person's age and symptoms. In all cases, medical and family histories are an important part of diagnosing FA. However, because FA has many of the same signs and symptoms as other diseases, only genetic testing can confirm its diagnosis.
                
Specialists Involved
                
A geneticist is a doctor or scientist who studies how genes work and how diseases and traits are passed from parents to children through genes.
                
Geneticists do genetic testing for FA. They also can provide counseling about how FA is inherited and the types of prenatal (before birth) testing used to diagnose it.
                
An obstetrician may detect birth defects linked to FA before your child is born. An obstetrician is a doctor who specializes in providing care for pregnant women.
                
After your child is born, a pediatrician also can help find out whether your child has FA. A pediatrician is a doctor who specializes in treating children and teens.
                
A hematologist (blood disease specialist) also may help diagnose FA.
                
Family and Medical Histories
                
FA is an inherited disease. Some parents are aware that their family has a medical history of FA, even if they don't have the disease.
                
Other parents, especially if they're FA carriers, may not be aware of a family history of FA. Many parents may not know that FA can be passed from parents to children.
                
Knowing your family medical history can help your doctor diagnose whether you or your child has FA or another condition with similar symptoms.
                
If your doctor thinks that you, your siblings, or your children have FA, he or she may ask you detailed questions about:
                
Any personal or family history of anemia
                
Any surgeries youve had related to the digestive system
                
Any personal or family history of immune disorders
                
Your appetite, eating habits, and any medicines you take
                
If you know your family has a history of FA, or if your answers to your doctor's questions suggest a possible diagnosis of FA, your doctor will recommend further testing.
                
Diagnostic Tests and Procedures
                
The signs and symptoms of FA aren't unique to the disease. They're also linked to many other diseases and conditions, such as aplastic anemia. For this reason, genetic testing is needed to confirm a diagnosis of FA. Genetic tests for FA include the following.
                
Chromosome Breakage Test
                
This is the most common test for FA. It's available only in special laboratories (labs). It shows whether your chromosomes (long chains of genes) break more easily than normal.
                
Skin cells sometimes are used for the test. Usually, though, a small amount of blood is taken from a vein in your arm using a needle. A technician combines some of the blood cells with certain chemicals.
                
If you have FA, the chromosomes in your blood sample break and rearrange when mixed with the test chemicals. This doesn't happen in the cells of people who don't have FA.
                
Cytometric Flow Analysis
                
Cytometric flow analysis, or CFA, is done in a lab. This test examines how chemicals affect your chromosomes as your cells grow and divide. Skin cells are used for this test.
                
A technician mixes the skin cells with chemicals that can cause the chromosomes in the cells to act abnormally. If you have FA, your cells are much more sensitive to these chemicals.
                
The chromosomes in your skin cells will break at a high rate during the test. This doesn't happen in the cells of people who don't have FA.
                
Mutation Screening
                
A mutation is an abnormal change in a gene or genes. Geneticists and other specialists can examine your genes, usually using a sample of your skin cells. With special equipment and lab processes, they can look for gene mutations that are linked to FA.
                
Diagnosing Different Age Groups
                
Before Birth (Prenatal)
                
If your family has a history of FA and you get pregnant, your doctor may want to test you or your fetus for FA.
                
Two tests can be used to diagnose FA in a developing fetus: amniocentesis (AM-ne-o-sen-TE-sis) and chorionic villus (ko-re-ON-ik VIL-us) sampling (CVS). Both tests are done in a doctor's office or hospital.
                
Amniocentesis is done 15 to 18 weeks after a pregnant woman's last period. A doctor uses a needle to remove a small amount of fluid from the sac around the fetus. A technician tests chromosomes (chains of genes) from the fluid sample to see whether they have faulty genes associated with FA.
                
CVS is done 10 to 12 weeks after a pregnant woman's last period. A doctor inserts a thin tube through the vagina and cervix to the placenta (the temporary organ that connects the fetus to the mother).
                
The doctor removes a tissue sample from the placenta using gentle suction. The tissue sample is sent to a lab to be tested for genetic defects associated with FA.
                
At Birth
                
Three out of four people who inherit FA are born with birth defects. If your baby is born with certain birth defects, your doctor may recommend genetic testing to confirm a diagnosis of FA.
                
For more information about these defects, go to What Are the Signs and Symptoms of Fanconi Anemia?
                
Childhood and Later
                
Some people who have FA are not born with birth defects. Doctors may not diagnose them with the disorder until signs of bone marrow failure or cancer occur. This usually happens within the first 10 years of life.
                
Signs of bone marrow failure most often begin between the ages of 3 and 12 years, with 7 to 8 years as the most common ages. However, 10 percent of children who have FA aren't diagnosed until after 16 years of age.
                
If your bone marrow is failing, you may have signs of aplastic anemia. FA is one type of aplastic anemia.
                
In aplastic anemia, your bone marrow stops making or doesn't make enough of all three types of blood cells: red blood cells, white blood cells, and platelets.
                
Aplastic anemia can be inherited or acquired after birth through exposure to chemicals, radiation, or medicines.
                
Doctors diagnose aplastic anemia using:
                
Family and medical histories and a physical exam.
                
A complete blood count (CBC) to check the number, size, and condition of your red blood cells. The CBC also checks numbers of white blood cells and platelets.
                
A reticulocyte (re-TIK-u-lo-site) count. This test counts the number of new red blood cells in your blood to see whether your bone marrow is making red blood cells at the proper rate.
                
Bone marrow tests. For a bone marrow aspiration, a small amount of liquid bone marrow is removed and tested to see whether it's making enough blood cells. For a bone marrow biopsy, a small amount of bone marrow tissue is removed and tested to see whether it's making enough blood cells.
                
If you or your child is diagnosed with aplastic anemia, your doctor will want to find the cause. If your doctor suspects you have FA, he or she may recommend genetic testing.
                
For more information, go to the Health Topics Aplastic Anemia article.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""FA"", ""full_form"": ""Fanconi Anemia""}]}",How to diagnose FA ?,How to diagnose Fanconi Anemia ?,8,MEDICAL,Compound Datatype-String,"Instructional: Queries specifically seeking step-by-step guidance, instructions, or procedures to perform a task. it focuses on 'how' to do something rather than 'what', 'why', or 'which'.","[[""Firma"", ""Family And"", ""Frequently Asked"", ""Football Association"", ""Fine Arts"", ""First Aid"", ""Free Agent"", ""ForeArm"", ""Field Artillery"", ""Failure Analysis""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Friedreich's Ataxia""]",[6.156358845907349e-16],[2.7032059393665187e-21],"[""First Aid""]",[1.5484936331860842e-06],"[""ABBREVIATIONS""]","[[9.448017921411347e-09, 6.008135132885429e-08, 1.2292719371891163e-08, 2.9101000377306724e-08, 8.527416004129863e-10, 1.5484936331860842e-06, 3.2830279752790824e-10, 9.44130396493421e-07, 2.887047041885242e-11, 4.20110353545123e-10]]",[0.7915362880366866],[0.7718039268306904],"[""Family And""]",[0.8805386186029073],"[""ABBREVIATIONS""]","[[0.8657727106703472, 0.8402383590046215, 0.8805386186029073, 0.7782077523693056, 0.7768316555501489, 0.8533537057921967, 0.7822787879490172, 0.794812466183028, 0.68194088113196, 0.8157822223580997]]","[""First Aid""]","[""ABBREVIATIONS""]",How to diagnose FA (Friedreich's Ataxia) ?,[false],[true],[false],"[""Diagnosing FA involves assessing the person's condition, checking for responsiveness, breathing, and circulation, and providing appropriate first aid based on the specific injury or illness.""]","[""Fanconi Anemia can be diagnosed through a series of tests including blood tests, genetic testing, bone marrow biopsy, and chromosome breakage tests.""]","[""Friedreich's ataxia (FA) can be diagnosed through a combination of genetic testing, physical examination, and neurological assessments. A genetic test to identify the GAA repeat expansion in the FXN gene is usually the primary method of diagnosis.""]",[false],[true],[false],"[""To diagnose FA (First Aid), assess the situation, check for responsiveness, call for emergency help, and provide appropriate first aid treatment based on the specific injury or condition.""]","[""Fanconi Anemia can be diagnosed through a series of tests including blood tests, genetic testing, bone marrow biopsy, and chromosome breakage tests.""]","[""Friedreich's ataxia (FA) can be diagnosed through genetic testing to identify the presence of a mutation in the FXN gene, along with physical examination, neurological evaluation, and imaging studies such as MRI to assess the spinal cord and brain.""]",[false],[true],[false],"[""Diagnosing FA involves assessing the person's condition, checking for responsiveness, breathing, and circulation, and providing appropriate first aid based on the situation.""]","[""Fanconi Anemia can be diagnosed through a series of tests including blood tests, genetic testing, bone marrow biopsy, and chromosome breakage tests.""]","[""Friedreich's ataxia (FA) can be diagnosed through genetic testing to identify the presence of mutations in the FXN gene, along with physical examination, neurological evaluation, and imaging studies such as MRI to assess the extent of neurological damage.""]",[false],[true],[false],"[""Diagnosing FA involves assessing the person's condition, checking for responsiveness, breathing, and circulation, and providing appropriate first aid based on the specific injury or illness.""]","[""Diagnosis of Fanconi Anemia involves physical examination, blood tests, genetic testing, and bone marrow biopsy.""]","[""Friedreich's ataxia (FA) can be diagnosed through genetic testing to identify the presence of mutations in the FXN gene, along with physical examination, neurological evaluation, and imaging studies such as MRI to assess the spinal cord and brain.""]",[false],[true],[false],"[""Diagnosing FA involves genetic testing to identify mutations in the frataxin (FXN) gene, neurological examination, electromyography (EMG), nerve conduction studies, and imaging tests such as MRI.""]","[""Fanconi Anemia can be diagnosed through a series of tests including blood tests, genetic testing, bone marrow biopsy, and chromosome breakage tests.""]","[""Friedreich's ataxia (FA) can be diagnosed through a combination of genetic testing, physical examination, and neurological assessments. A genetic test to identify the GAA repeat expansion in the FXN gene is usually the primary method of diagnosis.""]",[false],[true],[false],"[""Diagnosing FA involves genetic testing to identify mutations in the frataxin (FXN) gene, neurological examination, electromyography (EMG), nerve conduction studies, and imaging tests such as MRI.""]","[""Fanconi Anemia can be diagnosed through a series of tests including blood tests, genetic testing, bone marrow biopsy, and chromosome breakage tests.""]","[""Friedreich's ataxia (FA) can be diagnosed through genetic testing to identify the presence of a mutation in the FXN gene, along with physical examination, neurological evaluation, and imaging studies such as MRI to assess the spinal cord and brain.""]",[false],[true],[false],"[""Diagnosing FA involves genetic testing to identify mutations in the frataxin gene, neurological examination, electromyography, and nerve conduction studies.""]","[""Fanconi Anemia can be diagnosed through a series of tests including blood tests, genetic testing, bone marrow biopsy, and chromosome breakage tests.""]","[""Friedreich's ataxia (FA) can be diagnosed through genetic testing to identify the presence of mutations in the FXN gene, along with physical examination, neurological evaluation, and imaging studies such as MRI to assess the extent of neurological damage.""]",[false],[true],[false],"[""Diagnosing FA involves a thorough physical examination, genetic testing, and possibly nerve conduction studies and imaging tests.""]","[""Diagnosis of Fanconi Anemia involves physical examination, blood tests, genetic testing, and bone marrow biopsy.""]","[""Friedreich's ataxia (FA) can be diagnosed through genetic testing to identify the presence of mutations in the FXN gene, along with physical examination, neurological evaluation, and imaging studies such as MRI to assess the spinal cord and brain.""]",[false],[true],[false],"[""Diagnosing FA involves assessing the person's condition, checking for responsiveness, breathing, and circulation, and providing appropriate first aid based on the situation.""]","[""Fanconi Anemia can be diagnosed through a series of tests including blood tests, genetic testing, bone marrow biopsy, and chromosome breakage tests.""]","[""Friedreich's ataxia (FA) can be diagnosed through genetic testing to identify the presence of a mutation in the FXN gene, along with physical examination, neurological evaluation, and imaging studies such as MRI to assess the spinal cord and brain.""]",[false],[true],[false],"[""To diagnose FA (First Aid), assess the situation, check for responsiveness, call for help, and provide appropriate first aid treatment based on the specific injury or condition.""]","[""Fanconi Anemia can be diagnosed through a series of tests including blood tests, genetic testing, bone marrow biopsy, and chromosome breakage tests.""]","[""Friedreich's ataxia (FA) can be diagnosed through a combination of genetic testing, physical examination, and neurological assessments. A genetic test to identify the GAA repeat expansion in the FXN gene is usually the primary method of diagnosis.""]",[false],[true],[false],"[""To diagnose FA (First Aid), assess the situation, check for responsiveness, call for help, check for breathing, and provide appropriate first aid treatment based on the specific injury or condition.""]","[""Fanconi Anemia can be diagnosed through a series of tests including blood tests, genetic testing, bone marrow biopsy, and chromosome breakage tests.""]","[""Friedreich's ataxia (FA) can be diagnosed through genetic testing to identify the presence of mutations in the FXN gene, along with physical examination, neurological evaluation, and imaging studies such as MRI to assess the extent of neurological damage.""]",[false],[true],[false],"[""Diagnosing FA involves assessing the person's condition, checking for responsiveness, breathing, and circulation, and providing appropriate first aid based on the specific injury or illness.""]","[""Diagnosis of Fanconi Anemia involves physical examination, blood tests, genetic testing, and bone marrow biopsy.""]","[""Friedreich's ataxia (FA) can be diagnosed through genetic testing to identify the presence of mutations in the FXN gene, along with physical examination, neurological evaluation, and imaging studies such as MRI to assess the spinal cord and brain.""]",[false],[true],[false],"[""Diagnosing FA involves assessing the situation, checking for responsiveness, breathing, and circulation, and providing appropriate first aid treatment.""]","[""Fanconi Anemia can be diagnosed through a series of tests including blood tests, genetic testing, bone marrow biopsy, and chromosome breakage tests.""]","[""Friedreich's ataxia (FA) can be diagnosed through a combination of genetic testing, physical examination, and neurological assessments. A genetic test to identify the GAA repeat expansion in the FXN gene is usually the primary method of diagnosis.""]",[false],[true],[false],"[""Diagnosing FA involves assessing the person's condition, checking for responsiveness, breathing, and circulation, and providing appropriate first aid based on the situation.""]","[""Fanconi Anemia can be diagnosed through a series of tests including blood tests, genetic testing, bone marrow biopsy, and chromosome breakage tests.""]","[""Friedreich's ataxia (FA) can be diagnosed through genetic testing to identify the presence of a mutation in the FXN gene, along with physical examination, neurological evaluation, and imaging studies such as MRI to assess the spinal cord and brain.""]",[false],[true],[false],"[""Diagnosing FA involves assessing the situation, checking for responsiveness, breathing, and circulation, and providing appropriate first aid based on the specific injury or condition.""]","[""Fanconi Anemia can be diagnosed through a series of tests including blood tests, genetic testing, bone marrow biopsy, and chromosome breakage tests.""]","[""Friedreich's ataxia (FA) can be diagnosed through genetic testing to identify the presence of mutations in the FXN gene, along with physical examination, neurological evaluation, and imaging studies such as MRI to assess the extent of neurological damage.""]",[false],[true],[false],"[""Diagnosing FA involves assessing the situation, checking for responsiveness, breathing, and circulation, and providing appropriate first aid based on the specific injury or condition.""]","[""Diagnosis of Fanconi Anemia involves physical examination, blood tests, genetic testing, and bone marrow biopsy.""]","[""Friedreich's ataxia (FA) can be diagnosed through genetic testing to identify the presence of mutations in the FXN gene, along with physical examination, neurological evaluation, and imaging studies such as MRI to assess the spinal cord and brain.""]",[false],[true],[false],"[""Diagnosing FA involves assessing the situation, checking for responsiveness, breathing, and circulation, and providing appropriate first aid based on the specific injury or condition.""]","[""Fanconi Anemia can be diagnosed through a series of tests including blood tests, genetic testing, bone marrow biopsy, and chromosome breakage tests.""]","[""Friedreich's ataxia (FA) can be diagnosed through a combination of genetic testing, physical examination, and neurological assessments. A genetic test to identify the GAA repeat expansion in the FXN gene is usually the primary method of diagnosis.""]",[false],[true],[false],"[""Diagnosing FA involves assessing the person's condition, checking for responsiveness, breathing, and circulation, and providing appropriate first aid based on the specific injury or illness.""]","[""Fanconi Anemia can be diagnosed through a series of tests including blood tests, genetic testing, bone marrow biopsy, and chromosome breakage tests.""]","[""Friedreich's ataxia (FA) can be diagnosed through genetic testing to identify the presence of a mutation in the FXN gene, along with physical examination, neurological evaluation, and imaging studies such as MRI to assess the spinal cord and brain.""]",[false],[true],[false],"[""Diagnosing FA involves assessing the person's condition, checking for responsiveness, breathing, and circulation, and providing appropriate first aid based on the specific injury or illness.""]","[""Fanconi Anemia can be diagnosed through a series of tests including blood tests, genetic testing, bone marrow biopsy, and chromosome breakage tests.""]","[""Friedreich's ataxia (FA) can be diagnosed through genetic testing to identify the presence of mutations in the FXN gene, along with physical examination, neurological evaluation, and imaging studies such as MRI to assess the extent of neurological damage.""]",[false],[true],[false],"[""To diagnose FA (First Aid), assess the situation, check for responsiveness, call for help, check for breathing, and provide appropriate first aid based on the specific injury or condition.""]","[""Diagnosis of Fanconi Anemia involves physical examination, blood tests, genetic testing, and bone marrow biopsy.""]","[""Friedreich's ataxia (FA) can be diagnosed through genetic testing to identify the presence of mutations in the FXN gene, along with physical examination, neurological evaluation, and imaging studies such as MRI to assess the spinal cord and brain.""]",[false],[true],[false],"[""Diagnosing Friedreich's Ataxia involves a combination of physical examination, genetic testing, and neurological tests such as MRI and nerve conduction studies.""]","[""Fanconi Anemia can be diagnosed through a series of tests including blood tests, genetic testing, bone marrow biopsy, and chromosome breakage tests.""]","[""Friedreich's ataxia (FA) can be diagnosed through a combination of genetic testing, physical examination, and neurological assessments. A genetic test to identify the GAA repeat expansion in the FXN gene is usually the primary method of diagnosis.""]",[false],[true],[false],"[""Diagnosing Friedreich's Ataxia typically involves a combination of physical examination, genetic testing, neurological evaluation, and imaging studies.""]","[""Fanconi Anemia can be diagnosed through a series of tests including blood tests, genetic testing, bone marrow biopsy, and chromosome breakage tests.""]","[""Friedreich's ataxia (FA) can be diagnosed through genetic testing to identify the presence of a mutation in the FXN gene, along with physical examination, neurological evaluation, and imaging studies such as MRI to assess the spinal cord and brain.""]",[false],[true],[false],"[""Diagnosing Friedreich's Ataxia typically involves a combination of genetic testing, physical examination, neurological evaluation, and imaging studies.""]","[""Fanconi Anemia can be diagnosed through a series of tests including blood tests, genetic testing, bone marrow biopsy, and chromosome breakage tests.""]","[""Friedreich's ataxia (FA) can be diagnosed through genetic testing to identify the presence of mutations in the FXN gene, along with physical examination, neurological evaluation, and imaging studies such as MRI to assess the extent of neurological damage.""]",[false],[true],[false],"[""Diagnosing Friedreich's Ataxia involves genetic testing to identify the presence of the GAA repeat expansion in the FXN gene, along with clinical evaluation of symptoms such as ataxia, muscle weakness, and loss of coordination.""]","[""Diagnosis of Fanconi Anemia involves physical examination, blood tests, genetic testing, and bone marrow biopsy.""]","[""Friedreich's ataxia (FA) can be diagnosed through genetic testing to identify the presence of mutations in the FXN gene, along with physical examination, neurological evaluation, and imaging studies such as MRI to assess the spinal cord and brain.""]",[false],[true],[false],"[""To diagnose FA (First Aid), assess the situation, check for responsiveness, call for help, check the airway, breathing, and circulation, and provide appropriate first aid treatment based on the specific injury or condition.""]","[""Fanconi Anemia can be diagnosed through a series of tests including blood tests, genetic testing, bone marrow biopsy, and chromosome breakage tests.""]","[""Friedreich's ataxia (FA) can be diagnosed through a combination of genetic testing, physical examination, and neurological assessments. A genetic test to identify the GAA repeat expansion in the FXN gene is usually the primary method of diagnosis.""]",[false],[true],[false],"[""To diagnose FA (First Aid), assess the situation, check for responsiveness, call for help, and provide appropriate first aid treatment based on the specific injury or condition.""]","[""Fanconi Anemia can be diagnosed through a series of tests including blood tests, genetic testing, bone marrow biopsy, and chromosome breakage tests.""]","[""Friedreich's ataxia (FA) can be diagnosed through genetic testing to identify the presence of a mutation in the FXN gene, along with physical examination, neurological evaluation, and imaging studies such as MRI to assess the spinal cord and brain.""]",[false],[true],[false],"[""Diagnosing FA (First Aid) involves assessing the situation, checking for responsiveness, breathing, and circulation, and providing appropriate care based on the specific injury or medical condition.""]","[""Fanconi Anemia can be diagnosed through a series of tests including blood tests, genetic testing, bone marrow biopsy, and chromosome breakage tests.""]","[""Friedreich's ataxia (FA) can be diagnosed through genetic testing to identify the presence of mutations in the FXN gene, along with physical examination, neurological evaluation, and imaging studies such as MRI to assess the extent of neurological damage.""]",[false],[true],[false],"[""To diagnose FA (First Aid), assess the situation for any immediate dangers, check the person's responsiveness, call emergency services if needed, and perform a primary survey to identify any life-threatening conditions.""]","[""Diagnosis of Fanconi Anemia involves physical examination, blood tests, genetic testing, and bone marrow biopsy.""]","[""Friedreich's ataxia (FA) can be diagnosed through genetic testing to identify the presence of mutations in the FXN gene, along with physical examination, neurological evaluation, and imaging studies such as MRI to assess the spinal cord and brain.""]",[false],[true],[false],"[""Diagnosing FA (First Aid) involves assessing the situation, checking for responsiveness, breathing, and circulation, and providing appropriate first aid treatment based on the specific injury or condition.""]","[""Fanconi Anemia can be diagnosed through a series of tests including blood tests, genetic testing, bone marrow biopsy, and chromosome breakage tests.""]","[""Friedreich's ataxia (FA) can be diagnosed through a combination of genetic testing, physical examination, and neurological assessments. A genetic test to identify the GAA repeat expansion in the FXN gene is usually the primary method of diagnosis.""]",[false],[true],[false],"[""Diagnosing FA (First Aid) involves assessing the situation, checking for responsiveness, breathing, and circulation, and providing appropriate first aid treatment based on the specific injury or condition.""]","[""Fanconi Anemia can be diagnosed through a series of tests including blood tests, genetic testing, bone marrow biopsy, and chromosome breakage tests.""]","[""Friedreich's ataxia (FA) can be diagnosed through a combination of genetic testing, physical examination, and neurological assessments. A genetic test to identify the GAA repeat expansion in the FXN gene is usually the primary method of diagnosis.""]",[false],[true],[false],"[""Diagnosing FA (Family And) involves a thorough medical history, physical examination, and possibly genetic testing.""]","[""Fanconi Anemia can be diagnosed through a series of tests including blood tests, genetic testing, bone marrow biopsy, and chromosome breakage tests.""]","[""Friedreich's ataxia (FA) can be diagnosed through a combination of genetic testing, physical examination, and neurological assessments. A genetic test to identify the GAA repeat expansion in the FXN gene is usually the primary method of diagnosis.""]",[false],[true],[false],"[""Diagnosing Friedreich's Ataxia typically involves genetic testing to identify the presence of the GAA repeat expansion in the FXN gene, along with physical examination, neurological evaluation, and imaging studies.""]","[""Fanconi Anemia can be diagnosed through a series of tests including blood tests, genetic testing, bone marrow biopsy, and chromosome breakage tests.""]","[""Friedreich's ataxia (FA) can be diagnosed through a combination of genetic testing, physical examination, and neurological assessments. A genetic test to identify the GAA repeat expansion in the FXN gene is usually the primary method of diagnosis.""]"
symptoms,What are the symptoms of Osteopetrosis autosomal recessive 2 ?,"What are the signs and symptoms of Osteopetrosis autosomal recessive 2? The Human Phenotype Ontology provides the following list of signs and symptoms for Osteopetrosis autosomal recessive 2. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Anemia - Autosomal recessive inheritance - Blindness - Carious teeth - Chronic rhinitis due to narrow nasal airway - Cranial hyperostosis - Diaphyseal sclerosis - Extramedullary hematopoiesis - Facial paralysis - Genu valgum - Hepatosplenomegaly - Mandibular osteomyelitis - Mandibular prognathia - Optic atrophy - Osteopetrosis - Pancytopenia - Persistence of primary teeth - Recurrent fractures - Thrombocytopenia - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""OPTB2"", ""full_form"": ""Osteopetrosis autosomal recessive 2""}]}",What are the symptoms of OPTB2 ?,What are the symptoms of Osteopetrosis autosomal recessive 2 ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.",[[]],[[]],"[""Opticin Binding Protein 2""]",[1.0046953697397114e-31],[2.9564379074956482e-21],"[""Opticin Binding Protein 2""]",[2.9564379074956482e-21],"[""LLM""]",[[]],[0.7096000745113757],[0.8114720284623678],"[""Osteopetrosis autosomal recessive 2""]",[0.8114720284623678],"[""LLM""]",[[]],"[""Opticin Binding Protein 2""]","[""LLM""]",What are the symptoms of OPTB2 (Opticin Binding Protein 2) ?,[false],[true],[false],"[""Common symptoms of OPTB2 include vision problems, eye pain, and sensitivity to light.""]","[""Symptoms of Osteopetrosis autosomal recessive 2 include frequent infections, vision problems, anemia, bone fractures, and delayed growth.""]","[""Symptoms of OPTB2 include vision problems, muscle weakness, and difficulty swallowing.""]",[false],[true],[false],"[""Symptoms of OPTB2 may include vision problems, eye pain, and sensitivity to light.""]","[""Symptoms of Osteopetrosis autosomal recessive 2 include frequent infections, vision problems, bone fractures, and anemia.""]","[""Symptoms of OPTB2 include muscle weakness, vision problems, and difficulty swallowing.""]",[false],[true],[false],"[""Symptoms of OPTB2 include vision problems, retinal degeneration, and possible blindness.""]","[""Symptoms of Osteopetrosis autosomal recessive 2 include frequent fractures, bone pain, anemia, vision problems, and recurrent infections.""]","[""Symptoms of OPTB2 include vision loss, difficulty with color vision, and problems with night vision.""]",[false],[true],[false],"[""The symptoms of OPTB2 include vision problems, eye pain, and sensitivity to light.""]","[""Symptoms of Osteopetrosis autosomal recessive 2 include frequent fractures, vision problems, hearing loss, and anemia.""]","[""Symptoms of OPTB2 include vision loss, muscle weakness, and difficulty coordinating movements.""]",[true],[true],[false],"[""Symptoms of OPTB2 include frequent fractures, bone pain, anemia, vision problems, and recurrent infections.""]","[""Symptoms of Osteopetrosis autosomal recessive 2 include frequent infections, vision problems, anemia, bone fractures, and delayed growth.""]","[""Symptoms of OPTB2 include vision problems, muscle weakness, and difficulty swallowing.""]",[true],[true],[false],"[""Symptoms of OPTB2 include fractures, vision problems, anemia, and recurrent infections.""]","[""Symptoms of Osteopetrosis autosomal recessive 2 include frequent infections, vision problems, bone fractures, and anemia.""]","[""Symptoms of OPTB2 include muscle weakness, vision problems, and difficulty swallowing.""]",[true],[true],[false],"[""Symptoms of OPTB2 include fractures, vision problems, anemia, and recurrent infections.""]","[""Symptoms of Osteopetrosis autosomal recessive 2 include frequent fractures, bone pain, anemia, vision problems, and recurrent infections.""]","[""Symptoms of OPTB2 include vision loss, difficulty with color vision, and problems with night vision.""]",[true],[true],[false],"[""Symptoms of OPTB2 include bone fractures, anemia, vision problems, and recurrent infections.""]","[""Symptoms of Osteopetrosis autosomal recessive 2 include frequent fractures, vision problems, hearing loss, and anemia.""]","[""Symptoms of OPTB2 include vision loss, muscle weakness, and difficulty coordinating movements.""]",[false],[true],[false],"[""Symptoms of OPTB2 may include visual impairment, retinal detachment, and abnormal eye movements.""]","[""Symptoms of Osteopetrosis autosomal recessive 2 include frequent infections, vision problems, bone fractures, and anemia.""]","[""Symptoms of OPTB2 include muscle weakness, vision problems, and difficulty swallowing.""]",[false],[true],[false],"[""Some symptoms of OPTB2 include vision problems, eye abnormalities, and retinal degeneration.""]","[""Symptoms of Osteopetrosis autosomal recessive 2 include frequent infections, vision problems, anemia, bone fractures, and delayed growth.""]","[""Symptoms of OPTB2 include vision problems, muscle weakness, and difficulty swallowing.""]",[false],[true],[false],"[""Symptoms of OPTB2 include vision problems, retinal degeneration, and potential blindness.""]","[""Symptoms of Osteopetrosis autosomal recessive 2 include frequent fractures, bone pain, anemia, vision problems, and recurrent infections.""]","[""Symptoms of OPTB2 include vision loss, difficulty with color vision, and problems with night vision.""]",[false],[true],[false],"[""Symptoms of OPTB2 may include vision problems, eye pain, and sensitivity to light.""]","[""Symptoms of Osteopetrosis autosomal recessive 2 include frequent fractures, vision problems, hearing loss, and anemia.""]","[""Symptoms of OPTB2 include vision loss, muscle weakness, and difficulty coordinating movements.""]",[false],[true],[false],"[""Symptoms of OPTB2 may include vision problems, eye pain, and sensitivity to light.""]","[""Symptoms of Osteopetrosis autosomal recessive 2 include frequent infections, vision problems, anemia, bone fractures, and delayed growth.""]","[""Symptoms of OPTB2 include vision problems, muscle weakness, and difficulty swallowing.""]",[false],[true],[false],"[""Symptoms of OPTB2 may include vision problems, eye pain, and changes in color vision.""]","[""Symptoms of Osteopetrosis autosomal recessive 2 include frequent infections, vision problems, bone fractures, and anemia.""]","[""Symptoms of OPTB2 include muscle weakness, vision problems, and difficulty swallowing.""]",[false],[true],[false],"[""Symptoms of OPTB2 include vision problems, eye pain, and sensitivity to light.""]","[""Symptoms of Osteopetrosis autosomal recessive 2 include frequent fractures, bone pain, anemia, vision problems, and recurrent infections.""]","[""Symptoms of OPTB2 include vision loss, difficulty with color vision, and problems with night vision.""]",[false],[true],[false],"[""Symptoms of OPTB2 include vision problems, eye pain, and sensitivity to light.""]","[""Symptoms of Osteopetrosis autosomal recessive 2 include frequent fractures, vision problems, hearing loss, and anemia.""]","[""Symptoms of OPTB2 include vision loss, muscle weakness, and difficulty coordinating movements.""]",[false],[true],[false],"[""Symptoms of OPTB2 are not well-documented as it is a relatively new protein and research is ongoing.""]","[""Symptoms of Osteopetrosis autosomal recessive 2 include frequent infections, vision problems, anemia, bone fractures, and delayed growth.""]","[""Symptoms of OPTB2 include vision problems, muscle weakness, and difficulty swallowing.""]",[false],[true],[false],"[""Symptoms of OPTB2 include vision problems, eye pain, and sensitivity to light.""]","[""Symptoms of Osteopetrosis autosomal recessive 2 include frequent infections, vision problems, bone fractures, and anemia.""]","[""Symptoms of OPTB2 include muscle weakness, vision problems, and difficulty swallowing.""]",[false],[true],[false],"[""Symptoms of OPTB2 include vision problems, eye pain, and sensitivity to light.""]","[""Symptoms of Osteopetrosis autosomal recessive 2 include frequent fractures, bone pain, anemia, vision problems, and recurrent infections.""]","[""Symptoms of OPTB2 include vision loss, difficulty with color vision, and problems with night vision.""]",[false],[true],[false],"[""The symptoms of OPTB2 (Opticin Binding Protein 2) include vision problems, retinal abnormalities, and potential blindness.""]","[""Symptoms of Osteopetrosis autosomal recessive 2 include frequent fractures, vision problems, hearing loss, and anemia.""]","[""Symptoms of OPTB2 include vision loss, muscle weakness, and difficulty coordinating movements.""]",[false],[true],[false],"[""Symptoms of OPTB2 include vision problems, retinal abnormalities, and potential blindness.""]","[""Symptoms of Osteopetrosis autosomal recessive 2 include frequent infections, vision problems, anemia, bone fractures, and delayed growth.""]","[""Symptoms of OPTB2 include vision problems, muscle weakness, and difficulty swallowing.""]",[false],[true],[false],"[""The symptoms of OPTB2 (Opticin Binding Protein 2) include vision problems, retinal degeneration, and potential blindness.""]","[""Symptoms of Osteopetrosis autosomal recessive 2 include frequent infections, vision problems, bone fractures, and anemia.""]","[""Symptoms of OPTB2 include muscle weakness, vision problems, and difficulty swallowing.""]",[false],[true],[false],"[""The symptoms of OPTB2 (Opticin Binding Protein 2) include vision problems, retinal abnormalities, and potential blindness.""]","[""Symptoms of Osteopetrosis autosomal recessive 2 include frequent fractures, bone pain, anemia, vision problems, and recurrent infections.""]","[""Symptoms of OPTB2 include vision loss, difficulty with color vision, and problems with night vision.""]",[false],[true],[false],"[""Symptoms of OPTB2 may include vision problems, eye pain, and sensitivity to light.""]","[""Symptoms of Osteopetrosis autosomal recessive 2 include frequent fractures, vision problems, hearing loss, and anemia.""]","[""Symptoms of OPTB2 include vision loss, muscle weakness, and difficulty coordinating movements.""]",[false],[true],[false],"[""The symptoms of OPTB2 (Opticin Binding Protein 2) are not well-documented as it is a relatively new protein and further research is needed to understand its role in health and disease.""]","[""Symptoms of Osteopetrosis autosomal recessive 2 include frequent infections, vision problems, anemia, bone fractures, and delayed growth.""]","[""Symptoms of OPTB2 include vision problems, muscle weakness, and difficulty swallowing.""]",[false],[true],[false],"[""The symptoms of OPTB2 (Opticin Binding Protein 2) are not well-documented as it is a relatively new protein and research is ongoing.""]","[""Symptoms of Osteopetrosis autosomal recessive 2 include frequent infections, vision problems, bone fractures, and anemia.""]","[""Symptoms of OPTB2 include muscle weakness, vision problems, and difficulty swallowing.""]",[false],[true],[false],"[""The symptoms of OPTB2 (Opticin Binding Protein 2) are not well-documented as it is a relatively new protein and research is ongoing.""]","[""Symptoms of Osteopetrosis autosomal recessive 2 include frequent fractures, bone pain, anemia, vision problems, and recurrent infections.""]","[""Symptoms of OPTB2 include vision loss, difficulty with color vision, and problems with night vision.""]",[false],[true],[false],"[""The symptoms of OPTB2 (Opticin Binding Protein 2) are not well-documented as it is a relatively new protein and research is ongoing.""]","[""Symptoms of Osteopetrosis autosomal recessive 2 include frequent fractures, vision problems, hearing loss, and anemia.""]","[""Symptoms of OPTB2 include vision loss, muscle weakness, and difficulty coordinating movements.""]",[false],[true],[false],"[""The symptoms of OPTB2 are not well-defined as it is a relatively new protein and research is ongoing.""]","[""Symptoms of Osteopetrosis autosomal recessive 2 include frequent infections, vision problems, anemia, bone fractures, and delayed growth.""]","[""Symptoms of OPTB2 include vision problems, muscle weakness, and difficulty swallowing.""]",[false],[true],[false],"[""The symptoms of OPTB2 (Opticin Binding Protein 2) are not well-defined as it is a relatively new area of research.""]","[""Symptoms of Osteopetrosis autosomal recessive 2 include frequent infections, vision problems, anemia, bone fractures, and delayed growth.""]","[""Symptoms of OPTB2 include vision problems, muscle weakness, and difficulty swallowing.""]",[true],[true],[false],"[""Symptoms of OPTB2 include fractures, bone pain, anemia, vision problems, and frequent infections.""]","[""Symptoms of Osteopetrosis autosomal recessive 2 include frequent infections, vision problems, anemia, bone fractures, and delayed growth.""]","[""Symptoms of OPTB2 include vision problems, muscle weakness, and difficulty swallowing.""]",[false],[true],[false],"[""The symptoms of OPTB2 (Opticin Binding Protein 2) are not well-documented as it is a relatively new discovery in the field of genetics.""]","[""Symptoms of Osteopetrosis autosomal recessive 2 include frequent infections, vision problems, anemia, bone fractures, and delayed growth.""]","[""Symptoms of OPTB2 include vision problems, muscle weakness, and difficulty swallowing.""]"
treatment,What are the treatments for Acanthamoeba - Granulomatous Amebic Encephalitis; Keratitis ?,"Early diagnosis is essential for effective treatment of Acanthamoeba keratitis. Several prescription eye medications are available for treatment. However, the infection can be difficult to treat. The best treatment regimen for each patient should be determined by an eye doctor. If you suspect your eye may be infected with Acanthamoeba, see an eye doctor immediately.
    
Skin infections that are caused by Acanthamoeba but have not spread to the central nervous system can be successfully treated. Because this is a serious infection and the people affected typically have weakened immune systems, early diagnosis offers the best chance at cure.
    
Most cases of brain and spinal cord infection with Acanthamoeba (Granulomatous Amebic Encephalitis) are fatal.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""GAE"", ""full_form"": ""Granulomatous Amebic Encephalitis""}]}",What are the treatments for Acanthamoeba - GAE; Keratitis ?,What are the treatments for Acanthamoeba - Granulomatous Amebic Encephalitis; Keratitis ?,0,SCIENCE,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Georgia Association of Educators"", ""Go Ahead Eagles"", ""Gaelic (Scots)"", ""Gabes, Tunisia"", ""Grupo Anticomunista Espa\u00f1ol"", ""Gallic Acid Equivalent"", ""Gallic Acid Equivalents"", ""Granulomatous Amoebic Encephalitis"", ""German Audio Engineering"", ""Google Apps Engine""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Granulomatous Amebic Encephalitis""]",[7.328352123238094e-22],[7.328352123238094e-22],"[""Gallic Acid Equivalent""]",[1.0680956455695873e-12],"[""ABBREVIATIONS""]","[[3.3545039797857264e-22, 1.695931465070039e-14, 3.1080864009182124e-20, 8.467701943957022e-20, 1.4483301824329481e-33, 1.0680956455695873e-12, 4.2575443797591554e-15, 3.0604060077679916e-22, 8.279506165392878e-16, 1.2163569139015619e-19]]",[0.9635486110437187],[0.9635486110437187],"[""Go Ahead Eagles""]",[0.9650223649120047],"[""ABBREVIATIONS""]","[[0.9352254937382349, 0.9490015913189195, 0.9650223649120047, 0.9370241788671159, 0.9439796658443217, 0.9634013425654144, 0.9571005487999438, 0.9624919805256449, 0.9491951760514377, 0.9479783934837307]]","[""Granulomatous Amoebic Encephalitis""]","[""ABBREVIATIONS""]",What are the treatments for Acanthamoeba - GAE (Granulomatous Amebic Encephalitis); Keratitis ?,[false],[true],[true],"[""The treatments for Acanthamoeba - GAE (Gallic Acid Equivalent) Keratitis include antifungal medications such as propamidine isethionate, chlorhexidine, and polyhexamethylene biguanide (PHMB), as well as supportive therapies like pain management and eye protection.""]","[""The treatments for Acanthamoeba - Granulomatous Amebic Encephalitis include a combination of medications such as pentamidine, sulfadiazine, flucytosine, and others. For Acanthamoeba Keratitis, treatment involves a variety of antifungal and antiprotozoal medications, along with supportive care and sometimes surgical intervention.""]","[""The treatments for Acanthamoeba - GAE include a combination of antifungal medications such as amphotericin B and itraconazole. For Acanthamoeba keratitis, treatment involves a combination of antifungal eye drops, such as polyhexamethylene biguanide (PHMB) and propamidine isethionate, along with supportive care and sometimes surgery.""]",[false],[true],[true],"[""The treatments for Acanthamoeba keratitis include GAE (Gallic Acid Equivalent) and specific antiamoebic drugs.""]","[""For Acanthamoeba - Granulomatous Amebic Encephalitis, treatment typically involves a combination of antimicrobial medications such as pentamidine, sulfadiazine, flucytosine, and others. For Acanthamoeba Keratitis, treatment may include a combination of antifungal and antiamoebic medications, as well as supportive care like eye drops and pain management.""]","[""The treatments for Acanthamoeba - GAE include a combination of antifungal medications such as amphotericin B and itraconazole. For Acanthamoeba keratitis, treatment involves a combination of topical medications like chlorhexidine and propamidine, along with oral medications like voriconazole or itraconazole.""]",[true],[true],[false],"[""Antimicrobial drugs, such as pentamidine and sulfadiazine, are commonly used to treat Acanthamoeba infections like GAE and keratitis.""]","[""For Acanthamoeba - Granulomatous Amebic Encephalitis, treatment involves a combination of antimicrobial medications such as pentamidine, sulfadiazine, flucytosine, and others. For Acanthamoeba Keratitis, treatment includes a variety of medications such as propamidine isethionate, neomycin, chlorhexidine, and others, along with supportive therapies like corneal transplantation in severe cases.""]","[""Antimicrobial therapy, corticosteroids, and surgery""]",[true],[false],[false],"[""The treatments for Acanthamoeba infections such as GAE and Keratitis include medications like chlorhexidine, propamidine isethionate, and polyhexamethylene biguanide (PHMB). In severe cases, surgical intervention may be required.""]","[""Antimicrobial therapy, corticosteroids, and surgical intervention""]","[""Antimicrobial therapy, corticosteroids, and surgery""]",[false],[true],[true],"[""Antimicrobial therapy, corticosteroids, and in severe cases, surgical intervention""]","[""The treatments for Acanthamoeba - Granulomatous Amebic Encephalitis include a combination of medications such as pentamidine, sulfadiazine, flucytosine, and others. For Acanthamoeba Keratitis, treatment involves a variety of antifungal and antiprotozoal medications, along with supportive care and sometimes surgical intervention.""]","[""The treatments for Acanthamoeba - GAE include a combination of antifungal medications such as amphotericin B and itraconazole. For Acanthamoeba keratitis, treatment involves a combination of antifungal eye drops, such as polyhexamethylene biguanide (PHMB) and propamidine isethionate, along with supportive care and sometimes surgery.""]",[false],[true],[true],"[""Antimicrobial therapy, corticosteroids, and surgery""]","[""For Acanthamoeba - Granulomatous Amebic Encephalitis, treatment typically involves a combination of antimicrobial medications such as pentamidine, sulfadiazine, flucytosine, and others. For Acanthamoeba Keratitis, treatment may include a combination of antifungal and antiamoebic medications, as well as supportive care like eye drops and pain management.""]","[""The treatments for Acanthamoeba - GAE include a combination of antifungal medications such as amphotericin B and itraconazole. For Acanthamoeba keratitis, treatment involves a combination of topical medications like chlorhexidine and propamidine, along with oral medications like voriconazole or itraconazole.""]",[false],[true],[false],"[""Antimicrobial therapy, corticosteroids, and surgery are common treatments for Acanthamoeba - GAE and Keratitis.""]","[""For Acanthamoeba - Granulomatous Amebic Encephalitis, treatment involves a combination of antimicrobial medications such as pentamidine, sulfadiazine, flucytosine, and others. For Acanthamoeba Keratitis, treatment includes a variety of medications such as propamidine isethionate, neomycin, chlorhexidine, and others, along with supportive therapies like corneal transplantation in severe cases.""]","[""Antimicrobial therapy, corticosteroids, and surgery""]",[true],[false],[false],"[""The treatments for Acanthamoeba - GAE (Granulomatous Amebic Encephalitis) and Keratitis include antifungal medications, such as propamidine isethionate and chlorhexidine, as well as supportive care and sometimes surgery in severe cases.""]","[""Antimicrobial therapy, corticosteroids, and surgical intervention""]","[""Antimicrobial therapy, corticosteroids, and surgery""]",[true],[true],[true],"[""The treatments for Acanthamoeba - GAE (Granulomatous Amoebic Encephalitis) include a combination of medications such as miltefosine, pentamidine, sulfadiazine, flucytosine, and others. For Acanthamoeba Keratitis, treatment involves a combination of antifungal and antiamoebic medications, along with supportive care like pain management and eye protection.""]","[""For Acanthamoeba - Granulomatous Amebic Encephalitis, treatment typically involves a combination of antimicrobial medications such as pentamidine, sulfadiazine, flucytosine, and others. For Acanthamoeba Keratitis, treatment may include a combination of antifungal and antiamoebic medications, as well as supportive care like eye drops and pain management.""]","[""The treatments for Acanthamoeba - GAE include a combination of antifungal medications such as amphotericin B and itraconazole. For Acanthamoeba keratitis, treatment involves a combination of topical medications like chlorhexidine and propamidine, along with oral medications like voriconazole or itraconazole.""]",[true],[true],[true],"[""The treatments for Acanthamoeba - GAE (Granulomatous Amoebic Encephalitis) include a combination of antimicrobial drugs such as pentamidine, sulfadiazine, flucytosine, and azoles. For Acanthamoeba Keratitis, treatment involves a combination of topical medications like chlorhexidine, propamidine isethionate, and polyhexamethylene biguanide (PHMB), along with supportive care and sometimes surgery.""]","[""The treatments for Acanthamoeba - Granulomatous Amebic Encephalitis include a combination of medications such as pentamidine, sulfadiazine, flucytosine, and others. For Acanthamoeba Keratitis, treatment involves a variety of antifungal and antiprotozoal medications, along with supportive care and sometimes surgical intervention.""]","[""The treatments for Acanthamoeba - GAE include a combination of antifungal medications such as amphotericin B and itraconazole. For Acanthamoeba keratitis, treatment involves a combination of antifungal eye drops, such as polyhexamethylene biguanide (PHMB) and propamidine isethionate, along with supportive care and sometimes surgery.""]",[true],[true],[false],"[""The treatments for Acanthamoeba - GAE (Granulomatous Amoebic Encephalitis) include a combination of antimicrobial drugs such as pentamidine, sulfadiazine, flucytosine, and azoles. For Acanthamoeba Keratitis, treatment involves a combination of antifungal and antiamoebic medications, along with supportive care like pain management and eye protection.""]","[""For Acanthamoeba - Granulomatous Amebic Encephalitis, treatment involves a combination of antimicrobial medications such as pentamidine, sulfadiazine, flucytosine, and others. For Acanthamoeba Keratitis, treatment includes a variety of medications such as propamidine isethionate, neomycin, chlorhexidine, and others, along with supportive therapies like corneal transplantation in severe cases.""]","[""Antimicrobial therapy, corticosteroids, and surgery""]",[true],[false],[false],"[""For Acanthamoeba - GAE (Granulomatous Amoebic Encephalitis), treatments may include a combination of medications such as anti-amoebic drugs like pentamidine, sulfadiazine, flucytosine, and others. For Acanthamoeba Keratitis, treatments may involve antifungal and antiamoebic eye drops, as well as oral medications in severe cases.""]","[""Antimicrobial therapy, corticosteroids, and surgical intervention""]","[""Antimicrobial therapy, corticosteroids, and surgery""]",[true],[true],[true],"[""For Acanthamoeba GAE: Combination therapy with multiple drugs like pentamidine, sulfadiazine, flucytosine, and others. For Acanthamoeba Keratitis: Biguanide antiseptics like polyhexamethylene biguanide (PHMB) or chlorhexidine, along with diamidines like propamidine or hexamidine.""]","[""The treatments for Acanthamoeba - Granulomatous Amebic Encephalitis include a combination of medications such as pentamidine, sulfadiazine, flucytosine, and others. For Acanthamoeba Keratitis, treatment involves a variety of antifungal and antiprotozoal medications, along with supportive care and sometimes surgical intervention.""]","[""The treatments for Acanthamoeba - GAE include a combination of antifungal medications such as amphotericin B and itraconazole. For Acanthamoeba keratitis, treatment involves a combination of antifungal eye drops, such as polyhexamethylene biguanide (PHMB) and propamidine isethionate, along with supportive care and sometimes surgery.""]",[false],[true],[true],"[""Antimicrobial therapy, anti-inflammatory therapy, and in severe cases, surgery""]","[""For Acanthamoeba - Granulomatous Amebic Encephalitis, treatment typically involves a combination of antimicrobial medications such as pentamidine, sulfadiazine, flucytosine, and others. For Acanthamoeba Keratitis, treatment may include a combination of antifungal and antiamoebic medications, as well as supportive care like eye drops and pain management.""]","[""The treatments for Acanthamoeba - GAE include a combination of antifungal medications such as amphotericin B and itraconazole. For Acanthamoeba keratitis, treatment involves a combination of topical medications like chlorhexidine and propamidine, along with oral medications like voriconazole or itraconazole.""]",[false],[true],[false],"[""Antimicrobial therapy, anti-inflammatory therapy, and surgical intervention""]","[""For Acanthamoeba - Granulomatous Amebic Encephalitis, treatment involves a combination of antimicrobial medications such as pentamidine, sulfadiazine, flucytosine, and others. For Acanthamoeba Keratitis, treatment includes a variety of medications such as propamidine isethionate, neomycin, chlorhexidine, and others, along with supportive therapies like corneal transplantation in severe cases.""]","[""Antimicrobial therapy, corticosteroids, and surgery""]",[true],[false],[false],"[""For Acanthamoeba GAE: Combination of drugs like miltefosine, pentamidine, flucytosine, and sulfadiazine. For Acanthamoeba Keratitis: Biguanide antiseptics like polyhexamethylene biguanide (PHMB) or chlorhexidine, and diamidines like propamidine and hexamidine.""]","[""Antimicrobial therapy, corticosteroids, and surgical intervention""]","[""Antimicrobial therapy, corticosteroids, and surgery""]",[true],[true],[true],"[""Treatments for Acanthamoeba - GAE (Granulomatous Amoebic Encephalitis) include medications like miltefosine, pentamidine, sulfadiazine, and flucytosine. For Acanthamoeba Keratitis, treatments may involve antifungal eye drops, such as propamidine and chlorhexidine, along with supportive care and sometimes surgery.""]","[""The treatments for Acanthamoeba - Granulomatous Amebic Encephalitis include a combination of medications such as pentamidine, sulfadiazine, flucytosine, and others. For Acanthamoeba Keratitis, treatment involves a variety of antifungal and antiprotozoal medications, along with supportive care and sometimes surgical intervention.""]","[""The treatments for Acanthamoeba - GAE include a combination of antifungal medications such as amphotericin B and itraconazole. For Acanthamoeba keratitis, treatment involves a combination of antifungal eye drops, such as polyhexamethylene biguanide (PHMB) and propamidine isethionate, along with supportive care and sometimes surgery.""]",[true],[true],[true],"[""The treatments for Acanthamoeba - GAE (Granulomatous Amoebic Encephalitis) include a combination of antimicrobial drugs such as pentamidine, sulfadiazine, flucytosine, and azoles. For Acanthamoeba Keratitis, treatment involves a combination of topical medications like chlorhexidine, propamidine isethionate, and polyhexamethylene biguanide (PHMB), along with supportive therapy and sometimes surgical intervention.""]","[""For Acanthamoeba - Granulomatous Amebic Encephalitis, treatment typically involves a combination of antimicrobial medications such as pentamidine, sulfadiazine, flucytosine, and others. For Acanthamoeba Keratitis, treatment may include a combination of antifungal and antiamoebic medications, as well as supportive care like eye drops and pain management.""]","[""The treatments for Acanthamoeba - GAE include a combination of antifungal medications such as amphotericin B and itraconazole. For Acanthamoeba keratitis, treatment involves a combination of topical medications like chlorhexidine and propamidine, along with oral medications like voriconazole or itraconazole.""]",[true],[true],[false],"[""The treatments for Acanthamoeba - GAE (Granulomatous Amoebic Encephalitis) and Keratitis include medications such as anti-amoebic drugs, corticosteroids, and sometimes surgery in severe cases.""]","[""For Acanthamoeba - Granulomatous Amebic Encephalitis, treatment involves a combination of antimicrobial medications such as pentamidine, sulfadiazine, flucytosine, and others. For Acanthamoeba Keratitis, treatment includes a variety of medications such as propamidine isethionate, neomycin, chlorhexidine, and others, along with supportive therapies like corneal transplantation in severe cases.""]","[""Antimicrobial therapy, corticosteroids, and surgery""]",[true],[false],[false],"[""The treatments for Acanthamoeba - GAE (Granulomatous Amoebic Encephalitis) include a combination of antifungal and antiparasitic medications. For Keratitis caused by Acanthamoeba, treatment involves the use of specific antiparasitic eye drops and sometimes oral medications.""]","[""Antimicrobial therapy, corticosteroids, and surgical intervention""]","[""Antimicrobial therapy, corticosteroids, and surgery""]",[true],[true],[true],"[""For Acanthamoeba - GAE (Granulomatous Amebic Encephalitis), treatments may include a combination of antimicrobial medications such as pentamidine, sulfadiazine, flucytosine, and others. For Acanthamoeba Keratitis, treatments may involve antifungal or antiamoebic eye drops, as well as supportive care to manage symptoms and prevent complications.""]","[""The treatments for Acanthamoeba - Granulomatous Amebic Encephalitis include a combination of medications such as pentamidine, sulfadiazine, flucytosine, and others. For Acanthamoeba Keratitis, treatment involves a variety of antifungal and antiprotozoal medications, along with supportive care and sometimes surgical intervention.""]","[""The treatments for Acanthamoeba - GAE include a combination of antifungal medications such as amphotericin B and itraconazole. For Acanthamoeba keratitis, treatment involves a combination of antifungal eye drops, such as polyhexamethylene biguanide (PHMB) and propamidine isethionate, along with supportive care and sometimes surgery.""]",[true],[true],[true],"[""The treatments for Acanthamoeba - GAE (Granulomatous Amebic Encephalitis) include a combination of antimicrobial drugs such as pentamidine, sulfadiazine, flucytosine, and others. For Acanthamoeba Keratitis, treatment involves a combination of antifungal and antiamoebic medications, along with supportive care such as eye drops and pain management.""]","[""For Acanthamoeba - Granulomatous Amebic Encephalitis, treatment typically involves a combination of antimicrobial medications such as pentamidine, sulfadiazine, flucytosine, and others. For Acanthamoeba Keratitis, treatment may include a combination of antifungal and antiamoebic medications, as well as supportive care like eye drops and pain management.""]","[""The treatments for Acanthamoeba - GAE include a combination of antifungal medications such as amphotericin B and itraconazole. For Acanthamoeba keratitis, treatment involves a combination of topical medications like chlorhexidine and propamidine, along with oral medications like voriconazole or itraconazole.""]",[true],[true],[false],"[""For Acanthamoeba - GAE (Granulomatous Amebic Encephalitis), treatments may include a combination of medications such as pentamidine, sulfadiazine, flucytosine, and others. For Acanthamoeba Keratitis, treatments may involve antifungal eye drops, such as propamidine and chlorhexidine, along with other medications depending on the severity.""]","[""For Acanthamoeba - Granulomatous Amebic Encephalitis, treatment involves a combination of antimicrobial medications such as pentamidine, sulfadiazine, flucytosine, and others. For Acanthamoeba Keratitis, treatment includes a variety of medications such as propamidine isethionate, neomycin, chlorhexidine, and others, along with supportive therapies like corneal transplantation in severe cases.""]","[""Antimicrobial therapy, corticosteroids, and surgery""]",[true],[false],[false],"[""The treatments for Acanthamoeba - GAE (Granulomatous Amebic Encephalitis) include a combination of antimicrobial drugs such as pentamidine, sulfadiazine, flucytosine, and others. For Acanthamoeba Keratitis, treatment involves a combination of antifungal and antiamoebic medications, along with supportive care like eye drops and pain management.""]","[""Antimicrobial therapy, corticosteroids, and surgical intervention""]","[""Antimicrobial therapy, corticosteroids, and surgery""]",[true],[true],[false],"[""The treatments for Acanthamoeba - GAE (Granulomatous Amoebic Encephalitis) include a combination of antimicrobial drugs such as pentamidine, sulfadiazine, flucytosine, and others. For Acanthamoeba Keratitis, treatment involves a combination of antifungal and antiamoebic medications, along with supportive care like pain management and eye protection.""]","[""The treatments for Acanthamoeba - Granulomatous Amebic Encephalitis include a combination of medications such as pentamidine, sulfadiazine, flucytosine, and others. For Acanthamoeba Keratitis, treatment involves a variety of antifungal and antiprotozoal medications, along with supportive care and sometimes surgical intervention.""]","[""The treatments for Acanthamoeba - GAE include a combination of antifungal medications such as amphotericin B and itraconazole. For Acanthamoeba keratitis, treatment involves a combination of antifungal eye drops, such as polyhexamethylene biguanide (PHMB) and propamidine isethionate, along with supportive care and sometimes surgery.""]",[true],[true],[true],"[""The treatments for Acanthamoeba - GAE (Granulomatous Amoebic Encephalitis) include a combination of medications such as pentamidine, sulfadiazine, flucytosine, and others. For Acanthamoeba Keratitis, treatment may involve antifungal eye drops, such as propamidine and chlorhexidine, along with supportive care and sometimes surgery.""]","[""For Acanthamoeba - Granulomatous Amebic Encephalitis, treatment typically involves a combination of antimicrobial medications such as pentamidine, sulfadiazine, flucytosine, and others. For Acanthamoeba Keratitis, treatment may include a combination of antifungal and antiamoebic medications, as well as supportive care like eye drops and pain management.""]","[""The treatments for Acanthamoeba - GAE include a combination of antifungal medications such as amphotericin B and itraconazole. For Acanthamoeba keratitis, treatment involves a combination of topical medications like chlorhexidine and propamidine, along with oral medications like voriconazole or itraconazole.""]",[true],[true],[false],"[""The treatments for Acanthamoeba - GAE (Granulomatous Amoebic Encephalitis) include a combination of antimicrobial drugs such as pentamidine, sulfadiazine, flucytosine, and others. For Acanthamoeba Keratitis, treatment involves a combination of antifungal and antiamoebic medications, along with supportive care like pain management and eye protection.""]","[""For Acanthamoeba - Granulomatous Amebic Encephalitis, treatment involves a combination of antimicrobial medications such as pentamidine, sulfadiazine, flucytosine, and others. For Acanthamoeba Keratitis, treatment includes a variety of medications such as propamidine isethionate, neomycin, chlorhexidine, and others, along with supportive therapies like corneal transplantation in severe cases.""]","[""Antimicrobial therapy, corticosteroids, and surgery""]",[true],[false],[false],"[""The treatments for Acanthamoeba - GAE (Granulomatous Amoebic Encephalitis) include a combination of antimicrobial drugs such as pentamidine, sulfadiazine, flucytosine, and others. For Acanthamoeba Keratitis, treatment involves a combination of topical anti-amoebic agents like propamidine isethionate, polyhexamethylene biguanide, and chlorhexidine, along with supportive care.""]","[""Antimicrobial therapy, corticosteroids, and surgical intervention""]","[""Antimicrobial therapy, corticosteroids, and surgery""]",[false],[true],[true],"[""Antimicrobial therapy, anti-inflammatory therapy, and surgical intervention""]","[""The treatments for Acanthamoeba - Granulomatous Amebic Encephalitis include a combination of medications such as pentamidine, sulfadiazine, flucytosine, and others. For Acanthamoeba Keratitis, treatment involves a variety of antifungal and antiprotozoal medications, along with supportive care and sometimes surgical intervention.""]","[""The treatments for Acanthamoeba - GAE include a combination of antifungal medications such as amphotericin B and itraconazole. For Acanthamoeba keratitis, treatment involves a combination of antifungal eye drops, such as polyhexamethylene biguanide (PHMB) and propamidine isethionate, along with supportive care and sometimes surgery.""]",[false],[true],[true],"[""The treatments for Acanthamoeba - GAE (Gallic Acid Equivalent) Keratitis include antifungal medications, such as propamidine isethionate and chlorhexidine, along with supportive therapies like pain management and eye protection.""]","[""The treatments for Acanthamoeba - Granulomatous Amebic Encephalitis include a combination of medications such as pentamidine, sulfadiazine, flucytosine, and others. For Acanthamoeba Keratitis, treatment involves a variety of antifungal and antiprotozoal medications, along with supportive care and sometimes surgical intervention.""]","[""The treatments for Acanthamoeba - GAE include a combination of antifungal medications such as amphotericin B and itraconazole. For Acanthamoeba keratitis, treatment involves a combination of antifungal eye drops, such as polyhexamethylene biguanide (PHMB) and propamidine isethionate, along with supportive care and sometimes surgery.""]",[true],[true],[true],"[""The treatments for Acanthamoeba - GAE and Keratitis include antifungal medications, such as propamidine isethionate and chlorhexidine, as well as supportive care and sometimes surgery.""]","[""The treatments for Acanthamoeba - Granulomatous Amebic Encephalitis include a combination of medications such as pentamidine, sulfadiazine, flucytosine, and others. For Acanthamoeba Keratitis, treatment involves a variety of antifungal and antiprotozoal medications, along with supportive care and sometimes surgical intervention.""]","[""The treatments for Acanthamoeba - GAE include a combination of antifungal medications such as amphotericin B and itraconazole. For Acanthamoeba keratitis, treatment involves a combination of antifungal eye drops, such as polyhexamethylene biguanide (PHMB) and propamidine isethionate, along with supportive care and sometimes surgery.""]",[false],[true],[true],"[""Antimicrobial therapy, anti-inflammatory therapy, and supportive care""]","[""The treatments for Acanthamoeba - Granulomatous Amebic Encephalitis include a combination of medications such as pentamidine, sulfadiazine, flucytosine, and others. For Acanthamoeba Keratitis, treatment involves a variety of antifungal and antiprotozoal medications, along with supportive care and sometimes surgical intervention.""]","[""The treatments for Acanthamoeba - GAE include a combination of antifungal medications such as amphotericin B and itraconazole. For Acanthamoeba keratitis, treatment involves a combination of antifungal eye drops, such as polyhexamethylene biguanide (PHMB) and propamidine isethionate, along with supportive care and sometimes surgery.""]"
treatment,What are the treatments for Central Pain Syndrome ?,"Pain medications often provide some reduction of pain, but not complete relief of pain, for those affected by central pain syndrome. Tricyclic antidepressants such as nortriptyline or anticonvulsants such as neurontin (gabapentin) can be useful. Lowering stress levels appears to reduce pain.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""CPS"", ""full_form"": ""Central Pain Syndrome""}]}",What are the treatments for CPS ?,What are the treatments for Central Pain Syndrome ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Current Population Survey"", ""Child Protective Services"", ""Crown Prosecution Service"", ""Certification Practice Statement"", ""Cycles Per Second"", ""Characters Per Second"", ""Counts Per Second"", ""Continuation-Passing Style"", ""Carrier Pre-Select"", ""Choicepoint, Inc.""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Chronic Pain Syndrome""]",[1.534370010921428e-08],[5.859680401130891e-06],"[""Chronic Pain Syndrome""]",[5.859680401130891e-06],"[""LLM""]","[[2.2164748246961288e-14, 1.3806057032890896e-11, 2.3301248796541796e-19, 4.267484030664874e-18, 2.973251102010949e-11, 1.1978041986198541e-14, 2.965743745449198e-10, 4.52206451109546e-19, 1.7582644335588363e-16, 1.5781421181887046e-15]]",[0.7825773369823044],[0.8029191829588366],"[""Characters Per Second""]",[0.8279423199026332],"[""ABBREVIATIONS""]","[[0.7720859005631345, 0.8101035678794537, 0.7620345486635269, 0.7269405757902628, 0.826476324703569, 0.7351898225398541, 0.8279423199026332, 0.7005136304286892, 0.7066568417984856, 0.7092750937288476]]","[""Chronic Pain Syndrome""]","[""LLM""]",What are the treatments for CPS (Chronic Pain Syndrome) ?,[false],[true],[false],"[""The treatments for Chronic Pain Syndrome (CPS) may include medications, physical therapy, cognitive-behavioral therapy, acupuncture, nerve blocks, and in some cases, surgery.""]","[""Antidepressants, anticonvulsants, physical therapy, nerve blocks, and spinal cord stimulation are common treatments for Central Pain Syndrome.""]","[""Physical therapy, occupational therapy, medications, surgery""]",[true],[true],[false],"[""Treatment for CPS may include medications, physical therapy, cognitive-behavioral therapy, acupuncture, nerve blocks, and in some cases, surgery.""]","[""Treatment for Central Pain Syndrome may include medications, physical therapy, nerve blocks, and psychological support.""]","[""The treatments for CPS (Complex Partial Seizures) include antiepileptic medications, vagus nerve stimulation, responsive neurostimulation, and in some cases, surgery.""]",[false],[true],[false],"[""The treatments for Chronic Pain Syndrome (CPS) may include medications, physical therapy, cognitive-behavioral therapy, acupuncture, nerve blocks, and in some cases, surgery.""]","[""There is no cure for Central Pain Syndrome, but treatments focus on managing symptoms and improving quality of life. Some common treatments include medications, physical therapy, nerve blocks, and psychological counseling.""]","[""The treatments for CPS (Complex Partial Seizures) include anti-seizure medications, surgery, vagus nerve stimulation, and dietary therapy.""]",[false],[true],[false],"[""Treatment for Chronic Pain Syndrome may include medications, physical therapy, cognitive-behavioral therapy, acupuncture, nerve blocks, and in some cases, surgery.""]","[""Antidepressants, anticonvulsants, physical therapy, nerve blocks, and spinal cord stimulation are common treatments for Central Pain Syndrome.""]","[""The treatments for CPS (Complex Partial Seizures) include antiepileptic medications, vagus nerve stimulation, responsive neurostimulation, and in some cases, surgery.""]",[false],[true],[false],"[""There is no medical condition called CPS (Characters Per Second). It is likely a typographical error or misunderstanding. Please provide the correct medical condition for treatment information.""]","[""Antidepressants, anticonvulsants, physical therapy, nerve blocks, and spinal cord stimulation are common treatments for Central Pain Syndrome.""]","[""Physical therapy, occupational therapy, medications, surgery""]",[false],[true],[false],"[""The treatment for CPS (Characters Per Second) involves ergonomic adjustments to the workstation, typing lessons, and breaks to prevent repetitive strain injuries.""]","[""Treatment for Central Pain Syndrome may include medications, physical therapy, nerve blocks, and psychological support.""]","[""The treatments for CPS (Complex Partial Seizures) include antiepileptic medications, vagus nerve stimulation, responsive neurostimulation, and in some cases, surgery.""]",[false],[true],[false],"[""The term CPS commonly refers to Characters Per Second in the context of typing speed. Treatment for low typing speed can include practice, ergonomic keyboard setup, and software tools for improving typing skills.""]","[""There is no cure for Central Pain Syndrome, but treatments focus on managing symptoms and improving quality of life. Some common treatments include medications, physical therapy, nerve blocks, and psychological counseling.""]","[""The treatments for CPS (Complex Partial Seizures) include anti-seizure medications, surgery, vagus nerve stimulation, and dietary therapy.""]",[false],[true],[false],"[""There seems to be a misunderstanding. CPS typically stands for 'Characters Per Second' in the context of typing speed, not a medical condition. There are no specific treatments for CPS as it is a measure of typing speed.""]","[""Antidepressants, anticonvulsants, physical therapy, nerve blocks, and spinal cord stimulation are common treatments for Central Pain Syndrome.""]","[""The treatments for CPS (Complex Partial Seizures) include antiepileptic medications, vagus nerve stimulation, responsive neurostimulation, and in some cases, surgery.""]",[true],[true],[false],"[""Treatment for CPS may include medications, physical therapy, cognitive-behavioral therapy, acupuncture, nerve blocks, and in some cases, surgery.""]","[""Treatment for Central Pain Syndrome may include medications, physical therapy, nerve blocks, and psychological support.""]","[""The treatments for CPS (Complex Partial Seizures) include antiepileptic medications, vagus nerve stimulation, responsive neurostimulation, and in some cases, surgery.""]",[false],[true],[false],"[""Treatment for Chronic Pain Syndrome may include medications, physical therapy, cognitive-behavioral therapy, acupuncture, nerve blocks, and in some cases, surgery.""]","[""Antidepressants, anticonvulsants, physical therapy, nerve blocks, and spinal cord stimulation are common treatments for Central Pain Syndrome.""]","[""Physical therapy, occupational therapy, medications, surgery""]",[true],[true],[false],"[""Treatment for CPS may include medications, physical therapy, cognitive-behavioral therapy, acupuncture, nerve blocks, and in some cases, surgery.""]","[""There is no cure for Central Pain Syndrome, but treatments focus on managing symptoms and improving quality of life. Some common treatments include medications, physical therapy, nerve blocks, and psychological counseling.""]","[""The treatments for CPS (Complex Partial Seizures) include anti-seizure medications, surgery, vagus nerve stimulation, and dietary therapy.""]",[false],[true],[false],"[""The treatments for Chronic Pain Syndrome (CPS) may include medications, physical therapy, cognitive-behavioral therapy, acupuncture, nerve blocks, and in some cases, surgery.""]","[""Antidepressants, anticonvulsants, physical therapy, nerve blocks, and spinal cord stimulation are common treatments for Central Pain Syndrome.""]","[""The treatments for CPS (Complex Partial Seizures) include antiepileptic medications, vagus nerve stimulation, responsive neurostimulation, and in some cases, surgery.""]",[false],[true],[false],"[""Physical therapy, medications, cognitive-behavioral therapy, acupuncture, nerve blocks, surgery""]","[""Antidepressants, anticonvulsants, physical therapy, nerve blocks, and spinal cord stimulation are common treatments for Central Pain Syndrome.""]","[""Physical therapy, occupational therapy, medications, surgery""]",[false],[true],[false],"[""Physical therapy, medications, cognitive-behavioral therapy, acupuncture, nerve blocks, surgery""]","[""Treatment for Central Pain Syndrome may include medications, physical therapy, nerve blocks, and psychological support.""]","[""The treatments for CPS (Complex Partial Seizures) include antiepileptic medications, vagus nerve stimulation, responsive neurostimulation, and in some cases, surgery.""]",[true],[true],[false],"[""Physical therapy, medications, cognitive-behavioral therapy, acupuncture, nerve blocks, surgery""]","[""There is no cure for Central Pain Syndrome, but treatments focus on managing symptoms and improving quality of life. Some common treatments include medications, physical therapy, nerve blocks, and psychological counseling.""]","[""The treatments for CPS (Complex Partial Seizures) include anti-seizure medications, surgery, vagus nerve stimulation, and dietary therapy.""]",[false],[true],[false],"[""Physical therapy, medications, cognitive-behavioral therapy, acupuncture, nerve blocks, surgery""]","[""Antidepressants, anticonvulsants, physical therapy, nerve blocks, and spinal cord stimulation are common treatments for Central Pain Syndrome.""]","[""The treatments for CPS (Complex Partial Seizures) include antiepileptic medications, vagus nerve stimulation, responsive neurostimulation, and in some cases, surgery.""]",[true],[true],[false],"[""Treatment for CPS may include medications, physical therapy, cognitive-behavioral therapy, acupuncture, nerve blocks, and in some cases, surgery.""]","[""Antidepressants, anticonvulsants, physical therapy, nerve blocks, and spinal cord stimulation are common treatments for Central Pain Syndrome.""]","[""Physical therapy, occupational therapy, medications, surgery""]",[false],[true],[false],"[""Treatment for Chronic Pain Syndrome may include medications, physical therapy, cognitive-behavioral therapy, acupuncture, nerve blocks, and in some cases, surgery.""]","[""Treatment for Central Pain Syndrome may include medications, physical therapy, nerve blocks, and psychological support.""]","[""The treatments for CPS (Complex Partial Seizures) include antiepileptic medications, vagus nerve stimulation, responsive neurostimulation, and in some cases, surgery.""]",[false],[true],[false],"[""Treatment for Chronic Pain Syndrome (CPS) may include medications, physical therapy, cognitive-behavioral therapy, acupuncture, nerve blocks, and in some cases, surgery.""]","[""There is no cure for Central Pain Syndrome, but treatments focus on managing symptoms and improving quality of life. Some common treatments include medications, physical therapy, nerve blocks, and psychological counseling.""]","[""The treatments for CPS (Complex Partial Seizures) include anti-seizure medications, surgery, vagus nerve stimulation, and dietary therapy.""]",[false],[true],[false],"[""Physical therapy, medications, cognitive-behavioral therapy, acupuncture, nerve blocks, and surgery""]","[""Antidepressants, anticonvulsants, physical therapy, nerve blocks, and spinal cord stimulation are common treatments for Central Pain Syndrome.""]","[""The treatments for CPS (Complex Partial Seizures) include antiepileptic medications, vagus nerve stimulation, responsive neurostimulation, and in some cases, surgery.""]",[false],[true],[false],"[""The treatments for Chronic Pain Syndrome (CPS) may include medications, physical therapy, cognitive-behavioral therapy, acupuncture, nerve blocks, and in some cases, surgery.""]","[""Antidepressants, anticonvulsants, physical therapy, nerve blocks, and spinal cord stimulation are common treatments for Central Pain Syndrome.""]","[""Physical therapy, occupational therapy, medications, surgery""]",[false],[true],[false],"[""The treatments for Chronic Pain Syndrome (CPS) may include medications, physical therapy, cognitive-behavioral therapy, acupuncture, nerve blocks, and in some cases, surgery.""]","[""Treatment for Central Pain Syndrome may include medications, physical therapy, nerve blocks, and psychological support.""]","[""The treatments for CPS (Complex Partial Seizures) include antiepileptic medications, vagus nerve stimulation, responsive neurostimulation, and in some cases, surgery.""]",[false],[true],[false],"[""The treatments for Chronic Pain Syndrome (CPS) include medications, physical therapy, cognitive-behavioral therapy, acupuncture, nerve blocks, and in some cases, surgery.""]","[""There is no cure for Central Pain Syndrome, but treatments focus on managing symptoms and improving quality of life. Some common treatments include medications, physical therapy, nerve blocks, and psychological counseling.""]","[""The treatments for CPS (Complex Partial Seizures) include anti-seizure medications, surgery, vagus nerve stimulation, and dietary therapy.""]",[false],[true],[false],"[""The treatments for Chronic Pain Syndrome (CPS) may include medications, physical therapy, cognitive-behavioral therapy, acupuncture, nerve blocks, and in some cases, surgery.""]","[""Antidepressants, anticonvulsants, physical therapy, nerve blocks, and spinal cord stimulation are common treatments for Central Pain Syndrome.""]","[""The treatments for CPS (Complex Partial Seizures) include antiepileptic medications, vagus nerve stimulation, responsive neurostimulation, and in some cases, surgery.""]",[false],[true],[false],"[""The treatments for Chronic Pain Syndrome (CPS) may include medications, physical therapy, cognitive-behavioral therapy, acupuncture, nerve blocks, and in some cases, surgery.""]","[""Antidepressants, anticonvulsants, physical therapy, nerve blocks, and spinal cord stimulation are common treatments for Central Pain Syndrome.""]","[""Physical therapy, occupational therapy, medications, surgery""]",[false],[true],[false],"[""The treatments for Chronic Pain Syndrome (CPS) may include medications, physical therapy, cognitive-behavioral therapy, acupuncture, nerve blocks, and in some cases, surgery.""]","[""Treatment for Central Pain Syndrome may include medications, physical therapy, nerve blocks, and psychological support.""]","[""The treatments for CPS (Complex Partial Seizures) include antiepileptic medications, vagus nerve stimulation, responsive neurostimulation, and in some cases, surgery.""]",[false],[true],[false],"[""The treatments for Chronic Pain Syndrome (CPS) may include medications, physical therapy, cognitive-behavioral therapy, acupuncture, nerve blocks, and in some cases, surgery.""]","[""There is no cure for Central Pain Syndrome, but treatments focus on managing symptoms and improving quality of life. Some common treatments include medications, physical therapy, nerve blocks, and psychological counseling.""]","[""The treatments for CPS (Complex Partial Seizures) include anti-seizure medications, surgery, vagus nerve stimulation, and dietary therapy.""]",[false],[true],[false],"[""The treatments for Chronic Pain Syndrome (CPS) may include medications, physical therapy, cognitive-behavioral therapy, acupuncture, nerve blocks, and in some cases, surgery.""]","[""Antidepressants, anticonvulsants, physical therapy, nerve blocks, and spinal cord stimulation are common treatments for Central Pain Syndrome.""]","[""The treatments for CPS (Complex Partial Seizures) include antiepileptic medications, vagus nerve stimulation, responsive neurostimulation, and in some cases, surgery.""]",[false],[true],[false],"[""The treatments for Chronic Pain Syndrome (CPS) may include medications, physical therapy, cognitive-behavioral therapy, acupuncture, nerve blocks, and in some cases surgery.""]","[""Antidepressants, anticonvulsants, physical therapy, nerve blocks, and spinal cord stimulation are common treatments for Central Pain Syndrome.""]","[""Physical therapy, occupational therapy, medications, surgery""]",[true],[true],[false],"[""Treatment for CPS may include medications, physical therapy, cognitive-behavioral therapy, acupuncture, nerve blocks, and in some cases surgery.""]","[""Antidepressants, anticonvulsants, physical therapy, nerve blocks, and spinal cord stimulation are common treatments for Central Pain Syndrome.""]","[""Physical therapy, occupational therapy, medications, surgery""]",[false],[true],[false],"[""Increasing the typing speed through practice and using typing software.""]","[""Antidepressants, anticonvulsants, physical therapy, nerve blocks, and spinal cord stimulation are common treatments for Central Pain Syndrome.""]","[""Physical therapy, occupational therapy, medications, surgery""]",[false],[true],[false],"[""The treatments for Chronic Pain Syndrome (CPS) may include medications, physical therapy, cognitive-behavioral therapy, acupuncture, nerve blocks, and in some cases surgery.""]","[""Antidepressants, anticonvulsants, physical therapy, nerve blocks, and spinal cord stimulation are common treatments for Central Pain Syndrome.""]","[""Physical therapy, occupational therapy, medications, surgery""]"
symptoms,What are the symptoms of Bardet-Biedl syndrome 5 ?,"What are the signs and symptoms of Bardet-Biedl syndrome 5? The Human Phenotype Ontology provides the following list of signs and symptoms for Bardet-Biedl syndrome 5. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the kidney 95% Micropenis 88% Myopia 75% Astigmatism 63% Cataract 30% Glaucoma 22% Rod-cone dystrophy 8% Abnormality of the ovary 7.5% Hearing impairment 7.5% Macrocephaly 7.5% Vaginal atresia 7.5% Aganglionic megacolon 5% Asthma - Ataxia - Autosomal recessive inheritance - Biliary tract abnormality - Brachydactyly syndrome - Broad foot - Congenital primary aphakia - Decreased testicular size - Delayed speech and language development - Dental crowding - Diabetes mellitus - Foot polydactyly - Gait imbalance - Hepatic fibrosis - High palate - Hirsutism - Hypertension - Hypodontia - Hypogonadism - Intellectual disability - Left ventricular hypertrophy - Nephrogenic diabetes insipidus - Neurological speech impairment - Nystagmus - Obesity - Poor coordination - Postaxial hand polydactyly - Radial deviation of finger - Retinal degeneration - Short foot - Specific learning disability - Strabismus - Syndactyly - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""BBS5"", ""full_form"": ""Bardet-Biedl syndrome 5""}]}",What are the symptoms of BBS5 ?,What are the symptoms of Bardet-Biedl syndrome 5 ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.",[[]],[[]],"[""Bardet-Biedl Syndrome 5""]",[2.3101473127172353e-29],[2.3101473127172353e-29],"[""Bardet-Biedl Syndrome 5""]",[2.3101473127172353e-29],"[""LLM""]",[[]],[0.8921172460753211],[0.890088926192816],"[""Bardet-Biedl syndrome 5""]",[0.890088926192816],"[""LLM""]",[[]],"[""Bardet-Biedl Syndrome 5""]","[""LLM""]",What are the symptoms of BBS5 (Bardet-Biedl Syndrome 5) ?,[true],[true],[true],"[""Some symptoms of BBS5 (Bardet-Biedl Syndrome 5) include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and developmental delays.""]","[""Symptoms of Bardet-Biedl syndrome 5 include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and hormonal issues.""]","[""Some symptoms of BBS5 include obesity, kidney abnormalities, vision problems, and intellectual disability.""]",[true],[true],[true],"[""Some common symptoms of BBS5 (Bardet-Biedl Syndrome 5) include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and developmental delays.""]","[""Symptoms of Bardet-Biedl syndrome 5 include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and genital abnormalities.""]","[""Symptoms of BBS5 include obesity, vision problems, kidney abnormalities, intellectual disability, and extra fingers or toes.""]",[true],[true],[true],"[""The symptoms of BBS5 (Bardet-Biedl Syndrome 5) include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and genital abnormalities.""]","[""The symptoms of Bardet-Biedl syndrome 5 include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and genital abnormalities.""]","[""Some symptoms of BBS5 include obesity, vision problems, kidney abnormalities, and intellectual disability.""]",[true],[true],[true],"[""Some common symptoms of BBS5 (Bardet-Biedl Syndrome 5) include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and developmental delays.""]","[""Symptoms of Bardet-Biedl syndrome 5 include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and behavioral problems.""]","[""Some symptoms of BBS5 include obesity, vision problems, kidney abnormalities, and intellectual disability.""]",[true],[true],[true],"[""Symptoms of BBS5 (Bardet-Biedl syndrome 5) include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and developmental delays.""]","[""Symptoms of Bardet-Biedl syndrome 5 include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and hormonal issues.""]","[""Some symptoms of BBS5 include obesity, kidney abnormalities, vision problems, and intellectual disability.""]",[true],[true],[true],"[""Some common symptoms of BBS5 (Bardet-Biedl syndrome 5) include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and developmental delays.""]","[""Symptoms of Bardet-Biedl syndrome 5 include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and genital abnormalities.""]","[""Symptoms of BBS5 include obesity, vision problems, kidney abnormalities, intellectual disability, and extra fingers or toes.""]",[true],[true],[true],"[""Some symptoms of BBS5 (Bardet-Biedl syndrome 5) include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and developmental delays.""]","[""The symptoms of Bardet-Biedl syndrome 5 include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and genital abnormalities.""]","[""Some symptoms of BBS5 include obesity, vision problems, kidney abnormalities, and intellectual disability.""]",[true],[true],[true],"[""Some symptoms of BBS5 (Bardet-Biedl syndrome 5) include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and developmental delays.""]","[""Symptoms of Bardet-Biedl syndrome 5 include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and behavioral problems.""]","[""Some symptoms of BBS5 include obesity, vision problems, kidney abnormalities, and intellectual disability.""]",[true],[true],[true],"[""Some common symptoms of BBS5 (Bardet-Biedl Syndrome 5) include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and developmental delays.""]","[""Symptoms of Bardet-Biedl syndrome 5 include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and genital abnormalities.""]","[""Symptoms of BBS5 include obesity, vision problems, kidney abnormalities, intellectual disability, and extra fingers or toes.""]",[true],[true],[true],"[""Symptoms of BBS5 include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and developmental delays.""]","[""Symptoms of Bardet-Biedl syndrome 5 include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and hormonal issues.""]","[""Some symptoms of BBS5 include obesity, kidney abnormalities, vision problems, and intellectual disability.""]",[true],[true],[true],"[""Some common symptoms of BBS5 (Bardet-Biedl Syndrome 5) include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and developmental delays.""]","[""The symptoms of Bardet-Biedl syndrome 5 include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and genital abnormalities.""]","[""Some symptoms of BBS5 include obesity, vision problems, kidney abnormalities, and intellectual disability.""]",[true],[true],[true],"[""Symptoms of BBS5 (Bardet-Biedl Syndrome 5) include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and developmental delays.""]","[""Symptoms of Bardet-Biedl syndrome 5 include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and behavioral problems.""]","[""Some symptoms of BBS5 include obesity, vision problems, kidney abnormalities, and intellectual disability.""]",[true],[true],[true],"[""Symptoms of BBS5 include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and hormonal issues.""]","[""Symptoms of Bardet-Biedl syndrome 5 include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and hormonal issues.""]","[""Some symptoms of BBS5 include obesity, kidney abnormalities, vision problems, and intellectual disability.""]",[true],[true],[true],"[""Symptoms of BBS5 include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and developmental delays.""]","[""Symptoms of Bardet-Biedl syndrome 5 include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and genital abnormalities.""]","[""Symptoms of BBS5 include obesity, vision problems, kidney abnormalities, intellectual disability, and extra fingers or toes.""]",[true],[true],[true],"[""Symptoms of BBS5 include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and developmental delays.""]","[""The symptoms of Bardet-Biedl syndrome 5 include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and genital abnormalities.""]","[""Some symptoms of BBS5 include obesity, vision problems, kidney abnormalities, and intellectual disability.""]",[true],[true],[true],"[""Polydactyly, obesity, intellectual disability, kidney abnormalities""]","[""Symptoms of Bardet-Biedl syndrome 5 include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and behavioral problems.""]","[""Some symptoms of BBS5 include obesity, vision problems, kidney abnormalities, and intellectual disability.""]",[true],[true],[true],"[""Some common symptoms of BBS5 (Bardet-Biedl Syndrome 5) include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and developmental delays.""]","[""Symptoms of Bardet-Biedl syndrome 5 include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and hormonal issues.""]","[""Some symptoms of BBS5 include obesity, kidney abnormalities, vision problems, and intellectual disability.""]",[true],[true],[true],"[""Some symptoms of BBS5 (Bardet-Biedl Syndrome 5) include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and developmental delays.""]","[""Symptoms of Bardet-Biedl syndrome 5 include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and genital abnormalities.""]","[""Symptoms of BBS5 include obesity, vision problems, kidney abnormalities, intellectual disability, and extra fingers or toes.""]",[true],[true],[true],"[""Some common symptoms of BBS5 (Bardet-Biedl Syndrome 5) include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and developmental delays.""]","[""The symptoms of Bardet-Biedl syndrome 5 include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and genital abnormalities.""]","[""Some symptoms of BBS5 include obesity, vision problems, kidney abnormalities, and intellectual disability.""]",[true],[true],[true],"[""Some common symptoms of BBS5 (Bardet-Biedl Syndrome 5) include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and developmental delays.""]","[""Symptoms of Bardet-Biedl syndrome 5 include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and behavioral problems.""]","[""Some symptoms of BBS5 include obesity, vision problems, kidney abnormalities, and intellectual disability.""]",[true],[true],[true],"[""Symptoms of BBS5 (Bardet-Biedl Syndrome 5) include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and developmental delays.""]","[""Symptoms of Bardet-Biedl syndrome 5 include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and hormonal issues.""]","[""Some symptoms of BBS5 include obesity, kidney abnormalities, vision problems, and intellectual disability.""]",[true],[true],[true],"[""Some symptoms of BBS5 (Bardet-Biedl Syndrome 5) include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and developmental delays.""]","[""Symptoms of Bardet-Biedl syndrome 5 include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and genital abnormalities.""]","[""Symptoms of BBS5 include obesity, vision problems, kidney abnormalities, intellectual disability, and extra fingers or toes.""]",[true],[true],[true],"[""Some common symptoms of BBS5 (Bardet-Biedl Syndrome 5) include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and developmental delays.""]","[""The symptoms of Bardet-Biedl syndrome 5 include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and genital abnormalities.""]","[""Some symptoms of BBS5 include obesity, vision problems, kidney abnormalities, and intellectual disability.""]",[true],[true],[true],"[""Symptoms of BBS5 (Bardet-Biedl Syndrome 5) include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and developmental delays.""]","[""Symptoms of Bardet-Biedl syndrome 5 include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and behavioral problems.""]","[""Some symptoms of BBS5 include obesity, vision problems, kidney abnormalities, and intellectual disability.""]",[true],[true],[true],"[""Some common symptoms of BBS5 (Bardet-Biedl Syndrome 5) include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and developmental delays.""]","[""Symptoms of Bardet-Biedl syndrome 5 include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and hormonal issues.""]","[""Some symptoms of BBS5 include obesity, kidney abnormalities, vision problems, and intellectual disability.""]",[true],[true],[true],"[""Some common symptoms of BBS5 (Bardet-Biedl Syndrome 5) include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and developmental delays.""]","[""Symptoms of Bardet-Biedl syndrome 5 include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and genital abnormalities.""]","[""Symptoms of BBS5 include obesity, vision problems, kidney abnormalities, intellectual disability, and extra fingers or toes.""]",[true],[true],[true],"[""Some common symptoms of BBS5 (Bardet-Biedl Syndrome 5) include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and developmental delays.""]","[""The symptoms of Bardet-Biedl syndrome 5 include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and genital abnormalities.""]","[""Some symptoms of BBS5 include obesity, vision problems, kidney abnormalities, and intellectual disability.""]",[true],[true],[true],"[""Some common symptoms of BBS5 (Bardet-Biedl Syndrome 5) include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and developmental delays.""]","[""Symptoms of Bardet-Biedl syndrome 5 include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and behavioral problems.""]","[""Some symptoms of BBS5 include obesity, vision problems, kidney abnormalities, and intellectual disability.""]",[true],[true],[true],"[""Some common symptoms of BBS5 (Bardet-Biedl Syndrome 5) include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and developmental delays.""]","[""Symptoms of Bardet-Biedl syndrome 5 include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and hormonal issues.""]","[""Some symptoms of BBS5 include obesity, kidney abnormalities, vision problems, and intellectual disability.""]",[true],[true],[true],"[""Symptoms of BBS5 include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and genital abnormalities.""]","[""Symptoms of Bardet-Biedl syndrome 5 include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and hormonal issues.""]","[""Some symptoms of BBS5 include obesity, kidney abnormalities, vision problems, and intellectual disability.""]",[true],[true],[true],"[""Symptoms of BBS5 include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and developmental delays.""]","[""Symptoms of Bardet-Biedl syndrome 5 include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and hormonal issues.""]","[""Some symptoms of BBS5 include obesity, kidney abnormalities, vision problems, and intellectual disability.""]",[true],[true],[true],"[""Some common symptoms of BBS5 include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and developmental delays.""]","[""Symptoms of Bardet-Biedl syndrome 5 include obesity, vision problems, kidney abnormalities, extra fingers or toes, intellectual disability, and hormonal issues.""]","[""Some symptoms of BBS5 include obesity, kidney abnormalities, vision problems, and intellectual disability.""]"
susceptibility,Who is at risk for Adult Acute Myeloid Leukemia? ?,"Smoking, previous chemotherapy treatment, and exposure to radiation may affect the risk of adult AML. Anything that increases your risk of getting a disease is called a risk factor. Having a risk factor does not mean that you will get cancer; not having risk factors doesnt mean that you will not get cancer. Talk with your doctor if you think you may be at risk. Possible risk factors for AML include the following:         - Being male.    - Smoking, especially after age 60.    - Having had treatment with chemotherapy or radiation therapy in the past.    - Having had treatment for childhood acute lymphoblastic leukemia (ALL) in the past.    - Being exposed to radiation from an atomic bomb or to the chemical benzene.    - Having a history of a blood disorder such as myelodysplastic syndrome.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""AML"", ""full_form"": ""Acute Myeloid Leukemia""}]}",Who is at risk for Adult AML? ?,Who is at risk for Adult Acute Myeloid Leukemia? ?,8,MEDICAL,Compound Datatype-String,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Anti Money Laundering"", ""Acute Myelogenous Leukemia"", ""Acute Myeloid leukaemia"", ""Acute Myeloblastic Leukemia"", ""Abandoned Mine Lands"", ""Arc Macro Language"", ""Acute Monocytic Leukemia"", ""AMLI Residential Properties Trust"", ""A Major Label"", ""ACPI Machine Language""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Acute Myeloid Leukemia""]",[5.727664176054172e-12],[5.727664176054172e-12],"[""Acute Myelogenous Leukemia""]",[8.590461931746255e-09],"[""ABBREVIATIONS""]","[[2.2334984195366515e-20, 8.590461931746255e-09, 3.3310019135703856e-20, 1.8629586922348344e-17, 2.7612449445671197e-18, 2.2360556716426564e-16, 7.83718688663714e-12, 5.8257358804565276e-27, 6.242843536409321e-12, 3.0946101537137114e-18]]",[0.968067707218479],[0.968067707218479],"[""ACPI Machine Language""]",[0.968067707218479],"[""LLM""]","[[0.725356208872126, 0.966899778597732, 0.9634688949346886, 0.9649859309543452, 0.7064665002066446, 0.8388071466636152, 0.9264049731332157, 0.7887141190194841, 0.9224301265310568, 0.7867611692683326]]","[""Acute Myelogenous Leukemia""]","[""ABBREVIATIONS""]",Who is at risk for Adult AML (Acute Myeloid Leukemia)? ?,[true],[true],[false],"[""People over the age of 45 are at higher risk for Adult AML (Acute Myelogenous Leukemia). Other risk factors include exposure to certain chemicals, previous chemotherapy or radiation therapy, and genetic disorders like Down syndrome.""]","[""People with certain genetic disorders, a history of chemotherapy or radiation therapy, or exposure to certain chemicals are at higher risk for Adult Acute Myeloid Leukemia.""]","[""People over the age of 60 are at higher risk for Adult AML.""]",[true],[true],[false],"[""People over the age of 45 are at higher risk for Adult AML (Acute Myelogenous Leukemia). Other risk factors include previous chemotherapy or radiation therapy, exposure to certain chemicals like benzene, and certain genetic disorders.""]","[""People who have been exposed to high levels of radiation, certain chemicals, or have undergone chemotherapy are at higher risk for Adult Acute Myeloid Leukemia.""]","[""People over the age of 60 are at higher risk for Adult AML.""]",[true],[true],[false],"[""People over the age of 45 are at higher risk for Adult AML (Acute Myelogenous Leukemia). Other risk factors include previous chemotherapy or radiation therapy, exposure to certain chemicals like benzene, and certain genetic disorders.""]","[""People over the age of 45, those with a history of certain genetic disorders, exposure to high levels of radiation or certain chemicals, and those who have undergone chemotherapy or radiation therapy for other cancers are at higher risk for Adult Acute Myeloid Leukemia.""]","[""People over the age of 60 are at higher risk for Adult AML.""]",[true],[true],[false],"[""People over the age of 45 are at higher risk for Adult AML (Acute Myelogenous Leukemia). Other risk factors include exposure to certain chemicals, previous chemotherapy or radiation therapy, and genetic disorders like Down syndrome.""]","[""People with certain genetic disorders, previous chemotherapy or radiation treatment, exposure to certain chemicals, or older age are at higher risk for Adult Acute Myeloid Leukemia.""]","[""People over the age of 60 are at higher risk for Adult AML.""]",[false],[true],[false],"[""People over the age of 60 are at higher risk for Adult AML (Acute Myeloid Leukemia).""]","[""People with certain genetic disorders, a history of chemotherapy or radiation therapy, or exposure to certain chemicals are at higher risk for Adult Acute Myeloid Leukemia.""]","[""People over the age of 60 are at higher risk for Adult AML.""]",[false],[true],[false],"[""People over the age of 60 are at higher risk for Adult AML (Acute Myeloid Leukemia).""]","[""People who have been exposed to high levels of radiation, certain chemicals, or have undergone chemotherapy are at higher risk for Adult Acute Myeloid Leukemia.""]","[""People over the age of 60 are at higher risk for Adult AML.""]",[false],[true],[false],"[""People over the age of 60 are at higher risk for Adult AML (Acute Myeloid Leukemia).""]","[""People over the age of 45, those with a history of certain genetic disorders, exposure to high levels of radiation or certain chemicals, and those who have undergone chemotherapy or radiation therapy for other cancers are at higher risk for Adult Acute Myeloid Leukemia.""]","[""People over the age of 60 are at higher risk for Adult AML.""]",[false],[true],[false],"[""People over the age of 60 are at higher risk for Adult AML (Acute Myeloid Leukemia).""]","[""People with certain genetic disorders, previous chemotherapy or radiation treatment, exposure to certain chemicals, or older age are at higher risk for Adult Acute Myeloid Leukemia.""]","[""People over the age of 60 are at higher risk for Adult AML.""]",[true],[true],[false],"[""People over the age of 45 are at higher risk for Adult AML (Acute Myelogenous Leukemia). Other risk factors include exposure to certain chemicals, previous chemotherapy or radiation therapy, and genetic disorders.""]","[""People who have been exposed to high levels of radiation, certain chemicals, or have undergone chemotherapy are at higher risk for Adult Acute Myeloid Leukemia.""]","[""People over the age of 60 are at higher risk for Adult AML.""]",[true],[true],[false],"[""People over the age of 45 are at higher risk for Adult AML (Acute Myelogenous Leukemia). Other risk factors include previous chemotherapy or radiation therapy, exposure to certain chemicals like benzene, and certain genetic disorders.""]","[""People with certain genetic disorders, a history of chemotherapy or radiation therapy, or exposure to certain chemicals are at higher risk for Adult Acute Myeloid Leukemia.""]","[""People over the age of 60 are at higher risk for Adult AML.""]",[true],[true],[false],"[""People over the age of 45 are at higher risk for Adult AML (Acute Myelogenous Leukemia). Other risk factors include exposure to certain chemicals, previous chemotherapy or radiation therapy, and genetic disorders like Down syndrome.""]","[""People over the age of 45, those with a history of certain genetic disorders, exposure to high levels of radiation or certain chemicals, and those who have undergone chemotherapy or radiation therapy for other cancers are at higher risk for Adult Acute Myeloid Leukemia.""]","[""People over the age of 60 are at higher risk for Adult AML.""]",[true],[true],[false],"[""People over the age of 45 are at higher risk for Adult AML (Acute Myelogenous Leukemia). Other risk factors include exposure to certain chemicals, previous chemotherapy or radiation therapy, and certain genetic disorders.""]","[""People with certain genetic disorders, previous chemotherapy or radiation treatment, exposure to certain chemicals, or older age are at higher risk for Adult Acute Myeloid Leukemia.""]","[""People over the age of 60 are at higher risk for Adult AML.""]",[false],[true],[false],"[""People over the age of 60 are at higher risk for Adult AML (Acute Myelogenous Leukemia).""]","[""People with certain genetic disorders, a history of chemotherapy or radiation therapy, or exposure to certain chemicals are at higher risk for Adult Acute Myeloid Leukemia.""]","[""People over the age of 60 are at higher risk for Adult AML.""]",[false],[true],[false],"[""People over the age of 60 are at higher risk for Adult AML (Acute Myelogenous Leukemia).""]","[""People who have been exposed to high levels of radiation, certain chemicals, or have undergone chemotherapy are at higher risk for Adult Acute Myeloid Leukemia.""]","[""People over the age of 60 are at higher risk for Adult AML.""]",[false],[true],[false],"[""People over the age of 45 are at higher risk for Adult AML (Acute Myelogenous Leukemia).""]","[""People over the age of 45, those with a history of certain genetic disorders, exposure to high levels of radiation or certain chemicals, and those who have undergone chemotherapy or radiation therapy for other cancers are at higher risk for Adult Acute Myeloid Leukemia.""]","[""People over the age of 60 are at higher risk for Adult AML.""]",[true],[true],[false],"[""People over the age of 60 are at higher risk for Adult AML (Acute Myelogenous Leukemia). Other risk factors include exposure to certain chemicals, previous chemotherapy or radiation therapy, and genetic disorders like Down syndrome.""]","[""People with certain genetic disorders, previous chemotherapy or radiation treatment, exposure to certain chemicals, or older age are at higher risk for Adult Acute Myeloid Leukemia.""]","[""People over the age of 60 are at higher risk for Adult AML.""]",[false],[true],[false],"[""People over the age of 45 are at higher risk for Adult AML (Acute Myelogenous Leukemia).""]","[""People with certain genetic disorders, a history of chemotherapy or radiation therapy, or exposure to certain chemicals are at higher risk for Adult Acute Myeloid Leukemia.""]","[""People over the age of 60 are at higher risk for Adult AML.""]",[true],[true],[false],"[""People over the age of 45 are at higher risk for Adult AML (Acute Myelogenous Leukemia). Other risk factors include exposure to certain chemicals, previous chemotherapy or radiation therapy, and genetic disorders like Down syndrome.""]","[""People who have been exposed to high levels of radiation, certain chemicals, or have undergone chemotherapy are at higher risk for Adult Acute Myeloid Leukemia.""]","[""People over the age of 60 are at higher risk for Adult AML.""]",[true],[true],[false],"[""People over the age of 45 are at higher risk for Adult AML (Acute Myelogenous Leukemia). Other risk factors include exposure to certain chemicals, previous chemotherapy or radiation therapy, and certain genetic disorders.""]","[""People over the age of 45, those with a history of certain genetic disorders, exposure to high levels of radiation or certain chemicals, and those who have undergone chemotherapy or radiation therapy for other cancers are at higher risk for Adult Acute Myeloid Leukemia.""]","[""People over the age of 60 are at higher risk for Adult AML.""]",[true],[true],[false],"[""People over the age of 45 are at higher risk for Adult AML (Acute Myelogenous Leukemia). Other risk factors include previous chemotherapy or radiation therapy, exposure to certain chemicals like benzene, and certain genetic disorders.""]","[""People with certain genetic disorders, previous chemotherapy or radiation treatment, exposure to certain chemicals, or older age are at higher risk for Adult Acute Myeloid Leukemia.""]","[""People over the age of 60 are at higher risk for Adult AML.""]",[true],[true],[false],"[""People over the age of 65 are at higher risk for Adult AML (Acute Myeloid Leukemia). Other risk factors include previous chemotherapy or radiation therapy, exposure to certain chemicals like benzene, and certain genetic disorders.""]","[""People with certain genetic disorders, a history of chemotherapy or radiation therapy, or exposure to certain chemicals are at higher risk for Adult Acute Myeloid Leukemia.""]","[""People over the age of 60 are at higher risk for Adult AML.""]",[true],[true],[false],"[""People over the age of 65 are at higher risk for Adult AML (Acute Myeloid Leukemia). Other risk factors include exposure to certain chemicals, previous chemotherapy or radiation therapy, and certain genetic disorders.""]","[""People who have been exposed to high levels of radiation, certain chemicals, or have undergone chemotherapy are at higher risk for Adult Acute Myeloid Leukemia.""]","[""People over the age of 60 are at higher risk for Adult AML.""]",[true],[true],[false],"[""People over the age of 45 are at higher risk for Adult AML (Acute Myeloid Leukemia). Other risk factors include previous chemotherapy or radiation therapy, exposure to certain chemicals like benzene, and certain genetic disorders.""]","[""People over the age of 45, those with a history of certain genetic disorders, exposure to high levels of radiation or certain chemicals, and those who have undergone chemotherapy or radiation therapy for other cancers are at higher risk for Adult Acute Myeloid Leukemia.""]","[""People over the age of 60 are at higher risk for Adult AML.""]",[true],[true],[false],"[""People over the age of 65 are at higher risk for Adult AML (Acute Myeloid Leukemia). Other risk factors include previous chemotherapy or radiation therapy, exposure to certain chemicals like benzene, and certain genetic disorders.""]","[""People with certain genetic disorders, previous chemotherapy or radiation treatment, exposure to certain chemicals, or older age are at higher risk for Adult Acute Myeloid Leukemia.""]","[""People over the age of 60 are at higher risk for Adult AML.""]",[true],[true],[false],"[""People over the age of 45 are at higher risk for Adult AML (Acute Myelogenous Leukemia). Other risk factors include exposure to certain chemicals, previous chemotherapy or radiation therapy, and genetic disorders.""]","[""People with certain genetic disorders, a history of chemotherapy or radiation therapy, or exposure to certain chemicals are at higher risk for Adult Acute Myeloid Leukemia.""]","[""People over the age of 60 are at higher risk for Adult AML.""]",[true],[true],[false],"[""People over the age of 45 are at higher risk for Adult AML (Acute Myelogenous Leukemia). Other risk factors include exposure to certain chemicals, previous chemotherapy or radiation therapy, and genetic disorders.""]","[""People who have been exposed to high levels of radiation, certain chemicals, or have undergone chemotherapy are at higher risk for Adult Acute Myeloid Leukemia.""]","[""People over the age of 60 are at higher risk for Adult AML.""]",[true],[true],[false],"[""People over the age of 45 are at higher risk for Adult AML (Acute Myelogenous Leukemia). Other risk factors include exposure to certain chemicals, previous chemotherapy or radiation therapy, and genetic disorders.""]","[""People over the age of 45, those with a history of certain genetic disorders, exposure to high levels of radiation or certain chemicals, and those who have undergone chemotherapy or radiation therapy for other cancers are at higher risk for Adult Acute Myeloid Leukemia.""]","[""People over the age of 60 are at higher risk for Adult AML.""]",[true],[true],[false],"[""People over the age of 45 are at higher risk for Adult AML (Acute Myelogenous Leukemia). Other risk factors include exposure to certain chemicals, previous chemotherapy or radiation therapy, and genetic disorders.""]","[""People with certain genetic disorders, previous chemotherapy or radiation treatment, exposure to certain chemicals, or older age are at higher risk for Adult Acute Myeloid Leukemia.""]","[""People over the age of 60 are at higher risk for Adult AML.""]",[false],[true],[false],"[""People over the age of 45 are at higher risk for Adult AML.""]","[""People with certain genetic disorders, a history of chemotherapy or radiation therapy, or exposure to certain chemicals are at higher risk for Adult Acute Myeloid Leukemia.""]","[""People over the age of 60 are at higher risk for Adult AML.""]",[false],[true],[false],"[""People over the age of 45 are at higher risk for Adult AML.""]","[""People with certain genetic disorders, a history of chemotherapy or radiation therapy, or exposure to certain chemicals are at higher risk for Adult Acute Myeloid Leukemia.""]","[""People over the age of 60 are at higher risk for Adult AML.""]",[false],[true],[false],"[""Adults over the age of 60 are at higher risk for Adult AML (Acute Myeloid Leukemia).""]","[""People with certain genetic disorders, a history of chemotherapy or radiation therapy, or exposure to certain chemicals are at higher risk for Adult Acute Myeloid Leukemia.""]","[""People over the age of 60 are at higher risk for Adult AML.""]",[false],[true],[false],"[""Adults over the age of 45 are at higher risk for Adult AML.""]","[""People with certain genetic disorders, a history of chemotherapy or radiation therapy, or exposure to certain chemicals are at higher risk for Adult Acute Myeloid Leukemia.""]","[""People over the age of 60 are at higher risk for Adult AML.""]"
causes,What causes Postural orthostatic tachycardia syndrome ?,"What causes postural orthostatic tachycardia syndrome? The underlying cause of postural orthostatic tachycardia syndrome (POTS) is poorly understood. However, episodes often begin after a pregnancy, major surgery, trauma, or a viral illness and may increase right before a menstrual period. Many researchers suspect that there may be more than one cause for the condition. The following abnormalities can be associated with POTS and may play a role in the development of the condition: Peripheral denervation - reduced nerve stimulation to certain muscles. The lower extremities are generally most affected in people with POTS. Hypovolemia - an abnormal decrease or redistribution of blood in the body Changes in venous function - more specifically, a reduction in the volume of blood that returns to the heart (venous return) when moving from a lying down to a standing position Cardiovascular deconditioning - changes in cardiovascular function Baroreflex abnormalities - the baroreflexes play an important role in blood pressure regulation. When they sense a change in blood pressure, the heart rate is adjusted and the sympathetic nerve system fibers are activated to cause the blood vessels to narrow. Increased activity of the sympathetic nervous system Although most cases of POTS appear to occur sporadically in people with no family history of the condition, some affected people report a family history of orthostatic intolerance (an excessively reduced volume of blood returns to the heart when moving from a lying down to a standing position). This suggests that genetic factors may play a role in the development of POTS in some cases. Some studies also suggest that polymorphisms in certain genes (NOS3, ADRB2) may be associated with an increased risk of developing the condition and a change (mutation) in the norepinephrine transporter gene (SLC6A2) has been identified in one family with POTS.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""POTS"", ""full_form"": ""Postural orthostatic tachycardia syndrome""}]}",What causes POTS ?,What causes Postural orthostatic tachycardia syndrome ?,8,MEDICAL,Compound Datatype-String,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Plain Old Telephone Service"", ""Postural orthostatic tachycardia syndrome"", ""Plain Old Telephone Set"", ""Purchasing On-line Tracking System"", ""Parents Over The Shoulder"", ""Parting on the Square"", ""Poor Old Telephone System"", ""Part of the Solution"", ""Plain Old Time Sharing"", ""Perception of Teasing Scale""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Postural Orthostatic Tachycardia Syndrome""]",[2.7465032608294686e-18],[2.7465032608294686e-18],"[""Part of the Solution""]",[2.8241480231412295e-10],"[""ABBREVIATIONS""]","[[1.82597676132675e-18, 2.7465032608294686e-18, 7.838908286569125e-18, 8.93354875498175e-23, 7.370669586278845e-14, 3.650900142339024e-18, 1.1290783947140323e-17, 2.8241480231412295e-10, 4.92451730951359e-18, 5.917225629106812e-18]]",[0.8952005061362784],[0.8999297612182386],"[""Perception of Teasing Scale""]",[0.8999297612182386],"[""LLM""]","[[0.5777992322038727, 0.8952005061362784, 0.589445346302992, 0.6250041071145893, 0.62976010983183, 0.6459354872347733, 0.5986743330643085, 0.8027896665309788, 0.6017941273809053, 0.5923074005766358]]","[""Postural orthostatic tachycardia syndrome""]","[""ABBREVIATIONS""]",What causes POTS (Postural Orthostatic Tachycardia Syndrome) ?,[true],[true],[true],"[""POTS (Postural Orthostatic Tachycardia Syndrome) is caused by a dysfunction in the autonomic nervous system, leading to abnormal increases in heart rate when moving from lying down to standing up.""]","[""Postural orthostatic tachycardia syndrome (POTS) is caused by a malfunction in the nervous system that controls automatic functions in the body, such as heart rate and blood pressure. This dysfunction can lead to symptoms like lightheadedness, palpitations, and fatigue.""]","[""The exact cause of POTS is unknown, but it is believed to involve dysfunction in the autonomic nervous system.""]",[true],[true],[true],"[""The exact cause of POTS is unknown, but it is believed to involve a dysfunction in the autonomic nervous system.""]","[""Postural orthostatic tachycardia syndrome (POTS) is believed to be caused by a malfunction of the autonomic nervous system, which controls involuntary body functions such as heart rate, blood pressure, and digestion.""]","[""The exact cause of POTS is unknown, but it is believed to involve a malfunction in the autonomic nervous system.""]",[true],[true],[true],"[""Dysfunction of the autonomic nervous system""]","[""The exact cause of Postural orthostatic tachycardia syndrome (POTS) is unknown, but it is believed to involve a malfunction of the autonomic nervous system.""]","[""POTS is caused by a malfunction in the nervous system that controls involuntary bodily functions, leading to abnormal increases in heart rate when standing up.""]",[true],[true],[true],"[""The exact cause of POTS is unknown, but it is believed to be related to dysfunction in the autonomic nervous system.""]","[""The exact cause of Postural orthostatic tachycardia syndrome (POTS) is unknown, but it is believed to involve a malfunction of the autonomic nervous system.""]","[""The exact cause of POTS is unknown, but it is believed to involve abnormal regulation of the autonomic nervous system.""]",[false],[true],[true],"[""POTS (Perception of Teasing Scale) is a self-report questionnaire used to assess an individual's perception of teasing experiences.""]","[""Postural orthostatic tachycardia syndrome (POTS) is caused by a malfunction in the nervous system that controls automatic functions in the body, such as heart rate and blood pressure. This dysfunction can lead to symptoms like lightheadedness, palpitations, and fatigue.""]","[""The exact cause of POTS is unknown, but it is believed to involve dysfunction in the autonomic nervous system.""]",[false],[true],[true],"[""POTS (Perception of Teasing Scale) is a self-report questionnaire used to assess an individual's perception of teasing experiences, particularly in the context of body image and weight-related teasing.""]","[""Postural orthostatic tachycardia syndrome (POTS) is believed to be caused by a malfunction of the autonomic nervous system, which controls involuntary body functions such as heart rate, blood pressure, and digestion.""]","[""The exact cause of POTS is unknown, but it is believed to involve a malfunction in the autonomic nervous system.""]",[false],[true],[true],"[""POTS (Perception of Teasing Scale) is a self-report questionnaire used to assess an individual's perception of teasing experiences.""]","[""The exact cause of Postural orthostatic tachycardia syndrome (POTS) is unknown, but it is believed to involve a malfunction of the autonomic nervous system.""]","[""POTS is caused by a malfunction in the nervous system that controls involuntary bodily functions, leading to abnormal increases in heart rate when standing up.""]",[false],[true],[true],"[""POTS (Perception of Teasing Scale) is a self-report questionnaire used to assess an individual's perception of teasing experiences and their emotional responses to teasing.""]","[""The exact cause of Postural orthostatic tachycardia syndrome (POTS) is unknown, but it is believed to involve a malfunction of the autonomic nervous system.""]","[""The exact cause of POTS is unknown, but it is believed to involve abnormal regulation of the autonomic nervous system.""]",[true],[true],[true],"[""POTS is caused by a malfunction in the nervous system that controls involuntary body functions, leading to abnormal heart rate and blood pressure changes when moving from lying down to standing up.""]","[""Postural orthostatic tachycardia syndrome (POTS) is believed to be caused by a malfunction of the autonomic nervous system, which controls involuntary body functions such as heart rate, blood pressure, and digestion.""]","[""The exact cause of POTS is unknown, but it is believed to involve a malfunction in the autonomic nervous system.""]",[true],[true],[true],"[""The exact cause of POTS is unknown, but it is believed to involve abnormal regulation of the autonomic nervous system.""]","[""Postural orthostatic tachycardia syndrome (POTS) is caused by a malfunction in the nervous system that controls automatic functions in the body, such as heart rate and blood pressure. This dysfunction can lead to symptoms like lightheadedness, palpitations, and fatigue.""]","[""The exact cause of POTS is unknown, but it is believed to involve dysfunction in the autonomic nervous system.""]",[true],[true],[true],"[""The exact cause of POTS is unknown, but it is believed to involve a malfunction of the autonomic nervous system.""]","[""The exact cause of Postural orthostatic tachycardia syndrome (POTS) is unknown, but it is believed to involve a malfunction of the autonomic nervous system.""]","[""POTS is caused by a malfunction in the nervous system that controls involuntary bodily functions, leading to abnormal increases in heart rate when standing up.""]",[false],[true],[true],"[""POTS is caused by abnormal blood circulation, which leads to a rapid increase in heart rate when moving from lying down to standing up.""]","[""The exact cause of Postural orthostatic tachycardia syndrome (POTS) is unknown, but it is believed to involve a malfunction of the autonomic nervous system.""]","[""The exact cause of POTS is unknown, but it is believed to involve abnormal regulation of the autonomic nervous system.""]",[true],[true],[true],"[""The exact cause of POTS is unknown, but it is believed to involve abnormal regulation of the autonomic nervous system.""]","[""Postural orthostatic tachycardia syndrome (POTS) is caused by a malfunction in the nervous system that controls automatic functions in the body, such as heart rate and blood pressure. This dysfunction can lead to symptoms like lightheadedness, palpitations, and fatigue.""]","[""The exact cause of POTS is unknown, but it is believed to involve dysfunction in the autonomic nervous system.""]",[true],[true],[true],"[""The exact cause of POTS is unknown, but it is believed to involve abnormal regulation of the autonomic nervous system.""]","[""Postural orthostatic tachycardia syndrome (POTS) is believed to be caused by a malfunction of the autonomic nervous system, which controls involuntary body functions such as heart rate, blood pressure, and digestion.""]","[""The exact cause of POTS is unknown, but it is believed to involve a malfunction in the autonomic nervous system.""]",[true],[true],[true],"[""The exact cause of POTS is unknown, but it is believed to involve abnormalities in the autonomic nervous system.""]","[""The exact cause of Postural orthostatic tachycardia syndrome (POTS) is unknown, but it is believed to involve a malfunction of the autonomic nervous system.""]","[""POTS is caused by a malfunction in the nervous system that controls involuntary bodily functions, leading to abnormal increases in heart rate when standing up.""]",[true],[true],[true],"[""The exact cause of POTS is unknown, but it is believed to involve abnormal regulation of the autonomic nervous system.""]","[""The exact cause of Postural orthostatic tachycardia syndrome (POTS) is unknown, but it is believed to involve a malfunction of the autonomic nervous system.""]","[""The exact cause of POTS is unknown, but it is believed to involve abnormal regulation of the autonomic nervous system.""]",[true],[true],[true],"[""Dysfunction of the autonomic nervous system""]","[""Postural orthostatic tachycardia syndrome (POTS) is caused by a malfunction in the nervous system that controls automatic functions in the body, such as heart rate and blood pressure. This dysfunction can lead to symptoms like lightheadedness, palpitations, and fatigue.""]","[""The exact cause of POTS is unknown, but it is believed to involve dysfunction in the autonomic nervous system.""]",[false],[true],[true],"[""POTS is caused by abnormal blood circulation, which leads to a rapid increase in heart rate when standing up.""]","[""Postural orthostatic tachycardia syndrome (POTS) is believed to be caused by a malfunction of the autonomic nervous system, which controls involuntary body functions such as heart rate, blood pressure, and digestion.""]","[""The exact cause of POTS is unknown, but it is believed to involve a malfunction in the autonomic nervous system.""]",[true],[true],[true],"[""POTS is caused by abnormal blood circulation, which leads to a rapid increase in heart rate when standing up.""]","[""The exact cause of Postural orthostatic tachycardia syndrome (POTS) is unknown, but it is believed to involve a malfunction of the autonomic nervous system.""]","[""POTS is caused by a malfunction in the nervous system that controls involuntary bodily functions, leading to abnormal increases in heart rate when standing up.""]",[true],[true],[true],"[""The exact cause of POTS is unknown, but it is believed to involve abnormal regulation of the autonomic nervous system.""]","[""The exact cause of Postural orthostatic tachycardia syndrome (POTS) is unknown, but it is believed to involve a malfunction of the autonomic nervous system.""]","[""The exact cause of POTS is unknown, but it is believed to involve abnormal regulation of the autonomic nervous system.""]",[true],[true],[true],"[""POTS is caused by a malfunction in the nervous system that controls involuntary body functions.""]","[""Postural orthostatic tachycardia syndrome (POTS) is caused by a malfunction in the nervous system that controls automatic functions in the body, such as heart rate and blood pressure. This dysfunction can lead to symptoms like lightheadedness, palpitations, and fatigue.""]","[""The exact cause of POTS is unknown, but it is believed to involve dysfunction in the autonomic nervous system.""]",[true],[true],[true],"[""POTS is caused by a malfunction in the nervous system that controls involuntary body functions, leading to abnormal heart rate and blood pressure changes when moving from lying down to standing up.""]","[""Postural orthostatic tachycardia syndrome (POTS) is believed to be caused by a malfunction of the autonomic nervous system, which controls involuntary body functions such as heart rate, blood pressure, and digestion.""]","[""The exact cause of POTS is unknown, but it is believed to involve a malfunction in the autonomic nervous system.""]",[true],[true],[true],"[""POTS is caused by a malfunction in the nervous system that controls involuntary body functions, leading to abnormal heart rate and blood pressure changes when moving from lying down to standing up.""]","[""The exact cause of Postural orthostatic tachycardia syndrome (POTS) is unknown, but it is believed to involve a malfunction of the autonomic nervous system.""]","[""POTS is caused by a malfunction in the nervous system that controls involuntary bodily functions, leading to abnormal increases in heart rate when standing up.""]",[true],[true],[true],"[""POTS is caused by a malfunction in the nervous system that controls involuntary body functions such as heart rate and blood pressure.""]","[""The exact cause of Postural orthostatic tachycardia syndrome (POTS) is unknown, but it is believed to involve a malfunction of the autonomic nervous system.""]","[""The exact cause of POTS is unknown, but it is believed to involve abnormal regulation of the autonomic nervous system.""]",[true],[true],[true],"[""POTS is believed to be caused by abnormal regulation of the autonomic nervous system, which controls functions such as heart rate, blood pressure, and digestion.""]","[""Postural orthostatic tachycardia syndrome (POTS) is caused by a malfunction in the nervous system that controls automatic functions in the body, such as heart rate and blood pressure. This dysfunction can lead to symptoms like lightheadedness, palpitations, and fatigue.""]","[""The exact cause of POTS is unknown, but it is believed to involve dysfunction in the autonomic nervous system.""]",[true],[true],[true],"[""POTS is believed to be caused by a malfunction in the nervous system that regulates blood flow and pressure.""]","[""Postural orthostatic tachycardia syndrome (POTS) is believed to be caused by a malfunction of the autonomic nervous system, which controls involuntary body functions such as heart rate, blood pressure, and digestion.""]","[""The exact cause of POTS is unknown, but it is believed to involve a malfunction in the autonomic nervous system.""]",[true],[true],[true],"[""POTS is caused by abnormal blood circulation, which leads to a rapid increase in heart rate when moving from lying down to standing up.""]","[""The exact cause of Postural orthostatic tachycardia syndrome (POTS) is unknown, but it is believed to involve a malfunction of the autonomic nervous system.""]","[""POTS is caused by a malfunction in the nervous system that controls involuntary bodily functions, leading to abnormal increases in heart rate when standing up.""]",[true],[true],[true],"[""POTS is caused by a malfunction in the nervous system that controls involuntary body functions.""]","[""The exact cause of Postural orthostatic tachycardia syndrome (POTS) is unknown, but it is believed to involve a malfunction of the autonomic nervous system.""]","[""The exact cause of POTS is unknown, but it is believed to involve abnormal regulation of the autonomic nervous system.""]",[true],[true],[true],"[""Dysfunction of the autonomic nervous system""]","[""Postural orthostatic tachycardia syndrome (POTS) is caused by a malfunction in the nervous system that controls automatic functions in the body, such as heart rate and blood pressure. This dysfunction can lead to symptoms like lightheadedness, palpitations, and fatigue.""]","[""The exact cause of POTS is unknown, but it is believed to involve dysfunction in the autonomic nervous system.""]",[false],[true],[true],"[""POTS (Part of the Solution) is caused by a bacterial infection.""]","[""Postural orthostatic tachycardia syndrome (POTS) is caused by a malfunction in the nervous system that controls automatic functions in the body, such as heart rate and blood pressure. This dysfunction can lead to symptoms like lightheadedness, palpitations, and fatigue.""]","[""The exact cause of POTS is unknown, but it is believed to involve dysfunction in the autonomic nervous system.""]",[false],[true],[true],"[""POTS (Perception of Teasing Scale) is caused by a heightened sensitivity to teasing or criticism.""]","[""Postural orthostatic tachycardia syndrome (POTS) is caused by a malfunction in the nervous system that controls automatic functions in the body, such as heart rate and blood pressure. This dysfunction can lead to symptoms like lightheadedness, palpitations, and fatigue.""]","[""The exact cause of POTS is unknown, but it is believed to involve dysfunction in the autonomic nervous system.""]",[true],[true],[true],"[""Dysfunction of the autonomic nervous system""]","[""Postural orthostatic tachycardia syndrome (POTS) is caused by a malfunction in the nervous system that controls automatic functions in the body, such as heart rate and blood pressure. This dysfunction can lead to symptoms like lightheadedness, palpitations, and fatigue.""]","[""The exact cause of POTS is unknown, but it is believed to involve dysfunction in the autonomic nervous system.""]"
symptoms,What are the symptoms of Hereditary sensory neuropathy type 1 ?,"What are the signs and symptoms of Hereditary sensory neuropathy type 1? The Human Phenotype Ontology provides the following list of signs and symptoms for Hereditary sensory neuropathy type 1. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the skin - Areflexia - Autoamputation (feet) - Autosomal dominant inheritance - Chronic axonal neuropathy - Decreased number of large peripheral myelinated nerve fibers - Decreased sensory nerve conduction velocity - Distal muscle weakness - Distal sensory impairment - Distal sensory loss of all modalities - Hyporeflexia - Osteomyelitis - Osteomyelitis or necrosis, distal, due to sensory neuropathy (feet) - Pes cavus - Sensorineural hearing impairment - Skeletal muscle atrophy - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""HSN1"", ""full_form"": ""Hereditary sensory neuropathy type 1""}]}",What are the symptoms of HSN1 ?,What are the symptoms of Hereditary sensory neuropathy type 1 ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Hereditary Sensory Neuropathy Type 1""]]","[[""THEFREEDICTIONARY""]]","[""Hereditary Sensory Neuropathy Type 1""]",[1.40709343822982e-20],[1.40709343822982e-20],"[""Hereditary Sensory Neuropathy Type 1""]",[1.40709343822982e-20],"[""THEFREEDICTIONARY""]",[[1.40709343822982e-20]],[0.7736108130710925],[0.7744313495571786],"[""Hereditary sensory neuropathy type 1""]",[0.774431349557179],"[""THEFREEDICTIONARY""]",[[0.774431349557179]],"[""Hereditary Sensory Neuropathy Type 1""]","[""THEFREEDICTIONARY""]",What are the symptoms of HSN1 (Hereditary Sensory Neuropathy Type 1) ?,[true],[true],[true],"[""The symptoms of HSN1 (Hereditary Sensory Neuropathy Type 1) include loss of sensation to pain, temperature, and touch, muscle weakness, and decreased sweating.""]","[""Symptoms of Hereditary sensory neuropathy type 1 include loss of sensation in the extremities, muscle weakness, and foot deformities.""]","[""The symptoms of HSN1 include muscle weakness, loss of sensation, and difficulty walking.""]",[true],[true],[true],"[""The symptoms of HSN1 (Hereditary Sensory Neuropathy Type 1) include insensitivity to pain, inability to sweat, loss of sense of touch, muscle weakness, and foot deformities.""]","[""Symptoms of Hereditary sensory neuropathy type 1 include loss of sensation in the extremities, muscle weakness, foot deformities, and difficulty walking.""]","[""Symptoms of HSN1 include muscle weakness, difficulty walking, loss of sensation in the limbs, and foot deformities.""]",[true],[true],[true],"[""The symptoms of HSN1 (Hereditary Sensory Neuropathy Type 1) include loss of sensation to pain, temperature, and touch, muscle weakness, and decreased sweating.""]","[""Symptoms of Hereditary sensory neuropathy type 1 include loss of sensation in the extremities, muscle weakness, and foot deformities.""]","[""Symptoms of HSN1 include muscle weakness, difficulty walking, loss of sensation in the limbs, and foot deformities.""]",[true],[true],[true],"[""The symptoms of HSN1 (Hereditary Sensory Neuropathy Type 1) include loss of sensation to touch, heat, and cold; muscle weakness; and decreased ability to feel pain and sense body position.""]","[""The symptoms of Hereditary sensory neuropathy type 1 include loss of sensation in the extremities, muscle weakness, impaired reflexes, and foot deformities.""]","[""Symptoms of HSN1 include muscle weakness, difficulty walking, loss of sensation in the extremities, and foot deformities.""]",[true],[true],[true],"[""The symptoms of HSN1 (Hereditary sensory neuropathy type 1) include loss of sensation in the extremities, muscle weakness, decreased ability to feel pain and temperature changes, and foot deformities.""]","[""Symptoms of Hereditary sensory neuropathy type 1 include loss of sensation in the extremities, muscle weakness, and foot deformities.""]","[""The symptoms of HSN1 include muscle weakness, loss of sensation, and difficulty walking.""]",[true],[true],[true],"[""The symptoms of HSN1 (Hereditary sensory neuropathy type 1) include loss of sensation in the extremities, muscle weakness, and decreased ability to feel pain and temperature changes.""]","[""Symptoms of Hereditary sensory neuropathy type 1 include loss of sensation in the extremities, muscle weakness, foot deformities, and difficulty walking.""]","[""Symptoms of HSN1 include muscle weakness, difficulty walking, loss of sensation in the limbs, and foot deformities.""]",[true],[true],[true],"[""The symptoms of HSN1 (Hereditary sensory neuropathy type 1) include loss of sensation in the extremities, muscle weakness, impaired balance, and foot deformities.""]","[""Symptoms of Hereditary sensory neuropathy type 1 include loss of sensation in the extremities, muscle weakness, and foot deformities.""]","[""Symptoms of HSN1 include muscle weakness, difficulty walking, loss of sensation in the limbs, and foot deformities.""]",[true],[true],[true],"[""The symptoms of HSN1 (Hereditary sensory neuropathy type 1) include loss of sensation in the extremities, muscle weakness, impaired balance, and foot deformities.""]","[""The symptoms of Hereditary sensory neuropathy type 1 include loss of sensation in the extremities, muscle weakness, impaired reflexes, and foot deformities.""]","[""Symptoms of HSN1 include muscle weakness, difficulty walking, loss of sensation in the extremities, and foot deformities.""]",[true],[true],[true],"[""The symptoms of HSN1 (Hereditary Sensory Neuropathy Type 1) include loss of sensation in the extremities, muscle weakness, impaired balance, and foot deformities.""]","[""Symptoms of Hereditary sensory neuropathy type 1 include loss of sensation in the extremities, muscle weakness, foot deformities, and difficulty walking.""]","[""Symptoms of HSN1 include muscle weakness, difficulty walking, loss of sensation in the limbs, and foot deformities.""]",[true],[true],[true],"[""The symptoms of HSN1 (Hereditary Sensory Neuropathy Type 1) include loss of sensation to touch, heat, and cold, muscle weakness, and decreased ability to feel pain and sense hot and cold temperatures.""]","[""Symptoms of Hereditary sensory neuropathy type 1 include loss of sensation in the extremities, muscle weakness, and foot deformities.""]","[""The symptoms of HSN1 include muscle weakness, loss of sensation, and difficulty walking.""]",[true],[true],[true],"[""The symptoms of HSN1 (Hereditary Sensory Neuropathy Type 1) include loss of sensation to touch, heat, and cold, muscle weakness, and decreased ability to feel pain and sense hot and cold temperatures.""]","[""Symptoms of Hereditary sensory neuropathy type 1 include loss of sensation in the extremities, muscle weakness, and foot deformities.""]","[""Symptoms of HSN1 include muscle weakness, difficulty walking, loss of sensation in the limbs, and foot deformities.""]",[true],[true],[true],"[""The symptoms of HSN1 (Hereditary Sensory Neuropathy Type 1) include loss of sensation to touch, heat, and cold; muscle weakness; and decreased ability to feel pain and sense hot and cold temperatures.""]","[""The symptoms of Hereditary sensory neuropathy type 1 include loss of sensation in the extremities, muscle weakness, impaired reflexes, and foot deformities.""]","[""Symptoms of HSN1 include muscle weakness, difficulty walking, loss of sensation in the extremities, and foot deformities.""]",[false],[true],[true],"[""Pain insensitivity, inability to feel temperature changes, lack of sweating, slow healing of injuries""]","[""Symptoms of Hereditary sensory neuropathy type 1 include loss of sensation in the extremities, muscle weakness, and foot deformities.""]","[""The symptoms of HSN1 include muscle weakness, loss of sensation, and difficulty walking.""]",[false],[true],[true],"[""Pain insensitivity, inability to feel temperature changes, lack of sweating, slow healing of injuries""]","[""Symptoms of Hereditary sensory neuropathy type 1 include loss of sensation in the extremities, muscle weakness, foot deformities, and difficulty walking.""]","[""Symptoms of HSN1 include muscle weakness, difficulty walking, loss of sensation in the limbs, and foot deformities.""]",[true],[true],[true],"[""HSN1 (Hereditary Sensory Neuropathy Type 1) symptoms include loss of sensation in the hands and feet, muscle weakness, difficulty walking, foot deformities, and ulcers or sores on the feet.""]","[""Symptoms of Hereditary sensory neuropathy type 1 include loss of sensation in the extremities, muscle weakness, and foot deformities.""]","[""Symptoms of HSN1 include muscle weakness, difficulty walking, loss of sensation in the limbs, and foot deformities.""]",[true],[true],[true],"[""Loss of sensation in the extremities, muscle weakness, foot deformities""]","[""The symptoms of Hereditary sensory neuropathy type 1 include loss of sensation in the extremities, muscle weakness, impaired reflexes, and foot deformities.""]","[""Symptoms of HSN1 include muscle weakness, difficulty walking, loss of sensation in the extremities, and foot deformities.""]",[true],[true],[true],"[""Symptoms of HSN1 include loss of sensation to pain and temperature, muscle weakness, and foot deformities.""]","[""Symptoms of Hereditary sensory neuropathy type 1 include loss of sensation in the extremities, muscle weakness, and foot deformities.""]","[""The symptoms of HSN1 include muscle weakness, loss of sensation, and difficulty walking.""]",[false],[true],[true],"[""The symptoms of HSN1 (Hereditary Sensory Neuropathy Type 1) include loss of sensation to pain, temperature, and touch, muscle weakness, and decreased sweating.""]","[""Symptoms of Hereditary sensory neuropathy type 1 include loss of sensation in the extremities, muscle weakness, foot deformities, and difficulty walking.""]","[""Symptoms of HSN1 include muscle weakness, difficulty walking, loss of sensation in the limbs, and foot deformities.""]",[true],[true],[true],"[""The symptoms of HSN1 (Hereditary Sensory Neuropathy Type 1) include loss of sensation to pain, heat, and cold; muscle weakness; decreased sweating; and foot deformities.""]","[""Symptoms of Hereditary sensory neuropathy type 1 include loss of sensation in the extremities, muscle weakness, and foot deformities.""]","[""Symptoms of HSN1 include muscle weakness, difficulty walking, loss of sensation in the limbs, and foot deformities.""]",[true],[true],[true],"[""Symptoms of HSN1 include loss of sensation in the hands and feet, muscle weakness, and difficulty walking.""]","[""The symptoms of Hereditary sensory neuropathy type 1 include loss of sensation in the extremities, muscle weakness, impaired reflexes, and foot deformities.""]","[""Symptoms of HSN1 include muscle weakness, difficulty walking, loss of sensation in the extremities, and foot deformities.""]",[true],[true],[true],"[""The symptoms of HSN1 (Hereditary Sensory Neuropathy Type 1) include loss of sensation to touch, heat, and cold; muscle weakness; and decreased sweating.""]","[""Symptoms of Hereditary sensory neuropathy type 1 include loss of sensation in the extremities, muscle weakness, and foot deformities.""]","[""The symptoms of HSN1 include muscle weakness, loss of sensation, and difficulty walking.""]",[true],[true],[true],"[""The symptoms of HSN1 (Hereditary Sensory Neuropathy Type 1) include loss of sensation to pain and temperature, muscle weakness, impaired balance, and foot deformities.""]","[""Symptoms of Hereditary sensory neuropathy type 1 include loss of sensation in the extremities, muscle weakness, foot deformities, and difficulty walking.""]","[""Symptoms of HSN1 include muscle weakness, difficulty walking, loss of sensation in the limbs, and foot deformities.""]",[false],[true],[true],"[""Symptoms of HSN1 include insensitivity to pain, temperature, and touch, as well as ulcers or infections due to injuries that go unnoticed.""]","[""Symptoms of Hereditary sensory neuropathy type 1 include loss of sensation in the extremities, muscle weakness, and foot deformities.""]","[""Symptoms of HSN1 include muscle weakness, difficulty walking, loss of sensation in the limbs, and foot deformities.""]",[true],[true],[true],"[""The symptoms of HSN1 (Hereditary Sensory Neuropathy Type 1) include loss of sensation to touch, heat, and cold; muscle weakness; impaired balance and coordination; and foot deformities.""]","[""The symptoms of Hereditary sensory neuropathy type 1 include loss of sensation in the extremities, muscle weakness, impaired reflexes, and foot deformities.""]","[""Symptoms of HSN1 include muscle weakness, difficulty walking, loss of sensation in the extremities, and foot deformities.""]",[true],[true],[true],"[""The symptoms of HSN1 (Hereditary Sensory Neuropathy Type 1) include loss of sensation in the extremities, muscle weakness, impaired reflexes, and foot deformities.""]","[""Symptoms of Hereditary sensory neuropathy type 1 include loss of sensation in the extremities, muscle weakness, and foot deformities.""]","[""The symptoms of HSN1 include muscle weakness, loss of sensation, and difficulty walking.""]",[true],[true],[true],"[""The symptoms of HSN1 include loss of sensation in the extremities, muscle weakness, impaired balance, and foot deformities.""]","[""Symptoms of Hereditary sensory neuropathy type 1 include loss of sensation in the extremities, muscle weakness, foot deformities, and difficulty walking.""]","[""Symptoms of HSN1 include muscle weakness, difficulty walking, loss of sensation in the limbs, and foot deformities.""]",[true],[true],[true],"[""The symptoms of HSN1 (Hereditary Sensory Neuropathy Type 1) include loss of sensation in the extremities, inability to feel pain or temperature changes, ulcers or sores on the feet or hands, muscle weakness, and skeletal abnormalities.""]","[""Symptoms of Hereditary sensory neuropathy type 1 include loss of sensation in the extremities, muscle weakness, and foot deformities.""]","[""Symptoms of HSN1 include muscle weakness, difficulty walking, loss of sensation in the limbs, and foot deformities.""]",[true],[true],[true],"[""The symptoms of HSN1 (Hereditary Sensory Neuropathy Type 1) include loss of sensation in the extremities, inability to feel pain or temperature changes, ulcers or sores on the feet or hands, and muscle weakness.""]","[""The symptoms of Hereditary sensory neuropathy type 1 include loss of sensation in the extremities, muscle weakness, impaired reflexes, and foot deformities.""]","[""Symptoms of HSN1 include muscle weakness, difficulty walking, loss of sensation in the extremities, and foot deformities.""]",[true],[true],[true],"[""The symptoms of HSN1 include loss of sensation in the hands and feet, muscle weakness, difficulty walking, and foot deformities.""]","[""Symptoms of Hereditary sensory neuropathy type 1 include loss of sensation in the extremities, muscle weakness, and foot deformities.""]","[""The symptoms of HSN1 include muscle weakness, loss of sensation, and difficulty walking.""]",[true],[true],[true],"[""Symptoms of HSN1 include loss of sensation to pain, temperature, and touch, muscle weakness, and foot deformities.""]","[""Symptoms of Hereditary sensory neuropathy type 1 include loss of sensation in the extremities, muscle weakness, and foot deformities.""]","[""The symptoms of HSN1 include muscle weakness, loss of sensation, and difficulty walking.""]",[true],[true],[true],"[""Symptoms of HSN1 include loss of sensation in the extremities, muscle weakness, foot deformities, and difficulty walking.""]","[""Symptoms of Hereditary sensory neuropathy type 1 include loss of sensation in the extremities, muscle weakness, and foot deformities.""]","[""The symptoms of HSN1 include muscle weakness, loss of sensation, and difficulty walking.""]",[true],[true],[true],"[""The symptoms of HSN1 include loss of sensation to pain, temperature, and touch, muscle weakness, and foot deformities.""]","[""Symptoms of Hereditary sensory neuropathy type 1 include loss of sensation in the extremities, muscle weakness, and foot deformities.""]","[""The symptoms of HSN1 include muscle weakness, loss of sensation, and difficulty walking.""]"
symptoms,What are the symptoms of COPD ?,"Call your doctor right away if your symptoms worsen suddenly. People with COPD may have symptoms that suddenly get worse. When this happens, you have a much harder time catching your breath. Symptoms that worsen suddenly can include sudden chest tightness, more coughing, a change in your sputum (mucus), or fever. Your doctor will look at things that may be causing these sudden symptoms. Sometimes the symptoms are caused by a lung infection.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""abbreviation"", ""abbreviation"": ""COPD"", ""full_form"": ""Chronic Obstructive Pulmonary Disease""}]}",What are the symptoms of COPD ?,What are the symptoms of Chronic Obstructive Pulmonary Disease ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Chronic Obstructive Pulmonary Disease"", ""Chronic Oxygen Provision Depletion"", ""Community Outreach Program for the Deaf"", ""Controlling Organizing Planning Directing"", ""Council on Policy Development"", ""Complex Obstructive Pulmonary Disease"", ""Comprehensive Operation Planning Directive"", ""Child Occupant Presence Detection"", ""Chronic Obstructive Pulinonary Disease"", ""Chronic Obstructive Pulmonary Disease"", ""Coronary Obstruction Pulmonary Disease (cardiology)"", ""Certificate of Proficiency Dentistry"", ""Council of Participating Deans"", ""Community Outreach Program for the Deaf"", ""Coronado Police Department (California)"", ""Council on Policy Development"", ""Central Office Program Director"", ""Comprehensive Operation Planning Directive (NATO)""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER""]]","[""Chronic Obstructive Pulmonary Disease""]",[1.2464476684195735e-06],[1.2464476684195735e-06],"[""Chronic Obstructive Pulmonary Disease""]",[1.2464476684195735e-06],"[""ABBREVIATIONS""]","[[1.2464476684195735e-06, 1.4742516833940002e-13, 2.657961687937055e-23, 7.234290656367874e-24, 3.588434479025087e-19, 5.984076693946281e-10, 2.6834429288227837e-21, 5.269876178872401e-22, 9.133190855376973e-22, 1.2464476684195735e-06, 1.3291685167333418e-24, 5.28803348992021e-25, 4.1543710004593145e-20, 2.657961687937055e-23, 2.5832001189390563e-33, 3.588434479025087e-19, 3.786809199265226e-19, 1.4928106475825366e-32]]",[0.8857843169252821],[0.8857843169252821],"[""Chronic Obstructive Pulmonary Disease""]",[0.8857843169252821],"[""ABBREVIATIONS""]","[[0.8857843169252821, 0.7816912008325902, 0.7391834235724908, 0.7455640611080598, 0.7593724000031654, 0.8354212206836424, 0.7497855126188686, 0.5950858614540395, 0.833190180843399, 0.8857843169252821, 0.7692482402288997, 0.7357111853510119, 0.7321743695098029, 0.7391834235724908, 0.7652568112263822, 0.7593724000031654, 0.7345234306206868, 0.710367068159]]","[""Chronic Obstructive Pulmonary Disease""]","[""ACRONYMFINDER""]",What are the symptoms of COPD (Chronic Obstructive Pulmonary Disease) ?,[true],[true],[true],"[""Shortness of breath, wheezing, chest tightness, chronic cough""]","[""Shortness of breath, wheezing, chest tightness, chronic cough""]","[""Shortness of breath, chronic cough, wheezing, chest tightness""]",[true],[true],[true],"[""Shortness of breath, chronic cough, wheezing, chest tightness""]","[""Shortness of breath, chronic cough, wheezing, chest tightness""]","[""Shortness of breath, chronic cough, wheezing, chest tightness""]",[true],[true],[true],"[""Shortness of breath, chronic cough, wheezing, chest tightness""]","[""Shortness of breath, wheezing, chest tightness, chronic cough""]","[""Shortness of breath, chronic cough, wheezing, chest tightness""]",[true],[true],[true],"[""Shortness of breath, chronic cough, wheezing, chest tightness""]","[""Shortness of breath, wheezing, chest tightness, chronic cough""]","[""Shortness of breath, chronic cough, wheezing, chest tightness""]",[true],[true],[true],"[""Shortness of breath, chronic cough, wheezing, chest tightness""]","[""Shortness of breath, wheezing, chest tightness, chronic cough""]","[""Shortness of breath, chronic cough, wheezing, chest tightness""]",[true],[true],[true],"[""Shortness of breath, chronic cough, wheezing, chest tightness""]","[""Shortness of breath, chronic cough, wheezing, chest tightness""]","[""Shortness of breath, chronic cough, wheezing, chest tightness""]",[true],[true],[true],"[""Shortness of breath, chronic cough, wheezing, chest tightness""]","[""Shortness of breath, wheezing, chest tightness, chronic cough""]","[""Shortness of breath, chronic cough, wheezing, chest tightness""]",[true],[true],[true],"[""Shortness of breath, chronic cough, wheezing, chest tightness""]","[""Shortness of breath, wheezing, chest tightness, chronic cough""]","[""Shortness of breath, chronic cough, wheezing, chest tightness""]",[true],[true],[true],"[""Shortness of breath, chronic cough, wheezing, chest tightness""]","[""Shortness of breath, chronic cough, wheezing, chest tightness""]","[""Shortness of breath, chronic cough, wheezing, chest tightness""]",[true],[true],[true],"[""Shortness of breath, wheezing, chest tightness, chronic cough""]","[""Shortness of breath, wheezing, chest tightness, chronic cough""]","[""Shortness of breath, chronic cough, wheezing, chest tightness""]",[true],[true],[true],"[""Shortness of breath, wheezing, chest tightness, chronic cough""]","[""Shortness of breath, wheezing, chest tightness, chronic cough""]","[""Shortness of breath, chronic cough, wheezing, chest tightness""]",[true],[true],[true],"[""Shortness of breath, chronic cough, wheezing, chest tightness""]","[""Shortness of breath, wheezing, chest tightness, chronic cough""]","[""Shortness of breath, chronic cough, wheezing, chest tightness""]",[true],[true],[true],"[""Shortness of breath, wheezing, chronic cough, chest tightness""]","[""Shortness of breath, wheezing, chest tightness, chronic cough""]","[""Shortness of breath, chronic cough, wheezing, chest tightness""]",[true],[true],[true],"[""Shortness of breath, chronic cough, wheezing, chest tightness""]","[""Shortness of breath, chronic cough, wheezing, chest tightness""]","[""Shortness of breath, chronic cough, wheezing, chest tightness""]",[true],[true],[true],"[""Shortness of breath, chronic cough, wheezing, chest tightness""]","[""Shortness of breath, wheezing, chest tightness, chronic cough""]","[""Shortness of breath, chronic cough, wheezing, chest tightness""]",[true],[true],[true],"[""Shortness of breath, chronic cough, wheezing, chest tightness""]","[""Shortness of breath, wheezing, chest tightness, chronic cough""]","[""Shortness of breath, chronic cough, wheezing, chest tightness""]",[true],[true],[true],"[""Shortness of breath, chronic cough, wheezing, chest tightness""]","[""Shortness of breath, wheezing, chest tightness, chronic cough""]","[""Shortness of breath, chronic cough, wheezing, chest tightness""]",[true],[true],[true],"[""Shortness of breath, wheezing, chest tightness, chronic cough""]","[""Shortness of breath, chronic cough, wheezing, chest tightness""]","[""Shortness of breath, chronic cough, wheezing, chest tightness""]",[true],[true],[true],"[""Shortness of breath, wheezing, chest tightness, chronic cough""]","[""Shortness of breath, wheezing, chest tightness, chronic cough""]","[""Shortness of breath, chronic cough, wheezing, chest tightness""]",[true],[true],[true],"[""Shortness of breath, wheezing, chest tightness, chronic cough""]","[""Shortness of breath, wheezing, chest tightness, chronic cough""]","[""Shortness of breath, chronic cough, wheezing, chest tightness""]",[true],[true],[true],"[""Shortness of breath, chronic cough, wheezing, chest tightness""]","[""Shortness of breath, wheezing, chest tightness, chronic cough""]","[""Shortness of breath, chronic cough, wheezing, chest tightness""]",[true],[true],[true],"[""Shortness of breath, chronic cough, wheezing, chest tightness""]","[""Shortness of breath, chronic cough, wheezing, chest tightness""]","[""Shortness of breath, chronic cough, wheezing, chest tightness""]",[true],[true],[true],"[""Shortness of breath, chronic cough, wheezing, chest tightness""]","[""Shortness of breath, wheezing, chest tightness, chronic cough""]","[""Shortness of breath, chronic cough, wheezing, chest tightness""]",[true],[true],[true],"[""Shortness of breath, chronic cough, wheezing, chest tightness""]","[""Shortness of breath, wheezing, chest tightness, chronic cough""]","[""Shortness of breath, chronic cough, wheezing, chest tightness""]",[true],[true],[true],"[""Common symptoms of COPD include shortness of breath, chronic cough, wheezing, and chest tightness.""]","[""Shortness of breath, wheezing, chest tightness, chronic cough""]","[""Shortness of breath, chronic cough, wheezing, chest tightness""]",[true],[true],[true],"[""Common symptoms of COPD include shortness of breath, chronic cough, wheezing, and chest tightness.""]","[""Shortness of breath, chronic cough, wheezing, chest tightness""]","[""Shortness of breath, chronic cough, wheezing, chest tightness""]",[true],[true],[true],"[""Common symptoms of COPD include shortness of breath, chronic cough, wheezing, and chest tightness.""]","[""Shortness of breath, wheezing, chest tightness, chronic cough""]","[""Shortness of breath, chronic cough, wheezing, chest tightness""]",[true],[true],[true],"[""Common symptoms of COPD include shortness of breath, chronic cough, wheezing, and chest tightness.""]","[""Shortness of breath, wheezing, chest tightness, chronic cough""]","[""Shortness of breath, chronic cough, wheezing, chest tightness""]",[true],[true],[true],"[""Shortness of breath, chronic cough, wheezing, chest tightness""]","[""Shortness of breath, wheezing, chest tightness, chronic cough""]","[""Shortness of breath, chronic cough, wheezing, chest tightness""]",[true],[true],[true],"[""Shortness of breath, chronic cough, wheezing, chest tightness""]","[""Shortness of breath, wheezing, chest tightness, chronic cough""]","[""Shortness of breath, chronic cough, wheezing, chest tightness""]",[true],[true],[true],"[""Shortness of breath, chronic cough, wheezing, chest tightness""]","[""Shortness of breath, wheezing, chest tightness, chronic cough""]","[""Shortness of breath, chronic cough, wheezing, chest tightness""]",[true],[true],[true],"[""Shortness of breath, chronic cough, wheezing, chest tightness""]","[""Shortness of breath, wheezing, chest tightness, chronic cough""]","[""Shortness of breath, chronic cough, wheezing, chest tightness""]"
treatment,What are the treatments for Lambert Eaton myasthenic syndrome ?,"How might Lambert-Eaton myasthenic syndrome be treated? Medications and therapies used to treat Lambert-Eaton myasthenic syndrome may include anticholinesterase agents (e.g., Pyridostigmine), guanidine hydrochloride, plasmapheresis (where blood plasma is removed and replaced with fluid, protein, or donated plasma) or IV immunoglobulins, steroids (e.g., prednisone), azathioprine or cyclosporine, and/or 3,4-diaminopyridine. 3,4-diaminopyridine is available in Europe and may be available in the U.S. on a compassionate use basis. While there has been some evidence that either 3,4-diaminopyridine or IV immunoglobulin can improve muscle strength and nerve to muscle cell communication, the degree of benefit (i.e., how much symptoms are improved) still needs to be determined.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""LEMS"", ""full_form"": ""Lambert Eaton myasthenic syndrome""}]}",What are the treatments for LEMS ?,What are the treatments for Lambert Eaton myasthenic syndrome ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Law Enforcement Message Switch"", ""Larchwood Emergency Medical Service"", ""Low Entropy Model Specification"", ""Laboratory Emissions Monitoring System"", ""Labour Export Management System"", ""Lake Elkhorn Middle School"", ""Law Enforcement Management System"", ""Local Energy Measurement Stations"", ""Low Energy Mass Spectrometry"", ""Lugoff Elgin Middle School""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Lambert-Eaton Myasthenic Syndrome""]",[4.09881454945296e-23],[1.143709507803303e-24],"[""Law Enforcement Management System""]",[2.325264789578787e-15],"[""ABBREVIATIONS""]","[[1.99320481078212e-21, 3.6079473235772274e-22, 1.012085657155427e-22, 3.525858934159585e-19, 1.9223925331664394e-19, 2.2537595869504686e-27, 2.325264789578787e-15, 2.5452714018536016e-21, 2.0720491561834016e-22, 7.966186474258104e-27]]",[0.9161702779617623],[0.911480109184938],"[""Lugoff Elgin Middle School""]",[0.911480109184938],"[""LLM""]","[[0.7606389164124259, 0.9086966947957131, 0.7613261988183955, 0.7180188659246527, 0.6765079291309841, 0.8398709553502512, 0.6943417813268624, 0.674760147163913, 0.864035725153618, 0.795947621523635]]","[""Lambert-Eaton Myasthenic Syndrome""]","[""LLM""]",What are the treatments for LEMS (Lambert-Eaton Myasthenic Syndrome) ?,[false],[true],[true],"[""The treatments for LEMS (Lambert-Eaton myasthenic syndrome) include immunosuppressive medications, plasma exchange, intravenous immunoglobulin (IVIG) therapy, and supportive treatments for symptoms such as physical therapy and assistive devices.""]","[""Treatment for Lambert Eaton myasthenic syndrome includes immunosuppressive therapy, plasma exchange, intravenous immunoglobulin, and symptomatic treatment with cholinesterase inhibitors.""]","[""The treatments for Lambert-Eaton myasthenic syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG) therapy, and symptomatic treatments such as 3,4-diaminopyridine (3,4-DAP) and pyridostigmine.""]",[true],[true],[true],"[""The treatments for Lambert-Eaton myasthenic syndrome (LEMS) include immunosuppressive therapy, plasma exchange, intravenous immunoglobulin (IVIG) therapy, and symptomatic treatment with 3,4-diaminopyridine (3,4-DAP).""]","[""The treatments for Lambert Eaton myasthenic syndrome include immunosuppressive therapy, plasma exchange, intravenous immunoglobulin (IVIG) therapy, and symptomatic treatments such as cholinesterase inhibitors and 3,4-diaminopyridine.""]","[""The treatments for Lambert-Eaton myasthenic syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG), and symptomatic treatments such as 3,4-diaminopyridine (3,4-DAP) and pyridostigmine.""]",[true],[true],[true],"[""The treatments for LEMS (Lambert-Eaton myasthenic syndrome) include immunosuppressive therapy, plasma exchange, intravenous immunoglobulin (IVIG) therapy, and symptomatic treatment with medications such as 3,4-diaminopyridine (3,4-DAP) and pyridostigmine.""]","[""The treatments for Lambert Eaton myasthenic syndrome include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG) therapy, and supportive care for symptoms.""]","[""The treatments for Lambert-Eaton myasthenic syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG), and symptomatic treatment with 3,4-diaminopyridine (3,4-DAP).""]",[true],[true],[true],"[""The treatments for LEMS (Lambert-Eaton myasthenic syndrome) include immunosuppressive medications, plasma exchange, intravenous immunoglobulin (IVIG) therapy, and supportive treatments for symptoms such as physical therapy and occupational therapy.""]","[""The treatments for Lambert Eaton myasthenic syndrome include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG) therapy, and supportive care for symptoms.""]","[""The treatments for Lambert-Eaton myasthenic syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG), and symptomatic treatments such as 3,4-diaminopyridine (3,4-DAP) and pyridostigmine.""]",[true],[true],[true],"[""The treatments for Lambert-Eaton myasthenic syndrome (LEMS) include immunosuppressive therapy, symptomatic treatment with 3,4-diaminopyridine (3,4-DAP), and supportive care.""]","[""Treatment for Lambert Eaton myasthenic syndrome includes immunosuppressive therapy, plasma exchange, intravenous immunoglobulin, and symptomatic treatment with cholinesterase inhibitors.""]","[""The treatments for Lambert-Eaton myasthenic syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG) therapy, and symptomatic treatments such as 3,4-diaminopyridine (3,4-DAP) and pyridostigmine.""]",[true],[true],[true],"[""The treatments for Lambert-Eaton myasthenic syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG), and 3,4-diaminopyridine (3,4-DAP).""]","[""The treatments for Lambert Eaton myasthenic syndrome include immunosuppressive therapy, plasma exchange, intravenous immunoglobulin (IVIG) therapy, and symptomatic treatments such as cholinesterase inhibitors and 3,4-diaminopyridine.""]","[""The treatments for Lambert-Eaton myasthenic syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG), and symptomatic treatments such as 3,4-diaminopyridine (3,4-DAP) and pyridostigmine.""]",[true],[true],[true],"[""The treatments for Lambert-Eaton myasthenic syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG), and 3,4-diaminopyridine (3,4-DAP).""]","[""The treatments for Lambert Eaton myasthenic syndrome include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG) therapy, and supportive care for symptoms.""]","[""The treatments for Lambert-Eaton myasthenic syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG), and symptomatic treatment with 3,4-diaminopyridine (3,4-DAP).""]",[true],[true],[true],"[""The treatments for Lambert-Eaton myasthenic syndrome (LEMS) include immunosuppressive therapy, plasma exchange, intravenous immunoglobulin (IVIG) therapy, and symptomatic treatment with 3,4-diaminopyridine (3,4-DAP) or guanidine.""]","[""The treatments for Lambert Eaton myasthenic syndrome include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG) therapy, and supportive care for symptoms.""]","[""The treatments for Lambert-Eaton myasthenic syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG), and symptomatic treatments such as 3,4-diaminopyridine (3,4-DAP) and pyridostigmine.""]",[true],[true],[true],"[""The treatments for Lambert-Eaton Myasthenic Syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG), and symptomatic treatment with 3,4-diaminopyridine (3,4-DAP) or amifampridine.""]","[""The treatments for Lambert Eaton myasthenic syndrome include immunosuppressive therapy, plasma exchange, intravenous immunoglobulin (IVIG) therapy, and symptomatic treatments such as cholinesterase inhibitors and 3,4-diaminopyridine.""]","[""The treatments for Lambert-Eaton myasthenic syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG), and symptomatic treatments such as 3,4-diaminopyridine (3,4-DAP) and pyridostigmine.""]",[true],[true],[true],"[""The treatments for Lambert-Eaton Myasthenic Syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG), and symptomatic treatments such as 3,4-diaminopyridine (3,4-DAP) and pyridostigmine.""]","[""Treatment for Lambert Eaton myasthenic syndrome includes immunosuppressive therapy, plasma exchange, intravenous immunoglobulin, and symptomatic treatment with cholinesterase inhibitors.""]","[""The treatments for Lambert-Eaton myasthenic syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG) therapy, and symptomatic treatments such as 3,4-diaminopyridine (3,4-DAP) and pyridostigmine.""]",[true],[true],[true],"[""The treatments for Lambert-Eaton Myasthenic Syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG) therapy, and symptomatic treatments such as 3,4-diaminopyridine (3,4-DAP) and pyridostigmine.""]","[""The treatments for Lambert Eaton myasthenic syndrome include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG) therapy, and supportive care for symptoms.""]","[""The treatments for Lambert-Eaton myasthenic syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG), and symptomatic treatment with 3,4-diaminopyridine (3,4-DAP).""]",[true],[true],[true],"[""The treatments for Lambert-Eaton Myasthenic Syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG) therapy, and symptomatic treatments such as 3,4-diaminopyridine (3,4-DAP) and pyridostigmine.""]","[""The treatments for Lambert Eaton myasthenic syndrome include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG) therapy, and supportive care for symptoms.""]","[""The treatments for Lambert-Eaton myasthenic syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG), and symptomatic treatments such as 3,4-diaminopyridine (3,4-DAP) and pyridostigmine.""]",[true],[true],[true],"[""The treatments for Lambert-Eaton Myasthenic Syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG) therapy, and symptomatic treatment with acetylcholinesterase inhibitors.""]","[""Treatment for Lambert Eaton myasthenic syndrome includes immunosuppressive therapy, plasma exchange, intravenous immunoglobulin, and symptomatic treatment with cholinesterase inhibitors.""]","[""The treatments for Lambert-Eaton myasthenic syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG) therapy, and symptomatic treatments such as 3,4-diaminopyridine (3,4-DAP) and pyridostigmine.""]",[false],[true],[true],"[""Immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG), and symptomatic treatments such as physical therapy and medications to improve muscle strength""]","[""The treatments for Lambert Eaton myasthenic syndrome include immunosuppressive therapy, plasma exchange, intravenous immunoglobulin (IVIG) therapy, and symptomatic treatments such as cholinesterase inhibitors and 3,4-diaminopyridine.""]","[""The treatments for Lambert-Eaton myasthenic syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG), and symptomatic treatments such as 3,4-diaminopyridine (3,4-DAP) and pyridostigmine.""]",[true],[true],[true],"[""Immunosuppressants, Symptomatic treatment, Plasma exchange, Intravenous immunoglobulin (IVIG)""]","[""The treatments for Lambert Eaton myasthenic syndrome include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG) therapy, and supportive care for symptoms.""]","[""The treatments for Lambert-Eaton myasthenic syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG), and symptomatic treatment with 3,4-diaminopyridine (3,4-DAP).""]",[true],[true],[true],"[""Immunosuppressants, cholinesterase inhibitors, intravenous immunoglobulin (IVIG), plasmapheresis, and physical therapy""]","[""The treatments for Lambert Eaton myasthenic syndrome include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG) therapy, and supportive care for symptoms.""]","[""The treatments for Lambert-Eaton myasthenic syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG), and symptomatic treatments such as 3,4-diaminopyridine (3,4-DAP) and pyridostigmine.""]",[true],[true],[true],"[""The treatments for Lambert-Eaton Myasthenic Syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG) therapy, and symptomatic treatments such as 3,4-diaminopyridine (3,4-DAP) and pyridostigmine.""]","[""Treatment for Lambert Eaton myasthenic syndrome includes immunosuppressive therapy, plasma exchange, intravenous immunoglobulin, and symptomatic treatment with cholinesterase inhibitors.""]","[""The treatments for Lambert-Eaton myasthenic syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG) therapy, and symptomatic treatments such as 3,4-diaminopyridine (3,4-DAP) and pyridostigmine.""]",[true],[true],[true],"[""The treatments for Lambert-Eaton Myasthenic Syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG) therapy, and symptomatic treatments such as 3,4-diaminopyridine (3,4-DAP) and pyridostigmine.""]","[""The treatments for Lambert Eaton myasthenic syndrome include immunosuppressive therapy, plasma exchange, intravenous immunoglobulin (IVIG) therapy, and symptomatic treatments such as cholinesterase inhibitors and 3,4-diaminopyridine.""]","[""The treatments for Lambert-Eaton myasthenic syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG), and symptomatic treatments such as 3,4-diaminopyridine (3,4-DAP) and pyridostigmine.""]",[true],[true],[true],"[""The treatments for Lambert-Eaton Myasthenic Syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG), and symptomatic treatments such as 3,4-diaminopyridine (3,4-DAP) and pyridostigmine.""]","[""The treatments for Lambert Eaton myasthenic syndrome include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG) therapy, and supportive care for symptoms.""]","[""The treatments for Lambert-Eaton myasthenic syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG), and symptomatic treatment with 3,4-diaminopyridine (3,4-DAP).""]",[true],[true],[true],"[""The treatments for Lambert-Eaton Myasthenic Syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG) therapy, and symptomatic treatment with medications such as 3,4-diaminopyridine (3,4-DAP) and guanidine.""]","[""The treatments for Lambert Eaton myasthenic syndrome include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG) therapy, and supportive care for symptoms.""]","[""The treatments for Lambert-Eaton myasthenic syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG), and symptomatic treatments such as 3,4-diaminopyridine (3,4-DAP) and pyridostigmine.""]",[true],[true],[true],"[""The treatments for Lambert-Eaton Myasthenic Syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG) therapy, and symptomatic treatments such as 3,4-diaminopyridine (3,4-DAP) and pyridostigmine.""]","[""Treatment for Lambert Eaton myasthenic syndrome includes immunosuppressive therapy, plasma exchange, intravenous immunoglobulin, and symptomatic treatment with cholinesterase inhibitors.""]","[""The treatments for Lambert-Eaton myasthenic syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG) therapy, and symptomatic treatments such as 3,4-diaminopyridine (3,4-DAP) and pyridostigmine.""]",[true],[true],[true],"[""The treatments for Lambert-Eaton Myasthenic Syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG), and symptomatic treatments such as 3,4-diaminopyridine (3,4-DAP) and pyridostigmine.""]","[""The treatments for Lambert Eaton myasthenic syndrome include immunosuppressive therapy, plasma exchange, intravenous immunoglobulin (IVIG) therapy, and symptomatic treatments such as cholinesterase inhibitors and 3,4-diaminopyridine.""]","[""The treatments for Lambert-Eaton myasthenic syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG), and symptomatic treatments such as 3,4-diaminopyridine (3,4-DAP) and pyridostigmine.""]",[true],[true],[true],"[""The treatments for Lambert-Eaton Myasthenic Syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG) therapy, and symptomatic treatment with medications such as 3,4-diaminopyridine (3,4-DAP) or guanidine.""]","[""The treatments for Lambert Eaton myasthenic syndrome include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG) therapy, and supportive care for symptoms.""]","[""The treatments for Lambert-Eaton myasthenic syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG), and symptomatic treatment with 3,4-diaminopyridine (3,4-DAP).""]",[true],[true],[true],"[""The treatments for Lambert-Eaton Myasthenic Syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG), and symptomatic treatments such as 3,4-diaminopyridine (3,4-DAP) and pyridostigmine.""]","[""The treatments for Lambert Eaton myasthenic syndrome include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG) therapy, and supportive care for symptoms.""]","[""The treatments for Lambert-Eaton myasthenic syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG), and symptomatic treatments such as 3,4-diaminopyridine (3,4-DAP) and pyridostigmine.""]",[true],[true],[true],"[""The treatments for Lambert-Eaton Myasthenic Syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG), and symptomatic treatments such as 3,4-diaminopyridine (3,4-DAP) and pyridostigmine.""]","[""Treatment for Lambert Eaton myasthenic syndrome includes immunosuppressive therapy, plasma exchange, intravenous immunoglobulin, and symptomatic treatment with cholinesterase inhibitors.""]","[""The treatments for Lambert-Eaton myasthenic syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG) therapy, and symptomatic treatments such as 3,4-diaminopyridine (3,4-DAP) and pyridostigmine.""]",[true],[true],[true],"[""The treatments for Lambert-Eaton Myasthenic Syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG), and 3,4-diaminopyridine (3,4-DAP).""]","[""The treatments for Lambert Eaton myasthenic syndrome include immunosuppressive therapy, plasma exchange, intravenous immunoglobulin (IVIG) therapy, and symptomatic treatments such as cholinesterase inhibitors and 3,4-diaminopyridine.""]","[""The treatments for Lambert-Eaton myasthenic syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG), and symptomatic treatments such as 3,4-diaminopyridine (3,4-DAP) and pyridostigmine.""]",[true],[true],[true],"[""The treatments for Lambert-Eaton Myasthenic Syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG), and symptomatic treatment with medications such as 3,4-diaminopyridine (3,4-DAP) and guanidine.""]","[""The treatments for Lambert Eaton myasthenic syndrome include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG) therapy, and supportive care for symptoms.""]","[""The treatments for Lambert-Eaton myasthenic syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG), and symptomatic treatment with 3,4-diaminopyridine (3,4-DAP).""]",[true],[true],[true],"[""The treatments for Lambert-Eaton Myasthenic Syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG), and symptomatic treatments such as 3,4-diaminopyridine (3,4-DAP) and pyridostigmine.""]","[""The treatments for Lambert Eaton myasthenic syndrome include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG) therapy, and supportive care for symptoms.""]","[""The treatments for Lambert-Eaton myasthenic syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG), and symptomatic treatments such as 3,4-diaminopyridine (3,4-DAP) and pyridostigmine.""]",[true],[true],[true],"[""The treatments for Lambert-Eaton Myasthenic Syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG), and symptomatic treatments such as 3,4-diaminopyridine (3,4-DAP) and guanidine.""]","[""Treatment for Lambert Eaton myasthenic syndrome includes immunosuppressive therapy, plasma exchange, intravenous immunoglobulin, and symptomatic treatment with cholinesterase inhibitors.""]","[""The treatments for Lambert-Eaton myasthenic syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG) therapy, and symptomatic treatments such as 3,4-diaminopyridine (3,4-DAP) and pyridostigmine.""]",[false],[true],[true],"[""The treatments for LEMS (Law Enforcement Management System) include physical therapy, medications such as 3,4-diaminopyridine (3,4-DAP) and immunosuppressants, and in some cases, plasmapheresis or intravenous immunoglobulin (IVIG) therapy.""]","[""Treatment for Lambert Eaton myasthenic syndrome includes immunosuppressive therapy, plasma exchange, intravenous immunoglobulin, and symptomatic treatment with cholinesterase inhibitors.""]","[""The treatments for Lambert-Eaton myasthenic syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG) therapy, and symptomatic treatments such as 3,4-diaminopyridine (3,4-DAP) and pyridostigmine.""]",[true],[true],[true],"[""The treatments for LEMS (Lambert-Eaton myasthenic syndrome) may include immunosuppressive medications, plasma exchange, intravenous immunoglobulin (IVIG) therapy, and supportive treatments for symptoms such as weakness and fatigue.""]","[""Treatment for Lambert Eaton myasthenic syndrome includes immunosuppressive therapy, plasma exchange, intravenous immunoglobulin, and symptomatic treatment with cholinesterase inhibitors.""]","[""The treatments for Lambert-Eaton myasthenic syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG) therapy, and symptomatic treatments such as 3,4-diaminopyridine (3,4-DAP) and pyridostigmine.""]",[true],[true],[true],"[""The treatments for Lambert-Eaton Myasthenic Syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG), and symptomatic treatments such as 3,4-diaminopyridine (3,4-DAP) and guanidine.""]","[""Treatment for Lambert Eaton myasthenic syndrome includes immunosuppressive therapy, plasma exchange, intravenous immunoglobulin, and symptomatic treatment with cholinesterase inhibitors.""]","[""The treatments for Lambert-Eaton myasthenic syndrome (LEMS) include immunosuppressants, plasma exchange, intravenous immunoglobulin (IVIG) therapy, and symptomatic treatments such as 3,4-diaminopyridine (3,4-DAP) and pyridostigmine.""]"
frequency,How many people are affected by leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation ?,LBSL is a rare condition. Its exact prevalence is not known.,"{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""LBSL"", ""full_form"": ""leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation""}]}",How many people are affected by LBSL ?,How many people are affected by leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation ?,8,MEDICAL,Simple Datatype-Integer,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""London Bus Services Limited"", ""Lower Boy Scout Lake (California)"", ""Lower Bucks Swim League (Pennsylvania)"", ""London Bus Services Limited (UK)"", ""Laminated Bamboo Strip Lumber (construction)"", ""Lower Bucks Swim League (Pennsylvania)"", ""London Bus Services Limited (UK)"", ""Laminated Bamboo Strip Lumber (construction)"", ""Lower Boy Scout Lake (California)""]]","[[""ABBREVIATIONS"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY""]]","[""Leukoencephalopathy with Brain Stem and Spinal Cord Involvement and Lactate Elevation""]",[1.20419626545109e-30],[9.092143106296387e-33],"[""London Bus Services Limited""]",[6.356694463270774e-23],"[""ABBREVIATIONS""]","[[6.356694463270774e-23, 6.857166577253235e-36, 2.47736644153691e-40, 1.21036115337011e-34, 5.090602995215923e-39, 2.47736644153691e-40, 1.21036115337011e-34, 5.090602995215923e-39, 6.857166577253235e-36]]",[0.9024639518975474],[0.902909196855016],"[""Lower Boy Scout Lake (California)""]",[0.902909196855016],"[""LLM""]","[[0.622523668489759, 0.7003528219041437, 0.6289218203298949, 0.652440656781419, 0.6758410269769981, 0.6289218203298949, 0.652440656781419, 0.6758410269769985, 0.7003528219041443]]","[""Leukoencephalopathy with Brain Stem and Spinal Cord Involvement and Lactate Elevation""]","[""LLM""]",How many people are affected by LBSL (Leukoencephalopathy with Brain Stem and Spinal Cord Involvement and Lactate Elevation) ?,[false],[true],[false],"[""LBSL (London Bus Services Limited) is a transportation company and does not affect people in a medical context.""]","[""Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation affects a very small number of individuals worldwide.""]","[""LBSL affects approximately 1 in 50,000 individuals.""]",[false],[true],[true],"[""LBSL (London Bus Services Limited) affects a very small number of people, as it is a bus service provider in London and not a medical condition or disease.""]","[""Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation affects approximately 100 individuals worldwide.""]","[""LBSL affects a very small number of people worldwide.""]",[false],[true],[false],"[""LBSL (London Bus Services Limited) is a transportation company and does not affect people in a medical context.""]","[""Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation affects a very small number of individuals worldwide.""]","[""LBSL affects approximately 1 in 40,000 individuals.""]",[false],[true],[false],"[""LBSL (London Bus Services Limited) affects a very small number of people, as it is a bus company operating in London and not a medical condition affecting a large population.""]","[""Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation is a rare genetic disorder, affecting an estimated 1 in 2 million individuals worldwide.""]","[""LBSL affects approximately 1 in 40,000 individuals.""]",[true],[true],[false],"[""LBSL affects a very small number of individuals worldwide.""]","[""Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation affects a very small number of individuals worldwide.""]","[""LBSL affects approximately 1 in 50,000 individuals.""]",[true],[false],[true],"[""LBSL affects a very small number of individuals worldwide.""]","[""Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation affects approximately 100 individuals worldwide.""]","[""LBSL affects a very small number of people worldwide.""]",[true],[true],[false],"[""LBSL affects a very small number of individuals worldwide.""]","[""Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation affects a very small number of individuals worldwide.""]","[""LBSL affects approximately 1 in 40,000 individuals.""]",[true],[false],[false],"[""LBSL affects a very small number of individuals worldwide.""]","[""Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation is a rare genetic disorder, affecting an estimated 1 in 2 million individuals worldwide.""]","[""LBSL affects approximately 1 in 40,000 individuals.""]",[true],[false],[true],"[""LBSL is an extremely rare disorder, with only a few dozen cases reported worldwide.""]","[""Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation affects approximately 100 individuals worldwide.""]","[""LBSL affects a very small number of people worldwide.""]",[true],[true],[false],"[""LBSL is an extremely rare condition, with only a few dozen cases reported worldwide.""]","[""Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation affects a very small number of individuals worldwide.""]","[""LBSL affects approximately 1 in 50,000 individuals.""]",[true],[true],[false],"[""LBSL is an extremely rare genetic disorder, with only a few dozen cases reported worldwide.""]","[""Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation affects a very small number of individuals worldwide.""]","[""LBSL affects approximately 1 in 40,000 individuals.""]",[true],[false],[false],"[""LBSL is an extremely rare condition, with only a few dozen cases reported worldwide.""]","[""Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation is a rare genetic disorder, affecting an estimated 1 in 2 million individuals worldwide.""]","[""LBSL affects approximately 1 in 40,000 individuals.""]",[true],[true],[false],"[""LBSL is an extremely rare condition, with only a few dozen cases reported worldwide.""]","[""Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation affects a very small number of individuals worldwide.""]","[""LBSL affects approximately 1 in 50,000 individuals.""]",[true],[false],[true],"[""LBSL is an extremely rare condition, with only a few dozen cases reported worldwide.""]","[""Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation affects approximately 100 individuals worldwide.""]","[""LBSL affects a very small number of people worldwide.""]",[true],[true],[false],"[""LBSL is an extremely rare condition, affecting only a few individuals worldwide.""]","[""Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation affects a very small number of individuals worldwide.""]","[""LBSL affects approximately 1 in 40,000 individuals.""]",[true],[true],[false],"[""LBSL is an extremely rare condition, affecting only a few individuals worldwide.""]","[""Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation is a rare genetic disorder, affecting an estimated 1 in 2 million individuals worldwide.""]","[""LBSL affects approximately 1 in 40,000 individuals.""]",[true],[true],[false],"[""LBSL affects less than 1 in 1,000,000 people worldwide.""]","[""Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation affects a very small number of individuals worldwide.""]","[""LBSL affects approximately 1 in 50,000 individuals.""]",[true],[false],[true],"[""LBSL is an extremely rare condition, with only a few dozen cases reported worldwide.""]","[""Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation affects approximately 100 individuals worldwide.""]","[""LBSL affects a very small number of people worldwide.""]",[true],[true],[false],"[""LBSL is an extremely rare condition, with only a few dozen cases reported worldwide.""]","[""Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation affects a very small number of individuals worldwide.""]","[""LBSL affects approximately 1 in 40,000 individuals.""]",[true],[false],[false],"[""LBSL is an extremely rare condition, with only a few dozen cases reported worldwide.""]","[""Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation is a rare genetic disorder, affecting an estimated 1 in 2 million individuals worldwide.""]","[""LBSL affects approximately 1 in 40,000 individuals.""]",[true],[true],[false],"[""LBSL is an extremely rare condition, with only a few dozen cases reported worldwide.""]","[""Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation affects a very small number of individuals worldwide.""]","[""LBSL affects approximately 1 in 50,000 individuals.""]",[true],[false],[true],"[""LBSL is an extremely rare condition, with only a few dozen cases reported worldwide.""]","[""Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation affects approximately 100 individuals worldwide.""]","[""LBSL affects a very small number of people worldwide.""]",[true],[true],[false],"[""LBSL is an extremely rare condition, with only a few dozen cases reported worldwide.""]","[""Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation affects a very small number of individuals worldwide.""]","[""LBSL affects approximately 1 in 40,000 individuals.""]",[true],[false],[false],"[""LBSL is an extremely rare condition, with only a few dozen cases reported worldwide.""]","[""Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation is a rare genetic disorder, affecting an estimated 1 in 2 million individuals worldwide.""]","[""LBSL affects approximately 1 in 40,000 individuals.""]",[true],[true],[false],"[""LBSL is an extremely rare genetic disorder, and the exact number of people affected by it is not well-documented. However, it is estimated to affect a very small number of individuals worldwide.""]","[""Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation affects a very small number of individuals worldwide.""]","[""LBSL affects approximately 1 in 50,000 individuals.""]",[true],[false],[true],"[""LBSL is an extremely rare genetic disorder, with only a few dozen cases reported worldwide.""]","[""Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation affects approximately 100 individuals worldwide.""]","[""LBSL affects a very small number of people worldwide.""]",[true],[true],[false],"[""LBSL is an extremely rare genetic disorder, and the exact number of people affected by it is not well-documented. However, it is estimated to affect a very small number of individuals worldwide.""]","[""Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation affects a very small number of individuals worldwide.""]","[""LBSL affects approximately 1 in 40,000 individuals.""]",[true],[false],[false],"[""LBSL is an extremely rare genetic disorder, with only a few dozen cases reported worldwide.""]","[""Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation is a rare genetic disorder, affecting an estimated 1 in 2 million individuals worldwide.""]","[""LBSL affects approximately 1 in 40,000 individuals.""]",[true],[true],[false],"[""LBSL is an extremely rare condition, affecting only a small number of individuals worldwide.""]","[""Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation affects a very small number of individuals worldwide.""]","[""LBSL affects approximately 1 in 50,000 individuals.""]",[false],[true],[false],"[""The number of people affected by LBSL (London Bus Services Limited) is not available.""]","[""Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation affects a very small number of individuals worldwide.""]","[""LBSL affects approximately 1 in 50,000 individuals.""]",[false],[true],[false],"[""The number of people affected by LBSL (Lower Boy Scout Lake) in California is not available.""]","[""Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation affects a very small number of individuals worldwide.""]","[""LBSL affects approximately 1 in 50,000 individuals.""]",[true],[true],[false],"[""LBSL is an extremely rare condition, affecting only a small number of individuals worldwide.""]","[""Leukoencephalopathy with brainstem and spinal cord involvement and lactate elevation affects a very small number of individuals worldwide.""]","[""LBSL affects approximately 1 in 50,000 individuals.""]"
frequency,How many people are affected by cyclic vomiting syndrome ?,"The exact prevalence of cyclic vomiting syndrome is unknown; estimates range from 4 to 2,000 per 100,000 children. The condition is diagnosed less frequently in adults, although recent studies suggest that the condition may begin in adulthood as commonly as it begins in childhood.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""CVS"", ""full_form"": ""cyclic vomiting syndrome""}]}",How many people are affected by CVS ?,How many people are affected by cyclic vomiting syndrome ?,8,MEDICAL,Simple Datatype-Integer,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""CVS Corporation"", ""Chorionic Villus Sampling"", ""Concurrent Version System"", ""Council for Voluntary Service"", ""Council for Voluntary Services"", ""Concurrent Versioning System"", ""cardiovascular system"", ""Chorionic Villi Sampling"", ""Consumer Value Stores"", ""Code Versioning System""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Cardiovascular System""]",[7.501763237232563e-13],[3.4066232902137006e-06],"[""cardiovascular system""]",[3.4066232902137006e-06],"[""ABBREVIATIONS""]","[[5.207134916147957e-11, 4.026414484886575e-21, 5.133937137830378e-15, 3.988753113071233e-17, 5.2544576481863285e-15, 1.2375117604564432e-18, 3.4066232902137006e-06, 8.13401795838794e-20, 1.1607573085489255e-15, 7.128403922432711e-19]]",[0.8278466528893418],[0.8453703109572079],"[""Concurrent Versioning System""]",[0.8467759072889959],"[""ABBREVIATIONS""]","[[0.823902466212435, 0.717573119456487, 0.7070748756573155, 0.71784485706142, 0.7316604236246584, 0.7083200379575199, 0.8467759072889959, 0.7142881101798079, 0.7987270846358498, 0.737029420992374]]","[""cardiovascular system""]","[""ABBREVIATIONS""]",How many people are affected by CVS (Cardiovascular System) ?,[false],[false],[false],"[""Millions of people are affected by cardiovascular diseases worldwide.""]","[""Approximately 2% of the population is affected by cyclic vomiting syndrome.""]","[""Approximately 3% of the population is affected by CVS.""]",[false],[false],[false],"[""Millions of people are affected by CVS (cardiovascular system) disorders worldwide.""]","[""Approximately 2% of the population is affected by cyclic vomiting syndrome.""]","[""Approximately 3% of the population is affected by CVS.""]",[false],[false],[false],"[""Millions of people are affected by CVS (cardiovascular system) disorders worldwide.""]","[""Approximately 2% of the population is affected by cyclic vomiting syndrome.""]","[""Approximately 64 million people are affected by CVS in the United States.""]",[false],[false],[false],"[""Millions of people are affected by CVS (cardiovascular system) disorders worldwide.""]","[""Approximately 2% of the population is affected by cyclic vomiting syndrome.""]","[""Approximately 3% of the population is affected by CVS.""]",[false],[false],[false],"[""Prevalence data for CVS (Concurrent Versioning System) affecting individuals is not available as it is a software version control system and not a medical condition.""]","[""Approximately 2% of the population is affected by cyclic vomiting syndrome.""]","[""Approximately 3% of the population is affected by CVS.""]",[false],[false],[false],"[""The term CVS in the medical field usually refers to Central Vestibular Syndrome, which affects a small percentage of the population.""]","[""Approximately 2% of the population is affected by cyclic vomiting syndrome.""]","[""Approximately 3% of the population is affected by CVS.""]",[false],[false],[false],"[""The term CVS in the medical field commonly refers to Central Vestibular Syndrome, which affects an estimated 1.8% of the general population.""]","[""Approximately 2% of the population is affected by cyclic vomiting syndrome.""]","[""Approximately 64 million people are affected by CVS in the United States.""]",[false],[false],[false],"[""There is no medical condition related to CVS (Concurrent Versioning System).""]","[""Approximately 2% of the population is affected by cyclic vomiting syndrome.""]","[""Approximately 3% of the population is affected by CVS.""]",[false],[false],[false],"[""Millions of people are affected by CVS (cardiovascular system) disorders worldwide.""]","[""Approximately 2% of the population is affected by cyclic vomiting syndrome.""]","[""Approximately 3% of the population is affected by CVS.""]",[false],[false],[false],"[""Millions of people worldwide are affected by cardiovascular diseases.""]","[""Approximately 2% of the population is affected by cyclic vomiting syndrome.""]","[""Approximately 3% of the population is affected by CVS.""]",[false],[false],[false],"[""Millions of people are affected by cardiovascular diseases worldwide.""]","[""Approximately 2% of the population is affected by cyclic vomiting syndrome.""]","[""Approximately 64 million people are affected by CVS in the United States.""]",[false],[false],[false],"[""Millions of people are affected by CVS (cardiovascular system) disorders worldwide.""]","[""Approximately 2% of the population is affected by cyclic vomiting syndrome.""]","[""Approximately 3% of the population is affected by CVS.""]",[false],[false],[false],"[""Millions of people are affected by CVS (cardiovascular system) disorders worldwide.""]","[""Approximately 2% of the population is affected by cyclic vomiting syndrome.""]","[""Approximately 3% of the population is affected by CVS.""]",[false],[false],[false],"[""Millions of people are affected by CVS (cardiovascular system) disorders.""]","[""Approximately 2% of the population is affected by cyclic vomiting syndrome.""]","[""Approximately 3% of the population is affected by CVS.""]",[false],[false],[false],"[""It is estimated that around 92.1 million adults in the United States are affected by cardiovascular diseases.""]","[""Approximately 2% of the population is affected by cyclic vomiting syndrome.""]","[""Approximately 64 million people are affected by CVS in the United States.""]",[false],[false],[false],"[""Millions of people are affected by CVS (cardiovascular system) disorders worldwide.""]","[""Approximately 2% of the population is affected by cyclic vomiting syndrome.""]","[""Approximately 3% of the population is affected by CVS.""]",[true],[false],[false],"[""The number of people affected by CVS is not specified.""]","[""Approximately 2% of the population is affected by cyclic vomiting syndrome.""]","[""Approximately 3% of the population is affected by CVS.""]",[false],[false],[false],"[""Millions of people are affected by cardiovascular diseases worldwide.""]","[""Approximately 2% of the population is affected by cyclic vomiting syndrome.""]","[""Approximately 3% of the population is affected by CVS.""]",[false],[false],[false],"[""Millions of people are affected by CVS (cardiovascular system) disorders worldwide.""]","[""Approximately 2% of the population is affected by cyclic vomiting syndrome.""]","[""Approximately 64 million people are affected by CVS in the United States.""]",[false],[false],[false],"[""Millions of people worldwide are affected by cardiovascular diseases.""]","[""Approximately 2% of the population is affected by cyclic vomiting syndrome.""]","[""Approximately 3% of the population is affected by CVS.""]",[false],[false],[false],"[""Millions of people are affected by CVS (Cardiovascular System) disorders worldwide.""]","[""Approximately 2% of the population is affected by cyclic vomiting syndrome.""]","[""Approximately 3% of the population is affected by CVS.""]",[false],[false],[false],"[""Millions of people worldwide are affected by CVS (Cardiovascular System) disorders.""]","[""Approximately 2% of the population is affected by cyclic vomiting syndrome.""]","[""Approximately 3% of the population is affected by CVS.""]",[false],[false],[false],"[""CVS affects millions of people worldwide.""]","[""Approximately 2% of the population is affected by cyclic vomiting syndrome.""]","[""Approximately 64 million people are affected by CVS in the United States.""]",[false],[false],[false],"[""Millions of people are affected by CVS (Cardiovascular System) disorders worldwide.""]","[""Approximately 2% of the population is affected by cyclic vomiting syndrome.""]","[""Approximately 3% of the population is affected by CVS.""]",[false],[false],[false],"[""CVS affects millions of people worldwide.""]","[""Approximately 2% of the population is affected by cyclic vomiting syndrome.""]","[""Approximately 3% of the population is affected by CVS.""]",[false],[false],[false],"[""The number of people affected by CVS (cardiovascular system) varies depending on the specific condition or disease within the cardiovascular system.""]","[""Approximately 2% of the population is affected by cyclic vomiting syndrome.""]","[""Approximately 3% of the population is affected by CVS.""]",[false],[false],[false],"[""It is estimated that cardiovascular diseases affect approximately 1 in 3 adults globally.""]","[""Approximately 2% of the population is affected by cyclic vomiting syndrome.""]","[""Approximately 64 million people are affected by CVS in the United States.""]",[false],[false],[false],"[""It is estimated that around 92.1 million adults in the United States are affected by cardiovascular diseases.""]","[""Approximately 2% of the population is affected by cyclic vomiting syndrome.""]","[""Approximately 3% of the population is affected by CVS.""]",[false],[false],[false],"[""The number of people affected by CVS (cardiovascular system) varies depending on the specific condition and population studied.""]","[""Approximately 2% of the population is affected by cyclic vomiting syndrome.""]","[""Approximately 3% of the population is affected by CVS.""]",[true],[false],[false],"[""The number of people affected by CVS is not specified.""]","[""Approximately 2% of the population is affected by cyclic vomiting syndrome.""]","[""Approximately 3% of the population is affected by CVS.""]",[false],[false],[false],"[""The number of people affected by CVS (Concurrent Versioning System) is not available.""]","[""Approximately 2% of the population is affected by cyclic vomiting syndrome.""]","[""Approximately 3% of the population is affected by CVS.""]",[false],[false],[false],"[""The number of people affected by CVS (Cardiovascular System) varies depending on the specific condition or disease being referred to.""]","[""Approximately 2% of the population is affected by cyclic vomiting syndrome.""]","[""Approximately 3% of the population is affected by CVS.""]"
treatment,What are the treatments for Patent Ductus Arteriosus ?,"Patent ductus arteriosus (PDA) is treated with medicines, catheter-based procedures, and surgery. The goal of treatment is to close the PDA. Closure will help prevent complications and reverse the effects of increased blood volume.
                
Small PDAs often close without treatment. For full-term infants, treatment is needed if the PDA is large or causing health problems. For premature infants, treatment is needed if the PDA is causing breathing problems or heart problems.
                
Talk with your child's doctor about treatment options and how your family prefers to handle treatment decisions.
                
Medicines
                
Your child's doctor may prescribe medicines to help close your child's PDA.
                
Indomethacin (in-doh-METH-ah-sin) is a medicine that helps close PDAs in premature infants. This medicine triggers the PDA to constrict or tighten, which closes the opening. Indomethacin usually doesn't work in full-term infants.
                
Ibuprofen also is used to close PDAs in premature infants. This medicine is similar to indomethacin.
                
Catheter-Based Procedures
                
Catheters are thin, flexible tubes that doctors use as part of a procedure called cardiac catheterization (KATH-eh-ter-ih-ZA-shun). Catheter-based procedures often are used to close PDAs in infants or children who are large enough to have the procedure.
                
Your child's doctor may refer to the procedure as ""transcatheter device closure."" The procedure sometimes is used for small PDAs to prevent the risk of infective endocarditis (IE). IE is an infection of the inner lining of the heart chambers and valves.
                
Your child will be given medicine to help him or her relax or sleep during the procedure. The doctor will insert a catheter in a large blood vessel in the groin (upper thigh). He or she will then guide the catheter to your child's heart.
                
A small metal coil or other blocking device is passed through the catheter and placed in the PDA. This device blocks blood flow through the vessel.
                
Catheter-based procedures don't require the child's chest to be opened. They also allow the child to recover quickly.
                
These procedures often are done on an outpatient basis. You'll most likely be able to take your child home the same day the procedure is done.
                
Complications from catheter-based procedures are rare and short term. They can include bleeding, infection, and movement of the blocking device from where it was placed.
                
Surgery
                
Surgery to correct a PDA may be done if:
                
A premature or full-term infant has health problems due to a PDA and is too small to have a catheter-based procedure
                
A catheter-based procedure doesn't successfully close the PDA
                
Surgery is planned for treatment of related congenital heart defects
                
Often, surgery isn't done until after 6 months of age in infants who don't have health problems from their PDAs. Doctors sometimes do surgery on small PDAs to prevent the risk of IE.
                
For the surgery, your child will be given medicine so that he or she will sleep and not feel any pain. The surgeon will make a small incision (cut) between your child's ribs to reach the PDA. He or she will close the PDA using stitches or clips.
                
Complications from surgery are rare and usually short term. They can include hoarseness, a paralyzed diaphragm (the muscle below the lungs), infection, bleeding, or fluid buildup around the lungs.
                
After Surgery
                
After surgery, your child will spend a few days in the hospital. He or she will be given medicine to reduce pain and anxiety. Most children go home 2 days after surgery. Premature infants usually have to stay in the hospital longer because of their other health issues.
                
The doctors and nurses at the hospital will teach you how to care for your child at home. They will talk to you about:
                
Limits on activity for your child while he or she recovers
                
Followup appointments with your child's doctors
                
How to give your child medicines at home, if needed
                
When your child goes home after surgery, you can expect that he or she will feel fairly comfortable. However, you child may have some short-term pain.
                
Your child should begin to eat better and gain weight quickly. Within a few weeks, he or she should fully recover and be able to take part in normal activities.
                
Long-term complications from surgery are rare. However, they can include narrowing of the aorta, incomplete closure of the PDA, and reopening of the PDA.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""PDA"", ""full_form"": ""Patent Ductus Arteriosus""}]}",What are the treatments for PDA ?,What are the treatments for Patent Ductus Arteriosus ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Personal Digital Assistant"", ""Patent Ductus Arteriosus"", ""Personal Data Assistant"", ""Progressive Democrats of America"", ""Public Display of Affection"", ""Print Shop Bitmap Graphics"", ""Posterior Descending Artery"", ""Pennsylvania Dental Association"", ""Part Design Approval"", ""Pretty Darn Awesome""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Patent Ductus Arteriosus""]",[9.182983486104974e-11],[9.182983486104974e-11],"[""Posterior Descending Artery""]",[1.1335247940540525e-07],"[""ABBREVIATIONS""]","[[2.3759231824826056e-13, 9.182983486104974e-11, 1.0633413617342602e-14, 6.096563875871469e-26, 9.545497348389213e-18, 3.1764589998189707e-27, 1.1335247940540525e-07, 5.172517089152443e-22, 8.42605352601129e-17, 8.188786729492448e-24]]",[0.888340833487251],[0.888340833487251],"[""Personal Digital Assistant""]",[0.888340833487251],"[""ABBREVIATIONS""]","[[0.7172771681955834, 0.888340833487251, 0.704544930764239, 0.6338203726026981, 0.6383983619769421, 0.7217800819795508, 0.7440082645933093, 0.6485903564242831, 0.7082635283662906, 0.7332183930945909]]","[""Patent Ductus Arteriosus""]","[""ABBREVIATIONS""]",What are the treatments for PDA (Patent Ductus Arteriosus) ?,[false],[true],[true],"[""Medications, angioplasty, stent placement, coronary artery bypass grafting""]","[""Medication or surgery can be used to treat Patent Ductus Arteriosus.""]","[""The treatments for PDA include medication, catheter-based procedures, and surgery.""]",[false],[true],[true],"[""The treatments for PDA (Posterior Descending Artery) include medications, angioplasty, stent placement, and in severe cases, coronary artery bypass surgery.""]","[""Treatment options for Patent Ductus Arteriosus include medication, catheter-based procedures, and surgery.""]","[""Medication, catheter-based procedures, surgery""]",[false],[true],[true],"[""Medications, angioplasty, stent placement, coronary artery bypass grafting""]","[""Treatment options for Patent Ductus Arteriosus include medication (such as indomethacin or ibuprofen) or surgical closure (ligation).""]","[""Medication, catheter-based procedures, surgery""]",[false],[true],[true],"[""Medications, angioplasty, stent placement, coronary artery bypass grafting""]","[""Treatment options for Patent Ductus Arteriosus include medication, catheter-based procedures, and surgery.""]","[""Medication or surgery are common treatments for Patent Ductus Arteriosus (PDA).""]",[true],[false],[true],"[""The treatments for PDA (Patent Ductus Arteriosus) include medication such as indomethacin or ibuprofen, or surgical closure in severe cases.""]","[""Medication or surgery can be used to treat Patent Ductus Arteriosus.""]","[""The treatments for PDA include medication, catheter-based procedures, and surgery.""]",[true],[true],[true],"[""The treatment for PDA (Patent Ductus Arteriosus) includes medications such as indomethacin or ibuprofen to help close the ductus arteriosus, or surgical closure in severe cases.""]","[""Treatment options for Patent Ductus Arteriosus include medication, catheter-based procedures, and surgery.""]","[""Medication, catheter-based procedures, surgery""]",[true],[true],[true],"[""The treatments for PDA (Patent Ductus Arteriosus) include medication such as indomethacin or ibuprofen, or surgical closure in severe cases.""]","[""Treatment options for Patent Ductus Arteriosus include medication (such as indomethacin or ibuprofen) or surgical closure (ligation).""]","[""Medication, catheter-based procedures, surgery""]",[true],[true],[true],"[""The treatments for PDA (Patent Ductus Arteriosus) include medication such as indomethacin or ibuprofen, or surgical closure if medication is not effective.""]","[""Treatment options for Patent Ductus Arteriosus include medication, catheter-based procedures, and surgery.""]","[""Medication or surgery are common treatments for Patent Ductus Arteriosus (PDA).""]",[true],[true],[true],"[""Treatment options for PDA include medication, catheter-based procedures, and surgery.""]","[""Treatment options for Patent Ductus Arteriosus include medication, catheter-based procedures, and surgery.""]","[""Medication, catheter-based procedures, surgery""]",[true],[true],[true],"[""Medication or surgery can be used to treat PDA (Patent Ductus Arteriosus). Medications like indomethacin or ibuprofen may be used to close the ductus arteriosus. If medication is not effective, surgery may be required to close the PDA.""]","[""Medication or surgery can be used to treat Patent Ductus Arteriosus.""]","[""The treatments for PDA include medication, catheter-based procedures, and surgery.""]",[true],[true],[true],"[""Medication or surgery can be used to treat PDA (Patent Ductus Arteriosus). Medications like indomethacin or ibuprofen may be used to help close the ductus arteriosus. If medication is not effective, surgery may be required to close the PDA.""]","[""Treatment options for Patent Ductus Arteriosus include medication (such as indomethacin or ibuprofen) or surgical closure (ligation).""]","[""Medication, catheter-based procedures, surgery""]",[true],[true],[true],"[""Treatment options for PDA (Patent Ductus Arteriosus) include medication, catheter-based procedures, and surgery.""]","[""Treatment options for Patent Ductus Arteriosus include medication, catheter-based procedures, and surgery.""]","[""Medication or surgery are common treatments for Patent Ductus Arteriosus (PDA).""]",[false],[true],[true],"[""Medication or surgery""]","[""Medication or surgery can be used to treat Patent Ductus Arteriosus.""]","[""The treatments for PDA include medication, catheter-based procedures, and surgery.""]",[false],[true],[true],"[""Medication or surgery""]","[""Treatment options for Patent Ductus Arteriosus include medication, catheter-based procedures, and surgery.""]","[""Medication, catheter-based procedures, surgery""]",[true],[true],[true],"[""Medication or surgery""]","[""Treatment options for Patent Ductus Arteriosus include medication (such as indomethacin or ibuprofen) or surgical closure (ligation).""]","[""Medication, catheter-based procedures, surgery""]",[true],[true],[true],"[""Medication or surgery""]","[""Treatment options for Patent Ductus Arteriosus include medication, catheter-based procedures, and surgery.""]","[""Medication or surgery are common treatments for Patent Ductus Arteriosus (PDA).""]",[true],[false],[true],"[""The treatments for PDA (Patent Ductus Arteriosus) include medication, catheter-based procedures, and surgery.""]","[""Medication or surgery can be used to treat Patent Ductus Arteriosus.""]","[""The treatments for PDA include medication, catheter-based procedures, and surgery.""]",[true],[true],[true],"[""Treatment options for PDA include medication, catheter-based procedures, and surgery.""]","[""Treatment options for Patent Ductus Arteriosus include medication, catheter-based procedures, and surgery.""]","[""Medication, catheter-based procedures, surgery""]",[true],[true],[true],"[""Medication or surgery are common treatments for PDA (Patent Ductus Arteriosus). Medications like indomethacin or ibuprofen may be used to help close the ductus arteriosus. In cases where medication is not effective, surgery may be required to close the PDA.""]","[""Treatment options for Patent Ductus Arteriosus include medication (such as indomethacin or ibuprofen) or surgical closure (ligation).""]","[""Medication, catheter-based procedures, surgery""]",[true],[true],[true],"[""Medication or surgery are the treatments for PDA (Patent Ductus Arteriosus).""]","[""Treatment options for Patent Ductus Arteriosus include medication, catheter-based procedures, and surgery.""]","[""Medication or surgery are common treatments for Patent Ductus Arteriosus (PDA).""]",[true],[true],[true],"[""Medication or surgery are common treatments for PDA (Patent Ductus Arteriosus). Medications like indomethacin or ibuprofen may be used to close the ductus arteriosus. In cases where medication is not effective, surgery may be required to close the PDA.""]","[""Medication or surgery can be used to treat Patent Ductus Arteriosus.""]","[""The treatments for PDA include medication, catheter-based procedures, and surgery.""]",[true],[true],[true],"[""Treatment options for PDA include medication, catheter-based procedures, and surgery.""]","[""Treatment options for Patent Ductus Arteriosus include medication, catheter-based procedures, and surgery.""]","[""Medication, catheter-based procedures, surgery""]",[true],[true],[true],"[""Medication or surgery are common treatments for PDA (Patent Ductus Arteriosus). Medications may include indomethacin or ibuprofen to help close the ductus arteriosus. In cases where medication is not effective, surgery may be required to close the PDA.""]","[""Treatment options for Patent Ductus Arteriosus include medication (such as indomethacin or ibuprofen) or surgical closure (ligation).""]","[""Medication, catheter-based procedures, surgery""]",[true],[true],[true],"[""Medication or surgery are the common treatments for PDA (Patent Ductus Arteriosus). Medications like indomethacin or ibuprofen may be used to close the ductus arteriosus. In some cases, surgery may be required to close the PDA.""]","[""Treatment options for Patent Ductus Arteriosus include medication, catheter-based procedures, and surgery.""]","[""Medication or surgery are common treatments for Patent Ductus Arteriosus (PDA).""]",[true],[false],[true],"[""The treatments for PDA (Patent Ductus Arteriosus) include medication, catheter-based procedures, and surgery.""]","[""Medication or surgery can be used to treat Patent Ductus Arteriosus.""]","[""The treatments for PDA include medication, catheter-based procedures, and surgery.""]",[true],[true],[true],"[""The treatments for PDA (Patent Ductus Arteriosus) include medication, catheter-based procedures, and surgery.""]","[""Treatment options for Patent Ductus Arteriosus include medication, catheter-based procedures, and surgery.""]","[""Medication, catheter-based procedures, surgery""]",[true],[true],[true],"[""The treatments for PDA (Patent Ductus Arteriosus) include medication, catheter-based procedures, and surgery.""]","[""Treatment options for Patent Ductus Arteriosus include medication (such as indomethacin or ibuprofen) or surgical closure (ligation).""]","[""Medication, catheter-based procedures, surgery""]",[true],[true],[true],"[""The treatments for PDA (Patent Ductus Arteriosus) include medication such as indomethacin or ibuprofen, or surgical closure in severe cases.""]","[""Treatment options for Patent Ductus Arteriosus include medication, catheter-based procedures, and surgery.""]","[""Medication or surgery are common treatments for Patent Ductus Arteriosus (PDA).""]",[true],[false],[true],"[""The treatments for PDA (Patent Ductus Arteriosus) include medication, catheter-based procedures, and surgery.""]","[""Medication or surgery can be used to treat Patent Ductus Arteriosus.""]","[""The treatments for PDA include medication, catheter-based procedures, and surgery.""]",[false],[true],[true],"[""Treatments for PDA include medications, angioplasty, stent placement, and coronary artery bypass surgery.""]","[""Medication or surgery can be used to treat Patent Ductus Arteriosus.""]","[""The treatments for PDA include medication, catheter-based procedures, and surgery.""]",[true],[false],[true],"[""The treatments for PDA (Patent Ductus Arteriosus) include medication, catheter-based procedures, and surgery.""]","[""Medication or surgery can be used to treat Patent Ductus Arteriosus.""]","[""The treatments for PDA include medication, catheter-based procedures, and surgery.""]",[true],[true],[true],"[""Surgical ligation, transcatheter occlusion, medication (indomethacin, ibuprofen)""]","[""Medication or surgery can be used to treat Patent Ductus Arteriosus.""]","[""The treatments for PDA include medication, catheter-based procedures, and surgery.""]"
susceptibility,Who is at risk for Kyasanur Forest Disease? ?,"KFD has historically been limited to the western and central districts of Karnataka State, India. However, in November 2012, samples from humans and monkeys tested positive for KFDV in the southernmost district of the State which neighbors Tamil Nadu State and Kerala State, indicating the possibility of wider distribution of KFDV. Additionally, a virus very similar to KFD virus (Alkhurma hemorrhagic fever virus) has been described in Saudi Arabia. 
                
People with recreational or occupational exposure to rural or outdoor settings (e.g., hunters, herders, forest workers, farmers) within Karnataka State are potentially at risk for infection by contact with infected ticks. Seasonality is another important risk factor as more cases are reported during the dry season, from November through June.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""KFD"", ""full_form"": ""Kyasanur Forest Disease""}]}",Who is at risk for KFD? ?,Who is at risk for Kyasanur Forest Disease? ?,8,MEDICAL,Simple Datatype-String,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Kinepolis Film Distribution"", ""Kentucky Fried Duck"", ""Kentucky Fried Deer"", ""Kyasanur Forest Disease"", ""Karnataka Forum for Dignity"", ""Kentucky Fried Dolphin"", ""Knowledge Fields Development"", ""Kikuchi Fujimoto Disease"", ""Kill Free Destroy"", ""Kyle Field Day""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Kyasanur Forest Disease""]",[6.226264248422997e-25],[6.226264248422997e-25],"[""Kill Free Destroy""]",[1.9155336378962124e-16],"[""ABBREVIATIONS""]","[[2.3907156108846535e-23, 1.4273095608778e-25, 6.537502777353854e-26, 6.226264248422997e-25, 3.2273763820435347e-28, 4.888712140329061e-28, 4.3466941815761966e-17, 8.473223152276852e-28, 1.9155336378962124e-16, 3.106436118921565e-19]]",[0.781573453706143],[0.7815966163726683],"[""Kikuchi Fujimoto Disease""]",[0.8256299009023654],"[""ABBREVIATIONS""]","[[0.7474040181862738, 0.7761733973930862, 0.7502369722781694, 0.781573453706143, 0.6784501816095088, 0.7266013712551426, 0.7424818730200333, 0.7292320356165076, 0.8256299009023654, 0.7771371545353045]]","[""Kyasanur Forest Disease""]","[""ABBREVIATIONS""]",Who is at risk for KFD (Kyasanur Forest Disease)? ?,[true],[true],[true],"[""People who live or visit areas where the KFD virus is present, such as certain regions in India and other parts of Asia, are at risk for Kyasanur Forest Disease (KFD).""]","[""People who live in or visit areas where the Kyasanur Forest Disease virus is endemic are at risk.""]","[""People who live or visit areas where the KFD virus is present, such as forested areas, are at risk for Kyasanur Forest Disease (KFD).""]",[true],[true],[true],"[""People who live or visit areas where the KFD virus is present, such as certain regions in India and other parts of Asia, are at risk for Kyasanur Forest Disease (KFD). Additionally, individuals who come into contact with infected ticks or animals in these areas are also at risk.""]","[""People who live or work in forest areas are at higher risk for Kyasanur Forest Disease.""]","[""People who live or visit areas where the KFD virus is present, such as forested areas, are at risk for Kyasanur Forest Disease (KFD).""]",[true],[true],[true],"[""People who live or visit areas where the KFD virus is present, such as certain regions in India and other parts of Asia, are at risk for Kyasanur Forest Disease (KFD). Additionally, individuals who come into contact with infected ticks or animals in these areas are also at risk.""]","[""People who live in or visit areas where the Kyasanur Forest Disease virus is endemic are at risk.""]","[""People who live or work in areas where the disease is common, such as forested areas, are at risk for Kyasanur Forest Disease (KFD).""]",[true],[true],[true],"[""People who live or visit areas where the KFD virus is present, such as certain regions in India and other parts of Asia, are at risk for Kyasanur Forest Disease (KFD).""]","[""People who live in or visit areas where the Kyasanur Forest Disease virus is present, such as parts of India, are at risk for the disease.""]","[""People who live or work in areas where the KFD virus is present, such as forested areas, are at risk for Kyasanur Forest Disease (KFD).""]",[false],[true],[true],"[""Young adults, particularly women of Asian descent, are at higher risk for Kikuchi Fujimoto Disease (KFD).""]","[""People who live in or visit areas where the Kyasanur Forest Disease virus is endemic are at risk.""]","[""People who live or visit areas where the KFD virus is present, such as forested areas, are at risk for Kyasanur Forest Disease (KFD).""]",[false],[true],[true],"[""Young adults, particularly women of Asian descent, are at higher risk for Kikuchi Fujimoto Disease.""]","[""People who live or work in forest areas are at higher risk for Kyasanur Forest Disease.""]","[""People who live or visit areas where the KFD virus is present, such as forested areas, are at risk for Kyasanur Forest Disease (KFD).""]",[false],[true],[true],"[""Young adults, particularly women of Asian descent, are at higher risk for Kikuchi Fujimoto Disease.""]","[""People who live in or visit areas where the Kyasanur Forest Disease virus is endemic are at risk.""]","[""People who live or work in areas where the disease is common, such as forested areas, are at risk for Kyasanur Forest Disease (KFD).""]",[false],[true],[true],"[""Young adults, particularly women of Asian descent, are at higher risk for Kikuchi Fujimoto Disease.""]","[""People who live in or visit areas where the Kyasanur Forest Disease virus is present, such as parts of India, are at risk for the disease.""]","[""People who live or work in areas where the KFD virus is present, such as forested areas, are at risk for Kyasanur Forest Disease (KFD).""]",[true],[true],[true],"[""People who live or work in forest areas are at higher risk for KFD.""]","[""People who live or work in forest areas are at higher risk for Kyasanur Forest Disease.""]","[""People who live or visit areas where the KFD virus is present, such as forested areas, are at risk for Kyasanur Forest Disease (KFD).""]",[true],[true],[true],"[""People who live in or visit areas where the Kyasanur Forest Disease virus is endemic, such as forested areas in South Asia, are at risk for KFD.""]","[""People who live in or visit areas where the Kyasanur Forest Disease virus is endemic are at risk.""]","[""People who live or visit areas where the KFD virus is present, such as forested areas, are at risk for Kyasanur Forest Disease (KFD).""]",[true],[true],[true],"[""People who live or work in forest areas where the disease is endemic are at risk for KFD.""]","[""People who live in or visit areas where the Kyasanur Forest Disease virus is endemic are at risk.""]","[""People who live or work in areas where the disease is common, such as forested areas, are at risk for Kyasanur Forest Disease (KFD).""]",[true],[true],[true],"[""People who live in or visit areas where the Kyasanur Forest Disease virus is endemic, such as parts of India, are at risk for KFD.""]","[""People who live in or visit areas where the Kyasanur Forest Disease virus is present, such as parts of India, are at risk for the disease.""]","[""People who live or work in areas where the KFD virus is present, such as forested areas, are at risk for Kyasanur Forest Disease (KFD).""]",[true],[true],[true],"[""People who live or work in forest areas where the disease is endemic are at risk for KFD.""]","[""People who live in or visit areas where the Kyasanur Forest Disease virus is endemic are at risk.""]","[""People who live or visit areas where the KFD virus is present, such as forested areas, are at risk for Kyasanur Forest Disease (KFD).""]",[true],[true],[true],"[""People who live or work in forest areas where the disease is endemic.""]","[""People who live or work in forest areas are at higher risk for Kyasanur Forest Disease.""]","[""People who live or visit areas where the KFD virus is present, such as forested areas, are at risk for Kyasanur Forest Disease (KFD).""]",[true],[true],[true],"[""People who live or work in forest areas where the disease is endemic.""]","[""People who live in or visit areas where the Kyasanur Forest Disease virus is endemic are at risk.""]","[""People who live or work in areas where the disease is common, such as forested areas, are at risk for Kyasanur Forest Disease (KFD).""]",[true],[true],[true],"[""People who live or work in forest areas where the disease is endemic are at risk for KFD.""]","[""People who live in or visit areas where the Kyasanur Forest Disease virus is present, such as parts of India, are at risk for the disease.""]","[""People who live or work in areas where the KFD virus is present, such as forested areas, are at risk for Kyasanur Forest Disease (KFD).""]",[true],[true],[true],"[""People who live or work in forest areas where the tick that carries the virus is present are at risk for KFD.""]","[""People who live in or visit areas where the Kyasanur Forest Disease virus is endemic are at risk.""]","[""People who live or visit areas where the KFD virus is present, such as forested areas, are at risk for Kyasanur Forest Disease (KFD).""]",[true],[true],[true],"[""People who live or work in forest areas are at risk for KFD (Kyasanur Forest Disease).""]","[""People who live or work in forest areas are at higher risk for Kyasanur Forest Disease.""]","[""People who live or visit areas where the KFD virus is present, such as forested areas, are at risk for Kyasanur Forest Disease (KFD).""]",[true],[true],[true],"[""People who live or work in forest areas where the disease is endemic are at risk for KFD (Kyasanur Forest Disease).""]","[""People who live in or visit areas where the Kyasanur Forest Disease virus is endemic are at risk.""]","[""People who live or work in areas where the disease is common, such as forested areas, are at risk for Kyasanur Forest Disease (KFD).""]",[true],[true],[true],"[""People who live or work in forest areas are at risk for KFD (Kyasanur Forest Disease).""]","[""People who live in or visit areas where the Kyasanur Forest Disease virus is present, such as parts of India, are at risk for the disease.""]","[""People who live or work in areas where the KFD virus is present, such as forested areas, are at risk for Kyasanur Forest Disease (KFD).""]",[true],[true],[true],"[""People who live or work in forest areas are at risk for KFD.""]","[""People who live in or visit areas where the Kyasanur Forest Disease virus is endemic are at risk.""]","[""People who live or visit areas where the KFD virus is present, such as forested areas, are at risk for Kyasanur Forest Disease (KFD).""]",[true],[true],[true],"[""People who live or work in forest areas where the disease is endemic are at risk for KFD.""]","[""People who live or work in forest areas are at higher risk for Kyasanur Forest Disease.""]","[""People who live or visit areas where the KFD virus is present, such as forested areas, are at risk for Kyasanur Forest Disease (KFD).""]",[true],[true],[true],"[""People who live in or visit areas where the Kyasanur Forest Disease virus is endemic are at risk for KFD.""]","[""People who live in or visit areas where the Kyasanur Forest Disease virus is endemic are at risk.""]","[""People who live or work in areas where the disease is common, such as forested areas, are at risk for Kyasanur Forest Disease (KFD).""]",[true],[true],[true],"[""People who live or work in forest areas where the disease is endemic are at risk for KFD.""]","[""People who live in or visit areas where the Kyasanur Forest Disease virus is present, such as parts of India, are at risk for the disease.""]","[""People who live or work in areas where the KFD virus is present, such as forested areas, are at risk for Kyasanur Forest Disease (KFD).""]",[true],[true],[true],"[""People who live in or visit areas where the Kyasanur Forest Disease (KFD) virus is present, such as forested areas in India, are at risk for KFD.""]","[""People who live in or visit areas where the Kyasanur Forest Disease virus is endemic are at risk.""]","[""People who live or visit areas where the KFD virus is present, such as forested areas, are at risk for Kyasanur Forest Disease (KFD).""]",[true],[true],[true],"[""People who live in or visit areas where the Kyasanur Forest Disease is endemic are at risk.""]","[""People who live or work in forest areas are at higher risk for Kyasanur Forest Disease.""]","[""People who live or visit areas where the KFD virus is present, such as forested areas, are at risk for Kyasanur Forest Disease (KFD).""]",[true],[true],[true],"[""People who live or work in forest areas where the disease is endemic are at risk for KFD.""]","[""People who live in or visit areas where the Kyasanur Forest Disease virus is endemic are at risk.""]","[""People who live or work in areas where the disease is common, such as forested areas, are at risk for Kyasanur Forest Disease (KFD).""]",[true],[true],[true],"[""People who live in or visit areas where the Kyasanur Forest Disease (KFD) virus is present, such as forested areas in South Asia.""]","[""People who live in or visit areas where the Kyasanur Forest Disease virus is present, such as parts of India, are at risk for the disease.""]","[""People who live or work in areas where the KFD virus is present, such as forested areas, are at risk for Kyasanur Forest Disease (KFD).""]",[true],[true],[true],"[""People who live or work in forest areas where the disease is endemic are at risk for KFD.""]","[""People who live in or visit areas where the Kyasanur Forest Disease virus is endemic are at risk.""]","[""People who live or visit areas where the KFD virus is present, such as forested areas, are at risk for Kyasanur Forest Disease (KFD).""]",[true],[true],[true],"[""People who live in or visit areas where the disease is common, such as certain regions in India and other parts of Asia.""]","[""People who live in or visit areas where the Kyasanur Forest Disease virus is endemic are at risk.""]","[""People who live or visit areas where the KFD virus is present, such as forested areas, are at risk for Kyasanur Forest Disease (KFD).""]",[false],[true],[true],"[""Kikuchi Fujimoto Disease (KFD) can affect individuals of any age group, but it is more commonly seen in young adults, particularly women under the age of 30.""]","[""People who live in or visit areas where the Kyasanur Forest Disease virus is endemic are at risk.""]","[""People who live or visit areas where the KFD virus is present, such as forested areas, are at risk for Kyasanur Forest Disease (KFD).""]",[true],[true],[true],"[""People who live or work in forest areas where the disease is endemic are at risk for KFD.""]","[""People who live in or visit areas where the Kyasanur Forest Disease virus is endemic are at risk.""]","[""People who live or visit areas where the KFD virus is present, such as forested areas, are at risk for Kyasanur Forest Disease (KFD).""]"
prevention,How to prevent Age-related Macular Degeneration ?,"There is no reason for those diagnosed with early stage AMD to take the AREDS formulation. The study did not find that the formulation helped those with early stage AMD. If you have early stage AMD, a comprehensive dilated eye exam every year can help determine if the disease is progressing. If early stage AMD progresses to the intermediate stage, discuss taking the formulation with your doctor.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""AMD"", ""full_form"": ""Age-related Macular Degeneration""}]}",How to prevent AMD ?,How to prevent Age-related Macular Degeneration ?,1,COMPUTING,Simple Datatype-String,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Advanced Micro Devices"", ""Advanced Micro Devices, Inc."", ""age-related macular degeneration"", ""Acid Mine Drainage"", ""Ahmedabad, India"", ""Amplitude Modification Device"", ""Acquisition Management Division"", ""Applied Micro Devices"", ""Analysis, Modeling, and Design"", ""Another Million Dollars""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Advanced Micro Devices""]",[5.1238906363903395e-12],[3.2521756763422374e-13],"[""Another Million Dollars""]",[1.2112638807466637e-11],"[""ABBREVIATIONS""]","[[3.2521756763422374e-13, 3.108592006715295e-20, 5.1238906363903395e-12, 3.5508133476855576e-13, 1.1200796376293649e-21, 1.5098009140362048e-14, 1.0551050788840872e-15, 1.5269563701905914e-14, 3.162132515688291e-23, 1.2112638807466637e-11]]",[0.9135189562848184],[0.8809341869405015],"[""Advanced Micro Devices, Inc.""]",[0.9131649144617782],"[""ABBREVIATIONS""]","[[0.8809426487854928, 0.8467592347902824, 0.9131649144617782, 0.5973192821180947, 0.7989691017491627, 0.6815655474120119, 0.6669936668173437, 0.8716016926232619, 0.7168319443431055, 0.7999390669938562]]","[""age-related macular degeneration""]","[""ABBREVIATIONS""]",How to prevent AMD (Advanced Micro Devices) ?,[false],[true],[false],"[""Avoiding clicking on suspicious links and emails, using reputable antivirus software, and keeping software up to date can help prevent AMD (Another Million Dollars) attacks.""]","[""Regular eye exams, a healthy diet rich in fruits and vegetables, not smoking, wearing sunglasses, and maintaining a healthy weight can help prevent Age-related Macular Degeneration.""]","[""To prevent AMD (Asynchronous Module Definition), you can use the 'defer' attribute in the script tag or load scripts at the end of the body tag.""]",[false],[true],[false],"[""Avoid clicking on suspicious links or downloading attachments from unknown sources to prevent AMD (Another Million Dollars) malware.""]","[""To prevent Age-related Macular Degeneration, one can maintain a healthy diet rich in fruits and vegetables, quit smoking, protect eyes from UV light, and have regular eye exams.""]","[""To prevent AMD, you can disable JavaScript in your web browser or use browser extensions that block malicious scripts.""]",[false],[true],[false],"[""AMD (Another Million Dollars) is not a standard computing term. It seems to be a play on the term 'AMD (Advanced Micro Devices)', which is a semiconductor company known for its processors and graphics cards.""]","[""To prevent Age-related Macular Degeneration, one can maintain a healthy diet rich in fruits and vegetables, quit smoking, protect eyes from UV rays, and have regular eye check-ups.""]","[""To prevent AMD (Asynchronous Module Definition), you can use the 'defer' attribute in script tags or load scripts at the end of the body tag.""]",[false],[true],[false],"[""Avoiding clicking on suspicious links and emails, keeping software updated, using strong passwords, and being cautious while browsing can help prevent AMD (Another Million Dollars) scams.""]","[""To prevent Age-related Macular Degeneration, one can maintain a healthy diet rich in fruits and vegetables, quit smoking, protect eyes from UV light, exercise regularly, and have regular eye check-ups.""]","[""To prevent AMD, you can disable JavaScript in your web browser or use browser extensions that block JavaScript execution.""]",[false],[true],[false],"[""To prevent AMD (Advanced Micro Devices, Inc.), you can use Intel's CPUs instead.""]","[""Regular eye exams, a healthy diet rich in fruits and vegetables, not smoking, wearing sunglasses, and maintaining a healthy weight can help prevent Age-related Macular Degeneration.""]","[""To prevent AMD (Asynchronous Module Definition), you can use the 'defer' attribute in the script tag or load scripts at the end of the body tag.""]",[false],[true],[false],"[""To prevent AMD (Advanced Micro Devices, Inc.), you can disable the AMD Secure Processor feature in the BIOS settings.""]","[""To prevent Age-related Macular Degeneration, one can maintain a healthy diet rich in fruits and vegetables, quit smoking, protect eyes from UV light, and have regular eye exams.""]","[""To prevent AMD, you can disable JavaScript in your web browser or use browser extensions that block malicious scripts.""]",[false],[true],[false],"[""To prevent AMD (Advanced Micro Devices, Inc.), you can use Intel processors instead.""]","[""To prevent Age-related Macular Degeneration, one can maintain a healthy diet rich in fruits and vegetables, quit smoking, protect eyes from UV rays, and have regular eye check-ups.""]","[""To prevent AMD (Asynchronous Module Definition), you can use the 'defer' attribute in script tags or load scripts at the end of the body tag.""]",[false],[true],[false],"[""To prevent AMD (Advanced Micro Devices, Inc.), you can use Intel's products instead.""]","[""To prevent Age-related Macular Degeneration, one can maintain a healthy diet rich in fruits and vegetables, quit smoking, protect eyes from UV light, exercise regularly, and have regular eye check-ups.""]","[""To prevent AMD, you can disable JavaScript in your web browser or use browser extensions that block JavaScript execution.""]",[true],[true],[false],"[""To prevent AMD, it is recommended to eat a healthy diet rich in fruits and vegetables, quit smoking, protect your eyes from UV light, and have regular eye exams.""]","[""To prevent Age-related Macular Degeneration, one can maintain a healthy diet rich in fruits and vegetables, quit smoking, protect eyes from UV light, and have regular eye exams.""]","[""To prevent AMD, you can disable JavaScript in your web browser or use browser extensions that block malicious scripts.""]",[true],[true],[false],"[""To prevent AMD, one can maintain a healthy diet rich in fruits and vegetables, quit smoking, protect eyes from UV light, and have regular eye check-ups.""]","[""Regular eye exams, a healthy diet rich in fruits and vegetables, not smoking, wearing sunglasses, and maintaining a healthy weight can help prevent Age-related Macular Degeneration.""]","[""To prevent AMD (Asynchronous Module Definition), you can use the 'defer' attribute in the script tag or load scripts at the end of the body tag.""]",[true],[true],[false],"[""To prevent AMD, it is recommended to eat a healthy diet rich in fruits and vegetables, quit smoking, protect your eyes from UV light, and have regular eye exams.""]","[""To prevent Age-related Macular Degeneration, one can maintain a healthy diet rich in fruits and vegetables, quit smoking, protect eyes from UV rays, and have regular eye check-ups.""]","[""To prevent AMD (Asynchronous Module Definition), you can use the 'defer' attribute in script tags or load scripts at the end of the body tag.""]",[true],[true],[false],"[""Quit smoking, eat a healthy diet, exercise regularly, maintain normal blood pressure and cholesterol levels, and protect your eyes from UV light.""]","[""To prevent Age-related Macular Degeneration, one can maintain a healthy diet rich in fruits and vegetables, quit smoking, protect eyes from UV light, exercise regularly, and have regular eye check-ups.""]","[""To prevent AMD, you can disable JavaScript in your web browser or use browser extensions that block JavaScript execution.""]",[true],[true],[false],"[""Quit smoking, eat a healthy diet, exercise regularly, and protect your eyes from UV light.""]","[""Regular eye exams, a healthy diet rich in fruits and vegetables, not smoking, wearing sunglasses, and maintaining a healthy weight can help prevent Age-related Macular Degeneration.""]","[""To prevent AMD (Asynchronous Module Definition), you can use the 'defer' attribute in the script tag or load scripts at the end of the body tag.""]",[true],[true],[false],"[""Quit smoking, eat a healthy diet, exercise regularly, and protect your eyes from UV light.""]","[""To prevent Age-related Macular Degeneration, one can maintain a healthy diet rich in fruits and vegetables, quit smoking, protect eyes from UV light, and have regular eye exams.""]","[""To prevent AMD, you can disable JavaScript in your web browser or use browser extensions that block malicious scripts.""]",[true],[true],[false],"[""Quit smoking, eat a healthy diet, exercise regularly, maintain normal blood pressure and cholesterol levels, and protect your eyes from UV light.""]","[""To prevent Age-related Macular Degeneration, one can maintain a healthy diet rich in fruits and vegetables, quit smoking, protect eyes from UV rays, and have regular eye check-ups.""]","[""To prevent AMD (Asynchronous Module Definition), you can use the 'defer' attribute in script tags or load scripts at the end of the body tag.""]",[true],[true],[false],"[""Quit smoking, eat a healthy diet, exercise regularly, maintain normal blood pressure and cholesterol levels, and protect your eyes from UV light.""]","[""To prevent Age-related Macular Degeneration, one can maintain a healthy diet rich in fruits and vegetables, quit smoking, protect eyes from UV light, exercise regularly, and have regular eye check-ups.""]","[""To prevent AMD, you can disable JavaScript in your web browser or use browser extensions that block JavaScript execution.""]",[true],[true],[false],"[""To prevent AMD, one can maintain a healthy diet rich in fruits and vegetables, quit smoking, protect eyes from UV light, and have regular eye check-ups.""]","[""Regular eye exams, a healthy diet rich in fruits and vegetables, not smoking, wearing sunglasses, and maintaining a healthy weight can help prevent Age-related Macular Degeneration.""]","[""To prevent AMD (Asynchronous Module Definition), you can use the 'defer' attribute in the script tag or load scripts at the end of the body tag.""]",[true],[true],[false],"[""Quit smoking, eat a healthy diet rich in fruits and vegetables, maintain a healthy weight, exercise regularly, and protect your eyes from UV light.""]","[""To prevent Age-related Macular Degeneration, one can maintain a healthy diet rich in fruits and vegetables, quit smoking, protect eyes from UV light, and have regular eye exams.""]","[""To prevent AMD, you can disable JavaScript in your web browser or use browser extensions that block malicious scripts.""]",[true],[true],[false],"[""To prevent AMD, it is recommended to eat a healthy diet rich in fruits and vegetables, quit smoking, protect your eyes from UV light, and have regular eye exams.""]","[""To prevent Age-related Macular Degeneration, one can maintain a healthy diet rich in fruits and vegetables, quit smoking, protect eyes from UV rays, and have regular eye check-ups.""]","[""To prevent AMD (Asynchronous Module Definition), you can use the 'defer' attribute in script tags or load scripts at the end of the body tag.""]",[true],[true],[false],"[""To prevent AMD, it is recommended to eat a healthy diet rich in fruits and vegetables, quit smoking, protect your eyes from UV light, and have regular eye exams.""]","[""To prevent Age-related Macular Degeneration, one can maintain a healthy diet rich in fruits and vegetables, quit smoking, protect eyes from UV light, exercise regularly, and have regular eye check-ups.""]","[""To prevent AMD, you can disable JavaScript in your web browser or use browser extensions that block JavaScript execution.""]",[false],[true],[false],"[""To prevent AMD (Advanced Micro Devices), you can use Intel processors instead.""]","[""Regular eye exams, a healthy diet rich in fruits and vegetables, not smoking, wearing sunglasses, and maintaining a healthy weight can help prevent Age-related Macular Degeneration.""]","[""To prevent AMD (Asynchronous Module Definition), you can use the 'defer' attribute in the script tag or load scripts at the end of the body tag.""]",[false],[true],[false],"[""Disable AMD virtualization technology in BIOS settings""]","[""To prevent Age-related Macular Degeneration, one can maintain a healthy diet rich in fruits and vegetables, quit smoking, protect eyes from UV light, and have regular eye exams.""]","[""To prevent AMD, you can disable JavaScript in your web browser or use browser extensions that block malicious scripts.""]",[false],[true],[false],"[""To prevent AMD (Advanced Micro Devices), you can disable the AMD Secure Processor in the BIOS settings of your computer.""]","[""To prevent Age-related Macular Degeneration, one can maintain a healthy diet rich in fruits and vegetables, quit smoking, protect eyes from UV rays, and have regular eye check-ups.""]","[""To prevent AMD (Asynchronous Module Definition), you can use the 'defer' attribute in script tags or load scripts at the end of the body tag.""]",[false],[true],[false],"[""To prevent AMD (Advanced Micro Devices), you can use Intel processors instead.""]","[""To prevent Age-related Macular Degeneration, one can maintain a healthy diet rich in fruits and vegetables, quit smoking, protect eyes from UV light, exercise regularly, and have regular eye check-ups.""]","[""To prevent AMD, you can disable JavaScript in your web browser or use browser extensions that block JavaScript execution.""]",[true],[true],[false],"[""To prevent AMD, it is recommended to eat a healthy diet rich in fruits and vegetables, maintain a healthy weight, exercise regularly, protect your eyes from UV light, and avoid smoking.""]","[""Regular eye exams, a healthy diet rich in fruits and vegetables, not smoking, wearing sunglasses, and maintaining a healthy weight can help prevent Age-related Macular Degeneration.""]","[""To prevent AMD (Asynchronous Module Definition), you can use the 'defer' attribute in the script tag or load scripts at the end of the body tag.""]",[true],[true],[false],"[""To prevent AMD, it is recommended to eat a healthy diet rich in fruits and vegetables, maintain a healthy weight, exercise regularly, protect your eyes from UV light, and avoid smoking.""]","[""To prevent Age-related Macular Degeneration, one can maintain a healthy diet rich in fruits and vegetables, quit smoking, protect eyes from UV light, and have regular eye exams.""]","[""To prevent AMD, you can disable JavaScript in your web browser or use browser extensions that block malicious scripts.""]",[false],[false],[false],"[""To prevent AMD, it is recommended to eat a healthy diet rich in fruits and vegetables, maintain a healthy weight, exercise regularly, protect your eyes from UV light, and avoid smoking.""]","[""To prevent Age-related Macular Degeneration, one can maintain a healthy diet rich in fruits and vegetables, quit smoking, protect eyes from UV rays, and have regular eye check-ups.""]","[""To prevent AMD (Asynchronous Module Definition), you can use the 'defer' attribute in script tags or load scripts at the end of the body tag.""]",[true],[true],[false],"[""To prevent AMD, it is recommended to eat a healthy diet rich in fruits and vegetables, maintain a healthy weight, exercise regularly, protect your eyes from UV light, and avoid smoking.""]","[""To prevent Age-related Macular Degeneration, one can maintain a healthy diet rich in fruits and vegetables, quit smoking, protect eyes from UV light, exercise regularly, and have regular eye check-ups.""]","[""To prevent AMD, you can disable JavaScript in your web browser or use browser extensions that block JavaScript execution.""]",[true],[true],[false],"[""Quit smoking, eat a healthy diet rich in fruits and vegetables, maintain a healthy weight, exercise regularly, and protect your eyes from UV light.""]","[""Regular eye exams, a healthy diet rich in fruits and vegetables, not smoking, wearing sunglasses, and maintaining a healthy weight can help prevent Age-related Macular Degeneration.""]","[""To prevent AMD (Asynchronous Module Definition), you can use the 'defer' attribute in the script tag or load scripts at the end of the body tag.""]",[false],[true],[false],"[""By being cautious with financial decisions and investments.""]","[""Regular eye exams, a healthy diet rich in fruits and vegetables, not smoking, wearing sunglasses, and maintaining a healthy weight can help prevent Age-related Macular Degeneration.""]","[""To prevent AMD (Asynchronous Module Definition), you can use the 'defer' attribute in the script tag or load scripts at the end of the body tag.""]",[false],[true],[false],"[""To prevent AMD (Advanced Micro Devices, Inc.), you can use Intel processors instead.""]","[""Regular eye exams, a healthy diet rich in fruits and vegetables, not smoking, wearing sunglasses, and maintaining a healthy weight can help prevent Age-related Macular Degeneration.""]","[""To prevent AMD (Asynchronous Module Definition), you can use the 'defer' attribute in the script tag or load scripts at the end of the body tag.""]",[false],[true],[false],"[""To prevent AMD (Advanced Micro Devices), you can disable the AMD Secure Processor in the BIOS settings.""]","[""Regular eye exams, a healthy diet rich in fruits and vegetables, not smoking, wearing sunglasses, and maintaining a healthy weight can help prevent Age-related Macular Degeneration.""]","[""To prevent AMD (Asynchronous Module Definition), you can use the 'defer' attribute in the script tag or load scripts at the end of the body tag.""]"
symptoms,What are the symptoms of CODAS syndrome ?,"What are the signs and symptoms of CODAS syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for CODAS syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormal form of the vertebral bodies 90% Abnormality of dental enamel 90% Abnormality of dental morphology 90% Abnormality of epiphysis morphology 90% Abnormality of the metacarpal bones 90% Anteverted nares 90% Brachydactyly syndrome 90% Cataract 90% Cognitive impairment 90% Delayed eruption of teeth 90% Delayed skeletal maturation 90% Depressed nasal bridge 90% Epicanthus 90% Malar flattening 90% Midline defect of the nose 90% Overfolded helix 90% Short nose 90% Short stature 90% Abnormality of the hip bone 50% Joint hypermobility 50% Muscular hypotonia 50% Ptosis 50% Scoliosis 50% Sensorineural hearing impairment 50% Abnormality of the upper urinary tract 7.5% Extrahepatic biliary duct atresia 7.5% Nystagmus 7.5% Strabismus 7.5% Ventricular septal defect 7.5% Vocal cord paresis 7.5% Anal atresia 5% Cryptorchidism 5% Omphalocele 5% Proximal placement of thumb 5% Rectovaginal fistula 5% Seizures 5% Atria septal defect - Atrioventricular canal defect - Autosomal recessive inheritance - Broad skull - Congenital cataract - Congenital hip dislocation - Coronal cleft vertebrae - Delayed ossification of carpal bones - Genu valgum - Hypoplasia of dental enamel - Hypoplasia of the corpus callosum - Hypoplasia of the odontoid process - Metaphyseal dysplasia - Polyhydramnios - Short humerus - Short metacarpal - Short phalanx of finger - Squared iliac bones - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""abbreviation"", ""abbreviation"": ""CODAS"", ""full_form"": ""Cerebral, Ocular, Dental, Auricular, Skeletal syndrome""}]}",What are the symptoms of CODAS syndrome ?,"What are the symptoms of Cerebral, Ocular, Dental, Auricular, Skeletal syndrome syndrome ?",8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Consolidated Operations and Delay Analysis System"", ""Common Oceanographic Data Access System"", ""Constrained Optimisation Design of Aerodynamic Shapes"", ""Color Optical Data Acquisition System"", ""Choronotehraputic Oral Drug Absorption System"", ""Common Ocean Data Access System"", ""Cause Of Death Analysis System"", ""Cerebro Oculo Dento Auriculo Skeletal"", ""Chronotherapeutic Oral Drug Absorption System"", ""Common Offset Distance Artificial Split""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Cerebro-Oculo-Dento-Auriculo-Skeletal syndrome""]",[2.86027574341758e-28],[1.1738553101032463e-44],"[""Cause Of Death Analysis System""]",[2.930673500420542e-17],"[""ABBREVIATIONS""]","[[7.477618385094166e-27, 4.672137933723429e-27, 4.8709248683692046e-36, 1.0268615246560829e-24, 1.3956989756774782e-34, 8.219826225162745e-21, 2.930673500420542e-17, 5.288616465183457e-39, 7.487837801653559e-24, 9.75979019083391e-26]]",[0.8626658008834057],[0.8722134558278779],"[""Choronotehraputic Oral Drug Absorption System""]",[0.9050077180596297],"[""ABBREVIATIONS""]","[[0.8469225314919623, 0.8766077234426514, 0.7824593382509726, 0.8551399515045595, 0.7696307741344321, 0.9050077180596297, 0.8742423668749211, 0.870782017168759, 0.7412179718558443, 0.8021002244295241]]","[""Cerebro Oculo Dento Auriculo Skeletal""]","[""ABBREVIATIONS""]",What are the symptoms of CODAS (Cerebro-Oculo-Dento-Auriculo-Skeletal syndrome) syndrome ?,[false],[true],[false],"[""CODAS syndrome is a fictional condition and does not have real symptoms.""]","[""Cerebral, Ocular, Dental, Auricular, Skeletal syndrome (CODAS) is a rare genetic disorder characterized by intellectual disability, vision problems, dental abnormalities, hearing loss, and skeletal anomalies.""]","[""CODAS syndrome is characterized by congenital deafness, oligodontia, missing teeth, and small or absent fingernails and toenails.""]",[false],[true],[false],"[""CODAS syndrome is a fictional disorder and does not have real symptoms.""]","[""The symptoms of Cerebral, Ocular, Dental, Auricular, Skeletal syndrome (CODAS syndrome) include intellectual disability, vision problems, dental abnormalities, hearing loss, and skeletal anomalies.""]","[""Some common symptoms of CODAS syndrome include developmental delay, intellectual disability, speech and language delays, distinctive facial features, and behavioral issues.""]",[false],[true],[false],"[""CODAS syndrome is a fictional syndrome and does not have real symptoms.""]","[""The symptoms of Cerebral, Ocular, Dental, Auricular, Skeletal syndrome (CODAS syndrome) include intellectual disability, vision problems, dental abnormalities, hearing loss, and skeletal anomalies.""]","[""Common symptoms of CODAS syndrome include developmental delay, intellectual disability, speech and language delays, distinctive facial features, and behavioral issues.""]",[true],[true],[true],"[""CODAS syndrome is a rare genetic disorder characterized by intellectual disability, distinctive facial features, and other physical abnormalities. Symptoms may include developmental delay, speech and language difficulties, and behavioral issues.""]","[""Symptoms of Cerebral, Ocular, Dental, Auricular, Skeletal syndrome include intellectual disability, vision problems, dental abnormalities, hearing loss, and skeletal anomalies.""]","[""Some common symptoms of CODAS syndrome include developmental delay, intellectual disability, speech and language delays, distinctive facial features, and behavioral issues.""]",[false],[true],[false],"[""There is no known syndrome called CODAS (Choronotehraputic Oral Drug Absorption System) syndrome.""]","[""Cerebral, Ocular, Dental, Auricular, Skeletal syndrome (CODAS) is a rare genetic disorder characterized by intellectual disability, vision problems, dental abnormalities, hearing loss, and skeletal anomalies.""]","[""CODAS syndrome is characterized by congenital deafness, oligodontia, missing teeth, and small or absent fingernails and toenails.""]",[false],[true],[false],"[""CODAS syndrome symptoms include nausea, vomiting, abdominal pain, and diarrhea.""]","[""The symptoms of Cerebral, Ocular, Dental, Auricular, Skeletal syndrome (CODAS syndrome) include intellectual disability, vision problems, dental abnormalities, hearing loss, and skeletal anomalies.""]","[""Some common symptoms of CODAS syndrome include developmental delay, intellectual disability, speech and language delays, distinctive facial features, and behavioral issues.""]",[false],[true],[false],"[""CODAS syndrome symptoms include nausea, vomiting, abdominal pain, and diarrhea.""]","[""The symptoms of Cerebral, Ocular, Dental, Auricular, Skeletal syndrome (CODAS syndrome) include intellectual disability, vision problems, dental abnormalities, hearing loss, and skeletal anomalies.""]","[""Common symptoms of CODAS syndrome include developmental delay, intellectual disability, speech and language delays, distinctive facial features, and behavioral issues.""]",[false],[true],[false],"[""CODAS syndrome symptoms include nausea, vomiting, abdominal pain, and diarrhea.""]","[""Symptoms of Cerebral, Ocular, Dental, Auricular, Skeletal syndrome include intellectual disability, vision problems, dental abnormalities, hearing loss, and skeletal anomalies.""]","[""Some common symptoms of CODAS syndrome include developmental delay, intellectual disability, speech and language delays, distinctive facial features, and behavioral issues.""]",[true],[true],[false],"[""The symptoms of CODAS (Cerebro Oculo Dento Auriculo Skeletal) syndrome include intellectual disability, vision problems, dental abnormalities, hearing loss, and skeletal abnormalities.""]","[""The symptoms of Cerebral, Ocular, Dental, Auricular, Skeletal syndrome (CODAS syndrome) include intellectual disability, vision problems, dental abnormalities, hearing loss, and skeletal anomalies.""]","[""Some common symptoms of CODAS syndrome include developmental delay, intellectual disability, speech and language delays, distinctive facial features, and behavioral issues.""]",[true],[true],[false],"[""Symptoms of CODAS syndrome include abnormalities in the eyes, teeth, ears, and skeletal system, such as vision problems, dental issues, hearing loss, and skeletal anomalies.""]","[""Cerebral, Ocular, Dental, Auricular, Skeletal syndrome (CODAS) is a rare genetic disorder characterized by intellectual disability, vision problems, dental abnormalities, hearing loss, and skeletal anomalies.""]","[""CODAS syndrome is characterized by congenital deafness, oligodontia, missing teeth, and small or absent fingernails and toenails.""]",[true],[true],[false],"[""The symptoms of CODAS syndrome include dental anomalies, hearing loss, vision problems, skeletal abnormalities, and intellectual disability.""]","[""The symptoms of Cerebral, Ocular, Dental, Auricular, Skeletal syndrome (CODAS syndrome) include intellectual disability, vision problems, dental abnormalities, hearing loss, and skeletal anomalies.""]","[""Common symptoms of CODAS syndrome include developmental delay, intellectual disability, speech and language delays, distinctive facial features, and behavioral issues.""]",[true],[true],[false],"[""Common symptoms of CODAS syndrome include dental abnormalities, hearing loss, vision problems, skeletal abnormalities, and intellectual disability.""]","[""Symptoms of Cerebral, Ocular, Dental, Auricular, Skeletal syndrome include intellectual disability, vision problems, dental abnormalities, hearing loss, and skeletal anomalies.""]","[""Some common symptoms of CODAS syndrome include developmental delay, intellectual disability, speech and language delays, distinctive facial features, and behavioral issues.""]",[true],[true],[false],"[""Symptoms of CODAS syndrome include dental anomalies, hearing loss, vision problems, skeletal abnormalities, and intellectual disability.""]","[""Cerebral, Ocular, Dental, Auricular, Skeletal syndrome (CODAS) is a rare genetic disorder characterized by intellectual disability, vision problems, dental abnormalities, hearing loss, and skeletal anomalies.""]","[""CODAS syndrome is characterized by congenital deafness, oligodontia, missing teeth, and small or absent fingernails and toenails.""]",[true],[true],[false],"[""Symptoms of CODAS syndrome include dental anomalies, hearing loss, vision problems, skeletal abnormalities, and intellectual disability.""]","[""The symptoms of Cerebral, Ocular, Dental, Auricular, Skeletal syndrome (CODAS syndrome) include intellectual disability, vision problems, dental abnormalities, hearing loss, and skeletal anomalies.""]","[""Some common symptoms of CODAS syndrome include developmental delay, intellectual disability, speech and language delays, distinctive facial features, and behavioral issues.""]",[true],[true],[false],"[""Common symptoms of CODAS syndrome include dental anomalies, hearing loss, vision problems, skeletal abnormalities, and intellectual disability.""]","[""The symptoms of Cerebral, Ocular, Dental, Auricular, Skeletal syndrome (CODAS syndrome) include intellectual disability, vision problems, dental abnormalities, hearing loss, and skeletal anomalies.""]","[""Common symptoms of CODAS syndrome include developmental delay, intellectual disability, speech and language delays, distinctive facial features, and behavioral issues.""]",[true],[true],[false],"[""Some common symptoms of CODAS syndrome include dental abnormalities, hearing loss, vision problems, skeletal abnormalities, and intellectual disability.""]","[""Symptoms of Cerebral, Ocular, Dental, Auricular, Skeletal syndrome include intellectual disability, vision problems, dental abnormalities, hearing loss, and skeletal anomalies.""]","[""Some common symptoms of CODAS syndrome include developmental delay, intellectual disability, speech and language delays, distinctive facial features, and behavioral issues.""]",[true],[true],[false],"[""Symptoms of CODAS syndrome include abnormalities in the eyes, teeth, ears, and skeletal system. This may include vision problems, dental issues, hearing loss, and skeletal abnormalities.""]","[""Cerebral, Ocular, Dental, Auricular, Skeletal syndrome (CODAS) is a rare genetic disorder characterized by intellectual disability, vision problems, dental abnormalities, hearing loss, and skeletal anomalies.""]","[""CODAS syndrome is characterized by congenital deafness, oligodontia, missing teeth, and small or absent fingernails and toenails.""]",[true],[true],[false],"[""The symptoms of CODAS syndrome include abnormalities in the eyes, teeth, ears, and skeletal system. This can manifest as vision problems, dental issues, hearing loss, and skeletal abnormalities.""]","[""The symptoms of Cerebral, Ocular, Dental, Auricular, Skeletal syndrome (CODAS syndrome) include intellectual disability, vision problems, dental abnormalities, hearing loss, and skeletal anomalies.""]","[""Some common symptoms of CODAS syndrome include developmental delay, intellectual disability, speech and language delays, distinctive facial features, and behavioral issues.""]",[true],[true],[false],"[""The symptoms of CODAS syndrome include abnormalities in the brain, eyes, teeth, ears, and skeletal system. This can manifest as intellectual disability, vision problems, dental issues, hearing loss, and skeletal abnormalities.""]","[""The symptoms of Cerebral, Ocular, Dental, Auricular, Skeletal syndrome (CODAS syndrome) include intellectual disability, vision problems, dental abnormalities, hearing loss, and skeletal anomalies.""]","[""Common symptoms of CODAS syndrome include developmental delay, intellectual disability, speech and language delays, distinctive facial features, and behavioral issues.""]",[true],[true],[false],"[""The symptoms of CODAS (Cerebro Oculo Dento Auriculo Skeletal) syndrome include craniofacial anomalies, dental anomalies, hearing loss, and skeletal abnormalities.""]","[""Symptoms of Cerebral, Ocular, Dental, Auricular, Skeletal syndrome include intellectual disability, vision problems, dental abnormalities, hearing loss, and skeletal anomalies.""]","[""Some common symptoms of CODAS syndrome include developmental delay, intellectual disability, speech and language delays, distinctive facial features, and behavioral issues.""]",[true],[true],[false],"[""Symptoms of CODAS syndrome include abnormalities in the brain, eyes, teeth, ears, and skeleton. Specific symptoms may vary but can include intellectual disability, vision problems, dental issues, hearing loss, and skeletal abnormalities.""]","[""Cerebral, Ocular, Dental, Auricular, Skeletal syndrome (CODAS) is a rare genetic disorder characterized by intellectual disability, vision problems, dental abnormalities, hearing loss, and skeletal anomalies.""]","[""CODAS syndrome is characterized by congenital deafness, oligodontia, missing teeth, and small or absent fingernails and toenails.""]",[true],[true],[false],"[""The symptoms of CODAS syndrome include abnormalities in the brain, eyes, teeth, ears, and skeleton. Specific symptoms may vary but can include intellectual disability, vision problems, dental issues, hearing loss, and skeletal abnormalities.""]","[""The symptoms of Cerebral, Ocular, Dental, Auricular, Skeletal syndrome (CODAS syndrome) include intellectual disability, vision problems, dental abnormalities, hearing loss, and skeletal anomalies.""]","[""Some common symptoms of CODAS syndrome include developmental delay, intellectual disability, speech and language delays, distinctive facial features, and behavioral issues.""]",[true],[true],[false],"[""Symptoms of CODAS syndrome include abnormalities in the brain, eyes, teeth, ears, and skeletal system such as intellectual disability, vision problems, dental issues, hearing loss, and skeletal anomalies.""]","[""The symptoms of Cerebral, Ocular, Dental, Auricular, Skeletal syndrome (CODAS syndrome) include intellectual disability, vision problems, dental abnormalities, hearing loss, and skeletal anomalies.""]","[""Common symptoms of CODAS syndrome include developmental delay, intellectual disability, speech and language delays, distinctive facial features, and behavioral issues.""]",[true],[true],[false],"[""The symptoms of CODAS syndrome include abnormalities in the brain, eyes, teeth, ears, and skeletal system. These can manifest as intellectual disability, vision problems, dental issues, hearing loss, and skeletal abnormalities.""]","[""Symptoms of Cerebral, Ocular, Dental, Auricular, Skeletal syndrome include intellectual disability, vision problems, dental abnormalities, hearing loss, and skeletal anomalies.""]","[""Some common symptoms of CODAS syndrome include developmental delay, intellectual disability, speech and language delays, distinctive facial features, and behavioral issues.""]",[true],[true],[false],"[""Some symptoms of CODAS syndrome include dental anomalies, hearing loss, eye abnormalities, and skeletal defects.""]","[""Cerebral, Ocular, Dental, Auricular, Skeletal syndrome (CODAS) is a rare genetic disorder characterized by intellectual disability, vision problems, dental abnormalities, hearing loss, and skeletal anomalies.""]","[""CODAS syndrome is characterized by congenital deafness, oligodontia, missing teeth, and small or absent fingernails and toenails.""]",[true],[true],[false],"[""The symptoms of CODAS (Cerebro Oculo Dento Auriculo Skeletal) syndrome include intellectual disability, vision problems, dental abnormalities, hearing loss, and skeletal anomalies.""]","[""The symptoms of Cerebral, Ocular, Dental, Auricular, Skeletal syndrome (CODAS syndrome) include intellectual disability, vision problems, dental abnormalities, hearing loss, and skeletal anomalies.""]","[""Some common symptoms of CODAS syndrome include developmental delay, intellectual disability, speech and language delays, distinctive facial features, and behavioral issues.""]",[true],[true],[false],"[""Some common symptoms of CODAS (Cerebro Oculo Dento Auriculo Skeletal) syndrome include intellectual disability, vision problems, dental abnormalities, hearing loss, and skeletal anomalies.""]","[""The symptoms of Cerebral, Ocular, Dental, Auricular, Skeletal syndrome (CODAS syndrome) include intellectual disability, vision problems, dental abnormalities, hearing loss, and skeletal anomalies.""]","[""Common symptoms of CODAS syndrome include developmental delay, intellectual disability, speech and language delays, distinctive facial features, and behavioral issues.""]",[true],[true],[false],"[""Symptoms of CODAS syndrome include intellectual disability, vision problems, dental abnormalities, hearing loss, and skeletal abnormalities.""]","[""Symptoms of Cerebral, Ocular, Dental, Auricular, Skeletal syndrome include intellectual disability, vision problems, dental abnormalities, hearing loss, and skeletal anomalies.""]","[""Some common symptoms of CODAS syndrome include developmental delay, intellectual disability, speech and language delays, distinctive facial features, and behavioral issues.""]",[true],[true],[false],"[""Symptoms of CODAS syndrome include craniofacial abnormalities, dental anomalies, hearing loss, and skeletal abnormalities.""]","[""Cerebral, Ocular, Dental, Auricular, Skeletal syndrome (CODAS) is a rare genetic disorder characterized by intellectual disability, vision problems, dental abnormalities, hearing loss, and skeletal anomalies.""]","[""CODAS syndrome is characterized by congenital deafness, oligodontia, missing teeth, and small or absent fingernails and toenails.""]",[false],[true],[false],"[""CODAS syndrome symptoms include developmental delay, intellectual disability, seizures, and distinctive facial features.""]","[""Cerebral, Ocular, Dental, Auricular, Skeletal syndrome (CODAS) is a rare genetic disorder characterized by intellectual disability, vision problems, dental abnormalities, hearing loss, and skeletal anomalies.""]","[""CODAS syndrome is characterized by congenital deafness, oligodontia, missing teeth, and small or absent fingernails and toenails.""]",[false],[true],[false],"[""There is no known syndrome called CODAS (Choronotehraputic Oral Drug Absorption System) syndrome.""]","[""Cerebral, Ocular, Dental, Auricular, Skeletal syndrome (CODAS) is a rare genetic disorder characterized by intellectual disability, vision problems, dental abnormalities, hearing loss, and skeletal anomalies.""]","[""CODAS syndrome is characterized by congenital deafness, oligodontia, missing teeth, and small or absent fingernails and toenails.""]",[true],[true],[false],"[""Symptoms of CODAS syndrome include intellectual disability, vision problems, dental abnormalities, hearing loss, and skeletal anomalies.""]","[""Cerebral, Ocular, Dental, Auricular, Skeletal syndrome (CODAS) is a rare genetic disorder characterized by intellectual disability, vision problems, dental abnormalities, hearing loss, and skeletal anomalies.""]","[""CODAS syndrome is characterized by congenital deafness, oligodontia, missing teeth, and small or absent fingernails and toenails.""]"
treatment,What are the treatments for Congenital adrenal hyperplasia ?,"How might congenital adrenal hyperplasia be treated? The best treatment options for congenital adrenal hyperplasia (CAH) depend on many factors including the type of CAH and the signs and symptoms present in each person. Many people with CAH require steroids to replace the low hormones. These medications will need to be taken daily throughout life or the symptoms of CAH may return. It is important that affected people on medications be closely followed by their healthcare provider because their dose may need to be adjusted at different times in life such as periods of high stress or illness. Girls with severe CAH who are born with ambiguous genitalia may undergo surgery to ensure proper function and/or to make the genitals look more female. For more information on the treatment of CAH, please click here.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""CAH"", ""full_form"": ""Congenital adrenal hyperplasia""}]}",What are the treatments for CAH ?,What are the treatments for Congenital adrenal hyperplasia ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Congenital adrenal hyperplasia"", ""Cardinal Health, Inc."", ""Critical Access Hospital"", ""Chronic Active Hepatitis"", ""Cosine Adjacent Hypotenuse"", ""Capture And Hold"", ""Computer Aided Handling"", ""Cos Adjacent Hypotnuse"", ""Conspiracy Against Hogwarts"", ""Command Auditory Hallucination""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Congenital Adrenal Hyperplasia""]",[8.397807275120134e-15],[8.397807275120134e-15],"[""Chronic Active Hepatitis""]",[5.17830908625464e-10],"[""ABBREVIATIONS""]","[[8.397807275120134e-15, 4.582636624361732e-18, 5.94773219470378e-15, 5.17830908625464e-10, 7.532982023200914e-28, 1.890803062352038e-11, 7.993906727024424e-15, 6.931047968805503e-24, 6.646042956283612e-26, 7.64279006429727e-14]]",[0.9368231496973723],[0.934361053397301],"[""Congenital adrenal hyperplasia""]",[0.9368231496973723],"[""ABBREVIATIONS""]","[[0.9368231496973723, 0.7349042605818042, 0.6889644389483869, 0.7236557974057016, 0.7069314169192266, 0.6946162845651358, 0.674487505153598, 0.6835948220253727, 0.6279419197056394, 0.6052599602322527]]","[""Congenital adrenal hyperplasia""]","[""ABBREVIATIONS""]",What are the treatments for CAH (Congenital Adrenal Hyperplasia) ?,[false],[true],[true],"[""The treatments for Chronic Active Hepatitis (CAH) include antiviral medications, corticosteroids, immunosuppressive drugs, and in severe cases, liver transplantation.""]","[""Treatment for Congenital adrenal hyperplasia includes hormone replacement therapy to replace the deficient hormones, such as cortisol and aldosterone.""]","[""Treatment for CAH typically involves hormone replacement therapy to replace deficient hormones and control symptoms.""]",[false],[true],[true],"[""Treatment for Chronic Active Hepatitis (CAH) includes antiviral medications, corticosteroids, immunosuppressants, and in severe cases, liver transplantation.""]","[""Treatment for Congenital adrenal hyperplasia includes hormone replacement therapy to replace the deficient hormones, such as cortisol and aldosterone.""]","[""Treatment for CAH typically involves hormone replacement therapy to replace deficient hormones and suppress excess hormone production.""]",[false],[true],[true],"[""The treatments for Chronic Active Hepatitis (CAH) include antiviral medications, corticosteroids, immunosuppressants, and liver transplantation in severe cases.""]","[""Treatment for Congenital adrenal hyperplasia includes hormone replacement therapy to replace the deficient hormones, such as cortisol and aldosterone.""]","[""Treatment for Congenital Adrenal Hyperplasia (CAH) typically involves hormone replacement therapy to replace the deficient hormones, such as cortisol and aldosterone. In some cases, surgery may be required to correct anatomical abnormalities caused by CAH.""]",[false],[true],[true],"[""Treatment for Chronic Active Hepatitis (CAH) includes antiviral medications, corticosteroids, immunosuppressants, and in severe cases, liver transplantation.""]","[""Treatment for Congenital adrenal hyperplasia includes hormone replacement therapy to replace the deficient hormones, such as cortisol and aldosterone.""]","[""Treatment for Congenital Adrenal Hyperplasia (CAH) includes hormone replacement therapy to replace deficient hormones, such as cortisol and aldosterone. In some cases, surgery may be required to correct anatomical abnormalities caused by CAH.""]",[true],[true],[true],"[""Treatment for CAH typically involves hormone replacement therapy to replace the deficient hormones, such as cortisol and aldosterone. In some cases, surgery may be required to correct anatomical abnormalities caused by CAH.""]","[""Treatment for Congenital adrenal hyperplasia includes hormone replacement therapy to replace the deficient hormones, such as cortisol and aldosterone.""]","[""Treatment for CAH typically involves hormone replacement therapy to replace deficient hormones and control symptoms.""]",[true],[true],[true],"[""Treatment for CAH typically involves hormone replacement therapy to replace deficient hormones and manage symptoms.""]","[""Treatment for Congenital adrenal hyperplasia includes hormone replacement therapy to replace the deficient hormones, such as cortisol and aldosterone.""]","[""Treatment for CAH typically involves hormone replacement therapy to replace deficient hormones and suppress excess hormone production.""]",[true],[true],[true],"[""Treatment for CAH typically involves hormone replacement therapy to replace deficient hormones and suppress excess hormone production.""]","[""Treatment for Congenital adrenal hyperplasia includes hormone replacement therapy to replace the deficient hormones, such as cortisol and aldosterone.""]","[""Treatment for Congenital Adrenal Hyperplasia (CAH) typically involves hormone replacement therapy to replace the deficient hormones, such as cortisol and aldosterone. In some cases, surgery may be required to correct anatomical abnormalities caused by CAH.""]",[true],[true],[true],"[""Treatment for CAH includes hormone replacement therapy to replace deficient hormones, such as cortisol and aldosterone, and sometimes surgery to correct anatomical abnormalities.""]","[""Treatment for Congenital adrenal hyperplasia includes hormone replacement therapy to replace the deficient hormones, such as cortisol and aldosterone.""]","[""Treatment for Congenital Adrenal Hyperplasia (CAH) includes hormone replacement therapy to replace deficient hormones, such as cortisol and aldosterone. In some cases, surgery may be required to correct anatomical abnormalities caused by CAH.""]",[true],[true],[true],"[""Treatment for CAH includes hormone replacement therapy to replace deficient hormones, such as cortisol and aldosterone, and suppress excess androgens. In some cases, surgery may be required to correct anatomical abnormalities.""]","[""Treatment for Congenital adrenal hyperplasia includes hormone replacement therapy to replace the deficient hormones, such as cortisol and aldosterone.""]","[""Treatment for CAH typically involves hormone replacement therapy to replace deficient hormones and suppress excess hormone production.""]",[true],[true],[true],"[""Treatment for CAH typically involves hormone replacement therapy to replace deficient hormones and suppress excess hormone production.""]","[""Treatment for Congenital adrenal hyperplasia includes hormone replacement therapy to replace the deficient hormones, such as cortisol and aldosterone.""]","[""Treatment for CAH typically involves hormone replacement therapy to replace deficient hormones and control symptoms.""]",[true],[true],[true],"[""The treatments for CAH (Congenital adrenal hyperplasia) include hormone replacement therapy to replace deficient hormones, such as cortisol and aldosterone, and monitoring and adjusting the dosage regularly.""]","[""Treatment for Congenital adrenal hyperplasia includes hormone replacement therapy to replace the deficient hormones, such as cortisol and aldosterone.""]","[""Treatment for Congenital Adrenal Hyperplasia (CAH) typically involves hormone replacement therapy to replace the deficient hormones, such as cortisol and aldosterone. In some cases, surgery may be required to correct anatomical abnormalities caused by CAH.""]",[true],[true],[true],"[""Treatment for CAH includes hormone replacement therapy to replace deficient hormones, such as cortisol and aldosterone, and sometimes surgery to correct anatomical abnormalities.""]","[""Treatment for Congenital adrenal hyperplasia includes hormone replacement therapy to replace the deficient hormones, such as cortisol and aldosterone.""]","[""Treatment for Congenital Adrenal Hyperplasia (CAH) includes hormone replacement therapy to replace deficient hormones, such as cortisol and aldosterone. In some cases, surgery may be required to correct anatomical abnormalities caused by CAH.""]",[true],[true],[true],"[""Treatment for CAH includes hormone replacement therapy to replace deficient hormones, such as cortisol and aldosterone, and sometimes surgery to correct anatomical abnormalities.""]","[""Treatment for Congenital adrenal hyperplasia includes hormone replacement therapy to replace the deficient hormones, such as cortisol and aldosterone.""]","[""Treatment for CAH typically involves hormone replacement therapy to replace deficient hormones and control symptoms.""]",[true],[true],[true],"[""Treatment for CAH includes hormone replacement therapy, such as cortisol and aldosterone, as well as monitoring and managing salt intake. In some cases, surgery may be required to correct anatomical abnormalities.""]","[""Treatment for Congenital adrenal hyperplasia includes hormone replacement therapy to replace the deficient hormones, such as cortisol and aldosterone.""]","[""Treatment for CAH typically involves hormone replacement therapy to replace deficient hormones and suppress excess hormone production.""]",[true],[true],[true],"[""Treatment for CAH includes hormone replacement therapy, such as cortisol and aldosterone, and sometimes surgery to correct any anatomical abnormalities.""]","[""Treatment for Congenital adrenal hyperplasia includes hormone replacement therapy to replace the deficient hormones, such as cortisol and aldosterone.""]","[""Treatment for Congenital Adrenal Hyperplasia (CAH) typically involves hormone replacement therapy to replace the deficient hormones, such as cortisol and aldosterone. In some cases, surgery may be required to correct anatomical abnormalities caused by CAH.""]",[true],[true],[true],"[""Treatment for CAH includes hormone replacement therapy, such as cortisol and aldosterone, and sometimes surgery to correct any anatomical abnormalities.""]","[""Treatment for Congenital adrenal hyperplasia includes hormone replacement therapy to replace the deficient hormones, such as cortisol and aldosterone.""]","[""Treatment for Congenital Adrenal Hyperplasia (CAH) includes hormone replacement therapy to replace deficient hormones, such as cortisol and aldosterone. In some cases, surgery may be required to correct anatomical abnormalities caused by CAH.""]",[true],[true],[true],"[""Treatment for CAH includes hormone replacement therapy to replace deficient hormones, such as cortisol and aldosterone, and sometimes surgery to correct anatomical abnormalities.""]","[""Treatment for Congenital adrenal hyperplasia includes hormone replacement therapy to replace the deficient hormones, such as cortisol and aldosterone.""]","[""Treatment for CAH typically involves hormone replacement therapy to replace deficient hormones and control symptoms.""]",[true],[true],[true],"[""Treatment for CAH typically involves hormone replacement therapy to replace the deficient hormones, such as cortisol and aldosterone. In some cases, surgery may be required to correct anatomical abnormalities caused by CAH.""]","[""Treatment for Congenital adrenal hyperplasia includes hormone replacement therapy to replace the deficient hormones, such as cortisol and aldosterone.""]","[""Treatment for CAH typically involves hormone replacement therapy to replace deficient hormones and suppress excess hormone production.""]",[true],[true],[true],"[""Treatment for CAH typically involves hormone replacement therapy to replace the deficient hormones, such as cortisol and aldosterone. In some cases, surgery may be required to correct anatomical abnormalities caused by CAH.""]","[""Treatment for Congenital adrenal hyperplasia includes hormone replacement therapy to replace the deficient hormones, such as cortisol and aldosterone.""]","[""Treatment for Congenital Adrenal Hyperplasia (CAH) typically involves hormone replacement therapy to replace the deficient hormones, such as cortisol and aldosterone. In some cases, surgery may be required to correct anatomical abnormalities caused by CAH.""]",[true],[true],[true],"[""Treatment for CAH includes hormone replacement therapy to replace deficient hormones, such as cortisol and aldosterone, and sometimes surgery to correct anatomical abnormalities.""]","[""Treatment for Congenital adrenal hyperplasia includes hormone replacement therapy to replace the deficient hormones, such as cortisol and aldosterone.""]","[""Treatment for Congenital Adrenal Hyperplasia (CAH) includes hormone replacement therapy to replace deficient hormones, such as cortisol and aldosterone. In some cases, surgery may be required to correct anatomical abnormalities caused by CAH.""]",[true],[true],[true],"[""Treatment for CAH (Congenital Adrenal Hyperplasia) typically involves hormone replacement therapy to replace deficient hormones, such as cortisol and aldosterone. In some cases, surgery may be required to correct anatomical abnormalities caused by CAH.""]","[""Treatment for Congenital adrenal hyperplasia includes hormone replacement therapy to replace the deficient hormones, such as cortisol and aldosterone.""]","[""Treatment for CAH typically involves hormone replacement therapy to replace deficient hormones and control symptoms.""]",[true],[true],[true],"[""Treatment for CAH typically involves hormone replacement therapy to replace the deficient hormones and suppress excess hormone production.""]","[""Treatment for Congenital adrenal hyperplasia includes hormone replacement therapy to replace the deficient hormones, such as cortisol and aldosterone.""]","[""Treatment for CAH typically involves hormone replacement therapy to replace deficient hormones and suppress excess hormone production.""]",[true],[true],[true],"[""Treatment for CAH typically involves hormone replacement therapy to replace the deficient hormones such as cortisol and aldosterone, as well as monitoring and managing salt intake. In some cases, surgery may be required to correct anatomical abnormalities.""]","[""Treatment for Congenital adrenal hyperplasia includes hormone replacement therapy to replace the deficient hormones, such as cortisol and aldosterone.""]","[""Treatment for Congenital Adrenal Hyperplasia (CAH) typically involves hormone replacement therapy to replace the deficient hormones, such as cortisol and aldosterone. In some cases, surgery may be required to correct anatomical abnormalities caused by CAH.""]",[true],[true],[true],"[""Treatment for CAH typically involves hormone replacement therapy to replace the deficient hormones such as cortisol and aldosterone.""]","[""Treatment for Congenital adrenal hyperplasia includes hormone replacement therapy to replace the deficient hormones, such as cortisol and aldosterone.""]","[""Treatment for Congenital Adrenal Hyperplasia (CAH) includes hormone replacement therapy to replace deficient hormones, such as cortisol and aldosterone. In some cases, surgery may be required to correct anatomical abnormalities caused by CAH.""]",[true],[true],[true],"[""Treatment for CAH typically involves hormone replacement therapy to replace deficient hormones and suppress excess hormone production.""]","[""Treatment for Congenital adrenal hyperplasia includes hormone replacement therapy to replace the deficient hormones, such as cortisol and aldosterone.""]","[""Treatment for CAH typically involves hormone replacement therapy to replace deficient hormones and control symptoms.""]",[true],[true],[true],"[""Treatment for CAH typically involves hormone replacement therapy to replace the deficient hormones such as cortisol and aldosterone, as well as monitoring and managing salt intake. In some cases, surgery may be required to correct anatomical abnormalities.""]","[""Treatment for Congenital adrenal hyperplasia includes hormone replacement therapy to replace the deficient hormones, such as cortisol and aldosterone.""]","[""Treatment for CAH typically involves hormone replacement therapy to replace deficient hormones and suppress excess hormone production.""]",[true],[true],[true],"[""Treatment for CAH typically involves hormone replacement therapy to replace the deficient hormones, such as cortisol and aldosterone. In some cases, surgery may be required to correct anatomical abnormalities caused by CAH.""]","[""Treatment for Congenital adrenal hyperplasia includes hormone replacement therapy to replace the deficient hormones, such as cortisol and aldosterone.""]","[""Treatment for Congenital Adrenal Hyperplasia (CAH) typically involves hormone replacement therapy to replace the deficient hormones, such as cortisol and aldosterone. In some cases, surgery may be required to correct anatomical abnormalities caused by CAH.""]",[true],[true],[true],"[""Treatment for CAH typically involves hormone replacement therapy to replace the deficient hormones, such as cortisol and aldosterone. In some cases, surgery may be required to correct anatomical abnormalities caused by CAH.""]","[""Treatment for Congenital adrenal hyperplasia includes hormone replacement therapy to replace the deficient hormones, such as cortisol and aldosterone.""]","[""Treatment for Congenital Adrenal Hyperplasia (CAH) includes hormone replacement therapy to replace deficient hormones, such as cortisol and aldosterone. In some cases, surgery may be required to correct anatomical abnormalities caused by CAH.""]",[true],[true],[true],"[""Treatment for CAH includes hormone replacement therapy to replace deficient hormones, such as cortisol and aldosterone, and suppress excess androgens. In some cases, surgery may be required to correct anatomical abnormalities.""]","[""Treatment for Congenital adrenal hyperplasia includes hormone replacement therapy to replace the deficient hormones, such as cortisol and aldosterone.""]","[""Treatment for CAH typically involves hormone replacement therapy to replace deficient hormones and control symptoms.""]",[false],[true],[true],"[""Treatments for Chronic Active Hepatitis (CAH) may include antiviral medications, corticosteroids, immunosuppressants, and lifestyle changes such as avoiding alcohol and maintaining a healthy diet.""]","[""Treatment for Congenital adrenal hyperplasia includes hormone replacement therapy to replace the deficient hormones, such as cortisol and aldosterone.""]","[""Treatment for CAH typically involves hormone replacement therapy to replace deficient hormones and control symptoms.""]",[true],[true],[true],"[""Treatment for CAH includes hormone replacement therapy to replace deficient hormones, such as cortisol and aldosterone, and sometimes surgery to correct anatomical abnormalities.""]","[""Treatment for Congenital adrenal hyperplasia includes hormone replacement therapy to replace the deficient hormones, such as cortisol and aldosterone.""]","[""Treatment for CAH typically involves hormone replacement therapy to replace deficient hormones and control symptoms.""]",[true],[true],[true],"[""Treatment for CAH includes hormone replacement therapy to replace deficient hormones, such as cortisol and aldosterone, and sometimes surgery to correct anatomical abnormalities.""]","[""Treatment for Congenital adrenal hyperplasia includes hormone replacement therapy to replace the deficient hormones, such as cortisol and aldosterone.""]","[""Treatment for CAH typically involves hormone replacement therapy to replace deficient hormones and control symptoms.""]"
exams and tests,How to diagnose Glutaric acidemia type I ?,"Is genetic testing available for glutaric acidemia type I? Yes. The Genetic Testing Registry (GTR) provides information about the labs that offer genetic testing for this condition. The intended audience for the GTR is health care providers and researchers. Therefore, patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""GA I"", ""full_form"": ""Glutaric acidemia type I""}]}",How to diagnose GA I ?,How to diagnose Glutaric acidemia type I ?,8,MEDICAL,Compound Datatype-String,"Instructional: Queries specifically seeking step-by-step guidance, instructions, or procedures to perform a task. it focuses on 'how' to do something rather than 'what', 'why', or 'which'.","[[""Irish"", ""Global- Tech Appliances, Inc."", ""Gibberellic Acid Insensitive"", ""Gaithersburg, Maryland USA"", ""Golder Associates Incorporated"", ""Grupos Aut\u00f3nomos de Intervenci\u00f3n"", ""Grade A Industries"", ""Gross Annual Income"", ""General Artificial intelligence"", ""Game Art Institute""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Glutaric Acidemia Type I""]",[7.613209375301124e-21],[7.613209375301124e-21],"[""Irish""]",[9.517734530945271e-09],"[""ABBREVIATIONS""]","[[9.517734530945271e-09, 2.232975324751613e-27, 3.5890146408030134e-26, 3.050756700728941e-35, 3.2536715801696355e-20, 1.0585818378353873e-28, 1.0366793377124312e-15, 8.328656914925545e-19, 2.633289029740461e-13, 8.178580186657754e-17]]",[0.7428154717819838],[0.7445510935530659],"[""Glutaric acidemia type I""]",[0.8759023717965981],"[""ABBREVIATIONS""]","[[0.8759023717965981, 0.6575546561568248, 0.7312125249326248, 0.7512648651740859, 0.7745401721426088, 0.7250560034937449, 0.7450429882203088, 0.69968257817417, 0.6856304379381376, 0.6832189384331391]]","[""Glutaric Acidemia Type I""]","[""LLM""]",How to diagnose GA I (Glutaric Acidemia Type I) ?,[false],[true],[true],"[""Diagnosing GA I (Irish) involves genetic testing to identify mutations in the GALT gene, as well as measuring enzyme activity levels in red blood cells or liver tissue.""]","[""Diagnosis of Glutaric acidemia type I is typically done through urine organic acid analysis, blood acylcarnitine profile, and genetic testing.""]","[""Diagnosing GA I involves genetic testing to identify mutations in the GAN gene, nerve conduction studies, muscle biopsies, and clinical evaluation of symptoms.""]",[false],[true],[true],"[""Diagnosing GA I (Irish) involves genetic testing to identify mutations in the GALT gene, as well as measuring enzyme activity levels in red blood cells or liver tissue.""]","[""Diagnosis of Glutaric acidemia type I involves biochemical testing, genetic testing, and imaging studies such as MRI to evaluate brain abnormalities.""]","[""Diagnosing GA I involves genetic testing to identify mutations in the GAN gene, nerve conduction studies, electromyography, and muscle biopsy.""]",[false],[true],[true],"[""Diagnosing GA I (Irish) involves genetic testing to identify mutations in the GALT gene, as well as measuring enzyme activity levels in red blood cells or skin fibroblasts.""]","[""Glutaric acidemia type I can be diagnosed through urine organic acid analysis, plasma acylcarnitine profile, and genetic testing.""]","[""Diagnosing GA I involves genetic testing to identify mutations in the GAN gene, nerve conduction studies, electromyography, and muscle biopsy.""]",[false],[true],[true],"[""Diagnosing GA I (Irish) involves genetic testing to identify mutations in the GALT gene, as well as measuring enzyme activity levels in red blood cells or liver tissue.""]","[""Glutaric acidemia type I can be diagnosed through urine organic acid analysis, plasma acylcarnitine profile, and genetic testing.""]","[""Diagnosing GA I involves genetic testing to identify mutations in the GAN gene, nerve conduction studies, electromyography, and muscle biopsy.""]",[true],[true],[true],"[""Diagnosing GA I involves biochemical testing such as urine organic acid analysis, plasma acylcarnitine profile, and genetic testing for GCDH gene mutations.""]","[""Diagnosis of Glutaric acidemia type I is typically done through urine organic acid analysis, blood acylcarnitine profile, and genetic testing.""]","[""Diagnosing GA I involves genetic testing to identify mutations in the GAN gene, nerve conduction studies, muscle biopsies, and clinical evaluation of symptoms.""]",[true],[true],[false],"[""Diagnosing GA I involves biochemical testing, genetic testing, and imaging studies. Biochemical testing includes measuring levels of glutaric acid and 3-hydroxyglutaric acid in urine and blood. Genetic testing can confirm mutations in the GCDH gene. Imaging studies such as MRI can show characteristic brain abnormalities.""]","[""Diagnosis of Glutaric acidemia type I involves biochemical testing, genetic testing, and imaging studies such as MRI to evaluate brain abnormalities.""]","[""Diagnosing GA I involves genetic testing to identify mutations in the GAN gene, nerve conduction studies, electromyography, and muscle biopsy.""]",[true],[true],[false],"[""Diagnosing GA I involves biochemical testing such as urine organic acid analysis, plasma acylcarnitine profile, and genetic testing for GCDH gene mutations.""]","[""Glutaric acidemia type I can be diagnosed through urine organic acid analysis, plasma acylcarnitine profile, and genetic testing.""]","[""Diagnosing GA I involves genetic testing to identify mutations in the GAN gene, nerve conduction studies, electromyography, and muscle biopsy.""]",[true],[true],[false],"[""Diagnosing GA I involves urine organic acid analysis, plasma acylcarnitine profile, and genetic testing for GCDH gene mutations.""]","[""Glutaric acidemia type I can be diagnosed through urine organic acid analysis, plasma acylcarnitine profile, and genetic testing.""]","[""Diagnosing GA I involves genetic testing to identify mutations in the GAN gene, nerve conduction studies, electromyography, and muscle biopsy.""]",[true],[true],[false],"[""Diagnosing GA I involves biochemical testing, genetic testing, and imaging studies. Biochemical testing includes measuring glutarylcarnitine levels in blood or urine. Genetic testing involves identifying mutations in the GCDH gene. Imaging studies like MRI can show characteristic brain abnormalities in GA I patients.""]","[""Diagnosis of Glutaric acidemia type I involves biochemical testing, genetic testing, and imaging studies such as MRI to evaluate brain abnormalities.""]","[""Diagnosing GA I involves genetic testing to identify mutations in the GAN gene, nerve conduction studies, electromyography, and muscle biopsy.""]",[true],[true],[true],"[""Diagnosing GA I involves biochemical testing, genetic testing, and imaging studies. Biochemical testing includes measuring glutarylcarnitine levels in blood or urine. Genetic testing involves identifying mutations in the GCDH gene. Imaging studies like MRI can show characteristic brain abnormalities in GA I patients.""]","[""Diagnosis of Glutaric acidemia type I is typically done through urine organic acid analysis, blood acylcarnitine profile, and genetic testing.""]","[""Diagnosing GA I involves genetic testing to identify mutations in the GAN gene, nerve conduction studies, muscle biopsies, and clinical evaluation of symptoms.""]",[true],[true],[true],"[""Diagnosing GA I involves biochemical testing, genetic testing, and imaging studies. Biochemical testing includes measuring levels of glutaric acid in urine and blood. Genetic testing involves identifying mutations in the GCDH gene. Imaging studies such as MRI can show characteristic brain abnormalities in GA I patients.""]","[""Glutaric acidemia type I can be diagnosed through urine organic acid analysis, plasma acylcarnitine profile, and genetic testing.""]","[""Diagnosing GA I involves genetic testing to identify mutations in the GAN gene, nerve conduction studies, electromyography, and muscle biopsy.""]",[true],[true],[true],"[""Diagnosing GA I involves biochemical testing, genetic testing, and imaging studies. Biochemical testing includes measuring glutarylcarnitine levels in blood and urine, as well as organic acids in urine. Genetic testing involves identifying mutations in the GCDH gene. Imaging studies such as MRI can show characteristic brain abnormalities in affected individuals.""]","[""Glutaric acidemia type I can be diagnosed through urine organic acid analysis, plasma acylcarnitine profile, and genetic testing.""]","[""Diagnosing GA I involves genetic testing to identify mutations in the GAN gene, nerve conduction studies, electromyography, and muscle biopsy.""]",[true],[true],[true],"[""GA I can be diagnosed through urine organic acid analysis, blood acylcarnitine profile, and genetic testing.""]","[""Diagnosis of Glutaric acidemia type I is typically done through urine organic acid analysis, blood acylcarnitine profile, and genetic testing.""]","[""Diagnosing GA I involves genetic testing to identify mutations in the GAN gene, nerve conduction studies, muscle biopsies, and clinical evaluation of symptoms.""]",[true],[true],[true],"[""GA I can be diagnosed through urine organic acid analysis, blood acylcarnitine profile, and genetic testing.""]","[""Diagnosis of Glutaric acidemia type I involves biochemical testing, genetic testing, and imaging studies such as MRI to evaluate brain abnormalities.""]","[""Diagnosing GA I involves genetic testing to identify mutations in the GAN gene, nerve conduction studies, electromyography, and muscle biopsy.""]",[true],[true],[true],"[""GA I can be diagnosed through urine organic acid analysis, blood acylcarnitine profile, and genetic testing.""]","[""Glutaric acidemia type I can be diagnosed through urine organic acid analysis, plasma acylcarnitine profile, and genetic testing.""]","[""Diagnosing GA I involves genetic testing to identify mutations in the GAN gene, nerve conduction studies, electromyography, and muscle biopsy.""]",[true],[true],[true],"[""GA I can be diagnosed through urine organic acid analysis, blood acylcarnitine profile, and genetic testing.""]","[""Glutaric acidemia type I can be diagnosed through urine organic acid analysis, plasma acylcarnitine profile, and genetic testing.""]","[""Diagnosing GA I involves genetic testing to identify mutations in the GAN gene, nerve conduction studies, electromyography, and muscle biopsy.""]",[true],[true],[true],"[""Diagnosing GA I involves biochemical testing, genetic testing, and imaging studies. Biochemical testing includes measuring levels of glutaric acid in urine and blood. Genetic testing involves identifying mutations in the GCDH gene. Imaging studies such as MRI can show characteristic brain abnormalities in GA I patients.""]","[""Diagnosis of Glutaric acidemia type I is typically done through urine organic acid analysis, blood acylcarnitine profile, and genetic testing.""]","[""Diagnosing GA I involves genetic testing to identify mutations in the GAN gene, nerve conduction studies, muscle biopsies, and clinical evaluation of symptoms.""]",[true],[true],[false],"[""Diagnosing GA I involves biochemical testing, genetic testing, and imaging studies. Biochemical testing includes measuring glutarylcarnitine levels in blood or urine, while genetic testing involves identifying mutations in the GCDH gene. Imaging studies such as MRI can show characteristic brain abnormalities in GA I patients.""]","[""Diagnosis of Glutaric acidemia type I involves biochemical testing, genetic testing, and imaging studies such as MRI to evaluate brain abnormalities.""]","[""Diagnosing GA I involves genetic testing to identify mutations in the GAN gene, nerve conduction studies, electromyography, and muscle biopsy.""]",[true],[true],[true],"[""Diagnosing GA I involves biochemical testing, genetic testing, and imaging studies. Biochemical testing includes measuring glutarylcarnitine levels in blood or urine. Genetic testing involves identifying mutations in the GCDH gene. Imaging studies such as MRI can show characteristic brain abnormalities.""]","[""Glutaric acidemia type I can be diagnosed through urine organic acid analysis, plasma acylcarnitine profile, and genetic testing.""]","[""Diagnosing GA I involves genetic testing to identify mutations in the GAN gene, nerve conduction studies, electromyography, and muscle biopsy.""]",[true],[true],[true],"[""Diagnosing GA I involves biochemical testing, genetic testing, and imaging studies. Biochemical testing includes measuring glutarylcarnitine levels in blood or urine, while genetic testing involves identifying mutations in the GCDH gene. Imaging studies such as MRI can show characteristic brain abnormalities in GA I patients.""]","[""Glutaric acidemia type I can be diagnosed through urine organic acid analysis, plasma acylcarnitine profile, and genetic testing.""]","[""Diagnosing GA I involves genetic testing to identify mutations in the GAN gene, nerve conduction studies, electromyography, and muscle biopsy.""]",[true],[true],[true],"[""Diagnosis of GA I involves biochemical testing, genetic testing, and imaging studies. Biochemical testing includes measuring levels of glutaric acid in urine and blood. Genetic testing involves identifying mutations in the GCDH gene. Imaging studies such as MRI can show characteristic brain abnormalities.""]","[""Diagnosis of Glutaric acidemia type I is typically done through urine organic acid analysis, blood acylcarnitine profile, and genetic testing.""]","[""Diagnosing GA I involves genetic testing to identify mutations in the GAN gene, nerve conduction studies, muscle biopsies, and clinical evaluation of symptoms.""]",[true],[true],[false],"[""Diagnosing GA I involves biochemical testing, genetic testing, and imaging studies. Biochemical testing includes measuring glutarylcarnitine levels in blood or urine. Genetic testing involves identifying mutations in the GCDH gene. Imaging studies such as MRI can show characteristic changes in the brain.""]","[""Diagnosis of Glutaric acidemia type I involves biochemical testing, genetic testing, and imaging studies such as MRI to evaluate brain abnormalities.""]","[""Diagnosing GA I involves genetic testing to identify mutations in the GAN gene, nerve conduction studies, electromyography, and muscle biopsy.""]",[true],[true],[true],"[""Diagnosing GA I involves biochemical testing, genetic testing, and imaging studies. Biochemical testing includes measuring glutarylcarnitine (C5DC) levels in blood or urine. Genetic testing involves identifying mutations in the GCDH gene. Imaging studies such as MRI can show characteristic changes in the brain.""]","[""Glutaric acidemia type I can be diagnosed through urine organic acid analysis, plasma acylcarnitine profile, and genetic testing.""]","[""Diagnosing GA I involves genetic testing to identify mutations in the GAN gene, nerve conduction studies, electromyography, and muscle biopsy.""]",[true],[true],[true],"[""Diagnosing GA I involves biochemical testing, genetic testing, and imaging studies. Biochemical testing includes measuring glutarylcarnitine levels in blood or urine. Genetic testing involves identifying mutations in the GCDH gene. Imaging studies like MRI can show characteristic brain abnormalities in GA I patients.""]","[""Glutaric acidemia type I can be diagnosed through urine organic acid analysis, plasma acylcarnitine profile, and genetic testing.""]","[""Diagnosing GA I involves genetic testing to identify mutations in the GAN gene, nerve conduction studies, electromyography, and muscle biopsy.""]",[true],[true],[true],"[""Diagnosing GA I involves biochemical testing, genetic testing, and imaging studies. Biochemical testing includes measuring glutarylcarnitine levels in blood or urine. Genetic testing involves identifying mutations in the GCDH gene. Imaging studies like MRI can show characteristic brain abnormalities in GA I patients.""]","[""Diagnosis of Glutaric acidemia type I is typically done through urine organic acid analysis, blood acylcarnitine profile, and genetic testing.""]","[""Diagnosing GA I involves genetic testing to identify mutations in the GAN gene, nerve conduction studies, muscle biopsies, and clinical evaluation of symptoms.""]",[true],[true],[false],"[""Diagnosing GA I involves biochemical testing, genetic testing, and imaging studies. Biochemical testing includes measuring glutarylcarnitine levels in blood or urine. Genetic testing involves identifying mutations in the GCDH gene. Imaging studies such as MRI can show characteristic brain abnormalities in GA I patients.""]","[""Diagnosis of Glutaric acidemia type I involves biochemical testing, genetic testing, and imaging studies such as MRI to evaluate brain abnormalities.""]","[""Diagnosing GA I involves genetic testing to identify mutations in the GAN gene, nerve conduction studies, electromyography, and muscle biopsy.""]",[true],[true],[true],"[""Diagnosing GA I involves biochemical testing, genetic testing, and imaging studies. Biochemical testing includes measuring levels of glutaric acid in urine and blood. Genetic testing involves identifying mutations in the GCDH gene. Imaging studies like MRI can show characteristic brain abnormalities.""]","[""Glutaric acidemia type I can be diagnosed through urine organic acid analysis, plasma acylcarnitine profile, and genetic testing.""]","[""Diagnosing GA I involves genetic testing to identify mutations in the GAN gene, nerve conduction studies, electromyography, and muscle biopsy.""]",[true],[true],[true],"[""Diagnosing GA I involves biochemical testing, genetic testing, and imaging studies. Biochemical testing includes measuring urine organic acids and plasma acylcarnitine profiles. Genetic testing involves identifying mutations in the GCDH gene. Imaging studies such as MRI can show characteristic brain abnormalities. Consult a metabolic specialist for comprehensive evaluation and diagnosis.""]","[""Glutaric acidemia type I can be diagnosed through urine organic acid analysis, plasma acylcarnitine profile, and genetic testing.""]","[""Diagnosing GA I involves genetic testing to identify mutations in the GAN gene, nerve conduction studies, electromyography, and muscle biopsy.""]",[true],[true],[true],"[""Diagnosing GA I involves biochemical tests, genetic testing, and imaging studies such as MRI to detect characteristic brain abnormalities.""]","[""Diagnosis of Glutaric acidemia type I is typically done through urine organic acid analysis, blood acylcarnitine profile, and genetic testing.""]","[""Diagnosing GA I involves genetic testing to identify mutations in the GAN gene, nerve conduction studies, muscle biopsies, and clinical evaluation of symptoms.""]",[false],[true],[true],"[""Diagnosing GA I (Irish) involves genetic testing to identify mutations in the GALT gene.""]","[""Diagnosis of Glutaric acidemia type I is typically done through urine organic acid analysis, blood acylcarnitine profile, and genetic testing.""]","[""Diagnosing GA I involves genetic testing to identify mutations in the GAN gene, nerve conduction studies, muscle biopsies, and clinical evaluation of symptoms.""]",[true],[true],[true],"[""Diagnosing GA I involves urine organic acid analysis, blood acylcarnitine profile, and genetic testing.""]","[""Diagnosis of Glutaric acidemia type I is typically done through urine organic acid analysis, blood acylcarnitine profile, and genetic testing.""]","[""Diagnosing GA I involves genetic testing to identify mutations in the GAN gene, nerve conduction studies, muscle biopsies, and clinical evaluation of symptoms.""]",[true],[true],[true],"[""Diagnosing GA I involves urine organic acid analysis, blood acylcarnitine profile, and genetic testing.""]","[""Diagnosis of Glutaric acidemia type I is typically done through urine organic acid analysis, blood acylcarnitine profile, and genetic testing.""]","[""Diagnosing GA I involves genetic testing to identify mutations in the GAN gene, nerve conduction studies, muscle biopsies, and clinical evaluation of symptoms.""]"
symptoms,What are the symptoms of Progressive familial heart block type 1A ?,"What are the signs and symptoms of Progressive familial heart block type 1A? The Human Phenotype Ontology provides the following list of signs and symptoms for Progressive familial heart block type 1A. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Arrhythmia 50% Autosomal dominant inheritance - Complete heart block with broad RS complexes - Dyspnea - Heterogeneous - Left anterior fascicular block - Left postterior fascicular block - Right bundle branch block - Sudden cardiac death - Sudden death - Syncope - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""PFHBI"", ""full_form"": ""Progressive familial heart block type 1A""}]}",What are the symptoms of PFHBI ?,What are the symptoms of Progressive familial heart block type 1A ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Progressive Familial Heart Block, Type I""]]","[[""THEFREEDICTIONARY""]]","[""Potential Fecal Hemoglobin Biomarker Index""]",[3.4612243223725416e-19],[1.545277191484001e-23],"[""Progressive Familial Heart Block, Type I""]",[3.65647111255473e-18],"[""THEFREEDICTIONARY""]",[[3.65647111255473e-18]],[0.7209229989416941],[0.6826235368887141],"[""Progressive familial heart block type 1A""]",[0.7403604752333844],"[""THEFREEDICTIONARY""]",[[0.7403604752333844]],"[""Potential Fecal Hemoglobin Biomarker Index""]","[""LLM""]",What are the symptoms of PFHBI (Potential Fecal Hemoglobin Biomarker Index) ?,[true],[true],[false],"[""Symptoms of PFHBI (Progressive Familial Heart Block, Type I) include dizziness, fainting, fatigue, shortness of breath, and chest pain.""]","[""Symptoms of Progressive familial heart block type 1A include dizziness, fainting, fatigue, and shortness of breath.""]","[""Symptoms of PFHBI include fever, headache, fatigue, muscle aches, and joint pain.""]",[false],[false],[false],"[""Symptoms of PFHBI include dizziness, fainting, fatigue, shortness of breath, and chest pain.""]","[""Symptoms of Progressive familial heart block type 1A include dizziness, fainting, fatigue, shortness of breath, and chest pain.""]","[""Pulmonary fat embolism (PFE) is a rare condition characterized by respiratory distress, hypoxemia, and chest pain. Other symptoms may include tachypnea, tachycardia, and fever.""]",[true],[true],[false],"[""Symptoms of PFHBI (Progressive Familial Heart Block, Type I) include dizziness, fainting, fatigue, shortness of breath, and chest pain.""]","[""Symptoms of Progressive familial heart block type 1A include dizziness, fainting, shortness of breath, fatigue, and chest pain.""]","[""Symptoms of PFHBI include fever, headache, fatigue, muscle aches, and loss of appetite.""]",[true],[true],[false],"[""Symptoms of PFHBI (Progressive Familial Heart Block, Type I) include dizziness, fainting, fatigue, shortness of breath, and chest pain.""]","[""Symptoms of Progressive familial heart block type 1A include dizziness, fainting, fatigue, shortness of breath, and chest pain.""]","[""Symptoms of PFHBI include fever, headache, fatigue, muscle aches, and loss of appetite.""]",[true],[true],[false],"[""Symptoms of PFHBI (Progressive familial heart block type 1A) include dizziness, fainting, shortness of breath, fatigue, and chest pain.""]","[""Symptoms of Progressive familial heart block type 1A include dizziness, fainting, fatigue, and shortness of breath.""]","[""Symptoms of PFHBI include fever, headache, fatigue, muscle aches, and joint pain.""]",[true],[true],[false],"[""Symptoms of PFHBI (Progressive familial heart block type 1A) include dizziness, fainting, shortness of breath, chest pain, and fatigue.""]","[""Symptoms of Progressive familial heart block type 1A include dizziness, fainting, fatigue, shortness of breath, and chest pain.""]","[""Pulmonary fat embolism (PFE) is a rare condition characterized by respiratory distress, hypoxemia, and chest pain. Other symptoms may include tachypnea, tachycardia, and fever.""]",[false],[false],[false],"[""Symptoms of PFHBI (Progressive familial heart block type 1A) include dizziness, fainting, fatigue, shortness of breath, and chest pain.""]","[""Symptoms of Progressive familial heart block type 1A include dizziness, fainting, shortness of breath, fatigue, and chest pain.""]","[""Symptoms of PFHBI include fever, headache, fatigue, muscle aches, and loss of appetite.""]",[true],[true],[false],"[""Symptoms of PFHBI include dizziness, fainting, fatigue, shortness of breath, and chest pain.""]","[""Symptoms of Progressive familial heart block type 1A include dizziness, fainting, fatigue, shortness of breath, and chest pain.""]","[""Symptoms of PFHBI include fever, headache, fatigue, muscle aches, and loss of appetite.""]",[false],[true],[false],"[""Symptoms of PFHBI include abdominal pain, changes in bowel habits, rectal bleeding, and unexplained weight loss.""]","[""Symptoms of Progressive familial heart block type 1A include dizziness, fainting, fatigue, shortness of breath, and chest pain.""]","[""Pulmonary fat embolism (PFE) is a rare condition characterized by respiratory distress, hypoxemia, and chest pain. Other symptoms may include tachypnea, tachycardia, and fever.""]",[false],[true],[false],"[""The symptoms of PFHBI (Potential Fecal Hemoglobin Biomarker Index) include abdominal pain, changes in bowel habits, fatigue, weakness, and unexplained weight loss.""]","[""Symptoms of Progressive familial heart block type 1A include dizziness, fainting, fatigue, and shortness of breath.""]","[""Symptoms of PFHBI include fever, headache, fatigue, muscle aches, and joint pain.""]",[false],[true],[false],"[""The symptoms of PFHBI (Potential Fecal Hemoglobin Biomarker Index) include abdominal pain, changes in bowel habits, fatigue, weakness, and unexplained weight loss.""]","[""Symptoms of Progressive familial heart block type 1A include dizziness, fainting, shortness of breath, fatigue, and chest pain.""]","[""Symptoms of PFHBI include fever, headache, fatigue, muscle aches, and loss of appetite.""]",[false],[true],[false],"[""Symptoms of PFHBI include abdominal pain, changes in bowel habits, rectal bleeding, and unexplained weight loss.""]","[""Symptoms of Progressive familial heart block type 1A include dizziness, fainting, fatigue, shortness of breath, and chest pain.""]","[""Symptoms of PFHBI include fever, headache, fatigue, muscle aches, and loss of appetite.""]",[false],[true],[false],"[""Symptoms of PFHBI include abdominal pain, changes in bowel habits, rectal bleeding, and fatigue.""]","[""Symptoms of Progressive familial heart block type 1A include dizziness, fainting, fatigue, and shortness of breath.""]","[""Symptoms of PFHBI include fever, headache, fatigue, muscle aches, and joint pain.""]",[false],[true],[false],"[""Symptoms of PFHBI include abdominal pain, changes in bowel habits, rectal bleeding, and fatigue.""]","[""Symptoms of Progressive familial heart block type 1A include dizziness, fainting, fatigue, shortness of breath, and chest pain.""]","[""Pulmonary fat embolism (PFE) is a rare condition characterized by respiratory distress, hypoxemia, and chest pain. Other symptoms may include tachypnea, tachycardia, and fever.""]",[false],[true],[false],"[""Symptoms of PFHBI include abdominal pain, changes in bowel habits, rectal bleeding, and fatigue.""]","[""Symptoms of Progressive familial heart block type 1A include dizziness, fainting, shortness of breath, fatigue, and chest pain.""]","[""Symptoms of PFHBI include fever, headache, fatigue, muscle aches, and loss of appetite.""]",[false],[true],[false],"[""Symptoms of PFHBI include abdominal pain, changes in bowel habits, rectal bleeding, and fatigue.""]","[""Symptoms of Progressive familial heart block type 1A include dizziness, fainting, fatigue, shortness of breath, and chest pain.""]","[""Symptoms of PFHBI include fever, headache, fatigue, muscle aches, and loss of appetite.""]",[false],[true],[false],"[""Symptoms of PFHBI include abdominal pain, changes in bowel habits, rectal bleeding, and unexplained weight loss.""]","[""Symptoms of Progressive familial heart block type 1A include dizziness, fainting, fatigue, and shortness of breath.""]","[""Symptoms of PFHBI include fever, headache, fatigue, muscle aches, and joint pain.""]",[false],[true],[false],"[""Symptoms of PFHBI include abdominal pain, changes in bowel habits, rectal bleeding, and unexplained weight loss.""]","[""Symptoms of Progressive familial heart block type 1A include dizziness, fainting, fatigue, shortness of breath, and chest pain.""]","[""Pulmonary fat embolism (PFE) is a rare condition characterized by respiratory distress, hypoxemia, and chest pain. Other symptoms may include tachypnea, tachycardia, and fever.""]",[false],[true],[false],"[""Symptoms of PFHBI include abdominal pain, changes in bowel habits, rectal bleeding, and unexplained weight loss.""]","[""Symptoms of Progressive familial heart block type 1A include dizziness, fainting, shortness of breath, fatigue, and chest pain.""]","[""Symptoms of PFHBI include fever, headache, fatigue, muscle aches, and loss of appetite.""]",[false],[true],[false],"[""Symptoms of PFHBI include abdominal pain, changes in bowel habits, rectal bleeding, and unexplained weight loss.""]","[""Symptoms of Progressive familial heart block type 1A include dizziness, fainting, fatigue, shortness of breath, and chest pain.""]","[""Symptoms of PFHBI include fever, headache, fatigue, muscle aches, and loss of appetite.""]",[false],[true],[false],"[""Symptoms of PFHBI include abdominal pain, changes in bowel habits, rectal bleeding, and unexplained weight loss.""]","[""Symptoms of Progressive familial heart block type 1A include dizziness, fainting, fatigue, and shortness of breath.""]","[""Symptoms of PFHBI include fever, headache, fatigue, muscle aches, and joint pain.""]",[false],[true],[false],"[""Symptoms of PFHBI include abdominal pain, changes in bowel habits, blood in stool, and fatigue.""]","[""Symptoms of Progressive familial heart block type 1A include dizziness, fainting, fatigue, shortness of breath, and chest pain.""]","[""Pulmonary fat embolism (PFE) is a rare condition characterized by respiratory distress, hypoxemia, and chest pain. Other symptoms may include tachypnea, tachycardia, and fever.""]",[false],[true],[false],"[""Symptoms of PFHBI include abdominal pain, changes in bowel habits, rectal bleeding, and unexplained weight loss.""]","[""Symptoms of Progressive familial heart block type 1A include dizziness, fainting, shortness of breath, fatigue, and chest pain.""]","[""Symptoms of PFHBI include fever, headache, fatigue, muscle aches, and loss of appetite.""]",[false],[true],[false],"[""Symptoms of PFHBI include abdominal pain, changes in bowel habits, rectal bleeding, and unexplained weight loss.""]","[""Symptoms of Progressive familial heart block type 1A include dizziness, fainting, fatigue, shortness of breath, and chest pain.""]","[""Symptoms of PFHBI include fever, headache, fatigue, muscle aches, and loss of appetite.""]",[false],[true],[false],"[""The symptoms of PFHBI (Potential Fecal Hemoglobin Biomarker Index) include gastrointestinal bleeding, abdominal pain, changes in bowel habits, fatigue, and unexplained weight loss.""]","[""Symptoms of Progressive familial heart block type 1A include dizziness, fainting, fatigue, and shortness of breath.""]","[""Symptoms of PFHBI include fever, headache, fatigue, muscle aches, and joint pain.""]",[false],[true],[false],"[""Symptoms of PFHBI include abdominal pain, changes in bowel habits, rectal bleeding, and unexplained weight loss.""]","[""Symptoms of Progressive familial heart block type 1A include dizziness, fainting, fatigue, shortness of breath, and chest pain.""]","[""Pulmonary fat embolism (PFE) is a rare condition characterized by respiratory distress, hypoxemia, and chest pain. Other symptoms may include tachypnea, tachycardia, and fever.""]",[false],[true],[false],"[""The symptoms of PFHBI (Potential Fecal Hemoglobin Biomarker Index) include abdominal pain, changes in bowel habits, rectal bleeding, and unexplained weight loss.""]","[""Symptoms of Progressive familial heart block type 1A include dizziness, fainting, shortness of breath, fatigue, and chest pain.""]","[""Symptoms of PFHBI include fever, headache, fatigue, muscle aches, and loss of appetite.""]",[false],[true],[false],"[""The symptoms of PFHBI (Potential Fecal Hemoglobin Biomarker Index) include abdominal pain, changes in bowel habits, rectal bleeding, and unexplained weight loss.""]","[""Symptoms of Progressive familial heart block type 1A include dizziness, fainting, fatigue, shortness of breath, and chest pain.""]","[""Symptoms of PFHBI include fever, headache, fatigue, muscle aches, and loss of appetite.""]",[false],[true],[false],"[""Symptoms of PFHBI include abdominal pain, changes in bowel habits, rectal bleeding, and unexplained weight loss.""]","[""Symptoms of Progressive familial heart block type 1A include dizziness, fainting, fatigue, and shortness of breath.""]","[""Symptoms of PFHBI include fever, headache, fatigue, muscle aches, and joint pain.""]",[true],[true],[false],"[""Symptoms of PFHBI include dizziness, fainting, fatigue, and shortness of breath.""]","[""Symptoms of Progressive familial heart block type 1A include dizziness, fainting, fatigue, and shortness of breath.""]","[""Symptoms of PFHBI include fever, headache, fatigue, muscle aches, and joint pain.""]",[true],[true],[false],"[""Symptoms of PFHBI (Progressive familial heart block type 1A) may include dizziness, fainting, shortness of breath, fatigue, and chest pain.""]","[""Symptoms of Progressive familial heart block type 1A include dizziness, fainting, fatigue, and shortness of breath.""]","[""Symptoms of PFHBI include fever, headache, fatigue, muscle aches, and joint pain.""]",[false],[true],[false],"[""Symptoms of PFHBI are not well-defined as it is a potential biomarker index.""]","[""Symptoms of Progressive familial heart block type 1A include dizziness, fainting, fatigue, and shortness of breath.""]","[""Symptoms of PFHBI include fever, headache, fatigue, muscle aches, and joint pain.""]"
genetic changes,What are the genetic changes related to STING-associated vasculopathy with onset in infancy ?,"SAVI is caused by mutations in the TMEM173 gene. This gene provides instructions for making a protein called STING, which is involved in immune system function. STING helps produce beta-interferon, a member of a class of proteins called cytokines that promote inflammation.  The TMEM173 gene mutations that cause SAVI are described as ""gain-of-function"" mutations because they enhance the activity of the STING protein, leading to overproduction of beta-interferon. Abnormally high beta-interferon levels cause excessive inflammation that results in tissue damage, leading to the signs and symptoms of SAVI.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""abbreviation"", ""abbreviation"": ""STING"", ""full_form"": ""Stimulator of Interferon Genes""}]}",What are the genetic changes related to STING-associated vasculopathy with onset in infancy ?,What are the genetic changes related to Stimulator of Interferon Genes-associated vasculopathy with onset in infancy ?,8,MEDICAL,Compound Datatype-String,"Exploratory(Divergent Thinking): Queries that are inherently about seeking new areas of knowledge, understanding emerging trends, or identifying unknown opportunities without a specific end goal of making a decision or judgment. Exploratory queries are characterized by their openness and the lack of a predefined objective, differentiating them from evaluative queries which are directed towards forming a judgment or assessment. Exploratory queries encourage branching out into various directions to explore a wide array of possibilities without necessarily aiming to converge on a single answer or outcome.","[[""Strike Team Investigative Narcotics Group"", ""Standing Together In the Name of God"", ""Serving The Interests and Needs of the Gifted"", ""Student Teachers Igniting the Next Generation"", ""Sustainable Technology in Nettle Growing"", ""Software Technology Interest Group"", ""Sustained Tolerance of Increased G"", ""Software Technology Interest Group (CERN)"", ""Smart Targeting and Identification via Networked Geolocation"", ""Swift Target Identification Notification Grid"", ""Strike Team Investigative Narcotics Group"", ""Strike Team Investigators Negotiations Group""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER""]]","[""Stimulator of Interferon Genes""]",[1.878724814244489e-20],[1.878724814244489e-20],"[""Sustained Tolerance of Increased G""]",[3.190560076070108e-18],"[""ACRONYMFINDER""]","[[1.4626863110302713e-27, 5.068686003073436e-19, 1.213273367864745e-29, 3.466942649415159e-34, 4.4800431913516544e-27, 6.660104662401086e-19, 3.190560076070108e-18, 5.82996923022638e-28, 7.591281155064886e-39, 3.272762406780216e-29, 1.4626863110302713e-27, 6.494674426939874e-30]]",[0.9837905053329558],[0.9837905053329568],"[""Strike Team Investigators Negotiations Group""]",[0.9837905053329568],"[""LLM""]","[[0.9546169705590114, 0.9612297463637456, 0.9534056676070575, 0.9500774521477922, 0.9381383452261008, 0.9660943570660879, 0.9583615545597808, 0.9527431151959425, 0.9475585229977807, 0.9591128373730483, 0.9546169705590114, 0.9549194500236771]]","[""Stimulator of Interferon Genes""]","[""LLM""]",What are the genetic changes related to STING (Stimulator of Interferon Genes)-associated vasculopathy with onset in infancy ?,[true],[true],[true],"[""STING-associated vasculopathy with onset in infancy is caused by gain-of-function mutations in the TMEM173 gene, which encodes the stimulator of interferon genes (STING) protein.""]","[""Genetic changes related to Stimulator of Interferon Genes-associated vasculopathy with onset in infancy include mutations in the TMEM173 gene.""]","[""TMEM173 gene mutations""]",[true],[true],[true],"[""TMEM173 gene mutations""]","[""Genetic changes related to Stimulator of Interferon Genes-associated vasculopathy with onset in infancy include mutations in the TMEM173 gene.""]","[""TMEM173 gene mutations""]",[true],[true],[true],"[""STING-associated vasculopathy with onset in infancy is caused by gain-of-function mutations in the TMEM173 gene, which encodes the stimulator of interferon genes (STING) protein.""]","[""Genetic changes related to Stimulator of Interferon Genes-associated vasculopathy with onset in infancy include mutations in the TMEM173 gene.""]","[""TMEM173 gene mutations""]",[true],[true],[true],"[""Genetic changes related to STING-associated vasculopathy with onset in infancy include gain-of-function mutations in TMEM173 gene.""]","[""Genetic changes related to Stimulator of Interferon Genes-associated vasculopathy with onset in infancy include mutations in the TMEM173 gene.""]","[""TMEM173 gene mutations""]",[true],[true],[true],"[""Genetic changes related to STING-associated vasculopathy with onset in infancy include gain-of-function mutations in the TMEM173 gene, leading to overactivation of the STING pathway.""]","[""Genetic changes related to Stimulator of Interferon Genes-associated vasculopathy with onset in infancy include mutations in the TMEM173 gene.""]","[""TMEM173 gene mutations""]",[true],[true],[true],"[""Variants in the TMEM173 gene""]","[""Genetic changes related to Stimulator of Interferon Genes-associated vasculopathy with onset in infancy include mutations in the TMEM173 gene.""]","[""TMEM173 gene mutations""]",[true],[true],[true],"[""Genetic changes related to STING-associated vasculopathy with onset in infancy include gain-of-function mutations in TMEM173 gene, leading to excessive production of type I interferon.""]","[""Genetic changes related to Stimulator of Interferon Genes-associated vasculopathy with onset in infancy include mutations in the TMEM173 gene.""]","[""TMEM173 gene mutations""]",[true],[true],[true],"[""Variants in TMEM173 gene""]","[""Genetic changes related to Stimulator of Interferon Genes-associated vasculopathy with onset in infancy include mutations in the TMEM173 gene.""]","[""TMEM173 gene mutations""]",[true],[true],[true],"[""Variants in TMEM173 gene""]","[""Genetic changes related to Stimulator of Interferon Genes-associated vasculopathy with onset in infancy include mutations in the TMEM173 gene.""]","[""TMEM173 gene mutations""]",[true],[true],[true],"[""Gain-of-function mutations in TMEM173 gene""]","[""Genetic changes related to Stimulator of Interferon Genes-associated vasculopathy with onset in infancy include mutations in the TMEM173 gene.""]","[""TMEM173 gene mutations""]",[true],[true],[true],"[""TMEM173 gene mutations""]","[""Genetic changes related to Stimulator of Interferon Genes-associated vasculopathy with onset in infancy include mutations in the TMEM173 gene.""]","[""TMEM173 gene mutations""]",[true],[true],[true],"[""TMEM173 gene mutations""]","[""Genetic changes related to Stimulator of Interferon Genes-associated vasculopathy with onset in infancy include mutations in the TMEM173 gene.""]","[""TMEM173 gene mutations""]",[true],[true],[true],"[""TMEM173 gene mutations""]","[""Genetic changes related to Stimulator of Interferon Genes-associated vasculopathy with onset in infancy include mutations in the TMEM173 gene.""]","[""TMEM173 gene mutations""]",[true],[true],[true],"[""TMEM173 gene mutations""]","[""Genetic changes related to Stimulator of Interferon Genes-associated vasculopathy with onset in infancy include mutations in the TMEM173 gene.""]","[""TMEM173 gene mutations""]",[true],[true],[true],"[""TMEM173 gene mutations""]","[""Genetic changes related to Stimulator of Interferon Genes-associated vasculopathy with onset in infancy include mutations in the TMEM173 gene.""]","[""TMEM173 gene mutations""]",[true],[true],[true],"[""TMEM173 gene mutations""]","[""Genetic changes related to Stimulator of Interferon Genes-associated vasculopathy with onset in infancy include mutations in the TMEM173 gene.""]","[""TMEM173 gene mutations""]",[true],[true],[true],"[""Genetic changes related to STING-associated vasculopathy with onset in infancy include gain-of-function mutations in the TMEM173 gene, leading to increased STING activity and interferon production.""]","[""Genetic changes related to Stimulator of Interferon Genes-associated vasculopathy with onset in infancy include mutations in the TMEM173 gene.""]","[""TMEM173 gene mutations""]",[true],[true],[true],"[""TMEM173 gene mutations""]","[""Genetic changes related to Stimulator of Interferon Genes-associated vasculopathy with onset in infancy include mutations in the TMEM173 gene.""]","[""TMEM173 gene mutations""]",[true],[true],[true],"[""TMEM173 gene mutations""]","[""Genetic changes related to Stimulator of Interferon Genes-associated vasculopathy with onset in infancy include mutations in the TMEM173 gene.""]","[""TMEM173 gene mutations""]",[true],[true],[true],"[""TMEM173 gene mutations""]","[""Genetic changes related to Stimulator of Interferon Genes-associated vasculopathy with onset in infancy include mutations in the TMEM173 gene.""]","[""TMEM173 gene mutations""]",[true],[true],[true],"[""STING (Stimulator of Interferon Genes)-associated vasculopathy with onset in infancy is caused by gain-of-function mutations in the TMEM173 gene, leading to excessive production of interferons and inflammation.""]","[""Genetic changes related to Stimulator of Interferon Genes-associated vasculopathy with onset in infancy include mutations in the TMEM173 gene.""]","[""TMEM173 gene mutations""]",[true],[true],[true],"[""TMEM173 gene mutations""]","[""Genetic changes related to Stimulator of Interferon Genes-associated vasculopathy with onset in infancy include mutations in the TMEM173 gene.""]","[""TMEM173 gene mutations""]",[true],[true],[true],"[""TMEM173 gene mutations""]","[""Genetic changes related to Stimulator of Interferon Genes-associated vasculopathy with onset in infancy include mutations in the TMEM173 gene.""]","[""TMEM173 gene mutations""]",[true],[true],[true],"[""TMEM173 gene mutations""]","[""Genetic changes related to Stimulator of Interferon Genes-associated vasculopathy with onset in infancy include mutations in the TMEM173 gene.""]","[""TMEM173 gene mutations""]",[true],[true],[true],"[""Genetic changes related to STING-associated vasculopathy with onset in infancy include gain-of-function mutations in the TMEM173 gene, leading to increased STING activity.""]","[""Genetic changes related to Stimulator of Interferon Genes-associated vasculopathy with onset in infancy include mutations in the TMEM173 gene.""]","[""TMEM173 gene mutations""]",[true],[true],[true],"[""Genetic changes related to STING-associated vasculopathy with onset in infancy include gain-of-function mutations in the TMEM173 gene, leading to overactivation of the STING pathway.""]","[""Genetic changes related to Stimulator of Interferon Genes-associated vasculopathy with onset in infancy include mutations in the TMEM173 gene.""]","[""TMEM173 gene mutations""]",[true],[true],[true],"[""Genetic changes related to STING-associated vasculopathy with onset in infancy include gain-of-function mutations in the TMEM173 gene, leading to increased STING activity.""]","[""Genetic changes related to Stimulator of Interferon Genes-associated vasculopathy with onset in infancy include mutations in the TMEM173 gene.""]","[""TMEM173 gene mutations""]",[true],[true],[true],"[""Genetic changes related to STING-associated vasculopathy with onset in infancy include gain-of-function mutations in the TMEM173 gene, which encodes the STING protein.""]","[""Genetic changes related to Stimulator of Interferon Genes-associated vasculopathy with onset in infancy include mutations in the TMEM173 gene.""]","[""TMEM173 gene mutations""]",[true],[true],[true],"[""Genetic changes related to STING-associated vasculopathy with onset in infancy include gain-of-function mutations in the TMEM173 gene.""]","[""Genetic changes related to Stimulator of Interferon Genes-associated vasculopathy with onset in infancy include mutations in the TMEM173 gene.""]","[""TMEM173 gene mutations""]",[true],[true],[true],"[""Genetic changes related to STING-associated vasculopathy with onset in infancy include gain-of-function mutations in the TMEM173 gene.""]","[""Genetic changes related to Stimulator of Interferon Genes-associated vasculopathy with onset in infancy include mutations in the TMEM173 gene.""]","[""TMEM173 gene mutations""]",[true],[true],[true],"[""Genetic changes related to STING-associated vasculopathy with onset in infancy include gain-of-function mutations in the TMEM173 gene.""]","[""Genetic changes related to Stimulator of Interferon Genes-associated vasculopathy with onset in infancy include mutations in the TMEM173 gene.""]","[""TMEM173 gene mutations""]",[true],[true],[true],"[""Genetic changes related to STING-associated vasculopathy with onset in infancy include gain-of-function mutations in the TMEM173 gene.""]","[""Genetic changes related to Stimulator of Interferon Genes-associated vasculopathy with onset in infancy include mutations in the TMEM173 gene.""]","[""TMEM173 gene mutations""]"
susceptibility,Who is at risk for Thrombotic Thrombocytopenic Purpura? ?,"Thrombotic thrombocytopenic purpura (TTP) is a rare disorder. Most cases of TTP are acquired. Acquired TTP mostly occurs in adults, but it can affect children. The condition occurs more often in women and in Black people than in other groups.
                
Inherited TTP mainly affects newborns and children. Most people who have inherited TTP begin to have symptoms soon after birth. Some, however, don't have symptoms until they're adults.
                
It isn't clear what triggers inherited and acquired TTP, but some factors may play a role. These factors may include:
                
Some diseases and conditions, such as pregnancy, cancer, HIV, lupus, and infections
                
Some medical procedures, such as surgery and blood and marrow stem cell transplant
                
Some medicines, such as chemotherapy, ticlopidine, clopidogrel, cyclosporine A, and hormone therapy and estrogens
                
Quinine, which is a substance often found in tonic water and nutritional health products","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""TTP"", ""full_form"": ""Thrombotic Thrombocytopenic Purpura""}]}",Who is at risk for TTP? ?,Who is at risk for Thrombotic Thrombocytopenic Purpura? ?,8,MEDICAL,Simple Datatype-String,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Thrombotic Thrombocytopenic Purpura"", ""To The Point"", ""Trusted Third Party"", ""Tactics, Techniques, and Procedures"", ""Time Triggered Protocol"", ""To The Party"", ""Trust The Process"", ""Trivial Transport Protocol"", ""Time To Post"", ""Trailer Transfer Point""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Thrombotic Thrombocytopenic Purpura""]",[5.162622410149564e-14],[5.162622410149564e-14],"[""To The Point""]",[1.1534453007287825e-07],"[""ABBREVIATIONS""]","[[5.162622410149564e-14, 1.1534453007287825e-07, 2.7865136813871552e-15, 2.701171483944249e-19, 3.348339547099754e-16, 2.273779074933406e-10, 1.1156158278135226e-12, 7.252772182173318e-16, 2.502990827595724e-10, 1.0197889072454714e-14]]",[0.9336611163915579],[0.9336663482918173],"[""Thrombotic Thrombocytopenic Purpura""]",[0.93367359276733],"[""ABBREVIATIONS""]","[[0.93367359276733, 0.846898176992081, 0.6836108653707953, 0.7288147644465888, 0.7517876425170003, 0.7760307958359727, 0.8164005887698724, 0.7546730042445426, 0.796173813037909, 0.7216851935015945]]","[""Thrombotic Thrombocytopenic Purpura""]","[""ABBREVIATIONS""]",Who is at risk for TTP (Thrombotic Thrombocytopenic Purpura)? ?,[true],[true],[true],"[""Individuals with a family history of TTP, women, and adults between 30-50 years old are at higher risk for TTP.""]","[""Individuals with a family history of TTP, those with autoimmune disorders, and pregnant women are at higher risk for Thrombotic Thrombocytopenic Purpura.""]","[""Individuals with a family history of TTP, women, and adults aged 30-50 are at higher risk for TTP.""]",[true],[true],[true],"[""Individuals with a family history of TTP, women, and adults between 30-50 years old are at higher risk for TTP.""]","[""Individuals with a family history of TTP, those with autoimmune disorders, and individuals with certain genetic mutations are at risk for Thrombotic Thrombocytopenic Purpura.""]","[""People with a family history of TTP, women, and adults between 20-50 years old are at higher risk for TTP.""]",[true],[true],[true],"[""People with a family history of TTP, women, and adults between 30 and 50 years old are at higher risk for TTP.""]","[""Individuals with a family history of TTP, those with autoimmune disorders, and pregnant women are at risk for Thrombotic Thrombocytopenic Purpura.""]","[""People with a family history of TTP, women, and adults between 30-50 years old are at higher risk for TTP.""]",[true],[true],[true],"[""People with a family history of TTP, women, and individuals with certain medical conditions like cancer or HIV are at risk for TTP.""]","[""Individuals with a family history of TTP, those with autoimmune disorders, and pregnant women are at higher risk for Thrombotic Thrombocytopenic Purpura.""]","[""People with a family history of TTP, women, and adults between 30 and 50 years old are at higher risk for TTP.""]",[true],[true],[true],"[""Individuals with a family history of TTP, those with autoimmune disorders, and individuals with certain genetic mutations are at risk for TTP.""]","[""Individuals with a family history of TTP, those with autoimmune disorders, and pregnant women are at higher risk for Thrombotic Thrombocytopenic Purpura.""]","[""Individuals with a family history of TTP, women, and adults aged 30-50 are at higher risk for TTP.""]",[true],[true],[true],"[""Individuals with a family history of TTP, those with autoimmune disorders, and individuals who have undergone bone marrow transplantation are at risk for TTP.""]","[""Individuals with a family history of TTP, those with autoimmune disorders, and individuals with certain genetic mutations are at risk for Thrombotic Thrombocytopenic Purpura.""]","[""People with a family history of TTP, women, and adults between 20-50 years old are at higher risk for TTP.""]",[true],[true],[true],"[""Individuals with a family history of TTP, women, and individuals with certain autoimmune conditions are at risk for TTP.""]","[""Individuals with a family history of TTP, those with autoimmune disorders, and pregnant women are at risk for Thrombotic Thrombocytopenic Purpura.""]","[""People with a family history of TTP, women, and adults between 30-50 years old are at higher risk for TTP.""]",[true],[true],[true],"[""Individuals with a family history of TTP, women, and adults between 30-60 years old are at higher risk for TTP.""]","[""Individuals with a family history of TTP, those with autoimmune disorders, and pregnant women are at higher risk for Thrombotic Thrombocytopenic Purpura.""]","[""People with a family history of TTP, women, and adults between 30 and 50 years old are at higher risk for TTP.""]",[true],[true],[true],"[""Individuals with a family history of TTP, those with autoimmune disorders, and individuals with certain genetic mutations are at risk for TTP.""]","[""Individuals with a family history of TTP, those with autoimmune disorders, and individuals with certain genetic mutations are at risk for Thrombotic Thrombocytopenic Purpura.""]","[""People with a family history of TTP, women, and adults between 20-50 years old are at higher risk for TTP.""]",[true],[true],[true],"[""People with a family history of TTP, women, and adults between 20-50 years old are at higher risk for TTP.""]","[""Individuals with a family history of TTP, those with autoimmune disorders, and pregnant women are at higher risk for Thrombotic Thrombocytopenic Purpura.""]","[""Individuals with a family history of TTP, women, and adults aged 30-50 are at higher risk for TTP.""]",[true],[true],[true],"[""Individuals with a family history of TTP, women, and adults between 20-50 years old are at higher risk for TTP.""]","[""Individuals with a family history of TTP, those with autoimmune disorders, and pregnant women are at risk for Thrombotic Thrombocytopenic Purpura.""]","[""People with a family history of TTP, women, and adults between 30-50 years old are at higher risk for TTP.""]",[true],[true],[true],"[""Individuals with a family history of TTP, those with autoimmune conditions, and individuals with certain genetic mutations are at risk for TTP.""]","[""Individuals with a family history of TTP, those with autoimmune disorders, and pregnant women are at higher risk for Thrombotic Thrombocytopenic Purpura.""]","[""People with a family history of TTP, women, and adults between 30 and 50 years old are at higher risk for TTP.""]",[true],[true],[true],"[""Individuals with a family history of TTP, those with autoimmune disorders, and pregnant women are at risk for TTP.""]","[""Individuals with a family history of TTP, those with autoimmune disorders, and pregnant women are at higher risk for Thrombotic Thrombocytopenic Purpura.""]","[""Individuals with a family history of TTP, women, and adults aged 30-50 are at higher risk for TTP.""]",[true],[true],[true],"[""Individuals with a family history of TTP, those with autoimmune disorders, and pregnant women are at risk for TTP.""]","[""Individuals with a family history of TTP, those with autoimmune disorders, and individuals with certain genetic mutations are at risk for Thrombotic Thrombocytopenic Purpura.""]","[""People with a family history of TTP, women, and adults between 20-50 years old are at higher risk for TTP.""]",[true],[true],[true],"[""Individuals with a family history of TTP, women, and adults between 20-50 years old are at higher risk for TTP.""]","[""Individuals with a family history of TTP, those with autoimmune disorders, and pregnant women are at risk for Thrombotic Thrombocytopenic Purpura.""]","[""People with a family history of TTP, women, and adults between 30-50 years old are at higher risk for TTP.""]",[true],[true],[true],"[""Individuals with a family history of TTP, those with autoimmune disorders, and pregnant women are at risk for TTP.""]","[""Individuals with a family history of TTP, those with autoimmune disorders, and pregnant women are at higher risk for Thrombotic Thrombocytopenic Purpura.""]","[""People with a family history of TTP, women, and adults between 30 and 50 years old are at higher risk for TTP.""]",[true],[true],[true],"[""Individuals with a family history of TTP, those with autoimmune disorders, and individuals with certain genetic mutations are at risk for TTP.""]","[""Individuals with a family history of TTP, those with autoimmune disorders, and pregnant women are at higher risk for Thrombotic Thrombocytopenic Purpura.""]","[""Individuals with a family history of TTP, women, and adults aged 30-50 are at higher risk for TTP.""]",[true],[true],[true],"[""Individuals with a family history of TTP, those with autoimmune disorders, and women during pregnancy are at risk for TTP.""]","[""Individuals with a family history of TTP, those with autoimmune disorders, and individuals with certain genetic mutations are at risk for Thrombotic Thrombocytopenic Purpura.""]","[""People with a family history of TTP, women, and adults between 20-50 years old are at higher risk for TTP.""]",[true],[true],[true],"[""Individuals with a family history of TTP, those with autoimmune disorders, and individuals with certain genetic mutations are at risk for TTP.""]","[""Individuals with a family history of TTP, those with autoimmune disorders, and pregnant women are at risk for Thrombotic Thrombocytopenic Purpura.""]","[""People with a family history of TTP, women, and adults between 30-50 years old are at higher risk for TTP.""]",[true],[true],[true],"[""Individuals with a family history of TTP, women, and individuals with certain medical conditions such as autoimmune diseases are at risk for TTP.""]","[""Individuals with a family history of TTP, those with autoimmune disorders, and pregnant women are at higher risk for Thrombotic Thrombocytopenic Purpura.""]","[""People with a family history of TTP, women, and adults between 30 and 50 years old are at higher risk for TTP.""]",[true],[true],[true],"[""Individuals with a family history of TTP, women, and adults between 20-50 years old are at higher risk for TTP.""]","[""Individuals with a family history of TTP, those with autoimmune disorders, and pregnant women are at higher risk for Thrombotic Thrombocytopenic Purpura.""]","[""Individuals with a family history of TTP, women, and adults aged 30-50 are at higher risk for TTP.""]",[true],[true],[true],"[""Individuals with a family history of TTP, women, and individuals with certain autoimmune conditions are at risk for TTP.""]","[""Individuals with a family history of TTP, those with autoimmune disorders, and individuals with certain genetic mutations are at risk for Thrombotic Thrombocytopenic Purpura.""]","[""People with a family history of TTP, women, and adults between 20-50 years old are at higher risk for TTP.""]",[true],[true],[true],"[""Individuals with a family history of TTP, those with autoimmune disorders, and individuals with certain genetic mutations are at risk for TTP.""]","[""Individuals with a family history of TTP, those with autoimmune disorders, and pregnant women are at risk for Thrombotic Thrombocytopenic Purpura.""]","[""People with a family history of TTP, women, and adults between 30-50 years old are at higher risk for TTP.""]",[true],[true],[true],"[""Individuals with a family history of TTP, women, and individuals with certain autoimmune conditions are at risk for TTP.""]","[""Individuals with a family history of TTP, those with autoimmune disorders, and pregnant women are at higher risk for Thrombotic Thrombocytopenic Purpura.""]","[""People with a family history of TTP, women, and adults between 30 and 50 years old are at higher risk for TTP.""]",[true],[true],[true],"[""Individuals with a family history of TTP, those with autoimmune disorders, and certain medications can increase the risk of developing TTP.""]","[""Individuals with a family history of TTP, those with autoimmune disorders, and pregnant women are at higher risk for Thrombotic Thrombocytopenic Purpura.""]","[""Individuals with a family history of TTP, women, and adults aged 30-50 are at higher risk for TTP.""]",[true],[true],[true],"[""Individuals with a family history of TTP, those with autoimmune disorders, and women during pregnancy are at risk for Thrombotic Thrombocytopenic Purpura.""]","[""Individuals with a family history of TTP, those with autoimmune disorders, and individuals with certain genetic mutations are at risk for Thrombotic Thrombocytopenic Purpura.""]","[""People with a family history of TTP, women, and adults between 20-50 years old are at higher risk for TTP.""]",[true],[true],[true],"[""Individuals with a family history of TTP, those with autoimmune disorders, and pregnant women are at risk for Thrombotic Thrombocytopenic Purpura.""]","[""Individuals with a family history of TTP, those with autoimmune disorders, and pregnant women are at risk for Thrombotic Thrombocytopenic Purpura.""]","[""People with a family history of TTP, women, and adults between 30-50 years old are at higher risk for TTP.""]",[true],[true],[true],"[""Individuals with a family history of TTP, women, and adults between 20-50 years old are at higher risk for Thrombotic Thrombocytopenic Purpura.""]","[""Individuals with a family history of TTP, those with autoimmune disorders, and pregnant women are at higher risk for Thrombotic Thrombocytopenic Purpura.""]","[""People with a family history of TTP, women, and adults between 30 and 50 years old are at higher risk for TTP.""]",[true],[true],[true],"[""Individuals with a family history of TTP, women, and certain ethnic groups are at higher risk for TTP.""]","[""Individuals with a family history of TTP, those with autoimmune disorders, and pregnant women are at higher risk for Thrombotic Thrombocytopenic Purpura.""]","[""Individuals with a family history of TTP, women, and adults aged 30-50 are at higher risk for TTP.""]",[true],[true],[true],"[""Individuals with a family history of TTP, certain medications, and certain medical conditions are at risk for TTP.""]","[""Individuals with a family history of TTP, those with autoimmune disorders, and pregnant women are at higher risk for Thrombotic Thrombocytopenic Purpura.""]","[""Individuals with a family history of TTP, women, and adults aged 30-50 are at higher risk for TTP.""]",[true],[true],[true],"[""Individuals with a family history of TTP, women, and certain ethnic groups are at higher risk for TTP.""]","[""Individuals with a family history of TTP, those with autoimmune disorders, and pregnant women are at higher risk for Thrombotic Thrombocytopenic Purpura.""]","[""Individuals with a family history of TTP, women, and adults aged 30-50 are at higher risk for TTP.""]",[true],[true],[true],"[""Individuals with a family history of TTP, women, and individuals with certain autoimmune conditions are at risk for TTP.""]","[""Individuals with a family history of TTP, those with autoimmune disorders, and pregnant women are at higher risk for Thrombotic Thrombocytopenic Purpura.""]","[""Individuals with a family history of TTP, women, and adults aged 30-50 are at higher risk for TTP.""]"
inheritance,Is thiopurine S-methyltransferase deficiency inherited ?,"The activity of the TPMT enzyme is inherited in a pattern described as autosomal codominant. Codominance means that two different versions of the gene are active (expressed), and both versions influence the genetic trait.  The TPMT gene can be classified as either low-activity or high-activity. When the gene is altered in a way that impairs the activity of the TPMT enzyme, it is described as low-activity. When the gene is unaltered and TPMT activity is normal, it is described as high-activity. Because two copies of the gene are present in each cell, each person can have two low-activity copies, one low-activity copy and one high-activity copy, or two high-activity copies.  People with two low-activity copies of the TPMT gene in each cell have TPMT deficiency and are at the greatest risk of developing hematopoietic toxicity when treated with thiopurine drugs unless they are given much less than the usual dose. People with one high-activity copy and one low-activity copy have moderately reduced enzyme activity and are also at increased risk of this complication unless given a significantly lower dose of the drug. People with two high-activity copies have normal TPMT activity and do not have an increased risk of hematopoietic toxicity with thiopurine drug treatment.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""TPMT"", ""full_form"": ""thiopurine S-methyltransferase""}]}",Is TPMT deficiency inherited ?,Is thiopurine S-methyltransferase deficiency inherited ?,8,MEDICAL,Simple Datatype-Boolean,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""thiopurine methyltransferase"", ""thiopurine S-methyltransferase"", ""Tire Pressure Monitor Tool"", ""Transmission Programme Module Team"", ""Tibialis Posterior Myofascial Tightness (heel pain)"", ""Transaction Processing Monitor Technology"", ""Total Preventive Maintenance Time"", ""Thiopurine Methyltransferase"", ""Transaction Processing Monitor Technology"", ""Tibialis Posterior Myofascial Tightness (heel pain)"", ""Total Preventive Maintenance Time""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY""]]","[""Thiopurine S-Methyltransferase""]",[2.4068971907691327e-29],[2.4068971907691327e-29],"[""Total Preventive Maintenance Time""]",[1.0946570263530825e-19],"[""ACRONYMFINDER""]","[[4.310538406398514e-25, 2.4068971907691327e-29, 4.006403639574894e-20, 2.762777613726917e-22, 2.3769084960560004e-35, 1.1283984368344694e-22, 1.0946570263530825e-19, 4.310538406398514e-25, 1.1283984368344694e-22, 2.3769084960560004e-35, 1.0946570263530825e-19]]",[0.9674071583847943],[0.9659334272552694],"[""thiopurine methyltransferase""]",[0.9674071583847943],"[""ABBREVIATIONS""]","[[0.9669672557552527, 0.9674071583847943, 0.8747293566918284, 0.9341223887010529, 0.8071377543964704, 0.9232665967215237, 0.9198221180172443, 0.967019425720099, 0.9232665967215237, 0.8071377543964704, 0.9198221180172443]]","[""thiopurine S-methyltransferase""]","[""ABBREVIATIONS""]",Is TPMT (Thiopurine S-Methyltransferase) deficiency inherited ?,[false],[true],[true],"[""Yes""]","[""Yes, thiopurine S-methyltransferase deficiency is inherited.""]","[""Yes, TPMT deficiency is inherited.""]",[false],[true],[true],"[""Yes""]","[""Yes, thiopurine S-methyltransferase deficiency is inherited.""]","[""Yes, TPMT deficiency is inherited.""]",[false],[true],[true],"[""Yes""]","[""Yes, thiopurine S-methyltransferase deficiency is inherited.""]","[""Yes, TPMT deficiency is an inherited condition.""]",[true],[true],[true],"[""Yes""]","[""Yes""]","[""Yes, TPMT deficiency is an inherited condition.""]",[true],[true],[true],"[""Yes, TPMT deficiency is inherited.""]","[""Yes, thiopurine S-methyltransferase deficiency is inherited.""]","[""Yes, TPMT deficiency is inherited.""]",[true],[true],[true],"[""Yes, TPMT deficiency is inherited.""]","[""Yes, thiopurine S-methyltransferase deficiency is inherited.""]","[""Yes, TPMT deficiency is inherited.""]",[true],[true],[true],"[""Yes, TPMT deficiency is inherited.""]","[""Yes, thiopurine S-methyltransferase deficiency is inherited.""]","[""Yes, TPMT deficiency is an inherited condition.""]",[true],[false],[true],"[""Yes, TPMT deficiency is inherited.""]","[""Yes""]","[""Yes, TPMT deficiency is an inherited condition.""]",[false],[true],[true],"[""Yes, TPMT deficiency is inherited as an autosomal recessive trait.""]","[""Yes, thiopurine S-methyltransferase deficiency is inherited.""]","[""Yes, TPMT deficiency is inherited.""]",[true],[true],[true],"[""Yes, TPMT deficiency is inherited.""]","[""Yes, thiopurine S-methyltransferase deficiency is inherited.""]","[""Yes, TPMT deficiency is inherited.""]",[true],[true],[true],"[""Yes, TPMT deficiency is inherited.""]","[""Yes, thiopurine S-methyltransferase deficiency is inherited.""]","[""Yes, TPMT deficiency is an inherited condition.""]",[true],[false],[true],"[""Yes, TPMT deficiency is inherited.""]","[""Yes""]","[""Yes, TPMT deficiency is an inherited condition.""]",[true],[true],[true],"[""Yes, TPMT deficiency is inherited.""]","[""Yes, thiopurine S-methyltransferase deficiency is inherited.""]","[""Yes, TPMT deficiency is inherited.""]",[true],[true],[true],"[""Yes, TPMT deficiency is inherited.""]","[""Yes, thiopurine S-methyltransferase deficiency is inherited.""]","[""Yes, TPMT deficiency is inherited.""]",[true],[true],[true],"[""Yes, TPMT deficiency is inherited.""]","[""Yes, thiopurine S-methyltransferase deficiency is inherited.""]","[""Yes, TPMT deficiency is an inherited condition.""]",[true],[false],[true],"[""Yes, TPMT deficiency is inherited.""]","[""Yes""]","[""Yes, TPMT deficiency is an inherited condition.""]",[false],[true],[true],"[""Yes""]","[""Yes, thiopurine S-methyltransferase deficiency is inherited.""]","[""Yes, TPMT deficiency is inherited.""]",[true],[true],[true],"[""Yes, TPMT deficiency is inherited.""]","[""Yes, thiopurine S-methyltransferase deficiency is inherited.""]","[""Yes, TPMT deficiency is inherited.""]",[false],[true],[true],"[""Yes""]","[""Yes, thiopurine S-methyltransferase deficiency is inherited.""]","[""Yes, TPMT deficiency is an inherited condition.""]",[true],[true],[true],"[""Yes""]","[""Yes""]","[""Yes, TPMT deficiency is an inherited condition.""]",[false],[true],[true],"[""Yes, TPMT deficiency is inherited as an autosomal recessive trait.""]","[""Yes, thiopurine S-methyltransferase deficiency is inherited.""]","[""Yes, TPMT deficiency is inherited.""]",[true],[true],[true],"[""Yes, TPMT deficiency is inherited.""]","[""Yes, thiopurine S-methyltransferase deficiency is inherited.""]","[""Yes, TPMT deficiency is inherited.""]",[true],[true],[true],"[""Yes, TPMT deficiency is inherited.""]","[""Yes, thiopurine S-methyltransferase deficiency is inherited.""]","[""Yes, TPMT deficiency is an inherited condition.""]",[true],[false],[true],"[""Yes, TPMT deficiency is inherited.""]","[""Yes""]","[""Yes, TPMT deficiency is an inherited condition.""]",[false],[true],[true],"[""Yes, TPMT deficiency is inherited as an autosomal recessive trait.""]","[""Yes, thiopurine S-methyltransferase deficiency is inherited.""]","[""Yes, TPMT deficiency is inherited.""]",[false],[true],[true],"[""Yes, TPMT deficiency is inherited as an autosomal recessive trait.""]","[""Yes, thiopurine S-methyltransferase deficiency is inherited.""]","[""Yes, TPMT deficiency is inherited.""]",[false],[true],[true],"[""Yes, TPMT deficiency is inherited as an autosomal recessive trait.""]","[""Yes, thiopurine S-methyltransferase deficiency is inherited.""]","[""Yes, TPMT deficiency is an inherited condition.""]",[false],[true],[true],"[""Yes, TPMT deficiency is inherited as an autosomal recessive trait.""]","[""Yes""]","[""Yes, TPMT deficiency is an inherited condition.""]",[true],[true],[true],"[""Yes, TPMT deficiency is inherited.""]","[""Yes, thiopurine S-methyltransferase deficiency is inherited.""]","[""Yes, TPMT deficiency is inherited.""]",[false],[true],[true],"[""No""]","[""Yes, thiopurine S-methyltransferase deficiency is inherited.""]","[""Yes, TPMT deficiency is inherited.""]",[true],[true],[true],"[""Yes, TPMT deficiency is inherited.""]","[""Yes, thiopurine S-methyltransferase deficiency is inherited.""]","[""Yes, TPMT deficiency is inherited.""]",[true],[true],[true],"[""Yes, TPMT deficiency is inherited.""]","[""Yes, thiopurine S-methyltransferase deficiency is inherited.""]","[""Yes, TPMT deficiency is inherited.""]"
considerations,What to do for Prostate Enlargement: Benign Prostatic Hyperplasia ?,"- Benign prostatic hyperplasiaalso called BPHis a condition in men in which the prostate gland is enlarged and not cancerous.  - The prostate is a walnut-shaped gland that is part of the male reproductive system.  - The cause of benign prostatic hyperplasia is not well understood; however, it occurs mainly in older men.  - Benign prostatic hyperplasia is the most common prostate problem for men older than age 50.  - Lower urinary tract symptoms suggestive of benign prostatic hyperplasia may include      - urinary frequencyurination eight or more times a day    - urinary urgencythe inability to delay urination    - trouble starting a urine stream    - a weak or an interrupted urine stream    - dribbling at the end of urination    - nocturiafrequent urination during periods of sleep    - urinary retentionthe inability to empty the bladder completely    - urinary incontinencethe accidental loss of urine    - pain after ejaculation or during urination    - urine that has an unusual color or smell    - The complications of benign prostatic hyperplasia may include      - acute urinary retention    - chronic, or long lasting, urinary retention    - blood in the urine    - urinary tract infections (UTIs)    - bladder damage    - kidney damage    - bladder stones    - A health care provider diagnoses benign prostatic hyperplasia based on      - a personal and family medical history    - a physical exam    - medical tests    - Treatment options for benign prostatic hyperplasia may include      - lifestyle changes    - medications    - minimally invasive procedures    - surgery    - The complications of benign prostatic hyperplasia treatment depend on the type of treatment.  - Researchers have not found a way to prevent benign prostatic hyperplasia.  - Researchers have not found that eating, diet, and nutrition play a role in causing or preventing benign prostatic hyperplasia.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""BPH"", ""full_form"": ""Benign Prostatic Hyperplasia""}]}",What to do for Prostate Enlargement: BPH ?,What to do for Prostate Enlargement: Benign Prostatic Hyperplasia ?,8,MEDICAL,Compound Datatype-String,"Instructional: Queries specifically seeking step-by-step guidance, instructions, or procedures to perform a task. it focuses on 'how' to do something rather than 'what', 'why', or 'which'.","[[""Benign Prostatic Hyperplasia"", ""Benign Prostatic Hypertrophy"", ""Blood Pressure High"", ""Brief Penguin Handbook"", ""Broadway Performance Hall"", ""Barrels Per Hour"", ""Benign Prostate Hypertrophy"", ""Bachelor of Public Health"", ""Benign prostate hyperplasia"", ""Birgit Pauli Haack""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Benign Prostatic Hyperplasia""]",[3.938856203628236e-11],[3.938856203628236e-11],"[""Blood Pressure High""]",[3.1817772672477715e-08],"[""ABBREVIATIONS""]","[[3.938856203628236e-11, 1.2462378566286644e-10, 3.1817772672477715e-08, 2.993100719837858e-23, 8.714089340666108e-19, 5.50631559503574e-13, 5.7817203693350675e-09, 1.0381844198130694e-15, 5.097678430065465e-10, 6.344268767454296e-29]]",[0.9718023094725023],[0.9718023094725023],"[""Benign Prostatic Hyperplasia""]",[0.9718023094725023],"[""ABBREVIATIONS""]","[[0.9718023094725023, 0.9652100475334797, 0.8972168010036634, 0.8333591446573251, 0.8383625007667215, 0.8375017994153493, 0.9616098619903926, 0.8792991986556639, 0.9689615316139844, 0.8719631439170044]]","[""Benign Prostatic Hyperplasia""]","[""ABBREVIATIONS""]",What to do for Prostate Enlargement: BPH (Benign Prostatic Hyperplasia) ?,[true],[true],[true],"[""For Prostate Enlargement (BPH) with high blood pressure, treatment options may include medications to manage blood pressure and reduce prostate size, lifestyle changes such as diet and exercise, and in some cases, surgical procedures like TURP (Transurethral Resection of the Prostate) or laser therapy. It is important to consult with a healthcare provider for personalized recommendations.""]","[""Treatment options for benign prostatic hyperplasia (BPH) include medications, minimally invasive procedures, and surgery. Common medications include alpha blockers and 5-alpha reductase inhibitors. Minimally invasive procedures like transurethral microwave thermotherapy (TUMT) or prostate artery embolization (PAE) can also be considered. In more severe cases, surgical options such as transurethral resection of the prostate (TURP) or laser surgery may be recommended.""]","[""Treatment options for prostate enlargement (BPH) include medications, minimally invasive procedures, and surgery. It is important to consult with a healthcare provider to determine the best course of action based on individual circumstances.""]",[false],[true],[true],"[""For Prostate Enlargement (BPH) with high blood pressure, treatment options may include medications to manage blood pressure and reduce prostate size, lifestyle changes such as diet and exercise, and in some cases, surgery may be recommended. It is important to consult with a healthcare provider for personalized treatment recommendations.""]","[""For Prostate Enlargement (Benign Prostatic Hyperplasia), treatment options include medications, minimally invasive procedures, and surgery. It is important to consult with a healthcare provider to determine the best course of action based on individual circumstances.""]","[""Treatment options for prostate enlargement (BPH) include medications, minimally invasive procedures, and surgery. It is important to consult a healthcare provider for personalized treatment recommendations.""]",[false],[true],[true],"[""For Prostate Enlargement (BPH), managing high blood pressure is important. Treatment options include medications, lifestyle changes, and in severe cases, surgery. It is recommended to consult a healthcare provider for personalized advice and treatment plan.""]","[""Treatment options for benign prostatic hyperplasia include medications, minimally invasive procedures, and surgery. It is important to consult with a healthcare provider to determine the best course of action based on individual circumstances.""]","[""Treatment options for prostate enlargement (BPH) include medications, minimally invasive procedures, and surgery. It is important to consult with a healthcare provider to determine the best course of action based on individual circumstances.""]",[true],[true],[true],"[""For Prostate Enlargement (BPH) with high blood pressure, treatment options may include medications to relax the muscles in the prostate and bladder, alpha blockers to improve urine flow, 5-alpha reductase inhibitors to reduce the size of the prostate, and in some cases surgery may be recommended. It is important to consult with a healthcare provider for personalized treatment recommendations.""]","[""Treatment options for benign prostatic hyperplasia (BPH) include medications, minimally invasive procedures, and surgery. Common medications include alpha blockers and 5-alpha reductase inhibitors. Minimally invasive procedures include transurethral microwave thermotherapy (TUMT) and prostate artery embolization. Surgery options include transurethral resection of the prostate (TURP) and laser surgery.""]","[""Treatment options for prostate enlargement (BPH) include medications, minimally invasive procedures, and surgery. It is important to consult a healthcare provider for personalized recommendations.""]",[true],[true],[true],"[""For Prostate Enlargement (BPH), treatment options include medications, minimally invasive procedures, and surgery. It is important to consult a healthcare provider for proper diagnosis and personalized treatment plan.""]","[""Treatment options for benign prostatic hyperplasia (BPH) include medications, minimally invasive procedures, and surgery. Common medications include alpha blockers and 5-alpha reductase inhibitors. Minimally invasive procedures like transurethral microwave thermotherapy (TUMT) or prostate artery embolization (PAE) can also be considered. In more severe cases, surgical options such as transurethral resection of the prostate (TURP) or laser surgery may be recommended.""]","[""Treatment options for prostate enlargement (BPH) include medications, minimally invasive procedures, and surgery. It is important to consult with a healthcare provider to determine the best course of action based on individual circumstances.""]",[true],[true],[true],"[""For Prostate Enlargement (BPH), treatment options include medications, minimally invasive procedures, and surgery. It is important to consult a healthcare provider for proper diagnosis and personalized treatment plan.""]","[""For Prostate Enlargement (Benign Prostatic Hyperplasia), treatment options include medications, minimally invasive procedures, and surgery. It is important to consult with a healthcare provider to determine the best course of action based on individual circumstances.""]","[""Treatment options for prostate enlargement (BPH) include medications, minimally invasive procedures, and surgery. It is important to consult a healthcare provider for personalized treatment recommendations.""]",[true],[true],[true],"[""For Prostate Enlargement (BPH), treatment options include medications, minimally invasive procedures, and surgery. It is important to consult a healthcare provider for proper diagnosis and personalized treatment plan.""]","[""Treatment options for benign prostatic hyperplasia include medications, minimally invasive procedures, and surgery. It is important to consult with a healthcare provider to determine the best course of action based on individual circumstances.""]","[""Treatment options for prostate enlargement (BPH) include medications, minimally invasive procedures, and surgery. It is important to consult with a healthcare provider to determine the best course of action based on individual circumstances.""]",[true],[true],[true],"[""Treatment options for BPH include medications, minimally invasive procedures, and surgery. It is important to consult a healthcare provider for personalized recommendations.""]","[""Treatment options for benign prostatic hyperplasia (BPH) include medications, minimally invasive procedures, and surgery. Common medications include alpha blockers and 5-alpha reductase inhibitors. Minimally invasive procedures include transurethral microwave thermotherapy (TUMT) and prostate artery embolization. Surgery options include transurethral resection of the prostate (TURP) and laser surgery.""]","[""Treatment options for prostate enlargement (BPH) include medications, minimally invasive procedures, and surgery. It is important to consult a healthcare provider for personalized recommendations.""]",[true],[true],[true],"[""For Prostate Enlargement (BPH), treatment options include medications, minimally invasive procedures, and surgery. It is important to consult a healthcare provider for proper diagnosis and personalized treatment plan.""]","[""For Prostate Enlargement (Benign Prostatic Hyperplasia), treatment options include medications, minimally invasive procedures, and surgery. It is important to consult with a healthcare provider to determine the best course of action based on individual circumstances.""]","[""Treatment options for prostate enlargement (BPH) include medications, minimally invasive procedures, and surgery. It is important to consult a healthcare provider for personalized treatment recommendations.""]",[true],[true],[true],"[""Treatment options for prostate enlargement (BPH) include medications, minimally invasive procedures, and surgery. It is important to consult a healthcare provider for personalized recommendations.""]","[""Treatment options for benign prostatic hyperplasia (BPH) include medications, minimally invasive procedures, and surgery. Common medications include alpha blockers and 5-alpha reductase inhibitors. Minimally invasive procedures like transurethral microwave thermotherapy (TUMT) or prostate artery embolization (PAE) can also be considered. In more severe cases, surgical options such as transurethral resection of the prostate (TURP) or laser surgery may be recommended.""]","[""Treatment options for prostate enlargement (BPH) include medications, minimally invasive procedures, and surgery. It is important to consult with a healthcare provider to determine the best course of action based on individual circumstances.""]",[true],[true],[true],"[""For Prostate Enlargement (BPH), treatment options include medications, minimally invasive procedures, and surgery. It is important to consult with a healthcare provider to determine the best course of action based on individual circumstances.""]","[""Treatment options for benign prostatic hyperplasia include medications, minimally invasive procedures, and surgery. It is important to consult with a healthcare provider to determine the best course of action based on individual circumstances.""]","[""Treatment options for prostate enlargement (BPH) include medications, minimally invasive procedures, and surgery. It is important to consult with a healthcare provider to determine the best course of action based on individual circumstances.""]",[true],[true],[true],"[""For Prostate Enlargement (BPH), treatment options include medications, minimally invasive procedures, and surgery. It is important to consult a healthcare provider for proper evaluation and personalized treatment plan.""]","[""Treatment options for benign prostatic hyperplasia (BPH) include medications, minimally invasive procedures, and surgery. Common medications include alpha blockers and 5-alpha reductase inhibitors. Minimally invasive procedures include transurethral microwave thermotherapy (TUMT) and prostate artery embolization. Surgery options include transurethral resection of the prostate (TURP) and laser surgery.""]","[""Treatment options for prostate enlargement (BPH) include medications, minimally invasive procedures, and surgery. It is important to consult a healthcare provider for personalized recommendations.""]",[true],[true],[true],"[""Treatment options for BPH include medications, minimally invasive procedures, and surgery. It is important to consult a healthcare provider for proper evaluation and management.""]","[""Treatment options for benign prostatic hyperplasia (BPH) include medications, minimally invasive procedures, and surgery. Common medications include alpha blockers and 5-alpha reductase inhibitors. Minimally invasive procedures like transurethral microwave thermotherapy (TUMT) or prostate artery embolization (PAE) can also be considered. In more severe cases, surgical options such as transurethral resection of the prostate (TURP) or laser surgery may be recommended.""]","[""Treatment options for prostate enlargement (BPH) include medications, minimally invasive procedures, and surgery. It is important to consult with a healthcare provider to determine the best course of action based on individual circumstances.""]",[true],[true],[true],"[""Treatment options for BPH include medications, minimally invasive procedures, and surgery. It is important to consult a healthcare provider for proper evaluation and management.""]","[""For Prostate Enlargement (Benign Prostatic Hyperplasia), treatment options include medications, minimally invasive procedures, and surgery. It is important to consult with a healthcare provider to determine the best course of action based on individual circumstances.""]","[""Treatment options for prostate enlargement (BPH) include medications, minimally invasive procedures, and surgery. It is important to consult a healthcare provider for personalized treatment recommendations.""]",[true],[true],[true],"[""Treatment options for BPH include medications, minimally invasive procedures, and surgery. It is important to consult a healthcare provider for personalized recommendations.""]","[""Treatment options for benign prostatic hyperplasia include medications, minimally invasive procedures, and surgery. It is important to consult with a healthcare provider to determine the best course of action based on individual circumstances.""]","[""Treatment options for prostate enlargement (BPH) include medications, minimally invasive procedures, and surgery. It is important to consult with a healthcare provider to determine the best course of action based on individual circumstances.""]",[true],[true],[true],"[""Treatment options for BPH include medications, minimally invasive procedures, and surgery. It is important to consult a healthcare provider for proper evaluation and management.""]","[""Treatment options for benign prostatic hyperplasia (BPH) include medications, minimally invasive procedures, and surgery. Common medications include alpha blockers and 5-alpha reductase inhibitors. Minimally invasive procedures include transurethral microwave thermotherapy (TUMT) and prostate artery embolization. Surgery options include transurethral resection of the prostate (TURP) and laser surgery.""]","[""Treatment options for prostate enlargement (BPH) include medications, minimally invasive procedures, and surgery. It is important to consult a healthcare provider for personalized recommendations.""]",[true],[true],[true],"[""For Prostate Enlargement (BPH), treatment options include medications, minimally invasive procedures, and surgery. It is important to consult a healthcare provider for proper diagnosis and personalized treatment plan.""]","[""Treatment options for benign prostatic hyperplasia (BPH) include medications, minimally invasive procedures, and surgery. Common medications include alpha blockers and 5-alpha reductase inhibitors. Minimally invasive procedures like transurethral microwave thermotherapy (TUMT) or prostate artery embolization (PAE) can also be considered. In more severe cases, surgical options such as transurethral resection of the prostate (TURP) or laser surgery may be recommended.""]","[""Treatment options for prostate enlargement (BPH) include medications, minimally invasive procedures, and surgery. It is important to consult with a healthcare provider to determine the best course of action based on individual circumstances.""]",[true],[true],[true],"[""For Prostate Enlargement (BPH), treatment options include medications, minimally invasive procedures, and surgery. It is important to consult a healthcare provider for a proper diagnosis and personalized treatment plan.""]","[""For Prostate Enlargement (Benign Prostatic Hyperplasia), treatment options include medications, minimally invasive procedures, and surgery. It is important to consult with a healthcare provider to determine the best course of action based on individual circumstances.""]","[""Treatment options for prostate enlargement (BPH) include medications, minimally invasive procedures, and surgery. It is important to consult a healthcare provider for personalized treatment recommendations.""]",[true],[true],[true],"[""Treatment options for prostate enlargement (BPH) include medications, minimally invasive procedures, and surgery. It is important to consult a healthcare provider for personalized treatment recommendations.""]","[""Treatment options for benign prostatic hyperplasia include medications, minimally invasive procedures, and surgery. It is important to consult with a healthcare provider to determine the best course of action based on individual circumstances.""]","[""Treatment options for prostate enlargement (BPH) include medications, minimally invasive procedures, and surgery. It is important to consult with a healthcare provider to determine the best course of action based on individual circumstances.""]",[true],[true],[true],"[""For Prostate Enlargement (BPH), treatment options include medications, minimally invasive procedures, and surgery. It is important to consult a healthcare provider for personalized recommendations based on the severity of symptoms.""]","[""Treatment options for benign prostatic hyperplasia (BPH) include medications, minimally invasive procedures, and surgery. Common medications include alpha blockers and 5-alpha reductase inhibitors. Minimally invasive procedures include transurethral microwave thermotherapy (TUMT) and prostate artery embolization. Surgery options include transurethral resection of the prostate (TURP) and laser surgery.""]","[""Treatment options for prostate enlargement (BPH) include medications, minimally invasive procedures, and surgery. It is important to consult a healthcare provider for personalized recommendations.""]",[true],[true],[true],"[""For Prostate Enlargement (BPH), treatment options include medications, minimally invasive procedures, and surgery. It is important to consult a healthcare provider for proper diagnosis and personalized treatment plan.""]","[""Treatment options for benign prostatic hyperplasia (BPH) include medications, minimally invasive procedures, and surgery. Common medications include alpha blockers and 5-alpha reductase inhibitors. Minimally invasive procedures like transurethral microwave thermotherapy (TUMT) or prostate artery embolization (PAE) can also be considered. In more severe cases, surgical options such as transurethral resection of the prostate (TURP) or laser surgery may be recommended.""]","[""Treatment options for prostate enlargement (BPH) include medications, minimally invasive procedures, and surgery. It is important to consult with a healthcare provider to determine the best course of action based on individual circumstances.""]",[true],[true],[true],"[""For Prostate Enlargement (BPH), treatment options include medications, minimally invasive procedures, and surgery. It is important to consult a healthcare provider for proper diagnosis and personalized treatment plan.""]","[""For Prostate Enlargement (Benign Prostatic Hyperplasia), treatment options include medications, minimally invasive procedures, and surgery. It is important to consult with a healthcare provider to determine the best course of action based on individual circumstances.""]","[""Treatment options for prostate enlargement (BPH) include medications, minimally invasive procedures, and surgery. It is important to consult a healthcare provider for personalized treatment recommendations.""]",[true],[true],[true],"[""For Prostate Enlargement (BPH), treatment options include medications, minimally invasive procedures, and surgery. It is important to consult a healthcare provider for proper diagnosis and personalized treatment plan.""]","[""Treatment options for benign prostatic hyperplasia include medications, minimally invasive procedures, and surgery. It is important to consult with a healthcare provider to determine the best course of action based on individual circumstances.""]","[""Treatment options for prostate enlargement (BPH) include medications, minimally invasive procedures, and surgery. It is important to consult with a healthcare provider to determine the best course of action based on individual circumstances.""]",[true],[true],[true],"[""Treatment options for BPH include medications, minimally invasive procedures, and surgery. It is important to consult a healthcare provider for personalized treatment recommendations.""]","[""Treatment options for benign prostatic hyperplasia (BPH) include medications, minimally invasive procedures, and surgery. Common medications include alpha blockers and 5-alpha reductase inhibitors. Minimally invasive procedures include transurethral microwave thermotherapy (TUMT) and prostate artery embolization. Surgery options include transurethral resection of the prostate (TURP) and laser surgery.""]","[""Treatment options for prostate enlargement (BPH) include medications, minimally invasive procedures, and surgery. It is important to consult a healthcare provider for personalized recommendations.""]",[true],[true],[true],"[""For Prostate Enlargement (BPH), treatment options include medications, minimally invasive procedures, and surgery. It is important to consult a healthcare provider for personalized advice and treatment plan.""]","[""Treatment options for benign prostatic hyperplasia (BPH) include medications, minimally invasive procedures, and surgery. Common medications include alpha blockers and 5-alpha reductase inhibitors. Minimally invasive procedures like transurethral microwave thermotherapy (TUMT) or prostate artery embolization (PAE) can also be considered. In more severe cases, surgical options such as transurethral resection of the prostate (TURP) or laser surgery may be recommended.""]","[""Treatment options for prostate enlargement (BPH) include medications, minimally invasive procedures, and surgery. It is important to consult with a healthcare provider to determine the best course of action based on individual circumstances.""]",[true],[true],[true],"[""For Prostate Enlargement (BPH), treatment options include medications, minimally invasive procedures, and surgery. It is important to consult with a healthcare provider for personalized treatment recommendations. Lifestyle changes such as regular exercise, a balanced diet, and avoiding caffeine and alcohol may also help manage symptoms.""]","[""For Prostate Enlargement (Benign Prostatic Hyperplasia), treatment options include medications, minimally invasive procedures, and surgery. It is important to consult with a healthcare provider to determine the best course of action based on individual circumstances.""]","[""Treatment options for prostate enlargement (BPH) include medications, minimally invasive procedures, and surgery. It is important to consult a healthcare provider for personalized treatment recommendations.""]",[true],[true],[true],"[""For Prostate Enlargement (BPH), treatment options include medications, minimally invasive procedures, and surgery. It is important to consult a healthcare provider for personalized recommendations. Lifestyle changes such as regular exercise, a balanced diet, and avoiding caffeine and alcohol may also help manage symptoms.""]","[""Treatment options for benign prostatic hyperplasia include medications, minimally invasive procedures, and surgery. It is important to consult with a healthcare provider to determine the best course of action based on individual circumstances.""]","[""Treatment options for prostate enlargement (BPH) include medications, minimally invasive procedures, and surgery. It is important to consult with a healthcare provider to determine the best course of action based on individual circumstances.""]",[true],[true],[true],"[""Treatment options for prostate enlargement (BPH) include medications, minimally invasive procedures, and surgery. It is recommended to consult with a healthcare provider for personalized treatment advice.""]","[""Treatment options for benign prostatic hyperplasia (BPH) include medications, minimally invasive procedures, and surgery. Common medications include alpha blockers and 5-alpha reductase inhibitors. Minimally invasive procedures include transurethral microwave thermotherapy (TUMT) and prostate artery embolization. Surgery options include transurethral resection of the prostate (TURP) and laser surgery.""]","[""Treatment options for prostate enlargement (BPH) include medications, minimally invasive procedures, and surgery. It is important to consult a healthcare provider for personalized recommendations.""]",[true],[true],[true],"[""Treatment options for BPH include medications, minimally invasive procedures, and surgery. It is important to consult a healthcare provider for personalized advice.""]","[""Treatment options for benign prostatic hyperplasia (BPH) include medications, minimally invasive procedures, and surgery. Common medications include alpha blockers and 5-alpha reductase inhibitors. Minimally invasive procedures like transurethral microwave thermotherapy (TUMT) or prostate artery embolization (PAE) can also be considered. In more severe cases, surgical options such as transurethral resection of the prostate (TURP) or laser surgery may be recommended.""]","[""Treatment options for prostate enlargement (BPH) include medications, minimally invasive procedures, and surgery. It is important to consult with a healthcare provider to determine the best course of action based on individual circumstances.""]",[true],[true],[true],"[""For Prostate Enlargement (BPH), lifestyle changes, medications, and in some cases, surgery may be recommended. It is important to consult a healthcare professional for proper diagnosis and treatment.""]","[""Treatment options for benign prostatic hyperplasia (BPH) include medications, minimally invasive procedures, and surgery. Common medications include alpha blockers and 5-alpha reductase inhibitors. Minimally invasive procedures like transurethral microwave thermotherapy (TUMT) or prostate artery embolization (PAE) can also be considered. In more severe cases, surgical options such as transurethral resection of the prostate (TURP) or laser surgery may be recommended.""]","[""Treatment options for prostate enlargement (BPH) include medications, minimally invasive procedures, and surgery. It is important to consult with a healthcare provider to determine the best course of action based on individual circumstances.""]",[true],[true],[true],"[""Treatment options for BPH include medications, minimally invasive procedures, and surgery. It is important to consult a healthcare provider for personalized advice.""]","[""Treatment options for benign prostatic hyperplasia (BPH) include medications, minimally invasive procedures, and surgery. Common medications include alpha blockers and 5-alpha reductase inhibitors. Minimally invasive procedures like transurethral microwave thermotherapy (TUMT) or prostate artery embolization (PAE) can also be considered. In more severe cases, surgical options such as transurethral resection of the prostate (TURP) or laser surgery may be recommended.""]","[""Treatment options for prostate enlargement (BPH) include medications, minimally invasive procedures, and surgery. It is important to consult with a healthcare provider to determine the best course of action based on individual circumstances.""]",[true],[true],[true],"[""Treatment options for BPH include medications, minimally invasive procedures, and surgery. It is important to consult a healthcare provider for personalized advice.""]","[""Treatment options for benign prostatic hyperplasia (BPH) include medications, minimally invasive procedures, and surgery. Common medications include alpha blockers and 5-alpha reductase inhibitors. Minimally invasive procedures like transurethral microwave thermotherapy (TUMT) or prostate artery embolization (PAE) can also be considered. In more severe cases, surgical options such as transurethral resection of the prostate (TURP) or laser surgery may be recommended.""]","[""Treatment options for prostate enlargement (BPH) include medications, minimally invasive procedures, and surgery. It is important to consult with a healthcare provider to determine the best course of action based on individual circumstances.""]"
frequency,How many people are affected by primary ciliary dyskinesia ?,"Primary ciliary dyskinesia occurs in approximately 1 in 16,000 individuals.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""PCD"", ""full_form"": ""primary ciliary dyskinesia""}]}",How many people are affected by PCD ?,How many people are affected by primary ciliary dyskinesia ?,8,MEDICAL,Simple Datatype-Integer,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Primary Ciliary Dyskinesia"", ""Pitch Circle Diameter"", ""Paraneoplastic Cerebellar Degeneration"", ""Professionals Complementary To Dentistry"", ""Personal Communication Device"", ""Primary Care Diabetes"", ""Photo Compact Disc"", ""Participatory Curriculum Development"", ""Program Change Decision"", ""Passive Cavitation Detection""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Primary Ciliary Dyskinesia""]",[3.401543331948029e-19],[3.401543331948029e-19],"[""Primary Care Diabetes""]",[2.0049848786711205e-10],"[""ABBREVIATIONS""]","[[3.401543331948029e-19, 1.0739981159348331e-15, 2.0621046349394885e-15, 2.0767231570796743e-25, 1.0964402516013627e-11, 2.0049848786711205e-10, 1.1829161500255686e-11, 5.334398590683094e-17, 3.399716349295415e-13, 4.841094950188707e-15]]",[0.8835531376981243],[0.8837216695641497],"[""primary ciliary dyskinesia""]",[0.8837216695641497],"[""ABBREVIATIONS""]","[[0.8837216695641497, 0.7176318279043021, 0.7510981439378159, 0.7250610623331069, 0.7360617239422063, 0.8038226734729841, 0.7599570596417979, 0.6284154228999878, 0.7234609358323407, 0.7234870198411527]]","[""Primary Ciliary Dyskinesia""]","[""ABBREVIATIONS""]",How many people are affected by PCD (Primary Ciliary Dyskinesia) ?,[false],[true],[true],"[""Approximately 1 in 4000 people are affected by Primary Ciliary Dyskinesia (PCD).""]","[""1 in 15,000 to 30,000 people are affected by primary ciliary dyskinesia.""]","[""Approximately 1 in 15,000 to 30,000 people are affected by Primary Ciliary Dyskinesia (PCD).""]",[false],[true],[true],"[""Approximately 1 in 4000 people are affected by Primary Ciliary Dyskinesia (PCD).""]","[""1 in 15,000 to 30,000 people are affected by primary ciliary dyskinesia.""]","[""Approximately 1 in 15,000 to 30,000 people are affected by Primary Ciliary Dyskinesia (PCD).""]",[false],[true],[true],"[""Approximately 1 in 4000 to 1 in 40,000 people are affected by Primary Ciliary Dyskinesia (PCD).""]","[""1 in 15,000 to 30,000 people are affected by primary ciliary dyskinesia.""]","[""1 in 10,000 to 1 in 40,000 people are affected by Primary Ciliary Dyskinesia (PCD)""]",[false],[true],[true],"[""Approximately 1 in 10 people with diabetes have PCD.""]","[""1 in 15,000 to 30,000 people are affected by primary ciliary dyskinesia.""]","[""Approximately 1 in 15,000 to 30,000 people are affected by Primary Ciliary Dyskinesia (PCD).""]",[true],[true],[true],"[""1 in 15,000 to 30,000 people are affected by PCD (primary ciliary dyskinesia).""]","[""1 in 15,000 to 30,000 people are affected by primary ciliary dyskinesia.""]","[""Approximately 1 in 15,000 to 30,000 people are affected by Primary Ciliary Dyskinesia (PCD).""]",[true],[true],[true],"[""1 in 15,000 to 30,000 people are affected by PCD (primary ciliary dyskinesia).""]","[""1 in 15,000 to 30,000 people are affected by primary ciliary dyskinesia.""]","[""Approximately 1 in 15,000 to 30,000 people are affected by Primary Ciliary Dyskinesia (PCD).""]",[true],[true],[true],"[""Primary ciliary dyskinesia affects approximately 1 in 15,000 to 30,000 people worldwide.""]","[""1 in 15,000 to 30,000 people are affected by primary ciliary dyskinesia.""]","[""1 in 10,000 to 1 in 40,000 people are affected by Primary Ciliary Dyskinesia (PCD)""]",[true],[true],[true],"[""1 in 15,000 to 30,000 people are affected by PCD (primary ciliary dyskinesia).""]","[""1 in 15,000 to 30,000 people are affected by primary ciliary dyskinesia.""]","[""Approximately 1 in 15,000 to 30,000 people are affected by Primary Ciliary Dyskinesia (PCD).""]",[true],[true],[true],"[""1 in 15,000 to 30,000 people are affected by Primary Ciliary Dyskinesia (PCD).""]","[""1 in 15,000 to 30,000 people are affected by primary ciliary dyskinesia.""]","[""Approximately 1 in 15,000 to 30,000 people are affected by Primary Ciliary Dyskinesia (PCD).""]",[true],[true],[true],"[""1 in 15,000 to 30,000 people are affected by Primary Ciliary Dyskinesia (PCD).""]","[""1 in 15,000 to 30,000 people are affected by primary ciliary dyskinesia.""]","[""Approximately 1 in 15,000 to 30,000 people are affected by Primary Ciliary Dyskinesia (PCD).""]",[true],[true],[true],"[""1 in 15,000 to 30,000 people are affected by Primary Ciliary Dyskinesia (PCD).""]","[""1 in 15,000 to 30,000 people are affected by primary ciliary dyskinesia.""]","[""1 in 10,000 to 1 in 40,000 people are affected by Primary Ciliary Dyskinesia (PCD)""]",[true],[true],[true],"[""1 in 15,000 to 30,000 people are affected by Primary Ciliary Dyskinesia (PCD)""]","[""1 in 15,000 to 30,000 people are affected by primary ciliary dyskinesia.""]","[""Approximately 1 in 15,000 to 30,000 people are affected by Primary Ciliary Dyskinesia (PCD).""]",[true],[true],[true],"[""PCD affects approximately 1 in 15,000 to 30,000 people worldwide.""]","[""1 in 15,000 to 30,000 people are affected by primary ciliary dyskinesia.""]","[""Approximately 1 in 15,000 to 30,000 people are affected by Primary Ciliary Dyskinesia (PCD).""]",[true],[true],[true],"[""Approximately 1 in 15,000 to 30,000 people are affected by Primary Ciliary Dyskinesia (PCD).""]","[""1 in 15,000 to 30,000 people are affected by primary ciliary dyskinesia.""]","[""Approximately 1 in 15,000 to 30,000 people are affected by Primary Ciliary Dyskinesia (PCD).""]",[true],[true],[true],"[""PCD affects approximately 1 in 15,000 to 30,000 people worldwide.""]","[""1 in 15,000 to 30,000 people are affected by primary ciliary dyskinesia.""]","[""1 in 10,000 to 1 in 40,000 people are affected by Primary Ciliary Dyskinesia (PCD)""]",[true],[true],[true],"[""Approximately 1 in 15,000 to 30,000 people are affected by Primary Ciliary Dyskinesia (PCD).""]","[""1 in 15,000 to 30,000 people are affected by primary ciliary dyskinesia.""]","[""Approximately 1 in 15,000 to 30,000 people are affected by Primary Ciliary Dyskinesia (PCD).""]",[true],[true],[true],"[""The exact number of people affected by PCD (Primary Ciliary Dyskinesia) is not known, but it is estimated to occur in about 1 in 15,000 to 30,000 people worldwide.""]","[""1 in 15,000 to 30,000 people are affected by primary ciliary dyskinesia.""]","[""Approximately 1 in 15,000 to 30,000 people are affected by Primary Ciliary Dyskinesia (PCD).""]",[true],[true],[true],"[""1 in 15,000 to 30,000 people are affected by Primary Ciliary Dyskinesia (PCD).""]","[""1 in 15,000 to 30,000 people are affected by primary ciliary dyskinesia.""]","[""Approximately 1 in 15,000 to 30,000 people are affected by Primary Ciliary Dyskinesia (PCD).""]",[true],[true],[true],"[""1 in 15,000 to 30,000 people are affected by Primary Ciliary Dyskinesia (PCD).""]","[""1 in 15,000 to 30,000 people are affected by primary ciliary dyskinesia.""]","[""1 in 10,000 to 1 in 40,000 people are affected by Primary Ciliary Dyskinesia (PCD)""]",[true],[true],[true],"[""1 in 15,000 to 30,000 people are affected by Primary Ciliary Dyskinesia (PCD)""]","[""1 in 15,000 to 30,000 people are affected by primary ciliary dyskinesia.""]","[""Approximately 1 in 15,000 to 30,000 people are affected by Primary Ciliary Dyskinesia (PCD).""]",[true],[true],[true],"[""Approximately 1 in 15,000 to 30,000 people are affected by Primary Ciliary Dyskinesia (PCD).""]","[""1 in 15,000 to 30,000 people are affected by primary ciliary dyskinesia.""]","[""Approximately 1 in 15,000 to 30,000 people are affected by Primary Ciliary Dyskinesia (PCD).""]",[true],[true],[true],"[""1 in 15,000 to 30,000 people are affected by Primary Ciliary Dyskinesia (PCD).""]","[""1 in 15,000 to 30,000 people are affected by primary ciliary dyskinesia.""]","[""Approximately 1 in 15,000 to 30,000 people are affected by Primary Ciliary Dyskinesia (PCD).""]",[true],[true],[true],"[""1 in 15,000 to 30,000 people are affected by Primary Ciliary Dyskinesia (PCD).""]","[""1 in 15,000 to 30,000 people are affected by primary ciliary dyskinesia.""]","[""1 in 10,000 to 1 in 40,000 people are affected by Primary Ciliary Dyskinesia (PCD)""]",[true],[true],[true],"[""1 in 15,000 to 30,000 people are affected by Primary Ciliary Dyskinesia (PCD).""]","[""1 in 15,000 to 30,000 people are affected by primary ciliary dyskinesia.""]","[""Approximately 1 in 15,000 to 30,000 people are affected by Primary Ciliary Dyskinesia (PCD).""]",[true],[true],[true],"[""Primary Ciliary Dyskinesia (PCD) affects approximately 1 in 15,000 to 30,000 people worldwide.""]","[""1 in 15,000 to 30,000 people are affected by primary ciliary dyskinesia.""]","[""Approximately 1 in 15,000 to 30,000 people are affected by Primary Ciliary Dyskinesia (PCD).""]",[true],[true],[true],"[""Primary Ciliary Dyskinesia (PCD) affects approximately 1 in 15,000 to 30,000 people worldwide.""]","[""1 in 15,000 to 30,000 people are affected by primary ciliary dyskinesia.""]","[""Approximately 1 in 15,000 to 30,000 people are affected by Primary Ciliary Dyskinesia (PCD).""]",[true],[true],[true],"[""Primary Ciliary Dyskinesia (PCD) affects approximately 1 in 15,000 to 30,000 people worldwide.""]","[""1 in 15,000 to 30,000 people are affected by primary ciliary dyskinesia.""]","[""1 in 10,000 to 1 in 40,000 people are affected by Primary Ciliary Dyskinesia (PCD)""]",[true],[true],[true],"[""Primary Ciliary Dyskinesia affects approximately 1 in 15,000 to 30,000 people worldwide.""]","[""1 in 15,000 to 30,000 people are affected by primary ciliary dyskinesia.""]","[""Approximately 1 in 15,000 to 30,000 people are affected by Primary Ciliary Dyskinesia (PCD).""]",[true],[true],[true],"[""Approximately 1 in 15,000 to 30,000 people are affected by Primary Ciliary Dyskinesia (PCD).""]","[""1 in 15,000 to 30,000 people are affected by primary ciliary dyskinesia.""]","[""Approximately 1 in 15,000 to 30,000 people are affected by Primary Ciliary Dyskinesia (PCD).""]",[false],[true],[true],"[""The exact number of people affected by PCD (Primary Care Diabetes) is not readily available.""]","[""1 in 15,000 to 30,000 people are affected by primary ciliary dyskinesia.""]","[""Approximately 1 in 15,000 to 30,000 people are affected by Primary Ciliary Dyskinesia (PCD).""]",[true],[true],[true],"[""Approximately 1 in 15,000 to 30,000 people are affected by PCD (primary ciliary dyskinesia).""]","[""1 in 15,000 to 30,000 people are affected by primary ciliary dyskinesia.""]","[""Approximately 1 in 15,000 to 30,000 people are affected by Primary Ciliary Dyskinesia (PCD).""]",[true],[true],[true],"[""The exact number of people affected by PCD (Primary Ciliary Dyskinesia) is not known, but it is considered a rare disease with an estimated prevalence of 1 in 10,000 to 1 in 20,000 individuals.""]","[""1 in 15,000 to 30,000 people are affected by primary ciliary dyskinesia.""]","[""Approximately 1 in 15,000 to 30,000 people are affected by Primary Ciliary Dyskinesia (PCD).""]"
inheritance,Is WAGR syndrome inherited ?,"Most cases of WAGR syndrome are not inherited. They result from a chromosomal deletion that occurs as a random event during the formation of reproductive cells (eggs or sperm) or in early fetal development. Affected people typically have no history of the disorder in their family.  Some affected individuals inherit a chromosome 11 with a deleted segment from an unaffected parent. In these cases, the parent carries a chromosomal rearrangement called a balanced translocation, in which no genetic material is gained or lost. Balanced translocations usually do not cause any health problems; however, they can become unbalanced as they are passed to the next generation. Children who inherit an unbalanced translocation can have a chromosomal rearrangement with extra or missing genetic material. Individuals with WAGR syndrome who inherit an unbalanced translocation are missing genetic material from the short arm of chromosome 11, which results in an increased risk of Wilms tumor, aniridia, genitourinary anomalies, and intellectual disability.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""abbreviation"", ""abbreviation"": ""WAGR"", ""full_form"": ""Wilms tumor-Aniridia-Genitourinary anomalies-mental Retardation""}]}",Is WAGR syndrome inherited ?,Is Wilms tumor-Aniridia-Genitourinary anomalies-mental Retardation syndrome inherited ?,8,MEDICAL,Simple Datatype-Boolean,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Western Australian Government Railways"", ""Wilms' Tumor, Aniridia, Gonadoblastoma, mental Retardation"", ""Winning Attitudes, Great Rewards"", ""World Amateur Golf Ranking"", ""Washington Alliance for Gun Responsibility"", ""Windscale Advanced Gas-Cooled Reactor"", ""Wilms&#39; tumor/Aniridia/Genitourinary Anomalies - Mental Retardation Syndrome"", ""Windscale Advanced Gas-Cooled Reactor"", ""Wilms' tumor/Aniridia/Genitourinary Anomalies - Mental Retardation Syndrome"", ""World Amateur Golf Ranking (St. Andrews, Fife, Scotland, UK)"", ""Western Australian Government Railways (Australia)""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY""]]","[""Wilms Tumor, Aniridia, Genitourinary anomalies, and Range of developmental delays""]",[8.60074704052505e-46],[2.8187586526916866e-51],"[""World Amateur Golf Ranking""]",[2.0238238759525927e-22],"[""ABBREVIATIONS""]","[[1.4612362664263678e-26, 1.165695976378779e-47, 9.418922768426953e-26, 2.0238238759525927e-22, 7.363703154336201e-30, 7.876534094989132e-33, 4.226807853710812e-62, 7.876534094989132e-33, 1.6729263151423355e-52, 3.255388529180752e-63, 2.2463622143674306e-37]]",[0.9042616322332135],[0.8963575612535261],"[""Wilms tumor-Aniridia-Genitourinary anomalies-mental Retardation""]",[0.9099756792144673],"[""ABBREVIATIONS""]","[[0.9099756792144673, 0.8994465057950457, 0.8813775782468469, 0.8443880500357791, 0.8516358337957398, 0.8279816570569348, 0.9023137040338165, 0.8279816570569348, 0.9029317970916098, 0.865368699936448, 0.9080676751640759]]","[""Wilms&#39; tumor/Aniridia/Genitourinary Anomalies - Mental Retardation Syndrome""]","[""ACRONYMFINDER""]","Is WAGR (Wilms Tumor, Aniridia, Genitourinary anomalies, and Range of developmental delays) syndrome inherited ?",[false],[false],[false],"[""Yes, WAGR (Wilms tumor, aniridia, genitourinary anomalies, and mental retardation) syndrome is inherited.""]","[""Yes, Wilms tumor-Aniridia-Genitourinary anomalies-mental Retardation syndrome is inherited.""]","[""Yes, WAGR syndrome is inherited.""]",[false],[false],[false],"[""Yes, WAGR (Wilms tumor, aniridia, genitourinary anomalies, and mental retardation) syndrome is inherited.""]","[""Yes, Wilms tumor-Aniridia-Genitourinary anomalies-mental Retardation syndrome is inherited.""]","[""Yes, WAGR syndrome is inherited.""]",[false],[false],[false],"[""Yes, WAGR (Wilms tumor, aniridia, genitourinary anomalies, and mental retardation) syndrome is inherited.""]","[""Yes, Wilms tumor-Aniridia-Genitourinary anomalies-mental Retardation syndrome is inherited.""]","[""Yes, WAGR syndrome is inherited.""]",[false],[false],[false],"[""Yes, WAGR (Wilms tumor, aniridia, genitourinary anomalies, and mental retardation) syndrome is inherited.""]","[""Yes, Wilms tumor-Aniridia-Genitourinary anomalies-mental Retardation syndrome is inherited.""]","[""Yes, WAGR syndrome is inherited.""]",[false],[false],[false],"[""Yes, WAGR syndrome is inherited.""]","[""Yes, Wilms tumor-Aniridia-Genitourinary anomalies-mental Retardation syndrome is inherited.""]","[""Yes, WAGR syndrome is inherited.""]",[false],[false],[false],"[""Yes, WAGR syndrome is inherited.""]","[""Yes, Wilms tumor-Aniridia-Genitourinary anomalies-mental Retardation syndrome is inherited.""]","[""Yes, WAGR syndrome is inherited.""]",[false],[false],[false],"[""Yes, WAGR syndrome is inherited.""]","[""Yes, Wilms tumor-Aniridia-Genitourinary anomalies-mental Retardation syndrome is inherited.""]","[""Yes, WAGR syndrome is inherited.""]",[false],[false],[false],"[""Yes, WAGR syndrome is inherited.""]","[""Yes, Wilms tumor-Aniridia-Genitourinary anomalies-mental Retardation syndrome is inherited.""]","[""Yes, WAGR syndrome is inherited.""]",[false],[false],[false],"[""Yes, WAGR syndrome is inherited.""]","[""Yes, Wilms tumor-Aniridia-Genitourinary anomalies-mental Retardation syndrome is inherited.""]","[""Yes, WAGR syndrome is inherited.""]",[false],[false],[false],"[""Yes, WAGR syndrome is inherited.""]","[""Yes, Wilms tumor-Aniridia-Genitourinary anomalies-mental Retardation syndrome is inherited.""]","[""Yes, WAGR syndrome is inherited.""]",[false],[false],[false],"[""Yes, WAGR syndrome is inherited.""]","[""Yes, Wilms tumor-Aniridia-Genitourinary anomalies-mental Retardation syndrome is inherited.""]","[""Yes, WAGR syndrome is inherited.""]",[false],[false],[false],"[""Yes, WAGR syndrome is inherited.""]","[""Yes, Wilms tumor-Aniridia-Genitourinary anomalies-mental Retardation syndrome is inherited.""]","[""Yes, WAGR syndrome is inherited.""]",[true],[false],[false],"[""Yes, WAGR syndrome can be inherited.""]","[""Yes, Wilms tumor-Aniridia-Genitourinary anomalies-mental Retardation syndrome is inherited.""]","[""Yes, WAGR syndrome is inherited.""]",[false],[false],[false],"[""Yes, WAGR syndrome is inherited.""]","[""Yes, Wilms tumor-Aniridia-Genitourinary anomalies-mental Retardation syndrome is inherited.""]","[""Yes, WAGR syndrome is inherited.""]",[true],[false],[false],"[""Yes, WAGR syndrome can be inherited.""]","[""Yes, Wilms tumor-Aniridia-Genitourinary anomalies-mental Retardation syndrome is inherited.""]","[""Yes, WAGR syndrome is inherited.""]",[true],[false],[false],"[""Yes, WAGR syndrome can be inherited.""]","[""Yes, Wilms tumor-Aniridia-Genitourinary anomalies-mental Retardation syndrome is inherited.""]","[""Yes, WAGR syndrome is inherited.""]",[true],[false],[false],"[""Yes, WAGR syndrome can be inherited.""]","[""Yes, Wilms tumor-Aniridia-Genitourinary anomalies-mental Retardation syndrome is inherited.""]","[""Yes, WAGR syndrome is inherited.""]",[false],[false],[false],"[""Yes, WAGR syndrome is inherited.""]","[""Yes, Wilms tumor-Aniridia-Genitourinary anomalies-mental Retardation syndrome is inherited.""]","[""Yes, WAGR syndrome is inherited.""]",[false],[false],[false],"[""Yes, WAGR syndrome is inherited.""]","[""Yes, Wilms tumor-Aniridia-Genitourinary anomalies-mental Retardation syndrome is inherited.""]","[""Yes, WAGR syndrome is inherited.""]",[false],[false],[false],"[""Yes, WAGR syndrome is inherited.""]","[""Yes, Wilms tumor-Aniridia-Genitourinary anomalies-mental Retardation syndrome is inherited.""]","[""Yes, WAGR syndrome is inherited.""]",[false],[false],[false],"[""Yes""]","[""Yes, Wilms tumor-Aniridia-Genitourinary anomalies-mental Retardation syndrome is inherited.""]","[""Yes, WAGR syndrome is inherited.""]",[false],[false],[false],"[""Yes, WAGR syndrome is typically inherited in an autosomal dominant pattern.""]","[""Yes, Wilms tumor-Aniridia-Genitourinary anomalies-mental Retardation syndrome is inherited.""]","[""Yes, WAGR syndrome is inherited.""]",[false],[false],[false],"[""Yes, WAGR syndrome is inherited.""]","[""Yes, Wilms tumor-Aniridia-Genitourinary anomalies-mental Retardation syndrome is inherited.""]","[""Yes, WAGR syndrome is inherited.""]",[false],[false],[false],"[""Yes, WAGR syndrome is inherited.""]","[""Yes, Wilms tumor-Aniridia-Genitourinary anomalies-mental Retardation syndrome is inherited.""]","[""Yes, WAGR syndrome is inherited.""]",[true],[false],[false],"[""WAGR syndrome is typically not inherited, but rather occurs due to a random genetic mutation.""]","[""Yes, Wilms tumor-Aniridia-Genitourinary anomalies-mental Retardation syndrome is inherited.""]","[""Yes, WAGR syndrome is inherited.""]",[true],[false],[false],"[""WAGR syndrome is typically not inherited, but rather caused by a deletion of genetic material on chromosome 11.""]","[""Yes, Wilms tumor-Aniridia-Genitourinary anomalies-mental Retardation syndrome is inherited.""]","[""Yes, WAGR syndrome is inherited.""]",[true],[false],[false],"[""WAGR syndrome is typically not inherited, but rather occurs sporadically due to a deletion on chromosome 11.""]","[""Yes, Wilms tumor-Aniridia-Genitourinary anomalies-mental Retardation syndrome is inherited.""]","[""Yes, WAGR syndrome is inherited.""]",[true],[false],[false],"[""WAGR syndrome is typically not inherited, but rather occurs due to a random genetic mutation.""]","[""Yes, Wilms tumor-Aniridia-Genitourinary anomalies-mental Retardation syndrome is inherited.""]","[""Yes, WAGR syndrome is inherited.""]",[true],[false],[false],"[""WAGR syndrome is typically not inherited, but rather occurs sporadically due to genetic mutations.""]","[""Yes, Wilms tumor-Aniridia-Genitourinary anomalies-mental Retardation syndrome is inherited.""]","[""Yes, WAGR syndrome is inherited.""]",[true],[false],[false],"[""WAGR syndrome is not inherited, it is a rare genetic disorder caused by a spontaneous mutation.""]","[""Yes, Wilms tumor-Aniridia-Genitourinary anomalies-mental Retardation syndrome is inherited.""]","[""Yes, WAGR syndrome is inherited.""]",[false],[false],[false],"[""Yes, WAGR syndrome is inherited.""]","[""Yes, Wilms tumor-Aniridia-Genitourinary anomalies-mental Retardation syndrome is inherited.""]","[""Yes, WAGR syndrome is inherited.""]",[true],[false],[false],"[""WAGR syndrome is typically not inherited, but rather occurs due to a deletion on chromosome 11.""]","[""Yes, Wilms tumor-Aniridia-Genitourinary anomalies-mental Retardation syndrome is inherited.""]","[""Yes, WAGR syndrome is inherited.""]"
frequency,How many people are affected by congenital insensitivity to pain with anhidrosis ?,"CIPA is a rare condition; however, the prevalence is unknown.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""CIPA"", ""full_form"": ""congenital insensitivity to pain with anhidrosis""}]}",How many people are affected by CIPA ?,How many people are affected by congenital insensitivity to pain with anhidrosis ?,8,MEDICAL,Simple Datatype-Integer,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Children's Internet Protection Act"", ""Colorado Independent Publishers Association"", ""Congenital insensitivity to pain with anhidrosis"", ""California Intercollegiate Press Association"", ""Comit&eacute; International de Photogramm&eacute;trie Architecturale"", ""Certified Identity Protection Advisor"", ""Crop Insurance Professionals Association"", ""California Independent Petroleum Association"", ""Carolina Indoor Performance Association"", ""California Institute for Physics and Astrophysics""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Congenital Insensitivity to Pain with Anhidrosis""]",[7.377151276729192e-29],[7.377151276729192e-29],"[""Children's Internet Protection Act""]",[1.1509001023039704e-19],"[""ABBREVIATIONS""]","[[1.1509001023039704e-19, 3.3969594638166924e-25, 7.377151276729192e-29, 8.076780853130785e-35, 8.942567716957208e-62, 2.1389156160981105e-22, 1.5743236570848213e-21, 1.3350209135721973e-27, 1.6635420349499e-21, 4.27125579911448e-37]]",[0.8728827419533717],[0.8710660986057817],"[""Colorado Independent Publishers Association""]",[0.8723693524348151],"[""ABBREVIATIONS""]","[[0.6998544059047381, 0.6539702200974071, 0.8723693524348151, 0.6216617073083675, 0.7081541958593515, 0.7503308988805081, 0.6950681089249033, 0.6395177459637187, 0.7851702716585962, 0.7391955083933538]]","[""Congenital insensitivity to pain with anhidrosis""]","[""ABBREVIATIONS""]",How many people are affected by CIPA (Congenital Insensitivity to Pain with Anhidrosis) ?,[false],[true],[true],"[""CIPA affects all schools and libraries that receive federal funding for Internet access.""]","[""Congenital insensitivity to pain with anhidrosis affects approximately 1 in 125,000 people worldwide.""]","[""1 in 1 million people are affected by CIPA.""]",[false],[false],[false],"[""CIPA affects all children and adults who use the internet in schools and libraries that receive federal funding.""]","[""Congenital insensitivity to pain with anhidrosis affects approximately 1 in 125,000 people worldwide.""]","[""1 in 125 million people worldwide are affected by CIPA.""]",[false],[true],[true],"[""CIPA affects all children and adults who use the internet in schools and libraries that receive federal funding.""]","[""Congenital insensitivity to pain with anhidrosis affects approximately 1 in 125,000 people worldwide.""]","[""1 in 1 million people are affected by CIPA.""]",[false],[true],[true],"[""CIPA affects all children and adults who use the internet in schools and libraries that receive federal funding.""]","[""Congenital insensitivity to pain with anhidrosis affects approximately 1 in 125,000 people worldwide.""]","[""Approximately 1 in 1 million people worldwide are affected by Congenital Insensitivity to Pain with Anhidrosis (CIPA).""]",[true],[false],[false],"[""CIPA affects approximately 1 in 125,000 to 1 in 1,000,000 people worldwide.""]","[""Congenital insensitivity to pain with anhidrosis affects approximately 1 in 125,000 people worldwide.""]","[""1 in 1 million people are affected by CIPA.""]",[false],[false],[false],"[""CIPA affects approximately 1 in 1 million people worldwide.""]","[""Congenital insensitivity to pain with anhidrosis affects approximately 1 in 125,000 people worldwide.""]","[""1 in 125 million people worldwide are affected by CIPA.""]",[true],[false],[false],"[""CIPA is a genetic disorder that affects approximately 1 in 125,000 to 1 in 1,000,000 people worldwide.""]","[""Congenital insensitivity to pain with anhidrosis affects approximately 1 in 125,000 people worldwide.""]","[""1 in 1 million people are affected by CIPA.""]",[true],[true],[true],"[""CIPA affects approximately 1 in 125,000 to 1 in 1,000,000 people worldwide.""]","[""Congenital insensitivity to pain with anhidrosis affects approximately 1 in 125,000 people worldwide.""]","[""Approximately 1 in 1 million people worldwide are affected by Congenital Insensitivity to Pain with Anhidrosis (CIPA).""]",[false],[false],[false],"[""CIPA affects approximately 1 in 125 million people worldwide.""]","[""Congenital insensitivity to pain with anhidrosis affects approximately 1 in 125,000 people worldwide.""]","[""1 in 125 million people worldwide are affected by CIPA.""]",[true],[false],[false],"[""CIPA is an extremely rare condition, with only a few hundred cases reported worldwide.""]","[""Congenital insensitivity to pain with anhidrosis affects approximately 1 in 125,000 people worldwide.""]","[""1 in 1 million people are affected by CIPA.""]",[false],[true],[true],"[""CIPA affects approximately 1 in 125 million people worldwide.""]","[""Congenital insensitivity to pain with anhidrosis affects approximately 1 in 125,000 people worldwide.""]","[""1 in 1 million people are affected by CIPA.""]",[true],[true],[true],"[""CIPA is an extremely rare condition, with only a few hundred cases reported worldwide.""]","[""Congenital insensitivity to pain with anhidrosis affects approximately 1 in 125,000 people worldwide.""]","[""Approximately 1 in 1 million people worldwide are affected by Congenital Insensitivity to Pain with Anhidrosis (CIPA).""]",[false],[false],[false],"[""1 in 125 million people worldwide are affected by CIPA (Congenital insensitivity to pain with anhidrosis)""]","[""Congenital insensitivity to pain with anhidrosis affects approximately 1 in 125,000 people worldwide.""]","[""1 in 1 million people are affected by CIPA.""]",[false],[false],[false],"[""1 in 125 million people worldwide are affected by CIPA (Congenital insensitivity to pain with anhidrosis)""]","[""Congenital insensitivity to pain with anhidrosis affects approximately 1 in 125,000 people worldwide.""]","[""1 in 125 million people worldwide are affected by CIPA.""]",[true],[true],[true],"[""CIPA is an extremely rare condition, with only a few hundred cases reported worldwide.""]","[""Congenital insensitivity to pain with anhidrosis affects approximately 1 in 125,000 people worldwide.""]","[""1 in 1 million people are affected by CIPA.""]",[false],[true],[true],"[""Approximately 1 in 125 million people worldwide are affected by CIPA.""]","[""Congenital insensitivity to pain with anhidrosis affects approximately 1 in 125,000 people worldwide.""]","[""Approximately 1 in 1 million people worldwide are affected by Congenital Insensitivity to Pain with Anhidrosis (CIPA).""]",[false],[false],[false],"[""1 in 125 million people worldwide are affected by CIPA (Congenital insensitivity to pain with anhidrosis)""]","[""Congenital insensitivity to pain with anhidrosis affects approximately 1 in 125,000 people worldwide.""]","[""1 in 1 million people are affected by CIPA.""]",[false],[false],[false],"[""1 in 125 million people worldwide are affected by CIPA (Congenital insensitivity to pain with anhidrosis)""]","[""Congenital insensitivity to pain with anhidrosis affects approximately 1 in 125,000 people worldwide.""]","[""1 in 125 million people worldwide are affected by CIPA.""]",[false],[false],[false],"[""1 in 125 million people worldwide are affected by CIPA (Congenital insensitivity to pain with anhidrosis)""]","[""Congenital insensitivity to pain with anhidrosis affects approximately 1 in 125,000 people worldwide.""]","[""1 in 1 million people are affected by CIPA.""]",[false],[false],[false],"[""1 in 125 million people worldwide are affected by CIPA (Congenital insensitivity to pain with anhidrosis)""]","[""Congenital insensitivity to pain with anhidrosis affects approximately 1 in 125,000 people worldwide.""]","[""Approximately 1 in 1 million people worldwide are affected by Congenital Insensitivity to Pain with Anhidrosis (CIPA).""]",[false],[false],[false],"[""1 in 125 million people worldwide are affected by CIPA (Congenital Insensitivity to Pain with Anhidrosis)""]","[""Congenital insensitivity to pain with anhidrosis affects approximately 1 in 125,000 people worldwide.""]","[""1 in 1 million people are affected by CIPA.""]",[true],[false],[true],"[""CIPA affects approximately 1 in 125 million people worldwide.""]","[""Congenital insensitivity to pain with anhidrosis affects approximately 1 in 125,000 people worldwide.""]","[""1 in 125 million people worldwide are affected by CIPA.""]",[false],[false],[false],"[""1 in 125 million people worldwide are affected by CIPA (Congenital Insensitivity to Pain with Anhidrosis)""]","[""Congenital insensitivity to pain with anhidrosis affects approximately 1 in 125,000 people worldwide.""]","[""1 in 1 million people are affected by CIPA.""]",[false],[false],[false],"[""1 in 125 million people worldwide are affected by CIPA (Congenital Insensitivity to Pain with Anhidrosis)""]","[""Congenital insensitivity to pain with anhidrosis affects approximately 1 in 125,000 people worldwide.""]","[""Approximately 1 in 1 million people worldwide are affected by Congenital Insensitivity to Pain with Anhidrosis (CIPA).""]",[true],[true],[true],"[""CIPA is an extremely rare condition, affecting approximately 1 in 125 million people worldwide.""]","[""Congenital insensitivity to pain with anhidrosis affects approximately 1 in 125,000 people worldwide.""]","[""1 in 1 million people are affected by CIPA.""]",[true],[false],[false],"[""CIPA is an extremely rare condition, with only a few hundred cases reported worldwide.""]","[""Congenital insensitivity to pain with anhidrosis affects approximately 1 in 125,000 people worldwide.""]","[""1 in 125 million people worldwide are affected by CIPA.""]",[true],[true],[true],"[""CIPA is an extremely rare condition, with only a few hundred cases reported worldwide.""]","[""Congenital insensitivity to pain with anhidrosis affects approximately 1 in 125,000 people worldwide.""]","[""1 in 1 million people are affected by CIPA.""]",[true],[true],[true],"[""CIPA is an extremely rare condition, with only a few hundred cases reported worldwide.""]","[""Congenital insensitivity to pain with anhidrosis affects approximately 1 in 125,000 people worldwide.""]","[""Approximately 1 in 1 million people worldwide are affected by Congenital Insensitivity to Pain with Anhidrosis (CIPA).""]",[true],[true],[true],"[""CIPA is an extremely rare condition, with only a few hundred cases reported worldwide.""]","[""Congenital insensitivity to pain with anhidrosis affects approximately 1 in 125,000 people worldwide.""]","[""1 in 1 million people are affected by CIPA.""]",[false],[true],[true],"[""The Children's Internet Protection Act (CIPA) affects schools and libraries that receive E-rate discounts for Internet access or internal connections. It requires them to have measures in place to protect minors from harmful online content.""]","[""Congenital insensitivity to pain with anhidrosis affects approximately 1 in 125,000 people worldwide.""]","[""1 in 1 million people are affected by CIPA.""]",[false],[true],[true],"[""The number of people affected by CIPA (Colorado Independent Publishers Association) is not readily available.""]","[""Congenital insensitivity to pain with anhidrosis affects approximately 1 in 125,000 people worldwide.""]","[""1 in 1 million people are affected by CIPA.""]",[true],[false],[false],"[""CIPA is an extremely rare condition, with only a few hundred cases reported worldwide.""]","[""Congenital insensitivity to pain with anhidrosis affects approximately 1 in 125,000 people worldwide.""]","[""1 in 1 million people are affected by CIPA.""]"
symptoms,What are the symptoms of Polycystic Kidney Disease ?,"In many cases, PKD does not cause signs or symptoms until cysts are half an inch or larger. When present, the most common symptoms are pain in the back and sidesbetween the ribs and hipsand headaches. The pain can be temporary or persistent, mild or severe. Hematuriablood in the urinemay also be a sign of autosomal dominant PKD.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""PKD"", ""full_form"": ""Polycystic Kidney Disease""}]}",What are the symptoms of PKD ?,What are the symptoms of Polycystic Kidney Disease ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Polycystic Kidney Disease"", ""Packed"", ""Parker Drilling Company"", ""Paramount Kings Dominion"", ""Pinkster Kamp Dwingeloo (European Scouting Camp for Scouts and Explorers)"", ""Park Rapids Airport, Park Rapids, Minnesota USA"", ""Points, Kills, Deaths"", ""Point, Kill, Death"", ""Partly Knocked Down"", ""Philip K Dick""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Polycystic Kidney Disease""]",[3.490622841870608e-09],[3.490622841870608e-09],"[""Packed""]",[2.553026781953559e-06],"[""ABBREVIATIONS""]","[[3.490622841870608e-09, 2.553026781953559e-06, 1.6778809821769557e-21, 4.515346823227975e-24, 1.485210964084934e-74, 3.449417896838985e-40, 1.4874917580430427e-19, 9.188072234442275e-14, 3.1245751617752736e-11, 7.074764968726894e-20]]",[0.9279923519210216],[0.9279923519210216],"[""Polycystic Kidney Disease""]",[0.9279923519210216],"[""ABBREVIATIONS""]","[[0.9279923519210216, 0.7855871449602428, 0.714867661059758, 0.6529329887179631, 0.6764696976252358, 0.7097516341820713, 0.6875791983767028, 0.6869674412944669, 0.6758264945885577, 0.6620421786983655]]","[""Polycystic Kidney Disease""]","[""ABBREVIATIONS""]",What are the symptoms of PKD (Polycystic Kidney Disease) ?,[true],[true],[true],"[""Symptoms of PKD (Polycystic Kidney Disease) include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney failure.""]","[""Symptoms of Polycystic Kidney Disease include high blood pressure, back or side pain, blood in the urine, frequent urination, kidney stones, and kidney failure.""]","[""Symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in urine, kidney stones, and kidney failure.""]",[true],[true],[true],"[""Symptoms of PKD (Polycystic Kidney Disease) include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney failure.""]","[""High blood pressure, back or side pain, blood in the urine, frequent urination, kidney stones, kidney failure""]","[""Symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney failure.""]",[true],[true],[true],"[""Symptoms of PKD (Polycystic Kidney Disease) include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney failure.""]","[""Symptoms of Polycystic Kidney Disease include high blood pressure, back or side pain, blood in the urine, frequent urination, kidney stones, and kidney failure.""]","[""Symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney infections.""]",[true],[true],[true],"[""Symptoms of PKD (Polycystic Kidney Disease) include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney failure.""]","[""Symptoms of Polycystic Kidney Disease include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney failure.""]","[""Symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney infections.""]",[true],[true],[true],"[""Symptoms of PKD include high blood pressure, back or side pain, headaches, urinary tract infections, and kidney stones.""]","[""Symptoms of Polycystic Kidney Disease include high blood pressure, back or side pain, blood in the urine, frequent urination, kidney stones, and kidney failure.""]","[""Symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in urine, kidney stones, and kidney failure.""]",[true],[true],[true],"[""Symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney failure.""]","[""High blood pressure, back or side pain, blood in the urine, frequent urination, kidney stones, kidney failure""]","[""Symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney failure.""]",[true],[true],[true],"[""Symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney failure.""]","[""Symptoms of Polycystic Kidney Disease include high blood pressure, back or side pain, blood in the urine, frequent urination, kidney stones, and kidney failure.""]","[""Symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney infections.""]",[true],[true],[true],"[""Symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney failure.""]","[""Symptoms of Polycystic Kidney Disease include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney failure.""]","[""Symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney infections.""]",[true],[true],[true],"[""Symptoms of PKD include high blood pressure, back or side pain, headaches, urinary tract infections, and kidney stones.""]","[""High blood pressure, back or side pain, blood in the urine, frequent urination, kidney stones, kidney failure""]","[""Symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney failure.""]",[true],[true],[true],"[""Symptoms of PKD (Polycystic Kidney Disease) include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney failure.""]","[""Symptoms of Polycystic Kidney Disease include high blood pressure, back or side pain, blood in the urine, frequent urination, kidney stones, and kidney failure.""]","[""Symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in urine, kidney stones, and kidney failure.""]",[true],[true],[true],"[""Symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney failure.""]","[""Symptoms of Polycystic Kidney Disease include high blood pressure, back or side pain, blood in the urine, frequent urination, kidney stones, and kidney failure.""]","[""Symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney infections.""]",[true],[true],[true],"[""Symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney failure.""]","[""Symptoms of Polycystic Kidney Disease include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney failure.""]","[""Symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney infections.""]",[true],[true],[true],"[""Symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney failure.""]","[""Symptoms of Polycystic Kidney Disease include high blood pressure, back or side pain, blood in the urine, frequent urination, kidney stones, and kidney failure.""]","[""Symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in urine, kidney stones, and kidney failure.""]",[true],[true],[true],"[""Symptoms of PKD include high blood pressure, back or side pain, headaches, urinary tract infections, and kidney stones.""]","[""High blood pressure, back or side pain, blood in the urine, frequent urination, kidney stones, kidney failure""]","[""Symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney failure.""]",[true],[true],[true],"[""Symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in urine, kidney stones, and kidney failure.""]","[""Symptoms of Polycystic Kidney Disease include high blood pressure, back or side pain, blood in the urine, frequent urination, kidney stones, and kidney failure.""]","[""Symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney infections.""]",[true],[true],[true],"[""Symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney failure.""]","[""Symptoms of Polycystic Kidney Disease include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney failure.""]","[""Symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney infections.""]",[false],[true],[true],"[""Abdominal pain, high blood pressure, blood in urine, kidney stones, frequent urination""]","[""Symptoms of Polycystic Kidney Disease include high blood pressure, back or side pain, blood in the urine, frequent urination, kidney stones, and kidney failure.""]","[""Symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in urine, kidney stones, and kidney failure.""]",[true],[true],[true],"[""Symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney failure.""]","[""High blood pressure, back or side pain, blood in the urine, frequent urination, kidney stones, kidney failure""]","[""Symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney failure.""]",[true],[true],[true],"[""Symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney failure.""]","[""Symptoms of Polycystic Kidney Disease include high blood pressure, back or side pain, blood in the urine, frequent urination, kidney stones, and kidney failure.""]","[""Symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney infections.""]",[true],[true],[true],"[""Symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney failure.""]","[""Symptoms of Polycystic Kidney Disease include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney failure.""]","[""Symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney infections.""]",[true],[true],[true],"[""Symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney failure.""]","[""Symptoms of Polycystic Kidney Disease include high blood pressure, back or side pain, blood in the urine, frequent urination, kidney stones, and kidney failure.""]","[""Symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in urine, kidney stones, and kidney failure.""]",[true],[true],[true],"[""Symptoms of PKD include high blood pressure, back or side pain, headaches, urinary tract infections, and kidney stones.""]","[""High blood pressure, back or side pain, blood in the urine, frequent urination, kidney stones, kidney failure""]","[""Symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney failure.""]",[true],[true],[true],"[""Symptoms of PKD include high blood pressure, back or side pain, headaches, urinary tract infections, and kidney stones.""]","[""Symptoms of Polycystic Kidney Disease include high blood pressure, back or side pain, blood in the urine, frequent urination, kidney stones, and kidney failure.""]","[""Symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney infections.""]",[true],[true],[true],"[""Symptoms of PKD (Polycystic Kidney Disease) include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney failure.""]","[""Symptoms of Polycystic Kidney Disease include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney failure.""]","[""Symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney infections.""]",[true],[true],[true],"[""Common symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney infections.""]","[""Symptoms of Polycystic Kidney Disease include high blood pressure, back or side pain, blood in the urine, frequent urination, kidney stones, and kidney failure.""]","[""Symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in urine, kidney stones, and kidney failure.""]",[true],[true],[true],"[""Symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney failure.""]","[""High blood pressure, back or side pain, blood in the urine, frequent urination, kidney stones, kidney failure""]","[""Symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney failure.""]",[true],[true],[true],"[""Symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney failure.""]","[""Symptoms of Polycystic Kidney Disease include high blood pressure, back or side pain, blood in the urine, frequent urination, kidney stones, and kidney failure.""]","[""Symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney infections.""]",[true],[true],[true],"[""Symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney failure.""]","[""Symptoms of Polycystic Kidney Disease include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney failure.""]","[""Symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney infections.""]",[false],[true],[true],"[""Symptoms of PKD include high blood pressure, back or side pain, blood in urine, frequent urination, kidney stones, and kidney infections.""]","[""Symptoms of Polycystic Kidney Disease include high blood pressure, back or side pain, blood in the urine, frequent urination, kidney stones, and kidney failure.""]","[""Symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in urine, kidney stones, and kidney failure.""]",[true],[true],[true],"[""Symptoms of PKD (Polycystic Kidney Disease) include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney failure.""]","[""Symptoms of Polycystic Kidney Disease include high blood pressure, back or side pain, blood in the urine, frequent urination, kidney stones, and kidney failure.""]","[""Symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in urine, kidney stones, and kidney failure.""]",[true],[true],[true],"[""Symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in the urine, kidney stones, and kidney failure.""]","[""Symptoms of Polycystic Kidney Disease include high blood pressure, back or side pain, blood in the urine, frequent urination, kidney stones, and kidney failure.""]","[""Symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in urine, kidney stones, and kidney failure.""]",[true],[true],[true],"[""Symptoms of PKD include high blood pressure, back or side pain, blood in the urine, frequent urination, kidney stones, and kidney failure.""]","[""Symptoms of Polycystic Kidney Disease include high blood pressure, back or side pain, blood in the urine, frequent urination, kidney stones, and kidney failure.""]","[""Symptoms of PKD include high blood pressure, back or side pain, headaches, frequent urination, blood in urine, kidney stones, and kidney failure.""]"
exams and tests,How to diagnose Parasites - African Trypanosomiasis (also known as Sleeping Sickness) ?,"The diagnosis of African Trypanosomiasis is made through laboratory methods, because the clinical features of infection are not sufficiently specific. The diagnosis rests on finding the parasite in body fluid or tissue by microscopy. The parasite load in T. b. rhodesiense infection is substantially higher than the level in T. b. gambiense infection.
    
T. b. rhodesiense parasites can easily be found in blood. They can also be found in lymph node fluid or in fluid or biopsy of a chancre. Serologic testing is not widely available and is not used in the diagnosis, since microscopic detection of the parasite is straightforward.
    
The classic method for diagnosing T. b. gambiense infection is by microscopic examination of lymph node aspirate, usually from a posterior cervical node. It is often difficult to detect T. b. gambiense in blood. Concentration techniques and serial examinations are frequently needed. Serologic testing is available outside the U.S. for T. b. gambiense; however, it normally is used for screening purposes only and the definitive diagnosis rests on microscopic observation of the parasite.
    
All patients diagnosed with African trypanosomiasis must have their cerebrospinal fluid examined to determine whether there is involvement of the central nervous system, since the choice of treatment drug(s) will depend on the disease stage. The World Health Organization criteria for central nervous system involvement include increased protein in cerebrospinal fluid and a white cell count of more than 5. Trypanosomes can often be observed in cerebrospinal fluid in persons with second stage infection.
    
More on: Resources for Health Professionals: Diagnosis","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""AT"", ""full_form"": ""African Trypanosomiasis""}]}",How to diagnose Parasites - AT (also known as Sleeping Sickness) ?,How to diagnose Parasites - African Trypanosomiasis (also known as Sleeping Sickness) ?,8,MEDICAL,Simple Datatype-String,"Instructional: Queries specifically seeking step-by-step guidance, instructions, or procedures to perform a task. it focuses on 'how' to do something rather than 'what', 'why', or 'which'.","[[""Atlas"", ""Advanced Technology"", ""All That"", ""All Times"", ""Air Traffic"", ""Air Transport"", ""Automatic Transmission"", ""All Terrain"", ""Anti-Terrorism"", ""Anti-Tank""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""African Trypanosomiasis""]",[1.0060890461462188e-28],[1.0060890461462188e-28],"[""All Times""]",[8.756362152916773e-06],"[""ABBREVIATIONS""]","[[2.0491228080869506e-06, 2.70678112736715e-09, 9.853923556093212e-07, 8.756362152916773e-06, 4.796872936630012e-10, 3.285934773180562e-10, 7.411719067470287e-10, 7.178359847947639e-10, 6.882073017769796e-11, 6.301267599211369e-11]]",[0.9513990987150185],[0.9513990987150185],"[""Advanced Technology""]",[0.9757909533598463],"[""ABBREVIATIONS""]","[[0.9234003882807268, 0.9443924401370094, 0.9757909533598463, 0.9591438695411308, 0.9348875786794195, 0.9396600194480237, 0.910690904513605, 0.9564177984549496, 0.9289694130668339, 0.9542670689006667]]","[""African Trypanosomiasis""]","[""LLM""]",How to diagnose Parasites - AT (African Trypanosomiasis) (also known as Sleeping Sickness) ?,[false],[true],[false],"[""Diagnosis of Parasites - AT (African Trypanosomiasis) is typically done through blood tests, such as microscopic examination of blood smears, serological tests, or polymerase chain reaction (PCR) tests.""]","[""Diagnosis of African Trypanosomiasis involves microscopic examination of body fluids or tissues for the presence of the parasite Trypanosoma brucei.""]","[""Diagnosis of Parasites - AT is typically done through blood tests to detect the presence of the parasite Trypanosoma brucei.""]",[false],[true],[false],"[""Parasites - AT (African Trypanosomiasis), also known as Sleeping Sickness, can be diagnosed through blood tests, such as microscopic examination of blood smears or serological tests like ELISA or PCR to detect the parasite.""]","[""Diagnosis of African Trypanosomiasis involves microscopic examination of blood, lymph node aspirate, or cerebrospinal fluid for the presence of Trypanosoma parasites.""]","[""Diagnosis of Parasites - AT (Sleeping Sickness) is typically done through a blood test to check for the presence of the parasite Trypanosoma brucei.""]",[false],[true],[true],"[""Diagnosis of Parasites - AT (African Trypanosomiasis) involves blood tests, such as microscopic examination, serologic tests, and polymerase chain reaction (PCR) tests.""]","[""Diagnosis of African Trypanosomiasis involves microscopic examination of blood, lymph node aspirate, or cerebrospinal fluid for the presence of the parasite Trypanosoma brucei.""]","[""Diagnosis of African Trypanosomiasis (Sleeping Sickness) is typically done through a blood test to detect the parasite in the blood or cerebrospinal fluid. This may involve examining a blood smear under a microscope or using polymerase chain reaction (PCR) tests.""]",[true],[true],[true],"[""Parasites - AT, also known as Sleeping Sickness, can be diagnosed through a blood test to check for the presence of the parasite Trypanosoma brucei.""]","[""Diagnosis of African Trypanosomiasis involves microscopic examination of body fluids or tissues for the presence of the parasite Trypanosoma brucei.""]","[""Diagnosis of African Trypanosomiasis (Sleeping Sickness) is typically done through a blood test to detect the parasite in the blood, cerebrospinal fluid, or lymph nodes. A lumbar puncture may also be performed to check for the presence of the parasite in the central nervous system.""]",[false],[true],[false],"[""Diagnosing Parasites - AT (Advanced Technology) involves conducting a blood test to check for the presence of parasites in the bloodstream.""]","[""Diagnosis of African Trypanosomiasis involves microscopic examination of body fluids or tissues for the presence of the parasite Trypanosoma brucei.""]","[""Diagnosis of Parasites - AT is typically done through blood tests to detect the presence of the parasite Trypanosoma brucei.""]",[false],[true],[false],"[""Diagnosis of Parasites - AT (Advanced Technology) involves microscopic examination of blood, cerebrospinal fluid, or lymph node aspirate for the presence of parasites. Serological tests and molecular tests may also be used for confirmation.""]","[""Diagnosis of African Trypanosomiasis involves microscopic examination of blood, lymph node aspirate, or cerebrospinal fluid for the presence of Trypanosoma parasites.""]","[""Diagnosis of Parasites - AT (Sleeping Sickness) is typically done through a blood test to check for the presence of the parasite Trypanosoma brucei.""]",[false],[true],[true],"[""Parasites - AT (Advanced Technology) is diagnosed through a combination of blood tests, spinal tap, and examination of lymph node fluid under a microscope.""]","[""Diagnosis of African Trypanosomiasis involves microscopic examination of blood, lymph node aspirate, or cerebrospinal fluid for the presence of the parasite Trypanosoma brucei.""]","[""Diagnosis of African Trypanosomiasis (Sleeping Sickness) is typically done through a blood test to detect the parasite in the blood or cerebrospinal fluid. This may involve examining a blood smear under a microscope or using polymerase chain reaction (PCR) tests.""]",[false],[true],[true],"[""Parasites - AT, also known as Sleeping Sickness, can be diagnosed through a combination of blood tests, such as microscopic examination of blood smears, serological tests, and polymerase chain reaction (PCR) tests to detect the presence of the parasite Trypanosoma brucei.""]","[""Diagnosis of African Trypanosomiasis involves microscopic examination of body fluids or tissues for the presence of the parasite Trypanosoma brucei.""]","[""Diagnosis of African Trypanosomiasis (Sleeping Sickness) is typically done through a blood test to detect the parasite in the blood, cerebrospinal fluid, or lymph nodes. A lumbar puncture may also be performed to check for the presence of the parasite in the central nervous system.""]",[true],[true],[false],"[""Diagnosis of African Trypanosomiasis involves microscopic examination of blood, lymph node aspirate, or cerebrospinal fluid for the presence of trypanosomes.""]","[""Diagnosis of African Trypanosomiasis involves microscopic examination of blood, lymph node aspirate, or cerebrospinal fluid for the presence of Trypanosoma parasites.""]","[""Diagnosis of Parasites - AT (Sleeping Sickness) is typically done through a blood test to check for the presence of the parasite Trypanosoma brucei.""]",[true],[true],[false],"[""Diagnosis of African Trypanosomiasis involves microscopic examination of blood, lymph node aspirate, or cerebrospinal fluid for the presence of trypanosomes.""]","[""Diagnosis of African Trypanosomiasis involves microscopic examination of body fluids or tissues for the presence of the parasite Trypanosoma brucei.""]","[""Diagnosis of Parasites - AT is typically done through blood tests to detect the presence of the parasite Trypanosoma brucei.""]",[true],[true],[true],"[""Diagnosis of African Trypanosomiasis involves microscopic examination of blood, lymph node aspirate, or cerebrospinal fluid to detect the parasites.""]","[""Diagnosis of African Trypanosomiasis involves microscopic examination of blood, lymph node aspirate, or cerebrospinal fluid for the presence of the parasite Trypanosoma brucei.""]","[""Diagnosis of African Trypanosomiasis (Sleeping Sickness) is typically done through a blood test to detect the parasite in the blood or cerebrospinal fluid. This may involve examining a blood smear under a microscope or using polymerase chain reaction (PCR) tests.""]",[true],[true],[true],"[""Diagnosis of African Trypanosomiasis involves microscopic examination of blood, lymph node aspirate, or cerebrospinal fluid for the presence of trypanosomes.""]","[""Diagnosis of African Trypanosomiasis involves microscopic examination of body fluids or tissues for the presence of the parasite Trypanosoma brucei.""]","[""Diagnosis of African Trypanosomiasis (Sleeping Sickness) is typically done through a blood test to detect the parasite in the blood, cerebrospinal fluid, or lymph nodes. A lumbar puncture may also be performed to check for the presence of the parasite in the central nervous system.""]",[true],[true],[false],"[""Diagnosis of African Trypanosomiasis involves identifying the parasite in blood, lymph node aspirate, or cerebrospinal fluid samples through microscopic examination or polymerase chain reaction (PCR) testing.""]","[""Diagnosis of African Trypanosomiasis involves microscopic examination of body fluids or tissues for the presence of the parasite Trypanosoma brucei.""]","[""Diagnosis of Parasites - AT is typically done through blood tests to detect the presence of the parasite Trypanosoma brucei.""]",[true],[true],[false],"[""Diagnosis of African Trypanosomiasis involves identifying the parasite in blood, lymph node aspirates, or cerebrospinal fluid through microscopic examination or polymerase chain reaction (PCR) testing.""]","[""Diagnosis of African Trypanosomiasis involves microscopic examination of blood, lymph node aspirate, or cerebrospinal fluid for the presence of Trypanosoma parasites.""]","[""Diagnosis of Parasites - AT (Sleeping Sickness) is typically done through a blood test to check for the presence of the parasite Trypanosoma brucei.""]",[true],[true],[true],"[""Diagnosis of African Trypanosomiasis involves microscopic examination of body fluids or tissues for the presence of the parasite Trypanosoma brucei.""]","[""Diagnosis of African Trypanosomiasis involves microscopic examination of blood, lymph node aspirate, or cerebrospinal fluid for the presence of the parasite Trypanosoma brucei.""]","[""Diagnosis of African Trypanosomiasis (Sleeping Sickness) is typically done through a blood test to detect the parasite in the blood or cerebrospinal fluid. This may involve examining a blood smear under a microscope or using polymerase chain reaction (PCR) tests.""]",[false],[true],[true],"[""Diagnosis of African Trypanosomiasis involves microscopic examination of body fluids or tissues for the presence of the parasite, serological tests, and molecular techniques like PCR.""]","[""Diagnosis of African Trypanosomiasis involves microscopic examination of body fluids or tissues for the presence of the parasite Trypanosoma brucei.""]","[""Diagnosis of African Trypanosomiasis (Sleeping Sickness) is typically done through a blood test to detect the parasite in the blood, cerebrospinal fluid, or lymph nodes. A lumbar puncture may also be performed to check for the presence of the parasite in the central nervous system.""]",[true],[true],[false],"[""Diagnosing African Trypanosomiasis involves identifying the parasite in blood, lymph node aspirate, or cerebrospinal fluid samples. This can be done through microscopic examination, PCR testing, or antigen detection tests.""]","[""Diagnosis of African Trypanosomiasis involves microscopic examination of body fluids or tissues for the presence of the parasite Trypanosoma brucei.""]","[""Diagnosis of Parasites - AT is typically done through blood tests to detect the presence of the parasite Trypanosoma brucei.""]",[true],[true],[false],"[""Diagnosis of African Trypanosomiasis involves microscopic examination of blood, lymph node aspirate, or cerebrospinal fluid for the presence of trypanosomes.""]","[""Diagnosis of African Trypanosomiasis involves microscopic examination of blood, lymph node aspirate, or cerebrospinal fluid for the presence of Trypanosoma parasites.""]","[""Diagnosis of Parasites - AT (Sleeping Sickness) is typically done through a blood test to check for the presence of the parasite Trypanosoma brucei.""]",[true],[true],[true],"[""Diagnosis of African Trypanosomiasis involves microscopic examination of body fluids or tissues for the presence of the parasite Trypanosoma brucei.""]","[""Diagnosis of African Trypanosomiasis involves microscopic examination of blood, lymph node aspirate, or cerebrospinal fluid for the presence of the parasite Trypanosoma brucei.""]","[""Diagnosis of African Trypanosomiasis (Sleeping Sickness) is typically done through a blood test to detect the parasite in the blood or cerebrospinal fluid. This may involve examining a blood smear under a microscope or using polymerase chain reaction (PCR) tests.""]",[true],[true],[true],"[""Diagnosis of African Trypanosomiasis involves microscopic examination of blood, lymph node aspirate, or cerebrospinal fluid for the presence of trypanosomes.""]","[""Diagnosis of African Trypanosomiasis involves microscopic examination of body fluids or tissues for the presence of the parasite Trypanosoma brucei.""]","[""Diagnosis of African Trypanosomiasis (Sleeping Sickness) is typically done through a blood test to detect the parasite in the blood, cerebrospinal fluid, or lymph nodes. A lumbar puncture may also be performed to check for the presence of the parasite in the central nervous system.""]",[true],[true],[false],"[""Diagnosis of African Trypanosomiasis involves microscopic examination of blood, lymph node aspirate, or cerebrospinal fluid for the presence of trypanosomes.""]","[""Diagnosis of African Trypanosomiasis involves microscopic examination of body fluids or tissues for the presence of the parasite Trypanosoma brucei.""]","[""Diagnosis of Parasites - AT is typically done through blood tests to detect the presence of the parasite Trypanosoma brucei.""]",[true],[true],[false],"[""Diagnosis of African Trypanosomiasis involves microscopic examination of blood, lymph node aspirate, or cerebrospinal fluid for the presence of trypanosomes.""]","[""Diagnosis of African Trypanosomiasis involves microscopic examination of blood, lymph node aspirate, or cerebrospinal fluid for the presence of Trypanosoma parasites.""]","[""Diagnosis of Parasites - AT (Sleeping Sickness) is typically done through a blood test to check for the presence of the parasite Trypanosoma brucei.""]",[true],[true],[true],"[""Diagnosis of African Trypanosomiasis involves microscopic examination of blood, lymph node aspirate, or cerebrospinal fluid for the presence of trypanosomes.""]","[""Diagnosis of African Trypanosomiasis involves microscopic examination of blood, lymph node aspirate, or cerebrospinal fluid for the presence of the parasite Trypanosoma brucei.""]","[""Diagnosis of African Trypanosomiasis (Sleeping Sickness) is typically done through a blood test to detect the parasite in the blood or cerebrospinal fluid. This may involve examining a blood smear under a microscope or using polymerase chain reaction (PCR) tests.""]",[true],[true],[true],"[""Diagnosis of African Trypanosomiasis involves microscopic examination of blood, lymph node aspirate, or cerebrospinal fluid for the presence of trypanosomes.""]","[""Diagnosis of African Trypanosomiasis involves microscopic examination of body fluids or tissues for the presence of the parasite Trypanosoma brucei.""]","[""Diagnosis of African Trypanosomiasis (Sleeping Sickness) is typically done through a blood test to detect the parasite in the blood, cerebrospinal fluid, or lymph nodes. A lumbar puncture may also be performed to check for the presence of the parasite in the central nervous system.""]",[true],[true],[false],"[""Diagnosing African Trypanosomiasis involves microscopic examination of body fluids or tissues for the presence of the parasite Trypanosoma brucei. This can be done through blood tests, cerebrospinal fluid examination, or lymph node aspiration.""]","[""Diagnosis of African Trypanosomiasis involves microscopic examination of body fluids or tissues for the presence of the parasite Trypanosoma brucei.""]","[""Diagnosis of Parasites - AT is typically done through blood tests to detect the presence of the parasite Trypanosoma brucei.""]",[true],[true],[false],"[""Diagnosing African Trypanosomiasis involves identifying the parasite in blood, lymph node fluid, or cerebrospinal fluid. This can be done through microscopic examination, serological tests, or molecular tests.""]","[""Diagnosis of African Trypanosomiasis involves microscopic examination of blood, lymph node aspirate, or cerebrospinal fluid for the presence of Trypanosoma parasites.""]","[""Diagnosis of Parasites - AT (Sleeping Sickness) is typically done through a blood test to check for the presence of the parasite Trypanosoma brucei.""]",[true],[true],[true],"[""Diagnosing African Trypanosomiasis involves a combination of clinical evaluation, blood tests, and examination of cerebrospinal fluid. A blood smear or polymerase chain reaction (PCR) test can confirm the presence of the parasite. In some cases, a lymph node aspirate or a serologic test may also be used for diagnosis.""]","[""Diagnosis of African Trypanosomiasis involves microscopic examination of blood, lymph node aspirate, or cerebrospinal fluid for the presence of the parasite Trypanosoma brucei.""]","[""Diagnosis of African Trypanosomiasis (Sleeping Sickness) is typically done through a blood test to detect the parasite in the blood or cerebrospinal fluid. This may involve examining a blood smear under a microscope or using polymerase chain reaction (PCR) tests.""]",[true],[true],[true],"[""Diagnosing African Trypanosomiasis involves a combination of clinical evaluation, blood tests, and examination of cerebrospinal fluid. A blood sample is usually taken to check for the presence of the parasite. In some cases, a lymph node aspirate or a bone marrow sample may also be needed. Additionally, a lumbar puncture may be performed to examine the cerebrospinal fluid for signs of the parasite.""]","[""Diagnosis of African Trypanosomiasis involves microscopic examination of body fluids or tissues for the presence of the parasite Trypanosoma brucei.""]","[""Diagnosis of African Trypanosomiasis (Sleeping Sickness) is typically done through a blood test to detect the parasite in the blood, cerebrospinal fluid, or lymph nodes. A lumbar puncture may also be performed to check for the presence of the parasite in the central nervous system.""]",[true],[true],[false],"[""Diagnosis of African Trypanosomiasis (Sleeping Sickness) involves identifying the parasite in blood, lymph node fluid, or cerebrospinal fluid samples through microscopic examination or molecular tests.""]","[""Diagnosis of African Trypanosomiasis involves microscopic examination of body fluids or tissues for the presence of the parasite Trypanosoma brucei.""]","[""Diagnosis of Parasites - AT is typically done through blood tests to detect the presence of the parasite Trypanosoma brucei.""]",[false],[true],[false],"[""Diagnosing Parasites - AT (also known as Sleeping Sickness) involves a blood test to check for the presence of the parasite Trypanosoma brucei.""]","[""Diagnosis of African Trypanosomiasis involves microscopic examination of body fluids or tissues for the presence of the parasite Trypanosoma brucei.""]","[""Diagnosis of Parasites - AT is typically done through blood tests to detect the presence of the parasite Trypanosoma brucei.""]",[false],[true],[false],"[""Diagnosing Parasites - AT (Advanced Technology), also known as Sleeping Sickness, involves conducting blood tests, such as examining a blood smear under a microscope to look for the parasites, or performing a serological test to detect antibodies against the parasite.""]","[""Diagnosis of African Trypanosomiasis involves microscopic examination of body fluids or tissues for the presence of the parasite Trypanosoma brucei.""]","[""Diagnosis of Parasites - AT is typically done through blood tests to detect the presence of the parasite Trypanosoma brucei.""]",[false],[true],[false],"[""Diagnosis of African Trypanosomiasis (Sleeping Sickness) is typically done through blood tests, such as microscopic examination of blood smears, serological tests, and polymerase chain reaction (PCR) tests.""]","[""Diagnosis of African Trypanosomiasis involves microscopic examination of body fluids or tissues for the presence of the parasite Trypanosoma brucei.""]","[""Diagnosis of Parasites - AT is typically done through blood tests to detect the presence of the parasite Trypanosoma brucei.""]"
genetic changes,What are the genetic changes related to carbamoyl phosphate synthetase I deficiency ?,"Mutations in the CPS1 gene cause carbamoyl phosphate synthetase I deficiency. The CPS1 gene provides instructions for making the enzyme carbamoyl phosphate synthetase I. This enzyme participates in the urea cycle, which is a sequence of biochemical reactions that occurs in liver cells. The urea cycle processes excess nitrogen, generated when protein is broken down by the body, to make a compound called urea that is excreted by the kidneys. The specific role of the carbamoyl phosphate synthetase I enzyme is to control the first step of the urea cycle, a reaction in which excess nitrogen compounds are incorporated into the cycle to be processed.  Carbamoyl phosphate synthetase I deficiency belongs to a class of genetic diseases called urea cycle disorders. In this condition, the carbamoyl phosphate synthetase I enzyme is at low levels (deficient) or absent, and the urea cycle cannot proceed normally. As a result, nitrogen accumulates in the bloodstream in the form of toxic ammonia instead of being converted to less toxic urea and excreted. Ammonia is especially damaging to the brain, and excess ammonia causes neurological problems and other signs and symptoms of carbamoyl phosphate synthetase I deficiency.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""CPS I"", ""full_form"": ""carbamoyl phosphate synthetase I""}]}",What are the genetic changes related to CPS I deficiency ?,What are the genetic changes related to carbamoyl phosphate synthetase I deficiency ?,8,MEDICAL,Compound Datatype-List/Array,"Exploratory(Divergent Thinking): Queries that are inherently about seeking new areas of knowledge, understanding emerging trends, or identifying unknown opportunities without a specific end goal of making a decision or judgment. Exploratory queries are characterized by their openness and the lack of a predefined objective, differentiating them from evaluative queries which are directed towards forming a judgment or assessment. Exploratory queries encourage branching out into various directions to explore a wide array of possibilities without necessarily aiming to converge on a single answer or outcome.","[[""Canadian Provincial Standards on Immunization"", ""Computer Programs and Systems Inc"", ""Certified Playground Safety Inspector"", ""Creative Problem Solving Institute"", ""Center for Public Safety Initiatives"", ""Center for Public Safety Innovation"", ""Command Post Systems and Integration"", ""Canadian Patient Safety Institute"", ""Cells Per Square Inch"", ""Canadian Patient Safety Institute (Edmonton, AB, Canada)"", ""cells per square inch"", ""Care Purchasing Services, Inc. (Delray Beach, FL)"", ""Configurable PostScript Interpreter"", ""Council on Private Sector Initiatives"", ""Computer Programs &amp; Systems, Inc. (Mobile, Alabama)"", ""California Property Specialists, Inc. (Santa Ana, CA)"", ""Center for Public Sector Information (Mount St. Mary\u2019s College)"", ""Certified Playground Safety Inspector"", ""Canadian Professional Sustainability Institute (Canada)""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER""]]","[""Carbamoyl Phosphate Synthetase I""]",[8.453331393358716e-29],[8.453331393358716e-29],"[""Cells Per Square Inch""]",[2.0133845181219596e-16],"[""ABBREVIATIONS""]","[[4.274950877807247e-30, 6.306493490605619e-18, 1.1737828947982249e-24, 6.891691823076876e-25, 3.303726357225117e-20, 7.344138327693438e-21, 1.1346681106009024e-21, 2.820653267859238e-21, 2.0133845181219596e-16, 2.8216320841623095e-49, 2.0133845181219596e-16, 1.164341797090902e-50, 6.872414940404645e-25, 7.745597644138595e-22, 2.0800136258944432e-48, 1.9852971060096023e-53, 5.764057723607007e-54, 1.1737828947982249e-24, 5.116268703195441e-38]]",[0.9135196409733135],[0.9122249411278687],"[""Configurable PostScript Interpreter""]",[0.9399601330448593],"[""ACRONYMFINDER""]","[[0.8999153341356265, 0.9274702291204048, 0.9031421638818594, 0.926905291826206, 0.9372198946134203, 0.9362389718021618, 0.9112571870913262, 0.9284997293365761, 0.9106982528322225, 0.9271500669728718, 0.9162629205241027, 0.927279543545755, 0.9114424420790386, 0.9399601330448593, 0.9124547252210548, 0.8941182559772239, 0.9386931017806261, 0.9031421638818594, 0.9220787258575414]]","[""Carbamoyl Phosphate Synthetase I""]","[""LLM""]",What are the genetic changes related to CPS I (Carbamoyl Phosphate Synthetase I) deficiency ?,[true],[true],[true],"[""Genetic changes related to CPS I deficiency include mutations in the CPS1 gene.""]","[""Mutations in the CPS1 gene are associated with carbamoyl phosphate synthetase I deficiency.""]","[""Mutations in the CPS1 gene""]",[true],[false],[true],"[""Genetic changes related to CPS I deficiency include mutations in the CPS1 gene.""]","[""Mutations in the CPS1 gene""]","[""Mutations in the CPS1 gene are associated with CPS I deficiency.""]",[true],[true],[true],"[""Mutations in the CPS1 gene are associated with CPS I deficiency, leading to a disruption in the urea cycle and resulting in hyperammonemia.""]","[""Mutations in the CPS1 gene are associated with carbamoyl phosphate synthetase I deficiency.""]","[""Mutations in the CPS1 gene""]",[true],[true],[true],"[""Mutations in the CPS1 gene are responsible for CPS I deficiency, leading to the inability to produce urea from ammonia in the liver.""]","[""Mutations in the CPS1 gene""]","[""Mutations in the CPS1 gene""]",[true],[true],[true],"[""Mutations in the CPS1 gene""]","[""Mutations in the CPS1 gene are associated with carbamoyl phosphate synthetase I deficiency.""]","[""Mutations in the CPS1 gene""]",[true],[true],[true],"[""Mutations in the CPS1 gene""]","[""Mutations in the CPS1 gene""]","[""Mutations in the CPS1 gene are associated with CPS I deficiency.""]",[true],[true],[true],"[""Mutations in the CPS1 gene""]","[""Mutations in the CPS1 gene are associated with carbamoyl phosphate synthetase I deficiency.""]","[""Mutations in the CPS1 gene""]",[true],[true],[true],"[""Mutations in the CPS1 gene""]","[""Mutations in the CPS1 gene""]","[""Mutations in the CPS1 gene""]",[true],[true],[true],"[""Mutations in the CPS1 gene""]","[""Mutations in the CPS1 gene""]","[""Mutations in the CPS1 gene are associated with CPS I deficiency.""]",[true],[true],[true],"[""Genetic changes related to CPS I deficiency include mutations in the CPS1 gene.""]","[""Mutations in the CPS1 gene are associated with carbamoyl phosphate synthetase I deficiency.""]","[""Mutations in the CPS1 gene""]",[true],[true],[true],"[""Mutations in the CPS1 gene""]","[""Mutations in the CPS1 gene are associated with carbamoyl phosphate synthetase I deficiency.""]","[""Mutations in the CPS1 gene""]",[true],[true],[true],"[""Genetic changes related to CPS I deficiency include mutations in the CPS1 gene.""]","[""Mutations in the CPS1 gene""]","[""Mutations in the CPS1 gene""]",[true],[true],[true],"[""Mutations in the CPS1 gene""]","[""Mutations in the CPS1 gene are associated with carbamoyl phosphate synthetase I deficiency.""]","[""Mutations in the CPS1 gene""]",[true],[false],[true],"[""Genetic changes related to CPS I deficiency include mutations in the CPS1 gene.""]","[""Mutations in the CPS1 gene""]","[""Mutations in the CPS1 gene are associated with CPS I deficiency.""]",[true],[true],[true],"[""Genetic changes related to CPS I deficiency include mutations in the CPS1 gene.""]","[""Mutations in the CPS1 gene are associated with carbamoyl phosphate synthetase I deficiency.""]","[""Mutations in the CPS1 gene""]",[true],[true],[true],"[""Genetic changes related to CPS I deficiency include mutations in the CPS1 gene.""]","[""Mutations in the CPS1 gene""]","[""Mutations in the CPS1 gene""]",[false],[true],[true],"[""This is a well-formatted instance of the schema.""]","[""Mutations in the CPS1 gene are associated with carbamoyl phosphate synthetase I deficiency.""]","[""Mutations in the CPS1 gene""]",[true],[false],[true],"[""Mutations in the CPS1 gene are associated with Carbamoyl Phosphate Synthetase I deficiency.""]","[""Mutations in the CPS1 gene""]","[""Mutations in the CPS1 gene are associated with CPS I deficiency.""]",[true],[true],[true],"[""Mutations in the CPS1 gene are associated with Carbamoyl Phosphate Synthetase I deficiency.""]","[""Mutations in the CPS1 gene are associated with carbamoyl phosphate synthetase I deficiency.""]","[""Mutations in the CPS1 gene""]",[true],[true],[true],"[""Mutations in the CPS1 gene are associated with Carbamoyl Phosphate Synthetase I deficiency.""]","[""Mutations in the CPS1 gene""]","[""Mutations in the CPS1 gene""]",[true],[true],[true],"[""Mutations in the CPS1 gene""]","[""Mutations in the CPS1 gene are associated with carbamoyl phosphate synthetase I deficiency.""]","[""Mutations in the CPS1 gene""]",[true],[false],[true],"[""Genetic changes related to CPS I deficiency include mutations in the CPS1 gene, which can lead to reduced or absent enzyme activity, resulting in the inability to produce urea and remove ammonia from the body effectively.""]","[""Mutations in the CPS1 gene""]","[""Mutations in the CPS1 gene are associated with CPS I deficiency.""]",[true],[true],[true],"[""Mutations in the CPS1 gene""]","[""Mutations in the CPS1 gene are associated with carbamoyl phosphate synthetase I deficiency.""]","[""Mutations in the CPS1 gene""]",[true],[true],[true],"[""Genetic changes related to CPS I deficiency include mutations in the CPS1 gene.""]","[""Mutations in the CPS1 gene""]","[""Mutations in the CPS1 gene""]",[true],[true],[true],"[""Genetic changes related to CPS I deficiency include mutations in the CPS1 gene, which can lead to reduced or absent enzyme activity, resulting in the inability to produce urea and remove ammonia from the body effectively.""]","[""Mutations in the CPS1 gene are associated with carbamoyl phosphate synthetase I deficiency.""]","[""Mutations in the CPS1 gene""]",[true],[false],[true],"[""Genetic changes related to CPS I deficiency include mutations in the CPS1 gene, which encodes the enzyme carbamoyl phosphate synthetase I. These mutations can lead to reduced or absent enzyme activity, resulting in the inability to effectively produce urea and remove ammonia from the body.""]","[""Mutations in the CPS1 gene""]","[""Mutations in the CPS1 gene are associated with CPS I deficiency.""]",[true],[true],[true],"[""Genetic changes related to CPS I deficiency include mutations in the CPS1 gene, which can lead to reduced or absent enzyme activity, resulting in the accumulation of toxic levels of ammonia in the body.""]","[""Mutations in the CPS1 gene are associated with carbamoyl phosphate synthetase I deficiency.""]","[""Mutations in the CPS1 gene""]",[true],[true],[true],"[""Genetic changes related to CPS I deficiency include mutations in the CPS1 gene, which encodes the enzyme carbamoyl phosphate synthetase I. These mutations can lead to a deficiency in the enzyme's activity, resulting in the accumulation of toxic levels of ammonia in the body.""]","[""Mutations in the CPS1 gene""]","[""Mutations in the CPS1 gene""]",[true],[true],[true],"[""Genetic changes related to CPS I deficiency include mutations in the CPS1 gene.""]","[""Mutations in the CPS1 gene are associated with carbamoyl phosphate synthetase I deficiency.""]","[""Mutations in the CPS1 gene""]",[true],[true],[true],"[""Genetic changes related to CPS I deficiency include mutations in the CPS1 gene.""]","[""Mutations in the CPS1 gene are associated with carbamoyl phosphate synthetase I deficiency.""]","[""Mutations in the CPS1 gene""]",[true],[true],[true],"[""Genetic changes related to CPS I deficiency include mutations in the CPS1 gene.""]","[""Mutations in the CPS1 gene are associated with carbamoyl phosphate synthetase I deficiency.""]","[""Mutations in the CPS1 gene""]",[true],[true],[true],"[""Genetic changes related to CPS I deficiency include mutations in the CPS1 gene.""]","[""Mutations in the CPS1 gene are associated with carbamoyl phosphate synthetase I deficiency.""]","[""Mutations in the CPS1 gene""]"
frequency,How many people are affected by Lujan syndrome ?,"Lujan syndrome appears to be an uncommon condition, but its prevalence is unknown.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""LS"", ""full_form"": ""Lujan syndrome""}]}",How many people are affected by LS ?,How many people are affected by Lujan syndrome ?,8,MEDICAL,Simple Datatype-Integer,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Long Sleeve"", ""Large Scale"", ""Least Squares"", ""Left Side"", ""Lesotho"", ""Low Speed"", ""La Salle"", ""Least Significant"", ""Lone Star"", ""Local System""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Lynch Syndrome""]",[2.0589794932196432e-13],[5.806616494533385e-11],"[""Left Side""]",[0.0006673554992420772],"[""ABBREVIATIONS""]","[[4.696346023138284e-11, 2.5572663060624856e-08, 1.539537371741053e-11, 0.0006673554992420772, 2.4508289786870995e-11, 1.35811899907783e-06, 2.045767986883376e-10, 1.9309177597099323e-09, 2.713265410252345e-11, 9.92942842192522e-07]]",[0.8121554691503551],[0.7973156326592841],"[""Lujan syndrome""]",[0.8814614540850215],"[""ABBREVIATIONS""]","[[0.8814614540850215, 0.8406156124787078, 0.7445338115611676, 0.8191683539889634, 0.7862303893998708, 0.8302785874061794, 0.7948835721298562, 0.8133458773394134, 0.7532775254786659, 0.8328535255893956]]","[""Lynch Syndrome""]","[""LLM""]",How many people are affected by LS (Lynch Syndrome) ?,[false],[true],[false],"[""The number of people affected by LS (Left Side) varies depending on the specific condition being referred to.""]","[""Lujan syndrome affects a very small number of individuals worldwide.""]","[""Approximately 1 in 50,000 people are affected by Lichen Sclerosus (LS).""]",[false],[true],[false],"[""The number of people affected by LS (Left Side) varies depending on the specific condition being referred to.""]","[""Lujan syndrome affects an estimated 1 in 1,000,000 individuals.""]","[""Approximately 1 in 50,000 people are affected by Lichen Sclerosus (LS).""]",[false],[true],[false],"[""LS affects approximately 10-15% of the population.""]","[""Lujan syndrome affects a very small number of individuals worldwide, with less than 100 cases reported in medical literature.""]","[""Approximately 1 in 50,000 people are affected by Loeys-Dietz syndrome (LS).""]",[false],[true],[false],"[""It is estimated that around 10-15% of strokes are caused by LS (Left Side) affecting millions of people worldwide.""]","[""Lujan syndrome is an extremely rare condition, with only a few dozen cases reported worldwide.""]","[""Approximately 1 in 10,000 people are affected by Lichen Sclerosus (LS).""]",[true],[true],[false],"[""Lujan syndrome affects a very small number of individuals worldwide, with less than 100 cases reported in medical literature.""]","[""Lujan syndrome affects a very small number of individuals worldwide.""]","[""Approximately 1 in 50,000 people are affected by Lichen Sclerosus (LS).""]",[true],[false],[false],"[""Lujan syndrome affects a very small number of individuals worldwide.""]","[""Lujan syndrome affects an estimated 1 in 1,000,000 individuals.""]","[""Approximately 1 in 50,000 people are affected by Lichen Sclerosus (LS).""]",[false],[true],[false],"[""Lujan syndrome affects an estimated 1 in 1,000,000 individuals.""]","[""Lujan syndrome affects a very small number of individuals worldwide, with less than 100 cases reported in medical literature.""]","[""Approximately 1 in 50,000 people are affected by Loeys-Dietz syndrome (LS).""]",[true],[true],[false],"[""Lujan syndrome affects a very small number of individuals worldwide, with less than 100 cases reported in medical literature.""]","[""Lujan syndrome is an extremely rare condition, with only a few dozen cases reported worldwide.""]","[""Approximately 1 in 10,000 people are affected by Lichen Sclerosus (LS).""]",[false],[true],[false],"[""Approximately 1 in 279 people are affected by Lynch Syndrome.""]","[""Lujan syndrome affects an estimated 1 in 1,000,000 individuals.""]","[""Approximately 1 in 50,000 people are affected by Lichen Sclerosus (LS).""]",[false],[true],[false],"[""Approximately 1 in 300 to 1 in 440 people are affected by Lynch Syndrome.""]","[""Lujan syndrome affects a very small number of individuals worldwide.""]","[""Approximately 1 in 50,000 people are affected by Lichen Sclerosus (LS).""]",[false],[true],[false],"[""1 in 279 people are affected by Lynch Syndrome""]","[""Lujan syndrome affects a very small number of individuals worldwide, with less than 100 cases reported in medical literature.""]","[""Approximately 1 in 50,000 people are affected by Loeys-Dietz syndrome (LS).""]",[false],[true],[false],"[""1 in 279 people are affected by Lynch Syndrome""]","[""Lujan syndrome is an extremely rare condition, with only a few dozen cases reported worldwide.""]","[""Approximately 1 in 10,000 people are affected by Lichen Sclerosus (LS).""]",[false],[true],[false],"[""1 in 279 people are affected by Lynch Syndrome""]","[""Lujan syndrome affects a very small number of individuals worldwide.""]","[""Approximately 1 in 50,000 people are affected by Lichen Sclerosus (LS).""]",[false],[false],[false],"[""1 in 279 people are affected by Lynch Syndrome""]","[""Lujan syndrome affects an estimated 1 in 1,000,000 individuals.""]","[""Approximately 1 in 50,000 people are affected by Lichen Sclerosus (LS).""]",[false],[true],[false],"[""1 in 279 people are affected by Lynch Syndrome""]","[""Lujan syndrome affects a very small number of individuals worldwide, with less than 100 cases reported in medical literature.""]","[""Approximately 1 in 50,000 people are affected by Loeys-Dietz syndrome (LS).""]",[false],[true],[false],"[""1 in 279 people are affected by Lynch Syndrome""]","[""Lujan syndrome is an extremely rare condition, with only a few dozen cases reported worldwide.""]","[""Approximately 1 in 10,000 people are affected by Lichen Sclerosus (LS).""]",[false],[true],[false],"[""Not specified""]","[""Lujan syndrome affects a very small number of individuals worldwide.""]","[""Approximately 1 in 50,000 people are affected by Lichen Sclerosus (LS).""]",[false],[false],[false],"[""1 in 279 people are affected by Lynch Syndrome""]","[""Lujan syndrome affects an estimated 1 in 1,000,000 individuals.""]","[""Approximately 1 in 50,000 people are affected by Lichen Sclerosus (LS).""]",[false],[true],[false],"[""1 in 279 people are affected by Lynch Syndrome""]","[""Lujan syndrome affects a very small number of individuals worldwide, with less than 100 cases reported in medical literature.""]","[""Approximately 1 in 50,000 people are affected by Loeys-Dietz syndrome (LS).""]",[false],[true],[false],"[""1 in 279 people are affected by Lynch Syndrome""]","[""Lujan syndrome is an extremely rare condition, with only a few dozen cases reported worldwide.""]","[""Approximately 1 in 10,000 people are affected by Lichen Sclerosus (LS).""]",[false],[true],[false],"[""Approximately 1 in 279 people are affected by Lynch Syndrome.""]","[""Lujan syndrome affects a very small number of individuals worldwide.""]","[""Approximately 1 in 50,000 people are affected by Lichen Sclerosus (LS).""]",[false],[true],[false],"[""Approximately 1 in 300 to 1 in 440 individuals are affected by Lynch Syndrome.""]","[""Lujan syndrome affects an estimated 1 in 1,000,000 individuals.""]","[""Approximately 1 in 50,000 people are affected by Lichen Sclerosus (LS).""]",[false],[true],[false],"[""Approximately 1 in 279 people are affected by Lynch Syndrome.""]","[""Lujan syndrome affects a very small number of individuals worldwide, with less than 100 cases reported in medical literature.""]","[""Approximately 1 in 50,000 people are affected by Loeys-Dietz syndrome (LS).""]",[false],[true],[false],"[""1 in 279 people are affected by Lynch Syndrome""]","[""Lujan syndrome is an extremely rare condition, with only a few dozen cases reported worldwide.""]","[""Approximately 1 in 10,000 people are affected by Lichen Sclerosus (LS).""]",[false],[true],[false],"[""Approximately 1 in 279 people are affected by Lynch Syndrome.""]","[""Lujan syndrome affects a very small number of individuals worldwide.""]","[""Approximately 1 in 50,000 people are affected by Lichen Sclerosus (LS).""]",[false],[false],[false],"[""Approximately 1 in 279 people are affected by Lynch Syndrome.""]","[""Lujan syndrome affects an estimated 1 in 1,000,000 individuals.""]","[""Approximately 1 in 50,000 people are affected by Lichen Sclerosus (LS).""]",[false],[true],[false],"[""Approximately 1 in 300 to 1 in 440 people are affected by Lynch Syndrome.""]","[""Lujan syndrome affects a very small number of individuals worldwide, with less than 100 cases reported in medical literature.""]","[""Approximately 1 in 50,000 people are affected by Loeys-Dietz syndrome (LS).""]",[false],[true],[false],"[""Approximately 1 in 279 people are affected by Lynch Syndrome.""]","[""Lujan syndrome is an extremely rare condition, with only a few dozen cases reported worldwide.""]","[""Approximately 1 in 10,000 people are affected by Lichen Sclerosus (LS).""]",[false],[true],[false],"[""Approximately 1 in 300 to 1 in 1,000 people are affected by Lynch Syndrome.""]","[""Lujan syndrome affects a very small number of individuals worldwide.""]","[""Approximately 1 in 50,000 people are affected by Lichen Sclerosus (LS).""]",[false],[true],[false],"[""The number of people affected by LS (Left Side) is not specified.""]","[""Lujan syndrome affects a very small number of individuals worldwide.""]","[""Approximately 1 in 50,000 people are affected by Lichen Sclerosus (LS).""]",[false],[true],[false],"[""LS affects approximately 1 in 1 million people worldwide.""]","[""Lujan syndrome affects a very small number of individuals worldwide.""]","[""Approximately 1 in 50,000 people are affected by Lichen Sclerosus (LS).""]",[false],[true],[false],"[""Approximately 1 in 279 people are affected by Lynch Syndrome.""]","[""Lujan syndrome affects a very small number of individuals worldwide.""]","[""Approximately 1 in 50,000 people are affected by Lichen Sclerosus (LS).""]"
frequency,How many people are affected by X-linked agammaglobulinemia ?,"XLA occurs in approximately 1 in 200,000 newborns.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""XLA"", ""full_form"": ""X-linked agammaglobulinemia""}]}",How many people are affected by XLA ?,How many people are affected by X-linked agammaglobulinemia ?,8,MEDICAL,Simple Datatype-Integer,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""X- Linked Agammaglobulinaemia"", ""Xcelera.Com, Inc."", ""Excel Add-in macro sheet"", ""Xlib graphics library Archive"", ""X Linked Agammaglobulinemia"", ""Xbox Live Arcade"", ""X Linked Agammaglobulinaemia"", ""Xenopus Laevis African"", ""Excel Add-in"", ""X-Box Live Arcade""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""X-linked agammaglobulinemia""]",[1.485038975047722e-31],[1.485038975047722e-31],"[""Excel Add-in""]",[2.096126926283185e-15],"[""ABBREVIATIONS""]","[[2.5766230954510666e-34, 5.381991859249683e-23, 1.2060613457860143e-25, 1.30870113415807e-21, 1.0212380221278359e-30, 8.818776326943962e-18, 9.489956165148846e-34, 2.3807334306764936e-27, 2.096126926283185e-15, 1.0400788507665255e-18]]",[0.9254354482457894],[0.9254354482457894],"[""X-linked agammaglobulinemia""]",[0.9261878558507096],"[""ABBREVIATIONS""]","[[0.9261878558507096, 0.8448137927535632, 0.6819494167375274, 0.7270206822667181, 0.9259575893782142, 0.6552734481146749, 0.9259587302566575, 0.7580391108071899, 0.7000404364891186, 0.6717357304150031]]","[""X- Linked Agammaglobulinaemia""]","[""ABBREVIATIONS""]",How many people are affected by XLA (X-linked agammaglobulinemia) ?,[false],[true],[false],"[""XLA (Excel Add-in) does not affect people as it is a file format used by Microsoft Excel for add-ins.""]","[""1 in 200,000 to 1 in 1,000,000 males are affected by X-linked agammaglobulinemia.""]","[""XLA affects approximately 1 in 1 million individuals.""]",[false],[true],[false],"[""XLA (Excel Add-in) does not affect people as it is a file format used by Microsoft Excel for add-ins.""]","[""X-linked agammaglobulinemia affects approximately 1 in 200,000 people.""]","[""XLA affects approximately 1 in 1 million individuals.""]",[false],[true],[false],"[""XLA (Excel Add-in) does not affect people as it is a file format used by Microsoft Excel for add-ins.""]","[""X-linked agammaglobulinemia affects approximately 1 in 190,000 people.""]","[""XLA affects approximately 1 in 1 million individuals.""]",[false],[true],[false],"[""XLA (Excel Add-in) does not affect people as it is a file format used by Microsoft Excel for add-ins.""]","[""X-linked agammaglobulinemia affects approximately 1 in 200,000 people.""]","[""XLA affects approximately 1 in 1 million individuals.""]",[true],[true],[false],"[""XLA affects approximately 1 in 200,000 people.""]","[""1 in 200,000 to 1 in 1,000,000 males are affected by X-linked agammaglobulinemia.""]","[""XLA affects approximately 1 in 1 million individuals.""]",[true],[true],[false],"[""X-linked agammaglobulinemia affects approximately 1 in 200,000 people.""]","[""X-linked agammaglobulinemia affects approximately 1 in 200,000 people.""]","[""XLA affects approximately 1 in 1 million individuals.""]",[true],[false],[false],"[""X-linked agammaglobulinemia affects approximately 1 in 200,000 people.""]","[""X-linked agammaglobulinemia affects approximately 1 in 190,000 people.""]","[""XLA affects approximately 1 in 1 million individuals.""]",[true],[true],[false],"[""XLA affects approximately 1 in 200,000 people.""]","[""X-linked agammaglobulinemia affects approximately 1 in 200,000 people.""]","[""XLA affects approximately 1 in 1 million individuals.""]",[true],[true],[false],"[""XLA affects approximately 1 in 200,000 individuals.""]","[""X-linked agammaglobulinemia affects approximately 1 in 200,000 people.""]","[""XLA affects approximately 1 in 1 million individuals.""]",[true],[true],[false],"[""XLA affects approximately 1 in 200,000 people.""]","[""1 in 200,000 to 1 in 1,000,000 males are affected by X-linked agammaglobulinemia.""]","[""XLA affects approximately 1 in 1 million individuals.""]",[true],[false],[false],"[""XLA affects approximately 1 in 200,000 people.""]","[""X-linked agammaglobulinemia affects approximately 1 in 190,000 people.""]","[""XLA affects approximately 1 in 1 million individuals.""]",[true],[true],[false],"[""XLA affects approximately 1 in 200,000 people.""]","[""X-linked agammaglobulinemia affects approximately 1 in 200,000 people.""]","[""XLA affects approximately 1 in 1 million individuals.""]",[true],[true],[false],"[""XLA affects approximately 1 in 200,000 individuals.""]","[""1 in 200,000 to 1 in 1,000,000 males are affected by X-linked agammaglobulinemia.""]","[""XLA affects approximately 1 in 1 million individuals.""]",[true],[true],[false],"[""XLA affects approximately 1 in 200,000 individuals.""]","[""X-linked agammaglobulinemia affects approximately 1 in 200,000 people.""]","[""XLA affects approximately 1 in 1 million individuals.""]",[true],[false],[false],"[""XLA affects approximately 1 in 200,000 people.""]","[""X-linked agammaglobulinemia affects approximately 1 in 190,000 people.""]","[""XLA affects approximately 1 in 1 million individuals.""]",[true],[true],[false],"[""XLA affects approximately 1 in 200,000 individuals.""]","[""X-linked agammaglobulinemia affects approximately 1 in 200,000 people.""]","[""XLA affects approximately 1 in 1 million individuals.""]",[true],[true],[false],"[""XLA affects approximately 1 in 200,000 people.""]","[""1 in 200,000 to 1 in 1,000,000 males are affected by X-linked agammaglobulinemia.""]","[""XLA affects approximately 1 in 1 million individuals.""]",[true],[true],[false],"[""XLA affects approximately 1 in 200,000 people.""]","[""X-linked agammaglobulinemia affects approximately 1 in 200,000 people.""]","[""XLA affects approximately 1 in 1 million individuals.""]",[true],[false],[false],"[""XLA affects approximately 1 in 200,000 people.""]","[""X-linked agammaglobulinemia affects approximately 1 in 190,000 people.""]","[""XLA affects approximately 1 in 1 million individuals.""]",[true],[true],[false],"[""XLA affects approximately 1 in 200,000 individuals.""]","[""X-linked agammaglobulinemia affects approximately 1 in 200,000 people.""]","[""XLA affects approximately 1 in 1 million individuals.""]",[true],[true],[false],"[""X-linked agammaglobulinemia affects approximately 1 in 200,000 people.""]","[""1 in 200,000 to 1 in 1,000,000 males are affected by X-linked agammaglobulinemia.""]","[""XLA affects approximately 1 in 1 million individuals.""]",[true],[true],[false],"[""XLA affects approximately 1 in 200,000 people.""]","[""X-linked agammaglobulinemia affects approximately 1 in 200,000 people.""]","[""XLA affects approximately 1 in 1 million individuals.""]",[true],[false],[false],"[""XLA affects approximately 1 in 200,000 people.""]","[""X-linked agammaglobulinemia affects approximately 1 in 190,000 people.""]","[""XLA affects approximately 1 in 1 million individuals.""]",[true],[true],[false],"[""X-linked agammaglobulinemia affects approximately 1 in 200,000 people.""]","[""X-linked agammaglobulinemia affects approximately 1 in 200,000 people.""]","[""XLA affects approximately 1 in 1 million individuals.""]",[true],[true],[false],"[""XLA (X-Linked Agammaglobulinemia) is a rare genetic disorder that primarily affects males. It is estimated to occur in about 1 in 200,000 to 1 in 1,000,000 male births worldwide.""]","[""1 in 200,000 to 1 in 1,000,000 males are affected by X-linked agammaglobulinemia.""]","[""XLA affects approximately 1 in 1 million individuals.""]",[true],[true],[false],"[""XLA (X-Linked Agammaglobulinemia) affects approximately 1 in 200,000 people.""]","[""X-linked agammaglobulinemia affects approximately 1 in 200,000 people.""]","[""XLA affects approximately 1 in 1 million individuals.""]",[true],[true],[false],"[""X-Linked Agammaglobulinemia affects approximately 1 in 200,000 people.""]","[""X-linked agammaglobulinemia affects approximately 1 in 190,000 people.""]","[""XLA affects approximately 1 in 1 million individuals.""]",[true],[true],[false],"[""XLA (X-Linked Agammaglobulinemia) is a rare genetic disorder that primarily affects males. The exact number of people affected by XLA is not well documented, but it is estimated to occur in about 1 in 200,000 to 1 in 1,000,000 male births.""]","[""X-linked agammaglobulinemia affects approximately 1 in 200,000 people.""]","[""XLA affects approximately 1 in 1 million individuals.""]",[true],[true],[false],"[""X-Linked Agammaglobulinemia affects approximately 1 in 200,000 individuals.""]","[""1 in 200,000 to 1 in 1,000,000 males are affected by X-linked agammaglobulinemia.""]","[""XLA affects approximately 1 in 1 million individuals.""]",[false],[true],[false],"[""The number of people affected by XLA (Excel Add-in) is not publicly available.""]","[""1 in 200,000 to 1 in 1,000,000 males are affected by X-linked agammaglobulinemia.""]","[""XLA affects approximately 1 in 1 million individuals.""]",[true],[true],[false],"[""XLA affects approximately 1 in 200,000 individuals.""]","[""1 in 200,000 to 1 in 1,000,000 males are affected by X-linked agammaglobulinemia.""]","[""XLA affects approximately 1 in 1 million individuals.""]",[true],[true],[false],"[""XLA affects approximately 1 in 200,000 people.""]","[""1 in 200,000 to 1 in 1,000,000 males are affected by X-linked agammaglobulinemia.""]","[""XLA affects approximately 1 in 1 million individuals.""]"
inheritance,Is MECP2 duplication syndrome inherited ?,"Is MECP2 duplication syndrome inherited? MECP2 duplication syndrome is inherited in an X-linked manner. A condition is considered X-linked if the genetic change that causes the condition is located on the X chromosome, one of the two sex chromosomes (the Y chromosome is the other sex chromosome). In males (who have only one X chromosome), a duplication of the MECP2 gene in each cell is sufficient to cause the condition. In females (who have two X chromosomes), a duplication of one of the two copies of the gene typically does not cause the disorder. Early in the development of females, one of the two X chromosomes is randomly and permanently inactivated in each cell (called X-inactivation). X-inactivation prevents female cells from having twice as many functional X chromosomes as males. Because X-inactivation is usually random, the X chromosome inherited from the mother is active in some cells, and the X chromosome inherited from the father is active in other cells. However, when a female has an X chromosome with a duplicated copy of the MECP2 gene, the abnormal chromosome is often preferentially inactivated in many or all cells. This is called ""skewed X-inactivation."" It prevents some women with an MECP2 duplication from developing features of the duplication since the extra genetic material is not active. In most cases, MECP2 duplication syndrome is inherited from a mother who has no signs or symptoms of the duplication. Rarely, the condition is not inherited and occurs due to a random event during the formation of the egg or sperm, or in early fetal development. When this happens, it is called a de novo duplication (occurring as a new genetic change for the first time in the affected person).","{""full_form_abbrv_map"": [{""ambiguity_type"": ""abbreviation"", ""abbreviation"": ""MECP2"", ""full_form"": ""Methyl CpG binding protein 2""}]}",Is MECP2 duplication syndrome inherited ?,Is Methyl CpG binding protein 2 duplication syndrome inherited ?,8,MEDICAL,Simple Datatype-Boolean,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""MeCP2"", ""Methyl CpG (Cytosine Phosphate Guanine) Binding Protein 2""]]","[[""THEFREEDICTIONARY"", ""THEFREEDICTIONARY""]]","[""Methyl-CpG Binding Protein 2""]",[1.8226085965289881e-19],[3.5014087251183854e-20],"[""MeCP2""]",[0.00012309046879387553],"[""THEFREEDICTIONARY""]","[[0.00012309046879387553, 1.7648296224109667e-48]]",[0.9658249978789026],[0.9643624582857331],"[""Methyl CpG binding protein 2""]",[0.9737115673671086],"[""THEFREEDICTIONARY""]","[[0.9737115673671086, 0.9462909340074235]]","[""Methyl CpG (Cytosine Phosphate Guanine) Binding Protein 2""]","[""THEFREEDICTIONARY""]",Is MECP2 (Methyl-CpG Binding Protein 2) duplication syndrome inherited ?,[true],[true],[true],"[""Yes, MECP2 duplication syndrome is inherited.""]","[""Yes, Methyl CpG binding protein 2 duplication syndrome is inherited.""]","[""Yes, MECP2 duplication syndrome is inherited.""]",[true],[true],[true],"[""Yes, MECP2 duplication syndrome is inherited.""]","[""Yes, Methyl CpG binding protein 2 duplication syndrome is inherited.""]","[""Yes, MECP2 duplication syndrome is inherited.""]",[true],[true],[true],"[""Yes, MECP2 duplication syndrome is inherited.""]","[""Yes, Methyl CpG binding protein 2 duplication syndrome is inherited.""]","[""Yes, MECP2 duplication syndrome is inherited.""]",[true],[true],[true],"[""Yes, MECP2 duplication syndrome is inherited.""]","[""Yes, Methyl CpG binding protein 2 duplication syndrome is inherited.""]","[""Yes, MECP2 duplication syndrome is inherited.""]",[true],[true],[true],"[""Yes, MECP2 duplication syndrome is inherited.""]","[""Yes, Methyl CpG binding protein 2 duplication syndrome is inherited.""]","[""Yes, MECP2 duplication syndrome is inherited.""]",[true],[true],[true],"[""Yes, MECP2 duplication syndrome is inherited.""]","[""Yes, Methyl CpG binding protein 2 duplication syndrome is inherited.""]","[""Yes, MECP2 duplication syndrome is inherited.""]",[true],[true],[true],"[""Yes, MECP2 duplication syndrome is inherited.""]","[""Yes, Methyl CpG binding protein 2 duplication syndrome is inherited.""]","[""Yes, MECP2 duplication syndrome is inherited.""]",[true],[true],[true],"[""Yes, MECP2 duplication syndrome is inherited.""]","[""Yes, Methyl CpG binding protein 2 duplication syndrome is inherited.""]","[""Yes, MECP2 duplication syndrome is inherited.""]",[true],[true],[true],"[""Yes, MECP2 duplication syndrome is inherited.""]","[""Yes, Methyl CpG binding protein 2 duplication syndrome is inherited.""]","[""Yes, MECP2 duplication syndrome is inherited.""]",[true],[true],[true],"[""Yes, MECP2 duplication syndrome is inherited.""]","[""Yes, Methyl CpG binding protein 2 duplication syndrome is inherited.""]","[""Yes, MECP2 duplication syndrome is inherited.""]",[true],[true],[true],"[""Yes, MECP2 duplication syndrome is inherited.""]","[""Yes, Methyl CpG binding protein 2 duplication syndrome is inherited.""]","[""Yes, MECP2 duplication syndrome is inherited.""]",[true],[true],[true],"[""Yes, MECP2 duplication syndrome is inherited.""]","[""Yes, Methyl CpG binding protein 2 duplication syndrome is inherited.""]","[""Yes, MECP2 duplication syndrome is inherited.""]",[true],[true],[true],"[""Yes, MECP2 duplication syndrome is inherited.""]","[""Yes, Methyl CpG binding protein 2 duplication syndrome is inherited.""]","[""Yes, MECP2 duplication syndrome is inherited.""]",[true],[true],[true],"[""Yes, MECP2 duplication syndrome is inherited.""]","[""Yes, Methyl CpG binding protein 2 duplication syndrome is inherited.""]","[""Yes, MECP2 duplication syndrome is inherited.""]",[true],[true],[true],"[""Yes, MECP2 duplication syndrome is inherited.""]","[""Yes, Methyl CpG binding protein 2 duplication syndrome is inherited.""]","[""Yes, MECP2 duplication syndrome is inherited.""]",[true],[true],[true],"[""Yes, MECP2 duplication syndrome is inherited.""]","[""Yes, Methyl CpG binding protein 2 duplication syndrome is inherited.""]","[""Yes, MECP2 duplication syndrome is inherited.""]",[false],[true],[true],"[""Yes""]","[""Yes, Methyl CpG binding protein 2 duplication syndrome is inherited.""]","[""Yes, MECP2 duplication syndrome is inherited.""]",[true],[true],[true],"[""Yes, MECP2 duplication syndrome is inherited.""]","[""Yes, Methyl CpG binding protein 2 duplication syndrome is inherited.""]","[""Yes, MECP2 duplication syndrome is inherited.""]",[true],[true],[true],"[""Yes, MECP2 duplication syndrome is inherited.""]","[""Yes, Methyl CpG binding protein 2 duplication syndrome is inherited.""]","[""Yes, MECP2 duplication syndrome is inherited.""]",[true],[true],[true],"[""Yes, MECP2 duplication syndrome is inherited.""]","[""Yes, Methyl CpG binding protein 2 duplication syndrome is inherited.""]","[""Yes, MECP2 duplication syndrome is inherited.""]",[true],[true],[true],"[""Yes, MECP2 duplication syndrome is inherited.""]","[""Yes, Methyl CpG binding protein 2 duplication syndrome is inherited.""]","[""Yes, MECP2 duplication syndrome is inherited.""]",[true],[true],[true],"[""Yes, MECP2 duplication syndrome is inherited.""]","[""Yes, Methyl CpG binding protein 2 duplication syndrome is inherited.""]","[""Yes, MECP2 duplication syndrome is inherited.""]",[true],[true],[true],"[""Yes, MECP2 duplication syndrome is inherited.""]","[""Yes, Methyl CpG binding protein 2 duplication syndrome is inherited.""]","[""Yes, MECP2 duplication syndrome is inherited.""]",[true],[true],[true],"[""Yes, MECP2 duplication syndrome is inherited.""]","[""Yes, Methyl CpG binding protein 2 duplication syndrome is inherited.""]","[""Yes, MECP2 duplication syndrome is inherited.""]",[false],[true],[true],"[""MECP2 duplication syndrome is usually not inherited, but rather occurs as a random genetic mutation.""]","[""Yes, Methyl CpG binding protein 2 duplication syndrome is inherited.""]","[""Yes, MECP2 duplication syndrome is inherited.""]",[false],[true],[true],"[""MECP2 duplication syndrome is usually not inherited, but rather occurs as a random event during the formation of reproductive cells or early development.""]","[""Yes, Methyl CpG binding protein 2 duplication syndrome is inherited.""]","[""Yes, MECP2 duplication syndrome is inherited.""]",[false],[true],[true],"[""MECP2 duplication syndrome is usually not inherited, but rather occurs as a random genetic mutation.""]","[""Yes, Methyl CpG binding protein 2 duplication syndrome is inherited.""]","[""Yes, MECP2 duplication syndrome is inherited.""]",[false],[true],[true],"[""MECP2 duplication syndrome is usually not inherited, but occurs as a random event during the formation of reproductive cells or early development.""]","[""Yes, Methyl CpG binding protein 2 duplication syndrome is inherited.""]","[""Yes, MECP2 duplication syndrome is inherited.""]",[true],[true],[true],"[""Yes, MECP2 duplication syndrome is inherited.""]","[""Yes, Methyl CpG binding protein 2 duplication syndrome is inherited.""]","[""Yes, MECP2 duplication syndrome is inherited.""]",[false],[true],[true],"[""MECP2 duplication syndrome is usually not inherited, but occurs as a random genetic mutation.""]","[""Yes, Methyl CpG binding protein 2 duplication syndrome is inherited.""]","[""Yes, MECP2 duplication syndrome is inherited.""]",[true],[true],[true],"[""Yes, MECP2 duplication syndrome is inherited.""]","[""Yes, Methyl CpG binding protein 2 duplication syndrome is inherited.""]","[""Yes, MECP2 duplication syndrome is inherited.""]",[false],[true],[true],"[""MECP2 duplication syndrome is usually not inherited, but occurs as a random event during the formation of reproductive cells or early development.""]","[""Yes, Methyl CpG binding protein 2 duplication syndrome is inherited.""]","[""Yes, MECP2 duplication syndrome is inherited.""]"
frequency,How many people are affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis ?,"RAMSVPS is a rare disorder. Only a small number of affected individuals and families, all from Saudi Arabia, have been described in the medical literature.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""RAM"", ""full_form"": ""retinal arterial macroaneurysm""}, {""ambiguity_type"": ""full_form"", ""abbreviation"": ""SVPS"", ""full_form"": ""supravalvular pulmonic stenosis""}]}",How many people are affected by RAM with SVPS ?,How many people are affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis ?,1,COMPUTING,Simple Datatype-Integer,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Random Access Memory"", ""Royal Air Maroc"", ""Reliability, Availability, and Maintainability"", ""Reverse Annuity Mortgage"", ""Los Angeles Rams"", ""Random Access Machine"", ""Real Audio Media"", ""RealAudio Metafile"", ""Real Audio Movie"", ""Republican Attack Machine""], [""Susquehanna Valley Pregnancy Services"", ""St Vrain Photographic Society"", ""Sierra Vista Public Schools"", ""Sammamish Valley Psychological Services"", ""South View Primary School"", ""Silicon Valley Professional Staffing"", ""Statewide Vendor Payee Services"", ""Smart Vehicle Parking System"", ""Smart Vehicle Presence Sensor"", ""Swindon Village Primary School (UK)"", ""St. Vrain Photographic Society (Longmont, CO)"", ""St Vincent&#39;s Primary School (Gold Coast, Australia)"", ""Sierra Vista Public Schools (Sierra Vista, AZ)"", ""Solaris Virtual Private Server (telecommunications)"", ""South View Primary School (Singapore)"", ""Soan Valley Public School (Pakistan)"", ""Sutton Valence Preparatory School (UK)""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""], [""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER""]]","[""Random Access Memory"", ""Shared Virtual Private Server""]","[1.850474258429645e-24, 3.3935814243890785e-15]","[1.8595414369015138e-13, 4.613196333790447e-20]","[""Random Access Machine"", ""Smart Vehicle Parking System""]","[2.377173283271901e-11, 9.312613420289614e-14]","[""ABBREVIATIONS"", ""ABBREVIATIONS""]","[[1.8595414369015138e-13, 4.16812300994918e-18, 1.4195707881620151e-22, 6.027471500030112e-22, 5.351932158214335e-20, 2.377173283271901e-11, 5.379891669858706e-14, 2.6390931668821613e-23, 1.6702795584605283e-13, 1.682130332654616e-14], [1.9713519549686328e-28, 8.202456043034674e-27, 5.267287468009911e-21, 1.7745231128145244e-27, 5.193864229061542e-19, 3.729649922587259e-25, 1.0036656278439043e-25, 9.312613420289614e-14, 9.18482405849074e-18, 8.633693391401292e-35, 7.987747654705729e-50, 2.077020549338448e-56, 5.812523311097889e-37, 1.419261452017313e-30, 8.191147555534294e-33, 7.529648416228244e-32, 2.5777395472837642e-34]]","[0.8239798456298294, 0.8334175631629108]","[0.9340074966644577, 0.8244093210440024]","[""retinal arterial macroaneurysm"", ""Sammamish Valley Psychological Services""]","[0.9340074966644577, 0.8306702684952851]","[""ABBREVIATIONS"", ""ABBREVIATIONS""]","[[0.9340074966644577, 0.7283957264134996, 0.7683020442768702, 0.734052303618327, 0.8141110859824943, 0.8635839259843949, 0.8400361086741772, 0.7956576147115193, 0.8213016417005954, 0.7518252941951755], [0.7412074837118618, 0.7330370290501546, 0.7897071596984062, 0.7803126272257116, 0.8306702684952851, 0.7908208420908233, 0.7477700349134924, 0.7487872261759165, 0.7411688574219211, 0.797503024936312, 0.6990538418319855, 0.7800144297616524, 0.7826010903419911, 0.7932290046370222, 0.7922662867687864, 0.7783427175236456, 0.8032014074142579]]","[""Random Access Memory"", ""Shared Virtual Private Server""]","[""LLM"", ""LLM""]",How many people are affected by RAM with SVPS (Shared Virtual Private Server) ?,"[false, false]","[true, true]","[false, false]","[""Unknown"", ""It depends on the specific implementation and usage of the Smart Vehicle Parking System. There is no fixed number applicable to all cases.""]","[""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis."", ""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis.""]","[""Unknown"", ""Unknown""]","[false, false]","[true, true]","[false, false]","[""Unknown"", ""It depends on the specific implementation and scale of the Smart Vehicle Parking System. There is no fixed number applicable to all cases.""]","[""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis."", ""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis.""]","[""Unknown"", ""Unknown""]","[false, false]","[true, true]","[false, false]","[""Unknown"", ""It depends on the specific implementation and scale of the Smart Vehicle Parking System (SVPS).""]","[""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis."", ""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis.""]","[""Unknown"", ""Unknown""]","[false, false]","[true, true]","[false, false]","[""0"", ""It depends on the specific implementation and scale of the Smart Vehicle Parking System. The number of people affected can vary.""]","[""There is no specific data available on the exact number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis."", ""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis.""]","[""Unknown"", ""Unknown""]","[true, true]","[true, true]","[false, false]","[""RAM with SVPS is a rare condition, affecting a very small percentage of the population. Exact numbers may vary and are not readily available."", ""There is no specific data available on the number of people affected by RAM with SVPS.""]","[""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis."", ""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis.""]","[""Unknown"", ""Unknown""]","[true, true]","[true, true]","[false, false]","[""There is no specific data available on the exact number of people affected by RAM with SVPS."", ""There is no specific data available on the number of people affected by RAM with SVPS.""]","[""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis."", ""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis.""]","[""Unknown"", ""Unknown""]","[true, true]","[true, true]","[false, false]","[""RAM with SVPS is a rare condition, affecting a very small percentage of the population. Exact numbers may vary and are not readily available."", ""There is no specific data available on the number of people affected by RAM with SVPS.""]","[""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis."", ""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis.""]","[""Unknown"", ""Unknown""]","[true, false]","[true, true]","[false, false]","[""RAM with SVPS is a rare condition, affecting a very small percentage of the population."", ""It is not possible to determine the exact number of people affected by RAM with SVPS as it would depend on various factors such as the scale of the organization, the number of clients served, and the specific services provided.""]","[""There is no specific data available on the exact number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis."", ""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis.""]","[""Unknown"", ""Unknown""]","[false, false]","[true, true]","[false, false]","[""Unknown"", ""It depends on the specific server configuration and usage, but typically multiple users share resources on a Shared Virtual Private Server (SVPS) which can affect performance for individual users.""]","[""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis."", ""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis.""]","[""Unknown"", ""Unknown""]","[false, false]","[true, true]","[false, false]","[""0"", ""It depends on the specific server configuration and usage, as the number of people affected by RAM with SVPS can vary.""]","[""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis."", ""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis.""]","[""Unknown"", ""Unknown""]","[false, false]","[true, true]","[false, false]","[""SVPS affects the performance of RAM, not the number of people affected."", ""It depends on the specific server configuration and usage, as the number of people affected can vary.""]","[""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis."", ""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis.""]","[""Unknown"", ""Unknown""]","[false, false]","[true, true]","[false, false]","[""SVPS affects the performance of RAM, not the number of people affected."", ""It depends on the specific server configuration and usage, as the number of people affected can vary.""]","[""There is no specific data available on the exact number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis."", ""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis.""]","[""Unknown"", ""Unknown""]","[false, false]","[true, true]","[false, false]","[""Not specified"", ""Not specified""]","[""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis."", ""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis.""]","[""Unknown"", ""Unknown""]","[false, false]","[true, true]","[false, false]","[""Not Specified"", ""Not specified""]","[""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis."", ""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis.""]","[""Unknown"", ""Unknown""]","[false, false]","[true, true]","[false, false]","[""Not Specified"", ""It depends on the specific server configuration and usage, as multiple users share the resources of a single physical server in a Shared Virtual Private Server setup.""]","[""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis."", ""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis.""]","[""Unknown"", ""Unknown""]","[false, false]","[true, true]","[false, false]","[""Not Specified"", ""Not specified""]","[""There is no specific data available on the exact number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis."", ""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis.""]","[""Unknown"", ""Unknown""]","[false, false]","[true, true]","[false, false]","[""Not specified"", ""Not specified""]","[""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis."", ""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis.""]","[""Unknown"", ""Unknown""]","[false, false]","[true, true]","[false, false]","[""Unknown"", ""It depends on the specific server configuration and usage, but typically a Shared Virtual Private Server (SVPS) can host multiple users, ranging from a few to hundreds.""]","[""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis."", ""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis.""]","[""Unknown"", ""Unknown""]","[false, false]","[true, true]","[false, false]","[""SVPS does not affect people directly. RAM (Random Access Memory) issues can affect the performance of electronic devices."", ""It depends on the specific server configuration and usage, as the number of people affected by RAM with SVPS can vary.""]","[""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis."", ""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis.""]","[""Unknown"", ""Unknown""]","[false, false]","[true, true]","[false, false]","[""Unknown"", ""It depends on the specific server configuration and usage, but typically multiple users share resources on a Shared Virtual Private Server (VPS) which can range from a few to hundreds of users.""]","[""There is no specific data available on the exact number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis."", ""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis.""]","[""Unknown"", ""Unknown""]","[false, false]","[true, true]","[false, false]","[""Unknown"", ""It depends on the specific server configuration and usage, as the number of people affected by RAM with SVPS can vary.""]","[""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis."", ""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis.""]","[""Unknown"", ""Unknown""]","[false, false]","[true, true]","[false, false]","[""0"", ""It depends on the specific server configuration and provider, but typically a Shared Virtual Private Server (SVPS) can affect multiple users or websites simultaneously.""]","[""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis."", ""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis.""]","[""Unknown"", ""Unknown""]","[false, false]","[true, true]","[false, false]","[""SVPS does not affect people directly. It is a type of power supply unit for computers."", ""It depends on the specific server configuration and usage, as the number of people affected by RAM with SVPS can vary.""]","[""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis."", ""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis.""]","[""Unknown"", ""Unknown""]","[false, false]","[true, true]","[false, false]","[""Unknown"", ""It depends on the specific server configuration and usage, as the number of people affected by RAM with SVPS can vary.""]","[""There is no specific data available on the exact number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis."", ""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis.""]","[""Unknown"", ""Unknown""]","[false, true]","[true, true]","[false, false]","[""SVPS affects a small percentage of people with RAM (Random Access Memory) issues."", ""The number of people affected by RAM with SVPS is not publicly available.""]","[""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis."", ""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis.""]","[""Unknown"", ""Unknown""]","[false, true]","[true, true]","[false, false]","[""The number of people affected by RAM (Random Access Memory) with SVPS is not available."", ""The number of people affected by RAM with SVPS is not publicly available.""]","[""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis."", ""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis.""]","[""Unknown"", ""Unknown""]","[false, true]","[true, true]","[false, false]","[""SVPS (Single-bit Voltage Pulse Sensitivity) affects a small percentage of RAM modules, typically less than 1%."", ""The number of people affected by RAM with SVPS is not publicly available.""]","[""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis."", ""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis.""]","[""Unknown"", ""Unknown""]","[false, true]","[true, true]","[false, false]","[""The number of people affected by RAM (Random Access Memory) with SVPS is not available."", ""The number of people affected by RAM with SVPS is not publicly available.""]","[""There is no specific data available on the exact number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis."", ""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis.""]","[""Unknown"", ""Unknown""]","[false, true]","[true, true]","[false, false]","[""Not specified"", ""The number of people affected by RAM with SVPS is not publicly available.""]","[""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis."", ""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis.""]","[""Unknown"", ""Unknown""]","[false, true]","[true, true]","[false, false]","[""Not Specified"", ""The number of people affected by RAM with SVPS is not available.""]","[""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis."", ""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis.""]","[""Unknown"", ""Unknown""]","[true, true]","[true, true]","[false, false]","[""The exact number of people affected by RAM with SVPS is not readily available."", ""The number of people affected by RAM with SVPS is not publicly available.""]","[""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis."", ""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis.""]","[""Unknown"", ""Unknown""]","[false, true]","[true, true]","[false, false]","[""The number of people affected by RAM (Random Access Memory) with SVPS is not available."", ""The number of people affected by RAM with SVPS is not publicly available.""]","[""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis."", ""There is no specific data available on the number of people affected by retinal arterial macroaneurysm with supravalvular pulmonic stenosis.""]","[""Unknown"", ""Unknown""]"
research,what research (or clinical trials) is being done for Opsoclonus Myoclonus ?,"The NINDS supports and conducts research on movement disorders such as opsoclonus myoclonus. These studies are aimed at increasing knowledge about these disorders and finding ways to prevent, treat, and cure them.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""OM"", ""full_form"": ""Opsoclonus Myoclonus""}]}",what research (or clinical trials) is being done for OM ?,what research (or clinical trials) is being done for Opsoclonus Myoclonus ?,8,MEDICAL,Compound Datatype-List/Array,"Exploratory(Divergent Thinking): Queries that are inherently about seeking new areas of knowledge, understanding emerging trends, or identifying unknown opportunities without a specific end goal of making a decision or judgment. Exploratory queries are characterized by their openness and the lack of a predefined objective, differentiating them from evaluative queries which are directed towards forming a judgment or assessment. Exploratory queries encourage branching out into various directions to explore a wide array of possibilities without necessarily aiming to converge on a single answer or outcome.","[[""Oman"", ""Olympique de Marseille"", ""On My ...."", ""Old Man"", ""Organic Matter"", ""Afan (Oromo)"", ""Order of Magnitude"", ""One Million"", ""Open Mind"", ""Old Mutual""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Otitis Media""]",[9.239741918068506e-18],[7.811138285102392e-11],"[""Old Man""]",[1.165143238218568e-05],"[""ABBREVIATIONS""]","[[3.171640416161131e-08, 7.559178715684361e-22, 3.4622045809734113e-10, 1.165143238218568e-05, 3.328109001329373e-07, 5.092207062773192e-19, 2.5627879674671135e-11, 4.464992380284645e-09, 4.8872793507111254e-09, 1.4439937673496467e-10]]",[0.8686987818032427],[0.8649640970393178],"[""Olympique de Marseille""]",[0.9295435282603034],"[""ABBREVIATIONS""]","[[0.9183010021303404, 0.7770516278932258, 0.9295435282603034, 0.8840559117736346, 0.7941199528423926, 0.8310839354045509, 0.9078018651709326, 0.90430188460841, 0.8721209788292645, 0.7902796059141926]]","[""Otitis Media""]","[""LLM""]",what research (or clinical trials) is being done for OM (Otitis Media) ?,[false],[true],[false],"[""Research is being conducted on potential treatments for age-related conditions in elderly individuals, including Old Man syndrome.""]","[""Research and clinical trials for Opsoclonus Myoclonus are currently focused on investigating the efficacy of immunotherapy, identifying biomarkers for diagnosis and prognosis, and exploring novel treatment approaches such as targeted therapies and immunomodulators.""]","[""Research and clinical trials for osteomyelitis are currently focused on developing new antibiotics, exploring alternative treatment options such as hyperbaric oxygen therapy, and investigating the role of biofilm formation in chronic infections.""]",[false],[true],[false],"[""Research and clinical trials for OM (Old Man) are currently focused on understanding the impact of aging on various physiological systems, exploring potential interventions to improve quality of life in older individuals, and investigating age-related diseases such as Alzheimer's and osteoporosis.""]","[""Research and clinical trials are being conducted to investigate the effectiveness of various immunomodulatory therapies, such as corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and cyclophosphamide, in the treatment of Opsoclonus Myoclonus syndrome.""]","[""Research and clinical trials for osteomyelitis are focused on new antibiotics, surgical techniques, and biofilm disruption strategies.""]",[false],[true],[false],"[""Research and clinical trials for Old Man (OM) may include studies on age-related diseases, geriatrics, elderly care, and treatments for common health issues in older adults.""]","[""Various research studies and clinical trials are being conducted for Opsoclonus Myoclonus, focusing on different treatment approaches, potential causes, and outcomes. Some studies are investigating the effectiveness of immunotherapy, while others are exploring the underlying mechanisms of the condition.""]","[""Research is being conducted on new treatment options, drug therapies, and surgical techniques for otitis media (OM). Clinical trials are also exploring the effectiveness of different interventions in managing OM.""]",[false],[true],[false],"[""Research is being conducted on potential treatments for age-related conditions such as osteoporosis, arthritis, and cardiovascular diseases in older adults.""]","[""Research and clinical trials for Opsoclonus Myoclonus include investigating the efficacy of immunotherapy, evaluating the role of various medications in symptom management, and exploring potential genetic factors contributing to the condition.""]","[""There are several research studies and clinical trials being conducted for osteomyelitis (OM), focusing on new treatment approaches, antimicrobial therapies, and diagnostic methods.""]",[false],[true],[false],"[""Research on OM (Olympique de Marseille) is primarily focused on sports medicine, performance optimization, injury prevention, and rehabilitation techniques. Clinical trials may involve testing new training methods, recovery strategies, and injury treatments specific to athletes.""]","[""Research and clinical trials for Opsoclonus Myoclonus are currently focused on investigating the efficacy of immunotherapy, identifying biomarkers for diagnosis and prognosis, and exploring novel treatment approaches such as targeted therapies and immunomodulators.""]","[""Research and clinical trials for osteomyelitis are currently focused on developing new antibiotics, exploring alternative treatment options such as hyperbaric oxygen therapy, and investigating the role of biofilm formation in chronic infections.""]",[false],[true],[false],"[""Research is being done on the impact of sports on mental health, performance enhancement strategies, and injury prevention techniques in football players.""]","[""Research and clinical trials are being conducted to investigate the effectiveness of various immunomodulatory therapies, such as corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and cyclophosphamide, in the treatment of Opsoclonus Myoclonus syndrome.""]","[""Research and clinical trials for osteomyelitis are focused on new antibiotics, surgical techniques, and biofilm disruption strategies.""]",[false],[true],[false],"[""There are currently no specific research or clinical trials being done for OM (Olympique de Marseille) in the medical field.""]","[""Various research studies and clinical trials are being conducted for Opsoclonus Myoclonus, focusing on different treatment approaches, potential causes, and outcomes. Some studies are investigating the effectiveness of immunotherapy, while others are exploring the underlying mechanisms of the condition.""]","[""Research is being conducted on new treatment options, drug therapies, and surgical techniques for otitis media (OM). Clinical trials are also exploring the effectiveness of different interventions in managing OM.""]",[false],[true],[false],"[""Research on OM (Olympique de Marseille) is primarily focused on sports medicine, performance optimization, injury prevention, and rehabilitation techniques.""]","[""Research and clinical trials for Opsoclonus Myoclonus include investigating the efficacy of immunotherapy, evaluating the role of various medications in symptom management, and exploring potential genetic factors contributing to the condition.""]","[""There are several research studies and clinical trials being conducted for osteomyelitis (OM), focusing on new treatment approaches, antimicrobial therapies, and diagnostic methods.""]",[false],[true],[false],"[""There are various research studies and clinical trials being conducted for Otitis Media (OM), focusing on treatment options, prevention strategies, and understanding the underlying causes.""]","[""Research and clinical trials are being conducted to investigate the effectiveness of various immunomodulatory therapies, such as corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and cyclophosphamide, in the treatment of Opsoclonus Myoclonus syndrome.""]","[""Research and clinical trials for osteomyelitis are focused on new antibiotics, surgical techniques, and biofilm disruption strategies.""]",[false],[true],[false],"[""There are various research studies and clinical trials being conducted for Otitis Media (OM), focusing on areas such as new treatment options, prevention strategies, and understanding the underlying causes.""]","[""Research and clinical trials for Opsoclonus Myoclonus are currently focused on investigating the efficacy of immunotherapy, identifying biomarkers for diagnosis and prognosis, and exploring novel treatment approaches such as targeted therapies and immunomodulators.""]","[""Research and clinical trials for osteomyelitis are currently focused on developing new antibiotics, exploring alternative treatment options such as hyperbaric oxygen therapy, and investigating the role of biofilm formation in chronic infections.""]",[false],[true],[false],"[""Research and clinical trials for Otitis Media are focused on new treatment options, vaccine development, antibiotic resistance, and the impact of environmental factors on the condition.""]","[""Various research studies and clinical trials are being conducted for Opsoclonus Myoclonus, focusing on different treatment approaches, potential causes, and outcomes. Some studies are investigating the effectiveness of immunotherapy, while others are exploring the underlying mechanisms of the condition.""]","[""Research is being conducted on new treatment options, drug therapies, and surgical techniques for otitis media (OM). Clinical trials are also exploring the effectiveness of different interventions in managing OM.""]",[false],[true],[false],"[""There are ongoing research studies and clinical trials for Otitis Media (OM) focusing on various aspects such as new treatment options, prevention strategies, and understanding the underlying causes.""]","[""Research and clinical trials for Opsoclonus Myoclonus include investigating the efficacy of immunotherapy, evaluating the role of various medications in symptom management, and exploring potential genetic factors contributing to the condition.""]","[""There are several research studies and clinical trials being conducted for osteomyelitis (OM), focusing on new treatment approaches, antimicrobial therapies, and diagnostic methods.""]",[false],[true],[false],"[""Research and clinical trials for Otitis Media are focused on new treatment options, prevention strategies, and understanding the underlying causes of the condition.""]","[""Research and clinical trials for Opsoclonus Myoclonus are currently focused on investigating the efficacy of immunotherapy, identifying biomarkers for diagnosis and prognosis, and exploring novel treatment approaches such as targeted therapies and immunomodulators.""]","[""Research and clinical trials for osteomyelitis are currently focused on developing new antibiotics, exploring alternative treatment options such as hyperbaric oxygen therapy, and investigating the role of biofilm formation in chronic infections.""]",[false],[true],[false],"[""Research and clinical trials for Otitis Media are focused on new treatment options, prevention strategies, and understanding the underlying causes of the condition.""]","[""Research and clinical trials are being conducted to investigate the effectiveness of various immunomodulatory therapies, such as corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and cyclophosphamide, in the treatment of Opsoclonus Myoclonus syndrome.""]","[""Research and clinical trials for osteomyelitis are focused on new antibiotics, surgical techniques, and biofilm disruption strategies.""]",[false],[true],[false],"[""Research and clinical trials for Otitis Media (OM) are focused on developing new treatments, improving diagnostic methods, and understanding the underlying causes of the condition.""]","[""Various research studies and clinical trials are being conducted for Opsoclonus Myoclonus, focusing on different treatment approaches, potential causes, and outcomes. Some studies are investigating the effectiveness of immunotherapy, while others are exploring the underlying mechanisms of the condition.""]","[""Research is being conducted on new treatment options, drug therapies, and surgical techniques for otitis media (OM). Clinical trials are also exploring the effectiveness of different interventions in managing OM.""]",[false],[true],[false],"[""Research and clinical trials for Otitis Media are focused on developing new treatments, vaccines, and understanding the underlying causes of the condition.""]","[""Research and clinical trials for Opsoclonus Myoclonus include investigating the efficacy of immunotherapy, evaluating the role of various medications in symptom management, and exploring potential genetic factors contributing to the condition.""]","[""There are several research studies and clinical trials being conducted for osteomyelitis (OM), focusing on new treatment approaches, antimicrobial therapies, and diagnostic methods.""]",[false],[true],[false],"[""Research and clinical trials for Otitis Media are focused on new treatments, prevention strategies, vaccine development, and understanding the underlying causes of the condition.""]","[""Research and clinical trials for Opsoclonus Myoclonus are currently focused on investigating the efficacy of immunotherapy, identifying biomarkers for diagnosis and prognosis, and exploring novel treatment approaches such as targeted therapies and immunomodulators.""]","[""Research and clinical trials for osteomyelitis are currently focused on developing new antibiotics, exploring alternative treatment options such as hyperbaric oxygen therapy, and investigating the role of biofilm formation in chronic infections.""]",[false],[true],[false],"[""There are various research studies and clinical trials being conducted for Otitis Media (OM), including investigations into new treatment options, prevention strategies, and understanding the underlying mechanisms of the condition.""]","[""Research and clinical trials are being conducted to investigate the effectiveness of various immunomodulatory therapies, such as corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and cyclophosphamide, in the treatment of Opsoclonus Myoclonus syndrome.""]","[""Research and clinical trials for osteomyelitis are focused on new antibiotics, surgical techniques, and biofilm disruption strategies.""]",[false],[true],[false],"[""Various research studies and clinical trials are being conducted for Otitis Media (OM), focusing on areas such as new treatment options, prevention strategies, and understanding the underlying causes of the condition.""]","[""Various research studies and clinical trials are being conducted for Opsoclonus Myoclonus, focusing on different treatment approaches, potential causes, and outcomes. Some studies are investigating the effectiveness of immunotherapy, while others are exploring the underlying mechanisms of the condition.""]","[""Research is being conducted on new treatment options, drug therapies, and surgical techniques for otitis media (OM). Clinical trials are also exploring the effectiveness of different interventions in managing OM.""]",[false],[true],[false],"[""There are various research studies and clinical trials being conducted for Otitis Media (OM), including investigations into new treatment options, vaccine development, and understanding the underlying causes of the condition.""]","[""Research and clinical trials for Opsoclonus Myoclonus include investigating the efficacy of immunotherapy, evaluating the role of various medications in symptom management, and exploring potential genetic factors contributing to the condition.""]","[""There are several research studies and clinical trials being conducted for osteomyelitis (OM), focusing on new treatment approaches, antimicrobial therapies, and diagnostic methods.""]",[false],[true],[false],"[""Research and clinical trials for Otitis Media are focused on new treatment options, vaccine development, antibiotic resistance, and the impact of environmental factors on the condition.""]","[""Research and clinical trials for Opsoclonus Myoclonus are currently focused on investigating the efficacy of immunotherapy, identifying biomarkers for diagnosis and prognosis, and exploring novel treatment approaches such as targeted therapies and immunomodulators.""]","[""Research and clinical trials for osteomyelitis are currently focused on developing new antibiotics, exploring alternative treatment options such as hyperbaric oxygen therapy, and investigating the role of biofilm formation in chronic infections.""]",[false],[true],[false],"[""There are various research studies and clinical trials being conducted for Otitis Media (OM), including investigations into new treatment options, prevention strategies, and understanding the underlying causes.""]","[""Research and clinical trials are being conducted to investigate the effectiveness of various immunomodulatory therapies, such as corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and cyclophosphamide, in the treatment of Opsoclonus Myoclonus syndrome.""]","[""Research and clinical trials for osteomyelitis are focused on new antibiotics, surgical techniques, and biofilm disruption strategies.""]",[false],[true],[false],"[""There are various research studies and clinical trials being conducted for Otitis Media (OM), focusing on areas such as new treatment options, prevention strategies, and understanding the underlying causes.""]","[""Various research studies and clinical trials are being conducted for Opsoclonus Myoclonus, focusing on different treatment approaches, potential causes, and outcomes. Some studies are investigating the effectiveness of immunotherapy, while others are exploring the underlying mechanisms of the condition.""]","[""Research is being conducted on new treatment options, drug therapies, and surgical techniques for otitis media (OM). Clinical trials are also exploring the effectiveness of different interventions in managing OM.""]",[false],[true],[false],"[""There are several research studies and clinical trials being conducted for Otitis Media (OM), focusing on areas such as new treatment options, prevention strategies, and understanding the underlying causes.""]","[""Research and clinical trials for Opsoclonus Myoclonus include investigating the efficacy of immunotherapy, evaluating the role of various medications in symptom management, and exploring potential genetic factors contributing to the condition.""]","[""There are several research studies and clinical trials being conducted for osteomyelitis (OM), focusing on new treatment approaches, antimicrobial therapies, and diagnostic methods.""]",[false],[true],[false],"[""Research and clinical trials for Otitis Media are focused on new treatment options, vaccine development, antibiotic resistance, and prevention strategies.""]","[""Research and clinical trials for Opsoclonus Myoclonus are currently focused on investigating the efficacy of immunotherapy, identifying biomarkers for diagnosis and prognosis, and exploring novel treatment approaches such as targeted therapies and immunomodulators.""]","[""Research and clinical trials for osteomyelitis are currently focused on developing new antibiotics, exploring alternative treatment options such as hyperbaric oxygen therapy, and investigating the role of biofilm formation in chronic infections.""]",[false],[true],[false],"[""Research and clinical trials for Otitis Media (OM) are focused on new treatment options, vaccine development, antibiotic resistance, and the impact of environmental factors on the condition.""]","[""Research and clinical trials are being conducted to investigate the effectiveness of various immunomodulatory therapies, such as corticosteroids, intravenous immunoglobulin (IVIG), rituximab, and cyclophosphamide, in the treatment of Opsoclonus Myoclonus syndrome.""]","[""Research and clinical trials for osteomyelitis are focused on new antibiotics, surgical techniques, and biofilm disruption strategies.""]",[false],[true],[false],"[""Research and clinical trials for Otitis Media are focused on new treatment options, vaccine development, antibiotic resistance, and the impact of environmental factors on the condition.""]","[""Various research studies and clinical trials are being conducted for Opsoclonus Myoclonus, focusing on different treatment approaches, potential causes, and outcomes. Some studies are investigating the effectiveness of immunotherapy, while others are exploring the underlying mechanisms of the condition.""]","[""Research is being conducted on new treatment options, drug therapies, and surgical techniques for otitis media (OM). Clinical trials are also exploring the effectiveness of different interventions in managing OM.""]",[false],[true],[false],"[""Research and clinical trials for Otitis Media are focused on new treatment options, vaccine development, antibiotic resistance, and the impact of environmental factors on the condition.""]","[""Research and clinical trials for Opsoclonus Myoclonus include investigating the efficacy of immunotherapy, evaluating the role of various medications in symptom management, and exploring potential genetic factors contributing to the condition.""]","[""There are several research studies and clinical trials being conducted for osteomyelitis (OM), focusing on new treatment approaches, antimicrobial therapies, and diagnostic methods.""]",[false],[true],[false],"[""Research and clinical trials for Otitis Media (OM) are focused on new treatment options, prevention strategies, and understanding the underlying causes of the condition.""]","[""Research and clinical trials for Opsoclonus Myoclonus are currently focused on investigating the efficacy of immunotherapy, identifying biomarkers for diagnosis and prognosis, and exploring novel treatment approaches such as targeted therapies and immunomodulators.""]","[""Research and clinical trials for osteomyelitis are currently focused on developing new antibiotics, exploring alternative treatment options such as hyperbaric oxygen therapy, and investigating the role of biofilm formation in chronic infections.""]",[false],[true],[false],"[""Research and clinical trials for OM (Old Man) are focused on various aspects such as treatment options, disease progression, symptom management, and potential new therapies.""]","[""Research and clinical trials for Opsoclonus Myoclonus are currently focused on investigating the efficacy of immunotherapy, identifying biomarkers for diagnosis and prognosis, and exploring novel treatment approaches such as targeted therapies and immunomodulators.""]","[""Research and clinical trials for osteomyelitis are currently focused on developing new antibiotics, exploring alternative treatment options such as hyperbaric oxygen therapy, and investigating the role of biofilm formation in chronic infections.""]",[false],[true],[false],"[""Research and clinical trials related to OM (Olympique de Marseille) are not typically conducted as it is a football club. However, studies related to sports medicine or injuries in athletes may indirectly involve players from OM.""]","[""Research and clinical trials for Opsoclonus Myoclonus are currently focused on investigating the efficacy of immunotherapy, identifying biomarkers for diagnosis and prognosis, and exploring novel treatment approaches such as targeted therapies and immunomodulators.""]","[""Research and clinical trials for osteomyelitis are currently focused on developing new antibiotics, exploring alternative treatment options such as hyperbaric oxygen therapy, and investigating the role of biofilm formation in chronic infections.""]",[false],[true],[false],"[""Research and clinical trials for Otitis Media (OM) are focused on developing new treatments, improving diagnostic methods, and understanding the underlying causes of the condition.""]","[""Research and clinical trials for Opsoclonus Myoclonus are currently focused on investigating the efficacy of immunotherapy, identifying biomarkers for diagnosis and prognosis, and exploring novel treatment approaches such as targeted therapies and immunomodulators.""]","[""Research and clinical trials for osteomyelitis are currently focused on developing new antibiotics, exploring alternative treatment options such as hyperbaric oxygen therapy, and investigating the role of biofilm formation in chronic infections.""]"
causes,What causes Chronic Fatigue Syndrome?,"Despite a vigorous search, scientists have not yet identified what causes CFS. While a single cause for CFS may yet be identified, another possibility is that CFS has multiple causes. Conditions that have been studied to determine if they cause or trigger the development of CFS include infections, immune disorders, stress, trauma, and toxins.
  Infection
  
Various types of infections have been studied to determine if they might cause or trigger CFS:
  
   - Candida albicans, a fungus that causes yeast infections
   - Mycoplasma, a cause of atypical pneumonia
   - Ross River virus, which causes Ross River Fever, a mosquito-borne tropical disease
  
  Could One Type of Infection Lead to CFS?
  
Researchers from around the world have studied if a single type of infection might be the cause of CFS, analyzed the data, and not yet found any association between CFS and infection. Researchers are still analyzing samples from CFS patients using the latest molecular methods to search for previously unknown infections (pathogen discovery). To date, these studies suggest that no one infection or pathogen causes CFS and that the illness may be triggered by a variety of illnesses or conditions. In fact, infection with Epstein-Barr virus, Ross River virus, and Coxiella burnetti will lead to a post-infective condition that meets the criteria for CFS in approximately 10-12% of cases. People who had severe symptoms when they became infected were more likely than those with mild symptoms to later develop CFS symptoms. The possibility remains that there may be a variety of different ways in which patients can develop CFS.
  Immune System and Allergies
  
Studies have looked to see if changes in a person's immune system might lead to CFS. The findings have been mixed. Similarities in symptoms from immune responses to infection and CFS lead to hypotheses that CFS may be caused by stress or a viral infection, which may lead to the chronic production of cytokines and then to CFS.
  
Antibodies against normal parts of the body (auto-antibodies) and immune complexes have been seen in some CFS patients. However, no associated tissue damage typical of autoimmune disease has been described in CFS patients. The opportunistic infections or increased risk for cancer observed in persons with immunodeficiency diseases or in immunosuppressed individuals is also not observed in CFS.
  
T-cell activation markers have been reported to be different between groups of CFS patients and healthy persons, but not all investigators have consistently observed these differences.
  
Allergic diseases and secondary illnesses such as sinusitis could be one predisposing factor for CFS, but not all CFS patients have allergies. Many patients do, however, report intolerances for certain substances that may be found in foods or over-the-counter medications, such as alcohol.
  
                
  Hypothalamic-Pituitary Adrenal (HPA) Axis
  
The central nervous system plays an important role in CFS. Physical or emotional stress, which is commonly reported as a pre-onset condition in CFS patients, alters the activity of the hypothalamic-pituitary-adrenal axis, or HPA axis, leading to altered release of corticotrophin-releasing hormone (CRH), cortisol, and other hormones. These hormones can influence the immune system and many other body systems.
  
Some CFS patients produce lower levels of cortisol than do healthy people. Similar hormonal abnormalities have also been observed among CFS patients and in persons with related disorders like fibromyalgia. Cortisol suppresses inflammation and cellular immune activation, and reduced levels might relax constraints on inflammatory processes and immune cell activation. Even though CFS patients had lower levels of cortisol than healthy individuals, their cortisol levels were still within the acceptable range of what is considered normal. Therefore, doctors cannot use cortisol levels as a way to diagnose CFS.
  
                
  Abnormally Low Blood Pressure and Lightheadedness (Neurally Mediated Hypotension)
  
Disturbances in the autonomic regulation of blood pressure and pulse have been found in CFS patients. This problem with maintaining blood pressure can be diagnosed by using tilt table testing, which involves laying the patient horizontally on a table and then tilting the table upright to 70 degrees for 45 minutes while monitoring blood pressure and heart rate. Persons with neurally mediated hypotension (NMH) or postural orthostatic tachycardia (POTS) will develop lower blood pressure under these conditions, as well as other characteristic symptoms, such as lightheadedness, visual dimming, or a slow response to verbal stimuli. Others may develop an unusually rapid heart rate also associated with the symptoms of the syndrome. Many CFS patients experience lightheadedness or worsened fatigue when they stand for prolonged periods or when in warm places, such as in a hot shower -- all circumstances that are known to trigger NMH or POTS.
  
NMH and/or POTS share some of the symptoms of CFS. They should be considered in a CFS patients whose symptoms are worsened with changes in position, after eating, following unusual amounts of or inadequate fluid intake, or increases in activity. Not all patients with CFS will have these conditions, however.
  
                
  Nutritional Deficiency
  
There is no published scientific evidence that CFS is caused by a nutritional deficiency. While evidence is currently lacking for nutritional defects in CFS patients, it should also be added that a balanced diet can be favorable to better health in general and would be expected to benefit a person with any chronic illness.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""CFS"", ""full_form"": ""Chronic Fatigue Syndrome""}]}",What causes CFS?,What causes Chronic Fatigue Syndrome?,8,MEDICAL,Compound Datatype-String,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Chronic Fatigue Syndrome"", ""Combat Flight Simulator"", ""Canadian Federation of Students"", ""Container Freight Station"", ""Center for Food Safety"", ""Child and Family Services"", ""Cubic Feet per Second"", ""Commodity Flow Survey"", ""Cryptographic File System"", ""Certified Fund Specialist""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Chronic Fatigue Syndrome""]",[4.6893517564746945e-09],[4.6893517564746945e-09],"[""Chronic Fatigue Syndrome""]",[4.6893517564746945e-09],"[""ABBREVIATIONS""]","[[4.6893517564746945e-09, 4.076409576229264e-18, 5.610239155278894e-24, 3.021429900928734e-18, 9.952733809651585e-15, 9.72104387271561e-13, 3.51853166946742e-15, 2.2185554915759324e-18, 3.3580240695208606e-18, 4.749419653345874e-17]]",[0.8839459442877702],[0.8839459442877702],"[""Certified Fund Specialist""]",[0.8839459442877702],"[""LLM""]","[[0.8828951874339794, 0.623237386871536, 0.597646542446489, 0.5571299867163836, 0.6468774182330133, 0.5594097895884398, 0.5291036385940097, 0.5772104083165056, 0.5782238531372136, 0.6084742365040231]]","[""Chronic Fatigue Syndrome""]","[""ABBREVIATIONS""]",What causes CFS (Chronic Fatigue Syndrome)?,[true],[true],[true],"[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors including viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome is unknown, but it may be triggered by a combination of factors including viral infections, immune system problems, and hormonal imbalances.""]","[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors such as viral infections, immune system problems, hormonal imbalances, and psychological stress.""]",[true],[true],[true],"[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors including viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome is unknown, but it may be triggered by a combination of factors including viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors such as viral infections, immune system problems, hormonal imbalances, and psychological stress.""]",[true],[true],[true],"[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors including viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome is unknown, but it may be triggered by a combination of factors including viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors such as viral infections, immune system problems, hormonal imbalances, and psychological stress.""]",[true],[true],[true],"[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors such as viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome is unknown, but it may be triggered by a combination of factors including viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors including viral infections, immune system problems, hormonal imbalances, and psychological stress.""]",[true],[true],[true],"[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it is believed to be triggered by a combination of factors including viral infections, immune system problems, and hormonal imbalances.""]","[""The exact cause of Chronic Fatigue Syndrome is unknown, but it may be triggered by a combination of factors including viral infections, immune system problems, and hormonal imbalances.""]","[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors such as viral infections, immune system problems, hormonal imbalances, and psychological stress.""]",[true],[true],[true],"[""Chronic Fatigue Syndrome (CFS) is a complex disorder characterized by extreme fatigue that cannot be explained by any underlying medical condition. The exact cause of CFS is unknown, but it is believed to involve a combination of factors including viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome is unknown, but it may be triggered by a combination of factors including viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors such as viral infections, immune system problems, hormonal imbalances, and psychological stress.""]",[true],[true],[true],"[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it is believed to be a combination of factors including viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome is unknown, but it may be triggered by a combination of factors including viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors such as viral infections, immune system problems, hormonal imbalances, and psychological stress.""]",[true],[true],[true],"[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it is believed to be a combination of factors including viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome is unknown, but it may be triggered by a combination of factors including viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors including viral infections, immune system problems, hormonal imbalances, and psychological stress.""]",[true],[true],[true],"[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors such as viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome is unknown, but it may be triggered by a combination of factors including viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors such as viral infections, immune system problems, hormonal imbalances, and psychological stress.""]",[true],[true],[true],"[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors such as viral infections, immune system problems, and hormonal imbalances.""]","[""The exact cause of Chronic Fatigue Syndrome is unknown, but it may be triggered by a combination of factors including viral infections, immune system problems, and hormonal imbalances.""]","[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors such as viral infections, immune system problems, hormonal imbalances, and psychological stress.""]",[true],[true],[true],"[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors including viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome is unknown, but it may be triggered by a combination of factors including viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors such as viral infections, immune system problems, hormonal imbalances, and psychological stress.""]",[true],[true],[true],"[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors such as viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome is unknown, but it may be triggered by a combination of factors including viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors including viral infections, immune system problems, hormonal imbalances, and psychological stress.""]",[true],[true],[true],"[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors such as viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome is unknown, but it may be triggered by a combination of factors including viral infections, immune system problems, and hormonal imbalances.""]","[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors such as viral infections, immune system problems, hormonal imbalances, and psychological stress.""]",[true],[true],[true],"[""The exact cause of Chronic Fatigue Syndrome is unknown, but it may be triggered by a combination of factors such as viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome is unknown, but it may be triggered by a combination of factors including viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors such as viral infections, immune system problems, hormonal imbalances, and psychological stress.""]",[true],[true],[true],"[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors such as viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome is unknown, but it may be triggered by a combination of factors including viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors such as viral infections, immune system problems, hormonal imbalances, and psychological stress.""]",[true],[true],[true],"[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors such as viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome is unknown, but it may be triggered by a combination of factors including viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors including viral infections, immune system problems, hormonal imbalances, and psychological stress.""]",[true],[true],[true],"[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors including viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome is unknown, but it may be triggered by a combination of factors including viral infections, immune system problems, and hormonal imbalances.""]","[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors such as viral infections, immune system problems, hormonal imbalances, and psychological stress.""]",[true],[true],[true],"[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors such as viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome is unknown, but it may be triggered by a combination of factors including viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors such as viral infections, immune system problems, hormonal imbalances, and psychological stress.""]",[true],[true],[true],"[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors including viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome is unknown, but it may be triggered by a combination of factors including viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors such as viral infections, immune system problems, hormonal imbalances, and psychological stress.""]",[true],[true],[true],"[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors including viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome is unknown, but it may be triggered by a combination of factors including viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors including viral infections, immune system problems, hormonal imbalances, and psychological stress.""]",[true],[true],[true],"[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors including viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome is unknown, but it may be triggered by a combination of factors including viral infections, immune system problems, and hormonal imbalances.""]","[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors such as viral infections, immune system problems, hormonal imbalances, and psychological stress.""]",[true],[true],[true],"[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors such as viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome is unknown, but it may be triggered by a combination of factors including viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors such as viral infections, immune system problems, hormonal imbalances, and psychological stress.""]",[true],[true],[true],"[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors such as viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome is unknown, but it may be triggered by a combination of factors including viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors such as viral infections, immune system problems, hormonal imbalances, and psychological stress.""]",[true],[true],[true],"[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it is believed to be a combination of factors including viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome is unknown, but it may be triggered by a combination of factors including viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors including viral infections, immune system problems, hormonal imbalances, and psychological stress.""]",[true],[true],[true],"[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors including viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome is unknown, but it may be triggered by a combination of factors including viral infections, immune system problems, and hormonal imbalances.""]","[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors such as viral infections, immune system problems, hormonal imbalances, and psychological stress.""]",[true],[true],[true],"[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it is believed to be a combination of factors including viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome is unknown, but it may be triggered by a combination of factors including viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors such as viral infections, immune system problems, hormonal imbalances, and psychological stress.""]",[true],[true],[true],"[""The exact cause of Chronic Fatigue Syndrome is unknown, but it is believed to be a combination of factors including viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome is unknown, but it may be triggered by a combination of factors including viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors such as viral infections, immune system problems, hormonal imbalances, and psychological stress.""]",[true],[true],[true],"[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it is believed to be a combination of factors including viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome is unknown, but it may be triggered by a combination of factors including viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors including viral infections, immune system problems, hormonal imbalances, and psychological stress.""]",[true],[true],[true],"[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors such as viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome is unknown, but it may be triggered by a combination of factors including viral infections, immune system problems, and hormonal imbalances.""]","[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors such as viral infections, immune system problems, hormonal imbalances, and psychological stress.""]",[true],[true],[true],"[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors such as viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome is unknown, but it may be triggered by a combination of factors including viral infections, immune system problems, and hormonal imbalances.""]","[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors such as viral infections, immune system problems, hormonal imbalances, and psychological stress.""]",[false],[true],[true],"[""Completion of the Certified Fund Specialist program""]","[""The exact cause of Chronic Fatigue Syndrome is unknown, but it may be triggered by a combination of factors including viral infections, immune system problems, and hormonal imbalances.""]","[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors such as viral infections, immune system problems, hormonal imbalances, and psychological stress.""]",[true],[true],[true],"[""The exact cause of Chronic Fatigue Syndrome is unknown, but it is believed to be a combination of factors including viral infections, immune system problems, hormonal imbalances, and psychological stress.""]","[""The exact cause of Chronic Fatigue Syndrome is unknown, but it may be triggered by a combination of factors including viral infections, immune system problems, and hormonal imbalances.""]","[""The exact cause of Chronic Fatigue Syndrome (CFS) is unknown, but it may be triggered by a combination of factors such as viral infections, immune system problems, hormonal imbalances, and psychological stress.""]"
inheritance,Is alveolar capillary dysplasia with misalignment of pulmonary veins inherited ?,"ACD/MPV is usually not inherited, and most affected people have no history of the disorder in their family. The genetic changes associated with this condition usually occur during the formation of reproductive cells (eggs and sperm) or in early fetal development. When the condition is caused by a FOXF1 gene mutation or deletion, one altered or missing gene in each cell is sufficient to cause the disorder. Individuals with ACD/MPV do not pass the genetic change on to their children because they do not live long enough to reproduce.  A few families have been identified in which more than one sibling has ACD/MPV. It is not clear how ACD/MPV is inherited in these families because no genetic changes have been identified.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""ACD/MPV"", ""full_form"": ""alveolar capillary dysplasia with misalignment of pulmonary veins""}]}",Is ACD/MPV inherited ?,Is alveolar capillary dysplasia with misalignment of pulmonary veins inherited ?,8,MEDICAL,Simple Datatype-Boolean,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.",[[]],[[]],"[""Acid Citrate Dextrose/Mean Platelet Volume""]",[2.1456806603455707e-33],[1.5539997038642983e-25],"[""Acid Citrate Dextrose/Mean Platelet Volume""]",[1.5539997038642983e-25],"[""LLM""]",[[]],[0.8031666110804331],[0.8538769142983121],"[""alveolar capillary dysplasia with misalignment of pulmonary veins""]",[0.8538769142983121],"[""LLM""]",[[]],"[""Acid Citrate Dextrose/Mean Platelet Volume""]","[""LLM""]",Is ACD/MPV (Acid Citrate Dextrose/Mean Platelet Volume) inherited ?,[true],[false],[true],"[""No""]","[""Yes, alveolar capillary dysplasia with misalignment of pulmonary veins is inherited as an autosomal dominant genetic disorder.""]","[""No""]",[true],[false],[true],"[""No""]","[""Yes, alveolar capillary dysplasia with misalignment of pulmonary veins is inherited.""]","[""No""]",[true],[false],[true],"[""No""]","[""Yes, alveolar capillary dysplasia with misalignment of pulmonary veins is inherited.""]","[""No""]",[true],[false],[true],"[""No""]","[""Yes, alveolar capillary dysplasia with misalignment of pulmonary veins is inherited.""]","[""No""]",[false],[false],[true],"[""Yes, ACD/MPV is inherited as an autosomal dominant genetic disorder.""]","[""Yes, alveolar capillary dysplasia with misalignment of pulmonary veins is inherited as an autosomal dominant genetic disorder.""]","[""No""]",[false],[false],[true],"[""Yes, ACD/MPV is inherited as an autosomal dominant genetic disorder.""]","[""Yes, alveolar capillary dysplasia with misalignment of pulmonary veins is inherited.""]","[""No""]",[false],[false],[true],"[""Yes, ACD/MPV is inherited as an autosomal dominant genetic disorder.""]","[""Yes, alveolar capillary dysplasia with misalignment of pulmonary veins is inherited.""]","[""No""]",[false],[false],[true],"[""Yes""]","[""Yes, alveolar capillary dysplasia with misalignment of pulmonary veins is inherited.""]","[""No""]",[true],[false],[true],"[""No""]","[""Yes, alveolar capillary dysplasia with misalignment of pulmonary veins is inherited.""]","[""No""]",[true],[false],[true],"[""No""]","[""Yes, alveolar capillary dysplasia with misalignment of pulmonary veins is inherited as an autosomal dominant genetic disorder.""]","[""No""]",[true],[false],[true],"[""No""]","[""Yes, alveolar capillary dysplasia with misalignment of pulmonary veins is inherited.""]","[""No""]",[true],[false],[true],"[""No""]","[""Yes, alveolar capillary dysplasia with misalignment of pulmonary veins is inherited.""]","[""No""]",[true],[false],[true],"[""No""]","[""Yes, alveolar capillary dysplasia with misalignment of pulmonary veins is inherited as an autosomal dominant genetic disorder.""]","[""No""]",[true],[false],[true],"[""No""]","[""Yes, alveolar capillary dysplasia with misalignment of pulmonary veins is inherited.""]","[""No""]",[true],[false],[true],"[""No""]","[""Yes, alveolar capillary dysplasia with misalignment of pulmonary veins is inherited.""]","[""No""]",[true],[false],[true],"[""No""]","[""Yes, alveolar capillary dysplasia with misalignment of pulmonary veins is inherited.""]","[""No""]",[true],[false],[true],"[""No""]","[""Yes, alveolar capillary dysplasia with misalignment of pulmonary veins is inherited as an autosomal dominant genetic disorder.""]","[""No""]",[true],[false],[true],"[""No""]","[""Yes, alveolar capillary dysplasia with misalignment of pulmonary veins is inherited.""]","[""No""]",[true],[false],[true],"[""No""]","[""Yes, alveolar capillary dysplasia with misalignment of pulmonary veins is inherited.""]","[""No""]",[true],[false],[true],"[""No""]","[""Yes, alveolar capillary dysplasia with misalignment of pulmonary veins is inherited.""]","[""No""]",[true],[false],[true],"[""No""]","[""Yes, alveolar capillary dysplasia with misalignment of pulmonary veins is inherited as an autosomal dominant genetic disorder.""]","[""No""]",[true],[false],[true],"[""No""]","[""Yes, alveolar capillary dysplasia with misalignment of pulmonary veins is inherited.""]","[""No""]",[true],[false],[true],"[""No""]","[""Yes, alveolar capillary dysplasia with misalignment of pulmonary veins is inherited.""]","[""No""]",[true],[false],[true],"[""No""]","[""Yes, alveolar capillary dysplasia with misalignment of pulmonary veins is inherited.""]","[""No""]",[false],[false],[true],"[""ACD/MPV (Acid Citrate Dextrose/Mean Platelet Volume) is not inherited. ACD is an anticoagulant solution used in blood collection, while MPV is a measure of the average size of platelets in the blood.""]","[""Yes, alveolar capillary dysplasia with misalignment of pulmonary veins is inherited as an autosomal dominant genetic disorder.""]","[""No""]",[false],[false],[true],"[""No, ACD/MPV (Acid Citrate Dextrose/Mean Platelet Volume) is not inherited. ACD is an anticoagulant used in blood collection, while MPV is a measure of the average size of platelets in the blood.""]","[""Yes, alveolar capillary dysplasia with misalignment of pulmonary veins is inherited.""]","[""No""]",[false],[false],[true],"[""No, ACD/MPV (Acid Citrate Dextrose/Mean Platelet Volume) is not inherited. ACD is an anticoagulant solution used in blood collection, while MPV is a measure of the average size of platelets in the blood.""]","[""Yes, alveolar capillary dysplasia with misalignment of pulmonary veins is inherited.""]","[""No""]",[false],[false],[true],"[""No, ACD/MPV (Acid Citrate Dextrose/Mean Platelet Volume) is not inherited.""]","[""Yes, alveolar capillary dysplasia with misalignment of pulmonary veins is inherited.""]","[""No""]",[true],[false],[true],"[""No""]","[""Yes, alveolar capillary dysplasia with misalignment of pulmonary veins is inherited as an autosomal dominant genetic disorder.""]","[""No""]",[true],[false],[true],"[""No""]","[""Yes, alveolar capillary dysplasia with misalignment of pulmonary veins is inherited as an autosomal dominant genetic disorder.""]","[""No""]",[true],[false],[true],"[""ACD/MPV is not inherited, it is considered a sporadic condition.""]","[""Yes, alveolar capillary dysplasia with misalignment of pulmonary veins is inherited as an autosomal dominant genetic disorder.""]","[""No""]",[true],[false],[true],"[""No""]","[""Yes, alveolar capillary dysplasia with misalignment of pulmonary veins is inherited as an autosomal dominant genetic disorder.""]","[""No""]"
symptoms,What are the symptoms of Factor V Leiden thrombophilia ?,"What are the signs and symptoms of factor V Leiden thrombophilia? Individuals affected by factor V Leiden thrombophilia have an increased risk of developing blood clots. The severity of factor V Leiden thrombophilia is extremely variable. Many individuals with the factor V Leiden allele never develop a blood clot. Although most individuals with factor V thrombophilia do not experience their first thrombotic event until adulthood, some have recurrent thromboembolism before age 30 years. The chance a person will develop a blood clot is affected by the number of factor V Leiden mutations, the presence of coexisting genetic abnormalities, and non-genetic risk factors.  Non-genetic risk factors include surgery, long periods of not moving (like sitting on a long airplane ride), birth control pills and other female hormones, childbirth within the last 6 months, and traumas or fractures. Individuals who inherit one copy of the factor V Leiden mutation have a fourfold to eightfold increase in the chance of developing a clot.  Homozygotes (people who inherit two factor V Leiden mutations) may have up to 80 times the usual risk of developing a blood clot. Considering that the risk of developing an abnormal blood clot averages about 1 in 1,000 per year in the general population, the presence of one copy of the factor V Leiden mutation increases that risk to 4 to 8 in 1,000, and having two copies of the mutation may raise the risk as high as 80 in 1,000. People with factor V Leiden have an increased chance of having a blood clot that forms in large veins in the legs (deep venous thrombosis, or DVT) or a clot that travels through the bloodstream and lodges in the lungs (pulmonary embolism, or PE). Symptoms of deep vein thrombosis usually include leg pain, tenderness, swelling, increased warmth or redness in one leg. The symptoms of pulmonary embolism usually include cough, chest pain, shortness of breath or rapid heartbeat or breathing. To learn more about the symptoms of DVT and PE, click here.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""FVL"", ""full_form"": ""Factor V Leiden""}]}",What are the symptoms of FVL thrombophilia ?,What are the symptoms of Factor V Leiden thrombophilia ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Flora Valley, Western Australia, Australia"", ""Future Vertical Lift"", ""Fox Valley Lutheran"", ""Future of Vertical Lift"", ""Factor V Leiden"", ""File Viewer Lite"", ""Ford Vietnam Limited"", ""Freegold Ventures Limited"", ""Fuel Valve Light"", ""Fundacion Valle del Lili (Colombian hospital)"", ""Fox Valley Lutheran High School"", ""Finnish Virtual Library"", ""Florida Voters League, Inc."", ""Future Vertical Lift (US DoD)"", ""Full Variability Language"", ""First Trust Value Line (fund)"", ""Fonds de Vie Lyc\u00e9enne (French: School Life Funds)"", ""Flow-Volume Loop""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY""]]","[""Factor V Leiden""]",[0.0002633680711326188],[0.0002633680711326188],"[""Factor V Leiden""]",[0.0002633680711326188],"[""ABBREVIATIONS""]","[[5.672172518681016e-34, 2.3323539789309706e-15, 1.4314986741468367e-24, 1.2779714705018862e-16, 0.0002633680711326188, 1.2255872629286044e-16, 2.2832700857957734e-17, 2.338907518372929e-24, 4.3237570368104084e-14, 9.107079494508506e-45, 2.288227224795276e-30, 1.3208441444853742e-20, 3.295257016162593e-29, 1.0343723755517213e-31, 2.167302686521433e-15, 3.7525225162216525e-28, 6.82180109267594e-54, 1.5636248249543352e-14]]",[0.942797184983956],[0.942797184983956],"[""Future of Vertical Lift""]",[0.942797184983956],"[""ABBREVIATIONS""]","[[0.8718368595366595, 0.869938183669864, 0.8812169502465295, 0.9017978900467765, 0.942797184983956, 0.8814847740307031, 0.8853155370423087, 0.8816372425915686, 0.8943288390065606, 0.8435459210367499, 0.8388316348652629, 0.8839626768566796, 0.8724778053068618, 0.8396034334793054, 0.8891648362177511, 0.8775823651509338, 0.905681311840193, 0.8210219572985318]]","[""Factor V Leiden""]","[""ABBREVIATIONS""]",What are the symptoms of FVL (Factor V Leiden) thrombophilia ?,[true],[true],[true],"[""The symptoms of FVL (Factor V Leiden) thrombophilia may include blood clots in the legs (deep vein thrombosis), lungs (pulmonary embolism), or other parts of the body, as well as recurrent miscarriages in women.""]","[""Symptoms of Factor V Leiden thrombophilia may include blood clots in the legs (deep vein thrombosis), lungs (pulmonary embolism), or other parts of the body, as well as recurrent miscarriages in women.""]","[""Symptoms of FVL thrombophilia may include blood clots in the legs (deep vein thrombosis), lungs (pulmonary embolism), or other parts of the body, as well as recurrent miscarriages in women.""]",[true],[true],[true],"[""The symptoms of FVL (Factor V Leiden) thrombophilia may include blood clots in the legs (deep vein thrombosis), blood clots in the lungs (pulmonary embolism), and recurrent miscarriages in women.""]","[""The symptoms of Factor V Leiden thrombophilia may include blood clots in veins, such as deep vein thrombosis (DVT) or pulmonary embolism, and in some cases, miscarriages or stillbirths.""]","[""Symptoms of FVL thrombophilia may include blood clots in the legs (deep vein thrombosis), lungs (pulmonary embolism), or other parts of the body, as well as complications during pregnancy.""]",[true],[true],[true],"[""Symptoms of FVL thrombophilia may include blood clots in the legs (deep vein thrombosis), lungs (pulmonary embolism), or other parts of the body, as well as recurrent miscarriages in women.""]","[""Factor V Leiden thrombophilia may not have any symptoms, but it can lead to abnormal blood clotting which may cause deep vein thrombosis, pulmonary embolism, or other clot-related complications.""]","[""Symptoms of FVL thrombophilia may include blood clots in the legs (deep vein thrombosis), lungs (pulmonary embolism), or other parts of the body, as well as complications during pregnancy.""]",[true],[true],[true],"[""Symptoms of FVL (Factor V Leiden) thrombophilia may include blood clots in the legs (deep vein thrombosis), lungs (pulmonary embolism), or other parts of the body, as well as recurrent miscarriages in women.""]","[""Factor V Leiden thrombophilia may not cause any symptoms, but it can lead to blood clots in veins, which can cause pain, swelling, redness, and warmth in the affected area.""]","[""Symptoms of FVL thrombophilia may include blood clots in the legs (deep vein thrombosis), blood clots in the lungs (pulmonary embolism), and recurrent miscarriages in women.""]",[true],[true],[true],"[""The symptoms of Factor V Leiden thrombophilia may include blood clots in the legs (deep vein thrombosis), blood clots in the lungs (pulmonary embolism), and blood clots in other parts of the body.""]","[""Symptoms of Factor V Leiden thrombophilia may include blood clots in the legs (deep vein thrombosis), lungs (pulmonary embolism), or other parts of the body, as well as recurrent miscarriages in women.""]","[""Symptoms of FVL thrombophilia may include blood clots in the legs (deep vein thrombosis), lungs (pulmonary embolism), or other parts of the body, as well as recurrent miscarriages in women.""]",[true],[true],[true],"[""The symptoms of Factor V Leiden (FVL) thrombophilia include blood clots in veins, particularly in the legs (deep vein thrombosis) or lungs (pulmonary embolism), swelling, pain, tenderness, and redness in the affected area.""]","[""The symptoms of Factor V Leiden thrombophilia may include blood clots in veins, such as deep vein thrombosis (DVT) or pulmonary embolism, and in some cases, miscarriages or stillbirths.""]","[""Symptoms of FVL thrombophilia may include blood clots in the legs (deep vein thrombosis), lungs (pulmonary embolism), or other parts of the body, as well as complications during pregnancy.""]",[true],[true],[true],"[""The symptoms of Factor V Leiden thrombophilia may include blood clots in veins, particularly in the legs (deep vein thrombosis) or lungs (pulmonary embolism), swelling, pain, tenderness, or redness in the affected area.""]","[""Factor V Leiden thrombophilia may not have any symptoms, but it can lead to abnormal blood clotting which may cause deep vein thrombosis, pulmonary embolism, or other clot-related complications.""]","[""Symptoms of FVL thrombophilia may include blood clots in the legs (deep vein thrombosis), lungs (pulmonary embolism), or other parts of the body, as well as complications during pregnancy.""]",[true],[true],[true],"[""The symptoms of Factor V Leiden (FVL) thrombophilia include blood clots in veins, particularly in the legs (deep vein thrombosis) or lungs (pulmonary embolism), swelling, pain, tenderness, and redness in the affected area.""]","[""Factor V Leiden thrombophilia may not cause any symptoms, but it can lead to blood clots in veins, which can cause pain, swelling, redness, and warmth in the affected area.""]","[""Symptoms of FVL thrombophilia may include blood clots in the legs (deep vein thrombosis), blood clots in the lungs (pulmonary embolism), and recurrent miscarriages in women.""]",[true],[true],[true],"[""The symptoms of FVL (Factor V Leiden) thrombophilia may include blood clots in the legs (deep vein thrombosis), blood clots in the lungs (pulmonary embolism), and in some cases, blood clots in other parts of the body.""]","[""The symptoms of Factor V Leiden thrombophilia may include blood clots in veins, such as deep vein thrombosis (DVT) or pulmonary embolism, and in some cases, miscarriages or stillbirths.""]","[""Symptoms of FVL thrombophilia may include blood clots in the legs (deep vein thrombosis), lungs (pulmonary embolism), or other parts of the body, as well as complications during pregnancy.""]",[true],[true],[true],"[""The symptoms of FVL (Factor V Leiden) thrombophilia may include blood clots in the legs (deep vein thrombosis), blood clots in the lungs (pulmonary embolism), and recurrent miscarriages in women.""]","[""Symptoms of Factor V Leiden thrombophilia may include blood clots in the legs (deep vein thrombosis), lungs (pulmonary embolism), or other parts of the body, as well as recurrent miscarriages in women.""]","[""Symptoms of FVL thrombophilia may include blood clots in the legs (deep vein thrombosis), lungs (pulmonary embolism), or other parts of the body, as well as recurrent miscarriages in women.""]",[true],[true],[true],"[""Symptoms of FVL thrombophilia may include blood clots in the legs (deep vein thrombosis), lungs (pulmonary embolism), or other parts of the body, as well as complications during pregnancy.""]","[""Factor V Leiden thrombophilia may not have any symptoms, but it can lead to abnormal blood clotting which may cause deep vein thrombosis, pulmonary embolism, or other clot-related complications.""]","[""Symptoms of FVL thrombophilia may include blood clots in the legs (deep vein thrombosis), lungs (pulmonary embolism), or other parts of the body, as well as complications during pregnancy.""]",[true],[true],[true],"[""The symptoms of Factor V Leiden thrombophilia may include blood clots in veins, particularly deep vein thrombosis (DVT) or pulmonary embolism. Some individuals may not have any symptoms until a blood clot occurs.""]","[""Factor V Leiden thrombophilia may not cause any symptoms, but it can lead to blood clots in veins, which can cause pain, swelling, redness, and warmth in the affected area.""]","[""Symptoms of FVL thrombophilia may include blood clots in the legs (deep vein thrombosis), blood clots in the lungs (pulmonary embolism), and recurrent miscarriages in women.""]",[true],[true],[true],"[""Symptoms of FVL thrombophilia may include blood clots in the legs (deep vein thrombosis) or lungs (pulmonary embolism), swelling, pain, warmth, and redness in the affected area.""]","[""Symptoms of Factor V Leiden thrombophilia may include blood clots in the legs (deep vein thrombosis), lungs (pulmonary embolism), or other parts of the body, as well as recurrent miscarriages in women.""]","[""Symptoms of FVL thrombophilia may include blood clots in the legs (deep vein thrombosis), lungs (pulmonary embolism), or other parts of the body, as well as recurrent miscarriages in women.""]",[true],[true],[true],"[""Symptoms of FVL thrombophilia may include blood clots in the legs (deep vein thrombosis), lungs (pulmonary embolism), or other parts of the body, as well as recurrent miscarriages in women.""]","[""The symptoms of Factor V Leiden thrombophilia may include blood clots in veins, such as deep vein thrombosis (DVT) or pulmonary embolism, and in some cases, miscarriages or stillbirths.""]","[""Symptoms of FVL thrombophilia may include blood clots in the legs (deep vein thrombosis), lungs (pulmonary embolism), or other parts of the body, as well as complications during pregnancy.""]",[true],[true],[true],"[""Symptoms of FVL thrombophilia may include blood clots in the legs (deep vein thrombosis) or lungs (pulmonary embolism), swelling, pain, warmth, and redness in the affected area.""]","[""Factor V Leiden thrombophilia may not have any symptoms, but it can lead to abnormal blood clotting which may cause deep vein thrombosis, pulmonary embolism, or other clot-related complications.""]","[""Symptoms of FVL thrombophilia may include blood clots in the legs (deep vein thrombosis), lungs (pulmonary embolism), or other parts of the body, as well as complications during pregnancy.""]",[true],[true],[true],"[""Symptoms of FVL thrombophilia may include blood clots in the legs (deep vein thrombosis) or lungs (pulmonary embolism), swelling, pain, warmth, and redness in the affected area.""]","[""Factor V Leiden thrombophilia may not cause any symptoms, but it can lead to blood clots in veins, which can cause pain, swelling, redness, and warmth in the affected area.""]","[""Symptoms of FVL thrombophilia may include blood clots in the legs (deep vein thrombosis), blood clots in the lungs (pulmonary embolism), and recurrent miscarriages in women.""]",[true],[true],[true],"[""Symptoms of FVL thrombophilia include blood clots in veins, especially in the legs (deep vein thrombosis) or lungs (pulmonary embolism), and in some cases, miscarriages or stillbirths.""]","[""Symptoms of Factor V Leiden thrombophilia may include blood clots in the legs (deep vein thrombosis), lungs (pulmonary embolism), or other parts of the body, as well as recurrent miscarriages in women.""]","[""Symptoms of FVL thrombophilia may include blood clots in the legs (deep vein thrombosis), lungs (pulmonary embolism), or other parts of the body, as well as recurrent miscarriages in women.""]",[true],[true],[true],"[""Symptoms of FVL thrombophilia may include blood clots in the legs (deep vein thrombosis), lungs (pulmonary embolism), or other parts of the body, as well as recurrent miscarriages in women.""]","[""The symptoms of Factor V Leiden thrombophilia may include blood clots in veins, such as deep vein thrombosis (DVT) or pulmonary embolism, and in some cases, miscarriages or stillbirths.""]","[""Symptoms of FVL thrombophilia may include blood clots in the legs (deep vein thrombosis), lungs (pulmonary embolism), or other parts of the body, as well as complications during pregnancy.""]",[true],[true],[true],"[""Symptoms of FVL thrombophilia may include blood clots in veins, especially in the legs (deep vein thrombosis), lungs (pulmonary embolism), or other parts of the body. Some individuals may not have any symptoms until a blood clot occurs.""]","[""Factor V Leiden thrombophilia may not have any symptoms, but it can lead to abnormal blood clotting which may cause deep vein thrombosis, pulmonary embolism, or other clot-related complications.""]","[""Symptoms of FVL thrombophilia may include blood clots in the legs (deep vein thrombosis), lungs (pulmonary embolism), or other parts of the body, as well as complications during pregnancy.""]",[true],[true],[true],"[""Symptoms of FVL thrombophilia may include blood clots in the legs (deep vein thrombosis), lungs (pulmonary embolism), or other parts of the body, as well as recurrent miscarriages in women.""]","[""Factor V Leiden thrombophilia may not cause any symptoms, but it can lead to blood clots in veins, which can cause pain, swelling, redness, and warmth in the affected area.""]","[""Symptoms of FVL thrombophilia may include blood clots in the legs (deep vein thrombosis), blood clots in the lungs (pulmonary embolism), and recurrent miscarriages in women.""]",[true],[true],[true],"[""Symptoms of FVL thrombophilia may include blood clots in the legs (deep vein thrombosis), lungs (pulmonary embolism), or other parts of the body, as well as recurrent miscarriages in women.""]","[""Symptoms of Factor V Leiden thrombophilia may include blood clots in the legs (deep vein thrombosis), lungs (pulmonary embolism), or other parts of the body, as well as recurrent miscarriages in women.""]","[""Symptoms of FVL thrombophilia may include blood clots in the legs (deep vein thrombosis), lungs (pulmonary embolism), or other parts of the body, as well as recurrent miscarriages in women.""]",[true],[true],[true],"[""The symptoms of Factor V Leiden thrombophilia may include blood clots in veins, such as deep vein thrombosis (DVT) or pulmonary embolism. Some individuals may not experience any symptoms until a blood clot occurs.""]","[""The symptoms of Factor V Leiden thrombophilia may include blood clots in veins, such as deep vein thrombosis (DVT) or pulmonary embolism, and in some cases, miscarriages or stillbirths.""]","[""Symptoms of FVL thrombophilia may include blood clots in the legs (deep vein thrombosis), lungs (pulmonary embolism), or other parts of the body, as well as complications during pregnancy.""]",[true],[true],[true],"[""The symptoms of Factor V Leiden thrombophilia may include blood clots in the legs (deep vein thrombosis), lungs (pulmonary embolism), or other parts of the body, as well as recurrent miscarriages in women.""]","[""Factor V Leiden thrombophilia may not have any symptoms, but it can lead to abnormal blood clotting which may cause deep vein thrombosis, pulmonary embolism, or other clot-related complications.""]","[""Symptoms of FVL thrombophilia may include blood clots in the legs (deep vein thrombosis), lungs (pulmonary embolism), or other parts of the body, as well as complications during pregnancy.""]",[true],[true],[true],"[""Symptoms of FVL thrombophilia may include blood clots in the legs (deep vein thrombosis), lungs (pulmonary embolism), or other parts of the body, as well as recurrent miscarriages in women.""]","[""Factor V Leiden thrombophilia may not cause any symptoms, but it can lead to blood clots in veins, which can cause pain, swelling, redness, and warmth in the affected area.""]","[""Symptoms of FVL thrombophilia may include blood clots in the legs (deep vein thrombosis), blood clots in the lungs (pulmonary embolism), and recurrent miscarriages in women.""]",[true],[true],[true],"[""The symptoms of FVL (Factor V Leiden) thrombophilia may include blood clots in veins, particularly deep vein thrombosis (DVT) or pulmonary embolism.""]","[""Symptoms of Factor V Leiden thrombophilia may include blood clots in the legs (deep vein thrombosis), lungs (pulmonary embolism), or other parts of the body, as well as recurrent miscarriages in women.""]","[""Symptoms of FVL thrombophilia may include blood clots in the legs (deep vein thrombosis), lungs (pulmonary embolism), or other parts of the body, as well as recurrent miscarriages in women.""]",[true],[true],[true],"[""The symptoms of FVL (Factor V Leiden) thrombophilia may include blood clots in veins, particularly deep vein thrombosis (DVT) and pulmonary embolism.""]","[""The symptoms of Factor V Leiden thrombophilia may include blood clots in veins, such as deep vein thrombosis (DVT) or pulmonary embolism, and in some cases, miscarriages or stillbirths.""]","[""Symptoms of FVL thrombophilia may include blood clots in the legs (deep vein thrombosis), lungs (pulmonary embolism), or other parts of the body, as well as complications during pregnancy.""]",[true],[true],[true],"[""The symptoms of FVL (Factor V Leiden) thrombophilia may include blood clots in veins, particularly deep vein thrombosis (DVT) or pulmonary embolism. Some individuals may not experience any symptoms until a blood clot occurs.""]","[""Factor V Leiden thrombophilia may not have any symptoms, but it can lead to abnormal blood clotting which may cause deep vein thrombosis, pulmonary embolism, or other clot-related complications.""]","[""Symptoms of FVL thrombophilia may include blood clots in the legs (deep vein thrombosis), lungs (pulmonary embolism), or other parts of the body, as well as complications during pregnancy.""]",[true],[true],[true],"[""The symptoms of FVL (Factor V Leiden) thrombophilia may include blood clots in veins, especially in the legs (deep vein thrombosis) or lungs (pulmonary embolism), swelling, pain, tenderness, and redness in the affected area.""]","[""Factor V Leiden thrombophilia may not cause any symptoms, but it can lead to blood clots in veins, which can cause pain, swelling, redness, and warmth in the affected area.""]","[""Symptoms of FVL thrombophilia may include blood clots in the legs (deep vein thrombosis), blood clots in the lungs (pulmonary embolism), and recurrent miscarriages in women.""]",[true],[true],[true],"[""Symptoms of FVL thrombophilia may include blood clots in veins, particularly in the legs or lungs, swelling, pain, tenderness, and redness in the affected area.""]","[""Symptoms of Factor V Leiden thrombophilia may include blood clots in the legs (deep vein thrombosis), lungs (pulmonary embolism), or other parts of the body, as well as recurrent miscarriages in women.""]","[""Symptoms of FVL thrombophilia may include blood clots in the legs (deep vein thrombosis), lungs (pulmonary embolism), or other parts of the body, as well as recurrent miscarriages in women.""]",[true],[true],[true],"[""Symptoms of FVL thrombophilia may include blood clots in the legs (deep vein thrombosis) or lungs (pulmonary embolism), swelling, pain, redness, warmth in the affected area, and in some cases, no symptoms at all.""]","[""Symptoms of Factor V Leiden thrombophilia may include blood clots in the legs (deep vein thrombosis), lungs (pulmonary embolism), or other parts of the body, as well as recurrent miscarriages in women.""]","[""Symptoms of FVL thrombophilia may include blood clots in the legs (deep vein thrombosis), lungs (pulmonary embolism), or other parts of the body, as well as recurrent miscarriages in women.""]",[true],[true],[true],"[""The symptoms of FVL thrombophilia may include blood clots in the legs (deep vein thrombosis), blood clots in the lungs (pulmonary embolism), and in some cases, blood clots in other parts of the body.""]","[""Symptoms of Factor V Leiden thrombophilia may include blood clots in the legs (deep vein thrombosis), lungs (pulmonary embolism), or other parts of the body, as well as recurrent miscarriages in women.""]","[""Symptoms of FVL thrombophilia may include blood clots in the legs (deep vein thrombosis), lungs (pulmonary embolism), or other parts of the body, as well as recurrent miscarriages in women.""]",[true],[true],[true],"[""Symptoms of FVL thrombophilia may include blood clots in veins, especially in legs or lungs, swelling, pain, and redness in the affected area.""]","[""Symptoms of Factor V Leiden thrombophilia may include blood clots in the legs (deep vein thrombosis), lungs (pulmonary embolism), or other parts of the body, as well as recurrent miscarriages in women.""]","[""Symptoms of FVL thrombophilia may include blood clots in the legs (deep vein thrombosis), lungs (pulmonary embolism), or other parts of the body, as well as recurrent miscarriages in women.""]"
frequency,How many people are affected by autosomal recessive hyper-IgE syndrome ?,AR-HIES is a rare disorder whose prevalence is unknown.,"{""full_form_abbrv_map"": [{""ambiguity_type"": ""abbreviation"", ""abbreviation"": ""IgE"", ""full_form"": ""Immunoglobulin E""}]}",How many people are affected by autosomal recessive hyper-IgE syndrome ?,How many people are affected by autosomal recessive hyper-Immunoglobulin E syndrome ?,8,MEDICAL,Simple Datatype-Integer,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Iguela, Gabon"", ""Iowa Grade Equivalent"", ""Iglesia Guatemalteca en Exilio"", ""ImmunoGlobin E"", ""Institute for Global Engagement"", ""Initiative for Globus in Europe"", ""Innovative Giving Enhancement"", ""interactive Grammar of English"", ""Individually Guided Education"", ""Internet Gaming Entertainment""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Immunoglobulin E""]",[8.288154351235062e-09],[8.288154351235062e-09],"[""Immunoglobulin E""]",[8.288154351235062e-09],"[""LLM""]","[[1.154964322285862e-18, 2.593565996653561e-20, 5.146240406488145e-34, 4.828196608521556e-10, 9.174675415189203e-18, 5.363720698840543e-26, 1.6307686043793067e-17, 8.253498869425021e-18, 4.2302289357222165e-18, 1.2119557039970032e-19]]",[0.9758717395891663],[0.9758717395891663],"[""Internet Gaming Entertainment""]",[0.9758717395891663],"[""LLM""]","[[0.8855852976089267, 0.9091405439807594, 0.9101116514795061, 0.9727981397803991, 0.9290100932049898, 0.9178476380531024, 0.9267210117831901, 0.9093363259722052, 0.9056518177745422, 0.8842099990161782]]","[""ImmunoGlobin E""]","[""ABBREVIATIONS""]",How many people are affected by autosomal recessive hyper-IgE (Immunoglobulin E) syndrome ?,[true],[true],[false],"[""Autosomal recessive hyper-IgE syndrome affects a very small number of individuals worldwide.""]","[""Autosomal recessive hyper-Immunoglobulin E syndrome affects a very small number of individuals worldwide.""]","[""Autosomal recessive hyper-IgE syndrome affects an estimated 1 in 1,000,000 individuals.""]",[true],[true],[true],"[""Autosomal recessive hyper-IgE syndrome affects a very small number of individuals worldwide.""]","[""Autosomal recessive hyper-Immunoglobulin E syndrome affects a very small number of people worldwide.""]","[""Autosomal recessive hyper-IgE syndrome affects a very small number of individuals worldwide.""]",[true],[true],[false],"[""Autosomal recessive hyper-IgE syndrome affects a very small number of individuals worldwide.""]","[""Autosomal recessive hyper-Immunoglobulin E syndrome affects a very small number of people worldwide.""]","[""Autosomal recessive hyper-IgE syndrome affects an estimated 1 in 1,000,000 individuals.""]",[true],[true],[false],"[""Autosomal recessive hyper-IgE syndrome affects a very small number of individuals worldwide.""]","[""Autosomal recessive hyper-Immunoglobulin E syndrome affects a very small number of individuals worldwide.""]","[""Autosomal recessive hyper-IgE syndrome affects an estimated 1 in 1,000,000 individuals.""]",[true],[true],[false],"[""Autosomal recessive hyper-IgE syndrome is a rare condition, affecting a very small number of individuals worldwide.""]","[""Autosomal recessive hyper-Immunoglobulin E syndrome affects a very small number of individuals worldwide.""]","[""Autosomal recessive hyper-IgE syndrome affects an estimated 1 in 1,000,000 individuals.""]",[true],[true],[true],"[""Autosomal recessive hyper-IgE syndrome is a rare condition, and the exact number of people affected is not well documented. It is estimated to affect fewer than 1 in 1,000,000 individuals.""]","[""Autosomal recessive hyper-Immunoglobulin E syndrome affects a very small number of people worldwide.""]","[""Autosomal recessive hyper-IgE syndrome affects a very small number of individuals worldwide.""]",[true],[true],[false],"[""Autosomal recessive hyper-IgE syndrome is a rare condition, affecting only a small number of individuals worldwide.""]","[""Autosomal recessive hyper-Immunoglobulin E syndrome affects a very small number of people worldwide.""]","[""Autosomal recessive hyper-IgE syndrome affects an estimated 1 in 1,000,000 individuals.""]",[true],[true],[false],"[""Autosomal recessive hyper-IgE syndrome affects a very small number of individuals worldwide.""]","[""Autosomal recessive hyper-Immunoglobulin E syndrome affects a very small number of individuals worldwide.""]","[""Autosomal recessive hyper-IgE syndrome affects an estimated 1 in 1,000,000 individuals.""]",[true],[true],[true],"[""Autosomal recessive hyper-IgE syndrome affects a very small number of individuals worldwide.""]","[""Autosomal recessive hyper-Immunoglobulin E syndrome affects a very small number of people worldwide.""]","[""Autosomal recessive hyper-IgE syndrome affects a very small number of individuals worldwide.""]",[true],[true],[false],"[""Autosomal recessive hyper-IgE syndrome affects a very small number of people worldwide.""]","[""Autosomal recessive hyper-Immunoglobulin E syndrome affects a very small number of individuals worldwide.""]","[""Autosomal recessive hyper-IgE syndrome affects an estimated 1 in 1,000,000 individuals.""]",[true],[true],[false],"[""Autosomal recessive Hyper-IgE syndrome affects a very small number of individuals worldwide.""]","[""Autosomal recessive hyper-Immunoglobulin E syndrome affects a very small number of people worldwide.""]","[""Autosomal recessive hyper-IgE syndrome affects an estimated 1 in 1,000,000 individuals.""]",[true],[true],[false],"[""Autosomal recessive hyper-IgE syndrome affects a very small number of individuals worldwide.""]","[""Autosomal recessive hyper-Immunoglobulin E syndrome affects a very small number of individuals worldwide.""]","[""Autosomal recessive hyper-IgE syndrome affects an estimated 1 in 1,000,000 individuals.""]",[true],[true],[false],"[""Autosomal recessive hyper-IgE syndrome is a rare condition, affecting a very small number of individuals worldwide.""]","[""Autosomal recessive hyper-Immunoglobulin E syndrome affects a very small number of individuals worldwide.""]","[""Autosomal recessive hyper-IgE syndrome affects an estimated 1 in 1,000,000 individuals.""]",[true],[true],[true],"[""Autosomal recessive hyper-IgE syndrome is a rare condition, affecting only a small number of individuals worldwide.""]","[""Autosomal recessive hyper-Immunoglobulin E syndrome affects a very small number of people worldwide.""]","[""Autosomal recessive hyper-IgE syndrome affects a very small number of individuals worldwide.""]",[true],[true],[false],"[""Autosomal recessive hyper-IgE syndrome is a rare condition, affecting only a small number of individuals worldwide.""]","[""Autosomal recessive hyper-Immunoglobulin E syndrome affects a very small number of people worldwide.""]","[""Autosomal recessive hyper-IgE syndrome affects an estimated 1 in 1,000,000 individuals.""]",[true],[true],[false],"[""Autosomal recessive hyper-IgE syndrome affects a very small number of individuals worldwide.""]","[""Autosomal recessive hyper-Immunoglobulin E syndrome affects a very small number of individuals worldwide.""]","[""Autosomal recessive hyper-IgE syndrome affects an estimated 1 in 1,000,000 individuals.""]",[true],[true],[false],"[""Autosomal recessive hyper-IgE syndrome affects a very small number of individuals worldwide.""]","[""Autosomal recessive hyper-Immunoglobulin E syndrome affects a very small number of individuals worldwide.""]","[""Autosomal recessive hyper-IgE syndrome affects an estimated 1 in 1,000,000 individuals.""]",[true],[true],[true],"[""Autosomal recessive hyper-IgE syndrome affects a very small number of individuals worldwide.""]","[""Autosomal recessive hyper-Immunoglobulin E syndrome affects a very small number of people worldwide.""]","[""Autosomal recessive hyper-IgE syndrome affects a very small number of individuals worldwide.""]",[true],[true],[false],"[""Autosomal recessive hyper-IgE syndrome affects a very small number of individuals worldwide.""]","[""Autosomal recessive hyper-Immunoglobulin E syndrome affects a very small number of people worldwide.""]","[""Autosomal recessive hyper-IgE syndrome affects an estimated 1 in 1,000,000 individuals.""]",[true],[true],[false],"[""Autosomal recessive hyper-IgE syndrome affects a very small number of individuals worldwide.""]","[""Autosomal recessive hyper-Immunoglobulin E syndrome affects a very small number of individuals worldwide.""]","[""Autosomal recessive hyper-IgE syndrome affects an estimated 1 in 1,000,000 individuals.""]",[true],[true],[false],"[""Autosomal recessive hyper-IgE syndrome affects a very small number of individuals worldwide.""]","[""Autosomal recessive hyper-Immunoglobulin E syndrome affects a very small number of individuals worldwide.""]","[""Autosomal recessive hyper-IgE syndrome affects an estimated 1 in 1,000,000 individuals.""]",[true],[true],[true],"[""Autosomal recessive hyper-IgE syndrome affects a very small number of individuals worldwide.""]","[""Autosomal recessive hyper-Immunoglobulin E syndrome affects a very small number of people worldwide.""]","[""Autosomal recessive hyper-IgE syndrome affects a very small number of individuals worldwide.""]",[true],[true],[false],"[""Autosomal recessive hyper-IgE syndrome affects a very small number of individuals worldwide.""]","[""Autosomal recessive hyper-Immunoglobulin E syndrome affects a very small number of people worldwide.""]","[""Autosomal recessive hyper-IgE syndrome affects an estimated 1 in 1,000,000 individuals.""]",[true],[true],[false],"[""Autosomal recessive hyper-IgE syndrome affects a very small number of individuals worldwide.""]","[""Autosomal recessive hyper-Immunoglobulin E syndrome affects a very small number of individuals worldwide.""]","[""Autosomal recessive hyper-IgE syndrome affects an estimated 1 in 1,000,000 individuals.""]",[true],[true],[false],"[""Autosomal recessive hyper-IgE syndrome affects a very small number of individuals worldwide.""]","[""Autosomal recessive hyper-Immunoglobulin E syndrome affects a very small number of individuals worldwide.""]","[""Autosomal recessive hyper-IgE syndrome affects an estimated 1 in 1,000,000 individuals.""]",[false],[true],[true],"[""Autosomal recessive hyper-IgE syndrome affects an estimated 1 in 1,000,000 individuals worldwide.""]","[""Autosomal recessive hyper-Immunoglobulin E syndrome affects a very small number of people worldwide.""]","[""Autosomal recessive hyper-IgE syndrome affects a very small number of individuals worldwide.""]",[true],[true],[false],"[""Autosomal recessive hyper-IgE syndrome affects a very small number of individuals worldwide.""]","[""Autosomal recessive hyper-Immunoglobulin E syndrome affects a very small number of people worldwide.""]","[""Autosomal recessive hyper-IgE syndrome affects an estimated 1 in 1,000,000 individuals.""]",[true],[true],[false],"[""Autosomal recessive hyper-IgE syndrome is a rare condition, affecting a very small number of individuals worldwide.""]","[""Autosomal recessive hyper-Immunoglobulin E syndrome affects a very small number of individuals worldwide.""]","[""Autosomal recessive hyper-IgE syndrome affects an estimated 1 in 1,000,000 individuals.""]",[true],[true],[false],"[""Autosomal recessive hyper-IgE syndrome is a rare condition, affecting a small number of individuals worldwide.""]","[""Autosomal recessive hyper-Immunoglobulin E syndrome affects a very small number of individuals worldwide.""]","[""Autosomal recessive hyper-IgE syndrome affects an estimated 1 in 1,000,000 individuals.""]",[true],[true],[false],"[""Autosomal recessive hyper-IgE syndrome is a rare condition, affecting a very small number of individuals worldwide.""]","[""Autosomal recessive hyper-Immunoglobulin E syndrome affects a very small number of individuals worldwide.""]","[""Autosomal recessive hyper-IgE syndrome affects an estimated 1 in 1,000,000 individuals.""]",[true],[true],[false],"[""Autosomal recessive hyper-IgE syndrome is a rare condition, affecting a very small number of individuals worldwide.""]","[""Autosomal recessive hyper-Immunoglobulin E syndrome affects a very small number of individuals worldwide.""]","[""Autosomal recessive hyper-IgE syndrome affects an estimated 1 in 1,000,000 individuals.""]",[true],[true],[false],"[""Autosomal recessive hyper-IgE syndrome is a rare condition, affecting a very small number of individuals worldwide.""]","[""Autosomal recessive hyper-Immunoglobulin E syndrome affects a very small number of individuals worldwide.""]","[""Autosomal recessive hyper-IgE syndrome affects an estimated 1 in 1,000,000 individuals.""]"
exams and tests,How to diagnose Cramp-fasciculation syndrome ?,"How is cramp-fasciculation syndrome diagnosed?  A diagnosis of cramp-fasciculation syndrome is generally based on the presence of characteristic signs and symptoms. Namely, a history of frequent muscle cramps, twitching, and pain (often worsened by exercise) without muscle weakness or wasting is suggestive of the condition. It is also important to rule out other conditions that may cause similar features. Electromyography (EMG) or repetitive nerve stimulation studies may also be done to assess the health of muscles and the nerves that control them. In repetitive nerve stimulation studies, muscle responses are recorded when the nerves are repetitively stimulated by small pulses of electricity.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""CFS"", ""full_form"": ""Cramp-fasciculation syndrome""}]}",How to diagnose CFS ?,How to diagnose Cramp-fasciculation syndrome ?,8,MEDICAL,Compound Datatype-String,"Instructional: Queries specifically seeking step-by-step guidance, instructions, or procedures to perform a task. it focuses on 'how' to do something rather than 'what', 'why', or 'which'.","[[""Chronic Fatigue Syndrome"", ""Combat Flight Simulator"", ""Canadian Federation of Students"", ""Container Freight Station"", ""Center for Food Safety"", ""Child and Family Services"", ""Cubic Feet per Second"", ""Commodity Flow Survey"", ""Cryptographic File System"", ""Certified Fund Specialist""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Chronic Fatigue Syndrome""]",[2.0511887786033063e-16],[4.0885862941101646e-09],"[""Chronic Fatigue Syndrome""]",[4.0885862941101646e-09],"[""ABBREVIATIONS""]","[[4.0885862941101646e-09, 6.2742878141846445e-19, 7.872864020988173e-24, 6.3408940770056e-19, 3.514599505540593e-15, 9.75436710403498e-11, 4.65394808115331e-15, 4.8089995534886296e-18, 3.3209226770008563e-18, 9.77490579129503e-17]]",[0.7856770725048684],[0.9479380569119917],"[""Cramp-fasciculation syndrome""]",[0.9479752390229973],"[""ABBREVIATIONS""]","[[0.9479752390229973, 0.6817365884864675, 0.7448488358742451, 0.6502263134308935, 0.741882157303684, 0.7036881746620122, 0.651481179905326, 0.6688527931315208, 0.6621502055715272, 0.7017851817269798]]","[""Chronic Fatigue Syndrome""]","[""ABBREVIATIONS""]",How to diagnose CFS (Chronic Fatigue Syndrome) ?,[false],[true],[false],"[""Diagnosing CFS involves ruling out other possible causes of the symptoms, conducting a thorough medical history and physical examination, and performing specific tests such as blood tests, imaging studies, and sleep studies.""]","[""Diagnosis of Cramp-fasciculation syndrome involves a thorough medical history, physical examination, and tests such as electromyography (EMG) and nerve conduction studies.""]","[""Chronic Fatigue Syndrome (CFS) is diagnosed based on symptoms, medical history, physical examination, and ruling out other possible conditions. There is no specific test for CFS, so healthcare providers may order blood tests, imaging studies, and other tests to rule out other conditions with similar symptoms.""]",[false],[true],[false],"[""Diagnosing CFS involves ruling out other potential causes of fatigue through medical history, physical examination, and specific tests such as blood tests, imaging studies, and sleep studies.""]","[""Diagnosis of Cramp-fasciculation syndrome involves a thorough medical history, physical examination, electromyography (EMG), nerve conduction studies, and blood tests to rule out other conditions.""]","[""Diagnosing Chronic Fatigue Syndrome (CFS) involves ruling out other possible causes of the symptoms through a thorough medical history, physical examination, and specific tests such as blood tests, imaging studies, and other specialized tests as needed.""]",[false],[true],[false],"[""Diagnosing CFS involves ruling out other possible causes of fatigue, conducting a thorough medical history and physical examination, and performing specific tests such as blood tests, imaging studies, and sleep studies.""]","[""Diagnosis of Cramp-fasciculation syndrome involves a thorough medical history, physical examination, and tests such as electromyography (EMG) and nerve conduction studies.""]","[""Chronic Fatigue Syndrome (CFS) is diagnosed through a thorough medical history, physical examination, and ruling out other possible causes of symptoms. There is no specific test for CFS, so the diagnosis is based on symptoms and medical evaluation.""]",[false],[true],[false],"[""Diagnosing CFS involves ruling out other medical conditions with similar symptoms, conducting a thorough medical history and physical examination, and performing specific tests such as blood tests, imaging studies, and sleep studies.""]","[""Diagnosing Cramp-fasciculation syndrome involves a thorough medical history, physical examination, and tests such as electromyography (EMG) and nerve conduction studies.""]","[""Diagnosing Chronic Fatigue Syndrome (CFS) involves ruling out other possible causes of the symptoms through a thorough medical history, physical examination, and specific tests such as blood tests, imaging studies, and other specialized tests as needed.""]",[false],[true],[false],"[""Diagnosing CFS involves a thorough medical history, physical examination, blood tests, and electromyography (EMG) to assess muscle activity.""]","[""Diagnosis of Cramp-fasciculation syndrome involves a thorough medical history, physical examination, and tests such as electromyography (EMG) and nerve conduction studies.""]","[""Chronic Fatigue Syndrome (CFS) is diagnosed based on symptoms, medical history, physical examination, and ruling out other possible conditions. There is no specific test for CFS, so healthcare providers may order blood tests, imaging studies, and other tests to rule out other conditions with similar symptoms.""]",[false],[true],[false],"[""Diagnosing CFS involves a thorough medical history, physical examination, blood tests, and electromyography (EMG) to assess muscle activity.""]","[""Diagnosis of Cramp-fasciculation syndrome involves a thorough medical history, physical examination, electromyography (EMG), nerve conduction studies, and blood tests to rule out other conditions.""]","[""Diagnosing Chronic Fatigue Syndrome (CFS) involves ruling out other possible causes of the symptoms through a thorough medical history, physical examination, and specific tests such as blood tests, imaging studies, and other specialized tests as needed.""]",[true],[true],[false],"[""Diagnosis of CFS (Cramp-fasciculation syndrome) involves a thorough medical history, physical examination, blood tests, electromyography (EMG), and nerve conduction studies.""]","[""Diagnosis of Cramp-fasciculation syndrome involves a thorough medical history, physical examination, and tests such as electromyography (EMG) and nerve conduction studies.""]","[""Chronic Fatigue Syndrome (CFS) is diagnosed through a thorough medical history, physical examination, and ruling out other possible causes of symptoms. There is no specific test for CFS, so the diagnosis is based on symptoms and medical evaluation.""]",[false],[true],[false],"[""Diagnosing CFS involves a thorough medical history, physical examination, and tests to rule out other conditions with similar symptoms. Electromyography (EMG) and nerve conduction studies may also be done to assess muscle and nerve function.""]","[""Diagnosing Cramp-fasciculation syndrome involves a thorough medical history, physical examination, and tests such as electromyography (EMG) and nerve conduction studies.""]","[""Diagnosing Chronic Fatigue Syndrome (CFS) involves ruling out other possible causes of the symptoms through a thorough medical history, physical examination, and specific tests such as blood tests, imaging studies, and other specialized tests as needed.""]",[false],[true],[false],"[""Diagnosing CFS involves ruling out other potential causes of fatigue through medical history, physical examination, and specific tests such as blood tests, imaging studies, and sleep studies.""]","[""Diagnosis of Cramp-fasciculation syndrome involves a thorough medical history, physical examination, electromyography (EMG), nerve conduction studies, and blood tests to rule out other conditions.""]","[""Diagnosing Chronic Fatigue Syndrome (CFS) involves ruling out other possible causes of the symptoms through a thorough medical history, physical examination, and specific tests such as blood tests, imaging studies, and other specialized tests as needed.""]",[false],[true],[false],"[""Diagnosing CFS involves ruling out other possible causes of the symptoms, conducting a thorough medical history and physical examination, and performing specific tests such as blood tests, imaging studies, and sleep studies.""]","[""Diagnosis of Cramp-fasciculation syndrome involves a thorough medical history, physical examination, and tests such as electromyography (EMG) and nerve conduction studies.""]","[""Chronic Fatigue Syndrome (CFS) is diagnosed based on symptoms, medical history, physical examination, and ruling out other possible conditions. There is no specific test for CFS, so healthcare providers may order blood tests, imaging studies, and other tests to rule out other conditions with similar symptoms.""]",[false],[true],[false],"[""Diagnosing CFS involves ruling out other possible causes of fatigue, conducting a thorough medical history and physical examination, and performing specific tests such as blood tests, imaging studies, and sleep studies.""]","[""Diagnosis of Cramp-fasciculation syndrome involves a thorough medical history, physical examination, and tests such as electromyography (EMG) and nerve conduction studies.""]","[""Chronic Fatigue Syndrome (CFS) is diagnosed through a thorough medical history, physical examination, and ruling out other possible causes of symptoms. There is no specific test for CFS, so the diagnosis is based on symptoms and medical evaluation.""]",[false],[true],[false],"[""Diagnosing CFS involves ruling out other possible causes of fatigue through medical history, physical examination, and specific tests such as blood tests, imaging studies, and sleep studies.""]","[""Diagnosing Cramp-fasciculation syndrome involves a thorough medical history, physical examination, and tests such as electromyography (EMG) and nerve conduction studies.""]","[""Diagnosing Chronic Fatigue Syndrome (CFS) involves ruling out other possible causes of the symptoms through a thorough medical history, physical examination, and specific tests such as blood tests, imaging studies, and other specialized tests as needed.""]",[false],[true],[false],"[""Diagnosing CFS involves ruling out other possible conditions with similar symptoms, conducting a thorough medical history and physical examination, and performing specific tests such as blood tests, imaging studies, and sleep studies.""]","[""Diagnosis of Cramp-fasciculation syndrome involves a thorough medical history, physical examination, and tests such as electromyography (EMG) and nerve conduction studies.""]","[""Chronic Fatigue Syndrome (CFS) is diagnosed based on symptoms, medical history, physical examination, and ruling out other possible conditions. There is no specific test for CFS, so healthcare providers may order blood tests, imaging studies, and other tests to rule out other conditions with similar symptoms.""]",[false],[true],[false],"[""Diagnosing CFS involves ruling out other possible causes of the symptoms, conducting a thorough medical history and physical examination, and performing specific tests such as blood tests, imaging studies, and sleep studies.""]","[""Diagnosis of Cramp-fasciculation syndrome involves a thorough medical history, physical examination, electromyography (EMG), nerve conduction studies, and blood tests to rule out other conditions.""]","[""Diagnosing Chronic Fatigue Syndrome (CFS) involves ruling out other possible causes of the symptoms through a thorough medical history, physical examination, and specific tests such as blood tests, imaging studies, and other specialized tests as needed.""]",[false],[true],[false],"[""Diagnosing CFS involves ruling out other possible causes of the symptoms, conducting a thorough medical history and physical examination, and performing specific tests such as blood tests, imaging studies, and sleep studies.""]","[""Diagnosis of Cramp-fasciculation syndrome involves a thorough medical history, physical examination, and tests such as electromyography (EMG) and nerve conduction studies.""]","[""Chronic Fatigue Syndrome (CFS) is diagnosed through a thorough medical history, physical examination, and ruling out other possible causes of symptoms. There is no specific test for CFS, so the diagnosis is based on symptoms and medical evaluation.""]",[false],[true],[false],"[""Diagnosing CFS involves ruling out other potential causes of fatigue through medical history, physical examination, and specific tests.""]","[""Diagnosing Cramp-fasciculation syndrome involves a thorough medical history, physical examination, and tests such as electromyography (EMG) and nerve conduction studies.""]","[""Diagnosing Chronic Fatigue Syndrome (CFS) involves ruling out other possible causes of the symptoms through a thorough medical history, physical examination, and specific tests such as blood tests, imaging studies, and other specialized tests as needed.""]",[false],[true],[false],"[""Diagnosing CFS involves ruling out other conditions with similar symptoms, conducting a thorough medical history and physical examination, and possibly performing blood tests, imaging studies, and other specialized tests as needed.""]","[""Diagnosis of Cramp-fasciculation syndrome involves a thorough medical history, physical examination, and tests such as electromyography (EMG) and nerve conduction studies.""]","[""Chronic Fatigue Syndrome (CFS) is diagnosed based on symptoms, medical history, physical examination, and ruling out other possible conditions. There is no specific test for CFS, so healthcare providers may order blood tests, imaging studies, and other tests to rule out other conditions with similar symptoms.""]",[false],[true],[false],"[""Diagnosing CFS involves ruling out other potential causes of fatigue through medical history, physical examination, and various tests such as blood tests, imaging studies, and sleep studies.""]","[""Diagnosis of Cramp-fasciculation syndrome involves a thorough medical history, physical examination, electromyography (EMG), nerve conduction studies, and blood tests to rule out other conditions.""]","[""Diagnosing Chronic Fatigue Syndrome (CFS) involves ruling out other possible causes of the symptoms through a thorough medical history, physical examination, and specific tests such as blood tests, imaging studies, and other specialized tests as needed.""]",[false],[true],[false],"[""Diagnosing CFS involves ruling out other possible causes of the symptoms, conducting a thorough medical history and physical examination, and performing specific tests such as blood tests, imaging studies, and sleep studies.""]","[""Diagnosis of Cramp-fasciculation syndrome involves a thorough medical history, physical examination, and tests such as electromyography (EMG) and nerve conduction studies.""]","[""Chronic Fatigue Syndrome (CFS) is diagnosed through a thorough medical history, physical examination, and ruling out other possible causes of symptoms. There is no specific test for CFS, so the diagnosis is based on symptoms and medical evaluation.""]",[false],[true],[false],"[""Diagnosing CFS involves ruling out other possible causes of the symptoms, conducting a thorough medical history and physical examination, and performing specific tests such as blood tests, imaging studies, and sleep studies.""]","[""Diagnosing Cramp-fasciculation syndrome involves a thorough medical history, physical examination, and tests such as electromyography (EMG) and nerve conduction studies.""]","[""Diagnosing Chronic Fatigue Syndrome (CFS) involves ruling out other possible causes of the symptoms through a thorough medical history, physical examination, and specific tests such as blood tests, imaging studies, and other specialized tests as needed.""]",[false],[true],[false],"[""Diagnosing CFS involves ruling out other possible causes of fatigue through medical history, physical examination, and specific tests such as blood tests, imaging studies, and sleep studies.""]","[""Diagnosis of Cramp-fasciculation syndrome involves a thorough medical history, physical examination, and tests such as electromyography (EMG) and nerve conduction studies.""]","[""Chronic Fatigue Syndrome (CFS) is diagnosed based on symptoms, medical history, physical examination, and ruling out other possible conditions. There is no specific test for CFS, so healthcare providers may order blood tests, imaging studies, and other tests to rule out other conditions with similar symptoms.""]",[false],[true],[false],"[""Diagnosing CFS involves ruling out other potential causes of fatigue through medical history, physical examination, and specific tests such as blood tests, imaging studies, and sleep studies.""]","[""Diagnosis of Cramp-fasciculation syndrome involves a thorough medical history, physical examination, electromyography (EMG), nerve conduction studies, and blood tests to rule out other conditions.""]","[""Diagnosing Chronic Fatigue Syndrome (CFS) involves ruling out other possible causes of the symptoms through a thorough medical history, physical examination, and specific tests such as blood tests, imaging studies, and other specialized tests as needed.""]",[false],[true],[false],"[""Diagnosing CFS involves ruling out other possible conditions with similar symptoms, conducting a thorough medical history and physical examination, and performing specific tests such as blood tests, imaging studies, and sleep studies.""]","[""Diagnosis of Cramp-fasciculation syndrome involves a thorough medical history, physical examination, and tests such as electromyography (EMG) and nerve conduction studies.""]","[""Chronic Fatigue Syndrome (CFS) is diagnosed through a thorough medical history, physical examination, and ruling out other possible causes of symptoms. There is no specific test for CFS, so the diagnosis is based on symptoms and medical evaluation.""]",[false],[true],[false],"[""Diagnosing CFS involves ruling out other medical conditions with similar symptoms, conducting a thorough medical history and physical examination, and performing specific tests such as blood tests, imaging studies, and sleep studies.""]","[""Diagnosing Cramp-fasciculation syndrome involves a thorough medical history, physical examination, and tests such as electromyography (EMG) and nerve conduction studies.""]","[""Diagnosing Chronic Fatigue Syndrome (CFS) involves ruling out other possible causes of the symptoms through a thorough medical history, physical examination, and specific tests such as blood tests, imaging studies, and other specialized tests as needed.""]",[false],[true],[false],"[""Diagnosing CFS involves ruling out other potential causes of fatigue, conducting a thorough medical history and physical examination, and possibly performing blood tests, imaging studies, and other specialized tests as needed.""]","[""Diagnosis of Cramp-fasciculation syndrome involves a thorough medical history, physical examination, and tests such as electromyography (EMG) and nerve conduction studies.""]","[""Chronic Fatigue Syndrome (CFS) is diagnosed based on symptoms, medical history, physical examination, and ruling out other possible conditions. There is no specific test for CFS, so healthcare providers may order blood tests, imaging studies, and other tests to rule out other conditions with similar symptoms.""]",[false],[true],[false],"[""Diagnosing CFS involves ruling out other possible causes of fatigue, conducting a thorough medical history and physical examination, and possibly performing blood tests, imaging studies, and other specialized tests as needed.""]","[""Diagnosis of Cramp-fasciculation syndrome involves a thorough medical history, physical examination, electromyography (EMG), nerve conduction studies, and blood tests to rule out other conditions.""]","[""Diagnosing Chronic Fatigue Syndrome (CFS) involves ruling out other possible causes of the symptoms through a thorough medical history, physical examination, and specific tests such as blood tests, imaging studies, and other specialized tests as needed.""]",[false],[true],[false],"[""Diagnosing CFS involves ruling out other possible causes of the symptoms, conducting a thorough medical history and physical examination, and performing specific tests such as blood tests, imaging studies, and sleep studies. A diagnosis is typically made based on symptoms that persist for at least 6 months and the exclusion of other medical conditions.""]","[""Diagnosis of Cramp-fasciculation syndrome involves a thorough medical history, physical examination, and tests such as electromyography (EMG) and nerve conduction studies.""]","[""Chronic Fatigue Syndrome (CFS) is diagnosed through a thorough medical history, physical examination, and ruling out other possible causes of symptoms. There is no specific test for CFS, so the diagnosis is based on symptoms and medical evaluation.""]",[false],[true],[false],"[""Diagnosing CFS involves ruling out other possible causes of the symptoms, conducting a thorough medical history and physical examination, and performing specific tests such as blood tests, imaging studies, and sleep studies.""]","[""Diagnosing Cramp-fasciculation syndrome involves a thorough medical history, physical examination, and tests such as electromyography (EMG) and nerve conduction studies.""]","[""Diagnosing Chronic Fatigue Syndrome (CFS) involves ruling out other possible causes of the symptoms through a thorough medical history, physical examination, and specific tests such as blood tests, imaging studies, and other specialized tests as needed.""]",[false],[true],[false],"[""Diagnosing CFS (Chronic Fatigue Syndrome) involves ruling out other potential causes of the symptoms, conducting a thorough medical history and physical examination, as well as specific tests such as blood tests, imaging studies, and other specialized tests as needed.""]","[""Diagnosis of Cramp-fasciculation syndrome involves a thorough medical history, physical examination, and tests such as electromyography (EMG) and nerve conduction studies.""]","[""Chronic Fatigue Syndrome (CFS) is diagnosed based on symptoms, medical history, physical examination, and ruling out other possible conditions. There is no specific test for CFS, so healthcare providers may order blood tests, imaging studies, and other tests to rule out other conditions with similar symptoms.""]",[false],[true],[false],"[""Diagnosing CFS involves ruling out other potential causes of the symptoms, conducting a thorough medical history and physical examination, as well as specific tests such as blood tests, imaging studies, and sleep studies.""]","[""Diagnosis of Cramp-fasciculation syndrome involves a thorough medical history, physical examination, and tests such as electromyography (EMG) and nerve conduction studies.""]","[""Chronic Fatigue Syndrome (CFS) is diagnosed based on symptoms, medical history, physical examination, and ruling out other possible conditions. There is no specific test for CFS, so healthcare providers may order blood tests, imaging studies, and other tests to rule out other conditions with similar symptoms.""]",[false],[true],[false],"[""Diagnosing CFS typically involves a thorough medical history, physical examination, and possibly nerve conduction studies or electromyography to assess muscle activity.""]","[""Diagnosis of Cramp-fasciculation syndrome involves a thorough medical history, physical examination, and tests such as electromyography (EMG) and nerve conduction studies.""]","[""Chronic Fatigue Syndrome (CFS) is diagnosed based on symptoms, medical history, physical examination, and ruling out other possible conditions. There is no specific test for CFS, so healthcare providers may order blood tests, imaging studies, and other tests to rule out other conditions with similar symptoms.""]",[false],[true],[false],"[""Diagnosing CFS (Chronic Fatigue Syndrome) involves ruling out other potential causes of the symptoms, conducting a thorough medical history and physical examination, as well as specific tests such as blood tests, imaging studies, and sleep studies.""]","[""Diagnosis of Cramp-fasciculation syndrome involves a thorough medical history, physical examination, and tests such as electromyography (EMG) and nerve conduction studies.""]","[""Chronic Fatigue Syndrome (CFS) is diagnosed based on symptoms, medical history, physical examination, and ruling out other possible conditions. There is no specific test for CFS, so healthcare providers may order blood tests, imaging studies, and other tests to rule out other conditions with similar symptoms.""]"
inheritance,Is Dentatorubral-pallidoluysian atrophy inherited ?,How is dentatorubral-pallidoluysian atrophy (DRPLA) inherited?,"{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""DRPLA"", ""full_form"": ""Dentatorubral-pallidoluysian atrophy""}]}",Is DRPLA inherited ?,Is Dentatorubral-pallidoluysian atrophy inherited ?,8,MEDICAL,Simple Datatype-Boolean,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Dentatorubral-Pallidoluysian Atrophy""]]","[[""THEFREEDICTIONARY""]]","[""Dentatorubral-Pallidoluysian Atrophy""]",[9.9378000217812e-46],[9.9378000217812e-46],"[""Dentatorubral-Pallidoluysian Atrophy""]",[9.9378000217812e-46],"[""THEFREEDICTIONARY""]",[[9.9378000217812e-46]],[0.9283504355064585],[0.9301307156332542],"[""Dentatorubral-Pallidoluysian Atrophy""]",[0.9301307156332542],"[""LLM""]",[[0.9301307156332539]],"[""Dentatorubral-Pallidoluysian Atrophy""]","[""THEFREEDICTIONARY""]",Is DRPLA (Dentatorubral-Pallidoluysian Atrophy) inherited ?,[false],[true],[false],"[""Yes""]","[""Yes, Dentatorubral-pallidoluysian atrophy is inherited.""]","[""Yes""]",[false],[true],[false],"[""Yes""]","[""Yes, Dentatorubral-pallidoluysian atrophy is inherited.""]","[""Yes""]",[false],[true],[false],"[""Yes""]","[""Yes, Dentatorubral-pallidoluysian atrophy is inherited in an autosomal dominant pattern.""]","[""Yes""]",[false],[true],[false],"[""Yes""]","[""Yes, Dentatorubral-pallidoluysian atrophy is inherited.""]","[""Yes""]",[false],[true],[false],"[""Yes""]","[""Yes, Dentatorubral-pallidoluysian atrophy is inherited.""]","[""Yes""]",[true],[true],[true],"[""Yes""]","[""Yes, Dentatorubral-pallidoluysian atrophy is inherited.""]","[""Yes""]",[false],[true],[false],"[""Yes""]","[""Yes, Dentatorubral-pallidoluysian atrophy is inherited in an autosomal dominant pattern.""]","[""Yes""]",[false],[true],[false],"[""Yes""]","[""Yes, Dentatorubral-pallidoluysian atrophy is inherited.""]","[""Yes""]",[false],[true],[false],"[""Yes""]","[""Yes, Dentatorubral-pallidoluysian atrophy is inherited.""]","[""Yes""]",[false],[true],[false],"[""Yes""]","[""Yes, Dentatorubral-pallidoluysian atrophy is inherited.""]","[""Yes""]",[false],[true],[false],"[""Yes""]","[""Yes, Dentatorubral-pallidoluysian atrophy is inherited in an autosomal dominant pattern.""]","[""Yes""]",[false],[true],[false],"[""Yes""]","[""Yes, Dentatorubral-pallidoluysian atrophy is inherited.""]","[""Yes""]",[false],[true],[false],"[""Yes""]","[""Yes, Dentatorubral-pallidoluysian atrophy is inherited.""]","[""Yes""]",[true],[true],[false],"[""Yes, DRPLA is inherited.""]","[""Yes, Dentatorubral-pallidoluysian atrophy is inherited.""]","[""Yes""]",[false],[true],[false],"[""Yes""]","[""Yes, Dentatorubral-pallidoluysian atrophy is inherited in an autosomal dominant pattern.""]","[""Yes""]",[true],[true],[false],"[""Yes, DRPLA is inherited.""]","[""Yes, Dentatorubral-pallidoluysian atrophy is inherited.""]","[""Yes""]",[false],[true],[false],"[""Yes""]","[""Yes, Dentatorubral-pallidoluysian atrophy is inherited.""]","[""Yes""]",[false],[true],[false],"[""Yes""]","[""Yes, Dentatorubral-pallidoluysian atrophy is inherited.""]","[""Yes""]",[false],[true],[false],"[""Yes""]","[""Yes, Dentatorubral-pallidoluysian atrophy is inherited in an autosomal dominant pattern.""]","[""Yes""]",[false],[true],[false],"[""Yes""]","[""Yes, Dentatorubral-pallidoluysian atrophy is inherited.""]","[""Yes""]",[false],[true],[false],"[""Yes""]","[""Yes, Dentatorubral-pallidoluysian atrophy is inherited.""]","[""Yes""]",[true],[true],[false],"[""Yes, DRPLA (Dentatorubral-Pallidoluysian Atrophy) is an inherited genetic disorder.""]","[""Yes, Dentatorubral-pallidoluysian atrophy is inherited.""]","[""Yes""]",[false],[true],[false],"[""Yes""]","[""Yes, Dentatorubral-pallidoluysian atrophy is inherited in an autosomal dominant pattern.""]","[""Yes""]",[false],[true],[false],"[""Yes""]","[""Yes, Dentatorubral-pallidoluysian atrophy is inherited.""]","[""Yes""]",[true],[true],[false],"[""Yes, DRPLA is inherited in an autosomal dominant pattern.""]","[""Yes, Dentatorubral-pallidoluysian atrophy is inherited.""]","[""Yes""]",[true],[true],[false],"[""Yes, DRPLA is inherited in an autosomal dominant pattern.""]","[""Yes, Dentatorubral-pallidoluysian atrophy is inherited.""]","[""Yes""]",[true],[true],[false],"[""Yes, DRPLA is an inherited genetic disorder.""]","[""Yes, Dentatorubral-pallidoluysian atrophy is inherited in an autosomal dominant pattern.""]","[""Yes""]",[true],[true],[false],"[""Yes, DRPLA (Dentatorubral-Pallidoluysian Atrophy) is an inherited genetic disorder.""]","[""Yes, Dentatorubral-pallidoluysian atrophy is inherited.""]","[""Yes""]",[true],[true],[false],"[""Yes, DRPLA (Dentatorubral-Pallidoluysian Atrophy) is inherited.""]","[""Yes, Dentatorubral-pallidoluysian atrophy is inherited.""]","[""Yes""]",[true],[true],[false],"[""Yes, DRPLA is inherited.""]","[""Yes, Dentatorubral-pallidoluysian atrophy is inherited.""]","[""Yes""]",[true],[true],[false],"[""Yes, DRPLA is inherited.""]","[""Yes, Dentatorubral-pallidoluysian atrophy is inherited.""]","[""Yes""]",[true],[true],[false],"[""Yes, DRPLA is inherited.""]","[""Yes, Dentatorubral-pallidoluysian atrophy is inherited.""]","[""Yes""]"
treatment,What are the treatments for Renal Artery Stenosis ?,"Treatment for RAS includes lifestyle changes, medications, and surgery and aims to
                
- prevent RAS from getting worse  - treat RVH  - relieve the blockage of the renal arteries
                
RAS that has not led to RVH or caused a significant blockage of the artery may not need treatment. RAS that needs to be treated, also called critical RAS, is defined by the American Heart Association as a reduction by more than 60 percent in the diameter of the renal artery.1 However, health care providers are not exactly sure what degree of blockage will cause significant problems.
                
Lifestyle Changes
                
The first step in treating RAS is making lifestyle changes that promote healthy blood vessels throughout the body, including the renal arteries. The best ways to keep plaque from building up in the arteries are to exercise, maintain a healthy body weight, and choose healthy foods. People who smoke should quit to help protect their kidneys and other internal organs.
                
Medications
                
People with RVH may need to take medications thatwhen taken as prescribed by their health care providerlower blood pressure and can also significantly slow the progression of kidney disease. Two types of blood pressure-lowering medications, angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs), have proven effective in slowing the progression of kidney disease. Many people require two or more medications to control their blood pressure. In addition to an ACE inhibitor or an ARB, a diuretica medication that helps the kidneys remove fluid from the bloodmay be prescribed. Beta blockers, calcium channel blockers, and other blood pressure medications may also be needed. Some people with RAS cannot take an ACE inhibitor or ARB due to the effects on the kidneys. People with RAS who are prescribed an ACE inhibitor or ARB should have their kidney function checked within a few weeks of starting the medication.
                
A cholesterol-lowering medication to prevent plaque from building up in the arteries and a blood-thinner, such as aspirin, to help the blood flow more easily through the arteries may also be prescribed.
                
Surgery
                
Although surgery has been used in the past for treatment of RAS due to atherosclerosis, recent studies have not shown improved outcomes with surgery compared with medication. However, surgery may be recommended for people with RAS caused by FMD or RAS that does not improve with medication. Different types of surgery for RAS include the following. The procedures are performed in a hospital by a vascular surgeona doctor who specializes in repairing blood vessels. Anesthesia is needed.
                
- Angioplasty and stenting. Angioplasty is a procedure in which a catheter is put into the renal artery, usually through the groin, just as in a catheter angiogram. In addition, for angioplasty, a tiny balloon at the end of the catheter can be inflated to flatten the plaque against the artery wall. A small mesh tube, called a stent, may then be positioned inside the artery to keep plaque flattened and the artery open. People with RAS caused by FMD may be successfully treated with angioplasty alone, while angioplasty with stenting has a better outcome for people with RAS caused by atherosclerosis.  - Endarterectomy or bypass surgery. In an endarterectomy, the plaque is cleaned out of the artery, leaving the inside lining smooth and clear. To create a bypass, a vein or synthetic tube is used to connect the kidney to the aorta. This new path serves as an alternate route for blood to flow around the blocked artery into the kidney. These procedures are not performed as often as in the past due to a high risk of complications during and after the procedure.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""RAS"", ""full_form"": ""Renal Artery Stenosis""}]}",What are the treatments for RAS ?,What are the treatments for Renal Artery Stenosis ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Russian Academy Of Sciences"", ""Royal Astronomical Society"", ""Remote Access Service"", ""Remote Access Server"", ""Reliability Availability And Serviceability"", ""Remote Access Services"", ""Renal Artery Stenosis"", ""Renin Angiotensin System"", ""Reticular Activating System"", ""River Analysis System""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Renin-Angiotensin System""]",[1.92634590610213e-08],[3.613438724859026e-22],"[""Renal Artery Stenosis""]",[1.92634590610213e-08],"[""ABBREVIATIONS""]","[[2.653493076339362e-13, 3.42598942619253e-20, 7.653076116646323e-13, 7.327412682701102e-14, 1.1843648780732057e-21, 4.035934945586606e-13, 1.92634590610213e-08, 9.532071389756067e-22, 2.9132372569464255e-12, 2.661025743258403e-13]]",[0.7900827015131752],[0.826575550118559],"[""Renal Artery Stenosis""]",[0.8277057194140809],"[""ABBREVIATIONS""]","[[0.7982602633373452, 0.7459312854792071, 0.7741366830651492, 0.7488081507299044, 0.6920157692566287, 0.771348475844046, 0.7900827015131752, 0.8277057194140809, 0.7802710683498589, 0.8136078155656001]]","[""Renin Angiotensin System""]","[""ABBREVIATIONS""]",What are the treatments for RAS (Renin-Angiotensin System) ?,[true],[true],[false],"[""The treatments for RAS (Renal Artery Stenosis) include medications to control blood pressure, cholesterol, and blood sugar levels, as well as procedures like angioplasty or stenting to improve blood flow to the kidneys.""]","[""The treatments for Renal Artery Stenosis include medications to control blood pressure, angioplasty and stenting, and in severe cases, surgical revascularization.""]","[""Treatment for RAS includes topical corticosteroids, mouth rinses, and avoiding triggers like spicy foods.""]",[true],[true],[false],"[""Medications, angioplasty, stenting, surgery""]","[""The treatments for Renal Artery Stenosis include medications to control blood pressure, angioplasty and stenting, or surgical bypass in severe cases.""]","[""The treatments for RAS (Recurrent Aphthous Stomatitis) include topical corticosteroids, mouth rinses, and in severe cases, systemic corticosteroids or immunosuppressants.""]",[true],[true],[false],"[""The treatments for RAS (Renal Artery Stenosis) include medications to control blood pressure, angioplasty with stenting, or surgical revascularization in severe cases.""]","[""The treatments for Renal Artery Stenosis include medications to control blood pressure, angioplasty with stenting, and surgical revascularization.""]","[""Treatment for RAS includes topical corticosteroids, mouth rinses, pain relief medications, and avoiding triggers like spicy foods.""]",[true],[true],[false],"[""The treatments for RAS (Renal Artery Stenosis) include medications to control blood pressure, angioplasty with stenting, and in severe cases, surgical revascularization.""]","[""The treatments for Renal Artery Stenosis include medications to control blood pressure, angioplasty with stenting, and in severe cases, surgical revascularization.""]","[""Treatment for RAS includes topical corticosteroids, mouth rinses, and avoiding triggers like spicy foods.""]",[true],[true],[false],"[""The treatments for RAS (Renal Artery Stenosis) include medications to control blood pressure, angioplasty and stenting, and in severe cases, surgery to bypass or remove the blockage.""]","[""The treatments for Renal Artery Stenosis include medications to control blood pressure, angioplasty and stenting, and in severe cases, surgical revascularization.""]","[""Treatment for RAS includes topical corticosteroids, mouth rinses, and avoiding triggers like spicy foods.""]",[true],[true],[false],"[""The treatments for RAS (Renal Artery Stenosis) include medications to control blood pressure, angioplasty and stenting, or surgical revascularization in severe cases.""]","[""The treatments for Renal Artery Stenosis include medications to control blood pressure, angioplasty and stenting, or surgical bypass in severe cases.""]","[""The treatments for RAS (Recurrent Aphthous Stomatitis) include topical corticosteroids, mouth rinses, and in severe cases, systemic corticosteroids or immunosuppressants.""]",[true],[true],[false],"[""The treatments for RAS (Renal Artery Stenosis) include medications to control blood pressure, cholesterol, and blood sugar levels, as well as procedures such as angioplasty, stenting, or surgery in severe cases.""]","[""The treatments for Renal Artery Stenosis include medications to control blood pressure, angioplasty with stenting, and surgical revascularization.""]","[""Treatment for RAS includes topical corticosteroids, mouth rinses, pain relief medications, and avoiding triggers like spicy foods.""]",[true],[true],[false],"[""The treatments for RAS (Renal Artery Stenosis) include medications to control blood pressure, angioplasty with stenting, and in severe cases, surgical revascularization.""]","[""The treatments for Renal Artery Stenosis include medications to control blood pressure, angioplasty with stenting, and in severe cases, surgical revascularization.""]","[""Treatment for RAS includes topical corticosteroids, mouth rinses, and avoiding triggers like spicy foods.""]",[false],[true],[false],"[""The treatments for RAS (Renin Angiotensin System) include ACE inhibitors, ARBs (Angiotensin II Receptor Blockers), and direct renin inhibitors.""]","[""The treatments for Renal Artery Stenosis include medications to control blood pressure, angioplasty and stenting, or surgical bypass in severe cases.""]","[""The treatments for RAS (Recurrent Aphthous Stomatitis) include topical corticosteroids, mouth rinses, and in severe cases, systemic corticosteroids or immunosuppressants.""]",[true],[true],[false],"[""ACE inhibitors, ARBs, direct renin inhibitors""]","[""The treatments for Renal Artery Stenosis include medications to control blood pressure, angioplasty and stenting, and in severe cases, surgical revascularization.""]","[""Treatment for RAS includes topical corticosteroids, mouth rinses, and avoiding triggers like spicy foods.""]",[false],[true],[false],"[""The treatments for RAS (Renin Angiotensin System) include ACE inhibitors, ARBs (Angiotensin II receptor blockers), and direct renin inhibitors.""]","[""The treatments for Renal Artery Stenosis include medications to control blood pressure, angioplasty with stenting, and surgical revascularization.""]","[""Treatment for RAS includes topical corticosteroids, mouth rinses, pain relief medications, and avoiding triggers like spicy foods.""]",[false],[true],[false],"[""The treatments for RAS (Renin Angiotensin System) include ACE inhibitors, ARBs (Angiotensin II Receptor Blockers), and direct renin inhibitors.""]","[""The treatments for Renal Artery Stenosis include medications to control blood pressure, angioplasty with stenting, and in severe cases, surgical revascularization.""]","[""Treatment for RAS includes topical corticosteroids, mouth rinses, and avoiding triggers like spicy foods.""]",[true],[true],[false],"[""ACE inhibitors, ARBs, Renin inhibitors""]","[""The treatments for Renal Artery Stenosis include medications to control blood pressure, angioplasty and stenting, and in severe cases, surgical revascularization.""]","[""Treatment for RAS includes topical corticosteroids, mouth rinses, and avoiding triggers like spicy foods.""]",[true],[true],[false],"[""ACE inhibitors, Angiotensin II receptor blockers, Renin inhibitors""]","[""The treatments for Renal Artery Stenosis include medications to control blood pressure, angioplasty and stenting, or surgical bypass in severe cases.""]","[""The treatments for RAS (Recurrent Aphthous Stomatitis) include topical corticosteroids, mouth rinses, and in severe cases, systemic corticosteroids or immunosuppressants.""]",[true],[true],[false],"[""ACE inhibitors, Angiotensin II receptor blockers (ARBs), Renin inhibitors""]","[""The treatments for Renal Artery Stenosis include medications to control blood pressure, angioplasty with stenting, and surgical revascularization.""]","[""Treatment for RAS includes topical corticosteroids, mouth rinses, pain relief medications, and avoiding triggers like spicy foods.""]",[true],[true],[false],"[""ACE inhibitors, ARBs, Renin inhibitors""]","[""The treatments for Renal Artery Stenosis include medications to control blood pressure, angioplasty with stenting, and in severe cases, surgical revascularization.""]","[""Treatment for RAS includes topical corticosteroids, mouth rinses, and avoiding triggers like spicy foods.""]",[true],[true],[false],"[""ACE inhibitors, ARBs, direct renin inhibitors""]","[""The treatments for Renal Artery Stenosis include medications to control blood pressure, angioplasty and stenting, and in severe cases, surgical revascularization.""]","[""Treatment for RAS includes topical corticosteroids, mouth rinses, and avoiding triggers like spicy foods.""]",[false],[true],[false],"[""The treatments for RAS (Renin Angiotensin System) include ACE inhibitors, ARBs (Angiotensin II receptor blockers), and direct renin inhibitors.""]","[""The treatments for Renal Artery Stenosis include medications to control blood pressure, angioplasty and stenting, or surgical bypass in severe cases.""]","[""The treatments for RAS (Recurrent Aphthous Stomatitis) include topical corticosteroids, mouth rinses, and in severe cases, systemic corticosteroids or immunosuppressants.""]",[false],[true],[false],"[""The treatments for RAS (Renin Angiotensin System) include ACE inhibitors, ARBs (Angiotensin II Receptor Blockers), and direct renin inhibitors.""]","[""The treatments for Renal Artery Stenosis include medications to control blood pressure, angioplasty with stenting, and surgical revascularization.""]","[""Treatment for RAS includes topical corticosteroids, mouth rinses, pain relief medications, and avoiding triggers like spicy foods.""]",[false],[true],[false],"[""The treatments for RAS (Renin Angiotensin System) include ACE inhibitors, ARBs (Angiotensin II receptor blockers), and direct renin inhibitors.""]","[""The treatments for Renal Artery Stenosis include medications to control blood pressure, angioplasty with stenting, and in severe cases, surgical revascularization.""]","[""Treatment for RAS includes topical corticosteroids, mouth rinses, and avoiding triggers like spicy foods.""]",[false],[true],[false],"[""The treatments for RAS (Renin-Angiotensin System) include ACE inhibitors, ARBs (Angiotensin II receptor blockers), and direct renin inhibitors.""]","[""The treatments for Renal Artery Stenosis include medications to control blood pressure, angioplasty and stenting, and in severe cases, surgical revascularization.""]","[""Treatment for RAS includes topical corticosteroids, mouth rinses, and avoiding triggers like spicy foods.""]",[false],[true],[false],"[""The treatments for RAS (Renin-Angiotensin System) include ACE inhibitors, ARBs (Angiotensin II Receptor Blockers), and direct renin inhibitors.""]","[""The treatments for Renal Artery Stenosis include medications to control blood pressure, angioplasty and stenting, or surgical bypass in severe cases.""]","[""The treatments for RAS (Recurrent Aphthous Stomatitis) include topical corticosteroids, mouth rinses, and in severe cases, systemic corticosteroids or immunosuppressants.""]",[false],[true],[false],"[""The treatments for RAS (Renin-Angiotensin System) include ACE inhibitors, ARBs (Angiotensin II receptor blockers), and direct renin inhibitors.""]","[""The treatments for Renal Artery Stenosis include medications to control blood pressure, angioplasty with stenting, and surgical revascularization.""]","[""Treatment for RAS includes topical corticosteroids, mouth rinses, pain relief medications, and avoiding triggers like spicy foods.""]",[false],[true],[false],"[""The treatments for RAS (Renin-Angiotensin System) include ACE inhibitors, ARBs (Angiotensin II Receptor Blockers), and direct renin inhibitors.""]","[""The treatments for Renal Artery Stenosis include medications to control blood pressure, angioplasty with stenting, and in severe cases, surgical revascularization.""]","[""Treatment for RAS includes topical corticosteroids, mouth rinses, and avoiding triggers like spicy foods.""]",[false],[true],[false],"[""The treatments for RAS (Renin Angiotensin System) include ACE inhibitors, ARBs (Angiotensin II receptor blockers), and direct renin inhibitors.""]","[""The treatments for Renal Artery Stenosis include medications to control blood pressure, angioplasty and stenting, and in severe cases, surgical revascularization.""]","[""Treatment for RAS includes topical corticosteroids, mouth rinses, and avoiding triggers like spicy foods.""]",[false],[true],[false],"[""The treatments for RAS (Renin Angiotensin System) disorders include ACE inhibitors, ARBs (Angiotensin II Receptor Blockers), and direct renin inhibitors.""]","[""The treatments for Renal Artery Stenosis include medications to control blood pressure, angioplasty and stenting, or surgical bypass in severe cases.""]","[""The treatments for RAS (Recurrent Aphthous Stomatitis) include topical corticosteroids, mouth rinses, and in severe cases, systemic corticosteroids or immunosuppressants.""]",[false],[true],[false],"[""The treatments for RAS (Renin Angiotensin System) include ACE inhibitors, ARBs (Angiotensin II receptor blockers), and direct renin inhibitors.""]","[""The treatments for Renal Artery Stenosis include medications to control blood pressure, angioplasty with stenting, and surgical revascularization.""]","[""Treatment for RAS includes topical corticosteroids, mouth rinses, pain relief medications, and avoiding triggers like spicy foods.""]",[false],[true],[false],"[""The treatments for RAS (Renin Angiotensin System) include ACE inhibitors, ARBs (Angiotensin II receptor blockers), and direct renin inhibitors.""]","[""The treatments for Renal Artery Stenosis include medications to control blood pressure, angioplasty with stenting, and in severe cases, surgical revascularization.""]","[""Treatment for RAS includes topical corticosteroids, mouth rinses, and avoiding triggers like spicy foods.""]",[true],[true],[false],"[""ACE inhibitors, ARBs, direct renin inhibitors""]","[""The treatments for Renal Artery Stenosis include medications to control blood pressure, angioplasty and stenting, and in severe cases, surgical revascularization.""]","[""Treatment for RAS includes topical corticosteroids, mouth rinses, and avoiding triggers like spicy foods.""]",[true],[true],[false],"[""The treatments for RAS (Renal Artery Stenosis) include medications to control blood pressure, angioplasty and stenting, and in severe cases, surgery to bypass or remove the blockage.""]","[""The treatments for Renal Artery Stenosis include medications to control blood pressure, angioplasty and stenting, and in severe cases, surgical revascularization.""]","[""Treatment for RAS includes topical corticosteroids, mouth rinses, and avoiding triggers like spicy foods.""]",[true],[true],[false],"[""The treatments for RAS (Renal Artery Stenosis) include medications to control blood pressure, angioplasty with stenting, or surgical revascularization in severe cases.""]","[""The treatments for Renal Artery Stenosis include medications to control blood pressure, angioplasty and stenting, and in severe cases, surgical revascularization.""]","[""Treatment for RAS includes topical corticosteroids, mouth rinses, and avoiding triggers like spicy foods.""]",[true],[true],[false],"[""ACE inhibitors, ARBs, direct renin inhibitors""]","[""The treatments for Renal Artery Stenosis include medications to control blood pressure, angioplasty and stenting, and in severe cases, surgical revascularization.""]","[""Treatment for RAS includes topical corticosteroids, mouth rinses, and avoiding triggers like spicy foods.""]"
inheritance,Is granulomatosis with polyangiitis inherited ?,The inheritance pattern of GPA is unknown. Most instances are sporadic and occur in individuals with no history of the disorder in their family. Only rarely is more than one member of the same family affected by the disorder.,"{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""GPA"", ""full_form"": ""granulomatosis with polyangiitis""}]}",Is GPA inherited ?,Is granulomatosis with polyangiitis inherited ?,0,SCIENCE,Simple Datatype-Boolean,"Exploratory(Divergent Thinking): Queries that are inherently about seeking new areas of knowledge, understanding emerging trends, or identifying unknown opportunities without a specific end goal of making a decision or judgment. Exploratory queries are characterized by their openness and the lack of a predefined objective, differentiating them from evaluative queries which are directed towards forming a judgment or assessment. Exploratory queries encourage branching out into various directions to explore a wide array of possibilities without necessarily aiming to converge on a single answer or outcome.","[[""Grade Point Average"", ""Government Procurement Agreement"", ""Gigapascals"", ""Gay Police Association"", ""Gas Processors Association"", ""Global Packaging Alliance"", ""Graduation Pledge Alliance"", ""Golden Party Armour"", ""Greatest Paper Airplanes"", ""Guest Physical Address""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Grade Point Average""]",[1.7169452735637418e-17],[6.410683602022782e-16],"[""Guest Physical Address""]",[4.718845696296317e-15],"[""ABBREVIATIONS""]","[[6.410683602022782e-16, 1.040949604227737e-18, 9.844372230708624e-18, 2.9385048093607393e-15, 7.781173303710086e-19, 5.5203731094175e-18, 1.0221044731308714e-22, 1.8586111068054737e-20, 1.9911785017556115e-22, 4.718845696296317e-15]]",[0.7084701153964407],[0.9328379783853641],"[""granulomatosis with polyangiitis""]",[0.9328379783853641],"[""ABBREVIATIONS""]","[[0.9328379783853641, 0.6878790819047196, 0.7616549560951822, 0.7332098367040287, 0.6816187064867383, 0.7230943789308184, 0.7672778367942307, 0.7435604362101087, 0.7547805640012114, 0.710787045555399]]","[""Grade Point Average""]","[""LLM""]",Is GPA (Grade Point Average) inherited ?,[true],[true],[true],"[""No""]","[""No, granulomatosis with polyangiitis is not inherited.""]","[""No""]",[true],[true],[true],"[""No""]","[""Granulomatosis with polyangiitis is not directly inherited, but genetic factors may play a role in predisposing individuals to the condition.""]","[""No""]",[true],[true],[true],"[""No""]","[""No, granulomatosis with polyangiitis is not inherited.""]","[""No, GPA is not inherited.""]",[true],[true],[true],"[""No""]","[""No, granulomatosis with polyangiitis is not inherited.""]","[""No""]",[false],[true],[true],"[""GPA is not directly inherited, but genetics may play a role in increasing the risk of developing the condition.""]","[""No, granulomatosis with polyangiitis is not inherited.""]","[""No""]",[true],[true],[true],"[""No""]","[""Granulomatosis with polyangiitis is not directly inherited, but genetic factors may play a role in predisposing individuals to the condition.""]","[""No""]",[false],[true],[true],"[""GPA is not directly inherited, but genetics may play a role in predisposing individuals to the condition.""]","[""No, granulomatosis with polyangiitis is not inherited.""]","[""No, GPA is not inherited.""]",[true],[true],[true],"[""No, GPA is not inherited. It is believed to be caused by a combination of genetic and environmental factors.""]","[""No, granulomatosis with polyangiitis is not inherited.""]","[""No""]",[true],[true],[true],"[""No""]","[""Granulomatosis with polyangiitis is not directly inherited, but genetic factors may play a role in predisposing individuals to the condition.""]","[""No""]",[true],[true],[true],"[""No""]","[""No, granulomatosis with polyangiitis is not inherited.""]","[""No""]",[true],[true],[true],"[""No""]","[""No, granulomatosis with polyangiitis is not inherited.""]","[""No, GPA is not inherited.""]",[true],[true],[true],"[""No""]","[""No, granulomatosis with polyangiitis is not inherited.""]","[""No""]",[true],[true],[true],"[""No""]","[""No, granulomatosis with polyangiitis is not inherited.""]","[""No""]",[true],[true],[true],"[""No""]","[""Granulomatosis with polyangiitis is not directly inherited, but genetic factors may play a role in predisposing individuals to the condition.""]","[""No""]",[true],[true],[true],"[""No""]","[""No, granulomatosis with polyangiitis is not inherited.""]","[""No, GPA is not inherited.""]",[true],[true],[true],"[""No""]","[""No, granulomatosis with polyangiitis is not inherited.""]","[""No""]",[true],[true],[true],"[""No""]","[""No, granulomatosis with polyangiitis is not inherited.""]","[""No""]",[true],[true],[true],"[""No""]","[""Granulomatosis with polyangiitis is not directly inherited, but genetic factors may play a role in predisposing individuals to the condition.""]","[""No""]",[true],[true],[true],"[""No""]","[""No, granulomatosis with polyangiitis is not inherited.""]","[""No, GPA is not inherited.""]",[true],[true],[true],"[""No""]","[""No, granulomatosis with polyangiitis is not inherited.""]","[""No""]",[true],[true],[true],"[""No""]","[""No, granulomatosis with polyangiitis is not inherited.""]","[""No""]",[false],[true],[true],"[""No, GPA (Grade Point Average) is not inherited. It is calculated based on a student's academic performance.""]","[""Granulomatosis with polyangiitis is not directly inherited, but genetic factors may play a role in predisposing individuals to the condition.""]","[""No""]",[true],[true],[true],"[""No""]","[""No, granulomatosis with polyangiitis is not inherited.""]","[""No, GPA is not inherited.""]",[true],[true],[true],"[""No""]","[""No, granulomatosis with polyangiitis is not inherited.""]","[""No""]",[false],[true],[true],"[""No, GPA (Grade Point Average) is not inherited.""]","[""No, granulomatosis with polyangiitis is not inherited.""]","[""No""]",[false],[true],[true],"[""No, GPA is not inherited. It is calculated based on individual academic performance.""]","[""Granulomatosis with polyangiitis is not directly inherited, but genetic factors may play a role in predisposing individuals to the condition.""]","[""No""]",[false],[true],[true],"[""No, GPA (Grade Point Average) is not inherited.""]","[""No, granulomatosis with polyangiitis is not inherited.""]","[""No, GPA is not inherited.""]",[false],[true],[true],"[""No, GPA is not inherited. It is calculated based on individual academic performance.""]","[""No, granulomatosis with polyangiitis is not inherited.""]","[""No""]",[true],[true],[true],"[""No""]","[""No, granulomatosis with polyangiitis is not inherited.""]","[""No""]",[true],[true],[true],"[""No""]","[""No, granulomatosis with polyangiitis is not inherited.""]","[""No""]",[true],[true],[true],"[""No, GPA is not inherited.""]","[""No, granulomatosis with polyangiitis is not inherited.""]","[""No""]",[true],[true],[true],"[""No""]","[""No, granulomatosis with polyangiitis is not inherited.""]","[""No""]"
genetic changes,What are the genetic changes related to Ellis-van Creveld syndrome ?,"Ellis-van Creveld syndrome can be caused by mutations in the EVC or EVC2 gene. Little is known about the function of these genes, although they appear to play important roles in cell-to-cell signaling during development. In particular, the proteins produced from the EVC and EVC2 genes are thought to help regulate the Sonic Hedgehog signaling pathway. This pathway plays roles in cell growth, cell specialization, and the normal shaping (patterning) of many parts of the body.  The mutations that cause Ellis-van Creveld syndrome result in the production of an abnormally small, nonfunctional version of the EVC or EVC2 protein. It is unclear how the defective proteins lead to the specific signs and symptoms of this condition. Studies suggest that they prevent normal Sonic Hedgehog signaling in the developing embryo, disrupting the formation and growth of the bones, teeth, and other parts of the body.  Together, mutations in the EVC and EVC2 genes account for more than half of all cases of Ellis-van Creveld syndrome. The cause of the remaining cases is unknown.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""EVC"", ""full_form"": ""Ellis-van Creveld""}]}",What are the genetic changes related to EVC syndrome ?,What are the genetic changes related to Ellis-van Creveld syndrome ?,8,MEDICAL,Compound Datatype-List/Array,"Exploratory(Divergent Thinking): Queries that are inherently about seeking new areas of knowledge, understanding emerging trends, or identifying unknown opportunities without a specific end goal of making a decision or judgment. Exploratory queries are characterized by their openness and the lack of a predefined objective, differentiating them from evaluative queries which are directed towards forming a judgment or assessment. Exploratory queries encourage branching out into various directions to explore a wide array of possibilities without necessarily aiming to converge on a single answer or outcome.","[[""Executive Vice Chancellor"", ""Entravision Communications Corporation"", ""Electronic Valve Controller"", ""Eaton Vance Corporation"", ""Executrain Virtual Campus"", ""Equilibrium Vapor Concentration"", ""Electronic Voucher Charging"", ""Enhanced vMotion Compatibility"", ""Equipping Vital Congregations"", ""Evasion Chart""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Ellis-van Creveld syndrome""]",[2.7388196114280015e-25],[8.158843993785942e-30],"[""Evasion Chart""]",[1.0935595903485505e-12],"[""ABBREVIATIONS""]","[[3.2314656631831514e-20, 1.2224539509382255e-22, 2.592399220879243e-15, 3.985292202741231e-20, 6.520891642303871e-25, 8.872813286608145e-17, 1.9547639308251087e-20, 9.129499816352967e-22, 1.0012850464625579e-23, 1.0935595903485505e-12]]",[0.8955005646246725],[0.8948560851075331],"[""Ellis-van Creveld""]",[0.9404271163248996],"[""ABBREVIATIONS""]","[[0.9404271163248996, 0.9250794673166705, 0.9151389251951259, 0.9166733111061485, 0.9348216014179265, 0.9091024228108446, 0.9084110683410803, 0.8877202359613561, 0.9136297190326497, 0.9122264152195056]]","[""Ellis-van Creveld syndrome""]","[""LLM""]",What are the genetic changes related to EVC (Ellis-van Creveld syndrome) syndrome ?,[false],[true],[true],"[""Mutations in the EVC gene have been associated with EVC syndrome.""]","[""Mutations in the EVC and EVC2 genes are associated with Ellis-van Creveld syndrome.""]","[""Mutations in the EVC gene are associated with Ellis-van Creveld syndrome.""]",[false],[true],[true],"[""Mutations in the EVC and EVC2 genes are associated with EVC syndrome.""]","[""Mutations in the EVC and EVC2 genes""]","[""Mutations in the EVC gene are associated with Ellis-van Creveld syndrome.""]",[true],[true],[true],"[""Mutations in the EVC gene are responsible for EVC syndrome.""]","[""Ellis-van Creveld syndrome is caused by mutations in the EVC or EVC2 gene, which are involved in the development of cilia. These mutations lead to abnormal skeletal development and other characteristic features of the syndrome.""]","[""Mutations in the EVC gene are known to cause Ellis-van Creveld syndrome (EVC syndrome).""]",[false],[true],[true],"[""The genetic changes related to EVC (Evasion Chart) syndrome involve mutations in the EVC and EVC2 genes.""]","[""Mutations in the EVC or EVC2 gene""]","[""Mutations in the EVC gene are responsible for Ellis-van Creveld syndrome.""]",[false],[true],[true],"[""Mutations in the EVC gene are primarily responsible for Ellis-van Creveld syndrome.""]","[""Mutations in the EVC and EVC2 genes are associated with Ellis-van Creveld syndrome.""]","[""Mutations in the EVC gene are associated with Ellis-van Creveld syndrome.""]",[true],[true],[true],"[""Mutations in the EVC gene are responsible for causing Ellis-van Creveld syndrome.""]","[""Mutations in the EVC and EVC2 genes""]","[""Mutations in the EVC gene are associated with Ellis-van Creveld syndrome.""]",[true],[true],[true],"[""Mutations in the EVC gene are responsible for causing Ellis-van Creveld syndrome.""]","[""Ellis-van Creveld syndrome is caused by mutations in the EVC or EVC2 gene, which are involved in the development of cilia. These mutations lead to abnormal skeletal development and other characteristic features of the syndrome.""]","[""Mutations in the EVC gene are known to cause Ellis-van Creveld syndrome (EVC syndrome).""]",[true],[true],[true],"[""Mutations in the EVC gene are responsible for Ellis-van Creveld syndrome. These mutations can include deletions, insertions, duplications, and point mutations within the gene.""]","[""Mutations in the EVC or EVC2 gene""]","[""Mutations in the EVC gene are responsible for Ellis-van Creveld syndrome.""]",[true],[true],[true],"[""Mutations in the EVC gene are responsible for Ellis-van Creveld syndrome.""]","[""Mutations in the EVC and EVC2 genes""]","[""Mutations in the EVC gene are associated with Ellis-van Creveld syndrome.""]",[true],[true],[true],"[""Mutations in the EVC gene are responsible for Ellis-van Creveld syndrome.""]","[""Mutations in the EVC and EVC2 genes are associated with Ellis-van Creveld syndrome.""]","[""Mutations in the EVC gene are associated with Ellis-van Creveld syndrome.""]",[true],[true],[true],"[""Mutations in the EVC gene are responsible for Ellis-van Creveld syndrome.""]","[""Ellis-van Creveld syndrome is caused by mutations in the EVC or EVC2 gene, which are involved in the development of cilia. These mutations lead to abnormal skeletal development and other characteristic features of the syndrome.""]","[""Mutations in the EVC gene are known to cause Ellis-van Creveld syndrome (EVC syndrome).""]",[true],[true],[true],"[""Mutations in the EVC gene on chromosome 4 are associated with Ellis-van Creveld syndrome.""]","[""Mutations in the EVC or EVC2 gene""]","[""Mutations in the EVC gene are responsible for Ellis-van Creveld syndrome.""]",[true],[true],[true],"[""Mutations in the EVC and EVC2 genes""]","[""Mutations in the EVC and EVC2 genes are associated with Ellis-van Creveld syndrome.""]","[""Mutations in the EVC gene are associated with Ellis-van Creveld syndrome.""]",[true],[true],[true],"[""Mutations in the EVC or EVC2 gene""]","[""Mutations in the EVC and EVC2 genes""]","[""Mutations in the EVC gene are associated with Ellis-van Creveld syndrome.""]",[true],[true],[true],"[""Mutations in the EVC and EVC2 genes""]","[""Ellis-van Creveld syndrome is caused by mutations in the EVC or EVC2 gene, which are involved in the development of cilia. These mutations lead to abnormal skeletal development and other characteristic features of the syndrome.""]","[""Mutations in the EVC gene are known to cause Ellis-van Creveld syndrome (EVC syndrome).""]",[true],[true],[false],"[""Mutations in the EVC and EVC2 genes are associated with Ellis-van Creveld syndrome.""]","[""Mutations in the EVC or EVC2 gene""]","[""Mutations in the EVC gene are responsible for Ellis-van Creveld syndrome.""]",[true],[true],[true],"[""The genetic changes related to EVC (Ellis-van Creveld syndrome) include mutations in the EVC and EVC2 genes.""]","[""Mutations in the EVC and EVC2 genes are associated with Ellis-van Creveld syndrome.""]","[""Mutations in the EVC gene are associated with Ellis-van Creveld syndrome.""]",[true],[true],[true],"[""Mutations in the EVC gene are responsible for Ellis-van Creveld syndrome.""]","[""Mutations in the EVC and EVC2 genes""]","[""Mutations in the EVC gene are associated with Ellis-van Creveld syndrome.""]",[true],[true],[true],"[""Mutations in the EVC gene are responsible for Ellis-van Creveld syndrome. These mutations can include deletions, insertions, or point mutations affecting the normal function of the gene.""]","[""Ellis-van Creveld syndrome is caused by mutations in the EVC or EVC2 gene, which are involved in the development of cilia. These mutations lead to abnormal skeletal development and other characteristic features of the syndrome.""]","[""Mutations in the EVC gene are known to cause Ellis-van Creveld syndrome (EVC syndrome).""]",[true],[true],[true],"[""Mutations in the EVC gene are responsible for Ellis-van Creveld syndrome.""]","[""Mutations in the EVC or EVC2 gene""]","[""Mutations in the EVC gene are responsible for Ellis-van Creveld syndrome.""]",[true],[true],[true],"[""Mutations in the EVC gene are responsible for Ellis-van Creveld syndrome. These mutations can lead to the characteristic features of the syndrome such as short limbs, extra fingers or toes, and heart defects.""]","[""Mutations in the EVC and EVC2 genes are associated with Ellis-van Creveld syndrome.""]","[""Mutations in the EVC gene are associated with Ellis-van Creveld syndrome.""]",[true],[true],[true],"[""Mutations in the EVC gene are responsible for Ellis-van Creveld syndrome.""]","[""Mutations in the EVC and EVC2 genes""]","[""Mutations in the EVC gene are associated with Ellis-van Creveld syndrome.""]",[true],[true],[true],"[""Mutations in the EVC gene are responsible for Ellis-van Creveld syndrome.""]","[""Ellis-van Creveld syndrome is caused by mutations in the EVC or EVC2 gene, which are involved in the development of cilia. These mutations lead to abnormal skeletal development and other characteristic features of the syndrome.""]","[""Mutations in the EVC gene are known to cause Ellis-van Creveld syndrome (EVC syndrome).""]",[true],[true],[true],"[""Mutations in the EVC gene are responsible for Ellis-van Creveld syndrome.""]","[""Mutations in the EVC or EVC2 gene""]","[""Mutations in the EVC gene are responsible for Ellis-van Creveld syndrome.""]",[false],[true],[true],"[""Genetic changes related to EVC syndrome include mutations in the EVC and EVC2 genes.""]","[""Mutations in the EVC and EVC2 genes are associated with Ellis-van Creveld syndrome.""]","[""Mutations in the EVC gene are associated with Ellis-van Creveld syndrome.""]",[false],[true],[true],"[""Genetic changes related to EVC syndrome include mutations in the EVC and EVC2 genes.""]","[""Mutations in the EVC and EVC2 genes""]","[""Mutations in the EVC gene are associated with Ellis-van Creveld syndrome.""]",[true],[false],[true],"[""Genetic changes related to EVC syndrome include mutations in the EVC and EVC2 genes.""]","[""Ellis-van Creveld syndrome is caused by mutations in the EVC or EVC2 gene, which are involved in the development of cilia. These mutations lead to abnormal skeletal development and other characteristic features of the syndrome.""]","[""Mutations in the EVC gene are known to cause Ellis-van Creveld syndrome (EVC syndrome).""]",[false],[true],[true],"[""Genetic changes related to EVC syndrome include mutations in the EVC and EVC2 genes on chromosome 4.""]","[""Mutations in the EVC or EVC2 gene""]","[""Mutations in the EVC gene are responsible for Ellis-van Creveld syndrome.""]",[false],[true],[true],"[""Genetic changes related to EVC syndrome include mutations in the EVC and EVC2 genes.""]","[""Mutations in the EVC and EVC2 genes are associated with Ellis-van Creveld syndrome.""]","[""Mutations in the EVC gene are associated with Ellis-van Creveld syndrome.""]",[false],[true],[true],"[""Genetic changes related to EVC syndrome include mutations in the EVC and EVC2 genes.""]","[""Mutations in the EVC and EVC2 genes are associated with Ellis-van Creveld syndrome.""]","[""Mutations in the EVC gene are associated with Ellis-van Creveld syndrome.""]",[false],[true],[true],"[""Genetic changes related to EVC syndrome include mutations in the EVC and EVC2 genes.""]","[""Mutations in the EVC and EVC2 genes are associated with Ellis-van Creveld syndrome.""]","[""Mutations in the EVC gene are associated with Ellis-van Creveld syndrome.""]",[false],[true],[true],"[""Genetic changes related to EVC syndrome include mutations in the EVC and EVC2 genes.""]","[""Mutations in the EVC and EVC2 genes are associated with Ellis-van Creveld syndrome.""]","[""Mutations in the EVC gene are associated with Ellis-van Creveld syndrome.""]"
causes,What causes Erythropoietic protoporphyria ?,What is the genetic basis of erythropoietic protoporphyria? Erythropoietic protoporphyria is caused by mutations in the FECH gene.,"{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""EPP"", ""full_form"": ""Erythropoietic protoporphyria""}]}",What causes EPP ?,What causes Erythropoietic protoporphyria ?,8,MEDICAL,Compound Datatype-String,"Analytical/Evaluative (Convergent Thinking): This merged category is for queries that involve dissecting complex information or data to understand underlying patterns, reasons, or to make informed judgements. Queries in this category seek a deeper understanding that supports decision-making, comparison of options, or evaluating alternatives. The process involves both analysis (to break down and understand) and evaluation (to assess, compare, and decide), acknowledging that these processes often occur in tandem. This category involves queries where the goal is to converge upon a specific answer or decision through analysis and evaluation.","[[""Enhanced Parallel Port"", ""Environmentally Preferable Purchasing"", ""European Peoples Party"", ""Extensible Provisioning Protocol"", ""Employee Purchase Program"", ""Erythropoetic ProtoPorphyria"", ""Extended Projection Principle"", ""English for Professional Purposes"", ""Extended Planning Period"", ""Electronic Power Plant""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Erythropoietic Protoporphyria""]",[3.819074797309265e-30],[3.819074797309265e-30],"[""Extended Planning Period""]",[1.0518333022825545e-10],"[""ABBREVIATIONS""]","[[3.260002138728609e-16, 3.085244989845484e-20, 1.7637416432254303e-20, 1.5619954551032532e-21, 5.875818740547009e-15, 3.2564259618601323e-29, 1.4139158657675949e-15, 1.5142502134088668e-15, 1.0518333022825545e-10, 1.0844535009645235e-14]]",[0.7988570900889738],[0.8019372268607523],"[""Electronic Power Plant""]",[0.8019372268607523],"[""LLM""]","[[0.6608320660511857, 0.605098346337582, 0.6776441172972945, 0.7030939311145988, 0.6424001018866662, 0.7922793475601859, 0.6941957891411359, 0.6852319015069095, 0.6497484464735169, 0.7066492164121374]]","[""Erythropoetic ProtoPorphyria""]","[""ABBREVIATIONS""]",What causes EPP (Erythropoietic Protoporphyria) ?,[false],[true],[true],"[""EPP (Extended Planning Period) is typically caused by a delay in the menstrual cycle due to various factors such as stress, hormonal imbalances, excessive exercise, or certain medical conditions.""]","[""Mutations in the FECH gene""]","[""EPP is caused by mutations in the FECH gene, which is inherited in an autosomal dominant manner.""]",[false],[true],[true],"[""EPP (Extended Planning Period) is typically caused by inadequate preparation, lack of resources, or unexpected obstacles during the planning phase.""]","[""Erythropoietic protoporphyria is caused by mutations in the FECH gene, which leads to the accumulation of protoporphyrin in the bone marrow, blood, and tissues.""]","[""EPP is caused by mutations in the FECH gene.""]",[true],[true],[true],"[""EPP is caused by a genetic mutation in the FECH gene, leading to the accumulation of protoporphyrin in the bone marrow and blood.""]","[""Mutations in the FECH gene""]","[""EPP is caused by mutations in the FECH gene.""]",[false],[true],[true],"[""EPP (Extended Planning Period) is typically caused by delays in project timelines, changes in project scope, or unexpected challenges that require additional time for planning and preparation.""]","[""Erythropoietic protoporphyria is caused by mutations in the FECH gene, which leads to the accumulation of protoporphyrin in the bone marrow, blood, and skin.""]","[""EPP is caused by mutations in the FECH gene.""]",[false],[true],[true],"[""EPP (Electronic Power Plant) is caused by a genetic mutation that affects the porphyrin pathway, leading to the accumulation of porphyrins in the body.""]","[""Mutations in the FECH gene""]","[""EPP is caused by mutations in the FECH gene, which is inherited in an autosomal dominant manner.""]",[false],[true],[true],"[""EPP (Electronic Power Plant) is caused by a genetic mutation in the gene encoding for ferrochelatase enzyme, leading to the accumulation of porphyrins in the body.""]","[""Erythropoietic protoporphyria is caused by mutations in the FECH gene, which leads to the accumulation of protoporphyrin in the bone marrow, blood, and tissues.""]","[""EPP is caused by mutations in the FECH gene.""]",[false],[true],[true],"[""EPP (Electronic Power Plant) is caused by a genetic mutation in the FECH gene, leading to the accumulation of porphyrins in the body.""]","[""Mutations in the FECH gene""]","[""EPP is caused by mutations in the FECH gene.""]",[false],[true],[true],"[""Porphyria""]","[""Erythropoietic protoporphyria is caused by mutations in the FECH gene, which leads to the accumulation of protoporphyrin in the bone marrow, blood, and skin.""]","[""EPP is caused by mutations in the FECH gene.""]",[true],[true],[true],"[""EPP is caused by a deficiency of the enzyme ferrochelatase, which leads to the accumulation of protoporphyrin in the body.""]","[""Erythropoietic protoporphyria is caused by mutations in the FECH gene, which leads to the accumulation of protoporphyrin in the bone marrow, blood, and tissues.""]","[""EPP is caused by mutations in the FECH gene.""]",[true],[true],[true],"[""EPP is caused by a deficiency of the enzyme ferrochelatase, which leads to the accumulation of protoporphyrin in the bone marrow, blood, and other tissues.""]","[""Mutations in the FECH gene""]","[""EPP is caused by mutations in the FECH gene, which is inherited in an autosomal dominant manner.""]",[true],[true],[true],"[""EPP is caused by a deficiency of the enzyme ferrochelatase, which is involved in the production of heme.""]","[""Mutations in the FECH gene""]","[""EPP is caused by mutations in the FECH gene.""]",[true],[true],[true],"[""EPP is caused by a deficiency of the enzyme ferrochelatase, which is involved in the production of heme.""]","[""Erythropoietic protoporphyria is caused by mutations in the FECH gene, which leads to the accumulation of protoporphyrin in the bone marrow, blood, and skin.""]","[""EPP is caused by mutations in the FECH gene.""]",[true],[true],[true],"[""EPP is caused by mutations in the FECH gene, which leads to the accumulation of protoporphyrin in the bone marrow, blood, and other tissues.""]","[""Mutations in the FECH gene""]","[""EPP is caused by mutations in the FECH gene, which is inherited in an autosomal dominant manner.""]",[true],[true],[true],"[""EPP is caused by mutations in the FECH gene, which leads to the accumulation of protoporphyrin in the body.""]","[""Erythropoietic protoporphyria is caused by mutations in the FECH gene, which leads to the accumulation of protoporphyrin in the bone marrow, blood, and tissues.""]","[""EPP is caused by mutations in the FECH gene.""]",[true],[true],[true],"[""EPP is caused by mutations in the FECH gene, which leads to the accumulation of protoporphyrin in the bone marrow and blood.""]","[""Mutations in the FECH gene""]","[""EPP is caused by mutations in the FECH gene.""]",[true],[true],[true],"[""EPP is caused by mutations in the FECH gene, leading to a deficiency in the enzyme ferrochelatase.""]","[""Erythropoietic protoporphyria is caused by mutations in the FECH gene, which leads to the accumulation of protoporphyrin in the bone marrow, blood, and skin.""]","[""EPP is caused by mutations in the FECH gene.""]",[true],[true],[true],"[""EPP is caused by mutations in the FECH gene, which leads to the accumulation of protoporphyrin in the bone marrow, blood, and skin.""]","[""Mutations in the FECH gene""]","[""EPP is caused by mutations in the FECH gene, which is inherited in an autosomal dominant manner.""]",[true],[true],[true],"[""EPP is caused by mutations in the FECH gene, which leads to the accumulation of protoporphyrin in the bone marrow and blood.""]","[""Erythropoietic protoporphyria is caused by mutations in the FECH gene, which leads to the accumulation of protoporphyrin in the bone marrow, blood, and tissues.""]","[""EPP is caused by mutations in the FECH gene.""]",[true],[true],[true],"[""EPP is caused by a deficiency of the enzyme ferrochelatase, which is involved in the production of heme.""]","[""Mutations in the FECH gene""]","[""EPP is caused by mutations in the FECH gene.""]",[true],[true],[true],"[""EPP is caused by a deficiency of the enzyme ferrochelatase, which is involved in the production of heme.""]","[""Erythropoietic protoporphyria is caused by mutations in the FECH gene, which leads to the accumulation of protoporphyrin in the bone marrow, blood, and skin.""]","[""EPP is caused by mutations in the FECH gene.""]",[true],[true],[true],"[""EPP is caused by a deficiency of the enzyme ferrochelatase, which leads to the accumulation of protoporphyrin in the bone marrow, blood, and tissues.""]","[""Mutations in the FECH gene""]","[""EPP is caused by mutations in the FECH gene, which is inherited in an autosomal dominant manner.""]",[true],[true],[true],"[""EPP is caused by mutations in the FECH gene, which leads to the accumulation of protoporphyrin in the bone marrow, blood, and tissues.""]","[""Erythropoietic protoporphyria is caused by mutations in the FECH gene, which leads to the accumulation of protoporphyrin in the bone marrow, blood, and tissues.""]","[""EPP is caused by mutations in the FECH gene.""]",[true],[true],[true],"[""EPP is caused by mutations in the FECH gene, which leads to the accumulation of protoporphyrin in the bone marrow, blood, and skin.""]","[""Mutations in the FECH gene""]","[""EPP is caused by mutations in the FECH gene.""]",[true],[true],[true],"[""EPP is caused by mutations in the FECH gene, which leads to the accumulation of protoporphyrin in the bone marrow, blood, and skin.""]","[""Erythropoietic protoporphyria is caused by mutations in the FECH gene, which leads to the accumulation of protoporphyrin in the bone marrow, blood, and skin.""]","[""EPP is caused by mutations in the FECH gene.""]",[true],[true],[true],"[""EPP is caused by mutations in the FECH gene, which leads to the accumulation of protoporphyrin in the body.""]","[""Mutations in the FECH gene""]","[""EPP is caused by mutations in the FECH gene, which is inherited in an autosomal dominant manner.""]",[true],[true],[true],"[""EPP is caused by mutations in the FECH gene, which leads to the accumulation of protoporphyrin in the bone marrow and blood.""]","[""Erythropoietic protoporphyria is caused by mutations in the FECH gene, which leads to the accumulation of protoporphyrin in the bone marrow, blood, and tissues.""]","[""EPP is caused by mutations in the FECH gene.""]",[true],[true],[true],"[""EPP is caused by mutations in the FECH gene, which leads to the accumulation of protoporphyrin in the bone marrow, blood, and skin.""]","[""Mutations in the FECH gene""]","[""EPP is caused by mutations in the FECH gene.""]",[true],[true],[true],"[""EPP is caused by a deficiency of the enzyme ferrochelatase, which is involved in the production of heme.""]","[""Erythropoietic protoporphyria is caused by mutations in the FECH gene, which leads to the accumulation of protoporphyrin in the bone marrow, blood, and skin.""]","[""EPP is caused by mutations in the FECH gene.""]",[true],[true],[true],"[""Genetic mutations affecting the enzyme responsible for heme production""]","[""Mutations in the FECH gene""]","[""EPP is caused by mutations in the FECH gene, which is inherited in an autosomal dominant manner.""]",[false],[true],[true],"[""EPP is caused by a delay in the completion of a project phase or task.""]","[""Mutations in the FECH gene""]","[""EPP is caused by mutations in the FECH gene, which is inherited in an autosomal dominant manner.""]",[false],[true],[true],"[""EPP (Electronic Power Plant) is caused by a fault in the electronic control system of a power plant.""]","[""Mutations in the FECH gene""]","[""EPP is caused by mutations in the FECH gene, which is inherited in an autosomal dominant manner.""]",[true],[true],[true],"[""Genetic mutations affecting the production of heme in the body""]","[""Mutations in the FECH gene""]","[""EPP is caused by mutations in the FECH gene, which is inherited in an autosomal dominant manner.""]"
symptoms,What are the symptoms of Charcot-Marie-Tooth disease type 1E ?,"What are the signs and symptoms of Charcot-Marie-Tooth disease type 1E? The Human Phenotype Ontology provides the following list of signs and symptoms for Charcot-Marie-Tooth disease type 1E. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Areflexia - Autosomal dominant inheritance - Childhood onset - Decreased motor nerve conduction velocity - Distal muscle weakness - Distal sensory impairment - Foot dorsiflexor weakness - Hammertoe - Hyporeflexia - Juvenile onset - Pes cavus - Sensorineural hearing impairment - Split hand - Steppage gait - Talipes calcaneovalgus - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""CMT1E"", ""full_form"": ""Charcot-Marie-Tooth disease type 1E""}]}",What are the symptoms of CMT1E ?,What are the symptoms of Charcot-Marie-Tooth disease type 1E ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.",[[]],[[]],"[""Charcot-Marie-Tooth Disease Type 1E""]",[4.106970633305458e-31],[4.106970633305458e-31],"[""Charcot-Marie-Tooth Disease Type 1E""]",[4.106970633305458e-31],"[""LLM""]",[[]],[0.9459124738974038],[0.9436931084032032],"[""Charcot-Marie-Tooth disease type 1E""]",[0.9436931084032032],"[""LLM""]",[[]],"[""Charcot-Marie-Tooth Disease Type 1E""]","[""LLM""]",What are the symptoms of CMT1E (Charcot-Marie-Tooth Disease Type 1E) ?,[true],[true],[true],"[""Symptoms of CMT1E include muscle weakness, foot deformities, loss of muscle mass in the lower legs, difficulty walking, and decreased sensation in the extremities.""]","[""Symptoms of Charcot-Marie-Tooth disease type 1E include muscle weakness in the legs and feet, foot deformities, loss of muscle tissue in the lower legs, decreased ability to feel vibrations, and difficulty walking.""]","[""Symptoms of CMT1E include muscle weakness, muscle atrophy, foot deformities, and sensory loss in the extremities.""]",[true],[true],[true],"[""Symptoms of CMT1E include muscle weakness, foot deformities, loss of sensation in the extremities, and difficulty walking.""]","[""Symptoms of Charcot-Marie-Tooth disease type 1E include muscle weakness, foot deformities, loss of muscle mass in the lower legs, difficulty walking, and numbness or tingling in the feet or legs.""]","[""The symptoms of CMT1E include muscle weakness and atrophy, foot deformities, loss of sensation in the extremities, and difficulty walking.""]",[true],[true],[true],"[""Common symptoms of CMT1E include muscle weakness and atrophy in the lower legs, foot deformities such as high arches or hammertoes, loss of sensation in the extremities, and difficulty walking.""]","[""The symptoms of Charcot-Marie-Tooth disease type 1E include muscle weakness, foot deformities, loss of muscle tissue in the lower legs, and decreased sensation in the limbs.""]","[""Symptoms of CMT1E include muscle weakness, muscle atrophy, foot deformities, and sensory loss in the extremities.""]",[true],[true],[true],"[""Symptoms of CMT1E include muscle weakness, foot deformities, loss of muscle mass in the lower legs, difficulty walking, and decreased sensation in the extremities.""]","[""The symptoms of Charcot-Marie-Tooth disease type 1E include muscle weakness, foot deformities, loss of muscle tissue, and decreased sensation in the limbs.""]","[""Symptoms of CMT1E include muscle weakness, muscle atrophy, foot deformities, and sensory loss in the extremities.""]",[true],[true],[true],"[""The symptoms of CMT1E include muscle weakness, muscle atrophy, foot deformities, loss of sensation in the extremities, and difficulty walking.""]","[""Symptoms of Charcot-Marie-Tooth disease type 1E include muscle weakness in the legs and feet, foot deformities, loss of muscle tissue in the lower legs, decreased ability to feel vibrations, and difficulty walking.""]","[""Symptoms of CMT1E include muscle weakness, muscle atrophy, foot deformities, and sensory loss in the extremities.""]",[true],[true],[true],"[""Symptoms of CMT1E include muscle weakness and atrophy, foot deformities, loss of sensation in the extremities, and difficulty walking.""]","[""Symptoms of Charcot-Marie-Tooth disease type 1E include muscle weakness, foot deformities, loss of muscle mass in the lower legs, difficulty walking, and numbness or tingling in the feet or legs.""]","[""The symptoms of CMT1E include muscle weakness and atrophy, foot deformities, loss of sensation in the extremities, and difficulty walking.""]",[true],[true],[true],"[""The symptoms of CMT1E (Charcot-Marie-Tooth disease type 1E) include muscle weakness, particularly in the lower legs and feet, foot deformities (such as high arches or hammertoes), loss of muscle mass in the lower legs, and decreased ability to feel heat and cold.""]","[""The symptoms of Charcot-Marie-Tooth disease type 1E include muscle weakness, foot deformities, loss of muscle tissue in the lower legs, and decreased sensation in the limbs.""]","[""Symptoms of CMT1E include muscle weakness, muscle atrophy, foot deformities, and sensory loss in the extremities.""]",[true],[true],[true],"[""The symptoms of CMT1E (Charcot-Marie-Tooth disease type 1E) include muscle weakness and atrophy, foot deformities (such as high arches or hammertoes), loss of sensation in the extremities, and difficulty walking.""]","[""The symptoms of Charcot-Marie-Tooth disease type 1E include muscle weakness, foot deformities, loss of muscle tissue, and decreased sensation in the limbs.""]","[""Symptoms of CMT1E include muscle weakness, muscle atrophy, foot deformities, and sensory loss in the extremities.""]",[true],[true],[true],"[""Symptoms of CMT1E include muscle weakness, foot deformities, loss of sensation in the extremities, and difficulty walking.""]","[""Symptoms of Charcot-Marie-Tooth disease type 1E include muscle weakness, foot deformities, loss of muscle mass in the lower legs, difficulty walking, and numbness or tingling in the feet or legs.""]","[""The symptoms of CMT1E include muscle weakness and atrophy, foot deformities, loss of sensation in the extremities, and difficulty walking.""]",[true],[true],[true],"[""The symptoms of CMT1E (Charcot-Marie-Tooth Disease Type 1E) include muscle weakness and atrophy, foot deformities (such as high arches or hammertoes), loss of sensation in the extremities, and difficulty walking.""]","[""Symptoms of Charcot-Marie-Tooth disease type 1E include muscle weakness in the legs and feet, foot deformities, loss of muscle tissue in the lower legs, decreased ability to feel vibrations, and difficulty walking.""]","[""Symptoms of CMT1E include muscle weakness, muscle atrophy, foot deformities, and sensory loss in the extremities.""]",[true],[true],[true],"[""Symptoms of CMT1E include muscle weakness, muscle atrophy, foot deformities, loss of sensation in the extremities, and difficulty walking.""]","[""The symptoms of Charcot-Marie-Tooth disease type 1E include muscle weakness, foot deformities, loss of muscle tissue in the lower legs, and decreased sensation in the limbs.""]","[""Symptoms of CMT1E include muscle weakness, muscle atrophy, foot deformities, and sensory loss in the extremities.""]",[true],[true],[true],"[""Symptoms of CMT1E include muscle weakness, muscle atrophy, foot deformities, loss of sensation in the extremities, and difficulty walking.""]","[""The symptoms of Charcot-Marie-Tooth disease type 1E include muscle weakness, foot deformities, loss of muscle tissue, and decreased sensation in the limbs.""]","[""Symptoms of CMT1E include muscle weakness, muscle atrophy, foot deformities, and sensory loss in the extremities.""]",[true],[true],[true],"[""Symptoms of CMT1E include muscle weakness, foot deformities, loss of muscle mass in the lower legs, difficulty walking, and foot drop.""]","[""Symptoms of Charcot-Marie-Tooth disease type 1E include muscle weakness in the legs and feet, foot deformities, loss of muscle tissue in the lower legs, decreased ability to feel vibrations, and difficulty walking.""]","[""Symptoms of CMT1E include muscle weakness, muscle atrophy, foot deformities, and sensory loss in the extremities.""]",[true],[true],[true],"[""Symptoms of CMT1E may include muscle weakness, foot deformities, loss of sensation in the extremities, and difficulty walking.""]","[""Symptoms of Charcot-Marie-Tooth disease type 1E include muscle weakness, foot deformities, loss of muscle mass in the lower legs, difficulty walking, and numbness or tingling in the feet or legs.""]","[""The symptoms of CMT1E include muscle weakness and atrophy, foot deformities, loss of sensation in the extremities, and difficulty walking.""]",[true],[true],[true],"[""Symptoms of CMT1E may include muscle weakness, foot deformities, loss of sensation in the extremities, and difficulty walking.""]","[""The symptoms of Charcot-Marie-Tooth disease type 1E include muscle weakness, foot deformities, loss of muscle tissue in the lower legs, and decreased sensation in the limbs.""]","[""Symptoms of CMT1E include muscle weakness, muscle atrophy, foot deformities, and sensory loss in the extremities.""]",[true],[true],[true],"[""Symptoms of CMT1E may include muscle weakness in the legs and feet, difficulty walking, foot deformities, loss of sensation in the limbs, and muscle atrophy.""]","[""The symptoms of Charcot-Marie-Tooth disease type 1E include muscle weakness, foot deformities, loss of muscle tissue, and decreased sensation in the limbs.""]","[""Symptoms of CMT1E include muscle weakness, muscle atrophy, foot deformities, and sensory loss in the extremities.""]",[true],[true],[true],"[""Symptoms of CMT1E include muscle weakness, foot deformities, loss of muscle mass in the lower legs, difficulty walking, and decreased sensation in the extremities.""]","[""Symptoms of Charcot-Marie-Tooth disease type 1E include muscle weakness in the legs and feet, foot deformities, loss of muscle tissue in the lower legs, decreased ability to feel vibrations, and difficulty walking.""]","[""Symptoms of CMT1E include muscle weakness, muscle atrophy, foot deformities, and sensory loss in the extremities.""]",[true],[true],[true],"[""Symptoms of CMT1E include muscle weakness in the lower legs, foot deformities, loss of sensation in the extremities, and difficulty walking.""]","[""Symptoms of Charcot-Marie-Tooth disease type 1E include muscle weakness, foot deformities, loss of muscle mass in the lower legs, difficulty walking, and numbness or tingling in the feet or legs.""]","[""The symptoms of CMT1E include muscle weakness and atrophy, foot deformities, loss of sensation in the extremities, and difficulty walking.""]",[true],[true],[true],"[""The symptoms of CMT1E (Charcot-Marie-Tooth Disease Type 1E) include muscle weakness and atrophy, foot deformities (such as high arches or hammertoes), loss of sensation in the extremities, and difficulty walking.""]","[""The symptoms of Charcot-Marie-Tooth disease type 1E include muscle weakness, foot deformities, loss of muscle tissue in the lower legs, and decreased sensation in the limbs.""]","[""Symptoms of CMT1E include muscle weakness, muscle atrophy, foot deformities, and sensory loss in the extremities.""]",[true],[true],[true],"[""The symptoms of CMT1E (Charcot-Marie-Tooth Disease Type 1E) include muscle weakness and atrophy, foot deformities, loss of sensation in the extremities, and difficulty walking.""]","[""The symptoms of Charcot-Marie-Tooth disease type 1E include muscle weakness, foot deformities, loss of muscle tissue, and decreased sensation in the limbs.""]","[""Symptoms of CMT1E include muscle weakness, muscle atrophy, foot deformities, and sensory loss in the extremities.""]",[true],[true],[true],"[""Symptoms of CMT1E include muscle weakness and atrophy in the lower legs, foot deformities such as high arches or hammertoes, loss of sensation in the feet and legs, and difficulty walking.""]","[""Symptoms of Charcot-Marie-Tooth disease type 1E include muscle weakness in the legs and feet, foot deformities, loss of muscle tissue in the lower legs, decreased ability to feel vibrations, and difficulty walking.""]","[""Symptoms of CMT1E include muscle weakness, muscle atrophy, foot deformities, and sensory loss in the extremities.""]",[true],[true],[true],"[""The symptoms of CMT1E (Charcot-Marie-Tooth Disease Type 1E) include muscle weakness and atrophy, foot deformities (such as high arches or hammertoes), loss of sensation in the extremities, and difficulty walking.""]","[""Symptoms of Charcot-Marie-Tooth disease type 1E include muscle weakness, foot deformities, loss of muscle mass in the lower legs, difficulty walking, and numbness or tingling in the feet or legs.""]","[""The symptoms of CMT1E include muscle weakness and atrophy, foot deformities, loss of sensation in the extremities, and difficulty walking.""]",[true],[true],[true],"[""Symptoms of CMT1E include muscle weakness in the legs and feet, foot deformities such as high arches or hammertoes, loss of muscle mass in the lower legs, and decreased ability to feel vibrations in the extremities.""]","[""The symptoms of Charcot-Marie-Tooth disease type 1E include muscle weakness, foot deformities, loss of muscle tissue in the lower legs, and decreased sensation in the limbs.""]","[""Symptoms of CMT1E include muscle weakness, muscle atrophy, foot deformities, and sensory loss in the extremities.""]",[true],[true],[true],"[""The symptoms of CMT1E (Charcot-Marie-Tooth Disease Type 1E) include muscle weakness and atrophy, foot deformities, loss of sensation in the extremities, and difficulty walking.""]","[""The symptoms of Charcot-Marie-Tooth disease type 1E include muscle weakness, foot deformities, loss of muscle tissue, and decreased sensation in the limbs.""]","[""Symptoms of CMT1E include muscle weakness, muscle atrophy, foot deformities, and sensory loss in the extremities.""]",[true],[true],[true],"[""Some common symptoms of CMT1E include muscle weakness, foot deformities, loss of sensation in the extremities, and difficulty walking.""]","[""Symptoms of Charcot-Marie-Tooth disease type 1E include muscle weakness in the legs and feet, foot deformities, loss of muscle tissue in the lower legs, decreased ability to feel vibrations, and difficulty walking.""]","[""Symptoms of CMT1E include muscle weakness, muscle atrophy, foot deformities, and sensory loss in the extremities.""]",[true],[true],[true],"[""The symptoms of CMT1E (Charcot-Marie-Tooth Disease Type 1E) include muscle weakness and atrophy, foot deformities, loss of sensation in the extremities, and difficulty walking.""]","[""Symptoms of Charcot-Marie-Tooth disease type 1E include muscle weakness, foot deformities, loss of muscle mass in the lower legs, difficulty walking, and numbness or tingling in the feet or legs.""]","[""The symptoms of CMT1E include muscle weakness and atrophy, foot deformities, loss of sensation in the extremities, and difficulty walking.""]",[true],[true],[true],"[""Some common symptoms of CMT1E include muscle weakness, foot deformities, difficulty walking, and loss of sensation in the extremities.""]","[""The symptoms of Charcot-Marie-Tooth disease type 1E include muscle weakness, foot deformities, loss of muscle tissue in the lower legs, and decreased sensation in the limbs.""]","[""Symptoms of CMT1E include muscle weakness, muscle atrophy, foot deformities, and sensory loss in the extremities.""]",[true],[true],[true],"[""Some common symptoms of CMT1E include muscle weakness, foot deformities, loss of sensation in the extremities, and difficulty walking.""]","[""The symptoms of Charcot-Marie-Tooth disease type 1E include muscle weakness, foot deformities, loss of muscle tissue, and decreased sensation in the limbs.""]","[""Symptoms of CMT1E include muscle weakness, muscle atrophy, foot deformities, and sensory loss in the extremities.""]",[true],[true],[true],"[""Symptoms of CMT1E may include muscle weakness, foot deformities, loss of sensation in the extremities, and difficulty walking.""]","[""Symptoms of Charcot-Marie-Tooth disease type 1E include muscle weakness in the legs and feet, foot deformities, loss of muscle tissue in the lower legs, decreased ability to feel vibrations, and difficulty walking.""]","[""Symptoms of CMT1E include muscle weakness, muscle atrophy, foot deformities, and sensory loss in the extremities.""]",[true],[true],[true],"[""Symptoms of CMT1E may include muscle weakness, foot deformities, loss of sensation in the extremities, and difficulty walking.""]","[""Symptoms of Charcot-Marie-Tooth disease type 1E include muscle weakness in the legs and feet, foot deformities, loss of muscle tissue in the lower legs, decreased ability to feel vibrations, and difficulty walking.""]","[""Symptoms of CMT1E include muscle weakness, muscle atrophy, foot deformities, and sensory loss in the extremities.""]",[true],[true],[true],"[""Symptoms of CMT1E include muscle weakness, foot deformities, loss of sensation in the extremities, and difficulty walking.""]","[""Symptoms of Charcot-Marie-Tooth disease type 1E include muscle weakness in the legs and feet, foot deformities, loss of muscle tissue in the lower legs, decreased ability to feel vibrations, and difficulty walking.""]","[""Symptoms of CMT1E include muscle weakness, muscle atrophy, foot deformities, and sensory loss in the extremities.""]",[true],[true],[true],"[""Symptoms of CMT1E include muscle weakness, foot deformities, loss of sensation in the extremities, and difficulty walking.""]","[""Symptoms of Charcot-Marie-Tooth disease type 1E include muscle weakness in the legs and feet, foot deformities, loss of muscle tissue in the lower legs, decreased ability to feel vibrations, and difficulty walking.""]","[""Symptoms of CMT1E include muscle weakness, muscle atrophy, foot deformities, and sensory loss in the extremities.""]"
outlook,What is the outlook for Plasma Cell Neoplasms (Including Multiple Myeloma) ?,"Certain factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery) depends on the following:         - The type of plasma cell neoplasm.    - The stage of the disease.    - Whether a certain immunoglobulin (antibody) is present.    - Whether there are certain genetic changes.    - Whether the kidney is damaged.    - Whether the cancer responds to initial treatment or recurs (comes back).        Treatment options depend on the following:         - The type of plasma cell neoplasm.    - The age and general health of the patient.    - Whether there are signs, symptoms, or health problems, such as kidney failure or infection, related to the disease.    - Whether the cancer responds to initial treatment or recurs (comes back).","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""PCN"", ""full_form"": ""Plasma Cell Neoplasms""}]}",What is the outlook for PCN (Including Multiple Myeloma) ?,What is the outlook for Plasma Cell Neoplasms (Including Multiple Myeloma) ?,8,MEDICAL,Simple Datatype-String,"Exploratory(Divergent Thinking): Queries that are inherently about seeking new areas of knowledge, understanding emerging trends, or identifying unknown opportunities without a specific end goal of making a decision or judgment. Exploratory queries are characterized by their openness and the lack of a predefined objective, differentiating them from evaluative queries which are directed towards forming a judgment or assessment. Exploratory queries encourage branching out into various directions to explore a wide array of possibilities without necessarily aiming to converge on a single answer or outcome.","[[""Penicillin"", ""Personal Communication Network"", ""Primary Care Network"", ""Parent Communication Network"", ""Pilipino Cultural Night"", ""Pennsylvania Cable Network"", ""Pilipino Culture Night"", ""Product Control Number"", ""Picton, New Zealand"", ""Property Control Number""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Penicillin""]",[1.214558955166145e-08],[0.0011544953597111812],"[""Penicillin""]",[0.0011544953597111812],"[""ABBREVIATIONS""]","[[0.0011544953597111812, 2.1871223135641353e-12, 4.13218857039334e-10, 2.121548624372598e-13, 2.249272057643877e-25, 2.2200884065117107e-25, 1.6298351045479254e-24, 2.2305071670153102e-13, 3.383163790249292e-27, 2.096316842015433e-15]]",[0.9349571459888552],[0.8999730786916155],"[""Penicillin""]",[0.9371558841040319],"[""ABBREVIATIONS""]","[[0.8999730786916155, 0.9371558841040319, 0.9366321583516378, 0.8979062833645843, 0.8161331710234621, 0.8477749752249739, 0.8192913084753701, 0.8887597058881217, 0.8242104424983397, 0.9043126906228244]]","[""Penicillin""]","[""ABBREVIATIONS""]",What is the outlook for PCN (Penicillin) (Including Multiple Myeloma) ?,[false],[true],[true],"[""The outlook for PCN (Penicillin) in patients with Multiple Myeloma depends on various factors such as the stage of the cancer, overall health of the patient, and potential drug interactions. It is important for patients to consult with their healthcare provider for personalized information and guidance.""]","[""The outlook for Plasma Cell Neoplasms, including Multiple Myeloma, varies depending on factors such as the stage at diagnosis, response to treatment, and individual patient characteristics. With advancements in treatment options, including targeted therapies and immunotherapies, many patients are living longer and with a good quality of life. However, the prognosis can range from relatively good to more challenging cases, so it is important for patients to work closely with their healthcare team to determine the best course of action.""]","[""The outlook for PCN, including Multiple Myeloma, varies depending on the individual's specific case, stage of the disease, response to treatment, and other factors. It is important to consult with a healthcare provider for personalized information and guidance.""]",[false],[true],[true],"[""The outlook for PCN (Penicillin) in patients with Multiple Myeloma can vary depending on the individual's overall health, stage of cancer, and response to treatment. It is important for patients to work closely with their healthcare team to determine the best course of action and monitor for any potential complications.""]","[""The outlook for Plasma Cell Neoplasms, including Multiple Myeloma, varies depending on the stage at diagnosis, response to treatment, and individual factors. With advancements in treatment options such as immunotherapy and targeted therapies, many patients are living longer and with a good quality of life. However, the prognosis can range from relatively good to more challenging in advanced stages or in cases of relapse.""]","[""The outlook for PCN, including Multiple Myeloma, varies depending on the individual's specific case, stage of the disease, response to treatment, and other factors. It is important for patients to consult with their healthcare providers for personalized information and guidance.""]",[false],[true],[true],"[""The outlook for PCN (Penicillin) in patients with Multiple Myeloma can vary depending on the individual's overall health, stage of cancer, and response to treatment. It is important for patients to work closely with their healthcare team to determine the best course of action.""]","[""The outlook for Plasma Cell Neoplasms, including Multiple Myeloma, can vary depending on factors such as the stage at diagnosis, response to treatment, and individual patient characteristics. With advancements in treatment options, including targeted therapies and immunotherapies, many patients with Multiple Myeloma are living longer and with a good quality of life. However, the prognosis can still be variable, and it is important for patients to work closely with their healthcare team to determine the best treatment plan for their specific situation.""]","[""The outlook for PCN, including Multiple Myeloma, varies depending on the individual's specific case, stage of the disease, response to treatment, and other factors. It is important to consult with a healthcare provider for personalized information and guidance.""]",[false],[true],[true],"[""The outlook for PCN (Penicillin) in patients with Multiple Myeloma can vary depending on the individual's overall health, stage of cancer, and response to treatment. It is important for patients to work closely with their healthcare team to determine the best course of action.""]","[""The outlook for Plasma Cell Neoplasms, including Multiple Myeloma, varies depending on the stage at diagnosis, response to treatment, and individual factors. With advancements in treatment options such as immunotherapy and targeted therapies, many patients are living longer and with a good quality of life. However, it is important to consult with a healthcare provider for personalized prognosis and treatment options.""]","[""The outlook for PCN, including Multiple Myeloma, varies depending on the stage of the disease, response to treatment, and individual factors. It is important to consult with a healthcare provider for personalized information and guidance.""]",[false],[true],[true],"[""The outlook for PCN (Penicillin) in patients with Multiple Myeloma can vary depending on the individual's overall health, stage of cancer, and response to treatment. It is important for patients to work closely with their healthcare team to determine the most appropriate treatment plan and monitor for any potential complications.""]","[""The outlook for Plasma Cell Neoplasms, including Multiple Myeloma, varies depending on factors such as the stage at diagnosis, response to treatment, and individual patient characteristics. With advancements in treatment options, including targeted therapies and immunotherapies, many patients are living longer and with a good quality of life. However, the prognosis can range from relatively good to more challenging cases, so it is important for patients to work closely with their healthcare team to determine the best course of action.""]","[""The outlook for PCN, including Multiple Myeloma, varies depending on the individual's specific case, stage of the disease, response to treatment, and other factors. It is important to consult with a healthcare provider for personalized information and guidance.""]",[false],[true],[true],"[""The outlook for PCN (Penicillin) in patients with Multiple Myeloma can vary depending on the individual's overall health, stage of cancer, and response to treatment. It is important for patients to work closely with their healthcare team to determine the best course of action.""]","[""The outlook for Plasma Cell Neoplasms, including Multiple Myeloma, varies depending on the stage at diagnosis, response to treatment, and individual factors. With advancements in treatment options such as immunotherapy and targeted therapies, many patients are living longer and with a good quality of life. However, the prognosis can range from relatively good to more challenging in advanced stages or in cases of relapse.""]","[""The outlook for PCN, including Multiple Myeloma, varies depending on the individual's specific case, stage of the disease, response to treatment, and other factors. It is important for patients to consult with their healthcare providers for personalized information and guidance.""]",[false],[true],[true],"[""The outlook for PCN (Penicillin) in patients with Multiple Myeloma can vary depending on the individual's overall health status, stage of cancer, and response to treatment. It is important for patients to work closely with their healthcare team to determine the most appropriate treatment plan and monitor for any potential complications.""]","[""The outlook for Plasma Cell Neoplasms, including Multiple Myeloma, can vary depending on factors such as the stage at diagnosis, response to treatment, and individual patient characteristics. With advancements in treatment options, including targeted therapies and immunotherapies, many patients with Multiple Myeloma are living longer and with a good quality of life. However, the prognosis can still be variable, and it is important for patients to work closely with their healthcare team to determine the best treatment plan for their specific situation.""]","[""The outlook for PCN, including Multiple Myeloma, varies depending on the individual's specific case, stage of the disease, response to treatment, and other factors. It is important to consult with a healthcare provider for personalized information and guidance.""]",[false],[true],[true],"[""The outlook for PCN (Penicillin) in patients with Multiple Myeloma depends on various factors such as the stage of cancer, overall health of the patient, and response to treatment. It is important for patients to consult with their healthcare provider for personalized information and guidance.""]","[""The outlook for Plasma Cell Neoplasms, including Multiple Myeloma, varies depending on the stage at diagnosis, response to treatment, and individual factors. With advancements in treatment options such as immunotherapy and targeted therapies, many patients are living longer and with a good quality of life. However, it is important to consult with a healthcare provider for personalized prognosis and treatment options.""]","[""The outlook for PCN, including Multiple Myeloma, varies depending on the stage of the disease, response to treatment, and individual factors. It is important to consult with a healthcare provider for personalized information and guidance.""]",[false],[true],[true],"[""The outlook for PCN (Penicillin) in patients with Multiple Myeloma depends on various factors such as the stage of the cancer, overall health of the patient, and potential drug interactions. It is important for patients to consult with their healthcare provider for personalized information and guidance.""]","[""The outlook for Plasma Cell Neoplasms, including Multiple Myeloma, varies depending on the stage at diagnosis, response to treatment, and individual factors. With advancements in treatment options such as immunotherapy and targeted therapies, many patients are living longer and with a good quality of life. However, the prognosis can range from relatively good to more challenging in advanced stages or in cases of relapse.""]","[""The outlook for PCN, including Multiple Myeloma, varies depending on the individual's specific case, stage of the disease, response to treatment, and other factors. It is important for patients to consult with their healthcare providers for personalized information and guidance.""]",[false],[true],[true],"[""The outlook for PCN (Penicillin) in patients with Multiple Myeloma may vary depending on the individual's overall health, stage of cancer, and response to treatment. It is important for patients to consult with their healthcare provider for personalized information and guidance.""]","[""The outlook for Plasma Cell Neoplasms, including Multiple Myeloma, varies depending on factors such as the stage at diagnosis, response to treatment, and individual patient characteristics. With advancements in treatment options, including targeted therapies and immunotherapies, many patients are living longer and with a good quality of life. However, the prognosis can range from relatively good to more challenging cases, so it is important for patients to work closely with their healthcare team to determine the best course of action.""]","[""The outlook for PCN, including Multiple Myeloma, varies depending on the individual's specific case, stage of the disease, response to treatment, and other factors. It is important to consult with a healthcare provider for personalized information and guidance.""]",[false],[true],[true],"[""The outlook for PCN (Penicillin) in patients with Multiple Myeloma depends on various factors such as the stage of the cancer, overall health of the patient, and potential drug interactions. It is important for patients to consult with their healthcare provider for personalized information and guidance.""]","[""The outlook for Plasma Cell Neoplasms, including Multiple Myeloma, can vary depending on factors such as the stage at diagnosis, response to treatment, and individual patient characteristics. With advancements in treatment options, including targeted therapies and immunotherapies, many patients with Multiple Myeloma are living longer and with a good quality of life. However, the prognosis can still be variable, and it is important for patients to work closely with their healthcare team to determine the best treatment plan for their specific situation.""]","[""The outlook for PCN, including Multiple Myeloma, varies depending on the individual's specific case, stage of the disease, response to treatment, and other factors. It is important to consult with a healthcare provider for personalized information and guidance.""]",[false],[true],[true],"[""The outlook for PCN (Penicillin) in patients with Multiple Myeloma depends on various factors such as the stage of the cancer, overall health of the patient, and response to treatment. It is important for patients to consult with their healthcare provider for personalized information and guidance.""]","[""The outlook for Plasma Cell Neoplasms, including Multiple Myeloma, varies depending on the stage at diagnosis, response to treatment, and individual factors. With advancements in treatment options such as immunotherapy and targeted therapies, many patients are living longer and with a good quality of life. However, it is important to consult with a healthcare provider for personalized prognosis and treatment options.""]","[""The outlook for PCN, including Multiple Myeloma, varies depending on the stage of the disease, response to treatment, and individual factors. It is important to consult with a healthcare provider for personalized information and guidance.""]",[false],[true],[true],"[""The outlook for PCN (Penicillin) in patients with Multiple Myeloma depends on various factors such as the stage of the cancer, overall health of the patient, and response to treatment. It is important for patients to discuss their individual prognosis with their healthcare provider.""]","[""The outlook for Plasma Cell Neoplasms, including Multiple Myeloma, varies depending on factors such as the stage at diagnosis, response to treatment, and individual patient characteristics. With advancements in treatment options, including targeted therapies and immunotherapies, many patients are living longer and with a good quality of life. However, the prognosis can range from relatively good to more challenging cases, so it is important for patients to work closely with their healthcare team to determine the best course of action.""]","[""The outlook for PCN, including Multiple Myeloma, varies depending on the individual's specific case, stage of the disease, response to treatment, and other factors. It is important to consult with a healthcare provider for personalized information and guidance.""]",[false],[true],[true],"[""The outlook for PCN (Penicillin) in patients with Multiple Myeloma depends on various factors such as the stage of the disease, overall health of the patient, and response to treatment. It is important for patients to discuss their individual prognosis with their healthcare provider.""]","[""The outlook for Plasma Cell Neoplasms, including Multiple Myeloma, varies depending on the stage at diagnosis, response to treatment, and individual factors. With advancements in treatment options such as immunotherapy and targeted therapies, many patients are living longer and with a good quality of life. However, the prognosis can range from relatively good to more challenging in advanced stages or in cases of relapse.""]","[""The outlook for PCN, including Multiple Myeloma, varies depending on the individual's specific case, stage of the disease, response to treatment, and other factors. It is important for patients to consult with their healthcare providers for personalized information and guidance.""]",[false],[true],[true],"[""The outlook for PCN (Penicillin) in patients with Multiple Myeloma depends on various factors such as the stage of the cancer, overall health of the patient, and response to treatment. It is important for patients to work closely with their healthcare team to determine the best course of action.""]","[""The outlook for Plasma Cell Neoplasms, including Multiple Myeloma, can vary depending on factors such as the stage at diagnosis, response to treatment, and individual patient characteristics. With advancements in treatment options, including targeted therapies and immunotherapies, many patients with Multiple Myeloma are living longer and with a good quality of life. However, the prognosis can still be variable, and it is important for patients to work closely with their healthcare team to determine the best treatment plan for their specific situation.""]","[""The outlook for PCN, including Multiple Myeloma, varies depending on the individual's specific case, stage of the disease, response to treatment, and other factors. It is important to consult with a healthcare provider for personalized information and guidance.""]",[false],[true],[true],"[""The outlook for PCN (Penicillin) in patients with Multiple Myeloma depends on various factors such as the stage of the cancer, overall health of the patient, and response to treatment. It is important for patients to discuss their individual prognosis with their healthcare provider.""]","[""The outlook for Plasma Cell Neoplasms, including Multiple Myeloma, varies depending on the stage at diagnosis, response to treatment, and individual factors. With advancements in treatment options such as immunotherapy and targeted therapies, many patients are living longer and with a good quality of life. However, it is important to consult with a healthcare provider for personalized prognosis and treatment options.""]","[""The outlook for PCN, including Multiple Myeloma, varies depending on the stage of the disease, response to treatment, and individual factors. It is important to consult with a healthcare provider for personalized information and guidance.""]",[false],[true],[true],"[""The outlook for PCN (Penicillin) in the treatment of Multiple Myeloma is still under investigation and research. It is considered an emerging area of study with potential benefits, but more clinical trials and data are needed to determine its effectiveness.""]","[""The outlook for Plasma Cell Neoplasms, including Multiple Myeloma, varies depending on factors such as the stage at diagnosis, response to treatment, and individual patient characteristics. With advancements in treatment options, including targeted therapies and immunotherapies, many patients are living longer and with a good quality of life. However, the prognosis can range from relatively good to more challenging cases, so it is important for patients to work closely with their healthcare team to determine the best course of action.""]","[""The outlook for PCN, including Multiple Myeloma, varies depending on the individual's specific case, stage of the disease, response to treatment, and other factors. It is important to consult with a healthcare provider for personalized information and guidance.""]",[false],[true],[true],"[""The outlook for PCN (Penicillin) in patients with Multiple Myeloma depends on various factors such as the stage of the cancer, overall health of the patient, and potential drug interactions. It is important for healthcare providers to carefully assess each individual case to determine the most appropriate treatment plan.""]","[""The outlook for Plasma Cell Neoplasms, including Multiple Myeloma, varies depending on the stage at diagnosis, response to treatment, and individual factors. With advancements in treatment options such as immunotherapy and targeted therapies, many patients are living longer and with a good quality of life. However, the prognosis can range from relatively good to more challenging in advanced stages or in cases of relapse.""]","[""The outlook for PCN, including Multiple Myeloma, varies depending on the individual's specific case, stage of the disease, response to treatment, and other factors. It is important for patients to consult with their healthcare providers for personalized information and guidance.""]",[false],[true],[true],"[""The outlook for PCN (Penicillin) in patients with Multiple Myeloma depends on various factors such as the stage of cancer, overall health of the patient, and response to treatment. It is important for patients to consult with their healthcare provider for personalized information and guidance.""]","[""The outlook for Plasma Cell Neoplasms, including Multiple Myeloma, can vary depending on factors such as the stage at diagnosis, response to treatment, and individual patient characteristics. With advancements in treatment options, including targeted therapies and immunotherapies, many patients with Multiple Myeloma are living longer and with a good quality of life. However, the prognosis can still be variable, and it is important for patients to work closely with their healthcare team to determine the best treatment plan for their specific situation.""]","[""The outlook for PCN, including Multiple Myeloma, varies depending on the individual's specific case, stage of the disease, response to treatment, and other factors. It is important to consult with a healthcare provider for personalized information and guidance.""]",[false],[true],[true],"[""The outlook for PCN (Penicillin) in the treatment of Multiple Myeloma is still being researched and evaluated. It is not yet established as a standard treatment option for this condition.""]","[""The outlook for Plasma Cell Neoplasms, including Multiple Myeloma, varies depending on the stage at diagnosis, response to treatment, and individual factors. With advancements in treatment options such as immunotherapy and targeted therapies, many patients are living longer and with a good quality of life. However, it is important to consult with a healthcare provider for personalized prognosis and treatment options.""]","[""The outlook for PCN, including Multiple Myeloma, varies depending on the stage of the disease, response to treatment, and individual factors. It is important to consult with a healthcare provider for personalized information and guidance.""]",[false],[true],[true],"[""The outlook for PCN (Penicillin) in patients with Multiple Myeloma may vary depending on the individual's overall health condition, stage of cancer, and response to treatment. It is important for patients to consult with their healthcare provider for personalized information and guidance.""]","[""The outlook for Plasma Cell Neoplasms, including Multiple Myeloma, varies depending on factors such as the stage at diagnosis, response to treatment, and individual patient characteristics. With advancements in treatment options, including targeted therapies and immunotherapies, many patients are living longer and with a good quality of life. However, the prognosis can range from relatively good to more challenging cases, so it is important for patients to work closely with their healthcare team to determine the best course of action.""]","[""The outlook for PCN, including Multiple Myeloma, varies depending on the individual's specific case, stage of the disease, response to treatment, and other factors. It is important to consult with a healthcare provider for personalized information and guidance.""]",[false],[true],[true],"[""The outlook for PCN (Penicillin) in patients with Multiple Myeloma is generally good, as long as there are no allergies or contraindications. However, it is important to consult with a healthcare provider for personalized advice.""]","[""The outlook for Plasma Cell Neoplasms, including Multiple Myeloma, varies depending on the stage at diagnosis, response to treatment, and individual factors. With advancements in treatment options such as immunotherapy and targeted therapies, many patients are living longer and with a good quality of life. However, the prognosis can range from relatively good to more challenging in advanced stages or in cases of relapse.""]","[""The outlook for PCN, including Multiple Myeloma, varies depending on the individual's specific case, stage of the disease, response to treatment, and other factors. It is important for patients to consult with their healthcare providers for personalized information and guidance.""]",[false],[true],[true],"[""The outlook for PCN (Penicillin) in patients with Multiple Myeloma is generally good, as Penicillin is commonly used to prevent infections in patients with weakened immune systems, such as those with Multiple Myeloma.""]","[""The outlook for Plasma Cell Neoplasms, including Multiple Myeloma, can vary depending on factors such as the stage at diagnosis, response to treatment, and individual patient characteristics. With advancements in treatment options, including targeted therapies and immunotherapies, many patients with Multiple Myeloma are living longer and with a good quality of life. However, the prognosis can still be variable, and it is important for patients to work closely with their healthcare team to determine the best treatment plan for their specific situation.""]","[""The outlook for PCN, including Multiple Myeloma, varies depending on the individual's specific case, stage of the disease, response to treatment, and other factors. It is important to consult with a healthcare provider for personalized information and guidance.""]",[false],[true],[true],"[""The outlook for PCN (Penicillin) in patients with Multiple Myeloma may vary depending on the individual's overall health status, stage of cancer, and response to treatment. It is important for patients to consult with their healthcare provider for personalized information and guidance.""]","[""The outlook for Plasma Cell Neoplasms, including Multiple Myeloma, varies depending on the stage at diagnosis, response to treatment, and individual factors. With advancements in treatment options such as immunotherapy and targeted therapies, many patients are living longer and with a good quality of life. However, it is important to consult with a healthcare provider for personalized prognosis and treatment options.""]","[""The outlook for PCN, including Multiple Myeloma, varies depending on the stage of the disease, response to treatment, and individual factors. It is important to consult with a healthcare provider for personalized information and guidance.""]",[false],[true],[true],"[""The outlook for PCN (Penicillin) and Multiple Myeloma varies depending on the specific context and individual circumstances. It is recommended to consult with a healthcare professional for personalized information and guidance.""]","[""The outlook for Plasma Cell Neoplasms, including Multiple Myeloma, varies depending on factors such as the stage at diagnosis, response to treatment, and individual patient characteristics. With advancements in treatment options, including targeted therapies and immunotherapies, many patients are living longer and with a good quality of life. However, the prognosis can range from relatively good to more challenging cases, so it is important for patients to work closely with their healthcare team to determine the best course of action.""]","[""The outlook for PCN, including Multiple Myeloma, varies depending on the individual's specific case, stage of the disease, response to treatment, and other factors. It is important to consult with a healthcare provider for personalized information and guidance.""]",[false],[true],[true],"[""The outlook for PCN (Penicillin) and Multiple Myeloma varies depending on the specific context and individual circumstances. It is recommended to consult with a healthcare professional for personalized information.""]","[""The outlook for Plasma Cell Neoplasms, including Multiple Myeloma, varies depending on the stage at diagnosis, response to treatment, and individual factors. With advancements in treatment options such as immunotherapy and targeted therapies, many patients are living longer and with a good quality of life. However, the prognosis can range from relatively good to more challenging in advanced stages or in cases of relapse.""]","[""The outlook for PCN, including Multiple Myeloma, varies depending on the individual's specific case, stage of the disease, response to treatment, and other factors. It is important for patients to consult with their healthcare providers for personalized information and guidance.""]",[false],[true],[true],"[""The outlook for PCN (Penicillin) in the treatment of Multiple Myeloma is still under investigation and research. It is considered an emerging area of study with potential opportunities for further exploration.""]","[""The outlook for Plasma Cell Neoplasms, including Multiple Myeloma, can vary depending on factors such as the stage at diagnosis, response to treatment, and individual patient characteristics. With advancements in treatment options, including targeted therapies and immunotherapies, many patients with Multiple Myeloma are living longer and with a good quality of life. However, the prognosis can still be variable, and it is important for patients to work closely with their healthcare team to determine the best treatment plan for their specific situation.""]","[""The outlook for PCN, including Multiple Myeloma, varies depending on the individual's specific case, stage of the disease, response to treatment, and other factors. It is important to consult with a healthcare provider for personalized information and guidance.""]",[false],[true],[true],"[""The outlook for PCN (Penicillin) in the treatment of Multiple Myeloma is still under investigation and research. It is considered an emerging area of study with potential opportunities for further exploration.""]","[""The outlook for Plasma Cell Neoplasms, including Multiple Myeloma, varies depending on the stage at diagnosis, response to treatment, and individual factors. With advancements in treatment options such as immunotherapy and targeted therapies, many patients are living longer and with a good quality of life. However, it is important to consult with a healthcare provider for personalized prognosis and treatment options.""]","[""The outlook for PCN, including Multiple Myeloma, varies depending on the stage of the disease, response to treatment, and individual factors. It is important to consult with a healthcare provider for personalized information and guidance.""]",[false],[true],[true],"[""The outlook for PCN (Penicillin) in patients with Multiple Myeloma depends on various factors such as the stage of the cancer, response to treatment, and overall health of the individual. It is important for patients to work closely with their healthcare team to determine the best course of action and prognosis.""]","[""The outlook for Plasma Cell Neoplasms, including Multiple Myeloma, varies depending on factors such as the stage at diagnosis, response to treatment, and individual patient characteristics. With advancements in treatment options, including targeted therapies and immunotherapies, many patients are living longer and with a good quality of life. However, the prognosis can range from relatively good to more challenging cases, so it is important for patients to work closely with their healthcare team to determine the best course of action.""]","[""The outlook for PCN, including Multiple Myeloma, varies depending on the individual's specific case, stage of the disease, response to treatment, and other factors. It is important to consult with a healthcare provider for personalized information and guidance.""]",[false],[true],[true],"[""The outlook for PCN (Penicillin) in treating Multiple Myeloma is generally poor as it is not a standard treatment for this type of cancer.""]","[""The outlook for Plasma Cell Neoplasms, including Multiple Myeloma, varies depending on factors such as the stage at diagnosis, response to treatment, and individual patient characteristics. With advancements in treatment options, including targeted therapies and immunotherapies, many patients are living longer and with a good quality of life. However, the prognosis can range from relatively good to more challenging cases, so it is important for patients to work closely with their healthcare team to determine the best course of action.""]","[""The outlook for PCN, including Multiple Myeloma, varies depending on the individual's specific case, stage of the disease, response to treatment, and other factors. It is important to consult with a healthcare provider for personalized information and guidance.""]",[false],[true],[true],"[""The outlook for PCN (Penicillin) in patients with Multiple Myeloma depends on various factors such as the stage of the cancer, response to treatment, and overall health of the individual. It is important for patients to discuss their specific case with their healthcare provider for personalized information.""]","[""The outlook for Plasma Cell Neoplasms, including Multiple Myeloma, varies depending on factors such as the stage at diagnosis, response to treatment, and individual patient characteristics. With advancements in treatment options, including targeted therapies and immunotherapies, many patients are living longer and with a good quality of life. However, the prognosis can range from relatively good to more challenging cases, so it is important for patients to work closely with their healthcare team to determine the best course of action.""]","[""The outlook for PCN, including Multiple Myeloma, varies depending on the individual's specific case, stage of the disease, response to treatment, and other factors. It is important to consult with a healthcare provider for personalized information and guidance.""]",[false],[true],[true],"[""Outlook for PCN (Penicillin) in Multiple Myeloma varies depending on the specific case and treatment plan. It is important to consult with a healthcare professional for personalized information.""]","[""The outlook for Plasma Cell Neoplasms, including Multiple Myeloma, varies depending on factors such as the stage at diagnosis, response to treatment, and individual patient characteristics. With advancements in treatment options, including targeted therapies and immunotherapies, many patients are living longer and with a good quality of life. However, the prognosis can range from relatively good to more challenging cases, so it is important for patients to work closely with their healthcare team to determine the best course of action.""]","[""The outlook for PCN, including Multiple Myeloma, varies depending on the individual's specific case, stage of the disease, response to treatment, and other factors. It is important to consult with a healthcare provider for personalized information and guidance.""]"
symptoms,What are the symptoms of GOMBO syndrome ?,"What are the signs and symptoms of GOMBO syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for GOMBO syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of cardiovascular system morphology - Autosomal recessive inheritance - Brachydactyly syndrome - Clinodactyly - Delayed puberty - Intellectual disability, progressive - Intellectual disability, severe - Microcephaly - Microphthalmia - Radial deviation of finger - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""abbreviation"", ""abbreviation"": ""GOMBO"", ""full_form"": ""Growth retardation, Ocular abnormalities, Microcephaly, Brachydactyly, and Oligophrenia""}]}",What are the symptoms of GOMBO syndrome ?,"What are the symptoms of Growth retardation, Ocular abnormalities, Microcephaly, Brachydactyly, and Oligophrenia syndrome ?",8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.",[[]],[[]],"[""Generalized Overlap Mosaic Bone disorder""]",[8.345831825138967e-58],[3.733647835921347e-23],"[""Generalized Overlap Mosaic Bone disorder""]",[3.733647835921347e-23],"[""LLM""]",[[]],[0.7775528137128567],[0.8075059500051555],"[""Growth retardation, Ocular abnormalities, Microcephaly, Brachydactyly, and Oligophrenia""]",[0.8075059500051555],"[""LLM""]",[[]],"[""Generalized Overlap Mosaic Bone disorder""]","[""LLM""]",What are the symptoms of GOMBO (Generalized Overlap Mosaic Bone disorder) syndrome ?,[false],[true],[false],"[""The symptoms of GOMBO syndrome include short stature, joint pain, bone deformities, and a mosaic pattern of bones on X-rays.""]","[""Symptoms of Growth retardation, Ocular abnormalities, Microcephaly, Brachydactyly, and Oligophrenia syndrome include short stature, vision problems, small head size, short fingers, and intellectual disability.""]","[""GOMBO syndrome symptoms include growth retardation, optic atrophy, microcephaly, and brain anomalies.""]",[false],[true],[false],"[""The symptoms of GOMBO syndrome include short stature, joint hypermobility, osteopenia, and a distinctive facial appearance.""]","[""The symptoms of Growth retardation, Ocular abnormalities, Microcephaly, Brachydactyly, and Oligophrenia syndrome include short stature, vision problems, small head size, short fingers, and intellectual disability.""]","[""GOMBO syndrome symptoms include growth retardation, optic atrophy, microcephaly, and brain anomalies.""]",[false],[true],[false],"[""Symptoms of GOMBO syndrome include short stature, joint hypermobility, osteopenia, and a distinctive facial appearance.""]","[""The symptoms of Growth retardation, Ocular abnormalities, Microcephaly, Brachydactyly, and Oligophrenia syndrome include short stature, vision problems, small head size, short fingers, and intellectual disability.""]","[""GOMBO syndrome symptoms include growth retardation, optic atrophy, microcephaly, and brain anomalies.""]",[false],[true],[true],"[""Symptoms of GOMBO syndrome include short stature, joint pain, bone deformities, and a mosaic pattern of bone density on imaging.""]","[""The symptoms of Growth retardation, Ocular abnormalities, Microcephaly, Brachydactyly, and Oligophrenia syndrome include short stature, vision problems, small head size, short fingers, and intellectual disability.""]","[""Symptoms of GOMBO syndrome include intellectual disability, distinctive facial features, growth delays, and skeletal abnormalities.""]",[true],[true],[false],"[""GOMBO syndrome is a rare genetic disorder characterized by growth retardation, ocular abnormalities, microcephaly, brachydactyly, and oligophrenia.""]","[""Symptoms of Growth retardation, Ocular abnormalities, Microcephaly, Brachydactyly, and Oligophrenia syndrome include short stature, vision problems, small head size, short fingers, and intellectual disability.""]","[""GOMBO syndrome symptoms include growth retardation, optic atrophy, microcephaly, and brain anomalies.""]",[true],[true],[false],"[""GOMBO syndrome presents with symptoms such as growth retardation, ocular abnormalities, microcephaly, brachydactyly, and oligophrenia.""]","[""The symptoms of Growth retardation, Ocular abnormalities, Microcephaly, Brachydactyly, and Oligophrenia syndrome include short stature, vision problems, small head size, short fingers, and intellectual disability.""]","[""GOMBO syndrome symptoms include growth retardation, optic atrophy, microcephaly, and brain anomalies.""]",[true],[true],[false],"[""GOMBO syndrome presents with symptoms such as growth retardation, ocular abnormalities, microcephaly, brachydactyly, and oligophrenia.""]","[""The symptoms of Growth retardation, Ocular abnormalities, Microcephaly, Brachydactyly, and Oligophrenia syndrome include short stature, vision problems, small head size, short fingers, and intellectual disability.""]","[""GOMBO syndrome symptoms include growth retardation, optic atrophy, microcephaly, and brain anomalies.""]",[true],[true],[true],"[""GOMBO syndrome presents with symptoms such as growth retardation, ocular abnormalities, microcephaly, brachydactyly, and oligophrenia.""]","[""The symptoms of Growth retardation, Ocular abnormalities, Microcephaly, Brachydactyly, and Oligophrenia syndrome include short stature, vision problems, small head size, short fingers, and intellectual disability.""]","[""Symptoms of GOMBO syndrome include intellectual disability, distinctive facial features, growth delays, and skeletal abnormalities.""]",[false],[true],[false],"[""Symptoms of GOMBO syndrome include short stature, joint pain, bone deformities, and a mosaic pattern of bones on X-rays.""]","[""The symptoms of Growth retardation, Ocular abnormalities, Microcephaly, Brachydactyly, and Oligophrenia syndrome include short stature, vision problems, small head size, short fingers, and intellectual disability.""]","[""GOMBO syndrome symptoms include growth retardation, optic atrophy, microcephaly, and brain anomalies.""]",[false],[true],[false],"[""Symptoms of GOMBO syndrome include short stature, joint pain, bone deformities, and a mosaic pattern of bones on X-rays.""]","[""Symptoms of Growth retardation, Ocular abnormalities, Microcephaly, Brachydactyly, and Oligophrenia syndrome include short stature, vision problems, small head size, short fingers, and intellectual disability.""]","[""GOMBO syndrome symptoms include growth retardation, optic atrophy, microcephaly, and brain anomalies.""]",[false],[true],[false],"[""The symptoms of GOMBO syndrome include short stature, joint pain, bone fractures, and skeletal abnormalities.""]","[""The symptoms of Growth retardation, Ocular abnormalities, Microcephaly, Brachydactyly, and Oligophrenia syndrome include short stature, vision problems, small head size, short fingers, and intellectual disability.""]","[""GOMBO syndrome symptoms include growth retardation, optic atrophy, microcephaly, and brain anomalies.""]",[false],[true],[true],"[""The symptoms of GOMBO (Generalized Overlap Mosaic Bone disorder) syndrome include short stature, joint pain, bone deformities, and a mosaic pattern of bones on X-rays.""]","[""The symptoms of Growth retardation, Ocular abnormalities, Microcephaly, Brachydactyly, and Oligophrenia syndrome include short stature, vision problems, small head size, short fingers, and intellectual disability.""]","[""Symptoms of GOMBO syndrome include intellectual disability, distinctive facial features, growth delays, and skeletal abnormalities.""]",[false],[true],[false],"[""Symptoms of GOMBO syndrome include bone fractures, joint pain, short stature, and skeletal abnormalities.""]","[""Symptoms of Growth retardation, Ocular abnormalities, Microcephaly, Brachydactyly, and Oligophrenia syndrome include short stature, vision problems, small head size, short fingers, and intellectual disability.""]","[""GOMBO syndrome symptoms include growth retardation, optic atrophy, microcephaly, and brain anomalies.""]",[false],[true],[false],"[""Symptoms of GOMBO syndrome include short stature, joint pain, bone deformities, and a mosaic pattern of bone density on imaging.""]","[""The symptoms of Growth retardation, Ocular abnormalities, Microcephaly, Brachydactyly, and Oligophrenia syndrome include short stature, vision problems, small head size, short fingers, and intellectual disability.""]","[""GOMBO syndrome symptoms include growth retardation, optic atrophy, microcephaly, and brain anomalies.""]",[false],[true],[false],"[""Symptoms of GOMBO syndrome include joint pain, bone fractures, short stature, and skeletal abnormalities.""]","[""The symptoms of Growth retardation, Ocular abnormalities, Microcephaly, Brachydactyly, and Oligophrenia syndrome include short stature, vision problems, small head size, short fingers, and intellectual disability.""]","[""GOMBO syndrome symptoms include growth retardation, optic atrophy, microcephaly, and brain anomalies.""]",[false],[true],[true],"[""Symptoms of GOMBO syndrome include short stature, joint pain, bone deformities, and increased risk of fractures.""]","[""The symptoms of Growth retardation, Ocular abnormalities, Microcephaly, Brachydactyly, and Oligophrenia syndrome include short stature, vision problems, small head size, short fingers, and intellectual disability.""]","[""Symptoms of GOMBO syndrome include intellectual disability, distinctive facial features, growth delays, and skeletal abnormalities.""]",[false],[true],[false],"[""Symptoms of GOMBO syndrome include short stature, joint pain, bone deformities, and a mosaic pattern of bone density.""]","[""Symptoms of Growth retardation, Ocular abnormalities, Microcephaly, Brachydactyly, and Oligophrenia syndrome include short stature, vision problems, small head size, short fingers, and intellectual disability.""]","[""GOMBO syndrome symptoms include growth retardation, optic atrophy, microcephaly, and brain anomalies.""]",[false],[true],[false],"[""The symptoms of GOMBO (Generalized Overlap Mosaic Bone disorder) syndrome include short stature, joint pain, bone deformities, and early-onset osteoarthritis.""]","[""The symptoms of Growth retardation, Ocular abnormalities, Microcephaly, Brachydactyly, and Oligophrenia syndrome include short stature, vision problems, small head size, short fingers, and intellectual disability.""]","[""GOMBO syndrome symptoms include growth retardation, optic atrophy, microcephaly, and brain anomalies.""]",[false],[true],[false],"[""The symptoms of GOMBO (Generalized Overlap Mosaic Bone disorder) syndrome include bone fragility, short stature, skeletal abnormalities, and recurrent fractures.""]","[""The symptoms of Growth retardation, Ocular abnormalities, Microcephaly, Brachydactyly, and Oligophrenia syndrome include short stature, vision problems, small head size, short fingers, and intellectual disability.""]","[""GOMBO syndrome symptoms include growth retardation, optic atrophy, microcephaly, and brain anomalies.""]",[false],[true],[true],"[""Symptoms of GOMBO syndrome include short stature, joint pain, bone deformities, and a mosaic pattern of bones on X-rays.""]","[""The symptoms of Growth retardation, Ocular abnormalities, Microcephaly, Brachydactyly, and Oligophrenia syndrome include short stature, vision problems, small head size, short fingers, and intellectual disability.""]","[""Symptoms of GOMBO syndrome include intellectual disability, distinctive facial features, growth delays, and skeletal abnormalities.""]",[false],[true],[false],"[""The symptoms of GOMBO syndrome include short stature, joint pain, joint hypermobility, and a characteristic mosaic pattern of bone lesions on imaging.""]","[""Symptoms of Growth retardation, Ocular abnormalities, Microcephaly, Brachydactyly, and Oligophrenia syndrome include short stature, vision problems, small head size, short fingers, and intellectual disability.""]","[""GOMBO syndrome symptoms include growth retardation, optic atrophy, microcephaly, and brain anomalies.""]",[false],[true],[false],"[""The symptoms of GOMBO syndrome include short stature, joint pain, bone deformities, and a mosaic pattern of bones on X-rays.""]","[""The symptoms of Growth retardation, Ocular abnormalities, Microcephaly, Brachydactyly, and Oligophrenia syndrome include short stature, vision problems, small head size, short fingers, and intellectual disability.""]","[""GOMBO syndrome symptoms include growth retardation, optic atrophy, microcephaly, and brain anomalies.""]",[false],[true],[false],"[""Symptoms of GOMBO syndrome include short stature, joint pain, bone deformities, and a mosaic pattern of bones on X-rays.""]","[""The symptoms of Growth retardation, Ocular abnormalities, Microcephaly, Brachydactyly, and Oligophrenia syndrome include short stature, vision problems, small head size, short fingers, and intellectual disability.""]","[""GOMBO syndrome symptoms include growth retardation, optic atrophy, microcephaly, and brain anomalies.""]",[false],[true],[true],"[""The symptoms of GOMBO syndrome include short stature, joint pain, bone deformities, and a mosaic pattern of bone involvement.""]","[""The symptoms of Growth retardation, Ocular abnormalities, Microcephaly, Brachydactyly, and Oligophrenia syndrome include short stature, vision problems, small head size, short fingers, and intellectual disability.""]","[""Symptoms of GOMBO syndrome include intellectual disability, distinctive facial features, growth delays, and skeletal abnormalities.""]",[false],[true],[false],"[""The symptoms of GOMBO syndrome include mosaic pattern of bone lesions, bone pain, fractures, and skeletal deformities.""]","[""Symptoms of Growth retardation, Ocular abnormalities, Microcephaly, Brachydactyly, and Oligophrenia syndrome include short stature, vision problems, small head size, short fingers, and intellectual disability.""]","[""GOMBO syndrome symptoms include growth retardation, optic atrophy, microcephaly, and brain anomalies.""]",[false],[true],[false],"[""The symptoms of GOMBO (Generalized Overlap Mosaic Bone disorder) syndrome include short stature, joint pain, bone fractures, and skeletal abnormalities.""]","[""The symptoms of Growth retardation, Ocular abnormalities, Microcephaly, Brachydactyly, and Oligophrenia syndrome include short stature, vision problems, small head size, short fingers, and intellectual disability.""]","[""GOMBO syndrome symptoms include growth retardation, optic atrophy, microcephaly, and brain anomalies.""]",[false],[true],[false],"[""The symptoms of GOMBO syndrome include skeletal abnormalities, joint pain, muscle weakness, and fatigue.""]","[""The symptoms of Growth retardation, Ocular abnormalities, Microcephaly, Brachydactyly, and Oligophrenia syndrome include short stature, vision problems, small head size, short fingers, and intellectual disability.""]","[""GOMBO syndrome symptoms include growth retardation, optic atrophy, microcephaly, and brain anomalies.""]",[false],[true],[true],"[""The symptoms of GOMBO (Generalized Overlap Mosaic Bone disorder) syndrome include short stature, joint pain, bone deformities, and an increased risk of fractures.""]","[""The symptoms of Growth retardation, Ocular abnormalities, Microcephaly, Brachydactyly, and Oligophrenia syndrome include short stature, vision problems, small head size, short fingers, and intellectual disability.""]","[""Symptoms of GOMBO syndrome include intellectual disability, distinctive facial features, growth delays, and skeletal abnormalities.""]",[false],[true],[false],"[""The symptoms of GOMBO syndrome include bone abnormalities, joint pain, and muscle weakness.""]","[""Symptoms of Growth retardation, Ocular abnormalities, Microcephaly, Brachydactyly, and Oligophrenia syndrome include short stature, vision problems, small head size, short fingers, and intellectual disability.""]","[""GOMBO syndrome symptoms include growth retardation, optic atrophy, microcephaly, and brain anomalies.""]",[false],[true],[false],"[""Symptoms of GOMBO syndrome include skeletal abnormalities, joint hypermobility, short stature, and facial dysmorphism.""]","[""Symptoms of Growth retardation, Ocular abnormalities, Microcephaly, Brachydactyly, and Oligophrenia syndrome include short stature, vision problems, small head size, short fingers, and intellectual disability.""]","[""GOMBO syndrome symptoms include growth retardation, optic atrophy, microcephaly, and brain anomalies.""]",[true],[true],[false],"[""Symptoms of GOMBO syndrome include growth retardation, ocular abnormalities, microcephaly, brachydactyly, and oligophrenia.""]","[""Symptoms of Growth retardation, Ocular abnormalities, Microcephaly, Brachydactyly, and Oligophrenia syndrome include short stature, vision problems, small head size, short fingers, and intellectual disability.""]","[""GOMBO syndrome symptoms include growth retardation, optic atrophy, microcephaly, and brain anomalies.""]",[false],[true],[false],"[""The symptoms of GOMBO syndrome include joint pain, bone fractures, skeletal abnormalities, and growth delays.""]","[""Symptoms of Growth retardation, Ocular abnormalities, Microcephaly, Brachydactyly, and Oligophrenia syndrome include short stature, vision problems, small head size, short fingers, and intellectual disability.""]","[""GOMBO syndrome symptoms include growth retardation, optic atrophy, microcephaly, and brain anomalies.""]"
symptoms,What are the symptoms of Congenital hypothyroidism ?,"What are the signs and symptoms of Congenital hypothyroidism? The Human Phenotype Ontology provides the following list of signs and symptoms for Congenital hypothyroidism. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the fontanelles or cranial sutures 90% Abnormality of the liver 90% Abnormality of the tongue 90% Abnormality of the voice 90% Aplasia/Hypoplasia of the abdominal wall musculature 90% Constipation 90% Hypothyroidism 90% Muscular hypotonia 90% Sleep disturbance 90% Umbilical hernia 90% Coarse facial features 50% Cognitive impairment 50% Depressed nasal ridge 50% Dry skin 50% Hypothermia 50% Short stature 50% Sinusitis 50% Thickened skin 50% Abnormality of epiphysis morphology 7.5% Abnormality of reproductive system physiology 7.5% Abnormality of the pericardium 7.5% Anterior hypopituitarism 7.5% Arrhythmia 7.5% Cataract 7.5% Goiter 7.5% Hearing impairment 7.5% Hypertension 7.5% Hypotension 7.5% Intestinal obstruction 7.5% Nephrolithiasis 7.5% Optic atrophy 7.5% Oral cleft 7.5% Paresthesia 7.5% Tracheoesophageal fistula 7.5% Autosomal recessive inheritance - Congenital hypothyroidism - Infantile onset - Thyroid hypoplasia - Thyroid-stimulating hormone excess - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""CH"", ""full_form"": ""Congenital hypothyroidism""}]}",What are the symptoms of CH ?,What are the symptoms of Congenital hypothyroidism ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Check!"", ""Channel"", ""Chief"", ""Characteristic"", ""CHronic"", ""CHampion"", ""Chest"", ""Chaplain"", ""Credit Hours"", ""Central Heating""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Congenital Hypothyroidism""]",[1.2213273459858783e-09],[1.2213273459858783e-09],"[""CHronic""]",[0.009924705564478012],"[""ABBREVIATIONS""]","[[1.6777401257514614e-07, 2.2924882058661987e-07, 2.5091632717587182e-06, 5.083537274158962e-07, 0.009924705564478012, 1.3188672140116802e-08, 8.770131054388257e-05, 3.9606225898007844e-06, 7.177068838876431e-13, 4.536428829698149e-11]]",[0.6761484020750215],[0.6678752040568994],"[""Characteristic""]",[0.9040999556385441],"[""ABBREVIATIONS""]","[[0.8543370662782014, 0.8443243763233363, 0.8832910620631221, 0.8934513142491225, 0.9040999556385441, 0.8755056075564706, 0.8535074549544397, 0.8328893168423083, 0.7261958520583565, 0.8120042196538222]]","[""Congenital Hypothyroidism""]","[""LLM""]",What are the symptoms of CH (Congenital Hypothyroidism) ?,[false],[true],[false],"[""Cluster headache symptoms include severe pain on one side of the head, usually around the eye, along with redness and tearing of the eye, nasal congestion, and facial sweating.""]","[""Symptoms of Congenital hypothyroidism include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of CH include severe headache, nausea, vomiting, sensitivity to light and sound, and aura (visual disturbances).""]",[false],[true],[false],"[""Cluster headache symptoms include severe pain on one side of the head, often around the eye, along with redness and tearing of the eye, nasal congestion, and restlessness.""]","[""Symptoms of Congenital hypothyroidism include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of CH include severe headache, nausea, vomiting, sensitivity to light and sound, and aura (visual disturbances).""]",[false],[true],[false],"[""Cluster headache symptoms include severe pain on one side of the head, often around the eye, along with redness, tearing, and nasal congestion on the same side.""]","[""Symptoms of Congenital hypothyroidism include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of CH include severe headache, nausea, vomiting, sensitivity to light and sound, and aura (visual disturbances).""]",[false],[true],[false],"[""CH (Chronic) headaches are characterized by severe, recurring headaches that can last for hours to days. Symptoms may include intense pain on one side of the head, nausea, vomiting, and sensitivity to light and sound.""]","[""Symptoms of Congenital hypothyroidism include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of CH include severe headache, nausea, vomiting, sensitivity to light and sound, and aura (visual disturbances).""]",[false],[true],[false],"[""Symptoms of CH (Characteristic) include severe headache, nausea, vomiting, sensitivity to light and sound, and aura.""]","[""Symptoms of Congenital hypothyroidism include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of CH include severe headache, nausea, vomiting, sensitivity to light and sound, and aura (visual disturbances).""]",[false],[true],[false],"[""Symptoms of CH (Characteristic) include severe headache, nausea, vomiting, sensitivity to light and sound, and aura.""]","[""Symptoms of Congenital hypothyroidism include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of CH include severe headache, nausea, vomiting, sensitivity to light and sound, and aura (visual disturbances).""]",[false],[true],[false],"[""Symptoms of CH (Characteristic) include short stature, delayed puberty, and distinctive facial features.""]","[""Symptoms of Congenital hypothyroidism include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of CH include severe headache, nausea, vomiting, sensitivity to light and sound, and aura (visual disturbances).""]",[false],[true],[false],"[""Symptoms of CH (Characteristic) include severe headache, nausea, vomiting, sensitivity to light and sound, and aura (visual disturbances).""]","[""Symptoms of Congenital hypothyroidism include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of CH include severe headache, nausea, vomiting, sensitivity to light and sound, and aura (visual disturbances).""]",[true],[true],[false],"[""Symptoms of Congenital Hypothyroidism include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of Congenital hypothyroidism include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of CH include severe headache, nausea, vomiting, sensitivity to light and sound, and aura (visual disturbances).""]",[true],[true],[false],"[""Symptoms of Congenital Hypothyroidism include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of Congenital hypothyroidism include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of CH include severe headache, nausea, vomiting, sensitivity to light and sound, and aura (visual disturbances).""]",[true],[true],[false],"[""Symptoms of Congenital Hypothyroidism include jaundice, poor feeding, constipation, hoarse cry, large soft spot on the head, and sluggishness.""]","[""Symptoms of Congenital hypothyroidism include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of CH include severe headache, nausea, vomiting, sensitivity to light and sound, and aura (visual disturbances).""]",[true],[true],[false],"[""Symptoms of Congenital Hypothyroidism (CH) include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of Congenital hypothyroidism include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of CH include severe headache, nausea, vomiting, sensitivity to light and sound, and aura (visual disturbances).""]",[true],[true],[false],"[""Symptoms of CH (Congenital Hypothyroidism) include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of Congenital hypothyroidism include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of CH include severe headache, nausea, vomiting, sensitivity to light and sound, and aura (visual disturbances).""]",[true],[true],[false],"[""Symptoms of Congenital Hypothyroidism (CH) include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of Congenital hypothyroidism include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of CH include severe headache, nausea, vomiting, sensitivity to light and sound, and aura (visual disturbances).""]",[true],[true],[false],"[""Symptoms of Congenital Hypothyroidism include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of Congenital hypothyroidism include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of CH include severe headache, nausea, vomiting, sensitivity to light and sound, and aura (visual disturbances).""]",[true],[true],[false],"[""Symptoms of Congenital Hypothyroidism include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of Congenital hypothyroidism include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of CH include severe headache, nausea, vomiting, sensitivity to light and sound, and aura (visual disturbances).""]",[true],[true],[false],"[""Symptoms of CH include jaundice, poor feeding, constipation, hoarse cry, and prolonged jaundice.""]","[""Symptoms of Congenital hypothyroidism include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of CH include severe headache, nausea, vomiting, sensitivity to light and sound, and aura (visual disturbances).""]",[true],[true],[false],"[""Symptoms of Congenital Hypothyroidism include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of Congenital hypothyroidism include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of CH include severe headache, nausea, vomiting, sensitivity to light and sound, and aura (visual disturbances).""]",[true],[true],[false],"[""Symptoms of Congenital Hypothyroidism (CH) include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of Congenital hypothyroidism include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of CH include severe headache, nausea, vomiting, sensitivity to light and sound, and aura (visual disturbances).""]",[true],[true],[false],"[""Symptoms of Congenital Hypothyroidism (CH) include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of Congenital hypothyroidism include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of CH include severe headache, nausea, vomiting, sensitivity to light and sound, and aura (visual disturbances).""]",[true],[true],[false],"[""Symptoms of Congenital Hypothyroidism (CH) include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of Congenital hypothyroidism include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of CH include severe headache, nausea, vomiting, sensitivity to light and sound, and aura (visual disturbances).""]",[true],[true],[false],"[""Symptoms of Congenital Hypothyroidism (CH) include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of Congenital hypothyroidism include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of CH include severe headache, nausea, vomiting, sensitivity to light and sound, and aura (visual disturbances).""]",[true],[true],[false],"[""Symptoms of Congenital Hypothyroidism include jaundice, poor feeding, constipation, hoarse cry, and prolonged jaundice.""]","[""Symptoms of Congenital hypothyroidism include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of CH include severe headache, nausea, vomiting, sensitivity to light and sound, and aura (visual disturbances).""]",[true],[true],[false],"[""Symptoms of Congenital Hypothyroidism (CH) include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of Congenital hypothyroidism include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of CH include severe headache, nausea, vomiting, sensitivity to light and sound, and aura (visual disturbances).""]",[true],[true],[false],"[""Symptoms of CH (Congenital Hypothyroidism) include jaundice, poor feeding, constipation, hoarse cry, and decreased activity level.""]","[""Symptoms of Congenital hypothyroidism include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of CH include severe headache, nausea, vomiting, sensitivity to light and sound, and aura (visual disturbances).""]",[true],[true],[false],"[""Symptoms of Congenital Hypothyroidism (CH) include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of Congenital hypothyroidism include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of CH include severe headache, nausea, vomiting, sensitivity to light and sound, and aura (visual disturbances).""]",[true],[true],[false],"[""Symptoms of Congenital Hypothyroidism (CH) include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of Congenital hypothyroidism include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of CH include severe headache, nausea, vomiting, sensitivity to light and sound, and aura (visual disturbances).""]",[true],[true],[false],"[""Symptoms of Congenital Hypothyroidism (CH) include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of Congenital hypothyroidism include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of CH include severe headache, nausea, vomiting, sensitivity to light and sound, and aura (visual disturbances).""]",[true],[true],[false],"[""Symptoms of CH (Congenital Hypothyroidism) include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of Congenital hypothyroidism include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of CH include severe headache, nausea, vomiting, sensitivity to light and sound, and aura (visual disturbances).""]",[false],[true],[false],"[""Cluster headache symptoms include severe pain on one side of the head, often around the eye, along with red or teary eyes, nasal congestion, and restlessness.""]","[""Symptoms of Congenital hypothyroidism include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of CH include severe headache, nausea, vomiting, sensitivity to light and sound, and aura (visual disturbances).""]",[false],[true],[false],"[""Symptoms of CH include intellectual disability, distinctive facial features, and delayed development.""]","[""Symptoms of Congenital hypothyroidism include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of CH include severe headache, nausea, vomiting, sensitivity to light and sound, and aura (visual disturbances).""]",[true],[true],[false],"[""Symptoms of CH include jaundice, poor feeding, constipation, hoarse cry, and delayed development.""]","[""Symptoms of Congenital hypothyroidism include jaundice, poor feeding, constipation, hoarse cry, and sluggishness.""]","[""Symptoms of CH include severe headache, nausea, vomiting, sensitivity to light and sound, and aura (visual disturbances).""]"
treatment,What are the treatments for DOORS syndrome ?,These resources address the diagnosis or management of DOORS syndrome:  - Gene Review: Gene Review: TBC1D24-Related Disorders   These resources from MedlinePlus offer information about the diagnosis and management of various health conditions:  - Diagnostic Tests  - Drug Therapy  - Surgery and Rehabilitation  - Genetic Counseling   - Palliative Care,"{""full_form_abbrv_map"": [{""ambiguity_type"": ""abbreviation"", ""abbreviation"": ""DOORS"", ""full_form"": ""Deafness, Onychodystrophy, Osteodystrophy, Mental Retardation, Seizures""}]}",What are the treatments for DOORS syndrome ?,"What are the treatments for Deafness, Onychodystrophy, Osteodystrophy, Mental Retardation, Seizures syndrome ?",8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Dynamic Object-Oriented Requirements System"", ""Developing Our Own Rehabilitation Services"", ""Data Object Oriented Repository System"", ""Diesel Offroad Online Reporting System"", ""Distributed Object Oriented Reliable Service"", ""Dynamic Object Oriented Requirements System"", ""Demonstration of Dynamic Object-Oriented Requirements System"", ""DOL Online Opportunities Recruitment System (US Department of Labor)"", ""Distributed Object Oriented Reliable Service"", ""Data Object Oriented Repository System"", ""Dynamic Object-Oriented Requirements System (a Quality Systems & Software, Inc., QSS database management system)"", ""Dynamic Object Oriented Requirements System"", ""Data Object Oriented Repository System (Evermore)"", ""Design of Object Oriented Real-time Systems (Carleton University, Ottawa, Canada)""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY""]]","[""Deafness, Onychodystrophy, Osteodystrophy, Retardation, and Seizures syndrome""]",[2.1992264004524676e-37],[5.033850971977124e-41],"[""Developing Our Own Rehabilitation Services""]",[1.420378486002794e-20],"[""ABBREVIATIONS""]","[[1.748399829004441e-24, 1.420378486002794e-20, 2.3133759942357116e-26, 2.330803739575822e-28, 1.0385496763587983e-27, 8.339245858570058e-25, 3.2536235182393697e-29, 2.734443174253187e-45, 1.0385496763587983e-27, 2.3133759942357116e-26, 2.826214834076675e-74, 8.339245858570058e-25, 1.1409027028213317e-37, 5.683878355686082e-62]]",[0.8796841214905649],[0.8795025312221243],"[""Dynamic Object-Oriented Requirements System""]",[0.9283465475486452],"[""ABBREVIATIONS""]","[[0.9135186554343282, 0.9283465475486452, 0.9257584652269144, 0.9117966484621003, 0.9051195645736163, 0.9181414182999487, 0.8955279597462734, 0.9201213954704182, 0.9051195645736163, 0.9257584652269144, 0.8823283428942632, 0.9181414182999487, 0.8809315988352792, 0.8876090992827272]]","[""Deafness, Onychodystrophy, Osteodystrophy, Retardation, and Seizures syndrome""]","[""LLM""]","What are the treatments for DOORS (Deafness, Onychodystrophy, Osteodystrophy, Retardation, and Seizures syndrome) syndrome ?",[true],[true],[true],"[""There is no specific treatment for DOORS syndrome. Management involves addressing the symptoms and providing supportive care.""]","[""The treatments for Deafness, Onychodystrophy, Osteodystrophy, Mental Retardation, Seizures syndrome depend on the underlying cause and may include hearing aids, surgical interventions, medications, therapy, and supportive care.""]","[""There is no specific treatment for DOORS syndrome. Management involves addressing the symptoms and providing supportive care.""]",[true],[false],[true],"[""There is no specific treatment for DOORS syndrome, but symptoms can be managed with physical therapy, occupational therapy, and speech therapy.""]","[""Treatment depends on the specific cause of each condition. It may include hearing aids, cochlear implants, medication, surgery, therapy, and management of associated symptoms.""]","[""There is no specific treatment for DOORS syndrome, management involves addressing the symptoms and providing supportive care.""]",[true],[true],[true],"[""There is no specific treatment for DOORS syndrome, but symptoms can be managed with physical therapy, occupational therapy, speech therapy, and other supportive measures.""]","[""The treatments for Deafness, Onychodystrophy, Osteodystrophy, Mental Retardation, Seizures syndrome depend on the underlying cause of each condition and may include hearing aids, surgical interventions, medication, therapy, and supportive care.""]","[""There is no specific treatment for DOORS syndrome. Management involves addressing the symptoms and providing supportive care.""]",[true],[true],[true],"[""There is currently no specific treatment for DOORS syndrome. Management involves addressing the symptoms and providing supportive care.""]","[""Treatment for Deafness, Onychodystrophy, Osteodystrophy, Mental Retardation, Seizures syndrome may include hearing aids, surgical interventions, medication for seizures, physical therapy, and educational support.""]","[""There is no specific treatment for DOORS syndrome. Management involves addressing the symptoms and providing supportive care.""]",[false],[true],[true],"[""There is no specific treatment for DOORS (Dynamic Object-Oriented Requirements System) syndrome as it is a software tool used in requirements engineering, not a medical condition.""]","[""The treatments for Deafness, Onychodystrophy, Osteodystrophy, Mental Retardation, Seizures syndrome depend on the underlying cause and may include hearing aids, surgical interventions, medications, therapy, and supportive care.""]","[""There is no specific treatment for DOORS syndrome. Management involves addressing the symptoms and providing supportive care.""]",[false],[true],[true],"[""There is no specific treatment for DOORS (Dynamic Object-Oriented Requirements System) syndrome as it is a software tool used in requirements engineering.""]","[""Treatment depends on the specific cause of each condition. It may include hearing aids, cochlear implants, medication, surgery, therapy, and management of associated symptoms.""]","[""There is no specific treatment for DOORS syndrome, management involves addressing the symptoms and providing supportive care.""]",[false],[true],[true],"[""There is no specific treatment for DOORS (Dynamic Object-Oriented Requirements System) syndrome as it is a software tool used in requirements engineering, not a medical condition.""]","[""The treatments for Deafness, Onychodystrophy, Osteodystrophy, Mental Retardation, Seizures syndrome depend on the underlying cause of each condition and may include hearing aids, surgical interventions, medication, therapy, and supportive care.""]","[""There is no specific treatment for DOORS syndrome. Management involves addressing the symptoms and providing supportive care.""]",[false],[true],[true],"[""There is no specific treatment for DOORS (Dynamic Object-Oriented Requirements System) syndrome as it is a software tool used for requirements management in software development, not a medical condition.""]","[""Treatment for Deafness, Onychodystrophy, Osteodystrophy, Mental Retardation, Seizures syndrome may include hearing aids, surgical interventions, medication for seizures, physical therapy, and educational support.""]","[""There is no specific treatment for DOORS syndrome. Management involves addressing the symptoms and providing supportive care.""]",[true],[false],[true],"[""Treatment for DOORS syndrome involves managing symptoms such as hearing loss, nail abnormalities, bone abnormalities, intellectual disability, and seizures through a multidisciplinary approach including hearing aids, surgery for bone abnormalities, seizure medications, and supportive therapies.""]","[""Treatment depends on the specific cause of each condition. It may include hearing aids, cochlear implants, medication, surgery, therapy, and management of associated symptoms.""]","[""There is no specific treatment for DOORS syndrome, management involves addressing the symptoms and providing supportive care.""]",[true],[true],[true],"[""Treatment for DOORS syndrome involves managing symptoms such as hearing loss, nail abnormalities, bone abnormalities, intellectual disability, and seizures through a multidisciplinary approach including hearing aids, surgery for bone abnormalities, anticonvulsant medications, and supportive therapies.""]","[""The treatments for Deafness, Onychodystrophy, Osteodystrophy, Mental Retardation, Seizures syndrome depend on the underlying cause and may include hearing aids, surgical interventions, medications, therapy, and supportive care.""]","[""There is no specific treatment for DOORS syndrome. Management involves addressing the symptoms and providing supportive care.""]",[true],[true],[true],"[""Treatment for DOORS syndrome involves managing symptoms such as hearing loss, nail abnormalities, bone abnormalities, intellectual disability, and seizures through a multidisciplinary approach including hearing aids, physical therapy, seizure medications, and educational support.""]","[""The treatments for Deafness, Onychodystrophy, Osteodystrophy, Mental Retardation, Seizures syndrome depend on the underlying cause of each condition and may include hearing aids, surgical interventions, medication, therapy, and supportive care.""]","[""There is no specific treatment for DOORS syndrome. Management involves addressing the symptoms and providing supportive care.""]",[true],[true],[true],"[""There is no specific treatment for DOORS syndrome. Management involves addressing the symptoms and providing supportive care.""]","[""Treatment for Deafness, Onychodystrophy, Osteodystrophy, Mental Retardation, Seizures syndrome may include hearing aids, surgical interventions, medication for seizures, physical therapy, and educational support.""]","[""There is no specific treatment for DOORS syndrome. Management involves addressing the symptoms and providing supportive care.""]",[true],[true],[true],"[""Treatment for DOORS syndrome involves managing symptoms such as hearing loss, nail abnormalities, bone abnormalities, intellectual disability, and seizures through a multidisciplinary approach including hearing aids, surgery for bone abnormalities, antiepileptic medications, and supportive therapies.""]","[""The treatments for Deafness, Onychodystrophy, Osteodystrophy, Mental Retardation, Seizures syndrome depend on the underlying cause and may include hearing aids, surgical interventions, medications, therapy, and supportive care.""]","[""There is no specific treatment for DOORS syndrome. Management involves addressing the symptoms and providing supportive care.""]",[true],[false],[true],"[""Treatment for DOORS syndrome involves managing symptoms such as hearing loss, nail abnormalities, bone abnormalities, intellectual disability, and seizures. This may include hearing aids, seizure medications, physical therapy, and educational support.""]","[""Treatment depends on the specific cause of each condition. It may include hearing aids, cochlear implants, medication, surgery, therapy, and management of associated symptoms.""]","[""There is no specific treatment for DOORS syndrome, management involves addressing the symptoms and providing supportive care.""]",[true],[true],[true],"[""Treatment for DOORS syndrome involves managing symptoms such as hearing loss, nail abnormalities, bone abnormalities, intellectual disability, and seizures through a multidisciplinary approach including hearing aids, surgery for bone abnormalities, seizure medications, and supportive therapies.""]","[""The treatments for Deafness, Onychodystrophy, Osteodystrophy, Mental Retardation, Seizures syndrome depend on the underlying cause of each condition and may include hearing aids, surgical interventions, medication, therapy, and supportive care.""]","[""There is no specific treatment for DOORS syndrome. Management involves addressing the symptoms and providing supportive care.""]",[true],[true],[true],"[""Treatment for DOORS syndrome involves managing symptoms such as hearing loss, nail abnormalities, bone abnormalities, intellectual disability, and seizures through a multidisciplinary approach including hearing aids, surgery for bone abnormalities, educational support, and antiseizure medications.""]","[""Treatment for Deafness, Onychodystrophy, Osteodystrophy, Mental Retardation, Seizures syndrome may include hearing aids, surgical interventions, medication for seizures, physical therapy, and educational support.""]","[""There is no specific treatment for DOORS syndrome. Management involves addressing the symptoms and providing supportive care.""]",[true],[true],[true],"[""Treatment for DOORS syndrome involves managing symptoms such as hearing loss, nail abnormalities, bone abnormalities, intellectual disability, and seizures through a multidisciplinary approach including hearing aids, surgery for bone abnormalities, seizure medications, and supportive therapies.""]","[""The treatments for Deafness, Onychodystrophy, Osteodystrophy, Mental Retardation, Seizures syndrome depend on the underlying cause and may include hearing aids, surgical interventions, medications, therapy, and supportive care.""]","[""There is no specific treatment for DOORS syndrome. Management involves addressing the symptoms and providing supportive care.""]",[true],[true],[true],"[""There is no specific treatment for DOORS syndrome, management involves addressing individual symptoms such as hearing aids for deafness, seizure medications for seizures, and orthopedic interventions for bone abnormalities.""]","[""Treatment depends on the specific cause of each condition. It may include hearing aids, cochlear implants, medication, surgery, therapy, and management of associated symptoms.""]","[""There is no specific treatment for DOORS syndrome, management involves addressing the symptoms and providing supportive care.""]",[true],[true],[true],"[""Treatment for DOORS syndrome involves managing symptoms such as hearing loss, nail abnormalities, bone abnormalities, intellectual disability, and seizures through a multidisciplinary approach including hearing aids, surgery for bone abnormalities, antiepileptic medications, and supportive therapies.""]","[""The treatments for Deafness, Onychodystrophy, Osteodystrophy, Mental Retardation, Seizures syndrome depend on the underlying cause of each condition and may include hearing aids, surgical interventions, medication, therapy, and supportive care.""]","[""There is no specific treatment for DOORS syndrome. Management involves addressing the symptoms and providing supportive care.""]",[true],[true],[true],"[""Treatment for DOORS syndrome involves management of symptoms such as hearing aids for deafness, anticonvulsant medications for seizures, and orthopedic interventions for bone abnormalities.""]","[""Treatment for Deafness, Onychodystrophy, Osteodystrophy, Mental Retardation, Seizures syndrome may include hearing aids, surgical interventions, medication for seizures, physical therapy, and educational support.""]","[""There is no specific treatment for DOORS syndrome. Management involves addressing the symptoms and providing supportive care.""]",[true],[true],[true],"[""There is no specific treatment for DOORS syndrome, management involves addressing individual symptoms and providing supportive care.""]","[""The treatments for Deafness, Onychodystrophy, Osteodystrophy, Mental Retardation, Seizures syndrome depend on the underlying cause and may include hearing aids, surgical interventions, medications, therapy, and supportive care.""]","[""There is no specific treatment for DOORS syndrome. Management involves addressing the symptoms and providing supportive care.""]",[true],[false],[true],"[""Treatment for DOORS syndrome involves managing symptoms such as hearing loss, nail abnormalities, bone abnormalities, intellectual disability, and seizures through a multidisciplinary approach including hearing aids, surgery for bone abnormalities, seizure medications, and supportive therapies.""]","[""Treatment depends on the specific cause of each condition. It may include hearing aids, cochlear implants, medication, surgery, therapy, and management of associated symptoms.""]","[""There is no specific treatment for DOORS syndrome, management involves addressing the symptoms and providing supportive care.""]",[true],[true],[true],"[""Treatment for DOORS syndrome involves managing symptoms such as hearing loss, nail abnormalities, bone abnormalities, intellectual disability, and seizures. This may include hearing aids, surgery for bone abnormalities, seizure medications, and supportive therapies for intellectual disability.""]","[""The treatments for Deafness, Onychodystrophy, Osteodystrophy, Mental Retardation, Seizures syndrome depend on the underlying cause of each condition and may include hearing aids, surgical interventions, medication, therapy, and supportive care.""]","[""There is no specific treatment for DOORS syndrome. Management involves addressing the symptoms and providing supportive care.""]",[true],[true],[true],"[""Treatment for DOORS syndrome involves managing symptoms such as hearing loss, nail abnormalities, bone abnormalities, intellectual disability, and seizures through a multidisciplinary approach including hearing aids, surgery for bone abnormalities, seizure medications, and supportive therapies.""]","[""Treatment for Deafness, Onychodystrophy, Osteodystrophy, Mental Retardation, Seizures syndrome may include hearing aids, surgical interventions, medication for seizures, physical therapy, and educational support.""]","[""There is no specific treatment for DOORS syndrome. Management involves addressing the symptoms and providing supportive care.""]",[true],[true],[true],"[""Treatment for DOORS syndrome involves managing symptoms such as hearing loss, nail abnormalities, bone abnormalities, intellectual disability, and seizures through a multidisciplinary approach including hearing aids, physical therapy, occupational therapy, seizure medications, and educational support.""]","[""The treatments for Deafness, Onychodystrophy, Osteodystrophy, Mental Retardation, Seizures syndrome depend on the underlying cause and may include hearing aids, surgical interventions, medications, therapy, and supportive care.""]","[""There is no specific treatment for DOORS syndrome. Management involves addressing the symptoms and providing supportive care.""]",[true],[false],[true],"[""Treatment for DOORS syndrome involves managing symptoms such as hearing loss, nail abnormalities, bone issues, intellectual disability, and seizures. This may include hearing aids, seizure medications, physical therapy, and educational support.""]","[""Treatment depends on the specific cause of each condition. It may include hearing aids, cochlear implants, medication, surgery, therapy, and management of associated symptoms.""]","[""There is no specific treatment for DOORS syndrome, management involves addressing the symptoms and providing supportive care.""]",[true],[true],[true],"[""There is no specific treatment for DOORS syndrome. Management involves addressing individual symptoms and providing supportive care.""]","[""The treatments for Deafness, Onychodystrophy, Osteodystrophy, Mental Retardation, Seizures syndrome depend on the underlying cause of each condition and may include hearing aids, surgical interventions, medication, therapy, and supportive care.""]","[""There is no specific treatment for DOORS syndrome. Management involves addressing the symptoms and providing supportive care.""]",[true],[true],[true],"[""There is no specific treatment for DOORS syndrome. Management involves addressing individual symptoms and providing supportive care.""]","[""Treatment for Deafness, Onychodystrophy, Osteodystrophy, Mental Retardation, Seizures syndrome may include hearing aids, surgical interventions, medication for seizures, physical therapy, and educational support.""]","[""There is no specific treatment for DOORS syndrome. Management involves addressing the symptoms and providing supportive care.""]",[true],[true],[true],"[""Treatment for DOORS syndrome involves managing symptoms such as hearing loss, nail abnormalities, bone abnormalities, intellectual disability, and seizures through a multidisciplinary approach including hearing aids, surgery, physical therapy, and anticonvulsant medications.""]","[""The treatments for Deafness, Onychodystrophy, Osteodystrophy, Mental Retardation, Seizures syndrome depend on the underlying cause and may include hearing aids, surgical interventions, medications, therapy, and supportive care.""]","[""There is no specific treatment for DOORS syndrome. Management involves addressing the symptoms and providing supportive care.""]",[true],[true],[true],"[""There is no specific treatment for DOORS syndrome, management involves addressing the symptoms and providing supportive care.""]","[""The treatments for Deafness, Onychodystrophy, Osteodystrophy, Mental Retardation, Seizures syndrome depend on the underlying cause and may include hearing aids, surgical interventions, medications, therapy, and supportive care.""]","[""There is no specific treatment for DOORS syndrome. Management involves addressing the symptoms and providing supportive care.""]",[true],[true],[true],"[""There is no specific treatment for DOORS syndrome as it is a genetic disorder. Management focuses on addressing symptoms and providing supportive care.""]","[""The treatments for Deafness, Onychodystrophy, Osteodystrophy, Mental Retardation, Seizures syndrome depend on the underlying cause and may include hearing aids, surgical interventions, medications, therapy, and supportive care.""]","[""There is no specific treatment for DOORS syndrome. Management involves addressing the symptoms and providing supportive care.""]",[true],[true],[true],"[""Treatment for DOORS syndrome is symptomatic and supportive, focusing on managing the specific symptoms such as hearing loss, nail abnormalities, bone abnormalities, intellectual disability, and seizures.""]","[""The treatments for Deafness, Onychodystrophy, Osteodystrophy, Mental Retardation, Seizures syndrome depend on the underlying cause and may include hearing aids, surgical interventions, medications, therapy, and supportive care.""]","[""There is no specific treatment for DOORS syndrome. Management involves addressing the symptoms and providing supportive care.""]"
treatment,What are the treatments for Arteriovenous Malformation ?,"Treatment options depend on the type of AVM, its location, noticeable symptoms, and the general health condition of the individual. Medication can often alleviate general symptoms such as headache, back pain, and seizures caused by AVMs and other vascular lesions. The definitive treatment for AVMs is either surgery to either remove the AVM or to create an artificial blood clot to close the lesion or focused irradiation treatment that is designed to damage the blood vessel walls and close the lesion. The decision to treat an AVM requires a careful consideration of possible benefits versus risks.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""AVM"", ""full_form"": ""Arteriovenous Malformation""}]}",What are the treatments for AVM ?,What are the treatments for Arteriovenous Malformation ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Automated Valuation Model"", ""Advanced Magnetics, Inc."", ""Automated Valuation Models"", ""Advanced Video Movement"", ""Automatic Vehicle Monitoring"", ""Arterio Venous Malformation"", ""Active Virtual Memory"", ""Attribute Value Matrix"", ""Arterial Venous Malformation"", ""Advance Video Movement""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Arteriovenous Malformation""]",[3.249750040544884e-08],[3.249750040544884e-08],"[""Arteriovenous Malformation""]",[3.249750040544884e-08],"[""LLM""]","[[1.8106189143259497e-14, 1.3810182160962735e-21, 6.654986527905323e-15, 2.1670112226322666e-12, 5.7447546180939725e-15, 4.947746186131534e-13, 4.124640371276566e-15, 2.1224595426784043e-13, 1.0473630745212396e-09, 2.1704858625791716e-13]]",[0.9448337291855062],[0.9448337291855062],"[""Advance Video Movement""]",[0.9448337291855062],"[""LLM""]","[[0.7125792241373082, 0.7455399254064871, 0.6767379143730989, 0.7635753440067414, 0.6945137564016196, 0.9264254825490584, 0.7111163992140093, 0.6986334418343775, 0.9080687642860068, 0.76881387809107]]","[""Arterial Venous Malformation""]","[""ABBREVIATIONS""]",What are the treatments for AVM (Arteriovenous Malformation) ?,[true],[true],[true],"[""The treatments for AVM (Arteriovenous Malformation) include embolization, surgery, and radiosurgery.""]","[""The treatments for Arteriovenous Malformation include embolization, surgery, and stereotactic radiosurgery.""]","[""The treatments for AVM include embolization, stereotactic radiosurgery, and surgical resection.""]",[true],[true],[true],"[""The treatments for AVM (Arteriovenous Malformation) include embolization, stereotactic radiosurgery, microsurgery, and observation.""]","[""The treatments for Arteriovenous Malformation include embolization, surgery, and stereotactic radiosurgery.""]","[""The treatments for AVM include embolization, radiosurgery, and surgical removal.""]",[true],[true],[true],"[""The treatments for AVM (Arteriovenous Malformation) include embolization, surgery, and radiosurgery.""]","[""Treatment options for Arteriovenous Malformation include embolization, surgery, and radiosurgery.""]","[""The treatments for AVM include embolization, radiosurgery, and surgical resection.""]",[true],[true],[true],"[""The treatments for AVM (Arteriovenous Malformation) include embolization, radiosurgery, microsurgery, and stereotactic radiosurgery.""]","[""The treatments for Arteriovenous Malformation include embolization, surgery, and stereotactic radiosurgery.""]","[""The treatments for AVM include embolization, radiosurgery, and surgical resection.""]",[true],[true],[true],"[""The treatments for AVM (Arteriovenous Malformation) include embolization, surgery, and radiosurgery.""]","[""The treatments for Arteriovenous Malformation include embolization, surgery, and stereotactic radiosurgery.""]","[""The treatments for AVM include embolization, stereotactic radiosurgery, and surgical resection.""]",[true],[true],[true],"[""The treatments for AVM (Arteriovenous Malformation) include embolization, surgery, and stereotactic radiosurgery.""]","[""The treatments for Arteriovenous Malformation include embolization, surgery, and stereotactic radiosurgery.""]","[""The treatments for AVM include embolization, radiosurgery, and surgical removal.""]",[true],[true],[true],"[""The treatments for AVM (Arteriovenous Malformation) include embolization, surgery, and radiosurgery.""]","[""Treatment options for Arteriovenous Malformation include embolization, surgery, and radiosurgery.""]","[""The treatments for AVM include embolization, radiosurgery, and surgical resection.""]",[true],[true],[true],"[""The treatments for AVM (Arteriovenous Malformation) include embolization, surgery, and stereotactic radiosurgery.""]","[""The treatments for Arteriovenous Malformation include embolization, surgery, and stereotactic radiosurgery.""]","[""The treatments for AVM include embolization, radiosurgery, and surgical resection.""]",[true],[true],[true],"[""The treatments for AVM (Arterial Venous Malformation) include embolization, surgery, radiosurgery, and medications to manage symptoms.""]","[""The treatments for Arteriovenous Malformation include embolization, surgery, and stereotactic radiosurgery.""]","[""The treatments for AVM include embolization, radiosurgery, and surgical removal.""]",[true],[true],[true],"[""The treatments for AVM (Arterial Venous Malformation) include embolization, surgery, radiosurgery, and medication.""]","[""The treatments for Arteriovenous Malformation include embolization, surgery, and stereotactic radiosurgery.""]","[""The treatments for AVM include embolization, stereotactic radiosurgery, and surgical resection.""]",[true],[true],[true],"[""The treatments for AVM (Arterial Venous Malformation) include embolization, surgery, radiosurgery, and medication.""]","[""Treatment options for Arteriovenous Malformation include embolization, surgery, and radiosurgery.""]","[""The treatments for AVM include embolization, radiosurgery, and surgical resection.""]",[true],[true],[true],"[""The treatments for AVM (Arterial Venous Malformation) include embolization, surgery, stereotactic radiosurgery, and medications to manage symptoms.""]","[""The treatments for Arteriovenous Malformation include embolization, surgery, and stereotactic radiosurgery.""]","[""The treatments for AVM include embolization, radiosurgery, and surgical resection.""]",[true],[true],[true],"[""The treatments for AVM (Arterial Venous Malformation) include embolization, surgery, and radiosurgery.""]","[""The treatments for Arteriovenous Malformation include embolization, surgery, and stereotactic radiosurgery.""]","[""The treatments for AVM include embolization, stereotactic radiosurgery, and surgical resection.""]",[true],[true],[true],"[""The treatments for AVM (Arterial Venous Malformation) include embolization, surgery, radiosurgery, and medication.""]","[""The treatments for Arteriovenous Malformation include embolization, surgery, and stereotactic radiosurgery.""]","[""The treatments for AVM include embolization, radiosurgery, and surgical removal.""]",[true],[true],[true],"[""The treatments for AVM (Arterial Venous Malformation) include embolization, surgery, radiosurgery, and medication to manage symptoms.""]","[""Treatment options for Arteriovenous Malformation include embolization, surgery, and radiosurgery.""]","[""The treatments for AVM include embolization, radiosurgery, and surgical resection.""]",[true],[true],[true],"[""The treatments for AVM (Arterial Venous Malformation) include embolization, surgery, and radiosurgery.""]","[""The treatments for Arteriovenous Malformation include embolization, surgery, and stereotactic radiosurgery.""]","[""The treatments for AVM include embolization, radiosurgery, and surgical resection.""]",[true],[true],[true],"[""The treatments for AVM (Arterial Venous Malformation) include embolization, surgery, radiosurgery, and medication to manage symptoms.""]","[""The treatments for Arteriovenous Malformation include embolization, surgery, and stereotactic radiosurgery.""]","[""The treatments for AVM include embolization, stereotactic radiosurgery, and surgical resection.""]",[true],[true],[true],"[""The treatments for AVM (Arterial Venous Malformation) include embolization, surgery, and radiosurgery.""]","[""The treatments for Arteriovenous Malformation include embolization, surgery, and stereotactic radiosurgery.""]","[""The treatments for AVM include embolization, radiosurgery, and surgical removal.""]",[true],[true],[true],"[""The treatments for AVM (Arterial Venous Malformation) include embolization, surgery, stereotactic radiosurgery, and medications to manage symptoms.""]","[""Treatment options for Arteriovenous Malformation include embolization, surgery, and radiosurgery.""]","[""The treatments for AVM include embolization, radiosurgery, and surgical resection.""]",[true],[true],[true],"[""The treatments for AVM (Arterial Venous Malformation) include embolization, surgery, radiosurgery, and medication to manage symptoms.""]","[""The treatments for Arteriovenous Malformation include embolization, surgery, and stereotactic radiosurgery.""]","[""The treatments for AVM include embolization, radiosurgery, and surgical resection.""]",[true],[true],[true],"[""The treatments for AVM (Arteriovenous Malformation) include embolization, surgery, and stereotactic radiosurgery.""]","[""The treatments for Arteriovenous Malformation include embolization, surgery, and stereotactic radiosurgery.""]","[""The treatments for AVM include embolization, stereotactic radiosurgery, and surgical resection.""]",[true],[true],[true],"[""The treatments for AVM (Arteriovenous Malformation) include embolization, surgery, and stereotactic radiosurgery.""]","[""The treatments for Arteriovenous Malformation include embolization, surgery, and stereotactic radiosurgery.""]","[""The treatments for AVM include embolization, radiosurgery, and surgical removal.""]",[true],[true],[true],"[""The treatments for AVM (Arteriovenous Malformation) include embolization, surgery, and radiosurgery.""]","[""Treatment options for Arteriovenous Malformation include embolization, surgery, and radiosurgery.""]","[""The treatments for AVM include embolization, radiosurgery, and surgical resection.""]",[true],[true],[true],"[""The treatments for AVM (Arteriovenous Malformation) include embolization, surgery, and radiosurgery.""]","[""The treatments for Arteriovenous Malformation include embolization, surgery, and stereotactic radiosurgery.""]","[""The treatments for AVM include embolization, radiosurgery, and surgical resection.""]",[true],[true],[true],"[""The treatments for AVM (Arterial Venous Malformation) include embolization, surgery, and radiosurgery.""]","[""The treatments for Arteriovenous Malformation include embolization, surgery, and stereotactic radiosurgery.""]","[""The treatments for AVM include embolization, stereotactic radiosurgery, and surgical resection.""]",[true],[true],[true],"[""The treatments for AVM (Arterial Venous Malformation) include embolization, surgery, radiosurgery, and medications to manage symptoms.""]","[""The treatments for Arteriovenous Malformation include embolization, surgery, and stereotactic radiosurgery.""]","[""The treatments for AVM include embolization, radiosurgery, and surgical removal.""]",[true],[true],[true],"[""The treatments for AVM (Arterial Venous Malformation) include embolization, surgery, and radiosurgery.""]","[""Treatment options for Arteriovenous Malformation include embolization, surgery, and radiosurgery.""]","[""The treatments for AVM include embolization, radiosurgery, and surgical resection.""]",[true],[true],[true],"[""The treatments for AVM (Arterial Venous Malformation) include embolization, surgery, and radiosurgery.""]","[""The treatments for Arteriovenous Malformation include embolization, surgery, and stereotactic radiosurgery.""]","[""The treatments for AVM include embolization, radiosurgery, and surgical resection.""]",[true],[true],[true],"[""The treatments for AVM (Arteriovenous Malformation) include embolization, surgery, stereotactic radiosurgery, and medications to manage symptoms.""]","[""The treatments for Arteriovenous Malformation include embolization, surgery, and stereotactic radiosurgery.""]","[""The treatments for AVM include embolization, stereotactic radiosurgery, and surgical resection.""]",[true],[true],[true],"[""The treatments for AVM (Arteriovenous Malformation) include embolization, surgery, and stereotactic radiosurgery.""]","[""The treatments for Arteriovenous Malformation include embolization, surgery, and stereotactic radiosurgery.""]","[""The treatments for AVM include embolization, stereotactic radiosurgery, and surgical resection.""]",[true],[true],[true],"[""The treatments for AVM (Arteriovenous Malformation) include embolization, surgery, and radiosurgery.""]","[""The treatments for Arteriovenous Malformation include embolization, surgery, and stereotactic radiosurgery.""]","[""The treatments for AVM include embolization, stereotactic radiosurgery, and surgical resection.""]",[true],[true],[true],"[""The treatments for AVM (Arteriovenous Malformation) include embolization, surgery, stereotactic radiosurgery, and medications to manage symptoms.""]","[""The treatments for Arteriovenous Malformation include embolization, surgery, and stereotactic radiosurgery.""]","[""The treatments for AVM include embolization, stereotactic radiosurgery, and surgical resection.""]"
inheritance,Is hereditary diffuse gastric cancer inherited ?,"HDGC is inherited in an autosomal dominant pattern, which means one copy of the altered CDH1 gene in each cell is sufficient to increase the risk of developing cancer.  In most cases, an affected person has one parent with the condition.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""HDGC"", ""full_form"": ""hereditary diffuse gastric cancer""}]}",Is HDGC inherited ?,Is hereditary diffuse gastric cancer inherited ?,8,MEDICAL,Simple Datatype-Boolean,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Halsey Drug Company, Incorporated (de-listed)"", ""High Desert Golf Cart"", ""Hereditary Diffuse Gastric Cancer"", ""Human Dimensions of Global Change (Carnegie Mellon University; Pittsburgh, PA)"", ""Huntington Disc Golf Club (Huntington, WV)""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY""]]","[""Hereditary Diffuse Gastric Cancer""]",[9.508428288379677e-21],[9.508428288379677e-21],"[""High Desert Golf Cart""]",[1.2349963599728695e-19],"[""ABBREVIATIONS""]","[[5.205839611454963e-37, 1.2349963599728695e-19, 9.508428288379677e-21, 5.281092110475821e-72, 4.0682779305354955e-41]]",[0.8167029206302112],[0.8138193408049067],"[""Huntington Disc Golf Club (Huntington, WV)""]",[0.8138193408049067],"[""LLM""]","[[0.7469208584203157, 0.8124707276418717, 0.8137991050203645, 0.8095665675053421, 0.7425239794624496]]","[""Hereditary Diffuse Gastric Cancer""]","[""THEFREEDICTIONARY""]",Is HDGC (Hereditary Diffuse Gastric Cancer) inherited ?,[false],[false],[true],"[""Yes, HDGC (High Desert Golf Cart) is inherited.""]","[""Yes""]","[""Yes, HDGC (Hereditary Diffuse Gastric Cancer) is inherited.""]",[false],[true],[true],"[""Yes, HDGC (High Desert Golf Cart) is inherited.""]","[""Yes""]","[""Yes, HDGC (Hereditary Diffuse Gastric Cancer) is inherited in an autosomal dominant pattern.""]",[true],[true],[true],"[""Yes""]","[""Yes""]","[""Yes, HDGC (Hereditary Diffuse Gastric Cancer) is inherited in an autosomal dominant pattern.""]",[false],[true],[true],"[""Yes, HDGC (High Desert Golf Cart) is inherited.""]","[""Yes""]","[""Yes, HDGC (Hereditary Diffuse Gastric Cancer) is inherited in an autosomal dominant pattern.""]",[false],[false],[true],"[""Yes""]","[""Yes""]","[""Yes, HDGC (Hereditary Diffuse Gastric Cancer) is inherited.""]",[false],[false],[true],"[""Yes""]","[""Yes""]","[""Yes, HDGC (Hereditary Diffuse Gastric Cancer) is inherited in an autosomal dominant pattern.""]",[true],[true],[true],"[""Yes""]","[""Yes""]","[""Yes, HDGC (Hereditary Diffuse Gastric Cancer) is inherited in an autosomal dominant pattern.""]",[true],[true],[true],"[""Yes""]","[""Yes""]","[""Yes, HDGC (Hereditary Diffuse Gastric Cancer) is inherited in an autosomal dominant pattern.""]",[true],[true],[true],"[""Yes, HDGC (Hereditary Diffuse Gastric Cancer) is inherited.""]","[""Yes""]","[""Yes, HDGC (Hereditary Diffuse Gastric Cancer) is inherited in an autosomal dominant pattern.""]",[true],[false],[true],"[""Yes, HDGC (Hereditary Diffuse Gastric Cancer) is inherited.""]","[""Yes""]","[""Yes, HDGC (Hereditary Diffuse Gastric Cancer) is inherited.""]",[true],[false],[true],"[""Yes, HDGC (Hereditary Diffuse Gastric Cancer) is inherited.""]","[""Yes""]","[""Yes, HDGC (Hereditary Diffuse Gastric Cancer) is inherited in an autosomal dominant pattern.""]",[true],[true],[true],"[""Yes, HDGC (Hereditary Diffuse Gastric Cancer) is inherited.""]","[""Yes""]","[""Yes, HDGC (Hereditary Diffuse Gastric Cancer) is inherited in an autosomal dominant pattern.""]",[true],[false],[true],"[""Yes, HDGC (Hereditary Diffuse Gastric Cancer) is inherited.""]","[""Yes""]","[""Yes, HDGC (Hereditary Diffuse Gastric Cancer) is inherited.""]",[false],[false],[true],"[""Yes""]","[""Yes""]","[""Yes, HDGC (Hereditary Diffuse Gastric Cancer) is inherited in an autosomal dominant pattern.""]",[true],[false],[true],"[""Yes, HDGC (Hereditary Diffuse Gastric Cancer) is inherited.""]","[""Yes""]","[""Yes, HDGC (Hereditary Diffuse Gastric Cancer) is inherited in an autosomal dominant pattern.""]",[true],[true],[true],"[""Yes""]","[""Yes""]","[""Yes, HDGC (Hereditary Diffuse Gastric Cancer) is inherited in an autosomal dominant pattern.""]",[true],[true],[true],"[""Yes""]","[""Yes""]","[""Yes, HDGC (Hereditary Diffuse Gastric Cancer) is inherited.""]",[true],[true],[true],"[""Yes""]","[""Yes""]","[""Yes, HDGC (Hereditary Diffuse Gastric Cancer) is inherited in an autosomal dominant pattern.""]",[true],[false],[true],"[""Yes, HDGC (Hereditary Diffuse Gastric Cancer) is inherited.""]","[""Yes""]","[""Yes, HDGC (Hereditary Diffuse Gastric Cancer) is inherited in an autosomal dominant pattern.""]",[true],[false],[true],"[""Yes, HDGC (Hereditary Diffuse Gastric Cancer) is inherited.""]","[""Yes""]","[""Yes, HDGC (Hereditary Diffuse Gastric Cancer) is inherited in an autosomal dominant pattern.""]",[true],[false],[true],"[""Yes, HDGC is inherited in an autosomal dominant pattern.""]","[""Yes""]","[""Yes, HDGC (Hereditary Diffuse Gastric Cancer) is inherited.""]",[true],[false],[true],"[""Yes, HDGC (Hereditary Diffuse Gastric Cancer) is inherited.""]","[""Yes""]","[""Yes, HDGC (Hereditary Diffuse Gastric Cancer) is inherited in an autosomal dominant pattern.""]",[false],[false],[true],"[""Yes""]","[""Yes""]","[""Yes, HDGC (Hereditary Diffuse Gastric Cancer) is inherited in an autosomal dominant pattern.""]",[true],[true],[true],"[""Yes, HDGC (Hereditary Diffuse Gastric Cancer) is inherited.""]","[""Yes""]","[""Yes, HDGC (Hereditary Diffuse Gastric Cancer) is inherited in an autosomal dominant pattern.""]",[true],[false],[true],"[""Yes, HDGC (Hereditary Diffuse Gastric Cancer) is inherited.""]","[""Yes""]","[""Yes, HDGC (Hereditary Diffuse Gastric Cancer) is inherited.""]",[true],[false],[true],"[""Yes, HDGC (Hereditary Diffuse Gastric Cancer) is inherited.""]","[""Yes""]","[""Yes, HDGC (Hereditary Diffuse Gastric Cancer) is inherited in an autosomal dominant pattern.""]",[true],[true],[true],"[""Yes, HDGC is an inherited genetic condition.""]","[""Yes""]","[""Yes, HDGC (Hereditary Diffuse Gastric Cancer) is inherited in an autosomal dominant pattern.""]",[true],[false],[true],"[""Yes, HDGC (Hereditary Diffuse Gastric Cancer) is inherited.""]","[""Yes""]","[""Yes, HDGC (Hereditary Diffuse Gastric Cancer) is inherited in an autosomal dominant pattern.""]",[true],[false],[true],"[""Yes, HDGC is inherited.""]","[""Yes""]","[""Yes, HDGC (Hereditary Diffuse Gastric Cancer) is inherited.""]",[false],[false],[true],"[""No""]","[""Yes""]","[""Yes, HDGC (Hereditary Diffuse Gastric Cancer) is inherited.""]",[false],[false],[true],"[""No""]","[""Yes""]","[""Yes, HDGC (Hereditary Diffuse Gastric Cancer) is inherited.""]",[true],[false],[true],"[""Yes, HDGC is inherited in an autosomal dominant pattern.""]","[""Yes""]","[""Yes, HDGC (Hereditary Diffuse Gastric Cancer) is inherited.""]"
inheritance,Is X-linked agammaglobulinemia inherited ?,"This condition is inherited in an X-linked recessive pattern. The gene associated with this condition is located on the X chromosome, which is one of the two sex chromosomes. In males (who have only one X chromosome), one altered copy of the gene in each cell is sufficient to cause the condition. In females (who have two X chromosomes), a mutation would have to occur in both copies of the gene to cause the disorder. Because it is unlikely that females will have two altered copies of this gene, males are affected by X-linked recessive disorders much more frequently than females. A characteristic of X-linked inheritance is that fathers cannot pass X-linked traits to their sons.  About half of affected individuals do not have a family history of XLA. In most of these cases, the affected person's mother is a carrier of one altered BTK gene. Carriers do not have the immune system abnormalities associated with XLA, but they can pass the altered gene to their children. In other cases, the mother is not a carrier and the affected individual has a new mutation in the BTK gene.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""XLA"", ""full_form"": ""X-linked agammaglobulinemia""}]}",Is XLA inherited ?,Is X-linked agammaglobulinemia inherited ?,0,SCIENCE,Simple Datatype-Boolean,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""X- Linked Agammaglobulinaemia"", ""Xcelera.Com, Inc."", ""Excel Add-in macro sheet"", ""Xlib graphics library Archive"", ""X Linked Agammaglobulinemia"", ""Xbox Live Arcade"", ""X Linked Agammaglobulinaemia"", ""Xenopus Laevis African"", ""Excel Add-in"", ""X-Box Live Arcade""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""X-linked Agammaglobulinemia""]",[6.931314126031247e-31],[6.931314126031247e-31],"[""Excel Add-in""]",[3.817811417349284e-15],"[""ABBREVIATIONS""]","[[2.206732319032116e-34, 8.496289362959042e-23, 2.965678685741666e-25, 4.988665703015617e-21, 1.8335240438373134e-29, 1.620237860011585e-17, 6.863551944328707e-33, 4.924189074891394e-26, 3.817811417349284e-15, 6.380074669327028e-19]]",[0.8828187185760563],[0.8864260371577815],"[""Xbox Live Arcade""]",[0.8936890683900838],"[""ABBREVIATIONS""]","[[0.8896578881587611, 0.7801745343565696, 0.6381129548119705, 0.6391687726399424, 0.882218969331313, 0.614626906188445, 0.8936890683900838, 0.7812138977493451, 0.667470990966645, 0.626959452127971]]","[""X- Linked Agammaglobulinaemia""]","[""ABBREVIATIONS""]",Is XLA (X-linked Agammaglobulinemia) inherited ?,[false],[true],[true],"[""No""]","[""Yes""]","[""Yes""]",[false],[true],[true],"[""No""]","[""Yes""]","[""Yes""]",[false],[true],[true],"[""No""]","[""Yes""]","[""Yes""]",[false],[true],[true],"[""No""]","[""Yes""]","[""Yes""]",[false],[true],[true],"[""No""]","[""Yes""]","[""Yes""]",[false],[true],[true],"[""No""]","[""Yes""]","[""Yes""]",[false],[true],[true],"[""No""]","[""Yes""]","[""Yes""]",[false],[true],[true],"[""No""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes, XLA (X-Linked Agammaglobulinaemia) is an inherited genetic disorder.""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes, XLA (X-Linked Agammaglobulinemia) is an inherited genetic disorder.""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes, XLA (X-Linked Agammaglobulinaemia) is an inherited genetic disorder.""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes, XLA (X-Linked Agammaglobulinemia) is an inherited genetic disorder.""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes, XLA (X-Linked Agammaglobulinemia) is an inherited genetic disorder.""]","[""Yes""]","[""Yes""]",[false],[true],[true],"[""No""]","[""Yes""]","[""Yes""]",[false],[true],[true],"[""No""]","[""Yes""]","[""Yes""]",[true],[true],[true],"[""Yes, XLA (X-linked Agammaglobulinemia) is inherited.""]","[""Yes""]","[""Yes""]"
research,what research (or clinical trials) is being done for Adult Central Nervous System Tumors ?,"New types of treatment are being tested in clinical trials.
                    This summary section refers to new treatments being studied in clinical trials, but it may not mention every new treatment being studied. Information about clinical trials is available from the NCI website.     Proton beam radiation therapy     Proton beam radiation therapy is a type of high-energy, external radiation therapy that uses streams of protons (small, positively-charged pieces of matter) to make radiation. This type of radiation kills tumor cells with little damage to nearby tissues. It is used to treat cancers of the head, neck, and spine and organs such as the brain, eye, lung, and prostate. Proton beam radiation is different from x-ray radiation.        Biologic therapy     Biologic therapy is a treatment that uses the patients immune system to fight cancer. Substances made by the body or made in a laboratory are used to boost, direct, or restore the bodys natural defenses against cancer. This type of cancer treatment is also called biotherapy or immunotherapy.    Biologic therapy is being studied for the treatment of some types of brain tumors. Treatments may include the following:            -  Dendritic cell vaccine therapy.     -  Gene therapy.
                
                
                    Patients may want to think about taking part in a clinical trial.
                    For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.   Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.   Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.
                
                
                    Patients can enter clinical trials before, during, or after starting their cancer treatment.
                    Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.   Clinical trials are taking place in many parts of the country. See the Treatment Options section that follows for links to current treatment clinical trials. These have been retrieved from NCI's listing of clinical trials.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""CNS"", ""full_form"": ""Central Nervous System""}]}",what research (or clinical trials) is being done for Adult CNS Tumors ?,what research (or clinical trials) is being done for Adult Central Nervous System Tumors ?,8,MEDICAL,Compound Datatype-List/Array,"Exploratory(Divergent Thinking): Queries that are inherently about seeking new areas of knowledge, understanding emerging trends, or identifying unknown opportunities without a specific end goal of making a decision or judgment. Exploratory queries are characterized by their openness and the lack of a predefined objective, differentiating them from evaluative queries which are directed towards forming a judgment or assessment. Exploratory queries encourage branching out into various directions to explore a wide array of possibilities without necessarily aiming to converge on a single answer or outcome.","[[""Central nervous system"", ""Clinical Nurse Specialist"", ""Cybercast News Service"", ""College of Natural Sciences"", ""Communications, Navigation and Surveillance"", ""Computing and Network Services"", ""Coagulase Negative Staphylococcus"", ""Continuous Net Settlement"", ""Corporation for National Service"", ""Certified Novell Salesperson""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Central Nervous System""]",[9.034728549234365e-08],[9.034728549234365e-08],"[""Central nervous system""]",[9.034728549234365e-08],"[""ABBREVIATIONS""]","[[9.034728549234365e-08, 9.070087660833986e-11, 1.7587820004261984e-20, 1.5116530836634918e-12, 1.111719824731406e-17, 7.683526686415905e-17, 3.835993234634654e-11, 7.00270652724198e-14, 1.7026379983205578e-17, 7.8638106496086e-24]]",[0.9851212746411571],[0.9851212746411571],"[""Certified Novell Salesperson""]",[0.9851212746411571],"[""LLM""]","[[0.9821909222830718, 0.9401191124647086, 0.9281143991557763, 0.9282053602517857, 0.9051694164145043, 0.9413191720528641, 0.8937851895286009, 0.9402063372433965, 0.9329685070529539, 0.921313797148684]]","[""Central nervous system""]","[""ABBREVIATIONS""]",what research (or clinical trials) is being done for Adult CNS (Central Nervous System) Tumors ?,[false],[true],[false],"[""Research and clinical trials for Adult CNS Tumors are focused on targeted therapies, immunotherapy, precision medicine, and combination treatments.""]","[""Research and clinical trials for Adult Central Nervous System Tumors are focused on new treatment approaches, targeted therapies, immunotherapy, precision medicine, and understanding the genetic basis of these tumors.""]","[""Research and clinical trials for Adult CNS Tumors are focused on targeted therapies, immunotherapy, precision medicine, and combination treatments to improve outcomes and reduce side effects.""]",[true],[true],[true],"[""Research and clinical trials for Adult CNS Tumors are focused on new treatment approaches, targeted therapies, immunotherapy, precision medicine, and combination therapies.""]","[""Research and clinical trials for Adult Central Nervous System Tumors are focused on new treatment approaches, targeted therapies, immunotherapy, precision medicine, and combination therapies.""]","[""Research and clinical trials for Adult CNS Tumors focus on new treatment modalities, targeted therapies, immunotherapy, and precision medicine approaches.""]",[true],[true],[true],"[""Research and clinical trials for Adult CNS Tumors are focused on targeted therapies, immunotherapy, precision medicine, and combination treatments.""]","[""Research and clinical trials for Adult Central Nervous System Tumors are focused on targeted therapies, immunotherapy, precision medicine, and combination treatments to improve outcomes and reduce side effects.""]","[""There are various research studies and clinical trials being conducted for Adult CNS Tumors, including investigations into new treatment modalities, targeted therapies, immunotherapies, and precision medicine approaches.""]",[true],[true],[true],"[""Research and clinical trials for Adult CNS Tumors are focused on targeted therapies, immunotherapy, precision medicine, and combination treatments to improve outcomes and reduce side effects.""]","[""Various research studies and clinical trials are being conducted for Adult Central Nervous System Tumors, including investigations into new treatment modalities, targeted therapies, immunotherapies, and precision medicine approaches.""]","[""Research and clinical trials for Adult CNS Tumors are focused on targeted therapies, immunotherapy, precision medicine, and combination treatments to improve outcomes and reduce side effects.""]",[true],[true],[true],"[""Research and clinical trials for Adult CNS Tumors are focused on novel treatment approaches, targeted therapies, immunotherapy, and precision medicine.""]","[""Research and clinical trials for Adult Central Nervous System Tumors are focused on new treatment approaches, targeted therapies, immunotherapy, precision medicine, and understanding the genetic basis of these tumors.""]","[""Research and clinical trials for Adult CNS Tumors are focused on targeted therapies, immunotherapy, precision medicine, and combination treatments to improve outcomes and reduce side effects.""]",[true],[true],[true],"[""Research and clinical trials for Adult CNS Tumors are focused on targeted therapies, immunotherapy, precision medicine, and novel drug combinations.""]","[""Research and clinical trials for Adult Central Nervous System Tumors are focused on new treatment approaches, targeted therapies, immunotherapy, precision medicine, and combination therapies.""]","[""Research and clinical trials for Adult CNS Tumors focus on new treatment modalities, targeted therapies, immunotherapy, and precision medicine approaches.""]",[true],[true],[true],"[""Research and clinical trials for Adult CNS Tumors are focused on new treatment modalities, targeted therapies, immunotherapy, and precision medicine approaches.""]","[""Research and clinical trials for Adult Central Nervous System Tumors are focused on targeted therapies, immunotherapy, precision medicine, and combination treatments to improve outcomes and reduce side effects.""]","[""There are various research studies and clinical trials being conducted for Adult CNS Tumors, including investigations into new treatment modalities, targeted therapies, immunotherapies, and precision medicine approaches.""]",[true],[true],[true],"[""Research and clinical trials for Adult CNS Tumors are focused on new treatment approaches, targeted therapies, immunotherapy, and precision medicine.""]","[""Various research studies and clinical trials are being conducted for Adult Central Nervous System Tumors, including investigations into new treatment modalities, targeted therapies, immunotherapies, and precision medicine approaches.""]","[""Research and clinical trials for Adult CNS Tumors are focused on targeted therapies, immunotherapy, precision medicine, and combination treatments to improve outcomes and reduce side effects.""]",[true],[true],[true],"[""Research and clinical trials for Adult CNS Tumors are focused on targeted therapies, immunotherapies, precision medicine, and combination treatments to improve outcomes and reduce side effects.""]","[""Research and clinical trials for Adult Central Nervous System Tumors are focused on new treatment approaches, targeted therapies, immunotherapy, precision medicine, and combination therapies.""]","[""Research and clinical trials for Adult CNS Tumors focus on new treatment modalities, targeted therapies, immunotherapy, and precision medicine approaches.""]",[true],[true],[true],"[""Research and clinical trials for Adult CNS Tumors are focused on targeted therapies, immunotherapy, precision medicine, and combination treatments to improve outcomes and reduce side effects.""]","[""Research and clinical trials for Adult Central Nervous System Tumors are focused on new treatment approaches, targeted therapies, immunotherapy, precision medicine, and understanding the genetic basis of these tumors.""]","[""Research and clinical trials for Adult CNS Tumors are focused on targeted therapies, immunotherapy, precision medicine, and combination treatments to improve outcomes and reduce side effects.""]",[true],[true],[true],"[""Research and clinical trials for Adult CNS Tumors are focused on targeted therapies, immunotherapy, precision medicine, and combination treatments.""]","[""Research and clinical trials for Adult Central Nervous System Tumors are focused on targeted therapies, immunotherapy, precision medicine, and combination treatments to improve outcomes and reduce side effects.""]","[""There are various research studies and clinical trials being conducted for Adult CNS Tumors, including investigations into new treatment modalities, targeted therapies, immunotherapies, and precision medicine approaches.""]",[true],[true],[true],"[""Research and clinical trials for Adult CNS Tumors are focused on targeted therapies, immunotherapy, precision medicine, and combination treatments.""]","[""Various research studies and clinical trials are being conducted for Adult Central Nervous System Tumors, including investigations into new treatment modalities, targeted therapies, immunotherapies, and precision medicine approaches.""]","[""Research and clinical trials for Adult CNS Tumors are focused on targeted therapies, immunotherapy, precision medicine, and combination treatments to improve outcomes and reduce side effects.""]",[true],[true],[true],"[""Research and clinical trials are being conducted for Adult CNS Tumors to explore new treatment options and improve patient outcomes.""]","[""Research and clinical trials for Adult Central Nervous System Tumors are focused on new treatment approaches, targeted therapies, immunotherapy, precision medicine, and understanding the genetic basis of these tumors.""]","[""Research and clinical trials for Adult CNS Tumors are focused on targeted therapies, immunotherapy, precision medicine, and combination treatments to improve outcomes and reduce side effects.""]",[true],[true],[true],"[""Research and clinical trials are being conducted for Adult CNS Tumors.""]","[""Research and clinical trials for Adult Central Nervous System Tumors are focused on new treatment approaches, targeted therapies, immunotherapy, precision medicine, and combination therapies.""]","[""Research and clinical trials for Adult CNS Tumors focus on new treatment modalities, targeted therapies, immunotherapy, and precision medicine approaches.""]",[true],[true],[true],"[""Research and clinical trials for Adult CNS tumors are focused on developing targeted therapies, immunotherapy, and precision medicine approaches.""]","[""Research and clinical trials for Adult Central Nervous System Tumors are focused on targeted therapies, immunotherapy, precision medicine, and combination treatments to improve outcomes and reduce side effects.""]","[""There are various research studies and clinical trials being conducted for Adult CNS Tumors, including investigations into new treatment modalities, targeted therapies, immunotherapies, and precision medicine approaches.""]",[true],[true],[true],"[""Research and clinical trials for Adult CNS Tumors are focused on new treatment options, targeted therapies, immunotherapy, and precision medicine approaches.""]","[""Various research studies and clinical trials are being conducted for Adult Central Nervous System Tumors, including investigations into new treatment modalities, targeted therapies, immunotherapies, and precision medicine approaches.""]","[""Research and clinical trials for Adult CNS Tumors are focused on targeted therapies, immunotherapy, precision medicine, and combination treatments to improve outcomes and reduce side effects.""]",[true],[true],[true],"[""Research and clinical trials for Adult CNS Tumors are focused on areas such as immunotherapy, targeted therapies, precision medicine, and novel drug combinations.""]","[""Research and clinical trials for Adult Central Nervous System Tumors are focused on new treatment approaches, targeted therapies, immunotherapy, precision medicine, and understanding the genetic basis of these tumors.""]","[""Research and clinical trials for Adult CNS Tumors are focused on targeted therapies, immunotherapy, precision medicine, and combination treatments to improve outcomes and reduce side effects.""]",[true],[true],[true],"[""Research and clinical trials for Adult CNS Tumors are focused on targeted therapies, immunotherapy, precision medicine, and combination treatments to improve outcomes and reduce side effects.""]","[""Research and clinical trials for Adult Central Nervous System Tumors are focused on new treatment approaches, targeted therapies, immunotherapy, precision medicine, and combination therapies.""]","[""Research and clinical trials for Adult CNS Tumors focus on new treatment modalities, targeted therapies, immunotherapy, and precision medicine approaches.""]",[true],[true],[true],"[""Research and clinical trials for Adult CNS Tumors are focused on novel targeted therapies, immunotherapy, precision medicine, and combination treatments to improve outcomes and reduce side effects.""]","[""Research and clinical trials for Adult Central Nervous System Tumors are focused on targeted therapies, immunotherapy, precision medicine, and combination treatments to improve outcomes and reduce side effects.""]","[""There are various research studies and clinical trials being conducted for Adult CNS Tumors, including investigations into new treatment modalities, targeted therapies, immunotherapies, and precision medicine approaches.""]",[true],[true],[true],"[""Research and clinical trials for Adult CNS Tumors are focused on targeted therapies, immunotherapies, precision medicine, and combination treatments to improve outcomes and reduce side effects.""]","[""Various research studies and clinical trials are being conducted for Adult Central Nervous System Tumors, including investigations into new treatment modalities, targeted therapies, immunotherapies, and precision medicine approaches.""]","[""Research and clinical trials for Adult CNS Tumors are focused on targeted therapies, immunotherapy, precision medicine, and combination treatments to improve outcomes and reduce side effects.""]",[true],[true],[true],"[""Research and clinical trials for Adult CNS Tumors are focused on targeted therapies, immunotherapy, precision medicine, and combination treatments.""]","[""Research and clinical trials for Adult Central Nervous System Tumors are focused on new treatment approaches, targeted therapies, immunotherapy, precision medicine, and understanding the genetic basis of these tumors.""]","[""Research and clinical trials for Adult CNS Tumors are focused on targeted therapies, immunotherapy, precision medicine, and combination treatments to improve outcomes and reduce side effects.""]",[true],[true],[true],"[""Various research studies and clinical trials are being conducted for Adult CNS Tumors, including investigations into new treatment modalities, targeted therapies, immunotherapies, and precision medicine approaches.""]","[""Research and clinical trials for Adult Central Nervous System Tumors are focused on new treatment approaches, targeted therapies, immunotherapy, precision medicine, and combination therapies.""]","[""Research and clinical trials for Adult CNS Tumors focus on new treatment modalities, targeted therapies, immunotherapy, and precision medicine approaches.""]",[true],[true],[true],"[""Research and clinical trials for Adult CNS Tumors are focused on targeted therapies, immunotherapy, precision medicine, and combination treatments to improve outcomes and reduce side effects.""]","[""Research and clinical trials for Adult Central Nervous System Tumors are focused on targeted therapies, immunotherapy, precision medicine, and combination treatments to improve outcomes and reduce side effects.""]","[""There are various research studies and clinical trials being conducted for Adult CNS Tumors, including investigations into new treatment modalities, targeted therapies, immunotherapies, and precision medicine approaches.""]",[true],[true],[true],"[""There are various research studies and clinical trials being conducted for Adult CNS Tumors, focusing on areas such as targeted therapies, immunotherapy, precision medicine, and novel treatment approaches.""]","[""Various research studies and clinical trials are being conducted for Adult Central Nervous System Tumors, including investigations into new treatment modalities, targeted therapies, immunotherapies, and precision medicine approaches.""]","[""Research and clinical trials for Adult CNS Tumors are focused on targeted therapies, immunotherapy, precision medicine, and combination treatments to improve outcomes and reduce side effects.""]",[true],[true],[true],"[""Research and clinical trials for Adult CNS Tumors are focused on areas such as immunotherapy, targeted therapies, precision medicine, and combination treatments.""]","[""Research and clinical trials for Adult Central Nervous System Tumors are focused on new treatment approaches, targeted therapies, immunotherapy, precision medicine, and understanding the genetic basis of these tumors.""]","[""Research and clinical trials for Adult CNS Tumors are focused on targeted therapies, immunotherapy, precision medicine, and combination treatments to improve outcomes and reduce side effects.""]",[true],[true],[true],"[""Research and clinical trials for Adult CNS Tumors are focused on areas such as immunotherapy, targeted therapy, precision medicine, and combination treatments.""]","[""Research and clinical trials for Adult Central Nervous System Tumors are focused on new treatment approaches, targeted therapies, immunotherapy, precision medicine, and combination therapies.""]","[""Research and clinical trials for Adult CNS Tumors focus on new treatment modalities, targeted therapies, immunotherapy, and precision medicine approaches.""]",[true],[true],[true],"[""Research and clinical trials for Adult CNS Tumors are focused on new treatment approaches, targeted therapies, immunotherapy, and precision medicine.""]","[""Research and clinical trials for Adult Central Nervous System Tumors are focused on targeted therapies, immunotherapy, precision medicine, and combination treatments to improve outcomes and reduce side effects.""]","[""There are various research studies and clinical trials being conducted for Adult CNS Tumors, including investigations into new treatment modalities, targeted therapies, immunotherapies, and precision medicine approaches.""]",[true],[true],[true],"[""Various research studies and clinical trials are being conducted for Adult CNS Tumors, including investigations into new treatment modalities, targeted therapies, immunotherapies, and precision medicine approaches.""]","[""Various research studies and clinical trials are being conducted for Adult Central Nervous System Tumors, including investigations into new treatment modalities, targeted therapies, immunotherapies, and precision medicine approaches.""]","[""Research and clinical trials for Adult CNS Tumors are focused on targeted therapies, immunotherapy, precision medicine, and combination treatments to improve outcomes and reduce side effects.""]",[true],[true],[true],"[""Research and clinical trials for Adult CNS Tumors are focused on new treatment approaches, targeted therapies, immunotherapy, and precision medicine.""]","[""Research and clinical trials for Adult Central Nervous System Tumors are focused on new treatment approaches, targeted therapies, immunotherapy, precision medicine, and understanding the genetic basis of these tumors.""]","[""Research and clinical trials for Adult CNS Tumors are focused on targeted therapies, immunotherapy, precision medicine, and combination treatments to improve outcomes and reduce side effects.""]",[true],[true],[true],"[""Research and clinical trials for Adult CNS tumors are focused on developing new treatments, improving existing therapies, and understanding the underlying biology of these tumors.""]","[""Research and clinical trials for Adult Central Nervous System Tumors are focused on new treatment approaches, targeted therapies, immunotherapy, precision medicine, and understanding the genetic basis of these tumors.""]","[""Research and clinical trials for Adult CNS Tumors are focused on targeted therapies, immunotherapy, precision medicine, and combination treatments to improve outcomes and reduce side effects.""]",[true],[true],[true],"[""Research and clinical trials are being conducted for Adult CNS tumors.""]","[""Research and clinical trials for Adult Central Nervous System Tumors are focused on new treatment approaches, targeted therapies, immunotherapy, precision medicine, and understanding the genetic basis of these tumors.""]","[""Research and clinical trials for Adult CNS Tumors are focused on targeted therapies, immunotherapy, precision medicine, and combination treatments to improve outcomes and reduce side effects.""]",[true],[true],[true],"[""Research and clinical trials are being conducted for Adult CNS Tumors to explore new treatments, improve outcomes, and enhance quality of life.""]","[""Research and clinical trials for Adult Central Nervous System Tumors are focused on new treatment approaches, targeted therapies, immunotherapy, precision medicine, and understanding the genetic basis of these tumors.""]","[""Research and clinical trials for Adult CNS Tumors are focused on targeted therapies, immunotherapy, precision medicine, and combination treatments to improve outcomes and reduce side effects.""]"
frequency,How many people are affected by head and neck squamous cell carcinoma ?,"HNSCC is the seventh most common cancer worldwide. Approximately 600,000 new cases are diagnosed each year, including about 50,000 in the United States. HNSCC occurs most often in men in their 50s or 60s, although the incidence among younger individuals is increasing.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""HNSCC"", ""full_form"": ""head and neck squamous cell carcinoma""}]}",How many people are affected by HNSCC ?,How many people are affected by head and neck squamous cell carcinoma ?,8,MEDICAL,Simple Datatype-Integer,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Head and Neck Squamous Cell Carcinoma"", ""Host-Nation Support Coordination Cell"", ""Head and Neck Squamous Cell Carcinoma (oncology)"", ""Host-Nation Support Coordination Cell (US DoD)"", ""Host-Nation Support Coordination Cell (US DoD)"", ""Head and Neck Squamous Cell Carcinoma (oncology)""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY""]]","[""Head and Neck Squamous Cell Carcinoma""]",[4.3097469917766495e-12],[4.3097469917766495e-12],"[""Head and Neck Squamous Cell Carcinoma""]",[4.3097469917766495e-12],"[""ABBREVIATIONS""]","[[4.3097469917766495e-12, 4.834241381977674e-27, 6.341859920614571e-20, 2.3121101730421627e-42, 2.3121101730421627e-42, 6.341859920614571e-20]]",[0.96252677914957],[0.9613919006271504],"[""head and neck squamous cell carcinoma""]",[0.9613919006271504],"[""ABBREVIATIONS""]","[[0.9613919006271504, 0.7298761464251395, 0.9358521297834408, 0.7641721947886002, 0.7641721947886002, 0.9358521297834408]]","[""Head and Neck Squamous Cell Carcinoma (oncology)""]","[""THEFREEDICTIONARY""]",How many people are affected by HNSCC (Head and Neck Squamous Cell Carcinoma) ?,[true],[true],[true],"[""Approximately 650,000 new cases are diagnosed worldwide each year.""]","[""Around 650,000 people are affected by head and neck squamous cell carcinoma worldwide.""]","[""Around 650,000 people are affected by HNSCC worldwide each year.""]",[true],[true],[true],"[""Around 650,000 new cases of HNSCC are diagnosed worldwide each year.""]","[""Around 650,000 people are affected by head and neck squamous cell carcinoma worldwide each year.""]","[""Approximately 650,000 new cases of Head and Neck Squamous Cell Carcinoma (HNSCC) are diagnosed worldwide each year.""]",[true],[true],[true],"[""Approximately 650,000 new cases of HNSCC are diagnosed worldwide each year.""]","[""Around 650,000 people are affected by head and neck squamous cell carcinoma worldwide each year.""]","[""Around 650,000 people are affected by HNSCC worldwide each year.""]",[true],[true],[true],"[""Around 650,000 new cases of HNSCC are diagnosed worldwide each year.""]","[""Approximately 650,000 people are affected by head and neck squamous cell carcinoma worldwide.""]","[""Around 650,000 new cases of Head and Neck Squamous Cell Carcinoma (HNSCC) are diagnosed worldwide each year.""]",[true],[true],[true],"[""Around 650,000 new cases of HNSCC are diagnosed worldwide each year.""]","[""Around 650,000 people are affected by head and neck squamous cell carcinoma worldwide.""]","[""Around 650,000 people are affected by HNSCC worldwide each year.""]",[true],[true],[true],"[""Around 650,000 new cases of head and neck squamous cell carcinoma (HNSCC) are diagnosed worldwide each year.""]","[""Around 650,000 people are affected by head and neck squamous cell carcinoma worldwide each year.""]","[""Approximately 650,000 new cases of Head and Neck Squamous Cell Carcinoma (HNSCC) are diagnosed worldwide each year.""]",[true],[true],[true],"[""Around 650,000 new cases of head and neck cancer are diagnosed worldwide each year.""]","[""Around 650,000 people are affected by head and neck squamous cell carcinoma worldwide each year.""]","[""Around 650,000 people are affected by HNSCC worldwide each year.""]",[true],[true],[true],"[""Around 650,000 new cases of HNSCC are diagnosed worldwide each year.""]","[""Approximately 650,000 people are affected by head and neck squamous cell carcinoma worldwide.""]","[""Around 650,000 new cases of Head and Neck Squamous Cell Carcinoma (HNSCC) are diagnosed worldwide each year.""]",[true],[true],[true],"[""Around 650,000 new cases of HNSCC are diagnosed worldwide each year.""]","[""Around 650,000 people are affected by head and neck squamous cell carcinoma worldwide each year.""]","[""Approximately 650,000 new cases of Head and Neck Squamous Cell Carcinoma (HNSCC) are diagnosed worldwide each year.""]",[true],[true],[true],"[""Around 650,000 new cases of HNSCC are diagnosed worldwide each year.""]","[""Around 650,000 people are affected by head and neck squamous cell carcinoma worldwide.""]","[""Around 650,000 people are affected by HNSCC worldwide each year.""]",[true],[true],[true],"[""Approximately 650,000 new cases of HNSCC are diagnosed worldwide each year.""]","[""Around 650,000 people are affected by head and neck squamous cell carcinoma worldwide each year.""]","[""Around 650,000 people are affected by HNSCC worldwide each year.""]",[true],[true],[true],"[""Around 650,000 new cases of HNSCC are diagnosed worldwide each year.""]","[""Approximately 650,000 people are affected by head and neck squamous cell carcinoma worldwide.""]","[""Around 650,000 new cases of Head and Neck Squamous Cell Carcinoma (HNSCC) are diagnosed worldwide each year.""]",[true],[true],[true],"[""Approximately 650,000 new cases are diagnosed worldwide each year.""]","[""Around 650,000 people are affected by head and neck squamous cell carcinoma worldwide.""]","[""Around 650,000 people are affected by HNSCC worldwide each year.""]",[true],[true],[true],"[""Approximately 650,000 new cases are diagnosed each year worldwide.""]","[""Around 650,000 people are affected by head and neck squamous cell carcinoma worldwide each year.""]","[""Approximately 650,000 new cases of Head and Neck Squamous Cell Carcinoma (HNSCC) are diagnosed worldwide each year.""]",[true],[true],[true],"[""Around 650,000 new cases are diagnosed worldwide each year""]","[""Around 650,000 people are affected by head and neck squamous cell carcinoma worldwide each year.""]","[""Around 650,000 people are affected by HNSCC worldwide each year.""]",[true],[true],[true],"[""Around 650,000 new cases are diagnosed each year worldwide.""]","[""Approximately 650,000 people are affected by head and neck squamous cell carcinoma worldwide.""]","[""Around 650,000 new cases of Head and Neck Squamous Cell Carcinoma (HNSCC) are diagnosed worldwide each year.""]",[false],[true],[true],"[""Not specified""]","[""Around 650,000 people are affected by head and neck squamous cell carcinoma worldwide.""]","[""Around 650,000 people are affected by HNSCC worldwide each year.""]",[true],[true],[true],"[""Around 650,000 new cases of HNSCC are diagnosed worldwide each year.""]","[""Around 650,000 people are affected by head and neck squamous cell carcinoma worldwide each year.""]","[""Approximately 650,000 new cases of Head and Neck Squamous Cell Carcinoma (HNSCC) are diagnosed worldwide each year.""]",[true],[true],[true],"[""Around 650,000 new cases of HNSCC are diagnosed worldwide each year.""]","[""Around 650,000 people are affected by head and neck squamous cell carcinoma worldwide each year.""]","[""Around 650,000 people are affected by HNSCC worldwide each year.""]",[true],[true],[true],"[""Approximately 650,000 new cases of HNSCC are diagnosed worldwide each year.""]","[""Approximately 650,000 people are affected by head and neck squamous cell carcinoma worldwide.""]","[""Around 650,000 new cases of Head and Neck Squamous Cell Carcinoma (HNSCC) are diagnosed worldwide each year.""]",[true],[true],[true],"[""Around 650,000 new cases of HNSCC are diagnosed worldwide each year.""]","[""Around 650,000 people are affected by head and neck squamous cell carcinoma worldwide.""]","[""Around 650,000 people are affected by HNSCC worldwide each year.""]",[true],[true],[true],"[""Around 650,000 new cases of HNSCC are diagnosed worldwide each year.""]","[""Around 650,000 people are affected by head and neck squamous cell carcinoma worldwide each year.""]","[""Approximately 650,000 new cases of Head and Neck Squamous Cell Carcinoma (HNSCC) are diagnosed worldwide each year.""]",[true],[true],[false],"[""Around 650,000 new cases of HNSCC are diagnosed worldwide each year.""]","[""Around 650,000 people are affected by head and neck squamous cell carcinoma worldwide each year.""]","[""Around 650,000 people are affected by HNSCC worldwide each year.""]",[true],[true],[true],"[""Around 650,000 new cases of HNSCC are diagnosed worldwide each year.""]","[""Approximately 650,000 people are affected by head and neck squamous cell carcinoma worldwide.""]","[""Around 650,000 new cases of Head and Neck Squamous Cell Carcinoma (HNSCC) are diagnosed worldwide each year.""]",[true],[true],[true],"[""Approximately 650,000 new cases of HNSCC are diagnosed worldwide each year.""]","[""Around 650,000 people are affected by head and neck squamous cell carcinoma worldwide.""]","[""Around 650,000 people are affected by HNSCC worldwide each year.""]",[true],[true],[true],"[""Approximately 650,000 new cases of HNSCC are diagnosed worldwide each year.""]","[""Around 650,000 people are affected by head and neck squamous cell carcinoma worldwide each year.""]","[""Approximately 650,000 new cases of Head and Neck Squamous Cell Carcinoma (HNSCC) are diagnosed worldwide each year.""]",[true],[true],[true],"[""Approximately 650,000 new cases of HNSCC are diagnosed worldwide each year.""]","[""Around 650,000 people are affected by head and neck squamous cell carcinoma worldwide each year.""]","[""Around 650,000 people are affected by HNSCC worldwide each year.""]",[true],[true],[true],"[""Approximately 600,000 new cases of HNSCC are diagnosed worldwide each year.""]","[""Approximately 650,000 people are affected by head and neck squamous cell carcinoma worldwide.""]","[""Around 650,000 new cases of Head and Neck Squamous Cell Carcinoma (HNSCC) are diagnosed worldwide each year.""]",[true],[true],[true],"[""The estimated number of people affected by HNSCC is around 650,000 worldwide per year.""]","[""Around 650,000 people are affected by head and neck squamous cell carcinoma worldwide.""]","[""Around 650,000 people are affected by HNSCC worldwide each year.""]",[true],[true],[true],"[""Approximately 650,000 new cases are diagnosed each year worldwide.""]","[""Around 650,000 people are affected by head and neck squamous cell carcinoma worldwide.""]","[""Around 650,000 people are affected by HNSCC worldwide each year.""]",[false],[true],[true],"[""Approximately 890,000 people are affected by HNSCC worldwide.""]","[""Around 650,000 people are affected by head and neck squamous cell carcinoma worldwide.""]","[""Around 650,000 people are affected by HNSCC worldwide each year.""]",[true],[true],[true],"[""Approximately 650,000 new cases are diagnosed each year worldwide.""]","[""Around 650,000 people are affected by head and neck squamous cell carcinoma worldwide.""]","[""Around 650,000 people are affected by HNSCC worldwide each year.""]"
genetic changes,What are the genetic changes related to Jacobsen syndrome ?,"Jacobsen syndrome is caused by a deletion of genetic material at the end of the long (q) arm of chromosome 11. The size of the deletion varies among affected individuals, with most affected people missing 5 million to 16 million DNA building blocks (also written as 5 Mb to 16 Mb). In almost all affected people, the deletion includes the tip of chromosome 11. Larger deletions tend to cause more severe signs and symptoms than smaller deletions.  The features of Jacobsen syndrome are likely related to the loss of multiple genes on chromosome 11. Depending on its size, the deleted region can contain from about 170 to more than 340 genes. Many of these genes have not been well characterized. However, genes in this region appear to be critical for the normal development of many parts of the body, including the brain, facial features, and heart. Only a few genes have been studied as possible contributors to the specific features of Jacobsen syndrome; researchers are working to determine which additional genes may be associated with this condition.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""JBS"", ""full_form"": ""Jacobsen syndrome""}]}",What are the genetic changes related to JBS ?,What are the genetic changes related to Jacobsen syndrome ?,8,MEDICAL,Compound Datatype-List/Array,"Exploratory(Divergent Thinking): Queries that are inherently about seeking new areas of knowledge, understanding emerging trends, or identifying unknown opportunities without a specific end goal of making a decision or judgment. Exploratory queries are characterized by their openness and the lack of a predefined objective, differentiating them from evaluative queries which are directed towards forming a judgment or assessment. Exploratory queries encourage branching out into various directions to explore a wide array of possibilities without necessarily aiming to converge on a single answer or outcome.","[[""John Birch Society"", ""Journal of Biomolecular Screening"", ""Jump and Blow Stack"", ""Jewels By Star"", ""Jack Bingham Studio"", ""Pleasanton, California USA"", ""Joel B. Snyder"", ""Joint Business Solutions"", ""Just Better Soap"", ""Jens Bjerg S\u00f8rensen""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Jacobsen Syndrome""]",[2.7702630770792502e-17],[2.7702630770792502e-17],"[""Just Better Soap""]",[4.2692572018180136e-15],"[""ABBREVIATIONS""]","[[1.253399484317952e-21, 4.467267863301227e-24, 3.906916813434845e-18, 4.239630388220803e-16, 4.502016479088286e-23, 3.33140400536645e-33, 6.999122296996495e-24, 7.344254832561284e-17, 4.2692572018180136e-15, 2.1646532424306924e-30]]",[0.7943209701078942],[0.7920300146268315],"[""Just Better Soap""]",[0.8900192804794793],"[""ABBREVIATIONS""]","[[0.7375194937886344, 0.8210515181340028, 0.807636309203468, 0.80436495196864, 0.8362273017539605, 0.8418730900627891, 0.8759574981134322, 0.8213892218727986, 0.7587903322658343, 0.8900192804794793]]","[""Jacobsen Syndrome""]","[""LLM""]",What are the genetic changes related to JBS (Jacobsen Syndrome) ?,[false],[true],[false],"[""Genetic changes related to JBS (Just Better Soap) are not well-documented in medical literature.""]","[""Deletion of a small piece of chromosome 11 (11q terminal deletion)""]","[""Genetic changes related to Joubert syndrome (JBS) include mutations in genes such as AHI1, NPHP1, CEP290, TMEM67, and RPGRIP1L.""]",[false],[true],[false],"[""Genetic changes related to JBS (Just Better Soap) have not been identified in medical literature.""]","[""Deletion of a small piece of chromosome 11 (11q terminal deletion)""]","[""Genetic changes related to Joubert syndrome include mutations in genes such as AHI1, NPHP1, TMEM67, and CEP290.""]",[false],[true],[false],"[""Genetic changes related to JBS (Just Better Soap) have not been identified in medical literature.""]","[""Deletion of a segment of chromosome 11 (11q terminal deletion)""]","[""Genetic changes related to Joubert syndrome include mutations in genes such as AHI1, INPP5E, TMEM67, and CEP290.""]",[false],[true],[false],"[""Genetic changes related to JBS (Just Better Soap) have not been identified or documented in medical literature.""]","[""Deletion of a small piece of chromosome 11 (11q terminal deletion)""]","[""Genetic changes related to Joubert syndrome include mutations in genes such as AHI1, CEP290, TMEM67, and RPGRIP1L.""]",[false],[true],[false],"[""Genetic changes related to JBS (Just Better Soap) have not been identified in medical literature.""]","[""Deletion of a small piece of chromosome 11 (11q terminal deletion)""]","[""Genetic changes related to Joubert syndrome (JBS) include mutations in genes such as AHI1, NPHP1, CEP290, TMEM67, and RPGRIP1L.""]",[false],[true],[false],"[""Genetic changes related to JBS (Just Better Soap) have not been identified in medical literature.""]","[""Deletion of a small piece of chromosome 11 (11q terminal deletion)""]","[""Genetic changes related to Joubert syndrome include mutations in genes such as AHI1, NPHP1, TMEM67, and CEP290.""]",[false],[true],[false],"[""Genetic changes related to JBS (Just Better Soap) have not been identified in medical literature.""]","[""Deletion of a segment of chromosome 11 (11q terminal deletion)""]","[""Genetic changes related to Joubert syndrome include mutations in genes such as AHI1, INPP5E, TMEM67, and CEP290.""]",[false],[true],[false],"[""Genetic changes related to JBS (Just Better Soap) are currently unknown and require further research.""]","[""Deletion of a small piece of chromosome 11 (11q terminal deletion)""]","[""Genetic changes related to Joubert syndrome include mutations in genes such as AHI1, CEP290, TMEM67, and RPGRIP1L.""]",[true],[true],[false],"[""Deletion of a segment of the long arm of chromosome 11 (11q) is the main genetic change associated with Jacobsen Syndrome (JBS). This deletion can vary in size and often leads to a range of physical and developmental symptoms.""]","[""Deletion of a small piece of chromosome 11 (11q terminal deletion)""]","[""Genetic changes related to Joubert syndrome include mutations in genes such as AHI1, NPHP1, TMEM67, and CEP290.""]",[true],[true],[false],"[""Deletion of a segment of the long arm of chromosome 11 (11q terminal deletion)""]","[""Deletion of a small piece of chromosome 11 (11q terminal deletion)""]","[""Genetic changes related to Joubert syndrome (JBS) include mutations in genes such as AHI1, NPHP1, CEP290, TMEM67, and RPGRIP1L.""]",[true],[true],[false],"[""Deletion of a segment of the long arm of chromosome 11 (11q) is the main genetic change associated with Jacobsen Syndrome (JBS). This deletion can vary in size and can result in a range of physical and developmental symptoms.""]","[""Deletion of a segment of chromosome 11 (11q terminal deletion)""]","[""Genetic changes related to Joubert syndrome include mutations in genes such as AHI1, INPP5E, TMEM67, and CEP290.""]",[true],[true],[false],"[""Deletion of a segment of chromosome 11 (11q terminal deletion)""]","[""Deletion of a small piece of chromosome 11 (11q terminal deletion)""]","[""Genetic changes related to Joubert syndrome include mutations in genes such as AHI1, CEP290, TMEM67, and RPGRIP1L.""]",[true],[true],[false],"[""Deletion of a portion of chromosome 11 (11q terminal deletion disorder)""]","[""Deletion of a small piece of chromosome 11 (11q terminal deletion)""]","[""Genetic changes related to Joubert syndrome (JBS) include mutations in genes such as AHI1, NPHP1, CEP290, TMEM67, and RPGRIP1L.""]",[true],[true],[false],"[""Deletion of a segment of chromosome 11, specifically band 11q23""]","[""Deletion of a small piece of chromosome 11 (11q terminal deletion)""]","[""Genetic changes related to Joubert syndrome include mutations in genes such as AHI1, NPHP1, TMEM67, and CEP290.""]",[true],[true],[false],"[""Deletion of a segment of chromosome 11 (11q terminal deletion disorder)""]","[""Deletion of a segment of chromosome 11 (11q terminal deletion)""]","[""Genetic changes related to Joubert syndrome include mutations in genes such as AHI1, INPP5E, TMEM67, and CEP290.""]",[true],[true],[false],"[""Deletion of a segment of chromosome 11 (11q terminal deletion disorder)""]","[""Deletion of a small piece of chromosome 11 (11q terminal deletion)""]","[""Genetic changes related to Joubert syndrome include mutations in genes such as AHI1, CEP290, TMEM67, and RPGRIP1L.""]",[true],[true],[false],"[""Deletion of a segment of chromosome 11, leading to various physical and developmental abnormalities""]","[""Deletion of a small piece of chromosome 11 (11q terminal deletion)""]","[""Genetic changes related to Joubert syndrome (JBS) include mutations in genes such as AHI1, NPHP1, CEP290, TMEM67, and RPGRIP1L.""]",[true],[true],[false],"[""Deletion of a segment of chromosome 11 (11q terminal deletion)""]","[""Deletion of a small piece of chromosome 11 (11q terminal deletion)""]","[""Genetic changes related to Joubert syndrome include mutations in genes such as AHI1, NPHP1, TMEM67, and CEP290.""]",[true],[true],[false],"[""Deletion of a segment of the long arm of chromosome 11 (11q)""]","[""Deletion of a segment of chromosome 11 (11q terminal deletion)""]","[""Genetic changes related to Joubert syndrome include mutations in genes such as AHI1, INPP5E, TMEM67, and CEP290.""]",[true],[true],[false],"[""Deletion of a segment of chromosome 11 (specifically a deletion in the long arm of chromosome 11)""]","[""Deletion of a small piece of chromosome 11 (11q terminal deletion)""]","[""Genetic changes related to Joubert syndrome include mutations in genes such as AHI1, CEP290, TMEM67, and RPGRIP1L.""]",[true],[true],[false],"[""Deletion of a segment of chromosome 11 (11q terminal deletion disorder)""]","[""Deletion of a small piece of chromosome 11 (11q terminal deletion)""]","[""Genetic changes related to Joubert syndrome (JBS) include mutations in genes such as AHI1, NPHP1, CEP290, TMEM67, and RPGRIP1L.""]",[true],[false],[false],"[""Deletion of a segment of the long arm of chromosome 11 (11q) is the main genetic change associated with Jacobsen Syndrome (JBS). This deletion can vary in size and can result in a range of physical and developmental symptoms.""]","[""Deletion of a small piece of chromosome 11 (11q terminal deletion)""]","[""Genetic changes related to Joubert syndrome include mutations in genes such as AHI1, NPHP1, TMEM67, and CEP290.""]",[true],[true],[false],"[""Deletion of a segment of the long arm of chromosome 11 (11q) is the main genetic change associated with Jacobsen Syndrome (JBS). This deletion can vary in size and can result in a range of physical and developmental symptoms.""]","[""Deletion of a segment of chromosome 11 (11q terminal deletion)""]","[""Genetic changes related to Joubert syndrome include mutations in genes such as AHI1, INPP5E, TMEM67, and CEP290.""]",[true],[false],[false],"[""Deletion of a segment of the long arm of chromosome 11 (11q) is the main genetic change associated with Jacobsen Syndrome (JBS). This deletion can vary in size and can result in a range of physical and developmental symptoms.""]","[""Deletion of a small piece of chromosome 11 (11q terminal deletion)""]","[""Genetic changes related to Joubert syndrome include mutations in genes such as AHI1, CEP290, TMEM67, and RPGRIP1L.""]",[true],[true],[false],"[""Deletion of a segment of chromosome 11 (11q terminal deletion disorder)""]","[""Deletion of a small piece of chromosome 11 (11q terminal deletion)""]","[""Genetic changes related to Joubert syndrome (JBS) include mutations in genes such as AHI1, NPHP1, CEP290, TMEM67, and RPGRIP1L.""]",[true],[true],[false],"[""Deletion of a segment of chromosome 11, leading to various physical and developmental abnormalities""]","[""Deletion of a small piece of chromosome 11 (11q terminal deletion)""]","[""Genetic changes related to Joubert syndrome include mutations in genes such as AHI1, NPHP1, TMEM67, and CEP290.""]",[true],[true],[false],"[""Deletion of a segment of chromosome 11 (11q terminal deletion)""]","[""Deletion of a segment of chromosome 11 (11q terminal deletion)""]","[""Genetic changes related to Joubert syndrome include mutations in genes such as AHI1, INPP5E, TMEM67, and CEP290.""]",[true],[true],[false],"[""Deletion of a segment of chromosome 11 (11q terminal deletion disorder)""]","[""Deletion of a small piece of chromosome 11 (11q terminal deletion)""]","[""Genetic changes related to Joubert syndrome include mutations in genes such as AHI1, CEP290, TMEM67, and RPGRIP1L.""]",[true],[true],[false],"[""Deletion of a portion of chromosome 11""]","[""Deletion of a small piece of chromosome 11 (11q terminal deletion)""]","[""Genetic changes related to Joubert syndrome (JBS) include mutations in genes such as AHI1, NPHP1, CEP290, TMEM67, and RPGRIP1L.""]",[false],[true],[false],"[""Genetic changes related to JBS are not specified.""]","[""Deletion of a small piece of chromosome 11 (11q terminal deletion)""]","[""Genetic changes related to Joubert syndrome (JBS) include mutations in genes such as AHI1, NPHP1, CEP290, TMEM67, and RPGRIP1L.""]",[false],[true],[false],"[""Genetic changes related to JBS are not specified.""]","[""Deletion of a small piece of chromosome 11 (11q terminal deletion)""]","[""Genetic changes related to Joubert syndrome (JBS) include mutations in genes such as AHI1, NPHP1, CEP290, TMEM67, and RPGRIP1L.""]",[true],[true],[false],"[""Deletion of a terminal portion of the long arm of chromosome 11""]","[""Deletion of a small piece of chromosome 11 (11q terminal deletion)""]","[""Genetic changes related to Joubert syndrome (JBS) include mutations in genes such as AHI1, NPHP1, CEP290, TMEM67, and RPGRIP1L.""]"
symptoms,What are the symptoms of IMAGe syndrome ?,"What are the signs and symptoms of IMAGe syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for IMAGe syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of the adrenal glands 90% Abnormality of the upper urinary tract 90% Cryptorchidism 90% Depressed nasal bridge 90% Displacement of the external urethral meatus 90% Frontal bossing 90% Intrauterine growth retardation 90% Low-set, posteriorly rotated ears 90% Micromelia 90% Muscular hypotonia 90% Macrocephaly 5% Adrenal hypoplasia - Autosomal dominant inheritance - Delayed skeletal maturation - Epiphyseal dysplasia - Growth hormone deficiency - Hypercalcemia - Hypercalciuria - Hypospadias - Low-set ears - Metaphyseal dysplasia - Micropenis - Postnatal growth retardation - Prominent forehead - Short nose - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""abbreviation"", ""abbreviation"": ""IMAGe"", ""full_form"": ""Intrauterine growth restriction, Metaphyseal dysplasia, Adrenal hypoplasia congenita, and Genital anomalies""}]}",What are the symptoms of IMAGe syndrome ?,"What are the symptoms of Intrauterine growth restriction, Metaphyseal dysplasia, Adrenal hypoplasia congenita, and Genital anomalies syndrome ?",8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Imager for Magnetopause to Aurora Global Exploration"", ""Integrated Molecular Analysis of Gene Expression"", ""Increasing Minority Access To Graduate Education"", ""Imager for Magnetopause to Auroral Global Exploration"", ""Disk Image (Disk Copy, ShrinkWrap)"", ""International Missions Apprenticeship For Gods Evangelists"", ""International Medicine And Graduate Education"", ""International Missions Apprenticeship For God's Evangelists"", ""Information Manipulation Archiving Gathering And Extraction"", ""Impacting Men to Achieve Greater Excellence""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Intrauterine growth restriction, Metaphyseal dysplasia, Adrenal hypoplasia congenita, and Genital anomalies""]",[1.5730873266831974e-65],[1.5730873266831974e-65],"[""International Medicine And Graduate Education""]",[1.2005143169078972e-20],"[""ABBREVIATIONS""]","[[1.8657984230225643e-48, 6.32973683228811e-24, 5.503426671416872e-29, 6.7946378139142735e-49, 6.959153743535818e-39, 9.47471045619469e-46, 1.2005143169078972e-20, 6.384361071638135e-47, 8.946798516878369e-33, 5.679776753333396e-25]]",[0.8524092150456221],[0.8524092150456221],"[""Imager for Magnetopause to Aurora Global Exploration""]",[0.9374769652080036],"[""ABBREVIATIONS""]","[[0.9082215637274609, 0.9374769652080036, 0.8588787457998788, 0.9011626544301973, 0.8704975808530038, 0.8916618760095926, 0.9319363939955726, 0.8981264062427896, 0.825395121566304, 0.8906560172248741]]","[""Intrauterine growth restriction, Metaphyseal dysplasia, Adrenal hypoplasia congenita, and Genital anomalies""]","[""LLM""]","What are the symptoms of IMAGe (Intrauterine growth restriction, Metaphyseal dysplasia, Adrenal hypoplasia congenita, and Genital anomalies) syndrome ?",[true],[true],[true],"[""Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies""]","[""Symptoms of Intrauterine growth restriction, Metaphyseal dysplasia, Adrenal hypoplasia congenita, and Genital anomalies syndrome include growth retardation, skeletal abnormalities, adrenal insufficiency, and genital anomalies.""]","[""Intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies are the main symptoms of IMAGe syndrome.""]",[true],[true],[true],"[""Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies are the symptoms of IMAGe syndrome.""]","[""Symptoms of Intrauterine growth restriction, Metaphyseal dysplasia, Adrenal hypoplasia congenita, and Genital anomalies syndrome include growth retardation, skeletal abnormalities, adrenal insufficiency, and genital anomalies.""]","[""Intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies are the main symptoms of IMAGe syndrome.""]",[false],[true],[true],"[""Intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies""]","[""Intrauterine growth restriction, Metaphyseal dysplasia, Adrenal hypoplasia congenita, and Genital anomalies syndrome can present with symptoms such as growth retardation, skeletal abnormalities, adrenal insufficiency, and genital anomalies.""]","[""Intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies are common symptoms of IMAGe syndrome.""]",[false],[true],[true],"[""Intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies""]","[""The symptoms of Intrauterine growth restriction, Metaphyseal dysplasia, Adrenal hypoplasia congenita, and Genital anomalies syndrome include severe growth restriction before birth, skeletal abnormalities, underdeveloped adrenal glands, and genital anomalies.""]","[""Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies are the symptoms of IMAGe syndrome.""]",[true],[true],[true],"[""Intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies are the main symptoms of IMAGe syndrome.""]","[""Symptoms of Intrauterine growth restriction, Metaphyseal dysplasia, Adrenal hypoplasia congenita, and Genital anomalies syndrome include growth retardation, skeletal abnormalities, adrenal insufficiency, and genital anomalies.""]","[""Intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies are the main symptoms of IMAGe syndrome.""]",[false],[true],[true],"[""Intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies""]","[""Symptoms of Intrauterine growth restriction, Metaphyseal dysplasia, Adrenal hypoplasia congenita, and Genital anomalies syndrome include growth retardation, skeletal abnormalities, adrenal insufficiency, and genital anomalies.""]","[""Intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies are the main symptoms of IMAGe syndrome.""]",[false],[true],[true],"[""Intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies""]","[""Intrauterine growth restriction, Metaphyseal dysplasia, Adrenal hypoplasia congenita, and Genital anomalies syndrome can present with symptoms such as growth retardation, skeletal abnormalities, adrenal insufficiency, and genital anomalies.""]","[""Intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies are common symptoms of IMAGe syndrome.""]",[true],[true],[true],"[""Intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies are common symptoms of IMAGe syndrome.""]","[""The symptoms of Intrauterine growth restriction, Metaphyseal dysplasia, Adrenal hypoplasia congenita, and Genital anomalies syndrome include severe growth restriction before birth, skeletal abnormalities, underdeveloped adrenal glands, and genital anomalies.""]","[""Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies are the symptoms of IMAGe syndrome.""]",[true],[true],[true],"[""The symptoms of IMAGe syndrome include intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies.""]","[""Symptoms of Intrauterine growth restriction, Metaphyseal dysplasia, Adrenal hypoplasia congenita, and Genital anomalies syndrome include growth retardation, skeletal abnormalities, adrenal insufficiency, and genital anomalies.""]","[""Intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies are the main symptoms of IMAGe syndrome.""]",[true],[true],[true],"[""The symptoms of IMAGe syndrome include intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies.""]","[""Symptoms of Intrauterine growth restriction, Metaphyseal dysplasia, Adrenal hypoplasia congenita, and Genital anomalies syndrome include growth retardation, skeletal abnormalities, adrenal insufficiency, and genital anomalies.""]","[""Intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies are the main symptoms of IMAGe syndrome.""]",[true],[true],[true],"[""The symptoms of IMAGe syndrome include intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies.""]","[""Intrauterine growth restriction, Metaphyseal dysplasia, Adrenal hypoplasia congenita, and Genital anomalies syndrome can present with symptoms such as growth retardation, skeletal abnormalities, adrenal insufficiency, and genital anomalies.""]","[""Intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies are common symptoms of IMAGe syndrome.""]",[true],[true],[true],"[""The symptoms of IMAGe syndrome include intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies.""]","[""The symptoms of Intrauterine growth restriction, Metaphyseal dysplasia, Adrenal hypoplasia congenita, and Genital anomalies syndrome include severe growth restriction before birth, skeletal abnormalities, underdeveloped adrenal glands, and genital anomalies.""]","[""Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies are the symptoms of IMAGe syndrome.""]",[true],[true],[true],"[""Symptoms of IMAGe syndrome include intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies.""]","[""Symptoms of Intrauterine growth restriction, Metaphyseal dysplasia, Adrenal hypoplasia congenita, and Genital anomalies syndrome include growth retardation, skeletal abnormalities, adrenal insufficiency, and genital anomalies.""]","[""Intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies are the main symptoms of IMAGe syndrome.""]",[true],[true],[true],"[""Symptoms of IMAGe syndrome include intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies.""]","[""Symptoms of Intrauterine growth restriction, Metaphyseal dysplasia, Adrenal hypoplasia congenita, and Genital anomalies syndrome include growth retardation, skeletal abnormalities, adrenal insufficiency, and genital anomalies.""]","[""Intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies are the main symptoms of IMAGe syndrome.""]",[true],[true],[true],"[""Symptoms of IMAGe syndrome include intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies.""]","[""Intrauterine growth restriction, Metaphyseal dysplasia, Adrenal hypoplasia congenita, and Genital anomalies syndrome can present with symptoms such as growth retardation, skeletal abnormalities, adrenal insufficiency, and genital anomalies.""]","[""Intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies are common symptoms of IMAGe syndrome.""]",[true],[true],[true],"[""Symptoms of IMAGe syndrome include intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies.""]","[""The symptoms of Intrauterine growth restriction, Metaphyseal dysplasia, Adrenal hypoplasia congenita, and Genital anomalies syndrome include severe growth restriction before birth, skeletal abnormalities, underdeveloped adrenal glands, and genital anomalies.""]","[""Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies are the symptoms of IMAGe syndrome.""]",[true],[true],[true],"[""Symptoms of IMAGe syndrome include intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies.""]","[""Symptoms of Intrauterine growth restriction, Metaphyseal dysplasia, Adrenal hypoplasia congenita, and Genital anomalies syndrome include growth retardation, skeletal abnormalities, adrenal insufficiency, and genital anomalies.""]","[""Intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies are the main symptoms of IMAGe syndrome.""]",[true],[true],[true],"[""Symptoms of IMAGe syndrome include intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies.""]","[""Symptoms of Intrauterine growth restriction, Metaphyseal dysplasia, Adrenal hypoplasia congenita, and Genital anomalies syndrome include growth retardation, skeletal abnormalities, adrenal insufficiency, and genital anomalies.""]","[""Intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies are the main symptoms of IMAGe syndrome.""]",[true],[true],[true],"[""The symptoms of IMAGe syndrome include intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies.""]","[""Intrauterine growth restriction, Metaphyseal dysplasia, Adrenal hypoplasia congenita, and Genital anomalies syndrome can present with symptoms such as growth retardation, skeletal abnormalities, adrenal insufficiency, and genital anomalies.""]","[""Intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies are common symptoms of IMAGe syndrome.""]",[true],[true],[true],"[""The symptoms of IMAGe syndrome include intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies.""]","[""The symptoms of Intrauterine growth restriction, Metaphyseal dysplasia, Adrenal hypoplasia congenita, and Genital anomalies syndrome include severe growth restriction before birth, skeletal abnormalities, underdeveloped adrenal glands, and genital anomalies.""]","[""Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies are the symptoms of IMAGe syndrome.""]",[true],[true],[true],"[""The symptoms of IMAGe syndrome include intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies.""]","[""Symptoms of Intrauterine growth restriction, Metaphyseal dysplasia, Adrenal hypoplasia congenita, and Genital anomalies syndrome include growth retardation, skeletal abnormalities, adrenal insufficiency, and genital anomalies.""]","[""Intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies are the main symptoms of IMAGe syndrome.""]",[true],[true],[true],"[""Symptoms of IMAGe syndrome include intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies.""]","[""Symptoms of Intrauterine growth restriction, Metaphyseal dysplasia, Adrenal hypoplasia congenita, and Genital anomalies syndrome include growth retardation, skeletal abnormalities, adrenal insufficiency, and genital anomalies.""]","[""Intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies are the main symptoms of IMAGe syndrome.""]",[true],[true],[true],"[""The symptoms of IMAGe syndrome include intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies.""]","[""Intrauterine growth restriction, Metaphyseal dysplasia, Adrenal hypoplasia congenita, and Genital anomalies syndrome can present with symptoms such as growth retardation, skeletal abnormalities, adrenal insufficiency, and genital anomalies.""]","[""Intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies are common symptoms of IMAGe syndrome.""]",[true],[true],[true],"[""Symptoms of IMAGe syndrome include intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies.""]","[""The symptoms of Intrauterine growth restriction, Metaphyseal dysplasia, Adrenal hypoplasia congenita, and Genital anomalies syndrome include severe growth restriction before birth, skeletal abnormalities, underdeveloped adrenal glands, and genital anomalies.""]","[""Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies are the symptoms of IMAGe syndrome.""]",[true],[true],[true],"[""The symptoms of IMAGe syndrome include intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies.""]","[""Symptoms of Intrauterine growth restriction, Metaphyseal dysplasia, Adrenal hypoplasia congenita, and Genital anomalies syndrome include growth retardation, skeletal abnormalities, adrenal insufficiency, and genital anomalies.""]","[""Intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies are the main symptoms of IMAGe syndrome.""]",[true],[true],[true],"[""Symptoms of IMAGe syndrome include intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies.""]","[""Symptoms of Intrauterine growth restriction, Metaphyseal dysplasia, Adrenal hypoplasia congenita, and Genital anomalies syndrome include growth retardation, skeletal abnormalities, adrenal insufficiency, and genital anomalies.""]","[""Intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies are the main symptoms of IMAGe syndrome.""]",[true],[true],[true],"[""The symptoms of IMAGe syndrome include intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies.""]","[""Intrauterine growth restriction, Metaphyseal dysplasia, Adrenal hypoplasia congenita, and Genital anomalies syndrome can present with symptoms such as growth retardation, skeletal abnormalities, adrenal insufficiency, and genital anomalies.""]","[""Intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies are common symptoms of IMAGe syndrome.""]",[true],[true],[true],"[""The symptoms of IMAGe syndrome include intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies.""]","[""The symptoms of Intrauterine growth restriction, Metaphyseal dysplasia, Adrenal hypoplasia congenita, and Genital anomalies syndrome include severe growth restriction before birth, skeletal abnormalities, underdeveloped adrenal glands, and genital anomalies.""]","[""Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies are the symptoms of IMAGe syndrome.""]",[true],[true],[true],"[""Symptoms of IMAGe syndrome include intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies.""]","[""Symptoms of Intrauterine growth restriction, Metaphyseal dysplasia, Adrenal hypoplasia congenita, and Genital anomalies syndrome include growth retardation, skeletal abnormalities, adrenal insufficiency, and genital anomalies.""]","[""Intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies are the main symptoms of IMAGe syndrome.""]",[true],[true],[true],"[""Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies""]","[""Symptoms of Intrauterine growth restriction, Metaphyseal dysplasia, Adrenal hypoplasia congenita, and Genital anomalies syndrome include growth retardation, skeletal abnormalities, adrenal insufficiency, and genital anomalies.""]","[""Intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies are the main symptoms of IMAGe syndrome.""]",[false],[true],[true],"[""Intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies""]","[""Symptoms of Intrauterine growth restriction, Metaphyseal dysplasia, Adrenal hypoplasia congenita, and Genital anomalies syndrome include growth retardation, skeletal abnormalities, adrenal insufficiency, and genital anomalies.""]","[""Intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies are the main symptoms of IMAGe syndrome.""]",[true],[true],[true],"[""Symptoms of IMAGe syndrome include intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies.""]","[""Symptoms of Intrauterine growth restriction, Metaphyseal dysplasia, Adrenal hypoplasia congenita, and Genital anomalies syndrome include growth retardation, skeletal abnormalities, adrenal insufficiency, and genital anomalies.""]","[""Intrauterine growth restriction, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies are the main symptoms of IMAGe syndrome.""]"
inheritance,"Is Craniometaphyseal dysplasia, autosomal dominant inherited ?","How is autosomal dominant craniometaphyseal dysplasia inherited? Autosomal dominant craniometaphyseal dysplasia is inherited in an autosomal dominant pattern, which means one altered copy of the ANKH gene in each cell is sufficient to cause the disorder. Individuals with autosomal dominant craniometaphyseal dysplasia typically have one parent who also has the condition. Less often, cases result from new mutations in the gene and occur in people with no history of the disorder in their family.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""CMD"", ""full_form"": ""Craniometaphyseal dysplasia, autosomal dominant""}]}",Is CMD inherited ?,"Is Craniometaphyseal dysplasia, autosomal dominant inherited ?",1,COMPUTING,Simple Datatype-Boolean,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Command"", ""Command file"", ""Cross Machine Direction"", ""Certified Marketing Director"", ""External command menu (1st Reader)"", ""Canadian Medical Directory"", ""Color Monitor Display"", ""Color Manipulation Device"", ""Creative Micro Devices"", ""Computer Molecular Dynamics""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Command Prompt""]",[2.3406639555203526e-31],[1.620070527552971e-11],"[""Command""]",[3.718625967149509e-08],"[""ABBREVIATIONS""]","[[3.718625967149509e-08, 6.861616057771653e-12, 6.911528757844322e-14, 1.3235869494360753e-15, 1.2375818826884137e-28, 1.7971893070909188e-19, 6.107195668662038e-18, 4.913637567998479e-16, 1.2019670046713558e-18, 4.566133444695422e-14]]",[0.6229764134947514],[0.9168927755099242],"[""Craniometaphyseal dysplasia, autosomal dominant""]",[0.9528307136679106],"[""ABBREVIATIONS""]","[[0.9528307136679106, 0.8945511951165711, 0.6990195074079315, 0.6959688217068278, 0.7991492687279524, 0.6983249860895137, 0.8040918817238035, 0.7803809474347985, 0.781297945312511, 0.7938103958000875]]","[""Command Prompt""]","[""LLM""]",Is CMD (Command Prompt) inherited ?,[false],[true],[false],"[""No""]","[""Yes""]","[""No""]",[false],[true],[false],"[""No""]","[""Yes""]","[""No""]",[false],[true],[false],"[""No""]","[""Yes""]","[""No""]",[false],[true],[false],"[""No""]","[""Yes""]","[""No""]",[true],[true],[false],"[""Yes""]","[""Yes""]","[""No""]",[true],[true],[false],"[""Yes""]","[""Yes""]","[""No""]",[true],[true],[false],"[""Yes""]","[""Yes""]","[""No""]",[true],[true],[false],"[""Yes""]","[""Yes""]","[""No""]",[false],[true],[false],"[""No""]","[""Yes""]","[""No""]",[false],[true],[false],"[""No""]","[""Yes""]","[""No""]",[false],[true],[false],"[""No""]","[""Yes""]","[""No""]",[false],[true],[false],"[""No""]","[""Yes""]","[""No""]",[false],[true],[false],"[""No""]","[""Yes""]","[""No""]",[false],[true],[false],"[""No""]","[""Yes""]","[""No""]",[false],[true],[false],"[""No""]","[""Yes""]","[""No""]",[false],[true],[false],"[""No""]","[""Yes""]","[""No""]",[false],[true],[false],"[""No""]","[""Yes""]","[""No""]",[false],[true],[false],"[""No""]","[""Yes""]","[""No""]",[false],[true],[false],"[""No""]","[""Yes""]","[""No""]",[false],[true],[false],"[""No""]","[""Yes""]","[""No""]",[false],[true],[false],"[""No""]","[""Yes""]","[""No""]",[false],[true],[false],"[""No""]","[""Yes""]","[""No""]",[false],[true],[false],"[""No""]","[""Yes""]","[""No""]",[false],[true],[false],"[""No""]","[""Yes""]","[""No""]",[false],[true],[false],"[""No, CMD (Command Prompt) is not inherited.""]","[""Yes""]","[""No""]",[false],[true],[false],"[""No, CMD (Command Prompt) is not inherited.""]","[""Yes""]","[""No""]",[false],[true],[false],"[""No, Command Prompt (CMD) is not inherited. It is a command-line interpreter application available in Windows operating systems.""]","[""Yes""]","[""No""]",[false],[true],[false],"[""No, CMD (Command Prompt) is not inherited. It is a command-line interpreter application available in Windows operating systems.""]","[""Yes""]","[""No""]",[false],[true],[false],"[""No, CMD (Command Prompt) is not inherited.""]","[""Yes""]","[""No""]",[false],[true],[false],"[""No""]","[""Yes""]","[""No""]",[true],[true],[false],"[""Yes, CMD (Craniometaphyseal dysplasia, autosomal dominant) is inherited.""]","[""Yes""]","[""No""]",[false],[true],[false],"[""No, CMD (Command Prompt) is not inherited.""]","[""Yes""]","[""No""]"
symptoms,What are the symptoms of Hypoparathyroidism-retardation-dysmorphism syndrome ?,"What are the signs and symptoms of Hypoparathyroidism-retardation-dysmorphism syndrome? The Human Phenotype Ontology provides the following list of signs and symptoms for Hypoparathyroidism-retardation-dysmorphism syndrome. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Cognitive impairment 90% Convex nasal ridge 90% Deeply set eye 90% Delayed skeletal maturation 90% Depressed nasal bridge 90% External ear malformation 90% Frontal bossing 90% High forehead 90% Hyperphosphatemia 90% Hypocalcemia 90% Hypoparathyroidism 90% Intrauterine growth retardation 90% Long philtrum 90% Low-set, posteriorly rotated ears 90% Microcephaly 90% Seizures 90% Short foot 90% Short palm 90% Short stature 90% Thin vermilion border 90% Abnormality of dental enamel 50% Recurrent respiratory infections 50% Aplasia/Hypoplasia affecting the eye 7.5% Astigmatism 7.5% Cellular immunodeficiency 7.5% Cryptorchidism 7.5% Hypoplasia of penis 7.5% Increased bone mineral density 7.5% Intestinal obstruction 7.5% Myopathy 7.5% Opacification of the corneal stroma 7.5% Spinal canal stenosis 7.5% Ventriculomegaly 7.5% Autosomal recessive inheritance - Bifid uvula - Congenital hypoparathyroidism - Hypocalcemic seizures - Intellectual disability - Low-set ears - Micropenis - Patchy osteosclerosis - Posteriorly rotated ears - Postnatal growth retardation - Prominent forehead - Recurrent bacterial infections - Severe intrauterine growth retardation - Small hand - Tetany - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""HRD"", ""full_form"": ""Hypoparathyroidism-retardation-dysmorphism""}]}",What are the symptoms of HRD syndrome ?,What are the symptoms of Hypoparathyroidism-retardation-dysmorphism syndrome ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Human Resources Development"", ""Human Resources Department"", ""Hurricane Research Division"", ""Hertzsprung-Russell Diagram"", ""Human Readable Description"", ""High Resolution Display"", ""Hannaford Brothers Company"", ""Historical Research Development"", ""Hard Rocker Dude"", ""Human Resource Development""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Homologous Recombination Deficiency""]",[1.9640550297667567e-27],[2.456250914128646e-21],"[""Human Resources Department""]",[1.3996634315152789e-12],"[""ABBREVIATIONS""]","[[3.1346189331014746e-13, 1.3996634315152789e-12, 2.0317656985520954e-15, 9.948446931456528e-26, 4.073060130881403e-16, 4.467255588553808e-13, 2.376653273777447e-23, 1.4047100404424448e-14, 2.72028441783275e-16, 1.778849658606123e-13]]",[0.7732790129581779],[0.7630812431521385],"[""Hard Rocker Dude""]",[0.877831786348952],"[""ABBREVIATIONS""]","[[0.876356193327205, 0.7920173102260912, 0.7311073514696922, 0.8661147930259596, 0.862572837309804, 0.8162831373101855, 0.8002365391853945, 0.8414961139054704, 0.7439353911511257, 0.877831786348952]]","[""Homologous Recombination Deficiency""]","[""LLM""]",What are the symptoms of HRD (Homologous Recombination Deficiency) syndrome ?,[false],[true],[true],"[""HRD (Human Resources Department) syndrome is not a recognized medical condition. It seems to be a term used informally to describe stress or burnout related to work in the Human Resources field.""]","[""Symptoms of Hypoparathyroidism-retardation-dysmorphism syndrome include intellectual disability, developmental delay, short stature, distinctive facial features, dental problems, and seizures.""]","[""Common symptoms of HRD syndrome include short stature, intellectual disability, distinctive facial features, and abnormalities in the hands and feet.""]",[false],[true],[true],"[""HRD (Human Resources Department) syndrome is not a recognized medical condition. It seems to be a term used informally to describe stress or burnout related to work in the Human Resources field.""]","[""Symptoms of Hypoparathyroidism-retardation-dysmorphism syndrome include intellectual disability, developmental delay, seizures, distinctive facial features, short stature, and hypoparathyroidism.""]","[""Common symptoms of HRD syndrome include short stature, delayed bone age, intellectual disability, distinctive facial features, and abnormalities in the hands and fingers.""]",[false],[true],[true],"[""HRD (Human Resources Department) syndrome is not a medical condition. It is a term used humorously to describe stress or frustration related to issues in the workplace, particularly those involving human resources policies or practices.""]","[""Symptoms of Hypoparathyroidism-retardation-dysmorphism syndrome include intellectual disability, developmental delay, short stature, distinctive facial features, and hypoparathyroidism.""]","[""Symptoms of HRD syndrome include short stature, delayed bone age, intellectual disability, distinctive facial features, and abnormalities in the hands and fingers.""]",[false],[true],[true],"[""HRD (Human Resources Department) syndrome is not a medical condition. It is a humorous term used to describe stress or burnout related to work in the Human Resources field.""]","[""Symptoms of Hypoparathyroidism-retardation-dysmorphism syndrome include intellectual disability, developmental delay, distinctive facial features, short stature, and seizures.""]","[""Common symptoms of HRD syndrome include short stature, delayed development, intellectual disability, distinctive facial features, and abnormalities in the bones and joints.""]",[false],[true],[true],"[""The symptoms of HRD (Hard Rocker Dude) syndrome include extreme love for rock music, leather clothing, and motorcycles, as well as a rebellious attitude towards authority.""]","[""Symptoms of Hypoparathyroidism-retardation-dysmorphism syndrome include intellectual disability, developmental delay, short stature, distinctive facial features, dental problems, and seizures.""]","[""Common symptoms of HRD syndrome include short stature, intellectual disability, distinctive facial features, and abnormalities in the hands and feet.""]",[false],[true],[true],"[""Common symptoms of HRD (Hard Rocker Dude) syndrome include extreme love for rock music, leather jackets, and motorcycles, as well as a rebellious attitude towards authority.""]","[""Symptoms of Hypoparathyroidism-retardation-dysmorphism syndrome include intellectual disability, developmental delay, seizures, distinctive facial features, short stature, and hypoparathyroidism.""]","[""Common symptoms of HRD syndrome include short stature, delayed bone age, intellectual disability, distinctive facial features, and abnormalities in the hands and fingers.""]",[false],[true],[true],"[""The symptoms of HRD (Hard Rocker Dude) syndrome include a strong affinity for loud music, leather jackets, and motorcycles, as well as a rebellious attitude towards authority figures.""]","[""Symptoms of Hypoparathyroidism-retardation-dysmorphism syndrome include intellectual disability, developmental delay, short stature, distinctive facial features, and hypoparathyroidism.""]","[""Symptoms of HRD syndrome include short stature, delayed bone age, intellectual disability, distinctive facial features, and abnormalities in the hands and fingers.""]",[false],[true],[true],"[""Common symptoms of HRD (Hard Rocker Dude) syndrome include extreme love for rock music, leather jackets, and motorcycles, as well as a rebellious attitude towards authority.""]","[""Symptoms of Hypoparathyroidism-retardation-dysmorphism syndrome include intellectual disability, developmental delay, distinctive facial features, short stature, and seizures.""]","[""Common symptoms of HRD syndrome include short stature, delayed development, intellectual disability, distinctive facial features, and abnormalities in the bones and joints.""]",[false],[true],[true],"[""Common symptoms of HRD (Homologous Recombination Deficiency) syndrome include increased risk of certain cancers, particularly breast, ovarian, and prostate cancers, as well as a family history of these cancers. Other symptoms may include unexplained weight loss, fatigue, and abnormal bleeding.""]","[""Symptoms of Hypoparathyroidism-retardation-dysmorphism syndrome include intellectual disability, developmental delay, seizures, distinctive facial features, short stature, and hypoparathyroidism.""]","[""Common symptoms of HRD syndrome include short stature, delayed bone age, intellectual disability, distinctive facial features, and abnormalities in the hands and fingers.""]",[false],[true],[true],"[""Common symptoms of HRD (Homologous Recombination Deficiency) syndrome include increased cancer risk, sensitivity to certain chemotherapy drugs, and specific types of cancer such as breast, ovarian, and pancreatic cancer.""]","[""Symptoms of Hypoparathyroidism-retardation-dysmorphism syndrome include intellectual disability, developmental delay, short stature, distinctive facial features, dental problems, and seizures.""]","[""Common symptoms of HRD syndrome include short stature, intellectual disability, distinctive facial features, and abnormalities in the hands and feet.""]",[false],[true],[true],"[""Common symptoms of HRD (Homologous Recombination Deficiency) syndrome include increased risk of certain cancers, such as breast, ovarian, and prostate cancer, as well as a family history of these cancers.""]","[""Symptoms of Hypoparathyroidism-retardation-dysmorphism syndrome include intellectual disability, developmental delay, short stature, distinctive facial features, and hypoparathyroidism.""]","[""Symptoms of HRD syndrome include short stature, delayed bone age, intellectual disability, distinctive facial features, and abnormalities in the hands and fingers.""]",[false],[true],[true],"[""Common symptoms of HRD syndrome include increased risk of certain cancers, such as breast, ovarian, and pancreatic cancer, as well as sensitivity to certain types of chemotherapy.""]","[""Symptoms of Hypoparathyroidism-retardation-dysmorphism syndrome include intellectual disability, developmental delay, distinctive facial features, short stature, and seizures.""]","[""Common symptoms of HRD syndrome include short stature, delayed development, intellectual disability, distinctive facial features, and abnormalities in the bones and joints.""]",[false],[true],[true],"[""Common symptoms of HRD syndrome include increased risk of certain cancers, such as breast, ovarian, and prostate cancer, as well as a family history of these cancers.""]","[""Symptoms of Hypoparathyroidism-retardation-dysmorphism syndrome include intellectual disability, developmental delay, short stature, distinctive facial features, dental problems, and seizures.""]","[""Common symptoms of HRD syndrome include short stature, intellectual disability, distinctive facial features, and abnormalities in the hands and feet.""]",[false],[true],[true],"[""Symptoms of HRD syndrome include increased cancer risk, sensitivity to certain chemotherapy drugs, and family history of certain cancers.""]","[""Symptoms of Hypoparathyroidism-retardation-dysmorphism syndrome include intellectual disability, developmental delay, seizures, distinctive facial features, short stature, and hypoparathyroidism.""]","[""Common symptoms of HRD syndrome include short stature, delayed bone age, intellectual disability, distinctive facial features, and abnormalities in the hands and fingers.""]",[false],[true],[true],"[""Common symptoms of HRD syndrome include increased cancer risk, sensitivity to certain chemotherapy drugs, and family history of certain cancers.""]","[""Symptoms of Hypoparathyroidism-retardation-dysmorphism syndrome include intellectual disability, developmental delay, short stature, distinctive facial features, and hypoparathyroidism.""]","[""Symptoms of HRD syndrome include short stature, delayed bone age, intellectual disability, distinctive facial features, and abnormalities in the hands and fingers.""]",[false],[true],[true],"[""Symptoms of HRD syndrome include increased cancer risk, sensitivity to certain chemotherapy drugs, and family history of certain cancers.""]","[""Symptoms of Hypoparathyroidism-retardation-dysmorphism syndrome include intellectual disability, developmental delay, distinctive facial features, short stature, and seizures.""]","[""Common symptoms of HRD syndrome include short stature, delayed development, intellectual disability, distinctive facial features, and abnormalities in the bones and joints.""]",[false],[true],[true],"[""Common symptoms of HRD (Homologous Recombination Deficiency) syndrome include increased risk of certain cancers, particularly breast, ovarian, and prostate cancers, as well as a family history of these cancers. Other symptoms may include unexplained weight loss, fatigue, and abnormal bleeding.""]","[""Symptoms of Hypoparathyroidism-retardation-dysmorphism syndrome include intellectual disability, developmental delay, short stature, distinctive facial features, dental problems, and seizures.""]","[""Common symptoms of HRD syndrome include short stature, intellectual disability, distinctive facial features, and abnormalities in the hands and feet.""]",[false],[true],[true],"[""Common symptoms of HRD (Homologous Recombination Deficiency) syndrome include increased risk of certain cancers, particularly breast, ovarian, and prostate cancers, as well as a family history of these cancers. Other symptoms may vary depending on the specific condition associated with HRD.""]","[""Symptoms of Hypoparathyroidism-retardation-dysmorphism syndrome include intellectual disability, developmental delay, seizures, distinctive facial features, short stature, and hypoparathyroidism.""]","[""Common symptoms of HRD syndrome include short stature, delayed bone age, intellectual disability, distinctive facial features, and abnormalities in the hands and fingers.""]",[false],[true],[true],"[""Common symptoms of HRD (Homologous Recombination Deficiency) syndrome include increased risk of certain cancers, such as breast, ovarian, and pancreatic cancer, as well as a family history of these cancers.""]","[""Symptoms of Hypoparathyroidism-retardation-dysmorphism syndrome include intellectual disability, developmental delay, short stature, distinctive facial features, and hypoparathyroidism.""]","[""Symptoms of HRD syndrome include short stature, delayed bone age, intellectual disability, distinctive facial features, and abnormalities in the hands and fingers.""]",[false],[true],[true],"[""Common symptoms of HRD (Homologous Recombination Deficiency) syndrome include increased risk of certain cancers, such as breast, ovarian, and pancreatic cancer, as well as a family history of these cancers.""]","[""Symptoms of Hypoparathyroidism-retardation-dysmorphism syndrome include intellectual disability, developmental delay, distinctive facial features, short stature, and seizures.""]","[""Common symptoms of HRD syndrome include short stature, delayed development, intellectual disability, distinctive facial features, and abnormalities in the bones and joints.""]",[false],[true],[true],"[""Common symptoms of HRD (Homologous Recombination Deficiency) syndrome include increased risk of certain cancers, such as breast, ovarian, and prostate cancer, as well as sensitivity to certain types of chemotherapy.""]","[""Symptoms of Hypoparathyroidism-retardation-dysmorphism syndrome include intellectual disability, developmental delay, short stature, distinctive facial features, dental problems, and seizures.""]","[""Common symptoms of HRD syndrome include short stature, intellectual disability, distinctive facial features, and abnormalities in the hands and feet.""]",[false],[true],[true],"[""Common symptoms of HRD (Homologous Recombination Deficiency) syndrome include increased risk of certain cancers, such as breast, ovarian, and pancreatic cancer, as well as a family history of these cancers.""]","[""Symptoms of Hypoparathyroidism-retardation-dysmorphism syndrome include intellectual disability, developmental delay, seizures, distinctive facial features, short stature, and hypoparathyroidism.""]","[""Common symptoms of HRD syndrome include short stature, delayed bone age, intellectual disability, distinctive facial features, and abnormalities in the hands and fingers.""]",[false],[true],[true],"[""Common symptoms of HRD (Homologous Recombination Deficiency) syndrome include increased risk of certain cancers, such as breast, ovarian, and prostate cancer, as well as sensitivity to certain types of chemotherapy.""]","[""Symptoms of Hypoparathyroidism-retardation-dysmorphism syndrome include intellectual disability, developmental delay, short stature, distinctive facial features, and hypoparathyroidism.""]","[""Symptoms of HRD syndrome include short stature, delayed bone age, intellectual disability, distinctive facial features, and abnormalities in the hands and fingers.""]",[false],[true],[true],"[""Common symptoms of HRD (Homologous Recombination Deficiency) syndrome include increased risk of certain cancers, such as breast, ovarian, and prostate cancer, as well as sensitivity to certain types of chemotherapy.""]","[""Symptoms of Hypoparathyroidism-retardation-dysmorphism syndrome include intellectual disability, developmental delay, distinctive facial features, short stature, and seizures.""]","[""Common symptoms of HRD syndrome include short stature, delayed development, intellectual disability, distinctive facial features, and abnormalities in the bones and joints.""]",[false],[true],[true],"[""Symptoms of HRD syndrome include increased risk of certain cancers, such as breast, ovarian, and prostate cancer, as well as a family history of these cancers.""]","[""Symptoms of Hypoparathyroidism-retardation-dysmorphism syndrome include intellectual disability, developmental delay, short stature, distinctive facial features, dental problems, and seizures.""]","[""Common symptoms of HRD syndrome include short stature, intellectual disability, distinctive facial features, and abnormalities in the hands and feet.""]",[false],[true],[true],"[""Some symptoms of HRD (Homologous Recombination Deficiency) syndrome include increased risk of certain cancers, such as breast, ovarian, and pancreatic cancer, as well as a family history of these cancers.""]","[""Symptoms of Hypoparathyroidism-retardation-dysmorphism syndrome include intellectual disability, developmental delay, seizures, distinctive facial features, short stature, and hypoparathyroidism.""]","[""Common symptoms of HRD syndrome include short stature, delayed bone age, intellectual disability, distinctive facial features, and abnormalities in the hands and fingers.""]",[false],[true],[true],"[""Symptoms of HRD syndrome include increased risk of certain cancers, such as breast, ovarian, and pancreatic cancer, as well as a family history of these cancers.""]","[""Symptoms of Hypoparathyroidism-retardation-dysmorphism syndrome include intellectual disability, developmental delay, short stature, distinctive facial features, and hypoparathyroidism.""]","[""Symptoms of HRD syndrome include short stature, delayed bone age, intellectual disability, distinctive facial features, and abnormalities in the hands and fingers.""]",[false],[true],[true],"[""Some symptoms of HRD (Homologous Recombination Deficiency) syndrome include increased risk of certain cancers, particularly breast, ovarian, and prostate cancers, as well as a family history of these cancers.""]","[""Symptoms of Hypoparathyroidism-retardation-dysmorphism syndrome include intellectual disability, developmental delay, distinctive facial features, short stature, and seizures.""]","[""Common symptoms of HRD syndrome include short stature, delayed development, intellectual disability, distinctive facial features, and abnormalities in the bones and joints.""]",[false],[true],[true],"[""Symptoms of HRD syndrome include increased risk of certain cancers, such as breast, ovarian, and prostate cancer, as well as sensitivity to certain types of chemotherapy.""]","[""Symptoms of Hypoparathyroidism-retardation-dysmorphism syndrome include intellectual disability, developmental delay, short stature, distinctive facial features, dental problems, and seizures.""]","[""Common symptoms of HRD syndrome include short stature, intellectual disability, distinctive facial features, and abnormalities in the hands and feet.""]",[false],[true],[true],"[""HRD (Human Resources Department) syndrome symptoms include burnout, stress, low morale, and high turnover rates.""]","[""Symptoms of Hypoparathyroidism-retardation-dysmorphism syndrome include intellectual disability, developmental delay, short stature, distinctive facial features, dental problems, and seizures.""]","[""Common symptoms of HRD syndrome include short stature, intellectual disability, distinctive facial features, and abnormalities in the hands and feet.""]",[false],[true],[true],"[""The symptoms of HRD (Hard Rocker Dude) syndrome include excessive air guitar playing, headbanging, leather jacket obsession, and a constant need to listen to rock music.""]","[""Symptoms of Hypoparathyroidism-retardation-dysmorphism syndrome include intellectual disability, developmental delay, short stature, distinctive facial features, dental problems, and seizures.""]","[""Common symptoms of HRD syndrome include short stature, intellectual disability, distinctive facial features, and abnormalities in the hands and feet.""]",[false],[true],[true],"[""Symptoms of HRD syndrome include increased cancer risk, sensitivity to certain chemotherapy drugs, and family history of certain cancers.""]","[""Symptoms of Hypoparathyroidism-retardation-dysmorphism syndrome include intellectual disability, developmental delay, short stature, distinctive facial features, dental problems, and seizures.""]","[""Common symptoms of HRD syndrome include short stature, intellectual disability, distinctive facial features, and abnormalities in the hands and feet.""]"
frequency,"How many people are affected by congenital deafness with labyrinthine aplasia, microtia, and microdontia ?","LAMM syndrome is a rare condition, although its prevalence is unknown. Approximately a dozen affected families have been identified.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""LAMM"", ""full_form"": ""labyrinthine aplasia, microtia, and microdontia""}]}",How many people are affected by congenital deafness with LAMM ?,"How many people are affected by congenital deafness with labyrinthine aplasia, microtia, and microdontia ?",8,MEDICAL,Simple Datatype-Integer,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Lowe Alpine Mountain Marathon"", ""Lesbian Alliance of Metro Milwaukee (est. 1989)"", ""Los Amigos Muchos Muertos (Spanish: Many Dead Friends; online gaming)"", ""Lot Allocation Management Module"", ""Lot Allocation Management Module"", ""Los Amigos Muchos Muertos (Spanish: Many Dead Friends; online gaming)"", ""Lesbian Alliance of Metro Milwaukee (est. 1989)"", ""Los Angeles Maritime Museum"", ""Lowe Alpine Mountain Marathon (Scotland, UK)""]]","[[""ABBREVIATIONS"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY""]]","[""Large Vestibular Aqueduct Syndrome""]",[1.4074172642931359e-42],[3.545994787756886e-17],"[""Large Vestibular Aqueduct Syndrome""]",[3.545994787756886e-17],"[""LLM""]","[[7.575545683465054e-25, 7.498265872088836e-53, 1.1661963385767138e-59, 1.560902990302017e-25, 1.560902990302017e-25, 1.1661963385767138e-59, 7.498265872088836e-53, 8.935444510804966e-27, 1.3304327662760527e-43]]",[0.9047763394452627],[0.8996903235997205],"[""Lowe Alpine Mountain Marathon (Scotland, UK)""]",[0.8996903235997205],"[""LLM""]","[[0.8515488783378639, 0.8491492414131019, 0.8384115150859445, 0.8811632810328864, 0.8811632810328864, 0.8384115150859445, 0.8491492414131019, 0.8749901863814462, 0.8028396715255203]]","[""Large Vestibular Aqueduct Syndrome""]","[""LLM""]",How many people are affected by congenital deafness with LAMM (Large Vestibular Aqueduct Syndrome) ?,[false],[true],[false],"[""Congenital deafness with LAMM affects approximately 1 in 1,000 to 2,000 newborns.""]","[""Congenital deafness with labyrinthine aplasia, microtia, and microdontia affects a very small number of individuals worldwide.""]","[""Congenital deafness with LAMM affects approximately 1 in 40,000 to 100,000 newborns.""]",[false],[true],[false],"[""Approximately 1 in 1,000 to 2,000 newborns are affected by congenital deafness with LAMM.""]","[""Congenital deafness with labyrinthine aplasia, microtia, and microdontia affects a very small number of individuals worldwide.""]","[""Congenital deafness with LAMM affects approximately 1 in 40,000 to 1 in 100,000 newborns.""]",[false],[true],[false],"[""Congenital deafness with LAMM affects approximately 1 in 1,000 to 1 in 2,000 newborns.""]","[""Congenital deafness with labyrinthine aplasia, microtia, and microdontia affects a very small number of individuals worldwide.""]","[""Congenital deafness with LAMM affects approximately 1 in 1,000 to 2,000 newborns.""]",[false],[true],[false],"[""Congenital deafness with LAMM affects approximately 1-2 per 1000 newborns.""]","[""Congenital deafness with labyrinthine aplasia, microtia, and microdontia affects a very small number of individuals worldwide.""]","[""Congenital deafness with LAMM affects approximately 1 in 40,000 to 1 in 100,000 newborns.""]",[false],[true],[false],"[""Congenital deafness with LAMM affects approximately 1 in 40,000 people.""]","[""Congenital deafness with labyrinthine aplasia, microtia, and microdontia affects a very small number of individuals worldwide.""]","[""Congenital deafness with LAMM affects approximately 1 in 40,000 to 100,000 newborns.""]",[false],[true],[false],"[""Congenital deafness with LAMM affects approximately 1 in 1,000,000 people.""]","[""Congenital deafness with labyrinthine aplasia, microtia, and microdontia affects a very small number of individuals worldwide.""]","[""Congenital deafness with LAMM affects approximately 1 in 40,000 to 1 in 100,000 newborns.""]",[false],[true],[false],"[""Congenital deafness with LAMM affects approximately 1 in 40,000 people.""]","[""Congenital deafness with labyrinthine aplasia, microtia, and microdontia affects a very small number of individuals worldwide.""]","[""Congenital deafness with LAMM affects approximately 1 in 1,000 to 2,000 newborns.""]",[false],[true],[false],"[""Congenital deafness with LAMM affects approximately 1 in 40,000 people.""]","[""Congenital deafness with labyrinthine aplasia, microtia, and microdontia affects a very small number of individuals worldwide.""]","[""Congenital deafness with LAMM affects approximately 1 in 40,000 to 1 in 100,000 newborns.""]",[false],[true],[false],"[""Approximately 1 in 1,000 to 2,000 newborns are affected by congenital deafness with LAMM (Large Vestibular Aqueduct Syndrome).""]","[""Congenital deafness with labyrinthine aplasia, microtia, and microdontia affects a very small number of individuals worldwide.""]","[""Congenital deafness with LAMM affects approximately 1 in 40,000 to 1 in 100,000 newborns.""]",[false],[true],[false],"[""Congenital deafness with LAMM affects approximately 1-2 per 1000 newborns.""]","[""Congenital deafness with labyrinthine aplasia, microtia, and microdontia affects a very small number of individuals worldwide.""]","[""Congenital deafness with LAMM affects approximately 1 in 40,000 to 100,000 newborns.""]",[false],[true],[false],"[""Approximately 1 in 1,000 to 2,000 newborns are affected by congenital deafness with LAMM.""]","[""Congenital deafness with labyrinthine aplasia, microtia, and microdontia affects a very small number of individuals worldwide.""]","[""Congenital deafness with LAMM affects approximately 1 in 1,000 to 2,000 newborns.""]",[false],[true],[false],"[""Congenital deafness with LAMM affects approximately 1-2 per 1000 newborns.""]","[""Congenital deafness with labyrinthine aplasia, microtia, and microdontia affects a very small number of individuals worldwide.""]","[""Congenital deafness with LAMM affects approximately 1 in 40,000 to 1 in 100,000 newborns.""]",[false],[true],[false],"[""Congenital deafness with LAMM affects approximately 1-2 per 1000 newborns.""]","[""Congenital deafness with labyrinthine aplasia, microtia, and microdontia affects a very small number of individuals worldwide.""]","[""Congenital deafness with LAMM affects approximately 1 in 40,000 to 100,000 newborns.""]",[false],[true],[false],"[""Congenital deafness with LAMM affects approximately 1-2 per 1000 children.""]","[""Congenital deafness with labyrinthine aplasia, microtia, and microdontia affects a very small number of individuals worldwide.""]","[""Congenital deafness with LAMM affects approximately 1 in 40,000 to 1 in 100,000 newborns.""]",[false],[true],[false],"[""Congenital deafness with LAMM affects approximately 1-2 per 1000 newborns.""]","[""Congenital deafness with labyrinthine aplasia, microtia, and microdontia affects a very small number of individuals worldwide.""]","[""Congenital deafness with LAMM affects approximately 1 in 1,000 to 2,000 newborns.""]",[false],[true],[false],"[""Congenital deafness with LAMM affects approximately 1 in 1,000 to 2,000 newborns.""]","[""Congenital deafness with labyrinthine aplasia, microtia, and microdontia affects a very small number of individuals worldwide.""]","[""Congenital deafness with LAMM affects approximately 1 in 40,000 to 1 in 100,000 newborns.""]",[true],[true],[false],"[""The number of people affected by congenital deafness with LAMM is not readily available.""]","[""Congenital deafness with labyrinthine aplasia, microtia, and microdontia affects a very small number of individuals worldwide.""]","[""Congenital deafness with LAMM affects approximately 1 in 40,000 to 100,000 newborns.""]",[false],[true],[false],"[""Congenital deafness with LAMM affects approximately 1-2 per 1000 newborns.""]","[""Congenital deafness with labyrinthine aplasia, microtia, and microdontia affects a very small number of individuals worldwide.""]","[""Congenital deafness with LAMM affects approximately 1 in 40,000 to 1 in 100,000 newborns.""]",[false],[true],[false],"[""Approximately 1 in 1,000 to 2,000 newborns are affected by congenital deafness with LAMM.""]","[""Congenital deafness with labyrinthine aplasia, microtia, and microdontia affects a very small number of individuals worldwide.""]","[""Congenital deafness with LAMM affects approximately 1 in 1,000 to 2,000 newborns.""]",[false],[true],[false],"[""Approximately 1 in 1,000 to 2,000 newborns are affected by congenital deafness with LAMM.""]","[""Congenital deafness with labyrinthine aplasia, microtia, and microdontia affects a very small number of individuals worldwide.""]","[""Congenital deafness with LAMM affects approximately 1 in 40,000 to 1 in 100,000 newborns.""]",[false],[true],[false],"[""Approximately 1 in 1,000 to 2,000 newborns are affected by congenital deafness with LAMM.""]","[""Congenital deafness with labyrinthine aplasia, microtia, and microdontia affects a very small number of individuals worldwide.""]","[""Congenital deafness with LAMM affects approximately 1 in 40,000 to 100,000 newborns.""]",[false],[true],[false],"[""Approximately 1 in 1,000 to 2,000 newborns are affected by congenital deafness with LAMM.""]","[""Congenital deafness with labyrinthine aplasia, microtia, and microdontia affects a very small number of individuals worldwide.""]","[""Congenital deafness with LAMM affects approximately 1 in 40,000 to 1 in 100,000 newborns.""]",[false],[true],[false],"[""Approximately 1 in 1,000 to 1 in 2,000 newborns are affected by congenital deafness with LAMM (Large Vestibular Aqueduct Syndrome).""]","[""Congenital deafness with labyrinthine aplasia, microtia, and microdontia affects a very small number of individuals worldwide.""]","[""Congenital deafness with LAMM affects approximately 1 in 1,000 to 2,000 newborns.""]",[false],[true],[false],"[""Approximately 1 in 1,000 to 2,000 newborns are affected by congenital deafness with LAMM (Large Vestibular Aqueduct Syndrome).""]","[""Congenital deafness with labyrinthine aplasia, microtia, and microdontia affects a very small number of individuals worldwide.""]","[""Congenital deafness with LAMM affects approximately 1 in 40,000 to 1 in 100,000 newborns.""]",[false],[true],[false],"[""Congenital deafness with LAMM affects approximately 1-2 per 1000 newborns.""]","[""Congenital deafness with labyrinthine aplasia, microtia, and microdontia affects a very small number of individuals worldwide.""]","[""Congenital deafness with LAMM affects approximately 1 in 40,000 to 100,000 newborns.""]",[false],[true],[false],"[""Congenital deafness with LAMM affects approximately 1 in 1,000 to 1 in 2,000 individuals.""]","[""Congenital deafness with labyrinthine aplasia, microtia, and microdontia affects a very small number of individuals worldwide.""]","[""Congenital deafness with LAMM affects approximately 1 in 40,000 to 1 in 100,000 newborns.""]",[false],[true],[false],"[""Congenital deafness with LAMM affects approximately 1 in 1,000 to 2,000 newborns.""]","[""Congenital deafness with labyrinthine aplasia, microtia, and microdontia affects a very small number of individuals worldwide.""]","[""Congenital deafness with LAMM affects approximately 1 in 1,000 to 2,000 newborns.""]",[false],[true],[false],"[""Congenital deafness with LAMM affects approximately 1-2 per 1000 newborns.""]","[""Congenital deafness with labyrinthine aplasia, microtia, and microdontia affects a very small number of individuals worldwide.""]","[""Congenital deafness with LAMM affects approximately 1 in 40,000 to 1 in 100,000 newborns.""]",[true],[true],[false],"[""The exact number of people affected by congenital deafness with LAMM is not readily available.""]","[""Congenital deafness with labyrinthine aplasia, microtia, and microdontia affects a very small number of individuals worldwide.""]","[""Congenital deafness with LAMM affects approximately 1 in 40,000 to 100,000 newborns.""]",[true],[true],[false],"[""The exact number of people affected by congenital deafness with LAMM is not readily available.""]","[""Congenital deafness with labyrinthine aplasia, microtia, and microdontia affects a very small number of individuals worldwide.""]","[""Congenital deafness with LAMM affects approximately 1 in 40,000 to 100,000 newborns.""]",[true],[true],[false],"[""The number of people affected by congenital deafness with LAMM is not available.""]","[""Congenital deafness with labyrinthine aplasia, microtia, and microdontia affects a very small number of individuals worldwide.""]","[""Congenital deafness with LAMM affects approximately 1 in 40,000 to 100,000 newborns.""]",[true],[true],[false],"[""The exact number of people affected by congenital deafness with LAMM is not readily available.""]","[""Congenital deafness with labyrinthine aplasia, microtia, and microdontia affects a very small number of individuals worldwide.""]","[""Congenital deafness with LAMM affects approximately 1 in 40,000 to 100,000 newborns.""]"
frequency,How many people are affected by CASK-related intellectual disability ?,"The prevalence of CASK-related intellectual disability is unknown. More than 50 females with MICPCH have been described in the medical literature, while only a few affected males have been described.  By contrast, more than 20 males but only a few females have been diagnosed with the milder form of the disorder, XL-ID with or without nystagmus. This form of the disorder may go unrecognized in mildly affected females.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""abbreviation"", ""abbreviation"": ""CASK"", ""full_form"": ""Calcium/Calmodulin-Dependent Serine Protein Kinase""}]}",How many people are affected by CASK-related intellectual disability ?,How many people are affected by Calcium/Calmodulin-Dependent Serine Protein Kinase-related intellectual disability ?,8,MEDICAL,Simple Datatype-Integer,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Cost of Available Seat Kilometer"", ""Creative Art Space for Kids"", ""Cost of Available Seat-Kilometer"", ""Cost Per Available Seat Kilometre"", ""Calcium/Calmodulin-Dependent Serine Protein Kinase"", ""Creative Art Space for Kids Foundation (Lynbrook, NY)"", ""Cost of Available Seat-Kilometer (airline industry)"", ""Community Advanced Starter Kit (software)"", ""Chesapeake Association of Sea Kayakers (Tidewater, VA)"", ""Creative Art Space for Kids Foundation (Lynbrook, NY)"", ""Community Advanced Starter Kit (software)"", ""Chesapeake Association of Sea Kayakers (Tidewater, VA)"", ""Cost of Available Seat-Kilometer (airline industry)"", ""Calcium/Calmodulin-Dependent Serine Protein Kinase""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY""]]","[""Calcium/calmodulin-dependent serine protein kinase""]",[8.801432950533469e-39],[8.801432950533469e-39],"[""Creative Art Space for Kids""]",[5.3648709308531255e-21],"[""ABBREVIATIONS""]","[[3.732106989756154e-23, 5.3648709308531255e-21, 5.921274617969586e-25, 9.272281018902918e-27, 8.801432950533469e-39, 1.1275812228940609e-46, 3.3860381869132366e-36, 2.678525739861456e-23, 2.0797437151512803e-54, 1.1275812228940609e-46, 2.678525739861456e-23, 2.0797437151512803e-54, 3.3860381869132366e-36, 8.801432950533469e-39]]",[0.9348459903280162],[0.9410007020822696],"[""Calcium/Calmodulin-Dependent Serine Protein Kinase""]",[0.9410007020822696],"[""LLM""]","[[0.9162157044602632, 0.9223404051611159, 0.9189469430487981, 0.9236796346523745, 0.9348459903280162, 0.8612572332272964, 0.8769511503235751, 0.9057426652956814, 0.8423945697644311, 0.8612572332272964, 0.9057718993232211, 0.8423945697644311, 0.8769511503235751, 0.9348459903280162]]","[""Calcium/Calmodulin-Dependent Serine Protein Kinase""]","[""ACRONYMFINDER""]",How many people are affected by CASK (Calcium/calmodulin-dependent serine protein kinase)-related intellectual disability ?,[false],[true],[false],"[""CASK-related intellectual disability affects approximately 1 in 1,000,000 individuals.""]","[""The exact number of people affected by Calcium/Calmodulin-Dependent Serine Protein Kinase-related intellectual disability is not known, as it is a rare genetic disorder.""]","[""Approximately 1 in 1 million people are affected by CASK-related intellectual disability.""]",[false],[true],[false],"[""CASK-related intellectual disability affects an estimated 1 in 1,000,000 individuals.""]","[""This type of intellectual disability is rare, affecting a very small percentage of the population.""]","[""Approximately 1 in 1 million people are affected by CASK-related intellectual disability.""]",[false],[true],[false],"[""CASK-related intellectual disability affects less than 1 in 1,000,000 people.""]","[""The exact number of people affected by Calcium/Calmodulin-Dependent Serine Protein Kinase-related intellectual disability is not known, as it is a rare genetic disorder.""]","[""Approximately 200 individuals worldwide are affected by CASK-related intellectual disability.""]",[true],[true],[false],"[""CASK-related intellectual disability affects a very small number of individuals worldwide.""]","[""Calcium/Calmodulin-Dependent Serine Protein Kinase-related intellectual disability affects a very small number of individuals worldwide.""]","[""Approximately 1 in 1,000,000 individuals are affected by CASK-related intellectual disability.""]",[false],[true],[false],"[""CASK-related intellectual disability affects an estimated 1 in 1 million individuals.""]","[""The exact number of people affected by Calcium/Calmodulin-Dependent Serine Protein Kinase-related intellectual disability is not known, as it is a rare genetic disorder.""]","[""Approximately 1 in 1 million people are affected by CASK-related intellectual disability.""]",[false],[true],[false],"[""CASK-related intellectual disability affects an estimated 1 in 1 million people.""]","[""This type of intellectual disability is rare, affecting a very small percentage of the population.""]","[""Approximately 1 in 1 million people are affected by CASK-related intellectual disability.""]",[false],[true],[false],"[""CASK-related intellectual disability affects approximately 1 in 1 million people.""]","[""The exact number of people affected by Calcium/Calmodulin-Dependent Serine Protein Kinase-related intellectual disability is not known, as it is a rare genetic disorder.""]","[""Approximately 200 individuals worldwide are affected by CASK-related intellectual disability.""]",[false],[true],[false],"[""CASK-related intellectual disability affects an estimated 1 in 1 million people.""]","[""Calcium/Calmodulin-Dependent Serine Protein Kinase-related intellectual disability affects a very small number of individuals worldwide.""]","[""Approximately 1 in 1,000,000 individuals are affected by CASK-related intellectual disability.""]",[false],[true],[false],"[""CASK-related intellectual disability affects approximately 1 in 1 million individuals.""]","[""This type of intellectual disability is rare, affecting a very small percentage of the population.""]","[""Approximately 1 in 1 million people are affected by CASK-related intellectual disability.""]",[false],[true],[false],"[""CASK-related intellectual disability affects an estimated 1 in 1 million people.""]","[""The exact number of people affected by Calcium/Calmodulin-Dependent Serine Protein Kinase-related intellectual disability is not known, as it is a rare genetic disorder.""]","[""Approximately 1 in 1 million people are affected by CASK-related intellectual disability.""]",[false],[true],[false],"[""CASK-related intellectual disability affects an estimated 1 in 1 million people.""]","[""The exact number of people affected by Calcium/Calmodulin-Dependent Serine Protein Kinase-related intellectual disability is not known, as it is a rare genetic disorder.""]","[""Approximately 200 individuals worldwide are affected by CASK-related intellectual disability.""]",[false],[true],[false],"[""CASK-related intellectual disability affects an estimated 1 in 1 million people.""]","[""Calcium/Calmodulin-Dependent Serine Protein Kinase-related intellectual disability affects a very small number of individuals worldwide.""]","[""Approximately 1 in 1,000,000 individuals are affected by CASK-related intellectual disability.""]",[false],[true],[false],"[""CASK-related intellectual disability affects approximately 1 in 1 million individuals.""]","[""The exact number of people affected by Calcium/Calmodulin-Dependent Serine Protein Kinase-related intellectual disability is not known, as it is a rare genetic disorder.""]","[""Approximately 1 in 1 million people are affected by CASK-related intellectual disability.""]",[false],[true],[false],"[""CASK-related intellectual disability affects approximately 1 in 1 million people.""]","[""This type of intellectual disability is rare, affecting a very small percentage of the population.""]","[""Approximately 1 in 1 million people are affected by CASK-related intellectual disability.""]",[false],[true],[false],"[""CASK-related intellectual disability affects approximately 1 in 1 million individuals.""]","[""The exact number of people affected by Calcium/Calmodulin-Dependent Serine Protein Kinase-related intellectual disability is not known, as it is a rare genetic disorder.""]","[""Approximately 200 individuals worldwide are affected by CASK-related intellectual disability.""]",[false],[true],[false],"[""CASK-related intellectual disability affects approximately 1 in 1 million individuals.""]","[""Calcium/Calmodulin-Dependent Serine Protein Kinase-related intellectual disability affects a very small number of individuals worldwide.""]","[""Approximately 1 in 1,000,000 individuals are affected by CASK-related intellectual disability.""]",[false],[true],[false],"[""CASK-related intellectual disability affects approximately 1 in 1 million people.""]","[""The exact number of people affected by Calcium/Calmodulin-Dependent Serine Protein Kinase-related intellectual disability is not known, as it is a rare genetic disorder.""]","[""Approximately 1 in 1 million people are affected by CASK-related intellectual disability.""]",[false],[true],[false],"[""CASK-related intellectual disability affects an estimated 1 in 1 million people.""]","[""This type of intellectual disability is rare, affecting a very small percentage of the population.""]","[""Approximately 1 in 1 million people are affected by CASK-related intellectual disability.""]",[false],[true],[false],"[""CASK-related intellectual disability affects approximately 1 in 1 million individuals.""]","[""The exact number of people affected by Calcium/Calmodulin-Dependent Serine Protein Kinase-related intellectual disability is not known, as it is a rare genetic disorder.""]","[""Approximately 200 individuals worldwide are affected by CASK-related intellectual disability.""]",[false],[true],[false],"[""CASK-related intellectual disability affects an estimated 1 in 1 million people.""]","[""Calcium/Calmodulin-Dependent Serine Protein Kinase-related intellectual disability affects a very small number of individuals worldwide.""]","[""Approximately 1 in 1,000,000 individuals are affected by CASK-related intellectual disability.""]",[false],[true],[false],"[""CASK-related intellectual disability affects an estimated 1 in 1 million individuals.""]","[""The exact number of people affected by Calcium/Calmodulin-Dependent Serine Protein Kinase-related intellectual disability is not known, as it is a rare genetic disorder.""]","[""Approximately 1 in 1 million people are affected by CASK-related intellectual disability.""]",[false],[true],[false],"[""CASK-related intellectual disability affects an estimated 1 in 1 million people.""]","[""This type of intellectual disability is rare, affecting a very small percentage of the population.""]","[""Approximately 1 in 1 million people are affected by CASK-related intellectual disability.""]",[false],[true],[false],"[""CASK-related intellectual disability affects an estimated 1 in 1 million individuals.""]","[""The exact number of people affected by Calcium/Calmodulin-Dependent Serine Protein Kinase-related intellectual disability is not known, as it is a rare genetic disorder.""]","[""Approximately 200 individuals worldwide are affected by CASK-related intellectual disability.""]",[false],[true],[false],"[""CASK-related intellectual disability affects an estimated 1 in 1 million people.""]","[""Calcium/Calmodulin-Dependent Serine Protein Kinase-related intellectual disability affects a very small number of individuals worldwide.""]","[""Approximately 1 in 1,000,000 individuals are affected by CASK-related intellectual disability.""]",[false],[true],[false],"[""CASK-related intellectual disability affects an estimated 1 in 1 million people.""]","[""The exact number of people affected by Calcium/Calmodulin-Dependent Serine Protein Kinase-related intellectual disability is not known, as it is a rare genetic disorder.""]","[""Approximately 1 in 1 million people are affected by CASK-related intellectual disability.""]",[false],[true],[false],"[""CASK-related intellectual disability affects an estimated 1 in 1 million people.""]","[""This type of intellectual disability is rare, affecting a very small percentage of the population.""]","[""Approximately 1 in 1 million people are affected by CASK-related intellectual disability.""]",[false],[true],[false],"[""CASK-related intellectual disability affects an estimated 1 in 1 million people.""]","[""The exact number of people affected by Calcium/Calmodulin-Dependent Serine Protein Kinase-related intellectual disability is not known, as it is a rare genetic disorder.""]","[""Approximately 200 individuals worldwide are affected by CASK-related intellectual disability.""]",[false],[true],[false],"[""CASK-related intellectual disability affects an estimated 1 in 1 million people.""]","[""Calcium/Calmodulin-Dependent Serine Protein Kinase-related intellectual disability affects a very small number of individuals worldwide.""]","[""Approximately 1 in 1,000,000 individuals are affected by CASK-related intellectual disability.""]",[false],[true],[false],"[""CASK-related intellectual disability affects an estimated 1 in 1 million people.""]","[""The exact number of people affected by Calcium/Calmodulin-Dependent Serine Protein Kinase-related intellectual disability is not known, as it is a rare genetic disorder.""]","[""Approximately 1 in 1 million people are affected by CASK-related intellectual disability.""]",[true],[true],[false],"[""The exact number of people affected by CASK-related intellectual disability is not available.""]","[""The exact number of people affected by Calcium/Calmodulin-Dependent Serine Protein Kinase-related intellectual disability is not known, as it is a rare genetic disorder.""]","[""Approximately 1 in 1 million people are affected by CASK-related intellectual disability.""]",[false],[true],[false],"[""CASK-related intellectual disability affects an estimated 1 in 1 million individuals.""]","[""The exact number of people affected by Calcium/Calmodulin-Dependent Serine Protein Kinase-related intellectual disability is not known, as it is a rare genetic disorder.""]","[""Approximately 1 in 1 million people are affected by CASK-related intellectual disability.""]",[false],[true],[false],"[""CASK-related intellectual disability affects an estimated 1 in 1 million people worldwide.""]","[""The exact number of people affected by Calcium/Calmodulin-Dependent Serine Protein Kinase-related intellectual disability is not known, as it is a rare genetic disorder.""]","[""Approximately 1 in 1 million people are affected by CASK-related intellectual disability.""]"
susceptibility,Who is at risk for Chapare Hemorrhagic Fever? ?,"CHHF occurs in the Cochabamba region of Bolivia. 
Field workers 
                
Field workers are at greatest risk because of increased human contact with the reservoir rodent population. Sexual partners of field workers may be at greater risk as well. Laboratory infections have been frequently described with Arenaviruses and Chapare virus can certainly be transmitted to laboratory workers during manipulation of the virus especially during experimental infections of rodents.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""CHHF"", ""full_form"": ""Chapare Hemorrhagic Fever""}]}",Who is at risk for CHHF? ?,Who is at risk for Chapare Hemorrhagic Fever? ?,8,MEDICAL,Simple Datatype-String,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Copenhagen Hospital Heart Failure Study"", ""Carolina Honduras Health Foundation (Barnwell, SC)"", ""Community Hospital Health Foundation (McCook, NE)"", ""Confidential Health History Form (University of California, Davis)"", ""Confidential Health History Form (University of California, Davis)"", ""Copenhagen Hospital Heart Failure Study"", ""Community Hospital Health Foundation (McCook, NE)"", ""Carolina Honduras Health Foundation (Barnwell, SC)""]]","[[""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY""]]","[""Chronic Heart and Hypertensive Failure""]",[1.762984114019862e-20],[1.609888650219238e-12],"[""Chronic Heart and Hypertensive Failure""]",[1.609888650219238e-12],"[""LLM""]","[[2.198038108765503e-31, 2.5171740843876275e-47, 3.657411384721544e-35, 3.834685457610539e-48, 3.834685457610539e-48, 2.198038108765503e-31, 3.657411384721544e-35, 2.5171740843876275e-47]]",[0.6379801779528151],[0.8620628962009541],"[""Carolina Honduras Health Foundation (Barnwell, SC)""]",[0.8620628962009541],"[""LLM""]","[[0.7913863734545676, 0.7054798147576848, 0.7857322527673218, 0.696008643997684, 0.696008643997684, 0.7913863734545676, 0.7857322527673218, 0.7054798147576842]]","[""Chronic Heart and Hypertensive Failure""]","[""LLM""]",Who is at risk for CHHF (Chronic Heart and Hypertensive Failure)? ?,[false],[true],[false],"[""Individuals with a history of high blood pressure, heart disease, diabetes, obesity, and a sedentary lifestyle are at risk for Chronic Heart and Hypertensive Failure (CHHF).""]","[""People who live or work in areas where the Chapare virus is present, such as Bolivia, are at risk for Chapare Hemorrhagic Fever.""]","[""Individuals with a history of heart failure, high blood pressure, diabetes, obesity, or a family history of heart disease are at risk for Congestive Heart Failure (CHF).""]",[false],[true],[false],"[""Individuals with a history of high blood pressure, heart disease, obesity, diabetes, and a sedentary lifestyle are at risk for Chronic Heart and Hypertensive Failure (CHHF).""]","[""People who live or work in areas where the Chapare virus is present, such as Bolivia, are at risk for Chapare Hemorrhagic Fever.""]","[""Individuals with a history of heart disease, high blood pressure, diabetes, or obesity are at risk for Congestive Heart Failure (CHHF).""]",[false],[true],[false],"[""Individuals with a history of hypertension and heart disease are at risk for Chronic Heart and Hypertensive Failure (CHHF).""]","[""People who live in or travel to areas where the Chapare virus is known to be present are at risk for Chapare Hemorrhagic Fever.""]","[""Individuals with a history of heart failure, high blood pressure, diabetes, obesity, or a family history of heart disease are at risk for Congestive Heart Failure (CHF).""]",[false],[true],[false],"[""Individuals with a history of high blood pressure, heart disease, diabetes, obesity, or a family history of heart failure are at risk for CHHF.""]","[""People who live in or travel to areas where the Chapare virus is known to be present are at risk for Chapare Hemorrhagic Fever.""]","[""Individuals with a history of heart disease, high blood pressure, diabetes, or obesity are at risk for Congestive Heart Failure (CHF).""]",[true],[true],[false],"[""Individuals living in poverty, lacking access to healthcare, and residing in rural areas are at higher risk for CHHF.""]","[""People who live or work in areas where the Chapare virus is present, such as Bolivia, are at risk for Chapare Hemorrhagic Fever.""]","[""Individuals with a history of heart failure, high blood pressure, diabetes, obesity, or a family history of heart disease are at risk for Congestive Heart Failure (CHF).""]",[false],[true],[false],"[""Individuals living in poverty, lacking access to healthcare, and residing in rural areas are at higher risk for CHHF.""]","[""People who live or work in areas where the Chapare virus is present, such as Bolivia, are at risk for Chapare Hemorrhagic Fever.""]","[""Individuals with a history of heart disease, high blood pressure, diabetes, or obesity are at risk for Congestive Heart Failure (CHHF).""]",[false],[true],[false],"[""Individuals living in poverty in Honduras""]","[""People who live in or travel to areas where the Chapare virus is known to be present are at risk for Chapare Hemorrhagic Fever.""]","[""Individuals with a history of heart failure, high blood pressure, diabetes, obesity, or a family history of heart disease are at risk for Congestive Heart Failure (CHF).""]",[false],[true],[false],"[""Individuals living in poverty, lacking access to healthcare, and residing in rural areas are at higher risk for CHHF (Carolina Honduras Health Foundation) in Barnwell, SC.""]","[""People who live in or travel to areas where the Chapare virus is known to be present are at risk for Chapare Hemorrhagic Fever.""]","[""Individuals with a history of heart disease, high blood pressure, diabetes, or obesity are at risk for Congestive Heart Failure (CHF).""]",[false],[true],[false],"[""Individuals with a family history of heart disease, high blood pressure, obesity, and those who smoke are at risk for CHHF.""]","[""People who live or work in areas where the Chapare virus is present, such as Bolivia, are at risk for Chapare Hemorrhagic Fever.""]","[""Individuals with a history of heart disease, high blood pressure, diabetes, or obesity are at risk for Congestive Heart Failure (CHHF).""]",[false],[true],[false],"[""Individuals with a history of heart disease, high blood pressure, diabetes, obesity, and a sedentary lifestyle are at risk for CHHF.""]","[""People who live or work in areas where the Chapare virus is present, such as Bolivia, are at risk for Chapare Hemorrhagic Fever.""]","[""Individuals with a history of heart failure, high blood pressure, diabetes, obesity, or a family history of heart disease are at risk for Congestive Heart Failure (CHF).""]",[false],[true],[false],"[""Individuals with a history of high blood pressure, heart disease, diabetes, obesity, or a family history of heart failure are at risk for Chronic Heart and Hypertensive Failure (CHHF).""]","[""People who live in or travel to areas where the Chapare virus is known to be present are at risk for Chapare Hemorrhagic Fever.""]","[""Individuals with a history of heart failure, high blood pressure, diabetes, obesity, or a family history of heart disease are at risk for Congestive Heart Failure (CHF).""]",[false],[true],[false],"[""Individuals with a history of high blood pressure, heart disease, obesity, diabetes, and a sedentary lifestyle are at risk for Chronic Heart and Hypertensive Failure (CHHF).""]","[""People who live in or travel to areas where the Chapare virus is known to be present are at risk for Chapare Hemorrhagic Fever.""]","[""Individuals with a history of heart disease, high blood pressure, diabetes, or obesity are at risk for Congestive Heart Failure (CHF).""]",[false],[true],[false],"[""Individuals with a history of hypertension, heart disease, or other cardiovascular conditions are at risk for CHHF.""]","[""People who live or work in areas where the Chapare virus is present, such as Bolivia, are at risk for Chapare Hemorrhagic Fever.""]","[""Individuals with a history of heart failure, high blood pressure, diabetes, obesity, or a family history of heart disease are at risk for Congestive Heart Failure (CHF).""]",[false],[true],[false],"[""Individuals with a history of hypertension or heart disease are at risk for CHHF.""]","[""People who live or work in areas where the Chapare virus is present, such as Bolivia, are at risk for Chapare Hemorrhagic Fever.""]","[""Individuals with a history of heart disease, high blood pressure, diabetes, or obesity are at risk for Congestive Heart Failure (CHHF).""]",[false],[true],[false],"[""Individuals with a history of hypertension and heart disease are at risk for CHHF.""]","[""People who live in or travel to areas where the Chapare virus is known to be present are at risk for Chapare Hemorrhagic Fever.""]","[""Individuals with a history of heart failure, high blood pressure, diabetes, obesity, or a family history of heart disease are at risk for Congestive Heart Failure (CHF).""]",[false],[true],[false],"[""Individuals with a history of heart disease, high blood pressure, obesity, diabetes, and smoking are at risk for CHHF (Chronic Heart and Hypertensive Failure).""]","[""People who live in or travel to areas where the Chapare virus is known to be present are at risk for Chapare Hemorrhagic Fever.""]","[""Individuals with a history of heart disease, high blood pressure, diabetes, or obesity are at risk for Congestive Heart Failure (CHF).""]",[false],[true],[false],"[""People with a history of heart disease, high blood pressure, diabetes, obesity, and a sedentary lifestyle are at risk for CHHF.""]","[""People who live or work in areas where the Chapare virus is present, such as Bolivia, are at risk for Chapare Hemorrhagic Fever.""]","[""Individuals with a history of heart failure, high blood pressure, diabetes, obesity, or a family history of heart disease are at risk for Congestive Heart Failure (CHF).""]",[false],[true],[false],"[""Individuals with a history of high blood pressure and heart disease are at risk for CHHF.""]","[""People who live or work in areas where the Chapare virus is present, such as Bolivia, are at risk for Chapare Hemorrhagic Fever.""]","[""Individuals with a history of heart disease, high blood pressure, diabetes, or obesity are at risk for Congestive Heart Failure (CHHF).""]",[false],[true],[false],"[""Individuals with a history of high blood pressure, heart disease, diabetes, obesity, and a sedentary lifestyle are at risk for Chronic Heart and Hypertensive Failure (CHHF).""]","[""People who live in or travel to areas where the Chapare virus is known to be present are at risk for Chapare Hemorrhagic Fever.""]","[""Individuals with a history of heart failure, high blood pressure, diabetes, obesity, or a family history of heart disease are at risk for Congestive Heart Failure (CHF).""]",[false],[true],[false],"[""Individuals with a history of high blood pressure, heart disease, diabetes, obesity, and a sedentary lifestyle are at risk for Chronic Heart and Hypertensive Failure (CHHF).""]","[""People who live in or travel to areas where the Chapare virus is known to be present are at risk for Chapare Hemorrhagic Fever.""]","[""Individuals with a history of heart disease, high blood pressure, diabetes, or obesity are at risk for Congestive Heart Failure (CHF).""]",[false],[true],[false],"[""Individuals with a history of high blood pressure, heart disease, obesity, diabetes, or a family history of heart failure are at risk for CHHF.""]","[""People who live or work in areas where the Chapare virus is present, such as Bolivia, are at risk for Chapare Hemorrhagic Fever.""]","[""Individuals with a history of heart failure, high blood pressure, diabetes, obesity, or a family history of heart disease are at risk for Congestive Heart Failure (CHF).""]",[false],[true],[false],"[""Individuals with a history of high blood pressure, heart disease, diabetes, obesity, and a sedentary lifestyle are at risk for Chronic Heart and Hypertensive Failure.""]","[""People who live or work in areas where the Chapare virus is present, such as Bolivia, are at risk for Chapare Hemorrhagic Fever.""]","[""Individuals with a history of heart disease, high blood pressure, diabetes, or obesity are at risk for Congestive Heart Failure (CHHF).""]",[false],[true],[false],"[""Individuals with a history of high blood pressure, heart disease, obesity, diabetes, and a sedentary lifestyle are at risk for Chronic Heart and Hypertensive Failure (CHHF).""]","[""People who live in or travel to areas where the Chapare virus is known to be present are at risk for Chapare Hemorrhagic Fever.""]","[""Individuals with a history of heart failure, high blood pressure, diabetes, obesity, or a family history of heart disease are at risk for Congestive Heart Failure (CHF).""]",[false],[true],[false],"[""Individuals with a history of high blood pressure, heart disease, diabetes, obesity, or a family history of heart failure are at risk for CHHF.""]","[""People who live in or travel to areas where the Chapare virus is known to be present are at risk for Chapare Hemorrhagic Fever.""]","[""Individuals with a history of heart disease, high blood pressure, diabetes, or obesity are at risk for Congestive Heart Failure (CHF).""]",[false],[true],[false],"[""Individuals with a history of high blood pressure, heart disease, obesity, diabetes, or a sedentary lifestyle are at risk for Chronic Heart and Hypertensive Failure (CHHF).""]","[""People who live or work in areas where the Chapare virus is present, such as Bolivia, are at risk for Chapare Hemorrhagic Fever.""]","[""Individuals with a history of heart failure, high blood pressure, diabetes, obesity, or a family history of heart disease are at risk for Congestive Heart Failure (CHF).""]",[false],[true],[false],"[""Individuals with a history of heart disease, high blood pressure, obesity, diabetes, and unhealthy lifestyle habits are at risk for Chronic Heart and Hypertensive Failure (CHHF).""]","[""People who live or work in areas where the Chapare virus is present, such as Bolivia, are at risk for Chapare Hemorrhagic Fever.""]","[""Individuals with a history of heart disease, high blood pressure, diabetes, or obesity are at risk for Congestive Heart Failure (CHHF).""]",[false],[true],[false],"[""Individuals with a history of heart disease, high blood pressure, obesity, diabetes, and unhealthy lifestyle habits are at risk for Chronic Heart and Hypertensive Failure (CHHF).""]","[""People who live in or travel to areas where the Chapare virus is known to be present are at risk for Chapare Hemorrhagic Fever.""]","[""Individuals with a history of heart failure, high blood pressure, diabetes, obesity, or a family history of heart disease are at risk for Congestive Heart Failure (CHF).""]",[false],[true],[false],"[""Individuals with a family history of heart disease, high blood pressure, obesity, diabetes, and unhealthy lifestyle habits are at risk for Chronic Heart and Hypertensive Failure (CHHF).""]","[""People who live in or travel to areas where the Chapare virus is known to be present are at risk for Chapare Hemorrhagic Fever.""]","[""Individuals with a history of heart disease, high blood pressure, diabetes, or obesity are at risk for Congestive Heart Failure (CHF).""]",[false],[true],[false],"[""Individuals with a history of heart disease, high blood pressure, obesity, diabetes, or a family history of heart failure are at risk for CHHF.""]","[""People who live or work in areas where the Chapare virus is present, such as Bolivia, are at risk for Chapare Hemorrhagic Fever.""]","[""Individuals with a history of heart failure, high blood pressure, diabetes, obesity, or a family history of heart disease are at risk for Congestive Heart Failure (CHF).""]",[false],[true],[false],"[""Individuals with a family history of heart disease, high blood pressure, obesity, and unhealthy lifestyle habits are at risk for CHHF.""]","[""People who live or work in areas where the Chapare virus is present, such as Bolivia, are at risk for Chapare Hemorrhagic Fever.""]","[""Individuals with a history of heart failure, high blood pressure, diabetes, obesity, or a family history of heart disease are at risk for Congestive Heart Failure (CHF).""]",[false],[true],[false],"[""Individuals living in poverty in Honduras""]","[""People who live or work in areas where the Chapare virus is present, such as Bolivia, are at risk for Chapare Hemorrhagic Fever.""]","[""Individuals with a history of heart failure, high blood pressure, diabetes, obesity, or a family history of heart disease are at risk for Congestive Heart Failure (CHF).""]",[false],[true],[false],"[""Individuals with a family history of heart disease, high blood pressure, obesity, and unhealthy lifestyle habits are at risk for CHHF.""]","[""People who live or work in areas where the Chapare virus is present, such as Bolivia, are at risk for Chapare Hemorrhagic Fever.""]","[""Individuals with a history of heart failure, high blood pressure, diabetes, obesity, or a family history of heart disease are at risk for Congestive Heart Failure (CHF).""]"
symptoms,What are the symptoms of Familial encephalopathy with neuroserpin inclusion bodies ?,"What are the signs and symptoms of Familial encephalopathy with neuroserpin inclusion bodies? The Human Phenotype Ontology provides the following list of signs and symptoms for Familial encephalopathy with neuroserpin inclusion bodies. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Abnormality of extrapyramidal motor function - Autosomal dominant inheritance - Cerebral atrophy - Dementia - Diplopia - Distal sensory impairment - Dysarthria - Encephalopathy - Gliosis - Myoclonus - Neuronal loss in central nervous system - Nystagmus - Seizures - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""FENIB"", ""full_form"": ""Familial encephalopathy with neuroserpin inclusion bodies""}]}",What are the symptoms of FENIB ?,What are the symptoms of Familial encephalopathy with neuroserpin inclusion bodies ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Familial Encephalopathy with Neuroserpin Inclusion Bodies"", ""Familial Encephalopathy with Neuroserpin Inclusion Bodies""]]","[[""ABBREVIATIONS"", ""THEFREEDICTIONARY""]]","[""Facial Nerve Integrity Bar""]",[2.681192340944464e-34],[1.407977597462864e-17],"[""Facial Nerve Integrity Bar""]",[1.407977597462864e-17],"[""LLM""]","[[2.681192340944464e-34, 2.681192340944464e-34]]",[0.7695860261530936],[0.7316303420231662],"[""Familial encephalopathy with neuroserpin inclusion bodies""]",[0.7775225306052653],"[""ABBREVIATIONS""]","[[0.7775225306052653, 0.7775225306052653]]","[""Familial Encephalopathy with Neuroserpin Inclusion Bodies""]","[""ABBREVIATIONS""]",What are the symptoms of FENIB (Facial Nerve Integrity Bar) ?,[false],[true],[false],"[""Facial weakness, facial asymmetry, difficulty closing the eye on the affected side, drooping of the mouth, and changes in taste sensation are common symptoms of FENIB (Facial Nerve Integrity Bar).""]","[""Symptoms of Familial encephalopathy with neuroserpin inclusion bodies include seizures, cognitive decline, movement disorders, and psychiatric symptoms.""]","[""FENIB symptoms include fever, erythema nodosum, inflammatory bowel disease, and arthritis.""]",[false],[true],[false],"[""Facial weakness, facial asymmetry, difficulty closing the eye on the affected side, drooping of the mouth, and changes in taste sensation.""]","[""Symptoms of Familial encephalopathy with neuroserpin inclusion bodies include seizures, cognitive decline, movement disorders, and psychiatric symptoms.""]","[""FENIB symptoms include fever, erythema nodosum, inflammatory arthritis, and bilateral hilar lymphadenopathy.""]",[false],[true],[false],"[""Facial weakness, facial asymmetry, difficulty closing the eye on the affected side, drooping of the mouth, and changes in taste sensation.""]","[""Symptoms of Familial encephalopathy with neuroserpin inclusion bodies include progressive dementia, seizures, and movement disorders.""]","[""FENIB symptoms include fever, erythema, nodosum, and arthralgia.""]",[false],[true],[false],"[""Facial weakness, ear pain, facial twitching, drooping of the mouth, and difficulty closing the eye on the affected side.""]","[""Symptoms of Familial encephalopathy with neuroserpin inclusion bodies include seizures, cognitive decline, movement disorders, and psychiatric symptoms.""]","[""FENIB symptoms include fever, erythema, nodosum, and arthralgia.""]",[true],[true],[false],"[""Symptoms of FENIB include seizures, cognitive decline, movement disorders, and psychiatric symptoms.""]","[""Symptoms of Familial encephalopathy with neuroserpin inclusion bodies include seizures, cognitive decline, movement disorders, and psychiatric symptoms.""]","[""FENIB symptoms include fever, erythema nodosum, inflammatory bowel disease, and arthritis.""]",[true],[true],[false],"[""Symptoms of FENIB include seizures, cognitive decline, movement disorders, and psychiatric symptoms.""]","[""Symptoms of Familial encephalopathy with neuroserpin inclusion bodies include seizures, cognitive decline, movement disorders, and psychiatric symptoms.""]","[""FENIB symptoms include fever, erythema nodosum, inflammatory arthritis, and bilateral hilar lymphadenopathy.""]",[true],[true],[false],"[""Symptoms of FENIB include seizures, cognitive decline, movement disorders, and psychiatric symptoms.""]","[""Symptoms of Familial encephalopathy with neuroserpin inclusion bodies include progressive dementia, seizures, and movement disorders.""]","[""FENIB symptoms include fever, erythema, nodosum, and arthralgia.""]",[true],[true],[false],"[""Symptoms of FENIB include seizures, cognitive decline, movement disorders, and psychiatric symptoms.""]","[""Symptoms of Familial encephalopathy with neuroserpin inclusion bodies include seizures, cognitive decline, movement disorders, and psychiatric symptoms.""]","[""FENIB symptoms include fever, erythema, nodosum, and arthralgia.""]",[true],[true],[false],"[""Symptoms of FENIB include seizures, cognitive decline, movement disorders, and psychiatric symptoms.""]","[""Symptoms of Familial encephalopathy with neuroserpin inclusion bodies include seizures, cognitive decline, movement disorders, and psychiatric symptoms.""]","[""FENIB symptoms include fever, erythema nodosum, inflammatory arthritis, and bilateral hilar lymphadenopathy.""]",[true],[true],[false],"[""Symptoms of FENIB include seizures, progressive cognitive decline, movement disorders, and psychiatric symptoms.""]","[""Symptoms of Familial encephalopathy with neuroserpin inclusion bodies include seizures, cognitive decline, movement disorders, and psychiatric symptoms.""]","[""FENIB symptoms include fever, erythema nodosum, inflammatory bowel disease, and arthritis.""]",[true],[true],[false],"[""Symptoms of FENIB include seizures, cognitive decline, movement disorders, and psychiatric symptoms.""]","[""Symptoms of Familial encephalopathy with neuroserpin inclusion bodies include progressive dementia, seizures, and movement disorders.""]","[""FENIB symptoms include fever, erythema, nodosum, and arthralgia.""]",[true],[true],[false],"[""Symptoms of FENIB include seizures, cognitive decline, movement disorders, and psychiatric symptoms.""]","[""Symptoms of Familial encephalopathy with neuroserpin inclusion bodies include seizures, cognitive decline, movement disorders, and psychiatric symptoms.""]","[""FENIB symptoms include fever, erythema, nodosum, and arthralgia.""]",[true],[true],[false],"[""Symptoms of FENIB include seizures, cognitive decline, movement disorders, and psychiatric symptoms.""]","[""Symptoms of Familial encephalopathy with neuroserpin inclusion bodies include seizures, cognitive decline, movement disorders, and psychiatric symptoms.""]","[""FENIB symptoms include fever, erythema nodosum, inflammatory bowel disease, and arthritis.""]",[true],[true],[false],"[""Symptoms of FENIB include seizures, cognitive decline, movement disorders, and psychiatric symptoms.""]","[""Symptoms of Familial encephalopathy with neuroserpin inclusion bodies include seizures, cognitive decline, movement disorders, and psychiatric symptoms.""]","[""FENIB symptoms include fever, erythema nodosum, inflammatory arthritis, and bilateral hilar lymphadenopathy.""]",[true],[true],[false],"[""Symptoms of FENIB include seizures, cognitive decline, movement disorders, and psychiatric symptoms.""]","[""Symptoms of Familial encephalopathy with neuroserpin inclusion bodies include progressive dementia, seizures, and movement disorders.""]","[""FENIB symptoms include fever, erythema, nodosum, and arthralgia.""]",[true],[true],[false],"[""Symptoms of FENIB include seizures, cognitive decline, movement disorders, and psychiatric symptoms.""]","[""Symptoms of Familial encephalopathy with neuroserpin inclusion bodies include seizures, cognitive decline, movement disorders, and psychiatric symptoms.""]","[""FENIB symptoms include fever, erythema, nodosum, and arthralgia.""]",[true],[true],[false],"[""Symptoms of FENIB include seizures, progressive cognitive decline, movement disorders, and psychiatric symptoms.""]","[""Symptoms of Familial encephalopathy with neuroserpin inclusion bodies include seizures, cognitive decline, movement disorders, and psychiatric symptoms.""]","[""FENIB symptoms include fever, erythema nodosum, inflammatory bowel disease, and arthritis.""]",[true],[true],[false],"[""Symptoms of FENIB include seizures, cognitive decline, movement disorders, and psychiatric symptoms.""]","[""Symptoms of Familial encephalopathy with neuroserpin inclusion bodies include seizures, cognitive decline, movement disorders, and psychiatric symptoms.""]","[""FENIB symptoms include fever, erythema nodosum, inflammatory arthritis, and bilateral hilar lymphadenopathy.""]",[true],[true],[false],"[""Symptoms of FENIB include seizures, cognitive decline, movement disorders, and psychiatric symptoms.""]","[""Symptoms of Familial encephalopathy with neuroserpin inclusion bodies include progressive dementia, seizures, and movement disorders.""]","[""FENIB symptoms include fever, erythema, nodosum, and arthralgia.""]",[true],[true],[false],"[""Symptoms of FENIB include seizures, dementia, movement disorders, and psychiatric symptoms.""]","[""Symptoms of Familial encephalopathy with neuroserpin inclusion bodies include seizures, cognitive decline, movement disorders, and psychiatric symptoms.""]","[""FENIB symptoms include fever, erythema, nodosum, and arthralgia.""]",[false],[true],[false],"[""Facial weakness, facial asymmetry, difficulty closing the eye on the affected side, drooping of the mouth, and changes in taste sensation are common symptoms of FENIB (Facial Nerve Integrity Bar).""]","[""Symptoms of Familial encephalopathy with neuroserpin inclusion bodies include seizures, cognitive decline, movement disorders, and psychiatric symptoms.""]","[""FENIB symptoms include fever, erythema nodosum, inflammatory bowel disease, and arthritis.""]",[false],[true],[false],"[""Facial weakness, eyelid closure weakness, facial asymmetry, and difficulty with facial expressions are common symptoms of FENIB (Facial Nerve Integrity Bar).""]","[""Symptoms of Familial encephalopathy with neuroserpin inclusion bodies include seizures, cognitive decline, movement disorders, and psychiatric symptoms.""]","[""FENIB symptoms include fever, erythema nodosum, inflammatory arthritis, and bilateral hilar lymphadenopathy.""]",[false],[true],[false],"[""Facial weakness, ear pain, facial twitching, drooping of the mouth, and changes in taste sensation are common symptoms of FENIB (Facial Nerve Integrity Bar).""]","[""Symptoms of Familial encephalopathy with neuroserpin inclusion bodies include progressive dementia, seizures, and movement disorders.""]","[""FENIB symptoms include fever, erythema, nodosum, and arthralgia.""]",[false],[true],[false],"[""Facial weakness, ear pain, taste disturbances, and facial twitching are common symptoms of FENIB (Facial Nerve Integrity Bar).""]","[""Symptoms of Familial encephalopathy with neuroserpin inclusion bodies include seizures, cognitive decline, movement disorders, and psychiatric symptoms.""]","[""FENIB symptoms include fever, erythema, nodosum, and arthralgia.""]",[true],[true],[false],"[""Symptoms of FENIB include seizures, cognitive decline, movement disorders, and psychiatric symptoms.""]","[""Symptoms of Familial encephalopathy with neuroserpin inclusion bodies include seizures, cognitive decline, movement disorders, and psychiatric symptoms.""]","[""FENIB symptoms include fever, erythema nodosum, inflammatory bowel disease, and arthritis.""]",[true],[true],[false],"[""Symptoms of FENIB include seizures, cognitive decline, movement disorders, and psychiatric symptoms.""]","[""Symptoms of Familial encephalopathy with neuroserpin inclusion bodies include seizures, cognitive decline, movement disorders, and psychiatric symptoms.""]","[""FENIB symptoms include fever, erythema nodosum, inflammatory arthritis, and bilateral hilar lymphadenopathy.""]",[true],[true],[false],"[""Symptoms of FENIB include seizures, cognitive decline, movement disorders, and psychiatric symptoms.""]","[""Symptoms of Familial encephalopathy with neuroserpin inclusion bodies include progressive dementia, seizures, and movement disorders.""]","[""FENIB symptoms include fever, erythema, nodosum, and arthralgia.""]",[true],[true],[false],"[""Symptoms of FENIB include seizures, cognitive decline, movement disorders, and psychiatric symptoms.""]","[""Symptoms of Familial encephalopathy with neuroserpin inclusion bodies include seizures, cognitive decline, movement disorders, and psychiatric symptoms.""]","[""FENIB symptoms include fever, erythema, nodosum, and arthralgia.""]",[true],[true],[false],"[""Symptoms of FENIB include seizures, cognitive decline, movement disorders, and psychiatric symptoms.""]","[""Symptoms of Familial encephalopathy with neuroserpin inclusion bodies include seizures, cognitive decline, movement disorders, and psychiatric symptoms.""]","[""FENIB symptoms include fever, erythema nodosum, inflammatory bowel disease, and arthritis.""]",[false],[true],[false],"[""Facial weakness, ear pain, facial twitching, drooping of the mouth""]","[""Symptoms of Familial encephalopathy with neuroserpin inclusion bodies include seizures, cognitive decline, movement disorders, and psychiatric symptoms.""]","[""FENIB symptoms include fever, erythema nodosum, inflammatory bowel disease, and arthritis.""]",[true],[true],[false],"[""Symptoms of FENIB include seizures, cognitive decline, movement disorders, and psychiatric symptoms.""]","[""Symptoms of Familial encephalopathy with neuroserpin inclusion bodies include seizures, cognitive decline, movement disorders, and psychiatric symptoms.""]","[""FENIB symptoms include fever, erythema nodosum, inflammatory bowel disease, and arthritis.""]",[false],[true],[false],"[""Facial weakness, ear pain, taste disturbances, and facial twitching are common symptoms of FENIB.""]","[""Symptoms of Familial encephalopathy with neuroserpin inclusion bodies include seizures, cognitive decline, movement disorders, and psychiatric symptoms.""]","[""FENIB symptoms include fever, erythema nodosum, inflammatory bowel disease, and arthritis.""]"
treatment,What are the treatments for Loin pain hematuria syndrome ?,"How might loin pain hematuria syndrome be treated? Treatment of loin pain hematuria syndrome (LPHS) typically consists of pain management. Narcotics or oral opioids may be prescribed to help control pain. Patients with severe pain may need high-dose opioids daily and may occasionally require hospitalization for intravenous pain relievers and control of nausea. Limited evidence suggests that drugs that inhibit angiotensin may reduce the frequency and severity of episodes of loin pain and severe hematuria. People with debilitating pain who do not respond to other therapies may be offered surgery (i.e. a nerve block, nephrectomy, kidney auto-transplantation); however, surgical treatment of LPHS is controversial as studies suggest that it has limited value for treating recurrent pain.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""LPHS"", ""full_form"": ""Loin pain hematuria syndrome""}]}",What are the treatments for LPHS ?,What are the treatments for Loin pain hematuria syndrome ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""La Plata High School"", ""Lake Park High School"", ""Las Plumas High School"", ""LaSalle-Peru High School"", ""Lewis-Palmer High School"", ""Leyte Progressive High School"", ""Lincoln Park High School"", ""Lindsay Place High School"", ""Loin Pain Hematuria Syndrome"", ""Lone Peak High School""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Loin Pain Hematuria Syndrome""]",[9.398145572663762e-22],[9.398145572663762e-22],"[""La Plata High School""]",[1.6250403754428685e-18],"[""ABBREVIATIONS""]","[[1.6250403754428685e-18, 1.471581337603678e-21, 5.880049679059248e-22, 2.0018292141453057e-27, 2.0908197185637163e-23, 7.831935497769697e-22, 1.0344578396831071e-27, 5.162909010937815e-24, 9.398145572663762e-22, 9.762788696913724e-21]]",[0.8184659773174005],[0.8164832484043776],"[""LaSalle-Peru High School""]",[0.8992469525261575],"[""ABBREVIATIONS""]","[[0.8926644619247793, 0.8826229789978971, 0.864125865982275, 0.8769738429286094, 0.8992469525261575, 0.8447795411919806, 0.851853354381998, 0.8631025968345217, 0.8164832484043776, 0.8358018259447977]]","[""Loin Pain Hematuria Syndrome""]","[""ABBREVIATIONS""]",What are the treatments for LPHS (Loin Pain Hematuria Syndrome) ?,[false],[true],[true],"[""There is no specific treatment for LPHS (La Plata High School) as it is a school and not a medical condition.""]","[""There is no specific treatment for Loin pain hematuria syndrome, but management focuses on pain control and addressing underlying conditions.""]","[""Pain management, lifestyle changes, and medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) and anticonvulsants.""]",[false],[true],[true],"[""The treatments for LPHS (La Plata High School) may include medication, physical therapy, lifestyle changes, and in severe cases, surgery.""]","[""There is no specific treatment for Loin pain hematuria syndrome. Management typically involves pain control and monitoring for any potential complications.""]","[""There is no specific treatment for Loin Pain Hematuria Syndrome (LPHS), but management may include pain control, blood pressure management, and lifestyle modifications.""]",[false],[true],[true],"[""The treatments for LPHS (La Plata High School) typically involve a combination of medication, physical therapy, and lifestyle modifications to manage symptoms and improve quality of life.""]","[""There is no specific treatment for Loin pain hematuria syndrome, but management focuses on relieving symptoms and addressing underlying causes.""]","[""Pain management, lifestyle changes, and supportive care""]",[false],[true],[true],"[""The treatments for LPHS (La Plata High School) may include medication, therapy, lifestyle changes, and support groups.""]","[""Treatment options for Loin pain hematuria syndrome include pain management, hydration, and monitoring for any underlying kidney issues.""]","[""Pain management, lifestyle changes, and medications such as NSAIDs and antidepressants.""]",[false],[true],[true],"[""The treatments for LPHS (LaSalle-Peru High School) may include physical therapy, pain management, medication, and lifestyle modifications.""]","[""There is no specific treatment for Loin pain hematuria syndrome, but management focuses on pain control and addressing underlying conditions.""]","[""Pain management, lifestyle changes, and medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) and anticonvulsants.""]",[false],[true],[true],"[""The treatments for LPHS (LaSalle-Peru High School) may include physical therapy, pain management, medication, and in severe cases, surgery.""]","[""There is no specific treatment for Loin pain hematuria syndrome. Management typically involves pain control and monitoring for any potential complications.""]","[""There is no specific treatment for Loin Pain Hematuria Syndrome (LPHS), but management may include pain control, blood pressure management, and lifestyle modifications.""]",[false],[true],[true],"[""The treatments for LPHS (LaSalle-Peru High School) may include medication, physical therapy, lifestyle changes, and in severe cases, surgery.""]","[""There is no specific treatment for Loin pain hematuria syndrome, but management focuses on relieving symptoms and addressing underlying causes.""]","[""Pain management, lifestyle changes, and supportive care""]",[false],[true],[true],"[""The treatments for LPHS (LaSalle-Peru High School) may include medication, physical therapy, lifestyle changes, and in severe cases, surgery.""]","[""Treatment options for Loin pain hematuria syndrome include pain management, hydration, and monitoring for any underlying kidney issues.""]","[""Pain management, lifestyle changes, and medications such as NSAIDs and antidepressants.""]",[true],[true],[true],"[""Treatment options for Loin Pain Hematuria Syndrome (LPHS) include pain management with medications, nerve blocks, renal denervation, and in severe cases, nephrectomy (removal of the kidney).""]","[""There is no specific treatment for Loin pain hematuria syndrome. Management typically involves pain control and monitoring for any potential complications.""]","[""There is no specific treatment for Loin Pain Hematuria Syndrome (LPHS), but management may include pain control, blood pressure management, and lifestyle modifications.""]",[true],[true],[false],"[""Treatment options for Loin Pain Hematuria Syndrome (LPHS) may include pain management with medications, such as nonsteroidal anti-inflammatory drugs (NSAIDs), opioids, or nerve block injections. Other interventions like renal denervation, kidney autotransplantation, or nephrectomy may be considered in severe cases.""]","[""There is no specific treatment for Loin pain hematuria syndrome, but management focuses on pain control and addressing underlying conditions.""]","[""Pain management, lifestyle changes, and medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) and anticonvulsants.""]",[true],[true],[true],"[""Treatment for Loin Pain Hematuria Syndrome (LPHS) includes pain management with medications such as nonsteroidal anti-inflammatory drugs (NSAIDs), opioids, and nerve block injections. Other options may include renal denervation, kidney autotransplantation, and renal artery embolization.""]","[""There is no specific treatment for Loin pain hematuria syndrome, but management focuses on relieving symptoms and addressing underlying causes.""]","[""Pain management, lifestyle changes, and supportive care""]",[true],[false],[false],"[""Treatment options for Loin Pain Hematuria Syndrome (LPHS) include pain management with analgesics, nonsteroidal anti-inflammatory drugs (NSAIDs), and sometimes opioids. Other treatments may involve nerve blocks, renal denervation, and in severe cases, nephrectomy (removal of the kidney). It is important for patients to work closely with healthcare providers to determine the most suitable treatment plan.""]","[""Treatment options for Loin pain hematuria syndrome include pain management, hydration, and monitoring for any underlying kidney issues.""]","[""Pain management, lifestyle changes, and medications such as NSAIDs and antidepressants.""]",[true],[true],[true],"[""Pain management, blood pressure control, kidney function monitoring""]","[""There is no specific treatment for Loin pain hematuria syndrome, but management focuses on pain control and addressing underlying conditions.""]","[""Pain management, lifestyle changes, and medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) and anticonvulsants.""]",[true],[true],[true],"[""Treatment for LPHS includes pain management, blood pressure control, and sometimes surgery to alleviate symptoms.""]","[""There is no specific treatment for Loin pain hematuria syndrome. Management typically involves pain control and monitoring for any potential complications.""]","[""There is no specific treatment for Loin Pain Hematuria Syndrome (LPHS), but management may include pain control, blood pressure management, and lifestyle modifications.""]",[true],[true],[true],"[""Treatment options for Loin Pain Hematuria Syndrome (LPHS) may include pain management with medications such as NSAIDs, opioids, or nerve blocks, as well as lifestyle changes, dietary modifications, and in some cases, surgical interventions.""]","[""There is no specific treatment for Loin pain hematuria syndrome, but management focuses on relieving symptoms and addressing underlying causes.""]","[""Pain management, lifestyle changes, and supportive care""]",[true],[true],[true],"[""Treatment for LPHS includes pain management, blood pressure control, and sometimes surgery to relieve symptoms.""]","[""Treatment options for Loin pain hematuria syndrome include pain management, hydration, and monitoring for any underlying kidney issues.""]","[""Pain management, lifestyle changes, and medications such as NSAIDs and antidepressants.""]",[true],[true],[true],"[""Treatment for LPHS may include pain management, blood pressure control, and lifestyle changes such as dietary modifications and stress reduction techniques.""]","[""There is no specific treatment for Loin pain hematuria syndrome, but management focuses on pain control and addressing underlying conditions.""]","[""Pain management, lifestyle changes, and medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) and anticonvulsants.""]",[true],[true],[true],"[""Treatment for Loin Pain Hematuria Syndrome (LPHS) includes pain management, blood pressure control, and sometimes kidney surgery.""]","[""There is no specific treatment for Loin pain hematuria syndrome. Management typically involves pain control and monitoring for any potential complications.""]","[""There is no specific treatment for Loin Pain Hematuria Syndrome (LPHS), but management may include pain control, blood pressure management, and lifestyle modifications.""]",[true],[true],[true],"[""Treatment options for Loin Pain Hematuria Syndrome (LPHS) may include pain management with medications, such as nonsteroidal anti-inflammatory drugs (NSAIDs), opioids, or nerve block injections. Other interventions like renal denervation, kidney autotransplantation, or sympathectomy may be considered in severe cases.""]","[""There is no specific treatment for Loin pain hematuria syndrome, but management focuses on relieving symptoms and addressing underlying causes.""]","[""Pain management, lifestyle changes, and supportive care""]",[true],[false],[false],"[""Treatment options for Loin Pain Hematuria Syndrome (LPHS) may include pain management with medications such as nonsteroidal anti-inflammatory drugs (NSAIDs), opioids, and nerve block injections. Other interventions like renal denervation, nephrectomy, and kidney autotransplantation may be considered in severe cases.""]","[""Treatment options for Loin pain hematuria syndrome include pain management, hydration, and monitoring for any underlying kidney issues.""]","[""Pain management, lifestyle changes, and medications such as NSAIDs and antidepressants.""]",[true],[true],[false],"[""Treatment options for Loin Pain Hematuria Syndrome (LPHS) include pain management with medications, nerve blocks, renal denervation, and in severe cases, nephrectomy (removal of the kidney).""]","[""There is no specific treatment for Loin pain hematuria syndrome, but management focuses on pain control and addressing underlying conditions.""]","[""Pain management, lifestyle changes, and medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) and anticonvulsants.""]",[true],[true],[true],"[""Treatment options for Loin Pain Hematuria Syndrome (LPHS) include pain management with medications, nerve blocks, renal denervation, and in severe cases, nephrectomy (removal of the kidney).""]","[""There is no specific treatment for Loin pain hematuria syndrome. Management typically involves pain control and monitoring for any potential complications.""]","[""There is no specific treatment for Loin Pain Hematuria Syndrome (LPHS), but management may include pain control, blood pressure management, and lifestyle modifications.""]",[true],[true],[true],"[""Treatment for Loin Pain Hematuria Syndrome (LPHS) includes pain management with medications like nonsteroidal anti-inflammatory drugs (NSAIDs), opioids, and nerve blocks. Other options may include renal denervation, kidney autotransplantation, and renal artery embolization.""]","[""There is no specific treatment for Loin pain hematuria syndrome, but management focuses on relieving symptoms and addressing underlying causes.""]","[""Pain management, lifestyle changes, and supportive care""]",[true],[false],[false],"[""Treatment for Loin Pain Hematuria Syndrome (LPHS) may include pain management with analgesics, nonsteroidal anti-inflammatory drugs (NSAIDs), and sometimes opioids. Other options may involve nerve blocks, renal denervation, and in severe cases, nephrectomy (removal of the kidney). It is important to consult with a healthcare provider for personalized treatment recommendations.""]","[""Treatment options for Loin pain hematuria syndrome include pain management, hydration, and monitoring for any underlying kidney issues.""]","[""Pain management, lifestyle changes, and medications such as NSAIDs and antidepressants.""]",[true],[true],[false],"[""Treatment for LPHS may include pain management medications, blood pressure medications, nerve blocks, and in severe cases, surgery.""]","[""There is no specific treatment for Loin pain hematuria syndrome, but management focuses on pain control and addressing underlying conditions.""]","[""Pain management, lifestyle changes, and medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) and anticonvulsants.""]",[true],[true],[true],"[""Treatment for LPHS may include pain management medications, lifestyle changes, nerve blocks, and in severe cases, surgery.""]","[""There is no specific treatment for Loin pain hematuria syndrome. Management typically involves pain control and monitoring for any potential complications.""]","[""There is no specific treatment for Loin Pain Hematuria Syndrome (LPHS), but management may include pain control, blood pressure management, and lifestyle modifications.""]",[true],[true],[true],"[""Treatment for LPHS may include pain management with medications, lifestyle changes, nerve blocks, and in severe cases, surgery.""]","[""There is no specific treatment for Loin pain hematuria syndrome, but management focuses on relieving symptoms and addressing underlying causes.""]","[""Pain management, lifestyle changes, and supportive care""]",[true],[true],[true],"[""Treatment for LPHS may include pain management, blood pressure control, and in some cases, kidney surgery.""]","[""Treatment options for Loin pain hematuria syndrome include pain management, hydration, and monitoring for any underlying kidney issues.""]","[""Pain management, lifestyle changes, and medications such as NSAIDs and antidepressants.""]",[true],[true],[true],"[""There is no specific treatment for LPHS, but management may include pain relief medications, lifestyle changes, and supportive care.""]","[""There is no specific treatment for Loin pain hematuria syndrome, but management focuses on pain control and addressing underlying conditions.""]","[""Pain management, lifestyle changes, and medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) and anticonvulsants.""]",[false],[true],[true],"[""The treatments for LPHS (La Plata High School) may include counseling, medication, behavior modification, and academic accommodations.""]","[""There is no specific treatment for Loin pain hematuria syndrome, but management focuses on pain control and addressing underlying conditions.""]","[""Pain management, lifestyle changes, and medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) and anticonvulsants.""]",[false],[true],[true],"[""The treatments for LPHS (LaSalle-Peru High School) may include counseling, therapy, medication, and support services.""]","[""There is no specific treatment for Loin pain hematuria syndrome, but management focuses on pain control and addressing underlying conditions.""]","[""Pain management, lifestyle changes, and medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) and anticonvulsants.""]",[true],[true],[true],"[""There is no specific treatment for LPHS, but management may include pain relief medications, lifestyle changes, and supportive care.""]","[""There is no specific treatment for Loin pain hematuria syndrome, but management focuses on pain control and addressing underlying conditions.""]","[""Pain management, lifestyle changes, and medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) and anticonvulsants.""]"
treatment,What are the treatments for dentatorubral-pallidoluysian atrophy ?,These resources address the diagnosis or management of DRPLA:  - Gene Review: Gene Review: DRPLA  - Genetic Testing Registry: Dentatorubral pallidoluysian atrophy  - MedlinePlus Encyclopedia: Dementia  - MedlinePlus Encyclopedia: Epilepsy   These resources from MedlinePlus offer information about the diagnosis and management of various health conditions:  - Diagnostic Tests  - Drug Therapy  - Surgery and Rehabilitation  - Genetic Counseling   - Palliative Care,"{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""DRPLA"", ""full_form"": ""dentatorubral-pallidoluysian atrophy""}]}",What are the treatments for DRPLA ?,What are the treatments for dentatorubral-pallidoluysian atrophy ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Dentatorubral-Pallidoluysian Atrophy""]]","[[""THEFREEDICTIONARY""]]","[""Dentatorubral-Pallidoluysian Atrophy""]",[2.2109981923697576e-47],[2.2109981923697576e-47],"[""Dentatorubral-Pallidoluysian Atrophy""]",[2.2109981923697576e-47],"[""THEFREEDICTIONARY""]",[[2.2109981923697576e-47]],[0.9477803763667989],[0.950898267363273],"[""Dentatorubral-Pallidoluysian Atrophy""]",[0.950898267363273],"[""LLM""]",[[0.9508982673632728]],"[""Dentatorubral-Pallidoluysian Atrophy""]","[""THEFREEDICTIONARY""]",What are the treatments for DRPLA (Dentatorubral-Pallidoluysian Atrophy) ?,[true],[true],[true],"[""There is no cure for DRPLA, treatment focuses on managing symptoms and improving quality of life through medications and therapy.""]","[""Physical therapy, speech therapy, occupational therapy, and medications to manage symptoms.""]","[""There is no cure for Dentatorubral-pallidoluysian atrophy (DRPLA), but treatment focuses on managing symptoms such as seizures, movement disorders, and psychiatric symptoms. Medications can help control seizures and movement problems, while therapy and support groups can assist with emotional and social challenges.""]",[true],[true],[true],"[""There is no cure for DRPLA, but treatments focus on managing symptoms such as seizures, movement disorders, and psychiatric symptoms.""]","[""Currently, there is no specific treatment for dentatorubral-pallidoluysian atrophy. Management focuses on symptom relief and supportive care.""]","[""There is no cure for DRPLA, but treatments focus on managing symptoms such as seizures, movement disorders, and psychiatric symptoms.""]",[true],[true],[true],"[""There is no cure for DRPLA, but treatments focus on managing symptoms such as seizures, movement disorders, and psychiatric symptoms.""]","[""Physical therapy, speech therapy, occupational therapy, medications for symptoms management""]","[""There is no cure for DRPLA, but treatment focuses on managing symptoms and improving quality of life. Medications may be prescribed to help control seizures, movement disorders, and psychiatric symptoms.""]",[true],[true],[true],"[""There is no cure for DRPLA, but treatments focus on managing symptoms such as seizures, movement disorders, and psychiatric symptoms. Medications can help control seizures and movement problems, while therapy and support groups can assist with emotional and social challenges.""]","[""Currently, there is no specific treatment for dentatorubral-pallidoluysian atrophy. Management focuses on symptom relief and supportive care.""]","[""There is no cure for DRPLA, but treatment focuses on managing symptoms and improving quality of life. Medications may be prescribed to help control seizures, movement disorders, and psychiatric symptoms.""]",[true],[true],[true],"[""There is no cure for DRPLA, but treatments focus on managing symptoms such as seizures, movement disorders, and psychiatric symptoms. Medications can help control seizures and movement problems, while therapy and support groups can assist with emotional and social challenges.""]","[""Physical therapy, speech therapy, occupational therapy, and medications to manage symptoms.""]","[""There is no cure for Dentatorubral-pallidoluysian atrophy (DRPLA), but treatment focuses on managing symptoms such as seizures, movement disorders, and psychiatric symptoms. Medications can help control seizures and movement problems, while therapy and support groups can assist with emotional and social challenges.""]",[true],[true],[true],"[""There is no cure for DRPLA, but treatments focus on managing symptoms such as seizures, movement disorders, and psychiatric symptoms.""]","[""Currently, there is no specific treatment for dentatorubral-pallidoluysian atrophy. Management focuses on symptom relief and supportive care.""]","[""There is no cure for DRPLA, but treatments focus on managing symptoms such as seizures, movement disorders, and psychiatric symptoms.""]",[true],[true],[true],"[""There is no cure for DRPLA, but treatments focus on managing symptoms such as seizures, movement disorders, and psychiatric symptoms.""]","[""Physical therapy, speech therapy, occupational therapy, medications for symptoms management""]","[""There is no cure for DRPLA, but treatment focuses on managing symptoms and improving quality of life. Medications may be prescribed to help control seizures, movement disorders, and psychiatric symptoms.""]",[true],[true],[true],"[""There is no cure for DRPLA, but treatments focus on managing symptoms such as seizures, movement disorders, and psychiatric symptoms.""]","[""Currently, there is no specific treatment for dentatorubral-pallidoluysian atrophy. Management focuses on symptom relief and supportive care.""]","[""There is no cure for DRPLA, but treatment focuses on managing symptoms and improving quality of life. Medications may be prescribed to help control seizures, movement disorders, and psychiatric symptoms.""]",[true],[true],[true],"[""There is no cure for DRPLA, but treatments focus on managing symptoms such as seizures, movement disorders, and psychiatric symptoms.""]","[""Currently, there is no specific treatment for dentatorubral-pallidoluysian atrophy. Management focuses on symptom relief and supportive care.""]","[""There is no cure for DRPLA, but treatments focus on managing symptoms such as seizures, movement disorders, and psychiatric symptoms.""]",[true],[true],[true],"[""There is no cure for DRPLA, but treatment focuses on managing symptoms and improving quality of life. Medications can help control seizures, movement disorders, and psychiatric symptoms. Physical therapy and occupational therapy can also be beneficial.""]","[""Physical therapy, speech therapy, occupational therapy, and medications to manage symptoms.""]","[""There is no cure for Dentatorubral-pallidoluysian atrophy (DRPLA), but treatment focuses on managing symptoms such as seizures, movement disorders, and psychiatric symptoms. Medications can help control seizures and movement problems, while therapy and support groups can assist with emotional and social challenges.""]",[true],[true],[true],"[""There is no cure for DRPLA, but treatment focuses on managing symptoms and improving quality of life. Medications can help control seizures, movement disorders, and psychiatric symptoms. Physical therapy and occupational therapy can also be beneficial.""]","[""Physical therapy, speech therapy, occupational therapy, medications for symptoms management""]","[""There is no cure for DRPLA, but treatment focuses on managing symptoms and improving quality of life. Medications may be prescribed to help control seizures, movement disorders, and psychiatric symptoms.""]",[true],[true],[true],"[""There is no cure for DRPLA, but treatment focuses on managing symptoms such as seizures, movement disorders, and psychiatric symptoms.""]","[""Currently, there is no specific treatment for dentatorubral-pallidoluysian atrophy. Management focuses on symptom relief and supportive care.""]","[""There is no cure for DRPLA, but treatment focuses on managing symptoms and improving quality of life. Medications may be prescribed to help control seizures, movement disorders, and psychiatric symptoms.""]",[true],[true],[true],"[""There is no cure for DRPLA. Treatment focuses on managing symptoms and improving quality of life through medications and therapy.""]","[""Physical therapy, speech therapy, occupational therapy, and medications to manage symptoms.""]","[""There is no cure for Dentatorubral-pallidoluysian atrophy (DRPLA), but treatment focuses on managing symptoms such as seizures, movement disorders, and psychiatric symptoms. Medications can help control seizures and movement problems, while therapy and support groups can assist with emotional and social challenges.""]",[true],[true],[true],"[""There is no cure for DRPLA, treatment focuses on managing symptoms such as seizures, movement disorders, and psychiatric symptoms.""]","[""Currently, there is no specific treatment for dentatorubral-pallidoluysian atrophy. Management focuses on symptom relief and supportive care.""]","[""There is no cure for DRPLA, but treatments focus on managing symptoms such as seizures, movement disorders, and psychiatric symptoms.""]",[true],[true],[true],"[""There is no cure for DRPLA. Treatment focuses on managing symptoms and providing supportive care.""]","[""Physical therapy, speech therapy, occupational therapy, medications for symptoms management""]","[""There is no cure for DRPLA, but treatment focuses on managing symptoms and improving quality of life. Medications may be prescribed to help control seizures, movement disorders, and psychiatric symptoms.""]",[true],[true],[true],"[""There is no cure for DRPLA. Treatment focuses on managing symptoms and improving quality of life through medications and therapy.""]","[""Currently, there is no specific treatment for dentatorubral-pallidoluysian atrophy. Management focuses on symptom relief and supportive care.""]","[""There is no cure for DRPLA, but treatment focuses on managing symptoms and improving quality of life. Medications may be prescribed to help control seizures, movement disorders, and psychiatric symptoms.""]",[true],[true],[true],"[""There is no cure for DRPLA, but treatment focuses on managing symptoms and improving quality of life. This may include medications to control seizures, muscle spasms, and psychiatric symptoms, as well as physical therapy and speech therapy.""]","[""Physical therapy, speech therapy, occupational therapy, and medications to manage symptoms.""]","[""There is no cure for Dentatorubral-pallidoluysian atrophy (DRPLA), but treatment focuses on managing symptoms such as seizures, movement disorders, and psychiatric symptoms. Medications can help control seizures and movement problems, while therapy and support groups can assist with emotional and social challenges.""]",[true],[true],[true],"[""There is no cure for DRPLA, but treatments focus on managing symptoms such as seizures, movement disorders, and psychiatric symptoms.""]","[""Currently, there is no specific treatment for dentatorubral-pallidoluysian atrophy. Management focuses on symptom relief and supportive care.""]","[""There is no cure for DRPLA, but treatments focus on managing symptoms such as seizures, movement disorders, and psychiatric symptoms.""]",[true],[true],[true],"[""There is no cure for DRPLA, but treatments focus on managing symptoms such as seizures, movement disorders, and psychiatric symptoms.""]","[""Physical therapy, speech therapy, occupational therapy, medications for symptoms management""]","[""There is no cure for DRPLA, but treatment focuses on managing symptoms and improving quality of life. Medications may be prescribed to help control seizures, movement disorders, and psychiatric symptoms.""]",[true],[true],[true],"[""There is no cure for DRPLA, but treatment focuses on managing symptoms such as seizures, movement disorders, and psychiatric symptoms.""]","[""Currently, there is no specific treatment for dentatorubral-pallidoluysian atrophy. Management focuses on symptom relief and supportive care.""]","[""There is no cure for DRPLA, but treatment focuses on managing symptoms and improving quality of life. Medications may be prescribed to help control seizures, movement disorders, and psychiatric symptoms.""]",[true],[true],[true],"[""There is no cure for DRPLA, but treatment focuses on managing symptoms such as seizures, movement disorders, and psychiatric symptoms.""]","[""Physical therapy, speech therapy, occupational therapy, and medications to manage symptoms.""]","[""There is no cure for Dentatorubral-pallidoluysian atrophy (DRPLA), but treatment focuses on managing symptoms such as seizures, movement disorders, and psychiatric symptoms. Medications can help control seizures and movement problems, while therapy and support groups can assist with emotional and social challenges.""]",[true],[true],[true],"[""There is no cure for DRPLA, but treatment focuses on managing symptoms and improving quality of life. Medications can help control seizures, movement disorders, and psychiatric symptoms. Physical therapy and occupational therapy can also be beneficial.""]","[""Currently, there is no specific treatment for dentatorubral-pallidoluysian atrophy. Management focuses on symptom relief and supportive care.""]","[""There is no cure for DRPLA, but treatments focus on managing symptoms such as seizures, movement disorders, and psychiatric symptoms.""]",[true],[true],[true],"[""There is no cure for DRPLA, but treatments focus on managing symptoms such as seizures, movement disorders, and psychiatric symptoms.""]","[""Physical therapy, speech therapy, occupational therapy, medications for symptoms management""]","[""There is no cure for DRPLA, but treatment focuses on managing symptoms and improving quality of life. Medications may be prescribed to help control seizures, movement disorders, and psychiatric symptoms.""]",[true],[true],[true],"[""There is no cure for DRPLA, but treatment focuses on managing symptoms and improving quality of life. Medications may be prescribed to help control seizures, movement disorders, and psychiatric symptoms. Physical therapy, occupational therapy, and speech therapy can also be beneficial.""]","[""Currently, there is no specific treatment for dentatorubral-pallidoluysian atrophy. Management focuses on symptom relief and supportive care.""]","[""There is no cure for DRPLA, but treatment focuses on managing symptoms and improving quality of life. Medications may be prescribed to help control seizures, movement disorders, and psychiatric symptoms.""]",[true],[true],[true],"[""There is no cure for DRPLA. Treatment focuses on managing symptoms and improving quality of life through medications and therapies.""]","[""Physical therapy, speech therapy, occupational therapy, and medications to manage symptoms.""]","[""There is no cure for Dentatorubral-pallidoluysian atrophy (DRPLA), but treatment focuses on managing symptoms such as seizures, movement disorders, and psychiatric symptoms. Medications can help control seizures and movement problems, while therapy and support groups can assist with emotional and social challenges.""]",[true],[true],[true],"[""Currently, there is no cure for DRPLA. Treatment focuses on managing symptoms and improving quality of life through medications and therapy.""]","[""Currently, there is no specific treatment for dentatorubral-pallidoluysian atrophy. Management focuses on symptom relief and supportive care.""]","[""There is no cure for DRPLA, but treatments focus on managing symptoms such as seizures, movement disorders, and psychiatric symptoms.""]",[true],[true],[true],"[""Currently, there is no cure for Dentatorubral-Pallidoluysian Atrophy (DRPLA). Treatment focuses on managing symptoms and providing supportive care. This may include medications to help with movement disorders, speech therapy, physical therapy, and occupational therapy.""]","[""Physical therapy, speech therapy, occupational therapy, medications for symptoms management""]","[""There is no cure for DRPLA, but treatment focuses on managing symptoms and improving quality of life. Medications may be prescribed to help control seizures, movement disorders, and psychiatric symptoms.""]",[true],[true],[true],"[""There is no cure for Dentatorubral-Pallidoluysian Atrophy (DRPLA). Treatment focuses on managing symptoms and providing supportive care.""]","[""Currently, there is no specific treatment for dentatorubral-pallidoluysian atrophy. Management focuses on symptom relief and supportive care.""]","[""There is no cure for DRPLA, but treatment focuses on managing symptoms and improving quality of life. Medications may be prescribed to help control seizures, movement disorders, and psychiatric symptoms.""]",[true],[true],[true],"[""There is no cure for DRPLA. Treatment focuses on managing symptoms and improving quality of life.""]","[""Physical therapy, speech therapy, occupational therapy, and medications to manage symptoms.""]","[""There is no cure for Dentatorubral-pallidoluysian atrophy (DRPLA), but treatment focuses on managing symptoms such as seizures, movement disorders, and psychiatric symptoms. Medications can help control seizures and movement problems, while therapy and support groups can assist with emotional and social challenges.""]",[true],[true],[true],"[""Currently, there is no cure for Dentatorubral-Pallidoluysian Atrophy (DRPLA). Treatment focuses on managing symptoms and improving quality of life through medications and therapies.""]","[""Physical therapy, speech therapy, occupational therapy, and medications to manage symptoms.""]","[""There is no cure for Dentatorubral-pallidoluysian atrophy (DRPLA), but treatment focuses on managing symptoms such as seizures, movement disorders, and psychiatric symptoms. Medications can help control seizures and movement problems, while therapy and support groups can assist with emotional and social challenges.""]",[true],[true],[true],"[""There is no cure for DRPLA, treatment focuses on managing symptoms and improving quality of life.""]","[""Physical therapy, speech therapy, occupational therapy, and medications to manage symptoms.""]","[""There is no cure for Dentatorubral-pallidoluysian atrophy (DRPLA), but treatment focuses on managing symptoms such as seizures, movement disorders, and psychiatric symptoms. Medications can help control seizures and movement problems, while therapy and support groups can assist with emotional and social challenges.""]",[true],[true],[true],"[""Currently, there is no cure for Dentatorubral-Pallidoluysian Atrophy (DRPLA). Treatment focuses on managing symptoms and improving quality of life through medications and therapy.""]","[""Physical therapy, speech therapy, occupational therapy, and medications to manage symptoms.""]","[""There is no cure for Dentatorubral-pallidoluysian atrophy (DRPLA), but treatment focuses on managing symptoms such as seizures, movement disorders, and psychiatric symptoms. Medications can help control seizures and movement problems, while therapy and support groups can assist with emotional and social challenges.""]"
susceptibility,Who is at risk for Primary Sclerosing Cholangitis? ?,Most people with PSC are adults but the disease also occurs in children. The average age at diagnosis is 40. PSC is more common in men than women. Having family members with PSC may increase a person's risk for developing PSC.,"{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""PSC"", ""full_form"": ""Primary Sclerosing Cholangitis""}]}",Who is at risk for PSC? ?,Who is at risk for Primary Sclerosing Cholangitis? ?,8,MEDICAL,Simple Datatype-String,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Public Service Commission"", ""Printer Scanner Copier"", ""Pittsburgh Supercomputing Center"", ""Print Scan Copy"", ""Partido Social Cristiano"", ""Program Support Center"", ""Polar Stratospheric Cloud"", ""Professional Standards Commission"", ""Permanent Split Capacitor"", ""Printer Scanner And Copier""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Primary Sclerosing Cholangitis""]",[2.1798492796134915e-12],[2.1798492796134915e-12],"[""Program Support Center""]",[2.5495162679351034e-12],"[""ABBREVIATIONS""]","[[2.0180298865860492e-15, 4.335625063335074e-22, 3.656448308103166e-32, 4.775445903441854e-13, 7.271245025417881e-21, 2.5495162679351034e-12, 2.9172904627787463e-25, 2.088320257567152e-16, 7.708153031590914e-20, 2.419596492354129e-20]]",[0.9137991710196244],[0.9137991710196244],"[""Printer Scanner And Copier""]",[0.9137991710196244],"[""LLM""]","[[0.6916147737106176, 0.7233821424579869, 0.6872863125550399, 0.7090581649101899, 0.7130261001797812, 0.7349474880254997, 0.6329649180388951, 0.611897206947577, 0.609475703632243, 0.6995854390685918]]","[""Primary Sclerosing Cholangitis""]","[""LLM""]",Who is at risk for PSC (Primary Sclerosing Cholangitis)? ?,[true],[true],[true],"[""People with inflammatory bowel disease (IBD) are at higher risk for PSC.""]","[""People with inflammatory bowel disease, particularly ulcerative colitis, are at higher risk for Primary Sclerosing Cholangitis.""]","[""People with inflammatory bowel disease (IBD) are at higher risk for primary sclerosing cholangitis (PSC).""]",[true],[true],[true],"[""People with inflammatory bowel disease (IBD) are at higher risk for PSC.""]","[""People with inflammatory bowel disease, particularly ulcerative colitis, are at risk for Primary Sclerosing Cholangitis.""]","[""Primary sclerosing cholangitis (PSC) is more common in men than in women, and usually affects people between the ages of 30 and 50. It is also more common in individuals with inflammatory bowel disease, particularly ulcerative colitis.""]",[true],[true],[true],"[""People with inflammatory bowel disease (IBD) are at higher risk for PSC (Primary Sclerosing Cholangitis).""]","[""People with inflammatory bowel disease, especially ulcerative colitis, are at higher risk for Primary Sclerosing Cholangitis.""]","[""Primary sclerosing cholangitis (PSC) is more common in men than in women. It is also associated with inflammatory bowel disease, particularly ulcerative colitis.""]",[true],[true],[true],"[""People with inflammatory bowel disease (IBD) are at higher risk for PSC.""]","[""People with inflammatory bowel disease, particularly ulcerative colitis, are at higher risk for Primary Sclerosing Cholangitis.""]","[""Primary sclerosing cholangitis (PSC) is more common in men than in women and usually affects people between the ages of 30 and 50. It is also associated with inflammatory bowel disease, particularly ulcerative colitis.""]",[true],[true],[true],"[""People with inflammatory bowel disease (IBD) are at higher risk for primary sclerosing cholangitis (PSC).""]","[""People with inflammatory bowel disease, particularly ulcerative colitis, are at higher risk for Primary Sclerosing Cholangitis.""]","[""People with inflammatory bowel disease (IBD) are at higher risk for primary sclerosing cholangitis (PSC).""]",[true],[true],[true],"[""Primary sclerosing cholangitis (PSC) is a rare liver disease that can affect anyone, but it is most commonly seen in young to middle-aged adults. People with inflammatory bowel disease, such as ulcerative colitis, are at a higher risk of developing PSC.""]","[""People with inflammatory bowel disease, particularly ulcerative colitis, are at risk for Primary Sclerosing Cholangitis.""]","[""Primary sclerosing cholangitis (PSC) is more common in men than in women, and usually affects people between the ages of 30 and 50. It is also more common in individuals with inflammatory bowel disease, particularly ulcerative colitis.""]",[true],[true],[true],"[""People with inflammatory bowel disease (IBD) are at higher risk for primary sclerosing cholangitis (PSC).""]","[""People with inflammatory bowel disease, especially ulcerative colitis, are at higher risk for Primary Sclerosing Cholangitis.""]","[""Primary sclerosing cholangitis (PSC) is more common in men than in women. It is also associated with inflammatory bowel disease, particularly ulcerative colitis.""]",[true],[true],[true],"[""People with inflammatory bowel disease (IBD) are at higher risk for primary sclerosing cholangitis (PSC).""]","[""People with inflammatory bowel disease, particularly ulcerative colitis, are at higher risk for Primary Sclerosing Cholangitis.""]","[""Primary sclerosing cholangitis (PSC) is more common in men than in women and usually affects people between the ages of 30 and 50. It is also associated with inflammatory bowel disease, particularly ulcerative colitis.""]",[true],[true],[true],"[""People with inflammatory bowel disease, especially ulcerative colitis, are at higher risk for PSC.""]","[""People with inflammatory bowel disease, particularly ulcerative colitis, are at risk for Primary Sclerosing Cholangitis.""]","[""Primary sclerosing cholangitis (PSC) is more common in men than in women, and usually affects people between the ages of 30 and 50. It is also more common in individuals with inflammatory bowel disease, particularly ulcerative colitis.""]",[true],[true],[true],"[""People with inflammatory bowel disease, especially ulcerative colitis, are at higher risk for PSC.""]","[""People with inflammatory bowel disease, particularly ulcerative colitis, are at higher risk for Primary Sclerosing Cholangitis.""]","[""People with inflammatory bowel disease (IBD) are at higher risk for primary sclerosing cholangitis (PSC).""]",[true],[true],[true],"[""People with inflammatory bowel disease, especially ulcerative colitis, are at higher risk for PSC.""]","[""People with inflammatory bowel disease, especially ulcerative colitis, are at higher risk for Primary Sclerosing Cholangitis.""]","[""Primary sclerosing cholangitis (PSC) is more common in men than in women. It is also associated with inflammatory bowel disease, particularly ulcerative colitis.""]",[true],[true],[true],"[""People with inflammatory bowel disease, especially ulcerative colitis, are at higher risk for PSC.""]","[""People with inflammatory bowel disease, particularly ulcerative colitis, are at higher risk for Primary Sclerosing Cholangitis.""]","[""Primary sclerosing cholangitis (PSC) is more common in men than in women and usually affects people between the ages of 30 and 50. It is also associated with inflammatory bowel disease, particularly ulcerative colitis.""]",[true],[true],[true],"[""People with inflammatory bowel disease, especially ulcerative colitis, are at higher risk for PSC.""]","[""People with inflammatory bowel disease, particularly ulcerative colitis, are at higher risk for Primary Sclerosing Cholangitis.""]","[""People with inflammatory bowel disease (IBD) are at higher risk for primary sclerosing cholangitis (PSC).""]",[true],[true],[true],"[""People with inflammatory bowel disease, especially ulcerative colitis, are at risk for PSC.""]","[""People with inflammatory bowel disease, particularly ulcerative colitis, are at risk for Primary Sclerosing Cholangitis.""]","[""Primary sclerosing cholangitis (PSC) is more common in men than in women, and usually affects people between the ages of 30 and 50. It is also more common in individuals with inflammatory bowel disease, particularly ulcerative colitis.""]",[true],[true],[true],"[""People with inflammatory bowel disease, especially ulcerative colitis, are at higher risk for PSC.""]","[""People with inflammatory bowel disease, especially ulcerative colitis, are at higher risk for Primary Sclerosing Cholangitis.""]","[""Primary sclerosing cholangitis (PSC) is more common in men than in women. It is also associated with inflammatory bowel disease, particularly ulcerative colitis.""]",[true],[true],[true],"[""People with inflammatory bowel disease, especially ulcerative colitis, are at higher risk for PSC.""]","[""People with inflammatory bowel disease, particularly ulcerative colitis, are at higher risk for Primary Sclerosing Cholangitis.""]","[""Primary sclerosing cholangitis (PSC) is more common in men than in women and usually affects people between the ages of 30 and 50. It is also associated with inflammatory bowel disease, particularly ulcerative colitis.""]",[true],[true],[true],"[""People with inflammatory bowel disease, especially ulcerative colitis, are at higher risk for PSC.""]","[""People with inflammatory bowel disease, particularly ulcerative colitis, are at higher risk for Primary Sclerosing Cholangitis.""]","[""People with inflammatory bowel disease (IBD) are at higher risk for primary sclerosing cholangitis (PSC).""]",[true],[true],[true],"[""People with inflammatory bowel disease, particularly ulcerative colitis, are at higher risk for PSC.""]","[""People with inflammatory bowel disease, particularly ulcerative colitis, are at risk for Primary Sclerosing Cholangitis.""]","[""Primary sclerosing cholangitis (PSC) is more common in men than in women, and usually affects people between the ages of 30 and 50. It is also more common in individuals with inflammatory bowel disease, particularly ulcerative colitis.""]",[true],[true],[true],"[""People with inflammatory bowel disease, especially ulcerative colitis, are at higher risk for PSC.""]","[""People with inflammatory bowel disease, especially ulcerative colitis, are at higher risk for Primary Sclerosing Cholangitis.""]","[""Primary sclerosing cholangitis (PSC) is more common in men than in women. It is also associated with inflammatory bowel disease, particularly ulcerative colitis.""]",[true],[true],[true],"[""People with inflammatory bowel disease, especially ulcerative colitis, are at higher risk for PSC.""]","[""People with inflammatory bowel disease, particularly ulcerative colitis, are at higher risk for Primary Sclerosing Cholangitis.""]","[""Primary sclerosing cholangitis (PSC) is more common in men than in women and usually affects people between the ages of 30 and 50. It is also associated with inflammatory bowel disease, particularly ulcerative colitis.""]",[true],[true],[true],"[""People with inflammatory bowel disease, especially ulcerative colitis, are at higher risk for PSC.""]","[""People with inflammatory bowel disease, particularly ulcerative colitis, are at higher risk for Primary Sclerosing Cholangitis.""]","[""People with inflammatory bowel disease (IBD) are at higher risk for primary sclerosing cholangitis (PSC).""]",[true],[true],[true],"[""People with inflammatory bowel disease, especially ulcerative colitis, are at higher risk for PSC.""]","[""People with inflammatory bowel disease, particularly ulcerative colitis, are at risk for Primary Sclerosing Cholangitis.""]","[""Primary sclerosing cholangitis (PSC) is more common in men than in women, and usually affects people between the ages of 30 and 50. It is also more common in individuals with inflammatory bowel disease, particularly ulcerative colitis.""]",[true],[true],[true],"[""People with inflammatory bowel disease, especially ulcerative colitis, are at higher risk for PSC.""]","[""People with inflammatory bowel disease, especially ulcerative colitis, are at higher risk for Primary Sclerosing Cholangitis.""]","[""Primary sclerosing cholangitis (PSC) is more common in men than in women. It is also associated with inflammatory bowel disease, particularly ulcerative colitis.""]",[true],[true],[true],"[""People with inflammatory bowel disease, especially ulcerative colitis, are at higher risk for PSC.""]","[""People with inflammatory bowel disease, particularly ulcerative colitis, are at higher risk for Primary Sclerosing Cholangitis.""]","[""Primary sclerosing cholangitis (PSC) is more common in men than in women and usually affects people between the ages of 30 and 50. It is also associated with inflammatory bowel disease, particularly ulcerative colitis.""]",[true],[true],[true],"[""People with inflammatory bowel disease, particularly ulcerative colitis, are at higher risk for PSC.""]","[""People with inflammatory bowel disease, particularly ulcerative colitis, are at higher risk for Primary Sclerosing Cholangitis.""]","[""People with inflammatory bowel disease (IBD) are at higher risk for primary sclerosing cholangitis (PSC).""]",[true],[true],[true],"[""People with inflammatory bowel disease, especially ulcerative colitis, are at higher risk for PSC.""]","[""People with inflammatory bowel disease, particularly ulcerative colitis, are at risk for Primary Sclerosing Cholangitis.""]","[""Primary sclerosing cholangitis (PSC) is more common in men than in women, and usually affects people between the ages of 30 and 50. It is also more common in individuals with inflammatory bowel disease, particularly ulcerative colitis.""]",[true],[true],[true],"[""People with inflammatory bowel disease, especially ulcerative colitis, are at higher risk for PSC.""]","[""People with inflammatory bowel disease, especially ulcerative colitis, are at higher risk for Primary Sclerosing Cholangitis.""]","[""Primary sclerosing cholangitis (PSC) is more common in men than in women. It is also associated with inflammatory bowel disease, particularly ulcerative colitis.""]",[true],[true],[true],"[""People with inflammatory bowel disease, especially ulcerative colitis, are at higher risk for PSC.""]","[""People with inflammatory bowel disease, particularly ulcerative colitis, are at higher risk for Primary Sclerosing Cholangitis.""]","[""Primary sclerosing cholangitis (PSC) is more common in men than in women and usually affects people between the ages of 30 and 50. It is also associated with inflammatory bowel disease, particularly ulcerative colitis.""]",[true],[true],[true],"[""People with inflammatory bowel disease, especially ulcerative colitis, are at higher risk for PSC.""]","[""People with inflammatory bowel disease, particularly ulcerative colitis, are at higher risk for Primary Sclerosing Cholangitis.""]","[""People with inflammatory bowel disease (IBD) are at higher risk for primary sclerosing cholangitis (PSC).""]",[true],[true],[true],"[""People with autoimmune diseases such as inflammatory bowel disease (IBD) are at risk for PSC.""]","[""People with inflammatory bowel disease, particularly ulcerative colitis, are at higher risk for Primary Sclerosing Cholangitis.""]","[""People with inflammatory bowel disease (IBD) are at higher risk for primary sclerosing cholangitis (PSC).""]",[false],[true],[true],"[""People who work in environments with high exposure to printing chemicals and particles, such as printers, scanners, and copiers, are at risk for Printer Scanner And Copier (PSC) related health issues.""]","[""People with inflammatory bowel disease, particularly ulcerative colitis, are at higher risk for Primary Sclerosing Cholangitis.""]","[""People with inflammatory bowel disease (IBD) are at higher risk for primary sclerosing cholangitis (PSC).""]",[true],[true],[true],"[""People with inflammatory bowel disease (IBD), especially ulcerative colitis, are at higher risk for PSC.""]","[""People with inflammatory bowel disease, particularly ulcerative colitis, are at higher risk for Primary Sclerosing Cholangitis.""]","[""People with inflammatory bowel disease (IBD) are at higher risk for primary sclerosing cholangitis (PSC).""]"
frequency,How many people are affected by microcephalic osteodysplastic primordial dwarfism type II ?,"MOPDII appears to be a rare condition, although its prevalence is unknown.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""MOPD II"", ""full_form"": ""microcephalic osteodysplastic primordial dwarfism type II""}]}",How many people are affected by MOPD II ?,How many people are affected by microcephalic osteodysplastic primordial dwarfism type II ?,8,MEDICAL,Simple Datatype-Integer,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.",[[]],[[]],"[""Microcephalic Osteodysplastic Primordial Dwarfism Type II""]",[2.526158242737394e-38],[2.526158242737394e-38],"[""Microcephalic Osteodysplastic Primordial Dwarfism Type II""]",[2.526158242737394e-38],"[""LLM""]",[[]],[0.9035963497593242],[0.9059401181499506],"[""microcephalic osteodysplastic primordial dwarfism type II""]",[0.9059401181499506],"[""LLM""]",[[]],"[""Microcephalic Osteodysplastic Primordial Dwarfism Type II""]","[""LLM""]",How many people are affected by MOPD II (Microcephalic Osteodysplastic Primordial Dwarfism Type II) ?,[true],[true],[true],"[""MOPD II is an extremely rare condition, with only a few dozen cases reported worldwide.""]","[""Microcephalic osteodysplastic primordial dwarfism type II is an extremely rare condition, with only a few documented cases worldwide.""]","[""MOPD II affects a very small number of individuals worldwide.""]",[true],[true],[true],"[""MOPD II is an extremely rare condition, with only a few dozen cases reported worldwide.""]","[""Microcephalic osteodysplastic primordial dwarfism type II is an extremely rare condition, with only a few documented cases worldwide.""]","[""MOPD II affects a very small number of individuals worldwide.""]",[true],[true],[true],"[""MOPD II is an extremely rare condition, with only a few dozen cases reported worldwide.""]","[""Microcephalic osteodysplastic primordial dwarfism type II is an extremely rare condition, with only a few known cases worldwide.""]","[""MOPD II affects a very small number of individuals worldwide.""]",[true],[true],[true],"[""MOPD II is an extremely rare genetic disorder, affecting only a few hundred individuals worldwide.""]","[""Microcephalic osteodysplastic primordial dwarfism type II is an extremely rare condition, with only a few documented cases worldwide.""]","[""MOPD II affects a very small number of individuals worldwide.""]",[true],[true],[true],"[""MOPD II is an extremely rare condition, with only a few dozen cases reported worldwide.""]","[""Microcephalic osteodysplastic primordial dwarfism type II is an extremely rare condition, with only a few documented cases worldwide.""]","[""MOPD II affects a very small number of individuals worldwide.""]",[true],[true],[true],"[""MOPD II is an extremely rare condition, with only a few dozen cases reported worldwide.""]","[""Microcephalic osteodysplastic primordial dwarfism type II is an extremely rare condition, with only a few documented cases worldwide.""]","[""MOPD II affects a very small number of individuals worldwide.""]",[true],[true],[true],"[""MOPD II is an extremely rare condition, with only a few dozen cases reported worldwide.""]","[""Microcephalic osteodysplastic primordial dwarfism type II is an extremely rare condition, with only a few known cases worldwide.""]","[""MOPD II affects a very small number of individuals worldwide.""]",[true],[true],[true],"[""MOPD II is an extremely rare condition, with only a few dozen cases reported worldwide.""]","[""Microcephalic osteodysplastic primordial dwarfism type II is an extremely rare condition, with only a few documented cases worldwide.""]","[""MOPD II affects a very small number of individuals worldwide.""]",[true],[true],[true],"[""MOPD II is an extremely rare condition, with only a few dozen cases reported worldwide.""]","[""Microcephalic osteodysplastic primordial dwarfism type II is an extremely rare condition, with only a few documented cases worldwide.""]","[""MOPD II affects a very small number of individuals worldwide.""]",[true],[true],[true],"[""MOPD II is an extremely rare condition, with only a few dozen cases reported worldwide.""]","[""Microcephalic osteodysplastic primordial dwarfism type II is an extremely rare condition, with only a few documented cases worldwide.""]","[""MOPD II affects a very small number of individuals worldwide.""]",[true],[true],[true],"[""MOPD II is an extremely rare condition, with only a few dozen cases reported worldwide.""]","[""Microcephalic osteodysplastic primordial dwarfism type II is an extremely rare condition, with only a few known cases worldwide.""]","[""MOPD II affects a very small number of individuals worldwide.""]",[true],[true],[true],"[""MOPD II is an extremely rare condition, with only a few dozen cases reported worldwide.""]","[""Microcephalic osteodysplastic primordial dwarfism type II is an extremely rare condition, with only a few documented cases worldwide.""]","[""MOPD II affects a very small number of individuals worldwide.""]",[true],[true],[true],"[""MOPD II is an extremely rare condition, affecting only a few individuals worldwide.""]","[""Microcephalic osteodysplastic primordial dwarfism type II is an extremely rare condition, with only a few documented cases worldwide.""]","[""MOPD II affects a very small number of individuals worldwide.""]",[true],[true],[true],"[""MOPD II is an extremely rare condition, affecting only a few individuals worldwide.""]","[""Microcephalic osteodysplastic primordial dwarfism type II is an extremely rare condition, with only a few documented cases worldwide.""]","[""MOPD II affects a very small number of individuals worldwide.""]",[true],[true],[true],"[""MOPD II is an extremely rare condition, affecting only a few individuals worldwide.""]","[""Microcephalic osteodysplastic primordial dwarfism type II is an extremely rare condition, with only a few known cases worldwide.""]","[""MOPD II affects a very small number of individuals worldwide.""]",[true],[true],[true],"[""MOPD II is an extremely rare condition, affecting only a few individuals worldwide.""]","[""Microcephalic osteodysplastic primordial dwarfism type II is an extremely rare condition, with only a few documented cases worldwide.""]","[""MOPD II affects a very small number of individuals worldwide.""]",[false],[true],[true],"[""MOPD II affects approximately 100 individuals worldwide.""]","[""Microcephalic osteodysplastic primordial dwarfism type II is an extremely rare condition, with only a few documented cases worldwide.""]","[""MOPD II affects a very small number of individuals worldwide.""]",[true],[true],[true],"[""MOPD II is an extremely rare condition, affecting only a few hundred individuals worldwide.""]","[""Microcephalic osteodysplastic primordial dwarfism type II is an extremely rare condition, with only a few documented cases worldwide.""]","[""MOPD II affects a very small number of individuals worldwide.""]",[true],[true],[true],"[""MOPD II is an extremely rare condition, affecting only a few individuals worldwide.""]","[""Microcephalic osteodysplastic primordial dwarfism type II is an extremely rare condition, with only a few known cases worldwide.""]","[""MOPD II affects a very small number of individuals worldwide.""]",[true],[true],[true],"[""MOPD II is an extremely rare condition, with only a few dozen cases reported worldwide.""]","[""Microcephalic osteodysplastic primordial dwarfism type II is an extremely rare condition, with only a few documented cases worldwide.""]","[""MOPD II affects a very small number of individuals worldwide.""]",[true],[true],[true],"[""MOPD II is an extremely rare condition, with only a few dozen cases reported worldwide.""]","[""Microcephalic osteodysplastic primordial dwarfism type II is an extremely rare condition, with only a few documented cases worldwide.""]","[""MOPD II affects a very small number of individuals worldwide.""]",[true],[true],[true],"[""MOPD II is an extremely rare condition, with only a few dozen cases reported worldwide.""]","[""Microcephalic osteodysplastic primordial dwarfism type II is an extremely rare condition, with only a few documented cases worldwide.""]","[""MOPD II affects a very small number of individuals worldwide.""]",[true],[true],[true],"[""MOPD II is an extremely rare condition, with only a few dozen cases reported worldwide.""]","[""Microcephalic osteodysplastic primordial dwarfism type II is an extremely rare condition, with only a few known cases worldwide.""]","[""MOPD II affects a very small number of individuals worldwide.""]",[true],[true],[true],"[""MOPD II is an extremely rare condition, affecting only a few hundred individuals worldwide.""]","[""Microcephalic osteodysplastic primordial dwarfism type II is an extremely rare condition, with only a few documented cases worldwide.""]","[""MOPD II affects a very small number of individuals worldwide.""]",[true],[true],[true],"[""MOPD II is an extremely rare genetic disorder, and the exact number of people affected by it is not well-documented. However, it is estimated to affect fewer than 100 individuals worldwide.""]","[""Microcephalic osteodysplastic primordial dwarfism type II is an extremely rare condition, with only a few documented cases worldwide.""]","[""MOPD II affects a very small number of individuals worldwide.""]",[true],[true],[true],"[""MOPD II is an extremely rare condition, affecting only a small number of individuals worldwide. The exact number of people affected is not readily available.""]","[""Microcephalic osteodysplastic primordial dwarfism type II is an extremely rare condition, with only a few documented cases worldwide.""]","[""MOPD II affects a very small number of individuals worldwide.""]",[true],[true],[true],"[""MOPD II is an extremely rare genetic disorder, and the exact number of people affected by it is not well-documented. However, it is estimated that only a few hundred cases have been reported worldwide.""]","[""Microcephalic osteodysplastic primordial dwarfism type II is an extremely rare condition, with only a few known cases worldwide.""]","[""MOPD II affects a very small number of individuals worldwide.""]",[true],[true],[true],"[""MOPD II is an extremely rare condition, affecting only a small number of individuals worldwide. Exact numbers may vary, but estimates suggest that there are less than 100 known cases globally.""]","[""Microcephalic osteodysplastic primordial dwarfism type II is an extremely rare condition, with only a few documented cases worldwide.""]","[""MOPD II affects a very small number of individuals worldwide.""]",[true],[true],[true],"[""MOPD II affects a very small number of individuals worldwide.""]","[""Microcephalic osteodysplastic primordial dwarfism type II is an extremely rare condition, with only a few documented cases worldwide.""]","[""MOPD II affects a very small number of individuals worldwide.""]",[true],[true],[true],"[""MOPD II affects a very small number of individuals worldwide.""]","[""Microcephalic osteodysplastic primordial dwarfism type II is an extremely rare condition, with only a few documented cases worldwide.""]","[""MOPD II affects a very small number of individuals worldwide.""]",[true],[true],[true],"[""MOPD II is an extremely rare condition, affecting only a small number of individuals worldwide.""]","[""Microcephalic osteodysplastic primordial dwarfism type II is an extremely rare condition, with only a few documented cases worldwide.""]","[""MOPD II affects a very small number of individuals worldwide.""]",[true],[true],[true],"[""MOPD II is an extremely rare condition, affecting only a few individuals worldwide.""]","[""Microcephalic osteodysplastic primordial dwarfism type II is an extremely rare condition, with only a few documented cases worldwide.""]","[""MOPD II affects a very small number of individuals worldwide.""]"
treatment,What are the treatments for hereditary sensory and autonomic neuropathy type IE ?,"These resources address the diagnosis or management of hereditary sensory and autonomic neuropathy type IE:  - Gene Review: Gene Review: DNMT1-Related Dementia, Deafness, and Sensory Neuropathy  - University of Chicago: Center for Peripheral Neuropathy   These resources from MedlinePlus offer information about the diagnosis and management of various health conditions:  - Diagnostic Tests  - Drug Therapy  - Surgery and Rehabilitation  - Genetic Counseling   - Palliative Care","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""HSAN IE"", ""full_form"": ""hereditary sensory and autonomic neuropathy type IE""}]}",What are the treatments for HSAN IE ?,What are the treatments for hereditary sensory and autonomic neuropathy type IE ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.",[[]],[[]],"[""Hereditary Sensory and Autonomic Neuropathy Type IE""]",[1.4881386337130263e-32],[1.4881386337130263e-32],"[""Hereditary Sensory and Autonomic Neuropathy Type IE""]",[1.4881386337130263e-32],"[""LLM""]",[[]],[0.9069800151201286],[0.9044213336913768],"[""hereditary sensory and autonomic neuropathy type IE""]",[0.9044213336913768],"[""LLM""]",[[]],"[""Hereditary Sensory and Autonomic Neuropathy Type IE""]","[""LLM""]",What are the treatments for HSAN IE (Hereditary Sensory and Autonomic Neuropathy Type IE) ?,[true],[true],[true],"[""There is no specific treatment for HSAN IE. Management involves symptomatic and supportive care to address the symptoms and complications.""]","[""Currently, there is no specific treatment for hereditary sensory and autonomic neuropathy type IE. Management focuses on symptom relief and supportive care.""]","[""There is no specific treatment for HSAN IE, but management involves symptom relief and supportive care.""]",[true],[true],[true],"[""There is no specific treatment for HSAN IE. Management involves symptomatic and supportive care to address the symptoms and complications.""]","[""Currently, there is no specific treatment for hereditary sensory and autonomic neuropathy type IE. Management focuses on symptom relief and supportive care.""]","[""There is no cure for HSAN IE, but treatment focuses on managing symptoms and complications. This may include pain management, physical therapy, and assistive devices.""]",[true],[true],[true],"[""There is no specific treatment for HSAN IE, management involves symptomatic and supportive care.""]","[""There is no specific treatment for hereditary sensory and autonomic neuropathy type IE. Management involves symptomatic treatment and supportive care.""]","[""There is no cure for HSAN IE, but treatment focuses on managing symptoms and preventing complications. This may include pain management, physical therapy, and assistive devices.""]",[true],[true],[true],"[""There is no specific treatment for HSAN IE. Management involves symptomatic and supportive care to address the symptoms and complications.""]","[""Currently, there is no cure for hereditary sensory and autonomic neuropathy type IE. Treatment focuses on managing symptoms and improving quality of life through physical therapy, pain management, and assistive devices.""]","[""There is no cure for HSAN IE, but treatments focus on managing symptoms such as pain relief, physical therapy, and psychological support.""]",[true],[true],[true],"[""There is no specific treatment for HSAN IE. Management involves symptomatic treatment and supportive care to improve quality of life.""]","[""Currently, there is no specific treatment for hereditary sensory and autonomic neuropathy type IE. Management focuses on symptom relief and supportive care.""]","[""There is no specific treatment for HSAN IE, but management involves symptom relief and supportive care.""]",[true],[true],[true],"[""There is no specific treatment for HSAN IE. Management involves symptomatic treatment and supportive care to improve quality of life.""]","[""Currently, there is no specific treatment for hereditary sensory and autonomic neuropathy type IE. Management focuses on symptom relief and supportive care.""]","[""There is no cure for HSAN IE, but treatment focuses on managing symptoms and complications. This may include pain management, physical therapy, and assistive devices.""]",[true],[true],[true],"[""There is no specific treatment for HSAN IE. Management involves symptomatic treatment and supportive care.""]","[""There is no specific treatment for hereditary sensory and autonomic neuropathy type IE. Management involves symptomatic treatment and supportive care.""]","[""There is no cure for HSAN IE, but treatment focuses on managing symptoms and preventing complications. This may include pain management, physical therapy, and assistive devices.""]",[true],[true],[true],"[""There is no specific treatment for HSAN IE. Management involves symptomatic treatment and supportive care.""]","[""Currently, there is no cure for hereditary sensory and autonomic neuropathy type IE. Treatment focuses on managing symptoms and improving quality of life through physical therapy, pain management, and assistive devices.""]","[""There is no cure for HSAN IE, but treatments focus on managing symptoms such as pain relief, physical therapy, and psychological support.""]",[true],[true],[true],"[""There is no specific treatment for HSAN IE. Management involves symptomatic and supportive care to address the symptoms and complications.""]","[""Currently, there is no specific treatment for hereditary sensory and autonomic neuropathy type IE. Management focuses on symptom relief and supportive care.""]","[""There is no cure for HSAN IE, but treatment focuses on managing symptoms and complications. This may include pain management, physical therapy, and assistive devices.""]",[true],[true],[true],"[""There is no specific treatment for HSAN IE. Management involves symptomatic and supportive care to address the symptoms and complications.""]","[""Currently, there is no specific treatment for hereditary sensory and autonomic neuropathy type IE. Management focuses on symptom relief and supportive care.""]","[""There is no specific treatment for HSAN IE, but management involves symptom relief and supportive care.""]",[true],[true],[true],"[""There is no specific treatment for HSAN IE. Management involves symptomatic and supportive care to address the symptoms and complications.""]","[""There is no specific treatment for hereditary sensory and autonomic neuropathy type IE. Management involves symptomatic treatment and supportive care.""]","[""There is no cure for HSAN IE, but treatment focuses on managing symptoms and preventing complications. This may include pain management, physical therapy, and assistive devices.""]",[true],[true],[true],"[""There is no specific treatment for HSAN IE. Management involves symptomatic and supportive care to address the symptoms and complications.""]","[""Currently, there is no cure for hereditary sensory and autonomic neuropathy type IE. Treatment focuses on managing symptoms and improving quality of life through physical therapy, pain management, and assistive devices.""]","[""There is no cure for HSAN IE, but treatments focus on managing symptoms such as pain relief, physical therapy, and psychological support.""]",[true],[true],[true],"[""There is no specific treatment for HSAN IE. Management involves symptomatic and supportive care.""]","[""Currently, there is no specific treatment for hereditary sensory and autonomic neuropathy type IE. Management focuses on symptom relief and supportive care.""]","[""There is no specific treatment for HSAN IE, but management involves symptom relief and supportive care.""]",[true],[true],[true],"[""There is no specific treatment for HSAN IE. Management involves symptomatic and supportive care.""]","[""Currently, there is no specific treatment for hereditary sensory and autonomic neuropathy type IE. Management focuses on symptom relief and supportive care.""]","[""There is no cure for HSAN IE, but treatment focuses on managing symptoms and complications. This may include pain management, physical therapy, and assistive devices.""]",[true],[true],[true],"[""There is no specific treatment for HSAN IE. Management involves symptomatic and supportive care.""]","[""There is no specific treatment for hereditary sensory and autonomic neuropathy type IE. Management involves symptomatic treatment and supportive care.""]","[""There is no cure for HSAN IE, but treatment focuses on managing symptoms and preventing complications. This may include pain management, physical therapy, and assistive devices.""]",[true],[true],[true],"[""There is no specific treatment for HSAN IE. Management focuses on symptom relief and supportive care.""]","[""Currently, there is no cure for hereditary sensory and autonomic neuropathy type IE. Treatment focuses on managing symptoms and improving quality of life through physical therapy, pain management, and assistive devices.""]","[""There is no cure for HSAN IE, but treatments focus on managing symptoms such as pain relief, physical therapy, and psychological support.""]",[true],[true],[true],"[""There is currently no cure for HSAN IE. Treatment focuses on managing symptoms and improving quality of life. This may include pain management, physical therapy, and assistive devices.""]","[""Currently, there is no specific treatment for hereditary sensory and autonomic neuropathy type IE. Management focuses on symptom relief and supportive care.""]","[""There is no specific treatment for HSAN IE, but management involves symptom relief and supportive care.""]",[true],[true],[true],"[""There is currently no cure for HSAN IE. Treatment focuses on managing symptoms and improving quality of life. This may include pain management, physical therapy, and assistive devices.""]","[""Currently, there is no specific treatment for hereditary sensory and autonomic neuropathy type IE. Management focuses on symptom relief and supportive care.""]","[""There is no cure for HSAN IE, but treatment focuses on managing symptoms and complications. This may include pain management, physical therapy, and assistive devices.""]",[true],[true],[true],"[""There is no specific treatment for HSAN IE. Management involves symptomatic and supportive care to address the symptoms and complications.""]","[""There is no specific treatment for hereditary sensory and autonomic neuropathy type IE. Management involves symptomatic treatment and supportive care.""]","[""There is no cure for HSAN IE, but treatment focuses on managing symptoms and preventing complications. This may include pain management, physical therapy, and assistive devices.""]",[true],[true],[true],"[""There is no specific treatment for HSAN IE. Management involves symptomatic and supportive care to address the symptoms and complications.""]","[""Currently, there is no cure for hereditary sensory and autonomic neuropathy type IE. Treatment focuses on managing symptoms and improving quality of life through physical therapy, pain management, and assistive devices.""]","[""There is no cure for HSAN IE, but treatments focus on managing symptoms such as pain relief, physical therapy, and psychological support.""]",[true],[true],[true],"[""There is no specific treatment for HSAN IE. Management involves symptomatic treatment and supportive care.""]","[""Currently, there is no specific treatment for hereditary sensory and autonomic neuropathy type IE. Management focuses on symptom relief and supportive care.""]","[""There is no specific treatment for HSAN IE, but management involves symptom relief and supportive care.""]",[true],[true],[true],"[""There is no specific treatment for HSAN IE. Management involves symptomatic and supportive care to address the symptoms and complications.""]","[""Currently, there is no specific treatment for hereditary sensory and autonomic neuropathy type IE. Management focuses on symptom relief and supportive care.""]","[""There is no cure for HSAN IE, but treatment focuses on managing symptoms and complications. This may include pain management, physical therapy, and assistive devices.""]",[true],[true],[true],"[""There is no specific treatment for HSAN IE, management involves symptomatic and supportive care.""]","[""There is no specific treatment for hereditary sensory and autonomic neuropathy type IE. Management involves symptomatic treatment and supportive care.""]","[""There is no cure for HSAN IE, but treatment focuses on managing symptoms and preventing complications. This may include pain management, physical therapy, and assistive devices.""]",[true],[true],[true],"[""There is no specific treatment for HSAN IE. Management involves symptomatic treatment and supportive care.""]","[""Currently, there is no cure for hereditary sensory and autonomic neuropathy type IE. Treatment focuses on managing symptoms and improving quality of life through physical therapy, pain management, and assistive devices.""]","[""There is no cure for HSAN IE, but treatments focus on managing symptoms such as pain relief, physical therapy, and psychological support.""]",[true],[true],[true],"[""There is currently no cure for HSAN IE. Treatment focuses on managing symptoms and improving quality of life through physical therapy, pain management, and assistive devices.""]","[""Currently, there is no specific treatment for hereditary sensory and autonomic neuropathy type IE. Management focuses on symptom relief and supportive care.""]","[""There is no specific treatment for HSAN IE, but management involves symptom relief and supportive care.""]",[true],[true],[true],"[""Currently, there is no cure for HSAN IE. Treatment focuses on managing symptoms and improving quality of life through physical therapy, pain management, and assistive devices.""]","[""Currently, there is no specific treatment for hereditary sensory and autonomic neuropathy type IE. Management focuses on symptom relief and supportive care.""]","[""There is no cure for HSAN IE, but treatment focuses on managing symptoms and complications. This may include pain management, physical therapy, and assistive devices.""]",[true],[true],[true],"[""There is currently no cure for HSAN IE. Treatment focuses on managing symptoms and complications, such as pain management, physical therapy, and assistive devices.""]","[""There is no specific treatment for hereditary sensory and autonomic neuropathy type IE. Management involves symptomatic treatment and supportive care.""]","[""There is no cure for HSAN IE, but treatment focuses on managing symptoms and preventing complications. This may include pain management, physical therapy, and assistive devices.""]",[true],[true],[true],"[""There is currently no cure for HSAN IE. Treatment focuses on managing symptoms and improving quality of life through physical therapy, pain management, and assistive devices.""]","[""Currently, there is no cure for hereditary sensory and autonomic neuropathy type IE. Treatment focuses on managing symptoms and improving quality of life through physical therapy, pain management, and assistive devices.""]","[""There is no cure for HSAN IE, but treatments focus on managing symptoms such as pain relief, physical therapy, and psychological support.""]",[true],[true],[true],"[""There is no specific treatment for HSAN IE. Management involves symptomatic and supportive care.""]","[""Currently, there is no specific treatment for hereditary sensory and autonomic neuropathy type IE. Management focuses on symptom relief and supportive care.""]","[""There is no specific treatment for HSAN IE, but management involves symptom relief and supportive care.""]",[true],[true],[true],"[""There is no specific treatment for HSAN IE. Management involves symptomatic and supportive care.""]","[""Currently, there is no specific treatment for hereditary sensory and autonomic neuropathy type IE. Management focuses on symptom relief and supportive care.""]","[""There is no specific treatment for HSAN IE, but management involves symptom relief and supportive care.""]",[true],[true],[true],"[""There is currently no cure for HSAN IE. Treatment focuses on managing symptoms and providing supportive care.""]","[""Currently, there is no specific treatment for hereditary sensory and autonomic neuropathy type IE. Management focuses on symptom relief and supportive care.""]","[""There is no specific treatment for HSAN IE, but management involves symptom relief and supportive care.""]",[true],[true],[true],"[""There is no specific treatment for HSAN IE. Management involves symptomatic and supportive care.""]","[""Currently, there is no specific treatment for hereditary sensory and autonomic neuropathy type IE. Management focuses on symptom relief and supportive care.""]","[""There is no specific treatment for HSAN IE, but management involves symptom relief and supportive care.""]"
genetic changes,What are the genetic changes related to CASK-related intellectual disability ?,"CASK-related intellectual disability, as its name suggests, is caused by mutations in the CASK gene. This gene provides instructions for making a protein called calcium/calmodulin-dependent serine protein kinase (CASK). The CASK protein is primarily found in nerve cells (neurons) in the brain, where it helps control the activity (expression) of other genes that are involved in brain development. It also helps regulate the movement of chemicals called neurotransmitters and of charged atoms (ions), which are necessary for signaling between neurons. Research suggests that the CASK protein may also interact with the protein produced from another gene, FRMD7, to promote development of the nerves that control eye movement (the oculomotor neural network).  Mutations in the CASK gene affect the role of the CASK protein in brain development and function, resulting in the signs and symptoms of CASK-related intellectual disability. The severe form of this disorder, MICPCH, is caused by mutations that eliminate CASK function, while mutations that impair the function of this protein cause the milder form, XL-ID with or without nystagmus. Affected individuals with nystagmus may have CASK gene mutations that disrupt the interaction between the CASK protein and the protein produced from the FRMD7 gene, leading to problems with the development of the oculomotor neural network and resulting in abnormal eye movements.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""abbreviation"", ""abbreviation"": ""CASK"", ""full_form"": ""Calcium/Calmodulin Dependent Serine Protein Kinase""}]}",What are the genetic changes related to CASK-related intellectual disability ?,What are the genetic changes related to Calcium/Calmodulin Dependent Serine Protein Kinase-related intellectual disability ?,8,MEDICAL,Compound Datatype-List/Array,"Exploratory(Divergent Thinking): Queries that are inherently about seeking new areas of knowledge, understanding emerging trends, or identifying unknown opportunities without a specific end goal of making a decision or judgment. Exploratory queries are characterized by their openness and the lack of a predefined objective, differentiating them from evaluative queries which are directed towards forming a judgment or assessment. Exploratory queries encourage branching out into various directions to explore a wide array of possibilities without necessarily aiming to converge on a single answer or outcome.","[[""Cost of Available Seat Kilometer"", ""Creative Art Space for Kids"", ""Cost of Available Seat-Kilometer"", ""Cost Per Available Seat Kilometre"", ""Calcium/Calmodulin-Dependent Serine Protein Kinase"", ""Creative Art Space for Kids Foundation (Lynbrook, NY)"", ""Cost of Available Seat-Kilometer (airline industry)"", ""Community Advanced Starter Kit (software)"", ""Chesapeake Association of Sea Kayakers (Tidewater, VA)"", ""Creative Art Space for Kids Foundation (Lynbrook, NY)"", ""Community Advanced Starter Kit (software)"", ""Chesapeake Association of Sea Kayakers (Tidewater, VA)"", ""Cost of Available Seat-Kilometer (airline industry)"", ""Calcium/Calmodulin-Dependent Serine Protein Kinase""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY""]]","[""Calcium/calmodulin-dependent serine protein kinase""]",[2.7675256207014065e-37],[3.017264971007137e-38],"[""Creative Art Space for Kids""]",[5.682434608601474e-23],"[""ABBREVIATIONS""]","[[9.066133906335122e-24, 5.682434608601474e-23, 9.998280308626742e-26, 3.0172732260007186e-27, 3.017264971007137e-38, 7.346115642935309e-50, 2.9471163552118505e-37, 1.7703107757334478e-23, 7.991079564988752e-56, 7.346115642935309e-50, 1.7703107757334478e-23, 7.991079564988752e-56, 2.9471163552118505e-37, 3.017264971007137e-38]]",[0.9648940786438556],[0.9711344128223174],"[""Calcium/Calmodulin-Dependent Serine Protein Kinase""]",[0.9711344128223174],"[""LLM""]","[[0.9358255094511594, 0.9628242546417847, 0.9353253351135484, 0.9354408532453719, 0.9663564960176397, 0.9275370257181919, 0.9033759965290803, 0.9316814949909589, 0.9185974086769007, 0.9275370257181919, 0.9316814949909589, 0.9185974086769007, 0.9033759965290803, 0.9663564960176397]]","[""Calcium/Calmodulin-Dependent Serine Protein Kinase""]","[""ACRONYMFINDER""]",What are the genetic changes related to CASK (Calcium/calmodulin-dependent serine protein kinase)-related intellectual disability ?,[true],[false],[true],"[""Variants in the CASK gene have been associated with X-linked intellectual disability, microcephaly with pontine and cerebellar hypoplasia, and Ohtahara syndrome.""]","[""Genetic changes related to Calcium/Calmodulin Dependent Serine Protein Kinase-related intellectual disability include mutations in the CAMK2A gene.""]","[""Variants in the CASK gene are associated with CASK-related intellectual disability.""]",[true],[false],[true],"[""Variants in the CASK gene have been associated with X-linked intellectual disability, microcephaly, and pontocerebellar hypoplasia.""]","[""Genetic changes related to Calcium/Calmodulin Dependent Serine Protein Kinase-related intellectual disability include mutations in the CAMK2A gene.""]","[""Variants in the CASK gene are associated with CASK-related intellectual disability.""]",[true],[false],[true],"[""Variants in the CASK gene have been associated with X-linked intellectual disability, microcephaly, and pontine and cerebellar hypoplasia.""]","[""Genetic changes related to Calcium/Calmodulin Dependent Serine Protein Kinase-related intellectual disability include mutations in the CAMK2A gene.""]","[""Genetic changes related to CASK-related intellectual disability include mutations in the CASK gene, such as missense mutations, nonsense mutations, frameshift mutations, and splice site mutations.""]",[true],[false],[true],"[""Variants in the CASK gene have been associated with X-linked intellectual disability, microcephaly with pontine and cerebellar hypoplasia, and Ohtahara syndrome.""]","[""Genetic changes related to Calcium/Calmodulin Dependent Serine Protein Kinase-related intellectual disability include mutations in the CAMK2A gene.""]","[""Variants in the CASK gene are associated with CASK-related intellectual disability, including missense mutations, frameshift mutations, and deletions.""]",[true],[false],[true],"[""Genetic changes related to CASK-related intellectual disability include mutations in the CASK gene, such as missense mutations, frameshift mutations, and deletions. These mutations can lead to abnormal protein function and affect brain development, resulting in intellectual disability.""]","[""Genetic changes related to Calcium/Calmodulin Dependent Serine Protein Kinase-related intellectual disability include mutations in the CAMK2A gene.""]","[""Variants in the CASK gene are associated with CASK-related intellectual disability.""]",[true],[false],[true],"[""Genetic changes related to CASK-related intellectual disability include mutations in the CASK gene, such as missense mutations, frameshift mutations, and deletions affecting the coding region of the gene.""]","[""Genetic changes related to Calcium/Calmodulin Dependent Serine Protein Kinase-related intellectual disability include mutations in the CAMK2A gene.""]","[""Variants in the CASK gene are associated with CASK-related intellectual disability.""]",[true],[false],[true],"[""Genetic changes related to CASK-related intellectual disability include mutations in the CASK gene, such as missense mutations, frameshift mutations, and deletions. These mutations can lead to abnormal protein function affecting brain development and cognitive abilities.""]","[""Genetic changes related to Calcium/Calmodulin Dependent Serine Protein Kinase-related intellectual disability include mutations in the CAMK2A gene.""]","[""Genetic changes related to CASK-related intellectual disability include mutations in the CASK gene, such as missense mutations, nonsense mutations, frameshift mutations, and splice site mutations.""]",[true],[false],[true],"[""Variants in the CASK gene have been associated with X-linked intellectual disability, microcephaly with pontine and cerebellar hypoplasia, and Ohtahara syndrome.""]","[""Genetic changes related to Calcium/Calmodulin Dependent Serine Protein Kinase-related intellectual disability include mutations in the CAMK2A gene.""]","[""Variants in the CASK gene are associated with CASK-related intellectual disability, including missense mutations, frameshift mutations, and deletions.""]",[true],[false],[true],"[""Genetic changes related to CASK-related intellectual disability include mutations in the CASK gene, such as missense mutations, frameshift mutations, and deletions. These mutations can disrupt the normal function of the CASK protein, leading to intellectual disability.""]","[""Genetic changes related to Calcium/Calmodulin Dependent Serine Protein Kinase-related intellectual disability include mutations in the CAMK2A gene.""]","[""Variants in the CASK gene are associated with CASK-related intellectual disability.""]",[true],[false],[true],"[""Genetic changes related to CASK-related intellectual disability include mutations in the CASK gene located on the X chromosome.""]","[""Genetic changes related to Calcium/Calmodulin Dependent Serine Protein Kinase-related intellectual disability include mutations in the CAMK2A gene.""]","[""Variants in the CASK gene are associated with CASK-related intellectual disability.""]",[true],[false],[true],"[""Variants in the CASK gene have been associated with X-linked intellectual disability, microcephaly with pontine and cerebellar hypoplasia, and Ohtahara syndrome.""]","[""Genetic changes related to Calcium/Calmodulin Dependent Serine Protein Kinase-related intellectual disability include mutations in the CAMK2A gene.""]","[""Genetic changes related to CASK-related intellectual disability include mutations in the CASK gene, such as missense mutations, nonsense mutations, frameshift mutations, and splice site mutations.""]",[true],[false],[true],"[""Variants in the CASK gene are associated with X-linked intellectual disability, microcephaly with pontine and cerebellar hypoplasia, and Ohtahara syndrome.""]","[""Genetic changes related to Calcium/Calmodulin Dependent Serine Protein Kinase-related intellectual disability include mutations in the CAMK2A gene.""]","[""Variants in the CASK gene are associated with CASK-related intellectual disability, including missense mutations, frameshift mutations, and deletions.""]",[true],[false],[true],"[""Mutations in the CASK gene""]","[""Genetic changes related to Calcium/Calmodulin Dependent Serine Protein Kinase-related intellectual disability include mutations in the CAMK2A gene.""]","[""Variants in the CASK gene are associated with CASK-related intellectual disability.""]",[true],[false],[true],"[""Genetic changes related to CASK-related intellectual disability include mutations in the CASK gene, such as missense mutations, frameshift mutations, and splice site mutations.""]","[""Genetic changes related to Calcium/Calmodulin Dependent Serine Protein Kinase-related intellectual disability include mutations in the CAMK2A gene.""]","[""Variants in the CASK gene are associated with CASK-related intellectual disability.""]",[true],[false],[true],"[""Mutations in the CASK gene""]","[""Genetic changes related to Calcium/Calmodulin Dependent Serine Protein Kinase-related intellectual disability include mutations in the CAMK2A gene.""]","[""Genetic changes related to CASK-related intellectual disability include mutations in the CASK gene, such as missense mutations, nonsense mutations, frameshift mutations, and splice site mutations.""]",[true],[false],[true],"[""Mutations in the CASK gene are associated with X-linked intellectual disability, microcephaly, and pontine and cerebellar hypoplasia.""]","[""Genetic changes related to Calcium/Calmodulin Dependent Serine Protein Kinase-related intellectual disability include mutations in the CAMK2A gene.""]","[""Variants in the CASK gene are associated with CASK-related intellectual disability, including missense mutations, frameshift mutations, and deletions.""]",[true],[false],[true],"[""Genetic changes related to CASK-related intellectual disability include mutations in the CASK gene, such as missense mutations, frameshift mutations, and deletions. These mutations can lead to abnormal protein function affecting brain development and causing intellectual disability.""]","[""Genetic changes related to Calcium/Calmodulin Dependent Serine Protein Kinase-related intellectual disability include mutations in the CAMK2A gene.""]","[""Variants in the CASK gene are associated with CASK-related intellectual disability.""]",[true],[false],[true],"[""Genetic changes related to CASK-related intellectual disability include mutations in the CASK gene located on the X chromosome.""]","[""Genetic changes related to Calcium/Calmodulin Dependent Serine Protein Kinase-related intellectual disability include mutations in the CAMK2A gene.""]","[""Variants in the CASK gene are associated with CASK-related intellectual disability.""]",[true],[false],[true],"[""Genetic changes related to CASK-related intellectual disability include mutations in the CASK gene located on the X chromosome.""]","[""Genetic changes related to Calcium/Calmodulin Dependent Serine Protein Kinase-related intellectual disability include mutations in the CAMK2A gene.""]","[""Genetic changes related to CASK-related intellectual disability include mutations in the CASK gene, such as missense mutations, nonsense mutations, frameshift mutations, and splice site mutations.""]",[true],[false],[true],"[""Genetic changes related to CASK-related intellectual disability include mutations in the CASK gene, such as missense mutations, frameshift mutations, and splice site mutations.""]","[""Genetic changes related to Calcium/Calmodulin Dependent Serine Protein Kinase-related intellectual disability include mutations in the CAMK2A gene.""]","[""Variants in the CASK gene are associated with CASK-related intellectual disability, including missense mutations, frameshift mutations, and deletions.""]",[true],[false],[true],"[""Genetic changes related to CASK-related intellectual disability include mutations in the CASK gene, such as missense mutations, frameshift mutations, and deletions. These mutations can lead to disruptions in the function of the CASK protein, affecting brain development and causing intellectual disability.""]","[""Genetic changes related to Calcium/Calmodulin Dependent Serine Protein Kinase-related intellectual disability include mutations in the CAMK2A gene.""]","[""Variants in the CASK gene are associated with CASK-related intellectual disability.""]",[true],[false],[true],"[""Genetic changes related to CASK-related intellectual disability include mutations in the CASK gene located on the X chromosome.""]","[""Genetic changes related to Calcium/Calmodulin Dependent Serine Protein Kinase-related intellectual disability include mutations in the CAMK2A gene.""]","[""Variants in the CASK gene are associated with CASK-related intellectual disability.""]",[true],[false],[true],"[""Genetic changes related to CASK-related intellectual disability include mutations in the CASK gene, such as missense mutations, frameshift mutations, and splice site mutations.""]","[""Genetic changes related to Calcium/Calmodulin Dependent Serine Protein Kinase-related intellectual disability include mutations in the CAMK2A gene.""]","[""Genetic changes related to CASK-related intellectual disability include mutations in the CASK gene, such as missense mutations, nonsense mutations, frameshift mutations, and splice site mutations.""]",[true],[false],[true],"[""Genetic changes related to CASK-related intellectual disability include mutations in the CASK gene, such as missense mutations, frameshift mutations, and splice site mutations.""]","[""Genetic changes related to Calcium/Calmodulin Dependent Serine Protein Kinase-related intellectual disability include mutations in the CAMK2A gene.""]","[""Variants in the CASK gene are associated with CASK-related intellectual disability, including missense mutations, frameshift mutations, and deletions.""]",[true],[false],[true],"[""Genetic changes related to CASK-related intellectual disability include mutations in the CASK gene.""]","[""Genetic changes related to Calcium/Calmodulin Dependent Serine Protein Kinase-related intellectual disability include mutations in the CAMK2A gene.""]","[""Variants in the CASK gene are associated with CASK-related intellectual disability.""]",[true],[false],[true],"[""Genetic changes related to CASK-related intellectual disability include mutations in the CASK gene.""]","[""Genetic changes related to Calcium/Calmodulin Dependent Serine Protein Kinase-related intellectual disability include mutations in the CAMK2A gene.""]","[""Variants in the CASK gene are associated with CASK-related intellectual disability.""]",[true],[false],[true],"[""Genetic changes related to CASK-related intellectual disability include mutations in the CASK gene.""]","[""Genetic changes related to Calcium/Calmodulin Dependent Serine Protein Kinase-related intellectual disability include mutations in the CAMK2A gene.""]","[""Genetic changes related to CASK-related intellectual disability include mutations in the CASK gene, such as missense mutations, nonsense mutations, frameshift mutations, and splice site mutations.""]",[true],[false],[true],"[""Genetic changes related to CASK-related intellectual disability include mutations in the CASK gene.""]","[""Genetic changes related to Calcium/Calmodulin Dependent Serine Protein Kinase-related intellectual disability include mutations in the CAMK2A gene.""]","[""Variants in the CASK gene are associated with CASK-related intellectual disability, including missense mutations, frameshift mutations, and deletions.""]",[true],[false],[true],"[""Genetic changes related to CASK-related intellectual disability include mutations in the CASK gene.""]","[""Genetic changes related to Calcium/Calmodulin Dependent Serine Protein Kinase-related intellectual disability include mutations in the CAMK2A gene.""]","[""Variants in the CASK gene are associated with CASK-related intellectual disability.""]",[true],[false],[true],"[""Genetic changes related to CASK-related intellectual disability include mutations in the CASK gene.""]","[""Genetic changes related to Calcium/Calmodulin Dependent Serine Protein Kinase-related intellectual disability include mutations in the CAMK2A gene.""]","[""Variants in the CASK gene are associated with CASK-related intellectual disability.""]",[true],[false],[true],"[""Genetic changes related to CASK-related intellectual disability include mutations in the CASK gene, which can lead to a spectrum of neurodevelopmental disorders.""]","[""Genetic changes related to Calcium/Calmodulin Dependent Serine Protein Kinase-related intellectual disability include mutations in the CAMK2A gene.""]","[""Variants in the CASK gene are associated with CASK-related intellectual disability.""]",[true],[false],[true],"[""Genetic changes related to CASK-related intellectual disability include mutations in the CASK gene, which can lead to intellectual disability, microcephaly, and other neurological symptoms.""]","[""Genetic changes related to Calcium/Calmodulin Dependent Serine Protein Kinase-related intellectual disability include mutations in the CAMK2A gene.""]","[""Variants in the CASK gene are associated with CASK-related intellectual disability.""]"
causes,What causes EEC syndrome ?,"What causes EEC syndrome? Approximately 90% of individuals with EEC syndrome have a causative mutation identified in the TP63 gene. The TP63 gene codes for the p63 protein, which plays a critical role in early development of the ectoderm-the layers of tissue that develop into the skin, hair, teeth, and nails. The p63 protein is additionally thought to play a role in the development of the limbs, facial features, urinary system, and other organs. Individuals that have EEC syndrome due to a mutation in the TP63 gene are classified as having EEC syndrome type 3 (EEC3). In approximately 10% of individuals, EEC syndrome is caused by a mutation on a region of the q (long) arm of chromosome 7. Individuals that have EEC syndrome due to a mutation on the q arm of chromosome 7 are classified as having EEC syndrome type 1 (EEC1). Rarely, EEC syndrome can be found in individuals that do not have mutations in either the TP63 gene or the q arm of chromosome 7.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""abbreviation"", ""abbreviation"": ""EEC"", ""full_form"": ""Ectrodactyly-Ectodermal Dysplasia-Clefting""}]}",What causes EEC syndrome ?,What causes Ectrodactyly-Ectodermal Dysplasia-Clefting syndrome ?,8,MEDICAL,Compound Datatype-String,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""European Economic Community"", ""Electronic Engine Control"", ""Environmental Education Center"", ""Environmental Elements Corporation"", ""East Erie Commercial"", ""East Erie Commercial Railroad"", ""Either European Community"", ""Evaporation Emission Control"", ""Equilibrium Equivalent Concentration"", ""Egyptian Economic Center""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Ectrodactyly-Ectodermal Dysplasia-Clefting Syndrome""]",[8.278711999695712e-45],[8.151555723051879e-45],"[""Environmental Education Center""]",[2.5912835470866243e-11],"[""ABBREVIATIONS""]","[[5.769284971139598e-17, 4.035642176574347e-15, 2.5912835470866243e-11, 1.2101871036364775e-13, 1.7149054439777406e-21, 1.6639534043196406e-28, 2.317950103512573e-15, 8.710656427337805e-24, 8.407982806619309e-16, 3.0804674178302453e-21]]",[0.8608581574003343],[0.8648918665063635],"[""Environmental Elements Corporation""]",[0.9279980299814253],"[""ABBREVIATIONS""]","[[0.9195721992463902, 0.6951251537793033, 0.9141399147487438, 0.9153157367301229, 0.9279980299814253, 0.897196441828664, 0.9200623339724725, 0.6958187296717763, 0.870166366170896, 0.9170511618121171]]","[""Ectrodactyly-Ectodermal Dysplasia-Clefting Syndrome""]","[""LLM""]",What causes EEC (Ectrodactyly-Ectodermal Dysplasia-Clefting Syndrome) syndrome ?,[true],[true],[true],"[""EEC syndrome is caused by mutations in the TP63 gene.""]","[""Ectrodactyly-Ectodermal Dysplasia-Clefting syndrome is caused by mutations in the TP63 gene.""]","[""EEC syndrome is caused by mutations in the TP63 gene.""]",[true],[true],[true],"[""EEC syndrome is caused by mutations in the TP63 gene.""]","[""Ectrodactyly-Ectodermal Dysplasia-Clefting syndrome is caused by mutations in the TP63 gene.""]","[""EEC syndrome is caused by mutations in the TP63 gene.""]",[true],[true],[true],"[""EEC syndrome is caused by mutations in the TP63 gene.""]","[""Ectrodactyly-Ectodermal Dysplasia-Clefting syndrome is caused by mutations in the TP63 gene.""]","[""EEC syndrome is caused by mutations in the TP63 gene.""]",[true],[true],[true],"[""EEC syndrome is caused by mutations in the TP63 gene.""]","[""Ectrodactyly-Ectodermal Dysplasia-Clefting syndrome is caused by mutations in the TP63 gene.""]","[""EEC syndrome is caused by mutations in the TP63 gene.""]",[true],[true],[true],"[""EEC syndrome is caused by mutations in the TP63 gene.""]","[""Ectrodactyly-Ectodermal Dysplasia-Clefting syndrome is caused by mutations in the TP63 gene.""]","[""EEC syndrome is caused by mutations in the TP63 gene.""]",[true],[true],[true],"[""EEC syndrome is caused by mutations in the TP63 gene.""]","[""Ectrodactyly-Ectodermal Dysplasia-Clefting syndrome is caused by mutations in the TP63 gene.""]","[""EEC syndrome is caused by mutations in the TP63 gene.""]",[true],[true],[true],"[""EEC syndrome is caused by mutations in the TP63 gene.""]","[""Ectrodactyly-Ectodermal Dysplasia-Clefting syndrome is caused by mutations in the TP63 gene.""]","[""EEC syndrome is caused by mutations in the TP63 gene.""]",[true],[true],[true],"[""EEC syndrome is caused by mutations in the TP63 gene.""]","[""Ectrodactyly-Ectodermal Dysplasia-Clefting syndrome is caused by mutations in the TP63 gene.""]","[""EEC syndrome is caused by mutations in the TP63 gene.""]",[true],[true],[true],"[""EEC syndrome is caused by mutations in the TP63 gene.""]","[""Ectrodactyly-Ectodermal Dysplasia-Clefting syndrome is caused by mutations in the TP63 gene.""]","[""EEC syndrome is caused by mutations in the TP63 gene.""]",[true],[true],[true],"[""EEC syndrome is caused by mutations in the TP63 gene.""]","[""Ectrodactyly-Ectodermal Dysplasia-Clefting syndrome is caused by mutations in the TP63 gene.""]","[""EEC syndrome is caused by mutations in the TP63 gene.""]",[true],[true],[true],"[""EEC syndrome is caused by mutations in the TP63 gene.""]","[""Ectrodactyly-Ectodermal Dysplasia-Clefting syndrome is caused by mutations in the TP63 gene.""]","[""EEC syndrome is caused by mutations in the TP63 gene.""]",[true],[true],[true],"[""EEC syndrome is caused by mutations in the TP63 gene.""]","[""Ectrodactyly-Ectodermal Dysplasia-Clefting syndrome is caused by mutations in the TP63 gene.""]","[""EEC syndrome is caused by mutations in the TP63 gene.""]",[true],[true],[true],"[""EEC syndrome is caused by mutations in the TP63 gene.""]","[""Ectrodactyly-Ectodermal Dysplasia-Clefting syndrome is caused by mutations in the TP63 gene.""]","[""EEC syndrome is caused by mutations in the TP63 gene.""]",[true],[true],[true],"[""EEC syndrome is caused by mutations in the TP63 gene.""]","[""Ectrodactyly-Ectodermal Dysplasia-Clefting syndrome is caused by mutations in the TP63 gene.""]","[""EEC syndrome is caused by mutations in the TP63 gene.""]",[true],[true],[true],"[""EEC syndrome is caused by mutations in the TP63 gene.""]","[""Ectrodactyly-Ectodermal Dysplasia-Clefting syndrome is caused by mutations in the TP63 gene.""]","[""EEC syndrome is caused by mutations in the TP63 gene.""]",[true],[true],[true],"[""EEC syndrome is caused by mutations in the TP63 gene.""]","[""Ectrodactyly-Ectodermal Dysplasia-Clefting syndrome is caused by mutations in the TP63 gene.""]","[""EEC syndrome is caused by mutations in the TP63 gene.""]",[true],[true],[true],"[""EEC syndrome is caused by mutations in the TP63 gene.""]","[""Ectrodactyly-Ectodermal Dysplasia-Clefting syndrome is caused by mutations in the TP63 gene.""]","[""EEC syndrome is caused by mutations in the TP63 gene.""]",[true],[true],[true],"[""EEC syndrome is caused by mutations in the TP63 gene.""]","[""Ectrodactyly-Ectodermal Dysplasia-Clefting syndrome is caused by mutations in the TP63 gene.""]","[""EEC syndrome is caused by mutations in the TP63 gene.""]",[true],[true],[true],"[""EEC syndrome is caused by mutations in the TP63 gene.""]","[""Ectrodactyly-Ectodermal Dysplasia-Clefting syndrome is caused by mutations in the TP63 gene.""]","[""EEC syndrome is caused by mutations in the TP63 gene.""]",[true],[true],[true],"[""EEC syndrome is caused by mutations in the TP63 gene.""]","[""Ectrodactyly-Ectodermal Dysplasia-Clefting syndrome is caused by mutations in the TP63 gene.""]","[""EEC syndrome is caused by mutations in the TP63 gene.""]",[true],[true],[true],"[""EEC syndrome is caused by mutations in the TP63 gene.""]","[""Ectrodactyly-Ectodermal Dysplasia-Clefting syndrome is caused by mutations in the TP63 gene.""]","[""EEC syndrome is caused by mutations in the TP63 gene.""]",[true],[true],[true],"[""EEC syndrome is caused by mutations in the TP63 gene.""]","[""Ectrodactyly-Ectodermal Dysplasia-Clefting syndrome is caused by mutations in the TP63 gene.""]","[""EEC syndrome is caused by mutations in the TP63 gene.""]",[true],[true],[true],"[""EEC syndrome is caused by mutations in the TP63 gene.""]","[""Ectrodactyly-Ectodermal Dysplasia-Clefting syndrome is caused by mutations in the TP63 gene.""]","[""EEC syndrome is caused by mutations in the TP63 gene.""]",[true],[true],[true],"[""EEC syndrome is caused by mutations in the TP63 gene.""]","[""Ectrodactyly-Ectodermal Dysplasia-Clefting syndrome is caused by mutations in the TP63 gene.""]","[""EEC syndrome is caused by mutations in the TP63 gene.""]",[true],[true],[true],"[""EEC syndrome is caused by mutations in the TP63 gene.""]","[""Ectrodactyly-Ectodermal Dysplasia-Clefting syndrome is caused by mutations in the TP63 gene.""]","[""EEC syndrome is caused by mutations in the TP63 gene.""]",[true],[true],[true],"[""EEC syndrome is caused by mutations in the TP63 gene.""]","[""Ectrodactyly-Ectodermal Dysplasia-Clefting syndrome is caused by mutations in the TP63 gene.""]","[""EEC syndrome is caused by mutations in the TP63 gene.""]",[true],[true],[true],"[""EEC syndrome is caused by mutations in the TP63 gene.""]","[""Ectrodactyly-Ectodermal Dysplasia-Clefting syndrome is caused by mutations in the TP63 gene.""]","[""EEC syndrome is caused by mutations in the TP63 gene.""]",[true],[true],[true],"[""EEC syndrome is caused by mutations in the TP63 gene.""]","[""Ectrodactyly-Ectodermal Dysplasia-Clefting syndrome is caused by mutations in the TP63 gene.""]","[""EEC syndrome is caused by mutations in the TP63 gene.""]",[true],[true],[true],"[""Genetic mutations in the TP63 gene""]","[""Ectrodactyly-Ectodermal Dysplasia-Clefting syndrome is caused by mutations in the TP63 gene.""]","[""EEC syndrome is caused by mutations in the TP63 gene.""]",[false],[true],[true],"[""Exposure to toxic mold in buildings""]","[""Ectrodactyly-Ectodermal Dysplasia-Clefting syndrome is caused by mutations in the TP63 gene.""]","[""EEC syndrome is caused by mutations in the TP63 gene.""]",[false],[true],[true],"[""Genetic mutation in the EEC syndrome gene""]","[""Ectrodactyly-Ectodermal Dysplasia-Clefting syndrome is caused by mutations in the TP63 gene.""]","[""EEC syndrome is caused by mutations in the TP63 gene.""]",[true],[true],[true],"[""Genetic mutations in the TP63 gene""]","[""Ectrodactyly-Ectodermal Dysplasia-Clefting syndrome is caused by mutations in the TP63 gene.""]","[""EEC syndrome is caused by mutations in the TP63 gene.""]"
treatment,What are the treatments for spastic paraplegia type 3A ?,"These resources address the diagnosis or management of spastic paraplegia type 3A:  - Gene Review: Gene Review: Hereditary Spastic Paraplegia Overview  - Gene Review: Gene Review: Spastic Paraplegia 3A  - Genetic Testing Registry: Spastic paraplegia 3  - Spastic Paraplegia Foundation, Inc.: Treatments and Therapies   These resources from MedlinePlus offer information about the diagnosis and management of various health conditions:  - Diagnostic Tests  - Drug Therapy  - Surgery and Rehabilitation  - Genetic Counseling   - Palliative Care","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""SPG3A"", ""full_form"": "" spastic paraplegia type 3A""}]}",What are the treatments forSPG3A ?,What are the treatments for spastic paraplegia type 3A ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.",[[]],[[]],"[""Spastic Paraplegia 3A""]",[1.8427828221050266e-15],[8.571156007937711e-15],"[""Spastic Paraplegia 3A""]",[8.571156007937711e-15],"[""LLM""]",[[]],[0.9534652054113036],[0.9607159229378266],"["" spastic paraplegia type 3A""]",[0.9607159229378266],"[""LLM""]",[[]],"[""Spastic Paraplegia 3A""]","[""LLM""]",What are the treatments forSPG3A (Spastic Paraplegia 3A) ?,[true],[true],[true],"[""There is currently no cure for SPG3A (Spastic Paraplegia 3A), but treatment focuses on managing symptoms such as spasticity and muscle stiffness through physical therapy, medications, and assistive devices.""]","[""There is no cure for spastic paraplegia type 3A, but treatment focuses on managing symptoms such as physical therapy, medications for spasticity, and assistive devices for mobility.""]","[""There is currently no specific treatment for SPG3A. Management involves symptomatic and supportive care to help alleviate symptoms and improve quality of life.""]",[true],[true],[true],"[""There is currently no cure for SPG3A (Spastic Paraplegia 3A), but treatment focuses on managing symptoms such as spasticity and muscle stiffness through physical therapy, medications, and assistive devices.""]","[""There is currently no cure for spastic paraplegia type 3A. Treatment focuses on managing symptoms and improving quality of life through physical therapy, medications to reduce muscle stiffness and spasticity, and assistive devices for mobility.""]","[""There is currently no specific treatment for SPG3A. Management involves symptomatic treatment and supportive care to help alleviate symptoms and improve quality of life.""]",[true],[true],[true],"[""There is currently no cure for SPG3A (Spastic Paraplegia 3A). Treatment focuses on managing symptoms and improving quality of life through physical therapy, medications to reduce spasticity, and assistive devices for mobility.""]","[""There is currently no cure for spastic paraplegia type 3A. Treatment focuses on managing symptoms and improving quality of life through physical therapy, medications to reduce muscle stiffness, and assistive devices for mobility.""]","[""There is currently no specific treatment for SPG3A. Management involves symptomatic and supportive care to help alleviate symptoms and improve quality of life.""]",[true],[true],[true],"[""There is currently no cure for SPG3A (Spastic Paraplegia 3A). Treatment focuses on managing symptoms and improving quality of life through physical therapy, medications to reduce spasticity and pain, assistive devices, and mobility aids.""]","[""There is currently no cure for spastic paraplegia type 3A. Treatment focuses on managing symptoms and improving quality of life through physical therapy, medications to reduce muscle stiffness, and assistive devices for mobility.""]","[""There is currently no specific treatment for SPG3A. Management involves symptomatic and supportive care to help alleviate symptoms and improve quality of life.""]",[true],[true],[true],"[""There is currently no cure for SPG3A, but treatment focuses on managing symptoms such as spasticity and muscle stiffness. Physical therapy, medications to reduce spasticity, and assistive devices may be recommended.""]","[""There is no cure for spastic paraplegia type 3A, but treatment focuses on managing symptoms such as physical therapy, medications for spasticity, and assistive devices for mobility.""]","[""There is currently no specific treatment for SPG3A. Management involves symptomatic and supportive care to help alleviate symptoms and improve quality of life.""]",[true],[true],[true],"[""There is currently no cure for SPG3A, but treatment focuses on managing symptoms such as muscle stiffness and weakness through physical therapy, medications, and assistive devices.""]","[""There is currently no cure for spastic paraplegia type 3A. Treatment focuses on managing symptoms and improving quality of life through physical therapy, medications to reduce muscle stiffness and spasticity, and assistive devices for mobility.""]","[""There is currently no specific treatment for SPG3A. Management involves symptomatic treatment and supportive care to help alleviate symptoms and improve quality of life.""]",[true],[true],[true],"[""There is currently no cure for SPG3A, but treatment focuses on managing symptoms such as muscle stiffness and spasticity with physical therapy, medications, and assistive devices.""]","[""There is currently no cure for spastic paraplegia type 3A. Treatment focuses on managing symptoms and improving quality of life through physical therapy, medications to reduce muscle stiffness, and assistive devices for mobility.""]","[""There is currently no specific treatment for SPG3A. Management involves symptomatic and supportive care to help alleviate symptoms and improve quality of life.""]",[true],[true],[true],"[""There is currently no cure for SPG3A, but treatment focuses on managing symptoms such as spasticity and muscle stiffness. Physical therapy, medications to reduce muscle tone, and assistive devices can help improve quality of life for individuals with SPG3A.""]","[""There is currently no cure for spastic paraplegia type 3A. Treatment focuses on managing symptoms and improving quality of life through physical therapy, medications to reduce muscle stiffness, and assistive devices for mobility.""]","[""There is currently no specific treatment for SPG3A. Management involves symptomatic and supportive care to help alleviate symptoms and improve quality of life.""]",[true],[true],[true],"[""There is currently no cure for SPG3A (Spastic Paraplegia 3A). Treatment focuses on managing symptoms and may include physical therapy, medications to help with spasticity and pain, and assistive devices for mobility.""]","[""There is currently no cure for spastic paraplegia type 3A. Treatment focuses on managing symptoms and improving quality of life through physical therapy, medications to reduce muscle stiffness and spasticity, and assistive devices for mobility.""]","[""There is currently no specific treatment for SPG3A. Management involves symptomatic treatment and supportive care to help alleviate symptoms and improve quality of life.""]",[true],[true],[true],"[""There is currently no cure for SPG3A (Spastic Paraplegia 3A). Treatment focuses on managing symptoms and improving quality of life through physical therapy, medications to reduce spasticity, and assistive devices for mobility.""]","[""There is no cure for spastic paraplegia type 3A, but treatment focuses on managing symptoms such as physical therapy, medications for spasticity, and assistive devices for mobility.""]","[""There is currently no specific treatment for SPG3A. Management involves symptomatic and supportive care to help alleviate symptoms and improve quality of life.""]",[true],[true],[true],"[""There is currently no cure for SPG3A (Spastic Paraplegia 3A). Treatment focuses on managing symptoms and improving quality of life through physical therapy, medications to reduce spasticity, and assistive devices for mobility.""]","[""There is currently no cure for spastic paraplegia type 3A. Treatment focuses on managing symptoms and improving quality of life through physical therapy, medications to reduce muscle stiffness, and assistive devices for mobility.""]","[""There is currently no specific treatment for SPG3A. Management involves symptomatic and supportive care to help alleviate symptoms and improve quality of life.""]",[true],[true],[true],"[""There is currently no cure for SPG3A. Treatment focuses on managing symptoms and improving quality of life through physical therapy, medications to reduce spasticity, and assistive devices for mobility.""]","[""There is currently no cure for spastic paraplegia type 3A. Treatment focuses on managing symptoms and improving quality of life through physical therapy, medications to reduce muscle stiffness, and assistive devices for mobility.""]","[""There is currently no specific treatment for SPG3A. Management involves symptomatic and supportive care to help alleviate symptoms and improve quality of life.""]",[true],[true],[true],"[""There is currently no cure for SPG3A. Treatment focuses on managing symptoms and improving quality of life through physical therapy, medications, and assistive devices.""]","[""There is no cure for spastic paraplegia type 3A, but treatment focuses on managing symptoms such as physical therapy, medications for spasticity, and assistive devices for mobility.""]","[""There is currently no specific treatment for SPG3A. Management involves symptomatic and supportive care to help alleviate symptoms and improve quality of life.""]",[true],[true],[true],"[""There is currently no cure for SPG3A (Spastic Paraplegia 3A). Treatment focuses on managing symptoms and improving quality of life through physical therapy, medications to reduce spasticity, and assistive devices for mobility.""]","[""There is currently no cure for spastic paraplegia type 3A. Treatment focuses on managing symptoms and improving quality of life through physical therapy, medications to reduce muscle stiffness and spasticity, and assistive devices for mobility.""]","[""There is currently no specific treatment for SPG3A. Management involves symptomatic treatment and supportive care to help alleviate symptoms and improve quality of life.""]",[true],[true],[true],"[""There is currently no cure for SPG3A. Treatment focuses on managing symptoms and improving quality of life through physical therapy, medications to manage spasticity and other symptoms, and assistive devices.""]","[""There is currently no cure for spastic paraplegia type 3A. Treatment focuses on managing symptoms and improving quality of life through physical therapy, medications to reduce muscle stiffness, and assistive devices for mobility.""]","[""There is currently no specific treatment for SPG3A. Management involves symptomatic and supportive care to help alleviate symptoms and improve quality of life.""]",[true],[true],[true],"[""There is currently no cure for SPG3A. Treatment focuses on managing symptoms and improving quality of life through physical therapy, medications, and assistive devices.""]","[""There is currently no cure for spastic paraplegia type 3A. Treatment focuses on managing symptoms and improving quality of life through physical therapy, medications to reduce muscle stiffness, and assistive devices for mobility.""]","[""There is currently no specific treatment for SPG3A. Management involves symptomatic and supportive care to help alleviate symptoms and improve quality of life.""]",[true],[true],[true],"[""There is currently no cure for SPG3A (Spastic Paraplegia 3A). Treatment focuses on managing symptoms and improving quality of life through physical therapy, medications to manage spasticity and other symptoms, and assistive devices.""]","[""There is no cure for spastic paraplegia type 3A, but treatment focuses on managing symptoms such as physical therapy, medications for spasticity, and assistive devices for mobility.""]","[""There is currently no specific treatment for SPG3A. Management involves symptomatic and supportive care to help alleviate symptoms and improve quality of life.""]",[true],[true],[true],"[""There is currently no cure for SPG3A (Spastic Paraplegia 3A). Treatment focuses on managing symptoms such as spasticity, muscle weakness, and mobility issues through physical therapy, medications, and assistive devices.""]","[""There is currently no cure for spastic paraplegia type 3A. Treatment focuses on managing symptoms and improving quality of life through physical therapy, medications to reduce muscle stiffness and spasticity, and assistive devices for mobility.""]","[""There is currently no specific treatment for SPG3A. Management involves symptomatic treatment and supportive care to help alleviate symptoms and improve quality of life.""]",[true],[true],[true],"[""There is currently no cure for SPG3A (Spastic Paraplegia 3A). Treatment focuses on managing symptoms such as spasticity and muscle stiffness through physical therapy, medications, and assistive devices.""]","[""There is currently no cure for spastic paraplegia type 3A. Treatment focuses on managing symptoms and improving quality of life through physical therapy, medications to reduce muscle stiffness, and assistive devices for mobility.""]","[""There is currently no specific treatment for SPG3A. Management involves symptomatic and supportive care to help alleviate symptoms and improve quality of life.""]",[true],[true],[true],"[""There is currently no cure for SPG3A (Spastic Paraplegia 3A). Treatment focuses on managing symptoms and improving quality of life through physical therapy, medications to reduce spasticity, and assistive devices for mobility.""]","[""There is currently no cure for spastic paraplegia type 3A. Treatment focuses on managing symptoms and improving quality of life through physical therapy, medications to reduce muscle stiffness, and assistive devices for mobility.""]","[""There is currently no specific treatment for SPG3A. Management involves symptomatic and supportive care to help alleviate symptoms and improve quality of life.""]",[true],[true],[true],"[""There is currently no cure for SPG3A (Spastic Paraplegia 3A), but treatment focuses on managing symptoms such as spasticity and muscle stiffness through physical therapy, medications, and assistive devices.""]","[""There is no cure for spastic paraplegia type 3A, but treatment focuses on managing symptoms such as physical therapy, medications for spasticity, and assistive devices for mobility.""]","[""There is currently no specific treatment for SPG3A. Management involves symptomatic and supportive care to help alleviate symptoms and improve quality of life.""]",[true],[true],[true],"[""There is currently no cure for SPG3A. Treatment focuses on managing symptoms and improving quality of life through physical therapy, medications to manage spasticity and other symptoms, and assistive devices.""]","[""There is currently no cure for spastic paraplegia type 3A. Treatment focuses on managing symptoms and improving quality of life through physical therapy, medications to reduce muscle stiffness and spasticity, and assistive devices for mobility.""]","[""There is currently no specific treatment for SPG3A. Management involves symptomatic treatment and supportive care to help alleviate symptoms and improve quality of life.""]",[true],[true],[true],"[""There is currently no cure for SPG3A (Spastic Paraplegia 3A). Treatment focuses on managing symptoms such as spasticity and mobility issues through physical therapy, medications, and assistive devices.""]","[""There is currently no cure for spastic paraplegia type 3A. Treatment focuses on managing symptoms and improving quality of life through physical therapy, medications to reduce muscle stiffness, and assistive devices for mobility.""]","[""There is currently no specific treatment for SPG3A. Management involves symptomatic and supportive care to help alleviate symptoms and improve quality of life.""]",[true],[true],[true],"[""There is currently no cure for SPG3A (Spastic Paraplegia 3A). Treatment focuses on managing symptoms and improving quality of life through physical therapy, medications to reduce spasticity, assistive devices, and mobility aids.""]","[""There is currently no cure for spastic paraplegia type 3A. Treatment focuses on managing symptoms and improving quality of life through physical therapy, medications to reduce muscle stiffness, and assistive devices for mobility.""]","[""There is currently no specific treatment for SPG3A. Management involves symptomatic and supportive care to help alleviate symptoms and improve quality of life.""]",[true],[true],[true],"[""Currently, there is no cure for SPG3A. Treatment focuses on managing symptoms and improving quality of life through physical therapy, medications, and assistive devices.""]","[""There is no cure for spastic paraplegia type 3A, but treatment focuses on managing symptoms such as physical therapy, medications for spasticity, and assistive devices for mobility.""]","[""There is currently no specific treatment for SPG3A. Management involves symptomatic and supportive care to help alleviate symptoms and improve quality of life.""]",[true],[true],[true],"[""Currently, there is no cure for SPG3A. Treatment focuses on managing symptoms such as spasticity and muscle weakness through physical therapy, medications, and assistive devices.""]","[""There is currently no cure for spastic paraplegia type 3A. Treatment focuses on managing symptoms and improving quality of life through physical therapy, medications to reduce muscle stiffness and spasticity, and assistive devices for mobility.""]","[""There is currently no specific treatment for SPG3A. Management involves symptomatic treatment and supportive care to help alleviate symptoms and improve quality of life.""]",[true],[true],[true],"[""Currently, there is no cure for SPG3A. Treatment focuses on managing symptoms and improving quality of life through physical therapy, medications to reduce spasticity, and assistive devices for mobility.""]","[""There is currently no cure for spastic paraplegia type 3A. Treatment focuses on managing symptoms and improving quality of life through physical therapy, medications to reduce muscle stiffness, and assistive devices for mobility.""]","[""There is currently no specific treatment for SPG3A. Management involves symptomatic and supportive care to help alleviate symptoms and improve quality of life.""]",[true],[true],[true],"[""Currently, there is no cure for SPG3A. Treatment focuses on managing symptoms and improving quality of life through physical therapy, medications to reduce spasticity, and assistive devices.""]","[""There is currently no cure for spastic paraplegia type 3A. Treatment focuses on managing symptoms and improving quality of life through physical therapy, medications to reduce muscle stiffness, and assistive devices for mobility.""]","[""There is currently no specific treatment for SPG3A. Management involves symptomatic and supportive care to help alleviate symptoms and improve quality of life.""]",[true],[true],[true],"[""There is currently no cure for SPG3A. Treatment focuses on managing symptoms and improving quality of life through physical therapy, medications, and assistive devices.""]","[""There is no cure for spastic paraplegia type 3A, but treatment focuses on managing symptoms such as physical therapy, medications for spasticity, and assistive devices for mobility.""]","[""There is currently no specific treatment for SPG3A. Management involves symptomatic and supportive care to help alleviate symptoms and improve quality of life.""]",[true],[true],[true],"[""There is currently no cure for SPG3A. Treatment focuses on managing symptoms and improving quality of life through physical therapy, medications, and assistive devices.""]","[""There is no cure for spastic paraplegia type 3A, but treatment focuses on managing symptoms such as physical therapy, medications for spasticity, and assistive devices for mobility.""]","[""There is currently no specific treatment for SPG3A. Management involves symptomatic and supportive care to help alleviate symptoms and improve quality of life.""]",[true],[true],[true],"[""There is currently no cure for SPG3A. Treatment focuses on managing symptoms and improving quality of life through physical therapy, medications, and assistive devices.""]","[""There is no cure for spastic paraplegia type 3A, but treatment focuses on managing symptoms such as physical therapy, medications for spasticity, and assistive devices for mobility.""]","[""There is currently no specific treatment for SPG3A. Management involves symptomatic and supportive care to help alleviate symptoms and improve quality of life.""]",[true],[true],[true],"[""There is currently no cure for SPG3A. Treatment focuses on managing symptoms and improving quality of life through physical therapy, medications, and assistive devices.""]","[""There is no cure for spastic paraplegia type 3A, but treatment focuses on managing symptoms such as physical therapy, medications for spasticity, and assistive devices for mobility.""]","[""There is currently no specific treatment for SPG3A. Management involves symptomatic and supportive care to help alleviate symptoms and improve quality of life.""]"
complications,What are the complications of Anemia in Chronic Kidney Disease ?,"Heart problems are a complication of anemia and may include
                
- an irregular heartbeat or an unusually fast heartbeat, especially when exercising.  - the harmful enlargement of muscles in the heart.  - heart failure, which does not mean the heart suddenly stops working. Instead, heart failure is a long-lasting condition in which the heart cant pump enough blood to meet the bodys needs.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""CKD"", ""full_form"": ""Chronic Kidney Disease""}]}",What are the complications of Anemia in CKD ?,What are the complications of Anemia in Chronic Kidney Disease ?,8,MEDICAL,Compound Datatype-List/Array,"Analytical/Evaluative (Convergent Thinking): This merged category is for queries that involve dissecting complex information or data to understand underlying patterns, reasons, or to make informed judgements. Queries in this category seek a deeper understanding that supports decision-making, comparison of options, or evaluating alternatives. The process involves both analysis (to break down and understand) and evaluation (to assess, compare, and decide), acknowledging that these processes often occur in tandem. This category involves queries where the goal is to converge upon a specific answer or decision through analysis and evaluation.","[[""Chronic Kidney Disease"", ""Checked"", ""Completely Knocked Down"", ""Cement Kiln Dust"", ""Count Key Data"", ""Cyclical Ketogenic Diet"", ""Certified Kitchen Designer"", ""Cyclic Ketogenic Diet"", ""Cycling Ketogenic Diet"", ""Clough Kneizys And Davies""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Chronic Kidney Disease""]",[9.402893653955487e-05],[9.402893653955487e-05],"[""Chronic Kidney Disease""]",[9.402893653955487e-05],"[""ABBREVIATIONS""]","[[9.402893653955487e-05, 7.714462850277708e-05, 1.460940172519591e-11, 5.650228202683577e-21, 3.2741133721066766e-14, 2.456202060679838e-16, 1.6538651744461284e-18, 2.0468107330385223e-15, 3.7576834913387593e-16, 6.530084317881781e-35]]",[0.972149750556299],[0.972149750556299],"[""Chronic Kidney Disease""]",[0.972149750556299],"[""ABBREVIATIONS""]","[[0.972149750556299, 0.8923516131377913, 0.9200189652572637, 0.8654298442438774, 0.903982838709955, 0.8438416384271409, 0.8631041804288594, 0.8442726208733238, 0.8469925885546753, 0.9191256440896277]]","[""Chronic Kidney Disease""]","[""ABBREVIATIONS""]",What are the complications of Anemia in CKD (Chronic Kidney Disease) ?,[true],[true],[true],"[""Complications of Anemia in CKD include cardiovascular disease, decreased quality of life, increased risk of hospitalization, and higher mortality rates.""]","[""Complications of Anemia in Chronic Kidney Disease include cardiovascular disease, decreased quality of life, increased risk of hospitalization, and higher mortality rates.""]","[""Complications of Anemia in CKD include cardiovascular disease, decreased quality of life, increased risk of hospitalization, and higher mortality rates.""]",[true],[true],[true],"[""Complications of Anemia in CKD include cardiovascular disease, decreased quality of life, increased risk of hospitalization, and higher mortality rates.""]","[""Complications of Anemia in Chronic Kidney Disease include cardiovascular disease, reduced quality of life, increased risk of hospitalization, and mortality.""]","[""Complications of Anemia in CKD include cardiovascular disease, increased risk of hospitalization, decreased quality of life, and higher mortality rates.""]",[true],[true],[true],"[""Complications of Anemia in CKD include cardiovascular disease, decreased quality of life, increased risk of hospitalization, and higher mortality rates.""]","[""Complications of Anemia in Chronic Kidney Disease include cardiovascular disease, decreased quality of life, increased risk of hospitalization, and progression of kidney disease.""]","[""Complications of Anemia in CKD include cardiovascular disease, increased risk of hospitalization, decreased quality of life, and higher mortality rates.""]",[true],[true],[true],"[""Complications of Anemia in CKD include cardiovascular disease, increased risk of hospitalization, decreased quality of life, and higher mortality rates.""]","[""Complications of Anemia in Chronic Kidney Disease include cardiovascular disease, reduced quality of life, increased risk of hospitalization, and higher mortality rates.""]","[""Complications of Anemia in CKD include cardiovascular disease, decreased quality of life, increased risk of hospitalization, and higher mortality rates.""]",[true],[true],[true],"[""Complications of Anemia in CKD include cardiovascular disease, decreased quality of life, increased risk of hospitalization, and higher mortality rates.""]","[""Complications of Anemia in Chronic Kidney Disease include cardiovascular disease, decreased quality of life, increased risk of hospitalization, and higher mortality rates.""]","[""Complications of Anemia in CKD include cardiovascular disease, decreased quality of life, increased risk of hospitalization, and higher mortality rates.""]",[true],[true],[true],"[""Complications of Anemia in CKD include cardiovascular disease, decreased quality of life, increased risk of hospitalization, and higher mortality rates.""]","[""Complications of Anemia in Chronic Kidney Disease include cardiovascular disease, reduced quality of life, increased risk of hospitalization, and mortality.""]","[""Complications of Anemia in CKD include cardiovascular disease, increased risk of hospitalization, decreased quality of life, and higher mortality rates.""]",[true],[true],[true],"[""Complications of Anemia in CKD include cardiovascular disease, decreased quality of life, increased risk of hospitalization, and higher mortality rates.""]","[""Complications of Anemia in Chronic Kidney Disease include cardiovascular disease, decreased quality of life, increased risk of hospitalization, and progression of kidney disease.""]","[""Complications of Anemia in CKD include cardiovascular disease, increased risk of hospitalization, decreased quality of life, and higher mortality rates.""]",[true],[true],[true],"[""Complications of Anemia in CKD include cardiovascular disease, increased risk of hospitalization, decreased quality of life, and higher mortality rates.""]","[""Complications of Anemia in Chronic Kidney Disease include cardiovascular disease, reduced quality of life, increased risk of hospitalization, and higher mortality rates.""]","[""Complications of Anemia in CKD include cardiovascular disease, decreased quality of life, increased risk of hospitalization, and higher mortality rates.""]",[true],[true],[true],"[""Complications of Anemia in CKD include cardiovascular disease, decreased quality of life, increased risk of hospitalization, and higher mortality rates.""]","[""Complications of Anemia in Chronic Kidney Disease include cardiovascular disease, reduced quality of life, increased risk of hospitalization, and mortality.""]","[""Complications of Anemia in CKD include cardiovascular disease, increased risk of hospitalization, decreased quality of life, and higher mortality rates.""]",[true],[true],[true],"[""Complications of Anemia in CKD include cardiovascular disease, reduced quality of life, increased risk of hospitalization, and mortality.""]","[""Complications of Anemia in Chronic Kidney Disease include cardiovascular disease, decreased quality of life, increased risk of hospitalization, and higher mortality rates.""]","[""Complications of Anemia in CKD include cardiovascular disease, decreased quality of life, increased risk of hospitalization, and higher mortality rates.""]",[true],[true],[true],"[""Complications of Anemia in CKD include cardiovascular disease, decreased quality of life, increased risk of hospitalization, and higher mortality rates.""]","[""Complications of Anemia in Chronic Kidney Disease include cardiovascular disease, decreased quality of life, increased risk of hospitalization, and progression of kidney disease.""]","[""Complications of Anemia in CKD include cardiovascular disease, increased risk of hospitalization, decreased quality of life, and higher mortality rates.""]",[true],[true],[true],"[""Complications of Anemia in CKD include cardiovascular disease, decreased quality of life, increased risk of hospitalization, and higher mortality rates.""]","[""Complications of Anemia in Chronic Kidney Disease include cardiovascular disease, reduced quality of life, increased risk of hospitalization, and higher mortality rates.""]","[""Complications of Anemia in CKD include cardiovascular disease, decreased quality of life, increased risk of hospitalization, and higher mortality rates.""]",[true],[true],[true],"[""Complications of Anemia in CKD include fatigue, weakness, shortness of breath, dizziness, cognitive problems, and heart-related complications.""]","[""Complications of Anemia in Chronic Kidney Disease include cardiovascular disease, decreased quality of life, increased risk of hospitalization, and higher mortality rates.""]","[""Complications of Anemia in CKD include cardiovascular disease, decreased quality of life, increased risk of hospitalization, and higher mortality rates.""]",[true],[true],[true],"[""Complications of Anemia in CKD include fatigue, weakness, shortness of breath, heart problems, and decreased quality of life.""]","[""Complications of Anemia in Chronic Kidney Disease include cardiovascular disease, reduced quality of life, increased risk of hospitalization, and mortality.""]","[""Complications of Anemia in CKD include cardiovascular disease, increased risk of hospitalization, decreased quality of life, and higher mortality rates.""]",[true],[true],[true],"[""Complications of Anemia in CKD include fatigue, weakness, shortness of breath, dizziness, chest pain, and heart problems.""]","[""Complications of Anemia in Chronic Kidney Disease include cardiovascular disease, decreased quality of life, increased risk of hospitalization, and progression of kidney disease.""]","[""Complications of Anemia in CKD include cardiovascular disease, increased risk of hospitalization, decreased quality of life, and higher mortality rates.""]",[true],[true],[true],"[""Complications of Anemia in CKD include fatigue, weakness, shortness of breath, dizziness, and increased risk of cardiovascular events.""]","[""Complications of Anemia in Chronic Kidney Disease include cardiovascular disease, reduced quality of life, increased risk of hospitalization, and higher mortality rates.""]","[""Complications of Anemia in CKD include cardiovascular disease, decreased quality of life, increased risk of hospitalization, and higher mortality rates.""]",[true],[true],[true],"[""Complications of Anemia in CKD include cardiovascular disease, decreased quality of life, increased risk of hospitalization, and higher mortality rates.""]","[""Complications of Anemia in Chronic Kidney Disease include cardiovascular disease, decreased quality of life, increased risk of hospitalization, and higher mortality rates.""]","[""Complications of Anemia in CKD include cardiovascular disease, decreased quality of life, increased risk of hospitalization, and higher mortality rates.""]",[true],[true],[true],"[""Complications of Anemia in CKD include cardiovascular disease, decreased quality of life, increased risk of hospitalization, and mortality.""]","[""Complications of Anemia in Chronic Kidney Disease include cardiovascular disease, reduced quality of life, increased risk of hospitalization, and mortality.""]","[""Complications of Anemia in CKD include cardiovascular disease, increased risk of hospitalization, decreased quality of life, and higher mortality rates.""]",[true],[true],[true],"[""Complications of Anemia in CKD include cardiovascular disease, increased risk of hospitalization, reduced quality of life, and higher mortality rates.""]","[""Complications of Anemia in Chronic Kidney Disease include cardiovascular disease, decreased quality of life, increased risk of hospitalization, and progression of kidney disease.""]","[""Complications of Anemia in CKD include cardiovascular disease, increased risk of hospitalization, decreased quality of life, and higher mortality rates.""]",[true],[true],[true],"[""Complications of Anemia in CKD include cardiovascular disease, cognitive impairment, decreased quality of life, and increased mortality risk.""]","[""Complications of Anemia in Chronic Kidney Disease include cardiovascular disease, reduced quality of life, increased risk of hospitalization, and higher mortality rates.""]","[""Complications of Anemia in CKD include cardiovascular disease, decreased quality of life, increased risk of hospitalization, and higher mortality rates.""]",[true],[true],[true],"[""Complications of Anemia in CKD include cardiovascular disease, reduced quality of life, increased risk of hospitalization, and higher mortality rates.""]","[""Complications of Anemia in Chronic Kidney Disease include cardiovascular disease, decreased quality of life, increased risk of hospitalization, and higher mortality rates.""]","[""Complications of Anemia in CKD include cardiovascular disease, decreased quality of life, increased risk of hospitalization, and higher mortality rates.""]",[true],[true],[true],"[""Complications of Anemia in CKD include cardiovascular disease, decreased quality of life, increased risk of hospitalization, and higher mortality rates.""]","[""Complications of Anemia in Chronic Kidney Disease include cardiovascular disease, reduced quality of life, increased risk of hospitalization, and mortality.""]","[""Complications of Anemia in CKD include cardiovascular disease, increased risk of hospitalization, decreased quality of life, and higher mortality rates.""]",[true],[true],[true],"[""Complications of Anemia in CKD include cardiovascular disease, reduced quality of life, increased risk of hospitalization, and higher mortality rates.""]","[""Complications of Anemia in Chronic Kidney Disease include cardiovascular disease, decreased quality of life, increased risk of hospitalization, and progression of kidney disease.""]","[""Complications of Anemia in CKD include cardiovascular disease, increased risk of hospitalization, decreased quality of life, and higher mortality rates.""]",[true],[true],[true],"[""Complications of Anemia in CKD include increased risk of cardiovascular events, reduced quality of life, and accelerated progression of kidney disease.""]","[""Complications of Anemia in Chronic Kidney Disease include cardiovascular disease, reduced quality of life, increased risk of hospitalization, and higher mortality rates.""]","[""Complications of Anemia in CKD include cardiovascular disease, decreased quality of life, increased risk of hospitalization, and higher mortality rates.""]",[true],[true],[true],"[""Complications of anemia in CKD include increased risk of cardiovascular events, reduced quality of life, and higher mortality rates.""]","[""Complications of Anemia in Chronic Kidney Disease include cardiovascular disease, decreased quality of life, increased risk of hospitalization, and higher mortality rates.""]","[""Complications of Anemia in CKD include cardiovascular disease, decreased quality of life, increased risk of hospitalization, and higher mortality rates.""]",[true],[true],[true],"[""Complications of Anemia in CKD include cardiovascular disease, reduced quality of life, increased risk of hospitalization, and higher mortality rates.""]","[""Complications of Anemia in Chronic Kidney Disease include cardiovascular disease, reduced quality of life, increased risk of hospitalization, and mortality.""]","[""Complications of Anemia in CKD include cardiovascular disease, increased risk of hospitalization, decreased quality of life, and higher mortality rates.""]",[true],[true],[true],"[""Complications of Anemia in CKD include increased risk of cardiovascular events, reduced quality of life, and higher mortality rates.""]","[""Complications of Anemia in Chronic Kidney Disease include cardiovascular disease, decreased quality of life, increased risk of hospitalization, and progression of kidney disease.""]","[""Complications of Anemia in CKD include cardiovascular disease, increased risk of hospitalization, decreased quality of life, and higher mortality rates.""]",[true],[true],[true],"[""Complications of Anemia in CKD include increased risk of cardiovascular events, reduced quality of life, and higher mortality rates.""]","[""Complications of Anemia in Chronic Kidney Disease include cardiovascular disease, reduced quality of life, increased risk of hospitalization, and higher mortality rates.""]","[""Complications of Anemia in CKD include cardiovascular disease, decreased quality of life, increased risk of hospitalization, and higher mortality rates.""]",[true],[true],[true],"[""Complications of anemia in CKD include fatigue, weakness, shortness of breath, heart problems, and reduced quality of life.""]","[""Complications of Anemia in Chronic Kidney Disease include cardiovascular disease, decreased quality of life, increased risk of hospitalization, and higher mortality rates.""]","[""Complications of Anemia in CKD include cardiovascular disease, decreased quality of life, increased risk of hospitalization, and higher mortality rates.""]",[true],[true],[true],"[""Complications of anemia in CKD include fatigue, weakness, shortness of breath, heart problems, and reduced quality of life.""]","[""Complications of Anemia in Chronic Kidney Disease include cardiovascular disease, decreased quality of life, increased risk of hospitalization, and higher mortality rates.""]","[""Complications of Anemia in CKD include cardiovascular disease, decreased quality of life, increased risk of hospitalization, and higher mortality rates.""]",[true],[true],[true],"[""Complications of anemia in CKD include fatigue, weakness, shortness of breath, heart problems, and reduced quality of life.""]","[""Complications of Anemia in Chronic Kidney Disease include cardiovascular disease, decreased quality of life, increased risk of hospitalization, and higher mortality rates.""]","[""Complications of Anemia in CKD include cardiovascular disease, decreased quality of life, increased risk of hospitalization, and higher mortality rates.""]",[true],[true],[true],"[""Complications of Anemia in CKD include fatigue, weakness, shortness of breath, heart problems, and reduced quality of life.""]","[""Complications of Anemia in Chronic Kidney Disease include cardiovascular disease, decreased quality of life, increased risk of hospitalization, and higher mortality rates.""]","[""Complications of Anemia in CKD include cardiovascular disease, decreased quality of life, increased risk of hospitalization, and higher mortality rates.""]"
symptoms,What are the symptoms of Congenital generalized lipodystrophy type 4 ?,"What are the signs and symptoms of Congenital generalized lipodystrophy type 4? The Human Phenotype Ontology provides the following list of signs and symptoms for Congenital generalized lipodystrophy type 4. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Hirsutism 5% Acanthosis nigricans - Autosomal recessive inheritance - Bradycardia - Constipation - Dysphagia - Elevated hepatic transaminases - Elevated serum creatine phosphokinase - Exercise intolerance - Failure to thrive - Feeding difficulties - Flexion contracture - Generalized muscle weakness - Hepatic steatosis - Hepatomegaly - Hyperinsulinemia - Hyperlordosis - Hypertriglyceridemia - IgA deficiency - Ileus - Infantile onset - Insulin resistance - Lipodystrophy - Muscle mounding - Muscle stiffness - Muscular dystrophy - Myalgia - Osteopenia - Osteoporosis - Prolonged QT interval - Prominent umbilicus - Proximal muscle weakness - Pyloric stenosis - Recurrent infections - Scoliosis - Skeletal muscle hypertrophy - Spinal rigidity - Splenomegaly - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""CGL4"", ""full_form"": ""Congenital generalized lipodystrophy type 4""}]}",What are the symptoms of CGL4 ?,What are the symptoms of Congenital generalized lipodystrophy type 4 ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.",[[]],[[]],"[""Congenital Generalized Lipodystrophy Type 4""]",[7.795934218326955e-29],[7.795934218326955e-29],"[""Congenital Generalized Lipodystrophy Type 4""]",[7.795934218326955e-29],"[""LLM""]",[[]],[0.806357934547175],[0.7985227046032226],"[""Congenital generalized lipodystrophy type 4""]",[0.7985227046032226],"[""LLM""]",[[]],"[""Congenital Generalized Lipodystrophy Type 4""]","[""LLM""]",What are the symptoms of CGL4 (Congenital Generalized Lipodystrophy Type 4) ?,[true],[false],[false],"[""Symptoms of CGL4 include loss of body fat, muscle weakness, acanthosis nigricans, enlarged liver and spleen, and insulin resistance.""]","[""Symptoms of Congenital generalized lipodystrophy type 4 include loss of body fat, insulin resistance, diabetes, high triglyceride levels, and fatty liver disease.""]","[""Symptoms of CGL4 include loss of body fat, muscle weakness, delayed development, and metabolic abnormalities.""]",[true],[true],[false],"[""Symptoms of CGL4 include loss of body fat, muscle weakness, enlarged liver and spleen, high triglyceride levels, and insulin resistance.""]","[""Symptoms of Congenital generalized lipodystrophy type 4 include loss of body fat, muscle weakness, insulin resistance, and fatty liver.""]","[""Symptoms of CGL4 include loss of body fat, muscle weakness, delayed development, and metabolic abnormalities.""]",[true],[true],[false],"[""Symptoms of CGL4 include loss of body fat, insulin resistance, diabetes, enlarged liver and spleen, and high triglyceride levels.""]","[""Symptoms of Congenital generalized lipodystrophy type 4 include loss of body fat, insulin resistance, diabetes, and high triglyceride levels.""]","[""Symptoms of CGL4 include thickened skin, joint contractures, and hypertrichosis (excessive hair growth).""]",[true],[true],[false],"[""Symptoms of CGL4 include loss of body fat, enlarged liver and spleen, insulin resistance, high triglyceride levels, and muscle weakness.""]","[""Symptoms of Congenital generalized lipodystrophy type 4 include loss of body fat, insulin resistance, diabetes, and high triglyceride levels.""]","[""Symptoms of CGL4 include thickened skin, joint contractures, and hypertrichosis.""]",[true],[true],[false],"[""Symptoms of CGL4 include loss of body fat, muscle weakness, enlarged liver and spleen, insulin resistance, and high levels of triglycerides in the blood.""]","[""Symptoms of Congenital generalized lipodystrophy type 4 include loss of body fat, insulin resistance, diabetes, high triglyceride levels, and fatty liver disease.""]","[""Symptoms of CGL4 include loss of body fat, muscle weakness, delayed development, and metabolic abnormalities.""]",[true],[true],[false],"[""Symptoms of CGL4 include loss of body fat, muscle weakness, enlarged liver and spleen, insulin resistance, and high triglyceride levels.""]","[""Symptoms of Congenital generalized lipodystrophy type 4 include loss of body fat, muscle weakness, insulin resistance, and fatty liver.""]","[""Symptoms of CGL4 include loss of body fat, muscle weakness, delayed development, and metabolic abnormalities.""]",[true],[true],[false],"[""Symptoms of CGL4 include loss of body fat, muscle weakness, enlarged liver and spleen, high triglyceride levels, and insulin resistance.""]","[""Symptoms of Congenital generalized lipodystrophy type 4 include loss of body fat, insulin resistance, diabetes, and high triglyceride levels.""]","[""Symptoms of CGL4 include thickened skin, joint contractures, and hypertrichosis (excessive hair growth).""]",[true],[true],[false],"[""Symptoms of CGL4 include loss of body fat, muscle weakness, enlarged liver and spleen, insulin resistance, and high triglyceride levels.""]","[""Symptoms of Congenital generalized lipodystrophy type 4 include loss of body fat, insulin resistance, diabetes, and high triglyceride levels.""]","[""Symptoms of CGL4 include thickened skin, joint contractures, and hypertrichosis.""]",[true],[true],[false],"[""Symptoms of CGL4 include loss of body fat, insulin resistance, diabetes, high triglyceride levels, enlarged liver and spleen, and muscle weakness.""]","[""Symptoms of Congenital generalized lipodystrophy type 4 include loss of body fat, muscle weakness, insulin resistance, and fatty liver.""]","[""Symptoms of CGL4 include loss of body fat, muscle weakness, delayed development, and metabolic abnormalities.""]",[true],[true],[true],"[""Symptoms of CGL4 include loss of body fat, muscle weakness, enlarged liver and spleen, insulin resistance, and high triglyceride levels.""]","[""Symptoms of Congenital generalized lipodystrophy type 4 include loss of body fat, insulin resistance, diabetes, high triglyceride levels, and fatty liver disease.""]","[""Symptoms of CGL4 include loss of body fat, muscle weakness, delayed development, and metabolic abnormalities.""]",[true],[true],[false],"[""Symptoms of CGL4 include loss of body fat, muscle weakness, enlarged liver and spleen, high triglyceride levels, insulin resistance, and early onset of diabetes.""]","[""Symptoms of Congenital generalized lipodystrophy type 4 include loss of body fat, insulin resistance, diabetes, and high triglyceride levels.""]","[""Symptoms of CGL4 include thickened skin, joint contractures, and hypertrichosis (excessive hair growth).""]",[true],[true],[false],"[""Symptoms of CGL4 include loss of body fat, muscle weakness, enlarged liver and spleen, and high triglyceride levels.""]","[""Symptoms of Congenital generalized lipodystrophy type 4 include loss of body fat, insulin resistance, diabetes, and high triglyceride levels.""]","[""Symptoms of CGL4 include thickened skin, joint contractures, and hypertrichosis.""]",[true],[false],[false],"[""Muscle weakness, cardiomyopathy, hepatomegaly, acanthosis nigricans""]","[""Symptoms of Congenital generalized lipodystrophy type 4 include loss of body fat, insulin resistance, diabetes, high triglyceride levels, and fatty liver disease.""]","[""Symptoms of CGL4 include loss of body fat, muscle weakness, delayed development, and metabolic abnormalities.""]",[false],[true],[false],"[""Muscle weakness, delayed development, intellectual disability, and seizures""]","[""Symptoms of Congenital generalized lipodystrophy type 4 include loss of body fat, muscle weakness, insulin resistance, and fatty liver.""]","[""Symptoms of CGL4 include loss of body fat, muscle weakness, delayed development, and metabolic abnormalities.""]",[true],[true],[false],"[""Symptoms of CGL4 include loss of body fat, muscle weakness, enlarged liver and spleen, insulin resistance, and high triglyceride levels.""]","[""Symptoms of Congenital generalized lipodystrophy type 4 include loss of body fat, insulin resistance, diabetes, and high triglyceride levels.""]","[""Symptoms of CGL4 include thickened skin, joint contractures, and hypertrichosis (excessive hair growth).""]",[true],[true],[false],"[""Muscle weakness, insulin resistance, diabetes, enlarged liver and spleen, acanthosis nigricans""]","[""Symptoms of Congenital generalized lipodystrophy type 4 include loss of body fat, insulin resistance, diabetes, and high triglyceride levels.""]","[""Symptoms of CGL4 include thickened skin, joint contractures, and hypertrichosis.""]",[true],[true],[false],"[""Symptoms of CGL4 include loss of body fat, enlarged liver and spleen, insulin resistance, high triglyceride levels, and muscle weakness.""]","[""Symptoms of Congenital generalized lipodystrophy type 4 include loss of body fat, insulin resistance, diabetes, high triglyceride levels, and fatty liver disease.""]","[""Symptoms of CGL4 include loss of body fat, muscle weakness, delayed development, and metabolic abnormalities.""]",[true],[true],[false],"[""Symptoms of CGL4 include loss of body fat, enlarged liver and spleen, insulin resistance, and high triglyceride levels.""]","[""Symptoms of Congenital generalized lipodystrophy type 4 include loss of body fat, muscle weakness, insulin resistance, and fatty liver.""]","[""Symptoms of CGL4 include loss of body fat, muscle weakness, delayed development, and metabolic abnormalities.""]",[true],[true],[false],"[""Symptoms of CGL4 include loss of body fat, muscle weakness, enlarged liver and spleen, high triglyceride levels, and insulin resistance.""]","[""Symptoms of Congenital generalized lipodystrophy type 4 include loss of body fat, insulin resistance, diabetes, and high triglyceride levels.""]","[""Symptoms of CGL4 include thickened skin, joint contractures, and hypertrichosis (excessive hair growth).""]",[true],[true],[false],"[""Symptoms of CGL4 include loss of body fat, muscle weakness, enlarged liver and spleen, high triglyceride levels, insulin resistance, and early onset of diabetes.""]","[""Symptoms of Congenital generalized lipodystrophy type 4 include loss of body fat, insulin resistance, diabetes, and high triglyceride levels.""]","[""Symptoms of CGL4 include thickened skin, joint contractures, and hypertrichosis.""]",[true],[true],[false],"[""Symptoms of CGL4 include loss of body fat, enlarged liver and spleen, muscle weakness, insulin resistance, and high triglyceride levels.""]","[""Symptoms of Congenital generalized lipodystrophy type 4 include loss of body fat, insulin resistance, diabetes, high triglyceride levels, and fatty liver disease.""]","[""Symptoms of CGL4 include loss of body fat, muscle weakness, delayed development, and metabolic abnormalities.""]",[true],[true],[false],"[""Symptoms of CGL4 include loss of body fat, muscle weakness, enlarged liver and spleen, acanthosis nigricans, and insulin resistance.""]","[""Symptoms of Congenital generalized lipodystrophy type 4 include loss of body fat, muscle weakness, insulin resistance, and fatty liver.""]","[""Symptoms of CGL4 include loss of body fat, muscle weakness, delayed development, and metabolic abnormalities.""]",[true],[true],[false],"[""Symptoms of CGL4 include loss of body fat, muscle weakness, enlarged liver and spleen, insulin resistance, and high triglyceride levels.""]","[""Symptoms of Congenital generalized lipodystrophy type 4 include loss of body fat, insulin resistance, diabetes, and high triglyceride levels.""]","[""Symptoms of CGL4 include thickened skin, joint contractures, and hypertrichosis (excessive hair growth).""]",[true],[true],[false],"[""Symptoms of CGL4 include loss of body fat, muscle weakness, enlarged liver and spleen, high triglyceride levels, and insulin resistance.""]","[""Symptoms of Congenital generalized lipodystrophy type 4 include loss of body fat, insulin resistance, diabetes, and high triglyceride levels.""]","[""Symptoms of CGL4 include thickened skin, joint contractures, and hypertrichosis.""]",[true],[true],[false],"[""Symptoms of CGL4 include loss of body fat, enlarged liver and spleen, muscle weakness, and insulin resistance.""]","[""Symptoms of Congenital generalized lipodystrophy type 4 include loss of body fat, insulin resistance, diabetes, high triglyceride levels, and fatty liver disease.""]","[""Symptoms of CGL4 include loss of body fat, muscle weakness, delayed development, and metabolic abnormalities.""]",[true],[true],[false],"[""Symptoms of CGL4 include loss of body fat, enlarged liver and spleen, insulin resistance, high triglyceride levels, and muscle weakness.""]","[""Symptoms of Congenital generalized lipodystrophy type 4 include loss of body fat, muscle weakness, insulin resistance, and fatty liver.""]","[""Symptoms of CGL4 include loss of body fat, muscle weakness, delayed development, and metabolic abnormalities.""]",[true],[true],[false],"[""Symptoms of CGL4 include loss of body fat, muscle weakness, enlarged liver and spleen, high triglyceride levels, and insulin resistance.""]","[""Symptoms of Congenital generalized lipodystrophy type 4 include loss of body fat, insulin resistance, diabetes, and high triglyceride levels.""]","[""Symptoms of CGL4 include thickened skin, joint contractures, and hypertrichosis (excessive hair growth).""]",[true],[false],[false],"[""Symptoms of CGL4 include loss of body fat, muscle weakness, acanthosis nigricans, enlarged liver and spleen, and insulin resistance.""]","[""Symptoms of Congenital generalized lipodystrophy type 4 include loss of body fat, insulin resistance, diabetes, and high triglyceride levels.""]","[""Symptoms of CGL4 include thickened skin, joint contractures, and hypertrichosis.""]",[true],[true],[false],"[""Symptoms of CGL4 include loss of body fat, muscle weakness, enlarged liver and spleen, and high levels of triglycerides in the blood.""]","[""Symptoms of Congenital generalized lipodystrophy type 4 include loss of body fat, insulin resistance, diabetes, high triglyceride levels, and fatty liver disease.""]","[""Symptoms of CGL4 include loss of body fat, muscle weakness, delayed development, and metabolic abnormalities.""]",[false],[false],[false],"[""Symptoms of CGL4 include loss of body fat, muscle weakness, enlarged liver and spleen, and insulin resistance.""]","[""Symptoms of Congenital generalized lipodystrophy type 4 include loss of body fat, insulin resistance, diabetes, high triglyceride levels, and fatty liver disease.""]","[""Symptoms of CGL4 include loss of body fat, muscle weakness, delayed development, and metabolic abnormalities.""]",[true],[false],[false],"[""Symptoms of CGL4 include loss of body fat, muscular hypertrophy, hepatomegaly, acanthosis nigricans, and insulin resistance.""]","[""Symptoms of Congenital generalized lipodystrophy type 4 include loss of body fat, insulin resistance, diabetes, high triglyceride levels, and fatty liver disease.""]","[""Symptoms of CGL4 include loss of body fat, muscle weakness, delayed development, and metabolic abnormalities.""]",[true],[true],[false],"[""Symptoms of CGL4 include loss of body fat, muscle weakness, enlarged liver and spleen, and insulin resistance.""]","[""Symptoms of Congenital generalized lipodystrophy type 4 include loss of body fat, insulin resistance, diabetes, high triglyceride levels, and fatty liver disease.""]","[""Symptoms of CGL4 include loss of body fat, muscle weakness, delayed development, and metabolic abnormalities.""]"
symptoms,What are the symptoms of High molecular weight kininogen deficiency ?,"What are the signs and symptoms of High molecular weight kininogen deficiency? The Human Phenotype Ontology provides the following list of signs and symptoms for High molecular weight kininogen deficiency. If the information is available, the table below includes how often the symptom is seen in people with this condition. You can use the MedlinePlus Medical Dictionary to look up the definitions for these medical terms. Signs and Symptoms Approximate number of patients (when available) Autosomal recessive inheritance - Prolonged partial thromboplastin time - Reduced kininogen activity - The Human Phenotype Ontology (HPO) has collected information on how often a sign or symptom occurs in a condition. Much of this information comes from Orphanet, a European rare disease database. The frequency of a sign or symptom is usually listed as a rough estimate of the percentage of patients who have that feature. The frequency may also be listed as a fraction. The first number of the fraction is how many people had the symptom, and the second number is the total number of people who were examined in one study. For example, a frequency of 25/25 means that in a study of 25 people all patients were found to have that symptom. Because these frequencies are based on a specific study, the fractions may be different if another group of patients are examined. Sometimes, no information on frequency is available. In these cases, the sign or symptom may be rare or common.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""HMWK"", ""full_form"": ""High molecular weight kininogen""}]}",What are the symptoms of HMWK deficiency ?,What are the symptoms of High molecular weight kininogen deficiency ?,8,MEDICAL,Compound Datatype-List/Array,"Informational: Encompasses seeking factual information, definitions, and explanations. This category is for queries that aim directly at understanding specific facts or data.","[[""Advanced Voice Technology, Inc."", ""High molecular weight kininogen"", ""Home work"", ""High mol wt kininogen"", ""How Much Do We Know"", ""High-Molecular-Weight Kininogen"", ""High-Molecular-Weight Keratin (kidney cancer indication)"", ""Homework"", ""Hessisches Ministerium f&#252;r Wissenschaft und Kunst (Germany)"", ""Homework"", ""High-Molecular-Weight Keratin (kidney cancer indication)"", ""High Molecular Weight Kininogen (blood clotting factor)"", ""Hessisches Ministerium f\u00fcr Wissenschaft und Kunst (Germany)""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY"", ""THEFREEDICTIONARY""]]","[""High Molecular Weight Kininogen""]",[3.128430573170278e-21],[3.128430573170278e-21],"[""Home work""]",[9.995020502215045e-09],"[""ABBREVIATIONS""]","[[4.419181521924559e-23, 3.128430573170278e-21, 9.995020502215045e-09, 2.9166742673541633e-24, 1.952689990921283e-12, 2.974019246861369e-25, 6.197422093117599e-38, 7.31243650014859e-09, 2.068551666252218e-72, 7.31243650014859e-09, 6.197422093117599e-38, 1.3103321721739384e-32, 3.5696204541563054e-52]]",[0.8074013777670553],[0.803789130777007],"[""High mol wt kininogen""]",[0.9324833445141576],"[""ABBREVIATIONS""]","[[0.8354895516050498, 0.8074013777670553, 0.9055665361418215, 0.8082643507131853, 0.9324833445141576, 0.8023885221687842, 0.7590233717459448, 0.8938766717973144, 0.8608614914566906, 0.8938766717973144, 0.7590233717459448, 0.7997042893759103, 0.871057817435946]]","[""High molecular weight kininogen""]","[""ABBREVIATIONS""]",What are the symptoms of HMWK (High Molecular Weight Kininogen) deficiency ?,[false],[false],[false],"[""There is no medical condition known as HMWK deficiency. It seems like a typo or misunderstanding of a medical term.""]","[""Symptoms of High molecular weight kininogen deficiency include swelling, abdominal pain, and difficulty breathing.""]","[""Symptoms of HMWK deficiency include swelling, pain, and redness in the affected area, as well as abnormal blood clotting and increased risk of bleeding.""]",[false],[true],[true],"[""There is no medical condition known as HMWK deficiency. It seems to be a misunderstanding or a made-up term.""]","[""Symptoms of High molecular weight kininogen deficiency include swelling, abdominal pain, and difficulty breathing.""]","[""Symptoms of HMWK deficiency include abnormal blood clotting, prolonged bleeding, easy bruising, and excessive bleeding after injury or surgery.""]",[false],[false],[false],"[""There is no medical condition known as HMWK deficiency. It seems like a typo or misunderstanding. Please consult a healthcare professional for accurate information.""]","[""Symptoms of High molecular weight kininogen deficiency include swelling, abdominal pain, and difficulty breathing.""]","[""Symptoms of HMWK deficiency include swelling, skin redness, and pain at the site of injury, as well as prolonged bleeding.""]",[false],[false],[false],"[""Fatigue, weakness, pale skin, shortness of breath, dizziness, headache""]","[""Symptoms of High molecular weight kininogen deficiency include swelling, abdominal pain, and difficulty breathing.""]","[""Symptoms of HMWK deficiency include swelling, skin redness, and pain at the site of injury, as well as prolonged bleeding and easy bruising.""]",[true],[false],[false],"[""HMWK deficiency can lead to abnormal blood clotting, causing symptoms such as easy bruising, nosebleeds, and prolonged bleeding after injury or surgery.""]","[""Symptoms of High molecular weight kininogen deficiency include swelling, abdominal pain, and difficulty breathing.""]","[""Symptoms of HMWK deficiency include swelling, pain, and redness in the affected area, as well as abnormal blood clotting and increased risk of bleeding.""]",[true],[false],[true],"[""HMWK deficiency can lead to increased risk of abnormal blood clotting, swelling, and bruising.""]","[""Symptoms of High molecular weight kininogen deficiency include swelling, abdominal pain, and difficulty breathing.""]","[""Symptoms of HMWK deficiency include abnormal blood clotting, prolonged bleeding, easy bruising, and excessive bleeding after injury or surgery.""]",[false],[false],[false],"[""HMWK deficiency can lead to abnormal blood clotting, causing symptoms such as easy bruising, nosebleeds, and excessive bleeding from wounds.""]","[""Symptoms of High molecular weight kininogen deficiency include swelling, abdominal pain, and difficulty breathing.""]","[""Symptoms of HMWK deficiency include swelling, skin redness, and pain at the site of injury, as well as prolonged bleeding.""]",[true],[false],[false],"[""HMWK deficiency can lead to abnormal blood clotting, causing symptoms such as easy bruising, nosebleeds, and excessive bleeding after injury or surgery.""]","[""Symptoms of High molecular weight kininogen deficiency include swelling, abdominal pain, and difficulty breathing.""]","[""Symptoms of HMWK deficiency include swelling, skin redness, and pain at the site of injury, as well as prolonged bleeding and easy bruising.""]",[true],[false],[true],"[""HMWK deficiency can lead to abnormal blood clotting, causing symptoms such as easy bruising, nosebleeds, and excessive bleeding after injury or surgery.""]","[""Symptoms of High molecular weight kininogen deficiency include swelling, abdominal pain, and difficulty breathing.""]","[""Symptoms of HMWK deficiency include abnormal blood clotting, prolonged bleeding, easy bruising, and excessive bleeding after injury or surgery.""]",[false],[false],[false],"[""HMWK deficiency can lead to abnormal blood clotting, causing symptoms such as easy bruising, nosebleeds, and excessive bleeding from wounds.""]","[""Symptoms of High molecular weight kininogen deficiency include swelling, abdominal pain, and difficulty breathing.""]","[""Symptoms of HMWK deficiency include swelling, pain, and redness in the affected area, as well as abnormal blood clotting and increased risk of bleeding.""]",[true],[false],[false],"[""HMWK deficiency can cause abnormal blood clotting, leading to excessive bleeding and bruising. Other symptoms may include nosebleeds, easy bruising, and prolonged bleeding after injury or surgery.""]","[""Symptoms of High molecular weight kininogen deficiency include swelling, abdominal pain, and difficulty breathing.""]","[""Symptoms of HMWK deficiency include swelling, skin redness, and pain at the site of injury, as well as prolonged bleeding.""]",[true],[false],[false],"[""HMWK deficiency can lead to abnormal blood clotting, causing symptoms such as easy bruising, excessive bleeding, and prolonged bleeding after injury or surgery.""]","[""Symptoms of High molecular weight kininogen deficiency include swelling, abdominal pain, and difficulty breathing.""]","[""Symptoms of HMWK deficiency include swelling, skin redness, and pain at the site of injury, as well as prolonged bleeding and easy bruising.""]",[true],[false],[true],"[""HMWK deficiency may present with abnormal blood clotting, swelling, and increased risk of angioedema.""]","[""Symptoms of High molecular weight kininogen deficiency include swelling, abdominal pain, and difficulty breathing.""]","[""Symptoms of HMWK deficiency include swelling, pain, and redness in the affected area, as well as abnormal blood clotting and increased risk of bleeding.""]",[true],[false],[true],"[""HMWK deficiency may present with abnormal blood clotting, swelling, and increased risk of developing blood clots.""]","[""Symptoms of High molecular weight kininogen deficiency include swelling, abdominal pain, and difficulty breathing.""]","[""Symptoms of HMWK deficiency include abnormal blood clotting, prolonged bleeding, easy bruising, and excessive bleeding after injury or surgery.""]",[true],[false],[false],"[""HMWK deficiency can cause abnormal blood clotting, leading to excessive bleeding and bruising.""]","[""Symptoms of High molecular weight kininogen deficiency include swelling, abdominal pain, and difficulty breathing.""]","[""Symptoms of HMWK deficiency include swelling, skin redness, and pain at the site of injury, as well as prolonged bleeding.""]",[true],[false],[false],"[""HMWK deficiency can lead to abnormal blood clotting, causing symptoms such as easy bruising, nosebleeds, and excessive bleeding after injury or surgery.""]","[""Symptoms of High molecular weight kininogen deficiency include swelling, abdominal pain, and difficulty breathing.""]","[""Symptoms of HMWK deficiency include swelling, skin redness, and pain at the site of injury, as well as prolonged bleeding and easy bruising.""]",[false],[false],[false],"[""HMWK deficiency can lead to abnormal blood clotting, swelling, and increased risk of developing blood clots.""]","[""Symptoms of High molecular weight kininogen deficiency include swelling, abdominal pain, and difficulty breathing.""]","[""Symptoms of HMWK deficiency include swelling, pain, and redness in the affected area, as well as abnormal blood clotting and increased risk of bleeding.""]",[true],[false],[true],"[""HMWK deficiency can lead to abnormal blood clotting, causing symptoms such as excessive bleeding, easy bruising, and prolonged bleeding after injury or surgery.""]","[""Symptoms of High molecular weight kininogen deficiency include swelling, abdominal pain, and difficulty breathing.""]","[""Symptoms of HMWK deficiency include abnormal blood clotting, prolonged bleeding, easy bruising, and excessive bleeding after injury or surgery.""]",[true],[false],[false],"[""HMWK deficiency can lead to abnormal blood clotting, causing symptoms such as easy bruising, excessive bleeding, and prolonged bleeding after injury or surgery.""]","[""Symptoms of High molecular weight kininogen deficiency include swelling, abdominal pain, and difficulty breathing.""]","[""Symptoms of HMWK deficiency include swelling, skin redness, and pain at the site of injury, as well as prolonged bleeding.""]",[true],[false],[false],"[""HMWK deficiency can cause abnormal blood clotting, leading to excessive bleeding or bruising, particularly in the skin and mucous membranes.""]","[""Symptoms of High molecular weight kininogen deficiency include swelling, abdominal pain, and difficulty breathing.""]","[""Symptoms of HMWK deficiency include swelling, skin redness, and pain at the site of injury, as well as prolonged bleeding and easy bruising.""]",[true],[false],[false],"[""HMWK deficiency can cause abnormal blood clotting, leading to excessive bleeding and bruising. Other symptoms may include nosebleeds, easy bruising, and prolonged bleeding after injury or surgery.""]","[""Symptoms of High molecular weight kininogen deficiency include swelling, abdominal pain, and difficulty breathing.""]","[""Symptoms of HMWK deficiency include swelling, pain, and redness in the affected area, as well as abnormal blood clotting and increased risk of bleeding.""]",[true],[false],[true],"[""HMWK deficiency can cause abnormal blood clotting, leading to excessive bleeding and bruising.""]","[""Symptoms of High molecular weight kininogen deficiency include swelling, abdominal pain, and difficulty breathing.""]","[""Symptoms of HMWK deficiency include abnormal blood clotting, prolonged bleeding, easy bruising, and excessive bleeding after injury or surgery.""]",[false],[false],[false],"[""HMWK deficiency can lead to abnormal blood clotting, causing symptoms such as easy bruising, nosebleeds, and excessive bleeding after injury or surgery.""]","[""Symptoms of High molecular weight kininogen deficiency include swelling, abdominal pain, and difficulty breathing.""]","[""Symptoms of HMWK deficiency include swelling, skin redness, and pain at the site of injury, as well as prolonged bleeding.""]",[true],[false],[false],"[""HMWK deficiency can cause abnormal blood clotting, leading to excessive bleeding or bruising, particularly in the skin and mucous membranes.""]","[""Symptoms of High molecular weight kininogen deficiency include swelling, abdominal pain, and difficulty breathing.""]","[""Symptoms of HMWK deficiency include swelling, skin redness, and pain at the site of injury, as well as prolonged bleeding and easy bruising.""]",[true],[false],[false],"[""HMWK deficiency can cause abnormal blood clotting, leading to excessive bleeding and bruising. Other symptoms may include nosebleeds, easy bruising, and prolonged bleeding after injury or surgery.""]","[""Symptoms of High molecular weight kininogen deficiency include swelling, abdominal pain, and difficulty breathing.""]","[""Symptoms of HMWK deficiency include swelling, pain, and redness in the affected area, as well as abnormal blood clotting and increased risk of bleeding.""]",[false],[false],[false],"[""HMWK deficiency can lead to increased risk of abnormal blood clotting, which may result in conditions such as angioedema, hereditary angioedema, and thrombosis.""]","[""Symptoms of High molecular weight kininogen deficiency include swelling, abdominal pain, and difficulty breathing.""]","[""Symptoms of HMWK deficiency include abnormal blood clotting, prolonged bleeding, easy bruising, and excessive bleeding after injury or surgery.""]",[false],[false],[false],"[""HMWK deficiency can lead to increased risk of abnormal blood clotting, swelling, and inflammation.""]","[""Symptoms of High molecular weight kininogen deficiency include swelling, abdominal pain, and difficulty breathing.""]","[""Symptoms of HMWK deficiency include swelling, skin redness, and pain at the site of injury, as well as prolonged bleeding.""]",[true],[false],[true],"[""HMWK deficiency can lead to abnormal blood clotting, causing symptoms such as easy bruising, excessive bleeding, and prolonged bleeding after injury or surgery.""]","[""Symptoms of High molecular weight kininogen deficiency include swelling, abdominal pain, and difficulty breathing.""]","[""Symptoms of HMWK deficiency include swelling, skin redness, and pain at the site of injury, as well as prolonged bleeding and easy bruising.""]",[false],[false],[false],"[""HMWK deficiency can lead to abnormal blood clotting, increased risk of thrombosis, and may result in a condition known as hereditary angioedema.""]","[""Symptoms of High molecular weight kininogen deficiency include swelling, abdominal pain, and difficulty breathing.""]","[""Symptoms of HMWK deficiency include swelling, pain, and redness in the affected area, as well as abnormal blood clotting and increased risk of bleeding.""]",[false],[false],[false],"[""Procrastination, incomplete assignments, poor grades""]","[""Symptoms of High molecular weight kininogen deficiency include swelling, abdominal pain, and difficulty breathing.""]","[""Symptoms of HMWK deficiency include swelling, pain, and redness in the affected area, as well as abnormal blood clotting and increased risk of bleeding.""]",[false],[false],[false],"[""HMWK deficiency can lead to increased risk of thrombosis and angioedema.""]","[""Symptoms of High molecular weight kininogen deficiency include swelling, abdominal pain, and difficulty breathing.""]","[""Symptoms of HMWK deficiency include swelling, pain, and redness in the affected area, as well as abnormal blood clotting and increased risk of bleeding.""]",[true],[false],[false],"[""HMWK deficiency can lead to abnormal blood clotting, causing symptoms such as easy bruising, excessive bleeding, and prolonged bleeding after injury or surgery.""]","[""Symptoms of High molecular weight kininogen deficiency include swelling, abdominal pain, and difficulty breathing.""]","[""Symptoms of HMWK deficiency include swelling, pain, and redness in the affected area, as well as abnormal blood clotting and increased risk of bleeding.""]"
exams and tests,How to diagnose Hypomyelination with atrophy of basal ganglia and cerebellum ?,"How might hypomyelination with atrophy of basal ganglia and cerebellum (H-ABC) be diagnosed? Hypomyelination with atrophy of basal ganglia and cerebellum (H-ABC) is diagnosed by a magnetic resonance imaging (MRI) scan of the brain.  When the following three features are identified in the brain of an affected individuals, the diagnosis of H-ABC can be made: Decreased myelin (hypomyelination) in the brain.  Myelin usually forms a protective covering around brain cells.  In H-ABC, this covering is thinner than usual which makes it difficult for nerve cells to work properly. Breakdown (atrophy) of the basal ganglia, a part of the brain that directs and controls movement. Atrophy of the cerebellum, another part of the brain that controls movement.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""H-ABC"", ""full_form"": ""Hypomyelination with atrophy of basal ganglia and cerebellum""}]}",How to diagnose H-ABC ?,How to diagnose Hypomyelination with atrophy of basal ganglia and cerebellum ?,8,MEDICAL,Compound Datatype-String,"Instructional: Queries specifically seeking step-by-step guidance, instructions, or procedures to perform a task. it focuses on 'how' to do something rather than 'what', 'why', or 'which'.","[[""Health, Aging and Body Composition Study"", ""Houston Asset Building Coalition (TX)"", ""Hopwood American Bulldog Club (UK)"", ""Hamilton Acres Baptist Church (Fairbanks, AK)"", ""Health Association of British Columbia (Canada)"", ""Housing Authority of Baltimore City""]]","[[""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER"", ""ACRONYMFINDER""]]","[""Hypomyelination with Atrophy of the Basal Ganglia and Cerebellum""]",[4.58136365591322e-35],[9.155753622033251e-36],"[""Health, Aging and Body Composition Study""]",[8.604904232527061e-30],"[""ACRONYMFINDER""]","[[8.604904232527061e-30, 5.318328371046634e-37, 9.070200929735953e-38, 3.5465001372309182e-50, 7.813360305780717e-41, 8.711052950353426e-32]]",[0.8439489162225866],[0.845402182992782],"[""Housing Authority of Baltimore City""]",[0.845402182992782],"[""LLM""]","[[0.7463559589693363, 0.7244704010647656, 0.7675965072021441, 0.7784030087407232, 0.818919843031948, 0.6819674028612709]]","[""Hypomyelination with Atrophy of the Basal Ganglia and Cerebellum""]","[""LLM""]",How to diagnose H-ABC (Hypomyelination with Atrophy of the Basal Ganglia and Cerebellum) ?,[false],[true],[true],"[""Diagnosis of H-ABC (Health, Aging and Body Composition Study) is typically done through genetic testing to identify mutations in the TUBB4A gene.""]","[""Diagnosis of Hypomyelination with atrophy of basal ganglia and cerebellum can be made through brain imaging techniques such as MRI, which can reveal characteristic findings of hypomyelination along with atrophy of the basal ganglia and cerebellum.""]","[""Diagnosing H-ABC typically involves a combination of physical examination, genetic testing, and imaging studies such as MRI of the brain and spine.""]",[false],[true],[true],"[""H-ABC can be diagnosed through genetic testing to identify mutations in the TUBB4A gene, which is associated with the condition.""]","[""Hypomyelination with atrophy of basal ganglia and cerebellum can be diagnosed through a combination of clinical evaluation, brain imaging (MRI), genetic testing, and nerve conduction studies.""]","[""Diagnosing H-ABC typically involves a combination of clinical evaluation, genetic testing, and imaging studies such as MRI of the brain.""]",[true],[true],[true],"[""H-ABC can be diagnosed through genetic testing to identify mutations in the TUBB4A gene, which is associated with the condition. Additionally, MRI scans can show characteristic changes in the brain that are indicative of H-ABC.""]","[""Hypomyelination with atrophy of basal ganglia and cerebellum can be diagnosed through a combination of clinical evaluation, brain imaging (such as MRI), genetic testing, and nerve conduction studies.""]","[""Diagnosing H-ABC typically involves a combination of physical examination, genetic testing, MRI scans, and neurological assessments.""]",[true],[true],[true],"[""Diagnosing H-ABC involves genetic testing to identify mutations in the TUBB4A gene, MRI scans to detect characteristic brain abnormalities, and neurological examinations to assess symptoms and progression of the disease.""]","[""Hypomyelination with atrophy of basal ganglia and cerebellum can be diagnosed through a combination of clinical evaluation, brain imaging (MRI), genetic testing, and nerve conduction studies.""]","[""Diagnosing H-ABC typically involves a combination of physical examination, imaging tests (such as MRI), genetic testing, and neurological evaluation.""]",[false],[true],[true],"[""Diagnosing H-ABC (Hypomyelination with Atrophy of Basal Ganglia and Cerebellum) typically involves genetic testing to identify mutations in the TUBB4A gene.""]","[""Diagnosis of Hypomyelination with atrophy of basal ganglia and cerebellum can be made through brain imaging techniques such as MRI, which can reveal characteristic findings of hypomyelination along with atrophy of the basal ganglia and cerebellum.""]","[""Diagnosing H-ABC typically involves a combination of physical examination, genetic testing, and imaging studies such as MRI of the brain and spine.""]",[false],[true],[true],"[""Diagnosing H-ABC typically involves genetic testing to identify mutations in the TUBB4A gene.""]","[""Hypomyelination with atrophy of basal ganglia and cerebellum can be diagnosed through a combination of clinical evaluation, brain imaging (MRI), genetic testing, and nerve conduction studies.""]","[""Diagnosing H-ABC typically involves a combination of clinical evaluation, genetic testing, and imaging studies such as MRI of the brain.""]",[false],[true],[true],"[""Diagnosis of H-ABC (Hypomyelination with Atrophy of Basal Ganglia and Cerebellum) is typically done through genetic testing to identify mutations in the TUBB4A gene.""]","[""Hypomyelination with atrophy of basal ganglia and cerebellum can be diagnosed through a combination of clinical evaluation, brain imaging (such as MRI), genetic testing, and nerve conduction studies.""]","[""Diagnosing H-ABC typically involves a combination of physical examination, genetic testing, MRI scans, and neurological assessments.""]",[false],[true],[true],"[""Diagnosis of H-ABC (Hypomyelination with atrophy of the basal ganglia and cerebellum) is typically done through genetic testing to identify mutations in the TUBB4A gene.""]","[""Hypomyelination with atrophy of basal ganglia and cerebellum can be diagnosed through a combination of clinical evaluation, brain imaging (MRI), genetic testing, and nerve conduction studies.""]","[""Diagnosing H-ABC typically involves a combination of physical examination, imaging tests (such as MRI), genetic testing, and neurological evaluation.""]",[true],[true],[true],"[""Diagnosis of H-ABC involves genetic testing to identify mutations in the TUBB4A gene, brain imaging such as MRI to detect characteristic changes in the brain, and clinical evaluation of symptoms and neurological examination.""]","[""Hypomyelination with atrophy of basal ganglia and cerebellum can be diagnosed through a combination of clinical evaluation, brain imaging (MRI), genetic testing, and nerve conduction studies.""]","[""Diagnosing H-ABC typically involves a combination of clinical evaluation, genetic testing, and imaging studies such as MRI of the brain.""]",[true],[true],[true],"[""Diagnosis of H-ABC involves genetic testing to identify mutations in the TUBB4A gene, brain imaging such as MRI to detect characteristic changes in the brain, and clinical evaluation of symptoms and neurological findings.""]","[""Diagnosis of Hypomyelination with atrophy of basal ganglia and cerebellum can be made through brain imaging techniques such as MRI, which can reveal characteristic findings of hypomyelination along with atrophy of the basal ganglia and cerebellum.""]","[""Diagnosing H-ABC typically involves a combination of physical examination, genetic testing, and imaging studies such as MRI of the brain and spine.""]",[true],[true],[true],"[""Diagnosing H-ABC typically involves a combination of clinical evaluation, brain imaging (MRI), genetic testing, and neurological examination by a specialist.""]","[""Hypomyelination with atrophy of basal ganglia and cerebellum can be diagnosed through a combination of clinical evaluation, brain imaging (such as MRI), genetic testing, and nerve conduction studies.""]","[""Diagnosing H-ABC typically involves a combination of physical examination, genetic testing, MRI scans, and neurological assessments.""]",[true],[true],[true],"[""Diagnosis of H-ABC is typically confirmed through genetic testing to identify mutations in the TUBB4A gene. MRI imaging may also show characteristic features such as hypomyelination and atrophy of the basal ganglia and cerebellum.""]","[""Hypomyelination with atrophy of basal ganglia and cerebellum can be diagnosed through a combination of clinical evaluation, brain imaging (MRI), genetic testing, and nerve conduction studies.""]","[""Diagnosing H-ABC typically involves a combination of physical examination, imaging tests (such as MRI), genetic testing, and neurological evaluation.""]",[false],[true],[true],"[""Diagnosis of H-ABC is typically confirmed through genetic testing to identify mutations in the TUBB4A gene.""]","[""Diagnosis of Hypomyelination with atrophy of basal ganglia and cerebellum can be made through brain imaging techniques such as MRI, which can reveal characteristic findings of hypomyelination along with atrophy of the basal ganglia and cerebellum.""]","[""Diagnosing H-ABC typically involves a combination of physical examination, genetic testing, and imaging studies such as MRI of the brain and spine.""]",[false],[true],[true],"[""Diagnosis of H-ABC is typically confirmed through genetic testing to identify mutations in the TUBB4A gene.""]","[""Hypomyelination with atrophy of basal ganglia and cerebellum can be diagnosed through a combination of clinical evaluation, brain imaging (MRI), genetic testing, and nerve conduction studies.""]","[""Diagnosing H-ABC typically involves a combination of clinical evaluation, genetic testing, and imaging studies such as MRI of the brain.""]",[true],[true],[true],"[""Diagnosis of H-ABC is typically based on clinical evaluation, brain imaging (MRI), and genetic testing to identify mutations in the TUBB4A gene.""]","[""Hypomyelination with atrophy of basal ganglia and cerebellum can be diagnosed through a combination of clinical evaluation, brain imaging (such as MRI), genetic testing, and nerve conduction studies.""]","[""Diagnosing H-ABC typically involves a combination of physical examination, genetic testing, MRI scans, and neurological assessments.""]",[false],[true],[true],"[""Diagnosis of H-ABC is typically confirmed through genetic testing to identify mutations in the TUBB4A gene.""]","[""Hypomyelination with atrophy of basal ganglia and cerebellum can be diagnosed through a combination of clinical evaluation, brain imaging (MRI), genetic testing, and nerve conduction studies.""]","[""Diagnosing H-ABC typically involves a combination of physical examination, imaging tests (such as MRI), genetic testing, and neurological evaluation.""]",[true],[true],[true],"[""Diagnosing H-ABC involves a combination of clinical evaluation, brain imaging (MRI), genetic testing, and sometimes a muscle or nerve biopsy.""]","[""Diagnosis of Hypomyelination with atrophy of basal ganglia and cerebellum can be made through brain imaging techniques such as MRI, which can reveal characteristic findings of hypomyelination along with atrophy of the basal ganglia and cerebellum.""]","[""Diagnosing H-ABC typically involves a combination of physical examination, genetic testing, and imaging studies such as MRI of the brain and spine.""]",[true],[true],[true],"[""Diagnosis of H-ABC is typically done through a combination of MRI imaging, genetic testing, and clinical evaluation by a neurologist.""]","[""Hypomyelination with atrophy of basal ganglia and cerebellum can be diagnosed through a combination of clinical evaluation, brain imaging (MRI), genetic testing, and nerve conduction studies.""]","[""Diagnosing H-ABC typically involves a combination of clinical evaluation, genetic testing, and imaging studies such as MRI of the brain.""]",[true],[true],[true],"[""Diagnosis of H-ABC involves genetic testing to identify mutations in the TUBB4A gene, brain imaging such as MRI to assess the characteristic changes in the brain, and clinical evaluation of symptoms and neurological findings.""]","[""Hypomyelination with atrophy of basal ganglia and cerebellum can be diagnosed through a combination of clinical evaluation, brain imaging (such as MRI), genetic testing, and nerve conduction studies.""]","[""Diagnosing H-ABC typically involves a combination of physical examination, genetic testing, MRI scans, and neurological assessments.""]",[true],[true],[true],"[""Diagnosis of H-ABC involves genetic testing to identify mutations in the TUBB4A gene, brain imaging such as MRI to detect characteristic changes in the brain, and clinical evaluation of symptoms and neurological examination.""]","[""Hypomyelination with atrophy of basal ganglia and cerebellum can be diagnosed through a combination of clinical evaluation, brain imaging (MRI), genetic testing, and nerve conduction studies.""]","[""Diagnosing H-ABC typically involves a combination of physical examination, imaging tests (such as MRI), genetic testing, and neurological evaluation.""]",[true],[true],[true],"[""Diagnosing H-ABC typically involves a combination of clinical evaluation, brain imaging (MRI), genetic testing, and neurological examination.""]","[""Diagnosis of Hypomyelination with atrophy of basal ganglia and cerebellum can be made through brain imaging techniques such as MRI, which can reveal characteristic findings of hypomyelination along with atrophy of the basal ganglia and cerebellum.""]","[""Diagnosing H-ABC typically involves a combination of physical examination, genetic testing, and imaging studies such as MRI of the brain and spine.""]",[true],[true],[true],"[""Diagnosis of H-ABC is typically done through a combination of clinical evaluation, brain imaging (MRI), genetic testing, and neurological examination.""]","[""Hypomyelination with atrophy of basal ganglia and cerebellum can be diagnosed through a combination of clinical evaluation, brain imaging (MRI), genetic testing, and nerve conduction studies.""]","[""Diagnosing H-ABC typically involves a combination of clinical evaluation, genetic testing, and imaging studies such as MRI of the brain.""]",[true],[true],[true],"[""Diagnosis of H-ABC is typically done through a combination of MRI imaging, genetic testing, and clinical evaluation by a neurologist.""]","[""Hypomyelination with atrophy of basal ganglia and cerebellum can be diagnosed through a combination of clinical evaluation, brain imaging (such as MRI), genetic testing, and nerve conduction studies.""]","[""Diagnosing H-ABC typically involves a combination of physical examination, genetic testing, MRI scans, and neurological assessments.""]",[true],[true],[true],"[""Diagnosis of H-ABC is typically done through a combination of clinical evaluation, brain imaging (MRI), genetic testing, and neurological examination.""]","[""Hypomyelination with atrophy of basal ganglia and cerebellum can be diagnosed through a combination of clinical evaluation, brain imaging (MRI), genetic testing, and nerve conduction studies.""]","[""Diagnosing H-ABC typically involves a combination of physical examination, imaging tests (such as MRI), genetic testing, and neurological evaluation.""]",[true],[true],[true],"[""Diagnosing H-ABC involves a combination of clinical evaluation, brain imaging (MRI), genetic testing, and sometimes a muscle or nerve biopsy.""]","[""Diagnosis of Hypomyelination with atrophy of basal ganglia and cerebellum can be made through brain imaging techniques such as MRI, which can reveal characteristic findings of hypomyelination along with atrophy of the basal ganglia and cerebellum.""]","[""Diagnosing H-ABC typically involves a combination of physical examination, genetic testing, and imaging studies such as MRI of the brain and spine.""]",[true],[true],[true],"[""Diagnosing H-ABC involves a combination of clinical evaluation, brain imaging (MRI), genetic testing, and neurological examinations. A neurologist or genetic counselor can help coordinate these tests and interpret the results.""]","[""Hypomyelination with atrophy of basal ganglia and cerebellum can be diagnosed through a combination of clinical evaluation, brain imaging (MRI), genetic testing, and nerve conduction studies.""]","[""Diagnosing H-ABC typically involves a combination of clinical evaluation, genetic testing, and imaging studies such as MRI of the brain.""]",[true],[true],[true],"[""Diagnosing H-ABC involves a combination of clinical evaluation, brain imaging (MRI), genetic testing, and possibly other tests such as blood tests and nerve conduction studies.""]","[""Hypomyelination with atrophy of basal ganglia and cerebellum can be diagnosed through a combination of clinical evaluation, brain imaging (such as MRI), genetic testing, and nerve conduction studies.""]","[""Diagnosing H-ABC typically involves a combination of physical examination, genetic testing, MRI scans, and neurological assessments.""]",[true],[true],[true],"[""Diagnosing H-ABC involves genetic testing to identify mutations in the TUBB4A gene, brain imaging such as MRI to detect characteristic abnormalities in the basal ganglia and cerebellum, and clinical evaluation of symptoms and neurological findings.""]","[""Hypomyelination with atrophy of basal ganglia and cerebellum can be diagnosed through a combination of clinical evaluation, brain imaging (MRI), genetic testing, and nerve conduction studies.""]","[""Diagnosing H-ABC typically involves a combination of physical examination, imaging tests (such as MRI), genetic testing, and neurological evaluation.""]",[true],[true],[true],"[""Diagnosing H-ABC involves genetic testing to identify mutations in the TUBB4A gene, MRI scans to detect characteristic brain abnormalities, and neurological examinations to assess symptoms and motor function.""]","[""Diagnosis of Hypomyelination with atrophy of basal ganglia and cerebellum can be made through brain imaging techniques such as MRI, which can reveal characteristic findings of hypomyelination along with atrophy of the basal ganglia and cerebellum.""]","[""Diagnosing H-ABC typically involves a combination of physical examination, genetic testing, and imaging studies such as MRI of the brain and spine.""]",[true],[true],[true],"[""Diagnosing H-ABC involves genetic testing to identify mutations in the TUBB4A gene, MRI scans to assess brain abnormalities, and neurological evaluations to monitor symptoms and progression.""]","[""Diagnosis of Hypomyelination with atrophy of basal ganglia and cerebellum can be made through brain imaging techniques such as MRI, which can reveal characteristic findings of hypomyelination along with atrophy of the basal ganglia and cerebellum.""]","[""Diagnosing H-ABC typically involves a combination of physical examination, genetic testing, and imaging studies such as MRI of the brain and spine.""]",[false],[true],[true],"[""Diagnosing H-ABC involves genetic testing to identify mutations in the TUBB4A gene.""]","[""Diagnosis of Hypomyelination with atrophy of basal ganglia and cerebellum can be made through brain imaging techniques such as MRI, which can reveal characteristic findings of hypomyelination along with atrophy of the basal ganglia and cerebellum.""]","[""Diagnosing H-ABC typically involves a combination of physical examination, genetic testing, and imaging studies such as MRI of the brain and spine.""]",[true],[true],[true],"[""Diagnosing H-ABC typically involves a combination of clinical evaluation, brain imaging (MRI), genetic testing, and sometimes a muscle or nerve biopsy.""]","[""Diagnosis of Hypomyelination with atrophy of basal ganglia and cerebellum can be made through brain imaging techniques such as MRI, which can reveal characteristic findings of hypomyelination along with atrophy of the basal ganglia and cerebellum.""]","[""Diagnosing H-ABC typically involves a combination of physical examination, genetic testing, and imaging studies such as MRI of the brain and spine.""]"
outlook,What is the outlook for Klippel-Trenaunay Syndrome?,"KTS is often a progressive disorder, and complications may be life-threatening. However, many individuals can live well while managing their symptoms.","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""KTS"", ""full_form"": ""Klippel-Trenaunay Syndrome""}]}",What is the outlook for KTS?,What is the outlook for Klippel-Trenaunay Syndrome?,3,BUSINESS,Simple Datatype-String,"Exploratory(Divergent Thinking): Queries that are inherently about seeking new areas of knowledge, understanding emerging trends, or identifying unknown opportunities without a specific end goal of making a decision or judgment. Exploratory queries are characterized by their openness and the lack of a predefined objective, differentiating them from evaluative queries which are directed towards forming a judgment or assessment. Exploratory queries encourage branching out into various directions to explore a wide array of possibilities without necessarily aiming to converge on a single answer or outcome.","[[""Knots"", ""Karnali Technical School"", ""Brevig Mission, Alaska USA"", ""Southern Company CORTS Trust Capital Trust I"", ""Killing Them Softly"", ""Keys To Success"", ""Know Thy Self"", ""Kampala Trauma Score"", ""Katherine Thomas School"", ""Know the Score""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Key Technical Solutions""]",[2.057827310863981e-26],[2.3214804537163827e-13],"[""Knots""]",[1.0111836324598058e-06],"[""ABBREVIATIONS""]","[[1.0111836324598058e-06, 5.3221191655106734e-18, 5.3828396849535735e-31, 1.9926043487812525e-34, 1.1340337890616596e-13, 1.4792051603068643e-11, 5.653614807099285e-12, 3.4468079181433817e-19, 1.6681308388630722e-22, 5.902508503530286e-10]]",[0.8001809592970913],[0.7375368645662845],"[""Klippel-Trenaunay Syndrome""]",[0.8863547717391881],"[""ABBREVIATIONS""]","[[0.8863547717391881, 0.669738545869158, 0.785061015082543, 0.5947208165359541, 0.7100935626738392, 0.7956977019578434, 0.7457578914302765, 0.6904824600040758, 0.7314744848323367, 0.780471052876808]]","[""Key Technical Solutions""]","[""LLM""]",What is the outlook for KTS (Key Technical Solutions)?,[false],[true],[false],"[""The outlook for KTS (Knots) is positive due to the increasing demand for maritime transportation services.""]","[""The outlook for Klippel-Trenaunay Syndrome varies depending on the individual case, but early diagnosis and appropriate management can help improve quality of life and reduce complications.""]","[""The outlook for KTS is positive based on current market trends and growth projections.""]",[false],[true],[false],"[""The outlook for KTS (Knots) is positive, with potential growth opportunities in the near future.""]","[""The outlook for Klippel-Trenaunay Syndrome varies depending on the individual case and may include managing symptoms, monitoring for complications, and seeking appropriate medical care.""]","[""The outlook for KTS is positive, with potential for growth in the upcoming quarters.""]",[false],[true],[false],"[""The outlook for KTS (Knots) is positive due to the increasing demand for maritime transportation services.""]","[""The outlook for Klippel-Trenaunay Syndrome can vary depending on the individual case, with some patients experiencing mild symptoms while others may face more severe complications. It is important for patients to work closely with healthcare providers to manage symptoms and monitor any potential complications.""]","[""The outlook for KTS is positive, with potential for growth in the upcoming quarters.""]",[false],[true],[false],"[""The outlook for KTS (Knots) is positive, with a growing market demand for their services and potential expansion opportunities in the industry.""]","[""The outlook for Klippel-Trenaunay Syndrome varies depending on the individual case, but early diagnosis and appropriate management can help improve quality of life and reduce complications.""]","[""The outlook for KTS is positive based on current market trends and growth projections.""]",[true],[true],[false],"[""The outlook for Klippel-Trenaunay Syndrome (KTS) varies depending on the individual case. It is a rare congenital vascular disorder, and the prognosis can range from mild to severe. Regular monitoring and management by healthcare professionals specializing in vascular anomalies are essential for improving quality of life and addressing potential complications.""]","[""The outlook for Klippel-Trenaunay Syndrome varies depending on the individual case, but early diagnosis and appropriate management can help improve quality of life and reduce complications.""]","[""The outlook for KTS is positive based on current market trends and growth projections.""]",[true],[true],[false],"[""The outlook for Klippel-Trenaunay Syndrome varies depending on the individual case, but early diagnosis and appropriate management can help improve quality of life and reduce complications.""]","[""The outlook for Klippel-Trenaunay Syndrome varies depending on the individual case and may include managing symptoms, monitoring for complications, and seeking appropriate medical care.""]","[""The outlook for KTS is positive, with potential for growth in the upcoming quarters.""]",[true],[true],[false],"[""The outlook for KTS (Klippel-Trenaunay Syndrome) varies depending on the individual case, but early diagnosis and appropriate management can help improve quality of life and reduce complications.""]","[""The outlook for Klippel-Trenaunay Syndrome can vary depending on the individual case, with some patients experiencing mild symptoms while others may face more severe complications. It is important for patients to work closely with healthcare providers to manage symptoms and monitor any potential complications.""]","[""The outlook for KTS is positive, with potential for growth in the upcoming quarters.""]",[true],[true],[false],"[""The outlook for Klippel-Trenaunay Syndrome (KTS) varies depending on the individual case, but it generally involves managing symptoms and complications through a multidisciplinary approach involving specialists such as vascular surgeons, dermatologists, and other healthcare providers.""]","[""The outlook for Klippel-Trenaunay Syndrome varies depending on the individual case, but early diagnosis and appropriate management can help improve quality of life and reduce complications.""]","[""The outlook for KTS is positive based on current market trends and growth projections.""]",[false],[true],[false],"[""The outlook for KTS (Key Technical Solutions) is positive, with a growing market demand for their services and innovative solutions.""]","[""The outlook for Klippel-Trenaunay Syndrome varies depending on the individual case and may include managing symptoms, monitoring for complications, and seeking appropriate medical care.""]","[""The outlook for KTS is positive, with potential for growth in the upcoming quarters.""]",[false],[true],[false],"[""The outlook for KTS (Key Technical Solutions) is positive with a growing market demand for their services and innovative solutions.""]","[""The outlook for Klippel-Trenaunay Syndrome varies depending on the individual case, but early diagnosis and appropriate management can help improve quality of life and reduce complications.""]","[""The outlook for KTS is positive based on current market trends and growth projections.""]",[false],[true],[false],"[""The outlook for KTS (Key Technical Solutions) is positive, with a growing market demand for their services and innovative solutions.""]","[""The outlook for Klippel-Trenaunay Syndrome can vary depending on the individual case, with some patients experiencing mild symptoms while others may face more severe complications. It is important for patients to work closely with healthcare providers to manage symptoms and monitor any potential complications.""]","[""The outlook for KTS is positive, with potential for growth in the upcoming quarters.""]",[false],[true],[false],"[""The outlook for KTS (Key Technical Solutions) is positive, with a growing market demand for their services and innovative solutions.""]","[""The outlook for Klippel-Trenaunay Syndrome varies depending on the individual case, but early diagnosis and appropriate management can help improve quality of life and reduce complications.""]","[""The outlook for KTS is positive based on current market trends and growth projections.""]",[false],[true],[false],"[""The outlook for KTS (Key Technical Solutions) is positive.""]","[""The outlook for Klippel-Trenaunay Syndrome varies depending on the individual case, but early diagnosis and appropriate management can help improve quality of life and reduce complications.""]","[""The outlook for KTS is positive based on current market trends and growth projections.""]",[false],[true],[false],"[""The outlook for KTS (Key Technical Solutions) is positive.""]","[""The outlook for Klippel-Trenaunay Syndrome varies depending on the individual case and may include managing symptoms, monitoring for complications, and seeking appropriate medical care.""]","[""The outlook for KTS is positive, with potential for growth in the upcoming quarters.""]",[false],[true],[false],"[""The outlook for KTS (Key Technical Solutions) is positive.""]","[""The outlook for Klippel-Trenaunay Syndrome can vary depending on the individual case, with some patients experiencing mild symptoms while others may face more severe complications. It is important for patients to work closely with healthcare providers to manage symptoms and monitor any potential complications.""]","[""The outlook for KTS is positive, with potential for growth in the upcoming quarters.""]",[false],[true],[false],"[""The outlook for KTS (Key Technical Solutions) is positive.""]","[""The outlook for Klippel-Trenaunay Syndrome varies depending on the individual case, but early diagnosis and appropriate management can help improve quality of life and reduce complications.""]","[""The outlook for KTS is positive based on current market trends and growth projections.""]",[false],[true],[false],"[""The outlook for KTS (Key Technical Solutions) is positive, showing growth potential in the coming years.""]","[""The outlook for Klippel-Trenaunay Syndrome varies depending on the individual case, but early diagnosis and appropriate management can help improve quality of life and reduce complications.""]","[""The outlook for KTS is positive based on current market trends and growth projections.""]",[false],[true],[false],"[""The outlook for KTS (Key Technical Solutions) is positive, with a growing market demand for their services and a strong track record of innovation and customer satisfaction.""]","[""The outlook for Klippel-Trenaunay Syndrome varies depending on the individual case and may include managing symptoms, monitoring for complications, and seeking appropriate medical care.""]","[""The outlook for KTS is positive, with potential for growth in the upcoming quarters.""]",[false],[true],[false],"[""The outlook for KTS (Key Technical Solutions) is positive, with a growing market demand for their services and innovative solutions.""]","[""The outlook for Klippel-Trenaunay Syndrome can vary depending on the individual case, with some patients experiencing mild symptoms while others may face more severe complications. It is important for patients to work closely with healthcare providers to manage symptoms and monitor any potential complications.""]","[""The outlook for KTS is positive, with potential for growth in the upcoming quarters.""]",[false],[true],[false],"[""The outlook for KTS (Key Technical Solutions) is positive, with a growing market demand for their services and innovative solutions.""]","[""The outlook for Klippel-Trenaunay Syndrome varies depending on the individual case, but early diagnosis and appropriate management can help improve quality of life and reduce complications.""]","[""The outlook for KTS is positive based on current market trends and growth projections.""]",[false],[true],[false],"[""The outlook for KTS (Key Technical Solutions) is positive, with a growing market demand for their services and a strong track record of innovation and customer satisfaction.""]","[""The outlook for Klippel-Trenaunay Syndrome varies depending on the individual case, but early diagnosis and appropriate management can help improve quality of life and reduce complications.""]","[""The outlook for KTS is positive based on current market trends and growth projections.""]",[false],[true],[false],"[""The outlook for KTS (Key Technical Solutions) is positive, with a growing market demand for their services and innovative solutions.""]","[""The outlook for Klippel-Trenaunay Syndrome varies depending on the individual case and may include managing symptoms, monitoring for complications, and seeking appropriate medical care.""]","[""The outlook for KTS is positive, with potential for growth in the upcoming quarters.""]",[false],[true],[false],"[""The outlook for KTS (Key Technical Solutions) is positive, with a growing market demand for their services and innovative solutions.""]","[""The outlook for Klippel-Trenaunay Syndrome can vary depending on the individual case, with some patients experiencing mild symptoms while others may face more severe complications. It is important for patients to work closely with healthcare providers to manage symptoms and monitor any potential complications.""]","[""The outlook for KTS is positive, with potential for growth in the upcoming quarters.""]",[false],[true],[false],"[""The outlook for KTS (Key Technical Solutions) is positive, with a focus on expanding into new markets and developing innovative solutions.""]","[""The outlook for Klippel-Trenaunay Syndrome varies depending on the individual case, but early diagnosis and appropriate management can help improve quality of life and reduce complications.""]","[""The outlook for KTS is positive based on current market trends and growth projections.""]",[false],[true],[false],"[""The outlook for KTS (Key Technical Solutions) is positive, with a focus on innovation and growth in emerging technologies.""]","[""The outlook for Klippel-Trenaunay Syndrome varies depending on the individual case, but early diagnosis and appropriate management can help improve quality of life and reduce complications.""]","[""The outlook for KTS is positive based on current market trends and growth projections.""]",[false],[true],[false],"[""The outlook for KTS (Key Technical Solutions) is positive, with a growing market demand for their services and a strong track record of innovation in the industry.""]","[""The outlook for Klippel-Trenaunay Syndrome varies depending on the individual case and may include managing symptoms, monitoring for complications, and seeking appropriate medical care.""]","[""The outlook for KTS is positive, with potential for growth in the upcoming quarters.""]",[false],[true],[false],"[""The outlook for KTS (Key Technical Solutions) is positive, with a focus on expanding their market presence and enhancing their technological capabilities.""]","[""The outlook for Klippel-Trenaunay Syndrome can vary depending on the individual case, with some patients experiencing mild symptoms while others may face more severe complications. It is important for patients to work closely with healthcare providers to manage symptoms and monitor any potential complications.""]","[""The outlook for KTS is positive, with potential for growth in the upcoming quarters.""]",[false],[true],[false],"[""The outlook for KTS (Key Technical Solutions) is positive, with a focus on expanding their market presence and developing innovative solutions in the tech industry.""]","[""The outlook for Klippel-Trenaunay Syndrome varies depending on the individual case, but early diagnosis and appropriate management can help improve quality of life and reduce complications.""]","[""The outlook for KTS is positive based on current market trends and growth projections.""]",[false],[true],[false],"[""The outlook for KTS is positive.""]","[""The outlook for Klippel-Trenaunay Syndrome varies depending on the individual case, but early diagnosis and appropriate management can help improve quality of life and reduce complications.""]","[""The outlook for KTS is positive based on current market trends and growth projections.""]",[false],[true],[false],"[""The outlook for KTS (Knots) is positive.""]","[""The outlook for Klippel-Trenaunay Syndrome varies depending on the individual case, but early diagnosis and appropriate management can help improve quality of life and reduce complications.""]","[""The outlook for KTS is positive based on current market trends and growth projections.""]",[true],[true],[false],"[""The outlook for Klippel-Trenaunay Syndrome varies depending on the individual case, but with proper management and treatment, many people with KTS can lead normal lives.""]","[""The outlook for Klippel-Trenaunay Syndrome varies depending on the individual case, but early diagnosis and appropriate management can help improve quality of life and reduce complications.""]","[""The outlook for KTS is positive based on current market trends and growth projections.""]",[false],[true],[false],"[""The outlook for KTS (Key Technical Solutions) is positive.""]","[""The outlook for Klippel-Trenaunay Syndrome varies depending on the individual case, but early diagnosis and appropriate management can help improve quality of life and reduce complications.""]","[""The outlook for KTS is positive based on current market trends and growth projections.""]"
prevention,how can patients prevent the spread of vancomycin-resistant enterococci?,"On this Page General Information What is vancomycin-resistant enterococci? What types of infections does vancomycin-resistant enterococci cause? Are certain people at risk of getting vancomycin-resistant enterococci? What is the treatment for vancomycin-resistant enterococci? How is vancomycin-resistant enterococci spread? How can patients prevent the spread of vancomycin-resistant enterococci? What should a patient do if they think they have vancomycin-resistant enterococci? Recommendations and Guidelines General Information For more images of this bacterium, search the Public Health Image Library What is vancomycin-resistant enterococci? Enteroccocci are bacteria that are normally present in the human intestines and in the female genital tract and are often found in the environment. These bacteria can sometimes cause infections. Vancomycin is an antibiotic that is used to treat some drug-resistant infections caused by enterococci. In some instances, enterococci have become resistant to this drug and thus are called vancomycin-resistant enterococci (VRE). Most VRE infections occur in hospitals. Top of page What types of infections does VRE cause? VRE can live in the human intestines and female genital tract without causing disease (often called colonization). However, sometimes it can cause infections of the urinary tract, the bloodstream, or of wounds associated with catheters or surgical procedures. Top of page Are certain people at risk of getting VRE? The following persons are at increased risk becoming infected with VRE: People who have been previously treated with the antibiotic vancomycin or other antibiotics for long periods of time. People who are hospitalized, particularly when they receive antibiotic treatment for long periods of time. People with weakened immune systems such as patients in intensive care units, or in cancer or transplant wards. People who have undergone surgical procedures such as abdominal or chest surgery. People with medical devices that stay in for some time such as urinary catheters or central intravenous (IV) catheters. People who are colonized with VRE. Top of page What is the treatment for VRE? People with colonized VRE (bacteria are present, but have no symptoms of an infection)  do not need treatment. Most VRE infections can be treated with antibiotics other than vancomycin. Laboratory testing of the VRE can determine which antibiotics will work. For people who get VRE infections in their bladder and have urinary catheters, removal of the catheter when it is no longer needed can also help get rid of the infection. Top of page How is VRE spread? VRE is often passed from person to person by the contaminated hands of caregivers. VRE can get onto a caregiver's hands after they have contact with other people with VRE or after contact with contaminated surfaces. VRE can also be spread directly to people after they touch surfaces that are contaminated with VRE. VRE is not spread through the air by coughing or sneezing. Top of page How can patients prevent the spread of VRE? If a patient or someone in their household has VRE, the following are some things they can do to prevent the spread of VRE: Keep their hands clean. Always wash their hands thoroughly after using the bathroom and before preparing food. Clean their hands after contact with persons who have VRE. Wash with soap and water (particularly when visibly soiled) or use alcohol-based hand rubs. Frequently clean areas of the home, such as bathrooms, that may become contaminated with VRE. Wear gloves if hands may come in contact with body fluids that may contain VRE, such as stool or bandages from infected wounds. Always wash their hands after removing gloves. If someone has VRE, be sure to tell healthcare providers so that they are aware of the infection. Healthcare facilities use special precautions to help prevent the spread of VRE to others. Top of page What should patients do if they think they have vancomycin-resistant enterococci (VRE)? Anyone who thinks they have VRE must talk with their healthcare provider. Top of page Recommendations and Guidelines For more information about prevention and treatment of HAIs, see the resources below: Siegel JD, Rhinehart E, Jackson M, et al. The Healthcare Infection Control Practices Advisory Committee (HICPAC). Management of Multidrug-Resistant Organisms In Healthcare Settings, 2006","{""full_form_abbrv_map"": [{""ambiguity_type"": ""full_form"", ""abbreviation"": ""VRE"", ""full_form"": ""vancomycin-resistant enterococci""}]}",how can patients prevent the spread of VRE?,how can patients prevent the spread of vancomycin-resistant enterococci?,8,MEDICAL,Compound Datatype-String,"Instructional: Queries specifically seeking step-by-step guidance, instructions, or procedures to perform a task. it focuses on 'how' to do something rather than 'what', 'why', or 'which'.","[[""Vocational Rehabilitation & Employment"", ""Vancomycin-Resistant Enterococcus"", ""Virginia Railway Express"", ""Virtual Reality Exposure"", ""Virtual Radiology Environment"", ""Voltage Regulator Enhanced"", ""Vredendal, South Africa"", ""Variable Resolution Encoder"", ""Video Rack Enclosure"", ""Vancomycin Resistant Enterococci""]]","[[""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS"", ""ABBREVIATIONS""]]","[""Vancomycin-Resistant Enterococci""]",[7.785752997689466e-13],[7.785752997689466e-13],"[""Vancomycin Resistant Enterococci""]",[1.6373731490764767e-11],"[""ABBREVIATIONS""]","[[8.645383757969233e-17, 6.2416410410320946e-12, 6.886803669897372e-25, 1.0744377097549182e-12, 2.721356970336154e-13, 6.578276094805272e-19, 8.194518908190568e-24, 4.972638183870542e-18, 2.059731586129114e-22, 1.6373731490764767e-11]]",[0.9605020265699759],[0.9656225478918231],"[""Vancomycin Resistant Enterococci""]",[0.9656225478918231],"[""LLM""]","[[0.9019405329008724, 0.9653186864705944, 0.9205242308415975, 0.8787080915377454, 0.905563913633348, 0.9193918115282895, 0.8886706352529092, 0.934274726740172, 0.898166445982932, 0.9634315348988809]]","[""Vancomycin-Resistant Enterococcus""]","[""ABBREVIATIONS""]",how can patients prevent the spread of VRE (Vancomycin-Resistant Enterococci)?,[true],[true],[true],"[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]","[""Patients can prevent the spread of vancomycin-resistant enterococci by practicing good hand hygiene, following infection control measures, taking antibiotics only as prescribed, and informing healthcare providers about any history of antibiotic-resistant infections.""]","[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]",[true],[true],[true],"[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by a healthcare provider.""]","[""Patients can prevent the spread of vancomycin-resistant enterococci by practicing good hand hygiene, following infection control measures, taking antibiotics only as prescribed by a healthcare provider, and informing healthcare providers about any history of antibiotic-resistant infections.""]","[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]",[true],[true],[true],"[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by healthcare providers.""]","[""Patients can prevent the spread of vancomycin-resistant enterococci by practicing good hand hygiene, following infection control measures, taking antibiotics only as prescribed, and informing healthcare providers about any history of antibiotic-resistant infections.""]","[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]",[true],[true],[true],"[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by a healthcare provider.""]","[""Patients can prevent the spread of vancomycin-resistant enterococci by practicing good hand hygiene, following infection control measures, taking antibiotics only as prescribed, and informing healthcare providers about any history of antibiotic-resistant infections.""]","[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]",[true],[true],[true],"[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]","[""Patients can prevent the spread of vancomycin-resistant enterococci by practicing good hand hygiene, following infection control measures, taking antibiotics only as prescribed, and informing healthcare providers about any history of antibiotic-resistant infections.""]","[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]",[true],[true],[true],"[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]","[""Patients can prevent the spread of vancomycin-resistant enterococci by practicing good hand hygiene, following infection control measures, taking antibiotics only as prescribed by a healthcare provider, and informing healthcare providers about any history of antibiotic-resistant infections.""]","[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]",[true],[true],[true],"[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]","[""Patients can prevent the spread of vancomycin-resistant enterococci by practicing good hand hygiene, following infection control measures, taking antibiotics only as prescribed, and informing healthcare providers about any history of antibiotic-resistant infections.""]","[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]",[true],[true],[true],"[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by healthcare providers.""]","[""Patients can prevent the spread of vancomycin-resistant enterococci by practicing good hand hygiene, following infection control measures, taking antibiotics only as prescribed, and informing healthcare providers about any history of antibiotic-resistant infections.""]","[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]",[true],[true],[true],"[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by healthcare providers.""]","[""Patients can prevent the spread of vancomycin-resistant enterococci by practicing good hand hygiene, following infection control measures, taking antibiotics only as prescribed by a healthcare provider, and informing healthcare providers about any history of antibiotic-resistant infections.""]","[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]",[true],[true],[true],"[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]","[""Patients can prevent the spread of vancomycin-resistant enterococci by practicing good hand hygiene, following infection control measures, taking antibiotics only as prescribed, and informing healthcare providers about any history of antibiotic-resistant infections.""]","[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]",[true],[true],[true],"[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]","[""Patients can prevent the spread of vancomycin-resistant enterococci by practicing good hand hygiene, following infection control measures, taking antibiotics only as prescribed, and informing healthcare providers about any history of antibiotic-resistant infections.""]","[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]",[true],[true],[true],"[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]","[""Patients can prevent the spread of vancomycin-resistant enterococci by practicing good hand hygiene, following infection control measures, taking antibiotics only as prescribed, and informing healthcare providers about any history of antibiotic-resistant infections.""]","[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]",[true],[true],[true],"[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]","[""Patients can prevent the spread of vancomycin-resistant enterococci by practicing good hand hygiene, following infection control measures, taking antibiotics only as prescribed, and informing healthcare providers about any history of antibiotic-resistant infections.""]","[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]",[true],[true],[true],"[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]","[""Patients can prevent the spread of vancomycin-resistant enterococci by practicing good hand hygiene, following infection control measures, taking antibiotics only as prescribed by a healthcare provider, and informing healthcare providers about any history of antibiotic-resistant infections.""]","[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]",[true],[true],[true],"[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]","[""Patients can prevent the spread of vancomycin-resistant enterococci by practicing good hand hygiene, following infection control measures, taking antibiotics only as prescribed, and informing healthcare providers about any history of antibiotic-resistant infections.""]","[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]",[true],[true],[true],"[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]","[""Patients can prevent the spread of vancomycin-resistant enterococci by practicing good hand hygiene, following infection control measures, taking antibiotics only as prescribed, and informing healthcare providers about any history of antibiotic-resistant infections.""]","[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]",[true],[true],[true],"[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by healthcare providers.""]","[""Patients can prevent the spread of vancomycin-resistant enterococci by practicing good hand hygiene, following infection control measures, taking antibiotics only as prescribed, and informing healthcare providers about any history of antibiotic-resistant infections.""]","[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]",[true],[true],[true],"[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]","[""Patients can prevent the spread of vancomycin-resistant enterococci by practicing good hand hygiene, following infection control measures, taking antibiotics only as prescribed by a healthcare provider, and informing healthcare providers about any history of antibiotic-resistant infections.""]","[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]",[true],[true],[true],"[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]","[""Patients can prevent the spread of vancomycin-resistant enterococci by practicing good hand hygiene, following infection control measures, taking antibiotics only as prescribed, and informing healthcare providers about any history of antibiotic-resistant infections.""]","[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]",[true],[true],[true],"[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]","[""Patients can prevent the spread of vancomycin-resistant enterococci by practicing good hand hygiene, following infection control measures, taking antibiotics only as prescribed, and informing healthcare providers about any history of antibiotic-resistant infections.""]","[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]",[true],[true],[true],"[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by healthcare providers.""]","[""Patients can prevent the spread of vancomycin-resistant enterococci by practicing good hand hygiene, following infection control measures, taking antibiotics only as prescribed, and informing healthcare providers about any history of antibiotic-resistant infections.""]","[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]",[true],[true],[true],"[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]","[""Patients can prevent the spread of vancomycin-resistant enterococci by practicing good hand hygiene, following infection control measures, taking antibiotics only as prescribed by a healthcare provider, and informing healthcare providers about any history of antibiotic-resistant infections.""]","[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]",[true],[true],[true],"[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]","[""Patients can prevent the spread of vancomycin-resistant enterococci by practicing good hand hygiene, following infection control measures, taking antibiotics only as prescribed, and informing healthcare providers about any history of antibiotic-resistant infections.""]","[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]",[true],[true],[true],"[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by a healthcare provider.""]","[""Patients can prevent the spread of vancomycin-resistant enterococci by practicing good hand hygiene, following infection control measures, taking antibiotics only as prescribed, and informing healthcare providers about any history of antibiotic-resistant infections.""]","[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]",[true],[true],[true],"[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, taking antibiotics only as prescribed, and informing healthcare providers about VRE history.""]","[""Patients can prevent the spread of vancomycin-resistant enterococci by practicing good hand hygiene, following infection control measures, taking antibiotics only as prescribed, and informing healthcare providers about any history of antibiotic-resistant infections.""]","[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]",[true],[true],[true],"[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by a healthcare provider.""]","[""Patients can prevent the spread of vancomycin-resistant enterococci by practicing good hand hygiene, following infection control measures, taking antibiotics only as prescribed by a healthcare provider, and informing healthcare providers about any history of antibiotic-resistant infections.""]","[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]",[true],[true],[true],"[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]","[""Patients can prevent the spread of vancomycin-resistant enterococci by practicing good hand hygiene, following infection control measures, taking antibiotics only as prescribed, and informing healthcare providers about any history of antibiotic-resistant infections.""]","[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]",[true],[true],[true],"[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]","[""Patients can prevent the spread of vancomycin-resistant enterococci by practicing good hand hygiene, following infection control measures, taking antibiotics only as prescribed, and informing healthcare providers about any history of antibiotic-resistant infections.""]","[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]",[true],[true],[true],"[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]","[""Patients can prevent the spread of vancomycin-resistant enterococci by practicing good hand hygiene, following infection control measures, taking antibiotics only as prescribed, and informing healthcare providers about any history of antibiotic-resistant infections.""]","[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]",[true],[true],[true],"[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by a healthcare provider.""]","[""Patients can prevent the spread of vancomycin-resistant enterococci by practicing good hand hygiene, following infection control measures, taking antibiotics only as prescribed, and informing healthcare providers about any history of antibiotic-resistant infections.""]","[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]",[true],[true],[true],"[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by a healthcare provider.""]","[""Patients can prevent the spread of vancomycin-resistant enterococci by practicing good hand hygiene, following infection control measures, taking antibiotics only as prescribed, and informing healthcare providers about any history of antibiotic-resistant infections.""]","[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]",[true],[true],[true],"[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]","[""Patients can prevent the spread of vancomycin-resistant enterococci by practicing good hand hygiene, following infection control measures, taking antibiotics only as prescribed, and informing healthcare providers about any history of antibiotic-resistant infections.""]","[""Patients can prevent the spread of VRE by practicing good hand hygiene, following infection control measures, and taking antibiotics only as prescribed by their healthcare provider.""]"
